PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Arao, Y; Hamilton, KJ; Grimm, SA; Korach, KS				Arao, Yukitomo; Hamilton, Katherine J.; Grimm, Sara A.; Korach, Kenneth S.			The genomic regulatory elements for estrogen receptor alpha transactivation-function-1 regulated genes	FASEB JOURNAL			English	Article						estrogen receptor alpha; estrogen-responsive element; SERM; tamoxifen; transactivation domain	ACTIVATION; PHOSPHORYLATION; BINDING; AF-2; IDENTIFICATION; ANTIESTROGEN; SYNERGISM; CONTAINS; DOMAINS	Estrogen receptor alpha (ER alpha) is a ligand-dependent transcription regulator, containing two transactivation functional domains, AF-1 and AF-2. The selective estrogen receptor modulators (SERMs), including 4-hydroxytamoxifen (4OHT), activate AF-1 preferentially rather than AF-2. However, it is unclear whether this specific function is related to the tissue-selective functionality of SERMs. Moreover, there is no information determining AF-1-dependent estrogenic-genes existing in tissues. We sought to identify AF-1-dependent estrogenic-genes using the AF-2 mutated knock-in (KI) mouse model, AF2ERKI. AF2ER is an AF-2 disrupted estradiol (E2)-insensitive mutant ER alpha, but AF-1-dependent transcription can be activated by the estrogen-antagonists, fulvestrant (ICI) and 4OHT. Gene profiling and ChIP-Seq analysis identifiedKlk1b21as an ICI-inducible gene in AF2ERKI uterus. The regulatory activity was analyzed further using a cell-based reporter assay. The 5 '-flanking 0.4k bp region ofKlk1b21gene responded as an ER alpha AF-1-dependent estrogen-responsive promoter. The 150 bp minimum ER alpha binding element (EBE) consists of three direct repeats. These three half-site sequences were essential for the ER alpha-dependent transactivation and were differentially recognized by E2 and 4OHT for the gene activation. This response was impaired when the minimum EBE was fused with a thymidine-kinase promoter but could be restored by fusion with the 100 bp minimum transcription initiation element (TIE) ofKlk1b21, suggesting that the cooperative function of EBE and TIE is essential for mediating AF-1-dependent transactivation. These findings provide the first in vivo evidence that endogenous ER alpha AF-1 dominant estrogenic-genes exist in estrogen-responsive organs. Such findings will aid in understanding the mechanism of ER alpha-dependent tissue-selective activity of SERMs.	[Arao, Yukitomo; Hamilton, Katherine J.; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, Reprod & Dev Biol Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA; [Grimm, Sara A.] NIEHS, Integrat Bioinformat Support Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Arao, Y; Korach, KS (corresponding author), NIEHS, Receptor Biol Sect, Reprod & Dev Biol Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	araoy@niehs.nih.gov; korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021		Division of Intramural Research of the NIEHS/NIH [1ZIAES070065]	Division of Intramural Research of the NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr Kevin Gerrish and the NIEHS Microarray Group from the Molecular Genomics Core Laboratory for conducting the microarray analysis. We thank Ms Sylvia Hewitt and Dr Tatsuya Sueyoshi for the critical reading of the manuscript. This study was supported by the Division of Intramural Research of the NIEHS/NIH 1ZIAES070065 (to KSK).	Arao Y, 2018, J BIOL CHEM, V293, P8495, DOI 10.1074/jbc.RA117.001212; Arao Y, 2015, J BIOL CHEM, V290, P17611, DOI 10.1074/jbc.M115.638650; Arao Y, 2013, J BIOL CHEM, V288, P21105, DOI 10.1074/jbc.M113.463455; Arao Y, 2012, P NATL ACAD SCI USA, V109, P21140, DOI 10.1073/pnas.1216189110; Arao Y, 2011, P NATL ACAD SCI USA, V108, P14986, DOI 10.1073/pnas.1109180108; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Dutertre M, 2000, J PHARMACOL EXP THER, V295, P431; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Hamilton KJ, 2014, REPROD BIOL, V14, P3, DOI 10.1016/j.repbio.2013.12.002; HART JE, 1990, PHARMACOL THERAPEUT, V47, P203, DOI 10.1016/0163-7258(90)90087-I; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hewitt SC, 2006, ENDOCRINOLOGY, V147, P2203, DOI 10.1210/en.2005-1292; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hewitt SC, 2014, MOL ENDOCRINOL, V28, P899, DOI 10.1210/me.2014-1051; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; KATO S, 1995, MOL CELL BIOL, V15, P5858; KATO S, 1992, CELL, V68, P731, DOI 10.1016/0092-8674(92)90148-6; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Lahooti H, 1995, J STEROID BIOCHEM, V55, P305, DOI 10.1016/0960-0760(95)00188-3; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; McInerney EM, 1996, J BIOL CHEM, V271, P24172, DOI 10.1074/jbc.271.39.24172; Merot Y, 2004, J BIOL CHEM, V279, P26184, DOI 10.1074/jbc.M402148200; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; Osol G, 2014, MICROCIRCULATION, V21, P38, DOI 10.1111/micc.12080; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pike ACW, 2000, J STEROID BIOCHEM, V74, P261, DOI 10.1016/S0960-0760(00)00102-3; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Thomas RS, 2008, J MOL ENDOCRINOL, V40, P173, DOI 10.1677/JME-07-0165; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Valdes G, 2011, PLACENTA, V32, pS170, DOI 10.1016/j.placenta.2011.01.008; Yoon K, 2000, MOL CELL ENDOCRINOL, V162, P211, DOI 10.1016/S0303-7207(99)00261-0	38	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16003	16021		10.1096/fj.202001435R	http://dx.doi.org/10.1096/fj.202001435R		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33064339	Green Accepted			2022-12-26	WOS:000581162000001
J	Lopez-Alvarenga, JC; Chittoor, G; Paul, SFD; Puppala, S; Farook, VS; Fowler, SP; Resendez, RG; Hernandez-Ruiz, J; Diaz-Badillo, A; Salazar, D; Garza, DD; Lehman, DM; Mummidi, S; Arya, R; Jenkinson, CP; Lynch, JL; DeFronzo, RA; Blangero, J; Hale, DE; Duggirala, R				Lopez-Alvarenga, Juan C.; Chittoor, Geetha; Paul, Solomon F. D.; Puppala, Sobha; Farook, Vidya S.; Fowler, Sharon P.; Resendez, Roy G.; Hernandez-Ruiz, Joselin; Diaz-Badillo, Alvaro; Salazar, David; Garza, Doreen D.; Lehman, Donna M.; Mummidi, Srinivas; Arya, Rector; Jenkinson, Christopher P.; Lynch, Jane L.; DeFronzo, Ralph A.; Blangero, John; Hale, Daniel E.; Duggirala, Ravindranath			Acanthosis nigricans as a composite marker of cardiometabolic risk and its complex association with obesity and insulin resistance in Mexican American children	PLOS ONE			English	Article							ADOLESCENTS; OVERWEIGHT; PREVALENCE; EXTENSIONS; SAMPLE; MODELS	Aim Acanthosis nigricans (AN) is a strong correlate of obesity and is considered a marker of insulin resistance (IR). AN is associated with various other cardiometabolic risk factors (CMRFs). However, the direct causal relationship of IR with AN in obesity has been debated. Therefore, we aimed to examine the complex causal relationships among the troika of AN, obesity, and IR in Mexican Americans (MAs). Methods We used data from 670 non-diabetic MA children, aged 6-17 years (49% girls). AN (prevalence 33%) severity scores (range 0-5) were used as a quasi-quantitative trait (AN-q) for analysis. We used the program SOLAR for determining phenotypic, genetic, and environmental correlations between AN-q and CMRFs (e.g., BMI, HOMA-IR, lipids, blood pressure, hs-C-reactive protein (CRP), and Harvard physical fitness score (PFS)). The genetic and environmental correlations were subsequently used in mediation analysis (AMOS program). Model comparisons were made using goodness-of-fit indexes. Results Heritability of AN-q was 0.75 (p<0.0001). It was positively/significantly (p<0.05) correlated with traits such as BMI, HOMA-IR, and CRP, and negatively with HDL-C and PFS. Of the models tested, indirect mediation analysis of BMI -> HOMA-IR -> AN-q yielded lower goodness-of-fit than a partial mediation model where BMI explained the relationship with both HOMA-IR and AN-q simultaneously. Using complex models, BMI was associated with AN-q and IR mediating most of the CMRFs; but no relationship between IR and AN-q. Conclusion Our study suggests that obesity explains the association of IR with AN, but no causal relationship between IR and AN in Mexican American children.	[Lopez-Alvarenga, Juan C.; Farook, Vidya S.; Resendez, Roy G.; Diaz-Badillo, Alvaro; Mummidi, Srinivas; Arya, Rector; Jenkinson, Christopher P.; Blangero, John; Duggirala, Ravindranath] Univ Texas Rio Grande Valley, Dept Human Genet, Edinburg, TX 78539 USA; [Lopez-Alvarenga, Juan C.; Farook, Vidya S.; Resendez, Roy G.; Diaz-Badillo, Alvaro; Mummidi, Srinivas; Arya, Rector; Jenkinson, Christopher P.; Blangero, John; Duggirala, Ravindranath] Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Edinburg, TX 78539 USA; [Lopez-Alvarenga, Juan C.; Farook, Vidya S.; Resendez, Roy G.; Diaz-Badillo, Alvaro; Mummidi, Srinivas; Arya, Rector; Jenkinson, Christopher P.; Blangero, John; Duggirala, Ravindranath] Univ Texas Rio Grande Valley, Dept Human Genet, Brownsville, TX 78520 USA; [Lopez-Alvarenga, Juan C.; Farook, Vidya S.; Resendez, Roy G.; Diaz-Badillo, Alvaro; Mummidi, Srinivas; Arya, Rector; Jenkinson, Christopher P.; Blangero, John; Duggirala, Ravindranath] Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Brownsville, TX 78520 USA; [Chittoor, Geetha] Geisinger Hlth Syst, Biomed & Translat Informat, Danville, PA USA; [Paul, Solomon F. D.] Sri Ramachandra Inst Higher Educ & Res, Dept Human Genet, Chennai, Tamil Nadu, India; [Puppala, Sobha] Wake Forest Univ, Dept Internal Med, Winston Salem, NC 27101 USA; [Fowler, Sharon P.; Lehman, Donna M.; DeFronzo, Ralph A.] Univ Texas Hlth San Antonio, Dept Med, San Antonio, TX USA; [Hernandez-Ruiz, Joselin] Hosp Gen Mexico Dr Eduardo Liceaga, Dept Pharmacol, Mexico City, DF, Mexico; [Salazar, David; Garza, Doreen D.] Univ Texas Rio Grande Valley, Coll Hlth Profess, Border Hlth Off, Edinburg, TX USA; [Lynch, Jane L.] Univ Texas Hlth San Antonio, Dept Pediat, San Antonio, TX USA; [Hale, Daniel E.] Penn State Univ, Pediat Endocrinol & Diabet, Hershey, PA USA	University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; Geisinger Health System; Sri Ramachandra Institute of Higher Education & Research; Wake Forest University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Lopez-Alvarenga, JC (corresponding author), Univ Texas Rio Grande Valley, Dept Human Genet, Edinburg, TX 78539 USA.; Lopez-Alvarenga, JC (corresponding author), Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Edinburg, TX 78539 USA.; Lopez-Alvarenga, JC (corresponding author), Univ Texas Rio Grande Valley, Dept Human Genet, Brownsville, TX 78520 USA.; Lopez-Alvarenga, JC (corresponding author), Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Brownsville, TX 78520 USA.	juan.lopezalvarenga@utrgv.edu	Blangero, John/ABA-7175-2021; Paul, Solomon Franklin Durairaj/B-5368-2012	Paul, Solomon Franklin Durairaj/0000-0002-0829-7780; Lopez-Alvarenga, Juan/0000-0002-0966-8766; Hernandez Ruiz, Joselin/0000-0002-0571-2563	Veterans Administration Epidemiologic Grant; National Center for Research Resources [S10 RR029392]; Research Facilities Improvement Program from the National Center for Research Resources of the National Institutes of Health [C06 RR013556, C06 RR017515];  [R01 HD049051/HD0490515S1];  [HD041111];  [DK053889];  [DK042273];  [DK047482];  [MH059490];  [P01 HL045522];  [K01 DK064867];  [M01-RR-01346]	Veterans Administration Epidemiologic Grant; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Facilities Improvement Program from the National Center for Research Resources of the National Institutes of Health; ; ; ; ; ; ; ; ; 	This study was supported RD received grants: R01 HD049051/HD049051-5S1 [ARRA], HD041111, DK053889, DK042273, DK047482, MH059490, P01 HL045522, K01 DK064867, M01-RR-01346, and Veterans Administration Epidemiologic Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Some of the investigators received salaries from some of the grants as follows: R01 HD049051/HD0490515S1 [ARRA] (RD, DEH, JB, RAD, CPJ, RA, SP, VSF, SPF, RGR), HD041111 (RD, JB, RAD, CPJ, RA, RGR), DK053889 (RD, JB, CPJ, SP, VSF, SPF, RGR), DK042273 (DML, RD, JB), DK047482 (DML), MH059490 (JB), P01 HL045522 (JB, RD), and Veterans Administration Epidemiologic Grant (RAD, CPJ). The AT&T Genomics Computing Center supercomputing facilities used for this work were supported in part by a gift from the AT&T Foundation and with support from the National Center for Research Resources Grant Number S10 RR029392. This investigation was conducted in facilities constructed with support from Research Facilities Improvement Program grants C06 RR013556 and C06 RR017515 from the National Center for Research Resources of the National Institutes of Health.	Abraham C, 2012, J SCH NURS, V28, P195, DOI 10.1177/1059840511430952; Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS14, DOI 10.2337/dc20-S002; BERNSTEIN JE, 1983, J INVEST DERMATOL, V80, P7, DOI 10.1111/1523-1747.ep12530848; Brickman WJ, 2010, J PEDIATR-US, V156, P87, DOI 10.1016/j.jpeds.2009.07.011; Burke JP, 2000, HUM GENET, V106, P467, DOI 10.1007/s004390000274; Burke JP, 1999, DIABETES CARE, V22, P1655, DOI 10.2337/diacare.22.10.1655; Caceres M, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-31; Copeland Kenneth, 2006, J Okla State Med Assoc, V99, P19; CRUZ PD, 1992, J INVEST DERMATOL, V98, pS82, DOI 10.1111/1523-1747.ep12462293; Falconer DS, 1996, INTRO QUANTITATIVE G, P122; Fowler SP, 2013, HUM GENET, V132, P1059, DOI 10.1007/s00439-013-1315-2; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Garg A, 2009, BBA-MOL CELL BIOL L, V1791, P507, DOI 10.1016/j.bbalip.2008.12.014; Garofalo L, 2003, EUR J PEDIAT DERMATO, V13, P85; GHANEM Q, 1993, CLIN GENET, V44, P277; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Hudson LD, 2017, INT J OBESITY, V41, P1454, DOI 10.1038/ijo.2017.105; KAHN CR, 1976, NEW ENGL J MED, V294, P739, DOI 10.1056/NEJM197604012941401; Kobaissi HA, 2004, DIABETES CARE, V27, P1412, DOI 10.2337/diacare.27.6.1412; Kong AS, 2007, ANN FAM MED, V5, P202, DOI 10.1370/afm.678; Kong AS, 2012, J PEDIATR ENDOCR MET, V25, P1095, DOI 10.1515/jpem-2012-0117; Kong AS, 2010, J AM BOARD FAM MED, V23, P476, DOI 10.3122/jabfm.2010.04.090221; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; Liu Shao-Hsien, 2016, BMC Res Notes, V9, P354, DOI 10.1186/s13104-016-2163-7; Lopez-Alvarenga JC, 2006, ARCH MED RES, V37, P744, DOI 10.1016/j.arcmed.2005.12.007; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Kluczynik CEN, 2012, AN BRAS DERMATOL, V87, P531, DOI 10.1590/S0365-05962012000400002; Plascencia Gomez A, 2013, ACTA DERMOSIFILIOGR, DOI [10.1016/j.ad.2013.09.008, DOI 10.1016/J.AD.2013.09.00824238328]; Rosenbloom A, 2000, DIABETES CARE, V23, P381; Simha V, 2008, AM J MED GENET A, V146A, P2318, DOI 10.1002/ajmg.a.32457; Sinha S, 2007, J AM ACAD DERMATOL, V57, P502, DOI 10.1016/j.jaad.2006.08.016; SNEDDON IB, 1962, GUT, V3, P269, DOI 10.1136/gut.3.3.269; Stoddart ML, 2002, DIABETES CARE, V25, P1009, DOI 10.2337/diacare.25.6.1009; Rodriguez RV, 2011, GAC MED MEX, V147, P297; 2015, E ASIA FORUM Q, V7, P1	36	5	6	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240467	10.1371/journal.pone.0240467	http://dx.doi.org/10.1371/journal.pone.0240467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057385	Green Published, gold			2022-12-26	WOS:000581814700093
J	Shang, LR; Wan, LQ; Zhou, XX; Li, S; Li, XL				Shang, Lirong; Wan, Liqiang; Zhou, Xiaoxin; Li, Shuo; Li, Xianglin			Effects of organic fertilizer on soil nutrient status, enzyme activity, and bacterial community diversity in Leymus chinensis steppe in Inner Mongolia, China	PLOS ONE			English	Article							LONG-TERM FERTILIZATION; MICROBIAL COMMUNITY; LAND-USE; CHEMICAL FERTILIZERS; OXIDIZING BACTERIA; FARMYARD MANURE; GEN. NOV.; BIOMASS; MANAGEMENT; RHIZOSPHERE	The long-term impact of human exploitation and environmental changes has led to a decline in grassland productivity and soil fertility, which eventually results in grassland degradation. The application of organic fertilizer is an effective improvement measure; however, it is still not fully understood how the addition of organic fertilizer influences grassland soil fertility and plant composition. A set of experiments were conducted in Inner Mongolia in China to reveal the tradeoff between steppe plants and soil microorganisms and the eco-physiological mechanisms involved, and how the addition of vermicompost and mushroom residues affect microbial diversity, enzyme activities, and the chemical properties of soil in degradedLeymus chinensisgrassland. Organic fertilizer improved the soil nutrient status and shaped distinct bacterial communities. Compared with the control the available phosphorus (AP) and available potassium (AK) contents were highest under treatments a3 and b3, and the aboveground biomass was highest under the b3 treatment. Soil sucrase activities increased by 7.88% under the b3 treatment. Moreover, the richness index significantly increased by 7.07% and 7.23% under the a1 and b2 treatments, respectively. The most abundant Actinobacteria and Proteobacteria were detected in the organic fertilizer treatment. A linear discriminant analysis effect size (LEfSe) indicated that the bacterial community was significantly increased under the b3 treatment. A canonical correspondence analysis (RDA) and spearman correlation heatmap confirmed that total P (TP) and urease were the key driving factors for shaping bacterial communities in the soil. Our results indicated that the application of large amounts of vermicompost and mushroom residues increased the availability of nutrients and also enhanced the biodiversity of soil bacterial communities inL.chinensisgrasslands, which will contribute to the sustainable development of agro-ecosystems.	[Shang, Lirong; Wan, Liqiang; Zhou, Xiaoxin; Li, Shuo; Li, Xianglin] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Wan, LQ; Li, XL (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China.	wanliqiang@caas.cn; lxl@caas.cn			National Key Research and Development Program [2016YFC0500608-2]; National Forage Industry Technology System [CARS-34]	National Key Research and Development Program; National Forage Industry Technology System	This work was supported by the National Key Research and Development Program (2016YFC0500608-2) and the National Forage Industry Technology System (CARS-34).	Alguacil MM, 2011, SOIL BIOL BIOCHEM, V43, P1498, DOI 10.1016/j.soilbio.2011.03.026; Allen EB, 1997, RESTOR ECOL, V5, P275, DOI 10.1046/j.1526-100X.1997.00541.x; Anandham R, 2008, J BASIC MICROB, V48, P439, DOI 10.1002/jobm.200700380; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; BAO SD, 1981, SOIL AGR CHEM ANAL; Bardgett RD, 2005, BIOL SOIL COMMUNITY; Bhattacharyya R, 2007, SOIL TILL RES, V94, P386, DOI 10.1016/j.still.2006.08.014; Blanco-Canqui H, 2013, J ENVIRON QUAL, V42, P861, DOI 10.2134/jeq2012.0451; Bohme L, 2005, AGR ECOSYST ENVIRON, V109, P141, DOI 10.1016/j.agee.2005.01.017; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; Canals RM, 2019, PLANT SOIL, V445, P243, DOI 10.1007/s11104-019-04281-w; Chen DM, 2017, EUR J AGRON, V90, P34, DOI 10.1016/j.eja.2017.07.007; Chen XD, 2017, APPL SOIL ECOL, V119, P197, DOI 10.1016/j.apsoil.2017.06.019; Chen Y, 2010, J SOIL SEDIMENT, V10, P1018, DOI 10.1007/s11368-009-0123-8; Chu HY, 2007, APPL ENVIRON MICROB, V73, P485, DOI 10.1128/AEM.01536-06; CLARK F. E., 1970, Advances in Agronomy, V22, P375, DOI 10.1016/S0065-2113(08)60273-4; Cui XW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34685-0; Daquiado AR, 2016, APPL SOIL ECOL, V108, P84, DOI 10.1016/j.apsoil.2016.08.006; Doran JW, 1996, ADV AGRON, V56, P1, DOI 10.1016/S0065-2113(08)60178-9; Eo J, 2016, AGR ECOSYST ENVIRON, V231, P176, DOI 10.1016/j.agee.2016.06.039; Guan S., 1986, SOIL ENZYMES THEIR R, P296; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guo Z, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211163; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hartmann M, 2015, ISME J, V9, P1177, DOI 10.1038/ismej.2014.210; Hati KM, 2006, BIORESOURCE TECHNOL, V97, P2182, DOI 10.1016/j.biortech.2005.09.033; He NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077241; Hu JL, 2011, J SOIL SEDIMENT, V11, P271, DOI 10.1007/s11368-010-0308-1; Iino T, 2010, INT J SYST EVOL MICR, V60, P1376, DOI 10.1099/ijs.0.012484-0; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Jiao YJ, 2019, SOIL RES, V57, P779, DOI 10.1071/SR18240; [卡着才让 Ka Zhuocairang], 2015, [草地学报, Acta Agrestia Sinica], V23, P726; Kopecky J, 2011, FEMS MICROBIOL ECOL, V78, P386, DOI 10.1111/j.1574-6941.2011.01173.x; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Li M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01125; [刘淑英 LIU Shu-ying], 2010, [水土保持学报, Journal of Soil and Water Conservation], V24, P219; Liu WX, 2015, PLANT SOIL, V395, P415, DOI 10.1007/s11104-015-2569-3; Lu R.K., 2000, SOIL AGR CHEM ANAL; Maltas A, 2018, LAND DEGRAD DEV, V29, P926, DOI 10.1002/ldr.2913; Monreal CM, 2000, CAN J SOIL SCI, V80, P419, DOI 10.4141/S99-088; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Podosokorskaya OA, 2013, ENVIRON MICROBIOL, V15, P1759, DOI 10.1111/1462-2920.12067; Poulsen PHB, 2013, SOIL BIOL BIOCHEM, V57, P784, DOI 10.1016/j.soilbio.2011.12.023; Qi Z, 2017, ENVIRON SCI POLLUT R, V24, P6554, DOI 10.1007/s11356-017-8370-5; Roem WJ, 2000, BIOL CONSERV, V92, P151, DOI 10.1016/S0006-3207(99)00049-X; Ruiz A, 2000, INT J SYST EVOL MICR, V50, P1981, DOI 10.1099/00207713-50-6-1981; S BE, 2018, J CROHNS COLITIS, V12, pS049; Savci S., 2012, International Journal of Environmental Science and Development, V3, P77; Shen JP, 2010, APPL SOIL ECOL, V46, P119, DOI 10.1016/j.apsoil.2010.06.015; Shen ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098420; Singh H, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29015; Sturz AV, 2003, SOIL TILL RES, V72, P107, DOI 10.1016/S0167-1987(03)00082-5; Stybnarova M., 2014, AGRICULTURE, V59, P87, DOI [10.2478/agri-2014-0010, DOI 10.2478/AGRI-2014-0010]; Sun J, 2014, APPL SOIL ECOL, V78, P28, DOI 10.1016/j.apsoil.2014.02.004; Sun RB, 2015, SOIL BIOL BIOCHEM, V88, P9, DOI 10.1016/j.soilbio.2015.05.007; Verastegui Y, 2014, MBIO, V5, DOI 10.1128/mBio.01157-14; Vourlitis GL, 2007, SOIL SCI SOC AM J, V71, P836, DOI 10.2136/sssaj2006.0339; Wang QF, 2018, APPL SOIL ECOL, V125, P88, DOI 10.1016/j.apsoil.2017.12.007; Wang Shu-qi, 2008, Yingyong Shengtai Xuebao, V19, P551; Wei M, 2017, EUR J SOIL BIOL, V82, P27, DOI 10.1016/j.ejsobi.2017.08.002; Wu MN, 2011, BIOL FERT SOILS, V47, P397, DOI 10.1007/s00374-010-0535-z; Xu J, 2018, SOIL BIOL BIOCHEM, V120, P181, DOI 10.1016/j.soilbio.2018.02.010; Xun WB, 2015, SOIL BIOL BIOCHEM, V90, P10, DOI 10.1016/j.soilbio.2015.07.018; Yoon JH, 2010, INT J SYST EVOL MICR, V60, P615, DOI 10.1099/ijs.0.012591-0; Yun W, 2014, J INNER MONGOLIA AGR, V16, P18; Zeglin LH, 2007, OECOLOGIA, V154, P349, DOI 10.1007/s00442-007-0836-6; Zhao J, 2014, MICROB ECOL, V67, P443, DOI 10.1007/s00248-013-0322-0; Zhong WH, 2010, PLANT SOIL, V326, P511, DOI 10.1007/s11104-009-9988-y; Zhu LY, 2019, LAND DEGRAD DEV, V30, P636, DOI 10.1002/ldr.3249	71	18	19	7	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240559	10.1371/journal.pone.0240559	http://dx.doi.org/10.1371/journal.pone.0240559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057441	gold, Green Published			2022-12-26	WOS:000581814700015
J	Garcia-Fayos, P; Monleon, VJ; Espigares, T; Nicolau, JM; Bochet, E				Garcia-Fayos, Patricio; Monleon, Vicente J.; Espigares, Tiscar; Nicolau, Jose M.; Bochet, Esther			Increasing aridity threatens the sexual regeneration of Quercus ilex (holm oak) in Mediterranean ecosystems	PLOS ONE			English	Article							CLIMATE-CHANGE PROJECTIONS; SHRUBS FACILITATE; LAND-USE; RECRUITMENT; ESTABLISHMENT; PERSISTENCE; DISTURBANCE; CALIFORNIA; RESPONSES; SEEDLINGS	Knowledge of the recruitment of dominant forest species is a key aspect for forest conservation and the ecosystem services they provide. In this paper, we address how the simultaneous action of climate change and the intensity of land use in the past influence the recruitment of a forest species that depends on the provision of nurse plants to recruit. We compared the number of saplings (up to 15 years old) and juveniles (16 to 50 years old) of Quercus ilex in 17, 5.3 ha plots in the Iberian System (eastern Spain). We used a gradient of past deforestation intensity crossed with two levels of average annual precipitation, one of them at the lower limit of the species' precipitation niche (semi-arid) and the other at the optimum (sub-humid). We also examined the association between recruits and nurse plants and the effect on this association of plot-scale factors, such as seed abundance (reproductive Q. ilex), microsites (nurse species and soil availability), and large herbivores. The increase in aridity in the last decades has drastically reduced the recruitment of new individuals in the forests of Q. ilex located in the lower limit of their precipitation niche, regardless of the intensity of past deforestation that they suffered. Recruitment in these climatic conditions depends almost exclusively on large trees and shrubs whose abundance may also be limited by aridity. The lack of regeneration questions the future of these populations, as the number of individuals will decrease over time despite the strong resistance of adult trees to disturbance and drought.	[Garcia-Fayos, Patricio; Bochet, Esther] CSIC UV GV, Desertificat Res Ctr CIDE, Valencia, Spain; [Monleon, Vicente J.] US Forest Serv, Pacific Northwest Res Stn, Corvallis, OR 97331 USA; [Espigares, Tiscar] Univ Alcala, Fac Sci, Dept Life Sci, Madrid, Spain; [Nicolau, Jose M.] Univ Zaragoza, Tech Sch, Huesca, Spain; [Nicolau, Jose M.] Univ Zaragoza, Inst Environm Sci, Huesca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE); United States Department of Agriculture (USDA); United States Forest Service; Universidad de Alcala; University of Zaragoza; University of Zaragoza	Garcia-Fayos, P (corresponding author), CSIC UV GV, Desertificat Res Ctr CIDE, Valencia, Spain.	patricio.garcia-fayos@ext.uv.es	Garcia-Fayos, Patricio/D-5208-2016; Nicolau, José Manuel/AAY-1696-2021	Garcia-Fayos, Patricio/0000-0003-3449-5075; Espigares, Tiscar/0000-0002-9673-4046; Nicolau Ibarra, Jose Manuel/0000-0001-6514-3641	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana [CGL2013-42213-R]; Ministerio de Ciencia, Innovacion y Universidades and European Regional Development Fund [RTI2018-095037-B-I00]; Conselleria d'Educacio, Investigacio, Cultura i Esport [PROMETEO 2016/021]	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana(Spanish Government); Ministerio de Ciencia, Innovacion y Universidades and European Regional Development Fund; Conselleria d'Educacio, Investigacio, Cultura i Esport	This work was supported by Ministerio de Economia, Industria y Competitividad, Gobierno de Espana, CGL2013-42213-R, to Dr Esther Bochet; Ministerio de Ciencia, Innovacion y Universidades and European Regional Development Fund, RTI2018-095037-B-I00 to EB; Conselleria d'Educacio, Investigacio, Cultura i Esport, PROMETEO 2016/021 to PG-F. The CSIC Open Access Publication Support Initiative gave support of the publication fee through its Unit of Information Resources for Research (URICI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alla AQ, 2012, TREES-STRUCT FUNCT, V26, P841, DOI 10.1007/s00468-011-0658-3; Amat B, 2015, PERSPECT PLANT ECOL, V17, P24, DOI 10.1016/j.ppees.2014.10.001; Barbeta A, 2016, PLANT ECOL DIVERS, V9, P321, DOI 10.1080/17550874.2016.1212288; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Brunet M, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008249; Bulleri F, 2016, FUNCT ECOL, V30, P70, DOI 10.1111/1365-2435.12528; Callaway RM, 1998, J VEG SCI, V9, P647, DOI 10.2307/3237283; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Chauchard S, 2007, ECOSYSTEMS, V10, P936, DOI 10.1007/s10021-007-9065-4; Cierjacks A, 2004, PLANT ECOL, V173, P215, DOI 10.1023/B:VEGE.0000029322.75004.ad; Coll M, 2013, FOREST ECOL MANAG, V303, P195, DOI 10.1016/j.foreco.2013.04.010; Costa A, 2017, J VEG SCI, V28, P1047, DOI 10.1111/jvs.12550; Cruz-Alonso V, 2020, J ECOL, V108, P1125, DOI 10.1111/1365-2745.13309; Davis F. W., 2019, Ecosphere, V10, pe02570, DOI 10.1002/ecs2.2570; ESPELTA JM, 1995, J VEG SCI, V6, P465, DOI 10.2307/3236344; Espelta JM, 1999, ECOL STU AN, V137, P61; Gaston A, 2013, PRODUCCION MANEJO SE, V2, P615; Gavinet J, 2016, FOREST ECOL MANAG, V381, P289, DOI 10.1016/j.foreco.2016.09.045; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gomez JM, 2004, PLANT ECOL, V172, P287, DOI 10.1023/B:VEGE.0000026327.60991.f9; Gomez-Aparicio L, 2005, J VEG SCI, V16, P191, DOI 10.1111/j.1654-1103.2005.tb02355.x; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gracia M, 2001, ANN FOREST SCI, V58, P843, DOI 10.1051/forest:2001167; Koenig Walter D., 2007, Madrono, V54, P269, DOI 10.3120/0024-9637(2007)54[269:LGAPOB]2.0.CO;2; Leverkus AB, 2016, ECOLOGY, V97, P2628, DOI 10.1002/ecy.1527; Lopez-Sanchez A, 2019, J APPL ECOL, V56, P2663, DOI 10.1111/1365-2664.13500; Maranon T, 2012, TREES WOOD EXPLORATI, P291; Gomez JM, 2019, BIOL REV, V94, P874, DOI 10.1111/brv.12481; Matias L, 2011, PERSPECT PLANT ECOL, V13, P277, DOI 10.1016/j.ppees.2011.04.005; Moreno-de las Heras M, 2018, ECOSYSTEMS, V21, P1295, DOI 10.1007/s10021-017-0219-8; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Ninyerola M, 2005, DIGITAL CLIMATIC ATL; Pausas JG, 2019, BIOSCIENCE, V69, P143, DOI 10.1093/biosci/biy157; Perez-Ramos IM, 2010, ECOLOGY, V91, P3057, DOI 10.1890/09-2313.1; Perez-Ramos IM, 2013, PERSPECT PLANT ECOL, V15, P106, DOI 10.1016/j.ppees.2012.12.005; Petrie MD, 2017, ECOLOGY, V98, P1548, DOI 10.1002/ecy.1791; Plieninger T, 2004, J ARID ENVIRON, V57, P345, DOI 10.1016/S0140-1963(03)00103-4; Retana J, 1999, ECOL STU AN, V137, P89; Serra-Diaz JM, 2016, ECOGRAPHY, V39, P844, DOI 10.1111/ecog.02074; Siscart D, 1999, ECOL STU AN, V137, P75; Stellmes M, 2013, LAND USE POLICY, V30, P685, DOI 10.1016/j.landusepol.2012.05.007; Stocker T. F., 2013, CAMBRIDGE, P1535, DOI DOI 10.1017/CB09781107415324; Tejedor E, 2016, INT J BIOMETEOROL, V60, P361, DOI 10.1007/s00484-015-1033-7; Tyler CM, 2006, Q REV BIOL, V81, P127, DOI 10.1086/506025; Vicente-Serrano SM, 2017, CUAD INVESTIG GEOGR, V43, P209, DOI 10.18172/cig.3134; Vicente-Serrano SM, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/4/044001	46	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0239755	10.1371/journal.pone.0239755	http://dx.doi.org/10.1371/journal.pone.0239755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052951	Green Published, gold			2022-12-26	WOS:000581820200070
J	Mahande, MJ; Shayo, E; Amour, C; Mshana, G; Msuya, S				Mahande, Michael Johnson; Shayo, Emmanuel; Amour, Caroline; Mshana, Gerry; Msuya, Sia			Factors associated with modern contraceptives use among postpartum women in Bukombe district, Geita region, Tanzania	PLOS ONE			English	Article							PREGNANCIES	Introduction Modern contraceptive use during the first year postpartum potentially prevents unplanned pregnancies and help to improve maternal and child health. Therefore, identifying factors associated with contraceptive utilization among women of reproductive age during extended postpartum period is essential. Objective This study aimed to assess factors associated with modern contraceptives use among postpartum women in Bukombe District, Geita region. Method A community-based cross-sectional study was conducted among women who were in their first year after child birth in Bukombe district. A total of 511 women were included using multistage sampling techniques. Data were collected using a structured questionnaire. Data analysis was performed using Stata 15 (College Station, Texas, USA). Results The prevalence of postpartum modern contraceptive was 11.9%. The most frequently used method was implant (6.5%). Most women started to use the contraceptive during the first three months after delivery. Living in urban (AOR = 1.85, 95% CI: 1.20-3.79), having business (AOR = 2.35, 95% CI: 1.31-2.28), last born aged 3-4 months (AOR = 3.31, 95% CI: 1.11-9.85) and menses resumption (AOR = 9.24, 95% CI: 3.60-23.72) were predictors for postpartum contraceptive use. However, fear of side effects, poor knowledge about contraceptives, husband restrictions, distance to health facility and contraceptive availability were reported as barriers for postpartum modern contraceptive use. Conclusion Prevalence of postpartum modern contraceptive use in the study area is still low. Numerous factors were reported as barriers for postpartum contraceptive use. A strategy such as health education on befits of post-partum modern contraceptive use and counseling women about side effects may help to improve its uptake.	[Mahande, Michael Johnson; Shayo, Emmanuel; Amour, Caroline; Msuya, Sia] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Mahande, Michael Johnson; Amour, Caroline; Msuya, Sia] Kilimanjaro Christian Med Univ Coll, Dept Epidemiol & Biostat, Inst Publ Hlth, Moshi, Tanzania; [Mshana, Gerry] MITU Mwanza, Natl Inst Med Res, Mwanza, Tanzania; [Msuya, Sia] Kilimanjaro Christian Med Ctr, Dept Community Hlth, Inst Publ Hlth, Moshi, Tanzania	National Institute of Medical Research; Kilimanjaro Christian Medical Centre	Mahande, MJ (corresponding author), Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania.; Mahande, MJ (corresponding author), Kilimanjaro Christian Med Univ Coll, Dept Epidemiol & Biostat, Inst Publ Hlth, Moshi, Tanzania.	jmmahande@gmail.com	Mahande, Michael Johnson/I-6359-2015	Mahande, Michael Johnson/0000-0002-7750-7657	DELTAS Africa Initiative grant [DEL-15-011]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107742/Z/15/Z]; UK government	DELTAS Africa Initiative grant; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government	MJM received the Award. This work was supported through the DELTAS Africa Initiative grant # DEL-15-011 to THRiVE-2. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust grant # 107742/Z/15/Z and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha TH, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017012; Adetunji J.A., 2011, ETUDE POPUL AFR, V25, P587, DOI DOI 10.11564/25-2-247; Alemayehu M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-6; Anguzu Ronald, 2014, BMC Res Notes, V7, P153, DOI 10.1186/1756-0500-7-153; [Anonymous], 2015, RHEUMATOLOGY, V54, pii5; [Anonymous], 2017, EPLASTY, V17, pic25; Aziz Ali S, 2016, J MIDWIFERY REPROD H, V4, P513; Carlson C, 2016, SAGE OPEN NURS, V2, DOI 10.1177/2377960816680824; Cleland J, 2014, STUD FAMILY PLANN, V45, P105, DOI 10.1111/j.1728-4465.2014.00380.x; Daniels Kimberly, 2015, Natl Health Stat Report, P1; Exavery A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-63; Fekadu H, 2017, PREVALENCE DETERMINA; Garrett CC, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0227-9; Jalang'o R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4510-6; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Kasner E, 2013, ENVIRON POLLUT, V70, P646, DOI DOI 10.1002/ANA.22528.T0LL-LIKE; Keogh SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133933; Kopp DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170284; Leaf healthcare, 2015, CISC VIS NETW IND GL, P1; Masho SW, 2016, J PREGNANCY, V2016, DOI 10.1155/2016/2058127; Mengesha ZB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0598-9; Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC) Ministry of Health (MoH) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and ICF, 2016, TANZ DEM HLTH SURV M; MoHCDGEC, 2016, UN REP TANZ NAT ROAD; MOHSW, 2014, TANZ NAT FAM PLANN R; Potter JE, 2016, OBSTET GYNECOL, V127, P289, DOI 10.1097/AOG.0000000000001201; Ross John A, 2012, Afr J Reprod Health, V16, P68; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Sharma J, 2017, INT J REPROD CONTRAC, V4, P750; Tamrie Y. E., 2015, Health, V7, P1315, DOI 10.4236/health.2015.710146; Tebeje B., 2017, J WOMENS HLTH CARE, V6, P1, DOI [10.4172/2167-0420.1000351, DOI 10.4172/2167-0420.1000351]; Tibaijuka L, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0382-2; Weisband YL, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0307-4; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855; Yilmazel G, 2013, IRAN J REPROD MED, V11, P801; 2015, SEWAGE DISPOSAL CLOV, V15	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0239903	10.1371/journal.pone.0239903	http://dx.doi.org/10.1371/journal.pone.0239903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052975	Green Published, gold			2022-12-26	WOS:000581820200051
J	Thomsen, CR; Milidou, I; Hvidman, L; Khalil, MR; Rejnmark, L; Uldbjerg, N				Thomsen, Christine Rohr; Milidou, Ioanna; Hvidman, Lone; Khalil, Mohammed Rohi; Rejnmark, Lars; Uldbjerg, Niels			Vitamin D and the risk of dystocia: A case-control study	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; D DEFICIENCY; LABOR; PREGNANCY; CALCIUM; PREECLAMPSIA; ASSOCIATION; EXPRESSION; RECEPTORS; PROGRESS	Background Dystocia is one of the most common causes of cesarean section in nulliparous women. Studies have described the presence of vitamin D receptors in the myometrium, but it is still unclear whether vitamin D affects the contractility of the smooth muscles. We therefore aimed to determine the association between the vitamin D serum level at labor and the risk of dystocia. Method We conducted a case-control study between January 2012 and June 2017. Cases were primiparous women, with spontaneous onset of labor, who gave birth by cesarean section due to dystocia. Controls were primiparous women with a spontaneous vaginal delivery. We included 60 women (30 cases and 30 controls) in the analysis. The differences between cases and controls were assessed using chi-squared test for categorical variables and two-sample t-test or unequal t-test for continuous variables, as appropriate, after evaluation of whether they followed the normal distributions. Results The mean serum 25-hydroxyvitamin D concentrations were 53.1nmol/l (95%CI; 45.2 to 60.9) among cases and 69.9nmol/l (95%CI; 57.5 to 82.4) among controls (P= 0.02). The mean plasma parathyroid hormone levels were 2.25 pmol/l and 2.38, respectively (P= 0.57). Even though 78% of all women reported taking a minimum of 10 mu g/day of vitamin D throughout pregnancy, 43% had vitamin D insufficiency, defined as serum 25-hydroxyvitamin D levels below 50nmol/l. Conclusions In a Danish group of women having a cesarean section due to dystocia, we found decreased vitamin D levels.	[Thomsen, Christine Rohr; Hvidman, Lone; Uldbjerg, Niels] Aarhus Univ Hosp, Dept Obstet & Gynecol, Aarhus, Denmark; [Milidou, Ioanna] Hosp West Jutland, Dept Pediat, Herning, Denmark; [Khalil, Mohammed Rohi] Ctr Hosp Lillebaelt, Dept Obstet & Gynecol, Kolding, Denmark; [Rejnmark, Lars] Aarhus Univ Hosp, Dept Internal Med & Endocrinol, Aarhus, Denmark	Aarhus University; Aarhus University	Thomsen, CR (corresponding author), Aarhus Univ Hosp, Dept Obstet & Gynecol, Aarhus, Denmark.	christinerohrthomsen@gmail.com	Khalil, Mohammed Rohi/X-2671-2019; Uldbjerg, Niels/O-2038-2016	Uldbjerg, Niels/0000-0002-6449-6426; Milidou, Ioanna/0000-0003-2640-7848	Grosserer L.F. Foghts Foundation; Direktor Jacob Madsen & Hustru Olga Madsens Foundation [4947]; Aase og Ejnar Danielsens Foundation [10-000580]; CRT; Aarhus University Research Foundation [2011-21872-88]	Grosserer L.F. Foghts Foundation; Direktor Jacob Madsen & Hustru Olga Madsens Foundation; Aase og Ejnar Danielsens Foundation; CRT(Fondazione CRT); Aarhus University Research Foundation	This project is a result of a grant from Grosserer L.F. Foghts Foundation; www.foghtsfond.dk, no grant number. Direktor Jacob Madsen & Hustru Olga Madsens Foundation, www.jacob-og-olga-madsens-fond.dk, grant number 4947. And Aase og Ejnar Danielsens Foundation; www.danielsensfond.dk, grant number 10-000580. All three grants were received by CRT. The Aarhus University Research Foundation has supplied a scholarship to Christine Rohr Thomsen; grant number 2011-21872-88. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, OBSTET GYNECOL; Baker AM, 2010, J CLIN ENDOCR METAB, V95, P5105, DOI 10.1210/jc.2010-0996; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Boyle A, 2013, OBSTET GYNECOL, V122, P33, DOI 10.1097/AOG.0b013e3182952242; Brunvand L, 1998, ACTA OBSTET GYN SCAN, V77, P303, DOI 10.1034/j.1600-0412.1998.770309.x; Farrugia W, 2000, J ENDOCRINOL, V165, P657, DOI 10.1677/joe.0.1650657; FERGUSON JE, 1992, P NATL ACAD SCI USA, V89, P8384, DOI 10.1073/pnas.89.17.8384; Fu X, 2000, ACTA OBSTET GYN SCAN, V79, P174, DOI 10.1034/j.1600-0412.2000.079003174.x; GERMAIN AM, 1992, J CLIN ENDOCR METAB, V75, P1173, DOI 10.1210/jc.75.4.1173; Gifford DS, 2000, OBSTET GYNECOL, V95, P589, DOI 10.1016/S0029-7844(99)00575-X; HELLMAN P, 1992, ARCH BIOCHEM BIOPHYS, V293, P174, DOI 10.1016/0003-9861(92)90381-6; Hojskov CS, 2010, CLIN CHIM ACTA, V411, P114, DOI 10.1016/j.cca.2009.10.010; Hypponen E, 2013, ANN NUTR METAB, V63, P331, DOI 10.1159/000358338; Hypponen E, 2005, NUTR REV, V63, P225, DOI 10.1111/j.1753-4887.2005.tb00378.x; Kjaergaard H, 2009, ACTA OBSTET GYN SCAN, V88, P402, DOI 10.1080/00016340902811001; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; Merewood A, 2009, J CLIN ENDOCR METAB, V94, P940, DOI 10.1210/jc.2008-1217; Moller UK, 2013, OSTEOPOROSIS INT, V24, P1307, DOI 10.1007/s00198-012-2062-2; Moller UK, 2012, EUR J CLIN NUTR, V66, P862, DOI 10.1038/ejcn.2012.18; Mulligan ML, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.002; Niven Daniel J, 2012, Clin Epidemiol, V4, P99, DOI 10.2147/CLEP.S30816; Papandreou L, 2004, EUR J OBSTET GYN R B, V115, P17, DOI 10.1016/j.ejogrb.2003.11.032; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Selin L, 2008, ACTA OBSTET GYN SCAN, V87, P216, DOI 10.1080/00016340701837744; Sheiner E, 2002, ACTA OBSTET GYN SCAN, V81, P222, DOI 10.1034/j.1600-0412.2002.810306.x; SIMPSON RU, 1985, J BIOL CHEM, V260, P8882; Strid H, 2002, J ENDOCRINOL, V175, P517, DOI 10.1677/joe.0.1750517; Vienonen A, 2004, J SOC GYNECOL INVEST, V11, P104, DOI 10.1016/j.jsgi.2003.09.003; Wilson RL, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1887-x; Zhang J, 2010, AM J OBSTET GYNECOL, V203	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240406	10.1371/journal.pone.0240406	http://dx.doi.org/10.1371/journal.pone.0240406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052935	Green Published, gold			2022-12-26	WOS:000581820200049
J	Popugaev, KA; Bakharev, SA; Kiselev, KV; Samoylov, AS; Kruglykov, NM; Abudeev, SA; Zhuravel, SV; Shabanov, AK; Mueller, T; Mayer, SA; Petrikov, SS				Popugaev, Konstantin A.; Bakharev, Sergey A.; Kiselev, Kirill V.; Samoylov, Alexander S.; Kruglykov, Nikolay M.; Abudeev, Sergey A.; Zhuravel, Sergey V.; Shabanov, Aslan K.; Mueller, Thomas; Mayer, Stephan A.; Petrikov, Sergey S.			Clinical and pathophysiologic aspects of ECMO-associated hemorrhagic complications	PLOS ONE			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION; COAGULATION MANAGEMENT; SUPPORT; ANTICOAGULATION; HEPARIN; THROMBOELASTOMETRY	Extracorporeal membrane oxygenation (ECMO) is increasingly used to treat severe cases of acute respiratory or cardiac failure. Hemorrhagic complications represent one of the most common complications during ECMO, and can be life threatening. The purpose of this study was to elucidate pathophysiological mechanisms of ECMO-associated hemorrhagic complications and their impact on standard and viscoelastic coagulation tests. The study cohort included 27 patients treated with VV-ECMO or VA-ECMO. Hemostasis was evaluated using standard coagulation tests and viscoelastic parameters investigated with rotational thromboelastometry. Anticoagulation and hemorrhagic complications were analyzed for up to seven days depending on ECMO duration. Hemorrhagic complications developed in 16 (59%) patients. There were 102 discrete hemorrhagic episodes among 116 24-hour-intervals, of which 27% were considered to be clinically significant. The highest number of ECMO-associated hemorrhages occurred on the 2(nd)and 3(rd)day of treatment. Respiratory tract bleeding was the most common hemorrhagic complication, occurring in 62% of the 24-hour intervals. All 24-hours-intervals were divided into two groups: "with bleeding" and "without bleeding". The probability of hemorrhage was significantly associated with abnormalities of four parameters: increased international normalized ratio (INR, sensitivity 71%, specificity 94%), increased prothrombin time (PT, sensitivity 90%, specificity 72%), decreased intrinsic pathway maximal clot firmness (MCFin, sensitivity 76%, specificity 89%), and increased extrinsic pathway clot formation time (CFTex, sensitivity 77%, specificity 87%). In conclusions, early ECMO-associated hemorrhagic complications are related to one traditional and two novel viscoelastic coagulation abnormalities: PT/INR elevation, reduced maximum clot firmness due to intrinsic pathway dysfunction (MCFin), and prolonged clot formation time due to extrinsic pathway dysfunction (CFTex). When managing hemostasis during ECMO, derangements in PT/INR, MCFin and CFT(ex)should be focused on.	[Popugaev, Konstantin A.; Abudeev, Sergey A.; Zhuravel, Sergey V.; Shabanov, Aslan K.; Petrikov, Sergey S.] Sklifosovsky Res Inst Emergency Med, Moscow Healthcare Dept, Dept Intens Care, Moscow, Russia; [Popugaev, Konstantin A.; Bakharev, Sergey A.; Samoylov, Alexander S.; Kruglykov, Nikolay M.] Fed Med Biol Agcy, Burnasyan Fed Med Biophys Ctr, State Res Ctr, Dept Intens Care, Moscow, Russia; [Kiselev, Kirill V.] Pirogov Russian Natl Res Med Univ, Dept Stat & Cybernet, Moscow, Russia; [Mueller, Thomas] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany; [Mayer, Stephan A.] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA	Burnazyan Federal Medical Biophysical Center; Pirogov Russian National Research Medical University; University of Regensburg; Henry Ford Health System; Henry Ford Hospital	Popugaev, KA (corresponding author), Sklifosovsky Res Inst Emergency Med, Moscow Healthcare Dept, Dept Intens Care, Moscow, Russia.; Popugaev, KA (corresponding author), Fed Med Biol Agcy, Burnasyan Fed Med Biophys Ctr, State Res Ctr, Dept Intens Care, Moscow, Russia.	Stan.popugaev@yahoo.com	Zhuravel, Sergey/GZG-8507-2022	Popugaev, Konstantin/0000-0003-1945-323X				Abrams D, 2016, INTENS CARE MED, V42, P844, DOI 10.1007/s00134-016-4312-9; [Anonymous], 2016, J DIGITAL INVESTIGAT, V18, pS3; [Anonymous], 2014, CHINAS HIGHER ED EVA, V1, P38; Baird CW, 2007, ANN THORAC SURG, V83, P912, DOI 10.1016/j.athoracsur.2006.09.054; Balle CM, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00114; BULL BS, 1975, J THORAC CARDIOV SUR, V69, P685; Carter KT, 2019, J SURG RES, V243, P399, DOI 10.1016/j.jss.2019.05.050; Chan AKC, 1997, THROMB HAEMOSTASIS, V77, P270; Dotsch TM, 2017, BRIT J ANAESTH, V119, P402, DOI 10.1093/bja/aex122; Esper SA, 2017, VOX SANGUINIS; FINK SM, 1989, J PEDIATR-US, V115, P621, DOI 10.1016/S0022-3476(89)80298-7; Fletcher-Sandersjoo A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00548; Gorlinger K, 2012, BEST PRACT RES-CLIN, V26, P179, DOI 10.1016/j.bpa.2012.04.003; Hellmann C, 2018, PERFUSION-UK, V33, P289, DOI 10.1177/0267659117746231; Karagiannidis C, 2016, INTENS CARE MED, V42, P889, DOI 10.1007/s00134-016-4273-z; Kim HS, 2018, J THORAC DIS, V10, P1418, DOI 10.21037/jtd.2018.02.28; Lansink-Hartgring AO, 2019, J CRIT CARE, V54, P239, DOI 10.1016/j.jcrc.2019.09.013; Marasco SF, 2008, HEART LUNG CIRC, V17, pS41, DOI 10.1016/j.hlc.2008.08.009; Mazzeffi M, 2016, ANN THORAC SURG, V101, P682, DOI 10.1016/j.athoracsur.2015.07.046; MCVEEN RV, 1991, AM J HEMATOL, V38, P254, DOI 10.1002/ajh.2830380324; Millar JE, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1570-4; Nagrebetsky A, 2019, BRIT J ANAESTH, V122, P19, DOI 10.1016/j.bja.2018.09.010; Oliver WC, 2009, SEMIN CARDIOTHORAC V, V13, P154, DOI 10.1177/1089253209347384; Paden ML, 2013, ASAIO J, V59, P202, DOI 10.1097/MAT.0b013e3182904a52; Panigada M, 2016, MINERVA ANESTESIOL, V82, P170; Ranucci M, 2020, PLATELETS, V31, P88, DOI 10.1080/09537104.2019.1581920; Rastan AJ, 2006, INT J ARTIF ORGANS, V29, P1121, DOI 10.1177/039139880602901205; Serbian Regulation, 2011, OFF B REP SERB, P1; Spiezia L, 2016, INTERN EMERG MED, V11, P793, DOI 10.1007/s11739-016-1414-x; Ternstrom L, 2010, THROMB RES, V126, pE128, DOI 10.1016/j.thromres.2010.05.028; Theusinger OM, 2010, THROMB HAEMOSTASIS, V104, P385, DOI 10.1160/TH09-12-0858; Veigas PV, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0308-2; Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9	33	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240117	10.1371/journal.pone.0240117	http://dx.doi.org/10.1371/journal.pone.0240117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048966	Green Published, gold			2022-12-26	WOS:000581813300003
J	Asefaw, T; Wolde, M; Edao, A; Tsegaye, A; Teklu, G; Tesfay, F; Gebremariam, G				Asefaw, Tsegay; Wolde, Mistre; Edao, Abebe; Tsegaye, Aster; Teklu, Gebre; Tesfay, Feven; Gebremariam, Gebreslassie			Assessment of liver and renal function tests among gasoline exposed gas station workers in Mekelle city, Tigray region, Northern Ethiopia	PLOS ONE			English	Article							HEALTH-RISK ASSESSMENT; BTEX	Background Volatile organic compounds such as gasoline and other fuels are associated with a wide variety of deleterious health effects including liver and kidney diseases. Gasoline station workers are exposed to a mixture of hydrocarbons during dispensing. However, no published studies investigated the liver and renal function tests of gasoline station workers in Ethiopia. Therefore the aim of this study was to assess liver and renal function tests among gasoline station workers. Method A comparative cross sectional study was conduct from January 2018 to April 2018 at Mekelle city, Tigray region, Northern Ethiopia. Liver and renal function tests were analyzed on gasoline exposed (n = 43) and controls (n = 47) by Pentra C400 automated clinical chemistry analyzer. Student independent t-test and one way-ANOVA statistical methods were employed using SPSS Ver23. P-value < 0.05 was regarded as statistically significant. Result The mean level of ALT, AST, Urea, creatinine, and uric acid was significantly higher among gasoline stations workers when compared to control study participants. There was also a significant increase in ALT, AST, Urea, creatinine and uric acid among gasoline stations with above 6 years exposure when compared with those exposed for <= 2 and3-6years. Conclusion These findings suggest that increasing liver and renal parameters may be associated with exposure to gasoline and it is dependent on time of exposure to gasoline.	[Asefaw, Tsegay; Teklu, Gebre; Tesfay, Feven; Gebremariam, Gebreslassie] Mekelle Univ, Coll Hlth Sci, Dept Med Lab Sci, Mekelle, Ethiopia; [Asefaw, Tsegay; Wolde, Mistre; Edao, Abebe; Tsegaye, Aster] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia	Mekelle University; Addis Ababa University	Asefaw, T (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Med Lab Sci, Mekelle, Ethiopia.; Asefaw, T (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia.	tasefaw4@gmail.com		Tsegaye, Aster/0000-0002-9026-4629; Asefaw, Tsegay/0000-0002-3295-9967; Tesfay, Feven/0000-0002-7390-8234				Abdel Aziz II., 2006, J AL AQSA U, V10, P41; Abou-ElWafa HS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/418724; Akinosun O. M., 2006, Indian Journal of Occupational and Environmental Medicine, V10, P58; [Anonymous], 2006, J AM ACAD ORTHOP S1, V15, p104S; [Anonymous], 2017, Z IDEENGESCHICHTE, V11, P45; [Anonymous], 2007, CRITICAL CARE, V11, pR17; [Anonymous], 2016, ZHONG GUO WEN WU BAO, V2, P6; Arnold SM, 2013, CRIT REV TOXICOL, V43, P119, DOI 10.3109/10408444.2012.756455; Azari MR, 2012, INT J OCCUP ENV MED, V3, P39; Ekpenyong CE, 2017, INT J OCCUP MED ENV, V30, P1, DOI 10.13075/ijomeh.1896.00800; El-Mahdy N. M., 2015, British Journal of Applied Science & Technology, V7, P502; El-Said KF, 2010, JHIPH, V40, P586; Eltom A, 2017, SCH J APPL MED SCI, V5, P738; Federal Democratic Republic of Ethiopia Central Statistical Agency, 2013, POP PROJ ETH ALL REG; Gali RM, 2012, ADV LAB MED INT, V2, P123; Gowda S, 2010, N AM J MED SCI, V2, P170; Gupta N, 2017, NATL J PHYSL PHARM P, V7, P1099; Hall Philip, 2012, Ulster Med J, V81, P30; Hegazy R. M., 2014, AM J MED MED SCI, V4, P35; Hemalatha T, 2013, INDIAN J EXP BIOL, V51, P777; Hussain, 2016, ENG TECHNOL J, V19, P135, DOI 10.22401/JNUS.19.4.18; Jabir MS, 2016, ENG TECHNOL J B, V34, P375; Kim S, 2006, CANCER EPIDEM BIOMAR, V15, P2246, DOI 10.1158/1055-9965.EPI-06-0262; Kinawy Amal A., 2009, BMC Physiology, V9, P21, DOI 10.1186/1472-6793-9-21; Kitwattanavong M, 2013, HUM ECOL RISK ASSESS, V19, P1424, DOI 10.1080/10807039.2012.685814; Lichtenstein GR, 2002, GASTROENTEROLOGY, V123, P1364, DOI 10.1053/gast.2002.36060; Limdi JK, 2003, POSTGRAD MED J, V79, P307, DOI 10.1136/pmj.79.932.307; Malini S.S.N., 2017, ASIA PACIFIC J MED T, V6, P6; Micyus NJ, 2005, J CHROMATOGR A, V1086, P115, DOI 10.1016/j.chroma.2005.06.015; Moro AM, 2017, MUTAT RES-GEN TOX EN, V813, P1, DOI 10.1016/j.mrgentox.2016.11.002; Ogunneye AL, 2014, NIG J BASIC APPL SCI, V22, P57; Olmedo-Buenrostro BA, 2017, BIOMED RES, V28, P9859; Ravnskov Uffe, 2005, BMC Nephrol, V6, P15, DOI 10.1186/1471-2369-6-15; Sharif NEMA, 2016, SCH ACAD J BIOSCI, V4, P498; Sipos P., 2003, ACTA BIOL SZEGED, V47, P139; Soderland P, 2010, ADV CHRONIC KIDNEY D, V17, P254, DOI 10.1053/j.ackd.2010.03.011; Thapa BR, 2007, INDIAN J PEDIATR, V74, P663, DOI 10.1007/s12098-007-0118-7; Truong LD, 2009, FROZEN SECT LIBR, V2, P1, DOI 10.1007/978-1-4419-0691-5_1	38	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239716	10.1371/journal.pone.0239716	http://dx.doi.org/10.1371/journal.pone.0239716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035217	Green Published, gold			2022-12-26	WOS:000581817500059
J	Ling, SD; Cornwall, CE; Tilbrook, B; Hurd, CL				Ling, Scott D.; Cornwall, Christopher E.; Tilbrook, Bronte; Hurd, Catriona L.			Remnant kelp bed refugia and future phase-shifts under ocean acidification	PLOS ONE			English	Article							HABITAT-FORMING SEAWEEDS; MARINE; PH; MACROALGAE; VARIABILITY; DIVERSITY; RESPONSES; ECOSYSTEM	Ocean warming, ocean acidification and overfishing are major threats to the structure and function of marine ecosystems. Driven by increasing anthropogenic emissions of CO2, ocean warming is leading to global redistribution of marine biota and altered ecosystem dynamics, while ocean acidification threatens the ability of calcifying marine organisms to form skeletons due to decline in saturation state of carbonate omega and pH. In Tasmania, the interaction between overfishing of sea urchin predators and rapid ocean warming has caused a phase-shift from productive kelp beds to overgrazed sea urchin barren grounds, however potential impacts of ocean acidification on this system have not been considered despite this threat for marine ecosystems globally. Here we use automated loggers and point measures of pH, spanning kelp beds and barren grounds, to reveal that kelp beds have the capacity to locally ameliorate effects of ocean acidification, via photosynthetic drawdown of CO2, compared to unvegetated barren grounds. Based on meta-analysis of anticipated declines in physiological performance of grazing urchins to decreasing pH and assumptions of nil adaptation, future projection of OA across kelp-barrens transition zones reveals that kelp beds could act as important pH refugia, with urchins potentially becoming increasingly challenged at distances >40 m from kelp beds. Using spatially explicit simulation of physicochemical feedbacks between grazing urchins and their kelp prey, we show a stable mosaicked expression of kelp patches to emerge on barren grounds. Depending on the adaptative capacity of sea urchins, future declines in pH appear poised to further alter phase-shift dynamics for reef communities; thus, assessing change in spatial-patterning of reef-scapes may indicate cascading ecological impacts of ocean acidification.	[Ling, Scott D.; Cornwall, Christopher E.; Hurd, Catriona L.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Cornwall, Christopher E.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Tilbrook, Bronte] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Tilbrook, Bronte] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia	University of Tasmania; Victoria University Wellington; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania	Ling, SD (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Scott.Ling@utas.edu.au	Hurd, Catriona/J-2411-2013; Ling, Scott/J-7161-2014	Hurd, Catriona/0000-0001-9965-4917; Ling, Scott/0000-0002-5544-8174	Australian Research Council; IMAS Postdoctoral Fellowship by the Royal Society of New Zealand Te Aparangi [RDFVUW1701]; Rutherford Discovery Fellowship by the Royal Society of New Zealand Te Aparangi [RDFVUW1701]	Australian Research Council(Australian Research Council); IMAS Postdoctoral Fellowship by the Royal Society of New Zealand Te Aparangi; Rutherford Discovery Fellowship by the Royal Society of New Zealand Te Aparangi	S. D. Ling was supported by Australian Research Council funds. C. E. Cornwall was supported by an IMAS Postdoctoral Fellowship and a Rutherford Discovery Fellowship by the Royal Society of New Zealand Te Aparangi (RDFVUW1701).	[Anonymous], 2016, CANC DISCOV; Arafeh-Dalmau N, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00499; Bennett S, 2016, MAR FRESHWATER RES, V67, P47, DOI 10.1071/MF15232; Britton D, 2016, SCI REP-UK, V6, DOI 10.1038/srep26036; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Connell SD, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0442; Cornwall CE, 2020, NAT CLIM CHANGE, V10, P143, DOI 10.1038/s41558-019-0681-8; Cornwall CE, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1168; Cornwall CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097235; Cornwall CE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2201; Cornwall CE, 2012, J PHYCOL, V48, P137, DOI 10.1111/j.1529-8817.2011.01085.x; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Dickson A.G., 2007, GUIDE BEST PRACTICES; Donelson JM, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0186; Falter JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053303; Filbee-Dexter K, 2016, MAR ECOL PROG SER, V543, P141, DOI 10.3354/meps11554; Filbee-Dexter K, 2014, MAR ECOL PROG SER, V495, P1, DOI 10.3354/meps10573; Graham MH, 2007, P NATL ACAD SCI USA, V104, P16576, DOI 10.1073/pnas.0704778104; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hurd CL, 2015, J PHYCOL, V51, P599, DOI 10.1111/jpy.12307; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; JOHNSON KM, 1993, MAR CHEM, V44, P167, DOI 10.1016/0304-4203(93)90201-X; Koweek DA, 2017, BIOGEOSCIENCES, V14, P31, DOI 10.5194/bg-14-31-2017; Krause-Jensen D, 2015, BIOGEOSCIENCES, V12, P4895, DOI 10.5194/bg-12-4895-2015; Krause-Jensen D, 2016, NAT GEOSCI, V9, P737, DOI [10.1038/NGEO2790, 10.1038/ngeo2790]; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; Lenton A, 2015, AUST METEOROL OCEAN, V65, pS1, DOI 10.22499/2.6501.012; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Ling SD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0269; Ling SD, 2012, ECOL APPL, V22, P1232, DOI 10.1890/11-1587.1; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Ling SD, 2008, GLOBAL CHANGE BIOL, V14, P907, DOI 10.1111/j.1365-2486.2008.01543.x; Ling SD, 2018, ASSESSMENT ONGOING E; Martinez B, 2018, DIVERS DISTRIB, V24, P1350, DOI 10.1111/ddi.12767; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; Oliver ECJ, 2018, PROG OCEANOGR, V161, P116, DOI 10.1016/j.pocean.2018.02.007; Pecl GT, 2017, SCIENCE, V355, DOI 10.1126/science.aai9214; Pecorino D, 2014, MAR BIOL, V161, P101, DOI 10.1007/s00227-013-2318-1; Pfister CA, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2798; Provost EJ, 2017, GLOBAL CHANGE BIOL, V23, P353, DOI 10.1111/gcb.13414; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030393; Rivest EB, 2017, CURR CLIM CHANGE REP, V3, P271, DOI 10.1007/s40641-017-0082-x; Saderne V., 2015, BIOGEOSCI DISCUSS, V12, P11423, DOI [10.5194/bgd-12-11423-2015, DOI 10.5194/BGD-12-11423-2015]; Strain EMA, 2009, MAR ECOL PROG SER, V377, P169, DOI 10.3354/meps07816; Verges A, 2016, P NATL ACAD SCI USA, V113, P13791, DOI 10.1073/pnas.1610725113; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Wahl M, 2018, LIMNOL OCEANOGR, V63, P3, DOI 10.1002/lno.10608; Wernberg T, 2016, LIMNOL OCEANOGR, V61, P2180, DOI 10.1002/lno.10362; Wernberg T, 2016, SCIENCE, V353, P169, DOI 10.1126/science.aad8745	50	0	0	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239136	10.1371/journal.pone.0239136	http://dx.doi.org/10.1371/journal.pone.0239136			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035224	Green Accepted, Green Published, gold			2022-12-26	WOS:000581817500034
J	Sato, M; Minami, S; Nagai, N; Suzuki, M; Kurihara, T; Shinojima, A; Sonobe, H; Akino, K; Ban, N; Watanabe, K; Uchida, A; Shinoda, H; Tsubota, K; Ozawa, Y				Sato, Maho; Minami, Sakiko; Nagai, Norihiro; Suzuki, Misa; Kurihara, Toshihide; Shinojima, Ari; Sonobe, Hideki; Akino, Kunihiko; Ban, Norimitsu; Watanabe, Kazuhiro; Uchida, Atsuro; Shinoda, Hajime; Tsubota, Kazuo; Ozawa, Yoko			Association between axial length and choroidal thickness in early age-related macular degeneration	PLOS ONE			English	Article							VASCULOPATHY; MECHANISMS	The clinical course of age-related macular degeneration (AMD) is related to choroidal conditions, and can be determined by the evaluation of the central choroidal thickness (CCT). The aim of this study was to determine the association between the axial length (AL) and choroidal thickness in AMD by measuring these parameters in patients with and without AMD. Seventy eyes of 70 patients (34 men and 36 women; age, 64-88 years; mean age, 77.0 +/- 6.5 years) who underwent cataract surgery from February 2015 to March 2020 at the Department of Ophthalmology, Keio University School of Medicine were retrospectively analyzed. The AMD group (29 patients, 29 eyes) included eyes with early AMD, whereas the control group (41 patients, 41 eyes) included those without ocular diseases other than cataract. Optical coherence tomography images were used to measure the CCT and the choroidal vessel diameter (CVD). The IOL Master was used to measure the AL. The results revealed that mean CCT was greater in the AMD group (238.3 +/- 108.3 mu m) compared with the age-matched control group (187.2 +/- 66.8 mu m) (p = 0.03). The CCT was negatively correlated with AL in the overall sample (r = -0.42, p = 0.001), the AMD group (r = -0.42, p = 0.02), and the control group (r = -0.42, p = 0.006). Note that all eyes with CCT > 350 mu m were included in the AMD group. CCT and CVD were positively correlated in the overall sample (r = 0.76, p < 0.001) as well as in the individual groups (AMD: r = 0.82, p < 0.001; control: r = 0.76, p = 0.004). Given that CCT is an important parameter for predicting the prognosis of subfoveal diseases, routine evaluation of AL may be valuable for a better understanding of the pathogenesis of AMD.	[Sato, Maho; Minami, Sakiko; Nagai, Norihiro; Suzuki, Misa; Kurihara, Toshihide; Shinojima, Ari; Sonobe, Hideki; Akino, Kunihiko; Ban, Norimitsu; Watanabe, Kazuhiro; Uchida, Atsuro; Shinoda, Hajime; Tsubota, Kazuo; Ozawa, Yoko] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Nagai, Norihiro; Ozawa, Yoko] Keio Univ, Lab Retinal Cell Biol, Sch Med, Tokyo, Japan; [Ozawa, Yoko] St Lukes Int Hosp, Dept Ophthalmol, Tokyo, Japan; [Ozawa, Yoko] St Lukes Int Univ, Tokyo, Japan	Keio University; Keio University; St. Luke's International Hospital; St. Luke's International Hospital	Ozawa, Y (corresponding author), Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan.; Ozawa, Y (corresponding author), Keio Univ, Lab Retinal Cell Biol, Sch Med, Tokyo, Japan.; Ozawa, Y (corresponding author), St Lukes Int Hosp, Dept Ophthalmol, Tokyo, Japan.; Ozawa, Y (corresponding author), St Lukes Int Univ, Tokyo, Japan.	ozawa@a5.keio.jp	Shinojima, Ari/AAR-4442-2021; Uchida, Atsuro/GVT-8593-2022	Shinojima, Ari/0000-0003-2322-0332; 				Chen HY, 2012, MOL VIS, V18, P816; Cheung C.M.G., EYE; Cheung CMG, 2018, OPHTHALMOLOGY, V125, P708, DOI 10.1016/j.ophtha.2017.11.019; Cooper J, 2018, EYE CONTACT LENS, V44, P231, DOI 10.1097/ICL.0000000000000499; Dansingani KK, 2018, CLIN EXP OPHTHALMOL, V46, P189, DOI 10.1111/ceo.13114; Fan Qiao, 2017, J HUM GENET; Flores-Moreno I, 2013, AM J OPHTHALMOL, V155, P314, DOI 10.1016/j.ajo.2012.07.015; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Handy DE, 2011, CIRCULATION, V123, P2145, DOI 10.1161/CIRCULATIONAHA.110.956839; Hosoda Y, 2018, P NATL ACAD SCI USA, V115, P6261, DOI 10.1073/pnas.1802212115; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Kishi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206646; Koizumi H, 2011, GRAEF ARCH CLIN EXP, V249, P1123, DOI 10.1007/s00417-011-1620-1; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; Mansour AM, 2019, BR J OPHTHALMOL; McAfee PC, 2010, J SPINAL DISORD TECH, V23, P1, DOI 10.1097/BSD.0b013e31819e2ab8; Michalewski J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/639160; Morizane Y, 2019, JPN J OPHTHALMOL, V63, P26, DOI 10.1007/s10384-018-0623-4; Sasaki M, 2014, OPTOMETRY VISION SCI, V91, P849, DOI 10.1097/OPX.0000000000000317; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Stepanov A, 2018, CES SLOV OFTALMOL, V74, P3, DOI [10.31348/2018/1/1-1-2018, DOI 10.31348/2018/1/1-1-2018]; Suzuki M, 2016, AM J OPHTHALMOL, V166, P52, DOI 10.1016/j.ajo.2016.03.024; Suzuki M, 2014, BRIT J OPHTHALMOL, V98, P1186, DOI 10.1136/bjophthalmol-2013-304670; Ulaganathan S, 2019, EXP EYE RES, V189, DOI 10.1016/j.exer.2019.107850; Uyama M, 2000, OPHTHALMOLOGY, V107, P441, DOI 10.1016/S0161-6420(99)00141-4; Wakatsuki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144156; Wallman J, 1995, NAT MED; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Yoneyama S, 2016, RETINA-J RET VIT DIS, V36, P1535, DOI 10.1097/IAE.0000000000000964	29	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240357	10.1371/journal.pone.0240357	http://dx.doi.org/10.1371/journal.pone.0240357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035241	Green Published, gold			2022-12-26	WOS:000581817500002
J	Wexler, C; Nazir, N; Maloba, M; Brown, M; Goggin, K; Gautney, B; Maosa, N; Babu, S; Muchoki, E; Mabachi, N; Lwembe, R; Finocchario-Kessler, S				Wexler, Catherine; Nazir, Niaman; Maloba, May; Brown, Melinda; Goggin, Kathy; Gautney, Brad; Maosa, Nicodemus; Babu, Shadrack; Muchoki, Elizabeth; Mabachi, Natabhona; Lwembe, Raphael; Finocchario-Kessler, Sarah			Programmatic evaluation of feasibility and efficiency of at birth and 6-week, point of care HIV testing in Kenyan infant	PLOS ONE			English	Article							DIAGNOSIS SERVICES; MORTALITY	Background Testing infants at birth and with more efficient point of care (POC) HIV diagnostic can streamline EID and expedite infant ART initiation. We evaluated the implementation of at birth and 6-week POC testing to assess the effectiveness and feasibility when implemented by existing hospital staff in Kenya. Methods Four government hospitals were randomly assigned to receive a GeneXpert HIV-1 Qual (n = 2) or Alere m-PIMA (n = 2) machine for POC testing. All HIV-exposed infants enrolled were eligible to receive POC testing at birth and 6-weeks of age. The primary outcome was repeat POC testing, defined as testing both at birth and 6-weeks of age. Secondary outcomes included predictors of repeat POC testing, POC efficiency (turnaround times of key services), and operations (failed POC results, missed opportunities). Results Of 626 enrolled infants, 309 (49.4%) received repeat POC testing, 115 (18.4%) were lost to follow up after an at-birth test, 120 (19.2%) received POC testing at 6-weeks only, 80 (12.8%) received no POC testing, and 2 (0.3%) received delayed POC testing (>12 weeks of age). Three (0.4%) were identified as HIV-positive. Of the total 853 POC tests run at birth (n = 424) or 6-weeks (n = 429), 806 (94.5%) had a valid result documented and 792 (98.3%) results had documented maternal notification. Mean time from sample collection to notification was 1.08 days, with 751 (94.8%) notifications on the same day as sample collection. Machine error rates at birth and 6-weeks were 8.5% and 2.5%, respectively. A total of 198 infants presented for care (48 at birth; 150 at 6-weeks) without receiving a POC test, representing missed opportunities for testing. Discussion At birth POC testing can streamline infant HIV diagnosis, expedite ART initiation and can be implemented by existing hospital staff. However, maternal disengagement and missed opportunities for testing must be addressed to realize the full benefits of at birth POC testing.	[Wexler, Catherine; Brown, Melinda; Mabachi, Natabhona; Finocchario-Kessler, Sarah] Univ Kansas, Med Ctr, Dept Family Med, Kansas City, KS 66103 USA; [Nazir, Niaman] Univ Kansas, Med Ctr, Dept Prevent Med, Kansas City, KS 66103 USA; [Maloba, May; Maosa, Nicodemus] Global Hlth Innovat Kenya, Nairobi, Kenya; [Goggin, Kathy] Childrens Mercy Kansas City, Hlth Serv & Outcomes Res, Kansas City, MO USA; [Goggin, Kathy] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Gautney, Brad] Global Hlth Innovat, Dallas, TX USA; [Babu, Shadrack; Muchoki, Elizabeth; Lwembe, Raphael] Kenya Govt Med Res Ctr, Nairobi, Kenya	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Kenya Medical Research Institute	Wexler, C (corresponding author), Univ Kansas, Med Ctr, Dept Family Med, Kansas City, KS 66103 USA.	Cwexler@kumc.edu			National Institute of Child Health and Human Development (NICHD) of the NIH [3R01HD076673-04S2]; University of Kansas School of Medicine Bridging Award	National Institute of Child Health and Human Development (NICHD) of the NIH; University of Kansas School of Medicine Bridging Award	Research reported in this publication was supported by the National Institute of Child Health and Human Development (NICHD) of the NIH under award number 3R01HD076673-04S2, awarded to Dr Sarah Finocchario-Kessler, and the University of Kansas School of Medicine Bridging Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott, 2018, AL Q HIV 1 2 DET 201; AIDSinfo, 2016, COUNTR FACTSH KEN; Ambia J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20309; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2018, HIV DIAGN ARV US HIV; Bhairavabhotla R, 2018, POINT OF CARE TESTIN; Bianchi F, 2020, JAIDS-J ACQ IMM DEF, V84, pS41, DOI 10.1097/QAI.0000000000002372; Cepheid, 2018, XP HIV 1 QUAL 2018; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; Dunning L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189226; Dunning L, 2017, PEDIATR INFECT DIS J, V36, P1159, DOI 10.1097/INF.0000000000001677; Frank SC, 2019, LANCET HIV, V6, pE182, DOI 10.1016/S2352-3018(18)30328-X; Goggin K, 2016, AIDS BEHAV, V20, P2141, DOI 10.1007/s10461-016-1404-z; Health Mo Program NAaSC, 2014, GUID US ANT DRUGS TR; Hsiao NY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152672; Jani IV, 2018, AIDS, V32, P1453, DOI [10.1097/QAD.0000000000001846, 10.1097/qad.0000000000001846]; Jani IV, 2014, JAIDS-J ACQ IMM DEF, V67, pE1, DOI 10.1097/QAI.0000000000000250; Khumalo Philisiwe Ntombenhle, 2020, J Acquir Immune Defic Syndr, V84 Suppl 1, pS22, DOI 10.1097/QAI.0000000000002380; Koye DN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-398; McCann NC, 2020, JAIDS-J ACQ IMM DEF, V84, pS12, DOI 10.1097/QAI.0000000000002384; Ministry of Health, 2017, UT MULT TEST PLATF O; Ministry of Health, 2018, NAT POINT CAR TEST I; Ministry of Health National AIDS STI Control Program., 2018, GUIDELINES USE ANTIR; Ministry of Health National AIDS & STI Control Programme, 2016, GUID PREV MOTH TO CH; Mwau M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190659; Mwenda R, 2018, CLIN INFECT DIS, V67, P701, DOI 10.1093/cid/ciy169; National AIDS and STI Control Program, 2018, EID DASHB 2018; National AIDS and STI Control Program, 2019, VIR LOAD DASHB 2019; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Odeny TA, 2014, AIDS, V28, P2307, DOI 10.1097/QAD.0000000000000409; Opollo VS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209778; PEPFAR, 2018, PEPFAR 2018 COUNTR O; Sabi I, 2019, CLIN INFECT DIS, V68, P615, DOI 10.1093/cid/ciy538; Sandbulte MR, 2019, PILOT FEASIBILITY ST, V5, DOI 10.1186/s40814-019-0402-0; Sibanda EL, 2013, AIDS, V27, P2787, DOI 10.1097/QAD.0000000000000027; Spooner E, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6990-z; Sutcliffe CG, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4947-6; Teasdale CA, 2020, PEDIATR INFECT DIS J, V39, pE235, DOI 10.1097/INF.0000000000002734; Technau KG, 2017, LANCET HIV, V4, pE442, DOI 10.1016/S2352-3018(17)30097-8; Technau KG, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.01/21436; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127; UNAIDS, 2018, COUNTR FACTSH KEN 20; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wexler C, 2018, AIDS BEHAV; Wexler C, 2018, 22 INT AIDS C; Wexler C, AIDS CARE; Wexler C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225642; Wexler C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181005; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2013, FAC FOLL UP RET HIV; World Health Organization, WHO PREQ IN VITR DIA	52	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240621	10.1371/journal.pone.0240621	http://dx.doi.org/10.1371/journal.pone.0240621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035274	gold, Green Published			2022-12-26	WOS:000581817500051
J	Courtenay, LA; Herranz-Rodrigo, D; Huguet, R; Mate-Gonzalez, MA; Gonzalez-Aguilera, D; Yravedra, J				Courtenay, Lloyd A.; Herranz-Rodrigo, Dario; Huguet, Rosa; Mate-Gonzalez, Miguel angel; Gonzalez-Aguilera, Diego; Yravedra, Jose			Obtaining new resolutions in carnivore tooth pit morphological analyses: A methodological update for digital taphonomy	PLOS ONE			English	Article							CRANIAL SHAPE VARIATION; GEOMETRIC MORPHOMETRICS; MEASUREMENT ERROR; BONE MODIFICATIONS; OLDUVAI GORGE; LONG BONES; MEAN SHIFT; PATTERNS; BEHAVIOR; HOMINID	Modern day investigation in fields of archaeology and palaeontology can be greatly characterised by an exponential growth of integrated new technologies, nevertheless, while these advances are of great significance to multiple lines of research, their evaluation and update over time is equally as important. Here we present an application of inter and intra-observer analysis in taphonomy based geometric morphometrics, employing robust non-parametric statistical analyses for the study of experimental carnivore tooth pit morphologies. To fully understand the influence of measurement errors in the collection of this data, our statistical assessment was performed on fully superimposed, partially superimposed and raw landmark coordinates collected from 3D surface scanning. Experimental samples used to assess these errors includes wolf and dog tooth pits used in modern day ecological livestock predation analysis. Results obtained from this study highlight the importance of landmark type in the assessment of error, emphasising the value of semi-landmark models over the use of ambiguous Type III landmarks. In addition to this, data also reveals the importance of observer experience for the collection of data alongside an interesting increase in error when working with fully superimposed landmarks due to the "Pinocchio Effect". Through this study we are able to redefine the geometric morphometric models used for tooth pit morphological analyses. This final hybrid Type II fixed landmark and semi-landmark model presents a significant reduction in human induced error, generating a more metrically reliable and replicable method that can be used for data pooling in future inter-institutional research. These results can be considered a fundamental step forward for carnivore inspired studies, having an impact on archaeological, palaeontological, modern-day ecological research as well as applications in other forensic sciences.	[Courtenay, Lloyd A.; Mate-Gonzalez, Miguel angel; Gonzalez-Aguilera, Diego] Univ Salamanca, Dept Cartog & Terrain Engn, Higher Polytech Sch Avila, Avila, Spain; [Herranz-Rodrigo, Dario; Yravedra, Jose] Univ Complutense Madrid, Dept Prehist, Madrid, Spain; [Herranz-Rodrigo, Dario; Yravedra, Jose] Univ Complutense Madrid, CAI Archaeometry & Archaeol Anal, Madrid, Spain; [Huguet, Rosa] Inst Catala Paleoecol Humana Evolucio Social IPHE, Tarragona, Spain; [Huguet, Rosa] Univ Rovira & Virgili URV, Dept Hist & Hist Art, Tarragona, Spain; [Huguet, Rosa] Museo Ciencias Nat, Dept Paleobiol, Unit Associated CSIC, Madrid, Spain; [Mate-Gonzalez, Miguel angel; Gonzalez-Aguilera, Diego] Gran Duque de Alba Inst, Diputac Prov Avila, Avila, Spain; [Mate-Gonzalez, Miguel angel] Tech Univ Madrid, Higher Tech Sch Engineers Topog Geodesy & Cartog, Dept Topog & Cartog Engn, Madrid, Spain	University of Salamanca; Complutense University of Madrid; Complutense University of Madrid; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Consejo Superior de Investigaciones Cientificas (CSIC); Museu de Ciencies Naturals de Barcelona; Universidad Politecnica de Madrid	Courtenay, LA (corresponding author), Univ Salamanca, Dept Cartog & Terrain Engn, Higher Polytech Sch Avila, Avila, Spain.	ladc1995@gmail.com	Maté-González, Miguel Ángel/I-4466-2017	Maté-González, Miguel Ángel/0000-0001-5721-346X; Courtenay, Lloyd/0000-0002-4810-2001; Yravedra, Jose/0000-0002-4323-3379; Gonzalez-Aguilera, Diego/0000-0002-8949-4216; Herranz Rodrigo, Dario/0000-0002-4915-2019	Spanish Ministry of Science, Innovation and Universities with a FPI Predoctoral Grant [PRE2019-089411, RTI2018-099850-BI00]; University of Salamanca; MICINNFEDER [PGC2018-093925-BC32]; AGUAR project [SGR 2017-1040]; Universitat Rovira I Virgili [PFR-URV-B2-147]; CERCA Programme/Generalitat de Catalunya; Ministry of Science, Innovation and Universities [REF: PEJ2019005420-A]; General Foundation of the University of Salamanca; Project "WOLF_FOOTPRINT" [PC-TCUE1820_2013]	Spanish Ministry of Science, Innovation and Universities with a FPI Predoctoral Grant; University of Salamanca; MICINNFEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); AGUAR project; Universitat Rovira I Virgili; CERCA Programme/Generalitat de Catalunya; Ministry of Science, Innovation and Universities; General Foundation of the University of Salamanca; Project "WOLF_FOOTPRINT"	L.A.C. is supported by the Spanish Ministry of Science, Innovation and Universities with a FPI Predoctoral Grant (Ref. PRE2019-089411) associated to project RTI2018-099850-BI00 and the University of Salamanca. R.H. is supported by MICINNFEDER PGC2018-093925-BC32, the AGUAR project number SGR 2017-1040; the Universitat Rovira I Virgili (2014, 2015 and 2016 PFR-URV-B2-147) and CERCA Programme/Generalitat de Catalunya. D.H.R. is supported by the Ministry of Science, Innovation and Universities, under the contract REF: PEJ2019005420-A as part of the i+D+I Garantia Juvenil. Finally L.A.C., M.A.M.G and D.G.A. are supported by the General Foundation of the University of Salamanca under the Plan TCUE 2018-2020; Project "WOLF_FOOTPRINT" (PC-TCUE1820_2013); lead researcher D.G.A. Funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139800; AlBadawy EA, 2018, MED PHYS, V45, P1150, DOI 10.1002/mp.12752; Albrecht G.H., 1992, Human Evolution, V7, P49, DOI 10.1007/BF02436412; AMES JA, 1980, CALIF FISH GAME, V66, P196; Andres M, 2012, ARCHAEOL ANTHROP SCI, V4, P209, DOI 10.1007/s12520-012-0093-4; Mate-Gonzalez MA, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9090873; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; Aramendi J, 2019, QUATERN INT, V517, P118, DOI 10.1016/j.quaint.2019.05.029; Aramendi J, 2017, PALAEOGEOGR PALAEOCL, V488, P93, DOI 10.1016/j.palaeo.2017.05.021; Arnqvist G, 1998, ACTA ZOOL ACAD SCI H, V44, P73; Arriaza MC, 2021, HIST BIOL, V33, P176, DOI 10.1080/08912963.2019.1598401; Backwell LR, 2012, PALAEOGEOGR PALAEOCL, V337, P72, DOI 10.1016/j.palaeo.2012.03.032; Balak N, 2021, J NEUROSURG-SPINE, V34, P348, DOI 10.3171/2020.8.SPINE201586; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Baylac M, 2003, BIOL J LINN SOC, V80, P89, DOI 10.1046/j.1095-8312.2003.00221.x; Binford L.R., 1981, BONES ANCIENT MEN MO; Blackwell GL, 2006, J MAMMAL, V87, P216, DOI 10.1644/05-MAMM-A-215R1.1; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; BRAIN C. K, 1981, HUNTERS HUNTED INTRO; Caceres I, 2011, J ARCHAEOL SCI, V38, P2767, DOI 10.1016/j.jas.2011.06.020; Chang K, 2018, J AM MED INFORM ASSN, V25, P945, DOI 10.1093/jamia/ocy017; Chapman R.E., 1990, P MICHIGAN MORPHOMET, P251; CHENG YZ, 1995, IEEE T PATTERN ANAL, V17, P790, DOI 10.1109/34.400568; Cichosz P., 2015, DATA MINING ALGORITH; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Copes LE, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.1; Corner BD, 1992, J QUANT ANTHR, V3, P347; Courtenay LA, 2019, PALAEOGEOGR PALAEOCL, V522, P28, DOI 10.1016/j.palaeo.2019.03.007; Courtenay LA, 2019, ARCHAEOL ANTHROP SCI, V11, P651, DOI 10.1007/s12520-017-0554-x; Crosilla F, 2002, ISPRS J PHOTOGRAMM, V56, P195, DOI 10.1016/S0924-2716(02)00043-6; D'Amore DC, 2009, PALEOBIOLOGY, V35, P525, DOI 10.1666/0094-8373-35.4.525; Daboul A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197675; Delaney-Rivera C, 2009, J ARCHAEOL SCI, V36, P2597, DOI 10.1016/j.jas.2009.08.001; DEMERE TA, 1982, J PALEONTOL, V56, P1480; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P1385, DOI 10.1016/S0305-4403(03)00027-X; Dominguez-Solera SD, 2009, INT J OSTEOARCHAEOL, V19, P345, DOI 10.1002/oa.987; DominguezRodrigo M, 2007, VERTEBR PALEOBIOL PA, P1; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Erickson GM, 1996, J VERTEBR PALEONTOL, V16, P175, DOI 10.1080/02724634.1996.10011297; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Fernandez-Jalvo Y, 2011, J HUM EVOL, V60, P117, DOI 10.1016/j.jhevol.2010.08.003; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Galland M, 2016, AM J HUM BIOL, V28, P646, DOI 10.1002/ajhb.22845; Garcia-Medrano P, 2019, J ARCHAEOL METHOD TH, V26, P396, DOI 10.1007/s10816-018-9376-0; Gidna A, 2013, J ARCHAEOL SCI, V40, P1903, DOI 10.1016/j.jas.2012.11.023; Gonzalez-Aguilera D, 2008, NONDESTRUCT TEST EVA, V23, P301, DOI 10.1080/10589750802259000; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Gunz P, 2004, BAR INTERNAT SERIES, V1227; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz4729; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Guy F, 2003, AM J PHYS ANTHROPOL, V121, P198, DOI 10.1002/ajpa.10261; Hanihara T, 1999, ANTHROPOL SCI, V107, P25, DOI 10.1537/ase.107.25; Hasan A., 2011, HYDROLOGY EARTH SYST, V8, P5497, DOI DOI 10.5194/HESSD-8-5497-2011; HAYNES G, 1983, PALEOBIOLOGY, V9, P164, DOI 10.1017/S0094837300007545; HAYNES G, 1980, PALEOBIOLOGY, V6, P341, DOI 10.1017/S0094837300006849; Heathcote G., 1981, CAN REV PHYS ANTHR, V3, P18; Herrero-Huerta M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196004; Hohle J, 2009, ISPRS J PHOTOGRAMM, V64, P398, DOI 10.1016/j.isprsjprs.2009.02.003; Hutson JM, 2013, J ARCHAEOL SCI, V40, P4139, DOI 10.1016/j.jas.2013.06.004; JAMISON PL, 1993, AM J PHYS ANTHROPOL, V90, P495, DOI 10.1002/ajpa.1330900409; JOHNSON DL, 1985, QUATERNARY RES, V24, P365, DOI 10.1016/0033-5894(85)90060-2; Kieser J, 2008, INT J LEGAL MED, V122, P179, DOI 10.1007/s00414-007-0187-1; Komo L, 2018, FORENSIC SCI INT, V288, P189, DOI 10.1016/j.forsciint.2018.04.048; Koneny J, 2017, NEURAL INFO PROCESS; Koneny J, 2015, NEURAL INFO PROCESS; Kovarovic K, 2011, J ARCHAEOL SCI, V38, P3006, DOI 10.1016/j.jas.2011.06.028; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Larochelle Hugo, 2008, P 25 INT C MACHINE L, P536, DOI DOI 10.1145/1390156.1390224; Li FF, 2006, IEEE T PATTERN ANAL, V28, P594, DOI 10.1109/TPAMI.2006.79; Lloveras L, 2018, HIST BIOL, V30, P835, DOI 10.1080/08912963.2017.1319830; Lockwood CA, 2002, J ANAT, V201, P447, DOI 10.1046/j.1469-7580.2002.00122.x; Lombao D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14322-y; Longrich NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013419; Lycett SJ, 2006, J ARCHAEOL SCI, V33, P847, DOI 10.1016/j.jas.2005.10.014; Gonzalez MAM, 2015, J ARCHAEOL SCI, V62, P128, DOI 10.1016/j.jas.2015.08.006; McMahan B. H., 2017, P 20 INT C ART INT S; Mench Joy A., 1996, P5; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; Munoz-Munoz F, 2010, ANN ZOOL FENN, V47, P46, DOI 10.5735/086.047.0105; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; O'Higgins P, 2000, J ANAT, V197, P103, DOI 10.1046/j.1469-7580.2000.19710103.x; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; O'Regan Hannah J., 2011, Journal of Taphonomy, V9, P69; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Peterhans JCK, 2006, S AFR ARCHAEOL BULL, V61, P2; Peto R, 2018, J EXP CHILD PSYCHOL, V171, P99, DOI 10.1016/j.jecp.2018.02.007; Pineda A, 2019, ARCHAEOL ANTHROP SCI, V11, P2539, DOI 10.1007/s12520-018-0686-7; Raina R., 2006, PROC 23 INT C MACH L, P713, DOI DOI 10.1145/1143844.1143934; Richtsmeier Joan T., 2005, P49, DOI 10.1016/B978-012088777-4/50006-5; Robinson C, 2017, AM J PHYS ANTHROPOL, V164, P62, DOI 10.1002/ajpa.23257; Rodrigues M, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11030774; Rodriguez-Gonzalvez P, 2014, SENSORS-BASEL, V14, P13759, DOI 10.3390/s140813759; Rodriguez-Hidalgo A, 2017, J HUM EVOL, V105, P89, DOI 10.1016/j.jhevol.2017.01.007; Rogers RR, 2003, NATURE, V422, P515, DOI 10.1038/nature01532; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Saladie P, 2013, INT J OSTEOARCHAEOL, V23, P13, DOI 10.1002/oa.1237; Saladie P, 2019, HIST BIOL, V31, P665, DOI 10.1080/08912963.2017.1384476; Saladie P, 2013, J ARCHAEOL SCI, V40, P380, DOI 10.1016/j.jas.2012.08.002; Sanders WJ, 2003, J HUM EVOL, V44, P87, DOI 10.1016/S0047-2484(02)00196-3; Satopaa V., 2011, Proceedings of the 2011 31st International Conference on Distributed Computing Systems Workshops (ICDCS Workshops), P166, DOI 10.1109/ICDCSW.2011.20; Shearer BM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187452; Sholts SB, 2011, INT J OSTEOARCHAEOL, V21, P535, DOI 10.1002/oa.1156; SINGER R, 1956, AM ANTHROPOL, V58, P1127, DOI 10.1525/aa.1956.58.6.02a00110; Singleton M, 2002, J HUM EVOL, V42, P547, DOI 10.1006/jhev.2001.0539; Socher R., 2013, ADV NEURAL INFORM PR, P935; Srivastava N, 2014, J MACH LEARN RES, V15, P2949; TOMARKEN AJ, 1986, PSYCHOL BULL, V99, P90, DOI 10.1037/0033-2909.99.1.90; Valeri CJ, 1998, AM J PHYS ANTHROPOL, V107, P113, DOI 10.1002/(SICI)1096-8644(199809)107:1<113::AID-AJPA9>3.3.CO;2-U; Vargha A, 1998, J EDUC BEHAV STAT, V23, P170, DOI 10.3102/10769986023002170; Vioarsdottir US, 2002, J ANAT, V201, P211; von Cramon-Taubadel N, 2007, AM J PHYS ANTHROPOL, V134, P24, DOI 10.1002/ajpa.20616; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Wiley DF, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P431; YEZERINAC SM, 1992, SYST BIOL, V41, P471, DOI 10.2307/2992588; Yosinski J, 2014, ADV NEUR IN, V27; Yravedra J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52807-0; Yravedra J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194324; Yravedra J, 2017, J ARCHAEOL SCI-REP, V14, P106, DOI 10.1016/j.jasrep.2017.05.043; Yravedra J, 2017, BOREAS, V46, P860, DOI 10.1111/bor.12224; Yravedra Jose, 2011, Journal of Taphonomy, V9, P37	126	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240328	10.1371/journal.pone.0240328	http://dx.doi.org/10.1371/journal.pone.0240328			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TB	33031413	Green Published, gold			2022-12-26	WOS:000581809800084
J	Habukawa, C; Ohgami, N; Matsumoto, N; Hashino, K; Asai, K; Sato, T; Murakami, K				Habukawa, Chizu; Ohgami, Naoto; Matsumoto, Naoki; Hashino, Kenji; Asai, Kei; Sato, Tetsuya; Murakami, Katsumi			A wheeze recognition algorithm for practical implementation in children	PLOS ONE			English	Article							NOCTURNAL ASTHMA; YOUNG INFANTS; LUNG SOUNDS	Background The detection of wheezes as an exacerbation sign is important in certain respiratory diseases. However, few highly accurate clinical methods are available for automatic detection of wheezes in children. This study aimed to develop a wheeze detection algorithm for practical implementation in children. Methods A wheeze recognition algorithm was developed based on wheezes features following the Computerized Respiratory Sound Analysis guidelines. Wheezes can be detected by auscultation with a stethoscope and using an automatic computerized lung sound analysis. Lung sounds were recorded for 30 s in 214 children aged 2 months to 12 years and 11 months in a pediatric consultation room. Files containing recorded lung sounds were assessed by two specialist physicians and divided into two groups: 65 were designated as "wheeze" files, and 149 were designated as "no-wheeze" files. All lung sound judgments were agreed between two specialist physicians. We compared wheeze recognition between the specialist physicians and using the wheeze recognition algorithm and calculated the sensitivity, specificity, positive predictive value, and negative predictive value for all recorded sound files to evaluate the influence of age on the wheeze detection sensitivity. Results The detection of wheezes was not influenced by age. In all files, wheezes were differentiated from noise using the wheeze recognition algorithm. The sensitivity, specificity, positive predictive value, and negative predictive value of the wheeze recognition algorithm were 100%, 95.7%, 90.3%, and 100%, respectively. Conclusions The wheeze recognition algorithm could identify wheezes in sound files and therefore may be useful in the practical implementation of respiratory illness management at home using properly developed devices.	[Habukawa, Chizu] Minami Wakayama Med Ctr, Dept Paediat, Wakayama, Japan; [Ohgami, Naoto; Asai, Kei; Sato, Tetsuya] Omron Healthcare Co Ltd, Clin Dev Dept, Technol Dev HQ, Dev Ctr, Kyoto, Japan; [Matsumoto, Naoki; Hashino, Kenji] Omron Healthcare Co Ltd, Core Technol Dept, Technol Dev HQ, Dev Ctr, Kyoto, Japan; [Murakami, Katsumi] Sakai Sakibana Hosp, Dept Psychosomat Med, Osaka, Japan		Habukawa, C (corresponding author), Minami Wakayama Med Ctr, Dept Paediat, Wakayama, Japan.	gd6c-hbkw@asahi-net.or.jp		Habukawa, Chizu/0000-0002-6611-1446; Ohgami, Naoto/0000-0002-7275-1968	Omron Health Care Corporation	Omron Health Care Corporation	The Omron Health Care Corporation provided support in the form of salaries for authors Naoto Ohgami, Naoki Matsumoto, Kenji Hashino, Kei Asai and Tetsuya Sato, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. This does not alter our adherence to the policies of PlosOne on sharing data and materials. Chizu Habukawa and Katsumi Murakami received a research grant from Omron Health Care Corporation.	Andres E, 2018, J Med Life, V11, P89; Andres E, 2009, EUR J INTERN MED, V20, P323, DOI 10.1016/j.ejim.2008.08.013; Arakawa H, 2017, ALLERGOL INT, V66, P190, DOI 10.1016/j.alit.2016.11.003; BAUGHMAN RP, 1984, CHEST, V86, P718, DOI 10.1378/chest.86.5.718; Beck Raphael, 2007, BMC Pediatr, V7, P22, DOI 10.1186/1471-2431-7-22; Bentur L, 2003, EUR RESPIR J, V21, P621, DOI 10.1183/09031936.03.00036302; Boner AL, 2010, J ASTHMA, V47, P290, DOI 10.3109/02770900903497188; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Cane RS, 2000, ARCH DIS CHILD, V82, P327, DOI 10.1136/adc.82.4.327; Chicco D, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-019-6413-7; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dellinger RP, 2008, RESPIRATION, V75, P60, DOI 10.1159/000103558; Elphick HE, 2000, EUR RESPIR J, V16, P593, DOI 10.1034/j.1399-3003.2000.16d04.x; Finkelstein J, 2000, CHEST, V117, P148, DOI 10.1378/chest.117.1.148; FORGACS P, 1978, CHEST, V73, P399, DOI 10.1378/chest.73.3.399; Gavriely N, 1995, BREATH SOUNDS METHOD, DOI 10.1201/9780429260544; Godfrey S, 2004, PEDIATR PULM, V37, P193, DOI 10.1002/ppul.10434; GODFREY S, 1969, THORAX, V24, P4, DOI 10.1136/thx.24.1.4; Gurung A, 2011, RESP MED, V105, P1396, DOI 10.1016/j.rmed.2011.05.007; Hashizume H, 2015, J ORTHOP SCI, V20, P264, DOI 10.1007/s00776-014-0693-1; Jin F, 2011, IEEE T BIO-MED ENG, V58, P3078, DOI 10.1109/TBME.2011.2160721; Li SH, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010171; MCFADDEN ER, 1973, NEW ENGL J MED, V288, P221, DOI 10.1056/NEJM197302012880501; MESLIER N, 1995, EUR RESPIR J, V8, P1942, DOI 10.1183/09031936.95.08111942; Murphy RLH, 2008, RESP CARE, V53, P355; Peterson-Carmichael SL, 2014, PEDIATR PULM, V49, P126, DOI 10.1002/ppul.22807; Prodhan P, 2008, RESP CARE, V53, P1304; Puder LC, 2016, PHYSIOL MEAS, V37, P2170, DOI 10.1088/0967-3334/37/12/2170; Puder LC, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-257; R Core Team, 2018, R LANG ENV STAT COMP; Rao G, 2004, J FAM PRACTICE, V53, P53; Shaharum SM, 2012, BOSNIAN J BASIC MED, V12, P249; Sovijarvi A., 2000, EUR RESP REV, V10, P597; Sovijarvi A., 2000, EUR RESPIR REV, V10, P585; Taplidou SA, 2007, COMPUT BIOL MED, V37, P1073, DOI 10.1016/j.compbiomed.2006.09.007; Tenero L, 2013, EARLY HUM DEV, V89, pS13, DOI [10.1016/j.earlhumdev.2013.07.017, 10.1016/S0378-3782(13)70007-0]; Wisniewski JA, 2013, CLIN EXP ALLERGY, V43, P1160, DOI 10.1111/cea.12169; Yoshimasu T, 2015, ANN THORAC CARDIOVAS, V21, P1, DOI 10.5761/atcs.oa.13-00318	38	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240048	10.1371/journal.pone.0240048	http://dx.doi.org/10.1371/journal.pone.0240048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031408	gold, Green Published			2022-12-26	WOS:000581809800013
J	Hu, RC; Gu, YY; Luo, M; Lu, Z; Wei, M; Zhong, J				Hu, Ruocheng; Gu, Yiyun; Luo, Mei; Lu, Zhi; Wei, Ming; Zhong, Jia			Shifts in bird ranges and conservation priorities in China under climate change	PLOS ONE			English	Article							DISTRIBUTION MODELS; SELECTING THRESHOLDS; SPECIES-OCCURRENCE; EXTINCTION RISK; BIAS CORRECTION; SAMPLE-SIZE; DISTRIBUTIONS; BIODIVERSITY; PREDICTIONS; PERFORMANCE	Climate change is one of the most significant causes of species range shift and extinction. Based on a citizen science dataset of birds in China, the Bird Report, we developed a high-resolution map of bird species richness in China, and simulated the range shifts and area changes of the 1,042 birds through the year 2070 using three different General Circulation Models and two different Representative Concentration Pathways (RCPs, including RCP 2.6 and RCP 8.5). It was found that 241-244 (under different scenarios) bird species would lose a portion of their distribution ranges; and that most species in China would move to either higher elevations or northward. The other 798-801 species would experience range expansion. Compared to resident species (n = 516), migratory birds (n = 526) may undergo more limited range expansion but a longer range shift distance on average. The species diversity of birds will considerably increase in areas higher than 1,500 m in elevation under both RCPs. Conservation priorities with higher species richness were also identified using the Zonation model. The existing national nature reserves are not sufficient for protecting important bird habitats, especially after range shifts. Significant gaps in protected areas were observed in the northern Xinjiang, southern Tibet, Greater Khingan, Sanjiang Plain, Songnen Plain, northern Bohai Rim, and southeastern coastline areas. Many of these areas are characterized by high human populations and intensive development, and establishing sizable protected areas has become difficult. Inclusive conservation mechanisms that include restoring habitats in urban parks and sharing habitats in farmland areas, may be a feasible solution.	[Hu, Ruocheng; Luo, Mei; Lu, Zhi] Peking Univ, Sch Life Sci, Ctr Nat & Soc, Beijing, Peoples R China; [Hu, Ruocheng; Gu, Yiyun] Shan Shui Conservat Ctr, Beijing, Peoples R China; [Wei, Ming; Zhong, Jia] China Birdwatching Assoc, Kunming, Yunnan, Peoples R China; [Gu, Yiyun] Beijing Jinglang Ecol & Tech Co LTD, Beijing, Peoples R China	Peking University	Lu, Z (corresponding author), Peking Univ, Sch Life Sci, Ctr Nat & Soc, Beijing, Peoples R China.	luzhi@pku.edu.cn	Hu, Ruocheng/AAY-7463-2020	Hu, Ruocheng/0000-0002-6643-2055	Beijing Jinglang Ecology and Techniques Co., LTD	Beijing Jinglang Ecology and Techniques Co., LTD	This research has no specific funding. Beijing Jinglang Ecology and Techniques Co., LTD is the current employer of Ms. Yiyun Gu, but the employment relationship was established after Ms. Gu completed all her research presented in this paper. Other than this fact, this company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Adler FR, 2020, ANN NY ACAD SCI, V1469, P52, DOI 10.1111/nyas.14340; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Ashraf U, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1825; Bruckner A, 2008, SCIENCE, V321, P560, DOI [10.1126/science.1159196, DOI 10.1126/SCIENCE.115919618653892]; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Callaghan CT, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1487; Camara-Leret R, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaz1455; CBD, 2020, ZER DRAFT POST 2020; Cooper CB, 2007, ECOL SOC, V12; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Diaz S., 2019, GLOBAL ASSESSMENT RE, DOI [10.5281/zenodo.3553579, 10.5281/zenodo.3831674]; Distler T, 2015, J BIOGEOGR, V42, P976, DOI 10.1111/jbi.12479; El-Gabbas A, 2018, ECOGRAPHY, V41, P1161, DOI 10.1111/ecog.03149; Fithian W, 2015, METHODS ECOL EVOL, V6, P424, DOI 10.1111/2041-210X.12242; Foden WB, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.551; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Graham EM, 2019, AUSTRALAS J ENV MAN, V26, P112, DOI 10.1080/14486563.2019.1599742; Gregory R.D., 2003, Ornis Hungarica, V12-13, P11; Gu Lei, 2015, Biodiversity Science, V23, P583; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hanson JO, 2020, NATURE, V580, P232, DOI 10.1038/s41586-020-2138-7; Herkt KMB, 2017, GLOBAL ECOL BIOGEOGR, V26, P930, DOI 10.1111/geb.12601; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Hu J, 2014, REG ANESTH PAIN MED, V9, pe84529, DOI 10.1371/journal.pone.0084529; Hu RC, 2017, BIOL CONSERV, V211, P47, DOI 10.1016/j.biocon.2017.03.033; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; Isaac NJB, 2014, METHODS ECOL EVOL, V5, P1052, DOI 10.1111/2041-210X.12254; JIA YF, 2020, ECOL INDIC, V0114, DOI DOI 10.1016/J.EC0LIND.2020.106330; Johnston A, 2013, NAT CLIM CHANGE, V3, P1055, DOI 10.1038/NCLIMATE2035; Kosmala M, 2016, FRONT ECOL ENVIRON, V14, P551, DOI 10.1002/fee.1436; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Laitila J, 2012, ECOL MODEL, V247, P40, DOI 10.1016/j.ecolmodel.2012.08.010; Langham GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135350; Levy JS, 2013, MAR POLICY, V38, P16, DOI 10.1016/j.marpol.2012.05.015; Li L, 2020, NAT ECOL EVOL, V4, P772, DOI 10.1038/s41559-020-1161-2; Li XH, 2013, REG ENVIRON CHANGE, V13, P843, DOI 10.1007/s10113-012-0344-z; Liang J, 2018, SCI TOTAL ENVIRON, V645, P1040, DOI 10.1016/j.scitotenv.2018.07.196; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Luo ZH, 2015, ECOL APPL, V25, P24, DOI 10.1890/13-1499.1; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Minin E Di, 2014, QUICK INTRO ZONATION, V2 nd; Morales NS, 2017, PEERJ, V5, DOI 10.7717/peerj.3093; National Development and Reform Commission, 2014, NAT ACT PLAN CLIM CH; Pearce-Higgins J. W., 2015, NATURAL ENGLAND COMM; Pearman PB, 2007, BIOL CONSERV, V138, P109, DOI 10.1016/j.biocon.2007.04.005; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Rotenberry JT, 2020, ECOGRAPHY, V43, P897, DOI 10.1111/ecog.04871; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Sofaer HR, 2019, BIOSCIENCE, V69, P544, DOI 10.1093/biosci/biz045; Studds CE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14895; Su Liying, 2012, Chinese Birds, V3, P147; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Trisos A.C.H., 2020, NATURE, V580, P1, DOI DOI 10.1038/S41586-020-2189-932322063; UN Environment Programme, 2020, UPD ZER DRAFT POST 2, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; USGS, 1996, GLOB 30 ARC 2 EL GTO; van Strien AJ, 2013, J APPL ECOL, V50, P1450, DOI 10.1111/1365-2664.12158; VanDerWal J, 2013, NAT CLIM CHANGE, V3, P239, DOI [10.1038/nclimate1688, 10.1038/NCLIMATE1688]; Vollering J, 2019, ECOGRAPHY, V42, P1717, DOI 10.1111/ecog.04503; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Xu YJ, 2020, CONSERV BIOL, V34, P416, DOI 10.1111/cobi.13383; Yan YJ, 2017, BIOL CONSERV, V206, P143, DOI 10.1016/j.biocon.2016.12.023; Yu H, 2017, CURR BIOL, V27, pR376, DOI 10.1016/j.cub.2017.04.037; Yu XP, 2006, BIRD CONSERV INT, V16, P325, DOI 10.1017/S0959270906000499; Zheng G., 2017, CHECKLIST CLASSIFICA, V3rd ed.	77	15	17	8	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240225	10.1371/journal.pone.0240225	http://dx.doi.org/10.1371/journal.pone.0240225			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031430	gold, Green Published			2022-12-26	WOS:000581809800094
J	Barreda, RL; Guerrero, A; de la Cuadra, JC; Scotoni, M; Salas, W; Baraona, F; Arancibia, F; Uriarte, P				Lopez Barreda, Rodrigo; Guerrero, Alonso; de la Cuadra, Juan Cristobal; Scotoni, Manuela; Salas, Wilbaldo; Baraona, Fernando; Arancibia, Francisca; Uriarte, Polentzi			Poverty, quality of life and psychological wellbeing in adults with congenital heart disease in Chile	PLOS ONE			English	Article							HEALTH-CARE; SPANISH VERSION; ADOLESCENTS; ANXIETY; HOPELESSNESS; DEPRESSION; CHILDREN; SF-36; NEEDS	The objective of this study was to assess the quality of life and psychological wellbeing of adults with congenital heart disease (CHD) in Chile, and to identify other associated factors. The study enrolled 68 patients aged between 18 and 72 (median 29), 35 being females. They completed a questionnaire, which included a quality of life assessment tool (the Medical Outcome Study 36-Item Short Form Health Survey), a number of psychological scales (the General Health Questionnaire, the Basic Psychological Needs Scales and the Beck Hopelessness Scale), a socioeconomic survey, and some clinical data. CHD patients reported worse scores in those scales assessing physical dimensions of quality of life (physical function (70.5), physical role functioning (64), vitality (65.3)), and general quality of life (58.6), than in emotional or social dimensions. Female gender was associated with lower scores in physical function (59.12 versus 82.66; p<0.01) and physical role functioning (53.68 versus 75; p<0.05); poverty was associated with worse results in physical function (61.92 versus 82.96; p<0.01), role physical (53.21 versus 79.63; p<0.01), vitality (60.89 versus 71.67; p<0.05), social role functioning (70.19 versus 82.87; p<0.05) and bodily pain (65.77 versus 81.2; p<0.05). Furthermore, we found that psychological scales had an association with quality of life, but clinical variables did not show significant correlations to any dimension. Poverty has an impact on the quality of life of CHD patients. This population only has a decrease in the quality of life physical dimensions, suggesting that quality of life depends on many different factors.	[Lopez Barreda, Rodrigo; Salas, Wilbaldo] Pontificia Univ Catolica Chile, Sch Med, Dept Anesthesiol, Santiago, Chile; [Guerrero, Alonso; de la Cuadra, Juan Cristobal] Pontificia Univ Catolica Chile, Sch Med, Santiago, Chile; [Scotoni, Manuela] Kantonsspital Winterthur, Anesthesiol Dept, Winterthur, Switzerland; [Baraona, Fernando] Pontificia Univ Catolica Chile, Sch Med, Cardiol Dept, Santiago, Chile; [Baraona, Fernando; Arancibia, Francisca; Uriarte, Polentzi] Inst Nacl Torax, Dept Cardiol, Santiago, Chile; [Arancibia, Francisca] Pontificia Univ Catolica Chile, Sch Med, Pediat Dept, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Barreda, RL (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Dept Anesthesiol, Santiago, Chile.	ralopez@uc.cl	Lopez, Rodrigo/AGT-0993-2022	Lopez Barreda, Rodrigo/0000-0003-3144-9954				Aguilar EJ, 1995, AN PSIQUIATR, V11, P121; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Apablaza M, 2012, CHRONIC MULTIDIMENSI; Apers S, 2016, J AM COLL CARDIOL, V67, P2237, DOI 10.1016/j.jacc.2016.03.477; Areias MEG, 2014, CARDIOL YOUNG, V24, P60, DOI 10.1017/S1047951114001218; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Bhat AH, 2004, CURR OPIN PEDIATR, V16, P500, DOI 10.1097/01.mop.0000140996.24408.1a; Bratt EL, 2015, INT J CARDIOL, V195, P1, DOI 10.1016/j.ijcard.2015.05.070; Bromberg JI, 2003, HEART LUNG, V32, P105, DOI 10.1067/mhl.2003.26; Chirkov VI, 2011, CROSS CULT ADV POSIT, V1, P1, DOI 10.1007/978-90-481-9667-8; Eslami B, 2017, INT J CARDIOL, V230, P64, DOI 10.1016/j.ijcard.2016.12.090; Eslami B, 2013, J PSYCHOSOM RES, V74, P49, DOI 10.1016/j.jpsychores.2012.10.006; Facultad Economia y Negocios Universidad de Chile, 2011, ENC CASEN 2011; Fteropoulli T, 2013, CARDIOL YOUNG, V23, P473, DOI 10.1017/S1047951112002351; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; Gillet N, 2008, CAN J BEHAV SCI, V40, P230, DOI 10.1037/a0013201; Goldberg D, 1998, USERS GUIDE GEN HLTH; Humphreys D, 1991, 3 CHIL C NEUR PSYCH; Jackson JL, 2016, INT J CARDIOL, V202, P804, DOI 10.1016/j.ijcard.2015.09.116; Kamphuis M, 2002, HEART, V87, P356, DOI 10.1136/heart.87.4.356; Lane DA, 2002, HEART, V88, P71, DOI 10.1136/heart.88.1.71; Latal B, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-6; Leon J, 2011, AN PSICOL-SPAIN, V27, P405; Lopez R, 2016, WORLD J PEDIATR CONG, V7, P139, DOI 10.1177/2150135115623284; MEEBERG GA, 1993, J ADV NURS, V18, P32, DOI 10.1046/j.1365-2648.1993.18010032.x; MOLLER JH, 1994, CIRCULATION, V89, P923, DOI 10.1161/01.CIR.89.2.923; Moons P, 2004, ARCH PEDIAT ADOL MED, V158, P1062, DOI 10.1001/archpedi.158.11.1062; Moons P, 2018, INT J CARDIOL, V251, P34, DOI 10.1016/j.ijcard.2017.10.064; Moons Philip, 2006, Eur J Cardiovasc Nurs, V5, P16, DOI 10.1016/j.ejcnurse.2005.10.009; Muller J, 2013, INT J CARDIOL, V165, P142, DOI 10.1016/j.ijcard.2011.08.005; Pike NA, 2012, J CARDIOVASC NURS, V27, P539, DOI 10.1097/JCN.0b013e31822ce5f6; Rassart J, 2013, PSYCHOL HEALTH, V28, P319, DOI 10.1080/08870446.2012.729836; Silva AM, 2011, CARDIOL YOUNG, V21, P670, DOI 10.1017/S1047951111000576; Trucco M, 1999, REV MED CHILE, V127, P1453; van Rijen EHM, 2003, EUR HEART J, V24, P673, DOI 10.1016/S0195-668X(02)00749-2; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Westhoff-Bleck M, 2016, J AFFECT DISORDERS, V204, P180, DOI 10.1016/j.jad.2016.06.047; Williams GC, 2011, CROSS CULT ADV POSIT, V1, P133, DOI 10.1007/978-90-481-9667-8_7; Xiang L, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010616; Zomer AC, 2012, AM J CARDIOL, V109, P1657, DOI 10.1016/j.amjcard.2012.01.397	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240383	10.1371/journal.pone.0240383	http://dx.doi.org/10.1371/journal.pone.0240383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TB	33031469	gold, Green Published			2022-12-26	WOS:000581809800040
J	Morbach, C; Sahiti, F; Tiffe, T; Cejka, V; Eichner, FA; Gelbrich, G; Heuschmann, PU; Stork, S				Morbach, Caroline; Sahiti, Floran; Tiffe, Theresa; Cejka, Vladimir; Eichner, Felizitas A.; Gelbrich, Goetz; Heuschmann, Peter U.; Stoerk, Stefan		STAAB Consortium	Myocardial work-correlation patterns and reference values from the population-based STAAB cohort study	PLOS ONE			English	Article							EUROPEAN ASSOCIATION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; QUANTIFICATION; SOCIETY	Background Recently,myocardial workanalysis as an echocardiographic tool to non-invasively determine LV work has been introduced and validated against invasive measurements. Based on systolic blood pressure and speckle-tracking derived longitudinal strain (GLS) during systole and isovolumic relaxation, it is considered less load-dependent than LV ejection fraction (LVEF) or GLS and to integrate information on LV active systolic and diastolic work. Objectives We aimed to establish reference values for global constructive (GCW) and global wasted work (GWW) as well as of global work index (GWI) and global work efficiency (GWE) across a wide age range and to assess the association with standard echocardiography parameters to estimate the potential additional information provided by myocardial work (MyW). Methods TheCharacteristics and Course of Heart Failure STAges A/B and Determinants of Progression(STAAB) cohort study carefully characterized a representative sample of the population of the City of Wurzburg, Germany, aged 30-79 years. We performedmyocardial workanalysis using the standardized, quality-controlled transthoracic echocardiograms of all individuals lacking any cardiovascular risk factor. Results Out of 4965 participants, 779 (49 +/- 10 years, 59% women) were eligible for the present analysis. Levels of GCW, GWW, and GWE were independent of sex and body mass index, and were stable until the age of 45 years. Thereafter, we observed an upward shift to further stable values of GCW and a linear increase of GWW with advancing age, resulting in lower GWE. Age-adjusted percentiles for GCW, GWW, GWI, and GWE were derived. Higher levels of blood pressure or LV mass were associated with higher GCW, GWI, and GWW, resulting in lower GWE; higher LVEF correlated with higher GCW and GWI, but lower GWW. Higher E/e ' correlated with higher GWW, higher e ' with lower GWW. Conclusions Derived from a large sample of apparently healthy individuals from a population based-cohort, we provide age-adjusted reference values for myocardial work indices, applicable for either sex. Weak correlations with common echocardiographic parameters suggest MyW indices to potentially provide additional information, which has to be evaluated in diseased patient cohorts.	[Morbach, Caroline; Sahiti, Floran; Tiffe, Theresa; Cejka, Vladimir; Eichner, Felizitas A.; Gelbrich, Goetz; Heuschmann, Peter U.; Stoerk, Stefan] Univ Hosp, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Morbach, Caroline; Sahiti, Floran; Stoerk, Stefan] Univ Wurzburg, Wurzburg, Germany; [Tiffe, Theresa; Eichner, Felizitas A.; Gelbrich, Goetz; Heuschmann, Peter U.] Univ Hosp Wurzburg, Dept Med 1, Cardiol, Wurzburg, Germany; [Gelbrich, Goetz; Heuschmann, Peter U.] Univ Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany; Univ Hosp Wurzburg, Clin Trial Ctr, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Stork, S (corresponding author), Univ Hosp, Comprehens Heart Failure Ctr, Wurzburg, Germany.; Stork, S (corresponding author), Univ Wurzburg, Wurzburg, Germany.	Stoerk_S@ukw.de	Stork, Stefan/AAR-4182-2020; Sahiti, Floran/ABG-8521-2021; Morbach, Caroline/AAL-2121-2020	Stork, Stefan/0000-0002-1771-7249; Morbach, Caroline/0000-0002-0920-6094; /0000-0003-2033-9354; Cejka, Vladimir/0000-0003-4393-1772	German Ministry of Research and Education within the Comprehensive Heart Failure Center, Wurzburg [BMBF 01EO1004, 01EO1504]	German Ministry of Research and Education within the Comprehensive Heart Failure Center, Wurzburg	The study is supported by the German Ministry of Research and Education within the Comprehensive Heart Failure Center, Wurzburg (BMBF 01EO1004 and 01EO1504). There is no relationship with industry. SS and PUH received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner H, 2017, J AM SOC ECHOCARDIOG, V30, P372, DOI [10.1016/j.echo.2017.02.009, 10.1093/ehjci/jew335]; Fruhbeck G, 2013, OBESITY FACTS, V6, P117, DOI 10.1159/000350627; Galli E, 2019, ECHOCARDIOGR-J CARD, V36, P1814, DOI 10.1111/echo.14494; Hubert A, 2018, EUR HEART J-CARD IMG, V19, P1372, DOI 10.1093/ehjci/jey024; Lancellotti P, 2013, EUR HEART J-CARD IMG, V14, P611, DOI 10.1093/ehjci/jet105; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Manganaro R, 2019, EUR HEART J-CARD IMG, V20, P582, DOI 10.1093/ehjci/jey188; Merz AA, 2016, HEART, V102, P825, DOI 10.1136/heartjnl-2015-308769; Morbach C, 2018, INT J CARDIOVAS IMAG, V34, P1057, DOI 10.1007/s10554-018-1315-3; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Russell K, 2013, AM J PHYSIOL-HEART C, V305, pH996, DOI 10.1152/ajpheart.00191.2013; Russell K, 2012, EUR HEART J, V33, P724, DOI 10.1093/eurheartj/ehs016; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Voorhees AP, 2015, COMPR PHYSIOL, V5, P1623, DOI 10.1002/cphy.c140070; Wagner M, 2017, EUR J PREV CARDIOL, V24, P468, DOI 10.1177/2047487316680693	16	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239684	10.1371/journal.pone.0239684	http://dx.doi.org/10.1371/journal.pone.0239684			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031416	Green Published, gold			2022-12-26	WOS:000581809800009
J	Shiratsuchi, S; MacDonald, C; Srinivasan, M; Jones, GP				Shiratsuchi, Satoshi; MacDonald, Chancey; Srinivasan, Maya; Jones, Geoffrey P.			Sexual dimorphism in the horn size of a pair-forming coral reef butterflyfish	PLOS ONE			English	Article							VALENCIENNEA STRIGATA GOBIIDAE; MONOGAMOUS BUTTERFLYFISH; UNRELATED INDIVIDUALS; RYUKYU ISLANDS; BEHAVIOR; FISHES; EVOLUTION; GROWTH; CHAETODONTIDAE; SELECTION	Sexual dimorphism is a common in the animal kingdom and is often linked to mate choice or competition for mates in polygynous mating systems. However, sexual dimorphism is less common in species that form heterosexual pairs and has not been recorded in pair-forming coral-reef fish. Here we demonstrate a pronounced morphological difference between males and females in the humphead bannerfish (Heniochus varius)-a pair-forming coral reef butterflyfish. Males of paired individuals collected in Kimbe Bay, Papua New Guinea had substantially larger hump and horn protrusions on their heads than females. Fish were also sexed, sized and aged to determine the reproductive and demographic basis of the pairing behaviour.H.variuspairs were exclusively heterosexual and were assorted strongly by total length and slightly less so by age. Females in pairs were generally the same size as male partners, but were frequently older by a year and sometimes more. Hump and horn lengths increased proportionally to body-size in both sexes, with horns growing at a greater rate among males. These findings suggest thatH.variusform pairs primarily for reproductive purposes, with selection via a size-assortative process that likely also extends to selection for larger hump and horn protrusions among males. The larger humps and horns in males appear to be the first recorded example of a secondary sexual morphological characteristic in a pair-forming coral reef fish species.	[Shiratsuchi, Satoshi; MacDonald, Chancey; Srinivasan, Maya; Jones, Geoffrey P.] James Cook Univ, Coll Sci & Engn, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [MacDonald, Chancey] Calif Acad Sci, San Francisco, CA 94118 USA	James Cook University; California Academy of Sciences	MacDonald, C (corresponding author), James Cook Univ, Coll Sci & Engn, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	chancey.macdonald@gmail.com		Shiratsuchi, Satoshi/0000-0003-0042-5781	Australian Research Council Centre of Excellence for Coral Reef Studies Grant [CE140100020]	Australian Research Council Centre of Excellence for Coral Reef Studies Grant(Australian Research Council)	This research was funded by an Australian Research Council Centre of Excellence for Coral Reef Studies Grant (CE140100020), awarded to GPJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2009, MOL ECOL RESOUR, V9, P1460, DOI 10.1111/j.1755-0998.2009.02759.x; Andersson S, 1998, P ROY SOC B-BIOL SCI, V265, P445, DOI 10.1098/rspb.1998.0315; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2013, YOUTH WRITERS, V11, P200; [Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; [Anonymous], **DATA OBJECT**; Awata S, 2010, ICHTHYOL RES, V57, P161, DOI 10.1007/s10228-009-0142-x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bollache L, 2000, ARCH HYDROBIOL, V147, P547; Boyle KS, 2014, ANIM BEHAV, V92, P33, DOI 10.1016/j.anbehav.2014.03.022; Brandl SJ, 2013, CORAL REEFS, V32, P835, DOI 10.1007/s00338-013-1042-0; Brandl SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14556; Brandl SJ, 2014, OCEANOGR MAR BIOL, V52, P1; Cadoret L, 1999, J MAR BIOL ASSOC UK, V79, P725, DOI 10.1017/S0025315498000873; Cezilly F, 1997, IBIS, V139, P331, DOI 10.1111/j.1474-919X.1997.tb04632.x; Chambers KE, 2002, EVOL ANTHROPOL, V11, P37, DOI 10.1002/evan.10016; Choat JH, 1996, MAR ECOL PROG SER, V134, P15, DOI 10.3354/meps134015; Croft DP, 2005, OECOLOGIA, V143, P211, DOI 10.1007/s00442-004-1796-8; Darwin C., 1871, P423; DRISCOLL JW, 1988, ENVIRON BIOL FISH, V22, P29, DOI 10.1007/BF00000542; Duan Z X, 2006, J INNER MONGOLIA U T, V25, P85; Dugatkin L.A., 1997, COOPERATION ANIMALS; Dugatkin LA, 1996, BIOSYSTEMS, V37, P19, DOI 10.1016/0303-2647(95)01542-6; EHRLICH PR, 1977, J ZOOL, V183, P213; Emlen DJ, 1997, P ROY SOC B-BIOL SCI, V264, P567, DOI 10.1098/rspb.1997.0081; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FOWLER AJ, 1990, MAR ECOL PROG SER, V64, P25, DOI 10.3354/meps064025; Fox RJ, 2014, CORAL REEFS, V33, P253, DOI 10.1007/s00338-013-1108-z; Fox RJ, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150252; FRICKE HW, 1986, ETHOLOGY, V73, P307; GEIST V, 1966, BEHAVIOUR, V27, P175, DOI 10.1163/156853966X00155; Hart AM, 1996, MAR ECOL PROG SER, V136, P25, DOI 10.3354/meps136025; Hourigan T.F., 1988, P107; HOURIGAN TF, 1989, ENVIRON BIOL FISH, V25, P61, DOI 10.1007/BF00002201; Jiang YX, 2013, AM NAT, V181, pE125, DOI 10.1086/670160; KODRICBROWN A, 1984, AM NAT, V124, P309, DOI 10.1086/284275; KUWAMURA T, 1993, ETHOLOGY, V95, P65; Lecchini D, 2003, OCEANOL ACTA, V26, P537, DOI 10.1016/S0399-1784(03)00048-3; Littlewood DTJ, 2004, ZOOTAXA, P1; MacDonald C, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1545; MESTERTONGIBBONS M, 1992, Q REV BIOL, V67, P267, DOI 10.1086/417658; NEUDECKER S, 1989, Environmental Biology of Fishes, V25, P143, DOI 10.1007/BF00002208; Nowicki JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194465; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; R Core Team, 2021, R LANGUAGE ENV STAT; Reavis RH, 1998, BEHAV ECOL SOCIOBIOL, V43, P229, DOI 10.1007/s002650050487; Reavis RH, 1997, ENVIRON BIOL FISH, V49, P247, DOI 10.1023/A:1007320708862; REESE E S, 1975, Zeitschrift fuer Tierpsychologie, V37, P37; REESE ES, 1981, B MAR SCI, V31, P594; REESE ES, 1973, COPEIA, P145, DOI 10.2307/1442375; Reese ES, 1977, P 3 INT COR REEF S; ROBERTS CM, 1992, ENVIRON BIOL FISH, V34, P79, DOI 10.1007/BF00004786; Roff Derek, 2002, pi; Rueger T, 2019, MOL ECOL, V28, P2625, DOI 10.1111/mec.15103; Rueger T, 2016, BEHAV ECOL, V27, P1585, DOI 10.1093/beheco/arw082; Shealer DA, 2014, EVOL ECOL RES, V16, P37; Stankowich T, 2009, P ROY SOC B-BIOL SCI, V276, P4329, DOI 10.1098/rspb.2009.1256; Stearns S.C., 1992, pi; Strang DA, 2005, SOCIAL EVOLUTION BUT; Tanaka N., 1992, GALAXEA, V11, P66; Tricas T. C., 1985, P 5 INT COR REEF C, V5, P409; TRICAS TC, 1989, ENVIRON BIOL FISH, V25, P111, DOI 10.1007/BF00002205; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Whiteman EA, 2004, BIOL REV, V79, P351, DOI 10.1017/S1464793103006304; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson E.O., 1975, P1; Yabuta S, 1997, ICHTHYOL RES, V44, P183, DOI 10.1007/BF02678696; Yabuta S, 2000, J ETHOL, V18, P11, DOI 10.1007/s101640070018; Yabuta S, 1997, ICHTHYOL RES, V44, P177, DOI 10.1007/BF02678695; Zekeria ZA, 2006, MAR BIOL, V148, P1113, DOI 10.1007/s00227-005-0146-7	71	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240294	10.1371/journal.pone.0240294	http://dx.doi.org/10.1371/journal.pone.0240294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031445	gold, Green Published			2022-12-26	WOS:000581809800071
J	Berry, NL; Overholt, EP; Fisher, TJ; Williamson, CE				Berry, Nicole L.; Overholt, Erin P.; Fisher, Thomas J.; Williamson, Craig E.			Dissolved organic matter protects mosquito larvae from damaging solar UV radiation	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; ULTRAVIOLET-RADIATION; SENTINEL RESPONSES; CLIMATE-CHANGE; AEDES-AEGYPTI; LAKES; DAPHNIA; REPAIR; FOOD	Mosquitoes have increased in their abundance and geographic distribution in northeastern North America, coinciding with an increase in extreme precipitation events and up to a doubling of dissolved organic matter (DOM) concentrations in some inland waters. Increases in DOM can reduce exposure of mosquito larvae to solar ultraviolet (UV) radiation. Although mosquito larvae are most common in shaded habitats, almost nothing is known about their susceptibility to damage by solar UV radiation, or the ability of DOM to create a refuge from damaging UV in their shallow-water habitats. We hypothesize that 1) exposure to solar UV radiation is lethal to mosquito larvae, 2) larvae lack photo-enzymatic repair to fix UV-damaged DNA, and 3) DOM shades larvae from lethal solar UV radiation. We tested these hypotheses with experiments that manipulated UV radiation, the photo-repair radiation necessary for photo-enzymatic DNA repair, and DOM. Exposure to solar UV radiation significantly decreased larval survivorship, while DOM significantly increased it. There was no evidence of photo-enzymatic DNA repair. Our findings confirm that solar UV radiation decreases habitat suitability for mosquito larvae, but DOM provides a refuge from UV. This highlights the need for vector control managers to prioritize high DOM and shaded habitats in their efforts to reduce mosquito populations.	[Berry, Nicole L.; Overholt, Erin P.; Williamson, Craig E.] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Fisher, Thomas J.] Miami Univ, Dept Stat, Oxford, OH 45056 USA	University System of Ohio; Miami University; University System of Ohio; Miami University	Berry, NL (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	berrynl@miamioh.edu		Berry, Nicole/0000-0002-7889-197X				Afify A, 2015, J MED ENTOMOL, V52, P120, DOI 10.1093/jme/tju024; [Anonymous], 2017, J Prosthet Dent, V117, pe1, DOI 10.1016/j.prosdent.2016.12.001; [Anonymous], ANN WYOMING, V27, P14; Barnes PW, 2019, NAT SUSTAIN, V2, P569, DOI 10.1038/s41893-019-0314-2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BEARD RL, 1972, J ECON ENTOMOL, V65, P650, DOI 10.1093/jee/65.3.650; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Burch C, 2020, ANN GIS, DOI [10.1080/19475683.2019.1702099, DOI 10.1080/19475683.2019.1702099]; Cooke SL, 2006, J PLANKTON RES, V28, P171, DOI 10.1093/plankt/fbi108; Fang WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043069; Frick TB, 1996, ENTOMOL NEWS, V107, P77; Gao Q, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201607; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hessen DO, 2002, J PLANKTON RES, V24, P1009, DOI 10.1093/plankt/24.10.1009; Hoekman D, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1320; Hori M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07383; Hylander S, 2015, LIMNOL OCEANOGR, V60, P2197, DOI 10.1002/lno.10194; Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y; Lindholm M, 2018, HYDROBIOLOGIA, V813, P33, DOI 10.1007/s10750-017-3503-x; Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851; MacFadyen EJ, 2004, GLOBAL CHANGE BIOL, V10, P408, DOI 10.1111/j.1529-8817.2003.00750.x; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; National Research Council, 2001, GRAND CHALLENGES ENV, DOI [10.17226/9975, DOI 10.17226/9975]; Nikookar SH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005835; Overholt EP, 2012, ECOL LETT, V15, P47, DOI 10.1111/j.1461-0248.2011.01707.x; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; R Core Team, 2021, R LANGUAGE ENV STAT; Rautio Milla, 2010, Freshwater Reviews, V3, P105, DOI 10.1608/FRJ-3.2.157; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Roiz D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-333; Paramo MER, 2015, J INVERTEBR PATHOL, V130, P133, DOI 10.1016/j.jip.2015.08.002; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Solomon CT, 2015, ECOSYSTEMS, V18, P376, DOI 10.1007/s10021-015-9848-y; Springer YP, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1271; Stauffer GE, 2018, J WILDLIFE MANAGE, V82, P165, DOI 10.1002/jwmg.21347; Vezzani D, 2009, MED VET ENTOMOL, V23, P78, DOI 10.1111/j.1365-2915.2008.00783.x; Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]; Wada N, 2015, ANTIOXIDANTS-BASEL, V4, P603, DOI 10.3390/antiox4030603; Wickham H., 2019, TIDYVERSE EASILY INS; Williamson CE, 2001, ECOL APPL, V11, P1843, DOI 10.1890/1051-0761(2001)011[1843:BADEOU]2.0.CO;2; Williamson CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13392-2; Williamson CE, 2016, FRONT ECOL ENVIRON, V14, P102, DOI 10.1002/fee.1228; Williamson CE, 2015, SCI REP-UK, V5, DOI 10.1038/srep18666; Williamson CE, 2014, LIMNOL OCEANOGR, V59, P840, DOI 10.4319/lo.2014.59.3.0840; Williamson CE, 2011, LIMNOL OCEANOGR, V56, P1603, DOI 10.4319/lo.2011.56.5.1603; Zagarese HE, 2001, FISH FISH, V2, P250, DOI 10.1046/j.1467-2960.2001.00048.x; Zahouli JBZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005751	51	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240261	10.1371/journal.pone.0240261	http://dx.doi.org/10.1371/journal.pone.0240261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027279	Green Published, gold			2022-12-26	WOS:000581808000043
J	Kapp, KJ; Miller, RZ				Kapp, Kirsten J.; Miller, Rachael Z.			Electric clothes dryers: An underestimated source of microfiber pollution	PLOS ONE			English	Article							ENERGY-CONSUMPTION; MICROPLASTICS; RELEASE; BEHAVIOR; FIBERS	Microplastics, particularly microfibers, are ubiquitous, found in aquatic (freshwater and marine) and terrestrial environments and within the food web worldwide. It is well-established that microplastics in the form of textile fibers enter the environment via washing machines and wastewater treatment effluent. Less is known about the release of microfibers from electric clothes dryers. In this study we measure microfiber emissions from home installed dryers at two different sites. At each site the distribution of fibers landing on the snow's surface outside dryer vents and the weight of lint in dryer exhaust exiting dryer vents were measured. Fibers from the pink polyester fleece blankets used in this study were found in plots throughout a 30ft (9.14m) radius from the dryer vents, with an average number across all plots of 404 +/- 192 (SD) (Site 1) and 1,169 +/- 606 (SD) (Site 2). The majority of the fibers collected were located within 5 ft (1.52m) of the vents. Averages of 35 +/- 16(SD)mg (Site 1) and 70 +/- 77 (SD)mg (Site 2) of lint from three consecutive dry cycles were collected from dryer vent exhaust. This study establishes that electric clothes dryers emit masses of microfiber directly into the environment. Microfiber emissions vary based on dryer type, age, vent installation and lint trap characteristics. Therefore, dryers should be included in discussions when considering strategies, policies and innovations to prevent and mitigate microfiber pollution.	[Kapp, Kirsten J.] Cent Wyoming Coll, Dept Arts & Sci, Jackson, WY 83001 USA; [Miller, Rachael Z.] Rozalia Project Clean Ocean, Burlington, VT 05401 USA		Kapp, KJ (corresponding author), Cent Wyoming Coll, Dept Arts & Sci, Jackson, WY 83001 USA.; Miller, RZ (corresponding author), Rozalia Project Clean Ocean, Burlington, VT 05401 USA.	kkapp@cwc.edu; rachael@rozaliaproject.org	Kapp, Kirsten/GLS-9208-2022	Kapp, Kirsten/0000-0003-4397-3593; Miller, Rachael Z/0000-0002-7448-3119	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [2P20GM103432]	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant #2P20GM103432. The funder provided support in the form of salaries for author [K.K.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. Rozalia Project, a Vermontbased NGO. The funder provided support in the form of use of equipment for author [R.Z.M], but did not have any additional role in the funding, study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Ambrosini R, 2019, ENVIRON POLLUT, V253, P297, DOI 10.1016/j.envpol.2019.07.005; Au SY, 2015, ENVIRON TOXICOL CHEM, V34, P2564, DOI 10.1002/etc.3093; Australian Bureau of Statistics, 2014, 46020 55001 ENV ISS; Baldwin LM, 2020, IMPLEMENT SCI, V15; Barrows APW, 2018, WATER RES, V147, P382, DOI 10.1016/j.watres.2018.10.013; Bergmann M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax1157; Brasor P, 2016, JAPAN TIMES; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; China Household Electrical Appliances Association, 2017, CLOTH DRYER MARK GEA; China Household Electrical Appliances Association, 2020, CHEAA RUN CHINA APPL; De Falco F, 2020, ENVIRON SCI TECHNOL, V54, P3288, DOI 10.1021/acs.est.9b06892; De Falco F, 2018, ENVIRON POLLUT, V236, P916, DOI 10.1016/j.envpol.2017.10.057; Dris R, 2016, MAR POLLUT BULL, V104, P290, DOI 10.1016/j.marpolbul.2016.01.006; ESGCT, 2019, HUM GENE THER, V30, pA1; Gasperi Johnny, 2018, Current Opinion in Environmental Science & Health, V1, P1, DOI 10.1016/j.coesh.2017.10.002; Gooijer H, 2016, TENSIDE SURFACT DET, V53, P402, DOI 10.3139/113.110456; Hernandez E, 2017, ENVIRON SCI TECHNOL, V51, P7036, DOI 10.1021/acs.est.7b01750; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; Jewish Market Reports, 2020, EL DRYER MARK REP 20; Kapp KJ, 2018, ENVIRON POLLUT, V241, P1082, DOI 10.1016/j.envpol.2018.06.033; McCowan B, 2015, N ANDOVER ENERGY RES; McIlwraith HK, 2019, MAR POLLUT BULL, V139, P40, DOI 10.1016/j.marpolbul.2018.12.012; Miller RZ, 2017, MAR POLLUT BULL, V124, P245, DOI 10.1016/j.marpolbul.2017.07.028; Mohamed AMA, 2015, APPL ENERG, V146, P247, DOI 10.1016/j.apenergy.2015.02.008; Napper IE, 2020, SCI TOTAL ENVIRON, V738, DOI 10.1016/j.scitotenv.2020.140412; Napper IE, 2016, MAR POLLUT BULL, V112, P39, DOI 10.1016/j.marpolbul.2016.09.025; Pirc U, 2016, ENVIRON SCI POLLUT R, V23, P22206, DOI 10.1007/s11356-016-7703-0; Plastics Europe, 2020, PLAST FACTS 2020 AN; PlasticsEurope, 2016, PLAST FACTS 2016 AN; R Core Team, 2020, R LANG ENV STAT COMP; Research and Markets, 2020, EL DRYERS MARK SET R; Schmitz A, 2014, ENERG EFFIC, V7, P937, DOI 10.1007/s12053-014-9268-4; Statistica, 2017, SHAR PRIV HOUS OWN C; Statistica, 2018, PERC HOUS TUMBL DRYE; Statistica, 2011, PERC CAN HOM CLOTH D; Statistics Norway, 2014, SURV CONS EXP TABL 1; Textile Exchange, 2019, PREF FIB MAT MARK RE; U.S. Energy Information Administration, 2015, 2015 RES EN CONS SUR; United States Energy Information Administration, 2011, EN STAR MARK IND SCO; Ziajahromi S, 2017, ENVIRON SCI TECHNOL, V51, P13397, DOI 10.1021/acs.est.7b03574	40	24	24	7	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239165	10.1371/journal.pone.0239165	http://dx.doi.org/10.1371/journal.pone.0239165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027292	Green Submitted, Green Published, gold			2022-12-26	WOS:000581808000001
J	Machado, AF; Guimaraes, SEF; Guimaraes, JD; Santos, GM; Silva, AL; Silva, YFRS; Netto, DSL; Correa, PVF; Marcondes, MI				Machado, Andreia Ferreira; Guimaraes, Simone Elisa Facioni; Guimaraes, Jose Domingos; Santos, Giancarlo Magalhaes; Silva, Alex Lopes; Silva, Yame Fabres Robaina Sancler; Lollobrigida Netto, Domingos Souza; Correa, Pietro Vitor Felix; Marcondes, Marcos Inacio			Effect of protein supplement level on the productive and reproductive parameters of replacement heifers managed in intensive grazing systems	PLOS ONE			English	Article							VITRO EMBRYO PRODUCTION; OVARIAN-FOLLICLE DEVELOPMENT; MAMMARY-GLAND DEVELOPMENT; UREA NITROGEN LEVELS; IN-VITRO; BOS-INDICUS; GENE-EXPRESSION; DAIRY HEIFERS; CRUDE PROTEIN; UNDEGRADABLE PROTEIN	Evaluations of replacement heifers in intensively managed grazing systems in tropical conditions are warranted. Thus, we aimed to evaluate performance, muscle and mammary gland development, oocyte quality, and in vitro production of embryos of crossbred heifers grazing an intensively managed pasture and supplemented with high or low protein concentrates. Eighteen pubertal crossbred heifers (Holstein x Gyr) with an initial weight of 350 +/- 8.0 kg were used in a 60-day trial. Two supplement types, 12% crude protein (CP) (S12CP) or 24% CP (S24CP), and a control treatment (mineral mixture, CON) were randomly distributed to the heifers. Throughout the experiment, four digestibility trials were performed over four consecutive days. Four ovarium pick-ups were performed to evaluate oocyte quality and in vitro embryo production. Lastly, ultrasounds of carcasses and mammary glands were performed. The intakes of dry matter (DM), digestible energy (DE), and CP were greater for supplemented (SUP) compared with CON heifers. The SUP heifers had a greater average daily gain (ADG) (645 versus 390 g/d) and rib eye area (58.78 versus 53.32 cm(2)) than the CON heifers. Oocyte recovery, quality, and follicle features were not affected by supplementation strategy. However, the cleavage rate (47.17% versus 30.31%) and blastocyst rate (27.91% versus 10.12%) were negatively affected by supplementation. The S12CP presented a blastocyst rate much lower than the S24CP (3.02% versus 17.23%). Carcass ultrasonography indicated a trend for greater rib eye area for S24CP and mammary ultrasonography indicated no effects of supplementation on mammary gland development. In summary, supplementation seems to be an appropriate strategy for satisfactory performance, with greater muscle deposition and no negative impacts on mammary gland development. However, in vitro embryo production was impaired when the animals received the supplementation with 12% CP.	[Machado, Andreia Ferreira; Guimaraes, Simone Elisa Facioni; Silva, Yame Fabres Robaina Sancler; Marcondes, Marcos Inacio] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Guimaraes, Jose Domingos; Lollobrigida Netto, Domingos Souza; Correa, Pietro Vitor Felix] Univ Fed Vicosa, Dept Vet Med, Vicosa, MG, Brazil; [Santos, Giancarlo Magalhaes] Cenva Post Grad, Vicosa, MG, Brazil; [Silva, Alex Lopes] Univ Fed Rural Rio de Janeiro, Dept Anim Sci, Seropedica, RJ, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Marcondes, MI (corresponding author), Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil.	marcos.marcondes@ufv.br	Silva, Alex/H-8187-2015	Silva, Alex/0000-0002-3288-4387; Marcondes, Marcos/0000-0003-4843-2809	Minas Gerais State Research Support Foundation (FAPEMIG); National Council for Scientific and Technological Development (CNPq); Institute of Science and Technology of Animal Science (INCT) -CA; Bioclin and BH Embrioes laboratory; Higher Education Personnel Improvement Coordination (CAPES)	Minas Gerais State Research Support Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institute of Science and Technology of Animal Science (INCT) -CA; Bioclin and BH Embrioes laboratory; Higher Education Personnel Improvement Coordination (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by the Minas Gerais State Research Support Foundation (FAPEMIG), the National Council for Scientific and Technological Development (CNPq), Higher Education Personnel Improvement Coordination (CAPES), the Institute of Science and Technology of Animal Science (INCT) -CA), and the Bioclin and BH Embrioes laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino RL, 2017, J DAIRY SCI, V100, P8033, DOI 10.3168/jds.2016-12489; Albino RL, 2017, J DAIRY SCI, V100, P1588, DOI 10.3168/jds.2016-11668; Albino RL, 2015, J DAIRY RES, V82, P113, DOI 10.1017/S0022029914000697; [Anonymous], 1989, ANIMAL GROWTH REGULA; [Anonymous], 2018, MONIST, V101, P1, DOI DOI 10.3168/jds.2017-12962; Armstrong DG, 2001, BIOL REPROD, V64, P1624, DOI 10.1095/biolreprod64.6.1624; Bascom SA, 2007, J DAIRY SCI, V90, P5600, DOI 10.3168/jds.2007-0004; Batista ED, 2016, J ANIM SCI, V94, P201, DOI 10.2527/jas.2015-9493; Boval M, 2015, ANIMAL, V9, P973, DOI 10.1017/S1751731114003279; Brandao VLN, 2018, GRASSL SCI, V64, P175, DOI 10.1111/grs.12200; Broucek J, 2009, INT J BIOMETEOROL, V53, P201, DOI 10.1007/s00484-008-0204-1; Brown EG, 2005, J DAIRY SCI, V88, P585, DOI 10.3168/jds.S0022-0302(05)72722-3; Butler WR, 1996, J ANIM SCI, V74, P858; Butler WR, 1998, J DAIRY SCI, V81, P2533, DOI 10.3168/jds.S0022-0302(98)70146-8; Paciullo DSC, 2011, LIVEST SCI, V141, P166, DOI 10.1016/j.livsci.2011.05.012; Capuco AV, 2004, J DAIRY SCI, V87, P3762, DOI 10.3168/jds.S0022-0302(04)73514-6; Chen XB, 1992, ESTIMATION MICROBIAL, V21; Chizzotti ML, 2008, LIVEST SCI, V113, P218, DOI 10.1016/j.livsci.2007.03.013; Dawuda PM, 2002, THERIOGENOLOGY, V58, P1443, DOI 10.1016/S0093-691X(02)00973-1; De Wit AAC, 2001, J DAIRY SCI, V84, P1800, DOI 10.3168/jds.S0022-0302(01)74618-8; Detmann E., 2010, P 3 INT S BEEF CATTL, P191; Detmann E., 2012, METODOS ANALISE ALIM, Vfirst; Detmann E., 2014, SEMINACIENCIAS AGRAR, V35, P2829, DOI [10.5433/1679-0359.2014v35n4Suplp2829, DOI 10.5433/1679-0359.2014V35N4SUPLP2829]; Detmann E, 2014, LIVEST SCI, V162, P141, DOI 10.1016/j.livsci.2014.01.029; Diskin MG, 2006, ANIM REPROD SCI, V96, P297, DOI 10.1016/j.anireprosci.2006.08.008; Emmanuel N, 2015, ANIM NUTR, V1, P356, DOI 10.1016/j.aninu.2015.12.004; Ettema JF, 2004, J DAIRY SCI, V87, P2730, DOI 10.3168/jds.S0022-0302(04)73400-1; Fahey J, 2001, ANIM SCI, V72, P395; Ferreira FA, 2011, THERIOGENOLOGY, V76, P312, DOI 10.1016/j.theriogenology.2011.02.008; Fialho ALL, 2018, ARQ BRAS MED VET ZOO, V70, P64, DOI 10.1590/1678-4162-9494; FUJIHARA T, 1987, J AGR SCI, V109, P7, DOI 10.1017/S0021859600080916; Gendelman M, 2010, REPRODUCTION, V140, P73, DOI 10.1530/REP-10-0055; Gimenes LU, 2015, THERIOGENOLOGY, V83, P385, DOI 10.1016/j.theriogenology.2014.09.030; Gong JG, 1996, BIOL REPROD, V55, P68, DOI 10.1095/biolreprod55.1.68; Gong JG, 2002, DOMEST ANIM ENDOCRIN, V23, P229, DOI 10.1016/S0739-7240(02)00159-5; Gonzalez FHD, 2000, PERFIL METABOLICO RU; Gutierrez CG, 1997, J ANIM SCI, V75, P1876; Hammon DS, 2005, ANIM REPROD SCI, V86, P195, DOI 10.1016/j.anireprosci.2004.08.003; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Hutchison JL, 2017, J DAIRY SCI, V100, P6853, DOI 10.3168/jds.2016-12060; JORDAN ER, 1979, J DAIRY SCI, V62, P58, DOI 10.3168/jds.S0022-0302(79)83202-6; Juengel J L, 2005, Hum Reprod Update, V11, P143; Kenny DA, 2001, ANIM SCI, V73, P501, DOI 10.1017/S1357729800058471; Lane M, 2003, BIOL REPROD, V69, P1109, DOI 10.1095/biolreprod.103.018093; Laven RA, 2004, ANIM REPROD SCI, V84, P41, DOI 10.1016/j.anireprosci.2003.12.008; Lean IJ, 2012, ANIM FEED SCI TECH, V171, P31, DOI 10.1016/j.anifeedsci.2011.09.017; LEIBFRIED L, 1979, J ANIM SCI, V48, P76; Leroy JLMR, 2008, REPROD DOMEST ANIM, V43, P623, DOI 10.1111/j.1439-0531.2007.00961.x; Leroy JLMR, 2004, ANIM REPROD SCI, V80, P201, DOI 10.1016/S0378-4320(03)00173-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe JK, 2016, J DAIRY SCI, V99, P634, DOI 10.3168/jds.2015-9475; Machado WS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221651; McNatty KP, 2005, MOL CELL ENDOCRINOL, V234, P57, DOI 10.1016/j.mce.2004.08.013; McNatty KP, 2004, REPRODUCTION, V128, P379, DOI 10.1530/rep.1.00280; Mertens D., 2005, OFFICIAL METHODS ANA, V18th ed., P1; Meyer MJ, 2006, J DAIRY SCI, V89, P4289, DOI 10.3168/jds.S0022-0302(06)72475-4; Mikkola M, 2005, ANIM REPROD SCI, V87, P193, DOI 10.1016/j.anireprosci.2004.11.008; Miorin RL, 2016, TROP ANIM HEALTH PRO, V48, P1561, DOI 10.1007/s11250-016-1128-0; Ocon OM, 2003, J DAIRY SCI, V86, P1194, DOI 10.3168/jds.S0022-0302(03)73703-5; OWENS FN, 1995, J ANIM SCI, V73, P3152; Papadopoulos S, 2001, THERIOGENOLOGY, V55, P1059, DOI 10.1016/S0093-691X(01)00466-6; Valente TNP, 2011, REV BRAS ZOOTECN, V40, P2565, DOI 10.1590/S1516-35982011001100039; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pontes JHF, 2010, THERIOGENOLOGY, V74, P1349, DOI 10.1016/j.theriogenology.2010.06.004; POPPI DP, 1995, J ANIM SCI, V73, P278; Prates LL, 2012, LIVEST SCI, V150, P179, DOI 10.1016/j.livsci.2012.08.018; Rhoads ML, 2006, ANIM REPROD SCI, V91, P1, DOI 10.1016/j.anireprosci.2005.02.009; Rooke JA, 2004, ANIM REPROD SCI, V84, P53, DOI 10.1016/j.anireprosci.2003.12.005; Rosenvold K, 2001, J ANIM SCI, V79, P382; Roth Z, 2000, J REPROD FERTIL, V120, P83, DOI 10.1530/reprod/120.1.83; Ryan TP, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118439241; Sales JNS, 2015, J DAIRY SCI, V98, P3086, DOI 10.3168/jds.2014-8858; Sampaio CB, 2011, REV BRAS ZOOTECN, V40, P657, DOI 10.1590/S1516-35982011000300026; Sartori R, 2016, THERIOGENOLOGY, V86, P32, DOI 10.1016/j.theriogenology.2016.04.016; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Sinclair KD, 2000, J ANIM SCI, V78, P2659; SINHA YN, 1969, J DAIRY SCI, V52, P507, DOI 10.3168/jds.S0022-0302(69)86595-1; Sotelo D, 2019, ANIM PROD SCI, V59, P1244, DOI [10.1071/AN17485, 10.1071/an17485]; Souza-Cacares MB, 2019, THERIOGENOLOGY, V130, P103, DOI 10.1016/j.theriogenology.2019.02.039; Su YQ, 2004, DEV BIOL, V276, P64, DOI 10.1016/j.ydbio.2004.08.020; Valadares RFD, 1999, J DAIRY SCI, V82, P2686, DOI 10.3168/jds.S0022-0302(99)75525-6; Viana JHM, 2012, ANIM REPROD, V9, P12; Yoshino O, 2006, P NATL ACAD SCI USA, V103, P10678, DOI 10.1073/pnas.0600507103	83	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239786	10.1371/journal.pone.0239786	http://dx.doi.org/10.1371/journal.pone.0239786			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027259	gold, Green Published			2022-12-26	WOS:000581808000041
J	Horgan, FG; Arida, A; Ardestani, G; Almazan, MLP				Horgan, Finbarr G.; Arida, Arriza; Ardestani, Goli; Almazan, Maria Liberty P.			Intraspecific competition counters the effects of elevated and optimal temperatures on phloem-feeding insects in tropical and temperate rice	PLOS ONE			English	Article							NILAPARVATA-LUGENS HOMOPTERA; BROWN PLANTHOPPER; TOLERANCE; RESISTANT; DELPHACIDAE; NITROGEN; RESURGENCE; DENSITY; IMPACT; BORERS	The direct effects of rising global temperatures on insect herbivores could increase damage to cereal crops. However, the indirect effects of interactions between herbivores and their biotic environment at the same temperatures will potentially counter such direct effects. This study examines the potential for intraspecific competition to dampen the effects of optimal temperatures on fitness (survival x reproduction) of the brown planthopper,Nilaparvata lugens[BPH] and whitebacked planthopper,Sogatella furcifera[WBPH], two phloem-feeders that attack rice in Asia. We conducted a series of experiments with increasing densities of ovipositing females and developing nymphs on tropical and temperate rice varieties at 25, 30 and 35 degrees C. Damage from planthoppers to the tropical variety was greater at 30 degrees C compared to 25 degrees C, despite faster plant growth rates at 30 degrees C. Damage to the temperate variety from WBPH nymphs was greatest at 25 degrees C. BPH nymphs gained greater biomass at 25 degrees C than at 30 degrees C despite faster development at the higher temperature (temperature-size rule); however, the effect was apparent only at high nymph densities. WBPH survival, development rates and nymph weights all declined at >= 30 degrees C. At about the optimal temperature for WBPH (25 degrees C), intraspecific crowding reduced nymph weights. Temperature has little effect on oviposition responses to density, and intraspecific competition between females only weakly counters the effects of optimal temperatures on oviposition in both BPH and WBPH. Meanwhile, the deleterious effects of nymph crowding will counter the direct effects of optimal temperatures on voltinism in BPH and on body size in both BPH and WBPH. The negative effects of crowding on BPH nymphs may be decoupled from resource use at higher temperatures.	[Horgan, Finbarr G.] EcoLaVerna Integral Restorat Ecol, Kildinan, Co Cork, Ireland; [Horgan, Finbarr G.] Univ Coll Dublin, Environm & Sustainable Resource Management, Dublin, Ireland; [Arida, Arriza; Ardestani, Goli; Almazan, Maria Liberty P.] Int Rice Res Inst, Makati, Metro Manila, Philippines; [Ardestani, Goli] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University College Dublin; CGIAR; International Rice Research Institute (IRRI); University of Massachusetts System; University of Massachusetts Amherst	Horgan, FG (corresponding author), EcoLaVerna Integral Restorat Ecol, Kildinan, Co Cork, Ireland.; Horgan, FG (corresponding author), Univ Coll Dublin, Environm & Sustainable Resource Management, Dublin, Ireland.	f.horgan@ecolaverma.org		Horgan, Finbarr/0000-0003-3796-667X	Bill and Melinda Gates Foundation (Cereal Systems Initiative for South Asia [CSISA]) [OPP52303]	Bill and Melinda Gates Foundation (Cereal Systems Initiative for South Asia [CSISA])(CGIAR)	Funding for this research was provided by the Bill and Melinda Gates Foundation (Cereal Systems Initiative for South Asia [CSISA]: OPP52303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52034-7; AMMAR ED, 1980, DEUT ENTOMOL Z, V27, P21; Angilletta MJ, 2003, AM NAT, V162, P332; Barton BT, 2014, ECOLOGY, V95, P1479, DOI 10.1890/13-1977.1; Bauerfeind SS, 2013, ENTOMOL EXP APPL, V149, P148, DOI 10.1111/eea.12118; Bauerfeind SS, 2013, GLOBAL CHANGE BIOL, V19, P3272, DOI 10.1111/gcb.12297; Bottrell DG, 2012, J ASIA-PAC ENTOMOL, V15, P122, DOI 10.1016/j.aspen.2011.09.004; CHELLIAH S, 1980, ENVIRON ENTOMOL, V9, P773, DOI 10.1093/ee/9.6.773; Cheng JiaAn, 2001, Journal of Asia-Pacific Entomology, V4, P85, DOI 10.1016/S1226-8615(08)60108-9; Denno RF, 2000, ECOLOGY, V81, P1814, DOI 10.1890/0012-9658(2000)081[1814:FICIPQ]2.0.CO;2; Ferrater JB, 2013, ARTHROPOD-PLANT INTE, V7, P591, DOI 10.1007/s11829-013-9277-9; Goodsman DW, 2018, GLOBAL CHANGE BIOL, V24, P3620, DOI 10.1111/gcb.14284; Gurr GM, 2016, NAT PLANTS, V2, DOI 10.1038/nplants.2016.14; HEINRICHS EA, 1982, ENVIRON ENTOMOL, V11, P1269, DOI 10.1093/ee/11.6.1269; Horgan FG, 2016, ANN APPL BIOL, V169, P200, DOI 10.1111/aab.12296; Horgan F. G., 2020, SCI REPORTS; Horgan F.G., 2020, CROP PROTECTION CHAN, P101, DOI [10.1007/978-3-030-46111-9_5, DOI 10.1007/978-3-030-46111-9_5]; Horgan FG, 2021, FUNCT ECOL, V35, P181, DOI 10.1111/1365-2435.13683; Horgan FG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235506; Horgan FG, 2019, INSECTS, V10, DOI 10.3390/insects10100328; Horgan FG, 2018, FIELD CROP RES, V217, P53, DOI 10.1016/j.fcr.2017.12.008; Horgan FG, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7040062; Horgan FG, 2016, CROP PROT, V89, P223, DOI 10.1016/j.cropro.2016.07.033; Horgan FG, 2016, ENTOMOL EXP APPL, V158, P284, DOI 10.1111/eea.12400; Horgan FG, 2013, ENTOMOL EXP APPL, V148, P1, DOI 10.1111/eea.12080; Hu CX, 2015, CLIMATIC CHANGE, V132, P337, DOI 10.1007/s10584-015-1427-x; Hu SJ, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev131; Hu SJ, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev041; Hulle M, 2010, CR BIOL, V333, P497, DOI 10.1016/j.crvi.2010.03.005; ICHIKAWA T, 1982, APPL ENTOMOL ZOOL, V17, P439, DOI 10.1303/aez.17.439; Jeffs CT, 2013, ECOL ENTOMOL, V38, P209, DOI 10.1111/een.12026; JONES DB, 1976, CROP SCI, V16, P102, DOI 10.2135/cropsci1976.0011183X001600010026x; Kettle H, 2019, J APPL ECOL, V56, P2536, DOI 10.1111/1365-2664.13473; Khadioli N, 2014, ANN APPL BIOL, V165, P373, DOI 10.1111/aab.12157; KIRITANI K, 1988, JARQ-JPN AGR RES Q, V21, P264; Kocmankova E, 2010, CLIM RES, V44, P95, DOI 10.3354/cr00905; Lamichhane JR, 2015, AGRON SUSTAIN DEV, V35, P443, DOI 10.1007/s13593-014-0275-9; Lancaster LT, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0046; Long Y, 2012, ENVIRON ENTOMOL, V41, P1231, DOI 10.1603/EN12143; Macfadyen S, 2018, AGR ECOSYST ENVIRON, V253, P208, DOI 10.1016/j.agee.2016.08.029; NISHIYAMA I, 1976, P159; NODA H, 1977, Applied Entomology and Zoology, V12, P134; Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS); Park C. G., 1983, Korean Journal of Plant Protection, V22, P262; Park Chang-Gyu, 2013, Korean Journal of Applied Entomology, V52, P133, DOI 10.5656/KSAE.2013.02.1.070; Piyaphongkul J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029409; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Rashid MM, 2016, RICE SCI, V23, P119, DOI 10.1016/j.rsci.2016.04.001; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; Shi BK, 2014, J INTEGR AGR, V13, P1520, DOI 10.1016/S2095-3119(14)60804-2; Srinivasan TS, 2016, APPL ENTOMOL ZOOL, V51, P81, DOI 10.1007/s13355-015-0373-4; Svobodova E, 2014, PEST MANAG SCI, V70, P708, DOI 10.1002/ps.3622; Wu JC, 2020, ANNU REV ENTOMOL, V65, P409, DOI 10.1146/annurev-ento-011019-025215; Wu Y, 2019, 614743 BIORXIV, P614743; You LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep37430; Yukawa J, 2009, APPL ENTOMOL ZOOL, V44, P429, DOI 10.1303/aez.2009.429	56	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2020	15	10							e0240130	10.1371/journal.pone.0240130	http://dx.doi.org/10.1371/journal.pone.0240130			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OB4WW	33022691	gold, Green Published			2022-12-26	WOS:000578473000024
J	Kim, YH; Jung, BY; Han, SS; Woo, CW				Kim, Young Hyun; Jung, Bock-Young; Han, Sang-Sun; Woo, Chang-Woo			Accuracy evaluation of 3D printed interim prosthesis fabrication using a CBCT scanning based digital model	PLOS ONE			English	Article							IN-VITRO; DENTAL IMPRESSIONS; MARGINAL FIT; CAD/CAM; PRECISION; SYSTEMS; SCANNERS; INLAYS	Objectives This study aimed to evaluate the marginal and internal gaps in 3D-printed interim crowns made from digital models of cone-beam computed tomography (CBCT) conversion data. Materials and methods Sixteen polyvinylsiloxane impressions were taken from patients for single crown restorations and were scanned using CBCT. The scanning data were converted to positive Standard Triangulation Language (STL) files using custom-developed software. The fabricated stone models were scanned with an intraoral optical scanner (IOS) to compare the surface accuracy with the STL data obtained by CBCT. The converted STL files were utilized to fabricate interim crowns with a photopolymer using a digital light-processing 3D printer. The replica method was used to analyze the accuracy. The marginal and internal gaps in the replica specimen of each interim crown were measured with a digital microscope. The Friedman test and Mann-Whitney U test (Wilcoxon-signed rank test) were conducted to compare the measurements of the marginal and internal gaps with a 95% level of confidence. Results The root-mean-square values of the CBCT and IOS ranged from 41.00 to 126.60 mu m, and the mean was 60.12 mu m. The mean values of the marginal, internal, and total gaps were 132.96 (+/- 139.23) mu m, 137.86 (+/- 103.09) mu m, and 135.68 (+/- 120.30) mu m, respectively. There were no statistically significant differences in the marginal or internal gaps between the mesiodistal and buccolingual surfaces, but the marginal area (132.96 mu m) and occlusal area (255.88 mu m) had significant mean differences. Conclusion The marginal gap of the fabricated interim crowns based on CBCT STL data was within the acceptable range of clinical success. Through ongoing developments of high-resolution CBCT and the digital model conversion technique, CBCT might be an alternative method to acquire digital models for interim crown fabrication.	[Kim, Young Hyun; Han, Sang-Sun] Yonsei Univ, Dept Oral & Maxillofacial Radiol, Coll Dent, Seoul, South Korea; [Jung, Bock-Young] Yonsei Univ, Dept Adv Gen Dent, Coll Dent, Seoul, South Korea; [Woo, Chang-Woo] Yonsei Univ, Cent Dent Lab, Dent Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Han, SS (corresponding author), Yonsei Univ, Dept Oral & Maxillofacial Radiol, Coll Dent, Seoul, South Korea.	sshan@yuhs.ac		Jung, Bock-Young/0000-0002-8186-2109; Kim, Young Hyun/0000-0001-6541-3293; Han, Sang-Sun/0000-0003-1775-7862	Medical Device Technology Development Program [20006098]; Ministry of Trade, Industry and Energy (MOTIE, Korea)	Medical Device Technology Development Program; Ministry of Trade, Industry and Energy (MOTIE, Korea)	This work was supported by the Medical Device Technology Development Program (No.20006098, Development of soft-tissue diagnostic CT with 3lp/mm resolution using multisource and curved FPD) funded by the Ministry of Trade, Industry and Energy (MOTIE, Korea).	Alghazzawi TF, 2016, J PROSTHODONT RES, V60, P72, DOI 10.1016/j.jpor.2016.01.003; Bazi Y, 2007, PATTERN RECOGN, V40, P619, DOI 10.1016/j.patcog.2006.05.006; Burns DR, 2003, J PROSTHET DENT, V90, P474, DOI 10.1016/S0022-3913(03)00259-2; Emir F, 2019, J PROSTHODONT RES, V63, P434, DOI 10.1016/j.jpor.2019.03.001; Ender A, 2019, INT J COMPUT DENT, V22, P11; Fleming PS, 2011, ORTHOD CRANIOFAC RES, V14, P1, DOI 10.1111/j.1601-6343.2010.01503.x; Flugge TV, 2013, AM J ORTHOD DENTOFAC, V144, P471, DOI 10.1016/j.ajodo.2013.04.017; Fransson B, 1985, Dent Mater, V1, P197, DOI 10.1016/S0109-5641(85)80019-1; Givens Edward J Jr, 2008, J Prosthodont, V17, P97, DOI 10.1111/j.1532-849X.2007.00256.x; de Villaumbrosia PG, 2016, J PROSTHET DENT, V116, P543, DOI 10.1016/j.prosdent.2016.01.025; Gratton D.G., 2004, DENT CLIN N AM, V48, P487, DOI [10.1016/j.cden.2003.12.007, DOI 10.1016/J.CDEN.2003.12.007]; Gratton DG, 2004, DENT CLIN N AM, V48, P487, DOI [10.1016/j.cden.2003.12.007, DOI 10.1016/J.CDEN.2003.12.007]; Guth JF, 2017, CLIN ORAL INVEST, V21, P1445, DOI 10.1007/s00784-016-1902-4; Huang DY, 2011, INT J INNOV COMPUT I, V7, P5631; Hwang JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153884; Imburgia M, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0383-4; Joos-Kovacs G, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0976-1; Kale E, 2020, J PROSTHET DENT, V123, P731, DOI 10.1016/j.prosdent.2019.05.029; Karakaya S, 2005, J ORAL REHABIL, V32, P448, DOI 10.1111/j.1365-2842.2005.01443.x; Karaokutan I, 2015, J ADV PROSTHODONT, V7, P27, DOI 10.4047/jap.2015.7.1.27; Kauling AEC, 2019, CLIN ORAL INVEST, V23, P3739, DOI 10.1007/s00784-019-02802-6; Khng KYK, 2016, J PROSTHET DENT, V115, P617, DOI 10.1016/j.prosdent.2015.10.002; Kihara H, 2020, J PROSTHODONT RES, V64, P109, DOI 10.1016/j.jpor.2019.07.010; Kiljunen T, 2015, PHYS MEDICA, V31, P844, DOI 10.1016/j.ejmp.2015.09.004; Kim YH, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10082741; Kokubo Y, 2005, J ORAL REHABIL, V32, P526, DOI 10.1111/j.1365-2842.2005.01458.x; Lee WS, 2017, J ADV PROSTHODONT, V9, P265, DOI 10.4047/jap.2017.9.4.265; Bohner LOL, 2017, J PROSTHET DENT, V118, P617, DOI 10.1016/j.prosdent.2016.11.018; Mai HN, 2017, J PROSTHET DENT, V118, P208, DOI 10.1016/j.prosdent.2016.10.030; Mangano F, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0442-x; May KB, 1998, J PROSTHET DENT, V80, P394, DOI 10.1016/S0022-3913(98)70002-2; MCLEAN JW, 1971, BRIT DENT J, V131, P107, DOI 10.1038/sj.bdj.4802708; Medina-Sotomayor P, 2019, J PROSTHET DENT, V121, P811, DOI 10.1016/j.prosdent.2018.08.020; MOLIN M, 1993, ACTA ODONTOL SCAND, V51, P201, DOI 10.3109/00016359309040568; Park J-M, 2019, OPTICAL IMPRESSION R; Patras M, 2012, J ESTHET RESTOR DENT, V24, P26, DOI 10.1111/j.1708-8240.2011.00467.x; Poticny DJ, 2010, J AM DENT ASSOC, V141, p5S, DOI 10.14219/jada.archive.2010.0356; Proussaefs P, 2016, J ORAL IMPLANTOL, V42, P327, DOI 10.1563/aaid-joi-D-15-00087; Quimby ML, 2004, ANGLE ORTHOD, V74, P298; Rayyan MM, 2015, J PROSTHET DENT, V114, P414, DOI 10.1016/j.prosdent.2015.03.007; Regish KM, 2011, INT J DENT, V2011, DOI 10.1155/2011/134659; Roth I, 2020, LEARNING CURVE DIGIT; Santoro M, 2003, AM J ORTHOD DENTOFAC, V124, P101, DOI 10.1016/S0889-5406(03)00152-5; Seker E, 2016, J PROSTHET DENT, V115, P47, DOI 10.1016/j.prosdent.2015.08.006; Szymor P, 2016, J CRANIO MAXILL SURG, V44, P202, DOI 10.1016/j.jcms.2015.11.002; Taubin G., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P351, DOI 10.1145/218380.218473; Tjan AHL, 1997, J PROSTHET DENT, V77, P482, DOI 10.1016/S0022-3913(97)70140-9; van Noort R, 2012, DENT MATER, V28, P3, DOI 10.1016/j.dental.2011.10.014; Vecsei B, 2017, J PROSTHODONT RES, V61, P177, DOI 10.1016/j.jpor.2016.07.001; Winkler J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58075-7; Yeo IS, 2003, J PROSTHET DENT, V90, P459, DOI 10.1016/j.prosdent.2003.08.005	52	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240508	10.1371/journal.pone.0240508	http://dx.doi.org/10.1371/journal.pone.0240508			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064731	Green Published, gold			2022-12-26	WOS:000585918300012
J	Chen, S; Owolabi, Y; Li, A; Lo, E; Robinson, P; Janies, D; Lee, CH; Dulin, M				Chen, Shi; Owolabi, Yakubu; Li, Ang; Lo, Eugenia; Robinson, Patrick; Janies, Daniel; Lee, Chihoon; Dulin, Michael			Patch dynamics modeling framework from pathogens' perspective: Unified and standardized approach for complicated epidemic systems	PLOS ONE			English	Article							MATHEMATICAL-THEORY; ROYAL SOCIETY; 7 CHALLENGES; TRANSMISSION DYNAMICS; SUPER-SPREADERS; WITHIN-HOST; DISEASE; ENDEMICITY; INFECTION; PROTOCOL	Mathematical models are powerful tools to investigate, simulate, and evaluate potential interventions for infectious diseases dynamics. Much effort has focused on the Susceptible-Infected-Recovered (SIR)-type compartment models. These models consider host populations and measure change of each compartment. In this study, we propose an alternative patch dynamic modeling framework from pathogens' perspective. Each patch, the basic module of this modeling framework, has four standard mechanisms of pathogen population size change: birth (replication), death, inflow, and outflow. This framework naturally distinguishes between-host transmission process (inflow and outflow) and within-host infection process (replication) during the entire transmission-infection cycle. We demonstrate that the SIR-type model is actually a special cross-sectional and discretized case of our patch dynamics model in pathogens' viewpoint. In addition, this patch dynamics modeling framework is also an agent-based model from hosts' perspective by incorporating individual host's specific traits. We provide an operational standard to formulate this modular-designed patch dynamics model. Model parameterization is feasible with a wide range of sources, including genomics data, surveillance data, electronic health record, and from other emerging technologies such as multiomics. We then provide two proof-of-concept case studies to tackle some of the existing challenges of SIR-type models: sexually transmitted disease and healthcare acquired infections. This patch dynamics modeling framework not only provides theoretical explanations to known phenomena, but also generates novel insights of disease dynamics from a more holistic viewpoint. It is also able to simulate and handle more complicated scenarios across biological scales such as the current COVID-19 pandemic.	[Chen, Shi; Owolabi, Yakubu; Robinson, Patrick; Dulin, Michael] Univ N Carolina, Dept Publ Hlth Sci, Charlotte, NC 28223 USA; [Chen, Shi] Univ N Carolina, Sch Data Sci, Charlotte, NC 28223 USA; [Owolabi, Yakubu] Ctr Dis Control & Prevent, Div HIV & TB, Atlanta, GA USA; [Li, Ang] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Lo, Eugenia] Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA; [Robinson, Patrick; Dulin, Michael] Univ N Carolina, Acad Populat Hlth Innovat, Charlotte, NC 28223 USA; [Janies, Daniel] Univ N Carolina, Dept Bioinformat, Charlotte, NC 28223 USA; [Lee, Chihoon] Stevens Inst Technol, Sch Business, Hoboken, NJ 07030 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; Centers for Disease Control & Prevention - USA; Chinese Academy of Sciences; University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; Stevens Institute of Technology	Chen, S (corresponding author), Univ N Carolina, Dept Publ Hlth Sci, Charlotte, NC 28223 USA.; Chen, S (corresponding author), Univ N Carolina, Sch Data Sci, Charlotte, NC 28223 USA.	schen56@uncc.edu			North Carolina Biotechnology Center flash grant [FLG-3898]	North Carolina Biotechnology Center flash grant	This project is partially supported by the North Carolina Biotechnology Center flash grant (FLG-3898). We are grateful to the inspiring and constructive discussion on modeling patch dynamics and landscape ecology across biological scales with Dr. Jianguo (Jingle) Wu, distinguished professor of Sustainability Science in the School of Life Sciences, Arizona State University.	[Anonymous], 2015, RURAL MANAG, V10, P45; [Anonymous], PRINC EP PUBL HLTH P, V3rd; [Anonymous], 2013, EC J WATCH, V10, pA1; Ball F, 2015, EPIDEMICS-NETH, V10, P63, DOI 10.1016/j.epidem.2014.08.001; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Britton T, 2015, EPIDEMICS-NETH, V10, P54, DOI 10.1016/j.epidem.2014.05.002; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Buhnerkempe MG, 2015, EPIDEMICS-NETH, V10, P26, DOI 10.1016/j.epidem.2014.10.001; Chen M, 2017, IEEE ACCESS, V5, P8869, DOI 10.1109/ACCESS.2017.2694446; Chen S, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa333; Chen S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37938-0; Chen S, 2018, MATH MED BIOL, V35, P409, DOI 10.1093/imammb/dqx014; Chen S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03112; COLWELL RR, 1994, ANN NY ACAD SCI, V740, P44, DOI 10.1111/j.1749-6632.1994.tb19852.x; Coombs D, 2007, THEOR POPUL BIOL, V72, P576, DOI 10.1016/j.tpb.2007.08.005; Damodaran L, 2020, CLADISTICS, V36, P115, DOI 10.1111/cla.12402; De Angelis D, 2015, EPIDEMICS-NETH, V10, P83, DOI 10.1016/j.epidem.2014.09.004; Eames K, 2015, EPIDEMICS-NETH, V10, P72, DOI 10.1016/j.epidem.2014.08.006; Eisinger RW, 2019, JAMA-J AM MED ASSOC, V321, P451, DOI 10.1001/jama.2018.21167; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Fabre F, 2009, VIRUS RES, V141, P140, DOI 10.1016/j.virusres.2008.11.021; Feng ZL, 2012, NONLINEAR DYNAM, V68, P401, DOI 10.1007/s11071-011-0291-0; Fock V, 1924, MATH Z, V21, P161, DOI 10.1007/BF01187462; Funk S, 2015, EPIDEMICS-NETH, V10, P21, DOI 10.1016/j.epidem.2014.09.005; Garira W, 2017, J BIOL DYNAM, V11, P378, DOI 10.1080/17513758.2017.1367849; Giannella R.A., 1996, SALMONELLA BARONS ME, V4th; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hanski I., 1999, METAPOPULATION ECOLO; Hollingsworth TD, 2015, EPIDEMICS-NETH, V10, P16, DOI 10.1016/j.epidem.2014.08.007; Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Jopp F, 2011, MODELLING COMPLEX ECOLOGICAL DYNAMICS: AN INTRODUCTION INTO ECOLOGICAL MODELLING FOR STUDENTS, TEACHERS & SCIENTISTS, P1, DOI 10.1007/978-3-642-05029-9; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; KERMACK WO, 1991, B MATH BIOL, V53, P89, DOI 10.1007/BF02464425; KERMACK WO, 1991, B MATH BIOL, V53, P57, DOI 10.1016/S0092-8240(05)80041-2; KERMACK WO, 1991, B MATH BIOL, V53, P33, DOI 10.1016/S0092-8240(05)80040-0; Lanzas C, 2015, PREV VET MED, V118, P207, DOI 10.1016/j.prevetmed.2014.09.012; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Lessler J, 2015, EPIDEMICS-NETH, V10, P78, DOI 10.1016/j.epidem.2014.12.002; LEVIN SA, 1974, AM NAT, V108, P207, DOI 10.1086/282900; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lloyd-Smith JO, 2015, EPIDEMICS-NETH, V10, P35, DOI 10.1016/j.epidem.2014.09.002; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; McKendrick AG, 1912, P IMP MAL COM; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Pellis L, 2015, EPIDEMICS-NETH, V10, P58, DOI 10.1016/j.epidem.2014.07.003; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921; Riley S, 2015, EPIDEMICS-NETH, V10, P68, DOI 10.1016/j.epidem.2014.07.001; Roberts M, 2015, EPIDEMICS-NETH, V10, P49, DOI [10.1016/j.epidem.2014.09.006, 10.1016/j.]; Ross R., 1923, MEMOIRS FULL ACCOUNT, P24; Ross R., 1910, PREVENTION MALARIA; Schneider AD, 2020, BIOINFORMATICS, V36, P945, DOI 10.1093/bioinformatics/btz646; Sharomi O, 2008, MATH BIOSCI ENG, V5, P145; Slimi R, 2009, APPL MATH MODEL, V33, P1072, DOI 10.1016/j.apm.2007.12.028; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020; Steinmeyer SH, 2010, PHILOS T R SOC B, V365, P1931, DOI 10.1098/rstb.2010.0065; Viswanathan VK, 2010, GUT MICROBES, V1, P234, DOI 10.4161/gmic.1.4.12706; Vogels CBF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000130; Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013; Wood TK, 2013, APPL ENVIRON MICROB, V79, P7116, DOI 10.1128/AEM.02636-13; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	68	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0238186	10.1371/journal.pone.0238186	http://dx.doi.org/10.1371/journal.pone.0238186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057348	gold, Green Published			2022-12-26	WOS:000581814700031
J	Galvez-Garcia, G; Albayay, J; Fonseca, F; Bascour-Sandoval, C				Galvez-Garcia, German; Albayay, Javier; Fonseca, Fernando; Bascour-Sandoval, Claudio			Joint and individual effectiveness of galvanic cutaneous stimulation and tactile stimulation at decreasing Simulator Adaptation Syndrome	PLOS ONE			English	Article							INDUCED MOTION SICKNESS; SOPITE SYNDROME; VIBRATION; NEURONS; CORTEX; NECK	This research was focused on investigating the effectiveness of galvanic cutaneous stimulation and tactile stimulation jointly and individually at mitigating Simulator Adaptation Syndrome. Forty drivers (mean age = 23.1 +/- 3.4 years old, twenty women) participated in a driving simulation experiment. Total scores of the Simulator Sickness Questionnaire, head movements (an index of body balance), and driving performance variables were compared across four different stimulation conditions: i) baseline (where no stimulation was presented), ii) galvanic cutaneous stimulation and iii) tactile stimulation deployed individually, and iv) both techniques deployed jointly. The results showed that both techniques presented in conjunction alleviate Simulator Adaptation Syndrome and improve driving performance more effectively than when they are presented in isolation. Importantly, reduced head movements were only revealed when galvanic cutaneous stimulation was applied. We concluded that the reduction of this syndrome is due to an improvement of body balance (elicited by galvanic cutaneous stimulation), and a distraction from the symptoms (elicited by tactile stimulation). We encourage the use of both techniques simultaneously to decrease Simulator Adaptation Syndrome.	[Galvez-Garcia, German; Fonseca, Fernando] Univ La Frontera, Dept Psicol, Temuco, Chile; [Galvez-Garcia, German] Univ Lyon 2, Dept Psychol Cognit & Neuropsychol, Inst Psychol, Lab Etud Mecanismes Cognitifs, Bron, France; [Albayay, Javier] Univ Padua, Dipartimento Psicol Gen, Padua, Italy; [Bascour-Sandoval, Claudio] Univ Autonoma Chile, Fac Ciencias Salud, Carrera Kinesiol, Temuco, Chile; [Bascour-Sandoval, Claudio] Univ La Frontera, Dept Med Interna, Temuco, Chile	Universidad de La Frontera; Universite Lyon 2; University of Padua; Universidad Autonoma de Chile; Universidad de La Frontera	Galvez-Garcia, G (corresponding author), Univ La Frontera, Dept Psicol, Temuco, Chile.; Galvez-Garcia, G (corresponding author), Univ Lyon 2, Dept Psychol Cognit & Neuropsychol, Inst Psychol, Lab Etud Mecanismes Cognitifs, Bron, France.	german.galvez@ufrontera.cl	Bascour, Claudio/AAR-5889-2021; Gálvez-García, Germán/AGB-9683-2022; Gálvez-García, Germán/ACN-8491-2022	Bascour, Claudio/0000-0002-6250-8518; Gálvez-García, Germán/0000-0001-7390-4180; Albayay, Javier/0000-0003-2119-6316	FONDECYT from National Research and Development Agency (ANID, Chile) [1200326]; Home Office Research of the Universidad de La Frontera [DI20-2004]; ANID scholarship [72180384]	FONDECYT from National Research and Development Agency (ANID, Chile); Home Office Research of the Universidad de La Frontera; ANID scholarship	This research was supported by a FONDECYT project (1200326) from National Research and Development Agency (ANID, Chile) and by the Home Office Research of the Universidad de La Frontera (project DI20-2004) granted to German Galvez-Garcia, and ANID scholarship granted to Javier Albayay (PFCHA/DOCTORADO BECAS CHILE/2017 [72180384]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albayay J, 2019, BRAIN COGNITION, V137, DOI 10.1016/j.bandc.2019.103618; [Anonymous], 1993, INT J WILDLAND FIRE, V3, P203, DOI DOI 10.1207/S15327108IJAP0303_3; [Anonymous], 1991, SLUZBENI GLASNIK SR, V3, P195; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D, 2018, LME4 LINEAR MIXED EF; Bonnet CT, 2006, HUM MOVEMENT SCI, V25, P800, DOI 10.1016/j.humov.2006.03.001; Bos JE, 1998, BRAIN RES BULL, V47, P537, DOI 10.1016/S0361-9230(98)00088-4; Bos JE, 2015, J VESTIBUL RES-EQUIL, V25, P23, DOI 10.3233/VES-150541; Bos JE, 2011, DISPLAYS, V32, P189, DOI 10.1016/j.displa.2010.09.005; Cevette MJ, 2012, AVIAT SPACE ENVIR MD, V83, P549, DOI 10.3357/ASEM.3239.2012; Chu H, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-84; D'Amour S, 2017, EXP BRAIN RES, V235, P2811, DOI 10.1007/s00221-017-5009-1; Domeyer JE, 2013, ACCIDENT ANAL PREV, V53, P127, DOI 10.1016/j.aap.2012.12.039; Duzmanska N, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02132; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Galvez-Garcia G, 2020, APPL ERGON, V82, DOI 10.1016/j.apergo.2019.102931; Galvez-Garcia G, 2017, APPL ERGON, V58, P13, DOI 10.1016/j.apergo.2016.05.004; Galvez-Garcia G, 2015, ERGONOMICS, V58, P1365, DOI 10.1080/00140139.2015.1005168; Galvez-Garcia G, 2015, HUM FACTORS, V57, P649, DOI 10.1177/0018720814554948; Galvez-Garcia G, 2012, NEUROSCI LETT, V530, P18, DOI 10.1016/j.neulet.2012.09.056; Galvez-Garcia G, 2012, PSYCHOL RES-PSYCH FO, V76, P364, DOI 10.1007/s00426-011-0349-0; Gavgani AM, 2017, AUTON NEUROSCI-BASIC, V203, P41, DOI 10.1016/j.autneu.2016.12.004; Golding JF, 1998, BRAIN RES BULL, V47, P507, DOI 10.1016/S0361-9230(98)00091-4; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P559; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; Guariglia C, 2000, NEUROREPORT, V11, P1945, DOI 10.1097/00001756-200006260-00027; Helland A, 2016, ACCIDENT ANAL PREV, V94, P180, DOI 10.1016/j.aap.2016.05.008; Heutink J, 2019, ERGONOMICS, V62, P65, DOI 10.1080/00140139.2018.1518543; Jones J., 2011, THESIS; Keshavarz B, 2018, TRANSPORT RES F-TRAF, V54, P47, DOI 10.1016/j.trf.2018.01.007; Keshavarz Behrang, 2016, Virtual, Augmented and Mixed Reality. 8th International Conference, VAMR 2016, held as part of HCI International 2016. Proceedings: LNCS 9740, P147, DOI 10.1007/978-3-319-39907-2_14; Keshavarz B., 2014, HDB VIRTUAL ENV DESI, P652, DOI [10.1201/b17360-32, DOI 10.1201/B17360-32]; Keshavarz B, 2015, EXP BRAIN RES, V233, P1353, DOI 10.1007/s00221-015-4209-9; Keshavarz B, 2014, APPL ERGON, V45, P521, DOI 10.1016/j.apergo.2013.07.009; Lackner JR, 2014, EXP BRAIN RES, V232, P2493, DOI 10.1007/s00221-014-4008-8; Lawson BD, 1998, ACTA ASTRONAUT, V43, P181, DOI 10.1016/S0094-5765(98)00153-2; Lazorthes G, 1981, SYSTEME NERVEUX PERI; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lucot JB, 1998, J VESTIBUL RES-EQUIL, V8, P61; Matsangas P, 2014, AVIAT SPACE ENVIR MD, V85, P672, DOI 10.3357/ASEM.3891.2014; Mayo AM, 2011, PSYCHOL SCI, V22, P118, DOI 10.1177/0956797610392927; McElreath R., 2020, STAT RETHINKING BAYE, DOI DOI 10.1093/scipol/sct046; Merhi O, 2007, HUM FACTORS, V49, P920, DOI 10.1518/001872007X230262; Oman C M, 1982, Acta Otolaryngol Suppl, V392, P1; OMAN CM, 1990, CAN J PHYSIOL PHARM, V68, P294, DOI 10.1139/y90-044; Perennou DA, 2001, ARCH PHYS MED REHAB, V82, P440, DOI 10.1053/apmr.2001.21986; Pinheiro J., 2020, NLME LINEAR NONLINEA; Reason JT., 1975, MOTION SICKNESS; Reed N., 2007, P 1 INT S VIS IND MO, P156; Reed-Jones JG, 2009, COMP TECHNIQUES REDU, DOI [10.17077/drivingassessment.1332, DOI 10.17077/DRIVINGASSESSMENT.1332]; Reed-Jones RJ, 2008, NEUROSCI LETT, V435, P204, DOI 10.1016/j.neulet.2008.02.047; Sang FDYP, 2003, AVIAT SPACE ENVIR MD, V74, P998; Seno T, 2011, ATTEN PERCEPT PSYCHO, V73, P1467, DOI 10.3758/s13414-011-0129-3; Seno T, 2009, VISION RES, V49, P2973, DOI 10.1016/j.visres.2009.09.017; Singmann H., 2019, NEW METHODS COGNITIV, P4, DOI [10.4324/9780429318405-2, DOI 10.4324/9780429318405-2]; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; Stanney KM, 1997, PROCEEDINGS OF THE HUMAN FACTORS AND ERGONOMICS SOCIETY 41ST ANNUAL MEETING, 1997, VOLS 1 AND 2, P1138, DOI 10.1177/107118139704100292; Stanney KM, 1998, PRESENCE-TELEOP VIRT, V7, P327, DOI 10.1162/105474698565767; Team R, RSTUDIO INT DEV R; The MathWorks, 2012, MATLAB STAT TOOLB; VITTE E, 1994, EXP BRAIN RES, V102, P141; Wada T, 2012, HUM FACTORS, V54, P226, DOI 10.1177/0018720812436584; Walter HJ, 2019, HUM MOVEMENT SCI, V64, P389, DOI 10.1016/j.humov.2019.03.006; Webb CM, 2009, AVIAT SPACE ENVIR MD, V80, P541, DOI 10.3357/ASEM.2454.2009; Weech S, 2020, EXP BRAIN RES, V238, P427, DOI 10.1007/s00221-019-05718-5; Weech S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194137; Wei Y, 2018, ERGONOMICS, V61, P933, DOI 10.1080/00140139.2018.1427805; Wesley A.D., 2005, P HUM FACT ERG SOC A, V49, P1960; Wibirama S, 2018, ENTERTAIN COMPUT, V26, P117, DOI 10.1016/j.entcom.2018.02.003; Yagi T, 2000, ACTA OTO-LARYNGOL, V120, P182	73	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240627	10.1371/journal.pone.0240627	http://dx.doi.org/10.1371/journal.pone.0240627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057365	gold, Green Published			2022-12-26	WOS:000581814700058
J	Isono, T; Domon, H; Nagai, K; Maekawa, T; Tamura, H; Hiyoshi, T; Yanagihara, K; Kunitomo, E; Takenaka, S; Noiri, Y; Terao, Y				Isono, Toshihito; Domon, Hisanori; Nagai, Kosuke; Maekawa, Tomoki; Tamura, Hikaru; Hiyoshi, Takumi; Yanagihara, Katsunori; Kunitomo, Eiji; Takenaka, Shoji; Noiri, Yuichiro; Terao, Yutaka			Treatment of severe pneumonia by hinokitiol in a murine antimicrobial-resistant pneumococcal pneumonia model	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; MACROLIDE; INJURY; PHARMACOKINETICS; CEFTAROLINE; PNEUMOLYSIN; MANAGEMENT; MORTALITY; EFFICACY	Streptococcus pneumoniaeis often isolated from patients with community-acquired pneumonia. Antibiotics are the primary line of treatment for pneumococcal pneumonia; however, rising antimicrobial resistance is becoming more prevalent. Hinokitiol, which is isolated from trees in the cypress family, has been demonstrated to exert antibacterial activity againstS.pneumoniae in vitroregardless of antimicrobial resistance. In this study, the efficacy of hinokitiol was investigated in a mouse pneumonia model. Male 8-week-old BALB/c mice were intratracheally infected withS.pneumoniaestrains D39 (antimicrobial susceptible) and NU4471 (macrolide resistant). After 1 h, hinokitiol was injected via the tracheal route. Hinokitiol significantly decreased the number ofS.pneumoniaein the bronchoalveolar lavage fluid (BALF) and the concentration of pneumococcal DNA in the serum, regardless of whether bacteria were resistant or susceptible to macrolides. In addition, hinokitiol decreased the infiltration of neutrophils in the lungs, as well as the concentration of inflammatory cytokines in the BALF and serum. Repeated hinokitiol injection at 18 h intervals showed downward trend in the number ofS.pneumoniaein the BALF and the concentration ofS.pneumoniaeDNA in the serum with the number of hinokitiol administrations. These findings suggest that hinokitiol reduced bacterial load and suppressed excessive host immune response in the pneumonia mouse model. Accordingly, hinokitiol warrants further exploration as a potential candidate for the treatment of pneumococcal pneumonia.	[Isono, Toshihito; Domon, Hisanori; Nagai, Kosuke; Maekawa, Tomoki; Tamura, Hikaru; Hiyoshi, Takumi; Terao, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Div Microbiol & Infect Dis, Niigata, Japan; [Domon, Hisanori; Maekawa, Tomoki; Tamura, Hikaru; Terao, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Res Ctr Adv Oral Sci, Niigata, Japan; [Maekawa, Tomoki; Tamura, Hikaru; Hiyoshi, Takumi] Niigata Univ, Grad Sch Med & Dent Sci, Div Periodontol, Niigata, Japan; [Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki, Japan; [Kunitomo, Eiji] Kobayashi Pharmaceut Co Ltd, Cent Res & Dev Lab, Osaka, Japan; [Takenaka, Shoji; Noiri, Yuichiro] Niigata Univ, Fac Dent, Div Cariol Operat Dent & Endodont, Niigata, Japan; [Takenaka, Shoji; Noiri, Yuichiro] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan	Niigata University; Niigata University; Niigata University; Nagasaki University; Kobayashi Pharmaceutical Co Ltd; Niigata University; Niigata University	Terao, Y (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Microbiol & Infect Dis, Niigata, Japan.; Terao, Y (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Res Ctr Adv Oral Sci, Niigata, Japan.	terao@dent.niigata-u.ac.jp	Maekawa, Tomoki/AAA-4673-2020; Domon, Hisa/ADQ-4045-2022; Noiri, Yuichiro/AAA-4871-2021	Terao, Yutaka/0000-0002-4450-5583; Kunitomo, Eiji/0000-0003-4360-718X	Japan society for the promotion of science (JSPS) KAKENHI Grant [JP20H03858, JP20K09903]; Kobayashi International Scholarship Foundation; Takeda Science Foundation	Japan society for the promotion of science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kobayashi International Scholarship Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the Japan society for the promotion of science (JSPS) KAKENHI Grant (Numbers JP20H03858 to YT; JP20K09903 to HD). A comprehensive list of grants funding is available on the JSPS KAKENHI website (https://kaken.nii.ac.jp/en/).HD received funding from the Kobayashi International Scholarship Foundation (https://www.kisf.or.jp/english/) and the Takeda Science Foundation (https://www.takeda-sci.or.jp/business/abroad_e.html).Kobayashi Pharmaceutical, Co., Ltd provided support in the form of salaries for EK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2004, CANADIAN WOMAN STUDI, V24, P95; [Anonymous], 2017, LANCET HIV, V2017, pPE475; Appelbaum PC, 2002, CLIN INFECT DIS, V34, P1613, DOI 10.1086/340400; Bacci MR, 2015, BRAZ J MED BIOL RES, V48, P427, DOI 10.1590/1414-431X20144402; Badia JR, 2004, J ANTIMICROB CHEMOTH, V54, P508, DOI 10.1093/jac/dkh326; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Bhalodi AA, 2012, ANTIMICROB AGENTS CH, V56, P6160, DOI 10.1128/AAC.01078-12; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Brooks LRK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01366; Carlet J, 2011, LANCET, V378, P369, DOI 10.1016/S0140-6736(11)60401-7; Cho YM, 2011, FOOD CHEM TOXICOL, V49, P1782, DOI 10.1016/j.fct.2011.04.027; Dey SK, 2020, J MED VIROL, V92, P632, DOI 10.1002/jmv.25743; DINARELLO CA, 1997, CHEST S, V0112, pS 32, DOI DOI 10.1378/CHEST.112.6_SUPPLEMENT.321S; Domon H, 2019, MICROBIOL IMMUNOL, V63, P213, DOI 10.1111/1348-0421.12688; Domon H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00732; Domon H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38013; ERDTMAN H, 1948, NATURE, V161, P719, DOI 10.1038/161719a0; Fukuda Y, 2006, EUR RESPIR J, V27, P1020, DOI 10.1183/09031936.06.00116805; Hagio T, 2008, PULM PHARMACOL THER, V21, P884, DOI 10.1016/j.pupt.2008.10.002; Heffelfinger JD, 2000, ARCH INTERN MED, V160, P1399, DOI 10.1001/archinte.160.10.1399; Hiyoshi T, 2020, ARCH ORAL BIOL, V112, DOI 10.1016/j.archoralbio.2020.104679; Kaku N, 2017, J ANTIMICROB CHEMOTH, V72, P1123, DOI 10.1093/jac/dkw517; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Kirby BD, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02341-18; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lee JH, 2017, J INVEST DERMATOL, V137, P1257, DOI 10.1016/j.jid.2016.11.044; Loughran AJ, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0004-2018; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martinez JA, 2003, CLIN INFECT DIS, V36, P389, DOI 10.1086/367541; Matsunaga T, 1995, Kansenshogaku Zasshi, V69, P21; Matzneller P, 2016, ANTIMICROB AGENTS CH, V60, P3617, DOI 10.1128/AAC.00097-16; Nagai K, 2019, J INFECT CHEMOTHER, V25, P229, DOI 10.1016/j.jiac.2018.08.018; Nagai K, 2018, CELL IMMUNOL, V325, P14, DOI 10.1016/j.cellimm.2018.01.006; Nakamura Shigeki, 2008, Nihon Kokyuki Gakkai Zasshi, V46, P793; Nakanishi K, 2013, CHEM REC, V13, P343, DOI 10.1002/tcr.201300007; Oliva A, 2018, MOLECULES, V23, DOI 10.3390/molecules23102584; Pogue JM, 2017, CLIN MICROBIOL INFEC, V23, P229, DOI 10.1016/j.cmi.2017.02.023; Restrepo MI, 2009, EUR RESPIR J, V33, P153, DOI 10.1183/09031936.00054108; ROHWEDDER RW, 1990, DIAGN MICR INFEC DIS, V13, P127, DOI 10.1016/0732-8893(90)90095-D; Schroeder MR, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00098; Shih YH, 2013, MICROBIOL RES, V168, P254, DOI 10.1016/j.micres.2012.12.007; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Stephens DS, 2005, LANCET, V365, P855, DOI 10.1016/S0140-6736(05)71043-6; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; TRUST TJ, 1973, CAN J MICROBIOL, V19, P1341, DOI 10.1139/m73-216; Uranga A, 2016, JAMA INTERN MED, V176, P1257, DOI 10.1001/jamainternmed.2016.3633; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; VANDERKAMP BJ, 1986, WOOD FIBER SCI, V18, P421; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; WALKER JA, 1987, INFECT IMMUN, V55, P1184, DOI 10.1128/IAI.55.5.1184-1189.1987; Xu YF, 2017, CURR EYE RES, V42, P47, DOI 10.3109/02713683.2016.1151530; YAMATO M, 1985, J MED CHEM, V28, P1026, DOI 10.1021/jm00146a009; Yanagihara K, 2007, EXP LUNG RES, V33, P71, DOI 10.1080/01902140701198500; Ye J, 2015, EYE, V29, P964, DOI 10.1038/eye.2015.62; Zhang T, 2020, LIFE SCI, V248, DOI 10.1016/j.lfs.2020.117451	56	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240329	10.1371/journal.pone.0240329	http://dx.doi.org/10.1371/journal.pone.0240329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057343	gold, Green Published			2022-12-26	WOS:000581814700085
J	Kranker, K; Bardin, S; Luca, DL; O'Neil, S				Kranker, Keith; Bardin, Sarah; Lee Luca, Dara; O'Neil, So			Estimating the incidence of unintended births and pregnancies at the sub-state level to inform program design	PLOS ONE			English	Article							UNITED-STATES; NATIONAL-SURVEY; DISPARITIES; ABORTION; RATES	Objectives Unintended (mistimed or unwanted) pregnancies occur frequently in the United States and have negative effects. When designing prevention programs and intervention strategies for the provision of comprehensive birth control methods, it is necessary to identify (1) populations at high risk of unintended pregnancy, and (2) geographic areas with a concentration of need. Methods To estimate the proportion and incidence of unintended births and pregnancies for regions in Missouri, two machine-learning prediction models were developed using data from the National Survey of Family Growth and the Missouri Pregnancy Risk Assessment Monitoring System. Each model was applied to Missouri birth certificate data from 2014 to 2016 to estimate the number of unintended births and pregnancies across regions in Missouri. Population sizes from the American Community Survey were incorporated to estimate the incidence of unintended births and pregnancies. Results About 24,500 (34.0%) of the live births in Missouri each year were estimated to have resulted from unintended pregnancies: about 25 per 1,000 women (ages 15 to 45) annually. Further, 40,000 pregnancies (39.7%) were unintended each year: about 41 per 1,000 women annually. Unintended pregnancy was concentrated in Missouri's largest urban areas, and annual incidence varied substantially across regions. Conclusions Our proposed methodology was feasible to implement. Random forest modeling identified factors in the data that best predicted unintended birth and pregnancy and outperformed other approaches. Maternal age, marital status, health insurance status, parity, and month that prenatal care began predict unintended pregnancy among women with a recent live birth. Using this approach to estimate the rates of unintended births and pregnancies across regions within Missouri revealed substantial within-state variation in the proportion and incidence of unintended pregnancy. States and other agencies could use this study's results or methods to better target interventions to reduce unintended pregnancy or address other public health needs.	[Kranker, Keith; Bardin, Sarah; Lee Luca, Dara; O'Neil, So] Mathematica, Cambridge, MA 02139 USA	Mathematica	Kranker, K (corresponding author), Mathematica, Cambridge, MA 02139 USA.	kkranker@mathematica-mpr.org		Kranker, Keith/0000-0002-9230-5906; Bardin, Sarah/0000-0001-8657-1725; ONeil, Sasigant/0000-0003-1780-4016	Missouri Foundation for Health (MFH) [17-0203-PUP-17]	Missouri Foundation for Health (MFH)	The authors are affiliated with Mathematica, an independent research organization. Mathematica received funding from Missouri Foundation for Health (MFH) to conduct the study (contract number 17-0203-PUP-17). Funding was used to support direct and indirect costs of conducting the study through Mathematica as an organization, which supports the salaries and materials for authors to conduct the research. MFH did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2000, A55L2 UN; [Anonymous], 2020, OBSTET GYNECOL, V135, pe1; [Anonymous], 1968, ACONF3241 UN; Blumenstock J, 2015, SCIENCE, V350, P1073, DOI 10.1126/science.aac4420; Centers for Disease Control and Prevention, 2019, WELC NSFG PART 5 SCR; Centers for Disease Control and Prevention, 2017, REV US STAND CERT RE; Centers for Disease Control and Prevention, 2020, PRAMS 3 SCREENS; Centers for Disease Control & Prevention, 2019, NAT SURV FAM GROWTH; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Finer LB, 2014, AM J PUBLIC HEALTH, V104, pS43, DOI 10.2105/AJPH.2013.301416; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Finer LB, 2011, PERSPECT SEX REPRO H, V43, P78, DOI 10.1363/4307811; Fotheringham AS, 2008, SAGE HDB SPATIAL ANA; Frost JJ, 2014, MILBANK Q, V92, P696, DOI 10.1111/1468-0009.12080; Fu HS, 1998, FAM PLANN PERSPECT, V30, P128, DOI 10.2307/2991627; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; Jones RK, 2007, STUD FAMILY PLANN, V38, P187, DOI 10.1111/j.1728-4465.2007.00130.x; Kavanaugh ML., 2013, CONTRACEPTION HLTH B; Kost K., 2015, UNINTENDED PREGNANCY; Kost K, 2015, DEMOGRAPHY, V52, P83, DOI 10.1007/s13524-014-0359-9; Mooney SJ, 2018, ANNU REV PUBL HEALTH, V39, P95, DOI 10.1146/annurev-publhealth-040617-014208; Mosher William D, 2012, Natl Health Stat Report, P1; Shulman HB, 2018, AM J PUBLIC HEALTH, V108, P1305, DOI 10.2105/AJPH.2018.304563; Sonfield A, 2014, PREVENTING UNPLANNED; Sonfield A., 2015, PUBLIC COSTS UNINTEN; Tennekoon VS, 2017, DEMOGR RES, V36, P41, DOI 10.4054/DemRes.2017.36.2; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Wang W, 2015, INT J FORECASTING, V31, P980, DOI 10.1016/j.ijforecast.2014.06.001	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240407	10.1371/journal.pone.0240407	http://dx.doi.org/10.1371/journal.pone.0240407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057337	gold, Green Published			2022-12-26	WOS:000581814700025
J	Gysi, DM; Fragoso, TD; Zebardast, F; Bertoli, W; Busskamp, V; Almaas, E; Nowick, K				Morselli Gysi, Deisy; de Miranda Fragoso, Tiago; Zebardast, Fatemeh; Bertoli, Wesley; Busskamp, Volker; Almaas, Eivind; Nowick, Katja			Whole transcriptomic network analysis using Co-expression Differential Network Analysis (CoDiNA)	PLOS ONE			English	Article							GENE-EXPRESSION; R PACKAGE; TOOL; MODULARITY; DISEASES; MAPS	Biological and medical sciences are increasingly acknowledging the significance of gene co-expression-networks for investigating complex-systems, phenotypes or diseases. Typically, complex phenotypes are investigated under varying conditions. While approaches for comparing nodes and links in two networks exist, almost no methods for the comparison of multiple networks are available and-to best of our knowledge-no comparative method allows for whole transcriptomic network analysis. However, it is the aim of many studies to compare networks of different conditions, for example, tissues, diseases, treatments, time points, or species. Here we present a method for the systematic comparison of an unlimited number of networks, with unlimited number of transcripts:Co-expression Differential Network Analysis (CoDiNA). In particular, CoDiNA detects linksandnodes that are common, specific or different among the networks. We developed a statistical framework to normalize between these different categories of common or changed network links and nodes, resulting in a comprehensive network analysis method, more sophisticated than simply comparing the presence or absence of network nodes. Applying CoDiNA to a neurogenesis study we identified candidate genes involved in neuronal differentiation. We experimentally validated one candidate, demonstrating that its overexpression resulted in a significant disturbance in the underlying gene regulatory network of neurogenesis. Using clinical studies, we compared whole transcriptome co-expression networks from individuals with or without HIV and active tuberculosis (TB) and detected signature genes specific to HIV. Furthermore, analyzing multiple cancer transcription factor (TF) networks, we identified common and distinct features for particular cancer types. These CoDiNA applications demonstrate the successful detection of genes associated with specific phenotypes. Moreover, CoDiNA can also be used for comparing other types of undirected networks, for example, metabolic, protein-protein interaction, ecological and psychometric networks. CoDiNA is publicly available as anRpackage in CRAN (https://CRAN. R-project.org/package=CoDiNA).	[Morselli Gysi, Deisy] Univ Leipzig, Dept Comp Sci, Leipzig, Germany; [de Miranda Fragoso, Tiago] Fundacao Cesgranrio, Rio De Janeiro, Brazil; [Zebardast, Fatemeh; Nowick, Katja] Free Univ Berlin, Dept Biol, Chem, Pharm, Berlin, Germany; [Bertoli, Wesley] Univ Tecnol Fed Parana, Dept Stat, Curitiba, Parana, Brazil; [Busskamp, Volker] Tech Univ Dresden, Ctr Regenerat Therapies CRTD, Dresden, Germany; [Busskamp, Volker] Univ Bonn, Univ Augenklin Bonn, Dept Ophthalmol, Bonn, Germany; [Almaas, Eivind] NTNU Norwegian Univ Sci & Technol, Dept Biotechnol, Trondheim, Norway; [Almaas, Eivind] NTNU Norwegian Univ Sci & Technol, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway; [Morselli Gysi, Deisy] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA	Leipzig University; Free University of Berlin; Pontificia Universidade Catolica do Parana; Universidade Federal do Parana; Universidade Tecnologica Federal do Parana; Technische Universitat Dresden; University of Bonn; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Northeastern University	Gysi, DM (corresponding author), Univ Leipzig, Dept Comp Sci, Leipzig, Germany.; Nowick, K (corresponding author), Free Univ Berlin, Dept Biol, Chem, Pharm, Berlin, Germany.; Gysi, DM (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.	deisy.ccnr@gmail.com; katja.nowick@fu-berlin.de	Gysi, Deisy Morselli/ABC-2056-2020; Busskamp, Volker/E-6339-2015	Gysi, Deisy Morselli/0000-0002-5771-8182; Busskamp, Volker/0000-0001-7517-8944	Brazilian government's Science without Borders program [GDE 204111/2014-5]; Deutsche Forschungsgemeinschaft [SPP1738]	Brazilian government's Science without Borders program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	D.M.G. was supported partially by a doctoral grant from the Brazilian government's Science without Borders program (GDE 204111/2014-5). The authors also acknowledge funding from the Deutsche Forschungsgemeinschaft within the SPP1738 program.	Amar D, 2014, NUCLEIC ACIDS RES, V42, P4208, DOI 10.1093/nar/gku102; Amar D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002955; Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; Andrade-navarro, 2016, GENOMICS COMPUTATION, V2, P1, DOI [10.18547/gcb.2016.vol2.iss1.e33, DOI 10.18547/GCB.2016.VOL2.ISS1.E33]; [Anonymous], **DATA OBJECT**; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Berto S, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00031; Bhagwat AS, 2015, TRENDS CANCER, V1, P53, DOI 10.1016/j.trecan.2015.07.001; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chowdhury HA, 2020, IEEE ACM T COMPUT BI, V17, P1154, DOI 10.1109/TCBB.2019.2893170; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Csardi G, 2014, J COMPUTER APPL, VComplex Sy, P9; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; del Sol A, 2010, CURR OPIN BIOTECH, V21, P566, DOI 10.1016/j.copbio.2010.07.010; Dempsey K, 2013, INT CONF DAT MIN WOR, P327, DOI 10.1109/ICDMW.2013.125; Di Lena P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-159; Dost B, 2008, J COMPUT BIOL, V15, P913, DOI 10.1089/cmb.2007.0172; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farahbod M, 2019, BIOINFORMATICS, V35, P55, DOI 10.1093/bioinformatics/bty538; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Fukushima A, 2016, COMPUT NETW ANAL R A, V518, P1, DOI [10.1002/9783527694365.ch1, DOI 10.1002/9783527694365.CH1]; Fukushima A, 2013, GENE, V518, P209, DOI 10.1016/j.gene.2012.11.028; Furlong LI, 2013, TRENDS GENET, V29, P150, DOI 10.1016/j.tig.2012.11.004; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gysi DM, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2019.0610; Gysi DM, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2351-7; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Kovacs IA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09177-y; Kuntal BK, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1013-x; Kutsche LK, 2018, CELL SYST, V7, P438, DOI 10.1016/j.cels.2018.08.011; Lai YL, 2004, BIOINFORMATICS, V20, P3146, DOI 10.1093/bioinformatics/bth379; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Liang Z, 2006, BIOINFORMATICS, V22, P2175, DOI 10.1093/bioinformatics/btl287; Lichtblau Y, 2017, BRIEF BIOINFORM, V18, P837, DOI 10.1093/bib/bbw061; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu BH, 2010, BIOINFORMATICS, V26, P2637, DOI 10.1093/bioinformatics/btq471; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nowick K, 2009, P NATL ACAD SCI USA, V106, P22358, DOI 10.1073/pnas.0911376106; Perdomo-Sabogal A, 2019, GENOME BIOL EVOL, V11, P2178, DOI 10.1093/gbe/evz131; Pierson E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004220; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rosvall M, 2009, EUR PHYS J-SPEC TOP, V178, P13, DOI 10.1140/epjst/e2010-01179-1; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Siska C, 2016, BIOINFORMATICS, V32, P690, DOI 10.1093/bioinformatics/btv633; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Team RDC R Development Core Team R, 2016, R LANG ENV STAT COMP; Tesson BM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-497; Tian YY, 2007, BIOINFORMATICS, V23, P232, DOI 10.1093/bioinformatics/btl571; Traag VA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036115; van Dam S, 2018, BRIEF BIOINFORM, V19, P575, DOI 10.1093/bib/bbw139; Voigt A, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005739; Wang PZ, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2434-5; Watson M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-509; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079729; Yu H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-315; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	72	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240523	10.1371/journal.pone.0240523	http://dx.doi.org/10.1371/journal.pone.0240523			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057419	Green Published, Green Submitted, gold			2022-12-26	WOS:000581814700065
J	Singh, UM; Sinha, P; Dixit, S; Abbai, R; Venkateshwarlu, C; Chitikineni, A; Singh, VK; Varshney, RK; Kumar, A				Singh, Uma Maheshwar; Sinha, Pallavi; Dixit, Shilpi; Abbai, Ragavendran; Venkateshwarlu, Challa; Chitikineni, Annapurna; Singh, Vikas Kumar; Varshney, Rajeev K.; Kumar, Arvind			Unraveling candidate genomic regions responsible for delayed leaf senescence in rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; STAY-GREEN TRAIT; HARVESTING COMPLEX-II; CHLOROPHYLL DEGRADATION; GRAIN-SORGHUM; POPULATION; IDENTIFICATION; PRODUCTIVITY; EXPRESSION; CLONING	Photosynthates generated after heading contributes to 60% - 80% of grain yield in rice. Delay in leaf senescence can contribute to a long grain-filling period and thereby increased yield. The objective of this study was to identify genomic region(s) responsible for delayed leaf senescence (DLS) and validate the role of underlying candidate genes in controlling target traits. 302 BC(2)F(4)backcross-derived lines (BILs) developed from a cross between Swarna and Moroberekan were phenotyped for two seasons (DS2016 and WS2017) for chlorophyll content and yield parameters. KASPar-SNP assays based genotyping data with 193 SNPs of mapping population was used to identify the targeted genomic region(s). Significant positive correlation was observed between the two most important determinants of DLS traitsviz., RDCF (reduced decline degree of chlorophyll content of flag leaf) and RDCS (reduced decline degree of chlorophyll content of second leaf) with plant height (PH), grain number per panicle (GPN), panicle length (PL), number of tiller (NT) and grain yield (GY). A total of 41 and 29 QTLs with phenotypic variance (PVE) ranging from 8.2 to 25.1% were detected for six DLS traits during DS2016 and WS2017, respectively. Out of these identified QTLs, 19 were considered as stable QTLs detected across seasons. 17 of the identified stable QTLs were found to be novel.In-silicoanalysis revealed five key genes regulating chlorophyll metabolism. Expression analysis of these genes confirmed their strong association with the senescence pattern in leaf tissue of parents as well as selected phenotypically extreme lines. The identified stable QTLs regulating DLS traits and validation of potential candidate genes provides insight into genetic basis of delayed senescence and is expected to contribute in enhancing grain yield through genomics-assisted breeding (GAB).	[Singh, Uma Maheshwar; Sinha, Pallavi; Dixit, Shilpi; Abbai, Ragavendran; Venkateshwarlu, Challa; Singh, Vikas Kumar; Kumar, Arvind] Int Rice Res Inst IRRI, ICRISAT, South Asia Hub, Hyderabad, India; [Singh, Uma Maheshwar; Kumar, Arvind] Int Rice Res Inst, South Asia Reg Ctr ISARC, Varanasi, Uttar Pradesh, India; [Sinha, Pallavi; Chitikineni, Annapurna; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Ctr Excellence Genom & Syst Biol, Hyderabad, India	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Kumar, A (corresponding author), Int Rice Res Inst IRRI, ICRISAT, South Asia Hub, Hyderabad, India.; Kumar, A (corresponding author), Int Rice Res Inst, South Asia Reg Ctr ISARC, Varanasi, Uttar Pradesh, India.	a.kumar@irri.org	Abbai, Ragavendran/AAE-1936-2019; Varshney, Rajeev K/C-5295-2014; Kumar, Arvind/N-3181-2017	Abbai, Ragavendran/0000-0002-5712-910X; Varshney, Rajeev K/0000-0002-4562-9131; Kumar, Arvind/0000-0002-5488-9410; sinha, Pallavi/0000-0003-0810-0711	Department of Science and Technology (DST), Govt. of India [SERB/F/5044/2016-17]; Department of Biotechnology, Gov. of India, New Delhi [BT/AB/01/IRRI-India/2012]	Department of Science and Technology (DST), Govt. of India(Department of Science & Technology (India)); Department of Biotechnology, Gov. of India, New Delhi	This study was supported by Department of Science and Technology (DST), Govt. of India as National Post-Doctoral Fellowship (N-PDF) scheme (SERB/F/5044/2016-17) and Department of Biotechnology, Gov. of India, New Delhi (BT/AB/01/IRRI-India/2012).	Abdelkhalik AF, 2005, THEOR APPL GENET, V110, P1226, DOI 10.1007/s00122-005-1955-2; [Anonymous], 2016, UKRAINSKA ENTOMOFAUN; [Anonymous], 2016, PHYSL EFFICIENCY STA; BEAVIS WD, 1994, CROP SCI, V34, P882, DOI 10.2135/cropsci1994.0011183X003400040010x; Belicuas PR, 2014, EUPHYTICA, V198, P163, DOI 10.1007/s10681-014-1106-4; Ben-Yaakov E, 2006, ISR J PLANT SCI, V54, P129, DOI 10.1560/IJPS_54_2_129; Bolanos J, 1996, FIELD CROP RES, V48, P65, DOI 10.1016/0378-4290(96)00036-6; BuchananWollaston V, 1997, PLANT MOL BIOL, V33, P821, DOI 10.1023/A:1005774212410; Cairns JE, 2012, J INTEGR PLANT BIOL, V54, P1007, DOI 10.1111/j.1744-7909.2012.01156.x; Cha KW, 2002, THEOR APPL GENET, V104, P526, DOI 10.1007/s001220100750; Crasta OR, 1999, MOL GEN GENET, V262, P579, DOI 10.1007/s004380051120; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Dixit S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109574; Doorn WG Van Woltering EJ, 2004, SENESCENCE PROGRAMME, V55, P2147, DOI [10.1093/jxb/erh264, DOI 10.1093/JXB/ERH264]; Fang CY, 2016, MOL PLANT, V9, P1366, DOI 10.1016/j.molp.2016.07.007; Fu JD, 2011, GENOME, V54, P235, DOI 10.1139/G10-113; Gepstein S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-212; Guo YF, 2014, J EXP BOT, V65, P3901, DOI 10.1093/jxb/eru248; Jacob-Wilk D, 1999, PLANT J, V20, P653, DOI 10.1046/j.1365-313X.1999.00637.x; Jiang GH, 2004, THEOR APPL GENET, V108, P688, DOI 10.1007/s00122-003-1465-z; Jiang GH, 2014, GENE, V536, P287, DOI 10.1016/j.gene.2013.12.010; Kang K, 2011, PLANT J, V66, P247, DOI 10.1111/j.1365-313X.2011.04486.x; Kurp P, 2008, COMMUN ACM, V51, P11, DOI 10.1145/1400181.1400186; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Lee RH, 2001, J EXP BOT, V52, P1117, DOI 10.1093/jexbot/52.358.1117; Lim JungHyun, 2015, Plant Breeding and Biotechnology, V3, P95, DOI 10.9787/PBB.2015.3.2.095; Lim PO, 2005, CURR TOP DEV BIOL, V67, P49, DOI 10.1016/S0070-2153(05)67002-0; Liu XC, 2011, NUCLEIC ACIDS RES, V39, pD1103, DOI 10.1093/nar/gkq1169; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOHMAN KN, 1994, PHYSIOL PLANTARUM, V92, P322, DOI 10.1111/j.1399-3054.1994.tb05343.x; Mcnally KL, 2010, SOCIETY, V141, P26, DOI [10.1104/pp.106.077313.26, DOI 10.1104/PP.106.077313.26]; Rama Reddy NR, 2014, BMC GENOMICS, P15, DOI [10.1186/1471-2164-15-15, DOI 10.1186/1471-2164-15-15]; Ramkumar MK, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8100375; RODRIGUEZ MT, 1987, J PLANT PHYSIOL, V129, P369, DOI 10.1016/S0176-1617(87)80094-9; Sato Y, 2009, PLANT J, V57, P120, DOI 10.1111/j.1365-313X.2008.03670.x; Seo PJ, 2011, PLANTA, V233, P189, DOI 10.1007/s00425-010-1293-8; Shakiba E, 2019, AM J BIOMED SCI RES, V5, P16, DOI [10.34297/ajbsr.2019.05.000865, DOI 10.34297/AJBSR.2019.05.000865]; Subudhi PK, 2000, THEOR APPL GENET, V101, P733, DOI 10.1007/s001220051538; Tao YZ, 2000, THEOR APPL GENET, V100, P1225, DOI 10.1007/s001220051428; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomas H, 2000, J EXP BOT, V51, P329, DOI 10.1093/jexbot/51.suppl_1.329; Tsuchiya T, 1999, P NATL ACAD SCI USA, V96, P15362, DOI 10.1073/pnas.96.26.15362; VV.AA, 2012, COMPOSITE MAT HDB CM, V3, P1, DOI DOI 10.1007/S13244-011-0135-Y; Xu WW, 2000, GENOME, V43, P461, DOI 10.1139/g00-003; Yamamoto T, 2017, FIELD CROP RES, V206, P54, DOI 10.1016/j.fcr.2017.03.001; You SC, 2007, MOL CELLS, V24, P83; Yue Bing, 2006, Acta Genetica Sinica, V33, P824, DOI 10.1016/S0379-4172(06)60116-9; ZHAO Y, 2019, BIOINFORMATICS, V1, P9; Zheng HJ, 2009, PLANT BREEDING, V128, P54, DOI 10.1111/j.1439-0523.2008.01529.x	50	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240591	10.1371/journal.pone.0240591	http://dx.doi.org/10.1371/journal.pone.0240591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057376	gold, Green Published			2022-12-26	WOS:000581814700049
J	Ray, C; Rochefort, RM; Ransom, JI; Nesmith, JCB; Haultain, SA; Schaming, TD; Boetsch, JR; Holmgren, ML; Wilkerson, RL; Siegel, RB				Ray, Chris; Rochefort, Regina M.; Ransom, Jason I.; Nesmith, Jonathan C. B.; Haultain, Sylvia A.; Schaming, Taza D.; Boetsch, John R.; Holmgren, Mandy L.; Wilkerson, Robert L.; Siegel, Rodney B.			Assessing trends and vulnerabilities in the mutualism between whitebark pine (Pinus albicaulis) and Clark's nutcracker (Nucifraga columbiana) in national parks of the SierraCascade region	PLOS ONE			English	Article							BLISTER RUST; ROCKY-MOUNTAINS; CLIMATE-CHANGE; SEED HARVEST; DISPERSAL; WESTERN; MODEL; EXTINCTION; ABUNDANCE; SELECTION	Dispersal of whitebark pine (Pinus albicaulis Engelm.), a keystone species of many high-elevation ecosystems in western North America, depends on Clark's nutcracker (Nucifraga columbiana Wilson), a seed-caching bird with an affinity for whitebark seeds. To the extent that this dependence is mutual, declines in whitebark seed production could cause declines in nutcracker abundance. Whitebark pine is in decline across much of its range due to interacting stressors, including the non-native pathogen white pine blister rust (Cronartium ribicola J. C. Fisch.). We used avian point-count data and tree surveys from four national park units to investigate whether trends in whitebark pine can explain trends in Clark's nutcracker. Spatial trends were modeled using recent data from two parks, while temporal trends were modeled using longer time-series of nutcracker and whitebark data from two additional parks. To assess the potential dependence of nutcrackers on whitebark, we linked a model of nutcracker density (accounting for detection probability) with a model of whitebark trends, using a Bayesian framework to translate uncertainty in whitebark metrics to uncertainty in nutcracker density. In Mount Rainier National Park, temporal models showed dramatic declines in nutcracker density concurrent with significant increases in whitebark crown mortality and trees infected with white pine blister rust. However, nutcrackers did not trend with whitebark metrics in North Cascades National Park Service Complex. In spatial models of data from Yosemite National Park and Sequoia-Kings Canyon National Park, nutcracker density varied not only with local cover of whitebark but also with elevation and, in Sequoia-Kings Canyon, with cover of another species of white pine. Our results add support for the hypothesis that the mutualism between whitebark pine and Clark's	[Ray, Chris; Holmgren, Mandy L.; Wilkerson, Robert L.; Siegel, Rodney B.] Inst Bird Populat, Petaluma, CA 94953 USA; [Rochefort, Regina M.; Ransom, Jason I.] North Cascades Natl Pk Serv Complex, Sedro Woolley, WA USA; [Nesmith, Jonathan C. B.; Haultain, Sylvia A.] Natl Pk Serv, Sierra Nevada Network, Three Rivers, CA USA; [Schaming, Taza D.] Northern Rockies Conservat Cooperat, Jackson, WY USA; [Boetsch, John R.] Natl Pk Serv, North Coast & Cascades Network, Port Angeles, WA USA	United States Department of the Interior; United States Department of the Interior	Ray, C (corresponding author), Inst Bird Populat, Petaluma, CA 94953 USA.	cray@birdpop.org	Ransom, Jason/AAT-4025-2020	Ransom, Jason/0000-0002-5930-4004; Boetsch, John/0000-0003-0784-2211; RAY, CHRIS/0000-0002-7963-9637; Rochefort, Regina/0000-0003-4369-0606	National Park Service Inventory & Monitoring Division; North Coast and Cascades Research Learning Center; Institute for Bird Populations [P17AC01613]; National Park Service	National Park Service Inventory & Monitoring Division; North Coast and Cascades Research Learning Center; Institute for Bird Populations; National Park Service	This analysis was funded by the National Park Service Inventory & Monitoring Division (www.nps.gov/im) and North Coast and Cascades Research Learning Center (www.nps.gov/rlc/northcoastcascades), and was conducted under California Cooperative Ecosystem Studies Unit Agreement P17AC01613 with The Institute for Bird Populations (CR, MLH, RLW, RBS). Additional and in-kind support was provided by Mount Rainier National Park, North Cascades National Park Service Complex, Olympic National Park, Sequoia and Kings Canyon National Parks and Yosemite National Park. This research was sponsored by the National Park Service, personnel of which were coauthors who collaborated on elements of the study design related to data collection and analysis, decision to publish and preparation of the manuscript.	Alldredge MW, 2007, AUK, V124, P653, DOI 10.1642/0004-8038(2007)124[653:TMFEAF]2.0.CO;2; Amundson CL, 2014, AUK, V131, P476, DOI 10.1642/AUK-14-11.1; [Anonymous], 2019, R LANG ENV STAT COMP; Barringer LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037663; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Beedy EC, 2013, BIRDS OF THE SIERRA NEVADA: THEIR NATURAL HISTORY, STATUS, AND DISTRIBUTION, P1; Benedict WV, 1981, HIST WHITE PINE BLIS; Blanchard S, 2019, PHYSIOL ENTOMOL, V44, P77, DOI 10.1111/phen.12275; Boucher D.H., 1985, P1; Bronstein JL, 2015, MUTUALISM, P1; Buckland S.T., 2001, pi; Cox PA, 2000, CONSERV BIOL, V14, P1237, DOI 10.1046/j.1523-1739.2000.00017.x; Davey CA, 2007, NPSSIENNRTR2007042, P114; Davis J., 1957, Condor, V59, P297, DOI 10.2307/1364965; Davis J., 1964, Wilson Bulletin, V76, P10; Fancy SG, 2009, ENVIRON MONIT ASSESS, V151, P161, DOI 10.1007/s10661-008-0257-y; Farnsworth GL, 2002, AUK, V119, P414, DOI 10.1642/0004-8038(2002)119[0414:ARMFED]2.0.CO;2; Gibson K, 2006, 0603 USDA FOR SERV F, P7; GIUNTOLI M, 1978, AUK, V95, P595; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Hao YB, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150717, 10.1371/journal.pone.0163147]; Haroldson MA, 2018, YELLOWSTONE GRIZZLY, P62; Harrison RD, 2000, P ROY SOC B-BIOL SCI, V267, P911, DOI 10.1098/rspb.2000.1089; Haultain SA, 2019, NPSSIENNRR2019XXX; Hobson KA, 2014, J FIELD ORNITHOL, V85, P237, DOI 10.1111/jofo.12065; Hoff R.J, 1992, INT406 USDA FOR SERV; Holt RD, 2011, AM NAT, V178, P488, DOI 10.1086/661909; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; HUTCHINS HE, 1982, OECOLOGIA, V55, P192, DOI 10.1007/BF00384487; Irwin DE, 2011, MOL ECOL, V20, P3102, DOI 10.1111/j.1365-294X.2011.05159.x; Keane R. E., 1993, Western Journal of Applied Forestry, V8, P44; Keane RE., 2017, RMRSGTR361 USDA FOR; Keeler-Wolf T, 2012, YOSEMITE NATL PARK V; Kendall K.C., WHITEBARK PINE COMMU, P221; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M., 2016, APPL HIERARCHICAL MO, V1; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Krugman S.L., 1974, SEEDS WOODY PLANTS U, P598; Logan J.A., 2001, AM ENTOMOL, V47, P160; LOGAN JA, 1995, USDA ROCKY, V262, P92; Lorenz TJ, 2011, AUK, V128, P237, DOI 10.1525/auk.2011.10101; Lorenz TJ, 2009, CONDOR, V111, P326, DOI 10.1525/cond.2009.080070; McDonald G.I., 2001, WHITEBARK PINE COMMU, P193; McKinney ST, 2007, CAN J FOREST RES, V37, P1044, DOI 10.1139/X06-305; McKinney ST, 2009, ECOL APPL, V19, P597, DOI 10.1890/08-0151.1; McKinney ST, 2012, NPSPWRNRR2012533; Murray MP, 2003, NORTHWEST SCI, V77, P87; Nesmith JCB, 2019, FORESTS, V10, DOI 10.3390/f10010035; Nichols JD, 2019, ECOL EVOL, V9, P13991, DOI 10.1002/ece3.5836; Plard F, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2715; Plummer M, 2003, PROC 3 INT WORK DIST, V3, P1; Ray C, 2017, NPSNCCNNRR20171483; Ray C, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1902; Resler LM, 2008, ARCT ANTARCT ALP RES, V40, P161, DOI 10.1657/1523-0430(06-116)[RESLER]2.0.CO;2; Rochefort RM, 2018, FORESTS, V9, DOI 10.3390/f9050244; ROMME WH, 1991, CONSERV BIOL, V5, P373, DOI 10.1111/j.1523-1739.1991.tb00151.x; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; Running SW, 2006, SCIENCE, V313, P927, DOI 10.1126/science.1130370; Schaming TD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149116; Schaming TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123917; Schaming TD, 2016, THESIS; Schwandt JW, 2010, FOREST PATHOL, V40, P226, DOI 10.1111/j.1439-0329.2010.00656.x; Shanahan E, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1610; Siegel R. B., 2010, NPSSIENNRR2010231; Siegel RB, 2007, BIOL SCI A, P208; Smith CM, 2008, CAN J FOREST RES, V38, P982, DOI 10.1139/X07-182; Smith CM, 2013, CAN J FOREST RES, V43, P90, DOI 10.1139/cjfr-2012-0127; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tomback D., 2001, WHITEBARK PINE COMMU, P3; TOMBACK D F, 1977, Living Bird, V16, P123; TOMBACK DF, 1990, EVOL ECOL, V4, P185, DOI 10.1007/BF02214330; TOMBACK DF, 1980, CONDOR, V82, P467, DOI 10.2307/1367579; TOMBACK DF, 1982, J ANIM ECOL, V51, P451, DOI 10.2307/3976; Tomback DF, 1998, BIRDS N AM; Tomback DF, 2011, US FOR SERV RMRS-P, V63, P2; USFS Region 6, 2019, USFS REG 6 WHIT PIN; VANDERWALL SB, 1977, ECOL MONOGR, V47, P89, DOI 10.2307/1942225; VANDERWALL SB, 1981, CONDOR, V83, P162; VANDERWALL SB, 1988, CONDOR, V90, P621, DOI 10.2307/1368351; Venables WN., 2002, MODERN APPL STAT S 4; Williams PJ, 2019, ECOL MODEL, V404, P21, DOI 10.1016/j.ecolmodel.2019.04.012; Zipkin EF, 2018, BIOL CONSERV, V217, P240, DOI 10.1016/j.biocon.2017.10.017	84	0	0	8	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0227161	10.1371/journal.pone.0227161	http://dx.doi.org/10.1371/journal.pone.0227161			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052936	gold, Green Published			2022-12-26	WOS:000581820200031
J	White, ER; Hebert-Dufresne, L				White, Easton R.; Hebert-Dufresne, Laurent			State-level variation of initial COVID-19 dynamics in the United States	PLOS ONE			English	Article							DISPERSAL; EPIDEMIC	During an epidemic, metrics such asR(0), doubling time, and case fatality rates are important in understanding and predicting the course of an epidemic. However, if collected over country or regional scales, these metrics hide important smaller-scale, local dynamics. We examine how commonly used epidemiological metrics differ for each individual state within the United States during the initial COVID-19 outbreak. We found that the detected case number and trajectory of early detected cases differ considerably between states. We then test for correlations with testing protocols, interventions and population characteristics. We find that epidemic dynamics were most strongly associated with non-pharmaceutical government actions during the early phase of the epidemic. In particular, early social distancing restrictions, particularly on restaurant operations, was correlated with increased doubling times. Interestingly, we also found that states with little tolerance for deviance from enforced rules saw faster early epidemic growth. Together with other correlates such as population density, our results highlight the different factors involved in the heterogeneity in the early spread of COVID-19 throughout the United States. Although individual states are clearly not independent, they can serve as small, natural experiments in how different demographic patterns and government responses can impact the course of an epidemic.	[White, Easton R.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [White, Easton R.] Univ Vermont, Gund Inst Environm, Burlington, VT 05405 USA; [Hebert-Dufresne, Laurent] Univ Vermont, Dept Comp Sci, Burlington, VT USA; [Hebert-Dufresne, Laurent] Univ Vermont, Vermont Complex Syst Ctr, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont	White, ER (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.; White, ER (corresponding author), Univ Vermont, Gund Inst Environm, Burlington, VT 05405 USA.	Easton.White@uvm.edu	White, Easton/AAU-8761-2021	White, Easton/0000-0002-0768-9555	National Institutes of Health [1P20 GM125498-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	L.H.-D. acknowledges support from the National Institutes of Health 1P20 GM125498-01 Centers of Biomedical Research Excellence Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph C, 2021, J HEALTH POLIT POLIC, V46, P211, DOI 10.1215/03616878-8802162; Althouse Benjamin M, 2020, medRxiv, DOI 10.1101/2020.08.21.20179473; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, LANCET PSYCHIAT, V7, P1, DOI 10.1016/S2215-0366(19)30483-3; Apolloni A, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-3; Auger KA, 2020, JAMA-J AM MED ASSOC, V324, P859, DOI 10.1001/jama.2020.14348; Chin Taylor, 2020, medRxiv, DOI 10.1101/2020.04.08.20058248; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; Dalziel BD, 2018, SCIENCE, V362, P75, DOI 10.1126/science.aat6030; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; DOWD JB, 2020, DEMOGRAPHIC SCI AIDS, DOI DOI 10.1101/2020.03.15.20036293; Du ZW, 2020, EMERG INFECT DIS, V26, P2267, DOI 10.3201/eid2609.201932; Gelfand M, 2020, PSYARXIV, DOI [10.31234/osf.io/m7f8a, DOI 10.31234/OSF.IO/M7F8A]; Gostin LO, 2020, JAMA-J AM MED ASSOC, V323, P1547, DOI 10.1001/jama.2020.4335; GRENFELL BT, 1995, P ROY SOC B-BIOL SCI, V259, P97, DOI 10.1098/rspb.1995.0015; Gupta S, 2020, TRACKING PUBLIC PRIV; Hanski I, 2001, NATURWISSENSCHAFTEN, V88, P372, DOI 10.1007/s001140100246; Harrington JR, 2014, P NATL ACAD SCI USA, V111, P7990, DOI 10.1073/pnas.1317937111; Jombart T., 2020, Wellcome Open Research, V5, DOI 10.12688/wellcomeopenres.15786.1; Kaashoek J, 2020, ARXIV20043128874, P14; Kantor BN, 2020, NONPHARMACEUTICAL IN, DOI [10.1101/2020.04.26.20078618, DOI 10.1101/2020.04.26.20078618]; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kraemer, 2020, CROWDING EPIDEMIC IN, DOI [10.1101/2020.04.15.20064980, DOI 10.1101/2020.04.15.20064980]; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lonergan M, 2020, EUR RESPIR J, V56, P7, DOI [DOI 10.1183/13993003.01483-2020, 10.1183/13993003.01483-2020]; Lopes LC, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040413; Mervosh S., 2020, NEW YORK TIMES; Meunier T., 2020, FULL LOCKDOWN POLICI, DOI [10.1101/2020.04.24.20078717, DOI 10.1101/2020.04.24.20078717]; Park AW, 2012, ECOL EVOL, V2, P1398, DOI 10.1002/ece3.257; R Core Team, 2020, R LANG ENV STAT COMP; Ruktanonchai NW, 2020, SCIENCE, V369, P1465, DOI 10.1126/science.abc5096; Schreiber SJ, 2010, P ROY SOC B-BIOL SCI, V277, P1907, DOI 10.1098/rspb.2009.2006; Solis J, 2020, AM J TROP MED HYG, V103, P25, DOI 10.4269/ajtmh.20-0391; St-Onge G., 2020, ARXIV200305924; Stier A., 2020, COVID 19 ATTACK RATE, DOI [10.1101/2020.03.22.20041004v2, DOI 10.1101/2020.03.22.20041004V2]; Tsang TK, 2020, LANCET PUBLIC HEALTH, V5, pE289, DOI 10.1016/S2468-2667(20)30089-X; Utsunomiya YT, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00247; Vatcheva Kristina P, 2016, Epidemiology (Sunnyvale), V6; WHO, 2019, REP WHO CHIN JOINT M; Zhan D, 2020, WHICH MEASURES ARE E, DOI [10.1101/2020.03.28.20046110, DOI 10.1101/2020.03.28.20046110]; Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114	43	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240648	10.1371/journal.pone.0240648	http://dx.doi.org/10.1371/journal.pone.0240648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048967	gold, Green Published			2022-12-26	WOS:000581813300045
J	Wyffels, SA; Boss, DL; Sowell, BF; DelCurto, T; Bowman, JGP; McNew, LB				Wyffels, Samuel A.; Boss, Darrin L.; Sowell, Bok F.; DelCurto, Timothy; Bowman, Janice G. P.; McNew, Lance B.			Dormant season grazing on northern mixed grass prairie agroecosystems: Does protein supplement intake, cow age, weight and body condition impact beef cattle resource use and residual vegetation cover?	PLOS ONE			English	Article							LOW-QUALITY FORAGE; SPACE USE; BEHAVIOR; MANAGEMENT; SELECTION; HETEROGENEITY; PERFORMANCE; RUMINANTS; HERBIVORY; HABITAT	Dormant season livestock grazing reduces reliance on harvested feeds, but typically requires protein supplementation to maintain animal performance. Individual variation in supplement intake can impact animal performance; however, it is unknown if this variation leads to individual or herd-level effects on grazing behavior, resource utilization, and grazing impacts to native rangelands. To examine effects of protein supplementation on dormant season cattle resource use and, subsequently, post-grazing habitat conditions, we examined cattle grazing behavior, resource utilization and biomass removal of vegetation on a native rangeland in Montana. A commercial herd of 272 (yr 1) and 302 (yr 2) cows grazed a 329-ha rangeland pasture from November to January. Intake of a 30% crude protein supplement was measured for each individual. Five individuals within each of six age groups were equipped with GPS collars. Time spent grazing declined with supplement intake ((beta) over cap = -0.05 +/- 0.02;P< 0.01). Distance traveled per day had a positive asymptotic association with supplement intake (<(beta)over cap>= 0.35 +/- 0.09;P< 0.01). On average, resource utilization by cattle grazing dormant season forage decreased with terrain ruggedness (<(beta)over cap>= -0.09 +/- 0.03), but was unrelated to aspect, temperature and wind speed. Notably, we observed high individual variability in resource utilization for elevation, distance from supplement and water. A post-hoc analysis suggested that individual attributes (age, body weight, supplement intake) influenced cattle resource use. At moderate stocking rates, dormant season livestock grazing did not affect residual vegetation conditions (Pvalues > 0.22). However, residual cover of forbs and litter increased with relative grazing intensity ((beta) over cap = 1.04 +/- 0.41;(beta) over cap= 3.06 +/- 0.89; P <= 0.05). In summary, high individual variability in grazing resource utilization of cattle suggests individual-level factors could be the dominant drivers in grazing behavior and landscape use.	[Wyffels, Samuel A.; Boss, Darrin L.] Montana State Univ, Northern Ag Res Ctr, Havre, MT 59501 USA; [Sowell, Bok F.; DelCurto, Timothy; Bowman, Janice G. P.; McNew, Lance B.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Wyffels, SA (corresponding author), Montana State Univ, Northern Ag Res Ctr, Havre, MT 59501 USA.	samwyffels@montana.edu		Wyffels, Samuel/0000-0003-3533-5022	National Institute of Food and Agriculture, U.S. Department of Agriculture [2015-38640-23779]; Western Sustainable Agriculture Research and Education program [GW17-040]; Bair Ranch Foundation; DB The Nancy Cameron Endowment; SW The Montana Stockgrowers Association; Northern Agricultural Research Center; Montana Agricultural Experiment Stations; Animal and Range Sciences Department at Montana State University	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Western Sustainable Agriculture Research and Education program; Bair Ranch Foundation; DB The Nancy Cameron Endowment; SW The Montana Stockgrowers Association; Northern Agricultural Research Center; Montana Agricultural Experiment Stations; Animal and Range Sciences Department at Montana State University	National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2015-38640-23779 through the Western Sustainable Agriculture Research and Education program under sub-award number (GW17-040). https://www.westernsare.org/SW, JGPB, LM The Bair Ranch Foundation SW, JGPB, DB The Nancy Cameron Endowment .TD, SW The Montana Stockgrowers Association. https://mtbeef.org/.TD, SW The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Northern Agricultural Research Center, the Montana Agricultural Experiment Stations, and the Animal and Range Sciences Department at Montana State University for their support. We greatly appreciate data collection and technical support provided by Julia Dafoe, Cory Parsons, Noah Davis, Tori Chulyak and several field technicians. The Wildlife Habitat and Ecology Laboratory at Montana State University provided helpful comments that improved this study.	Adams D. C., 1996, Rangelands, V18, P57; ADAMS DC, 1986, J ANIM SCI, V62, P1240, DOI 10.2527/jas1986.6251240x; ADAMS DC, 1985, J ANIM SCI, V61, P1037, DOI 10.2527/jas1985.6151037x; ALLISON CD, 1985, J RANGE MANAGE, V38, P305, DOI 10.2307/3899409; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; ARES FRED N., 1953, JOUR RANGE MANAGEMENT, V6, P341, DOI 10.2307/3894319; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Augustine DJ, 2013, SENSORS-BASEL, V13, P3711, DOI 10.3390/s130303711; Bailey D W, 2004, J Anim Sci, V82 E-Suppl, pE147; Bailey DW, 2005, RANGELAND ECOL MANAG, V58, P109, DOI 10.2111/03-147.1; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Bailey DW, 1999, J RANGE MANAGE, V52, P575, DOI 10.2307/4003626; Barton K., 2016, MUMIN MULTIMODEL INF; BARTON RK, 1992, J ANIM SCI, V70, P547, DOI 10.2527/1992.702547x; Beaver JM, 1997, APPL ANIM BEHAV SCI, V51, P1, DOI 10.1016/S0168-1591(96)01081-7; Belsky AJ, 1997, CONSERV BIOL, V11, P315, DOI 10.1046/j.1523-1739.1997.95405.x; Beyer HL, 2010, GEOSPATIAL MODELLING; BINES JA, 1969, BRIT J NUTR, V23, P695, DOI 10.1079/BJN19690077; Bodine TN, 2001, J ANIM SCI, V79, P1041; Bowman JGP, 1997, J ANIM SCI, V75, P543; BOWMAN JGP, 1995, ANIM FEED SCI TECH, V55, P105, DOI 10.1016/0377-8401(95)98203-9; Bradford DF, 1998, ENVIRON MONIT ASSESS, V49, P1, DOI 10.1023/A:1005712405487; Brooks AN, 2012, THESIS; Brosh A, 2010, J ANIM SCI, V88, P315, DOI 10.2527/jas.2009-2108; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Christensen N.L, 1997, ECOLOGICAL BASIS CON, P167, DOI [10.1007/978-1-4615-6003-6_17, DOI 10.1007/978-1-4615-6003-6_17]; Clark A, 2013, RANGELAND ECOL MANAG, V66, P714, DOI 10.2111/REM-D-12-00122.1; COUGHENOUR MB, 1991, J RANGE MANAGE, V44, P530, DOI 10.2307/4003033; Damiran D., 2007, P W SECTION AM SOC A, V58, P225; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; DelCurto T., 2000, J ANIM SCI, V77, P1, DOI [DOI 10.2527/JAS2000.77E-SUPPL1V, 10.2527/jas2000.77E-Suppl1v]; Derner JD, 2009, RANGELAND ECOL MANAG, V62, P111, DOI 10.2111/08-008.1; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dowhower SL, 2001, J RANGE MANAGE, V54, P71, DOI 10.2307/4003531; DUNN RW, 1988, APPL ANIM BEHAV SCI, V21, P201, DOI 10.1016/0168-1591(88)90109-8; Fieberg J, 2015, J WILDLIFE MANAGE, V79, P708, DOI 10.1002/jwmg.894; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; Fuhlendorf SD, 2006, ECOL APPL, V16, P1706, DOI 10.1890/1051-0761(2006)016[1706:SHBTBF]2.0.CO;2; Fuhlendorf SD, 2009, CONSERV BIOL, V23, P588, DOI 10.1111/j.1523-1739.2008.01139.x; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Fuhlendorf SD, 1998, PLANT ECOL, V138, P89, DOI 10.1023/A:1009704723526; GANSKOPP D, 1987, NORTHWEST SCI, V61, P74; HAVSTAD KM, 1982, J RANGE MANAGE, V35, P447, DOI 10.2307/3898602; Hovick TJ, 2015, ECOL APPL, V25, P662, DOI 10.1890/14-1067.1; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kertson BN, 2011, ECOL APPL, V21, P2866, DOI 10.1890/11-0947.1; Kertson BN, 2011, ENVIRON CONSERV, V38, P18, DOI 10.1017/S0376892910000706; KRYSL LJ, 1993, J ANIM SCI, V71, P2546, DOI 10.2527/1993.7192546x; Loucks RR, 2002, COW CALF MANAGEMENT, V735, P1; LUSBY KS, 1976, J ANIM SCI, V43, P543, DOI 10.2527/jas1976.432543x; MANNETJE L.'T., 1963, JOUR BRIT GRASSLAND SOC, V18, P268; Marten G.C, 1989, CROP SCI SOC AM SPEC, V16; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; Mertens D.R., 1994, FORAGE QUALITY EVALU, P450, DOI DOI 10.2134/1994.FORAGEQUALITY.C11; Mertens DR, 1985, P GEORG NUTR C; Meyer AM, 2015, J ANIM SCI, V93, P4223, DOI 10.2527/jas.2015-9466; MILLER RF, 1976, J RANGE MANAGE, V29, P367, DOI 10.2307/3897141; Moore J, 1995, P AFIA LIQ FEED S 19, P81; Mulliniks JT, 2013, J ANIM SCI, V91, P2902, DOI 10.2527/jas.2012-6029; NAETH MA, 1991, J RANGE MANAGE, V44, P7, DOI 10.2307/4002629; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; National Research Council, 2016, NUTR REQ BEEF CATTL, V8th; PATTEN RS, 1995, VEGETATIO, V117, P69, DOI 10.1007/BF00033260; Petersen CA, 2014, RANGELAND ECOL MANAG, V67, P78, DOI 10.2111/REM-D-13-00038.1; Reuter R. R., 2016, Professional Animal Scientist, V32, P19, DOI 10.15232/pas.2015-01424; RIBEIRO JMDCR, 1977, ANIM PROD, V25, P107, DOI 10.1017/S0003356100039118; Riggs RA, 2004, TRANS N AM WILDL NAT, V69, P759; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Schauer CS, 2005, J ANIM SCI, V83, P1715; SENFT RL, 1985, J RANGE MANAGE, V38, P295, DOI 10.2307/3899406; Skinner RM, 1984, BIRD HABITAT MISSOUR; SMITH MA, 1992, J RANGE MANAGE, V45, P391, DOI 10.2307/4003089; Turner LW, 2000, CAN J ANIM SCI, V80, P405, DOI 10.4141/A99-093; Ungar ED, 2005, RANGELAND ECOL MANAG, V58, P256, DOI 10.2111/1551-5028(2005)58[256:IOAAFG]2.0.CO;2; Unidentified, 1999, BEIJING SCENE ONLINE, V5, P23; USGS, 2022, NATL MAP; Van Vuren D. H., 2001, Animal Biodiversity and Conservation, V24, P117; Walburger KJ, 2007, RANGELAND ECOL MANAG, V60, P172, DOI 10.2111/05-223R3.1; Walburger KJ, 2009, RANGELAND ECOL MANAG, V62, P290, DOI 10.2111/08-163R1.1; WALKER JW, 1985, J RANGE MANAGE, V38, P90, DOI 10.2307/3899343; Wiens J. A., 1997, ECOLOGICAL BASIS CON, P93; Willms WD, 1998, J RANGE MANAGE, V51, P496, DOI 10.2307/4003364; Winder VL, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00206.1; Wyffels SA, 2019, RANGELAND ECOL MANAG, V72, P878, DOI 10.1016/j.rama.2019.06.006; [No title captured]	85	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240629	10.1371/journal.pone.0240629	http://dx.doi.org/10.1371/journal.pone.0240629			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048976	gold, Green Published			2022-12-26	WOS:000581813300010
J	Fernandes, P; Briquet, S; Patarot, D; Loubens, M; Hoareau-Coudert, B; Silvie, O				Fernandes, Priyanka; Briquet, Sylvie; Patarot, Delphine; Loubens, Manon; Hoareau-Coudert, Benedicte; Silvie, Olivier			The dimerisable Cre recombinase allows conditional genome editing in the mosquito stages ofPlasmodium berghei	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; BLOOD STAGES; PLASMODIUM; EXPRESSION; INVASION	Asexual blood stages of the malaria parasite are readily amenable to genetic modification via homologous recombination, allowing functional studies of parasite genes that are not essential in this part of the life cycle. However, conventional reverse genetics cannot be applied for the functional analysis of genes that are essential during asexual blood-stage replication. Various strategies have been developed for conditional mutagenesis ofPlasmodium, including recombinase-based gene deletion, regulatable promoters, and mRNA or protein destabilization systems. Among these, the dimerisable Cre (DiCre) recombinase system has emerged as a powerful approach for conditional gene deletion inP.falciparum. In this system, the bacteriophage Cre is expressed in the form of two separate, enzymatically inactive polypeptides, each fused to a different rapamycin-binding protein. Rapamycin-induced heterodimerization of the two components restores recombinase activity. We have implemented the DiCre system in the rodent malaria parasiteP.berghei, and show that rapamycin-induced excision of floxed DNA sequences can be achieved with very high efficiency in both mammalian and mosquito parasite stages. This tool can be used to investigate the function of essential genes not only in asexual blood stages, but also in other parts of the malaria parasite life cycle.	[Fernandes, Priyanka; Briquet, Sylvie; Patarot, Delphine; Loubens, Manon; Silvie, Olivier] Sorbonne Univ, Ctr Immunol & Malad Infect, CIMI Paris, CNRS,INSERM, Paris, France; [Hoareau-Coudert, Benedicte] Sorbonne Univ, UMS PASS, Plateforme Cytometrie Pitie Salpetriere CyPS, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Silvie, O (corresponding author), Sorbonne Univ, Ctr Immunol & Malad Infect, CIMI Paris, CNRS,INSERM, Paris, France.	olivier.silvie@inserm.fr	Silvie, Olivier/AAF-5437-2021; Silvie, Olivier/K-7290-2017	Silvie, Olivier/0000-0002-0525-6940; Silvie, Olivier/0000-0002-0525-6940; Fernandes, Priyanka/0000-0003-3459-7098; Loubens, Manon/0000-0002-2865-3543; Hoareau, Benedicte/0000-0002-6575-7085	Laboratoire d'Excellence ParaFrap [ANR-11-LABX-0024]; Agence Nationale de la Recherche [ANR-16CE15-0004, ANR-16-CE15-0010]; 'DIM1Health' doctoral fellowship; Conseil Regional d'Ile-de-France	Laboratoire d'Excellence ParaFrap; Agence Nationale de la Recherche(French National Research Agency (ANR)); 'DIM1Health' doctoral fellowship; Conseil Regional d'Ile-de-France(Region Ile-de-France)	OS received funding from the Laboratoire d'Excellence ParaFrap (ANR-11-LABX-0024), and the Agence Nationale de la Recherche (ANR-16CE15-0004 and ANR-16-CE15-0010). ML was supported by a 'DIM1Health' doctoral fellowship awarded by the Conseil Regional d'Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agop-Nersesian C, 2008, INT J PARASITOL, V38, P673, DOI 10.1016/j.ijpara.2007.10.015; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Arsic D, 2008, J INSECT PHYSIOL, V54, P1226, DOI 10.1016/j.jinsphys.2008.06.003; Bannister L, 2003, TRENDS PARASITOL, V19, P209, DOI 10.1016/S1471-4922(03)00086-2; Carvalho TG, 2004, P NATL ACAD SCI USA, V101, P14931, DOI 10.1073/pnas.0404416101; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Govindasamy K, 2016, MOL MICROBIOL, V102, P349, DOI 10.1111/mmi.13466; Ishino T, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12964; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Jones ML, 2016, SCI REP, P6, DOI [10.1038/s41598-016-0015-2, DOI 10.1038/S41598-016-0015-2]; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Kent RS, 2018, NAT MICROBIOL, V3, P1206, DOI 10.1038/s41564-018-0223-6; Klug D, 2018, J CELL SCI, V131, DOI 10.1242/jcs.210971; Laurentino EC, 2011, CELL MICROBIOL, V13, P1956, DOI 10.1111/j.1462-5822.2011.01683.x; Manzoni G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04760; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Ramakrishnan Chandra, 2013, Methods Mol Biol, V923, P51; Sebastian S, 2012, CELL HOST MICROBE, V12, P9, DOI 10.1016/j.chom.2012.05.014; Siden-Kiamos I, 2011, CELL MICROBIOL, V13, P1996, DOI 10.1111/j.1462-5822.2011.01686.x; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Silvie O, 2007, INT J PARASITOL, V37, P173, DOI 10.1016/j.ijpara.2006.10.005; Tiburcio M, 2019, MBIO, V10, DOI 10.1128/mBio.01170-19; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; Yap A, 2014, CELL MICROBIOL, V16, P642, DOI 10.1111/cmi.12287	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0236616	10.1371/journal.pone.0236616	http://dx.doi.org/10.1371/journal.pone.0236616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044964	gold, Green Submitted, Green Published			2022-12-26	WOS:000581811700021
J	Rajindrajith, S; Ranathunga, N; Jayawickrama, N; van Dijk, M; Benninga, MA; Devanarayana, NM				Rajindrajith, Shaman; Ranathunga, Nayomi; Jayawickrama, Nirodha; van Dijk, Marieke; Benninga, Marc A.; Devanarayana, Niranga Manjuri			Behavioral and emotional problems in adolescents with constipation and their association with quality of life	PLOS ONE			English	Article							GASTROINTESTINAL-DISEASES; FECAL INCONTINENCE; CHILDREN; RELIABILITY; PREVALENCE; SYMPTOMS; VALIDITY; HEALTHY; COHORT; SCALES	Objectives To assess behavioral and emotional problems in children and adolescents with functional constipation and their relationship with psychological maladjustment and health-related quality of life (HRQoL). Design A school-based cross-sectional survey conducted in 8 randomly selected schools from 4 randomly selected districts in Sri Lanka. A previously validated questionnaire was used for data collection. Behavioral and emotional problems were assessed using the Sinhala version of the Child Behavior Check List (CBCL-S/4-18). Constipation was diagnosed by applying the Rome III criteria. Results A total of 1000 questionnaires were distributed, and 913 completed questionnaires were included in the analysis. Sixty adolescents (6.5%) had functional constipation. Scores obtained for isolated psychological problems such as withdrawal (3.1 [3.1] vs. 1.9 [2.4],p<0.001), somatic complaints (3.2 [2.8] vs. 2.3 [2.5],p<0.05) anxiety/depression (5.8 [2.5] vs. 3.9 [3.6],p<0.001), social problems (3.0 [2.7] vs. 2.2 [1.9]p<0.001) and attention problems (5.4 [4.1] vs. 3.9 [3.4], p<0.001), and broadband scale of internalization (12.1 [8.4] vs. 8.3 [7.2],p<0.05) and mean total CBCL-S/4-18 score (29.4 [19.5] vs. 23.2 [17.0],p<0.001) were higher in adolescents with functional constipation. Clinical characteristics, socio-demographic and family factors and psychological maladjustment had no relationship with externalization, internalization and total CBCL-S/4-18 score. Internalization (-0.49,p<0.0001), externalization (-0.30,p<0.05), and total CBCL-S/4-18 (-0.44,p<0.001) scores had a negative impact on HRQoL of adolescents with functional constipation. Conclusions Adolescents with functional constipation are suffering from significant behavioral and emotional problems. These problems negatively affect their HRQoL.	[Rajindrajith, Shaman] Univ Colombo, Dept Pediat, Fac Med, Colombo, Western Provinc, Sri Lanka; [Rajindrajith, Shaman] Lady Ridgeway Hosp Children, Colombo, Sri Lanka; [Ranathunga, Nayomi] Wyamba Univ Sri Lanka, Fac Med, Dept Physiol, Kuliyapitiya, North Cent Prov, Sri Lanka; [Jayawickrama, Nirodha] Natl Eye Hosp, Colombo, Western Provinc, Sri Lanka; [van Dijk, Marieke] Univ Amsterdam, Med Ctr, Emma Children Hosp, Psychol Dept, Amsterdam, Netherlands; [Benninga, Marc A.] Univ Amsterdam, Med Ctr, Emma Children Hosp, Dept Pediat Gastroenterol & Nutr, Amsterdam, Netherlands; [Devanarayana, Niranga Manjuri] Univ Kelaniya, Dept Physiol, Fac Med, Ragama, Western Provinc, Sri Lanka	University of Colombo; Wayamba University of Sri Lanka; Emma Children's Hospital; University of Amsterdam; Emma Children's Hospital; University of Amsterdam; University Kelaniya	Devanarayana, NM (corresponding author), Univ Kelaniya, Dept Physiol, Fac Med, Ragama, Western Provinc, Sri Lanka.	niranga@kln.ac.lk			University of Kelaniya [RP/03/04/13/01/2013]	University of Kelaniya	This research project was funded by the University of Kelaniya in the form of a grant awarded to SR (RP/03/04/13/01/2013).	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; [Anonymous], 2011, CRITICAL STUDIES ED, V52, P47; Appak YC, 2017, TURK J GASTROENTEROL, V28, P465, DOI 10.5152/tjg.2017.17216; Coburn SS, 2019, J PEDIATR GASTR NUTR, V69, pE25, DOI 10.1097/MPG.0000000000002407; de Zoysa P, 2007, NEW PSYCHOL TEST TES, P185; Devanarayana NM, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-150; Devanarayana NM, 2011, J TROP PEDIATRICS, V57, P34, DOI 10.1093/tropej/fmq039; Devanarayana NM, 2010, J TROP PEDIATRICS, V56, P144, DOI 10.1093/tropej/fmp077; Joinson C, 2006, PEDIATRICS, V117, P1575, DOI 10.1542/peds.2005-1773; Kaugars AS, 2010, J PEDIATR GASTR NUTR, V51, P747, DOI 10.1097/MPG.0b013e3181de0651; Khaleque A, 2002, J CROSS CULT PSYCHOL, V33, P87, DOI 10.1177/0022022102033001006; Kilincaslan H, 2014, PEDIATR INT, V56, P588, DOI 10.1111/ped.12282; Koppen IJN, 2018, J PEDIATR-US, V198, P121, DOI 10.1016/j.jpeds.2018.02.029; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Rajindrajith S, 2016, J PEDIATR GASTR NUTR, V62, P698, DOI 10.1097/MPG.0000000000001006; Rajindrajith S, 2014, J PEDIATR GASTR NUTR, V58, P486, DOI 10.1097/MPG.0000000000000249; Rajindrajith S, 2013, J PEDIATR-US, V163, P1069, DOI 10.1016/j.jpeds.2013.05.012; Rajindrajith S, 2012, ARCH DIS CHILD, V97, P43, DOI 10.1136/adc.2009.173716; Ranasinghe N, 2017, ARCH DIS CHILD, V102, P268, DOI 10.1136/archdischild-2016-310694; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Rohner R. P., 2005, HDB STUDY PARENTAL A; Rouster AS, 2016, J PEDIATR GASTR NUTR, V62, P847, DOI 10.1097/MPG.0000000000001023; Senaratna B. C. V., 2008, CEYLON MEDICAL JOURNAL, V53, P40; van Dijk M, 2010, PEDIATRICS, V125, pE309, DOI 10.1542/peds.2008-3055; Varni JW, 2015, QUAL LIFE RES, V24, P363, DOI 10.1007/s11136-014-0781-x; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Vriesman MH, 2020, NAT REV GASTRO HEPAT, V17, P21, DOI 10.1038/s41575-019-0222-y; Vriesman MH, 2019, J PEDIATR-US, V214, P141, DOI 10.1016/j.jpeds.2019.06.059; Walker L, 2006, ROME 3 FUNCTIONAL GA, P961	29	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0239092	10.1371/journal.pone.0239092	http://dx.doi.org/10.1371/journal.pone.0239092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044960	Green Published, gold			2022-12-26	WOS:000581811700024
J	Sanchez, J; Velasquez, M; Jaimes, F				Sanchez, Jorge; Velasquez, Margarita; Jaimes, Fabian			A protocol for the development and internal validation of a model to predict clinical response to antihistamines in urticaria patients	PLOS ONE			English	Article							INDUCIBLE URTICARIA; D-DIMER; BIOMARKERS; OMALIZUMAB; MARKERS	Chronic urticaria causes a significant limitation to quality of life. In the literature, various studies can be found that have reviewed several clinical and laboratory markers, but none of these variables alone is sufficient to predict the patient's prognosis. In this study, we present a protocol to develop a prognostic model that can predict the clinical response of urticaria patients to antihistamines. This is a protocol for a bidirectional cohort study. Urticaria data will be routinely collected from a population of patients over 18 years old. A full multivariable logistic regression model will be fitted, following five steps: 1) Selection of predictive variables for the model; 2) Evaluation of the quality of the collected data and control of lost data; 3) Data statistical management; 4) Strategies to select the variables to include at the end of the model; 5) Evaluation of the performance of the different possible models (predictive accuracy) and selection of the best model. The performance and internal validation of the model will be assessed. Some clinical and paraclinical variables will be measured for further exploration.	[Sanchez, Jorge] Univ Antioquia, IPS Univ Clin, Grp Clin & Expt Allergy, Medellin, Colombia; [Velasquez, Margarita] Univ Antioquia, Dermatol Res Ctr, Medellin, Colombia; [Jaimes, Fabian] Univ Antioquia, Internal Med Dept, San Vicente Clin, Medellin, Colombia; [Sanchez, Jorge] IPS Univ Clin, Allergy Ctr, Medellin, Colombia; [Velasquez, Margarita] San Vicente Hosp, Dermatol Ctr, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia	Sanchez, J (corresponding author), Univ Antioquia, IPS Univ Clin, Grp Clin & Expt Allergy, Medellin, Colombia.; Sanchez, J (corresponding author), IPS Univ Clin, Allergy Ctr, Medellin, Colombia.	jorgem.sanchez@udea.edu.co		Sanchez, Jorge/0000-0001-6341-783X; Velasquez, Margarita/0000-0001-8604-6488	University of Antioquia; "IPS University"clinic; San Vicente Hospital	University of Antioquia; "IPS University"clinic; San Vicente Hospital	This project was funded by an interinstitutional grant (2019-2020) from the following institutions: University of Antioquia, "IPS University"clinic, and San Vicente Hospital. We appreciate their logistical and financial support.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Altrichter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014794; [Anonymous], 2018, METODO INT STUDIES P, V6, P177; Asero R, 2017, INT ARCH ALLERGY IMM, V172, P40, DOI 10.1159/000453453; Ben-Shoshan M, 2018, J ALLER CL IMM-PRACT, V6, P1152, DOI 10.1016/j.jaip.2018.02.015; Church MK, 2018, IMMUNOL REV, V282, P232, DOI 10.1111/imr.12632; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Dressler C, 2018, J ALLERGY CLIN IMMUN, V141, P1726, DOI 10.1016/j.jaci.2018.01.031; Grzanka R, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0255-8; Guillen-Aguinaga S, 2016, BRIT J DERMATOL, V175, P1153, DOI 10.1111/bjd.14768; Hernandez-Avila M, 2000, SALUD PUBLICA MEXICO, V42, P438; Heus P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025611; Heus P, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1099-2; Kay AB, 2014, BRIT J DERMATOL, V171, P505, DOI 10.1111/bjd.12991; Kolkhir P, 2017, ALLERGY, V72, P1440, DOI 10.1111/all.13182; Kolkhir P, 2017, EUR ANN ALLERGY CLIN, V49, P189, DOI 10.23822/EurAnnACI.1764-1489.05; Kolkhir P, 2017, CLIN EXP ALLERGY, V47, P19, DOI 10.1111/cea.12870; Kolkhir P, 2017, AUTOIMMUN REV; Kolkhir P, 2019, J ALLERGY CLIN IMMUN; Kulthanan K, 2018, J ALLER CL IMM-PRACT, V6, P586, DOI 10.1016/j.jaip.2017.07.017; Lee SJ, 2017, ALLERGY ASTHMA IMMUN, V9, P212, DOI 10.4168/aair.2017.9.3.212; Maurer M, 2011, ALLERGY, V66, P317, DOI 10.1111/j.1398-9995.2010.02496.x; Maurer M, 2018, J ALLERGY CLIN IMMUN, V141, P638, DOI 10.1016/j.jaci.2017.06.032; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Nunez E, 2011, REV ESP CARDIOL, V64, P501, DOI [10.1016/j.recesp.2011.01.019, 10.1016/j.rec.2011.01.017]; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Riley RD, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m441; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Sanchez Borges Mario, 2015, Rev Alerg Mex, V62, P279; Sanchez J, 2019, ALLERGY ASTHMA IMMUN, V11, P29, DOI 10.4168/aair.2019.11.1.29; Sanchez J, 2017, J ALLER CL IMM-PRACT, V5, P464, DOI 10.1016/j.jaip.2016.09.029; Sanchez Jorge J, 2018, J INVESTIG ALLERGOL, V0; Sanchez-Borges M, 2018, EUR ANN ALLERGY CLIN, V50, P5, DOI 10.23822/EurAnnACI.1764-1489.24; Sanchez-Borges M, 2017, ALLERGOL IMMUNOPATH, V45, P573, DOI 10.1016/j.aller.2016.08.010; Sanchez-Borges M, 2017, J EUR ACAD DERMATOL, V31, P964, DOI 10.1111/jdv.14221; Sanchez-Borges M, 2010, J INVEST ALLERG CLIN, V20, P139; Sharma M, 2015, J AM ACAD DERMATOL, V73, P710, DOI 10.1016/j.jaad.2015.06.048; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Sussman G, 2018, ALLERGY, V73, P1724, DOI 10.1111/all.13430; Weldon D, 2014, ALLERGY ASTHMA PROC, V35, P4, DOI 10.2500/aap.2014.35.3713; Zuberbier T, 2018, EAACI GA2 LEN EDF WA	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2020	15	10							e0239962	10.1371/journal.pone.0239962	http://dx.doi.org/10.1371/journal.pone.0239962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OB4WW	33022026	gold, Green Published			2022-12-26	WOS:000578473000014
J	Selwyn, M; Garrote, PJ; Castilla, AR; Fedriani, JM				Selwyn, Miriam; Garrote, Pedro J.; Castilla, Antonio R.; Fedriani, Jose M.			Interspecific interactions among functionally diverse frugivores and their outcomes for plant reproduction: A new approach based on camera-trap data and tailored null models	PLOS ONE			English	Article							SEED DISPERSAL; IBERIAN PEAR; SOLIDAGO-ALTISSIMA; CHAMAEROPS-HUMILIS; PYRUS-BOURGAEANA; COMPETITION; POLLINATOR; PREDATION; MUTUALISM; GOLDENROD	The study of plant-frugivore interactions is essential to understand the ecology and evolution of many plant communities. However, very little is known about how interactions among frugivores indirectly affect plant reproductive success. In this study, we examined direct interactions among vertebrate frugivores sharing the same fruit resources. Then, we inferred how the revealed direct interspecific interactions could lead to indirect (positive or negative) effects on reproductive success of fleshy fruited plants. To do so, we developed a new analytical approach that combines camera trap data (spatial location, visitor species, date and time, activity) and tailored null models that allowed us to infer spatial-temporal interactions (attraction, avoidance or indifference) between pairs of frugivore species. To illustrate our approach, we chose to study the system composed by the Mediterranean dwarf palm,Chamaerops humilis, the Iberian pear tree,Pyrus bourgaeana, and their shared functionally diverse assemblages of vertebrate frugivores in a Mediterranean area of SW Spain. We first assessed the extent to which different pairs of frugivore species tend to visit the same or different fruiting individual plants. Then, for pairs of species that used the same individual plants, we evaluated their spatial-temporal relationship. Our first step showed, for instance, that some prey frugivore species (e.g. lagomorphs) tend to avoid thoseC.humilisindividuals that were most visited by their predators (e.g. red foxes). Also, the second step revealed temporal attraction between large wild and domestic frugivore ungulates (e.g. red deer, cows) and medium-sized frugivores (e.g. red foxes) suggesting that large mammals could facilitate theC.humilisandP.bourgaeanaexploitation to other smaller frugivores by making fruits more easily accessible. Finally, our results allowed us to identify direct interaction pathways, that revealed how the mutualistic and antagonistic relations between animal associates derived into indirect effects on both plants seed dispersal success. For instance, we found that large-sized seed predators (e.g. ungulates) had a direct positive effect on the likelihood of visits by legitimate seed dispersers (e.g. red foxes) to both fleshy fruited plants. Then, seed predators showed an indirect positive effect on the plants' reproductive success. Our new analytical approach provides a widely applicable framework for further studies on multispecies interactions in different systems beyond plant-frugivore interactions, including plant-pollinator interactions, the exploitation of plants by herbivores, and the use of carcasses by vertebrate scavengers.	[Selwyn, Miriam; Garrote, Pedro J.; Castilla, Antonio R.] Univ Lisbon, Inst Super Agron, Ctr Ecol Aplicada Prof Baeta Neves CEABN InBIO, Lisbon, Portugal; [Fedriani, Jose M.] Ctr Invest Desertificac CIDE CSIC, Carretera Moncada Naquera, Valencia, Spain; [Fedriani, Jose M.] Estn Biol Donana EBD CSIC, Seville, Spain	Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Selwyn, M (corresponding author), Univ Lisbon, Inst Super Agron, Ctr Ecol Aplicada Prof Baeta Neves CEABN InBIO, Lisbon, Portugal.; Fedriani, JM (corresponding author), Ctr Invest Desertificac CIDE CSIC, Carretera Moncada Naquera, Valencia, Spain.; Fedriani, JM (corresponding author), Estn Biol Donana EBD CSIC, Seville, Spain.	mimselwyn@gmail.com; fedriani@csic.es	Castilla, Antonio R./A-3877-2019	Castilla, Antonio R./0000-0002-4124-738X; Selwyn, Miriam/0000-0002-3773-1734	Ministerio de Ciencia, Innovacion y Universidades [PGC2018-094808-B-I00]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/130527/2017]; Fundacao para a Ciencia e a Tecnologia; Fundacao para a Ciencia e Tecnologia; Consejeria de Educacion, Junta de Castilla y Leon	Ministerio de Ciencia, Innovacion y Universidades; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Consejeria de Educacion, Junta de Castilla y Leon(Junta de Castilla y Leon)	This study has been funded by a grant from the Ministerio de Ciencia, Innovacion y Universidades, PGC2018-094808-B-I00, to Jose M. Fedriani. Pedro J. Garrote was supported by a fellowship from Fundacao para a Ciencia e a Tecnologia, SFRH/BD/130527/2017. Antonio R. Castilla was supported by a fellowship from Fundacao para a Ciencia e a Tecnologia, Fundacao para a Ciencia e Tecnologia. Miriam Selwyn was supported by a felowship from Consejeria de Educacion, Junta de Castilla y Leon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Ameztegui A, 2015, FOREST ECOL MANAG, V342, P103, DOI 10.1016/j.foreco.2015.01.021; Anderson S, 2012, QUICK INTRO PLYR; [Anonymous], 2016, INT J SPECIALEDUCATI, V31, P1; Anstett MC, 1999, ACTA OECOL, V20, P551, DOI 10.1016/S1146-609X(00)86622-9; Apps P, 2018, AFR J ECOL, V56, P710, DOI 10.1111/aje.12573; Arsenault R, 2002, OIKOS, V97, P313, DOI 10.1034/j.1600-0706.2002.970301.x; Bahaa-el-din L, 2018, AFR J ECOL, V56, P690, DOI 10.1111/aje.12581; Barasona JA, 2014, VET RES, V45, DOI 10.1186/s13567-014-0122-7; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Buckley YM, 2006, J APPL ECOL, V43, P848, DOI 10.1111/j.1365-2664.2006.01210.x; Callaway R. M., 2007, POSITIVE INTERACTION; Carreira DC, 2020, J MAMMALOGY; Castaneda I, 2018, MAMM BIOL, V90, P89, DOI 10.1016/j.mambio.2017.10.004; Chase J.M., 2009, ECOLOGICAL NICHES LI; CORONA MG, 1988, VEGETATIO, V75, P73, DOI 10.1007/BF00044628; Dufay M, 2010, J EVOLUTION BIOL, V23, P977, DOI 10.1111/j.1420-9101.2010.01968.x; Eldridge DJ, 2017, ECOLOGY, V98, P1922, DOI 10.1002/ecy.1879; Fedriani JM, 2006, FUNCT ECOL, V20, P1070, DOI 10.1111/j.1365-2435.2006.01199.x; Fedriani JM, 2020, ECOGRAPHY, V43, P1352, DOI 10.1111/ecog.05047; Fedriani JM, 1999, OECOLOGIA, V121, P138, DOI 10.1007/s004420050915; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; Fedriani JM, 2018, J APPL ECOL, V55, P600, DOI 10.1111/1365-2664.13000; Fedriani JM, 2014, ECOLOGY, V95, P514, DOI 10.1890/13-0718.1; Fedriani JM, 2013, J ECOL, V101, P1581, DOI 10.1111/1365-2745.12146; Fedriani JM, 2012, ECOLOGY, V93, P575, DOI 10.1890/11-0429.1; Fedriani JM, 2011, ECOLOGY, V92, P304, DOI 10.1890/09-2194.1; Fedriani JM, 2010, ECOGRAPHY, V33, P545, DOI 10.1111/j.1600-0587.2009.06052.x; Fedriani JM, 2009, ECOSCIENCE, V16, P311, DOI 10.2980/16-3-3253; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Garcia D, 2012, P ROY SOC B-BIOL SCI, V279, P3106, DOI 10.1098/rspb.2012.0175; Garcia D, 2011, ECOL MONOGR, V81, P103, DOI 10.1890/10-0470.1; Garcia Y, 2018, ANN BOT-LONDON, V122, P961, DOI 10.1093/aob/mcy122; Garrote PJ, 2019, J ENVIRON MANAGE, V250, DOI 10.1016/j.jenvman.2019.109478; Garrote PJ, 2018, OECOLOGIA, V187, P143, DOI 10.1007/s00442-018-4102-x; Grolemond G, 2011, J STAT SOFTW, V40, P1; Guzman B, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1108-1; Haurez B, 2015, J TROP ECOL, V31, P395, DOI 10.1017/S0266467415000322; Hernandez A, 2008, POL J ECOL, V56, P127; Herrera CM, 2009, INTERSPEC INTERACT, P186; HERRERA J, 1988, J ECOL, V76, P274, DOI 10.2307/2260469; Holland JN, 2009, ECOL LETT, V12, P1357, DOI 10.1111/j.1461-0248.2009.01390.x; HOWE HF, 1979, AM NAT, V114, P925, DOI 10.1086/283540; HOWE HF, 1980, ECOLOGY, V61, P944, DOI 10.2307/1936763; Jacome-Flores ME, 2018, ANN BOT-LONDON, V121, P471, DOI 10.1093/aob/mcx177; Jacome-Flores ME, 2020, OIKOS, V129, P367, DOI 10.1111/oik.06688; Juenger T, 1998, EVOLUTION, V52, P1583, DOI 10.1111/j.1558-5646.1998.tb02239.x; Karanth KU, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.1860; Kissling WD, 2015, ECOGRAPHY, V38, P346, DOI 10.1111/ecog.00819; Kitamura Shumpei, 2009, Ornithological Science, V8, P75, DOI 10.2326/048.008.0110; KOENIG WD, 1994, CAN J FOREST RES, V24, P2105, DOI 10.1139/x94-270; MADDOX GD, 1987, OECOLOGIA, V72, P8, DOI 10.1007/BF00385037; MADDOX GD, 1990, ECOLOGY, V71, P2115, DOI 10.2307/1938625; Mailund T., 2019, R DATA SCI QUICK REF, P109, DOI [10.1007/978-1-4842-4894-2, DOI 10.1007/978-1-4842-4894-2]; Manly BFJ., 2018, RANDOMIZATION BOOTST; Moegenburg SM, 2003, ECOLOGY, V84, P2600, DOI 10.1890/02-0063; Monterroso P, 2020, ECOLOGY, V101, DOI 10.1002/ecy.3059; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Munoz-Gallego R, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00161; Nakajima A., 2015, OPEN J FOR, V05, P651, DOI DOI 10.4236/0JF.2015.57057; Nielsen BL, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00226; Nordlund DA, 1976, J CHEM ECOL, V2, P211, DOI 10.1007/BF00987744; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; Owen-Smith RN., 2002, CAMB ST ECO, DOI 10.1017/CBO9780511525605; Palacio FX, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00018; Palomares F, 1996, J APPL ECOL, V33, P5, DOI 10.2307/2405010; Parsons MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010403; Perry Roger W., 1999, Southern Journal of Applied Forestry, V23, P164; Pilosof S, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0101; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Quitian M, 2018, ECOGRAPHY, V41, P1497, DOI 10.1111/ecog.03247; R Core Team, 2013, R LANG ENV STAT COMP; Railsback S.F., 2019, AGENT BASED INDIVIDU; Rauscher MD, 1989, EVOLUTION US; Sauve A.M., 2014, OIKOS, V123, P378, DOI DOI 10.1111/J.1600-0706.2013.00743.X; Schaefer HM, 2011, PLANT-ANIMAL COMMUNICATION, P1, DOI 10.1093/acprof:osobl/9780199563609.001.0001; SEVERONETO F, 2011, ATUALIDADES ORNITOLO, V169, P15; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; Thompson JN, 2014, INTERACTION COEVOLUT; TRAVESET A, 1994, EVOL ECOL, V8, P618, DOI 10.1007/BF01237845; Triguero-Ocana R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211216; Valdes Castrillon B, 1987, FLORA VASCULAR ANDAL; Valverde JA, 1967, MONOGRAFIA, V1; Wallace JR., 2015, CARRION ECOLOGY EVOL; Wang YS, 2012, B MATH BIOL, V74, P2142, DOI 10.1007/s11538-012-9750-0; Waser NM., 2006, PLANT POLLINATOR INT; Wearn O. R., 2017, WWF CONSERV TECHNO 1, V1, P1; Wei T., 2013, STATISTICIAN, V56, P316; WHITTAKER R. H., 1970, Chemical ecology, P43; Zywiec M, 2012, OECOLOGIA, V169, P713, DOI 10.1007/s00442-011-2232-5	92	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240614	10.1371/journal.pone.0240614	http://dx.doi.org/10.1371/journal.pone.0240614			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064761	Green Published, gold			2022-12-26	WOS:000585918300046
J	Zhang, Y; Zhang, ZY; Li, LW; Xu, KY; Ma, ZS; Chow, HM; Herrup, K; Li, JL				Zhang, Ying; Zhang, Zhongyu; Li, Lianwei; Xu, Kaiyu; Ma, Zhanshan; Chow, Hei-Man; Herrup, Karl; Li, Jiali			Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer's disease	FASEB JOURNAL			English	Article						5hmC; Alzheimer's disease; neurodegeneration; TET enzymes	GLOBAL DNA METHYLATION; A-BETA; 5-HYDROXYMETHYLCYTOSINE; HYDROXYMETHYLATION; EPIGENETICS; GENES; BRAIN; TET1; HIPPOCAMPUS; MECHANISMS	5-hydroxymethylcytosine (5hmC) is an intermediate stage of DNA de-methylation. Its location in the genome also serves as an important regulatory signal for many biological processes and its levels change significantly with the etiology of Alzheimer's disease (AD). In keeping with this relationship, the TET family of enzymes which convert 5-methylcytosine (5mC) to 5hmC are responsive to the presence of A beta. Using hMeDIP-seq, we show that there is a genome-wide reduction of 5hmC that is found in neurons but not in astrocytes from 3xTg mice (an AD mouse model). Decreased TET enzymatic activities in the brains of persons who died with AD suggest that this reduction is the main cause for the loss of 5hmC. Overexpression of human TET catalytic domains (hTETCDs) from the TET family members, especially for hTET3CD, significantly attenuates the neurodegenerative process, including reduced A beta accumulation as well as tau hyperphosphorylation, and improve synaptic dysfunction in 3xTg mouse brain. Our findings define a crucial role of deregulated 5hmC epigenetics in the events leading to AD neurodegeneration.	[Zhang, Ying; Xu, Kaiyu; Li, Jiali] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Zhang, Ying; Li, Lianwei; Xu, Kaiyu] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Zhang, Zhongyu; Li, Jiali] Peking Univ, Natl Inst Drug Dependence, Beijing, Peoples R China; [Li, Lianwei; Chow, Hei-Man] Chinese Univ Hongkong, Sch Life Sci, Hong Kong, Peoples R China; [Ma, Zhanshan] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Herrup, Karl] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Li, Jiali] Peking Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Li, Jiali] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Chinese University of Hong Kong; Chinese Academy of Sciences; Kunming Institute of Zoology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Peking University; Chinese Academy of Sciences	Li, JL (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.	jialili@bjmu.edu.cn	li, Jiali/HGF-2395-2022	li, Jiali/0000-0001-6202-7741	National Science Foundation of China [81471313]; Ministry of Science and Technology of China [2016YFC1305902]; Peking University [BMU2019YJ001]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Peking University(Peking University)	The authors are grateful to Gongping Chen (Huazhong University of Science and Technology) for providing 3xTg mice. This work was financially supported by the National Science Foundation of China (81471313) to JL; the Ministry of Science and Technology of China (2016YFC1305902) to JL; and Peking University (BMU2019YJ001) to J	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Agis-Balboa RC, 2013, J ALZHEIMERS DIS, V33, P35, DOI 10.3233/JAD-2012-121009; Alagiakrishnan K, 2012, POSTGRAD MED J, V88, P522, DOI 10.1136/postgradmedj-2011-130363; Bakulski KM, 2012, CURR ALZHEIMER RES, V9, P563; Barbash S, 2012, CURR ALZHEIMER RES, V9, P425, DOI 10.2174/156720512800492512; Benito E, 2015, J CLIN INVEST, V125, P3572, DOI 10.1172/JCI79942; Bernstein AI, 2016, HUM MOL GENET, V25, P2437, DOI 10.1093/hmg/ddw109; Bihaqi SW, 2012, CURR ALZHEIMER RES, V9, P574; Bradley-Whitman MA, 2013, MECH AGEING DEV, V134, P486, DOI 10.1016/j.mad.2013.08.005; Cheng Y, 2018, CELL REP, V25, P3194, DOI 10.1016/j.celrep.2018.11.061; Chhatwal JP, 2018, BRAIN, V141, P1486, DOI 10.1093/brain/awy053; Chia N, 2011, EPIGENETICS-US, V6, P853, DOI 10.4161/epi.6.7.16461; Chouliaras L, 2013, NEUROBIOL AGING, V34, P2091, DOI 10.1016/j.neurobiolaging.2013.02.021; Chouliaras L, 2012, CURR ALZHEIMER RES, V9, P536, DOI 10.2174/156720512800618035; Condliffe D, 2014, NEUROBIOL AGING, V35, P1850, DOI 10.1016/j.neurobiolaging.2014.02.002; Coppieters N, 2014, NEUROBIOL AGING, V35, P1334, DOI 10.1016/j.neurobiolaging.2013.11.031; Coppieters N, 2011, CURR PHARM DESIGN, V17, P3398, DOI 10.2174/138161211798072544; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Dahl C, 2011, CLIN CHIM ACTA, V412, P831, DOI 10.1016/j.cca.2011.02.013; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Ellison EM, 2017, J MOL NEUROSCI, V63, P185, DOI 10.1007/s12031-017-0969-y; Feng J, 2015, NAT NEUROSCI, V18, P536, DOI 10.1038/nn.3976; Fetahu IS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2880; Gasparoni G, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0211-3; Gontier G, 2018, CELL REP, V22, P1974, DOI 10.1016/j.celrep.2018.02.001; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Haffner MC, 2011, ONCOTARGET, V2, P627; Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang DW, 2015, BRAIN, V138, P3520, DOI 10.1093/brain/awv284; Khare T, 2012, NAT STRUCT MOL BIOL, V19, P1037, DOI 10.1038/nsmb.2372; Kinney SRM, 2013, ADV EXP MED BIOL, V754, P57, DOI 10.1007/978-1-4419-9967-2_3; Konsoula Z, 2012, J PHARMACOL TOX MET, V66, P215, DOI 10.1016/j.vascn.2012.08.001; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Kwok JBJ, 2010, EPIGENOMICS-UK, V2, P671, DOI 10.2217/EPI.10.43; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lashley T, 2015, NEUROPATH APPL NEURO, V41, P497, DOI 10.1111/nan.12183; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Li JL, 2009, CURR BIOL, V19, P2091, DOI 10.1016/j.cub.2009.10.039; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lunnon K, 2014, NAT NEUROSCI, V17, P1164, DOI 10.1038/nn.3782; Maekawa M, 2007, CURR MED CHEM, V14, P2642, DOI 10.2174/092986707782023172; Malzkorn B, 2011, BRAIN PATHOL, V21, P619, DOI 10.1111/j.1750-3639.2011.00536.x; Marques SCF, 2011, PROG NEURO-PSYCHOPH, V35, P348, DOI 10.1016/j.pnpbp.2010.08.008; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Phipps AJ, 2016, NEUROBIOL AGING, V45, P30, DOI 10.1016/j.neurobiolaging.2016.05.003; Shu LQ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2731-1; Sims R, 2020, NAT NEUROSCI, V23, P311, DOI 10.1038/s41593-020-0599-5; Smith AR, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0636-y; Sun ZX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11905-3; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; van den Hove DLA, 2012, CURR ALZHEIMER RES, V9, P545; Wang T, 2012, HUM MOL GENET, V21, P5500, DOI 10.1093/hmg/dds394; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049; Yu HM, 2015, NAT NEUROSCI, V18, P836, DOI 10.1038/nn.4008; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao JY, 2017, ALZHEIMERS DEMENT, V13, P674, DOI 10.1016/j.jalz.2016.10.004	72	13	14	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16364	16382		10.1096/fj.202001271R	http://dx.doi.org/10.1096/fj.202001271R		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058355				2022-12-26	WOS:000581159000001
J	Moore, T; Yanes, RE; Calton, MA; Vollrath, D; Enns, GM; Cowan, TM				Moore, Tereza; Yanes, Rolando E.; Calton, Melissa A.; Vollrath, Douglas; Enns, Gregory M.; Cowan, Tina M.			AMP-independent activator of AMPK for treatment of mitochondrial disorders	PLOS ONE			English	Article							PROTEIN-KINASE; MECHANISMS; TARGET; MODEL	Mitochondrial diseases are a clinically heterogenous group of disorders caused by respiratory chain dysfunction and associated with progressive, multi-systemic phenotype. There is no effective treatment or cure, and no FDA-approved drug for treating mitochondrial disease. To identify and characterize potential therapeutic compounds, we developed anin vitroscreening assay and identified a group of direct AMP-activated protein kinase (AMPK) activators originally developed for the treatment of diabetes and metabolic syndrome. Unlike previously investigated AMPK agonists such as AICAR, these compounds allosterically activate AMPK in an AMP-independent manner, thereby increasing specificity and decreasing pleiotropic effects. The direct AMPK activator PT1 significantly improved mitochondrial function in assays of cellular respiration, energy status, and cellular redox. PT1 also protected against retinal degeneration in a mouse model of photoreceptor degeneration associated with mitochondrial dysfunction and oxidative stress, further supporting the therapeutic potential of AMP-independent AMPK agonists in the treatment of mitochondrial disease.	[Moore, Tereza; Cowan, Tina M.] Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA; [Yanes, Rolando E.] Stanford Univ, Dept Immunol & Rheumatol, Palo Alto, CA 94304 USA; [Calton, Melissa A.; Vollrath, Douglas] Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA; [Enns, Gregory M.] Stanford Univ, Dept Pediat Med Genet, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University	Cowan, TM (corresponding author), Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA.	TCowan@stanfordhealthcare.org			Raptor Pharmaceuticals; Mangold Foundation; Schwab Foundation; Grace Science Foundation; Dianne and Tad Taube Pediatric Neurodegenerative Disease Program; Stanford Maternal & Child Health Institute; National Eye Institute [R01 EY025790]	Raptor Pharmaceuticals; Mangold Foundation; Schwab Foundation; Grace Science Foundation; Dianne and Tad Taube Pediatric Neurodegenerative Disease Program; Stanford Maternal & Child Health Institute; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants awarded to TM, GME, and TMC from Raptor Pharmaceuticals, the Mangold Foundation, the Schwab Foundation, the Grace Science Foundation, Dianne and Tad Taube Pediatric Neurodegenerative Disease Program, Stanford Maternal & Child Health Institute, and to MC and DV from the National Eye Institute (R01 EY025790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Camp KM, 2016, MOL GENET METAB, V119, P187, DOI 10.1016/j.ymgme.2016.09.002; Chinnery PF, 2014, MITOCHONDRIAL DISORD; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Costa AL, 2014, HUM MOL GENET, V23, P2106, DOI 10.1093/hmg/ddt603; Coughlan KA, 2014, DIABET METAB SYND OB, V7, P241, DOI 10.2147/DMSO.S43731; Douiev L, 2017, J CLIN MED, V6, DOI 10.3390/jcm6010001; El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009; Enns GM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050050; Franco LM, 2009, INVEST OPHTH VIS SCI, V50, P4004, DOI 10.1167/iovs.08-2898; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Golubitzky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026883; Goodyear LJ, 2008, NEW ENGL J MED, V359, P1842, DOI 10.1056/NEJMcibr0806723; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Jensen B, 2014, GENETIC ENG BIOTECHN, V34, DOI DOI 10.1089/GEN.34.10.10; Jia HQ, 2008, J NEUROSCI RES, V86, P2083, DOI 10.1002/jnr.21650; Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300; Lan F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070751; Li J, 2010, DIABETES; Li XD, 2015, CELL RES, V25, P50, DOI 10.1038/cr.2014.150; Li YY, 2013, TOXICOL APPL PHARM, V273, P325, DOI 10.1016/j.taap.2013.09.006; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Peralta S, 2016, HUM MOL GENET, V25, P3178, DOI 10.1093/hmg/ddw167; Pfeffer G, 2012, COCHRANE DB SYST REV, V18, P4; Redfern WS, 2011, J PHARMACOL TOXICOL, V63, P102, DOI 10.1016/j.vascn.2010.06.008; Salt IP, 2017, CIRC RES, V120, P1825, DOI 10.1161/CIRCRESAHA.117.309633; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Shahripour RB, 2014, BRAIN BEHAV, V4, P108, DOI 10.1002/brb3.208; Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011; Wright DJ, 2015, TRANSL PSYCHIAT, P5; Yu LF, 2013, ACS MED CHEM LETT, V4, P475, DOI 10.1021/ml400028q; Zhang L. R., 2013, PLOS ONE, V8	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240517	10.1371/journal.pone.0240517	http://dx.doi.org/10.1371/journal.pone.0240517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052980	Green Published, gold			2022-12-26	WOS:000581820200030
J	Jin, Y; Zhou, Y; Deng, WF; Wang, YC; Lee, RJ; Liu, YN; Elias, N; Hu, YC; Luo, MH; Liu, RM; Guan, BW; Geng, J; Xu, J; Ma, JF; Zhou, JP; Liu, N; Blute, ML; Colvin, RB; Wu, CL; Miao, Y				Jin, Yu; Zhou, Yi; Deng, Wenfeng; Wang, Yuchen; Lee, Richard J.; Liu, Yanna; Elias, Nahel; Hu, Yangcheng; Luo, Min-Hua; Liu, Rumin; Guan, Bowen; Geng, Jian; Xu, Jian; Ma, Junfeng; Zhou, Jiapeng; Liu, Na; Blute, Michael L.; Colvin, Robert B.; Wu, Chin-Lee; Miao, Yun			Genome-wide profiling of BK polyomavirus integration in bladder cancer of kidney transplant recipients reveals mechanisms of the integration at the nucleotide level	ONCOGENE			English	Article							INFECTION; VIRUS; MICROHOMOLOGY; REPLICATION; BLOOD	Chronic BK polyomavirus (BKPyV) infection is recognized as a potential oncogenic factor of urothelial carcinoma (UC) in renal transplant recipients. Recent studies have reported a positive correlation among BKPyV integration, persistent overexpression of viral large T antigen (TAg), and malignancy, yet little is known about the specific integration mechanisms and the impacts of viral integration. Here, we performed whole-genome sequencing (WGS) and viral capture-based sequencing on high-grade immunohistochemically TAg-positive UCs in two renal transplant recipients. A total of 181 integration sites, including the three found by WGS, were identified by viral capture-based sequencing, indicating its enhanced sensitivity and ability in identifying low-read integration sites in subpopulations of the tumor cells. The microhomologies between human and BKPyV genomes were significantly enriched in the flanking regions of 84.5% the integration sites, with a median length of 7 bp. Notably, 75 human genes formed fusion sequences due to viral insertional integration. Among them, the expression of 15 genes were statistically associated with UC based on GEO2R expression analysis. Our results indicated a multisite and multifragment linear integration pattern and a potential microhomology or nonhomologous end joining integration mechanism at the single-nucleotide level. We put forward a potential selection mechanism driven by immunity and centered on viral integration in the carcinogenesis of BKPyV.	[Jin, Yu; Zhou, Yi; Deng, Wenfeng; Wang, Yuchen; Liu, Yanna; Hu, Yangcheng; Liu, Rumin; Guan, Bowen; Geng, Jian; Xu, Jian; Miao, Yun] Southern Med Univ, Nanfang Hosp, Div Transplantat, Guangzhou, Peoples R China; [Lee, Richard J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Elias, Nahel] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA; [Luo, Min-Hua] Wuhan Inst Virol, State Key Lab Virol, CAS Ctr Excellence Brain Sci & Intelligence Techn, Wuhan, Peoples R China; [Ma, Junfeng; Zhou, Jiapeng; Liu, Na] Mygenostics Co, Beijing, Peoples R China; [Blute, Michael L.; Wu, Chin-Lee] Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA; [Colvin, Robert B.; Wu, Chin-Lee] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA	Southern Medical University - China; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Miao, Y (corresponding author), Southern Med Univ, Nanfang Hosp, Div Transplantat, Guangzhou, Peoples R China.; Wu, CL (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02115 USA.; Wu, CL (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA.	cwu2@mgh.harvard.edu; miaoyunecho@126.com		Elias, Nahel/0000-0001-6466-7347	National Natural Science Foundation of China [81500573]; Science Foundation of Guangdong Province [2020A1515010674]; Science and Technology Planning Project of Guangzhou [201803010109]; President Funding of Nanfang Hospital [2018B009, 2018C003]; College Students' Innovative Entrepreneurial Training Plan Program [201812121148, X202012121239, 202012121046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangzhou; President Funding of Nanfang Hospital; College Students' Innovative Entrepreneurial Training Plan Program	This work was funded by the National Natural Science Foundation of China (81500573), the Science Foundation of Guangdong Province (2020A1515010674), the Science and Technology Planning Project of Guangzhou (201803010109), the President Funding of Nanfang Hospital (2018B009, 2018C003) and College Students' Innovative Entrepreneurial Training Plan Program (201812121148, X202012121239, 202012121046).	Awan AA, 2018, AM J NEPHROL, V48, P472, DOI 10.1159/000495081; Billups K, 2015, PROG TRANSPLANT, V25, P182, DOI 10.7182/pit2015826; Cangemi M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00160; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Elfadawy N, 2018, INFECT DIS CLIN N AM, V32, P599, DOI 10.1016/j.idc.2018.04.009; Fu FX, 2018, CLIN SCI, V132, P1753, DOI 10.1042/CS20180443; Groves IJ, 2018, J PATHOL, V245, P9, DOI 10.1002/path.5058; Gupta G, 2018, AM J TRANSPLANT, V18, P245, DOI 10.1111/ajt.14530; Hesbacher S, 2016, ONCOTARGET, V7, P32956, DOI 10.18632/oncotarget.8793; Houben R, 2015, INT J CANCER, V136, pE290, DOI 10.1002/ijc.29200; Hu Z, 2015, NAT GENET, V47, P158, DOI 10.1038/ng.3178; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kenan DJ, 2017, AM J TRANSPLANT, V17, P1674, DOI 10.1111/ajt.14191; Kenan DJ, 2015, J PATHOL, V237, P379, DOI 10.1002/path.4584; Lee YJ, 2014, BIOL BLOOD MARROW TR, V20, P1204, DOI 10.1016/j.bbmt.2014.04.017; Li WY, 2013, GENOMICS, V102, P338, DOI 10.1016/j.ygeno.2013.07.002; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; McCabe M, 2006, ONCOGENE, V25, P2727, DOI 10.1038/sj.onc.1209266; Michel Ortega Rosa M, 2016, J Immunother Cancer, V4, P63; Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444; Muller DC, 2018, J PATHOL, V244, P265, DOI 10.1002/path.5012; Nickeleit V, 2018, J PATHOL, V246, P7, DOI 10.1002/path.5127; O'Neill JP, 2019, CLIN TRANSPLANT, V33, DOI 10.1111/ctr.13669; Ottaviani D, 2014, TRENDS GENET, V30, P85, DOI 10.1016/j.tig.2014.01.001; Papadimitriou JC, 2016, AM J TRANSPLANT, V16, P398, DOI 10.1111/ajt.13550; Pinto M, 2014, J INFECTION, V68, pS2, DOI 10.1016/j.jinf.2013.09.009; Roberts ISD, 2008, BRIT J CANCER, V99, P1383, DOI 10.1038/sj.bjc.6604711; Rosales BM, 2020, INT J CANCER, V146, P2703, DOI 10.1002/ijc.32585; Saribas AS, 2016, J CELL PHYSIOL, V231, P2115, DOI 10.1002/jcp.25329; Sirohi D, 2018, MODERN PATHOL, V31, P1429, DOI 10.1038/s41379-018-0065-z; Starrett GJ, 2019, CURR OPIN VIROL, V39, P8, DOI 10.1016/j.coviro.2019.06.009; Trofe-Clark J, 2016, SEMIN NEPHROL, V36, P372, DOI 10.1016/j.semnephrol.2016.05.014; Wang YC, 2020, ONCOGENE, V39, P5734, DOI 10.1038/s41388-020-01398-6; Yi K, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0112-3; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; Zhou XS, 2015, MOL MED REP, V11, P910, DOI 10.3892/mmr.2014.2861	37	3	4	0	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					46	54		10.1038/s41388-020-01502-w	http://dx.doi.org/10.1038/s41388-020-01502-w		OCT 2020	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33051598				2022-12-26	WOS:000577556100003
J	Zimmerman, A; Fox, S; Griffin, RD; Nelp, T; Thomaz, EBAF; Mvungi, M; Mmbaga, BT; Sakita, F; Gerardo, CJ; Vissoci, JRN; Staton, CA				Zimmerman, Armand; Fox, Samara; Griffin, Randi; Nelp, Taylor; Thomaz, Erika Barbara Abreu Fonseca; Mvungi, Mark; Mmbaga, Blandina T.; Sakita, Francis; Gerardo, Charles J.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.			An analysis of emergency care delays experienced by traumatic brain injury patients presenting to a regional referral hospital in a low-income country	PLOS ONE			English	Article							ADJUSTED LIFE YEARS; TRIAGE SCORE SATS; GLOBAL BURDEN; OUTCOMES; EPIDEMIOLOGY; DISABILITY; QUALITY; SYSTEMS; AFRICA; TIME	Background Trauma is a leading cause of death and disability worldwide. In low- and middle-income countries (LMICs), trauma patients have a higher risk of experiencing delays to care due to limited hospital resources and difficulties in reaching a health facility. Reducing delays to care is an effective method for improving trauma outcomes. However, few studies have investigated the variety of care delays experienced by trauma patients in LMICs. The objective of this study was to describe the prevalence of pre- and in-hospital delays to care, and their association with poor outcomes among trauma patients in a low-income setting. Methods We used a prospective traumatic brain injury (TBI) registry from Kilimanjaro Christian Medical Center in Moshi, Tanzania to model nine unique delays to care. Multiple regression was used to identify delays significantly associated with poor in-hospital outcomes. Results Our analysis included 3209 TBI patients. The most common delay from injury occurrence to hospital arrival was 1.1 to 4.0 hours (31.9%). Most patients were evaluated by a physician within 15.0 minutes of arrival (69.2%). Nearly all severely injured patients needed and did not receive a brain computed tomography scan (95.0%). A majority of severely injured patients needed and did not receive oxygen (80.8%). Predictors of a poor outcome included delays to lab tests, fluids, oxygen, and non-TBI surgery. Conclusions Time to care data is informative, easy to collect, and available in any setting. Our time to care data revealed significant constraints to non-personnel related hospital resources. Severely injured patients with the greatest need for care lacked access to medical imaging, oxygen, and surgery. Insights from our study and future studies will help optimize resource allocation in low-income hospitals thereby reducing delays to care and improving trauma outcomes in LMICs.	[Zimmerman, Armand; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Fox, Samara] Yale Sch Med, New Haven, CT USA; [Griffin, Randi] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [Nelp, Taylor; Gerardo, Charles J.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA; [Thomaz, Erika Barbara Abreu Fonseca] Univ Fed Maranhao, Sao Luis, Maranhao, Brazil; [Mvungi, Mark; Mmbaga, Blandina T.; Sakita, Francis] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Mmbaga, Blandina T.] Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Mmbaga, Blandina T.; Sakita, Francis] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania	Duke University; Yale University; Duke University; Duke University; Universidade Federal do Maranhao; Kilimanjaro Christian Medical Centre	Staton, CA (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Staton, CA (corresponding author), Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA.	catherine.staton@duke.edu	THOMAZ, ERIKA/AAU-7752-2021; THOMAZ, ERIKA/AAU-7762-2021; Mmbaga, Blandina Theophil/AAR-8707-2021	THOMAZ, ERIKA/0000-0003-4156-4067; Mmbaga, Blandina Theophil/0000-0002-5550-1916; Sakita, Francis/0000-0001-5879-6564; Zimmerman, Armand/0000-0002-1216-581X; Staton, Catherine/0000-0002-6468-2894	KCMC MEPI [T84HA21123-02]; U.S. National Institutes of Health; Duke Division of Emergency Medicine; NSF Graduate Research Fellowship; e Fogarty International Center [K01 TW010000-01A1]	KCMC MEPI; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke Division of Emergency Medicine; NSF Graduate Research Fellowship(National Science Foundation (NSF)); e Fogarty International Center	This project was made possible by the Mentored Research Training Program in collaboration with the HRSA-funded KCMC MEPI grant #T84HA21123-02; U.S. National Institutes of Health and the Duke Division of Emergency Medicine. Randi Griffin would like to cknowledge support from the NSF Graduate Research Fellowship. Dr. Staton would like to acknowledge salary support funding from the Fogarty International Center (Staton, dK01 TW010000-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgadir J, 2017, WORLD NEUROSURG, V102, P526, DOI 10.1016/j.wneu.2017.03.019; Alibhai A, 2019, AFR J EMERG MED, V9, pS38, DOI 10.1016/j.afjem.2019.01.004; Amu H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201833; [Anonymous], 2014, INJURIES AND VIOLENC; Anonymous, 2012, MMWR-MORBID MORTAL W, V59, P1, DOI DOI 10.3791/3636; [Anonymous], 2015, HAINAN TODAY; [Anonymous], 2017, HEART LUNG CIRC, V26, pe125; Baker T, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-140; Beavogui Kezely, 2015, J Vasc Interv Neurol, V8, P30; Berg LM, 2019, ANN EMERG MED, V74, P345, DOI 10.1016/j.annemergmed.2019.04.012; Bruijns SR, 2008, EMERG MED J, V25, P398, DOI 10.1136/emj.2007.051177; Carney N, GUIDELINES MANAGEMEN, P244; Carter EJ, 2014, J NURS SCHOLARSHIP, V46, P106, DOI 10.1111/jnu.12055; Casalino E, 2013, EMERG MED J, V30, P638, DOI 10.1136/emermed-2012-201404; Cavallaro FL, 2013, ACTA OBSTET GYN SCAN, V92, P496, DOI 10.1111/aogs.12071; Dalwai MK, 2014, SAMJ S AFR MED J, V104, P372, DOI [10.7196/SAMJ.7604, 10.7196/samj.7604]; Dalwai M, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000160; de Andrade L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103577; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diamond MB, 2018, INJURY PREV, V24, P272, DOI 10.1136/injuryprev-2016-042254; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Gottschalk SB, 2006, EMERG MED J, V23, P149, DOI 10.1136/emj.2005.028332; Groenland CN, 2019, CRIT CARE MED, V47, P1564, DOI 10.1097/CCM.0000000000003957; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Haglund MM, 2019, J NEUROSURG, V131, P993, DOI 10.3171/2019.4.JNS181747; Hansmann A, 2017, AFR J EMERG MED, V7, pS10, DOI 10.1016/j.afjem.2017.10.001; Hashmi ZG, 2013, J TRAUMA ACUTE CARE, V75, P60, DOI 10.1097/TA.0b013e31829880a0; Horwitz LI, 2010, ANN EMERG MED, V55, P133, DOI 10.1016/j.annemergmed.2009.07.023; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson KD, 2011, ADV EMERG NURS J, V33, P39, DOI 10.1097/TME.0b013e318207e86a; Kawooya MG, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.97747; Kawooya MG, 2011, J CLIN IMAG SCI, V1, DOI 10.4103/2156-7514.90035; Khan BA, 2016, J PAK MED ASSOC, V66, P509; Kobusingye OC, 2005, B WORLD HEALTH ORGAN, V83, P626; Krebs E, 2017, WORLD NEUROSURG, V102, P571, DOI 10.1016/j.wneu.2017.03.001; London JA, 2001, J TRAUMA, V51, P747, DOI 10.1097/00005373-200110000-00021; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; McKenna P, 2019, CLIN EXP EMERG MED, V6, P189, DOI 10.15441/ceem.18.022; McQueen K, 2016, WORLD J SURG, V40, P249, DOI 10.1007/s00268-015-3284-1; Mock C., 2004, GUIDELINES ESSENTIAL; Morley C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203316; Mould-Millman NK, 2017, PREHOSP DISASTER MED, V32, P273, DOI 10.1017/S1049023X17000061; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ngoya PS, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.99.9736; Nielsen K, 2012, PREHOSP EMERG CARE, V16, P381, DOI 10.3109/10903127.2012.664245; Obermeyer Z, 2015, B WORLD HEALTH ORGAN, V93, P577, DOI 10.2471/BLT.14.148338; Ormond DR, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18239; Rocha TAH, 2020, J NEUROSURG, V132, P1961, DOI 10.3171/2019.2.JNS182098; Rominski S, 2014, AFR J EMERG MED, V4, P71, DOI 10.1016/j.afjem.2013.11.001; Rosedale K, 2011, SAMJ S AFR MED J, V101, P537; Rosseau G, 2020, J NEUROSURG, V132, P1256, DOI 10.3171/2019.11.JNS191823; Sasser SM, 2006, B WORLD HEALTH ORGAN, V84, P507, DOI 10.2471/BLT.06.033605; Schuur JD, 2013, HEALTH AFFAIR, V32, P2129, DOI 10.1377/hlthaff.2013.0730; Singer AJ, 2011, ACAD EMERG MED, V18, P1324, DOI 10.1111/j.1553-2712.2011.01236.x; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Sunyoto T, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0531-3; Twomey M, 2012, EMERG MED J, V29, P650, DOI 10.1136/emermed-2011-200503; Wangara AA, 2019, INT J EMERG MED, V12, DOI 10.1186/s12245-019-0221-3; Wllper AP, 2008, HEALTH AFFAIR, V27, pW84, DOI 10.1377/hlthaff.27.2.w84; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877; Yeboah D, 2014, WORLD J SURG, V38, P1707, DOI 10.1007/s00268-014-2452-z	64	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240528	10.1371/journal.pone.0240528	http://dx.doi.org/10.1371/journal.pone.0240528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TU	33045030	gold, Green Published			2022-12-26	WOS:000581811700044
J	Chang, TC; Matossian, MD; Elliott, S; Burks, HE; Sabol, RA; Ucar, DA; Wathieu, H; Zabaleta, J; De Valle, L; Gill, S; Martin, E; Riker, AI; Miele, L; Bunnell, BA; Burow, ME; Collins-Burow, BM				Chang, Tiffany C.; Matossian, Margarite D.; Elliott, Steven; Burks, Hope E.; Sabol, Rachel A.; Ucar, Deniz A.; Wathieu, Henri; Zabaleta, Jovanny; De Valle, Luis; Gill, Sukhmani; Martin, Elizabeth; Riker, Adam I.; Miele, Lucio; Bunnell, Bruce A.; Burow, Matthew E.; Collins-Burow, Bridgette M.			Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; PARP INHIBITOR; REVEALS FREQUENT; DRUG-RESISTANCE; STEM-CELLS; CANCER; EMT; COMBINATION; PANOBINOSTAT; DOXORUBICIN	Metaplastic breast carcinoma (MBC) is a clinically aggressive and rare subtype of breast cancer, with similar features to basal-like breast cancers. Due to rapid growth rates and characteristic heterogeneity, MBC is often unresponsive to standard chemotherapies; and novel targeted therapeutic discovery is urgently needed. Histone deacetylase inhibitors (DACi) suppress tumor growth and metastasis through regulation of the epithelial-to-mesenchymal transition axis in various cancers, including basal-like breast cancers. We utilized a new MBC patient-derived xenograft (PDX) to examine the effect of DACi therapy on MBC. Cell morphology, cell cycle-associated gene expressions, transwell migration, and metastasis were evaluated in patient-derived cells and tumors after treatment with romidepsin and panobinostat. Derivations of our PDX model, including cells, spheres, organoids, explants, andin vivoimplanted tumors were treated. Finally, we tested the effects of combining DACi with approved chemotherapeutics on relative cell biomass. DACi significantly suppressed the total number of lung metastasisin vivousing our PDX model, suggesting a role for DACi in preventing circulating tumor cells from seeding distal tissue sites. These data were supported by our findings that DACi reduced cell migration, populations, and expression of mesenchymal-associated genes. While DACi treatment did affect cell cycle-regulating genesin vitro, tumor growth was not affected compared to controls. Importantly, gene expression results varied depending on the cellular or tumor system used, emphasizing the importance of using multiple derivations of cancer models in preclinical therapeutic discovery research. Furthermore, DACi sensitized and produced a synergistic effect with approved oncology therapeutics on inherently resistant MBC. This study introduced a role for DACi in suppressing the migratory and mesenchymal phenotype of MBC cells through regulation of the epithelial-mesenchymal transition axis and suppression of the CTC population. Preliminary evidence that DACi treatment in combination with MEK1/2 inhibitors exerts a synergistic effect on MBC cells was also demonstrated.	[Chang, Tiffany C.; Matossian, Margarite D.; Elliott, Steven; Burks, Hope E.; Wathieu, Henri; Gill, Sukhmani; Burow, Matthew E.; Collins-Burow, Bridgette M.] Tulane Univ, Sch Med, Dept Med, Sect Hematol Oncol, New Orleans, LA 70112 USA; [Chang, Tiffany C.; Matossian, Margarite D.; Elliott, Steven; Burks, Hope E.; Sabol, Rachel A.; Wathieu, Henri; Bunnell, Bruce A.; Burow, Matthew E.] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; [Ucar, Deniz A.; Miele, Lucio] Louisiana State Univ, Sch Med, Dept Genet, New Orleans, LA USA; [Zabaleta, Jovanny] Louisiana State Univ, Sch Med, Dept Pediat, New Orleans, LA USA; [De Valle, Luis] Louisiana State Univ, Dept Pathol, Sch Med, New Orleans, LA USA; [Martin, Elizabeth] Louisiana State Univ, Dept Agr Engn, Baton Rouge, LA 70803 USA; [Riker, Adam I.] Louisiana State Univ, Dept Surg, Sch Med, New Orleans, LA USA	Tulane University; Tulane University; Louisiana State University System; Louisiana State University System; Louisiana State University System; Louisiana State University System; Louisiana State University; Louisiana State University System	Chang, TC; Collins-Burow, BM (corresponding author), Tulane Univ, Sch Med, Dept Med, Sect Hematol Oncol, New Orleans, LA 70112 USA.; Chang, TC (corresponding author), Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.	tchang10@tulane.edu; bcollin1@tulane.edu	Del Valle, Luis/J-4085-2015	Del Valle, Luis/0000-0003-3894-9206; Chang, Tiffany/0000-0002-0468-7546; Sabol, Rachel/0000-0002-0280-8818	National Institute of Health (NIH) [R01-CA125806-04, 1R15CA176496-01A1, R01-CA174785-A1]; National Institute of General Medical Sciences of the National Institutes of Health [U54 GM104940]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from National Institute of Health (NIH) (Grants No. R01-CA125806-04 (MEB), 1R15CA176496-01A1 (MEB) and R01-CA174785-A1 (BMC-B)). This work was also supported in part by U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds the Louisiana Clinical and Translational Science Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0011-0; Aggarwal R, 2017, J CLIN ONCOL, V35, P1231, DOI 10.1200/JCO.2016.70.5350; Al-Hilli Z, 2019, BREAST CANCER RES TR, V176, P709, DOI 10.1007/s10549-019-05264-2; Alluri P, 2014, SURG ONCOL CLIN N AM, V23, P567, DOI 10.1016/j.soc.2014.03.003; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; [Anonymous], 2014, SCI RES, V2, P78; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Basho RK, 2017, JAMA ONCOL, V3, P509, DOI 10.1001/jamaoncol.2016.5281; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Breslin S, 2016, ONCOTARGET, V7, P45745, DOI 10.18632/oncotarget.9935; Carson R, 2015, CLIN CANCER RES, V21, P3230, DOI 10.1158/1078-0432.CCR-14-2701; Choy E, 2015, CANCER-AM CANCER SOC, V121, P1223, DOI 10.1002/cncr.29175; Dave B, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw292; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; El Zein D, 2017, CLIN BREAST CANCER, V17, P382, DOI 10.1016/j.clbc.2017.04.009; Fedele P, 2017, EXPERT OPIN INV DRUG, V26, P1199, DOI 10.1080/13543784.2017.1386172; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Garmpis N, 2017, CANCER GENOM PROTEOM, V14, P299, DOI 10.21873/cgp.20041; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Guerriero JL, 2017, NATURE, V543, P428, DOI 10.1038/nature21409; Guo JH, 2017, CHINESE MED J-PEKING, V130, P203, DOI 10.4103/0366-6999.198003; Ha K, 2014, ONCOTARGET, V5, P5637, DOI 10.18632/oncotarget.2154; Han M, 2019, MODERN PATHOL, V32, P807, DOI 10.1038/s41379-019-0208-x; Henneman L, 2015, P NATL ACAD SCI USA, V112, P8409, DOI 10.1073/pnas.1500223112; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hennessy BT, 2006, ANN ONCOL, V17, P605, DOI 10.1093/annonc/mdl006; Joneja U, 2017, J CLIN PATHOL, V70, P255, DOI 10.1136/jclinpath-2016-203874; Kawaguchi T, 2017, J MAMMARY GLAND BIOL, V22, P131, DOI 10.1007/s10911-017-9378-7; Kieburtz K, 2007, MT SINAI J MED, V74, P7, DOI 10.1002/msj.20006; Leibl S, 2005, J CLIN PATHOL, V58, P700, DOI 10.1136/jcp.2004.025163; Li YX, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026831; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matossian Margarite D, 2018, Oncoscience, V5, P99, DOI 10.18632/oncoscience.412; McCart Reed AE, 2019, J PATHOL, V247, P214, DOI 10.1002/path.5184; McDermott J, 2014, DRUG TODAY, V50, P337, DOI 10.1358/dot.2014.50.5.2138703; Min A, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0534-y; Muraro MG, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1331798; Nelson RA, 2015, ANN SURG ONCOL, V22, P24, DOI 10.1245/s10434-014-3890-4; Ong CT, 2017, POPULATION BASED S15, V34, P532; Ono H, 2018, BREAST CANCER RES TR, V171, P43, DOI 10.1007/s10549-018-4815-x; Ozaki K, 2008, CANCER SCI, V99, P376, DOI 10.1111/j.1349-7006.2007.00669.x; Pezzi CM, 2007, ANN SURG ONCOL, V14, P166, DOI 10.1245/s10434-006-9124-7; Pili R, 2017, BRIT J CANCER, V116, P874, DOI 10.1038/bjc.2017.33; Rayson D, 1999, ANN ONCOL, V10, P413, DOI 10.1023/A:1008329910362; Rhodes LV, 2014, BREAST CANCER RES TR, V145, P593, DOI 10.1007/s10549-014-2979-6; Ross JS, 2015, ARCH PATHOL LAB MED, V139, P642, DOI 10.5858/arpa.2014-0200-OA; Shah DR, 2012, ISRN ONCOLOGY; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Sikandar SS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01666-2; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Tate CR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3192; Tseng WH, 2011, ANN SURG ONCOL, V18, P94, DOI 10.1245/s10434-010-1198-6; VanderMolen KM, 2011, J ANTIBIOT, V64, P525, DOI 10.1038/ja.2011.35; Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774; Weigelt B, 2009, BREAST CANCER RES TR, V117, P273, DOI 10.1007/s10549-008-0197-9; Whittle JR, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0523-1; Yamada T, 2018, MOL CANCER THER, V17, P17, DOI 10.1158/1535-7163.MCT-17-0146; Yamaguchi R, 2010, HUM PATHOL, V41, P679, DOI 10.1016/j.humpath.2009.10.009; Ye X, 2017, NATURE, V547, pE1, DOI 10.1038/nature22816; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yu C, 2005, LEUKEMIA, V19, P1579, DOI 10.1038/sj.leu.2403868; Zhai J, 2019, HUM PATHOL, V86, P85, DOI 10.1016/j.humpath.2018.11.023; 2018, JAMA-J AM MED ASSOC, V319, P1427, DOI DOI 10.1001/JAMA.2018.3760	67	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0226464	10.1371/journal.pone.0226464	http://dx.doi.org/10.1371/journal.pone.0226464			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035223	Green Submitted, Green Published, gold			2022-12-26	WOS:000581817500042
J	Choi, JY; Chin, HJ; Lee, HY; Bae, EH; Chang, TI; Lim, JH; Jung, HY; Cho, JH; Kim, CD; Kim, YL; Park, SH				Choi, Ji-Young; Chin, Ho Jun; Lee, Hajeong; Bae, Eun Hui; Chang, Tae Ik; Lim, Jeong-Hoon; Jung, Hee-Yeon; Cho, Jang-Hee; Kim, Chan-Duck; Kim, Yong-Lim; Park, Sun-Hee		Korean GlomeruloNEphritis Study	Idiopathic membranous nephropathy in older patients: Clinical features and outcomes	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; NEPHROTIC SYNDROME; NATURAL-HISTORY; RENAL-DISEASES; GLOMERULONEPHRITIS; REMISSION	Background Various factors can affect renal and patient outcome in idiopathic membranous nephropathy (iMN). We aimed to identify predictors of renal and patient survival in patients with iMN, with a special focus on outcomes among older patients. Methods We retrieved data on 1,776 patients (mean age 53.0 +/- 14.7 years; 1,075 [60.5%] males) diagnosed with iMN from the Korean GlomeruloNEphritis sTudy (KoGNET), a database compiled from 18 centers in Korea. Results The cohort included 428 (24.1%) patients over 65 years old. Compared to younger patients, this group had lower hemoglobin and serum albumin levels, a higher incidence of nephrotic-range proteinuria, and higher prevalences of hypertension and diabetes. At last follow-up, complete or partial remission rates were not significantly different between the older and younger groups. Older age (HR: 0.98, 95%CI: 0.97-0.99), elevated hemoglobin (HR: 0.82, 95%CI: 0.72-0.93), high serum albumin (HR: 0.66, 95%CI: 0.44-0.99), and a high estimated glomerular filtration rate (HR: 0.96, 95%CI: 0.95-0.97) at biopsy were good predictors of renal outcomes. Significant risk factors for patient survival were older age (HR: 1.04, 95%CI: 1.01-1.10) and hypertension at biopsy (HR: 2.76, 95%CI: 1.30-5.90). Conclusions Older patients with iMN had favorable renal outcomes, but poor patient survival, compared to younger patients. Prognostic information on outcomes in this study might be helpful for optimizing the management of patients with iMN.	[Choi, Ji-Young; Lim, Jeong-Hoon; Jung, Hee-Yeon; Cho, Jang-Hee; Kim, Chan-Duck; Kim, Yong-Lim; Park, Sun-Hee] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Chin, Ho Jun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seongnam, South Korea; [Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea; [Lee, Hajeong] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Bae, Eun Hui] Chonnam Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Chang, Tae Ik] Ilsan Hosp, Dept Internal Med, Natl Hlth Insurance Serv, Med Ctr, Goyangshi, Gyeonggi Do, South Korea	Kyungpook National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Chonnam National University; Chonnam National University Hospital; National Health Insurance Service; NHIS Ilsan Hospital	Park, SH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea.	sh-park@knu.ac.kr	Lim, Jeong-Hoon/ABE-6003-2020; Cho, Jang-hee/ABD-3534-2020; Park, Sun/GSD-9620-2022	Lim, Jeong-Hoon/0000-0001-5517-9886; Cho, Jang-hee/0000-0002-7031-5214; 	Korean Society of Nephrology	Korean Society of Nephrology	This work was supported by Cooperative Research Grant 2017 from the Korean Society of Nephrology. The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE S, 1986, J CLIN PATHOL, V39, P1193, DOI 10.1136/jcp.39.11.1193; [Anonymous], 2018, MED BALTIMORE, V97, pe9654; Cattran DC, 2017, J AM SOC NEPHROL, V28, P995, DOI 10.1681/ASN.2015111262; Cattran DC, 1997, KIDNEY INT, V51, P901, DOI 10.1038/ki.1997.127; Chen XX, 2019, RENAL FAILURE, V41, P363, DOI 10.1080/0886022X.2019.1605294; Churg J, 1973, Perspect Nephrol Hypertens, V1 Pt 1, P443; DONADIO JV, 1988, KIDNEY INT, V33, P708, DOI 10.1038/ki.1988.56; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Floege J, 2019, KIDNEY INT, V95, P268, DOI 10.1016/j.kint.2018.10.018; GLUCK MC, 1973, ANN INTERN MED, V78, P1, DOI 10.7326/0003-4819-78-1-1; Hladunewich MA, 2009, CLIN J AM SOC NEPHRO, V4, P1417, DOI 10.2215/CJN.01330209; Hu XF, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1792-8; Laluck BJ, 1999, AM J KIDNEY DIS, V33, P1026, DOI 10.1016/S0272-6386(99)70138-1; Li LS, 2004, KIDNEY INT, V66, P920, DOI 10.1111/j.1523-1755.2004.00837.x; MACTIER R, 1986, Q J MED, V60, P793; Mahmud M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221293; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; McQuarrie EP, 2012, NEPHROL DIAL TRANSPL, V27, P235, DOI 10.1093/ndt/gfr220; Navaratnarajah A, 2019, CLIN KIDNEY J, V12, P512, DOI 10.1093/ckj/sfz006; Polanco N, 2010, J AM SOC NEPHROL, V21, P697, DOI 10.1681/ASN.2009080861; PONTICELLI C, 1995, KIDNEY INT, V48, P1600, DOI 10.1038/ki.1995.453; PONTICELLI C, 1992, NEPHROL DIAL TRANSPL, V7, P85; Ponticelli C, 2010, J NEPHROL, V23, P156; Reichert LJM, 1998, AM J KIDNEY DIS, V31, P1, DOI 10.1053/ajkd.1998.v31.pm9428445; Shiiki H, 2004, KIDNEY INT, V65, P1400, DOI 10.1111/j.1523-1755.2004.00518.x; Sugiyama H, 2011, CLIN EXP NEPHROL, V15, P493, DOI 10.1007/s10157-011-0430-4; Troyanov S, 2006, KIDNEY INT, V69, P1641, DOI 10.1038/sj.ki.5000289; Troyanov S, 2004, KIDNEY INT, V66, P1199, DOI 10.1111/j.1523-1755.2004.00873.x; Wasserstein AG, 1997, J AM SOC NEPHROL, V8, P664; WEHRMANN M, 1989, CLIN NEPHROL, V31, P67; Yamaguchi M, 2018, RENAL FAILURE, V40, P435, DOI 10.1080/0886022X.2018.1487864; Yamaguchi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110376; Yim T, 2020, KIDNEY RES CLIN PRAC, V39, P60, DOI 10.23876/j.krcp.19.077; Zeng CH, 2008, AM J KIDNEY DIS, V52, P691, DOI 10.1053/j.ajkd.2008.06.006; Zent R, 1997, AM J KIDNEY DIS, V29, P200, DOI 10.1016/S0272-6386(97)90030-5; Zuo K, 2013, CLIN NEPHROL, V79, P445, DOI 10.5414/CN107681	36	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240566	10.1371/journal.pone.0240566	http://dx.doi.org/10.1371/journal.pone.0240566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035278	Green Published, gold			2022-12-26	WOS:000581817500018
J	Haidl, H; Schlagenhauf, A; Krebs, A; Plank, H; Wonisch, W; Fengler, V; Fiegl, A; Horl, G; Koestenberger, M; Wagner, T; Tafeit, E; Cvirn, G; Hallstrom, S				Haidl, Harald; Schlagenhauf, Axel; Krebs, Angelika; Plank, Harald; Wonisch, Willibald; Fengler, Vera; Fiegl, August; Hoerl, Gerd; Koestenberger, Martin; Wagner, Thomas; Tafeit, Erwin; Cvirn, Gerhard; Hallstroem, Seth			The anticoagulant effects of ethyl pyruvate in whole blood samples	PLOS ONE			English	Article							PLATELETS; INFLAMMATION; LEUKOCYTES; SECRETION; PREVENTS; ATP	Background Ethyl pyruvate (EP), the ethyl ester of pyruvate, has proven antiinflammatory and antioxidative properties. Additionally, anticoagulant properties have been suggested recently. EP, therefore, is a potentially antiatherosclerotic drug. We aimed to investigate whether EP possesses antiplatelet and anticoagulant properties particularly in the physiological environment of whole blood. Methods We investigated the effects of increasing concentrations of EP on platelet function, on the course of clot development, and on standard coagulation times. Additionally, clot ultrastructure using scanning electron microscopy was analysed. Results EP exerted significant antiplatelet actions: i) Impedance aggregometry amplitudes (11.7 +/- 3.0 ohm, 0 mu g/mL EP) dose dependently decreased (7.8 +/- 3.1 ohm, 1000 mu g/mL EP; -33.3%). ATP exocytosis (0.87 +/- 0.24 nM, 0 mu g/mL EP) measured by the luminiscent method dose-dependently decreased (0.56 +/- 0.14 nM, 1000 mu g/mL; -35.6%). ii) Closure times (104.4 +/- 23.8 s, 0 mu g/mL EP) using the Platelet function analyzer were dose-dependently prolonged (180.5 +/- 82.5 s, 1000 mu g/mL EP; +72.9%) using membranes coated with collagen/ADP. iii) Surface coverage (15.9 +/- 5.1%, 0 mu g/mL EP) dose-dependently decreased (9.0 +/- 3.7%, 1000 mu g/mL EP; -43.4%) using the Cone and Platelet analyzer. EP also exerted significant anticoagulant actions: Coagulation times (177.9 +/- 37.8, 0 mu g/mL EP) evaluated by means of thrombelastometry were dose-dependently prolonged (212.8 +/- 57.7 s, 1000 mu g/mL EP; +19.6%). Activated partial thromboplastin times (31.5 +/- 1.8 s, 0 mu g/mL EP) were dose-dependently prolonged (35.6 +/- 2.3 s, 1000 mu g/mL EP; +13.0%). Prothrombin times (0.94 +/- 0.02 INR, 0 mu g/mL EP) were dose-dependently prolonged (1.09 +/- 0.04 INR, 1000 mu g/mL EP; +16.0%). Conclusion We found that EP possesses antiplatelet and anticoagulant properties in whole blood. Together with its proven anti-inflammatory and antioxidative properties, EP is a potentially antiatherogenic drug.	[Haidl, Harald; Schlagenhauf, Axel; Koestenberger, Martin] Med Univ Graz, Dept Pediat, Graz, Austria; [Krebs, Angelika] Med Univ Graz, Ctr Med Res, Graz, Austria; [Plank, Harald] Graz Univ Technol, Inst Electron Microscopy & Nanoanal, Graz, Austria; [Wonisch, Willibald; Fengler, Vera; Fiegl, August; Hoerl, Gerd; Tafeit, Erwin; Cvirn, Gerhard; Hallstroem, Seth] Med Univ Graz, Div Physiol Chem, Otto Loewi Res Ctr, Graz, Austria; [Wagner, Thomas] Med Univ Graz, Dept Blood Grp Serol & Transfus Med, Graz, Austria	Medical University of Graz; Medical University of Graz; Graz University of Technology; Medical University of Graz; Medical University of Graz	Cvirn, G (corresponding author), Med Univ Graz, Div Physiol Chem, Otto Loewi Res Ctr, Graz, Austria.	gerhard.cvirn@medunigraz.at	Schlagenhauf, Axel/AAK-9598-2021; Koestenberger, Martin/J-5008-2019	Schlagenhauf, Axel/0000-0003-3408-6415; Koestenberger, Martin/0000-0003-1766-7859; Hoerl, Gerd/0000-0002-0884-0851				Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; ANDREW M, 1992, BLOOD, V80, P1998, DOI 10.1182/blood.V80.8.1998.1998; [Anonymous], 2009, ALIRAN MONTHLY, V29, P7; [Anonymous], 2010, J AFRICANISTES, V80, P151; Bennett-Guerrero E, 2009, J CARDIOTHOR VASC AN, V23, P324, DOI 10.1053/j.jvca.2008.08.005; Chang Yao-Wen, 2009, Acta Anaesthesiol Taiwan, V47, P110; Crawford RS, 2011, J TRAUMA, V70, P103, DOI 10.1097/TA.0b013e3182031ccb; Cvirn G, 2003, J THROMB HAEMOST, V1, P1785, DOI 10.1046/j.1538-7836.2003.00320.x; DANILATOS GD, 1982, SCAN ELECTRON MICROS, P1; Deak AT, 2014, J CELL SCI, V127, P2944, DOI 10.1242/jcs.149807; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; Fritsma GA, 2017, METHODS MOL BIOL, V1646, P333, DOI 10.1007/978-1-4939-7196-1_26; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Ghasemzadeh M, 2013, THROMB RES, V131, P191, DOI 10.1016/j.thromres.2012.11.028; Hallstrom S, 2002, CIRCULATION, V105, P3032, DOI 10.1161/01.CIR.0000018745.11739.9B; Heemskerk JWM, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12045; Hermann A, 2001, PLATELETS, V12, P74, DOI 10.1080/09537100020031207; JOY DC, 1992, ULTRAMICROSCOPY, V47, P80, DOI 10.1016/0304-3991(92)90186-N; Jurimae T, 2005, COLLEGIUM ANTROPOL, V29, P499; Kruschitz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072002; Kung CW, 2011, THROMB RES, V127, P582, DOI 10.1016/j.thromres.2011.01.017; Lamprecht M, 2013, J APPL PHYSIOL, V115, P57, DOI 10.1152/japplphysiol.00187.2013; Li WJ, 2017, BIOCHEM BIOPH RES CO, V487, P560, DOI 10.1016/j.bbrc.2017.04.087; Lin CT, 2010, ONLINE INFORM REV, V34, P205, DOI 10.1108/14684521011036954; McEver RP, 2001, THROMB HAEMOSTASIS, V86, P746; Miyaji T, 2003, KIDNEY INT, V64, P1620, DOI 10.1046/j.1523-1755.2003.00268.x; Morel-Kopp MC, 2012, THROMB HAEMOSTASIS, V107, P575, DOI 10.1160/TH11-09-0631; Oury C, 2006, CURR PHARM DESIGN, V12, P859, DOI 10.2174/138161206776056029; Rossmann C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191477; Shin JH, 2014, NEUROSCI LETT, V558, P159, DOI 10.1016/j.neulet.2013.11.006; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; ten Cate H, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003553; Thomas MR, 2015, THROMB HAEMOSTASIS, V114, P449, DOI 10.1160/TH14-12-1067; Totani L, 2016, J THROMB HAEMOST, V14, P191, DOI 10.1111/jth.13173; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; van Zoelen MAD, 2006, THROMB HAEMOSTASIS, V96, P789, DOI 10.1160/TH06-07-0393; Varon D, 1997, THROMB RES, V85, P283, DOI 10.1016/S0049-3848(97)00014-5; von Papen M, 2013, TRANSFUS MED HEMOTH, V40, P109, DOI 10.1159/000350294; Zuern CS, 2009, SEMIN THROMB HEMOST, V35, P295, DOI 10.1055/s-0029-1222608	40	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240541	10.1371/journal.pone.0240541	http://dx.doi.org/10.1371/journal.pone.0240541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035271	Green Published, gold			2022-12-26	WOS:000581817500052
J	Ketema, S; Tesfaye, B; Keneni, G; Fenta, BA; Assefa, E; Greliche, N; Machuka, E; Yao, NA				Ketema, Selamawit; Tesfaye, Bizuayehu; Keneni, Gemechu; Amsalu Fenta, Berhanu; Assefa, Ermias; Greliche, Nicolas; Machuka, Eunice; Yao, Nasser			DArTSeq SNP-based markers revealed high genetic diversity and structured population in Ethiopian cowpea [Vigna unguiculata (L.) Walp] germplasms	PLOS ONE			English	Article							CULTIVATED COWPEA; DNA; COLLECTIONS; EVOLUTION; GENOTYPE; PROGRAM; WILD; FLOW	Cowpea [Vigna unguiculata (L.) Walp] is one of the important climate-resilient legume crops for food and nutrition security in sub-Saharan Africa. Ethiopia is believed to harbor high cowpea genetic diversity, but this has not yet been efficiently characterized and exploited in breeding. The objective of this study was to evaluate the extent and pattern of genetic diversity in 357 cowpea accestions comprising landraces (87%), breeding lines (11%) and released varieties (2%), using single nucleotide polymorphism markers. The overall gene diversity and heterozygosity were 0.28 and 0.12, respectively. The genetic diversity indices indicated substantial diversity in Ethiopian cowpea landraces. Analysis of molecular variance showed that most of the variation was within in the population (46%) and 44% between individuals, with only 10% of the variation being among populations. Model-based ancestry analysis, the phylogenetic tree, discriminant analysis of principal components and principal coordinate analysis classified the 357 genotypes into three well-differentiated genetic populations. Genotypes from the same region grouped into different clusters, while others from different regions fell into the same cluster. This indicates that differences in regions of origin may not be the main driver determining the genetic diversity in cowpea in Ethiopia. Therefore, differences in sources of origin, as currently distributed in Ethiopia, should not necessarily be used as indices of genetic diversity. Choice of parental lines should rather be based on a systematic assessment of genetic diversity in a specific population. The study also suggested 94 accesstions as core collection which retained 100% of the genetic diversity from the entire collection. This core set represents 26% of the entire collection pinpointing a wide distribution of the diversity within the ethiopian landraces. The outcome of this study provided new insights into the genetic diversity and population structure in Ethiopian cowpea genetic resources for designing effective collection and conservation strategies for efficient utilization in breeding.	[Ketema, Selamawit; Amsalu Fenta, Berhanu] Melkassa Res Ctr, Ethiopian Inst Agr Res, Melkassa, Ethiopia; [Ketema, Selamawit; Tesfaye, Bizuayehu] Hawassa Univ, Sch Plant & Hort Sci, Hawassa, Ethiopia; [Keneni, Gemechu] Ethiopian Inst Agr Res, Addis Ababa, Ethiopia; [Assefa, Ermias] Ethiopian Biotechnol Inst, Genom Res Directorate, Addis Ababa, Ethiopia; [Greliche, Nicolas] Stat Sustainable Dev, Reading, Berks, England; [Machuka, Eunice; Yao, Nasser] Biosci Eastern & Cent Africa Int Livestock Res In, Nairobi, Kenya	Ethiopian Institute of Agricultural Research (EIAR); Hawassa University; Ethiopian Institute of Agricultural Research (EIAR)	Yao, NA (corresponding author), Biosci Eastern & Cent Africa Int Livestock Res In, Nairobi, Kenya.	nasseryao@gmail.com	Machuka, Eunice/AAG-2443-2022; Machuka, Eunice/AFK-3646-2022	Machuka, Eunice/0000-0002-1142-3442; Machuka, Eunice/0000-0002-1142-3442	BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; Syngenta Foundation for Sustainable Agriculture (SFSA); Bill & Melinda Gates Foundation (BMGF); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida); Collaborative Crop Research Project of McKnight Foundation	BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership(Australian Government); Syngenta Foundation for Sustainable Agriculture (SFSA)(Syngenta); Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida); Collaborative Crop Research Project of McKnight Foundation	The laboratory work was supported by the BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program. The ABCF Program is funded by the Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; the Syngenta Foundation for Sustainable Agriculture (SFSA); the Bill & Melinda Gates Foundation (BMGF); the UK Department for International Development (DFID) and; the Swedish International Development Cooperation Agency (Sida). The authors are also grateful to the Collaborative Crop Research Project of McKnight Foundation for the financial support for the collection of the landraces and maintenance of the germplasm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; ANATALA TJ, 2014, INT J AGR ENV BIOTEC, V7, P269, DOI DOI 10.5958/2230-732X.2014.00244.7; [Anonymous], 2017, LANCET ONCOL, V18, P1, DOI 10.1016/S1470-2045(16)30642-8; [Anonymous], 2012, AM J TRANSPLANT, V12, P1, DOI 10.1111/j.1600-6143.2011.03886.x; [Anonymous], 2015, BRIDGES WEEKLY  1008, V19, P1, DOI DOI 10.1177/2331216515593385; [Anonymous], 2011, SUMUNTAN ANUARIO EST, V29, P197; [Anonymous], 2016, KDG, V56, P1; Asare AT, 2010, PLANT GENET RESOUR-C, V8, P142, DOI 10.1017/S1479262110000092; Asfaw A, 2009, THEOR APPL GENET, V120, P1, DOI 10.1007/s00122-009-1154-7; Ba FS, 2004, GENET RESOUR CROP EV, V51, P539, DOI 10.1023/B:GRES.0000024158.83190.4e; Badiane FA, 2012, GENET MOL RES, V11, P292, DOI 10.4238/2012.February.8.4; Baraket G, 2011, PLANT MOL BIOL REP, V29, P171, DOI 10.1007/s11105-010-0217-x; Bedru B, 2019, PRODUCTION MARKETING; Bernard D, 2019, CELL CYCLE, V18, P795, DOI 10.1080/15384101.2019.1591125; Blambert L, 2016, ANN BOT-LONDON, V118, P93, DOI 10.1093/aob/mcw014; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Chahal G.S., 2002, PRINCIPLES PROCEDURE; Chen HL, 2017, CROP J, V5, P363, DOI 10.1016/j.cj.2017.04.002; Coulibaly S, 2002, THEOR APPL GENET, V104, P358, DOI 10.1007/s001220100740; de Vicente M., 2004, GENETIC DIVERSITY AN; Desalegne B. A., 2017, Journal of Crop Science and Biotechnology, V20, P107, DOI 10.1007/s12892-016-0051-0; Desalegne BA, 2016, PLANT MOL BIOL REP, V34, P978, DOI 10.1007/s11105-016-0979-x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards SB, 1991, PLANT GENETIC RESOUR, P58; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falconer D. S., 1996, Introduction to quantitative genetics.; Fang JG, 2007, GENET RESOUR CROP EV, V54, P1197, DOI 10.1007/s10722-006-9101-9; FAO, 1996, FAO INT TECHN C PLAN; FARIS DG, 1964, CAN J GENET CYTOL, V6, P255, DOI 10.1139/g64-033; Fatokun C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34555-9; Food and Agriculture Organization of the United Nations, 2018, FAOSTAT; Govindaraj M, 2015, GENET RES INT, V2015, DOI 10.1155/2015/431487; Gruber B, 2018, MOL ECOL RESOUR, V18, P691, DOI 10.1111/1755-0998.12745; GRUENBAUM Y, 1981, FEBS LETT, V124, P67, DOI 10.1016/0014-5793(81)80055-5; Hartl Daniel L., 1997; HIjMAns R.J., 2012, DIVA GIS VERSION 7 5; Huynh BL, 2013, PLANT GENOME, V6, P2; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171394; Kirkegaard J, 2008, FIELD CROP RES, V107, P185, DOI 10.1016/j.fcr.2008.02.010; Kong QS, 2011, PLANT MOL BIOL REP, V29, P217, DOI 10.1007/s11105-010-0228-7; Perseguini JMKC, 2015, GENET MOL BIOL, V38, P67, DOI 10.1590/S1415-475738120140126; Li CD, 2001, CROP SCI, V41, P189, DOI 10.2135/cropsci2001.411189x; Liu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163836; Magurran A.E, 2004, MEASURING BIOL DIVER; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; MALHOTRA RS, 1991, EUPHYTICA, V58, P5, DOI 10.1007/BF00035334; Malviya N, 2012, PLANT SYST EVOL, V298, P523, DOI 10.1007/s00606-011-0545-9; Mduma I, 2010, THESIS; National Research Council, 2006, LOST CROPS AFR, VII, P53; Ng N. Q., 1985, COWPEA RES PRODUCTIO, P11; Nkongolo KK, 2003, EUPHYTICA, V129, P219, DOI 10.1023/A:1021935431873; Odong TL, 2011, THEOR APPL GENET, V123, P195, DOI 10.1007/s00122-011-1576-x; Ogunkanmi LA, 2008, J FOOD AGRIC ENVIRON, V6, P263; Olasupo F. O., 2018, American Journal of Plant Sciences, V9, P2728, DOI 10.4236/ajps.2018.913199; Pasquet RS, 2000, THEOR APPL GENET, V101, P211, DOI 10.1007/s001220051471; Pasquet RS, 1999, THEOR APPL GENET, V98, P1104, DOI 10.1007/s001220051174; Pembleton LW, 2013, MOL ECOL RESOUR, V13, P946, DOI 10.1111/1755-0998.12129; Perrier X., 2006, DARWIN SOFTWARE; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Reis CM, 2001, ACTA HORTIC, P497, DOI 10.17660/ActaHortic.2001.546.68; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sharma SS, 2011, PLANT MOL BIOL REP, V29, P12, DOI 10.1007/s11105-010-0204-2; Singh B.B., 2002, CHALLENGES OPPORTUNI, P3; Smith Jason E., 2010, DECALAGES, V1.1, P1, DOI DOI 10.2202/2152-2812.1013; Steele W. M., 1976, Evolution of crop plants., P183; Thulin M, 1989, FLORA ETHIOPIA, V3, P49; USDA, 2015, 27 USDA; Vaillancourt R E, 1992, Am J Bot, V79, P1194, DOI [10.2307/2445219, 10.1002/j.1537-2197.1992.tb13716.x]; VAILLANCOURT RE, 1993, CROP SCI, V33, P606, DOI 10.2135/cropsci1993.0011183X003300030037x; Van Hintum TJL, 2000, IPGRI TEC B, V3, P51; Vavilov NI, 1951, CHRON BOT, V13, P366; Venter HM, 1996, BIODIVERSITY OF AFRICAN PLANTS, P656; VERDCOURT B, 1970, Kew Bulletin, V24, P507, DOI 10.2307/4102859; Villa Tania Carolina Camacho, 2005, Plant Genetic Resources Characterization and Utilization, V3, P373, DOI 10.1079/PGR200591; Wells SJ, 2018, PEERJ, V6, DOI 10.7717/peerj.5462; Wright S, 1931, GENETICS, V16, P0097; Wright S., 1977, EVOLUTION GENETICS P, V3; Xiong HZ, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-017-2088-9; Xu P, 2010, MOL BREEDING, V25, P675, DOI 10.1007/s11032-009-9364-x; Xu YB, 2017, J EXP BOT, V68, P2641, DOI 10.1093/jxb/erx135; Yonezawa K., 1995, P35; Zannou A, 2008, AFR J BIOTECHNOL, V7, P4407; Zhukovashii PM, 1962, CULTIVATED PLANTS TH	92	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239122	10.1371/journal.pone.0239122	http://dx.doi.org/10.1371/journal.pone.0239122			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031381	Green Published, gold			2022-12-26	WOS:000581809800052
J	Nofal, AM; Cacciotti, G; Lee, N				Nofal, Ahmed Maged; Cacciotti, Gabriella; Lee, Nick			Who complies with COVID-19 transmission mitigation behavioral guidelines?	PLOS ONE			English	Article							5 PERSONALITY DIMENSIONS; REGULATORY FIT; OPENNESS; NEUROTICISM; PERSUASION; EXPERIENCE; TENDENCY; TRAITS	During the past 6 months, the world has lost almost 950,000 lives because of the outbreak of COVID-19, with more than 31 million individuals diagnosed with COVID-19 worldwide. In response, lockdowns, and various other policies have been implemented. Unfortunately, many individuals are violating those policies and governments have been urging people to comply with the behavioral guidelines. In this paper, we argue that personality traits need to be considered to understand and encourage more effective public compliance with COVID 19 transmission mitigation behavioral guidelines. Using a sample of 8,548 individuals from Japan, we show that certain personality traits are related to the tendency to comply with COVID-19 transmission mitigation behavioral guidelines. We emphasize the importance of understanding why people respond differently to the same authority's messages and provide actionable insights for government policy makers and those who implement policies.	[Nofal, Ahmed Maged] Emlyon Business Sch, Ecully, France; [Cacciotti, Gabriella] Hankamer Sch Business, Waco, TX USA; [Lee, Nick] Univ Warwick, Warwick Business Sch, Coventry, W Midlands, England	EMLYON Business School; University of Warwick	Nofal, AM (corresponding author), Emlyon Business Sch, Ecully, France.	nofal@em-lyon.com		Lee, Nick/0000-0002-6209-0262; Nofal, Ahmed Maged/0000-0002-2532-1981				Allen TA, 2018, J PERS, V86, P714, DOI 10.1111/jopy.12352; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Back MD, 2010, PSYCHOL SCI, V21, P372, DOI 10.1177/0956797609360756; BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; Bilancini E, 2020, ARXIV200503998; Campbell RJ, 2019, ACAD MANAGE J, V62, P1278, DOI 10.5465/amj.2017.0790; Capraro V., 2020, SPECIAL ISSUE, V2, P45; Carver CS, 2000, PERS SOC PSYCHOL B, V26, P741, DOI 10.1177/0146167200268008; Cavallo A.F., 2020, HBS COVID 19 GLOBAL; Cesario J, 2004, J PERS SOC PSYCHOL, V86, P388, DOI 10.1037/0022-3514.86.3.388; Cialdini R., 1993, PSYCHOL INFLUENCE; Costa PT, 2007, REVISED NEO PERSONAL; Cunningham WA, 2010, NEUROPSYCHOLOGIA, V48, P3399, DOI 10.1016/j.neuropsychologia.2010.06.026; Davidai S., 2020, COVID 19 PROVIDES RA; DeYoung CG, 2002, PERS INDIV DIFFER, V33, P533, DOI 10.1016/S0191-8869(01)00171-4; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Dunning T., 2012, NATURAL EXPT SOCIAL; Dweck CS, 2008, CURR DIR PSYCHOL SCI, V17, P391, DOI 10.1111/j.1467-8721.2008.00612.x; Everett JA, 2020, EFFECTIVENESS MORAL; Fiddick L, 2016, J RES PERS, V62, P6, DOI 10.1016/j.jrp.2016.02.007; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Graziano W.G., 1997, HDB PERSONALITY PSYC, P795, DOI DOI 10.1016/B978-012134645-4/50031-7; Guzman J, 2019, RES POLICY, V48, P1666, DOI 10.1016/j.respol.2019.03.012; Heffner J., 2020, EMOTIONAL RESPONSES; Higgins ET, 2003, J PERS SOC PSYCHOL, V84, P1140, DOI 10.1037/0022-3514.84.6.1140; Hirsh JB, 2008, PSYCHOL SCI, V19, P962, DOI 10.1111/j.1467-9280.2008.02183.x; Hirsh JB, 2012, PSYCHOL SCI, V23, P578, DOI 10.1177/0956797611436349; Hudson NW, 2016, PERS SOC PSYCHOL B, V42, P603, DOI 10.1177/0146167216637840; Izekor A, 2016, BIG 5 PERSONALITY TR; Jackson JJ, 2012, PSYCHOL AGING, V27, P286, DOI 10.1037/a0025918; Jamieson S, 2004, MED EDUC, V38, P1217, DOI 10.1111/j.1365-2929.2004.02012.x; Johnson W, 2009, CURR DIR PSYCHOL SCI, V18, P217, DOI 10.1111/j.1467-8721.2009.01639.x; Jordan RE., 2020, COVID 19 RISK FACTOR; Kim JS, 2006, PSYCHOMETRIKA, V71, P659, DOI 10.1007/s11336-005-1283-0; Kreuter MW, 2003, AM J HEALTH BEHAV, V27, pS227; Lee AY, 2004, J PERS SOC PSYCHOL, V86, P205, DOI 10.1037/0022-3514.86.2.205; Li WD, 2015, LEADERSHIP QUART, V26, P671, DOI 10.1016/j.leaqua.2014.12.005; Lubke GH, 2004, STRUCT EQU MODELING, V11, P514, DOI 10.1207/s15328007sem1104_2; Lucas RE, 2000, J PERS SOC PSYCHOL, V79, P452, DOI 10.1037//0022-3514.79.3.452; Markman Arts, 2012, HARVARD BUSINESS REV; Matz SC, 2017, P NATL ACAD SCI USA, V114, P12714, DOI 10.1073/pnas.1710966114; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P1258, DOI 10.1037/0022-3514.52.6.1258; Nicolaou N, 2018, MANAGE SCI, V64, P1825, DOI 10.1287/mnsc.2016.2664; Organization WH, 2020, POP BAS AG STRAT SER; Paakkari L, 2020, LANCET PUBLIC HLTH; Park H. H., 2020, J APPL PSYCHOL; Petty RE, 1996, ATTITUDES PERSUASION; Peugh JL, 2010, J SCHOOL PSYCHOL, V48, P85, DOI 10.1016/j.jsp.2009.09.002; Pollack JM, 2012, J ORGAN BEHAV, V33, P789, DOI 10.1002/job.1794; Rand D, 2020, PSYARXIV, DOI DOI 10.31234/OSF.IO/YUQ7X; Roberts BW, 2005, PERS PSYCHOL, V58, P103, DOI 10.1111/j.1744-6570.2005.00301.x; Roccas S, 2002, PERS SOC PSYCHOL B, V28, P789, DOI 10.1177/0146167202289008; Romero E, 2012, PERS INDIV DIFFER, V53, P289, DOI 10.1016/j.paid.2012.03.035; Schiffer AM, 2020, NAT HUM BEHAV, V4, P450, DOI 10.1038/s41562-020-0883-0; Shane S, 2010, J APPL PSYCHOL, V95, P1154, DOI 10.1037/a0020294; Shane S, 2010, HUM RESOUR MANAGE-US, V49, P291, DOI 10.1002/hrm.20343; Smidt W, 2015, J EDUC TEACHING, V41, P385, DOI 10.1080/02607476.2015.1080419; Soper G A, 1919, Science, V49, P501, DOI 10.1126/science.49.1274.501; Tasselli S, 2018, BECOMING MORE CONSCI; Thompson ER, 2008, PERS INDIV DIFFER, V45, P542, DOI 10.1016/j.paid.2008.06.013; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Weible CM, 2020, POLICY SCI, V53, P225, DOI 10.1007/s11077-020-09381-4; West D, 1964, BRIT MED J, V2, P999; White TB, 2008, MARKET LETT, V19, P39, DOI 10.1007/s11002-007-9027-9; Wiest B., 2020, FORBES; World Health Organization, WHO DIR GEN OP REM M; Zhao H, 2006, J APPL PSYCHOL, V91, P259, DOI 10.1037/0021-9010.91.2.259	68	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240396	10.1371/journal.pone.0240396	http://dx.doi.org/10.1371/journal.pone.0240396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TB	33031476	Green Published, gold			2022-12-26	WOS:000581809800005
J	Hoitz, F; Vienneau, J; Nigg, BM				Hoitz, Fabian; Vienneau, Jordyn; Nigg, Benno M.			Influence of running shoes on muscle activity	PLOS ONE			English	Article							PREFERRED MOVEMENT; IMPACT FORCES; INJURIES; PATH; FREQUENCY; VELOCITY; BAREFOOT; RUNNERS	Studies on the paradigm of the preferred movement path are scarce, and as a result, many aspects of the paradigm remain elusive. It remains unknown, for instance, how muscle activity adapts when differences in joint kinematics, due to altered running conditions, are of low / high magnitudes. Therefore, the purpose of this work was to investigate changes in muscle activity of the lower extremities in runners with minimal (<= 3 degrees) or substantial (> 3 degrees) mean absolute differences in the ankle and knee joint angle trajectories when subjected to different running footwear. Mean absolute differences in the integral of the muscle activity were quantified for the tibialis anterior (TA), peroneus longus (PL), gastrocnemius medialis (GM), soleus (SO), vastus lateralis (VL), and biceps femoris (BF) muscles during over ground running. In runners with minimal changes in 3D joint angle trajectories (<= 3 degrees), muscle activity was found to change drastically when comparing barefoot to shod running (TA: 35%; PL: 11%; GM: 17%; SO: 10%; VL: 27%; BF: 16%), and minimally when comparing shod to shod running (TA: 10%; PL: 9%; GM: 13%; SO: 8%; VL: 8%; BF: 12%). For runners who showed substantial changes in joint angle trajectories (> 3 degrees), muscle activity changed drastically in barefoot to shod comparisons (TA: 39%; PL: 14%; GM: 16%; SO: 16%; VL: 25%; BF: 24%). It was concluded that a movement path can be maintained with small adaptations in muscle activation when running conditions are similar, while large adaptations in muscle activation are needed when running conditions are substantially different.	[Hoitz, Fabian] Univ Calgary, Schulich Sch Engn, Biomed Engn, Calgary, AB, Canada; [Hoitz, Fabian; Vienneau, Jordyn; Nigg, Benno M.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada	University of Calgary; University of Calgary	Hoitz, F (corresponding author), Univ Calgary, Schulich Sch Engn, Biomed Engn, Calgary, AB, Canada.; Hoitz, F (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	fabian.hoitz@ucalgary.ca		Hoitz, Fabian/0000-0002-8512-1543	Mizuno Corporation (Osaka, Japan); Biomechanigg Sport and Health Research (Calgary, Canada)	Mizuno Corporation (Osaka, Japan); Biomechanigg Sport and Health Research (Calgary, Canada)	This study was funded by Mizuno Corporation (Osaka, Japan) and Biomechanigg Sport and Health Research (Calgary, Canada). Mizuno Corporation (Osaka, Japan) also provided the shoes that were used in the testing. However, the results presented in this article do not in any way represent a bias toward Mizuno products over other brands. The results of the study are also presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BIOMECHANICS SPORT S; [Anonymous], 2016, PREV CHRONIC DIS, V13, pE40; Barandun M, 2009, J ELECTROMYOGR KINES, V19, P65, DOI 10.1016/j.jelekin.2007.07.003; BATES BT, 1989, J BIOMECH, V22, P963, DOI 10.1016/0021-9290(89)90081-X; Beierle Ryan, 2019, Int J Exerc Sci, V12, P1110; Federolf P, 2018, CURR ISSUES SPORT SC; Hall JPL, 2013, SPORTS MED, V43, P1335, DOI 10.1007/s40279-013-0084-3; Hermens HJ, 1999, EUROPEAN RECOMMENDAT, V8, P13, DOI [10.1016/S1050-6411(00)00027-4, DOI 10.1016/S1050-6411(00)00027-4]; Larson P, 2011, J SPORT SCI, V29, P1665, DOI 10.1080/02640414.2011.610347; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Nigg BM, 2015, BRIT J SPORT MED, V49, P1290, DOI 10.1136/bjsports-2015-095054; Nigg B.M., 2017, CURRENT ISSUES SPORT, V2, P1, DOI [https://doi.org/10.15203/CISS_2017.007, DOI 10.15203/CISS_2017.007, 10.15203/CISS_2017.007]; Nigg BM, 2017, MED SCI SPORT EXER, V49, P1641, DOI 10.1249/MSS.0000000000001260; Nigg BM, 1999, MED SCI SPORT EXER, V31, pS421, DOI 10.1097/00005768-199907001-00003; Nigg BM, 2001, CLIN J SPORT MED, V11, P2, DOI 10.1097/00042752-200101000-00002; Olin ED, 2013, HUM MOVEMENT SCI, V32, P343, DOI 10.1016/j.humov.2012.11.005; Trudeau MB, 2019, FOOTWEAR SCI, V11, P135, DOI 10.1080/19424280.2019.1615004; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; Van Middelkoop M, 2008, SCAND J MED SCI SPOR, V18, P140, DOI 10.1111/j.1600-0838.2007.00683.x; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Vanwanseele B, 2018, CURR ISSUES SPORT SC; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; Wilson DR, 1996, P 9 BIENN C CAN SOC, P194	23	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239852	10.1371/journal.pone.0239852	http://dx.doi.org/10.1371/journal.pone.0239852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027311	gold, Green Published			2022-12-26	WOS:000581808000022
J	Osman, SM; Ayoub, NA; Hafez, SA; Ibrahim, HA; El Raey, MA; El-Emam, SZ; Seada, AA; Saadeldeen, AM				Osman, Samir M.; Ayoub, Nahla A.; Hafez, Safaa A.; Ibrahim, Haitham A.; El Raey, Mohamed A.; El-Emam, Soad Z.; Seada, Ahmed A.; Saadeldeen, Amr M.			Aldose reductase inhibitor formCassia glauca: A comparative study of cytotoxic activity with Ag nanoparticles (NPs) and molecular docking evaluation	PLOS ONE			English	Article							SILVER NANOPARTICLES; FLAVONOL; EXTRACT; KINASES; CARDIOTOXICITY; IDENTIFICATION; DOXORUBICIN; ANTICANCER; GLYCOSIDES; ASSAY	UPLC-MS/MS profiling ofCassia glaucaleaves extract revealed the identification of 10 flavonoids. Kaempferol 3-O-beta-D-rutinoside was isolated and studied for its cytotoxic activity. It showed high cytotoxic effects against MCF-7 (IC(50)of 4.6 +/- 0.038 mu g/ml) and HepG-2 (IC(50)of 8.2 +/- 0.024 mu g/ml) cancer cell lines, compared to the leaves extracts, their Ag nanoparticles, and doxorubicin. Moreover, Kaempferol 3-O-beta-D-rutinoside exerted a synergistic cytotoxic effect with doxorubicin on MCF-7 cell lines. It was discovered as kinases and aldose reductase inhibitor while rationalizing its cytotoxic activity through molecular docking study. Thus, it is expected that the cardiotoxic effects of doxorubicin can be also decreased by using Kaempferol 3-O-beta-D-rutinoside due to its aldose reductase inhibitory effect. These findings suggested that Kaempferol 3-O-beta-D-rutinoside could be used in combination with chemotherapeutic drugs to increase the sensitivity to their cytotoxic activity and protect against their side effects.	[Osman, Samir M.; Hafez, Safaa A.] October 6 Univ, Dept Pharmacognosy, Fac Pharm, Giza, Egypt; [Ayoub, Nahla A.] Ain Shams Univ, Dept Pharmacognosy, Fac Pharm, Cairo, Egypt; [Ayoub, Nahla A.] Umm Al Qura Univ, Dept Pharmacol & Toxicol, Fac Med, Mecca, Saudi Arabia; [Ibrahim, Haitham A.] Helwan Univ, Dept Pharmacognosy, Fac Pharm, Cairo, Egypt; [El Raey, Mohamed A.] Natl Res Ctr, Dept Phytochem & Plant Systemat, Giza, Egypt; [El-Emam, Soad Z.] October 6 Univ, Dept Pharmacol & Toxicol, Fac Pharm, Giza, Egypt; [Seada, Ahmed A.] Cairo Univ, Dept Pharmacognosy, Fac Pharm, Cairo, Egypt; [Saadeldeen, Amr M.] Newgiza Univ, Sch Pharm, Dept Pharmacognosy, Giza, Egypt	Egyptian Knowledge Bank (EKB); October 6 University (O6U); Egyptian Knowledge Bank (EKB); Ain Shams University; Umm Al Qura University; Egyptian Knowledge Bank (EKB); Helwan University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); October 6 University (O6U); Egyptian Knowledge Bank (EKB); Cairo University; Newgiza University (NGU)	Saadeldeen, AM (corresponding author), Newgiza Univ, Sch Pharm, Dept Pharmacognosy, Giza, Egypt.	amr.saadeldeen@ngu.edu.eg	El Raey, Mohamed/ABE-1299-2021	El Raey, Mohamed/0000-0002-5960-3012; Ayoub, Nahla/0000-0003-4490-889X; Saadeldeen, Amr/0000-0001-5272-0630				Afify AMR, 2016, ASIAN PAC J TROP BIO, V6, P771, DOI 10.1016/j.apjtb.2016.07.006; Alfuraydi AA, 2019, J PHOTOCH PHOTOBIO B, V192, P83, DOI 10.1016/j.jphotobiol.2019.01.011; [Anonymous], 2012, CLIN CANC RES, V18, pPR61; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2011, KUYPER CTR REV, V2, P200; Antony P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138186; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Balcke GU, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-47; Bhardwaj P, 2019, CHEMOSPHERE, V235, P976, DOI 10.1016/j.chemosphere.2019.07.027; Boly R, 2011, INT J ONCOL, V38, P833, DOI 10.3892/ijo.2010.890; BUZDAR AU, 1985, CANCER, V55, P2761, DOI 10.1002/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chan EWC, 2011, PHARMACOGN RES, V3, P178, DOI 10.4103/0974-8490.85003; Ciniglia C, 2010, ALLELOPATHY J, V26, P301; Coppin JP, 2013, J FUNCT FOODS, V5, P1892, DOI 10.1016/j.jff.2013.09.010; Dabeek WM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102288; Delazar A, 2005, PHARMAZIE, V60, P878; El-Helby AGA, 2019, ARCH PHARM, V352, DOI 10.1002/ardp.201900178; El-Sawi S. A., 2010, Australian Journal of Basic and Applied Sciences, V4, P1326; ELSAYED MM, 2013, LIFE SCI J, V10, P1617; Emam M., 2017, J APPL PHARM SCI, V7, P226; Encarnacion DR, 1999, ACTA CHEM SCAND, V53, P375, DOI 10.3891/acta.chem.scand.53-0375; Fabre N, 2001, J AM SOC MASS SPECTR, V12, P707, DOI 10.1016/S1044-0305(01)00226-4; Gruz J, 2008, FOOD CHEM, V111, P789, DOI 10.1016/j.foodchem.2008.05.014; Halgren TA, 1999, J COMPUT CHEM, V20, P720, DOI 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X; Hemen Dave, 2012, Indian Journal of Natural Products and Resources, V3, P291; Hou DX, 2010, ANTIOXID REDOX SIGN, V13, P691, DOI 10.1089/ars.2009.2816; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Rivero PJ, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-101; Justesen U, 2000, J CHROMATOGR A, V902, P369, DOI 10.1016/S0021-9673(00)00861-X; Kasapi I., 2017, MEDITERR J SOC SCI, V8, P129, DOI [10.1515/mjss-2017-0012, DOI 10.1515/MJSS-2017-0012]; Kazuma K, 2003, PHYTOCHEMISTRY, V62, P229, DOI 10.1016/S0031-9422(02)00486-7; Kumar A, 2013, INT J PHARM SCI RES, V4, P113, DOI 10.13040/IJPSR.0975-8232.4(1).13-23; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kumar U. Seeta Uthaya, 2018, Proceedings of the Indian National Science Academy Part B Biological Sciences, V88, P313, DOI 10.1007/s40011-016-0761-8; Kumar USU, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6841348; Lalitha LJ, 2020, J KING SAUD UNIV SCI, V32, P1246, DOI 10.1016/j.jksus.2019.11.022; Lee KM, 2010, CARCINOGENESIS, V31, P1338, DOI 10.1093/carcin/bgq102; Link S, 2003, ANNU REV PHYS CHEM, V54, P331, DOI 10.1146/annurev.physchem.54.011002.103759; Lv Q, 2014, J FUNCT FOODS, V7, P621, DOI 10.1016/j.jff.2013.12.023; MARKHAM KR, 1976, TETRAHEDRON, V32, P2607, DOI 10.1016/0040-4020(76)88036-2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nam TG, 2015, FOOD CHEM, V170, P97, DOI 10.1016/j.foodchem.2014.08.067; Noginov MA, 2007, APPL PHYS B-LASERS O, V86, P455, DOI 10.1007/s00340-006-2401-0; Park S, 2012, FOOD CHEM, V130, P981, DOI 10.1016/j.foodchem.2011.08.026; Rolim WR, 2019, APPL SURF SCI, V463, P66, DOI 10.1016/j.apsusc.2018.08.203; Rudnitskaya A, 2010, BIOCHEM MOL BIOL EDU, V38, P261, DOI 10.1002/bmb.20392; Salahuddin M, 2010, IRAN J PHARM THER, V9, P20; Sanyal S., 2015, INT J INNOV SCI ENG, V2, P414; Saraswat M, 2006, MED SCI MONITOR, V12, pCR525; Selvaraj K., 2013, INT J CLIN PHARM, V5, P743; Simirgiotis MJ, 2010, J CHROMATOGR A, V1217, P443, DOI 10.1016/j.chroma.2009.11.014; Sonowal H, 2018, BIOCHEM PHARMACOL, V150, P179, DOI 10.1016/j.bcp.2018.02.018; Sonowal H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03284-w; Steuber H, 2007, J MOL BIOL, V368, P618, DOI 10.1016/j.jmb.2006.12.004; SUZUKI H, 1976, AGR BIOL CHEM TOKYO, V40, P819, DOI 10.1080/00021369.1976.10862133; Tambunan USF, 2017, AIP CONF PROC, V1862, DOI 10.1063/1.4991195; Tammali R, 2011, CURR CANCER DRUG TAR, V11, P560, DOI 10.2174/156800911795655958; Tanagala KKK, 2018, ANTI-CANCER AGENT ME, V18, P2042, DOI 10.2174/1871520618666180731093433; Thilagam E, 2018, ASIAN J PHARM CLIN R, V11, P160, DOI DOI 10.22159/AJPCR.2018.V11I4.23632; Thilagam E, 2013, J ACUPUNCT MERIDIAN, V6, P24, DOI 10.1016/j.jams.2012.10.005; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Utepbergenov D, 2012, BIOCHEMISTRY-US, V51, P6499, DOI 10.1021/bi300620c; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Veerapur VP, 2017, J ETHNOPHARMACOL, V198, P489, DOI 10.1016/j.jep.2017.01.025; Wojciechowski M, 2004, J PHYS CHEM B, V108, P18368, DOI 10.1021/jp046748b; Yadav UCS, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/690545; Zayed MF, 2015, J IND ENG CHEM, V23, P50, DOI 10.1016/j.jiec.2014.07.041	68	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240856	10.1371/journal.pone.0240856	http://dx.doi.org/10.1371/journal.pone.0240856			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064762	Green Published, gold			2022-12-26	WOS:000585918300047
J	Soto-Rubio, A; Valero-Moreno, S; Diaz, JL; Andreu, Y; Perez-Marin, M				Soto-Rubio, Ana; Valero-Moreno, Selene; Diaz, Jose Luis; Andreu, Yolanda; Perez-Marin, Marian			COPD at the end of life: Predictors of the emotional distress of patients and their family caregivers	PLOS ONE			English	Article							HOSPITAL ANXIETY; UNMET NEEDS; BURDEN; INTERVENTIONS; DEPRESSION; CARE	Background Few studies have focused on patients' emotional distress with end-stage chronic obstructive pulmonary disease (COPD) and their main family caregivers. Methods Cross-sectional data about emotional, functional, and burden-related variables were collected from 85 patients with end-stage COPD and their 85 respective main family caregivers to determine the variables that could predict their emotional well-being. Descriptive analyses, comparison of means, hierarchical regression models, and comparative quali-quantitative analyses were carried out. Results Data show that the great majority of patients with COPD spend years with this diagnosis, and have been admitted to the hospital several times in advance stage of illness the previous year of the moment of end-of-life stage. Furthermore, only a tiny percentage of the patients were functionally independent in the advanced stage of illness. Conclusions The emotional distress and the burden of the family caregiver play an essential role in the distress of the patient, in conjunction with the patient's own functional independence and the time living with the disease, and comorbidity. On the other hand, variables of the patient, such as time since diagnosis, number of hospital admissions, comorbidity, functional dependence, and emotional distress, play an important role in the family caregiver's emotional distress and burden. Understanding how these variables are related is key to designing appropriate programs to reduce the emotional distress the patients with COPD at the end of life and their family caregivers.	[Soto-Rubio, Ana; Valero-Moreno, Selene; Andreu, Yolanda; Perez-Marin, Marian] Univ Valencia, Fac Psychol, Personal Assessment & Psychol Treatments Dept, Valencia, Spain; [Diaz, Jose Luis] Air Liquide Healthcare, Valencia, Spain; [Diaz, Jose Luis] Hosp Clin Univ Valencia, Resp Care Unit, Valencia, Spain; [Diaz, Jose Luis] Int Univ Valencia VIU, Valencia, Spain	University of Valencia; Air Liquide; Universidad Internacional de Valencia VIU	Perez-Marin, M (corresponding author), Univ Valencia, Fac Psychol, Personal Assessment & Psychol Treatments Dept, Valencia, Spain.	marian.perez@uv.es	Valero-Moreno, Selene/Y-8905-2019; Perez-Marin, Marian/G-9394-2011	Perez-Marin, Marian/0000-0003-3532-8818; Valero-Moreno, Selene/0000-0002-5228-2738	Ministry of Economy and Competitiveness [PSI2014-51962-R]; Air Liquide Healthcare	Ministry of Economy and Competitiveness; Air Liquide Healthcare	This work was supported by the Spanish M.P.M. [PSI2014-51962-R]. Ministry of Economy and Competitiveness. http://www.ciencia.gob.es/portal/site/MICINN/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Air Liquide Healthcare provided support in the form of salary for author J.L.D., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abellan-Garcia A, 2018, INDICADORES ESTADIST; Al-Daken LI, 2018, SUPPORT CARE CANCER, V26, P3967, DOI 10.1007/s00520-018-4287-x; Al-Rawashdeh SY, 2016, J CARDIOVASC NURS, V31, pE21, DOI 10.1097/JCN.0000000000000348; Aoun S, 2015, PALLIATIVE MED, V29, P508, DOI 10.1177/0269216314566061; Badr H, 2018, DEPRESSION INDIVIDUA, V21, P975; Burgio LD, 2016, SPECTRUM FAMILY CARE; Terol-Cantero MC, 2015, AN PSICOL-SPAIN, V31, P494, DOI 10.6018/analesps.31.2.172701; Cheng ST, 2020, PSYCHOL AGING, V35, P55, DOI 10.1037/pag0000401; Cheng ST, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-1045-9; DeSteno D, 2019, HDB PSYCHOL HLTH MED; Djukanovic I, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0759-9; Finucane AM, 2019, BMC PALLIAT CARE, V18, DOI 10.1186/s12904-019-0490-x; Fiss PC, 2011, ACAD MANAGE J, V54, P393, DOI 10.5465/AMJ.2011.60263120; Fombuena M, 2016, J HEALTH PSYCHOL, V21, P2765, DOI 10.1177/1359105315586213; Gatti V, 2018, ENLIGHTENING CHRONIC, P3095; Gonzalez N, 2018, AGING CLIN EXP RES, V30, P489, DOI 10.1007/s40520-017-0809-5; Hagell P, 2017, J PAIN SYMPTOM MANAG, V53, P272, DOI 10.1016/j.jpainsymman.2016.09.007; Harris DL, 2019, PRINCIPLES PRACTICE; Hyland KA, 2019, J PAIN SYMPTOM MANAG, V58, P289, DOI 10.1016/j.jpainsymman.2019.05.003; Kedia SK, 2020, PSYCHO-ONCOLOGY, V29, P251, DOI 10.1002/pon.5271; Kent EE, 2016, CANCER-AM CANCER SOC, V122, P1987, DOI 10.1002/cncr.29939; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Kleine AK, 2019, CRIT REV ONCOL HEMAT, V140, P52, DOI 10.1016/j.critrevonc.2019.05.008; Lippiett KA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2017-020515; Liu S, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201901530; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Maddocks M, 2019, HLTH SERVICES DELIVE, V7, DOI 10.3310/hsdr07220; Mahoney FI, 1965, MD STATE MED J; Mansfield E, 2016, COPD, V13, P662, DOI 10.3109/15412555.2016.1151488; Matte DL, 2016, RESP MED, V117, P154, DOI 10.1016/j.rmed.2016.06.006; Medalie J, 1999, PATIENTS DOCTORS LIF, P173; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Ragin C.C., 2008, REDESIGNING SOCIAL I, DOI DOI 10.7208/CHICAGO/9780226702797.001.0001; Rodenbach RA, 2019, PATIENT EDUC COUNS, V102, P909, DOI 10.1016/j.pec.2018.12.014; Schneider CQ, 2012, STRAT SOC INQ, P1; Secinti E, 2019, CLIN PSYCHOL REV, V71, P27, DOI 10.1016/j.cpr.2019.05.001; Shanghai Clinical Treatment Expert Group for corona virus disease, 2020, CHIN J INFECT DIS, V38; Singh G, 2016, CHEST, V149, P905, DOI 10.1378/chest.15-0449; Soto-Rubio A, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02199; Soto-Rubio A, 2017, ARCH GERONTOL GERIAT, V73, P113, DOI 10.1016/j.archger.2017.07.024; Spanish Society of Palliative Care, 2018, DEFF ENF TERM; Tan JY, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12691; Trevino KM, 2018, PSYCHO-ONCOLOGY, V27, P243, DOI 10.1002/pon.4441; Ventura AD, 2014, PALLIATIVE MED, V28, P391, DOI 10.1177/0269216313511141; Wasilewski MB, 2017, INT J MED INFORM, V103, P109, DOI 10.1016/j.ijmedinf.2017.04.009; Winn P, 2016, INTEGRATING PALLIATI, P177; Yildiz E, 2017, HOLIST NURS PRACT, V31, P7, DOI 10.1097/HNP.0000000000000185; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240821	10.1371/journal.pone.0240821	http://dx.doi.org/10.1371/journal.pone.0240821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064747	Green Published, gold			2022-12-26	WOS:000585918300040
J	Greene, DN; Jackson, ML; Hillyard, DR; Delgado, JC; Schmidt, RL				Greene, Dina N.; Jackson, Michael L.; Hillyard, David R.; Delgado, Julio C.; Schmidt, Robert L.			Decreasing median age of COVID-19 cases in the United States-Changing epidemiology or changing surveillance?	PLOS ONE			English	Article								Background Understanding and monitoring the demographics of SARS-CoV-2 infection can inform strategies for prevention. Surveillance monitoring has suggested that the age distribution of people infected with SARS-CoV-2 has changed since the pandemic began, but no formal analysis has been performed. Methods Retrospective review of SARS-CoV-2 molecular testing results from a national reference laboratory was performed. Result distributions by age and positivity were compared between early period (March-April 2020) and late periods (June-July 2020) of the COVID-19 pandemic. Additionally, a sub-analysis compared changing age distributions between inpatients and outpatients. Results There were 277,601 test results of which 19320 (7.0%) were positive. The median age of infected people declined over time (p < 0.0005). In March-April, the median age of positive people was 40.8 years (Interquartile range (IQR): 29.0-54.1). In June-July, the median age of positive people was 35.8 years (IQR: 24.0-50.2). The positivity rate of patients under 50 increased from 6.0 to 10.6 percent and the positivity rate for those over 50 decreased from 6.3 to 5.0 percent between the early and late periods. The trend was only observed for outpatient populations. Conclusions We confirm that there is a trend toward decreasing age among persons with laboratory-confirmed SARS-CoV-2 infection, but that these trends seem to be specific to the outpatient population. Overall, this suggests that observed age-related trends are driven by changes in testing patterns rather than true changes in the epidemiology of SARS-CoV-2 infection. This calls for caution in interpretation of routine surveillance data until testing patterns stabilize.	[Greene, Dina N.; Jackson, Michael L.] Kaiser Permanente Washington, Renton, WA USA; [Greene, Dina N.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Hillyard, David R.; Delgado, Julio C.; Schmidt, Robert L.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Hillyard, David R.; Delgado, Julio C.; Schmidt, Robert L.] ARUP Labs, Salt Lake City, UT 84108 USA	Kaiser Permanente; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories	Schmidt, RL (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.; Schmidt, RL (corresponding author), ARUP Labs, Salt Lake City, UT 84108 USA.	Robert.schmidt@hsc.utah.edu			Kaiser Permanente Washington	Kaiser Permanente Washington	This work was supported by internal funds at Kaiser Permanente Washington (MLJ, DG). No specific funding was provided to (RLS, JCD, DRH). The funder provided support in the form of salaries for authors [MLJ, DG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2020, ATLANTIC MONTHLY; Bhopal R, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1366; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Lewnard JA, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1923; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Washington State Department of Health, 2020, NEW YORK STAT DEP HL	8	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240783	10.1371/journal.pone.0240783	http://dx.doi.org/10.1371/journal.pone.0240783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057403	Green Submitted, Green Published, gold			2022-12-26	WOS:000581814700037
J	Gruber, LZ; Ahissar, E				Gruber, Liron Zipora; Ahissar, Ehud			Closed loop motor-sensory dynamics in human vision	PLOS ONE			English	Article							FIXATIONAL EYE-MOVEMENTS; VISUAL-STIMULI; MICROSACCADES; RESPONSES; INTEGRATION; SACCADES; ACUITY; MOTION; MONKEY; SPACE	Vision is obtained with a continuous motion of the eyes. The kinematic analysis of eye motion, during any visual or ocular task, typically reveals two (kinematic) components: saccades, which quickly replace the visual content in the retinal fovea, and drifts, which slowly scan the image after each saccade. While the saccadic exchange of regions of interest (ROIs) is commonly considered to be included in motor-sensory closed-loops, it is commonly assumed that drifts function in an open-loop manner, that is, independent of the concurrent visual input. Accordingly, visual perception is assumed to be based on a sequence of open-loop processes, each initiated by a saccade-triggered retinal snapshot. Here we directly challenged this assumption by testing the dependency of drift kinematics on concurrent visual inputs using real-time gaze-contingent-display. Our results demonstrate a dependency of the trajectory on the concurrent visual input, convergence of speed to condition-specific values and maintenance of selected drift-related motor-sensory controlled variables, all strongly indicative of drifts being included in a closed-loop brain-world process, and thus suggesting that vision is inherently a closed-loop process.yy	[Gruber, Liron Zipora; Ahissar, Ehud] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel	Weizmann Institute of Science	Ahissar, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel.	ehud.ahissar@weizmann.ac.il		Gruber, Liron/0000-0003-1914-6176	European Research Council (ERC) [786949]	European Research Council (ERC)(European Research Council (ERC))	This research was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 786949). E.A. holds the Helen Diller Family Professorial Chair of Neurobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu MN, 2020, J VISION, V20, DOI 10.1167/jov.20.2.12; Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Ahissar E, 1998, NEURAL COMPUT, V10, P597, DOI 10.1162/089976698300017683; Ahissar E, 2016, ELIFE, V5, DOI 10.7554/eLife.12830; Ahissar E, 2016, VISION RES, V118, P25, DOI 10.1016/j.visres.2014.12.004; Ahissar E, 2015, PERCEPTION, V44, P986, DOI 10.1177/0301006615594946; [Anonymous], 2019, FRONTIERS PLANT SCI; [Anonymous], 1997, DYNAMIC PATTERNS SEL; BARLOW HB, 1952, J PHYSIOL-LONDON, V116, P290, DOI 10.1113/jphysiol.1952.sp004706; Behling S, 2020, J NEUROPHYSIOL, V123, P1265, DOI 10.1152/jn.00710.2019; Biswas D, 2018, CURR BIOL, V28, P4029, DOI 10.1016/j.cub.2018.11.002; Bonneh YS, 2010, J VISION, V10, DOI 10.1167/10.14.22; Buckley CL, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005926; BURR DC, 1981, PROC R SOC SER B-BIO, V211, P321, DOI 10.1098/rspb.1981.0010; Cadieu CF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003963; Carpenter RHS, 1988, MOVEMENTS EYES; Chen CY, 2013, J NEUROSCI, V33, P5375, DOI 10.1523/JNEUROSCI.3703-12.2013; Cherici C, 2012, J VISION, V12, DOI 10.1167/12.6.31; Clarke RJ, 2003, J NEUROPHYSIOL, V89, P3179, DOI 10.1152/jn.01131.2002; Coe BC, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0192; Crick FHC, 1981, ORG CEREBRAL CORTEX, P505; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dadarlat MC, 2017, J NEUROSCI, V37, P3764, DOI 10.1523/JNEUROSCI.2728-16.2017; Ditchburn R.W., 1973, EYE MOVEMENTS VISUAL; Drewes J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111197; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Fang Y, 2018, J VISION, V18, DOI 10.1167/18.3.18; Findlay JM, 2006, VISION RES, V46, P216, DOI 10.1016/j.visres.2005.07.035; Fried M, 2014, VISION RES; FUCHS AF, 1985, ANNU REV NEUROSCI, V8, P307, DOI 10.1146/annurev.ne.08.030185.001515; Gilchrist ID, 1997, NATURE, V390, P130, DOI 10.1038/36478; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; Grunewald A, 2004, J NEUROSCI, V24, P9185, DOI 10.1523/JNEUROSCI.1884-04.2004; Guobis Z, 2012, J ORAL MAXILLOFAC RE, V3, pe2; Hafed ZM, 2020, J NEUROPHYSIOL, V123, P308, DOI 10.1152/jn.00588.2019; Herrmann CJJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13489-8; Horev G, 2011, PHILOS T R SOC B, V366, P3070, DOI 10.1098/rstb.2011.0157; HUBEL DH, 1958, AM J OPHTHALMOL, V46, P110, DOI 10.1016/0002-9394(58)90060-6; Intoy J., 2020, NATURE COMMUNICATION, V11, P1; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Jv Uexkull, 1926, THEORETICAL BIOL; Kagan I, 2012, CURR BIOL, V22, pR186, DOI 10.1016/j.cub.2012.02.009; KAWANO K, 1986, J NEUROPHYSIOL, V56, P1355, DOI 10.1152/jn.1986.56.5.1355; Keller EL, 2003, SHARED BRAINSTEM PAT; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Ko HK, 2016, VISION RES, V122, P93, DOI 10.1016/j.visres.2016.03.006; Ko HK, 2010, NAT NEUROSCI, V13, P1549, DOI 10.1038/nn.2663; KOWLER E, 1979, VISION RES, V19, P619, DOI 10.1016/0042-6989(79)90238-4; Krauzlis RJ, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0205; Leszczynski M, 2019, FRONTIERS INTEGRATIV, P13, DOI [10.3389/fnint.2019.00013, DOI 10.3389/FNINT.2019.00013]; Manookin MB, 2018, NEURON, V97, P1327, DOI 10.1016/j.neuron.2018.02.006; Marken RS, 2009, REV GEN PSYCHOL, V13, P137, DOI 10.1037/a0015106; Marken RS, 2001, AM J PSYCHOL, V114, P259, DOI 10.2307/1423517; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Meermeier A, 2016, J VISION, V16, DOI 10.1167/16.8.17; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; NOTON D, 1971, SCIENCE, V171, P308, DOI 10.1126/science.171.3968.308; NOTON D, 1971, SCI AM, V224, P34; Nystrom M, 2013, BEHAV RES METHODS, V45, P272, DOI 10.3758/s13428-012-0247-4; Pack CC, 2003, NEURON, V37, P525, DOI 10.1016/S0896-6273(02)01187-X; Pitkow X, 2007, PLOS BIOL, V5, P2898, DOI 10.1371/journal.pbio.0050331; Poggio T., 2013, SCHOLARPEDIA, V8, P3516, DOI DOI 10.4249/SCHOLARPEDIA.3516; Poletti M, 2015, CURR BIOL, V25, P3253, DOI 10.1016/j.cub.2015.11.004; POWERS WT, 1973, SCIENCE, V179, P351, DOI 10.1126/science.179.4071.351; ROBINSON DA, 1981, ANNU REV NEUROSCI, V4, P463, DOI 10.1146/annurev.ne.04.030181.002335; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Rolfs M, 2008, J VISION, V8, DOI 10.1167/8.11.5; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Rossi EA, 2010, NAT NEUROSCI, V13, P156, DOI 10.1038/nn.2465; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; Rucci M, 2018, TRENDS COGN SCI, V22, P883, DOI 10.1016/j.tics.2018.07.009; Rucci M, 2015, TRENDS NEUROSCI, V38, P195, DOI 10.1016/j.tins.2015.01.005; Saig A, 2012, J NEUROSCI, V32, P14022, DOI 10.1523/JNEUROSCI.2432-12.2012; Saraf-Sinik I, 2015, J NEUROSCI, V35, P8777, DOI 10.1523/JNEUROSCI.4149-14.2015; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schutz AC, 2011, J VISION, V11, DOI 10.1167/11.14.21; Shen K, 2014, J NEUROSCI, V34, P5640, DOI 10.1523/JNEUROSCI.3880-13.2014; SKAVENSKI AA, 1979, VISION RES, V19, P675, DOI 10.1016/0042-6989(79)90243-8; SKOTTUN BC, 1988, J NEUROPHYSIOL, V59, P1719, DOI 10.1152/jn.1988.59.6.1719; Steinman R M, 1990, Rev Oculomot Res, V4, P115; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Van Gelder T, 1995, MIND MOTION EXPLORAT, V1, P43; VANGISBERGEN JAM, 1981, J NEUROPHYSIOL, V45, P417, DOI 10.1152/jn.1981.45.3.417; Wang XL, 2007, NAT NEUROSCI, V10, P640, DOI 10.1038/nn1878; WATT RJ, 1987, J OPT SOC AM A, V4, P2006, DOI 10.1364/JOSAA.4.002006; Wolf C, 2015, J VISION, V15, DOI 10.1167/15.16.1; Yang SCH, 2016, ELIFE, V5, DOI 10.7554/eLife.12215; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; ZUBER BL, 1965, SCIENCE, V150, P1459, DOI 10.1126/science.150.3702.1459	90	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240660	10.1371/journal.pone.0240660	http://dx.doi.org/10.1371/journal.pone.0240660			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057398	Green Submitted, gold, Green Published			2022-12-26	WOS:000581814700040
J	Macharia, LW; Wexler, C; Brown, M; Maloba, M; Pricilla, RA; Mabachi, NM; Muchoki, E; Babu, S; Ochieng, M; Gautney, B; Goggin, K; Finocchario-Kessler, S				Macharia, Lynton W.; Wexler, Catherine; Brown, Melinda; Maloba, May; Pricilla, Ruby Angeline; Mabachi, Natabhona M.; Muchoki, Elizabeth; Babu, Shadrack; Ochieng, Martin; Gautney, Brad; Goggin, Kathy; Finocchario-Kessler, Sarah			Implementation planning for community-based point-of-care HIV testing for infants: Recommendations from community leaders in Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; LINKAGE	Background Early infant diagnosis (EID) establishes the presence of HIV infection in HIV-exposed infants and children younger than 18 months of age. EID services are hospital-based, and thus fail to capture HIV-exposed infants who are not brought to the hospital for care. Point-of-care (POC) diagnostic systems deployed in the community could increase the proportion tested and linked to treatment, but little feasibility and acceptability data is available. Methods Semi-structured interviews (n = 74) were conducted by a Kenyan team with community members (Community Health Workers/Volunteers [CHW/CHV], Traditional Birth Attendants [TBAs], community leaders) and parents of HIV-exposed infants at four study sites in Kenya to elicit feedback on the acceptability and feasibility of community-based POC HIV testing. Results Participants described existing community health resources that could be leveraged to support integration of community-based POC HIV testing; however, the added demand placed on CHW/CHV could pose a challenge. Participants indicated that other potential barriers (concerns about confidentiality, disclosure, and HIV stigma) could be overcome with strong engagement from trusted community leaders and health providers, community sensitization, and strategic location and timing of testing. These steps were seen to improve acceptability and maximize the recognized benefits (rapid results, improved reach) of community-based testing. Conclusion Community members felt that with strategic planning and engagement, community-based POC HIV testing could be a feasible and acceptable strategy to overcome the existing barriers of hospital-based EID.	[Macharia, Lynton W.; Wexler, Catherine; Brown, Melinda; Mabachi, Natabhona M.; Finocchario-Kessler, Sarah] Univ Kansas, Med Ctr, Dept Family Med, Kansas City, KS 66103 USA; [Maloba, May] Global Hlth Innovat, Nairobi, Kenya; [Pricilla, Ruby Angeline] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Muchoki, Elizabeth; Babu, Shadrack; Ochieng, Martin] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Gautney, Brad] Global Hlth Innovat, Dallas, TX USA; [Goggin, Kathy] Childrens Mercy Hosp & Clin, Hlth Serv & Outcomes Res, Kansas City, MO USA; [Goggin, Kathy] Univ Missouri Kansas City, Sch Med, Kansas City, MO USA; [Goggin, Kathy] Univ Missouri Kansas City, Sch Pharm, Kansas City, MO USA	University of Kansas; University of Kansas Medical Center; Christian Medical College & Hospital (CMCH) Vellore; Kenya Medical Research Institute; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Finocchario-Kessler, S (corresponding author), Univ Kansas, Med Ctr, Dept Family Med, Kansas City, KS 66103 USA.	skessler2@kumc.edu			National Institute of Child Health & Human Development [R01HD076673, R01HD076673S2]	National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research reported in this publication is supported by grant numbers R01HD076673 and R01HD076673S2 awarded to Dr. Sarah Finocchario-Kessler and funded by National Institute of Child Health & Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2013, AIDS, V27, pS159; [Anonymous], 2013, WOUNDS COMPENDIUM CL, V25, pA18; Asiimwe S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21633; Bigogo G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-376; Decroo T, 2013, INT HEALTH, V5, P169, DOI 10.1093/inthealth/iht016; Drain PK, 2015, LANCET GLOB HEALTH, V3, pE663, DOI 10.1016/S2214-109X(15)00186-2; Hassan AS, 2012, AIDS BEHAV, V16, P5, DOI 10.1007/s10461-010-9877-7; Jani IV, 2014, JAIDS-J ACQ IMM DEF, V67, pE1, DOI 10.1097/QAI.0000000000000250; Kimaiyo S, 2010, East Afr Med J, V87, P100; KNBS, 2015, KEN 2014 DEM HLTH SU; Labhardt ND, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001768; Ministry of Health National AIDS & STI Control Programme, 2009, GUID PREV MOTH CHILD; Moshoeu MP, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6471-4; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; Mwau M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183860; NASCOP, 2017, DIFF CAR OP GUID; Ochieng BM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-S1-S4; Rachlis B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3462-6; Rachlis B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149412; Ruzagira E, 2017, TROP MED INT HEALTH, V22, P807, DOI 10.1111/tmi.12888; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; UNAIDS, 2017, COUNTR FACTSH; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Vreeman RC, 2010, JAIDS-J ACQ IMM DEF, V55, pE3, DOI 10.1097/QAI.0b013e3181f0758f; Wexler C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181005; WHO, 2016, 022603200 WHO PQDX	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240476	10.1371/journal.pone.0240476	http://dx.doi.org/10.1371/journal.pone.0240476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057444	Green Published, gold			2022-12-26	WOS:000581814700054
J	Nanni, M; Tortosa, L; Vicent, JF; Yeghikyan, G				Nanni, Mirco; Tortosa, Leandro; Vicent, Jose F.; Yeghikyan, Gevorg			Ranking places in attributed temporal urban mobility networks	PLOS ONE			English	Article							CENTRALITY; ALGORITHM; PATTERNS; STREETS	Drawing on the recent advances in complex network theory, urban mobility flow patterns, typically encoded as origin-destination (OD) matrices, can be represented as weighted directed graphs, with nodes denoting city locations and weighted edges the number of trips between them. Such a graph can further be augmented by node attributes denoting the various socio-economic characteristics at a particular location in the city. In this paper, we study the spatio-temporal characteristics of "hotspots" of different types of socio-economic activities as characterized by recently developed attribute-augmented network centrality measures within the urbanODnetwork. The workflow of the proposed paper comprises the construction of temporalODnetworks using two custom data sets on urban mobility in Rome and London, the addition of socio-economic activity attributes to theODnetwork nodes, the computation of network centrality measures, the identification of "hotspots" and, finally, the visualization and analysis of measures of their spatio-temporal heterogeneity. Our results show structural similarities and distinctions between the spatial patterns of different types of human activity in the two cities. Our approach produces simple indicators thus opening up opportunities for practitioners to develop tools for real-time monitoring and visualization of interactions between mobility and economic activity in cities.	[Tortosa, Leandro; Vicent, Jose F.] Univ Alicante, Dept Comp Sci & Artificial Intelligence, Alicante, Spain; [Nanni, Mirco] Italian Natl Res Council, Inst Informat Sci & Technol, Pisa, Italy; [Yeghikyan, Gevorg] Univ Pisa, Scuola Normale Super, Pisa, Italy	Universitat d'Alacant; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologie dell'Informazione "Alessandro Faedo" (ISTI-CNR); Scuola Normale Superiore di Pisa; University of Pisa	Vicent, JF (corresponding author), Univ Alicante, Dept Comp Sci & Artificial Intelligence, Alicante, Spain.	jvicent@ua.es	Vicent, Jose F./AAE-5434-2020; Tortosa, Leandro/AAB-1742-2021; Tortosa, Leandro/AAU-9297-2021; Tortosa, Leandro/K-4441-2014	Vicent, Jose F./0000-0002-2990-1879; Tortosa, Leandro/0000-0002-2562-8123; Tortosa, Leandro/0000-0002-2562-8123	Spanish Government, Ministerio de Economia y Competividad [TIN2017-84821-P]; EU [780754]	Spanish Government, Ministerio de Economia y Competividad(Spanish Government); EU(European Commission)	This work is supported by the Spanish Government, Ministerio de Economia y Competividad, grant number TIN2017-84821-P. It is also funded by the EU H2020 programme under Grant Agreement No. 780754, "Track & Know".	Agryzkov T, 2016, APPL MATH COMPUT, V291, P14, DOI 10.1016/j.amc.2016.06.036; Agryzkov T, 2012, APPL MATH COMPUT, V219, P2186, DOI 10.1016/j.amc.2012.08.064; Ahas R, 2010, TRANSPORT RES C-EMER, V18, P45, DOI 10.1016/j.trc.2009.04.011; Ahmed N, 2007, J TRANSP GEOGR, V15, P2, DOI 10.1016/j.jtrangeo.2005.11.004; Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Bachelard G, 2005, ANGELAKI, V10, P73, DOI 10.1080/09697250500417225; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Barthelemy M., 2016, STRUCTURE DYNAMICS C; Bavelas A., 1950, J ACOUST SOC AM, V22, P725, DOI [10.1121/1.1906679, DOI 10.1121/1.1906679]; Benyahia O, 2015, PROCEEDINGS OF THE 2015 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2015), P1348, DOI 10.1145/2808797.2808844; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bianchini M., 2005, ACM Transactions on Internet Technology, V5, P92, DOI 10.1145/1052934.1052938; Bingham-Hall J, 2015, BIG DATA SOC, V2, DOI 10.1177/2053951715597457; Bonaventura M., 2019, ARXIV191100436; Botta F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174198; Bretagnolle A., 2006, CYBERGEO EUR J GEOGR, V335, P1; Chen QJ, 2016, AAAI CONF ARTIF INTE, P338; Chin WCB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139509; De Montis A, 2007, ENVIRON PLANN B, V34, P905, DOI 10.1068/b32128; Fontanari A, 2018, PHYSICA A, V502, P256, DOI 10.1016/j.physa.2018.02.102; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Hamedmoghadam H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44005-9; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hu YJ, 2014, T GIS, V18, P911, DOI 10.1111/tgis.12076; Jia Y., 2016, P 19 INT C INT TRANS, P217; Kirkin AF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03217-9; Lenormand M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150449; Lichman M, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P35, DOI 10.1145/2623330.2623681; Louail T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7007; Louail T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05276; Mao F, 2016, FRONT EARTH SCI-PRC, V10, P205, DOI 10.1007/s11707-015-0525-4; Newman MEJ., 2008, NEW PALGRAVE DICT EC, V2, P1, DOI [10.1057/978-1-349-95121-5_2565-1, DOI 10.1057/978-1-349-95121-5_2565-1]; Nie K, 2015, SUSTAINABILITY-BASEL, V7, P2662, DOI 10.3390/su7032662; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Pedroche F., 2007, B SOC ESP MAT APL, V39, P7; Porta S, 2006, ENVIRON PLANN B, V33, P705, DOI 10.1068/b32045; Porta S, 2006, PHYSICA A, V369, P853, DOI 10.1016/j.physa.2005.12.063; Porta S, 2009, ENVIRON PLANN B, V36, P450, DOI 10.1068/b34098; Ramachandra TV, 2012, INT J APPL EARTH OBS, V18, P329, DOI 10.1016/j.jag.2012.03.005; Rey SJ, 2013, LETT SPAT RESOUR SCI, V6, P55, DOI 10.1007/s12076-012-0086-z; Rinzivillo S, 2012, KUNSTL INTELL, V26, P253, DOI 10.1007/s13218-012-0181-8; Saberi M, 2017, TRANSPORTATION, V44, P1383, DOI 10.1007/s11116-016-9706-6; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; Vlahogianni E.I., 2015, ENG APPL SCI OPTIMIZ, V38, P107, DOI [DOI 10.1007/978-3-319-18320-6_7, 10.1007/978-3-319-18320-6_7]; Volpati V., 2018, SPATIAL ORG POPULATI; Wang XY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2734960; Yamada I., 2004, J TRANSP GEOGR, V12, DOI [10.1016/j.jtrangeo.2003.10.006, DOI 10.1016/J.JTRANGEO.2003.10.006, DOI 10.1016/j.jtrangeo.2003.10.006]; Yildirimoglu M, 2018, TRANSPORT RES C-EMER, V89, P254, DOI 10.1016/j.trc.2018.02.015; Zhao P., 2017, INT J GEOGR INF SYST, V31, P1; Zheng Y., 2009, P 18 INT C WORLD WID, P791, DOI DOI 10.1145/1526709.1526816; Zhou YR, 2018, IEEE COMMUN MAG, V56, P52, DOI 10.1109/MCOM.2018.1700569	54	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0239319	10.1371/journal.pone.0239319	http://dx.doi.org/10.1371/journal.pone.0239319			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3XB	33052916	Green Published, gold			2022-12-26	WOS:000581820200065
J	Sorrie, MB; Amaje, E; Gebremeskel, F				Sorrie, Muluken Bekele; Amaje, Elias; Gebremeskel, Feleke			Pre-lacteal feeding practices and associated factors among mothers of children aged less than 12 months in Jinka Town, South Ethiopia, 2018/19	PLOS ONE			English	Article								Background Pre-lacteal feeding is one of the major harmful practices being faced while feeding the newborns. Although it affects child health, little is known about the extent of the problem and its contributing factors in the study area. Therefore, this study aimed to figure the prevalence of pre-lacteal feeding practices and associated factors among mothers of children aged less than 12 months in Jinka Town. Methods A community-based cross-sectional study was conducted at Jinka Town from March 1 to 30, 2019. A total of 430 mothers, having children less than 12 months of age, were selected by systematic sampling technique. The data were collected by using pretested and interviewer-administered structured questionnaires. The data were entered using epidata 4.2.1 and exported to SPSS version 23 for analysis. Adjusted odds ratios, 95% confidence intervals and p-values were reported. Results The prevalence of pre-lacteal feeding practice was 12.6% [95% CI (9.5-15.7)]. Having no maternal education [AOR = 4.82(95%CI 1.60-14.24)], colostrum avoidance [AOR = 4.09(95% CI 1.62-7.67)], lack of breast feeding counseling [AOR: = 2.51(95% CI 1.20-5.25)], home delivery [AOR = 3.34 (95% CI 1.52-7.33)], lack of knowledge about risks of pre-lacteal feeding [AOR = 2.86 (95% CI 1.30-6.29] and poor knowledge on breast feeding practices [AOR = 3.63(95% CI 1.62-8.11)] were factors associated with pre-lacteal feeding practices. Conclusion Pre-lacteal feeding practice among mothers of children aged less than 12 months in Jinka town was found to be higher than the national prevalence. Illiterate, colostrum avoidance, lack of breastfeeding counseling, home delivery, lack of knowledge on the risk of pre-lacteal feeding, and poor knowledge on breastfeeding practice were factors associated with pre-lacteal feeding practices.	[Sorrie, Muluken Bekele; Gebremeskel, Feleke] Arba Minch Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Arba Minch, Ethiopia; [Amaje, Elias] Bule Hora Univ, Dept Publ Hlth, Hagere Maryam, Ethiopia	Arba Minch University	Sorrie, MB (corresponding author), Arba Minch Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Arba Minch, Ethiopia.	mulukenbekele51@gmail.com	Amaje, Elias/AAA-7536-2022	Amaje, Elias/0000-0002-8991-9579; Bekele, Muluken/0000-0002-3464-2584				[Anonymous], 2011, ANNU REV NUCL PART S, V61, P99; [Anonymous], 2018, BNJ M; Anupam Parashar, 2017, International Journal of Health and Allied Sciences, V6, P30; Argaw MD, 2019, BMC NUTR, V5, DOI 10.1186/s40795-019-0277-8; Bililign N, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0073-x; Central Statistical Agency [Ethiopia] and ICF, 2016, NAT AD YOUTH REPR HL; El-Gilany AH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/258470; Federal Ministry of Health FHD, 2004, NAT STRAT INF YOUNG; Fetene N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156438; Goldman AS, 2000, J NUTR, V130, p426S, DOI 10.1093/jn/130.2.426S; Gualu T, 2017, NUTR DIET SUPPL, V9, P97, DOI 10.2147/NDS.S146188; Hailemariam TW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2420-z; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Ibadin O, 2013, NIGER J PAEDIAT, V40, P139; Jayarama S., 2017, INT J COMMUNITY MED, V4, P2919; Khanal V, 2014, J PEDIATR GASTR NUTR, V59, P162, DOI 10.1097/MPG.0000000000000429; Khanal V, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-9; Laroia N, 2006, BREASTFEED MED, V1, P94, DOI 10.1089/bfm.2006.1.94; Legesse M, 2014, INT BREASTFEED J, V9, DOI 10.1186/s13006-014-0025-2; Lenja A, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0091-8; Liben ML, 2015, FACTORS ASS PRELACTE; Nguyen PH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-932; Ogah A, 2012, ASIAN J MED SCI, V4, P79; Organization WH, 2009, GLOB HLTH RISKS MORT; Rogers NL, 2011, PUBLIC HEALTH NUTR, V14, P2029, DOI 10.1017/S1368980011000073; Salve Dawal, 2014, Scholars Journal of Applied Medical Sciences, V2, P1422; Shankar Kanagasabapathy, 2015, International Journal of Biomedical and Advance Research, V6, P484; Singh B., 2010, EUR J SCI RES, V40, P404; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Tariku A, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0074-9; Tekaly G, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1284-7; Tongun JB, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1523304; WHO U, 2018, CAPT MOM ERL IN BREA; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Wolde TF, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4044-3; Yoseph Bekele, 2014, Open Journal of Preventive Medicine, V4, P529, DOI 10.4236/ojpm.2014.47063	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240583	10.1371/journal.pone.0240583	http://dx.doi.org/10.1371/journal.pone.0240583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048981	Green Published, gold			2022-12-26	WOS:000581813300055
J	Leung, LB; Steers, WN; Hoggatt, KJ; Washington, DL				Leung, Lucinda B.; Steers, W. Neil; Hoggatt, Katherine J.; Washington, Donna L.			Explaining racial-ethnic differences in hypertension and diabetes control among veterans before and after patient-centered medical home implementation	PLOS ONE			English	Article							PRIMARY-CARE; RACIAL/ETHNIC DISPARITIES; MENTAL-HEALTH; ACCESS; ASSOCIATIONS; QUALITY; RACE	Patient-centered medical homes (PCMH) are primary care delivery models that improve care access and population-level health outcomes, yet they have not been observed to narrow racial-ethnic disparities in the Veteran Health Administration (VHA) or other health systems. We aimed to identify and compare underlying drivers of persistent hypertension and diabetes control differences between non-Hispanic Black (Black) and Hispanic versus non-Hispanic White (White) patients before and after PCMH implementation in the VHA. Among Black and Hispanic versus White VHA primary care patients in 2009 (n(hypertension)= 26,906; n(diabetes)= 21,141) and 2014 (n(hypertension)= 83,809; n(diabetes)= 38,887), we retrospectively examined hypertension control (blood pressure<140/90) and diabetes control (hemoglobin A1c <9) obtained through random chart abstraction of patient health records nationally via VHA's quality monitoring program. We fit linear probability regression models, adjusting for age, gender, comorbidity, and socioeconomic status (SES). Blinder-Oaxaca and Smith-Welch decomposition methods were used to parse out explained and unexplained contributors to health disparity between racial-ethnic groups pre- and post-PCMH implementation. Compared to White patients, hypertension and diabetes control remained significantly lower for Black (-6.2%[0.4%] and -3.1%[0.6%], respectively; p's<0.001) and Hispanic (-1.4%[0.8%] and -4.0%[1.0%], respectively; p's<0.001) patients following VHA PCMH implementation. Most racial-ethnic differences (55.7-92.3%; all p<0.05) were not attributed to age, gender, comorbidity, and SES. The contribution of explained versus unexplained factors did not significantly change over time. While many explanations for persistent racial-ethnic disparities in disease control among veterans exist, our study did not find that it was due to an influx of "sick" or "socioeconomically vulnerable" patients into the VHA following PCMH implementation. Instead, unexplained differences may be due to differential healthcare and community experiences (e.g., discrimination). Understanding underlying pathways leading to health disparities will better inform policy and clinical interventions to improve PCMH care delivery to racial-ethnic minority patients in health systems.	[Leung, Lucinda B.; Steers, W. Neil; Washington, Donna L.] VA Greater Angeles Healthcare Syst, Natl Partnered Evaluat Ctr, VA HSR&D Ctr Study Healthcare Innovat Implementat, Los Angeles, CA 90073 USA; [Leung, Lucinda B.; Steers, W. Neil; Washington, Donna L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; [Hoggatt, Katherine J.] San Francisco VA Hlth Care Syst, San Francisco, CA USA; [Hoggatt, Katherine J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco	Leung, LB (corresponding author), VA Greater Angeles Healthcare Syst, Natl Partnered Evaluat Ctr, VA HSR&D Ctr Study Healthcare Innovat Implementat, Los Angeles, CA 90073 USA.; Leung, LB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA.	Lucinda.Leung@va.gov	Washington, Donna/AAW-2191-2021		Veterans Health Administration (VA) Office of Health Equity (OHE)-Quality Enhancement Research Initiative (QUERI) National Partnered Evaluation Center [PEC-15-239]; VA Health Services Research & Development Service (HSRD) [IIR-17-289, IK2 HX002867]; Veterans Assessment & Improvement Laboratory for Patient Centered Care [XVA 65-018]; UCLA	Veterans Health Administration (VA) Office of Health Equity (OHE)-Quality Enhancement Research Initiative (QUERI) National Partnered Evaluation Center; VA Health Services Research & Development Service (HSRD); Veterans Assessment & Improvement Laboratory for Patient Centered Care; UCLA	This work was conducted through the Veterans Health Administration (VA) Office of Health Equity (OHE)-Quality Enhancement Research Initiative (QUERI) National Partnered Evaluation Center in the form of a grant awarded to DW (PEC-15-239). The study was also supported by the VA Health Services Research & Development Service (HSR&D) in the form of a grant awarded to DW (IIR-17-289) and a Career Development Award awarded to LL (IK2 HX002867). The study was additionally supported by the Veterans Assessment & Improvement Laboratory for Patient Centered Care (XVA 65-018) and UCLA in the form of a Faculty Research Grant awarded to LL.	Aysola J, 2013, MED CARE, V51, P68, DOI 10.1097/MLR.0b013e318270bb0d; Aysola J, 2011, HEALTH AFFAIR, V30, P2080, DOI 10.1377/hlthaff.2011.0656; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Bolen SD, 2009, DIABETES CARE, V32, P25, DOI 10.2337/dc08-1297; Chin MH, 2012, J GEN INTERN MED, V27, P992, DOI 10.1007/s11606-012-2082-9; Cooper LA, 2012, AM J PUBLIC HEALTH, V102, P979, DOI 10.2105/AJPH.2011.300558; Dong LM, 2018, MED CARE RES REV, V75, P263, DOI 10.1177/1077558717725884; Fan VS, 2002, J CLIN EPIDEMIOL, V55, P371, DOI 10.1016/S0895-4356(01)00493-0; Farber EW, 2017, AM PSYCHOL, V72, P28, DOI 10.1037/a0040358; Fraze TK, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2169; Heckman JJ, 2000, AM ECON REV, V90, P344, DOI 10.1257/aer.90.2.344; Hernandez SE, 2016, MED CARE, V54, P253, DOI 10.1097/MLR.0000000000000512; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; Jones AL, 2016, J GEN INTERN MED, V31, P1435, DOI 10.1007/s11606-016-3776-1; Jones DE, 2012, PATIENT EDUC COUNS, V89, P57, DOI 10.1016/j.pec.2012.06.003; Katz JN, 2001, JAMA-J AM MED ASSOC, V286, P1506, DOI 10.1001/jama.286.12.1506; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; Kiran T, 2016, ANN FAM MED, V14, P517, DOI 10.1370/afm.2000; Le Cook B, 2012, HEALTH SERV RES, V47, P1232, DOI 10.1111/j.1475-6773.2012.01387.x; Le Cook B, 2010, HEALTH SERV RES, V45, P825, DOI 10.1111/j.1475-6773.2010.01100.x; Lee K, 2011, J NATL MED ASSOC, V103, P250, DOI 10.1016/S0027-9684(15)30293-5; Markovitz AR, 2015, JAMA INTERN MED, V175, P598, DOI 10.1001/jamainternmed.2014.8263; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Nelson KM, 2014, JAMA INTERN MED, V174, P1350, DOI 10.1001/jamainternmed.2014.2488; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Pincus T, 1998, ANN INTERN MED, V129, P406, DOI 10.7326/0003-4819-129-5-199809010-00011; Raphael JL, 2009, ACAD PEDIATR, V9, P221, DOI 10.1016/j.acap.2009.01.011; Reibling N, 2016, MED CARE, V54, P9, DOI 10.1097/MLR.0000000000000451; Rodriguez F, 2015, ADV CHRONIC KIDNEY D, V22, P145, DOI 10.1053/j.ackd.2014.08.004; Rogers William H, 2004, J Ambul Care Manage, V27, P249; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; SMITH JP, 1989, J ECON LIT, V27, P519; Washington DL, 2005, AM J PUBLIC HEALTH, V95, P2231, DOI 10.2105/AJPH.2004.043570; Washington DL, 2017, HEALTH AFFAIR, V36, P1086, DOI 10.1377/hlthaff.2017.0029; Woodard LD, 2018, J GEN INTERN MED, V33, P1276, DOI 10.1007/s11606-018-4386-x; Zuvekas SH, 2003, HEALTH AFFAIR, V22, P139, DOI 10.1377/hlthaff.22.2.139	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240306	10.1371/journal.pone.0240306	http://dx.doi.org/10.1371/journal.pone.0240306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TU	33044984	gold, Green Published			2022-12-26	WOS:000581811700018
J	Savoia, E; Argentini, G; Gori, D; Neri, E; Piltch-Loeb, R; Fantini, MP				Savoia, Elena; Argentini, Giorgia; Gori, Davide; Neri, Elena; Piltch-Loeb, Rachael; Fantini, Maria Pia			Factors associated with access and use of PPE during COVID-19: A cross-sectional study of Italian physicians	PLOS ONE			English	Article								Objectives During the course of the Novel Coronavirus (SARS-CoV-2) pandemic, Italy has reported one of the highest number of infections. Nearly ten percent of reported coronavirus infections in Italy occurred in healthcare workers. This study aimed to understand physicians' access to personal protective equipment (PPE) and to information about their use, risk perception and strategies adopted to prevent contracting the infection. Methods We undertook a cross-sectional, online self-reported survey implemented between March 31 and April 5 2020 of Italian physicians. Results Responses were received from 516 physicians, only 13% of which reported to have access to PPE every time they need them. Approximately half of the physicians reported that the information received about the use of PPE was either clear (47%) or complete (54%). Risk perception about contracting the infection was influenced by receiving adequate information on the use of PPE. Access to adequate information on the use of PPE was associated with better ability to perform donning and doffing procedures [OR = 2.2 95% C.I. 1.7-2.8] and reduced perception of risk [OR = 0.5, 95% C.I. 0.4-0.6]. Conclusions Results from this rapid survey indicate that while ramping up supplies on PPE for healthcare workers is certainly of mandatory importance, adequate training and clear instructions are just as important.	[Savoia, Elena; Piltch-Loeb, Rachael] Harvard TH Chan Sch Publ Hlth, Emergency Preparedness Res Evaluat & Practice EPR, Div Policy Translat & Leadership Dev, Boston, MA 02115 USA; [Argentini, Giorgia] IRCCS Burlo Garofolo, Trieste, Italy; [Gori, Davide; Fantini, Maria Pia] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy; [Neri, Elena] Azienda Sanit Giuliano Isontina, Trieste, Italy	Harvard University; Harvard T.H. Chan School of Public Health; IRCCS Burlo Garofolo; University of Bologna	Piltch-Loeb, R (corresponding author), Harvard TH Chan Sch Publ Hlth, Emergency Preparedness Res Evaluat & Practice EPR, Div Policy Translat & Leadership Dev, Boston, MA 02115 USA.	piltch-loeb@hsph.harvard.edu		Gori, Davide/0000-0003-4954-9419				Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Christensen L, 2020, DISASTER MED PUBLIC, V14, P514, DOI 10.1017/dmp.2020.56; Donatini A, INT HLTH CARE SYSTEM; Federazione Nazionale degli Ordini dei Medici Chirurghi e degli Odontoiatri, EL MED CAD NEL CORS; Istituto Superiore di Sanita, SORV INT COVID 19 IT; KAMEROW D, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1367; SAYBURN A, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1391; Sorbello M, 2020, ANAESTHESIA, V75, P724, DOI 10.1111/anae.15049; World Health Organization, 2020, RAT US PERS PROT EQ; World Health Organization (WHO), 2020, SHORT PERS PROT EQ E; World Health organization (WHO), 2020, 78 WHO	11	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0239024	10.1371/journal.pone.0239024	http://dx.doi.org/10.1371/journal.pone.0239024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044978	Green Published, Green Submitted, gold			2022-12-26	WOS:000581811700048
J	Smith, ST; Meiler, J				Smith, Shannon T.; Meiler, Jens			Assessing multiple score functions in Rosetta for drug discovery	PLOS ONE			English	Article							PROTEIN-LIGAND DOCKING; ENERGY FUNCTION; DESIGN; OPTIMIZATION; MODEL; LEAD	Rosetta is a computational software suite containing algorithms for a wide variety of macromolecular structure prediction and design tasks including small molecule protocols commonly used in drug discovery or enzyme design. Here, we benchmark RosettaLigand score functions and protocols in comparison to results of other software recently published in the Comparative Assessment of Score Functions (CASF-2016). The CASF-2016 benchmark covers a wide variety of tests including scoring and ranking multiple compounds against a target, ligand docking of a small molecule to a target, and virtual screening to extract binders from a compound library. Direct comparison to the score functions provided by CASF-2016 results shows that the original RosettaLigand score function ranks among the top software for scoring, ranking, docking and screening tests. Most notably, the RosettaLigand score function ranked 2/34 among other report score functions in CASF-2016. We additionally perform a ligand docking test with full sampling to mimic typical use cases. Despite improved performance of newer score functions in canonical protein structure prediction and design, we demonstrate here that more recent Rosetta score functions have reduced performance across all small molecule benchmarks. The tests described here have also been uploaded to the Rosetta scientific benchmarking server and will be run weekly to track performance as the code is continually being developed.	[Smith, Shannon T.] Vanderbilt Univ, Chem & Phys Biol Program, 221 Kirkland Hall, Nashville, TN 37235 USA; [Smith, Shannon T.; Meiler, Jens] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Meiler, Jens] Ctr Struct Biol, Dept Chem, Nashville, TN 37240 USA; [Meiler, Jens] Ctr Struct Biol, Dept Pharmacol, Nashville, TN 37240 USA; [Meiler, Jens] Ctr Struct Biol, Dept Biomed Informat, Nashville, TN 37240 USA; [Meiler, Jens] Inst Chem Biol, Nashville, TN 37240 USA; [Meiler, Jens] Univ Leipzig, Inst Drug Discovery, Med Sch, Leipzig, Stadelschule, Germany	Vanderbilt University; Vanderbilt University; Leipzig University	Meiler, J (corresponding author), Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Meiler, J (corresponding author), Ctr Struct Biol, Dept Chem, Nashville, TN 37240 USA.; Meiler, J (corresponding author), Ctr Struct Biol, Dept Pharmacol, Nashville, TN 37240 USA.; Meiler, J (corresponding author), Ctr Struct Biol, Dept Biomed Informat, Nashville, TN 37240 USA.; Meiler, J (corresponding author), Inst Chem Biol, Nashville, TN 37240 USA.; Meiler, J (corresponding author), Univ Leipzig, Inst Drug Discovery, Med Sch, Leipzig, Stadelschule, Germany.	jens@meilerlab.org		Meiler, Jens/0000-0001-8945-193X; Smith, Shannon/0000-0002-1225-8928	National Cancer Institute of the National Institutes of Health [F31 CA243353]; STS also received funding through the PhRMA Foundation	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); STS also received funding through the PhRMA Foundation	STS received funding for this work through the National Cancer Institute of the National Institutes of Health (F31 CA243353). STS also received funding through the PhRMA Foundation's Pre-Doctoral Fellowship in Informatics (phrmafoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RF, 2017, J CHEM THEORY COMPUT, V13, P3031, DOI 10.1021/acs.jctc.7b00125; Aucar MG, 2020, METHODS MOL BIOL, V2114, P269, DOI 10.1007/978-1-0716-0282-9_17; Ballante F, 2018, METHODS MOL BIOL, V1824, P67, DOI 10.1007/978-1-4939-8630-9_5; Baumgartner MP, 2018, J COMPUT AID MOL DES, V32, P45, DOI 10.1007/s10822-017-0081-y; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhardwaj G, 2016, NATURE, V538, P329, DOI 10.1038/nature19791; Cavasotto CN, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00188; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Cole DJ, 2019, FUTURE MED CHEM, V11, P2359, DOI 10.4155/fmc-2019-0196; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; DeLuca S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132508; dos Santos RN, 2018, METHODS MOL BIOL, V1762, P31, DOI 10.1007/978-1-4939-7756-7_3; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Heifetz A, 2018, METHODS MOL BIOL, V1705, P375, DOI 10.1007/978-1-4939-7465-8_19; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Kothiwale S, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0095-1; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Lewis SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020872; Li Y, 2018, NAT PROTOC, V13, P666, DOI 10.1038/nprot.2017.114; Macalino SJY, 2015, ARCH PHARM RES, V38, P1686, DOI 10.1007/s12272-015-0640-5; Marze NA, 2018, BIOINFORMATICS, V34, P3461, DOI 10.1093/bioinformatics/bty355; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Muegge I, 2006, J MED CHEM, V49, P5895, DOI 10.1021/jm050038s; Nivon LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059004; O'Meara MJ, 2015, J CHEM THEORY COMPUT, V11, P609, DOI 10.1021/ct500864r; Park H, 2016, J CHEM THEORY COMPUT, V12, P6201, DOI 10.1021/acs.jctc.6b00819; Pavlovicz RE, 2019, EFFICIENT CONSIDERAT, DOI [10.1101/618603, DOI 10.1101/618603]; Perez-Sianes J, 2019, CURR COMPUT-AID DRUG, V15, P6, DOI 10.2174/1573409914666181018141602; Schulz-Gasch Tanja, 2004, Drug Discov Today Technol, V1, P231, DOI 10.1016/j.ddtec.2004.08.004; Shaikh SA, 2007, CURR PHARM DESIGN, V13, P3454, DOI 10.2174/138161207782794220; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082; Stranges PB, 2013, PROTEIN SCI, V22, P74, DOI 10.1002/pro.2187; Su MY, 2019, J CHEM INF MODEL, V59, P895, DOI 10.1021/acs.jcim.8b00545; Tropsha A, 2000, Curr Opin Drug Discov Devel, V3, P310; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	41	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240450	10.1371/journal.pone.0240450	http://dx.doi.org/10.1371/journal.pone.0240450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044994	Green Published, gold			2022-12-26	WOS:000581811700037
J	Galen, SC; Borner, J; Perkins, SL; Weckstein, JD				Galen, Spencer C.; Borner, Janus; Perkins, Susan L.; Weckstein, Jason D.			Phylogenomics from transcriptomic "bycatch" clarify the origins and diversity of avian trypanosomes in North America	PLOS ONE			English	Article							SPECIES DELIMITATION; HOST-SPECIFICITY; BLOOD PARASITES; RIBOSOMAL-RNA; SP-NOV; BIRDS; IDENTIFICATION; TRANSMISSION; ALIGNMENTS; PREVALENCE	The eukaryotic blood parasite genusTrypanosomaincludes several important pathogens of humans and livestock, but has been understudied in wildlife broadly. The trypanosomes that infect birds are in particular need of increased attention, as these parasites are abundant and globally distributed, yet few studies have addressed their evolutionary origins and diversity using modern molecular and analytical approaches. Of specific interest are the deep evolutionary relationships of the avian trypanosomes relative to the trypanosome species that are pathogenic in humans, as well as their species level diversity in regions where they have been understudied such as North America. Here, we address these unresolved areas of study using phylogenomic data for two species of avian trypanosomes that were isolated as "bycatch" from host transcriptome assemblies, as well as a large 18S DNA barcode sequence dataset that includes 143 novel avianTrypanosoma18S sequences from North America. Using a phylogenomic approach, we find that the avian trypanosomes are nested within a clade of primarily mammalian trypanosomes that includes the human pathogenTrypanosoma cruzi, and are paraphyletic with respect to the ruminant trypanosomeTrypanosoma theileri. DNA barcode sequences showed thatT.aviumand an unidentified small, non-striated trypanosome that was morphologically similar toT.everettiare each represented by highly abundant and divergent 18S haplotypes in North America. Community-level sampling revealed that additional species-levelTrypanosomalineages exist in this region. We compared the newly sequenced DNA barcodes from North America to a global database, and found that avianTrypanosoma18S haplotypes generally exhibited a marked lack of host specificity with at least oneT.aviumhaplotype having an intercontinental distribution. This highly abundantT.aviumhaplotype appears to have a remarkably high dispersal ability and cosmopolitan capacity to evade avian host immune defenses, which warrant further study.	[Galen, Spencer C.; Weckstein, Jason D.] Drexel Univ, Acad Nat Sci, Dept Ornithol, Philadelphia, PA 19104 USA; [Galen, Spencer C.; Borner, Janus; Perkins, Susan L.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Galen, Spencer C.] Univ Scranton, Dept Biol, Scranton, PA 18510 USA; [Borner, Janus] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Ulm, Germany; [Perkins, Susan L.] CUNY City Coll, Div Sci, New York, NY 10031 USA; [Weckstein, Jason D.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA	Drexel University; American Museum of Natural History (AMNH); University of Scranton; Ulm University; City University of New York (CUNY) System; City College of New York (CUNY); Drexel University	Galen, SC (corresponding author), Drexel Univ, Acad Nat Sci, Dept Ornithol, Philadelphia, PA 19104 USA.; Galen, SC (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.; Galen, SC (corresponding author), Univ Scranton, Dept Biol, Scranton, PA 18510 USA.	spgalen@gmail.com	Borner, Janus/E-1430-2012	Borner, Janus/0000-0001-9612-6668	Nation Science Foundation Postdoctoral Research Fellowship in Biology [1811806]; German Academic Exchange Service (DAAD); German Federal Ministry of Education and Research (BMBF); European Union [605728]	Nation Science Foundation Postdoctoral Research Fellowship in Biology; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	SCG was funded by a Nation Science Foundation Postdoctoral Research Fellowship in Biology (award 1811806) (https://nsf.gov/).JB was funded by the German Academic Exchange Service (DAAD) (https://www.daad.org/en/) with funds from the German Federal Ministry of Education and Research (BMBF) (https://www.bmbf.de/en/index.html) and the European Union (FP7-PEOPLE-2013COFUND -grant agreement no 605728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APANIUS V, 1991, PARASITOL TODAY, V7, P87, DOI 10.1016/0169-4758(91)90203-Z; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Aurrecoechea C, 2017, NUCLEIC ACIDS RES, V45, pD581, DOI 10.1093/nar/gkw1105; Baker J.R., 1976, P131; BAKER JR, 1963, EXP PARASITOL, V13, P219, DOI 10.1016/0014-4894(63)90074-2; Bardsley J.E., 1973, Advances Parasit, V11, P1, DOI 10.1016/S0065-308X(08)60184-0; BENNETT G. F., 1960, CANADIAN JOUR ZOOL, V38, P261, DOI 10.1139/z60-033; BENNETT GF, 1994, ONDERSTEPOORT J VET, V61, P263; BENNETT GF, 1994, MEM I OSWALDO CRUZ, V89, P531, DOI 10.1590/S0074-02761994000400007; BENNETT GF, 1961, CAN J ZOOLOG, V39, P17, DOI 10.1139/z61-003; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bernotiene R, 2020, ACTA TROP, V210, DOI 10.1016/j.actatropica.2020.105555; Borner J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3504-1; Borner J, 2016, MOL PHYLOGENET EVOL, V94, P221, DOI 10.1016/j.ympev.2015.09.003; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Clark NJ, 2017, MOL ECOL, V26, P3074, DOI 10.1111/mec.14101; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2173-x; Danilewsky B., 1885, BIOL ZBL, V5, P537; Deviche P, 2001, J WILDLIFE DIS, V37, P28, DOI 10.7589/0090-3558-37.1.28; Ezard T, 2009, SPLITS SPECIES LIMIT; Fermino BR, 2015, INT J PARASITOL-PAR, V4, P368, DOI 10.1016/j.ijppaw.2015.10.005; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Galen SC, 2020, MOL ECOL RESOUR, V20, P14, DOI 10.1111/1755-0998.13091; Galen SC, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1242-x; Galen SC, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171780; Hamer Gabriel L., 2013, International Journal for Parasitology Parasites and Wildlife, V2, P42, DOI 10.1016/j.ijppaw.2012.11.005; Hamilton PB, 2007, MOL PHYLOGENET EVOL, V44, P15, DOI 10.1016/j.ympev.2007.03.023; Hamilton PB, 2004, INT J PARASITOL, V34, P1393, DOI 10.1016/j.ijpara.2004.08.011; HOARE CECIL A., 1967, ADVAN PARASITOL, VVol. 5-5, P47; Igloi GL, 2019, PLANT SYST EVOL, V305, P563, DOI 10.1007/s00606-019-01586-2; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lom J., 1979, P269; Lopes RJ, 2017, TRENDS PARASITOL, V33, P750, DOI 10.1016/j.pt.2017.06.006; MOLYNEUX DH, 1973, ANN TROP MED PARASIT, V67, P219, DOI 10.1080/00034983.1973.11686880; MOLYNEUX DH, 1983, PARASITOLOGY, V87, P49, DOI 10.1017/S0031182000052409; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Noyes HA, 2002, PARASITOLOGY, V124, P185, DOI 10.1017/S0031182001001019; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Santos JC, 2018, MOL PHYLOGENET EVOL, V125, P40, DOI 10.1016/j.ympev.2018.03.015; Sehgal RNM, 2015, ZOOTAXA, V4034, P342, DOI 10.11646/zootaxa.4034.2.6; Sehgal RNM, 2001, MOL ECOL, V10, P2319, DOI 10.1046/j.1365-294X.2001.01339.x; Slapeta J, 2016, PARASITOLOGY, V143, P1012, DOI 10.1017/S0031182016000329; Soares L, 2016, PARASITOLOGY, V143, P1930, DOI 10.1017/S0031182016001384; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Telford Jr SR, 1995, PARASIT PROTOZ, P161; Valkiunas G, 2011, J PARASITOL, V97, P924, DOI 10.1645/GE-2796.1; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Votypka J, 2004, ACTA PROTOZOOL, V43, P225; Votypka J, 2004, PARASITOL RES, V92, P147, DOI 10.1007/s00436-003-1034-z; Votypka J, 2002, PARASITOLOGY, V125, P253, DOI 10.1017/S0031182002002093; Votypka J, 2012, INT J SYST EVOL MICR, V62, P745, DOI 10.1099/ijs.0.032110-0; Zhang C, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2129-y; Zidkova L, 2012, INFECT GENET EVOL, V12, P102, DOI 10.1016/j.meegid.2011.10.022	60	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240062	10.1371/journal.pone.0240062	http://dx.doi.org/10.1371/journal.pone.0240062			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031471	Green Published, gold			2022-12-26	WOS:000581809800091
J	Hung, HY; Tseng, YH; Chao, HS; Chiu, CH; Hsu, WH; Hsu, HS; Wu, YC; Chou, TY; Chen, CK; Lan, KL; Chen, YW; Wu, YH; Chen, YM				Hung, Hsiu-Ying; Tseng, Yen-Han; Chao, Heng-Sheng; Chiu, Chao-Hua; Hsu, Wen-Hu; Hsu, Han-Shui; Wu, Yu-Chung; Chou, Teh-Ying; Chen, Chun-Ku; Lan, Keng-Li; Chen, Yi-Wei; Wu, Yuan-Hung; Chen, Yuh-Min			Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer	PLOS ONE			English	Article							PHASE-III; CONCURRENT CHEMORADIOTHERAPY; CONSOLIDATION CHEMOTHERAPY; ADJUVANT THERAPY; GENDER; MANAGEMENT; DOCETAXEL; CISPLATIN; ONCOLOGY; TRIAL	Background The treatment for stage III non-small cell lung cancer (NSCLC) often involves multi-modality treatment. This retrospective study aimed to evaluate whether multidisciplinary team (MDT) discussion results in better patient survival. Materials and methods MDT discussion was optional before February 2016 and was actively encouraged by the MDT committee beginning February 2016. We reviewed the medical charts and computer records of patients with stage III NSCLC between January 2013 and December 2018. Results A total of 515 patients were included. The median survival of all the patients was 33.9 months (M). The median survival of patients who were treated after MDT discussion was 41.2 M and that of patients treated without MDT discussion was 25.7 M (p = 0.018). The median survival of patients treated before February 2016 was 25.7 M and that of patients treated after February 2016 was 33.9 M (p = 0.003). The median survival of patients with stage IIIA tumors and those with stage IIIB tumors was 39.4 M and 25.7 M, respectively (p = 0.141). Multivariate analysis showed that MDT or not (p<0.001), T staging (p = 0.009), performance status (p<0.001), and surgery (p = 0.016) to be significant prognostic factors. Conclusion The results of the study show that MDT discussion results in survival benefit in patients with stage III NSCLC. The MDT discussion, performance status, and if surgery was performed were independent prognostic factors for patients with stage III NSCLC.	[Hung, Hsiu-Ying] Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan; [Tseng, Yen-Han; Chao, Heng-Sheng; Chiu, Chao-Hua; Chen, Yuh-Min] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Tseng, Yen-Han; Chao, Heng-Sheng; Chiu, Chao-Hua; Hsu, Wen-Hu; Hsu, Han-Shui; Wu, Yu-Chung; Chou, Teh-Ying; Chen, Chun-Ku; Lan, Keng-Li; Chen, Yi-Wei; Wu, Yuan-Hung; Chen, Yuh-Min] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Hsu, Wen-Hu; Hsu, Han-Shui; Wu, Yu-Chung] Taipei Vet Gen Hosp, Div Thorac Surg, Dept Surg, Taipei, Taiwan; [Chou, Teh-Ying] Taipei Vet Gen Hosp, Div Mol Pathol, Dept Pathol & Lab Med, Taipei, Taiwan; [Chen, Chun-Ku] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Lan, Keng-Li; Chen, Yi-Wei; Wu, Yuan-Hung] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan; [Chen, Yuh-Min] Taipei Med Univ, Taipei Canc Ctr, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Medical University	Chen, YM (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.; Chen, YM (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chen, YM (corresponding author), Taipei Med Univ, Taipei Canc Ctr, Taipei, Taiwan.	ymchen@vghtpe.gov.tw	Chen, Yi/HIR-2608-2022					Ahn JS, 2015, J CLIN ONCOL, V33, P2660, DOI 10.1200/JCO.2014.60.0130; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; Boxer MM, 2011, CANCER-AM CANCER SOC, V117, P5112, DOI 10.1002/cncr.26149; Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0; Bugge A, 2017, ACTA ONCOL, V56, P448, DOI 10.1080/0284186X.2016.1253862; Bydder S, 2009, INTERN MED J, V39, P838, DOI 10.1111/j.1445-5994.2009.02019.x; Curran WJ, 2011, J NATL CANCER I, V103, P1452, DOI 10.1093/jnci/djr325; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; FINKELSTEIN DM, 1986, J CLIN ONCOL, V4, P702, DOI 10.1200/JCO.1986.4.5.702; Forrest LM, 2005, BRIT J CANCER, V93, P977, DOI 10.1038/sj.bjc.6602825; Furuse K, 1999, J CLIN ONCOL, V17, P2692, DOI 10.1200/JCO.1999.17.9.2692; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Gebbia V, 2005, ANN ONCOL, V16, P123, DOI 10.1093/annonc/mdi921; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; GROSS GE, 1987, CA-CANCER J CLIN, V37, P88, DOI 10.3322/canjclin.37.2.88; Gulati S, 2014, TRANSL LUNG CANCER R, V3, P131, DOI 10.3978/j.issn.2218-6751.2014.06.12; Hanna N, 2008, J CLIN ONCOL, V26, P5755, DOI 10.1200/JCO.2008.17.7840; Keller SM, 2002, LUNG CANCER, V37, P303, DOI 10.1016/S0169-5002(02)00103-4; Kelly K, 2008, J CLIN ONCOL, V26, P2450, DOI 10.1200/JCO.2007.14.4824; Lewis J, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00005; Mancia G., 2014, BLOOD PRES, V23, P3, DOI 10.3109/08037051.2014.868629; Ozkaya S, 2012, EXP THER MED, V4, P1035, DOI 10.3892/etm.2012.714; Parsons A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5569; Pinto JA, 2018, ESMO OPEN, V3, DOI 10.1136/esmoopen-2018-000344; Powell HA, 2014, EUR RESPIR J, V43, P1776, DOI 10.1183/09031936.00150813; Ramnath N, 2013, CHEST, V143, pE314, DOI 10.1378/chest.12-2360; Ryan KJ, 2019, MED ONCOL, V36, DOI 10.1007/s12032-019-1249-1; Sakurai H, 2010, J THORAC ONCOL, V5, P1594, DOI 10.1097/JTO.0b013e3181f1923b; Salloum RG, 2012, LUNG CANCER, V77, P545, DOI 10.1016/j.lungcan.2012.04.019; Santana-Davila R, 2016, J ONCOL PRACT, V12, P601, DOI 10.1200/JOP.2016.013052; Sobus SL, 2014, CANCER-AM CANCER SOC, V120, P3617, DOI 10.1002/cncr.28904; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Tsujino K, 2013, J THORAC ONCOL, V8, P1181, DOI 10.1097/JTO.0b013e3182988348; Urvay Semiha Elmaci, 2016, Asian Pac J Cancer Prev, V17, P4693; Visbal AL, 2004, ANN THORAC SURG, V78, P209, DOI 10.1016/j.athoracsur.2003.11.021; Warren GW, 2015, TRANSL LUNG CANCER R, V4, P339, DOI 10.3978/j.issn.2218-6751.2015.07.15; Warren GW, 2014, LANCET ONCOL, V15, pE568, DOI 10.1016/S1470-2045(14)70266-9; Warren Graham W, 2013, J Carcinog, V12, P1, DOI 10.4103/1477-3163.106680; Watanabe S, 2017, JPN J CLIN ONCOL, V47, P1112, DOI 10.1093/jjco/hyx147; Zhong WZ, 2018, LANCET ONCOL, V19, P139, DOI 10.1016/S1470-2045(17)30729-5	43	13	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0236503	10.1371/journal.pone.0236503	http://dx.doi.org/10.1371/journal.pone.0236503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031375	gold, Green Published			2022-12-26	WOS:000581809800017
J	Lee, KY; Lee, HJ; Choi, HJ; Han, ST; Lee, KH; Park, KJ; Park, JS; Jung, KM; Kim, YM; Han, HJ; Han, JY				Lee, Kyung Youn; Lee, Hong Jo; Choi, Hee Jung; Han, Soo Taek; Lee, Kyu Hyuk; Park, Kyung Je; Park, Jin Se; Jung, Kyung Min; Kim, Young Min; Han, Ho Jae; Han, Jae Yong			Highly elevated base excision repair pathway in primordial germ cells causes low base editing activity in chickens	FASEB JOURNAL			English	Article						base editing; base excision repair; chicken; editing activity; primordial germ cell; uracil N-glycosylase	RECOMBINATION; TRANSFERRIN; PERFORMANCE; KNOCKOUT; RECEPTOR; PROTEIN; TRAITS; DNA	Base editing technology enables the generation of precisely genome-modified animal models. In this study, we applied base editing to chicken, an important livestock animal in the fields of agriculture, nutrition, and research through primordial germ cell (PGC)-mediated germline transmission. Using this approach, we successfully produced two genome-modified chicken lines harboring mutations in the genes encoding ovotransferrin (TF) and myostatin (MSTN); however, only 55.5% and 35.7% of genome-modified chickens had the desired base substitutions inTFandMSTN, respectively. To explain the low base-editing activity, we performed molecular analysis to compare DNA repair pathways between PGCs and the chicken fibroblast cell line DF-1. The results revealed that base excision repair (BER)-related genes were significantly elevated in PGCs relative to DF-1 cells. Subsequent functional studies confirmed that the editing activity could be regulated by modulating the expression of uracil N-glycosylase (UNG), an upstream gene of the BER pathway. Collectively, our findings indicate that the distinct DNA repair property of chicken PGCs causes low editing activity during genome modification, however, modulation of BER functions could promote the production of genome-modified organisms with the desired genotypes.	[Lee, Kyung Youn; Lee, Hong Jo; Choi, Hee Jung; Han, Soo Taek; Lee, Kyu Hyuk; Park, Kyung Je; Park, Jin Se; Jung, Kyung Min; Kim, Young Min; Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Kyung Youn; Lee, Hong Jo; Choi, Hee Jung; Han, Soo Taek; Lee, Kyu Hyuk; Park, Kyung Je; Park, Jin Se; Jung, Kyung Min; Kim, Young Min; Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Seoul, South Korea; [Han, Ho Jae] Seoul Natl Univ, Dept Vet Physiol, Coll Vet Med, Res Inst Vet Sci,PLUS Program Creat Vet Sci Res B, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Han, JY (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea.	jaehan@snu.ac.kr		Jung, Kyung Min/0000-0002-5791-2655	National Research Foundation of Korea (NRF) [NRF-2015R1A3A2033826]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2015R1A3A2033826	Aird EJ, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0054-2; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Giannesini B, 2013, AM J PHYSIOL-ENDOC M, V305, pE33, DOI 10.1152/ajpendo.00651.2012; Giansanti F, 2012, BBA-GEN SUBJECTS, V1820, P218, DOI 10.1016/j.bbagen.2011.08.004; Han JY, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0234-4; II I, 1982, DEV BIOL, V94, P366, DOI 10.1016/0012-1606(82)90354-2; Intano GW, 2001, NUCLEIC ACIDS RES, V29, P1366, DOI 10.1093/nar/29.6.1366; Jin S, 2019, SCIENCE, V364, P292, DOI 10.1126/science.aaw7166; Kim GD, 2020, FASEB J, V34, P5688, DOI 10.1096/fj.201903035R; Kim Yun-Jeong, 2012, Curr Mol Pharmacol, V5, P3; Komor AC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4774; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Lee HJ, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-019-0333-x; Lee HJ, 2019, FASEB J, V33, P8519, DOI 10.1096/fj.201802671R; Lee HJ, 2016, FASEB J, V30, P555, DOI 10.1096/fj.15-274712; Lee J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041504; Lei M, 2007, POULTRY SCI, V86, P835, DOI 10.1093/ps/86.5.835; Lillico SG, 2005, DRUG DISCOV TODAY, V10, P191, DOI 10.1016/S1359-6446(04)03317-3; Liu RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061172; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Liu ZQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05232-2; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; Molla KA, 2019, TRENDS BIOTECHNOL, V37, P1121, DOI 10.1016/j.tibtech.2019.03.008; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; OH TH, 1986, DEV BRAIN RES, V30, P207, DOI 10.1016/0165-3806(86)90111-2; Oishi I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28438-2; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Olsen AK, 2001, NUCLEIC ACIDS RES, V29, P1781, DOI 10.1093/nar/29.8.1781; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Qin L, 2020, PLANT BIOTECHNOL J, V18, P45, DOI 10.1111/pbi.13168; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Rengaraj D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-757; Sasaguri H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05262-w; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Taylor L, 2017, DEVELOPMENT, V144, P928, DOI 10.1242/dev.145367; Testa E, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214411; Wang LJ, 2017, CELL RES, V27, P1289, DOI 10.1038/cr.2017.111; Xu K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072584; Ye XH, 2007, GENET SEL EVOL, V39, P73, DOI 10.1051/gse:2006029; Zhang H, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4252-y; Zhang YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00175-6; Zheng K, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0035-5; Zuo EW, 2019, SCIENCE, V364, P289, DOI 10.1126/science.aav9973	47	7	7	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15907	15921		10.1096/fj.202001065RRR	http://dx.doi.org/10.1096/fj.202001065RRR		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33031594	Bronze			2022-12-26	WOS:000576979800001
J	Viana, PVD; Paiva, NS; Villela, DAM; Bastos, LS; Bierrenbach, ALD; Basta, PC				Viana, Paulo Victor de Sousa; Paiva, Natalia Santana; Villela, Daniel Antunes Maciel; Bastos, Leonardo Soares; de Souza Bierrenbach, Ana Luiza; Basta, Paulo Cesar			Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis	PLOS ONE			English	Article							INFECTED PERSONS; MORTALITY; HIV; SURVIVAL	Objectives This study aimed to analyze the factors associated with likely TB deaths, likely TB-related deaths and deaths from other causes. Understanding the factors associated with mortality could help the strategy to End TB, especially the goal of reducing TB deaths by 95% between 2015 and 2035. Methods A retrospective, population-based cohort study of the causes of death was performed using a competing risk model in patients receiving treatment for TB. Patients had started TB treatment in Brazil 2008-2013 with any death certificates dated in the same period. We used three categories of deaths, according to ICD-10 codes: i) probable TB deaths; ii) TB-related deaths; iii) deaths from other causes. Results In this cohort, 39,997 individuals (14.1%) died, out of a total of 283,508 individuals. Of these, 8,936 were probable TB deaths (22.4%) and 3,365 TB-related deaths (8.4%), illustrating high mortality rates. 27,696 deaths (69.2%) were from other causes. From our analysis, factors strongly associated with probable TB deaths were male gender (sHR = 1.33, 95% CI: 1.26-1.40), age over 60 years (sHR = 9.29, 95% CI: 8.15-10.60), illiterate schooling (sHR = 2.33, 95% CI: 2.09-2.59), black (sHR = 1.33, 95% CI: 1.26-1.40) and brown (sHR = 13, 95% CI: 1.07-1.19) color/race, from the Southern region (sHR = 1.19, 95% CI: 1.10-1.28), clinical mixed forms (sHR = 1.91, 95% CI: 1.73-2.11) and alcoholism (sHR = 1.90, 95% CI: 1.81-2.00). Also, HIV positive serology was strongly associated with probable TB deaths (sHR = 62.78; 95% CI: 55.01-71.63). Conclusions In conclusion, specific strategies for active surveillance and early case detection can reduce mortality among patients with tuberculosis, leading to more timely detection and treatment.	[Viana, Paulo Victor de Sousa] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Ctr Referencia Prof Helio Fraga, Rio De Janeiro, RJ, Brazil; [Paiva, Natalia Santana] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Villela, Daniel Antunes Maciel; Bastos, Leonardo Soares] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil; [de Souza Bierrenbach, Ana Luiza] Hosp Sirio Libanes, Inst Ensino & Pesquisa, Sao Paulo, SP, Brazil; [Basta, Paulo Cesar] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Hospital Sirio Libanes; Fundacao Oswaldo Cruz	Viana, PVD (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Ctr Referencia Prof Helio Fraga, Rio De Janeiro, RJ, Brazil.	paulovictorsviana@gmail.com	Basta, Paulo Cesar/AAP-5358-2021; Bierrenbach, Ana/F-3185-2014	Basta, Paulo/0000-0003-0804-0413; Bierrenbach, Ana/0000-0002-6837-0636	Coordination for the Improvement of Higher Education Personnel (CAPES); Graduate Program in Epidemiology in Public Health of the National School of Public Health (ENSP)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Graduate Program in Epidemiology in Public Health of the National School of Public Health (ENSP)	The Brazilian Ministry of Health and the National Tuberculosis Control Program (PNCT) for the availability of data, especially Maria de Fatima Marino de Souza, Denise Arakaki-Sanchez, Patricia Barthlomay and Danielle Pelissari. Noteworthy is the important support of Antony Stevens in one of the stages of database linkage. We also thank MD Joseph Kempton of the University Hospitals Plymouth NHS Trust for their critical review of the manuscript. We are grateful for support from the Coordination for the Improvement of Higher Education Personnel (CAPES). The support and assistance offered by the Graduate Program in Epidemiology in Public Health of the National School of Public Health (ENSP) under the coordination of Leticia Oliveira Cardoso and the administrative support provided by Marcella Fagundes and Joyce Torres. Thank you all very much!	Adamu AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183270; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Albuquerque Maria de Fátima Pessoa Militão de, 2009, Rev. bras. epidemiol., V12, P513, DOI 10.1590/S1415-790X2009000400001; [Anonymous], 2019, **NON-TRADITIONAL**, V28, P1, DOI DOI DOI:10.1017/S0954579419001159; [Anonymous], 2019, CIRCULATION, V2019; Basta PC, 2013, REV SAUDE PUBL, V47, DOI 10.1590/S0034-8910.2013047004628; Belo EN, 2013, REV PANAM SALUD PUBL, V34, P321; Bernabe-Ortiz A, 2008, REV CHIL INFECTOL, V25, P104, DOI /S0716-10182008000300002; Bierrenbach AL, 2010, INT J TUBERC LUNG D, V14, P593; Brasier AR, 2009, CELLULAR SIGNALING AND INNATE IMMUNE RESPONSES TO RNA VIRUS INFECTIONS, P3; BRASIL, 2018, B EPIDEMIOL BRASILIA, P2358; Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; de Lima EEC, 2014, CAD SAUDE PUBLICA, V30, P1721, DOI 10.1590/0102-311X00131113; Chang CC, 2013, IMMUNOL REV, V254, P114, DOI 10.1111/imr.12063; Chung-Delgado K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119332; Dale K, 2016, INT J TUBERC LUNG D, V20, P515, DOI 10.5588/ijtld.15.0659; de Oliveira Gisele Pinto, 2012, Rev Bras Epidemiol, V15, P468, DOI 10.1590/S1415-790X2012000300003; Viana PVD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154658; Duarte EC, 2009, J EPIDEMIOL COMMUN H, V63, P233, DOI 10.1136/jech.2008.078972; Façanha Mônica Cardoso, 2005, Rev. bras. epidemiol., V8, P25; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Garcia LP, 2015, EPIDEMIOL SERV SAUDE, V24, P227, DOI 10.5123/S1679-49742015000200005; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Heunis JC, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3972-2; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Hone T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002306; Horne DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-258; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Laguardia J, 2004, EPIDEMIOL SERV SAUDE, V13, P135; Lo H-Y, 2015, ASIA PAC J PUBLIC HL, V27, DOI 10.1177/1010539511429591; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Long NH, 1999, SOC SCI MED, V49, P815, DOI 10.1016/S0277-9536(99)00171-9; Low S, 2009, INT J TUBERC LUNG D, V13, P328; Melo TEMD, 2012, CAD SAUDE PUBLICA, V28, P267, DOI 10.1590/S0102-311X2012000200006; Maruza M, 2012, INT J TUBERC LUNG D, V16, P618, DOI 10.5588/ijtld.11.0110; Mathew TA, 2006, INT J TUBERC LUNG D, V10, P857; Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de Vigilancia Epidemiologica, 2009, GUIA VIGILANCIA EPID, V7th; Monk EP, 2016, SOC PROBL, V63, P413, DOI 10.1093/socpro/spw014; Nahid P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-1; Oliveira Gisele Pinto de, 2016, Rev. Saúde Pública, V50, P49, DOI 10.1590/S1518-8787.2016050006327; Oliveira Gisele Pinto de, 2012, Rev. bras. epidemiol., V15, P468; Onifade DA, 2010, BMC PUBLIC HLTH, V10, DOI [10.1186/1471-2458-10-10, DOI 10.1186/1471-2458-10-1020064237]; Pacheco AG, 2008, AM J EPIDEMIOL, V168, P1326, DOI 10.1093/aje/kwn249; Rocha M, 2017, INT J POPUL DATA SCI, DOI [10.23889/ijpds.v1i1.97, DOI 10.23889/IJPDS.V1I1.97]; Sanni Ali M, 2019, FRONT PHARMACOL, DOI [10.3389/fphar.2019.00984, DOI 10.3389/FPHAR.2019.0098431607900, DOI 10.3389/FPHAR.2019.00984]; Saraceni V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207859; Schnell R, 2019, P ESA WORKSH AER EMC, P1, DOI DOI 10.23919/AEROEMC.2019.8788929; Schnell R, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-41; SELIG L, 2010, REV SAUDE PUBL, V44, P1072; Shuldiner J, 2016, INT J TUBERC LUNG D, V20, P43, DOI 10.5588/ijtld.14.0427; Shuldiner J, 2014, INT J TUBERC LUNG D, V18, P818, DOI 10.5588/ijtld.13.0591; StataCorp, 2015, STATA STAT SOFTW REL; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Travassos Claudia, 2004, Cad. Saúde Pública, V20, P660, DOI 10.1590/S0102-311X2004000300003; Ventura M, 2018, CAD SAUDE PUBLICA, V34, DOI 10.1590/0102-311X00106818; Volkmann Tyson, 2016, J Tuberc Res, V4, P18; **DATA OBJECT**	57	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240090	10.1371/journal.pone.0240090	http://dx.doi.org/10.1371/journal.pone.0240090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TB	33031403	Green Published, gold			2022-12-26	WOS:000581809800037
J	Peverill, RE; Chou, B; Donelan, L; Thai, WE				Peverill, Roger E.; Chou, Bon; Donelan, Lesley; Thai, Wai-ee			Left ventricular long-axis function in hypertrophic cardiomyopathy-Relationships between e', early diastolic excursion and duration, and systolic excursion	PLOS ONE			English	Article							DOPPLER-ECHOCARDIOGRAPHY; HEART-FAILURE; FILLING PRESSURES; RELAXATION; ABNORMALITIES; DYSFUNCTION; VELOCITY; DISEASE; IMPACT; TOOL	Background The peak velocity of early diastolic mitral annular motion (e') is believed to provide sensitive detection of left ventricular (LV) diastolic dysfunction in hypertrophic cardiomyopathy (HCM), but other aspects of LV long-axis function in HCM have received less attention. Systolic mitral annular excursion (SExc) is also reduced in HCM and must be an intrinsic limitation to the extent of the subsequent motion during diastole. However, the effects of HCM on excursion during early diastole (EDExc) and atrial contraction (AExc), the duration of early diastolic motion (EDDur), and the relationships of EDExc with SExc, and of e'with EDExc and EDDur, are all unknown. Methods The study group was 22 subjects with HCM and there were 22 age and sex matched control subjects. SExc, EDExc, e', AExc and EDDur were measured from pulsed wave tissue Doppler signals acquired from the septal and lateral walls. In the combined group of HCM and control subjects, multivariate analyses were performed to identify independent predictors of EDExc and e'for both LV walls. Results SExc, EDExc and e'were all lower, and EDDur was longer in the HCM group compared to the control group for both LV walls (p<0.05 for all). In contrast, AExc was lower for the septal wall in the HCM group (p<0.05), but not different between the groups for the lateral wall. In regression analyses of the combined group, EDExc was positively correlated with SExc, and SExc explained 57-86% of the variances in septal and lateral EDExc, e'was positively correlated with EDExc, and EDExc explained 58-68% of the variances of e', whereas the combination of EDExc with EDDur explained 87-92% of the variances in e'. A diagnosis of HCM was not an independent predictor of EDExc when in combination with SExc, but was a minor contributor to the prediction of e'in combination with EDExc and EDDur. Conclusion In HCM, the decrease in LV longitudinal contraction is the major mechanism accounting for a lower EDExc, the lower e'is accounted for by contributions from the lower EDExc and prolongation of early diastolic motion, and there is no atrial compensation for the reduction of long-axis contraction.	[Peverill, Roger E.; Chou, Bon; Donelan, Lesley; Thai, Wai-ee] Monash Univ, Monash Cardiovasc Res Ctr, MonashHeart, Clayton, Vic, Australia; [Peverill, Roger E.; Chou, Bon; Donelan, Lesley; Thai, Wai-ee] Monash Univ, Dept Med, Sch Clin Sci, Clayton, Vic, Australia; [Peverill, Roger E.; Chou, Bon; Donelan, Lesley; Thai, Wai-ee] Monash Hlth, Clayton, Vic, Australia	Monash University; Monash University	Peverill, RE (corresponding author), Monash Univ, Monash Cardiovasc Res Ctr, MonashHeart, Clayton, Vic, Australia.	roger.peverill@monash.edu		Peverill, Roger/0000-0002-3319-5356				Cardim Nuno, 2002, Rev Port Cardiol, V21, P271; Cardim Nuno, 2002, Rev Port Cardiol, V21, P953; Carrick-Ranson G, 2012, AM J PHYSIOL-HEART C, V303, P315, DOI 10.1152/ajpheart.00142.2012; Dalen H, 2010, CIRC-CARDIOVASC IMAG, V3, P614, DOI 10.1161/CIRCIMAGING.109.926022; Doesch C, 2015, ARCH CARDIOVASC DIS, V108, P356, DOI 10.1016/j.acvd.2015.01.010; Duncan AM, 2001, HEART, V86, P397, DOI 10.1136/heart.86.4.397; Geske JB, 2007, CIRCULATION, V116, P2702, DOI 10.1161/CIRCULATIONAHA.107.698985; Gibson DG, 2003, HEART, V89, P231, DOI 10.1136/heart.89.2.231; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; Jarnert C, 2000, EUR J HEART FAIL, V2, P151, DOI 10.1016/S1388-9842(00)00075-1; Kalra A, 2016, AM J CARDIOL, V117, P1808, DOI 10.1016/j.amjcard.2016.03.018; McMahon CJ, 2004, CIRCULATION, V109, P1756, DOI 10.1161/01.CIR.0000124723.16433.31; Mogelvang R, 2009, CIRCULATION, V119, P2679, DOI 10.1161/CIRCULATIONAHA.108.793471; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2003, CIRCULATION, V108, P395, DOI 10.1161/01.CIR.0000084500.72232.8D; Nagueh SF, 2001, CIRCULATION, V104, P128, DOI 10.1161/01.CIR.104.2.128; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nikitin NP, 2005, AGE AGEING, V34, P343, DOI 10.1093/ageing/afi043; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Oki T, 1997, AM J CARDIOL, V79, P921, DOI 10.1016/S0002-9149(97)00015-5; Oki T, 2000, AM HEART J, V139, P497, DOI 10.1016/S0002-8703(00)90094-2; Ommen SR, 2000, CIRCULATION, V102, P1788; Ommen SR, 2004, CURR PROB CARDIOLOGY, V29, P239, DOI 10.1016/j.cpcardiol.2004.01.001; Opdahl A, 2009, CIRCULATION, V119, P2578, DOI 10.1161/CIRCULATIONAHA.108.791681; Peverill RE, 2004, J AM SOC ECHOCARDIOG, V17, P1146, DOI 10.1016/j.echo.2004.06.007; Peverill RE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210277; Peverill RE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173383; Peverill RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158302; Popovic ZB, 2011, EUR J ECHOCARDIOGR, V12, P818, DOI 10.1093/ejechocard/jer146; SANDERSON JE, 1978, BRIT HEART J, V40, P596; Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0; SPIRITO P, 1985, CIRCULATION, V72, P310, DOI 10.1161/01.CIR.72.2.310; STJOHNSUTTON MG, 1978, CIRCULATION, V57, P512, DOI 10.1161/01.CIR.57.3.512; Wenzelburger FWG, 2011, EUR J HEART FAIL, V13, P953, DOI 10.1093/eurjhf/hfr081; WIGLE ED, 1995, CIRCULATION, V92, P1680, DOI 10.1161/01.CIR.92.7.1680; Yip GW, 2002, CLIN SCI, V102, P515, DOI 10.1042/CS20010196	36	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240296	10.1371/journal.pone.0240296	http://dx.doi.org/10.1371/journal.pone.0240296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027274	Green Published, gold			2022-12-26	WOS:000581808000025
J	Weiss, J; Puterman, E; Prather, AA; Ware, EB; Rehkopf, DH				Weiss, Jordan; Puterman, Eli; Prather, Aric A.; Ware, Erin B.; Rehkopf, David H.			A data-driven prospective study of dementia among older adults in the United States	PLOS ONE			English	Article							COGNITIVE RESERVE; COMPETING RISK; HEALTH; DEATH; DEMOGRAPHICS; RETIREMENT; HAZARDS; DISEASE; MODEL; TIME	Background Studies examining risk factors for dementia have typically focused on testing a priori hypotheses within specific risk factor domains, leaving unanswered the question of what risk factors across broad and diverse research fields may be most important to predicting dementia. We examined the relative importance of 65 sociodemographic, early-life, economic, health and behavioral, social, and genetic risk factors across the life course in predicting incident dementia and how these rankings may vary across racial/ethnic (non-Hispanic white and black) and gender (men and women) groups. Methods and findings We conducted a prospective analysis of dementia and its association with 65 risk factors in a sample of 7,908 adults aged 51 years and older from the nationally representative US-based Health and Retirement Study. We used traditional survival analysis methods (Fine and Gray models) and a data-driven approach (random survival forests for competing risks) which allowed us to account for the semi-competing risk of death with up to 14 years of follow-up. Overall, the top five predictors across all groups were lower education, loneliness, lower wealth and income, and lower self-reported health. However, we observed variation in the leading predictors of dementia across racial/ethnic and gender groups such that at most four risk factors were consistently observed in the top ten predictors across the four demographic strata (non-Hispanic white men, non-Hispanic white women, non-Hispanic black men, non-Hispanic black women). Conclusions We identified leading risk factors across racial/ethnic and gender groups that predict incident dementia over a 14-year period among a nationally representative sample of US aged 51 years and older. Our ranked lists may be useful for guiding future observational and quasi-experimental research that investigates understudied domains of risk and emphasizes life course economic and health conditions as well as disparities therein.	[Weiss, Jordan] Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA; [Weiss, Jordan] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Puterman, Eli] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada; [Prather, Aric A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Ware, Erin B.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA; [Rehkopf, David H.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Weiss, Jordan] Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA	University of Pennsylvania; University of Pennsylvania; University of British Columbia; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Stanford University; University of California System; University of California Berkeley	Weiss, J (corresponding author), Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA.; Weiss, J (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA.; Rehkopf, DH (corresponding author), Stanford Univ, Sch Med, Palo Alto, CA 94304 USA.; Weiss, J (corresponding author), Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA.	jordanmnw@gmail.com; drehkopf@stanford.edu	Puterman, Eli/AAA-5237-2022	Puterman, Eli/0000-0002-5898-2348; Weiss, Jordan/0000-0002-0392-3535; Rehkopf, David/0000-0002-7597-6513; Ware, Erin/0000-0003-4731-8158				Anjum I, 2018, CUREUS, V10, DOI 10.7759/cureus.2660; Aschwanden D, 2020, J ALZHEIMERS DIS, V75, P717, DOI 10.3233/JAD-190967; Babulal GM, 2019, ALZHEIMERS DEMENT, V15, P292, DOI 10.1016/j.jalz.2018.09.009; Berry SD, 2010, J AM GERIATR SOC, V58, P783, DOI 10.1111/j.1532-5415.2010.02767.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Callahan BL, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0152-z; Casanova R, 2018, J GERONTOL B-PSYCHOL, DOI [10.1093/geronb/gby054, DOI 10.1093/GER0NB/GBY05429718387]; Chang CCH, 2012, ALZ DIS ASSOC DIS, V26, P300, DOI 10.1097/WAD.0b013e3182420b6e; Chen Cynthia, 2018, Alzheimers Dement (N Y), V4, P510, DOI 10.1016/j.trci.2018.08.009; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P162, DOI 10.1093/geronb/gbr048; Domingue BW, 2017, INT J EPIDEMIOL, V46, P1285, DOI 10.1093/ije/dyx041; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Gatz M, 2014, BEHAV GENETICS COGNI, P201; Gianattasio KZ, 2020, EPIDEMIOLOGY, V31, P126, DOI 10.1097/EDE.0000000000001101; Gianattasio KZ, 2019, EPIDEMIOLOGY, V30, P291, DOI [10.1097/EDE.0000000000000945, 10.1097/ede.0000000000000945]; Ishwaran H, 2019, FAST UNIFIED RANDOM; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Kaup AR, 2015, JAMA NEUROL, V72, P340, DOI 10.1001/jamaneurol.2014.3978; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Latouche A, 2013, J CLIN EPIDEMIOL, V66, P648, DOI 10.1016/j.jclinepi.2012.09.017; Leffondre K, 2013, INT J EPIDEMIOL, V42, P1177, DOI 10.1093/ije/dyt126; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lourida I, 2019, JAMA-J AM MED ASSOC, V322, P430, DOI 10.1001/jama.2019.9879; Matthews KA, 2018, ALZHEIMERS DEMENT, DOI [10.1016/j.jalz.2018.06.3063, DOI 10.1016/J.JALZ.2018.06.306330243772]; Mazure CM, 2016, LANCET NEUROL, V15, P451, DOI 10.1016/S1474-4422(16)00067-3; Mielke Michelle M, 2018, Psychiatr Times, V35, P14; Ofstedal M, 2005, DOCUMENTATION COGNIT, DOI DOI 10.1371/journal.pone.0144722; Pankratz VS, 2015, NEUROLOGY, V84, P1433, DOI 10.1212/WNL.0000000000001437; R Core Team, 2021, R LANGUAGE ENV STAT; Sapkota S, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00296; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Seligman B, 2018, SSM-POPUL HLTH, V4, P95, DOI 10.1016/j.ssmph.2017.11.008; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Suemoto CK, 2015, INT J OBESITY, V39, P1383, DOI 10.1038/ijo.2015.83; Ware E., 2018, HRS POLYGENIC SCORES; Wu YT, 2017, NAT REV NEUROL, V13, P327, DOI 10.1038/nrneurol.2017.63; Xu H, 2019, JAMA NEUROL, V76, P1184, DOI 10.1001/jamaneurol.2019.2455	42	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239994	10.1371/journal.pone.0239994	http://dx.doi.org/10.1371/journal.pone.0239994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027275	Green Submitted, gold, Green Published			2022-12-26	WOS:000581808000059
J	Fournier, AL; Parienti, JJ; Champenois, K; Feret, P; Papot, E; Yazdanpanah, Y; Verdon, R				Fournier, Anna Lucie; Parienti, Jean-Jacques; Champenois, Karen; Feret, Philippe; Papot, Emmanuelle; Yazdanpanah, Yazdan; Verdon, Renaud			Incidence and risk factors for medical care interruption in people living with HIV in a French provincial city	PLOS ONE			English	Article							FOLLOW-UP; INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; DEPRIVATION INDEX; COHORT; PREDICTORS; MORTALITY; OUTCOMES; YOUTH	Objectives The aim of our study was to identify HIV-positive patients at risk of medical care interruption (MCI) in a provincial city of a high-income country. Methods We estimated the incidence rate of MCI in 989 individuals followed in an HIV clinic in Caen University Hospital, Normandy, France, between January 2010 and May 2016. We enrolled patients over 18 years old who were seen at the clinic at least twice after HIV diagnosis. Patients were considered to be in MCI if they did not attend care in or outside the clinic for at least 18 months, regardless of whether or not they came back after interruption. We investigated sociodemographic, clinical and immunovirological characteristics at HIV diagnosis and during follow-up through a Cox model analysis. Results The incidence rate of MCI was estimated to be 3.0 per 100 persons-years (95% confidence interval [CI] = 2.6-3.5). The independent risk factors for MCI were a linkage to care >6 months after HIV diagnosis (hazard ratio [HR] = 1.14; 95% CI = 1.08-1.21), a hepatitis C coinfection (HR = 1.76; 95% CI = 1.07-2.88), being born in Sub-Saharan Africa (HR = 2.18; 95% CI = 1.42-3.34 vs. in France) and not having a mailing address reported in the file (HR = 1.73; 95% CI = 1.07-2.80). During follow-up, the risk of MCI decreased when the patient was older (HR = 0.28; 95% CI = 0.15-0.51 when >45 vs. <= 30 years old) and increased when the patient was not on antiretroviral therapy (HR = 2.78; 95% CI = 1.66-4.63). Conclusions Our findings show that it is important to link HIV-positive individuals to care quickly after diagnosis and initiate antiretroviral therapy as soon as possible to retain them in care.	[Fournier, Anna Lucie; Parienti, Jean-Jacques; Verdon, Renaud] UNICAEN, Normandie Univ Hosp, GRAM 2 0, EA2656, Caen, France; [Fournier, Anna Lucie; Parienti, Jean-Jacques; Feret, Philippe; Verdon, Renaud] UNICAEN, Normandie Univ Hosp, Dept Infect Dis, Caen, France; [Champenois, Karen; Papot, Emmanuelle; Yazdanpanah, Yazdan] Paris Diderot Univ, IAME, UMR1137, INSERM,Sorbonne Paris Cite, Paris, France; [Yazdanpanah, Yazdan] Hop Bichat Claude Bernard, AP HP, Dept Infect Dis, Paris, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Fournier, AL (corresponding author), UNICAEN, Normandie Univ Hosp, GRAM 2 0, EA2656, Caen, France.; Fournier, AL (corresponding author), UNICAEN, Normandie Univ Hosp, Dept Infect Dis, Caen, France.	annafournier87@gmail.com	Parienti, Jean-Jacques/AAD-1701-2021; Fournier, Anna/AAJ-5905-2021	Parienti, Jean-Jacques/0000-0002-4774-5590; Anna, Fournier/0000-0001-5865-9033				Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Cuzin L, 2016, EPIDEMIOL INFECT, V144, P2363, DOI 10.1017/S0950268816000625; Fournier AL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213526; Giordano TR, 2009, HIV CLIN TRIALS, V10, P299, DOI 10.1310/hct1005-299; Goswami ND, 2016, JAIDS-J ACQ IMM DEF, V72, P65, DOI 10.1097/QAI.0000000000000914; Guillaume E, 2016, J EPIDEMIOL COMMUN H, V70, P493, DOI 10.1136/jech-2015-205729; Hernando V, 2015, JAIDS-J ACQ IMM DEF, V70, P204, DOI 10.1097/QAI.0000000000000717; Hoen B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19034; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Koenig SP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002357; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; Lebouche B, 2006, HIV MED, V7, P140, DOI 10.1111/j.1468-1293.2006.00357.x; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; McNairy ML, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002420; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Mocroft A, 2008, HIV MED, V9, P261, DOI 10.1111/j.1468-1293.2008.00557.x; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Nacher M, 2010, AIDS CARE, V22, P1086, DOI 10.1080/09540121003599232; Ndiaye B, 2009, AIDS, V23, P1786, DOI 10.1097/QAD.0b013e32832e3469; Ndiaye B, 2009, ANTIVIR THER, V14, P567; Pilcher CD, 2017, JAIDS-J ACQ IMM DEF, V74, P44, DOI 10.1097/QAI.0000000000001134; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Rice BD, 2011, SEX TRANSM DIS, V38, P685, DOI 10.1097/OLQ.0b013e318214b92e; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Rosen S, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002015, 10.1371/journal.pmed.1002106]; Setse RW, 2011, PEDIATR INFECT DIS J, V30, P967, DOI 10.1097/INF.0b013e3182326779; Stricker SM, 2014, AIDS BEHAV, V18, pS465, DOI 10.1007/s10461-013-0598-6; UNAIDS, GLOB AIDS UPD 2016; UNAIDS, 2014, 90 90 90 AMB TREATM; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240417	10.1371/journal.pone.0240417	http://dx.doi.org/10.1371/journal.pone.0240417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057366	gold, Green Published			2022-12-26	WOS:000581814700043
J	Meng, QY; Zou, HT; Zhang, CF; Zhu, BG; Wang, NN; Yang, XH; Gai, ZJ; Han, YY				Meng, Qingying; Zou, Hongtao; Zhang, Chunfeng; Zhu, Baoguo; Wang, Nannan; Yang, Xiaohe; Gai, Zhijia; Han, Yanyu			Soil mixing with organic matter amendment improves Albic soil physicochemical properties and crop yield in Heilongjiang province, China	PLOS ONE			English	Article							PLANOSOL SOLUM; CARBON	Crop productivity in Albic soil is poor, owing to poor soil physicochemical properties. Mixing of Aw layers, representing Albic soil, with B layers, could improve the physicochemical properties of Albic soil, which is characterized by poor humus on the topsoil and high penetration resistance. The objective of the present study conducted in 2015-2016 in an Albic soil region in Heilongjiang province, China, was to explore the effects of different soil mixing strategies on the physicochemical properties of Albic soil and crop yield. There were four soil mixing treatments: conventional subsoiler (CS), three-stage subsoil mixing plough (TSMP), four-stage subsoil mixing plough (FSMP), and three-stage subsoil interval mixing plough (TSIMP). Our results demonstrated that the Aw layer bulk density of Albic soil under TSMP, FSMP, and TSIMP decreased significantly compared to that under CS. In addition, the total porosity of the soil under these treatments increased significantly in 2 years. Compared to the water holding capacity under the CS treatment, other treatments increased significantly in the Aw layer. Furthermore, soil penetration resistance of the Aw layer decreased following Aw and B layer mixing. All three soil mixing treatments also increased soil aggregate stability and cation exchange capacity but reduced soil organic carbon content in the Aw layer. Soil mixing increased soybean and maize seed yield. Overall, Aw and B layer mixing improved Albic soil structure and physiochemical properties and increased crop yield; thus, this mixing is a feasible approach for Albic soil improvement, with optimal improvements observed under the FMSP strategy, which also added organic substances to the Aw layer.	[Meng, Qingying; Zou, Hongtao; Yang, Xiaohe; Han, Yanyu] Shenyang Agr Univ, Dept Land & Environm, Shenyang, Liaoning, Peoples R China; [Meng, Qingying; Zhang, Chunfeng; Zhu, Baoguo; Wang, Nannan; Yang, Xiaohe; Gai, Zhijia] Heilongjiang Acad Agr Sci, Jiamusi Branch, Jiamusi, Heilongjiang, Peoples R China	Shenyang Agricultural University; Heilongjiang Academy of Agricultural Sciences	Zou, HT (corresponding author), Shenyang Agr Univ, Dept Land & Environm, Shenyang, Liaoning, Peoples R China.	zhtsynd@163.com		/0000-0001-6772-5338	Heilongjiang Academy of Agricultural Sciences "Agricultural science and technology innovation leap project", special technology for sustainable utilization of black soil cultivated land resources [HNK2019CX13]	Heilongjiang Academy of Agricultural Sciences "Agricultural science and technology innovation leap project", special technology for sustainable utilization of black soil cultivated land resources	The work supported by the Heilongjiang Academy of Agricultural Sciences "Agricultural science and technology innovation leap project", special technology for sustainable utilization of black soil cultivated land resources (HNK2019CX13)".	Akazawa T, 1987, J HOKKAIDO HEILONGJI, V26, P11; Akazawa T., 1986, J HOKKAIDO HEILONGJI, V17, P13; [Anonymous], 1992, HEIL SOILS, P124; [Anonymous], 2000, SOIL CHEM NUTR ANAL; Araya K, 1996, J AGR ENG RES, V65, P143, DOI 10.1006/jaer.1996.0086; Araya K, 1991, SESHU U HOKKAIDO, V2, P181; Bockheim JG, 2016, GEODERMA, V262, P85, DOI 10.1016/j.geoderma.2015.08.010; CAMBARDELLA CA, 1993, SOIL SCI SOC AM J, V57, P1071, DOI 10.2136/sssaj1993.03615995005700040032x; Gao Z, 1988, ACTA PEDOLOGICA SINI, V25, P111; Guo G, 2002, BIOSYST ENG, V83, P481, DOI 10.1006/bioe.2002.0137; He YB, 2018, SOIL TILL RES, V184, P281, DOI 10.1016/j.still.2018.08.008; Heilongjiang Bayi Agricultural University, SOIL SCI, P141; Institute of Soil Science Chinese Academy of Sciences, 1978, SOILS CHINA, P128; IUSS working Group WRB, INT SOIL CLASS SYST, V106; Iwama H, 1988, STUDIES PHYS PROPERT, V150, P114; Jia H., 2013, ENG AGR ENV FOOD, V6, P184; Jia HuiBin, 1997, Acta Pedologica Sinica, V34, P130; Liu F, 1998, J AGR ENG RES, V71, P213, DOI 10.1006/jaer.1998.0308; Liu F, 2001, T CHINESE SOC AGR EN, V164, P103; Loud, 1993, HASKINS SOC J, V4, P37; Martyniuk S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37087-4; [孟庆英 Meng Qingying], 2017, [中国土壤与肥料, Soil and Fertilizer Sciences in China], P56; Murai S, 1987, J HOKKAIDO HEILONGJI, V26, P11; Six J, 2014, SOIL BIOL BIOCHEM, V68, pA4, DOI 10.1016/j.soilbio.2013.06.014; The Japan Society of Soil Physics, 1979, SOIL PHYS PROP PLANT, P12; Wu ZJ, 1995, CHINESE J SOIL SCI, V26, P250; Xiu LQ, 2019, CATENA, V173, P481, DOI 10.1016/j.catena.2018.10.041; Xiu LQ, 2016, THESIS; Xu Q., 1979, PROGR SOIL SCI, P21; Xu XR, 2019, GEODERMA, V337, P622, DOI 10.1016/j.geoderma.2018.08.018; Yin D., 2013, THESIS; Zeng ZS, 1963, ACTA PEDOL SIN, V11, P111; Zhang G., 2012, SOIL SURVEY LAB METH; Zhang ZY, 1983, J HEILONGJIANG BAYI, P73; Zhao D., 1992, IMPROVEMENT LOW SOIL, P9; Zhao DL, 1989, J CHINESE SCI AGR SI, V22, P47; Zhao DL, 1983, SCI AGR SINICA, V1, P54; Zhao L.P., 1996, CHIN J SOIL SCI, V27, P76; Zhao YP, 1986, ACTA AGR U PEKINENSI, P79; Zhou XQ, 1983, SOIL, P101	40	1	1	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0239788	10.1371/journal.pone.0239788	http://dx.doi.org/10.1371/journal.pone.0239788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048953	gold, Green Published			2022-12-26	WOS:000581813300048
J	Peng, JF; Zhou, M; Chen, C; Xie, XH; Luo, CH				Peng, Junfeng; Zhou, Mi; Chen, Chuan; Xie, Xiaohua; Luo, Ching-Hsing			Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms	PLOS ONE			English	Article							SERUM SODIUM; MELD; PREDICTION; MORTALITY; MODEL	The prediction of the liver failure (LF) and its proper diagnosis would lead to a reduction in the complications of the disease and prevents the progress of the disease. To improve the treatment of LF patients and reduce the cost of treatment, we build a machine learning model to forecast whether a patient would deteriorate after admission to the hospital. First, a total of 348 LF patients were included from May 2011 to March 2018 retrospectively in this study. Then, 15 key clinical indicators are selected as the input of the machine learning algorithm. Finally, machine learning and the Model for End-Stage Liver Disease (MELD) are used to forecast the LF deterioration. The area under the receiver operating characteristic (AUC) of MELD, GLMs, CART, SVM and NNET with 10 fold-cross validation was 0.670, 0.554, 0.794, 0.853 and 0.912 respectively. Additionally, the accuracy of MELD, GLMs, CART, SVM and NNET was 0.669, 0.456, 0.794, 0.853 and 0.912. The predictive performance of the developed machine model execept the GLMs exceeds the classic MELD model. The machine learning method could support the physicians to trigger the initiation of timely treatment for the LD patients.	[Peng, Junfeng; Chen, Chuan; Xie, Xiaohua; Luo, Ching-Hsing] Sun Yat Sen Univ, Sch Data & Comp Sci, Guangzhou, Guangdong, Peoples R China; [Zhou, Mi] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Luo, CH (corresponding author), Sun Yat Sen Univ, Sch Data & Comp Sci, Guangzhou, Guangdong, Peoples R China.	luojinx5@mail.sysu.edu.cn		Luo, Ching-Hsing/0000-0003-1152-0557; Peng, Junfeng/0000-0002-3039-0308	Sun Yat-sen University, China	Sun Yat-sen University, China	This work was supported by Sun Yat-sen University, China, under Scientific Initiation Project No.67000-18821109 for High-level Experts. No competing financial interests exist.	Biggins SW, 2006, GASTROENTEROLOGY, V130, P1652, DOI 10.1053/j.gastro.2006.02.010; Cholongitas E, 2006, LIVER TRANSPLANT, V12, P1049, DOI 10.1002/lt.20824; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, 2019, LANCET, V6, pe105; Cunha A, 2015, INT C INF TECHN BIO; Jarmulski W, 2018, COMPUT SCI-AGH, V19, P223, DOI 10.7494/csci.2018.19.2.2746; Lee YS, 2013, J KOREAN MED SCI, V28, P1048, DOI 10.3346/jkms.2013.28.7.1048; Lok ASF, 2002, NEW ENGL J MED, V346, P1682, DOI 10.1056/NEJM200205303462202; Luca A, 2007, LIVER TRANSPLANT, V13, P1174, DOI 10.1002/lt.21197; Olaniyi EO, 2013, ADV COMPUTATIONAL IN, P48; OlaniyI EO, 2012, ADV COMPUTATIONAL IN, P48; Pratt DS., 2002, HARRISONS PRINCIPLES, P1711; Vijayarani S., 2015, INT J SCI ENG TECHNO, V4, P816; Watt KDS, 2005, TRANSPLANT P, V37, P2172, DOI 10.1016/j.transproceed.2005.03.004; Wu CC, 2019, COMPUT METH PROG BIO, V170, P23, DOI 10.1016/j.cmpb.2018.12.032; Zhang HD, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/5146573	15	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239266	10.1371/journal.pone.0239266	http://dx.doi.org/10.1371/journal.pone.0239266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035213	gold, Green Published			2022-12-26	WOS:000581817500045
J	Uuskula, A; Vickerman, P; Raag, M; Walker, J; Paraskevis, D; Eritsyan, K; Sypsa, V; Lioznov, D; Avi, R; Des Jarlais, D				Uuskula, Anneli; Vickerman, Peter; Raag, Mait; Walker, Josephine; Paraskevis, Dimitrios; Eritsyan, Ksenia; Sypsa, Vana; Lioznov, Dmitry; Avi, Radko; Des Jarlais, Don			Presenting a conceptual framework for an HIV prevention and care continuum and assessing the feasibility of empirical measurement in Estonia: A case study	PLOS ONE			English	Article							OPIOID SUBSTITUTION THERAPY; ANTIRETROVIRAL THERAPY; INJECT DRUGS; VIRAL LOAD; PEOPLE; TRANSMISSION; ADHERENCE; IMPACT	Objective We aim to show the feasibility of using an integrated prevention and care continuum (PCC) model as a complete and improved tool for HIV control measurement and programming. Alignment of prevention and care continua is essential to further improve health outcomes and minimize HIV transmission risk. Design Cross-sectional study. Methods Data from 977 persons who inject drugs (PWID) collected in 2011-2016 in Tallinn, Estonia, were used to construct an HIV PCC for PWID, stratified by risk for acquiring or transmitting HIV infection and by coverage of combined interventions. We also estimated the average protective effect of current levels of intervention provision. Results 74.4%, 20.3% and 35.2% of PWID were currently using needle and syringe programmes (NSP), drug treatment and HIV testing, respectively. 51.1% of current PWID were HIV seropositive and of those 62.5% were currently on ART and 19.0% were virally suppressed. Across the PCC, individuals moved between categories of being aware and ever using drug treatment (resulting in -50% "leakage"); from ever having used to currently using drug treatment (-59%); between "ever testing" and "current (continuous) testing" (-62%); and from self-reported antiretroviral therapy (ART) adherence to viral suppression (-70%). Use of prevention services was higher among those at risk of transmission (HIV positive). The overall reduction in acquisition risk among HIV-negative PWID was 77.7% (95% CrI 67.8-84.5%), estimated by the modelled protective effects of current levels of NSP, drug treatment and ART compared to none of these services. Conclusions Our findings suggest that developing a cohesive model for HIV prevention and treatment is feasible and reflects the bi-directional relationships between prevention and care. The integrated continuum model indicates the major factors which may predict the epidemic course and control response.	[Uuskula, Anneli; Raag, Mait] Univ Tartu, Dept Family Med & Publ Hlth, Tartu, Estonia; [Vickerman, Peter; Walker, Josephine] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Paraskevis, Dimitrios; Sypsa, Vana] Natl & Kapodistrian Univ Athens, Med Sch, Athens, Greece; [Eritsyan, Ksenia] Natl Res Univ Higher Sch Econ, St Petersburg, Russia; [Lioznov, Dmitry] Smorodintsev Res Inst Influenza, St Petersburg, Russia; [Lioznov, Dmitry] First Pavlov State Med Univ, St Petersburg, Russia; [Avi, Radko] Univ Tartu, Dept Microbiol, Tartu, Estonia; [Des Jarlais, Don] NYU, Coll Global Publ Hlth, New York, NY USA	University of Tartu; University of Bristol; National & Kapodistrian University of Athens; HSE University (National Research University Higher School of Economics); Pavlov First Saint Petersburg State Medical University; University of Tartu; New York University	Uuskula, A (corresponding author), Univ Tartu, Dept Family Med & Publ Hlth, Tartu, Estonia.	anneli.uuskula@ut.ee	Eritsyan, Ksenia/K-7144-2013	Eritsyan, Ksenia/0000-0002-4400-0593; SYPSA, VANA/0000-0002-9430-7614; Paraskevis, Dimitrios/0000-0001-6167-7152	Ministry of Education and Research [IUT34-17, IUT34-24]; Estonian Research Council [PUT 1580]; National Institute on Drug Abuse, USA [1DP1DA039542]	Ministry of Education and Research; Estonian Research Council(Estonian Research Council); National Institute on Drug Abuse, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	AU - Ministry of Education and Research grant IUT34-17; RA - Estonian Research Council (grant PUT 1580) and Ministry of Education and Research grant IUT34-24; DDS and AU - grant 1DP1DA039542 from the National Institute on Drug Abuse, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Aspinall EJ, 2014, INT J EPIDEMIOL, V43, P235, DOI 10.1093/ije/dyt243; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bezabhe WM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003361; Centers for Disease Control and Prevention, 2015, NAT HIV BEH SURV SYS; Desai M, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5011; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2019, HIV AIDS SURV EUR 20; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2010, GUID TEST HIV VIR HE; Garnett GP, 2016, LANCET HIV, V3, pE297, DOI 10.1016/S2352-3018(16)30039-X; Giordano TP, 2004, HIV CLIN TRIALS, V5, P74, DOI 10.1310/JFXH-G3X2-EYM6-D6UG; Gowing L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub4; Grebely J, 2013, CLIN INFECT DIS, V57, P1014, DOI 10.1093/cid/cit377; Handcock M.S., 2012, RDS RESPONDENT DRIVE; Hargreaves JR, 2016, LANCET HIV, V3, pE318, DOI 10.1016/S2352-3018(16)30063-7; HIV nakkuse ja kaasuvate infektsioonide epidemioloogiline olukord Eestis 2000-2016, 2017, HIV NAKK JA KAAS INF; Horn T, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21263; Jose S, 2018, LANCET HIV, V5, pE301, DOI 10.1016/S2352-3018(18)30048-1; Karnite A, 2014, ASSESSMENT HIV TB KN; Kelley CF, 2015, CLIN INFECT DIS, V61, P1590, DOI 10.1093/cid/civ664; Low AJ, 2016, CLIN INFECT DIS, V63, P1094, DOI 10.1093/cid/ciw416; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; McNairy ML, 2014, CLIN INFECT DIS, V59, pS12, DOI 10.1093/cid/ciu251; Moorhouse L, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25309; Mukandavire C, 2017, AIDS, V31, P1181, DOI 10.1097/QAD.0000000000001458; Murray M, 2012, HIV MED, V13, P89, DOI 10.1111/j.1468-1293.2011.00940.x; Nosyk B, 2013, AIDS, V27, P1159, DOI 10.1097/QAD.0b013e32835f1d68; Platt L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012021.pub2; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raben D, 2014, HIV AIDS TREATMENT C; UNAIDS, 2010, COMB HIV PREV TAIL C; UNAIDS, 2014, 90 90 90 AMB TREATM; United States Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG AD AD; Uuskula A, 2015, AIDS CARE, V27, P105, DOI 10.1080/09540121.2014.940271; Uuskula A, 2018, AIDS BEHAV, V22, P224, DOI 10.1007/s10461-017-1859-6; Vickerman P, 2014, INT J DRUG POLICY, V25, P1163, DOI 10.1016/j.drugpo.2014.09.013; WHO, 2003, WHO DRUG INJ STUD PH; World Health Organization, 2016, GLOB HLTH SECT STRAT	37	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240224	10.1371/journal.pone.0240224	http://dx.doi.org/10.1371/journal.pone.0240224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035238	gold, Green Published			2022-12-26	WOS:000581817500050
J	Warncke, ML; Wiese, NJ; Tahir, E; Sehner, S; Heinemann, A; Regier, M; Puschel, K; Adam, G; Weinrich, JM; Laqmani, A				Warncke, Malte Lennart; Wiese, Nis Jesper; Tahir, Enver; Sehner, Susanne; Heinemann, Axel; Regier, Marc; Pueschel, Klaus; Adam, Gerhard; Weinrich, Julius Matthias; Laqmani, Azien			Highly reduced-dose CT of the lumbar spine in a human cadaver model	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; IMAGE QUALITY; ITERATIVE RECONSTRUCTION; PLAIN RADIOGRAPHS; MULTIDETECTOR CT; CERVICAL-SPINE; ACCURACY; FRACTURE; RISK; TRAUMA	Purpose Feasibility of a highly reduced-dose lumbar spine CT protocol using iterative reconstruction (IR) in a human cadaver model. Materials and methods The lumbar spine of 20 human cadavers was repeatedly examined using three different reduced-dose protocols (RDCT) with decreasing reference tube current-exposure time products (RDCT-1: 50 mAs; RDCT-2: 30 mAs; RDCT-3: 10 mAs) at a constant tube voltage of 140 kV. A clinical standard-dose protocol (SDCT) served as the reference (reference tube current-exposure time product: 70 mAs; tube voltage: 140 kV). Images were reconstructed using filtered back projection (FBP) and two increasing levels of IR: IRL4 and IRL6. A five-point scale was used by two observers to assess the diagnostic quality of anatomical structures (cortical and trabecular bone, intervertebral foramina, pedicles and intervertebral joints, spinous and transverse processes). Objective image noise (OIN) was measured. Results were interpreted using a linear mixed-effects regression model. Results RDCT-2 with IRL6 (1.2 +/- 0.5mSv) was the lowest reduced-dose protocol which provided diagnostically acceptable and equivalent image quality compared to the SDCT (2.3 +/- 1.1mSV) with FBP (p > 0.05). All RDCT protocols achieved a significant reduction of the mean (+/- SD) effective radiation doses (RDCT-1: 1.7 +/- 0.9mSv; RDCT-2: 1.2 +/- 0.5mSv; RDCT-3: 0.4 +/- 0.2mSv; p < 0.05) compared to SDCT. OIN was lower in all RDCT protocols with the application of IRL4 and IRL6, compared to the SDCT with FBP (p < 0.05). Conclusion Highly reduced-dose lumbar spine CT providing diagnostically acceptable image quality is feasible using IR in this cadaver model and may be transferred into a clinical setting.	[Warncke, Malte Lennart; Wiese, Nis Jesper; Tahir, Enver; Regier, Marc; Adam, Gerhard; Weinrich, Julius Matthias; Laqmani, Azien] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany; [Sehner, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Heinemann, Axel; Pueschel, Klaus] Univ Med Ctr Hamburg Eppendorf, Dept Legal Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Warncke, ML (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany.	m.warncke@uke.de	Tahir, Enver/AAI-6469-2021	Warncke, Malte/0000-0002-8774-0145; Tahir, Enver/0000-0002-6999-2787; Weinrich, Julius/0000-0002-5119-6563				Alshamari M, 2017, ACTA RADIOL, V58, P702, DOI 10.1177/0284185116669870; Alshamari M, 2016, EUR RADIOL, V26, P1766, DOI 10.1007/s00330-015-3984-9; Alshamari M, 2016, ACTA RADIOL, V57, P602, DOI 10.1177/0284185115595667; Alshamari M, 2014, ACTA RADIOL, V55, P824, DOI 10.1177/0284185113509615; Biswas D, 2009, J BONE JOINT SURG AM, V91A, P1882, DOI 10.2106/JBJS.H.01199; Bongartz G, EUROPEAN GUIDELINES; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Geyer LL, 2015, RADIOLOGY, V276, P338, DOI 10.1148/radiol.2015132766; Gleeson TG, 2009, SKELETAL RADIOL, V38, P225, DOI 10.1007/s00256-008-0607-4; Gleeson TG, 2010, CAN ASSOC RADIOL J, V61, P258, DOI 10.1016/j.carj.2010.01.003; Hunter BR, 2014, J EMERG MED, V46, P257, DOI 10.1016/j.jemermed.2013.08.094; Kanal KM, 2017, RADIOLOGY, V284, P120, DOI 10.1148/radiol.2017161911; KJS John M. Boone, 2011, REPORT NO 204 SIZE S; Laqmani A, 2014, EUR J RADIOL, V83, P1962, DOI 10.1016/j.ejrad.2014.06.016; McCollough CH, 2012, RADIOLOGY, V264, P567, DOI 10.1148/radiol.12112265; McLaughlin PD, 2013, CAN ASSOC RADIOL J, V64, P314, DOI 10.1016/j.carj.2013.09.004; Miller P, 2002, SPINE, V27, P2291, DOI 10.1097/00007632-200210150-00021; Nekolla EA, 2017, RADIOLOGE, V57, P555, DOI 10.1007/s00117-017-0242-y; Noel PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081141; Padole A, 2015, AM J ROENTGENOL, V204, pW384, DOI 10.2214/AJR.14.13241; Phal PM, 2008, AM J NEURORADIOL, V29, P1446, DOI 10.3174/ajnr.A1152; Pourjabbar S, 2015, ACTA RADIOL, V56, P688, DOI 10.1177/0284185114537256; Prasad KN, 2004, BRIT J RADIOL, V77, P97, DOI 10.1259/bjr/88081058; Richards PJ, 2010, SPINE, V35, P430, DOI 10.1097/BRS.0b013e3181cdde47; Schegerer AA, 2017, EUR J RADIOL, V90, P114, DOI 10.1016/j.ejrad.2017.02.021; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Spelic DC, 2004, RADIOLOGY, V232, P115, DOI 10.1148/radiol.2321020397; Subhas N, 2018, AM J ROENTGENOL, V210, P593, DOI 10.2214/AJR.17.18544; VandenBerg J, 2019, J EMERG MED, V56, P153, DOI 10.1016/j.jemermed.2018.10.032; Venkatesan M, 2012, J BONE JOINT SURG BR, V94B, P1097, DOI 10.1302/0301-620X.94B8.29397; Weinrich JM, 2018, CLIN RADIOL, V73, DOI 10.1016/j.crad.2018.02.015; Weinrich JM, 2019, AM J ROENTGENOL, V213, P903, DOI 10.2214/AJR.18.20933; Yang CH, 2014, SPINE J, V14, P2682, DOI 10.1016/j.spinee.2014.03.007; [No title captured]	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240199	10.1371/journal.pone.0240199	http://dx.doi.org/10.1371/journal.pone.0240199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031418	gold, Green Published			2022-12-26	WOS:000581809800054
J	Rang, NN; Hien, TQ; Chanh, TQ; Thuyen, TK				Rang, Nguyen N.; Hien, Tran Q.; Chanh, Ton Q.; Thuyen, Tran K.			Preterm birth and secondhand smoking during pregnancy: A case-control study from Vietnam	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; MATERNAL CIGARETTE-SMOKING; PASSIVE SMOKING; FREE LEGISLATION; EXPOSURE; ASSOCIATION; DELIVERY; OUTCOMES; WEIGHT; HEALTH	Background The relationship between women who are exposed to secondhand smoke and preterm birth is still controversial. The present study aimed to examine the association between maternal secondhand smoking (SHS) during pregnancy and preterm birth. Methods A 1:1 case-control study was conducted at delivery room of The Women's and Children's Hospital of An Giang, Vietnam. A total of 288 cases of preterm birth and 288 controls included in this study. A structured questionnaire in a face-to-face interview was used to assess SHS and potential confounders (maternal age, body mass index, occupation, education level, parity, antenatal care visits, history of preterm birth, prenatal bleeding and preeclampsia/eclampsia). Results SHS was reported more frequently by women who delivered preterm babies compared with women of term deliveries (67.4% vs. 51.0%;P <0.001). After controlling all potential confounders, multivariable logistic regression analysis showed a relationship between SHS during pregnancy and preterm delivery (adjusted Odds ratio: 1.92; 95% CI 1.31, 2.81) Conclusions Our findings suggest that exposure to household tobacco smoke during pregnancy is associated with preterm birth.	[Rang, Nguyen N.] Can Tho Univ Med & Pharm, Dept Pediat, Can Tho, Vietnam; [Rang, Nguyen N.; Chanh, Ton Q.] Women & Children Hosp Giang, Dept Pediat, Long Xuyen, An Giang, Vietnam; [Hien, Tran Q.; Thuyen, Tran K.] Women & Children Hosp An Giang, Dept Obstet & Gynecol, Long Xuyen, An Giang, Vietnam	Can Tho University of Medicine & Pharmacy (CTUMP)	Rang, NN (corresponding author), Can Tho Univ Med & Pharm, Dept Pediat, Can Tho, Vietnam.; Rang, NN (corresponding author), Women & Children Hosp Giang, Dept Pediat, Long Xuyen, An Giang, Vietnam.	nguyenngocrang@gmail.com		Nguyen, Rang/0000-0003-4072-660X				AHLBORG G, 1991, AM J EPIDEMIOL, V133, P338, DOI 10.1093/oxfordjournals.aje.a115886; [Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2012, REGEN MED S3, V7, pS14; Bakolis I, 2016, EPIDEMIOLOGY, V27, P810, DOI 10.1097/EDE.0000000000000534; Been JV, 2014, LANCET, V383, P1549, DOI 10.1016/S0140-6736(14)60082-9; Centers for Disease Control and Prevention, 2004, SMOK HOUS TOB INF PR; Cox B, 2013, BMJ-BRIT MED J, V346, pf441, DOI DOI 10.1136/bmj.f441; Cui H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147848; Editorial, 2012, ECON POLIT WEEKLY, VXLVII, P13; Fantuzzi G, 2007, PAEDIATR PERINAT EP, V21, P194, DOI 10.1111/j.1365-3016.2007.00815.x; FORTIER I, 1994, AM J EPIDEMIOL, V139, P294, DOI 10.1093/oxfordjournals.aje.a116997; Goel P, 2004, J Postgrad Med, V50, P12; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hanke W, 1999, HUM EXP TOXICOL, V18, P265, DOI 10.1191/096032799678840020; Minh HV, 2017, INT J PUBLIC HEALTH, V62, pS121, DOI 10.1007/s00038-017-0955-8; Hoyt AT, 2018, MATERN CHILD HLTH J, V22, P1418, DOI 10.1007/s10995-018-2522-1; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Jamal A, 2018, MMWR-MORBID MORTAL W, V67, P53, DOI 10.15585/mmwr.mm6702a1; Khader YS, 2011, MATERN CHILD HLTH J, V15, P453, DOI 10.1007/s10995-010-0599-2; King BA, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2012-050582; LAZZARONI F, 1990, INT J EPIDEMIOL, V19, P960, DOI 10.1093/ije/19.4.960; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Miyake Y, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-157; Mojibyan Mahdiyeh, 2013, Int J High Risk Behav Addict, V1, P149, DOI 10.5812/ijhrba.7630; Qiu J, 2014, AM J EPIDEMIOL, V180, P94, DOI 10.1093/aje/kwu092; Sadler L, 1999, AM J EPIDEMIOL, V150, P695; Savitz DA, 2010, EPIDEMIOLOGY, V21, P291, DOI 10.1097/EDE.0b013e3181d3ca63; Shah NR, 2000, AM J OBSTET GYNECOL, V182, P465, DOI 10.1016/S0002-9378(00)70240-7; Steyn K, 2006, PAEDIATR PERINAT EP, V20, P90, DOI 10.1111/j.1365-3016.2006.00707.x; Vicedo-Cabrera AM, 2016, TOB CONTROL, V25, pE135, DOI 10.1136/tobaccocontrol-2015-052739; Ward C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-81; Windham GC, 2000, EPIDEMIOLOGY, V11, P427, DOI 10.1097/00001648-200007000-00011	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240289	10.1371/journal.pone.0240289	http://dx.doi.org/10.1371/journal.pone.0240289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027283	Green Published, gold			2022-12-26	WOS:000581808000017
J	Bonnevie, E; Rosenberg, SD; Kummeth, C; Goldbarg, J; Wartella, E; Smyser, J				Bonnevie, Erika; Rosenberg, Sarah D.; Kummeth, Caitlin; Goldbarg, Jaclyn; Wartella, Ellen; Smyser, Joe			Using social media influencers to increase knowledge and positive attitudes toward the flu vaccine	PLOS ONE			English	Article							AFRICAN-AMERICAN; WHITE; BEHAVIOR	Seasonal influenza affects millions of people across the United States each year. African Americans and Hispanics have significantly lower vaccination rates, and large-scale campaigns have had difficulty increasing vaccination among these two groups. This study assessed the feasibility of delivering a flu vaccination promotion campaign using influencers, and examined shifts in social norms regarding flu vaccine acceptability after a social media micro influencer campaign. Influencers were asked to choose from vetted messages and create their own original content promoting flu vaccination, which was posted to their social media pages. Content was intentionally unbranded to ensure that it aligned with the look and feel of their pages. Cross-sectional pre- and post-campaign surveys were conducted within regions that received the campaign and control regions to examine potential campaign impact. Digital metrics assessed campaign exposure. Overall, 117 influencers generated 69,495 engagements. Results from the region that received the campaign showed significant increases in positive beliefs about the flu vaccine, and significant decreases in negative community attitudes toward the vaccine. This study suggests that flu campaigns using a ground-up rather than top-down approach can feasibly reach at-risk groups with lower vaccination rates, and shows the potentials of using an influencer-based model to communicate information about flu vaccination on a large scale.	[Bonnevie, Erika; Rosenberg, Sarah D.; Goldbarg, Jaclyn; Smyser, Joe] Publ Good Projects, Dept Hlth Commun, New York, NY 10010 USA; [Kummeth, Caitlin] Publ Good Projects, Dept Mkt, New York, NY USA; [Wartella, Ellen] Northwestern Univ, Sch Commun, Evanston, IL USA	Northwestern University	Bonnevie, E (corresponding author), Publ Good Projects, Dept Hlth Commun, New York, NY 10010 USA.	erika.bonnevie@publicgoodprojects.org			Kaiser Permanente	Kaiser Permanente	This work was supported by Kaiser Permanente. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2018, VACCINE, V36, P7556, DOI 10.1016/j.vaccine.2018.10.049; Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; [Anonymous], 2018, FORBES; [Anonymous], 2019, FLUVIEW NAT REG STAT; [Anonymous], 2017, COMMUN MATH STAT, V5, P1, DOI DOI 10.1007/S40304-017-0103-Z; Bonnevie E, 2020, USING SOCIAL MEDIA I; Centers for Control and Disease Prevention, 2019, FLUVIEW PNEUM INFL M; Centers for Disease Control and Prevention, 2019, CDC DIG MED TOOLK 20; Centers for Disease Control and Prevention, 2012, DAT REL DOC NAT 2009; Centers for Disease Control and Prevention, 2018, EST INFL VACC COV AD; Centers for Disease Control and Prevention, 2019, KEY FACTS INFL FLU; Centers for Disease Control and Prevention, 2019, MEASL CAS OUTBR; Chan LL, 2020, J MED INTERNET RES, V22, DOI 10.2196/17432; Christiano A., 2017, STANFORD SOC INNOVAT, V15, P34; Diaz-Martin AM, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00779; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; Fortuna LR, 2020, PSYCHOL TRAUMA THEOR; Glenza J., 2020, GUARDIAN; Gough Aisling, 2017, JMIR Public Health Surveill, V3, pe14, DOI 10.2196/publichealth.6313; Hanke M., 2015, ELON J UNDERGRADUATE, V6, P69; Harrison K., 2017, FORBES; Hoffman J, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-018-1085-9; Hutchins SS, 2009, AM J PUBLIC HEALTH, V99, pS261, DOI 10.2105/AJPH.2009.161505; John LK, 2018, HARVARD BUS REV, V96, P62; Karlamangla S, 2019, LOS ANGELES TIMES; Khamis S, 2017, CELEBR STUD, V8, P191, DOI 10.1080/19392397.2016.1218292; Kolff CA, 2018, HUM VACC IMMUNOTHER, V14, P1636, DOI 10.1080/21645515.2018.1477458; Kostygina G, 2020, SOC MEDIA SOC, V6, DOI 10.1177/2056305120912475; Laursen J., 2016, NATIVE ADVERTISING T; Lu P-J, 2015, VACCINE, V33; Lutkenhaus RO, 2019, DIGIT HEALTH, V5, DOI 10.1177/2055207618821521; Moniz MH, 2013, OBSTET GYNECOL, V121, P734, DOI 10.1097/AOG.0b013e31828642b1; National Foundation for Infectious Diseases, 2016, NAT SURV COLL STUD F; Nowak GJ, 2015, VACCINE, V33, P2741, DOI 10.1016/j.vaccine.2015.04.064; Popovich ML, 2016, HEALTH TECHNOL-GER, V6, P11, DOI 10.1007/s12553-015-0121-3; Quinn SC, 2018, HUM VACC IMMUNOTHER, V14, P719, DOI 10.1080/21645515.2017.1376152; Quinn SC, 2018, SSM-POPUL HLTH, V4, P25, DOI 10.1016/j.ssmph.2017.11.003; Quinn SC, 2017, HEALTH EDUC RES, V32, P473, DOI 10.1093/her/cyx070; Quinn SC, 2017, VACCINE, V35, P7154, DOI 10.1016/j.vaccine.2017.10.083; Quinn SC, 2017, VACCINE, V35, P1167, DOI 10.1016/j.vaccine.2016.12.046; Sharethrough, NEUR PERSP ASS VIS F; Shui I, 2005, J NATL MED ASSOC, V97, P657; Thota S, ANIMATED BANNER ADS; Velazquez JC, 2016, ENGAGING HISPANIC LA; Wessel K., 2018, FORBES; Wilson K, 2014, EXPERT REV VACCINES, V13, P969, DOI 10.1586/14760584.2014.928208; Wojdynski BW, NATIVE ADVERTISING F; Wooten KG, 2012, VACCINE, V30, P6927, DOI 10.1016/j.vaccine.2012.08.036; World Health Organization, 2016, BARR INFL VACC INT B; Xu XY, 2019, MMWR-MORBID MORTAL W, V68, P544, DOI 10.15585/mmwr.mm6824a3; Yun GW, 2016, INT J MED INFORM, V91, P67, DOI 10.1016/j.ijmedinf.2016.04.009; [No title captured]; [No title captured]	53	35	35	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240828	10.1371/journal.pone.0240828	http://dx.doi.org/10.1371/journal.pone.0240828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064738	gold, Green Published			2022-12-26	WOS:000585918300011
J	DeTemple, DE; Cammann, S; Bahlmann, J; Buettner, M; Heisterkamp, A; Vondran, FWR; Kalies, SK				DeTemple, Daphne E.; Cammann, Sebastian; Bahlmann, Julia; Buettner, Manuela; Heisterkamp, Alexander; Vondran, Florian W. R.; Kalies, Stefan K.			Longitudinal imaging and femtosecond laser manipulation of the liver: How to generate and trace single-cell-resolved micro-damagein vivo	PLOS ONE			English	Article								The liver is known to possess extensive regenerative capabilities, the processes and pathways of which are not fully understood. A necessary step towards a better understanding involves the analysis of regeneration on the microscopic level in thein vivoenvironment. We developed an evaluation method combining longitudinal imaging analysisin vivowith simultaneous manipulation on single cell level. An abdominal imaging window was implantedin vivoin Balb/C mice for recurrent imaging after implantation. Intravenous injection of Fluorescein Isothiocyanate (FITC)-Dextran was used for labelling of vessels and Rhodamine 6G for hepatocytes. Minimal cell injury was induced via ablation with a femtosecond laser system during simultaneous visualisation of targeted cells using multiphoton microscopy. High-resolution imagingin vivoon single cell level including re-localisation of ablated regions in follow-up measurements after 2-7 days was feasible. Targeted single cell manipulation using femtosecond laser pulses at peak intensities of 3-6.6 mu J led to enhancement of FITC-Dextran in the surrounding tissue. These reactions reached their maxima 5-15 minutes after ablation and were no longer detectable after 24 hours. The procedures were well tolerated by all animals. Multiphoton microscopyin vivo, combined with a femtosecond laser system for single cell manipulation provides a refined procedure for longitudinal evaluation of liver micro-regeneration in the same region of interest. Immediate reactions after cell ablation and tissue regeneration can be analysed.	[DeTemple, Daphne E.; Cammann, Sebastian; Vondran, Florian W. R.] Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany; [DeTemple, Daphne E.; Bahlmann, Julia; Heisterkamp, Alexander; Kalies, Stefan K.] Leibniz Univ Hannover, Inst Quantum Opt, Hannover, Germany; [DeTemple, Daphne E.; Bahlmann, Julia; Heisterkamp, Alexander; Kalies, Stefan K.] Lower Saxony Ctr Biomed Engn Implant Res & Dev NI, Hannover, Germany; [Bahlmann, Julia; Heisterkamp, Alexander] Deutsch Zentrum Lungenforsch eV DZL, Giessen, Germany; [Buettner, Manuela] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; [Vondran, Florian W. R.] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany	Hannover Medical School; Leibniz University Hannover; Hannover Medical School; German Center for Infection Research	DeTemple, DE (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany.; DeTemple, DE (corresponding author), Leibniz Univ Hannover, Inst Quantum Opt, Hannover, Germany.; DeTemple, DE (corresponding author), Lower Saxony Ctr Biomed Engn Implant Res & Dev NI, Hannover, Germany.	detemple.daphne@mh-hannover.de			REBIRTH Cluster of Excellence, Hannover (Funds of the "Niedersachsisches Vorab"); german lung center (DZL); German Centre for Infection Research (DZIF)	REBIRTH Cluster of Excellence, Hannover (Funds of the "Niedersachsisches Vorab"); german lung center (DZL); German Centre for Infection Research (DZIF)	SKK and AH received funding from the REBIRTH Cluster of Excellence, Hannover (Funding by Funds of the "Niedersachsisches Vorab"). AH and JB are supported by the biomedical research in endstage and obstructive lung disease Hannover (BREATH) from the german lung center (DZL). FWRV is supported by the German Centre for Infection Research (DZIF) running the Primary Human Hepatocyte Core Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva Maria, 2014, Intravital, V3, pe29917, DOI 10.4161/intv.29917; Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Gilgenkrantz H, 2011, CLIN RES HEPATOL GAS, V35, P623, DOI 10.1016/j.clinre.2011.04.002; Gilgenkrantz H, 2018, AM J PATHOL, V188, P1316, DOI 10.1016/j.ajpath.2018.03.008; Guo H, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1165-3; Hui TH, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893734; Kolachala VL, 2016, J PEDIATR GASTR NUTR, V62, P429, DOI 10.1097/MPG.0000000000001008; Kordes C, 2013, J CLIN INVEST, V123, P1874, DOI 10.1172/JCI66027; Krull A., 2018, ARXIV181110980; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; MACPHEE PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG692, DOI 10.1152/ajpgi.1995.269.5.G692; Manco R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124115; Marques PE, 2015, NAT PROTOC, V10, P258, DOI 10.1038/nprot.2015.006; MAYROVITZ HN, 1992, MICROVASC RES, V43, P46, DOI 10.1016/0026-2862(92)90005-A; Meesat R, 2012, P NATL ACAD SCI USA, V109, pE2508, DOI 10.1073/pnas.1116286109; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Orzekowsky-Schroeder R, 2014, BIOMED OPT EXPRESS, V5, P3521, DOI 10.1364/BOE.5.003521; Prunier C, 2017, METHODS, V128, P52, DOI 10.1016/j.ymeth.2017.06.029; Reif R, 2017, ARCH TOXICOL, V91, P1335, DOI 10.1007/s00204-016-1906-5; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Ritsma L, 2013, NAT PROTOC, V8, P583, DOI 10.1038/nprot.2013.026; Ritsma L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004394; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Thorling CA, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3647597; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Wang HL, 2015, BIOMED OPT EXPRESS, V6, P780, DOI 10.1364/BOE.6.000780	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240405	10.1371/journal.pone.0240405	http://dx.doi.org/10.1371/journal.pone.0240405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057345	gold, Green Published			2022-12-26	WOS:000581814700026
J	Ngcobo, S; Rossouw, T				Ngcobo, Sanele; Rossouw, Theresa			"They come and knock at the gate until the neighbours see". Perceived barriers and benefits of implementing HIV care at the community level in Tshwane district: A qualitative study	PLOS ONE			English	Article							ADHERENCE; AFRICA	Little is known about the barriers and benefits of home-based HIV services offered by community health workers. These are especially important as the South African government embarks on scaling up community-based health services, which include HIV care. This study set out to understand potential benefits and barriers of these services in Tshwane district and develop recommendations for improvement. From June to August 2019, seven focus group discussions were conducted with 58 participants: four with 36 ward-based outreach team (WBOT) members and three with 22 people living with HIV (PLWHIV). Three aspects of care were explored: 1. Experience of performing, receiving or observing home-based HIV care; 2. Barriers to conducting home visits; and 3. The perceived value of WBOTs and home-based HIV care. While home-based HIV care was seen as a support strategy which could motivate patients to take their medication, the unpredictability of patients' responses to HIV test results, incorrect addresses (driven by the need for identity documents), fear of stigma through association with WBOTs, especially those in uniform, little or no preparation of patients for home-based care, and lack of confidentiality and trust were raised as potential barriers. To successfully implement effective home-based HIV care in South Africa, perceived barriers should be addressed and recommendations offered by people providing and receiving these services should be seriously considered. Pertinent recommendations include integrating WBOTs into clinics and existing support structures, improving training on confidentiality and HIV testing, and rethinking the recruitment, scope of work and safety of WBOTs. In addition, research should be conducted into the impact of the requirements for identity documents and community health worker uniforms.	[Ngcobo, Sanele] Univ Pretoria, Dept Family Med, Pretoria, South Africa; [Rossouw, Theresa] Univ Pretoria, Dept Immunol, Pretoria, South Africa	University of Pretoria; University of Pretoria	Ngcobo, S (corresponding author), Univ Pretoria, Dept Family Med, Pretoria, South Africa.	Sanele.Ngcobo@up.ac.za		Ngcobo, Sanele/0000-0002-5968-0181; Rossouw, Theresa/0000-0003-4066-922X				[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; Bristow CC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-801; Castleberry A, 2018, CURR PHARM TEACH LEA, V10, P807, DOI 10.1016/j.cptl.2018.03.019; Chellaiyan Vinoth Gnana, 2018, J Family Med Prim Care, V7, P791, DOI 10.4103/jfmpc.jfmpc_128_17; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; Conserve DF, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4120-3; Grant M, 2017, AFR J PRIM HEALTH CA, V9, DOI 10.4102/phcfm.v9i1.1281; Grobler A, 2017, LANCET HIV, V4, pE505, DOI 10.1016/S2352-3018(17)30122-4; Hennink MM, 2019, QUAL HEALTH RES, V29, P1483, DOI 10.1177/1049732318821692; HIV/AIDS JUNPo, 2019, UNAIDS DAT 2019; Hunter J. R., 2017, South African Health Review, V2017, P111; Jennings JD, 2016, CLIN ORTHOP RELAT R, V474, P1908, DOI 10.1007/s11999-016-4855-7; Jinabhai CC, 2015, RAPID APPRAISAL WARD; Karel, 2014, WHY POL IS FAIL COMM; Katz IT, 2015, AIDS BEHAV, V19, P704, DOI 10.1007/s10461-014-0920-y; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Liamputtong Pranee, 2011, FOCUS GROUP METHODOL; Marcus TS, 2020, AFR J PRIM HEALTH CA, V12, DOI 10.4102/phcfm.v12i1.2155; Marcus TS, 2018, COPC A PRACTICAL GUI; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Moneyham L, 2010, J ASSOC NURSE AIDS C, V21, P467, DOI 10.1016/j.jana.2010.03.003; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; Mwisongo A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0940-y; Nachega Jean B., 2011, Infectious Disorders - Drug Targets, V11, P167; Naidoo N, 2018, S AFR J HIV MED, V19, DOI 10.4102/sajhivmed.v19i1.778; Naik SB, 2013, INDIAN J CRIT CARE M, V17, P178, DOI 10.4103/0972-5229.117067; O'Donovan J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021467; O'Hara LM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2659-3; Otiso L, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000107; Ponthieu A, 2016, REFUG SURV Q, V35, P98, DOI 10.1093/rsq/hdw006; Schneider H, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1109-4; Shand T, 2014, IDS BULL-I DEV STUD, V45, P53, DOI 10.1111/1759-5436.12068; Steege R, 2018, SOC SCI MED, V209, P1, DOI 10.1016/j.socscimed.2018.05.002; Treves-Kagan S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2753-2; WHO, 2019, GLOB TUB REP	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240740	10.1371/journal.pone.0240740	http://dx.doi.org/10.1371/journal.pone.0240740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057451	Green Published, gold			2022-12-26	WOS:000581814700095
J	Bowles, J; Larreguy, H; Liu, S				Bowles, Jeremy; Larreguy, Horacio; Liu, Shelley			Countering misinformation via WhatsApp: Preliminary evidence from the COVID-19 pandemic in Zimbabwe	PLOS ONE			English	Article								We examine how information from trusted social media sources can shape knowledge and behavior when misinformation and mistrust are widespread. In the context of the COVID-19 pandemic in Zimbabwe, we partnered with a trusted civil society organization to randomize the timing of the dissemination of messages aimed at targeting misinformation about the virus to 27,000 newsletter WhatsApp subscribers. We examine how exposure to these messages affects individuals' beliefs about how to deal with the virus and preventative behavior. In a survey of 864 survey respondents, we find a 0.26 sigma increase in knowledge about COVID-19 as measured by responses to factual questions. Through a list experiment embedded in the survey, we further find that potentially harmful behavior-not abiding by lockdown guidelines-decreased by 30 percentage points. The results show that social media messaging from trusted sources may have substantively large effects not only on individuals' knowledge but also ultimately on related behavior.	[Bowles, Jeremy; Larreguy, Horacio] Harvard Univ, Dept Govt, Cambridge, MA 02138 USA; [Liu, Shelley] Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA USA	Harvard University; University of California System; University of California Berkeley	Larreguy, H (corresponding author), Harvard Univ, Dept Govt, Cambridge, MA 02138 USA.	hlarreguy@fas.harvard.edu		Liu, Shelley X./0000-0002-1601-9692				Afrobarometer, 2018, ZIMB ROUND 7 DAT; Agadjanian A, 2019, RES POLITICS, V6, DOI 10.1177/2053168019870351; [Anonymous], EXAMINER 0422; [Anonymous], 2020, SPOT COVID 19 MIS WH; [Anonymous], 2019, THE ECONOMIST; [Anonymous], 2017, TECH ZIM        0411; [Anonymous], 2020, GUARDIAN 1026; Banerjee Abhijit V., 2017, HDB FIELD EXPT; Bode L, 2018, HEALTH COMMUN, V33, P1131, DOI 10.1080/10410236.2017.1331312; Carey JM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaw7449; Chan MPS, 2017, PSYCHOL SCI, V28, P1531, DOI 10.1177/0956797617714579; Cone J, 2019, P NATL ACAD SCI USA, V116, P9802, DOI 10.1073/pnas.1903222116; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Gesser-Edelsburg A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209505; Glynn AN, 2013, PUBLIC OPIN QUART, V77, P159, DOI 10.1093/poq/nfs070; Grinberg N, 2019, SCIENCE, V363, P374, DOI 10.1126/science.aau2706; Grover E, 2018, TROP MED INT HEALTH, V23, P10, DOI 10.1111/tmi.12999; Hoffmann K, 2020, ONLINE SURVEYS DIGIT; Huang HF, 2017, BRIT J POLIT SCI, V47, P283, DOI 10.1017/S0007123415000253; Imai K, 2008, J R STAT SOC A STAT, V171, P481, DOI 10.1111/j.1467-985X.2007.00527.x; Kawasaki J, 2020, ED POLICY ANAL ARCH, V28; Lazer DMJ, 2018, SCIENCE, V359, P1094, DOI 10.1126/science.aao2998; Limaye RJ, 2020, LANCET DIGIT HEALTH, V2, pE277, DOI 10.1016/S2589-7500(20)30084-4; Newman N., 2017, REUTERS I DIGITAL NE; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2; Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178; Pluviano S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181640; Sondheimer RachelMilstein., 2011, CAMBRIDGE HDB EXPT P, P494, DOI 10.1017/CBO9780511921452.034; Spinney L, 2019, SCIENCE, V363, P213, DOI 10.1126/science.363.6424.213; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; Walter N, 2018, COMMUN MONOGR, V85, P423, DOI 10.1080/03637751.2018.1467564; Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X	33	17	19	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240005	10.1371/journal.pone.0240005	http://dx.doi.org/10.1371/journal.pone.0240005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3XB	33052967	gold, Green Published			2022-12-26	WOS:000581820200020
J	Tasbihgou, SR; Dijkstra, S; Atmosoerodjo, SD; Tigchelaar, I; Huet, R; Mariani, MA; Absalom, AR				Tasbihgou, Setayesh R.; Dijkstra, Sandra; Atmosoerodjo, Sawal D.; Tigchelaar, Iris; Huet, Rolf; Mariani, Massimo A.; Absalom, Anthony R.			A prospective pilot study assessing levels of preoperative physical activity and postoperative neurocognitive disorder among patients undergoing elective coronary artery bypass graft surgery	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE DYSFUNCTION; FRAILTY ASSESSMENT; HOSPITAL ANXIETY; CARDIAC-SURGERY; MATTER VOLUME; OLDER-ADULTS; EXERCISE; INFLAMMATION; HEALTH	Physical inactivity and a sedentary lifestyle are associated with a chronic low-level inflammatory state which has been implicated in the pathogenesis of cardiovascular disease. There is growing interest in exercise programs as part of surgical 'prehabilitation'. We therefore studied preoperative physical activity levels of patients undergoing elective Coronary Artery Bypass Graft (CABG) surgery, and performed an exploratory analysis of the influence of physical activity on postoperative outcome. The Short Questionnaire to Assess Health (SQUASH) was used to assess physical activity among 100 patients, of mean (SD) age 65.4 (7.6) years. Additionally, handgrip strength was measured, and the get-up-and-go test was conducted. Anxiety, depression, and quality of life were assessed, and a computerised cognitive test battery was used to assess cognitive performance preoperatively, and three months after surgery. Preoperatively, 76% of patients met the recommended national guidelines for physical activity. The incidence of pre-existing medical conditions, and other pre-operative patient features were similar in active and inactive patients. Preoperative physical activity was significantly inversely related to the logistic EuroSCORE. The level of physical activity was also significantly inversely related with preoperative C-reactive protein (CRP) and peak postoperative CRP, but physical activity did not appear to be associated with any adverse postoperative outcomes or extended length of hospital stay. The incidence of postoperative neurocognitive disorder (PNCD) at 3 months postoperatively was 26%. Cognitive performance was not related with physical activity levels. In summary, this was the first study to assess activity levels of cardiac surgical patients with the SQUASH questionnaire. The majority of patients were physically active. Although physical activity was associated with lower levels of inflammation in this pilot study, it was not associated with an improved clinical or cognitive postoperative outcome.	[Tasbihgou, Setayesh R.; Atmosoerodjo, Sawal D.; Huet, Rolf; Absalom, Anthony R.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands; [Dijkstra, Sandra; Mariani, Massimo A.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiothorac Surg, Groningen, Netherlands; [Tigchelaar, Iris] Univ Med Ctr Groningen, Lab Expt Ophthalmol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Tasbihgou, SR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands.	s.r.tasbihgou@umcg.nl	Tigchelaar, Iris/ABE-3610-2021; Absalom, Anthony/GPG-1582-2022	Tigchelaar, Iris/0000-0003-2853-0495; Dijkstra, Sandra/0000-0001-7937-9743; Absalom, Anthony/0000-0001-7563-9157; Tasbihgou, Setayesh/0000-0002-6147-6163				Acree LS, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-37; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Bohannon RW, 2006, PHYSIOTHERAPY, V92, P11, DOI 10.1016/j.physio.2005.05.003; Brach JS, 2004, J AM GERIATR SOC, V52, P502, DOI 10.1111/j.1532-5415.2004.52154.x; Brown CH, 2016, ANESTH ANALG, V123, P430, DOI 10.1213/ANE.0000000000001271; Bunevicius A, 2011, AM HEART J, V162, P310, DOI 10.1016/j.ahj.2011.05.003; Cabilan C J, 2015, JBI Database System Rev Implement Rep, V13, P146, DOI 10.11124/jbisrir-2015-1885; Carli F, 2012, CAN J ANESTH, V59, P779, DOI 10.1007/s12630-012-9734-4; Chupel MU, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00377; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Elderkin-Thompson V, 2012, AM J GERIAT PSYCHIAT, V20, P753, DOI 10.1097/JGP.0b013e31825d08d6; Evered L, 2018, BRIT J ANAESTH, V121, P1005, DOI 10.1016/j.bja.2017.11.087; Evered LA, 2018, ANESTH ANALG, V127, P496, DOI 10.1213/ANE.0000000000003514; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Foundation ER, 2017, EQ 5D 5L ABOUT ROTTE; Fredrickson J, 2010, NEUROEPIDEMIOLOGY, V34, P65, DOI 10.1159/000264823; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fu LY, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-1241-x; Gezondheidsraad, 2017, BEWEEGRICHTLIJNEN 20; Hayashi K, 2018, ANN THORAC SURG, V106, P505, DOI 10.1016/j.athoracsur.2018.03.010; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Hildebrandt BH, 2015, TRENDRAPPORT BEWEGEN; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hofhuis J, 2003, INTENS CARE MED, V29, P974, DOI 10.1007/s00134-003-1763-6; Hovens IB, 2014, BRAIN BEHAV IMMUN, V38, P202, DOI 10.1016/j.bbi.2014.02.002; Iyengar A, 2020, ANN THORAC SURG, V109, P1120, DOI [10.1016/j.athoracsur.2016.10.087, 10.1016/j.athoracsur.2019.10.087]; Jung P, 2015, J THORAC CARDIOV SUR, V149, P869, DOI 10.1016/j.jtcvs.2014.10.118; Kehler DS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015712; Kemper HGC, 2000, TIJDSCHR SOC GEZONDH, V78, P180; Kim DH, 2016, ANN INTERN MED, V165, P650, DOI 10.7326/M16-0652; Kok WF, 2014, ANAESTHESIA, V69, P613, DOI 10.1111/anae.12634; Lal S, 2019, HEART LUNG CIRC; Lamb SE, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1675; Lavie CJ, 2019, CIRC RES, V124, P799, DOI 10.1161/CIRCRESAHA.118.312669; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Markou Athanasios L P, 2008, Interact Cardiovasc Thorac Surg, V7, P96, DOI 10.1510/icvts.2007.160382; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; Marsland AL, 2006, PSYCHOSOM MED, V68, P895, DOI 10.1097/01.psy.0000238451.22174.92; Marsland AL, 2015, BRAIN BEHAV IMMUN, V48, P195, DOI 10.1016/j.bbi.2015.03.015; Milieu RvVe, 2018, HOEV MENS VOLD DOOR, P1; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Moran J, 2016, SURGERY, V160, P1189, DOI 10.1016/j.surg.2016.05.014; Newman MF, 2006, LANCET, V368, P694, DOI 10.1016/S0140-6736(06)69254-4; Newman MF, 2001, STROKE, V32, P2874, DOI 10.1161/hs1201.099803; Northey JM, 2018, BRIT J SPORT MED, V52, P154, DOI 10.1136/bjsports-2016-096587; Noyez L, 2013, NETH HEART J, V21, P439, DOI 10.1007/s12471-013-0444-5; Olotu C, 2020, CURR OPIN ANESTHESIO, V33, P101, DOI 10.1097/ACO.0000000000000812; Organization WH, 2018, WHO DIS ASS SCHED 2; Papenberg G, 2016, HUM BRAIN MAPP, V37, P3462, DOI 10.1002/hbm.23252; Pedersen BK, 2011, BRAIN BEHAV IMMUN, V25, P811, DOI 10.1016/j.bbi.2011.02.010; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Pol MC, 2011, J AM GERIATR SOC, V59, P1554, DOI 10.1111/j.1532-5415.2011.03514.x; Rasmussen LS, 2006, BEST PRACT RES-CLIN, V20, P315, DOI 10.1016/j.bpa.2005.10.011; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Reeve TE, 2018, J VASC SURG, V67, P1512, DOI 10.1016/j.jvs.2017.08.078; Rogers J, 1997, ANAESTHESIA, V52, P1137, DOI 10.1111/j.1365-2044.1997.240-az0374.x; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Scales DC, 2006, INTENS CARE MED, V32, P1826, DOI 10.1007/s00134-006-0333-0; Sorensen L, 2018, PHYSIOTHER THEOR PR, V34, P637, DOI 10.1080/09593985.2017.1423143; Steffen-Batey L, 2000, CIRCULATION, V102, P2204; Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9; van Harten AE, 2012, ANAESTHESIA, V67, P280, DOI 10.1111/j.1365-2044.2011.07008.x; van Laar C, 2015, NETH HEART J, V23, P174, DOI 10.1007/s12471-015-0660-2; Voelcker-Rehage C, 2013, NEUROSCI BIOBEHAV R, V37, P2268, DOI 10.1016/j.neubiorev.2013.01.028; Wagenmakers R, 2008, PHYS THER, V88, P1039, DOI 10.2522/ptj.20070375; Wagenmakers R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-141; WEBB AR, 1989, JPEN-PARENTER ENTER, V13, P30, DOI 10.1177/014860718901300130; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	74	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240128	10.1371/journal.pone.0240128	http://dx.doi.org/10.1371/journal.pone.0240128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	33048965	Green Published, gold			2022-12-26	WOS:000581813300018
J	Phan, HD; Nguyen, TNP; Bui, PL; Pham, TT; Doan, TV; Nguyen, DT; Minh, HV				Phan, Huong Duong; Nguyen, Thi Ngoc Phuong; Bui, Phuong Linh; Pham, Thanh Tung; Doan, Tuan Vu; Nguyen, Duc Thanh; Van Minh, Hoang			Overweight and obesity among Vietnamese school-aged children: National prevalence estimates based on the World Health Organization and International Obesity Task Force definition	PLOS ONE			English	Article							CHI MINH CITY; RISK-FACTORS; PHYSICAL-ACTIVITY; ASIAN COUNTRIES; ADOLESCENTS; CHILDHOOD; TRENDS; TIME; STUDENTS; DISEASE	Background Overweight and obesity is a severe global health issue in both developed and developing nations. This study aims to estimate the national prevalence of overweight and obesity among school-aged children in Vietnam. Method We conducted a national cross-sectional study on 2788 children aged from 11-14 years old from September to November 2018. We applied the WHO 2007 and IOTF criteria to estimate the prevalence of overweight and obesity among participants. Poison regression analysis with cluster sampling adjustment was employed to assess associated factors with obesity and overweight. Metadata on sociodemographic characteristics, physical measurements, and lifestyle behaviors were also extracted to investigate these factors in association with overweight and obesity prevalence. Results The prevalences of overweight and obesity in Vietnamese children were 17.4% and 8.6%, respectively by WHO Z-score criteria, and 17.1% and 5.4%, according to the IOTF reference. Using WHO Z-score yielded a higher prevalence of obesity than the IOTF and CDC criteria of all ages and both sexes. The proportions of overweight and obesity were substantially higher among boys than girls across ages. Parental BMI was shown to be a significant factor associated with overweight/obesity status in both girls and boys. Only for boys, age (PR = 0.83, 95% CI 0.76-0.90) and belonging to ethnic minorities (PR = 0.43, 95% CI 0.24-0.76) were significant risk factors for overweight/obesity. Conclusion Our findings indicate a high prevalence of childhood overweight and obesity in Vietnam, especially in boys.	[Phan, Huong Duong; Doan, Tuan Vu; Nguyen, Duc Thanh] Natl Hosp Endocrinol, Hanoi, Vietnam; [Nguyen, Thi Ngoc Phuong; Bui, Phuong Linh; Pham, Thanh Tung; Van Minh, Hoang] Hanoi Univ Publ Hlth, Ctr Populat Hlth Sci, Hanoi, Vietnam; [Bui, Phuong Linh] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Pham, Thanh Tung] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Hanoi University of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Bui, PL (corresponding author), Hanoi Univ Publ Hlth, Ctr Populat Hlth Sci, Hanoi, Vietnam.; Bui, PL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	bpl@huph.edu.vn		Pham, Tung/0000-0002-7242-8976; Bui, Linh/0000-0001-5655-3884	State budget for prevention of hazardous infectious diseases and common non-communicable diseases [0649]	State budget for prevention of hazardous infectious diseases and common non-communicable diseases	This study was supported by the State budget for prevention of hazardous infectious diseases and common non-communicable diseases (Funding number: 0649).	Andegiorgish AK, 2012, EUR J PEDIATR, V171, P697, DOI 10.1007/s00431-011-1636-x; Asian & Pacific Islander American Health Forum, 2016, OB OV AS AM CHILDR A; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Sa MPBO, 2017, BRAZ J CARDIOVA SURG, V32, P1, DOI 10.21470/1678-9741-2016-0030; Butte NF, 2007, J NUTR, V137, P153, DOI 10.1093/jn/137.1.153; Cai YJ, 2017, J SPORT HEALTH SCI, V6, P404, DOI 10.1016/j.jshs.2017.09.002; Caleyachetty R, 2015, LANCET DIABETES ENDO, V3, P535, DOI 10.1016/S2213-8587(15)00076-5; Centers for Disease Control and Prevention, 2000, CDC GROWTH CHARTS; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Chung A, 2016, OBES REV, V17, P276, DOI 10.1111/obr.12360; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Garipagaoglu Muazzez, 2009, J Pediatr Nurs, V24, P332, DOI 10.1016/j.pedn.2008.04.003; General Statistics Office of Viet Nam, 2009, 2009 VIETN POP HOUS; Ghanbari S, 2016, J RES MED SCI, V21, DOI 10.4103/1735-1995.193512; Hong TK, 2013, INT J OBESITY, V37, P1261, DOI 10.1038/ijo.2012.217; Huong Thi Le, 2013, Health, V5, P24; Khang YH, 2011, INT J PEDIATR OBES, V6, P206, DOI 10.3109/17477166.2010.490270; Kilpatrick M, 1999, J SCHOOL HEALTH, V69, P148, DOI 10.1111/j.1746-1561.1999.tb04173.x; Loomba-Albrecht LA, 2009, CURR OPIN ENDOCRINOL, V16, P10, DOI 10.1097/MED.0b013e328320d54c; Ma J, 2010, PUBLIC HEALTH NUTR, V13, P1990, DOI 10.1017/S1368980010000492; Mazidi M, 2018, ARCH MED SCI, V14, P1185, DOI 10.5114/aoms.2018.79001; McElhone S, 1999, PUBLIC HEALTH NUTR, V2, P143, DOI 10.1017/S1368980099000191; Ministry of Health NioN The United Nations in Vietnam, 2010, GEN NUTR SURV 2009 2; Mistry SK, 2015, PUBLIC HEALTH, V129, P200, DOI 10.1016/j.puhe.2014.12.004; National Hospital of Endocrinology, 2012, EP NAT DIAB PREV VIE; Nguyen THHD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-141; Nutrition Lanscape Information System (NLIS), 2010, COUNTR PROF IND INT; Organization WH, 2009, GLOB HLTH RISKS MORT; Nguyen PVN, 2016, ASIA PAC J CLIN NUTR, V25, P174, DOI 10.6133/apjcn.2016.25.1.21; Nguyen PVN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-141; Ramachandran A, 2010, J OBES, V2010, DOI 10.1155/2010/868573; Shields M, 2010, INT J PEDIATR OBES, V5, P265, DOI 10.3109/17477160903268282; Song Y, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011904; Suguitan Jr AL, 2011, PLOS ONE, V6; Suguitan Jr AL, 2011, PLOS ONE, V6; SWEETING HN, 2007, NUTR J, V6, DOI DOI 10.1186/1475-2891-6-32; Tang HK, 2007, ASIA PAC J CLIN NUTR, V16, P74; Tang KH, 2010, INT J PEDIATR OBES, V5, P396, DOI 10.3109/17477160903540735; Tewari Aakanksha, 2017, International Journal of Advanced Intelligence Paradigms, V9, P111; To QG, 2018, PUBLIC HEALTH, V160, P18, DOI 10.1016/j.puhe.2018.03.021; Tran Thi Xuan Ngoc, 2012, CURRENT SITUATION EF; Valerio G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083793; Vasques C, 2012, REV PORT CARDIOL, V31, P783, DOI 10.1016/j.repc.2012.03.005; Wang H, 2017, INT J OBESITY, V41, P964, DOI 10.1038/ijo.2017.53; World Health Organization, GROWTH REF 5 19 YEAR; World Health Organization, OB OV 2018; World Health Organization, STUNT NUTSH 2020; World Health Organization, 2017, COMM END CHILDH OB 2; Yang Wai Yew, 2012, JBI Libr Syst Rev, V10, P4568; 2014, REG ANESTH PAIN MED, V9	54	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240459	10.1371/journal.pone.0240459	http://dx.doi.org/10.1371/journal.pone.0240459			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044981	Green Published, gold			2022-12-26	WOS:000581811700059
J	Solari, KA; Hadly, EA				Solari, Katherine A.; Hadly, Elizabeth A.			Experimental study of hypoxia-induced changes in gene expression in an Asian pika, Ochotona dauurica	PLOS ONE			English	Article							PERIPHERAL-BLOOD TRANSCRIPTOME; CYTOCHROME-C-OXIDASE; ALTITUDE DEER MICE; CLIMATE-CHANGE; REVEALS ADAPTATION; GENOME; HEMOGLOBIN; PLASTICITY; EVOLUTION; CAPACITY	Acclimation to environmental changes driven by alterations in gene expression will serve as an important response for some species facing rapid Anthropogenic climate change. Pikas, genusOchotona, are particularly vulnerable to climate change and current trends suggest that only the highest, coldest elevations within their ranges may remain suitable habitat for these species. In this study we aimed to assess the role of changes in gene expression in potentially facilitating elevational movements in pikas by measuring gene expression in the only known captive pika population,Ochotona dauurica, in response to hypoxic conditions. Using a controlled experiment, we exposed four male pikas to oxygen concentrations characteristic of sea-level, 2,000 m, and 4,000 m for 5 days each. Using blood samples collected after each treatment, we used RNAseq to determine if candidate pathways were undergoing significant changes in gene expression at different levels of oxygen (similar to 100%, similar to 77%, and similar to 1% of sea-level oxygen concentrations). Gene set enrichment analyses showed that gene sets associated with the oxidative phosphorylation pathway and electron transport chain were significantly enriched for up-regulated genes in the 4,000 m samples compared to samples from the same individuals at lower-elevation conditions. Up-regulation of these pathways is consistent with known mechanisms of oxygen compensation. Our results suggest that these pikas have the acclimation capacity to tolerate oxygen concentrations characteristic of any elevation within their species range and that gene expression can be changed in a matter of days to accommodate drastically different oxygen concentrations. Thus, rapid and radical elevational movements that may be required of some pika species to avoid warmer temperatures in the Anthropocene will likely not be limited by hypoxic stress.	[Solari, Katherine A.; Hadly, Elizabeth A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Solari, Katherine A.; Hadly, Elizabeth A.] Stanford Univ, Program Conservat Genom, Stanford, CA 94305 USA; [Hadly, Elizabeth A.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Hadly, Elizabeth A.] Stanford Univ, Ctr Innovat Global Hlth, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Solari, KA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Solari, KA (corresponding author), Stanford Univ, Program Conservat Genom, Stanford, CA 94305 USA.	ksolari@stanford.edu			Stanford University; Lewis and Clark Fund for Exploration and Field Research	Stanford University(Stanford University); Lewis and Clark Fund for Exploration and Field Research	This work was supported by Stanford University (KAS and EAH, www.stanford.edu), The Stanford Center for Computational, Evolutionary, and Human Genomics (KAS, cehg.stanford.edu/), the Professor Gilda H. Loew Fellowship (KAS), and the Lewis and Clark Fund for Exploration and Field Research (KAS, www.amphilsoc.org/grants/lewis-and-clark-fund-exploration-and-field-research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2005, HSB (Health Science Bulletin), V3, P5; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2012, REGEN MED S3, V7, pS14; Appenzeller O, 2006, J NEUROL SCI, V247, P93, DOI 10.1016/j.jns.2006.03.021; Barnosky AD, 2007, BIOSCIENCE, V57, P523, DOI 10.1641/B570615; Beall CM, 2002, P NATL ACAD SCI USA, V99, P17215, DOI 10.1073/pnas.252649199; Beall CM, 1998, AM J PHYS ANTHROPOL, V106, P385, DOI 10.1002/(SICI)1096-8644(199807)106:3<385::AID-AJPA10>3.3.CO;2-6; Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Bhattacharyya S, 2019, MOL ECOL, V28, P250, DOI 10.1111/mec.14842; Bhattacharyya S, 2014, ZOOL STUD, V53, DOI 10.1186/s40555-014-0073-8; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cheviron ZA, 2008, MOL ECOL, V17, P4556, DOI 10.1111/j.1365-294X.2008.03942.x; Cheviron ZA, 2014, EVOLUTION, V68, P48, DOI 10.1111/evo.12257; Cheviron ZA, 2012, P NATL ACAD SCI USA, V109, P8635, DOI 10.1073/pnas.1120523109; Cho YS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3433; Cook, 2016, IUCN RED LIST THREAT, V2016, DOI DOI 10.2305/IUCN.UK.2016-3.RLTS.T41259A45182905.EN; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Dosek A, 2007, RESP PHYSIOL NEUROBI, V158, P128, DOI 10.1016/j.resp.2007.03.013; Fujibuchi W, 1998, PACIFIC S BIOCOMPUT, V3, P683; Ge DY, 2012, PALAEOGEOGR PALAEOCL, V326, P160, DOI 10.1016/j.palaeo.2012.02.016; Ge RL, 1998, AM J PHYSIOL-HEART C, V274, pH1792, DOI 10.1152/ajpheart.1998.274.5.H1792; Gibson PH, 2010, AM J CARDIOL, V105, P186, DOI 10.1016/j.amjcard.2009.09.007; Gou X, 2014, GENOME RES, V24, P1308, DOI 10.1101/gr.171876.113; Guan LH, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0192-1; Guralnick R, 2007, GLOBAL ECOL BIOGEOGR, V16, P14, DOI [10.1111/j.1466-822X.2006.00260.x, 10.1111/j.1466-8238.2006.00260.x]; Habersetzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075429; Huang ZX, 2016, MOL ECOL RESOUR, V16, P150, DOI 10.1111/1755-0998.12447; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Johnson B, 2014, ADV GENOMICS GENET; Koju NP, 2017, MOL PHYLOGENET EVOL, V107, P239, DOI 10.1016/j.ympev.2016.11.005; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Liao J, 2006, ACTA ZOOL ACAD SCI H, V52, P319; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Lincoln JR, 1996, DICT ECOLOGY EVOLUTI; Lissovsky AA, 2016, ZOOL SCR, V45, P583, DOI 10.1111/zsc.12180; Lissovsky AA, 2014, MAMMALIA, V78, P199, DOI 10.1515/mammalia-2012-0134; Liu G, 2019, ORG DIVERS EVOL; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Luo YJ, 2008, MITOCHONDRION, V8, P352, DOI 10.1016/j.mito.2008.07.005; MACARTHUR RA, 1974, CAN J ZOOL, V52, P353, DOI 10.1139/z74-042; Mach N, 2016, SCI REP-UK, V6, DOI 10.1038/srep22932; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moyer-Horner L, 2015, ECOL EVOL, V5, pS810, DOI 10.1002/ece3.1848; Pan SK, 2017, MOL ECOL, V26, P2993, DOI 10.1111/mec.14090; Parry M., 2007, WORKING GROUP 2 CONT, P883, DOI DOI 10.2134/JEQ2008.0015BR; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Quintero I, 2013, ECOL LETT, V16, P1095, DOI 10.1111/ele.12144; Scott GR, 2015, MOL BIOL EVOL, V32, P1962, DOI 10.1093/molbev/msv076; Scott GR, 2011, MOL BIOL EVOL, V28, P351, DOI 10.1093/molbev/msq205; SMITH A E, 1990, P14; SMITH A T, 1990, Mammalian Species, P1, DOI 10.2307/3504319; Solari KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207936; Solari KA, 2018, INTEGR ZOOL, V13, P517, DOI 10.1111/1749-4877.12332; Solari KA, 2016, EVOL ECOL RES, V17, P787; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stewart JAE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181834; Stewart JAE, 2015, J BIOGEOGR, V42, P880, DOI 10.1111/jbi.12466; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Storz JF, 2019, ANN REV ECOL EVOL SY; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tomasco IH, 2014, GENE, V534, P371, DOI 10.1016/j.gene.2013.09.097; Tufts DM, 2015, MOL BIOL EVOL, V32, P287, DOI 10.1093/molbev/msu311; Velotta JP, 2016, MOL ECOL, V25, P2870, DOI 10.1111/mec.13661; Wilkening JL, 2016, J MAMMAL, V97, P1366, DOI 10.1093/jmammal/gyw097; Windsor JS, 2007, POSTGRAD MED J, V83, P148, DOI 10.1136/pgmj.2006.049734; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang WP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004466	78	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240435	10.1371/journal.pone.0240435	http://dx.doi.org/10.1371/journal.pone.0240435			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044983	gold, Green Published			2022-12-26	WOS:000581811700007
J	Younis, I; Longsheng, C; Basheer, MF; Joyo, AS				Younis, Ijaz; Longsheng, Cheng; Basheer, Muhammad Farhan; Joyo, Ahmed Shafique			Stock market comovements among Asian emerging economies: A wavelet-based approach	PLOS ONE			English	Article							BUSINESS-CYCLE SYNCHRONIZATION; HEMISPHERIC SUNSPOT ACTIVITY; COMMON STOCHASTIC TRENDS; PHASE COHERENCE ANALYSIS; CO-MOVEMENT; COINTEGRATION ANALYSIS; CONVERGENCE EVIDENCE; FINANCIAL CRISIS; EQUITY MARKETS; PACIFIC	Stock market, is one of the most important financial market which has a close relationship with a country's economy, due to which it is often called the barometer of the economy. Over the past 25 years, the stock markets have been affected by different global economic shocks. Various researchers have analyzed different aspects of these effects one by one, however, this study is an assessment of stock market interrelationship of emeriging Asian economies which include most of the East Asian, and Southeast Asian emerging economies with special focus on China for past decades during which different crisis occurred. We used Morgan Stanley capital international (MSCI) daily indices data for each stock market and compared Chinese stock market with the stock markets of India, Pakistan, Malaysia, Singapore, and Indonesia. We analyzed the data through the individual wavelet power spectrum, cross-wavelet transform and wavelet coherence, to determine the correlation and volatility among the selected stock markets. These model have the power to analyze co-movements among these countries with respect to both frequency and time spaces. Our findings show that there are co-movement patterns of higher frequencies during the crises periods of 1997, 2008 and 2015. The dependency strength among the considered economies is noted to increase in the crisis periods, which implies increased short- and long-term benefits for the investors. From a financial point of view, it has been determined that the co-movement strength among the emerging economies of Asia may have an effect on the VaR (Value at Risk) levels of a multi-country portfolio. Furthermore, the stock market of China shows a high correlation with the other six Asian stock emerging markets in both high and low-frequency spectrums. The association of the south and east Asian stock market with Chinese stock markets show the interconnection of these economies with the economy of China since past two decades. These findings are useful for investors, portfolio managers and the policymaker around the globe.	[Younis, Ijaz; Longsheng, Cheng] Nanjing Univ Sci & Technol, Sch Econ & Management, Nanjing, Peoples R China; [Basheer, Muhammad Farhan] Univ Utara Malaysia UUM, Sch Econ Finance & Banking SEFB, Sintok, Kedah, Malaysia; [Joyo, Ahmed Shafique] Shaheed Benazir Bhutto Univ, Dept Business Adm, Shaheed Benazirabad, Pakistan	Nanjing University of Science & Technology; Universiti Utara Malaysia	Younis, I; Longsheng, C (corresponding author), Nanjing Univ Sci & Technol, Sch Econ & Management, Nanjing, Peoples R China.	ijazyounis@njust.edu.cn; cheng_longsheng@163.com	Younis, Ijaz/AID-3974-2022	Younis, Ijaz/0000-0001-9828-8441; Basheer, Muhammad Farhan/0000-0001-8622-9866	National Nature Science Foundation of China [71271114]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by The National Nature Science Foundation of China (71271114). In addition, NUST Business School (NBS), National University of Science and Technology (NUST) paid for the authors to access the data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aamir M, 2018, J RISK FINANC MANAG, V11, DOI 10.3390/jrfm11030032; Aguiar-Conraria L, 2008, PHYSICA A, V387, P2863, DOI 10.1016/j.physa.2008.01.063; Akoum I, 2012, Q REV ECON FINANC, V52, P385, DOI 10.1016/j.qref.2012.07.005; Aloui C, 2018, RES INT BUS FINANC, V44, P411, DOI 10.1016/j.ribaf.2017.07.112; Aloui C, 2016, ECON MODEL, V52, P322, DOI 10.1016/j.econmod.2015.09.009; Aloui C, 2014, ECON MODEL, V36, P421, DOI 10.1016/j.econmod.2013.09.043; [Anonymous], 2019, VOXEU; [Anonymous], 1995, PAC-BASIN FINANC J, DOI DOI 10.1016/0927-538X(94)00025-3; [Anonymous], 2004, LEVIA GRAVIA, V6, P81; [Anonymous], 2003, J ASIAN ECON, DOI DOI 10.1016/S1049-0078(03)00018-6; Awokuse TO, 2009, ECON MODEL, V26, P549, DOI 10.1016/j.econmod.2008.12.001; Banerjee S, 2014, P 2014 INT C CONTR I; Benhmad F, 2013, ECON MODEL, V32, P576, DOI 10.1016/j.econmod.2013.02.031; Berdiev AN, 2015, J ASIAN ECON, V37, P20, DOI 10.1016/j.asieco.2015.01.004; Bloomfield DS, 2004, ASTROPHYS J, V617, P623, DOI 10.1086/425300; Bu H, 2019, TIME VARYING COMOVEM; Burdekin R, 2012, ENTER DRAGON INTERAC; Burdekin RCK, 2012, PAC-BASIN FINANC J, V20, P521, DOI 10.1016/j.pacfin.2011.12.004; Carvalho M, 2019, ECONOMIES, V7, DOI 10.3390/economies7020045; Chen CH, 2012, INT J FORECASTING, V28, P366, DOI 10.1016/j.ijforecast.2011.04.005; Cheng H, 2005, REV QUANT FINANC ACC, V24, P343, DOI 10.1007/s11156-005-7017-7; Chien MS, 2015, ECON MODEL, V51, P84, DOI 10.1016/j.econmod.2015.06.024; Chittedi KR, 2015, GLOB BUS REV, V16, P50, DOI 10.1177/0972150914553507; Choudhry T., 2007, INT REV FINANCIAL AN, V16, P242, DOI DOI 10.1016/J.IRFA.2006.12.001; CHOWDHURY AR, 1994, J MACROECON, V16, P629, DOI 10.1016/0164-0704(94)90004-3; CHUNG PJ, 1994, Q REV ECON FINANC, V34, P241, DOI 10.1016/1062-9769(94)90026-4; Conlon T, 2008, PHYSICA A, V387, P5197, DOI 10.1016/j.physa.2008.05.046; Conlon T, 2016, EUR J FINANC, V22, P1534, DOI 10.1080/1351847X.2015.1031912; Conlon T, 2012, J FUTURES MARKETS, V32, P272, DOI 10.1002/fut.20519; CORHAY A, 1993, ECON LETT, V42, P385, DOI 10.1016/0165-1765(93)90090-Y; Crowley PM., 2009, J BUS CYCLE MEAS ANA, V2008, P63, DOI [10.1787/jbcma-v2008-art4-en, DOI 10.1787/JBCMA-V2008-ART4-EN]; Darrat A. F., 2002, FINANC REV, V37, P35; Dhanaraj S, 2013, DYNAMIC INTERDEPENDE; Dommer L, 2012, BEHAV BRAIN RES, V234, P212, DOI 10.1016/j.bbr.2012.06.024; Donner R, 2007, ASTRON ASTROPHYS, V475, pL33, DOI 10.1051/0004-6361:20078672; EUN CS, 1989, J FINANC QUANT ANAL, V24, P241, DOI 10.2307/2330774; Fernandez V., 2006, INT REV FINANC ANAL, V15, P203, DOI [10.1016/j.irfa.2005.02.004, DOI 10.1016/J.IRFA.2005.02.004]; Forbes K, 2000, CONTAGION LATIN AM D; Gallegati M, 2005, WAVELET VARIANCE COR, V512017, P1; Gallegati M, 2018, CLIMATIC CHANGE, V148, P325, DOI 10.1007/s10584-018-2172-8; Gencay R, 2005, J INT MONEY FINANC, V24, P55, DOI 10.1016/j.jimonfin.2004.10.003; Graham M, 2013, J ECON BUS, V65, P86, DOI 10.1016/j.jeconbus.2012.09.005; Graham M, 2012, GLOB FINANC J, V23, P34, DOI 10.1016/j.gfj.2012.01.003; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; GRUBEL HG, 1968, AM ECON REV, V58, P1299; Hassan M, 2010, IRBM, V31, P182, DOI 10.1016/j.irbm.2009.12.004; Hee Ng TJAEJ, 2002, STOCK MARKET LINKAGE, V16, P353; Huang Bwo-Nung., 2000, INT REV FINANC ANAL, V9, P281, DOI [DOI 10.1016/S1057-5219(00)00031-4, 10.1016/S1057-5219(00)00031-4]; Huang CHJIJoEM, 2012, STABILITY LONG RUN R; Huang Y, 2019, IMF ECON REV, V67, P349, DOI 10.1057/s41308-019-00079-z; Hung B., 1995, J BUSINESS FINANCE A, V22, P281; In F, 2006, J MULTINATL FINANC M, V16, P411, DOI 10.1016/j.mulfin.2005.09.002; Jiang YH, 2017, ECON MODEL, V64, P384, DOI 10.1016/j.econmod.2017.04.012; Jorion PJJoB, 1985, INT PORTFOLIO DIVERS, P259; Keim MJ, 2015, J R STAT SOC C-APPL, V64, P377, DOI 10.1111/rssc.12079; Kelly BC, 2003, ASTROPHYS J, V591, P695, DOI 10.1086/375511; Khan S, 2009, J ASIAN ECON, V20, P561, DOI 10.1016/j.asieco.2009.07.001; Kim S., 2005, J EMPIR FINANC, V12, P435, DOI [10.1016/j.jempfin.2004.04.008, DOI 10.1016/J.JEMPFIN.2004.04.008]; 김유신, 2012, [Journal of Intelligence and Information Systems, 지능정보연구], V18, P143; Lai Y, 2010, INT REV ECON FINANC, V19, P211, DOI 10.1016/j.iref.2009.10.004; Li KJ, 2009, ASTROPHYS J, V691, P537, DOI 10.1088/0004-637X/691/1/537; Lin KP, 2009, CHINA ECON REV, V20, P29, DOI 10.1016/j.chieco.2008.11.003; Liu LT, 2005, J GEODYN, V39, P267, DOI 10.1016/j.jog.2004.11.003; Loh LX, 2013, RES INT BUS FINANC, V29, P1, DOI 10.1016/j.ribaf.2013.01.001; Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684; Madaleno M., 2010, REV EC FINANCIERA, V20, P69; Madaleno M, 2012, INT J FINANC ECON, V17, P89, DOI 10.1002/ijfe.448; Manning N, 2002, J INT MONEY FINANC, V21, P183, DOI 10.1016/S0261-5606(01)00038-9; Masih M., 2010, INT REV FINANC ANAL, V19, P10, DOI [DOI 10.1016/J.IRFA.2009.12.001, DOI 10.1016/j.irfa.2009.12.001]; Masson, 1998, CONTAGION MONSOONAL; Mobarek A., 2013, GLOBAL STOCK MARKET; Mobarek A., 2015, GLOBAL STOCK MARKET; Mylonidis N, 2010, J BANK FINANC, V34, P2056, DOI 10.1016/j.jbankfin.2010.01.012; Paramati SR, 2015, APPL ECON, V47, P5303, DOI 10.1080/00036846.2015.1047088; Qassim YT, 2013, COMPUT BIOL MED, V43, P23, DOI 10.1016/j.compbiomed.2012.10.008; Quach A, 2019, Aging, V11, P303; Reinhart CM, 2008, AM ECON REV, V98, P339, DOI 10.1257/aer.98.2.339; Reinhart CM, 2009, AM ECON REV, V99, P466, DOI 10.1257/aer.99.2.466; Rua A, 2012, Q REV ECON FINANC, V52, P84, DOI 10.1016/j.qref.2011.12.001; Rua A, 2009, J EMPIR FINANC, V16, P632, DOI 10.1016/j.jempfin.2009.02.002; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Trimech A, 2009, J RISK FINANC, V10, P179, DOI 10.1108/15265940910938251; Vacha L., 2011, CO MOVEMENT CENTRAL, V22; Vacha L, 2012, ENERG ECON, V34, P241, DOI 10.1016/j.eneco.2011.10.007; Wang K, 2011, INT REV ECON FINANC, V20, P654, DOI 10.1016/j.iref.2010.12.003; Vo XV, 2018, EMERG MARK REV, V36, P19, DOI 10.1016/j.ememar.2018.03.007; Yang J, 2003, APPL FINANCIAL EC, V13, P477, DOI DOI 10.1080/09603100210161965; Zamani A, 2013, TECTONOPHYSICS, V601, P139, DOI 10.1016/j.tecto.2013.05.005; Zhao SM, 2019, PHYSICA A, V520, P161, DOI 10.1016/j.physa.2019.01.006; ZIOBROWSKI BJ, 1995, J INT MONEY FINANC, V14, P65, DOI 10.1016/0261-5606(94)00007-N; Zonouzi SJM, 2014, INT J ISLAMIC MIDDLE, V7, P457, DOI 10.1108/IMEFM-02-2014-0017	93	9	9	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240472	10.1371/journal.pone.0240472	http://dx.doi.org/10.1371/journal.pone.0240472			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TU	33044995	Green Published, gold			2022-12-26	WOS:000581811700001
J	Adhitama, N; Kato, Y; Matsuura, T; Watanabe, H				Adhitama, Nikko; Kato, Yasuhiko; Matsuura, Tomoaki; Watanabe, Hajime			Roles of and cross-talk between ecdysteroid and sesquiterpenoid pathways in embryogenesis of branchiopod crustaceanDaphnia magna	PLOS ONE			English	Article							STEROID-HORMONE BIOSYNTHESIS; JUVENILE-HORMONE; WATER FLEA; DAPHNIA-MAGNA; CYTOCHROME-P450 ENZYME; METHYL FARNESOATE; P450 ENZYMES; ECDYSONE; GENES; METHYLTRANSFERASE	The ecdysteroid and sesquiterpenoid pathways control growth, developmental transition, and embryogenesis in insects. However, the function of orthologous genes and the cross-talk between both pathways remain largely uncharacterized in non-insect arthropods.Spook(Spo) andJuvenile hormone acid o-methyltransferase(Jhamt) have been suggested to function as rate-limiting factors in ecdysteroid and sesquiterpenoid biosynthesis, respectively, in insects. In this study, we report on the functions ofSpoandJhamtand the cross-talk between them in embryos of the branchiopod crustaceanDaphnia magna.Spoexpression was activated at the onset of gastrulation, with the depletion ofSpotranscript by RNAi resulting in developmental arrest at this stage. This phenotype could be partially rescued by supplementation with 20-hydroxyecdysone, indicating thatSpomay play the same role in ecdysteroid biosynthesis in early embryos, as reported in insects. After hatching,Spoexpression was repressed, whileJhamtexpression was activated transiently, despite its silencing during other embryonic stages.JhamtRNAi showed little effect on survival, but shortened the embryonic period. Exposure to the sesquiterpenoid analog Fenoxycarb extended the embryonic period and rescued theJhamtRNAi phenotype, demonstrating a previously unidentified role of sesquiterpenoid in the repression of precocious embryogenesis. Interestingly, the knockdown ofJhamtresulted in the derepression of ecdysteroid biosynthesis genes, includingSpo, similar to regulation during insect hormonal biosynthesis. Sesquiterpenoid signaling via theMethoprene-tolerantgene was found to be responsible for the repression of ecdysteroid biosynthesis genes. It upregulated an ortholog ofCYP18a1that degrades ecdysteroid in insects. These results illuminate the conserved and specific functions of the ecdysteroid and sesquiterpenoid pathways inDaphniaembryos. We also infer that the common ancestor of branchiopod crustaceans and insects exhibited antagonism between the two endocrine hormones before their divergence 400 million years ago.	[Adhitama, Nikko; Kato, Yasuhiko; Matsuura, Tomoaki; Watanabe, Hajime] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Adhitama, Nikko] Osaka Univ, Biotechnol Global Human Resource Dev Program, Div Adv Sci & Biotechnol, Dept Biotechnol,Grad Sch Engn, Suita, Osaka, Japan; [Kato, Yasuhiko] Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Watanabe, H (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan.	watanabe@bio.eng.osaka-u.ac.jp	WATANABE, Hajime/AAJ-8904-2021; matsuura, tomoaki/O-7368-2018; Kato, Yasuhiko/AES-3929-2022	matsuura, tomoaki/0000-0003-1015-6781; Kato, Yasuhiko/0000-0002-1041-1044; Watanabe, Hajime/0000-0001-9657-6554; Adhitama, Nikko/0000-0001-7864-7654	Japan Society for Promotion of Science, KAKENHI, Japan [17H01880 18H04619, 19H05423 20H04923, 18H04884]; Frontier Research Base for Global Young Researchers, Osaka University	Japan Society for Promotion of Science, KAKENHI, Japan; Frontier Research Base for Global Young Researchers, Osaka University	HW: 17H01880 18H04619 YK: 19H05423 20H04923 Kato Yasuhiko; 18H04884. from Japan Society for Promotion of Science, KAKENHI, Japan https://www.jsps.go.jp/english/index.html.; YK gratefully acknowledges the support of the Frontier Research Base for Global Young Researchers, Osaka University.	Adhitama N, 2018, MAR ENVIRON RES, V140, P375, DOI 10.1016/j.marenvres.2018.07.003; [Anonymous], 2018, LANCET HAEMATOL, V5, pE127, DOI 10.1016/S2352-3026(18)30037-1; Asada M, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu043; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Daimon T, 2015, P NATL ACAD SCI USA, V112, pE4226, DOI 10.1073/pnas.1506645112; ELENDT BP, 1990, WATER RES, V24, P1157, DOI 10.1016/0043-1354(90)90180-E; Fernandez-Nicolas A, 2017, DEVELOPMENT, V144, P4637, DOI 10.1242/dev.152827; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gunawardene YINS, 2002, EUR J BIOCHEM, V269, P3587, DOI 10.1046/j.1432-1033.2002.03048.x; Jindra M, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2019.0064; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Jockusch E. L., 2015, EVOLUTIONARY DEV BIO, V5, P111, DOI DOI 10.1007/978-3-7091-1868-9_; Kato Y, 2007, J ENDOCRINOL, V193, P183, DOI 10.1677/JOE-06-0228; Kato Y, 2018, CURR BIOL, V28, P1811, DOI 10.1016/j.cub.2018.04.029; Kato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045318; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Kumagai H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186112; Lee BY, 2019, AQUAT TOXICOL, V210, P69, DOI 10.1016/j.aquatox.2019.02.009; Mittmann B, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-12; Miura T, 2019, DEV GROWTH DIFFER, V61, P85, DOI 10.1111/dgd.12572; Miyakawa H, 2014, CURR OPIN INSECT SCI, V1, P81, DOI 10.1016/j.cois.2014.04.006; Miyakawa H, 2013, J EXP ZOOL PART A, V319, P440, DOI 10.1002/jez.1807; Miyakawa H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2868; Miyakawa H, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-45; Naitou A, 2015, BIOL OPEN, V4, P364, DOI 10.1242/bio.20149738; Nakanishi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36252; Nakanishi T, 2015, SCI REP-UK, V5, DOI 10.1038/srep18312; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa YS, 2016, DEV GROWTH DIFFER, V58, P94, DOI 10.1111/dgd.12248; Noriega Fernando G., 2014, ISRN Zoology, P967361, DOI 10.1155/2014/967361; Oda S, 2011, ENVIRON TOXICOL CHEM, V30, P232, DOI 10.1002/etc.378; Olesen J, 2004, CRUSTACEAN ISS, V15, P217; Olmstead AW, 2002, J EXP ZOOL, V293, P736, DOI 10.1002/jez.10162; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Ono H, 2014, DEV BIOL, V391, P32, DOI 10.1016/j.ydbio.2014.04.004; Orsini L, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.30; Panfilio KA, 2008, DEV BIOL, V313, P471, DOI 10.1016/j.ydbio.2007.11.004; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Qu Z, 2015, GENOME BIOL EVOL, V7, P1951, DOI 10.1093/gbe/evv120; Rewitz KF, 2006, BIOCHEM SOC T, V34, P1256, DOI 10.1042/BST0341256; Rewitz KF, 2006, INSECT BIOCHEM MOLEC, V36, P188, DOI 10.1016/j.ibmb.2005.12.002; Rewitz KF, 2010, DEV CELL, V19, P895, DOI 10.1016/j.devcel.2010.10.021; Rewitz KF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-60; Sagawa K, 2005, GENE EXPR PATTERNS, V5, P669, DOI 10.1016/j.modgep.2005.02.007; Schwentner M, 2017, CURR BIOL, V27, P1818, DOI 10.1016/j.cub.2017.05.040; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Sin YW, 2015, GEN COMP ENDOCR, V214, P167, DOI 10.1016/j.ygcen.2014.07.018; Sonobe H, 2004, ZOOL SCI, V21, P503, DOI 10.2108/zsj.21.503; Subcomision de Humanidades, 2017, ARCH ARGENT PEDIA S5, V115, P599; Sumiya E, 2016, J APPL TOXICOL, V36, P1476, DOI 10.1002/jat.3306; Sumiya E, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0060-2; Tatarazako N, 2003, CHEMOSPHERE, V53, P827, DOI 10.1016/S0045-6535(03)00761-6; Torner K, 2014, MOL GENET GENOMICS, V289, P707, DOI 10.1007/s00438-014-0830-8; Toyota K, 2015, J INSECT PHYSIOL, V80, P22, DOI 10.1016/j.jinsphys.2015.02.002; Truman JW, 2019, CURR BIOL, V29, pR1252, DOI 10.1016/j.cub.2019.10.009; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230	62	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239893	10.1371/journal.pone.0239893	http://dx.doi.org/10.1371/journal.pone.0239893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035251	Green Published, gold			2022-12-26	WOS:000581817500031
J	Bhagirath, D; Liston, M; Patel, N; Akoto, T; Lui, B; Yang, TL; To, DM; Majid, S; Dahiya, R; Tabatabai, ZL; Saini, S				Bhagirath, Divya; Liston, Michael; Patel, Nikhil; Akoto, Theresa; Lui, Byron; Yang, Thao Ly; To, Dat My; Majid, Shahana; Dahiya, Rajvir; Tabatabai, Z. Laura; Saini, Sharanjot			MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer	ONCOGENE			English	Article							INCREASED SURVIVAL; ENZALUTAMIDE; ABIRATERONE; CELLS; IDENTIFICATION; COMMON; MEN; AR	Therapy-induced neuroendocrine prostate cancer (NEPC), an extremely aggressive variant of castration-resistant prostate cancer (CRPC), is increasing in incidence with the widespread use of highly potent androgen receptor (AR)-pathway inhibitors (APIs) such as Enzalutamide (ENZ) and Abiraterone and arises via a reversible trans-differentiation process, referred to as neuroendocrine differentiation (NED). The molecular basis of NED is not completely understood leading to a lack of effective molecular markers for its diagnosis. Here, we demonstrate for the first time, that lineage switching to NE states is accompanied by key miRNA alterations including downregulation of miR-106a similar to 363 cluster and upregulation of miR-301a and miR-375. To systematically investigate the key miRNAs alterations driving therapy-induced NED, we performed small RNA-NGS in a retrospective cohort of human metastatic CRPC clinical samples + PDX models with adenocarcinoma features (CRPC-adeno) vs those with neuroendocrine features (CRPC-NE). Further, with the application of machine learning algorithms to sequencing data, we trained a 'miRNA classifier' that could robustly classify 'CRPC-NE' from 'CRPC-Adeno' cases. The performance of classifier was validated in an additional cohort of mCRPC patients and publicly available PCa cohorts. Importantly, we demonstrate that miR-106a similar to 363 cluster pleiotropically regulate cardinal nodal proteins instrumental in driving NEPC including Aurora Kinase A, N-Myc, E2F1 and STAT3. Our study has important clinical implications and transformative potential as our 'miRNA classifier' can be used as a molecular tool to stratify mCRPC patients into those with/without NED and guide treatment decisions. Further, we identify novel miRNA NED drivers that can be exploited for NEPC therapeutic targeting.	[Bhagirath, Divya; Akoto, Theresa; Saini, Sharanjot] Augusta Univ, Dept Biochem & Mol Biol, Augusta, GA USA; [Liston, Michael; Lui, Byron; Yang, Thao Ly; To, Dat My; Majid, Shahana; Dahiya, Rajvir; Tabatabai, Z. Laura] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Liston, Michael; Lui, Byron; Yang, Thao Ly; To, Dat My; Majid, Shahana; Dahiya, Rajvir; Tabatabai, Z. Laura] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Patel, Nikhil] Augusta Univ, Dept Pathol, Augusta, GA USA	University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University System of Georgia; Augusta University	Saini, S (corresponding author), Augusta Univ, Dept Biochem & Mol Biol, Augusta, GA USA.	ssaini@augusta.edu	Patel, Nikhil/O-6072-2018	Patel, Nikhil/0000-0001-9335-0082	US Army Medical Research Acquisition Activity (USAMRAA) through the Idea Development Award [W81XWH-18-1-0303]; National Cancer Institute at the National Institutes of Health [RO1CA177984]; Prostate Cancer Biorepository Network (PCBN) [W81XWH-18-2-0013, W81XWH-18-2-0015, W81XWH-18-2-0016, W81XWH-18-2-0017, W81XWH-18-2-0018, W81XWH-18-2-0019]	US Army Medical Research Acquisition Activity (USAMRAA) through the Idea Development Award; National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Biorepository Network (PCBN)	We sincerely thank Dr. Paul Jedlicka at University of Colorado, Denver for miR-106a-363 sponge and control constructs and Dr. Felix Feng at UCSF for LNCaP-AR-Enzalutamide resistant cell line. This work is supported by the US Army Medical Research Acquisition Activity (USAMRAA) through the Idea Development Award under Award No. W81XWH-18-1-0303. Additionally, supported by Award no. W81XWH-18-2-0013, W81XWH-18-2-0015, W81XWH-18-2-0016, W81XWH-18-2-0017, W81XWH-18-2-0018, and W81XWH-18-2-0019 Prostate Cancer Biorepository Network (PCBN). Funding support by the National Cancer Institute at the National Institutes of Health (Grant Number RO1CA177984) is also acknowledged. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense or the U.S. Army.	Aggarwal R, 2018, J CLIN ONCOL, V36, P2492, DOI 10.1200/JCO.2017.77.6880; Aggarwal R, 2014, J NATL COMPR CANC NE, V12, P719, DOI 10.6004/jnccn.2014.0073; Aggarwal RR, 2014, ONCOLOGY-NY, V28, P838; Alshalalfa M, 2019, INT J CANCER, V145, P3453, DOI 10.1002/ijc.32430; Antonarakis ES, 2017, J CLIN ONCOL, V35, P2149, DOI 10.1200/JCO.2016.70.1961; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Beltran H, 2019, CLIN CANCER RES, V25, P43, DOI 10.1158/1078-0432.CCR-18-1912; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Berger A, 2019, J CLIN INVEST, V129, P3924, DOI 10.1172/JCI127961; Bhagirath D, 2019, CLIN CANCER RES, V25, P6532, DOI 10.1158/1078-0432.CCR-19-0498; Bishop JL, 2017, CANCER DISCOV, V7, P54, DOI 10.1158/2159-8290.CD-15-1263; Chen SY, 2019, AM J CLIN EXP UROL, V7, P327; Damodaran C, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.03.009; Dang Q, 2015, MOL ONCOL, V9, P1241, DOI 10.1016/j.molonc.2015.02.010; Dankert JT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200472; Dardenne E, 2016, CANCER CELL, V30, P563, DOI 10.1016/j.ccell.2016.09.005; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Ding M, 2015, ONCOTARGET, V6, P7686, DOI 10.18632/oncotarget.3480; Dylla L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063032; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Fernandes RC, 2019, ENDOCR-RELAT CANCER, V26, pR237, DOI 10.1530/ERC-18-0571; Gupta K, 2017, TRANSL CANCER RES, V6, pS104, DOI 10.21037/tcr.2017.01.20; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Hu CD, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00090; Hussain M, 2018, NEW ENGL J MED, V379, P1381, DOI 10.1056/NEJMc1810065; Hussain M, 2018, NEW ENGL J MED, V378, P2465, DOI 10.1056/NEJMoa1800536; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Kojima S, 2017, J HUM GENET, V62, P25, DOI 10.1038/jhg.2016.69; Labrecque MP, 2019, J CLIN INVEST, V129, P4492, DOI 10.1172/JCI128212; LAI SL, 1995, ANTICANCER RES, V15, P225; Lee JK, 2016, CANCER CELL, V29, P536, DOI 10.1016/j.ccell.2016.03.001; Li Z, 2015, MOL CANCER RES, V13, P584, DOI 10.1158/1541-7786.MCR-14-0277-T; Liu B, 2019, CLIN CANCER RES, V25, P6839, DOI 10.1158/1078-0432.CCR-19-0317; Lotan TL, 2011, MODERN PATHOL, V24, P820, DOI 10.1038/modpathol.2011.7; Maina PK, 2016, ONCOTARGET, V7, P75585, DOI 10.18632/oncotarget.12310; Nam Robert K, 2018, Oncotarget, V9, P19159, DOI 10.18632/oncotarget.24937; Nam RK, 2016, PROSTATE, V76, P869, DOI 10.1002/pros.23177; Nam RK, 2015, J CANCER, V6, P1160, DOI 10.7150/jca.13397; Nguyen HM, 2017, PROSTATE, V77, P654, DOI 10.1002/pros.23313; Park JW, 2018, SCIENCE, V362, P91, DOI 10.1126/science.aat5749; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sasaki T, 2005, EUR UROL, V48, P224, DOI 10.1016/j.eururo.2005.03.017; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schlomm T, 2016, EUR UROL, V69, P1157, DOI 10.1016/j.eururo.2016.02.024; Selth LA, 2017, ONCOGENE, V36, P24, DOI 10.1038/onc.2016.185; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; TAKAYAMA K, 2017, CANCERS, V9; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thieu W, 2014, UROL ONCOL-SEMIN ORI, V32, P517, DOI 10.1016/j.urolonc.2013.11.004; WANG Y, 2016, MOL CANCER, V15	51	15	15	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2020	39	49					7209	7223		10.1038/s41388-020-01493-8	http://dx.doi.org/10.1038/s41388-020-01493-8		OCT 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PB0GA	33037409	Green Accepted, Green Submitted			2022-12-26	WOS:000578440800003
J	Blangiardo, M; Cameletti, M; Pirani, M; Corsetti, G; Battaglini, M; Baio, G				Blangiardo, Marta; Cameletti, Michela; Pirani, Monica; Corsetti, Gianni; Battaglini, Marco; Baio, Gianluca			Estimating weekly excess mortality at sub-national level in Italy during the COVID-19 pandemic	PLOS ONE			English	Article							MODEL	In this study we present the first comprehensive analysis of the spatio-temporal differences in excess mortality during the COVID-19 pandemic in Italy. We used a population-based design on all-cause mortality data, for the 7,904 Italian municipalities. We estimated sex-specific weekly mortality rates for each municipality, based on the first four months of 2016-2019, while adjusting for age, localised temporal trends and the effect of temperature. Then, we predicted all-cause weekly deaths and mortality rates at municipality level for the same period in 2020, based on the modelled spatio-temporal trends. Lombardia showed higher mortality rates than expected from the end of February, with 23,946 (23,013 to 24,786) total excess deaths. North-West and North-East regions showed one week lag, with higher mortality from the beginning of March and 6,942 (6,142 to 7,667) and 8,033 (7,061 to 9,044) total excess deaths respectively. We observed marked geographical differences also at municipality level. For males, the city of Bergamo (Lombardia) showed the largest percent excess, 88.9% (81.9% to 95.2%), at the peak of the pandemic. An excess of 84.2% (73.8% to 93.4%) was also estimated at the same time for males in the city of Pesaro (Central Italy), in stark contrast with the rest of the region, which does not show evidence of excess deaths. We provided a fully probabilistic analysis of excess mortality during the COVID-19 pandemic at sub-national level, suggesting a differential direct and indirect effect in space and time. Our model can be used to help policy-makers target measures locally to contain the burden on the health-care system as well as reducing social and economic consequences. Additionally, this framework can be used for real-time mortality surveillance, continuous monitoring of local temporal trends and to flag where and when mortality rates deviate from the expected range, which might suggest a second wave of the pandemic.	[Blangiardo, Marta; Pirani, Monica] Imperial Coll London, Dept Epidemiol & Biostat, MRC Ctr Environm & Hlth, London, England; [Cameletti, Michela] Univ Bergamo, Dept Management Econ & Quantitat Methods, Bergamo, Italy; [Corsetti, Gianni; Battaglini, Marco] Directorate Social Stat & Populat Census, Istat, Rome, Italy; [Baio, Gianluca] UCL, Dept Stat Sci, London, England	Imperial College London; University of Bergamo; University of London; University College London	Blangiardo, M (corresponding author), Imperial Coll London, Dept Epidemiol & Biostat, MRC Ctr Environm & Hlth, London, England.	m.blangiardo@imperial.ac.uk		Blangiardo, Marta/0000-0002-1621-704X; Baio, Gianluca/0000-0003-4314-2570	National Institutes of Health [R01HD092580-01A1]; MRC Centre for Environment and Health - Medical Research Council [MR/S019669/1]; MRC [MR/S019669/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC Centre for Environment and Health - Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MBl acknowledges partial support from National Institutes of Health, grant number R01HD092580-01A1. Infrastructure support for the Department of Epidemiology and Biostatistics was provided by the NIHR Imperial Biomedical Research Centre (BRC). This work was part supported by the MRC Centre for Environment and Health, which is currently funded by the Medical Research Council (MR/S019669/1). All the authors were supported by core funding from their institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, YB INT LAW COMMISSIO, VII; Baio G, 2020, GUARDIAN; Banerjee A, 2020, LANCET, V395, P1715, DOI 10.1016/S0140-6736(20)30854-0; Bauwens M, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL087978; Bennett JE, 2015, LANCET, V386, P163, DOI 10.1016/S0140-6736(15)60296-3; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Best N, 2005, STAT METHODS MED RES, V14, P35, DOI 10.1191/0962280205sm388oa; Blangiardo M, 2015, SPATIAL AND SPATIO-TEMPORAL BAYESIAN MODELS WITH R-INLA, P1, DOI 10.1002/9781118950203; Boulieri A, 2018, BIOSTATISTICS, DOI [10.1093/biostatistics/kxy038, DOI 10.1093/BI0STATISTICS/KXY038]; Boulieri A, 2017, J R STAT SOC A STAT, V180, P119, DOI 10.1111/rssa.12178; Chen K, 2020, LANCET PLANET HEALTH, V4, pE210, DOI 10.1016/S2542-5196(20)30107-8; Coleman M, 2020, BMJOPINION; Copernicus Climate Change Service (C3S), 2017, ERA5 5 GEN ECMWF ATM; Crisanti A., 2020, GUARDIAN; Felix-Cardoso J., 2020, EXCESS MORTALITY COV, DOI [10.1101/2020.04.28.20083147v1, DOI 10.1101/2020.04.28.20083147V1]; Flisch R., 2009, AGRARFORSCHUNG, V16, P1; Foreman KJ, 2017, J R STAT SOC C-APPL, V66, P121, DOI 10.1111/rssc.12157; Gomez-Rubio V, 2020, BAYESIAN INFERENCE I; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Kontis V, 2020, AGE SEX SPECIFIC TOT, DOI [10.1101/2020.05.20.20107680, DOI 10.1101/2020.05.20.20107680]; Kontopantelis E, 2021, J EPIDEMIOL COMMUN H, V75, P213, DOI 10.1136/jech-2020-214764; Lawson A., 2017, HDB STAT DIS MODEL P, P443, DOI [10.1016/bs.host.2017.05.001, DOI 10.1016/BS.HOST.2017.05.001]; Leon DA, 2020, LANCET, V395, pE81, DOI 10.1016/S0140-6736(20)30933-8; Michelozzi P, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.19.2000620; Modi C, 2020, DEADLY IS COVID 19 R, DOI 10.1101/2020.04.15.20067074v3; Modig K, 2020, EXCESS MORTALITY COV, DOI [10.1101/2020.05.10.20096909, DOI 10.1101/2020.05.10.20096909]; Muhammad S, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138820; Myllyvirta L, 2020, 11000 AIR POLLUTION; Odone A, 2020, LANCET PUBLIC HEALTH, V5, pE310, DOI 10.1016/S2468-2667(20)30099-2; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Riccardo F, 2020, MEDRXIV, DOI [10.1101/2020.04.08.20056861, DOI 10.1101/2020.04.08.20056861V1]; Signorelli Carlo, 2020, Acta Biomed, V91, P23, DOI 10.23750/abm.v91i2.9600; WHO, 2020, GLOBAL EXCESS DEATHS	33	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240286	10.1371/journal.pone.0240286	http://dx.doi.org/10.1371/journal.pone.0240286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035253	Green Published, Green Submitted, gold			2022-12-26	WOS:000581817500024
J	Rosas, M; Slatter, DA; Obaji, SG; Webber, JP; Alvarez-Jarreta, J; Thomas, CP; Aldrovandi, M; Tyrrell, VJ; Jenkins, PV; O'Donnell, VB; Collins, PW				Rosas, Marcela; Slatter, David A.; Obaji, Samya G.; Webber, Jason P.; Alvarez-Jarreta, Jorge; Thomas, Christopher P.; Aldrovandi, Maceler; Tyrrell, Victoria J.; Jenkins, Peter V.; O'Donnell, Valerie B.; Collins, Peter W.			The procoagulant activity of tissue factor expressed on fibroblasts is increased by tissue factor-negative extracellular vesicles	PLOS ONE			English	Article							FACTOR-VIIA; MOLECULAR DETERMINANTS; FACTOR DECRYPTION; ACTIVATION; MICROPARTICLES; GENERATION; THROMBOSIS; PATHWAYS	Tissue factor (TF) is critical for the activation of blood coagulation. TF function is regulated by the amount of externalised phosphatidylserine (PS) and phosphatidylethanolamine (PE) on the surface of the cell in which it is expressed. We investigated the role PS and PE in fibroblast TF function. Fibroblasts expressed 6-9 x 10(4)TF molecules/cell but had low specific activity for FXa generation. We confirmed that this was associated with minimal externalized PS and PE and characterised for the first time the molecular species of PS/PE demonstrating that these differed from those found in platelets. Mechanical damage of fibroblasts, used to simulate vascular injury, increased externalized PS/PE and led to a 7-fold increase in FXa generation that was inhibited by annexin V and an anti-TF antibody. Platelet-derived extracellular vesicles (EVs), that did not express TF, supported minimal FVIIa-dependent FXa generation but substantially increased fibroblast TF activity. This enhancement in fibroblast TF activity could also be achieved using synthetic liposomes comprising 10% PS without TF. In conclusion, despite high levels of surface TF expression, healthy fibroblasts express low levels of external-facing PS and PE limiting their ability to generate FXa. Addition of platelet-derived TF-negative EVs or artificial liposomes enhanced fibroblast TF activity in a PS dependent manner. These findings contribute information about the mechanisms that control TF function in the fibroblast membrane.	[Rosas, Marcela; Slatter, David A.; Obaji, Samya G.; Alvarez-Jarreta, Jorge; Aldrovandi, Maceler; Tyrrell, Victoria J.; Jenkins, Peter V.; O'Donnell, Valerie B.; Collins, Peter W.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, Wales; [Rosas, Marcela; Slatter, David A.; Obaji, Samya G.; Alvarez-Jarreta, Jorge; Aldrovandi, Maceler; Tyrrell, Victoria J.; Jenkins, Peter V.; O'Donnell, Valerie B.; Collins, Peter W.] Cardiff Univ, Sch Med, Syst Immun Res Inst, Cardiff, Wales; [Webber, Jason P.] Cardiff Univ, Inst Canc & Genet, Sch Med, Cardiff, Wales; [Thomas, Christopher P.] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff, Wales	Cardiff University; Cardiff University; Cardiff University; Cardiff University	Collins, PW (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, Wales.; Collins, PW (corresponding author), Cardiff Univ, Sch Med, Syst Immun Res Inst, Cardiff, Wales.	peter.collins@wales.nhs.uk	Slatter, David/AAW-6938-2021; Rosas Nexticapa, Marcela/HGU-1088-2022	Alvarez-Jarreta, Jorge/0000-0002-0946-0957	British Heart Foundation [PG/14/29/30783]; Wellcome Trust [094143/Z/10/Z]; Medical Research Council [MR/M011445/1]	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding is acknowledged from: The British Heart Foundation (PG/14/29/30783) to PWC. Wellcome Trust (094143/Z/10/Z) to VOD European Research Council (LipidArrays) to VOD. CPT and VJT were funded by Medical Research Council grant (MR/M011445/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman MM, 2011, J THROMB HAEMOST, V9, P2251, DOI 10.1111/j.1538-7836.2011.04488.x; Ansari SA, 2019, THROMB HAEMOSTASIS, V119, P860, DOI 10.1055/s-0039-1681102; Ansari SA, 2017, BLOOD ADV, V1, P2399, DOI 10.1182/bloodadvances.2017010132; Ansari SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158377; Butenas S, 2009, ARTERIOSCL THROM VAS, V29, P1989, DOI 10.1161/ATVBAHA.108.177402; Chance TC, 2019, J TRAUMA ACUTE CARE, V87, pS74, DOI 10.1097/TA.0000000000002225; Clark SR, 2013, P NATL ACAD SCI USA, V110, P5875, DOI 10.1073/pnas.1222419110; D'Alessandro E, 2018, THROMB RES, V168, P130, DOI 10.1016/j.thromres.2018.06.020; Flaumenhaft R, 2016, BLOOD, V128, P893, DOI 10.1182/blood-2016-04-636456; Gajsiewicz JM, 2015, SEMIN THROMB HEMOST, V41, P682, DOI 10.1055/s-0035-1564044; Geddings JE, 2016, J THROMB HAEMOST, V14, P153, DOI 10.1111/jth.13181; Grover SP, 2018, ARTERIOSCL THROM VAS, V38, P709, DOI 10.1161/ATVBAHA.117.309846; Hathcock JJ, 2006, BLOOD CELL MOL DIS, V36, P194, DOI 10.1016/j.bcmd.2005.12.032; Hisada Y, 2019, CURR OPIN HEMATOL, V26, P349, DOI 10.1097/MOH.0000000000000521; Hisada Y, 2018, THROMB RES, V164, pS48, DOI 10.1016/j.thromres.2017.12.018; Horstman LL, 2019, SEMIN THROMB HEMOST, V45, P509, DOI 10.1055/s-0039-1688570; Iba T, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0340-6; Ke K, 2014, PLOS ONE, V9; Kothari H, 2013, J THROMB HAEMOST, V11, P1353, DOI 10.1111/jth.12272; Lauder SN, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan2787; Mandal SK, 2006, BLOOD, V107, P4746, DOI 10.1182/blood-2005-11-4674; Morrissey JH, 2011, J THROMB HAEMOST, V9, P162, DOI 10.1111/j.1538-7836.2011.04300.x; Morrissey JH, 2010, THROMB RES, V125, pS23, DOI 10.1016/j.thromres.2010.01.027; Nomura S, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-014-0066-z; O'Donnell JS, 2019, BRIT J HAEMATOL, V186, P24, DOI 10.1111/bjh.15872; Ohkubo YZ, 2010, J THROMB HAEMOST, V8, P1044, DOI 10.1111/j.1538-7836.2010.03826.x; Okamoto K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0149-0; Osterud B, 2019, PLATELETS, V30, P957, DOI 10.1080/09537104.2019.1624708; Quillard T, 2017, CURR OPIN LIPIDOL, V28, P434, DOI 10.1097/MOL.0000000000000440; Ramacciotti E, 2010, THROMB RES, V125, pE269, DOI 10.1016/j.thromres.2010.01.019; Section on Breastfeeding, 2012, PEDIATRICS, V129, pe827; Shaw AW, 2007, J BIOL CHEM, V282, P6556, DOI 10.1074/jbc.M607973200; Slatter DA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98459; Stephens P, 2004, J CELL SCI, V117, P3389, DOI 10.1242/jcs.01188; Tavoosi N, 2011, J BIOL CHEM, V286, P23247, DOI 10.1074/jbc.M111.251769; Thomas CP, 2014, NAT PROTOC, V9, P51, DOI 10.1038/nprot.2013.163; Tripisciano C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03262-2; van Berkel SS, 2012, CHEMMEDCHEM, V7, P606, DOI 10.1002/cmdc.201100560; Vatsyayan R, 2013, ARTERIOSCL THROM VAS, V33, P1601, DOI 10.1161/ATVBAHA.113.300972; Versteeg HH, 2011, CURR OPIN HEMATOL, V18, P343, DOI 10.1097/MOH.0b013e32834981de; Wang J, 2019, BLOOD, V134, P645, DOI 10.1182/blood.2019001400; Wang J, 2017, BLOOD ADV, V1, P849, DOI 10.1182/bloodadvances.2016003947; Wang L, 2016, CURRENT PROTOCOLS CY, V2016; Wang L, 2009, BLOOD, V113, P705, DOI 10.1182/blood-2007-05-090944; Watts JA, 2012, THROMB RES, V130, P122, DOI 10.1016/j.thromres.2011.09.016; Wei H, 2018, SCI REPORTS, V8; Yu YJ, 2018, THROMB HAEMOSTASIS, V118, P990, DOI 10.1055/s-0038-1642031; Zwicker JI, 2011, ARTERIOSCL THROM VAS, V31, P728, DOI 10.1161/ATVBAHA.109.200964	48	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240189	10.1371/journal.pone.0240189	http://dx.doi.org/10.1371/journal.pone.0240189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031441	gold, Green Accepted, Green Published			2022-12-26	WOS:000581809800095
J	Thomen, RP; Woods, JC; Sturm, PF; Jain, V; Walkup, LL; Higano, NS; Quirk, JD; Varisco, BM				Thomen, Robert P.; Woods, Jason C.; Sturm, Peter F.; Jain, Viral; Walkup, Laura L.; Higano, Nara S.; Quirk, James D.; Varisco, Brian M.			Lung microstructure in adolescent idiopathic scoliosis before and after posterior spinal fusion	PLOS ONE			English	Article							HE-3 DIFFUSION MRI; CHILDREN; GROWTH; ALVEOLARIZATION; MORPHOMETRY; SAFETY	Adolescent idiopathic scoliosis (AIS) is associated with decreased respiratory quality of life and impaired diaphragm function. Recent hyperpolarized helium (HHe) MRI studies show alveolarization continues throughout adolescence, and mechanical forces are known to impact alveolarization. We therefore hypothesized that patients with AIS would have alterations in alveolar size, alveolar number, or alveolar septal dimensions compared to adolescents without AIS, and that posterior spinal fusion (PSF) might reverse these differences. We conducted a prospective observational trial using HHe MRI to test for changes in alveolar microstructure in control and AIS subjects at baseline and one year. After obtaining written informed consent from subjects' legal guardians and assent from the subjects, we performed HHe and proton MRI in 14 AIS and 16 control subjects aged 8-21 years. The mean age of control subjects (12.9 years) was significantly less than AIS (14.9 years, p = 0.003). At baseline, there were no significant differences in alveolar size, number, or alveolar duct morphometry between AIS and control subjects or between the concave (compressed) and convex (expanded) lungs of AIS subjects. At one year after PSF AIS subjects had an increase in alveolar density in the formerly convex lung (p = 0.05), likely reflecting a change in thoracic anatomy, but there were no other significant changes in lung microstructure. Modeling of alveolar size over time demonstrated similar rates of alveolar growth in control and AIS subjects in both right and left lungs pre- and post-PSF. Although this study suffered from poor age-matching, we found no evidence that AIS or PSF impacts lung microstructure.	[Thomen, Robert P.] Univ Missouri, Sch Med, Columbia, MO USA; [Thomen, Robert P.] Univ Missouri, Div Radiol, Columbia, MO USA; [Woods, Jason C.; Sturm, Peter F.; Jain, Viral; Varisco, Brian M.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Woods, Jason C.; Walkup, Laura L.; Higano, Nara S.] Cincinnati Childrens Hosp, Pulm Med, Cincinnati, OH USA; [Sturm, Peter F.; Jain, Viral] Cincinnati Childrens Hosp, Orthopaed, Cincinnati, OH USA; [Quirk, James D.] Washington Univ, Mallincrodt Inst Radiol, St Louis, MO 63110 USA; [Quirk, James D.] Washington Univ, Sch Med, St Louis, MO USA; [Varisco, Brian M.] Cincinnati Childrens Hosp, Crit Care Med, Cincinnati, OH 45229 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Washington University (WUSTL); Washington University (WUSTL); Cincinnati Children's Hospital Medical Center	Varisco, BM (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA.; Varisco, BM (corresponding author), Cincinnati Childrens Hosp, Crit Care Med, Cincinnati, OH 45229 USA.	brian.varisco@cchmc.org	; Walkup, Laura/D-7513-2011	Varisco, Brian/0000-0003-0180-2577; Walkup, Laura/0000-0002-5060-6401	Scoliosis Research Society Investigatory Grant Research Grant; Pediatric Orthopedic Society of North America/NuVasive Spine Research Grant; NIH/NHLBI [R01HL141229, K08HL131261]	Scoliosis Research Society Investigatory Grant Research Grant; Pediatric Orthopedic Society of North America/NuVasive Spine Research Grant; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	BMV: Scoliosis Research Society Investigatory Grant & Research Grant BMV: Pediatric Orthopedic Society of North America/NuVasive Spine Research Grant BMV: NIH/NHLBI R01HL141229 BMV: NIH/NHLBI K08HL131261.	Balinotti JE, 2009, AM J RESP CRIT CARE, V179, P134, DOI 10.1164/rccm.200808-1224OC; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Butler JP, 2012, NEW ENGL J MED, V367, P244, DOI 10.1056/NEJMoa1203983; Dane DM, 2013, J APPL PHYSIOL, V114, P99, DOI 10.1152/japplphysiol.01213.2012; Flors L, 2017, J THORAC IMAG, V32, P323, DOI 10.1097/RTI.0000000000000244; HASLETON PS, 1972, J ANAT, V112, P391; Kim YJ, 2007, SPINE, V32, P2685, DOI 10.1097/BRS.0b013e31815a7b17; Langensiepen S, 2013, EUR SPINE J, V22, P2360, DOI 10.1007/s00586-013-2693-9; Leawoods JC, 2001, CONCEPT MAGNETIC RES, V13, P277, DOI 10.1002/cmr.1014; Lorente A, 2017, SPINE, V42, P1391, DOI 10.1097/BRS.0000000000002105; Lutey BA, 2008, RADIOLOGY, V248, P655, DOI 10.1148/radiol.2482071838; Mahmoud O, 2018, AM J RESP CRIT CARE, V198, P1539, DOI 10.1164/rccm.201802-0274OC; Narayanan M, 2013, AM J RESP CRIT CARE, V187, P1104, DOI 10.1164/rccm.201210-1850OC; Narayanan M, 2012, AM J RESP CRIT CARE, V185, P186, DOI 10.1164/rccm.201107-1348OC; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Olson JC, 2011, CLIN ORTHOP RELAT R, V469, P1375, DOI 10.1007/s11999-011-1807-0; Ouriadov A, 2018, MAGN RESON MED, V79, P439, DOI 10.1002/mrm.26642; Pennati F, 2014, RADIOLOGY, V273, P580, DOI 10.1148/radiol.14132470; Quirk JD, 2015, MAGN RESON MED, V73, P1252, DOI 10.1002/mrm.25241; Reamy BV, 2001, AM FAM PHYSICIAN, V64, P111; Redding G, 2008, SPINE J, V8, P639, DOI 10.1016/j.spinee.2007.04.020; Roach DJ, 2016, ANN AM THORAC SOC, V13, P1923, DOI 10.1513/AnnalsATS.201603-203OC; Sukstanskii AL, 2008, J MAGN RESON, V190, P200, DOI 10.1016/j.jmr.2007.10.015; THORSTEINSSON A, 1990, ANESTHESIOLOGY, V73, P876, DOI 10.1097/00000542-199011000-00014; Tsiligiannis T, 2012, SCOLIOSIS SPINAL DIS, V7, DOI 10.1186/1748-7161-7-7; Urquhart DS, 2014, ARCH DIS CHILD, V99, P922, DOI 10.1136/archdischild-2013-305739; Walkup LL, 2016, PEDIATR RADIOL, V46, P1651, DOI 10.1007/s00247-016-3672-1; Wang W, 2013, AM J RESP CELL MOL, V49, P697, DOI 10.1165/rcmb.2012-0332MA; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Woods JC, 2006, MAGN RESON MED, V56, P1293, DOI 10.1002/mrm.21076; Yablonskiy DA, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3448; Ysasi AB, 2013, AM J PHYSIOL-LUNG C, V305, pL439, DOI 10.1152/ajplung.00134.2013; 2007, EUROPEAN FLAME RETAR, V2, P20	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240265	10.1371/journal.pone.0240265	http://dx.doi.org/10.1371/journal.pone.0240265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031412	Green Published, gold			2022-12-26	WOS:000581809800046
J	Carvelli, A; Scaramozzino, P; Iacoponi, F; Condoleo, R; Della Marta, U				Carvelli, Andrea; Scaramozzino, Paola; Iacoponi, Francesca; Condoleo, Roberto; Della Marta, Ugo			Size, demography, ownership profiles, and identification rate of the owned dog population in central Italy	PLOS ONE			English	Article							PET OWNERSHIP; REGISTRY; CAT	The One Health paradigm recognizes that information on infectious diseases, zoonosis and related predictors in animal populations is essential. Pets live in close contact with humans and interact with wild animals, but the lack of reliable information on pet population size, demography and ownership profiles is a constant worldwide. Reliable data must be made available in order to address proper public health policies regarding the design of surveillance plans, the management of canine welfare and stray dog phenomenon, the control of dog behaviour-related problems, and the livestock/wildlife endangerment. Dog identification & registration (I&R) have become mandatory in most European countries in recent years, but the process is far from being widely accomplished, thus resulting in an underestimation of the real canine population. To date, data on the completeness of Dog Registries is very limited. A cross-sectional survey through 630 face-to-face questionnaires was performed with the aim of investigating the dog population size, demography, ownership profiles, and the I&R rate in central Italy. Logistic regression models investigated risk factors with the following outcome variables: dog presence into the Dog Registry, veterinary care frequency, and dog ownership. The present study identified that the dog population is higher than previously reported in Italy and in Europe, whilst lower compared to countries with a poor Human Development Index (a statistic composite index of life expectancy, education, and per capita income indicators used by United Nation). Almost half of the interviewed people (47%) owned at least one dog, totalling 315 dogs. The mean number of dogs per household was 0.7 and 1.5 per dog-owning household. The Bayesian model estimated 481,294 (95% CI: 470,860-491,978) dogs (90 dogs/km(2); human:dog ratio 9.0, 95% CI: 8.8-9.2) suggesting that a high density of people does not limit the dog ownership. Dogs resulted predominant among pets. The majority of dogs were males, crossbred, acquires as a gift, lived in rural areas, outdoors and attended a veterinary visit 1-2 times per year. The percentage of neutered dogs were higher in females (55%) than in males (8%). Only 75.3% (95% CI: 73.676.9) of the dogs were correctly identified and registered. The Dog Registry completeness increased during the first decades after its establishment, but no improvement has been made afterwards. The dogs correctly identified and registered were more likely to be purebred, neutered, lived in urban areas and visited a veterinarian frequently. Several strategies are recommended to encourage I&R, including promoting responsible dog ownership, engaging private veterinarians and dog breeders, and establishing an effective control system. The present study identified also that the dog source and the kind of feeding were variables associated with the veterinary care frequency. Owning a dog was associated with living in rural areas and the presence of children. The present study reported the poor presence of reliable predictors for the dog ownership. This is the first study to provide an estimate of the canine population abundance, characteristics, and ownership profiles in a European large metropolitan area.	[Carvelli, Andrea; Scaramozzino, Paola; Iacoponi, Francesca; Condoleo, Roberto] Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Epidemiol Unit, Via Appia Nuova, Rome, Italy; [Della Marta, Ugo] Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Via Appia Nuova, Rome, Italy; [Iacoponi, Francesca] Ist Super Sanita, Dept Food Safety Nutr & Vet Publ Hlth, Viale Regina Elena, Rome, Italy	IZS Lazio e Toscana; IZS Lazio e Toscana; Istituto Superiore di Sanita (ISS)	Carvelli, A (corresponding author), Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Epidemiol Unit, Via Appia Nuova, Rome, Italy.	andrea.carvelli@izslt.it	carvelli, andrea/P-2246-2019	carvelli, andrea/0000-0003-1320-9682; Condoleo, Roberto/0000-0002-2439-6295				[Anonymous], 2012, CLIN CANC RES, V18, pPR61; [Anonymous], CORINE LAND COVER CL; [Anonymous], 2019, TERR AN HLTH COD TAH; [Anonymous], 1990, J NUTR, V120, p1557S; [Anonymous], 2005, APPMA PET CAR SERV, P11; Asher L, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-74; Baquero OS, 2019, TRANSBOUND EMERG DIS, V66, P1693, DOI 10.1111/tbed.13204; Bortolotti L, 2011, REV EPID SAN ANIM, V59-60, P35; Caminiti A, 2014, PREV VET MED, V113, P146, DOI 10.1016/j.prevetmed.2013.10.003; Capello K, 2015, PREV VET MED, V118, P142, DOI 10.1016/j.prevetmed.2014.10.017; Carvelli A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3796872; Costa ED, 2017, PREV VET MED, V139, P33, DOI 10.1016/j.prevetmed.2017.01.001; Day M J, 2016, J Comp Pathol, V155, pS1, DOI 10.1016/j.jcpa.2015.01.005; Dobson J. M., 2013, ISRN VET SCI, V2013, DOI DOI 10.1155/2013/941275); Downes M, 2009, PREV VET MED, V92, P140, DOI 10.1016/j.prevetmed.2009.07.005; Downes MJ, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-121; FEDIAF, 2019, ANN REP 2019, P52; Gates MC, 2019, NEW ZEAL VET J, V67, P306, DOI 10.1080/00480169.2019.1645626; Hiby E, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1051-2; Horisberger U, 2004, SCHWEIZ ARCH TIERH, V146, P223, DOI 10.1024/0036-7281.146.5.223; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hsu YY, 2010, APPL ANIM BEHAV SCI, V123, P108, DOI 10.1016/j.applanim.2010.01.013; Kisiel LM, 2016, PREV VET MED, V135, P37, DOI 10.1016/j.prevetmed.2016.10.021; LESLIE BE, 1994, CAN VET J, V35, P218; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; Prata JC, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10050848; Pulczer AS, 2013, PREV VET MED, V108, P209, DOI 10.1016/j.prevetmed.2012.07.012; Reif JS, 2011, PUBLIC HEALTH REP, V126, P50, DOI 10.1177/00333549111260S108; Saunders J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179494; Slater MR, 2008, PREV VET MED, V85, P267, DOI 10.1016/j.prevetmed.2008.02.001; Vascellari M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-39; Vose D., 2008, RISK ANAL QUANTITATI; WHO/Bill & Melinda Gates Foundation, 2009, HUM DOG RAB PREV CON, V43	34	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240551	10.1371/journal.pone.0240551	http://dx.doi.org/10.1371/journal.pone.0240551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057370	Green Published, gold			2022-12-26	WOS:000581814700005
J	Cesa-Luna, C; Baez, A; Aguayo-Acosta, A; Llano-Villarreal, RC; Juarez-Gonzalez, VR; Gaytan, P; Bustillos-Cristales, MD; Rivera-Urbalejo, A; Munoz-Rojas, J; Quintero-Hernandez, V				Cesa-Luna, Catherine; Baez, Antonino; Aguayo-Acosta, Alberto; Llano-Villarreal, Roberto Carlos; Juarez-Gonzalez, Victor Rivelino; Gaytan, Paul; Bustillos-Cristales, Maria del Rocio; Rivera-Urbalejo, America; Munoz-Rojas, Jesus; Quintero-Hernandez, Veronica			Growth inhibition of pathogenic microorganisms by Pseudomonas protegens EMM-1 and partial characterization of inhibitory substances	PLOS ONE			English	Article							SP NOV.; BIOCONTROL; FLUORESCENS; BACTERIA; DISCOVERY; STRAINS	The bacterial strain, EMM-1, was isolated from the rhizosphere of red maize ("Rojo Criollo") and identified as Pseudomonas protegens EMM-1 based on phylogenetic analysis of 16S rDNA, rpoB, rpoD, and gyrB gene sequences. We uncovered genes involved in the production of antimicrobial compounds like 2,4-diacetylphloroglucinol (2,4-DAPG), pyoluteorin, and lectin-like bacteriocins. These antimicrobial compounds are also produced by other fluorescent pseudomonads alike P. protegens. Double-layer agar assay showed that P. protegens EMM-1 inhibited the growth of several multidrug-resistant (MDR) bacteria, especially clinical isolates of the genera Klebsiella and beta- hemolytic Streptococcus. This strain also displayed inhibitory effects against diverse fungi, such as Aspergillus, Botrytis, and Fusarium. Besides, a crude extract of inhibitory substances secreted into agar was obtained after the cold-leaching process, and physicochemical characterization was performed. The partially purified inhibitory substances produced by P. protegens EMM-1 inhibited the growth of Streptococcus sp. and Microbacterium sp., but no inhibitory effect was noted for other bacterial or fungal strains. The molecular weight determined after ultrafiltration was between 3 and 10 kDa. The inhibitory activity was thermally stable up to 60 degrees C (but completely lost at 100 degrees C), and the inhibitory activity remained active in a wide pH range (from 3 to 9). After treatment with a protease from Bacillus licheniformis, the inhibitory activity was decreased by 90%, suggesting the presence of proteic natural compounds. All these findings suggested that P. protegens EMM-1 is a potential source of antimicrobials to be used against pathogens for humans and plants.	[Cesa-Luna, Catherine; Baez, Antonino; Llano-Villarreal, Roberto Carlos; Bustillos-Cristales, Maria del Rocio; Rivera-Urbalejo, America; Munoz-Rojas, Jesus; Quintero-Hernandez, Veronica] Benemerita Univ Autonoma Puebla BUAP, Ctr Invest Ciencias Microbiol CICM, Ecol & Survival Microorganisms Grp ESMG, Inst Ciencias IC,Lab Ecol Mol Microbiana LEMM, Puebla, Pue, Mexico; [Aguayo-Acosta, Alberto] Univ Autonoma Nuevo Leon, Biol Sci Fac, Dept Microbiol & Immunol, Ciudad Univ, San Nicolas De La Garza, Nuevo Leon, Mexico; [Juarez-Gonzalez, Victor Rivelino] Univ Autonoma Nuevo Leon, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca, Morelos, Mexico; [Gaytan, Paul] Univ Nacl Autonoma Mexico, Inst Biotecnol, Unidad Sintesis & Secuenciac ADN, Cuernavaca, Morelos, Mexico; [Rivera-Urbalejo, America] BUAP, Fac Estomatol, Puebla, Pue, Mexico; [Quintero-Hernandez, Veronica] IC BUAP, CICM, LEMM, CONACYT,ESMG, Puebla, Pue, Mexico	Benemerita Universidad Autonoma de Puebla; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla	Munoz-Rojas, J; Quintero-Hernandez, V (corresponding author), Benemerita Univ Autonoma Puebla BUAP, Ctr Invest Ciencias Microbiol CICM, Ecol & Survival Microorganisms Grp ESMG, Inst Ciencias IC,Lab Ecol Mol Microbiana LEMM, Puebla, Pue, Mexico.; Quintero-Hernandez, V (corresponding author), IC BUAP, CICM, LEMM, CONACYT,ESMG, Puebla, Pue, Mexico.	joymerre@yahoo.com.mx; vquinterohe@conacyt.mx	Aguayo-Acosta, Alberto/GMW-8641-2022; Cesa, Catherine/AAV-1113-2020; Muñoz-Rojas, Jesús/B-9786-2019; Baez, Antonino/T-6638-2017	Cesa, Catherine/0000-0003-2482-1316; Muñoz-Rojas, Jesús/0000-0002-1151-9778; Bustillos, Rocio/0000-0002-6325-3764; Baez, Antonino/0000-0001-8453-3178; Quintero-Hernandez, Veronica/0000-0002-1856-8134; Rivera-Urbalejo, America/0000-0002-6452-6808	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [538125/294272]; Apoyo Redes del Programa para el Desarrollo Profesional Docente (PRODEP) [CA-262]; Direccion de Innovacion y Transferencia de Conocimiento (DITCo) [2016-3, 2016-4]; Vicerrectoria de Investigacion y Estudios de Posgrado-Benemerita Universidad Autonoma de Puebla (VIEP-BUAP) [COL525704-VIEP2018, 100524554-VIEP2018, 100425788VIEP2018]; CONACYT	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Apoyo Redes del Programa para el Desarrollo Profesional Docente (PRODEP); Direccion de Innovacion y Transferencia de Conocimiento (DITCo); Vicerrectoria de Investigacion y Estudios de Posgrado-Benemerita Universidad Autonoma de Puebla (VIEP-BUAP); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CCL: Consejo Nacional de Ciencia y Tecnologia (CONACYT): 538125/294272; JMR: Apoyo Redes del Programa para el Desarrollo Profesional Docente (PRODEP): 2015-2018: CA-262; JMR: Direccion de Innovacion y Transferencia de Conocimiento (DITCo): 2016-3, 2016-4; Vicerrectoria de Investigacion y Estudios de Posgrado-Benemerita Universidad Autonoma de Puebla (VIEP-BUAP): VQH:COL525704-VIEP2018; AB:100524554-VIEP2018; JMR:100425788VIEP2018. We are grateful to CONACYT for the fellowship awarded to Catherine Cesa-Luna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2013, PROBIOTICS ANTIMICRO, V5, P165, DOI 10.1007/s12602-013-9140-4; Andreolli M, 2019, MICROBIOL RES, V219, P123, DOI 10.1016/j.micres.2018.11.003; [Anonymous], 2003, NCBI HDB; Caballero-Mellado J, 2004, INT J SYST EVOL MICR, V54, P1165, DOI 10.1099/ijs.0.02951-0; Castro-Gonzalez R, 2011, PLANT SOIL, V345, P155, DOI 10.1007/s11104-011-0768-0; Cesa-Luna C, 2020, PROTOCOLS IO, P1, DOI [10.17504/protocols.io.bhs3j6gn, DOI 10.17504/PROTOCOLS.IO.BHS3J6GN]; Cesa-Luna C, 2020, ACTA BIOL COLOMB, V25, P140, DOI 10.15446/abc.v25n1.76867; Cesa-Luna C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222438; Couillerot O, 2009, LETT APPL MICROBIOL, V48, P505, DOI 10.1111/j.1472-765X.2009.02566.x; De Giani A, 2019, AMB EXPRESS, V9, DOI 10.1186/s13568-019-0813-6; Feliatra Feli, 2018, F1000Res, V7, P415, DOI 10.12688/f1000research.13958.1; Ghequire MGK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02706; Gionco B, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00066; Hall T., 2011, GERF B BIOSCI, V2, P60; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kang YJ, 2014, MICROBIOLOGY+, V83, P666, DOI 10.1134/S0026261714050166; Klockgether Jens, 2017, F1000Res, V6, P1261, DOI 10.12688/f1000research.10506.1; Kohl J, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00845; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lucas JA, 2015, ADV APPL MICROBIOL, V90, P29, DOI 10.1016/bs.aambs.2014.09.001; Mahrous H., 2013, Food and Nutrition Sciences, V4, P342, DOI 10.4236/fns.2013.43045; Mariam Solomon H, 2014, BMC Res Notes, V7, P606, DOI 10.1186/1756-0500-7-606; Mascher F, 2014, FEMS MICROBIOL ECOL, V87, P441, DOI 10.1111/1574-6941.12234; Matthijs S, 2014, RES MICROBIOL, V165, P695, DOI 10.1016/j.resmic.2014.09.009; McCaughey LC, 2016, BIOCHEM J, V473, P2345, DOI 10.1042/BCJ20160470; Molina-Romero D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187913; Morales-Garcia YE, 2011, REV ARGENT MICROBIOL, V43, P287, DOI 10.1590/S0325-75412011000400009; Morfin-Otero R, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0116-y; Munoz-Rojas J, 2005, FEMS MICROBIOL ECOL, V54, P57, DOI 10.1016/j.femsec.2005.02.011; Munoz-Rojas J, 2016, SCI ASS, P67; Munoz-Rojas J, 2013, FORMULACION INOCULAN; Nguyen DD, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.197; Parret AHA, 2005, APPL ENVIRON MICROB, V71, P5197, DOI 10.1128/AEM.71.9.5197-5207.2005; Perez-Santos JLM, 2017, MULTISPECIES FORMULA; Powers MJ, 2015, J BACTERIOL, V197, P2129, DOI 10.1128/JB.02535-14; Preciado GM, 2016, ANTIBIOTIC RESISTANCE: MECHANISMS AND NEW ANTIMICROBIAL APPROACHES, P329, DOI 10.1016/B978-0-12-803642-6.00016-2; Ramette A, 2011, SYST APPL MICROBIOL, V34, P180, DOI 10.1016/j.syapm.2010.10.005; Rodriguez C. E. A., 1982, APPL ENVIRON MICROB, V44, P990, DOI DOI 10.1128/AEM.44.4.990-991.1982; Rodriguez-Andrade O., 2019, OPEN MICROBIOL J, V13, P256, DOI DOI 10.2174/1874285801913010256; Bernabeu PR, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-018-2461-4; Rumende CM, 2018, ACTA MED INDONES, V50, P1; Sadiq H, 2018, PAK J PHARM SCI, V31, P919; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salvucci E, 2012, FOODBORNE PATHOG DIS, V9, P68, DOI 10.1089/fpd.2011.0972; Silva CCG, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00594; Souli M, 2008, Euro Surveill, V13; Sundin GW, 2018, ANNU REV PHYTOPATHOL, V56, P161, DOI 10.1146/annurev-phyto-080417-045946; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Takeuchi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093683; Tanwar Jyoti, 2014, Interdiscip Perspect Infect Dis, V2014, P541340, DOI 10.1155/2014/541340; Trapet P, 2016, PLANT PHYSIOL, V171, P675, DOI 10.1104/pp.15.01537; Rojas-Rojas FU, 2018, MICROBIOL-SGM, V164, P1072, DOI 10.1099/mic.0.000675; Vacheron J, 2019, ISME J, V13, P1318, DOI 10.1038/s41396-019-0353-8; van Staden ADP, 2016, ANTIMICROB AGENTS CH, V60, P3948, DOI 10.1128/AAC.02938-15; Wang XB, 2020, BIOCONTROL, V65, P751, DOI 10.1007/s10526-020-10042-x; Yi LH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01567; Zhang QX, 2020, AUSTRALAS PLANT PATH, V49, P307, DOI 10.1007/s13313-020-00696-7	59	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240545	10.1371/journal.pone.0240545	http://dx.doi.org/10.1371/journal.pone.0240545			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057351	gold, Green Published			2022-12-26	WOS:000581814700033
J	Chen, C; Ahlqvist, VH; Henriksson, P; Magnusson, C; Berglind, D				Chen, Chu; Ahlqvist, Viktor H.; Henriksson, Pontus; Magnusson, Cecilia; Berglind, Daniel			Preschool environment and preschool teacher's physical activity and their association with children's activity levels at preschool	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; CARE CENTERS; POLICIES; INTERVENTIONS; HEALTH; ADOLESCENTS; IMPACT	Objective The aim of this study was to investigate the association between preschool playground size, formalized physical activity (PA) policies, time spent outdoors and preschool teacher's levels of PA and children's objectively assessed levels of PA and sedentary time (ST) during preschool hours. Methods In total, 369 children and 84 preschool teachers from 27 preschools in Sodermalm municipally, Stockholm Sweden wore an Actigraph GT3X+ accelerometer during 7 consecutive days. Preschool environmental and structural characteristics were measured via the Environment and Policy Evaluation Self-Report ( EPAO-SR) instrument and time in- and outdoors was recorded by preschool teachers during the PA measurements. Weight and height of children were measured via validated scales and parents filled out a questionnaire on demographical and descriptive variables. Linear mixed models, nested on preschool level, were used to assess the association between predictors and outcomes. Results The mean child age was 4.7 years (SD 0.8) and 45% were girls. We found that children were more active in preschools with a formalized PA policy, compared to preschools without such a policy, but not less sedentary. The association between policy and activity seemed to be more pronounced when accounting for other environmental factors. Similar associations were found in children spent most time outdoors (uppermost quartile) compared with children spent least time outdoors (Lowermost quartile). Preschool teachers' light PA (LPA) (beta = 0.25, P = 0.004) and steps (beta = 0.52, P<0.001) were associated with children's LPA and steps while the preschool playground size showed no association with PA in children, when accounting for other environmental factors. Conclusion The current study showed that preschool structural characteristics such as formalized PA policies and more time spent outdoors were positively associated with children's PA. These findings suggest that formalized PA policies and time outdoors may be of importance for promoting children's PA during preschool hours.	[Chen, Chu; Magnusson, Cecilia; Berglind, Daniel] Region Stockholm, Ctr Epidemiol & Community Med, Stockholm, Sweden; [Chen, Chu; Ahlqvist, Viktor H.; Magnusson, Cecilia; Berglind, Daniel] Karolinska Inst, Dept Global Publ Hlth, Solna, Sweden; [Henriksson, Pontus] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden	Karolinska Institutet; Linkoping University	Chen, C (corresponding author), Region Stockholm, Ctr Epidemiol & Community Med, Stockholm, Sweden.; Chen, C (corresponding author), Karolinska Inst, Dept Global Publ Hlth, Solna, Sweden.	chen.chu@ki.se	Ahlqvist, Viktor/AAE-2716-2021	Ahlqvist, Viktor/0000-0003-1383-3194; Chen, Chu/0000-0001-6350-3797	Lindhes Advokatbyra; Sodermalm municipally	Lindhes Advokatbyra; Sodermalm municipally	DB received the funding for this study. This study was partly funded by Lindhes Advokatbyra and by Sodermalm municipally. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2020, ZHONGHUA JIE HE HE H, V17, DOI 10.3760/cma.j.issn.1001-0939.2020.0020; Berglind D, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4600-5; Boldemann C, 2006, PREV MED, V42, P301, DOI 10.1016/j.ypmed.2005.12.006; Bornstein DB, 2011, J SCI MED SPORT, V14, P504, DOI 10.1016/j.jsams.2011.05.007; Bower JK, 2008, AM J PREV MED, V34, P23, DOI 10.1016/j.amepre.2007.09.022; Broekhuizen K, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-59; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Butte NF, 2014, MED SCI SPORT EXER, V46, P1216, DOI 10.1249/MSS.0000000000000209; Byrd-Williams CE, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6588-5; Carson V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4860-0; Cliff DP, 2016, OBES REV, V17, P330, DOI 10.1111/obr.12371; Cliff DP, 2009, J SCI MED SPORT, V12, P557, DOI 10.1016/j.jsams.2008.10.008; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dolinsky DH, 2011, PREV CHRONIC DIS, V8; Dowda M, 2009, PEDIATRICS, V123, pE261, DOI 10.1542/peds.2008-2498; Erinosho T, 2016, J PHYS ACT HEALTH, V13, P59, DOI 10.1123/jpah.2014-0467; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Finch M, 2016, OBES REV, V17, P412, DOI 10.1111/obr.12392; Fossdal TS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208001; Gordon ES, 2013, RES Q EXERCISE SPORT, V84, P287, DOI 10.1080/02701367.2013.813894; Hibbing PR, 2020, RES Q EXERCISE SPORT, V91, P514, DOI 10.1080/02701367.2019.1688227; Hinkley T, 2015, CHILD CARE HLTH DEV, V41, P132, DOI 10.1111/cch.12156; Hinkley T, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-66; Hnatiuk JA, 2014, AM J PREV MED, V47, P487, DOI 10.1016/j.amepre.2014.05.042; Jones RA, 2013, AM J PREV MED, V44, P651, DOI 10.1016/j.amepre.2013.03.001; Marissa Hope M, 2020, PHYSL MEASUREMENT; Mehtala MAK, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-22; Migueles J. H., 2017, SPORTS MED; Mikkelsen BE, 2011, INT J PEDIATR OBES, V6, P12, DOI 10.3109/17477166.2011.613655; NIH Public Access Author Manuscript, 2011, J PHYS ACT HLTH, V8, pS257; Pearce M, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-45; Razak LA, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0665-5; Santos-Lozano A, 2013, INT J SPORTS MED; Sheridan S, 2014, EDUC RES-UK, V56, P379, DOI 10.1080/00131881.2014.965562; Skolverket, CURR PRESCH LPFO 18; Swerissen H, 2004, HEALTH PROMOT INT, V19, P123, DOI 10.1093/heapro/dah113; Tremblay L, 2012, CAN PSYCHOL, V53, P280, DOI 10.1037/a0030210; Tudor-Locke C, 2015, MED SCI SPORT EXER, V47, P839, DOI 10.1249/MSS.0000000000000476; Villarreal-Calderon A, 2002, ARCH ENVIRON HEALTH, V57, P450, DOI 10.1080/00039890209601437; Ward DS, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0287-0; Williamson EJ, 2014, RESPIROLOGY, V19, P303, DOI 10.1111/resp.12238; World Health Organization, 2019, ADD BEH	45	4	4	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0239838	10.1371/journal.pone.0239838	http://dx.doi.org/10.1371/journal.pone.0239838			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057340	Green Submitted, Green Published, gold			2022-12-26	WOS:000581814700045
J	de Medeiros, OL; Barreto, JOM; Harris, M; Russo, LX; da Silva, EN				de Medeiros, Olivia Lucena; Barreto, Jorge Otavio Maia; Harris, Matthew; Russo, Leticia Xander; da Silva, Everton Nunes			Delivering maternal and childcare at primary healthcare level: The role of PMAQ as a pay for performance strategy in Brazil	PLOS ONE			English	Article							SYSTEM; PROGRAMS; PAYMENT; POLICY	Background Improving access and quality in health care is a pressing issue worldwide and pay for performance (P4P) strategies have emerged as an alternative to enhance structure, process and outcomes in health. In 2011, Brazil adopted its first P4P scheme at national level, the National Programme for Improving Primary Care Access and Quality (PMAQ). The contribution of PMAQ in achieving the Sustainable Development Goals related to maternal and childcare remains under investigated in Brazil. Objective To estimate the association of PMAQ with the provision of maternal and childcare in Brazil, controlling for socioeconomic, geographic and family health team characteristics. Method We used cross-sectional quantile regression (QR) models for two periods, corresponding to 33,368 Family Health Teams (FHTs) in the first cycle and 39,211 FHTs in the second cycle of PMAQ. FHTs were analysed using data from the Brazilian Ministry of Health (SIAB and CNES) and the Brazilian Institute for Geography and Statistics (IBGE). Results The average number of antenatal consultations per month were positively associated with PMAQ participating teams, with larger effect in the lower tail (10th and 25th quantiles) of the conditional distribution of the response variable. There was a positive association between PMAQ and the average number of consultations under 2 years old per month in the 10th and 25th quantiles, but a negative association in the upper tail (75th and 90th quantiles). For the average number of physician consultations for children under 1 year old per month, PMAQ participating teams were positively associated with the response variable in the lower tail, but different from the previous models, there is no clear evidence that the second cycle gives larger coefficients compared with first cycle. Conclusion PMAQ has contributed to increase the provision of care to pregnant women and children under 2 years at primary healthcare level. Teams with lower average number of antenatal or child consultations benefited the most by participating in PMAQ, which suggests that PMAQ might motivate worse performing health providers to catch up.	[de Medeiros, Olivia Lucena; Barreto, Jorge Otavio Maia; da Silva, Everton Nunes] Univ Brasilia, Grad Program Publ Hlth, Brasilia, DF, Brazil; [de Medeiros, Olivia Lucena] Minist Hlth, Brasilia, DF, Brazil; [Barreto, Jorge Otavio Maia] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Harris, Matthew] Imperial Coll, Fac Med, Sch Publ Hlth, London, England; [Russo, Leticia Xander] Univ Estadual Maringa, Dept Econ, Maringa, Parana, Brazil	Universidade de Brasilia; Fundacao Oswaldo Cruz; Imperial College London; Universidade Estadual de Maringa	da Silva, EN (corresponding author), Univ Brasilia, Grad Program Publ Hlth, Brasilia, DF, Brazil.	evertonsilva@unb.br	; Barreto, Jorge/P-5738-2018	Harris, Matthew/0000-0002-0005-9710; Russo, Leticia Xander/0000-0001-9592-8212; Silva, Everton/0000-0001-8747-4185; Barreto, Jorge/0000-0002-7648-0472	NW London NIHR Applied Research Collaboration; Imperial NIHR Biomedical Research Centre; MRC [MR/R022828/1] Funding Source: UKRI	NW London NIHR Applied Research Collaboration; Imperial NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MH is supported in part by the NW London NIHR Applied Research Collaboration. Imperial College London is grateful for support from the NW London NIHR Applied Research Collaboration and the Imperial NIHR Biomedical Research Centre. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. No additional external funding received for this study.	[Anonymous], 2017, ARTIFICIAL ORGANS, V41, pE141; [Anonymous], 2017, CLIN GENITOURIN CANC; [Anonymous], 2018, CAN J DIABETES S1; [Anonymous], 2016, BIRDS NZ, V9, P8; [Anonymous], 2008, MEDWAVE, V8, pe1717, DOI 10.5867/medwave.2008.09.1717; [Anonymous], 2017, EPLASTY, V17, pic25; [Anonymous], 2007, SPINE J S, V7, p1S; Barros AJD, 2016, LANCET GLOB HEALTH, V4, pE873, DOI 10.1016/S2214-109X(16)30298-4; Brasil, 2015, MAN INSTR PMAQ EQ AT; Brazi, 2012, HLTH CLOS YOU ACC QU, P60; Brazil, 2012, CHILD HLTH GROWTH DE, V33; Brazil, SUPP ROOM STRAT MAN; Brazil, 2015, NOT MET CERT PMAQ EQ; Brazil, HIST REP COV PRIM CA; Brazil, PMAQ PAYM REP; Collaborative Study Group on Perioperative ScvO2 Monitoring, 2006, CRIT CARE, V10, pR158; da Silva EN, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000242; Damberg Cheryl L, 2014, Rand Health Q, V4, P9; Alonso CMD, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000395, 10.11606/s1518-8787.2018052000395]; dos Santos AS, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000186, 10.11606/s1518-8787.2018052000186]; dos Santos EP, 2016, REV ESC ENFERM USP, V50, P390, DOI 10.1590/S0080-623420160000400003; Engineer CY, 2016, INT J EPIDEMIOL, V45, P451, DOI 10.1093/ije/dyv362; Franca GVA, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0445-2; Harrison SE, 2018, SOUTH MED J, V111, P12, DOI 10.14423/SMJ.0000000000000754; Hequet D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1658-0; Josephson E, 2017, HEALTH POLICY PLANN, V32, P1120, DOI 10.1093/heapol/czx053; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Landrine H, 2016, TOB CONTROL, V25, pe142; Lansky S, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00133213; Leal MD, 2018, CIENC SAUDE COLETIVA, V23, P1915, DOI [10.1590/1413-81232018236.03942018, 10.1590/1413-81232018236.039420181]; Macinko J, 2017, J AMBUL CARE MANAG, V40, pS4, DOI 10.1097/JAC.0000000000000189; Malta DC, 2017, CIENC SAUDE COLETIVA, V22, P179, DOI 10.1590/1413-81232017221.16782015; Mendelson A, 2017, ANN INTERN MED, V166, P341, DOI 10.7326/M16-1881; OCDE, 2010, HLTH CAR SYST GETT M; Oxman AD, 2008, 162008 NOKC; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Paul E, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000664; Rasella D, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002570; Ribeiro JM, 2018, CIENC SAUDE COLETIVA, V23, P1777, DOI 10.1590/1413-81232018236.07932018; Saddi FC, 2018, J AMBUL CARE MANAG, V41, P25, DOI 10.1097/JAC.0000000000000220; Saddi FD, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00202417, 10.1590/0102-311X00202417]; Scott A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008451.pub2; Shorey S, 2018, J PSYCHIATR RES, V104, P235, DOI 10.1016/j.jpsychires.2018.08.001; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Domingues RMSM, 2015, REV PANAM SALUD PUBL, V37, P140; Tekelab T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222566; The editors of Pharmaceutical Technology, 2015, PHARM TECHNOL S, V39, ps24; Tomasi Elaine, 2017, Cad. Saúde Pública, V33, pe00195815, DOI 10.1590/0102-311x00195815; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; WHO, 2016, WHO TECH REP SER, V997, P1; Yuan BB, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011153.pub2; 2003, DIABETES CARE S1, V1	54	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240631	10.1371/journal.pone.0240631	http://dx.doi.org/10.1371/journal.pone.0240631			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057414	gold, Green Published			2022-12-26	WOS:000581814700053
J	Gallo, E; Abbasciano, I; Mingozzi, S; Lavacca, A; Presta, R; Bruno, S; Deambrosis, I; Barreca, A; Romagnoli, R; Mella, A; Fop, F; Biancone, L				Gallo, Ester; Abbasciano, Isabella; Mingozzi, Silvia; Lavacca, Antonio; Presta, Roberto; Bruno, Stefania; Deambrosis, Ilaria; Barreca, Antonella; Romagnoli, Renato; Mella, Alberto; Fop, Fabrizio; Biancone, Luigi			Prevention of acute rejection after rescue with Belatacept by association of low-dose Tacrolimus maintenance in medically complex kidney transplant recipients with early or late graft dysfunction	PLOS ONE			English	Article							CALCINEURIN INHIBITOR THERAPY; CONVERSION; IMMUNOSUPPRESSION; OUTCOMES; EXPERIENCE; EFFICACY; SAFETY	Background Increased acute rejection risk in rescue protocols with Belatacept may limit its use particularly in medically complex patients where preexisting increased risk of rejection couples with CNI toxicity. Methods Retrospective analysis was performed in 19 KTs shifted to a Belatacept-based immunosuppression with low-dose Tacrolimus (2-3 ng/mL) after evidence of allograft disfunction, including patients with primary non-function (PNF), chronic-active antibody-mediated rejection (cAMR), history of previous KTs and/or other concomitant transplants (liver, pancreas). Evaluation of CD28(+) CD4(+) effector memory T cell (T-EM) before conversion was performed in 10/19. Results Kidney function significantly improved (median eGFR 16.5 ml/min/1.73 m(2) before vs 25 ml/min after; p = 0.001) at a median time after conversion of 12.5 months (9.1-17.8). Overall graft and patient survival were 89.5% and 100% respectively. Definitive weaning from dialysis in 5/5 KTs with PNF was observed, whereas 7/8 patients lost their graft within first year in a control group. eGFR significantly ameliorated in re-trasplants (p = 0.001) and stabilized in KTs with other organ transplants or cAMR. No acute rejection episodes occurred, despite the significant risk suggested by high frequency of CD28(+) CD4(+) T-EM in most patients. Opportunistic infections were limited and most common in early vs late-converted. Conclusions Rescue association of Belatacept with low-dose Tacrolimus in medically complex KTs is a feasible option that allows prevention of acute rejection and amelioration of graft function.	[Gallo, Ester; Abbasciano, Isabella; Mingozzi, Silvia; Lavacca, Antonio; Presta, Roberto; Bruno, Stefania; Deambrosis, Ilaria; Mella, Alberto; Fop, Fabrizio; Biancone, Luigi] Univ Turin, Renal Transplant Ctr A Vercellone Nephrol, Citta Salute & Sci Hosp, Dept Med Sci,Dialysis & Renal Transplant Div, Turin, Italy; [Barreca, Antonella] Univ Turin, Citta Salute & Sci Hosp, Div Pathol, Dept Med Sci, Turin, Italy; [Romagnoli, Renato] Univ Turin, Citta Salute & Sci Hosp, Gen Surg 2U, Liver Transplant Unit, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin	Biancone, L (corresponding author), Univ Turin, Renal Transplant Ctr A Vercellone Nephrol, Citta Salute & Sci Hosp, Dept Med Sci,Dialysis & Renal Transplant Div, Turin, Italy.	luigi.biancone@unito.it	Mella, Alberto/AAN-5083-2020	Mella, Alberto/0000-0001-6387-5005; Presta, Roberto/0000-0001-6680-7681; BRUNO, Stefania/0000-0002-8879-9536; BIANCONE, Luigi/0000-0002-7700-6350; Romagnoli, Renato/0000-0001-8340-8885				Adams AB, 2017, AM J TRANSPLANT, V17, P2922, DOI 10.1111/ajt.14353; [Anonymous], 2019, LANCET DIGITAL HLTH; [Anonymous], 2018, J ORTHOP TRAUMA, V32, pS141; Banham G, 2019, TRANSPLANTATION, P1; Bertrand D, 2020, NEPHROL DIAL TRANSPL, V35, P336, DOI 10.1093/ndt/gfz255; Brakemeier S, 2016, TRANSPL INT, V29, P1184, DOI 10.1111/tri.12822; Choi J, 2017, AM J TRANSPLANT, V17, P2381, DOI 10.1111/ajt.14228; Cohen JB, 2017, TRANSPLANTATION, V101, P2582, DOI 10.1097/TP.0000000000001589; Cortes-Cerisuelo M, 2017, AM J TRANSPLANT, V17, P2350, DOI 10.1111/ajt.14350; Dahmen M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47772-7; Darres A, 2018, TRANSPLANTATION, V102, P1545, DOI 10.1097/TP.0000000000002192; de Graav GN, 2017, TRANSPLANTATION, V101, P2571, DOI 10.1097/TP.0000000000001755; Dharnidharka VR, 2014, NEW ENGL J MED, V371, P549, DOI 10.1056/NEJMra1314376; Durr M, 2017, TRANSPL P, V49, P1747, DOI 10.1016/j.transproceed.2017.05.013; Grinyo JM, 2017, AM J KIDNEY DIS, V69, P587, DOI 10.1053/j.ajkd.2016.09.021; Gupta G, 2015, AM J TRANSPLANT, V15, P2726, DOI 10.1111/ajt.13322; Holdaas H, 2011, TRANSPLANTATION, V92, P410, DOI 10.1097/TP.0b013e318224c12d; Perez-Saez MJ, 2019, CLIN KIDNEY J, V12, P586, DOI 10.1093/ckj/sfy115; Klintmalm GB, 2014, AM J TRANSPLANT, V14, P1817, DOI 10.1111/ajt.12810; Lavacca A, 2020, CLIN TRANSPLANT, V34, DOI 10.1111/ctr.13908; Le Meur Y, 2016, AM J TRANSPLANT, V16, P2181, DOI 10.1111/ajt.13698; Leibler C, 2019, AM J TRANSPLANT, V19, P894, DOI 10.1111/ajt.15229; Li PKT, 2012, NAT REV NEPHROL, V8, P77, DOI 10.1038/nrneph.2011.194; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Malvezzi P, 2019, TRANSPL IMMUNOL, V56, DOI 10.1016/j.trim.2019.04.002; Malvezzi P, 2016, TRANSPLANTATION, V100, P2315, DOI 10.1097/TP.0000000000001344; Mannon RB, 2020, AM J TRANSPLANT, V20, P3599, DOI 10.1111/ajt.16152; Naik S., 2017, APPL ORGANOMETAL CHE, V31, pe3549, DOI 10.1002/aoc.3549; Perez CP, 2018, TRANSPLANTATION, V102, P1440, DOI 10.1097/TP.0000000000002291; Rostaing L, 2013, AM J TRANSPLANT, V13, P2875, DOI 10.1111/ajt.12460; Santeusanio AD, 2020, CLIN TRANSPLANT, V34; Stallone G, 2009, TRANSPLANTATION S, V87; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; Vincenti F, 2012, AM J TRANSPLANT, V12, P210, DOI 10.1111/j.1600-6143.2011.03785.x; Vincenti F, 2010, AM J TRANSPLANT, V10, P535, DOI 10.1111/j.1600-6143.2009.03005.x; Vincenti F, 2016, NEW ENGL J MED, V374, P333, DOI 10.1056/NEJMoa1506027; Wen X, 2016, AM J TRANSPLANT, V16, P3202, DOI 10.1111/ajt.13853	37	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240335	10.1371/journal.pone.0240335	http://dx.doi.org/10.1371/journal.pone.0240335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057374	gold, Green Published			2022-12-26	WOS:000581814700077
J	Habuta, M; Yasue, A; Suzuki, KT; Fujita, H; Sato, K; Kono, H; Takayama, A; Bando, T; Miyaishi, S; Oyadomari, S; Tanaka, E; Ohuchi, H				Habuta, Munenori; Yasue, Akihiro; Suzuki, Ken-ichi T.; Fujita, Hirofumi; Sato, Keita; Kono, Hitomi; Takayama, Ayuko; Bando, Tetsuya; Miyaishi, Satoru; Oyadomari, Seiichi; Tanaka, Eiji; Ohuchi, Hideyo			Fgf10-CRISPR mosaic mutants demonstrate the gene dose-related loss of the accessory lobe and decrease in the number of alveolar type 2 epithelial cells in mouse lung	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; SOMATIC MOSAICISM; FGF10 EXPRESSION; DIFFERENTIATION; MICE; LIMB; FIBROBLAST-GROWTH-FACTOR-10; ELECTROPORATION; PROGENITORS; GENERATION	CRISPR/Cas9-mediated gene editing often generates founder generation (F0) mice that exhibit somatic mosaicism in the targeted gene(s). It has been known thatFibroblast growth factor 10(Fgf10)-null mice exhibit limbless and lungless phenotypes, while intermediate limb phenotypes (variable defective limbs) are observed in theFgf10-CRISPR F0 mice. However, how the lung phenotype in theFgf10-mosaic mutants is related to the limb phenotype and genotype has not been investigated. In this study, we examined variable lung phenotypes in theFgf10-targeted F0 mice to determine if the lung phenotype was correlated with percentage of functionalFgf10genotypes. Firstly, according to a previous report,Fgf10-CRISPR F0 embryos on embryonic day 16.5 (E16.5) were classified into three types: type I, no limb; type II, limb defect; and type III, normal limbs. Cartilage and bone staining showed that limb truncations were observed in the girdle, (type I), stylopodial, or zeugopodial region (type II). Deep sequencing of theFgf10-mutant genomes revealed that the mean proportion of codons that encode putative functional FGF10 was 8.3 +/- 6.2% in type I, 25.3 +/- 2.7% in type II, and 54.3 +/- 9.5% in type III (mean +/- standard error of the mean) mutants at E16.5. Histological studies showed that almost all lung lobes were absent in type I embryos. The accessory lung lobe was often absent in type II embryos with other lobes dysplastic. All lung lobes formed in type III embryos. The number of terminal tubules was significantly lower in type I and II embryos, but unchanged in type III embryos. To identify alveolar type 2 epithelial (AECII) cells, known to be reduced in theFgf10-heterozygous mutant, immunostaining using anti-surfactant protein C (SPC) antibody was performed: In the E18.5 lungs, the number of AECII was correlated to the percentage of functionalFgf10genotypes. These data suggest theFgf10gene dose-related loss of the accessory lobe and decrease in the number of alveolar type 2 epithelial cells in mouse lung. Since dysfunction of AECII cells has been implicated in the pathogenesis of parenchymal lung diseases, theFgf10-CRISPR F0 mouse would present an ideal experimental system to explore it.	[Habuta, Munenori; Fujita, Hirofumi; Sato, Keita; Kono, Hitomi; Bando, Tetsuya; Ohuchi, Hideyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cytol & Histol, Okayama, Japan; [Yasue, Akihiro; Tanaka, Eiji] Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Tokushima, Japan; [Suzuki, Ken-ichi T.] Hiroshima Univ, Dept Math & Life Sci, Hiroshima, Japan; [Suzuki, Ken-ichi T.; Takayama, Ayuko] Natl Inst Basic Biol, Ctr Dev New Model Organisms, Okazaki, Aichi, Japan; [Miyaishi, Satoru] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Legal Med, Okayama, Japan; [Oyadomari, Seiichi] Tokushima Univ, Inst Adv Med Sci, Div Mol Biol, Tokushima, Japan	Okayama University; Tokushima University; Hiroshima University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okayama University; Tokushima University	Ohuchi, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cytol & Histol, Okayama, Japan.; Yasue, A (corresponding author), Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Tokushima, Japan.	hohuchi@okayama-u.ac.jp; yasuea@tokushima-u.ac.jp	Tanaka, Eiji/E-7105-2015; Oyadomari, Seiichi/GZA-7157-2022; Oyadomari, Seiichi/GZA-7072-2022	Tanaka, Eiji/0000-0002-2707-1613; 	Sasakawa Scientific Research Grant from The Japan Science Society [2019-4012]; MEXT, Japan [26293436, 16H05551]; Pfizer Japan, Inc.	Sasakawa Scientific Research Grant from The Japan Science Society; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Pfizer Japan, Inc.(Pfizer)	This work was partly funded by the Sasakawa Scientific Research Grant from The Japan Science Society (https://www.jss.or.jp/en/) (2019-4012 to M.H), grants-in-aid from MEXT, Japan (https://www.mext.go.jp/en/index.htm) (26293436 to E.T., 16H05551 to A.Y.), and an academic grant from Pfizer Japan, Inc. (https://pfizer-ac-web.pfizer.co.jp) (Academic Contributions to H.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Bonsrah KD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34524; Ackerman KG, 2007, AM J RESP CELL MOL, V36, P391, DOI 10.1165/rcmb.2006-0211RC; Ackerman KG, 2005, PLOS GENET, V1, P58, DOI 10.1371/journal.pgen.0010010; [Anonymous], 2018, DEVELOPMENT, V145, pe0201; [Anonymous], 2012, J OPT COMMUN NETW, V4, pB94; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Brinkman EK, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky164; Burns RC, 2004, DEV BIOL, V265, P61, DOI 10.1016/j.ydbio.2003.09.021; Chao CM, 2017, J PATHOL, V241, P91, DOI 10.1002/path.4834; Cornu TI, 2017, NAT MED, V23, P415, DOI 10.1038/nm.4313; Danopoulos S, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00170; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Durland JL, 2008, J ANAT, V212, P590, DOI 10.1111/j.1469-7580.2008.00879.x; El Agha E, 2014, DEVELOPMENT, V141, P296, DOI 10.1242/dev.099747; Frank DB, 2019, P NATL ACAD SCI USA, V116, P4362, DOI 10.1073/pnas.1813952116; Gajecka M, 2016, MOL GENET GENOMICS, V291, P513, DOI 10.1007/s00438-015-1130-7; Gao X, 2016, KAUFMANS ATLAS MOUSE; Grindley JC, 1997, DEV BIOL, V188, P337, DOI 10.1006/dbio.1997.8644; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Hobbs BD, 2017, NAT GENET, V49, P426, DOI 10.1038/ng.3752; Hogan B, 1994, MANIPULATING MOUSE E; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; Iida M, 2020, GENES CELLS, V25, P498, DOI 10.1111/gtc.12775; Li J, 2018, DEV CELL, V44, P297, DOI 10.1016/j.devcel.2018.01.008; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Ramasamy SK, 2007, DEV BIOL, V307, P237, DOI 10.1016/j.ydbio.2007.04.033; Sala FG, 2006, DEV BIOL, V299, P373, DOI 10.1016/j.ydbio.2006.08.001; Sears KE, 2015, EVOLUTION, V69, P2543, DOI 10.1111/evo.12773; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Smith BM, 2018, P NATL ACAD SCI USA, V115, pE974, DOI 10.1073/pnas.1715564115; SORIANO P, 1986, CELL, V46, P19, DOI 10.1016/0092-8674(86)90856-1; Stachtea XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140279; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Teshima THN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00488; Valasek P, 2010, J ANAT, V216, P482, DOI 10.1111/j.1469-7580.2009.01200.x; Volckaert T, 2013, DEVELOPMENT, V140, P3731, DOI 10.1242/dev.096560; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yasue A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00088-w; Yasue A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05705; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366	47	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240333	10.1371/journal.pone.0240333	http://dx.doi.org/10.1371/journal.pone.0240333			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057360	Green Submitted, Green Published, gold			2022-12-26	WOS:000581814700082
J	Tomczyk, M; Kraszewska, I; Maka, R; Waligorska, A; Dulak, J; Jazwa-Kusior, A				Tomczyk, Mateusz; Kraszewska, Izabela; Maka, Robert; Waligorska, Agnieszka; Dulak, Jozef; Jazwa-Kusior, Agnieszka			Characterization of hepatic macrophages and evaluation of inflammatory response in heme oxygenase-1 deficient mice exposed to scAAV9 vectors	PLOS ONE			English	Article							TISSUE-RESIDENT MACROPHAGES; INNATE IMMUNE-RESPONSES; KUPFFER CELLS; GENE-TRANSFER; HOST-DEFENSE; FACTOR-IX; LIVER; AAV; TRANSDUCTION; INJURY	Adeno-associated viral (AAV) vectors are characterised by low immunogenicity, although humoral and cellular responses may be triggered upon infection. Following systemic administration high levels of vector particles accumulate within the liver. Kupffer cells (KCs) are liver resident macrophages and an important part of the liver innate immune system. Decreased functional activity of KCs can contribute to exaggerated inflammatory response upon antigen exposure. Heme oxygenase-1 (HO-1) deficiency is associated with considerably reduced numbers of KCs. In this study we aimed to investigate the inflammatory responses in liver and to characterise two populations of hepatic macrophages in adult wild type (WT) and HO-1 knockout (KO) mice following systemic administration of one or two doses (separated by 3 months) of self-complementary (sc)AAV9 vectors. At steady state, the livers of HO-1 KO mice contained significantly higher numbers of monocyte-derived macrophages (MDMs), but significantly less KCs than their WT littermates. Three days after re-administration of scAAV9 we observed increased mRNA level of monocyte chemoattractant protein-1 (Mcp-1) in the livers of both WT and HO-1 KO mice, but the protein level and the macrophage infiltration were not affected. Three days after the 1(st)and 3 days after the 2(nd)vector dose the numbers of AAV genomes in the liver were comparable between both genotypes indicating similar transduction efficiency, but the percentage of transgene-expressing MDMs and KCs was higher in WT than in HO-1 KO mice. In the primary culture, KCs were able to internalize AAV9 particles without induction of TLR9-mediated immune responses, but no transgene expression was observed. In conclusion,in vivoandin vitrocultured KCs have different susceptibility to scAAV9 vectors. Regardless of the presence or absence of HO-1 and initial numbers of KCs in the liver, scAAV9 exhibits a low potential to stimulate inflammatory response at the analysed time points.	[Tomczyk, Mateusz; Kraszewska, Izabela; Maka, Robert; Dulak, Jozef; Jazwa-Kusior, Agnieszka] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, Krakow, Poland; [Waligorska, Agnieszka] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biophys, Krakow, Poland	Jagiellonian University; Jagiellonian University	Jazwa-Kusior, A (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, Krakow, Poland.	agnieszka.jazwa@uj.edu.pl	Tomczyk, Mateusz/Y-1377-2019	Kraszewska, Izabela/0000-0003-1196-262X; Tomczyk, Mateusz/0000-0001-9322-748X; Jazwa-Kusior, Agnieszka/0000-0001-9107-4395	Polish National Science Center [2014/14/E/NZ1/00139]; Ministry of Science and Higher Education [0249/IP1/2013/72]	Polish National Science Center; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by grant No. 2014/14/E/NZ1/00139 from the Polish National Science Center and grant No. 0249/IP1/2013/72 from the Ministry of Science and Higher Education (both awarded to A.J.-K.).	[Anonymous], 2012, P NATL ACAD SCI US, V109, pE1377; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Bostick B, 2007, GENE THER, V14, P1605, DOI 10.1038/sj.gt.3303029; Chen SF, 2005, P NATL ACAD SCI USA, V102, P7251, DOI 10.1073/pnas.0502407102; Clinical Practice Guideline, 2006, J PEDIAT GASTROENTER, V43, pe1; Colella P, 2018, MOL THER-METH CLIN D, V8, P87, DOI 10.1016/j.omtm.2017.11.007; Denard J, 2018, MOL THER-METH CLIN D, V10, P291, DOI 10.1016/j.omtm.2018.08.001; Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Fields PA, 2001, MOL THER, V4, P201, DOI 10.1006/mthe.2001.0441; Fitzpatrick Z, 2018, MOL THER-METH CLIN D, V9, P119, DOI 10.1016/j.omtm.2018.02.003; Galastri S, 2012, CLIN SCI, V123, P459, DOI 10.1042/CS20110515; Gurda BL, 2013, J VIROL, V87, P9111, DOI 10.1128/JVI.00622-13; Halbert CL, 2000, J VIROL, V74, P1524, DOI 10.1128/JVI.74.3.1524-1532.2000; Hosel M, 2012, HEPATOLOGY, V55, P287, DOI 10.1002/hep.24625; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Ju C, 2005, TOXICOLOGY, V209, P109, DOI 10.1016/j.tox.2004.12.017; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kim KS, 2018, BLOOD ADV, V2, P2732, DOI 10.1182/bloodadvances.2018019737; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kotchey NM, 2011, MOL THER, V19, P1079, DOI 10.1038/mt.2011.3; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Kuranda K, 2018, J CLIN INVEST, V128, P5267, DOI 10.1172/JCI122372; Lai SM, 2018, CELL REP, V25, P3099, DOI 10.1016/j.celrep.2018.11.059; Li PZ, 2014, IMMUNOL LETT, V158, P52, DOI 10.1016/j.imlet.2013.12.002; Loboda A, 2008, ANTIOXID REDOX SIGN, V10, P1767, DOI 10.1089/ars.2008.2043; Majowicz A, 2019, MOL THER-METH CLIN D, V14, P27, DOI 10.1016/j.omtm.2019.05.009; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Martino AT, 2011, BLOOD, V117, P6459, DOI 10.1182/blood-2010-10-314518; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Mingozzi F, 2013, GENE THER, V20, P417, DOI 10.1038/gt.2012.55; Mingozzi F, 2017, ANNU REV VIROL, V4, P511, DOI 10.1146/annurev-virology-101416-041936; Mingozzi F, 2011, CURR GENE THER, V11, P321, DOI 10.2174/156652311796150354; Movita D, 2012, J LEUKOCYTE BIOL, V92, P723, DOI 10.1189/jlb.1111566; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Naito M, 1997, MICROSC RES TECHNIQ, V39, P350, DOI 10.1002/(SICI)1097-0029(19971115)39:4<350::AID-JEMT5>3.0.CO;2-L; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Radhakrishnan N, 2011, J PEDIAT HEMATOL ONC, V33, P74, DOI 10.1097/MPH.0b013e3181fd2aae; Repesse Y, 2013, HAEMATOLOGICA, V98, P1650, DOI 10.3324/haematol.2013.084665; Schumacher A, 2015, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00288; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Steube KG, 1999, LEUKEMIA RES, V23, P843, DOI 10.1016/S0145-2126(99)00107-1; Stone D, 2008, J VIROL, V82, P7711, DOI 10.1128/JVI.00542-08; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Taha H, 2010, ARTERIOSCL THROM VAS, V30, P1634, DOI 10.1161/ATVBAHA.110.207316; Tomczyk M, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0629-y; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Wenzel P, 2015, EUR HEART J, V36, P3437, DOI 10.1093/eurheartj/ehv544; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	61	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240691	10.1371/journal.pone.0240691	http://dx.doi.org/10.1371/journal.pone.0240691			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057437	Green Published, gold			2022-12-26	WOS:000581814700071
J	Marseille, E; Kahn, JG; Yazar-Klosinski, B; Doblin, R				Marseille, Elliot; Kahn, James G.; Yazar-Klosinski, Berra; Doblin, Rick			The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; LONG-TERM; 3,4-METHYLENEDIOXYMETHAMPHETAMINE-ASSISTED PSYCHOTHERAPY; HEALTH; SYMPTOMS; CARE; COMORBIDITY; METAANALYSIS; DEPRESSION; MEDICAID	Background Chronic posttraumatic stress disorder (PTSD) is a disabling condition that generates considerable morbidity, mortality, and both medical and indirect social costs. Treatment options are limited. A novel therapy using 3,4-methylenedioxymethamphetamine (MDMA) has shown efficacy in six phase 2 trials. Its cost-effectiveness is unknown. Methods and findings To assess the cost-effectiveness of MDMA-assisted psychotherapy (MAP) from the health care payer's perspective, we constructed a decision-analytic Markov model to portray the costs and health benefits of treating patients with chronic, severe, or extreme, treatment-resistant PTSD with MAP. In six double-blind phase 2 trials, MAP consisted of a mean of 2.5 90-minute trauma-focused psychotherapy sessions before two 8-hour sessions with MDMA (mean dose of 125 mg), followed by a mean of 3.5 integration sessions for each active session. The control group received an inactive placebo or 25-40 mg. of MDMA, and otherwise followed the same regimen. Our model calculates net medical costs, mortality, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios. Efficacy was based on the pooled results of six randomized controlled phase 2 trials with 105 subjects; and a four-year follow-up of 19 subjects. Other inputs were based on published literature and on assumptions when data were unavailable. We modeled results over a 30-year analytic horizon and conducted extensive sensitivity analyses. Our model calculates expected medical costs, mortality, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratio. Future costs and QALYs were discounted at 3% per year. For 1,000 individuals, MAP generates discounted net savings of $103.2 million over 30 years while accruing 5,553 discounted QALYs, compared to continued standard of care. MAP breaks even on cost at 3.1 years while delivering 918 QALYs. Making the conservative assumption that benefits cease after one year, MAP would accrue net costs of $7.6 million while generating 288 QALYS, or $26,427 per QALY gained. Conclusion MAP provided to patients with severe or extreme, chronic PTSD appears to be cost-saving while delivering substantial clinical benefit. Third-party payers are likely to save money within three years by covering this form of therapy.	[Marseille, Elliot] Hlth Strategies Int, Oakland, CA 94609 USA; [Marseille, Elliot; Kahn, James G.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Yazar-Klosinski, Berra; Doblin, Rick] Multidisciplinary Assoc Psychedel Studies MAPS, Santa Cruz, CA USA	University of California System; University of California San Francisco	Marseille, E (corresponding author), Hlth Strategies Int, Oakland, CA 94609 USA.; Marseille, E (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	emarseille@comcast.net						Ahmadi N, 2011, AM J CARDIOL, V108, P29, DOI 10.1016/j.amjcard.2011.02.340; [Anonymous], 2017, MDMA INV BROCH; [Anonymous], 2020, CONS PRIC IND; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Brady K, 2000, JAMA-J AM MED ASSOC, V283, P1837, DOI 10.1001/jama.283.14.1837; Chan D, 2009, PSYCHIAT SERV, V60, P1612, DOI 10.1176/ps.2009.60.12.1612; Davis MT, 2014, PSYCHOL TRAUMA-US, V6, P610, DOI 10.1037/a0033941; Dedert EA, 2010, ANN BEHAV MED, V39, P61, DOI 10.1007/s12160-010-9165-9; Feduccia AA, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00650; Fronstin Paul, 2017, EBRI Issue Brief, P1; Goldman AL, 2020, HEALTH AFFAIR, V39, P85, DOI 10.1377/hlthaff.2019.00378; Haviland MG, 2016, J NERV MENT DIS, V204, P78, DOI 10.1097/NMD.0000000000000432; Ivanova JI, 2011, AM J MANAG CARE, V17, pE314; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lavelle TA, 2018, AM J MANAG CARE, V24, P91; Liang LL, 2020, PSYCHIAT QUART, V91, P841, DOI 10.1007/s11126-020-09744-3; Lukaschek K, 2013, J PSYCHOSOM RES, V74, P340, DOI 10.1016/j.jpsychores.2012.12.011; Mancino MJ, 2006, J NERV MENT DIS, V194, P877, DOI 10.1097/01.nmd.0000244686.79689.21; Marciniak MD, 2005, DEPRESS ANXIETY, V21, P178, DOI 10.1002/da.20074; Mithoefer MC, 2019, PSYCHOPHARMACOLOGY; Mithoefer MC, 2013, J PSYCHOPHARMACOL, V27, P28, DOI 10.1177/0269881112456611; Mithoefer MC, 2011, J PSYCHOPHARMACOL, V25, P439, DOI 10.1177/0269881110378371; Morina N, 2014, CLIN PSYCHOL REV, V34, P249, DOI 10.1016/j.cpr.2014.03.002; National Comorbidity Survey, 2005, NCS R APP TABL TABL; Oehen P, 2013, J PSYCHOPHARMACOL, V27, P40, DOI 10.1177/0269881112464827; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Ramsawh HJ, 2014, J AFFECT DISORDERS, V161, P116, DOI 10.1016/j.jad.2014.03.016; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Sareen J, 2007, PSYCHOSOM MED, V69, P242, DOI 10.1097/PSY.0b013e31803146d8; Savoca Elizabeth, 2000, J Ment Health Policy Econ, V3, P199, DOI 10.1002/mhp.102; Solomon Z, 2006, AM J PSYCHIAT, V163, P659, DOI 10.1176/appi.ajp.163.4.659; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Steinert C, 2015, NORD J PSYCHIAT, V69, P483, DOI 10.3109/08039488.2015.1005023; Walker EA, 2003, ARCH GEN PSYCHIAT, V60, P369, DOI 10.1001/archpsyc.60.4.369; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	36	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0239997	10.1371/journal.pone.0239997	http://dx.doi.org/10.1371/journal.pone.0239997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052965	gold, Green Published			2022-12-26	WOS:000581820200071
J	Chan, V; Hurst, M; Petersen, T; Liu, JQ; Mollayeva, T; Colantonio, A; Sutton, M; Escobar, MD				Chan, Vincy; Hurst, Mackenzie; Petersen, Tierza; Liu, Jingqian; Mollayeva, Tatyana; Colantonio, Angela; Sutton, Mitchell; Escobar, Michael D.			A population-based sex-stratified study to understand how health status preceding traumatic brain injury affects direct medical cost	PLOS ONE			English	Article							OUTCOMES; GENDER; SERVICES; CARE; FACILITATORS; BARRIERS; SYSTEMS	Objective To understand how pre-injury health status present five-years preceding traumatic brain injury (TBI) affects direct medical cost two years post-injury. Methods Patients age >= 19 years in the emergency department (ED) or acute care for a TBI between April 1, 2007 and March 31, 2014 in Ontario, Canada (N = 55,669) were identified from population-based health administrative data. Forty-three factors of pre-injury health status (i.e., comorbidities and personal, social, and environmental factors) that were internally validated for the TBI population were assessed in this study. The outcome of interest was direct medical cost within two years of discharge. Sex-specific multivariable linear regressions were conducted to understand the associations between direct medical cost within two years of discharge and pre-injury health status. Results Patients who received care in the ED (81.9% of total sample) incurred a median cost of $2,492/male patient (average $12,342/patient) and $3,508/female patient (average $65,285/patient) within two years of injury; 37 pre-injury factors were significantly associated with increased direct medical costs. Patients who first received care for their TBI in acute care (18.1%) incurred a median cost of $25,081/male patient (average $63,060/patient) and $30,277/female patient (average $65,285/patient) within two years of injury; 21 factors were significantly associated with increased direct medical costs. Among more prevalent factors, those associated with increased medical cost by at least 50% included mental health disorders, substance abuse, disorders or medical conditions frequently observed among the elderly, cardiovascular disorders, stroke and emergencies involving the brain, metabolic disorders and abdominal symptoms, conditions and symptoms of abdomen and pelvis, genitourinary disorders and disorders of prostate, and pulmonary abdominal and other emergencies. Conclusions Direct medical costs two years post-TBI differed significantly between patients with and without adverse pre-existing health status. Interdisciplinary teams to promote early identification of pre-existing health conditions and appropriate management and integration of these conditions in TBI care across the continuum of healthcare may be opportunities to reduce direct medical costs post-injury.	[Chan, Vincy; Hurst, Mackenzie; Petersen, Tierza; Liu, Jingqian; Mollayeva, Tatyana; Colantonio, Angela; Sutton, Mitchell] Univ Hlth Network, KITE Toronto Rehab, Toronto, ON, Canada; [Colantonio, Angela; Escobar, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Colantonio, Angela] ICES, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Chan, V (corresponding author), Univ Hlth Network, KITE Toronto Rehab, Toronto, ON, Canada.	vincy.chan@uhn.ca	, Mollayeva/A-4522-2018	, Mollayeva/0000-0002-2787-1848	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R21HD089106]; Alzheimer's Association [AARF-16-442937]; Canada's Strategy for Patient-Oriented Research (SPOR); Ontario SPOR Support Unit; Canadian Institutes of Health Research; Government of Ontario	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Alzheimer's Association(Alzheimer's Association); Canada's Strategy for Patient-Oriented Research (SPOR); Ontario SPOR Support Unit; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Government of Ontario	This study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD089106) to AC. A Postdoctoral research fellowship from the Alzheimer's Association (AARF-16-442937) was awarded to TM.; This study made use of de-identified data from the ICES Data Repository, which is managed by the Institute for Clinical Evaluative Sciences with support from its funders and partners: Canada's Strategy for Patient-Oriented Research (SPOR), the Ontario SPOR Support Unit, the Canadian Institutes of Health Research and the Government of Ontario. The opinions, results and conclusions reported are those of the authors. No endorsement by ICES or any of its funders or partners is intended or should be inferred. Parts of this material are based on data and information compiled and provided by CIHI. However, the analyses, conclusions, opinions and statements expressed herein are those of the author, and not necessarily those of CIHI.	Abbreviated Injury Scale (AIS), 2019, ASS ADV AUT MED; [Anonymous], 2015, BRAIN DISORDERS ONTA; Association of Public Health Epidemiologists in Ontario, 2019, REC ICD 10 CA COD IN; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; Balogh R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007492.pub2; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Canadian Institute for Health Information, 2019, NACRS DAT EL 2018 20; Canadian Institute for Health Information, 2019, DAD DAT EL 2018 2019; Centre for Disease Prevention and Control, 2019, ICD INJ MATR CTR DIS; Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Chan V, 2016, ARCH PHYS MED REHAB, V97, P772, DOI 10.1016/j.apmr.2016.01.011; Chan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0259-7; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; CHEN A, 2012, HEALTHC POLICY, V7, P41, DOI DOI 10.12927/hcpol.2013.22883; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Damian AJ, 2018, CHILD YOUTH SERV REV, V85, P273, DOI 10.1016/j.childyouth.2018.01.003; Haldane V, 2018, AIDS CARE, V30, P103, DOI 10.1080/09540121.2017.1344350; Haldane V, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21585; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Juurlink D, 2006, CANADIAN I HLTH INFO; Kantor V, 2017, CLIN PSYCHOL REV, V52, P52, DOI 10.1016/j.cpr.2016.12.001; Legido-Quigley H, 2013, TROP MED INT HEALTH, V18, P199, DOI 10.1111/tmi.12029; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ministry of Health and Long-Term Care, 2019, ALT LEV CAR ALC DAYS; Mollayeva T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41916-5; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Munce SEP, 2014, BRAIN INJURY, V28, P1042, DOI 10.3109/02699052.2014.890744; Nations U, 2019, PROB POP PROJ BAS WO; Raukar NP, 2014, ACAD EMERG MED, V21, P1370, DOI 10.1111/acem.12535; Roberts KC, 2015, HEALTH PROMOT CHRON, V35, DOI 10.24095/hpcdp.35.6.01; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Secretariat WHO, 2016, FRAM INT PEOPL CTR H; Shi HY, 2013, J NEUROSURG, V118, P732, DOI 10.3171/2012.12.JNS12693; Sigfrid L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181156; Statistics Canada, 2018, TABLE 17 10 0005 01; Sutton M, 2019, J WOMENS HEALTH, V28, P473, DOI 10.1089/jwh.2018.7282; Thompson AE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0440-0; Toor GK, 2016, ARCH PHYS MED REHAB, V97, pS54, DOI 10.1016/j.apmr.2015.02.010; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; West LM, 2018, RES SOC ADMIN PHARM, V14, P1015, DOI 10.1016/j.sapharm.2017.12.003; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Wodchis WP, 2013, GUIDELINES PERSON LE; World Health Organization, INT CHRON DIS PREV C	52	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240208	10.1371/journal.pone.0240208	http://dx.doi.org/10.1371/journal.pone.0240208			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	33048973	Green Published, gold			2022-12-26	WOS:000581813300044
J	Nweke, EE; Naicker, P; Aron, S; Stoychev, S; Devar, J; Tabb, DL; Omoshoro-Jones, J; Smith, M; Candy, G				Nweke, Ekene Emmanuel; Naicker, Previn; Aron, Shaun; Stoychev, Stoyan; Devar, John; Tabb, David L.; Omoshoro-Jones, Jones; Smith, Martin; Candy, Geoffrey			SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways	PLOS ONE			English	Article							CANCER-CELLS; LYSYL OXIDASE; TISSUE TRANSGLUTAMINASE; STROMA INTERACTION; MASS-SPECTROMETRY; PROTEIN; ASSOCIATION; EXPRESSION; HYPOXIA; METASTASIS	Pancreatic cancer accounts for 2.8% of new cancer cases worldwide and is projected to become the second leading cause of cancer-related deaths by 2030. Patients of African ancestry appear to be at an increased risk for pancreatic ductal adenocarcinoma (PDAC), with more severe disease and outcomes. The purpose of this study was to map the proteomic and genomic landscape of a cohort of PDAC patients of African ancestry. Thirty tissues (15 tumours and 15 normal adjacent tissues) were obtained from consenting South African PDAC patients. Optimisation of the sample preparation method allowed for the simultaneous extraction of high-purity protein and DNA for SWATH-MS and OncoArray SNV analyses. We quantified 3402 proteins with 49 upregulated and 35 downregulated proteins at a minimum 2.1 fold change and FDR adjusted p-value (q-value) <= 0.01 when comparing tumour to normal adjacent tissue. Many of the upregulated proteins in the tumour samples are involved in extracellular matrix formation (ECM) and related intracellular pathways. In addition, proteins such as EMIL1, KBTB2, and ZCCHV involved in the regulation of ECM proteins were observed to be dysregulated in pancreatic tumours. Downregulation of pathways involved in oxygen and carbon dioxide transport were observed. Genotype data showed missense mutations in some upregulated proteins, such as MYPN, ESTY2 and SERPINB8. Approximately 11% of the dysregulated proteins, including ISLR, BP1, PTK7 and OLFL3, were predicted to be secretory proteins. These findings help in further elucidating the biology of PDAC and may aid in identifying future plausible markers for the disease.	[Nweke, Ekene Emmanuel; Devar, John; Omoshoro-Jones, Jones; Smith, Martin; Candy, Geoffrey] Univ Witwatersrand, Dept Surg, Fac Hlth Sci, Johannesburg, South Africa; [Naicker, Previn; Stoychev, Stoyan] CSIR, Dept Biosci, Pretoria, South Africa; [Aron, Shaun] Univ Witwatersrand, Sydney Brenner Inst Mol Biosci, Johannesburg, South Africa; [Tabb, David L.] Stellenbosch Univ, Bioinformat Unit, South African TB Bioinformat Initiat, Div Mol Biol & Human Genet,Dept Biomed Sci, Cape Town, South Africa	University of Witwatersrand; Council for Scientific & Industrial Research (CSIR) - South Africa; University of Witwatersrand; Stellenbosch University	Nweke, EE (corresponding author), Univ Witwatersrand, Dept Surg, Fac Hlth Sci, Johannesburg, South Africa.	ekene.nweke@wits.ac.za	Naicker, Previn/GRR-8492-2022; Omoshoro-Jones, Jones A. O./AAV-1341-2020; Nweke, Ekene/ABE-7894-2020	Naicker, Previn/0000-0001-9418-6472; Omoshoro-Jones, Jones A. O./0000-0002-1071-298X; Nweke, Ekene/0000-0003-4026-1697; Tabb, David/0000-0001-7223-578X; Aron, Shaun/0000-0001-6200-0485; Stoychev, Stoyan/0000-0001-7504-4313	Council for Scientific and Industrial Research; Strategic Health Innovation Partnership (SHIP) grant from the South African (SA) Department of Science and Technology (DST); SA Medical Research Council (SAMRC) - Cancer Association of South Africa (CANSA); South African Medical Research Council through Wits Common Epithelial Cancer Research Centre	Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Strategic Health Innovation Partnership (SHIP) grant from the South African (SA) Department of Science and Technology (DST); SA Medical Research Council (SAMRC) - Cancer Association of South Africa (CANSA); South African Medical Research Council through Wits Common Epithelial Cancer Research Centre	The study was funded by the Council for Scientific and Industrial Research and the South African Medical Research Council through a grant awarded to the Wits Common Epithelial Cancer Research Centre. DLT was supported in part by a Strategic Health Innovation Partnership (SHIP) grant from the South African (SA) Department of Science and Technology (DST) and the SA Medical Research Council (SAMRC) to Gerhard Walzl. GC is funded by The Cancer Association of South Africa (CANSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola PG, 2019, CANCERS, V11, DOI 10.3390/cancers11050729; Amrutkar M, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5803-1; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Bhatia A, 2018, PATHOL RES PRACT, V214, P290, DOI 10.1016/j.prp.2017.09.026; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buthelezi SG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209373; Chaika NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032996; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chen X, 2018, EBIOMEDICINE, V30, P129, DOI 10.1016/j.ebiom.2018.03.008; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Dasgupta S, 2014, BLOOD, V124; Dasgupta SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162897; de Miguel FJ, 2016, MOL ONCOL, V10, P1437, DOI 10.1016/j.molonc.2016.08.001; Erazo A, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0182-4; Erkan M, 2016, EXPERT REV GASTROENT, V10, P301, DOI 10.1586/17474124.2016.1117386; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Ge SX, 2020, BIOINFORMATICS, V36, P2628, DOI 10.1093/bioinformatics/btz931; Geurts N, 2012, PHARMACOL THERAPEUT, V133, P257, DOI 10.1016/j.pharmthera.2011.11.008; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Grzesiak JJ, 2006, BRIT J CANCER, V94, P1311, DOI 10.1038/sj.bjc.6603088; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Hastings Jordan F, 2019, Br J Pharmacol, V176, P82, DOI 10.1111/bph.14195; Heiska L, 2005, J BIOL CHEM, V280, P10244, DOI 10.1074/jbc.M411353200; Hosein AN, 2020, NAT REV GASTRO HEPAT, V17, P487, DOI 10.1038/s41575-020-0300-1; Huang CB, 2019, CLIN CANCER RES, V25, P4091, DOI 10.1158/1078-0432.CCR-18-3533; Huang L, 2015, AM J CANCER RES, V5, P2756; Huzil JT, 2007, CANCER INFORM, V3, P159; Hwang HJ, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1225-9; Kelley MJ, 2001, J NATL CANCER I, V93, P1886, DOI 10.1093/jnci/93.24.1886; Kelly KA, 2008, PLOS MED, V5, P657, DOI 10.1371/journal.pmed.0050085; Khawja SN, 2015, PANCREAS, V44, P522, DOI 10.1097/MPA.0000000000000323; Kim K, 2014, CANCER INFORM, V13, P45, DOI [10.4137/CIN.s16341, 10.4137/CIN.S16341]; Kovac B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196986; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Lecine P, 2000, BLOOD, V96, P1366, DOI 10.1182/blood.V96.4.1366.h8001366_1366_1373; Lee HJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14122; Lee J, 2015, CLIN CANCER RES, V21, P4482, DOI 10.1158/1078-0432.CCR-15-0226; Liu ZW, 2013, CANCER BIOL THER, V14, P428, DOI 10.4161/cbt.23786; Lu K, 2016, ONCOL LETT, V12, P243, DOI 10.3892/ol.2016.4586; Ludwig C, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178126; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyamoto H, 2004, PANCREAS, V28, P38, DOI 10.1097/00006676-200401000-00006; Murakami T, 2019, ANN GASTROENT SURG, V3, P130, DOI 10.1002/ags3.12225; Naba A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-518; Nami B, 2018, CANCERS, V10, DOI 10.3390/cancers10080274; Nguyen AV, 2016, INTEGR BIOL-UK, V8, P1232, DOI 10.1039/c6ib00135a; Nordfors K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-148; Nweke E, 2020, ONCOL LETT, V19, P4133, DOI 10.3892/ol.2020.11473; Olsson AK, 2018, PLATELETS, V29, P569, DOI 10.1080/09537104.2018.1453059; Parker AL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00153; Pickup MW, 2013, CANCER RES, V73, P5336, DOI 10.1158/0008-5472.CAN-13-0012; Procacci P, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100158; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rajamani D, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0282-3; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]; Rice AJ, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.54; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Saeki N, 2018, CANCER GENOM PROTEOM, V15, P165, DOI 10.21873/cgp.20074; Schroeder MC, 2012, SEMIN CELL DEV BIOL, V23, P803, DOI 10.1016/j.semcdb.2012.06.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharen G, 2017, ONCOTARGET, V8, P19760, DOI 10.18632/oncotarget.15035; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Silverman DT, 2003, EPIDEMIOLOGY, V14, P45, DOI 10.1097/00001648-200301000-00013; Skhinas JN, 2018, CELL ADHES MIGR, V12, P529, DOI 10.1080/19336918.2017.1405208; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Sommariva M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9041040; Spence HJ, 2000, ONCOGENE, V19, P1266, DOI 10.1038/sj.onc.1203433; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Thul PJ, 2018, PROTEIN SCI, V27, P233, DOI 10.1002/pro.3307; Tian CX, 2020, CANCER RES, V80, P1461, DOI 10.1158/0008-5472.CAN-19-2578; Tian CX, 2019, P NATL ACAD SCI USA, V116, P19609, DOI 10.1073/pnas.1908626116; Tsinias G, 2018, ANAL CELL PATHOL, V2018, DOI 10.1155/2018/2989635; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uzunparmak B, 2019, CLIN TRANSL MED, V8, DOI 10.1186/s40169-019-0221-1; Velichkova M, 2002, CELL MOTIL CYTOSKEL, V51, P147, DOI 10.1002/cm.10025; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Vick AD, 2019, PANCREAS, V48, P242, DOI 10.1097/MPA.0000000000001238; Wang L, 2016, NATURE, V540, P579, DOI 10.1038/nature20602; Wang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039159; Weniger M, 2018, CANCERS, V10, DOI 10.3390/cancers10090316; Yang HJ, 2016, TRANSL ONCOL, V9, P583, DOI 10.1016/j.tranon.2016.08.004; Yang L, 2009, GASTROENTEROLOGY, V136, P1514, DOI 10.1053/j.gastro.2009.01.006; Yang Z, 2019, J INT MED RES, V47, P2371, DOI 10.1177/0300060519838385; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	99	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240453	10.1371/journal.pone.0240453	http://dx.doi.org/10.1371/journal.pone.0240453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048956	Green Submitted, Green Published, gold			2022-12-26	WOS:000581813300040
J	Suttinun, C; Gattolliat, JL; Boonsoong, B				Suttinun, Chanaporn; Gattolliat, Jean-Luc; Boonsoong, Boonsatien			Cymbalcloeongen. nov., an incredible new mayfly genus (Ephemeroptera: Baetidae) from Thailand	PLOS ONE			English	Article							LABIOBAETIS NOVIKOVA; INSECTA EPHEMEROPTERA; KLUGE; DIVERSITY; TAXONOMY	The genusCymbalcloeongen. nov. (Ephemeroptera: Baetidae) is established for a new speciesCymbalcloeon sartoriisp. nov. from Thailand, based on larval stage. This genus is unique among all of the Baetidae by the presence of three pairs of single gills on segments V-VII, ventrally oriented to cover the sterna VI-IX.Cymbalcloeon sartoriigen. nov.etsp. nov. presents unique or rare morphological characters such as a deeply concave margin between the prostheca and mola, without setae; a very large subtriangular process of the left mandible; a maxillary palp segment II with scarce and very long setae; almost completely fused labial palp segments II and III with numerous very long setae; elongate tarsal claw with two rows of teeth; a shagreen surface of the terga and paraproct; and a very reduced body size. The gills of the new genus move very quickly during respiration and present a near-synchronous protraction. Due to the very derived larval morphological character and the unknown imaginal stage, the exact phylogenetic position of the genus remains unclear; it most certainly belongs to the concept of Anteropatellata and is possibly closely related to the genusBaetopus.	[Suttinun, Chanaporn; Boonsoong, Boonsatien] Kasetsart Univ, Fac Sci, Dept Zool, Anim Systemat & Ecol Special Res Unit ASESRU, Bangkok, Thailand; [Gattolliat, Jean-Luc] Museum Zool, Lausanne, Switzerland; [Gattolliat, Jean-Luc] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	Kasetsart University; University of Lausanne	Boonsoong, B (corresponding author), Kasetsart Univ, Fac Sci, Dept Zool, Anim Systemat & Ecol Special Res Unit ASESRU, Bangkok, Thailand.	fscibtb@ku.ac.th		Boonsoong, Boonsatien/0000-0002-8166-0021; Gattolliat, Jean-Luc/0000-0001-5873-5083	Science Achievement Scholarship of Thailand (SAST); Centre of Excellence on Biodiversity (BDC) Office of Higher Education Commission [BDC-PG2-161004]; Department of Zoology, Faculty of Science, Kasetsart University	Science Achievement Scholarship of Thailand (SAST); Centre of Excellence on Biodiversity (BDC) Office of Higher Education Commission; Department of Zoology, Faculty of Science, Kasetsart University	The first author (CS) was funded by a Science Achievement Scholarship of Thailand (SAST). BB has been supported by the Centre of Excellence on Biodiversity (BDC) Office of Higher Education Commission (BDC-PG2-161004) and Department of Zoology, Faculty of Science, Kasetsart University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cruz PV, 2013, ANN LIMNOL-INT J LIM, V49, P1, DOI 10.1051/limn/2013033; Gattolliat JL, 2009, AQUAT INSECT, V31, P41, DOI 10.1080/01650420902812214; Gillies Michael T., 1997, P113; Jacobus LM, 2019, INSECTS, V10, DOI 10.3390/insects10060170; Kaltenbach T, 2020, EUR J TAXON, V612, P1, DOI 10.5852/ejt.2020.612; Kaltenbach T, 2020, ZOOKEYS, P43, DOI 10.3897/zookeys.914.47067; Kaltenbach T, 2019, ZOOKEYS, P1, DOI [10.3897/zookeys.893.38576, 10.3897/zookeys.895.38576]; Kaltenbach T, 2018, ZOOKEYS, P1, DOI 10.3897/zookeys.804.28988; Keffermuller M., 1960, BADNANIA FAUNA JETEK, V19, P411; Kluge N.J., 2004, PHYLOGENETIC SYSTEM; Kluge Nikita J., 2011, Russian Entomological Journal, V20, P1; Kluge NJ, CLADOENDESIS EPHEMER; Kluge NJ., 1992, ENTOMOL REV, V71, P4; Lugo-Ortiz CR, 1995, ANN LIMNOL-INT J LIM, V31, P233, DOI 10.1051/limn/1995021; MULLERLIEBENAU I, 1978, ARCH HYDROBIOL, V82, P465; Nieto C, 2010, SYST ENTOMOL, V35, P512, DOI 10.1111/j.1365-3113.2010.00523.x; Salles FF, 2010, ANN LIMNOL-INT J LIM, V46, P207, DOI 10.1051/limn/2010018; Sartori M, 2015, ECOLOGY AND GENERAL BIOLOGY, VOL I: THORP AND COVICH'S FRESHWATER INVERTEBRATES, 4TH EDITION, P873, DOI 10.1016/B978-0-12-385026-3.00034-6; Waltz RD, 1997, ENTOMOL NEWS, V108, P134; Waltz RD, 2002, ENTOMOL NEWS, V113, P187	20	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240635	10.1371/journal.pone.0240635	http://dx.doi.org/10.1371/journal.pone.0240635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048998	Green Published, gold			2022-12-26	WOS:000581813300028
J	Tela, FG; Gebremariam, LW; Beyene, SA				Tela, Freweini Gebrearegay; Gebremariam, Lemlem Weldegerima; Beyene, Selemawit Asfaw			Food taboos and related misperceptions during pregnancy in Mekelle city, Tigray, Northern Ethiopia	PLOS ONE			English	Article							POSTPARTUM	Introduction Most communities, rural or urban, have taboos regarding foods to avoid during pregnancy, and most have local explanations for why certain foods should be avoided. Such taboos may have health benefits, but they also can have large nutritional and health costs to mothers and fetuses. As such, understanding local pregnancy food taboos is an important public health goal, especially in contexts where food resources are limited. Despite this, information regarding food taboos is limited in Ethiopia. Therefore, this study assessed food taboos, related misconceptions, and associated factors among pregnant women in Northern Ethiopia. Methods A cross-sectional study of 332 pregnant women in antenatal care (ANC) follow-up at selected private clinics in Mekelle city, Tigray, Ethiopa, recruited between April and May, 2017. Using a semi-structured questionnaire, we assessed whether respondents' observed food taboos, what types of foods they avoided, their perceived reasons for avoidance, diversity of respondents' diets during pregnancy, and respondents' socio-demographic characteristics. After reporting frequency statistics for categorical variables and central tendencies (mean and standard deviation) of continuous variables, bivariate and multivariable logistic regression analyses were conducted to identify the socio-demographic factors and diet diversity associated with food taboo practices. Results Around 12% of the pregnant women avoided at least one type of food during their current pregnancy for one or more reasons. These mothers avoided eating items such as yogurt, banana, legumes, honey, and "kollo" (roasted barley and wheat). The most common reasons given for the avoidances were that the foods were (mistakenly) believed to cause: abortion; abdominal cramps in the mother and newborn; prolonged labor; or coating of the fetus's body. Maternal education (diploma and above) (AOR: 4.55, 95% CI: 1.93, 10.31) and marital status (single) were found to be negatively associated (protective factors) with observances of pregnancy food taboos. Approximately 79% of respondents had pregnancy diets that were insufficiently diverse, although we did not find any statistical evidence that this was associated with adhering to food taboos. Conclusion The misconceptions related to pregnancy food taboos should be discouraged insofar as they may restrict women's consumption of nutritious foods which could support maternal health and healthy fetal development. Health providers should counsel pregnant women and their husbands about appropriate pregnancy nutrition during ANC visits.	[Tela, Freweini Gebrearegay; Gebremariam, Lemlem Weldegerima; Beyene, Selemawit Asfaw] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Nutr & Dietet, Tigray, Ethiopia	Mekelle University	Tela, FG (corresponding author), Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Nutr & Dietet, Tigray, Ethiopia.	gebrearegayfreweini@gmail.com		Beyene, Selemawit/0000-0003-2595-5885; Gebrearegay, Freweini/0000-0003-0890-770X				[Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2016, J GERIATR CARDIOL; [Anonymous], 2018, LANCET HAEMATOL, V5, P378; Arzoaquoi SK, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0044-0; Belbasis L, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0692-5; BhanKhanna S., 2007, JK SCI, V9, P206, DOI [10.1016/j.cppeds.2011.01.001, DOI 10.1016/J.CPPEDS.2011.01.001]; Biza N., 2012, SCI J PUBLIC HEAL; Central Statistical Agency, 2017, FED DEM REP ETH POP; Demissie T, 1998, ETHIOP J HEALTH DEV, V12, P45; Eram Uzma, 2016, INT J INF RES REV, V03, P3407; Escuredo O, 2013, FOOD CHEM, V138, P851, DOI 10.1016/j.foodchem.2012.11.015; FAO, 2004, FAO FOOD NUTR PAP GL; FHI 360/LINKAGES, 2016, MINIMUM DIETARY DIVE; Gadegbeku C., 2013, FOOD SCI QUAL MANAG, V15, P21; Guindeuil T., 2018, WHAT DO CHRISTIANS N, V29, P59; Henrich J, 2010, EVOLUTION CULTURAL A; Khatun W, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081818; Koirala AK, 2018, J PREGNANCY CHILD HE, V5, P10; McKerracher L, 2016, HUM NATURE-INT BIOS, V27, P296, DOI 10.1007/s12110-016-9262-y; Meyer-Rochow VB, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-18; Murphy SP, 2003, J NUTR, P3932; Navarrete C. D., 2003, J COGN CULT, V3, P1, DOI [10.1163/156853703321598563, DOI 10.1163/156853703321598563]; Otoo P, 2015, ADV REPROD SCI, V3, P41, DOI [10.4236/arsci.2015.33005, DOI 10.4236/ARSCI.2015.33005]; Parmar A., 2013, HEALTHLINE, V4, P2; Piperata BA, 2008, SOC SCI MED, V67, P1094, DOI 10.1016/j.socscimed.2008.05.031; Pitale DL, 2018, INT J REPROD CONTRAC, V7, P622; Placek CD, 2017, EVOL HUM BEHAV; Pradesh A., 2019, BRIEF ANAL FOOD PRAC, V6, P5088; Sholeye O, 2014, INT J NUTR METAB, V6, P42; Someya S, 2002, FOOD CHEM, V79, P351, DOI 10.1016/S0308-8146(02)00186-3; Tahir HMH, 2018, INT J SCI HEALTHCARE, V3, P13; USAID, 2017, ADDR BARR MAT NUTR E; Vasalou S., 2012, J ETHICS, V16, P67, DOI [10.1007/s10892-011-9111-5, DOI 10.1007/S10892-011-9111-5]; Vasilevsk Vidanka MC-O, 2016, J CLIN NURS; Vatcheva K.P., 2016, EPIDEMIOLOGY, V6, P2, DOI DOI https://doi.org/10.4172/2161-1165.1000227; Wells JCK, 2017, ANAT REC, V300, P716, DOI 10.1002/ar.23540; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Withers M, 2018, MIDWIFERY, V56, P158, DOI 10.1016/j.midw.2017.10.019; Young AG, 2012, ECOLOGY FOOD NUTR BI, P37; Zabari Freitas W, 1998, SOCIOCULTURAL BARRIE	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0239451	10.1371/journal.pone.0239451	http://dx.doi.org/10.1371/journal.pone.0239451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048926	Green Published, gold			2022-12-26	WOS:000581813300017
J	Krishnavajhala, A; Armstrong, BA; Lopez, JE				Krishnavajhala, Aparna; Armstrong, Brittany A.; Lopez, Job E.			The impact ofin vitrocultivation on the natural life cycle of the tick-borne relapsing fever spirocheteBorrelia turicatae	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; BORRELIA-BURGDORFERI; CULTIVATION; INFECTIVITY; GENOME	Tick-borne relapsing fever is an infectious disease caused byBorreliaspecies and are primarily transmitted byOrnithodorosticks. Prior work indicated thatin vitrocultivated spirochetes remain infectious to mice by needle inoculation; however, the impact of laboratory propagation on the pathogens natural life cycle has not been determined. Our current study assessed the effect of serial cultivation on the natural tick-mammalian transmission cycle. First, we evaluated genomic DNA profiles fromB.turicataegrown to 30, 60, 120, and 300 generations, and these spirochetes were used to needle inoculate mice. Uninfected nymphal ticks were fed on these mice and acquisition, transstadial maintenance, and subsequent transmission after tick bite was determined. Infection frequencies in mice that were fed upon by ticks colonized withB.turicataegrown to 30, 60, and 120 generations were 100%, 100%, and 30%, respectively. Successful infection of mice by tick feeding was not detected after 120 generations. QuantifyingB.turicataein tick tissues indicated that by 300 generations they no longer colonized the vector. The results indicate thatin vitrocultivation significantly affects the establishment of tick colonization and murine infection. This work provides a foundation for the identification of essential genetic elements in the tick-mammalian infectious cycle.	[Krishnavajhala, Aparna; Armstrong, Brittany A.; Lopez, Job E.] Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Houston, TX 77030 USA; [Armstrong, Brittany A.; Lopez, Job E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Lopez, JE (corresponding author), Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Houston, TX 77030 USA.; Lopez, JE (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	job.lopez@bcm.edu	Krishnavajhala, Aparna/ABI-3036-2020	Krishnavajhala, Aparna/0000-0002-9327-5470; Lopez, Job/0000-0003-4802-5779	NIH [AI137412, AI123651]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH grants AI137412 and AI123651 (JEL). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. AK, BAA, and JEL received salary support from these NIH grants.	BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1990, ANNU REV MICROBIOL, V44, P155, DOI 10.1146/annurev.mi.44.100190.001103; BARBOUR AG, 1988, J CLIN MICROBIOL, V26, P475, DOI 10.1128/JCM.26.3.475-478.1988; Battisti James M., 2008, V431, P69; Boyle WK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002767; Brenner NE, 2017, TICKS TICK-BORNE DIS, V8, P677, DOI 10.1016/j.ttbdis.2017.03.008; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3553-5; Dworkin MS, 2008, INFECT DIS CLIN N AM, V22, P449, DOI 10.1016/j.idc.2008.03.006; Elbir H, 2012, J BACTERIOL, V194, P3723, DOI 10.1128/JB.00118-12; KELLY R, 1971, SCIENCE, V173, P443, DOI 10.1126/science.173.3995.443; Krishnavajhala A, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01505-18; Krishnavajhala A, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02503-16; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; Lopez JE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002514; Lopez JE, 2008, VECTOR-BORNE ZOONOT, V8, P813, DOI 10.1089/vbz.2008.0033; Porcella SF, 2005, INFECT IMMUN, V73, P6647, DOI 10.1128/IAI.73.10.6647-6658.2005; Schwan TG, 2005, J CLIN MICROBIOL, V43, P3851, DOI 10.1128/JCM.43.8.3851-3859.2005; SCHWAN TG, 1988, INFECT IMMUN, V56, P1831, DOI 10.1128/IAI.56.8.1831-1836.1988	19	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0239089	10.1371/journal.pone.0239089	http://dx.doi.org/10.1371/journal.pone.0239089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044963	gold, Green Published			2022-12-26	WOS:000581811700004
J	Vargas-Fonseca, OA; Kirkman, SP; Oosthuizen, WC; Bouveroux, T; Cockcroft, V; Conry, DS; Pistorius, PA				Vargas-Fonseca, O. Alejandra; Kirkman, Stephen P.; Oosthuizen, W. Chris; Bouveroux, Thibaut; Cockcroft, Vic; Conry, Danielle S.; Pistorius, Pierre A.			Abundance of Indo-Pacific bottlenose dolphins (Tursiops aduncus) along the south coast of South Africa	PLOS ONE			English	Article							ALGOA BAY; CARCHARODON-CARCHARIAS; ROBBERG PENINSULA; PLETTENBERG BAY; WHITE SHARKS; TRUNCATUS; CAPTURE; POPULATION; PATTERNS; TRENDS	Coastally distributed dolphin species are vulnerable to a variety of anthropogenic pressures, yet a lack of abundance data often prevents data-driven conservation management strategies from being implemented. We investigated the abundance of Indo-Pacific bottlenose dolphins (Tursiops aduncus) along the south coast of South Africa, from the Goukamma Marine Protected Area (MPA) to the Tsitsikamma MPA, between 2014 and 2016. During this period, 662.3h of boat-based photo-identification survey effort was carried out during 189 surveys. The sighting histories of 817 identified individuals were used to estimate abundance using capture-recapture modelling. Using open population (POPAN) models, we estimated that 2,155 individuals (95% CI: 1,873-2,479) occurred in the study area, although many individuals appeared to be transients. We recorded smaller group sizes and an apparent decline in abundance in a subset of the study area (Plettenberg Bay) compared to estimates obtained in 2002-2003 at this location. We recorded declines of more than 70% in both abundance and group size for a subset of the study area (Plettenberg Bay), in relation to estimates obtained in 2002-2003 at this location. We discuss plausible hypotheses for causes of the declines, including anthropogenic pressure, ecosystem change, and methodological inconsistencies. Our study highlights the importance of assessing trends in abundance at other locations to inform data-driven conservation management strategies ofT.aduncusin South Africa.	[Vargas-Fonseca, O. Alejandra; Oosthuizen, W. Chris; Bouveroux, Thibaut; Cockcroft, Vic; Conry, Danielle S.; Pistorius, Pierre A.] Nelson Mandela Univ, Dept Zool, Port Elizabeth, South Africa; [Vargas-Fonseca, O. Alejandra; Oosthuizen, W. Chris; Bouveroux, Thibaut; Conry, Danielle S.; Pistorius, Pierre A.] Nelson Mandela Univ, Inst Coastal & Marine Res, Marine Apex Predator Res Unit MAPRU, Port Elizabeth, South Africa; [Kirkman, Stephen P.] Dept Environm Forestry & Fisheries DEFF, Branch Oceans & Coasts, Cape Town, South Africa; [Oosthuizen, W. Chris] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Hatfield, South Africa	Nelson Mandela University; Nelson Mandela University; University of Pretoria	Vargas-Fonseca, OA (corresponding author), Nelson Mandela Univ, Dept Zool, Port Elizabeth, South Africa.; Vargas-Fonseca, OA (corresponding author), Nelson Mandela Univ, Inst Coastal & Marine Res, Marine Apex Predator Res Unit MAPRU, Port Elizabeth, South Africa.	alejandra7979@hotmail.com	Oosthuizen, W. Chris/I-2947-2016; Kirkman, Stephen/AAA-9139-2021	Oosthuizen, W. Chris/0000-0003-2905-6297; Kirkman, Stephen/0000-0001-5428-7375; Vargas Fonseca, Olga Alejandra/0000-0002-9131-4624; Bouveroux, Thibaut/0000-0002-7339-0316	Nelson Mandela University Postgraduate Research Scholarship; Society for Marine Mammalogy	Nelson Mandela University Postgraduate Research Scholarship; Society for Marine Mammalogy	The Nelson Mandela University Postgraduate Research Scholarship provided a fellowship to OAVF (2015-2018). The field work was also supported by: Rufford Foundation (UK), https://www.rufford.org/. Small Grant in Aid of Research from the Society for Marine Mammalogy https://www.marinemammalscience.org/jobs-grants/grants-in-aid-of-research-information/ International Union for Conservation of Nature (IUCN) Species Survival Commission. https://www.iucn.org/species/about/species-survival-commission.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Special thanks to numerous individuals from Ocean Odyssey, Enrico's Fishing Charters, Orca Foundation, Ocean Blue Adventures and South African National Parks (Tsitsikamma) for providing research vessels and skippers. Thanks you to Sally Sivewright for the assistance with photograph processing and to students and volunteers who assisted with data collection. Constructive comments were provided by two anonymous reviewers and Rodrigo Tardin that helped to improve the original manuscript. This research was conducted under a Memorandum of Understanding for research between Nelson Mandela University and the former Department of Environmental Affairs (DEA), which is now the Department of Environment, Forestry and Fisheries (DEFF). The study would not have been possible without DEA support.	Amir OA, 2005, ESTUAR COAST SHELF S, V63, P429, DOI 10.1016/j.ecss.2004.12.006; [Anonymous], 2020, LANCET PSYCHIAT, V7, P1, DOI 10.1016/S2215-0366(19)30483-3; [Anonymous], 2019, S AFR PROT CONS AR D; [Anonymous], 1991, USERS GUIDE INTERACT; Ansmann IC, 2012, ANIM BEHAV, V84, P575, DOI 10.1016/j.anbehav.2012.06.009; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Bouveroux TN, 2018, MAR MAMMAL SCI, V34, P645, DOI 10.1111/mms.12471; Braulik G, 2019, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2019-3.RLTS.T41714A50381127.en; Brown AM, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00004; Burnham K.P., 1987, American Fisheries Society Monograph, P1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Calix M., 2018, EUROPEAN RED LIST SA; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cockcroft V, 2016, RED LIST MAMM S AFRI; Cockcroft V.G., 1990, P295; COCKCROFT VG, 1990, S AFR J MARINE SCI, V9, P1; COCKCROFT VG, 1992, J ZOOL, V226, P123, DOI 10.1111/j.1469-7998.1992.tb06131.x; Conry D., 2017, THESIS; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Cooch E, 2012, PROGRAM MARK GENTLE, V11th; Dicken ML, 2013, AFR J MAR SCI, V35, P175, DOI 10.2989/1814232X.2013.800579; Elwen SH, 2011, AFR J MAR SCI, V33, P469, DOI 10.2989/1814232X.2011.637614; Findlay KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172002; Frederiksen M, 2007, MAR ECOL PROG SER, V352, P205, DOI 10.3354/meps07071; Greenwood G., 2013, THESIS; Gui D, 2016, ENVIRON SCI TECHNOL, V50, P4008, DOI 10.1021/acs.est.5b06009; Hale P. T., 2000, Aquatic Mammals, V26, P101; Hammerschlag N, 2017, ECOLOGY, V98, P3199, DOI 10.1002/ecy.2049; Huang SL, 2012, BIOL CONSERV, V147, P234, DOI 10.1016/j.biocon.2012.01.004; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Huisamen J, 2012, AFR J MAR SCI, V34, P431, DOI 10.2989/1814232X.2012.725524; Huisamen J, 2011, AFR J MAR SCI, V33, P453, DOI 10.2989/1814232X.2011.637349; Hussey Nigel E., 2012, P27; IRVINE AB, 1981, FISH B-NOAA, V79, P671; Jefferson T.A., 2015, MARINE MAMMALS WORLD; Jefferson TA, 2017, IUCN RED LIST THREAT; Karczmarski L, 1999, S AFR J MARINE SCI, V21, P89; Lombard AT, 2020, MARINE PROTECTED AREAS: SCIENCE, POLICY AND MANAGEMENT, P237, DOI 10.1016/B978-0-08-102698-4.00013-7; Lukoschek V, 2008, WILDLIFE RES, V35, P593, DOI 10.1071/WR07021; Moore JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052770; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Natoli A, 2008, CONSERV GENET, V9, P627, DOI 10.1007/s10592-007-9379-y; O'Donoghue SH, 2010, AFR J MAR SCI, V32, P361, DOI 10.2989/1814232X.2010.502640; OTIS DL, 1978, WILDLIFE MONOGR, P1; Parra G, 2018, IUCN RED LIST THREAT; Peddemors V. M., 1999, Journal of Cetacean Research and Management, V1, P157; Phillips G., 2006, THESIS; Photopoulou T, 2011, AFR J MAR SCI, V33, P393, DOI 10.2989/1814232X.2011.637346; Plon S, 2016, CONSERVATION ASSESSM, P1; Plon S, 2015, ADV MAR BIOL, V72, P143, DOI 10.1016/bs.amb.2015.08.005; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Pradel R., 2005, Animal Biodiversity and Conservation, V28, P189; Purdon J, 2020, MAR ECOL PROG SER, V633, P1, DOI 10.3354/meps13190; Reeves R., 2013, IUCN RED LIST THREAT, V2013, DOI DOI 10.2305/IUCN.UK.2013-1.RLTS.T4162A44199757.EN; Reisinger RR, 2010, MAR MAMMAL SCI, V26, P86, DOI 10.1111/j.1748-7692.2009.00324.x; Roberts MJ, 2005, ICES J MAR SCI, V62, P33, DOI 10.1016/j.icesjms.2004.10.002; Rojas-Bracho L, 2017, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2017-2.RLTS.T17028A50370296.en; ROSS GJB, 1987, S AFR J ZOOL, V22, P50; Rossman S, 2015, MAR MAMMAL SCI, V31, P155, DOI 10.1111/mms.12143; Ryklief R, 2014, AFR J MAR SCI, V36, P449, DOI 10.2989/1814232X.2014.967296; SAAYMAN GS, 1973, J MAMMAL, V54, P993, DOI 10.2307/1379100; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Steckenreuter A, 2011, WILDLIFE RES, V38, P455, DOI 10.1071/WR11048; Tunley K., 2009, WWF S AFRICA REPORT; Urian K, 2015, MAR MAMMAL SCI, V31, P298, DOI 10.1111/mms.12141; van der Lingen C, 2015, FISHERIES, V2005, P1; Vargas-Fonseca OA, 2018, AFR J MAR SCI, V40, P439, DOI 10.2989/1814232X.2018.1547221; Vargas-Fonseca OA., 2018, THESIS; Vermeulen E, 2018, AQUAT CONSERV, V28, P231, DOI 10.1002/aqc.2836; Wang JY, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P602; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; WILLIAMS JA, 1993, CAN J ZOOL, V71, P2080, DOI 10.1139/z93-293; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43; Yates P., 2018, POPULATION GENETICS; Zolman ES, 2002, MAR MAMMAL SCI, V18, P879, DOI 10.1111/j.1748-7692.2002.tb01079.x	78	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0227085	10.1371/journal.pone.0227085	http://dx.doi.org/10.1371/journal.pone.0227085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044970	gold, Green Published, Green Submitted			2022-12-26	WOS:000581811700029
J	Ferdous, MZ; Islam, MS; Sikder, MT; Mosaddek, AM; Zegarra-Valdivia, JA; Gozal, D				Ferdous, Most. Zannatul; Islam, Md. Saiful; Sikder, Md. Tajuddin; Mosaddek, Abu Syed Md.; Zegarra-Valdivia, J. A.; Gozal, David			Knowledge, attitude, and practice regarding COVID-19 outbreak in Bangladesh: An online-based cross-sectional study	PLOS ONE			English	Article							PHARMACISTS; DISEASE; SARS	In Bangladesh, an array of measures have been adopted to control the rapid spread of the COVID-19 epidemic. Such general population control measures could significantly influence perception, knowledge, attitudes, and practices (KAP) towards COVID-19. Here, we assessed KAP towards COVID-19 immediately after the lock-down measures were implemented and during the rapid rise period of the outbreak. Online-based cross-sectional study conducted from March 29 to April 19, 2020, involving Bangladeshi residents aged 12-64 years, recruited via social media. After consenting, participants completed an online survey assessing socio-demographic variables, perception, and KAP towards COVID-19. Of the 2017 survey participants, 59.8% were male, the majority were students (71.2%), aged 21-30 years (57.9%), having a bachelor's degree (61.0%), having family income >30,000 BDT (50.0%), and living in urban areas (69.8). The survey revealed that 48.3% of participants had more accurate knowledge, 62.3% had more positive attitudes, and 55.1% had more frequent practices regarding COVID-19 prevention. Majority (96.7%) of the participants agreed 'COVID-19 is a dangerous disease', almost all (98.7%) participants wore a face mask in crowded places, 98.8% agreed to report a suspected case to health authorities, and 93.8% implemented washing hands with soap and water. In multiple logistic regression analyses, COVID-19 more accurate knowledge was associated with age and residence. Sociodemographic factors such as being older, higher education, employment, monthly family income >30,000 BDT, and having more frequent prevention practices were the more positive attitude factors. More frequent prevention practice factors were associated with female sex, older age, higher education, family income > 30,000 BDT, urban area residence, and having more positive attitudes. To improve KAP of general populations is crucial during the rapid rise period of a pandemic outbreak such as COVID-19. Therefore, development of effective health education programs that incorporate considerations of KAP-modifying factors is needed.	[Ferdous, Most. Zannatul; Islam, Md. Saiful; Sikder, Md. Tajuddin] Jahangirnagar Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh; [Ferdous, Most. Zannatul; Mosaddek, Abu Syed Md.] Quest Bangladesh, Dhaka, Bangladesh; [Islam, Md. Saiful] Youth Res Assoc, Dhaka, Bangladesh; [Mosaddek, Abu Syed Md.] Uttara Adhunik Med Coll, Dept Pharmacol, Dhaka, Bangladesh; [Zegarra-Valdivia, J. A.] Univ Nacl San Agustin Arequipa, Arequipa, Peru; [Gozal, David] Univ Missouri, Sch Med, Dept Child Hlth, Columbia, MO 65211 USA; [Gozal, David] Univ Missouri, Sch Med, Child Hlth Res Inst, Columbia, MO 65211 USA	Jahangirnagar University; Universidad Nacional de San Agustin de Arequipa; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Gozal, D (corresponding author), Univ Missouri, Sch Med, Dept Child Hlth, Columbia, MO 65211 USA.; Gozal, D (corresponding author), Univ Missouri, Sch Med, Child Hlth Res Inst, Columbia, MO 65211 USA.	gozald@health.missouri.edu	Gozal, David/ABH-3805-2020; Islam, Md. Saiful/AAS-1169-2020; Zegarra-Valdivia, Jonathan Adrián/I-5382-2016	Islam, Md. Saiful/0000-0003-3979-2423; Zegarra-Valdivia, Jonathan Adrián/0000-0003-0497-5270; Ferdous, Most. Zannatul/0000-0001-5810-3844; Gozal, David/0000-0001-8195-6036; Sikder, Dr. Md. Tajuddin/0000-0002-5717-2263				Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Ajilore K, 2017, HEALTH EDUC J, V76, P648, DOI 10.1177/0017896917710969; Albarrak AI, 2019, J INFECT PUBLIC HEAL, DOI [10.1016/j.jiph.2019.06.029, DOI 10.1016/J.JIPH.2019.06.02931431424]; [Anonymous], 2020, EP UPD MONK MULT OUT; [Anonymous], 2020, BDNEWS24; [Anonymous], 2020, DHAKA TRIBUNE; [Anonymous], 2013, HOSP CASE MANAGE, V21, P78; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2016, EVIDENCE, V8, pe1000; Bewick S, 2016, ZIKA VIRUS ENDEMIC V, P41897; Biskup E, 2020, SWISS MED WEEKLY, V150, DOI [10.4414/smw.2020.20216, DOI 10.4414/SMW.2020.2021632134111]; Corona Info, 2020, LOCKD STAT; Corrin T, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0061-x; Hocking A, 2013, AUST FAM PHYSICIAN, V42, P411; Hussain R, 2018, J PHARM POLICY PRACT, V11, DOI 10.1186/s40545-018-0143-0; Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396; Institute of Epidemiology Disease Control and Research (IEDCR), 2020, INT INF PREV CONTR R; Islam MS, 2020, J AFFECT DISORDERS, V276, P30, DOI 10.1016/j.jad.2020.06.049; Ivey MF, 2019, AM J HEALTH-SYST PH, V76, P869, DOI 10.1093/ajhp/zxz071; Janjua NZ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-81; Khan MU, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1281; Lau JTF, 2007, AM J INFECT CONTROL, V35, P38, DOI 10.1016/j.ajic.2006.07.010; Medani KE, 2018, INDO AM J PHARM SCI, V5, P16288, DOI 10.5281/zenodo.2362589; Nour MO, 2015, INT RES J MED SCI, V3, P103; Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Ruan SG, 2020, LANCET INFECT DIS, V20, P630, DOI 10.1016/S1473-3099(20)30257-7; Saqlain M, 2020, KNOWLEDGE ATTITUDE P, DOI [10.1101/2020.04.13.20063198, DOI 10.1101/2020.04.13.20063198]; Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004; Srichan Peeradone, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3546046, DOI 10.2139/SSRN.3546046]; Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2; Tachfouti N, 2012, PAN AFR MED J, V12; WHO, 2020, 11 WHO; World Health Organization, 2020, 2019 NCOV OUTBR IS E; World Health Organization, 2020, COR DIS COVID 19 ADV; Zegarra A, 2020, PANDEMIC PERUVIAN PO, DOI [10.31234/osf.io/kr9ya, DOI 10.31234/0SF.I0/KR9YA]; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zhou M, 2020, J HOSP INFECT, DOI [10.1016/j.jhin.2020.04.01218, DOI 10.1016/J.JHIN.2020.04.01218]	39	177	179	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239254	10.1371/journal.pone.0239254	http://dx.doi.org/10.1371/journal.pone.0239254			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3WA	33035219	Green Submitted, Green Published, gold			2022-12-26	WOS:000581817500014
J	Guan, WZ; Qiu, GF; Feng-Liu				Guan, Wen-Zhi; Qiu, Gao-Feng; Feng-Liu			Transcriptome analysis of the growth performance of hybrid mandarin fish after food conversion	PLOS ONE			English	Article							SINIPERCA-CHUATSI; ACID-SECRETION; DOMESTICATION; GENE; EXPRESSION; IGFBP1; BEHAVIOR; CLONING; MUSCLE; FAMILY	During recent years, China has become a hotspot for the domestication of mandarin fish, and this is of great commercial value. Although the food preference of domesticated mandarin fish has been studied, little is known about genes regulating their growth. We raised hybrid mandarin fish on artificial feed for 3 months, the results showed that the survival rate of hybrid mandarin fish was 60.00%. Their total length and body weight were 18.34 +/- 0.43 cm and 100.44 +/- 4.87 g. The absolute length and weight gain rates were 0.14 cm/d and 1.08 g/d, respectively. Finally, RNA sequencing (RNA-Seq) was performed to identify potential genes and pathways activated in response to growth performance. The transcriptome analysis generated 68, 197 transcripts and 45,871 unigenes. Among them, 1025 genes were up-regulated and 593 genes were down-regulated between the fast- and slow-growth fish. Finally, we obtained 32 differentially expressed genes, which were mainly related to fatty acid biosynthesis (e.g. FASN and ACACB), collecting duct acid secretion (e.g. ATP6E and KCC4), cell cycle (e.g. CDC20 and CCNB), and the insulin-like growth factor (IGF) system (IGFBP1). These pathways might be related to the growth of hybrid mandarin fish. In addition, more potential single nucleotide polymorphisms (SNPs) were detected in the fast-growth fish than in the slow-growth fish. The results suggest that the interaction of metabolism and abundant alleles might determine the growth of hybrid mandarin fish after food conversion.	[Guan, Wen-Zhi; Qiu, Gao-Feng] Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Natl Demonstrat Ctr Expt Fisheries Sci Educ,Shang, Shanghai, Peoples R China; [Guan, Wen-Zhi; Feng-Liu] Shanghai Fisheries Res Inst, Shanghai Fisheries Tech Extens Stn, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University	Qiu, GF (corresponding author), Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Natl Demonstrat Ctr Expt Fisheries Sci Educ,Shang, Shanghai, Peoples R China.; Feng-Liu (corresponding author), Shanghai Fisheries Res Inst, Shanghai Fisheries Tech Extens Stn, Shanghai, Peoples R China.	gfqiu@shou.edu.cn; lf6475@sina.com			Youth Talent Development Plan of Shanghai Municipal Agricultural System, China [20180303]; Shanghai Agriculture Applied Technology Development Program, China [Z20170204]	Youth Talent Development Plan of Shanghai Municipal Agricultural System, China; Shanghai Agriculture Applied Technology Development Program, China	This work was supported by the Youth Talent Development Plan of Shanghai Municipal Agricultural System, China (Grant No. 20180303), and the Shanghai Agriculture Applied Technology Development Program, China (Grant No. Z20170204). This funding body has no role in the design of the study, collection, analysis, interpretation of data or in writing the manuscript.	[Anonymous], 2014, J DENT RES S, V93, p120S; Baskerville C, 2008, GENETICS, V178, P2361, DOI 10.1534/genetics.107.085308; Bilyk KT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-634; Campbell JM, 2015, BEHAV GENET, V45, P245, DOI 10.1007/s10519-014-9696-0; Chu ZW, 2019, INT J ONCOL, V54, P1534, DOI 10.3892/ijo.2019.4727; Dou YQ, 2015, GENET MOL RES, V14, P19317, DOI 10.4238/2015.December.29.41; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; Fang DA, 2015, GENET MOL RES, V14, P14181, DOI 10.4238/2015.November.13.1; Garcia G, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100789; Gomes F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212755; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han B, 2018, ANIM GENET, V49, P169, DOI 10.1111/age.12651; He S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-601; Hu G, 2010, J GENET GENOMICS, V37, P505, DOI 10.1016/S1673-8527(09)60070-9; [胡培培 Hu Peipei], 2014, [华中农业大学学报, Journal of Huazhong Agricultural University], V33, P106; Hu P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28952; Jensen P, 2014, ANNU REV ANIM BIOSCI, V2, P85, DOI 10.1146/annurev-animal-022513-114135; Kaiser S, 2015, FRONT ZOOL, V12, DOI 10.1186/1742-9994-12-S1-S19; Kang JL, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1074-0; Kang WQ, 2003, FEBS LETT, V540, P21, DOI 10.1016/S0014-5793(03)00217-5; Klopfenstein DV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28948-z; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li Y, 2017, AQUAC RES, V48, P4479, DOI 10.1111/are.13273; Liang XF, 2001, AQUAC RES, V32, P76, DOI 10.1046/j.1355-557x.2001.00006.x; Liu F, 2019, FISHERIES SCI TECHNO, V46, P324, DOI [10.16446/j.cnki.1001-1994.2019.06.006, DOI 10.16446/J.CNKI.1001-1994.2019.06.006]; Liu H, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0044-8; Liu XD, 2019, NEOPLASMA, V66, P946, DOI 10.4149/neo_2019_190207N109; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes-Marques M, 2018, GENE, V664, P111, DOI 10.1016/j.gene.2018.04.058; Lorenzen K, 2012, BIOL REV, V87, P639, DOI 10.1111/j.1469-185X.2011.00215.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu J, 2016, EMBO J, V35, P2026, DOI 10.15252/embj.201592903; Lynch IJ, 2008, AM J PHYSIOL-RENAL, V294, pF621, DOI 10.1152/ajprenal.00412.2007; Lynch IJ, 2010, AM J PHYSIOL-RENAL, V298, pF408, DOI 10.1152/ajprenal.00333.2009; Matsuoka Y, 2008, MOL REPROD DEV, V75, P989, DOI 10.1002/mrd.20843; Palstra AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053171; Pitel F, 1998, MAMM GENOME, V9, P297, DOI 10.1007/s003359900752; Qi DL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01326; Renaville B, 2018, MEAT SCI, V139, P220, DOI 10.1016/j.meatsci.2018.02.005; Safian D, 2012, J ENDOCRINOL, V214, P95, DOI 10.1530/JOE-12-0057; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smith-Unna R, 2016, GENOME RES, V26, P1134, DOI 10.1101/gr.196469.115; Sudhagar A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010245; Sun CF, 2019, J GENET, V98, DOI 10.1007/s12041-019-1100-7; Sun LF, 2015, GENET MOL RES, V14, P19128, DOI 10.4238/2015.December.29.22; Sun Y, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0328-y; Tao JJ, 2007, AQUACULTURE, V262, P1, DOI 10.1016/j.aquaculture.2006.09.030; Tian CX, 2014, GENET MOL RES, V13, P546, DOI 10.4238/2014.January.22.1; Tian JM, 2013, ADV EXP MED BIOL, V793, P69, DOI 10.1007/978-1-4614-8289-5_5; Toye AA, 1997, ANIM GENET, V28, P457, DOI 10.1111/j.1365-2052.1997.tb03296.x; Velazquez H, 2003, AM J PHYSIOL-RENAL, V285, pF49, DOI 10.1152/ajprenal.00389.2002; Wall SM, 1996, AM J PHYSIOL-RENAL, V271, pF1037, DOI 10.1152/ajprenal.1996.271.5.F1037; Wang JG, 2009, MODERN FISHERIES INF, V24, P28; Wang ZQ, 2014, DEV CELL, V29, P217, DOI 10.1016/j.devcel.2014.03.012; Wright D, 2006, ZEBRAFISH, V3, P141, DOI 10.1089/zeb.2006.3.141; Xu HG, 2019, COMP BIOCHEM PHYS D, V29, P106, DOI 10.1016/j.cbd.2018.11.005; Yang WX, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1245072; Zhang L, 2009, J FISH BIOL, V75, P1158, DOI 10.1111/j.1095-8649.2009.02328.x; Zhang ST, 2013, MOL CELL ENDOCRINOL, V376, P33, DOI 10.1016/j.mce.2013.05.025	60	5	5	8	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240308	10.1371/journal.pone.0240308	http://dx.doi.org/10.1371/journal.pone.0240308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035258	gold, Green Published			2022-12-26	WOS:000581817500006
J	Levy, AF; Labrador, A; Knecht, L; Van Dyken, JD				Levy, Alyssa Francesca; Labrador, Anthony; Knecht, Leslie; Van Dyken, J. David			An inexpensive, high-throughput mu PAD assay of microbial growth rate and motility on solid surfaces usingSaccharomyces cerevisiaeandEscherichia colias model organisms	PLOS ONE			English	Article							ANALYTICAL DEVICES; CELL DIAMETER; PAPER; BIOFILMS	Many microbial phenotypes are differentially or exclusively expressed on agar surfaces, including biofilms, motility, and sociality. However, agar-based assays are limited by their low throughput, which increases costs, lab waste, space requirements, and the time required to conduct experiments. Here, we demonstrate the use of wax-printed microfluidic paper-based analytical devices (mu PADs) to measure linear growth rate of microbes on an agar growth media as a means of circumventing the aforementioned limitations. The main production materials of the proposed mu PAD design are a wax printer, filter paper, and empty pipet boxes. A single wax-printed mu PAD allowing 8 independent, agar-grown colonies costs $0.07, compared to $0.20 and $9.37 for the same number of replicates on traditional microtiter/spectrophotometry and Petri dish assays, respectively. We optimized the mu PAD design for channel width (3 mm), agar volume (780 mu L/channel), and microbe inoculation method (razor-blade). Comparative analyses of the traditional and proposed mu PAD methods for measuring growth rate of nonmotile (Saccharomyces cerevisiae) and motile (flagellatedEscherichia coli) microorganisms suggested the mu PAD assays conferred a comparable degree of accuracy and reliability to growth rate measurements as their traditional counterparts. We substantiated this claim with strong, positive correlations between the traditional and mu PAD assay, a significant nonzero slope in the model relating the two assays, a nonsignificant difference between the relative standard errors of the two techniques, and an analysis of inter-device reliability. Therefore, mu PAD designs merit consideration for the development of enhanced-throughput, low-cost microbial growth and motility assays.	[Levy, Alyssa Francesca; Labrador, Anthony] Univ Miami, Coral Gables, FL 33124 USA; [Knecht, Leslie] Univ Miami, Dept Chem, Coral Gables, FL 33124 USA; [Van Dyken, J. David] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	University of Miami; University of Miami; University of Miami	Knecht, L (corresponding author), Univ Miami, Dept Chem, Coral Gables, FL 33124 USA.; Van Dyken, JD (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	lknecht@miami.edu; vandyken@bio.miami.edu		Knecht, Leslie/0000-0001-9504-1769; Levy, Alyssa/0000-0002-7669-2942	University of Miami College of Arts and Sciences summer grant	University of Miami College of Arts and Sciences summer grant	The authors would like to acknowledge that this work began in the University of Miami Howard Hughes Medical Institute undergraduate biology-chemistry integrated authentic research lab. L.D.K. would like to thank the University of Miami College of Arts and Sciences summer grant for support for this work.	Ataide VN, 2020, ANAL METHODS-UK, V12, P1030, DOI 10.1039/c9ay02350j; Boehle KE, 2017, ANGEW CHEM INT EDIT, V56, P6886, DOI 10.1002/anie.201702776; Cao QP, 2019, RSC ADV, V9, P5674, DOI 10.1039/c8ra09157a; Carpio A, 2019, INT J NONLIN MECH, V109, P1, DOI 10.1016/j.ijnonlinmec.2018.10.012; Carrilho E, 2009, ANAL CHEM, V81, P7091, DOI 10.1021/ac901071p; Chiang CK, 2019, TALANTA, V194, P837, DOI 10.1016/j.talanta.2018.10.104; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Ellerbee AK, 2009, ANAL CHEM, V81, P8447, DOI 10.1021/ac901307q; ELORZA MV, 1969, BIOCHEM BIOPH RES CO, V36, P741, DOI 10.1016/0006-291X(69)90672-X; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fu LM, 2018, TRAC-TREND ANAL CHEM, V107, P196, DOI 10.1016/j.trac.2018.08.018; Funes-Huacca M, 2012, LAB CHIP, V12, P4269, DOI 10.1039/c2lc40391a; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Hallatschek O, 2008, THEOR POPUL BIOL, V73, P158, DOI 10.1016/j.tpb.2007.08.008; HURST CJ, 1994, APPL ENVIRON MICROB, V60, P3462, DOI 10.1128/AEM.60.9.3462-3465.1994; Jokerst JC, 2012, ANAL CHEM, V84, P2900, DOI 10.1021/ac203466y; Lee H, 2015, NANO ENERGY, V15, P549, DOI 10.1016/j.nanoen.2015.05.019; LI CY, 1993, J BACTERIOL, V175, P2229, DOI 10.1128/JB.175.8.2229-2235.1993; Malekghasemi S, 2016, TALANTA, V159, P401, DOI 10.1016/j.talanta.2016.06.040; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Martinez AW, 2008, P NATL ACAD SCI USA, V105, P19606, DOI 10.1073/pnas.0810903105; Nelson DE, 2000, J BACTERIOL, V182, P1714, DOI 10.1128/JB.182.6.1714-1721.2000; Nie ZH, 2010, LAB CHIP, V10, P477, DOI 10.1039/b917150a; Noviana E, 2020, LAB CHIP, V20, P9, DOI 10.1039/c9lc00903e; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; SAGER BM, 1988, ANAL BIOCHEM, V173, P271, DOI 10.1016/0003-2697(88)90189-3; Satarpai T, 2018, ANAL SCI, V34, P605, DOI 10.2116/analsci.17P620; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Singh AT, 2018, SENSORS, V18, P28; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Thi NAN, 2007, ANAL BIOANAL CHEM, V387, P1769, DOI 10.1007/s00216-006-0829-z; TRUEBA FJ, 1980, J BACTERIOL, V142, P869, DOI 10.1128/JB.142.3.869-878.1980; Van Dyken JD, 2013, CURR BIOL, V23, P919, DOI 10.1016/j.cub.2013.04.026; Wang SM, 2012, BIOSENS BIOELECTRON, V31, P212, DOI 10.1016/j.bios.2011.10.019; Xia YY, 2016, BIOSENS BIOELECTRON, V77, P774, DOI 10.1016/j.bios.2015.10.032; Xu S, 2018, EVOLUTION, V72, P153, DOI 10.1111/evo.13393; Zhu XL, 2017, NANOSCALE, V9, P5658, DOI 10.1039/c7nr00958e	37	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0225020	10.1371/journal.pone.0225020	http://dx.doi.org/10.1371/journal.pone.0225020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031388	gold, Green Published			2022-12-26	WOS:000581809800018
J	Miyake, S; Miwa, T; Yoneda, G; Kanemaru, A; Saito, H; Minoda, R; Orita, Y; Saito, H; Jono, H				Miyake, Shunsuke; Miwa, Toru; Yoneda, Go; Kanemaru, Ayumi; Saito, Haruki; Minoda, Ryosei; Orita, Yorihisa; Saito, Hideyuki; Jono, Hirofumi			Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma	PLOS ONE			English	Article							KAPPA-B ACTIVATION; DOWN-REGULATION; OTITIS-MEDIA; INTERLEUKIN-1-ALPHA; PATHOGENESIS; IDENTIFICATION; RESISTANCE; PROTEIN; GENE	Middle ear cholesteatoma is a destructive disease in which inflammation plays an important role in development and progression, and there are currently no biomarkers predicting prognosis or recurrence. Cylindromatosis (CYLD), a tumor suppressor deubiquitinase, serves as a negative regulator of inflammation expressed in tissues including the middle ear. To determine the clinical significance of CYLD in acquired cholesteatoma, we evaluated CYLD expression in acquired cholesteatoma tissue by immunostaining and analyzed its correlation with clinicopathological characteristics. Our immunohistochemical analysis revealed that CYLD expression levels were varied in the tissues of acquired cholesteatoma patients. The relative expression levels of CYLD in cholesteatoma exhibited a significant correlation with the grade of otorrhea (R = 0.532,p= 0.039). Moreover, the period of epithelialization was also significantly associated with the relative expression levels of CYLD (R = 0.720,p= 0.002). In addition, CYLD expression tended to be lower in the group with recurrence. These results suggest that low CYLD expression correlates with postoperative recovery of acquired cholesteatoma, while potentially affecting the induction of recurrence. This is the first report showing that low CYLD expression correlates with accelerated disease recovery, and suggests a new aspect of CYLD as a prognostic predictor of acquired cholesteatoma.	[Miyake, Shunsuke; Kanemaru, Ayumi; Saito, Hideyuki; Jono, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut Sci, Kumamoto, Japan; [Miyake, Shunsuke; Saito, Hideyuki; Jono, Hirofumi] Kumamoto Univ Hosp, Dept Pharm, Kumamoto, Japan; [Miwa, Toru] Kyoto Univ, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Miwa, Toru] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Otolaryngol Head & Neck Surg, Osaka, Japan; [Yoneda, Go] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Saito, Haruki; Orita, Yorihisa] Kumamoto Univ Hosp, Dept Otolaryngol Head & Neck Surg, Kumamoto, Japan; [Minoda, Ryosei] Kumamoto Gen Hosp, Dept Otolaryngol Head & Neck Surg, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kyoto University; Kitano Hospital; University System of Georgia; Georgia State University; Kumamoto University	Jono, H (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut Sci, Kumamoto, Japan.; Jono, H (corresponding author), Kumamoto Univ Hosp, Dept Pharm, Kumamoto, Japan.	hjono@kuh.kumamoto-u.ac.jp	Miwa, Toru/K-2955-2019	Miwa, Toru/0000-0002-5977-0056; Jono, Hirofumi/0000-0002-7977-7597; Saito, Haruki/0000-0001-9610-0951	MEXT KAKENHI the Ministry of Education, Culture, Sports, Science and Technology of Japan [18H02591, 26713006]	MEXT KAKENHI the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by Grants-in-Aid for Scientific Research (B) 18H02591 (to HJ) and by a Grant-in-Aid for Young Scientists (A) 26713006 (to HJ) from MEXT KAKENHI the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alameda JP, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.82; Albino AP, 1998, AM J OTOL, V19, P30; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Bonnick SL, 2010, MENOPAUSE, V17, P25, DOI [10.1097/gme.0b013e3181c617e6, 10.1097/gme.0b013e3181e617e6]; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Byun JY, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/796315; Guo JY, 2014, ONCOTARGET, V5, P6353, DOI 10.18632/oncotarget.2216; Hayashi M, 2014, BREAST CANCER RES TR, V143, P447, DOI 10.1007/s10549-013-2824-3; Hellerbrand C, 2007, CARCINOGENESIS, V28, P21, DOI 10.1093/carcin/bgl081; Ishikawa Y, 2012, INT J ONCOL, V41, P53, DOI 10.3892/ijo.2012.1424; Japan Otological Society, 2008, OTOLOGY JAPAN, V18, P611; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Kim CS, 1996, ACTA OTO-LARYNGOL, V116, P302, DOI 10.3109/00016489609137846; Kinoshita H, 2013, MOL CLIN ONCOL, V1, P309, DOI 10.3892/mco.2013.68; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kuczkowski J, 2006, ORL-J OTO-RHIN-LARYN, V68, P296, DOI 10.1159/000094377; Kuo CL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/854024; Kuphal S, 2011, ONCOGENE, V30, P4523, DOI 10.1038/onc.2011.163; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Louw L, 2013, J LARYNGOL OTOL, V127, P542, DOI 10.1017/S0022215113000601; Louw L, 2010, J LARYNGOL OTOL, V124, P587, DOI 10.1017/S0022215109992763; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; MEYERHOFF WL, 1986, LARYNGOSCOPE, V96, P935; Olszewska E, 2004, EUR ARCH OTO-RHINO-L, V261, P6, DOI 10.1007/s00405-003-0623-x; Saleh HA, 1999, CLIN OTOLARYNGOL, V24, P355, DOI 10.1046/j.1365-2273.1999.00272.x; SCHILLING V, 1992, AM J OTOL, V13, P350; Semaan MT, 2006, OTOLARYNG CLIN N AM, V39, P1143, DOI 10.1016/j.otc.2006.08.003; Shinriki S, 2018, J PATHOL, V244, P367, DOI 10.1002/path.5019; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Urbanik T, 2011, INT J ONCOL, V38, P121, DOI 10.3892/ijo_00000831; Yetiser S, 2002, OTOL NEUROTOL, V23, P647, DOI 10.1097/00129492-200209000-00007; Zhang QA, 2008, ARCH OTOLARYNGOL, V134, P306, DOI 10.1001/archotol.134.3.306	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240216	10.1371/journal.pone.0240216	http://dx.doi.org/10.1371/journal.pone.0240216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031450	gold, Green Published			2022-12-26	WOS:000581809800073
J	Reid, JA; McDonald, A; Callanan, A				Reid, James Alexander; McDonald, Alison; Callanan, Anthony			Modulating electrospun polycaprolactone scaffold morphology and composition to alter endothelial cell proliferation and angiogenic gene response	PLOS ONE			English	Article							FIBER DIAMETER; DIFFERENTIATION; EXPRESSION; ADHESION; PEPTIDE	The aim of this study was to look at how the composition and morphology of polymer scaffolds could be altered to create an optimized environment for endothelial cells. Four polycaprolactone (PCL) scaffolds were electrospun with increasing fibre diameters ranging from 1.64 mu m to 4.83 mu m. The scaffolds were seeded with human umbilical vein endothelial cells (HUVEC) and cultured for 12 days. PCL scaffolds were then electrospun incorporating decellularized bovine aorta ECM and cultured in a hypoxic environment. We noted deeper cell infiltration on the largest fibre diameter compared to the other three scaffolds which resulted in an increase in the gene expression of CD31; a key angiogenic marker. Increased cell viability and cell proliferation were also noted on the largest fibre. Furthermore, we noted that the incorporation of extracellular matrix (ECM) had minimal effect on cell viability, both in normoxic and hypoxic culture conditions. Our results showed that these environments had limited influences on hypoxic gene expression. Interestingly, the major findings from this study was the production of excretory ECM components as shown in the scanning electron microscopy (SEM) images. The results from this study suggest that fibre diameter had a bigger impact on the seeded HUVECs than the incorporation of ECM or the culture conditions. The largest fibre dimeter (4.83 mu m) is more suitable for seeding of HUVECs.	[Reid, James Alexander; McDonald, Alison; Callanan, Anthony] Univ Edinburgh, Inst Bioengn, Sch Engn, Edinburgh, Midlothian, Scotland	University of Edinburgh	Callanan, A (corresponding author), Univ Edinburgh, Inst Bioengn, Sch Engn, Edinburgh, Midlothian, Scotland.	Anthony.Callanan@ed.ac.uk		Callanan, Anthony/0000-0002-1871-2853	Engineering & Physical Sciences Research Council (ESPRC) [EP/N509644/1]; UK Regenerative Medicine Platform II [MR/L022974/1]	Engineering & Physical Sciences Research Council (ESPRC); UK Regenerative Medicine Platform II	The rewards were received by James Reid and Anthony Callanan. This work was funded by an Engineering & Physical Sciences Research Council (ESPRC) doctoral training partnership studentship EP/N509644/1 (https://epsrc.ukri.org/skills/students/dta/) and a UK Regenerative Medicine Platform II grant MR/L022974/1 (https://www.ukrmp.org.uk/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; [Anonymous], 2018, LANCET DIABETES ENDO, V6, P1, DOI DOI 10.1080/08927022.2018.1510179; Atashrouz S, 2018, MATER CHEM PHYS, DOI [10.1016/j.matchemphys.2018.10.045, DOI 10.1016/J.MATCHEMPHYS.2018.10.045]; Balint R, 2013, TISSUE ENG PART B-RE, V19, P48, DOI [10.1089/ten.teb.2012.0183, 10.1089/ten.TEB.2012.0183]; Bate TSR, 2020, JOVE-J VIS EXP, DOI 10.3791/61043; Bonvini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033557; Brizzi MF, 1999, MOL BIOL CELL, V10, P3463, DOI 10.1091/mbc.10.10.3463; Burton TP, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aa8dde; Callanan A, 2014, J BIOMECH, V47, P1885, DOI 10.1016/j.jbiomech.2014.02.037; Callanan A, 2014, J BIOMED MATER RES B, V102, P781, DOI 10.1002/jbm.b.33059; Callanan A, 2012, MED ENG PHYS, V34, P1368, DOI 10.1016/j.medengphy.2012.06.022; DEJANA E, 1993, KIDNEY INT, V43, P61, DOI 10.1038/ki.1993.11; Deroanne CF, 2005, J CELL SCI, V118, P1173, DOI 10.1242/jcs.01707; Dettin M, 2015, J PEPT SCI, V21, P786, DOI 10.1002/psc.2808; Dhandayuthapani B, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/290602; Diodato Michael, 2014, Surg Res Pract, V2014, P726158, DOI 10.1155/2014/726158; Dunphy SE, 2018, BIOMED PHYS ENG EXPR, V4, DOI 10.1088/2057-1976/aad56f; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Fischer LJ, 2009, J SURG RES, V152, P157, DOI 10.1016/j.jss.2008.06.029; Friedrich CC, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12387; Gniesmer S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227563; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Grant R, 2017, TISSUE ENG PT A, V23, P650, DOI [10.1089/ten.tea.2016.0419, 10.1089/ten.TEA.2016.0419]; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Gualtero DF, 2019, MOL ORAL MICROBIOL, V34, P183, DOI 10.1111/omi.12263; Han JJ, 2013, BIOMACROMOLECULES, V14, P1338, DOI 10.1021/bm400450m; Hartman O, 2010, BIOMATERIALS, V31, P5700, DOI 10.1016/j.biomaterials.2010.03.017; Heiss C, 2015, ANTIOXID REDOX SIGN, V22, P1230, DOI 10.1089/ars.2014.6158; Hotaling NA, 2015, BIOMATERIALS, V61, P327, DOI 10.1016/j.biomaterials.2015.05.015; Iturri J, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9080383; Janaszak-Jasiecka A, 2018, ANGIOGENESIS, V21, P711, DOI 10.1007/s10456-018-9620-y; Ko YG, 2016, TISSUE ENG REGEN MED, V13, P343, DOI 10.1007/s13770-016-0053-7; Kopp PM, 2010, EUR J CELL BIOL, V89, P661, DOI 10.1016/j.ejcb.2010.05.003; Kurobe H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120328; Lam CXF, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034108; Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malinin NL, 2012, CURR OPIN HEMATOL, V19, P206, DOI 10.1097/MOH.0b013e3283523df0; Mouras R, 2013, J RAMAN SPECTROSC, V44, P1373, DOI 10.1002/jrs.4305; Munir N, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aac91f; Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98; Noriega SE, 2012, CELLS TISSUES ORGANS, V195, P207, DOI 10.1159/000325144; Pashneh-Tala S, 2016, TISSUE ENG PART B-RE, V22, P68, DOI 10.1089/ten.teb.2015.0100; Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j; Post A, 2019, ANN BIOMED ENG, V47, P366, DOI 10.1007/s10439-018-02171-3; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Rampichova M, 2013, CELL PROLIFERAT, V46, P23, DOI 10.1111/cpr.12001; Reid JA, 2019, J APPL POLYM SCI, V136, DOI 10.1002/app.48181; Reid JA, 2020, J BIOMED MATER RES B, V108, P910, DOI 10.1002/jbm.b.34444; Romanova OA, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12598; Ruder C, 2013, CLIN HEMORHEOL MICRO, V55, P513, DOI 10.3233/CH-131787; Sabik JF, 2011, CIRCULATION, V124, P273, DOI 10.1161/CIRCULATIONAHA.111.039842; Sizeland KH, 2018, MATERIALIA, V3, P90, DOI 10.1016/j.mtla.2018.10.001; Stalder AF, 2010, COLLOID SURFACE A, V364, P72, DOI 10.1016/j.colsurfa.2010.04.040; Stekelenburg M, 2009, TISSUE ENG PT A, V15, P1081, DOI 10.1089/ten.tea.2008.0183; Sukanya VS, 2018, COLLOID SURFACE B, V163, P107, DOI 10.1016/j.colsurfb.2017.12.039; Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019; Suzanne M, 2013, CELL DEATH DIFFER, V20, P669, DOI 10.1038/cdd.2013.11; Taskin MB, 2017, NANOSCALE, V9, P9218, DOI 10.1039/c7nr03326e; THIERY G, 1995, J HISTOCHEM CYTOCHEM, V43, P1079, DOI 10.1177/43.10.7560886; Weymann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103588; Wilkins E., 2017, EUROPEAN CARDIOVASCU; Xie Q, 2016, CELL PROLIFERAT, V49, P236, DOI 10.1111/cpr.12244; Young RE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219254; Zhang QH, 2017, J VASC RES, V54, P376, DOI 10.1159/000481778	65	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240332	10.1371/journal.pone.0240332	http://dx.doi.org/10.1371/journal.pone.0240332			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031435	gold, Green Published			2022-12-26	WOS:000581809800079
J	Zhang, WD; Yao, WL; He, WH; Li, JF; Wu, XP; Chen, ZH; Liu, L; Wang, WH				Zhang, Wang-Dong; Yao, Wan-Ling; He, Wan-Hong; Li, Jian-Fei; Wu, Xiu-Ping; Chen, Zhi-Hua; Liu, Lei; Wang, Wen-Hui			Bacterial community analysis on the different mucosal immune inductive sites of gastrointestinal tract in Bactrian camels	PLOS ONE			English	Article							AGGREGATED LYMPHOID NODULES; CHAIN FATTY-ACIDS; MICROBIAL METABOLITES; GUT MICROBIOTA; DIETARY FIBER; EVOLUTION; IMPACT; ABOMASUM; HEALTH; CELLS	The microbial communities colonize the mucosal immune inductive sites could be captured by hosts, which could initiate the mucosal immune responses. The aggregated lymphoid nodule area (ALNA) and the ileal Payer's patches (PPs) in Bactrian camels are both the mucosal immune inductive sites of the gastrointestinal tract. Here, the bacteria community associated with the ALNA and ileal PPs were analyzed using of 16S rDNA-Illumina Miseq sequencing. The mutual dominant bacterial phyla at the two sites were the Bacteroidetes, Firmicutes, Verrucomicrobia and Proteobacteria, and the mutual dominant genus in both sits wasPrevotella. The abundances of the Fibrobacter, Campylobacter and RFP12 were all higher in ALNA than in ileal PPs. While, the abundances of the 5-7N15, Clostridium, and Escherichia were all higher in ileal PPs than in ALNA. The results suggested that the host's intestinal microenvironment is selective for the symbiotic bacteria colonizing the corresponding sites, on the contrary, the symbiotic bacteria could impact on the physiological functions of this local site. In ALNA and ileal PPs of Bactrian camel, the bacteria which colonized different immune inductive sites have the potential to stimulate different immune responses, which is the result of the mutual selection and adaptation between microbial communities and their host.	[Zhang, Wang-Dong; Yao, Wan-Ling; He, Wan-Hong; Li, Jian-Fei; Wu, Xiu-Ping; Chen, Zhi-Hua; Liu, Lei; Wang, Wen-Hui] Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University	Wang, WH (corresponding author), Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China.	wwh777@126.com		, Wang-Dong/0000-0002-4277-3437	National Natural Science Foundation of China [31960693, 31760723]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 31960693 and 31760723) to W.H.W, and the URL is http://www.nsfc.gov.cn.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DIGEST LIVER DIS, V45, pS54; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Colosimo DA, 2019, CELL HOST MICROBE, V26, P273, DOI 10.1016/j.chom.2019.07.002; Costa MC, 2015, VET J, V205, P74, DOI 10.1016/j.tvjl.2015.03.018; Coyne MJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11494-1; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donaldson GP, 2018, SCIENCE, V360, P795, DOI 10.1126/science.aaq0926; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; Frey JC, 2010, J APPL MICROBIOL, V108, P1982, DOI 10.1111/j.1365-2672.2009.04602.x; Ganal-Vonarburg SC, 2020, SCIENCE, V368, P604, DOI 10.1126/science.aba0478; Garrett WS, 2020, NAT REV IMMUNOL, V20, P91, DOI 10.1038/s41577-019-0252-2; Goff JP, 2015, DUKES PHYSL DOMESTIC, P522; He J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18298-7; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kim M, 2016, CELL HOST MICROBE, V20, P202, DOI 10.1016/j.chom.2016.07.001; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kuhn KA, 2018, MUCOSAL IMMUNOL, V11, P357, DOI 10.1038/mi.2017.55; Lapebie P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10068-5; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Makala LHC, 2002, PATHOBIOLOGY, V70, P55, DOI 10.1159/000067305; Makki K, 2018, CELL HOST MICROBE, V23, P705, DOI 10.1016/j.chom.2018.05.012; MALOIY GMO, 1980, J ANIM SCI, V51, P917, DOI 10.2527/jas1980.514917x; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Rabee AE, 2020, INT MICROBIOL, V23, P137, DOI 10.1007/s10123-019-00093-1; Reece WO, 2015, DUKES PHYSL DOMESTIC, P149; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Seth P, 2019, CELL, V176, P1014, DOI 10.1016/j.cell.2019.01.037; Shapira M, 2016, TRENDS ECOL EVOL, V31, P539, DOI 10.1016/j.tree.2016.03.006; Shen F, 2017, HEPATOB PANCREAT DIS, V16, P375, DOI 10.1016/S1499-3872(17)60019-5; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Steimle A, 2019, MOL THER, V27, P1974, DOI 10.1016/j.ymthe.2019.07.007; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang J, 2017, ASIAN AUSTRAL J ANIM, V30, P100, DOI 10.5713/ajas.16.0166; Wang WH, 2003, VET J, V166, P205, DOI 10.1016/S1090-0233(02)00263-0; White BA, 2014, ANNU REV MICROBIOL, V68, P279, DOI 10.1146/annurev-micro-092412-155618; Xu XH, 2010, VET J, V184, P362, DOI 10.1016/j.tvjl.2009.03.003; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang WD, 2017, EXP GERONTOL, V100, P36, DOI 10.1016/j.exger.2017.09.022; Zhang WD, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0847-9; Zhang WD, 2012, VET IMMUNOL IMMUNOP, V147, P147, DOI 10.1016/j.vetimm.2012.04.007; Zhaxi YP, 2014, ANAT REC, V297, P1292, DOI 10.1002/ar.22939	53	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239987	10.1371/journal.pone.0239987	http://dx.doi.org/10.1371/journal.pone.0239987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031424	gold, Green Published			2022-12-26	WOS:000581809800086
J	Borrion, H; Kurland, J; Tilley, N; Chen, P				Borrion, Herve; Kurland, Justin; Tilley, Nick; Chen, Peng			Measuring the resilience of criminogenic ecosystems to global disruption: A case-study of COVID-19 in China	PLOS ONE			English	Article							CRIME; FRAMEWORK; IMPACT; TIME	This paper uses resilience as a lens through which to analyse disasters and other major threats to patterns of criminal behaviour. A set of indicators and mathematical models are introduced that aim to quantitatively describe changes in crime levels in comparison to what could otherwise be expected, and what might be expected by way of adaptation and subsequent resumption of those patterns. The validity of the proposed resilience assessment tool is demonstrated using commercial theft data from the COVID-19 pandemic period. A 64 per cent reduction in crime was found in the studied city (China) during an 83-day period, before daily crime levels bounced back to higher than expected values. The proposed resilience indicators are recommended as benchmarking instruments for evaluating and comparing the global impact of COVID-19 policies on crime and public safety.	[Borrion, Herve; Tilley, Nick] UCL, Dept Secur & Crime Sci, London, England; [Kurland, Justin] Univ Southern Mississippi, Sch Criminal Justice Forens Sci & Secur, Inst Adv Analyt Secur, Hattiesburg, MS 39406 USA; [Chen, Peng] Peoples Publ Secur Univ China, Sch Policing & Informat Engn, Beijing, Peoples R China	University of London; University College London; University of Southern Mississippi; People's Public Security University of China	Borrion, H (corresponding author), UCL, Dept Secur & Crime Sci, London, England.	h.borrion@ucl.ac.uk		Kurland, Justin/0000-0001-9546-4307; Borrion, Herve/0000-0003-3624-4763; Tilley, Nicholas/0000-0002-4984-4875	Engineering and Physical Sciences Research Council (EPSRC) [EP/P011896/1]; EPSRC [EP/P011896/2, EP/P011896/1] Funding Source: UKRI; ESRC [ES/V00445X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	HB received funding from the Engineering and Physical Sciences Research Council (EPSRC) [EP/P011896/1] url: https://epsrc.ukri.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen MA, 2012, CAN J CRIMINOL CRIM, V54, P333, DOI 10.3138/cjccj.2011.E44; [Anonymous], 2020, NEW YORK COMPSTAT; [Anonymous], 2018, CUADERNOS DERECHO TR, V10, P167; [Anonymous], 2020, LOS ANGELES COMPSTAT; [Anonymous], 2020, BBC NEWS; [Anonymous], 2016, INNOVATION SYSTEME S, V2, P7; [Anonymous], 2020, CHICAGO COMPSTAT; Baker S. R., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Below R., 2009, DISASTER CATEGORY CL; Bischoff P, 2019, SURVEILLANCE CAMERA, P1; Borrion H, 2020, BRIT J CRIMINOL, V60, P219, DOI 10.1093/bjc/azz029; Breetzke G., 2018, POSTEARTHQUAKE ANAL; Breetzke GD, 2018, AUST NZ J CRIMINOL, V51, P135, DOI 10.1177/0004865816679687; Bruneau M, 2003, EARTHQ SPECTRA, V19, P733, DOI 10.1193/1.1623497; Campaniello N, 2013, J SPORT ECON, V14, P148, DOI 10.1177/1527002511415536; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Chalfin A, 2020, SSRN ELECT J; COHEN LE, 1979, AM SOCIOL REV, V44, P588, DOI 10.2307/2094589; Coleman L., 2006, J CONTINGENCIES CRIS, V14, P3, DOI DOI 10.1111/J.1468-5973.2006.00476.X; Cox A, 2011, TRANSPORT POLICY, V18, P307, DOI 10.1016/j.tranpol.2010.09.004; Curtis T, 2000, CHILD ABUSE NEGLECT, V24, P1151, DOI 10.1016/S0145-2134(00)00176-9; Davila M, 2005, DEVIANT BEHAV, V26, P271, DOI 10.1080/01639620590927623; De Livera AM, 2011, J AM STAT ASSOC, V106, P1513, DOI 10.1198/jasa.2011.tm09771; Decker SH, 2007, J CRIM JUST, V35, P89, DOI 10.1016/j.jcrimjus.2006.11.018; Dunham R., 1995, EUROPEAN J CRIMINAL, V3, P56, DOI DOI 10.1007/BF02242928; Ellemers JE, 1953, STUDIES HOLLAND FLOO, V3; Emrouznejad A, 2016, TECHNOL FORECAST SOC, V111, P235, DOI 10.1016/j.techfore.2016.07.004; Ensor B, 2020, CORONAVIRUS REPORTED; Fisher R., 2016, ACAD ENTREPRENEURSHI, V22, P39; Frailing K., 2007, SOCIOLOGY KATRINA PE, P51; Frailing K, 2017, DISASTER STUD, P1, DOI 10.1057/978-1-137-46914-4_1; Francis R, 2014, RELIAB ENG SYST SAFE, V121, P90, DOI 10.1016/j.ress.2013.07.004; Fraume MCM, 2020, SAFETY SCI, V127, DOI 10.1016/j.ssci.2020.104739; Fritz CE, 1954, J SOC ISSUES, V10, P26, DOI 10.1111/j.1540-4560.1954.tb01996.x; Ganin AA, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701079; Greenfield VA, 2013, BRIT J CRIMINOL, V53, P864, DOI 10.1093/bjc/azt018; Haring I., 2016, EUR J SECUR RES, V1, P21, DOI [10.1007/s41125-015-0001-x, DOI 10.1007/S41125-015-0001-X]; Hodgson B., 2006, EUR J CRIMINOL, V3, P115, DOI DOI 10.1177/1477370806059083; Hoyland SA, 2018, SAFETY SCI, V110, P7, DOI 10.1016/j.ssci.2017.10.019; Hynes William, 2020, Environment Systems & Decisions, V40, DOI 10.1007/s10669-020-09776-x; Ishiguro Y., 1998, KOREA J, V38, P331; Iskander J, 2013, EMERG INFECT DIS, V19, P879, DOI 10.3201/eid1906.121478; Keating C, 2013, QUANT FINANC, V13, P1693, DOI 10.1080/14697688.2013.830860; King M.E., 2016, EXAMINING SPATIAL TE, DOI 10.26021/7548; Kroener I., 2016, CCTV TECHNOLOGY RADA; Kurzban R, 2012, STRUNGMANN FORUM REP, P183; LindelOv JK, 2020, MCP R PACKAGE REGRES, P1; Linkov I, 2019, RESILIENCE QUANTIFIC; Linkov I, 2017, RESILIENCE RISK METH; Linkov I, 2018, RISK ANAL, V38, P1772, DOI 10.1111/risa.12991; Linkov I, 2014, NAT CLIM CHANGE, V4, P407, DOI 10.1038/nclimate2227; Linkov I, 2012, J HOMEL SECUR EMERG, V9; Liu GG, 2018, URBANIZATION SOCIAL; MacIntyre CR, 2020, MED J AUSTRALIA, V212, P440, DOI 10.5694/mja2.50592; Martin RL, 2018, NEW OXFORD HDB EC GE, P839, DOI DOI 10.1093/OXFORDHB/9780198755609.013.43; Munasinghe M, 2007, ECOL ECON, V64, P9, DOI 10.1016/j.ecolecon.2007.05.003; Ouyang M, 2015, RELIAB ENG SYST SAFE, V141, P74, DOI 10.1016/j.ress.2015.03.011; Patriarca R, 2018, SAFETY SCI, V102, P79, DOI 10.1016/j.ssci.2017.10.005; Peng L., 2020, ARXIV200206563; Quarantelli, 2007, NATURAL HAZARDS OBSE, V23, P2; Quarantelli E., 1994, LOOTING ANTISOCIAL B; Quarantelli EL, 2007, NAT HAZARDS OBSERV, V31, P1; Quinlan AE, 2016, J APPL ECOL, V53, P677, DOI 10.1111/1365-2664.12550; Roach J, 2016, CRIME PREV SECUR MAN, P1, DOI 10.1057/978-1-137-46852-9; Rose A., 2007, ENVIRON HAZARDS-UK, V7, P383, DOI [10.1016/j.envhaz.2007.10.001, DOI 10.1016/J.ENVHAZ.2007.10.001]; ROTTON J, 1985, PSYCHOL BULL, V97, P286, DOI 10.1037/0033-2909.97.2.286; Sekhri S., 2011, ECONOMICS; Song Wang, 2002, CHINA WATER WASTEWAT, V18, P23; Sun WJ, 2020, SUSTAIN RESIL INFRAS, V5, P168, DOI 10.1080/23789689.2018.1448663; Tompson L, 2013, J RES CRIME DELINQ, V50, P616, DOI 10.1177/0022427812469114; Trump Benjamin D, 2020, Environ Syst Decis, V40, P171, DOI 10.1007/s10669-020-09781-0; van Koppen PJ, 1999, J RES CRIME DELINQ, V36, P7, DOI 10.1177/0022427899036001003; Webster S., VARIATION GOVT RESPO; Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8	74	21	22	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240077	10.1371/journal.pone.0240077	http://dx.doi.org/10.1371/journal.pone.0240077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3XB	33052950	Green Published, Green Submitted, gold			2022-12-26	WOS:000581820200006
J	Lundwall, A; Persson, M; Hansson, K; Jonsson, M				Lundwall, Ake; Persson, Margareta; Hansson, Karin; Jonsson, Magnus			Identification of the major rabbit and guinea pig semen coagulum proteins and description of the diversity of the REST gene locus in the mammalian clade Glires	PLOS ONE			English	Article							SEMINAL-VESICLE SECRETION; SEMENOGELIN-I; ISOLATED EPITHELIUM; MOLECULAR-CLONING; TRANSGLUTAMINASE; EVOLUTION; SEQUENCE; SKALP/ELAFIN; LIQUEFACTION; PRECURSORS	The seminal vesicle secretions of guinea pig and rabbit were analyzed for semen coagulum proteins. Using SDS-PAGE we discovered a previously not fully recognized semen coagulum protein, Svp5, in the guinea pig and a single predominant component, SVP200, in the rabbit. Potential genes of these proteins were identified in genome databases by their homology with human and murine genes. The structure of their fullength transcripts was determined using seminal vesicle cDNA and sequencing primers based on genomic sequences. Homology searching indicated that both Svp5 and SVP200 were synthesized from composite genes that were the result of merger between two genes showing homology with humanSEMG2andPI3. For a deeper understanding of the evolution of the genes, we retrieved and analyzed genome sequences from the REST gene loci, encompassing genes of semen coagulum proteins and related rapidly evolving seminal vesicle-transcribed genes, of 14 rodents and 2 lagomorphs. The analysis showed that rodents of the suborders myomorpha, hystricomorpha, and castorimorpha had unique sets of REST genes, whereas sciuromorpha seemed to be lacking such genes. It also indicated a closer relationship between myomorpha and castorimorpha than to rodents of the two other analyzed suborders. In the lagomorph species, the pika appeared to be devoid of REST genes, whereas the rabbit had a single expressed REST gene, SVP200, and two pseudogenes. The structural similarity of semen coagulum proteins in rabbit and hystricomph species suggests that they are closely related. This was also supported by other similarities at their REST gene loci,e.g. the finding of a PI3-like gene in the rabbit that also had features in common withcaltrin2of hystricomorph rodents. The homologies indicate that hystricomorpha may have separated from myomorpha and castorimorpha before the separation of hystricomorpha from lagomorpha.	[Lundwall, Ake; Persson, Margareta] Lund Univ, Div Translat Canc Res, Dept Lab Med, Lund, Sweden; [Hansson, Karin] Lund Univ, Div Clin Chem & Pharmacol, Dept Lab Med, Lund, Sweden; [Hansson, Karin] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Jonsson, Magnus] Lund Univ, Sect Clin Chem, Dept Translat Med, Malmo, Sweden	Lund University; Lund University; Lund University; Lund University	Lundwall, A (corresponding author), Lund Univ, Div Translat Canc Res, Dept Lab Med, Lund, Sweden.	ake.lundwall@med.lu.se			Alfred Osterlunds stiftelse; Malmo, Sweden	Alfred Osterlunds stiftelse; Malmo, Sweden	The study was funded by a grant from Alfred Osterlunds stiftelse, Malmo, Sweden http://www.alfredosterlundsstiftelse.se/ The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clauss A, 2005, BIOCHEM BIOPH RES CO, V333, P383, DOI 10.1016/j.bbrc.2005.05.125; Clauss A, 2002, BIOCHEM J, V368, P233, DOI 10.1042/BJ20020869; Clauss A, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-55; Furutani Y, 2005, J BIOL CHEM, V280, P20204, DOI 10.1074/jbc.M501678200; Guan YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13370; HAGSTROM JE, 1989, MOL ENDOCRINOL, V3, P1797, DOI 10.1210/mend-3-11-1797; Hagstrom JE, 1996, J BIOL CHEM, V271, P21114, DOI 10.1074/jbc.271.35.21114; HARRIS SE, 1990, J BIOL CHEM, V265, P9896; JAMES P, 1993, BIOCHEM BIOPH RES CO, V195, P58, DOI 10.1006/bbrc.1993.2009; Jensen-Seaman MI, 2003, J MOL EVOL, V57, P261, DOI 10.1007/s00239-003-2474-x; Kingan SB, 2003, J MOL EVOL, V57, P159, DOI 10.1007/s00239-002-2463-0; LILJA H, 1992, P NATL ACAD SCI USA, V89, P4559, DOI 10.1073/pnas.89.10.4559; LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070; LILJA H, 1984, SCAND J CLIN LAB INV, V44, P447, DOI 10.3109/00365518409083836; Lundwall A, 2003, BIOL REPROD, V69, P1923, DOI 10.1095/biolreprod.103.019984; Lundwall A, 2003, MOL HUM REPROD, V9, P345, DOI 10.1093/molehr/gag049; Lundwall A, 2002, BIOCHEM BIOPH RES CO, V290, P452, DOI 10.1006/bbrc.2001.6224; Lundwall A, 1997, EUR J BIOCHEM, V249, P39, DOI 10.1111/j.1432-1033.1997.t01-2-00039.x; Lundwall A, 1996, BIOCHEM BIOPH RES CO, V221, P323, DOI 10.1006/bbrc.1996.0594; Lundwall A, 1996, EUR J BIOCHEM, V235, P424, DOI 10.1111/j.1432-1033.1996.00424.x; LUNDWALL A, 1995, FEBS LETT, V374, P53, DOI 10.1016/0014-5793(95)01076-Q; Malm J, 1996, EUR J BIOCHEM, V238, P48, DOI 10.1111/j.1432-1033.1996.0048q.x; Miyano S, 2003, INT J MOL MED, V11, P435; MOORE JT, 1987, P NATL ACAD SCI USA, V84, P6712, DOI 10.1073/pnas.84.19.6712; NORVITCH ME, 1988, BIOL REPROD, V38, P1155, DOI 10.1095/biolreprod38.5.1155; OSTROWSKI MC, 1979, J BIOL CHEM, V254, P383; PELUSO G, 1994, BIOL REPROD, V50, P593, DOI 10.1095/biolreprod50.3.593; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; SAHEKI T, 1992, BIOCHEM BIOPH RES CO, V185, P240, DOI 10.1016/S0006-291X(05)80981-7; Sapir T, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00092; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Ulvsback M, 1997, EUR J BIOCHEM, V245, P25, DOI 10.1111/j.1432-1033.1997.00025.x; VENEZIALE CM, 1977, BIOCHEM J, V166, P167, DOI 10.1042/bj1660167; VENEZIALE CM, 1977, BIOCHEM J, V166, P155, DOI 10.1042/bj1660155; WAGNER CL, 1987, BIOL REPROD, V36, P501, DOI 10.1095/biolreprod36.2.501; Williams-Ashman H G, 1980, Adv Enzyme Regul, V18, P239, DOI 10.1016/0065-2571(80)90018-7; WILLIAMSASHMAN HG, 1984, MOL CELL BIOCHEM, V58, P51, DOI 10.1007/BF00240604; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; ZAKUTHOURI R, 1983, NATURE, V306, P594, DOI 10.1038/306594a0; Zeeuwen PLJM, 1997, J BIOL CHEM, V272, P20471, DOI 10.1074/jbc.272.33.20471	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240607	10.1371/journal.pone.0240607	http://dx.doi.org/10.1371/journal.pone.0240607			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052982	Green Published, gold			2022-12-26	WOS:000581820200046
J	Yan, YC; Huang, PB; Mao, K; He, CC; Xu, QD; Zhang, MY; Liu, HH; Zhou, ZY; Zhou, QM; Zhou, QL; Ou, B; Liu, QH; Lin, JH; Chen, RB; Wang, J; Zhang, JL; Xiao, ZY				Yan, Yongcong; Huang, Pinbo; Mao, Kai; He, Chuanchao; Xu, Qiaodong; Zhang, Mengyu; Liu, Haohan; Zhou, Zhenyu; Zhou, Qiming; Zhou, Qianlei; Ou, Bing; Liu, Qinghua; Lin, Jianhong; Chen, Ruibin; Wang, Jie; Zhang, Jianlong; Xiao, Zhiyu			Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression	ONCOGENE			English	Article							TUMOR-SUPPRESSOR GENE; CANCER; EXPRESSION; GROWTH; ACTIVATION; RESISTANCE; DEGRADATION; SURVIVAL; PATHWAY; MYC	Hepatitis B x protein (HBx) affects cellular protein expression and participates in the tumorigenesis and progression of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Metabolic reprogramming contributed to the HCC development, but its role in HBV-related HCC remains largely unclear. Tyrosine-protein phosphatase nonreceptor type 13 (PTPN13) is a significant regulator in tumor development, however, its specific role in hepatocarcinogenesis remains to be explored. Here, we found that decreased PTPN13 expression was associated with HBV/HBx. Patients with low PTPN13 expression showed a poor prognosis. Functional assays revealed that PTPN13 inhibited proliferation and tumorigenesis in vitro and in vivo. Further mechanistic studies indicated that HBx inhibited PTPN13 expression by upregulating the expression of DNMT3A and interacting with DNMT3A. Furthermore, we found that DNMT3A bound to the PTPN13 promoter (-343 to -313 bp) in an epigenetically controlled manner associated with elevated DNA methylation and then inhibited PTPN13 transcription. In addition, we identified IGF2BP1 as a novel PTPN13-interacting gene and demonstrated that PTPN13 influences c-Myc expression by directly and competitively binding to IGF2BP1 to decrease the intracellular concentration of functional IGF2BP1. Overexpressing PTPN13 promoted c-Myc mRNA degradation independent of the protein tyrosine phosphatase (PTP) activity of PTPN13. Importantly, we discovered that the PTPN13-IGF2BP1-c-Myc axis was important for cancer cell growth through promoting metabolic reprogramming. We verified the significant negative correlations between PTPN13 expression and c-Myc, PSPH, and SLC7A1 expression in clinical HCC tissue samples. In summary, our findings demonstrate that PTPN13 is a novel regulator of HBV-related hepatocarcinogenesis and may play an important role in HCC. PTPN13 may serve as a prognostic marker and therapeutic target in HBV-related HCC patients.	[Yan, Yongcong; Huang, Pinbo; Mao, Kai; He, Chuanchao; Liu, Haohan; Zhou, Zhenyu; Zhou, Qiming; Zhou, Qianlei; Liu, Qinghua; Lin, Jianhong; Chen, Ruibin; Wang, Jie; Zhang, Jianlong; Xiao, Zhiyu] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepatobiliary Surg, Guangzhou 510120, Peoples R China; [Yan, Yongcong; Liu, Haohan; Zhou, Qiming; Zhou, Qianlei; Liu, Qinghua; Lin, Jianhong; Chen, Ruibin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Peoples R China; [Yan, Yongcong; Liu, Haohan; Zhou, Qiming; Zhou, Qianlei; Liu, Qinghua; Lin, Jianhong; Chen, Ruibin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, RNA Biomed Inst, Guangzhou 510120, Peoples R China; [Xu, Qiaodong] Shantou Univ, Med Coll, Affiliated Hosp 1, Dept Biliary Pancreat Minimally Invas Surg, Shantou 515041, Peoples R China; [Zhang, Mengyu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol & Hepatol, Guangzhou 510120, Peoples R China; [Ou, Bing] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasound, Guangzhou 510120, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Shantou University; Sun Yat Sen University; Sun Yat Sen University	Huang, PB; Xiao, ZY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepatobiliary Surg, Guangzhou 510120, Peoples R China.	huangpb@mail2.sysu.edu.cn; xiaozhiy@mail.sysu.edu.cn		Yan, Yongcong/0000-0002-7269-764X	National Natural Science Foundation of China [81572407, 81602112, 81672405, 81702404]; Key project of Natural Science Foundation of Guangdong Province, China [2016A030311051]; Guangdong Basic and Applied Basic Research Foundation [2015A030313096, 2016A030313184, 2017A030313536, 2019A1515011418, 2019A1515011195]; Natural Science Foundation of Guangzhou, China [201607010225]; China Postdoctoral Science Foundation [2020TQ0384]; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [[2013]163]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes [KLB09001]; Guangdong Science and Technology Department [2017B030314026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key project of Natural Science Foundation of Guangdong Province, China; Guangdong Basic and Applied Basic Research Foundation; Natural Science Foundation of Guangzhou, China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes; Guangdong Science and Technology Department	This work was supported by the National Natural Science Foundation of China (Nos. 81572407, 81602112, 81672405, 81702404); Key project of Natural Science Foundation of Guangdong Province, China (No. 2016A030311051); Guangdong Basic and Applied Basic Research Foundation (Nos. 2015A030313096, 2016A030313184, 2017A030313536, 2019A1515011418, 2019A1515011195); Natural Science Foundation of Guangzhou, China (No. 201607010225); Project funded by China Postdoctoral Science Foundation (2020TQ0384); Grant [2013]163 from Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; Grant KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes. Grant from Guangdong Science and Technology Department (2017B030314026).	Bamberg A, 2018, AM J RESP CRIT CARE, V198, P914, DOI 10.1164/rccm.201707-1497OC; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Bollu LR, 2017, CLIN CANCER RES, V23, P2136, DOI 10.1158/1078-0432.CCR-16-0934; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheng Y, 2018, MOL CANCER, V17, DOI 10.1186/s12943-017-0747-z; Cilia E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002794; Costantini JL, 2009, BLOOD, V114, P4703, DOI 10.1182/blood-2009-03-213058; Dang H, 2017, CANCER CELL, V32, P101, DOI 10.1016/j.ccell.2017.06.002; Dou CW, 2019, ONCOGENE, V38, P1239, DOI 10.1038/s41388-018-0505-8; Freiss G, 2011, ANTI-CANCER AGENT ME, V11, P78, DOI 10.2174/187152011794941262; Gao Y, 2017, HEPATOLOGY, V66, P1413, DOI 10.1002/hep.29316; Glondu-Lassis M, 2010, CANCER RES, V70, P5116, DOI 10.1158/0008-5472.CAN-09-4368; Gutschner T, 2014, HEPATOLOGY, V59, P1900, DOI 10.1002/hep.26997; Hagemann N, 2013, ONCOGENE, V32, P4602, DOI 10.1038/onc.2012.485; Hamyeh M, 2020, THERANOSTICS, V10, P1016, DOI 10.7150/thno.38537; Han XJ, 2013, EXP MOL PATHOL, V95, P270, DOI 10.1016/j.yexmp.2013.07.008; He J, 2019, CANCER LETT, V450, P98, DOI 10.1016/j.canlet.2019.02.033; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hosono Y, 2017, CELL, V171, P1559, DOI 10.1016/j.cell.2017.11.040; Huang PB, 2020, ONCOGENE, V39, P3774, DOI 10.1038/s41388-020-1254-z; Huang PB, 2015, CLIN CANCER RES, V21, P4420, DOI 10.1158/1078-0432.CCR-14-2067; Huang WY, 2015, NUCLEIC ACIDS RES, V43, pD856, DOI 10.1093/nar/gku1151; Huang XW, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0628-y; Huang YD, 2018, CANCERS, V10, DOI 10.3390/cancers10030082; Kassel O, 2004, GENE DEV, V18, P2518, DOI 10.1101/gad.322404; Kuchay S, 2013, NAT CELL BIOL, V15, P472, DOI 10.1038/ncb2731; Kulik L, 2019, GASTROENTEROLOGY, V156, P477, DOI 10.1053/j.gastro.2018.08.065; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Li Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04006-0; Liao B, 2017, INT J ONCOL, V51, P1449, DOI 10.3892/ijo.2017.4126; Lu M, 2019, CELL METAB, V29, P886, DOI 10.1016/j.cmet.2018.12.019; Lucci MA, 2010, CELL ONCOL, V32, P361, DOI 10.3233/CLO-2010-0520; Post A, 2013, P NATL ACAD SCI USA, V110, P11427, DOI 10.1073/pnas.1306595110; Revillion F, 2009, INT J CANCER, V124, P638, DOI 10.1002/ijc.23989; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Sun LC, 2015, CELL RES, V25, P429, DOI 10.1038/cr.2015.33; Sun W, 2018, HEPATOLOGY, V67, P2302, DOI 10.1002/hep.29750; Turner M, 2018, NAT IMMUNOL, V19, P120, DOI 10.1038/s41590-017-0028-4; Varum S, 2019, CELL STEM CELL, V24, P637, DOI 10.1016/j.stem.2019.03.011; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; Wang SH, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv190; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wang ZC, 2015, HEPATOLOGY, V62, P1201, DOI 10.1002/hep.27911; Wieckowski E, 2007, J CELL BIOCHEM, V100, P16, DOI 10.1002/jcb.20922; Wolf E, 2015, TRENDS CELL BIOL, V25, P241, DOI 10.1016/j.tcb.2014.10.006; Yeh SH, 2006, CLIN CANCER RES, V12, P1097, DOI 10.1158/1078-0432.CCR-05-1383; Ying J, 2006, LEUKEMIA, V20, P1173, DOI 10.1038/sj.leu.2404193; Zhan H, 2016, TUMOR BIOL, V37, P9691, DOI 10.1007/s13277-016-4843-2; Zhuang L, 2017, J CELL MOL MED, V21, P2852, DOI 10.1111/jcmm.13198	51	10	10	4	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					28	45		10.1038/s41388-020-01498-3	http://dx.doi.org/10.1038/s41388-020-01498-3		OCT 2020	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33051595	Green Published, hybrid			2022-12-26	WOS:000577556100001
J	Steglich, M; Lombide, R; Lopez, I; Portela, M; Flo, M; Marin, M; Alvarez, B; Turell, L				Steglich, Martina; Lombide, Rodrigo; Lopez, Ignacio; Portela, Madelon; Flo, Martin; Marin, Monica; Alvarez, Beatriz; Turell, Lucia			Expression, purification and initial characterization of human serum albumin domain I and its cysteine 34	PLOS ONE			English	Article							YEAST PICHIA-PASTORIS; SULFENIC ACID; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HUMAN-PLASMA; FATTY-ACIDS; BINDING; THIOL; REACTIVITY; OPTIMIZATION	Human serum albumin presents in its primary structure only one free cysteine (Cys34) which constitutes the most abundant thiol of plasma. An antioxidant role can be attributed to this thiol, which is located in domain I of the protein. Herein we expressed domain I as a secretion protein using the yeastPichia pastoris. In the initial step of ammonium sulfate precipitation, a brown pigment co-precipitated with domain I. Three chromatographic methods were evaluated, aiming to purify domain I from the pigment and other contaminants. Purification was achieved by cation exchange chromatography. The protein behaved as a non-covalent dimer. The primary sequence of domain I and the possibility of reducing Cys34 to the thiol state while avoiding the reduction of internal disulfides were confirmed by mass spectrometry. The reactivity of the thiol towards the disulfide 5,5 '-dithiobis(2-nitrobenzoate) was studied and compared to that of full-length albumin. A similar to 24-fold increase in the rate constant was observed for domain I with respect to the entire protein. These results open the door to further characterization of the Cys34 thiol and its oxidized derivatives.	[Steglich, Martina; Lombide, Rodrigo; Alvarez, Beatriz; Turell, Lucia] Univ Republica, Fac Ciencias, Lab Enzimol, Montevideo, Uruguay; [Steglich, Martina; Alvarez, Beatriz; Turell, Lucia] Univ Republica, Ctr Free Radical & Biomed Res, Montevideo, Uruguay; [Lopez, Ignacio; Marin, Monica] Univ Republica, Secc Bioquim, Fac Ciencias, Montevideo, Uruguay; [Portela, Madelon] Inst Pasteur Montevideo, Unidad Bioquim & Prote Analit, Montevideo, Uruguay; [Portela, Madelon] Inst Invest Biol Clemente Estable, Montevideo, Uruguay; [Portela, Madelon] Univ Republica, Fac Ciencias, Montevideo, Uruguay; [Flo, Martin] Univ Republica, Dept Inmunobiol, Fac Med, Montevideo, Uruguay; [Flo, Martin] Inst Pasteur Montevideo, Lab Inmunobiol, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Turell, L (corresponding author), Univ Republica, Fac Ciencias, Lab Enzimol, Montevideo, Uruguay.; Turell, L (corresponding author), Univ Republica, Ctr Free Radical & Biomed Res, Montevideo, Uruguay.	lturell@fcien.edu.uy		Lopez, Ignacio/0000-0001-9669-8906; Turell, Lucia/0000-0002-6660-0784	Agencia Nacional de Investigacion (ANII, Uruguay) [PR_FCE_2009_1988]; Comision Sectorial de Investigacion Cientifica (CSIC, Uruguay); Agencia Nacional de Investigacion e innovacion (ANII, Uruguay); (UDELAR, Uruguay)	Agencia Nacional de Investigacion (ANII, Uruguay); Comision Sectorial de Investigacion Cientifica (CSIC, Uruguay); Agencia Nacional de Investigacion e innovacion (ANII, Uruguay); (UDELAR, Uruguay)	This work was supported by grants from Agencia Nacional de Investigacion (ANII, Uruguay, PR_FCE_2009_1988) to L.T. and Comision Sectorial de Investigacion Cientifica (CSIC, Uruguay) to B.A. and L.T., and fellowships from Agencia Nacional de Investigacion e innovacion (ANII, Uruguay) to R.L. and Comision Academica de Posgrado, Universidad de la Republica (CAP, UDELAR, Uruguay) to M.S.	Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Alvarez B, 2010, METHOD ENZYMOL, V473, P117, DOI 10.1016/S0076-6879(10)73005-6; ARNHOLD J, 1990, BIOMED BIOCHIM ACTA, V49, P991; Azadi S, 2018, RES PHARM SCI, V13, P222, DOI 10.4103/1735-5362.228953; Belew M, 2008, SEP SCI TECHNOL, V43, P3134, DOI 10.1080/01496390802221857; Bobik TV, 2008, RUSS J BIOORG CHEM+, V34, P49, DOI 10.1134/S1068162008010068; Bocedi A, 2018, FEBS J, V285, P3225, DOI 10.1111/febs.14609; Bonanata J, 2017, FREE RADICAL BIO MED, V108, P952, DOI 10.1016/j.freeradbiomed.2017.04.021; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; CHEN RF, 1967, J BIOL CHEM, V242, P173; Compagnini A, 1996, J CHROMATOGR A, V736, P115, DOI 10.1016/0021-9673(95)01362-8; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Dockal M, 1999, J BIOL CHEM, V274, P29303, DOI 10.1074/jbc.274.41.29303; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Torres MJ, 2012, ARCH BIOCHEM BIOPHYS, V521, P102, DOI 10.1016/j.abb.2012.03.011; Jovanovic VB, 2014, ANAL BIOCHEM, V448, P50, DOI 10.1016/j.ab.2013.11.030; Juturu V, 2018, CHEMBIOCHEM, V19, P7, DOI 10.1002/cbic.201700460; Kobayashi K, 2000, J BIOSCI BIOENG, V89, P55, DOI 10.1016/S1389-1723(00)88050-0; LEATHERBARROW RJ, 1980, BIOCHEM J, V189, P27, DOI 10.1042/bj1890027; Li SJ, 2018, PROTEIN EXPRES PURIF, V149, P37, DOI 10.1016/j.pep.2018.04.012; Mallem M, 2014, BIOTECHNOL PROGR, V30, P1488, DOI 10.1002/btpr.1990; Moore BD, 2010, BIOTECHNOL BIOENG, V106, P764, DOI 10.1002/bit.22730; Narazaki R, 1997, BBA-PROTEIN STRUCT M, V1338, P275, DOI 10.1016/S0167-4838(96)00221-X; Ohya T, 2005, BIOTECHNOL BIOENG, V90, P876, DOI 10.1002/bit.20507; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Petitpas I, 2003, P NATL ACAD SCI USA, V100, P6440, DOI 10.1073/pnas.1137188100; RADI R, 1991, J BIOL CHEM, V266, P4244; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Sengupta S, 2001, J BIOL CHEM, V276, P30111, DOI 10.1074/jbc.M104324200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stewart AJ, 2005, FEBS J, V272, P353, DOI 10.1111/j.1742-4658.2004.04474.x; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; TRAVIS J, 1976, BIOCHEM J, V157, P301, DOI 10.1042/bj1570301; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Turell L, 2013, FREE RADICAL BIO MED, V65, P244, DOI 10.1016/j.freeradbiomed.2013.05.050; Turell L, 2009, J CHROMATOGR B, V877, P3384, DOI 10.1016/j.jchromb.2009.03.035; Wardell M, 2002, BIOCHEM BIOPH RES CO, V291, P813, DOI 10.1006/bbrc.2002.6540; Watanabe H, 2001, PHARMACEUT RES, V18, P1775, DOI 10.1023/A:1013391001141; Zhu W, 2018, PROTEIN EXPRES PURIF, V147, P59, DOI 10.1016/j.pep.2018.02.003	42	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240580	10.1371/journal.pone.0240580	http://dx.doi.org/10.1371/journal.pone.0240580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045024	gold, Green Published			2022-12-26	WOS:000581811700050
J	Takasu, C; Nishi, M; Yoshikawa, K; Tokunaga, T; Kashihara, H; Yoshimoto, T; Shimada, M				Takasu, Chie; Nishi, Masaaki; Yoshikawa, Kozo; Tokunaga, Takuya; Kashihara, Hideya; Yoshimoto, Toshiaki; Shimada, Mitsuo			Impact of sidedness of colorectal cancer on tumor immunity	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; INDEPENDENT PROGNOSTIC-FACTOR; T-CELLS; DISTAL	Background Clinical and molecular characteristics differ between right-sided and left-sided colorectal cancer (CRC). This study aimed to clarify the correlation between CRC sidedness and tumor immunity. Methods A total of 102 patients who underwent curative colectomy for stage II/III CRC were included in this study. The expression of programmed cell death (PD)-1, PD1-ligand 1 (PD-L1), forkhead box P3 (Foxp3), transforming growth factor (TGF)-beta, and indoleamine-pyrrole 2,3-dioxygenase (IDO) were examined using immunohistochemistry and the relationships between sidedness and several prognostic factors were examined. Results Clinicopathological factors were not significantly different between right- and left-sided CRC. The tumor immunity-related molecule PD-L1 was more highly expressed in right-sided than in left-sided CRC (62.9% vs. 30.6%, p<0.01). No significant difference was found in overall survival (OS) and disease-free survival (DFS) by sidedness. PD-1 and Foxp3 expression were significant prognostic factors for OS. Lymph node metastasis (N), lymphatic invasion (ly), and PD-L1 expression were significant prognostic factors for DFS. In right-sided CRC, IDO-positive patients had a poor OS (p<0.05), and IDO was the only independent prognostic indicator for OS. N and venous invasion were identified as independent prognostic indicators for DFS. In left-sided CRC, univariate analysis identified PD-1, PD-L1, and Foxp3 expression as significant predictors of poor OS. Multivariate analysis confirmed PD-L1 expression as an independent prognostic indicator. N, ly, and PD-L1 expression levels were identified as significant predictors of poor DFS. Conclusions The prognostic factors were IDO in right-sided CRC and PD-L1 and Foxp3 in left-sided CRC. These findings indicated that tumor immunity might play different roles depending upon sidedness. Tumor location may be an important factor to consider when assessing immune response and therapeutic decisions in CRC patients.	[Takasu, Chie; Nishi, Masaaki; Yoshikawa, Kozo; Tokunaga, Takuya; Kashihara, Hideya; Yoshimoto, Toshiaki; Shimada, Mitsuo] Univ Tokushima, Dept Surg, Tokushima, Japan	Tokushima University	Takasu, C (corresponding author), Univ Tokushima, Dept Surg, Tokushima, Japan.	takasu.chie@tokushima-u.ac.jp; first-ec@tokushima-u.ac						Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Berntsson J, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1465165; Berntsson J, 2017, INT J CANCER, V141, P1654, DOI 10.1002/ijc.30869; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Breivik J, 1997, INT J CANCER, V74, P664, DOI 10.1002/(SICI)1097-0215(19971219)74:6<664::AID-IJC18>3.0.CO;2-5; CAUT Bulletin, 2012, CAUT B, pA7; Douglass S, 2012, CANCER METAST REV, V31, P843, DOI 10.1007/s10555-012-9395-3; Enkhbat T, 2018, ANTICANCER RES, V38, P3367, DOI 10.21873/anticanres.12603; Eto S, 2016, GASTRIC CANCER, V19, P466, DOI 10.1007/s10120-015-0519-7; Flammiger A, 2013, EUR J CANCER, V49, P1273, DOI 10.1016/j.ejca.2012.11.035; Flies DB, 2007, J IMMUNOTHER, V30, P251, DOI 10.1097/CJI.0b013e31802e085a; Godin-Ethier J, 2011, CLIN CANCER RES, V17, P6985, DOI 10.1158/1078-0432.CCR-11-1331; Han YM, 2014, J MOL MED, V92, P539, DOI 10.1007/s00109-014-1143-4; Kim SE, 2015, WORLD J GASTROENTERO, V21, P5167, DOI 10.3748/wjg.v21.i17.5167; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lee GH, 2015, EJSO-EUR J SURG ONC, V41, P300, DOI 10.1016/j.ejso.2014.11.001; Missiaglia E, 2014, ANN ONCOL, V25, P1995, DOI 10.1093/annonc/mdu275; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Naito Y, 1998, CANCER RES, V58, P3491; Saito H, 2007, J SURG ONCOL, V95, P123, DOI 10.1002/jso.20612; Salem ME, 2018, MOL CANCER RES, V16, P805, DOI 10.1158/1541-7786.MCR-17-0735; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Wainwright DA, 2012, CLIN CANCER RES, V18, P6110, DOI 10.1158/1078-0432.CCR-12-2130	24	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240408	10.1371/journal.pone.0240408	http://dx.doi.org/10.1371/journal.pone.0240408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045001	gold, Green Published			2022-12-26	WOS:000581811700043
J	Church, RJ; Schomaker, SJ; Eaddy, JS; Boucher, GG; Kreeger, JM; Aubrecht, J; Watkins, PB				Church, Rachel J.; Schomaker, Shelli J.; Eaddy, J. Scott; Boucher, Germaine G.; Kreeger, John M.; Aubrecht, Jiri; Watkins, Paul B.			Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse	PLOS ONE			English	Article							LIVER-INJURY; CELL-DEATH; DAMAGE	Glutamate dehydrogenase (GLDH) is a liver-specific biomarker of hepatocellular damage currently undergoing qualification as a drug development tool. Since GLDH is located within the mitochondrial matrix, it has been hypothesized that it might also be useful in assessing mitotoxicity as an initiating event during drug-induced liver injury. According to this hypothesis, hepatocyte death that does not involve primary mitochondrial injury would result in release of intact mitochondria into circulation that could be removed by high speed centrifugation and result in lower GLDH activity measured in spun serum vs un-spun serum. A single prior study in mice has provided some support for this hypothesis. We sought to repeat and extend the findings of this study. Accordingly, mice were treated with the known mitochondrial toxicant, acetaminophen (APAP), or with furosemide (FS), a toxicant believed to cause hepatocyte death through mechanisms not involving mitotoxicity as initiating event. We measured GLDH levels in fresh plasma before and after high speed centrifugation to remove intact mitochondria. We found that both APAP and FS treatments caused substantial hepatocellular necrosis that correlated with plasma alanine aminotransferase (ALT) and GLDH elevations. The plasma GLDH activity in both the APAP- and FS- treated mice was not affected by high-speed centrifugation. Interestingly, the ratio of GLDH:ALT was 5-fold lower during FS compared to APAP hepatotoxicity. Electron microscopy confirmed that both APAP- and FS-treatments had resulted in mitochondrial injury. Mitochondria within vesicles were only observed in the FS-treated mice raising the possibility that mitophagy might account for reduced release of GLDH in the FS-treated mice. Although our results show that plasma GLDH is not clinically useful for evaluating mitotoxicity, the GLDH:ALT ratio as a measure of mitophagy needs to be further studied.	[Church, Rachel J.; Eaddy, J. Scott; Watkins, Paul B.] Univ N Carolina, Inst Drug Safety Sci, Chapel Hill, NC 27515 USA; [Church, Rachel J.; Watkins, Paul B.] Univ N Carolina, Div Pharmacotherapy & Expt Therapeut, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA; [Schomaker, Shelli J.; Boucher, Germaine G.; Kreeger, John M.; Aubrecht, Jiri] Pfizer Inc, Groton, CT 06340 USA; [Aubrecht, Jiri] Takeda Pharmaceut, Cambridge, MA USA	The Hamner Institutes for Health Sciences; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Pfizer	Church, RJ (corresponding author), Univ N Carolina, Inst Drug Safety Sci, Chapel Hill, NC 27515 USA.; Church, RJ (corresponding author), Univ N Carolina, Div Pharmacotherapy & Expt Therapeut, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA.	rchurch@unc.edu		Church, Rachel/0000-0002-1080-6046				[Anonymous], 2012, INT J SPORTS MED, V33, P36; Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294; Church RJ, 2019, HEPATOLOGY, V69, P760, DOI 10.1002/hep.29802; Dache ZA, 2020, FASEB J, V34, P3616, DOI 10.1096/fj.201901917RR; FDA, 2020, QUAL PLAN DET; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Jaeschke H, 2013, TOXICOL SCI, V134, P221, DOI 10.1093/toxsci/kft087; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Kang JW, 2016, J PINEAL RES, V60, P383, DOI 10.1111/jpi.12319; LINDENA J, 1986, J CLIN CHEM CLIN BIO, V24, P35, DOI 10.1515/cclm.1986.24.1.35; McGill MR, 2015, XENOBIOTICA, V45, P442, DOI 10.3109/00498254.2014.986250; McGill MR, 2014, HEPATOLOGY, V60, P1336, DOI 10.1002/hep.27265; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; McMillan HJ, 2011, PEDIATRICS, V127, pE132, DOI 10.1542/peds.2010-0929; Nathwani RA, 2005, HEPATOLOGY, V41, P380, DOI 10.1002/hep.20548; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; O'Brien PJ, 2002, LAB ANIM-UK, V36, P313, DOI 10.1258/002367702320162414; Pettersson J, 2008, BRIT J CLIN PHARMACO, V65, P253, DOI 10.1111/j.1365-2125.2007.03001.x; SCHMIDT ES, 1988, CLIN CHIM ACTA, V173, P43, DOI 10.1016/0009-8981(88)90356-7; Schomaker S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229753; Schomaker S, 2013, TOXICOL SCI, V132, P276, DOI 10.1093/toxsci/kft009; Wong SGW, 2000, TOXICOL LETT, V116, P171, DOI 10.1016/S0378-4274(00)00218-6	22	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240562	10.1371/journal.pone.0240562	http://dx.doi.org/10.1371/journal.pone.0240562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035276	Green Published, gold			2022-12-26	WOS:000581817500027
J	Moreno-Barbosa, F; de Celis-Alonso, B; Moreno-Barbosa, E; Hernandez-Lopez, JM; Geoghegan, T; Ramos-Mendez, J				Moreno-Barbosa, Fernando; de Celis-Alonso, Benito; Moreno-Barbosa, Eduardo; Hernandez-Lopez, Javier Miguel; Geoghegan, Theodore; Ramos-Mendez, Jose			Monte Carlo simulation of the effect of magnetic fields on brachytherapy dose distributions in lung tissue material	PLOS ONE			English	Article							MV RADIOTHERAPY ACCELERATOR; MRI SCANNER; ELECTRON; DOSIMETRY; ALGORITHM; TOMOGRAPHY; DEPOSITION; GEANT4; TOPAS	The aim of this work was to use TOPAS Monte Carlo simulations to model the effect of magnetic fields on dose distributions in brachytherapy lung treatments, under ideal and clinical conditions. Idealistic studies were modeled consisting of either a monoenergetic electron source of 432 keV, or a polyenergetic electron source using the spectrum of secondary electrons produced by(192)Ir gamma-ray irradiation. The electron source was positioned in the center of a homogeneous, lung tissue phantom (rho = 0.26 g/cm(3)). Conversely, the clinical study was simulated using the VariSource VS2000 Ir-192 source in a patient with a lung tumor. Three contoured volumes were considered: the tumor, the planning tumor volume (PTV), and the lung. In all studies, dose distributions were calculated in the presence or absence of a constant magnetic field of 3T. Also, TG-43 parameters were calculated for the VariSource and compared with published data from EGS-brachy (EGSnrc) and PENELOPE. The magnetic field affected the dose distributions in the idealistic studies. For the monoenergetic and poly-energetic studies, the radial distance of the 10% iso-dose line was reduced in the presence of the magnetic field by 64.9% and 24.6%, respectively. For the clinical study, the magnetic field caused differences of 10% on average in the patient dose distributions. Nevertheless, differences in dose-volume histograms were below 2%. Finally, for TG-43 parameters, the dose-rate constant from TOPAS differed by 0.09% +/- 0.33% and 0.18% +/- 0.33% with respect to EGS-brachy and PENELOPE, respectively. The geometry and anisotropy functions differed within 1.2% +/- 1.1%, and within 0.0% +/- 0.3%, respectively. The Lorentz forces inside a 3T magnetic resonance machine during(192)Ir brachytherapy treatment of the lung are not large enough to affect the tumor dose distributions significantly, as expected. Nevertheless, large local differences were found in the lung tissue. Applications of this effect are therefore limited by the fact that meaningful differences appeared only in regions containing air, which is not abundant inside the human.	[Moreno-Barbosa, Fernando; de Celis-Alonso, Benito; Moreno-Barbosa, Eduardo; Hernandez-Lopez, Javier Miguel] Benemerita Univ Autonoma Puebla, Fac Math & Phys Sci, Mexico City, DF, Mexico; [Geoghegan, Theodore] Univ Iowa Hosp & Clin, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Ramos-Mendez, Jose] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA	Benemerita Universidad Autonoma de Puebla; University of Iowa; University of California System; University of California San Francisco	Moreno-Barbosa, E (corresponding author), Benemerita Univ Autonoma Puebla, Fac Math & Phys Sci, Mexico City, DF, Mexico.	emoreno@fcfm.buap.mx	Moreno-Barbosa, Eduardo/AAX-6669-2020; Mendez, Jose Ramos/J-8491-2019; Moreno-Barbosa, Fernando/GYU-2935-2022; , de Celis Alonso Benito/AAP-4512-2021; , db/GRS-6835-2022	Moreno-Barbosa, Eduardo/0000-0002-1114-2640; Mendez, Jose Ramos/0000-0002-8106-5142; , de Celis Alonso Benito/0000-0003-2124-1084; Moreno-Barbosa, Fernando/0000-0003-4001-1671	CONACyT; UCSF School of Medicine; National Cancer Institute [U24 CA215123]; Laboratorio Nacional de Supercomputo del Sureste de Mexico (LNS), a member of the CONACYT national laboratories	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UCSF School of Medicine; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Laboratorio Nacional de Supercomputo del Sureste de Mexico (LNS), a member of the CONACYT national laboratories	Authors would like to thank CONACyT for the support of Ph.D. student FMB. JRM was partially funded by UCSF School of Medicine bridge fundingand National Cancer Institute under U24 CA215123 (The TOPAS Tool for Particle Simulation, a Monte Carlo Simulation Tool for Physics, Biology and Clinical Research). The authors thankfully acknowledge computer resources, technical advice and support provided by the Laboratorio Nacional de Supercomputo del Sureste de Mexico (LNS), a member of the CONACYT national laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsharpour H, 2012, PHYS MED BIOL, V57, P3273, DOI 10.1088/0031-9155/57/11/3273; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Angelopoulos A, 2000, MED PHYS, V27, P2521, DOI 10.1118/1.1315316; [Anonymous], 2007, ANN THORAC SURG, V83, pS27; BARO J, 1995, NUCL INSTRUM METH B, V100, P31, DOI 10.1016/0168-583X(95)00349-5; Belanger C, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab1817; Beld E, 2016, PHYS MED BIOL, V61, P6791, DOI 10.1088/0031-9155/61/18/6791; Berger M.J., 2018, ESTAR PSTAR ASTAR CO; BIELAJEW AF, 1993, MED PHYS, V20, P1171, DOI 10.1118/1.597149; Brown JMC, 2014, NUCL INSTRUM METH B, V338, P77, DOI 10.1016/j.nimb.2014.07.042; Chamberland MJP, 2016, PHYS MED BIOL, V61, P8214, DOI 10.1088/0031-9155/61/23/8214; Chen Y, 2005, MED PHYS, V32, P3810, DOI 10.1118/1.2011091; Earl MA, 2002, MED PHYS, V29, P484, DOI 10.1118/1.1461374; Enger SA, 2012, PHYS MED BIOL, V57, P6269, DOI 10.1088/0031-9155/57/19/6269; FROMSON BH, 1988, THORAX, V43, P120, DOI 10.1136/thx.43.2.120; GBD 2015 Eastern Mediterranean Region Collaborators, 2018, INT J PUBLIC HLTH S1, V63, pS11; Grove O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118261; Hauf S, 2013, IEEE T NUCL SCI, V60, P2966, DOI 10.1109/TNS.2013.2270894; Kirisits C, 2014, RADIOTHER ONCOL, V110, P199, DOI 10.1016/j.radonc.2013.11.002; National Toxicology Program, 2011, Rep Carcinog, V12, P159; O'Brien DJ, 2016, MED PHYS, V43, P4915, DOI 10.1118/1.4959785; Oborn BM, 2014, MED PHYS, V41, DOI 10.1118/1.4871618; Padilla-Cabal F, 2020, MED PHYS, V47, P223, DOI 10.1002/mp.13883; Perl J, 2012, MED PHYS, V39, P6818, DOI 10.1118/1.4758060; Piersimoni P, 2017, MED PHYS, V44, P284, DOI 10.1002/mp.12013; Piersimoni P, 2018, MED PHYS, V45, P3264, DOI 10.1002/mp.12942; Raaijmakers AJE, 2007, PHYS MED BIOL, V52, P4283, DOI 10.1088/0031-9155/52/14/017; Raaijmakers AJE, 2005, PHYS MED BIOL, V50, P1363, DOI 10.1088/0031-9155/50/7/002; Raaymakers BW, 2004, PHYS MED BIOL, V49, P4109, DOI 10.1088/0031-9155/49/17/019; Ricke J, 2005, CHEST, V127, P2237, DOI 10.1378/chest.127.6.2237; Rivard MJ, 2004, MED PHYS, V31, P633, DOI 10.1118/1.1646040; Schneider W, 2013, PHYS MED BIOL, V58, P4255; Schumann J, 2012, PHYS MED BIOL, V57, P3281, DOI 10.1088/0031-9155/57/11/3281; Sempau J, 1997, NUCL INSTRUM METH B, V132, P377, DOI 10.1016/S0168-583X(97)00414-X; Sharma DN, 2011, J CANCER RES THER, V7, P174, DOI 10.4103/0973-1482.82914; Simiele E, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aaedc9; Suntharalingam N., 2005, RAD ONCOLOGY PHYS; Taylor REP, 2007, MED PHYS, V34, P445, DOI 10.1118/1.2400843	38	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0238704	10.1371/journal.pone.0238704	http://dx.doi.org/10.1371/journal.pone.0238704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035214	Green Published, gold			2022-12-26	WOS:000581817500058
J	Klaps, J; de Vega, C; Herrera, CM; Junker, RR; Lievens, B; Alvarez-Perez, S				Klaps, Joon; de Vega, Clara; Herrera, Carlos M.; Junker, Robert R.; Lievens, Bart; Alvarez-Perez, Sergio			Candida metrosideripro tempore sp. nov. andCandida ohialehuaepro tempore sp. nov., two antifungal-resistant yeasts associated withMetrosideros polymorphaflowers in Hawaii	PLOS ONE			English	Article							AMPHOTERICIN-B-RESISTANT; LARGE-SUBUNIT RDNA; ENDEMIC YEASTS; FLORAL NECTAR; D1/D2 DOMAIN; FLOWERS; MODELS; BIODIVERSITY; COMPLEX; F.A.	Flowers produce an array of nutrient-rich exudates in which microbes can thrive, making them hotspots for microbial abundance and diversity. During a diversity study of yeasts inhabiting the flowers ofMetrosideros polymorpha(Myrtaceae) in the Hawai'i Volcanoes National Park (HI, USA), five isolates were found to represent two novel species. Morphological and physiological characterization, and sequence analysis of the small subunit ribosomal RNA (rRNA) genes, the D1/D2 domains of the large subunit rRNA genes, the internal transcribed spacer (ITS) regions, and the genes encoding the largest and second largest subunits of the RNA polymerase II (RPB1andRPB2, respectively), classified both species in the familyMetschnikowiaceae, and we propose the namesCandida metrosideripro tempore sp. nov. (JK22(T)= CBS 16091 = MUCL 57821) andCandida ohialehuaepro tempore sp. nov. (JK58.2(T)= CBS 16092 = MUCL 57822) for such new taxa. Both novelCandidaspecies form a well-supported subclade in theMetschnikowiaceaecontaining species associated with insects, flowers, and a few species of clinical importance. The ascosporic state of the novel species was not observed. The two novel yeast species showed elevated minimum inhibitory concentrations to the antifungal drug amphotericin B (>4 mu g/mL). The ecology and phylogenetic relationships ofC.metrosideriandC.ohialehuaeare also discussed.	[Klaps, Joon; Lievens, Bart] Katholieke Univ Leuven, Lab Proc Microbial Ecol & Bioinspirat Management, Dept Microbial & Mol Syst, Leuven, Belgium; [de Vega, Clara] Univ Seville, Dept Plant Biol & Ecol, Seville, Spain; [Herrera, Carlos M.] CSIC, Estn Biol Donana, Seville, Spain; [Junker, Robert R.] Univ Salzburg, Dept Biosci, Salzburg, Austria; [Junker, Robert R.] Philipps Univ Marburg, Fac Biol, Evolutionary Ecol Plants, Marburg, Germany; [Alvarez-Perez, Sergio] Univ Complutense Madrid, Fac Vet Med, Dept Anim Hlth, Madrid, Spain; [Alvarez-Perez, Sergio] Univ Complutense Madrid, Vet Clin Hosp, Madrid, Spain	KU Leuven; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Salzburg University; Philipps University Marburg; Complutense University of Madrid; Complutense University of Madrid	Klaps, J; Lievens, B (corresponding author), Katholieke Univ Leuven, Lab Proc Microbial Ecol & Bioinspirat Management, Dept Microbial & Mol Syst, Leuven, Belgium.	bart.lievens@kuleuven.be; joonklaps@gmail.com	de Vega, Clara/A-5822-2012; de Vega, Clara/AAQ-8839-2021; Alvarez-Perez, Sergio/J-5737-2016	de Vega, Clara/0000-0003-4553-798X; de Vega, Clara/0000-0003-4553-798X; Klaps, Joon/0000-0002-2507-0430; Alvarez-Perez, Sergio/0000-0002-6587-8995	Deutsche Forschungsgemeinschaft (DFG) [JU2856/2-2]; Spanish Ministry of Science [RYC2018-023847-I]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	RRJ was supported by the Deutsche Forschungsgemeinschaft (DFG, JU2856/2-2) https://www.dfg.de/.SAP acknowledges a 'Ramon y Cajal' contract funded by the Spanish Ministry of Science [RYC2018-023847-I] https://www.ciencia. gob.es. The funders had no tole in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Robin Gottlieb for assistance in the field, Curtis C. Daehler for organizational support and the United States Department of the Interior (National Park Service) and Rhonda Loh for the scientific research and collecting permit (HAVO-2013-SCI-0003). The authors also thank Dr. Sofie Houtmeyer's assistance with the optical microscope at KU Leuven Campus De Nayer.	Aleklett K, 2014, BOTANY, V92, DOI 10.1139/cjb-2013-0166; Alimadadi N, 2016, INT J SYST EVOL MICR, V66, P1476, DOI 10.1099/ijsem.0.000905; Alvarez-Perez S, 2019, TRENDS PLANT SCI, V24, P393, DOI 10.1016/j.tplants.2019.01.012; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; Alvarez-Perez S, 2010, MED MYCOL, V48, P273, DOI [10.3109/13693780903095414, 10.1080/13693780903095414]; Amoikon TLS, 2018, INT J SYST EVOL MICR, V68, P2299, DOI 10.1099/ijsem.0.002829; Arvanitis M, 2013, BBA-MOL BASIS DIS, V1832, P1378, DOI 10.1016/j.bbadis.2013.03.008; Ben-Ami R, 2017, EMERG INFECT DIS, V23, P195, DOI 10.3201/eid2302.161486; BRAJTBURG J, 1990, ANTIMICROB AGENTS CH, V34, P183, DOI 10.1128/AAC.34.2.183; Casadevall A, 2019, MBIO, V10, DOI 10.1128/mBio.01397-19; Cendejas-Bueno E, 2012, J CLIN MICROBIOL, V50, P3641, DOI 10.1128/JCM.02248-12; Chowdhary A, 2018, J ANTIMICROB CHEMOTH, V73, P891, DOI 10.1093/jac/dkx480; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dawson J., 1999, MANUAL FLOWERING PLA, P964; de Vega C, 2018, INT J SYST EVOL MICR, V68, P2028, DOI 10.1099/ijsem.0.002784; de Vega C, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fox054; de Vega C, 2014, INT J SYST EVOL MICR, V64, P3724, DOI 10.1099/ijs.0.068445-0; de Vega C, 2012, INT J SYST EVOL MICR, V62, P2538, DOI 10.1099/ijs.0.040790-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis D, 2002, J ANTIMICROB CHEMOTH, V49, P7, DOI 10.1093/jac/49.suppl_1.7; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guzman B, 2013, MOL PHYLOGENET EVOL, V68, P161, DOI 10.1016/j.ympev.2013.04.003; Hanna C, 2014, ECOLOGY, V95, P1622, DOI 10.1890/13-1276.1; Hanna C, 2013, J APPL ECOL, V50, P147, DOI 10.1111/1365-2664.12027; Herrera CM, 2010, P ROY SOC B-BIOL SCI, V277, P747, DOI 10.1098/rspb.2009.1485; Hohl TM, 2014, J IMMUNOL METHODS, V410, P100, DOI 10.1016/j.jim.2014.03.022; James SA, 2004, NEW ZEAL J BOT, V42, P263, DOI 10.1080/0028825X.2004.9512903; Junker RR, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv097; Junker RR, 2010, ECOL ENTOMOL, V35, P760, DOI 10.1111/j.1365-2311.2010.01237.x; Klaps Joon, 2020, Fungal Biol Biotechnol, V7, P1, DOI 10.1186/s40694-019-0091-8; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 2005, INT J SYST EVOL MICR, V55, P1369, DOI 10.1099/ijs.0.63615-0; Lachance MA, 2003, FEMS YEAST RES, V4, P253, DOI 10.1016/S1567-1356(03)00113-2; Lachance MA, 2003, FEMS YEAST RES, V4, P105, DOI 10.1016/S1567-1356(03)00149-1; Lachance MA, 2016, YEAST, V33, P563, DOI 10.1002/yea.3208; Li SL, 2013, INT J SYST EVOL MICR, V63, P388, DOI 10.1099/ijs.0.044081-0; Lievens B, 2015, ENVIRON MICROBIOL, V17, P278, DOI 10.1111/1462-2920.12570; Limtong S, 2010, ANTON LEEUW INT J G, V98, P379, DOI 10.1007/s10482-010-9451-3; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Mesa-Arango AC, 2016, ANTIMICROB AGENTS CH, V60, P2326, DOI 10.1128/AAC.02681-15; Mittelbach M, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0036-x; Mueller-Dombois D, 1998, VEGETATION TROPICAL; Opulente DA, 2019, FEMS YEAST RES, V19, DOI 10.1093/femsyr/foz032; Pozo MI, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy196; RALPH CJ, 1995, CONDOR, V97, P729, DOI 10.2307/1369181; Saluja P, 2008, FEMS YEAST RES, V8, P660, DOI 10.1111/j.1567-1364.2008.00372.x; Sarawan S, 2013, WORLD J MICROB BIOT, V29, P1481, DOI 10.1007/s11274-013-1313-5; Shen XX, 2018, CELL, V175, P1533, DOI 10.1016/j.cell.2018.10.023; Sipiczki M, 2016, INT J SYST EVOL MICR, V66, P4009, DOI 10.1099/ijsem.0.001302; Sipiczki M, 2015, ANTON LEEUW INT J G, V107, P847, DOI 10.1007/s10482-015-0377-7; Sipiczki M, 2009, INT J SYST EVOL MICR, V59, P914, DOI 10.1099/ijs.0.003939-0; Spivak ES, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01588-17; Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004; Sugita T, 2006, MICROBIOL IMMUNOL, V50, P469, DOI 10.1111/j.1348-0421.2006.tb03816.x; Vincent BM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001692; Vu D, 2016, STUD MYCOL, P91, DOI 10.1016/j.simyco.2016.11.007; Wan L, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0504-7; Wang QM, 2015, STUD MYCOL, P55, DOI 10.1016/j.simyco.2015.10.004; Wang SA, 2008, ANTON LEEUW INT J G, V94, P257, DOI 10.1007/s10482-008-9238-y; Wiens F, 2008, P NATL ACAD SCI USA, V105, P10426, DOI 10.1073/pnas.0801628105	64	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240093	10.1371/journal.pone.0240093	http://dx.doi.org/10.1371/journal.pone.0240093			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031481	Green Published, gold			2022-12-26	WOS:000581809800027
J	Schaanning, SG; Skjaervold, NK				Schaanning, Sebastian Grovdal; Skjaervold, Nils Kristian			Rapid declines in systolic blood pressure are associated with an increase in pulse transit time	PLOS ONE			English	Article							WAVE	Background The correlation between pulse transit time and blood pressure has been proposed as a route to measure continuous non-invasive blood pressure. We investigated whether pulse transit time trends could model blood pressure trends during episodes of rapid declines in blood pressure. Methods From the Medical Information Mart for Intensive Care waveform database we identified substantial blood pressure reductions. Pulse transit time was calculated from the R-peak of the electrocardiogram to the peak of the arterial pulse waveform. The time-series were processed with a moving average filter before comparison. Averaged, continuous heart rate was also analysed as a control. The intra-individual association between variables was assessed per subject using linear regression. Results In the 511 patients included we found a median correlation coefficient between blood pressure and pulse transit time of -0.93 (IQR -0.98 to -0.76) with regression slopes of -1.23 mmHg/ms (IQR -1.73 to -0.81). The median correlation coefficient between blood pressure and heart rate was 0.46 (IQR -0.16 to 0.83). In supplementary analysis, results did not differ substantially when widening inclusion criteria, but the results were not always consistent within subjects across episodes of hypotension. Conclusions In a large cohort of critically ill patients experiencing episodes of rapid declines in systolic blood pressure, there was a moderate-strong intra-individual correlation between averaged systolic blood pressure and averaged pulse transit time. Our findings encourage further investigation into using the pulse transit time for non-invasive real-time detection of hypotension.	[Schaanning, Sebastian Grovdal; Skjaervold, Nils Kristian] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Skjaervold, Nils Kristian] Trondheim Reg & Univ Hosp, Dept Anaesthesia & Intens Care Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Skjaervold, NK (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway.; Skjaervold, NK (corresponding author), Trondheim Reg & Univ Hosp, Dept Anaesthesia & Intens Care Med, Trondheim, Norway.	nils.k.skjervold@ntnu.no		Skjaervold, Nils Kristian/0000-0002-0085-7042	Trondheim University Hospital; Norwegian University of Science and Technology; Central Norway Health Authority [46056918]	Trondheim University Hospital; Norwegian University of Science and Technology; Central Norway Health Authority	SGS was internally funded within Trondheim University Hospital and the Norwegian University of Science and Technology. The funding body did not participate in the design, collection, analysis, interpretation or writing of the study/manuscript. NKS receives postdoctoral funding from Central Norway Health Authority, Grant nr 46056918	[Anonymous], PHYTH LANG REF VERS; Bennis FC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218784; Carreiras C., 2015, BIOSPPY BIOSIGNAL PR; Ding XR, 2019, BIOMED ENG LETT, V9, P37, DOI 10.1007/s13534-019-00096-x; DRZEWIECKI GM, 1983, J BIOMECH, V16, P141, DOI 10.1016/0021-9290(83)90037-4; Gasser TC, 2017, ESC TXB VASCULAR BIO, DOI DOI 10.1093/MED/9780198755777.001.0001/MED-9780198755777-CHAPTER-3; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; GRIBBIN B, 1976, PSYCHOPHYSIOLOGY, V13, P86, DOI 10.1111/j.1469-8986.1976.tb03344.x; HUGHES DJ, 1979, ULTRASONIC IMAGING, V1, P356, DOI 10.1016/0161-7346(79)90028-2; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Kachuee M, 2015, IEEE INT SYMP CIRC S, P1006, DOI 10.1109/ISCAS.2015.7168806; Liang Y, 2019, J CLIN MED, P8; Lin YT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221319; MAREY EJ, 1876, PHYSL EXPT, V2, P307; NEWLIN DB, 1981, PSYCHOPHYSIOLOGY, V18, P316, DOI 10.1111/j.1469-8986.1981.tb03042.x; Penaz J., 1973, 10 INT C MED BIOL EN; POLLAK MH, 1983, PSYCHOPHYSIOLOGY, V20, P21, DOI 10.1111/j.1469-8986.1983.tb00895.x; SHIRER HW, 1962, IRE T BIOMED ELECTR, VBME9, P116, DOI 10.1109/TBMEL.1962.4322975; TOSKA K, 1993, J PHYSIOL-LONDON, V472, P501, DOI 10.1113/jphysiol.1993.sp019958; Turan A, 2019, ANESTHESIOLOGY, V130, P550, DOI 10.1097/ALN.0000000000002626; Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943; Virtanen Pauli, 2019, SCIPY 10 FUNDAMENTAL; WALLACE AG, 1963, CIRC RES, V12, P611, DOI 10.1161/01.RES.12.6.611; Wesseling K.H., 1990, BLOOD PRESSURE MEASU, P161; Zhu YW, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING (DSP), P403, DOI 10.1109/ICDSP.2015.7251902	25	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240126	10.1371/journal.pone.0240126	http://dx.doi.org/10.1371/journal.pone.0240126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031455	gold, Green Submitted, Green Published			2022-12-26	WOS:000581809800062
J	Coroiu, A; Moran, C; Campbell, T; Geller, AC				Coroiu, Adina; Moran, Chelsea; Campbell, Tavis; Geller, Alan C.			Barriers and facilitators of adherence to social distancing recommendations during COVID-19 among a large international sample of adults	PLOS ONE			English	Article								Background Social distancing measures (e.g., avoiding travel, limiting physical contact with people outside of one's household, and maintaining a 1 or 2-metre distance between self and others when in public, depending on the country) are the primary strategies used to prevent transmission of the SARS-Cov-2 virus that causes COVID-19. Given that there is no effective treatment or vaccine for COVID-19, it is important to identify barriers and facilitators to adherence to social distancing to inform ongoing and future public health campaigns. Method This cross-sectional study was conducted online with a convenience sample of English-speaking adults. The survey was administered over the course of three weeks (March 30 -April 16, 2020) when social distancing measures were well-enforced in North America and Europe. Participants were asked to complete measures assessing socio-demographic characteristics, psychological constructs, including motivations to engage in social distancing, prosocial attitudes, distress, and social distancing behaviors. Descriptive (mean, standard deviation, percentage) and inferential statistics (logistic regression) were used to describes endorsement rates for various motivations, rates of adherence to social distancing recommendations, and predictors of adherence. Results Data were collected from 2013 adults living primarily in North America and Europe. Most frequently endorsed motivations to engage in social distancing (or facilitators) included "I want to protect others" (86%), "I want to protect myself" (84%), and I feel a sense of responsibility to protect our community" (84%). Most frequently endorsed motivations against social distancing (or barriers) included "There are many people walking on the streets in my area" (31%), "I have friends or family who need me to run errands for them" (25%), "I don't trust the messages my government provides about the pandemic" (13%), and "I feel stressed when I am alone or in isolation" (13%). Adherence to social distancing recommendations ranged from 45% for "working from home or remotely" to 90% for "avoiding crowded places/non-essential travel", with men and younger individuals (18-24 years) showing lower adherence compared to women and older individuals. Conclusion This study found that adherence to social distancing recommendations vary depending on the behaviour, with none of the surveyed behaviours showing perfect adherence. Strongest facilitators included wanting to protect the self, feeling a responsibility to protect the community, and being able to work/study remotely; strongest barriers included having friends or family who needed help with running errands and socializing in order to avoid feeling lonely. Future interventions to improve adherence to social distancing measures should couple individual-level strategies targeting key barriers to social distancing identified herein, with effective institutional measures and public health interventions. Public health campaigns should continue to highlight compassionate attitudes towards social distancing.	[Coroiu, Adina; Geller, Alan C.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Moran, Chelsea; Campbell, Tavis] Univ Calgary, Dept Psychol, Calgary, AB, Canada	Harvard University; Harvard T.H. Chan School of Public Health; University of Calgary	Coroiu, A (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA.	acoroiu@hsph.harvard.edu			Canadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec - Sante (FRQS); Vanier Canada Graduate Scholarship; University of Calgary Training in Research and Clinical Trials in Integrative Oncology (TRACTION) fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); Vanier Canada Graduate Scholarship; University of Calgary Training in Research and Clinical Trials in Integrative Oncology (TRACTION) fellowship	AC is supported by post-doctoral research fellowships from the Canadian Institutes of Health Research (CIHR) and Fonds de Recherche du Quebec - Sante (FRQS). CM is supported by a Vanier Canada Graduate Scholarship and a University of Calgary Training in Research and Clinical Trials in Integrative Oncology (TRACTION) fellowship.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2016, SPECIAL EDGE, V29, P1; [Anonymous], 2020, COVID 19 ICARE STUD; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Baumsteiger R, 2019, J PERS ASSESS, V101, P305, DOI 10.1080/00223891.2017.1411918; Bonell C, 2020, J EPIDEMIOL COMMUN H, V74, P617, DOI 10.1136/jech-2020-214290; CDC, 2020, SOC DIST COR DIS 201; CDC, 2020, COR DIS 2019 COVID 1; Center for Disease Control, 2020, SOC DIST QUAR IS; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Clark Cory, 2020, Glob Transit, V2, P76, DOI 10.1016/j.glt.2020.06.003; Davies N, 2020, CMMID REPOS     0401; Ek S, 2015, HEALTH PROMOT INT, V30, P736, DOI 10.1093/heapro/dat063; Giatti L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1096; Grad S., 2020, SOCIAL DISTANCING ST, V2020, DOI [10.11392/jsao.49.40, DOI 10.1101/2020.03.22.20041079]; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harris CR, 2006, GENDER DIFFERENCES R; Heffner J, 2020, PSYARXIV; Iaccarino G, 2020, HYPERTENSION, V76, P366, DOI 10.1161/HYPERTENSIONAHA.120.15324; Inglesby TV, 2020, JAMA-J AM MED ASSOC, V323, P2186, DOI 10.1001/jama.2020.7878; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Jordan J., 2020, DONT GET IT DONT SPR, DOI DOI 10.31234/OSF.IO/YUQ7X; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lab GenderSCI, US GEND SEX COVID 19; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Lunn PD, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113478; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; MILLER WR, 1983, BEHAV PSYCHOTHER, V11, P147, DOI 10.1017/S0141347300006583; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Patel JA, 2020, PUBLIC HEALTH, V183, P110, DOI 10.1016/j.puhe.2020.05.006; Perkins A, 2020, OPTIMAL CONTROL COVI, DOI [10.1101/2020.04.22.20076018v1, DOI 10.1101/2020.04.22.20076018V1]; Pfattheicher S., 2020, EMOTIONAL PATH ACTIO, DOI 10.31234/osf.io/y2cg5; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Public Health Agency of Canada, 2020, VULN POP COVID 19; Qualls N, 2017, MMWR RECOMM REP, P66; Roche B, 2020, OPTIMAL STRATEGIES Q; Rollnick S, 1995, BEHAV COGN PSYCHOTH, V23, P325, DOI DOI 10.1017/S135246580001643X; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sharma Garima, 2020, JACC Case Rep, V2, P1407, DOI 10.1016/j.jaccas.2020.04.027; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WHO, COR DIS COVID 19 ADV; WHO CC for IDM MRC Centre for Global Infectious Disease Analysis Abdul Latif Jameel Institute for Disease and Emergency Analytics Imperial College London  UK, 2020, 9 WHO CC IDM MRC CTR; World Health Organization, 2020, PNEUM UNKN CAUS CHIN	50	151	154	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239795	10.1371/journal.pone.0239795	http://dx.doi.org/10.1371/journal.pone.0239795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3SJ	33027281	Green Published, gold			2022-12-26	WOS:000581808000053
J	Han, JH; Cho, YC; Koh, WG; Choy, YB				Han, Jae Hoon; Cho, Yong Chan; Koh, Won-Gun; Choy, Young Bin			Preocular sensor system for concurrent monitoring of glucose levels and dry eye syndrome using tear fluids	PLOS ONE			English	Article							TOPICAL ANESTHESIA; DIAGNOSIS	The present study demonstrated a noninvasive preocular sensor system for the concurrent monitoring of diabetes and one of its prevalent complications, dry eye syndrome (DES), using tear fluids. Two distinct sensors, i.e., the glucose and DES sensors, were prepared and encased together in a single housing unit to produce the sensor system, and the tip was designed to be in contact with the eye surface noninvasively to collect and deliver tear fluid to the sensors. The glucose sensor was modified from a commercially available electrochemical sensor to allow for the measurement of glucose concentrations, even in a small amount of collected tear fluid. The DES sensor was equipped with a microchannel spaced with two parallel electrodes to determine the amount of collected tear fluid.In vivoexperimental results revealed that with the collected tear fluid of about 0.6-1.0 mu l, the sensor system estimated the blood glucose concentrations with acceptable accuracy compared with that of the glucometer in clinical use. The DES condition in animals was diagnosed with high sensitivity (91.7%) and specificity (83.3%).	[Han, Jae Hoon; Cho, Yong Chan; Choy, Young Bin] Seoul Natl Univ, Coll Engn, Interdisciplinary Program Bioengineering, Seoul, South Korea; [Koh, Won-Gun] Yonsei Univ, Dept Chem & Biomol Engn, Seoul, South Korea; [Choy, Young Bin] Seoul Natl Univ, Med Res Ctr, Inst Med & Biol Engn, Seoul, South Korea; [Choy, Young Bin] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea	Seoul National University (SNU); Yonsei University; Seoul National University (SNU); Seoul National University (SNU)	Choy, YB (corresponding author), Seoul Natl Univ, Coll Engn, Interdisciplinary Program Bioengineering, Seoul, South Korea.; Choy, YB (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Med & Biol Engn, Seoul, South Korea.; Choy, YB (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea.	ybchoy@snu.ac.kr		Choy, Young Bin/0000-0001-6300-9377	Bio AMP; Medical Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015M3A9E2030129]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2017R1A2B3004830]; Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea [HI15C1744]	Bio AMP; Medical Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea	Y.B.C. has received grants from the Bio & Medical Technology Development Program (2015M3A9E2030129) and Basic Science Research Program (2017R1A2B3004830) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning, and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (HI15C1744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Achi A, 2013, INTEGRATED PHARMACEU; [Anonymous], 2014, REG ANESTH PAIN MED; Baca JT, 2007, OCUL SURF, V5, P280, DOI 10.1016/S1542-0124(12)70094-0; Baca JT, 2007, CLIN CHEM, V53, P1370, DOI 10.1373/clinchem.2006.078543; Bhatnagar KR, 2015, INT J OPHTHALMOL-CHI, V8, P174, DOI 10.3980/j.issn.2222-3959.2015.01.31; Burgalassi S, 1999, OPHTHALMIC RES, V31, P229, DOI 10.1159/000055537; Cha KH, 2014, ANAL CHEM, V86, P1902, DOI 10.1021/ac4040168; Chatterjee P R, 2003, J Indian Med Assoc, V101, P481; Chu MX, 2011, TALANTA, V83, P960, DOI 10.1016/j.talanta.2010.10.055; DAUM KM, 1984, ACTA OPHTHALMOL, V62, P472; Dogru M, 2006, INVEST OPHTH VIS SCI, V47, P1895, DOI 10.1167/iovs.05-0802; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gouveia SM, 2005, BBA-PROTEINS PROTEOM, V1753, P155, DOI 10.1016/j.bbapap.2005.08.023; Heinemann Lutz, 2008, J Diabetes Sci Technol, V2, P919; Herreras JM, 1997, OCUL IMMUNOL INFLAMM, V5, P33, DOI 10.3109/09273949709085048; Jendrike Nina, 2017, J Diabetes Sci Technol, V11, P1275, DOI 10.1177/1932296817727550; Kashkouli MB, 2010, CORNEA, V29, P384, DOI 10.1097/ICO.0b013e3181ba6ef3; Khanal S, 2008, INVEST OPHTH VIS SCI, V49, P1407, DOI 10.1167/iovs.07-0635; Kim S, 2019, BIOMED ENG LETT, V9, P267, DOI 10.1007/s13534-019-00111-1; King-Smith PE, 2004, CURR EYE RES, V29, P357, DOI 10.1080/02713680490516099; Kuphaldt T.R., 2006, LESSONS ELECT CIRCUI, V1; La Belle JT, 2016, CHEM COMMUN, V52, P9197, DOI 10.1039/c6cc03609k; La Belle Jeffrey T, 2014, J Diabetes Sci Technol, V8, P109; Lee Seung Ho, 2019, Sci Rep, V9, P4747, DOI 10.1038/s41598-019-41066-8; Lee SH, 2018, CORNEA, V37, P1163, DOI 10.1097/ICO.0000000000001603; Li N, 2012, INT J OPHTHALMOL-CHI, V5, P478, DOI 10.3980/j.issn.2222-3959.2012.04.14; Manaviat MR, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-10; Mansour RF, 2018, BIOMED ENG LETT, V8, P41, DOI 10.1007/s13534-017-0047-y; Meetoo Danny D, 2011, Br J Nurs, V20, P919; Meetoo DD, 2011, BR J NURS, V20, P922, DOI DOI 10.12968/BJON.2011.20.15.919; Meetoo DD, 2011, BR J NURS, V20, P919, DOI DOI 10.12968/BJON.2011.20.15.919; MISHIMA S., 1966, INVEST OPHTHALMOL, V5, P264; Nathan DM, 2015, JAMA-J AM MED ASSOC, V314, P1052, DOI 10.1001/jama.2015.9536; Peng B, 2013, BIOSENS BIOELECTRON, V49, P204, DOI 10.1016/j.bios.2013.05.014; Potts RO, 2002, DIABETES-METAB RES, V18, pS49, DOI 10.1002/dmrr.210; Rahman Atiya, 2007, J Pak Med Assoc, V57, P577; Rege A, 2013, J CLIN DIAGN RES, V7, P2207, DOI 10.7860/JCDR/2013/6089.3472; SEN DK, 1980, BRIT J OPHTHALMOL, V64, P693, DOI 10.1136/bjo.64.9.693; Shih KC, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.4; Taormina CR, 2007, J AM SOC MASS SPECTR, V18, P332, DOI 10.1016/j.jasms.2006.10.002; Valeri C, 2004, DIABETES-METAB RES, V20, pS1, DOI 10.1002/dmrr.512; Vieira-Potter VJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3801570; Wachtel TJ, 2007, GERIATRIC CLIN ADVIS; Yan QY, 2011, ANAL CHEM, V83, P8341, DOI 10.1021/ac201700c; Yokoi N, 2004, ARCH OPHTHALMOL-CHIC, V122, P1265, DOI 10.1001/archopht.122.9.1265; Zhang Jin, 2011, J Diabetes Sci Technol, V5, P166; Zhang XY, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/8201053; Zoukhri D, 2006, EXP EYE RES, V82, P885, DOI 10.1016/j.exer.2005.10.018	48	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239317	10.1371/journal.pone.0239317	http://dx.doi.org/10.1371/journal.pone.0239317			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027299	Green Published, gold			2022-12-26	WOS:000581808000050
J	Nielsen, J; Hedeholm, RB; Lynghammar, A; McClusky, LM; Berland, B; Steffensen, JF; Christiansen, JS				Nielsen, Julius; Hedeholm, Rasmus B.; Lynghammar, Arve; McClusky, Leon M.; Berland, Bjorn; Steffensen, John F.; Christiansen, Jorgen S.			Assessing the reproductive biology of the Greenland shark (Somniosus microcephalus)	PLOS ONE			English	Article							DOGFISH SQUALUS-ACANTHIAS; ANGULAR ROUGH SHARK; DEEP-WATER SHARKS; CENTROSCYMNUS-COELOLEPIS; SPINY DOGFISH; CENTROPHORUS-SQUAMOSUS; GULPER SHARK; EMBRYONIC-DEVELOPMENT; OXYNOTUS-CENTRINA; SLEEPER SHARK	The Greenland shark (Somniosus microcephalus, Squaliformes: Somniosidae) is a long-lived Arctic top predator, which in combination with the high historical and modern fishing pressures, has made it subject to increased scientific focus in recent years. Key aspects of reproduction are not well known as exemplified by sparse and contradictory information e.g. on birth size and number of pups per pregnancy. This study represents the first comprehensive work on Greenland shark reproductive biology based on data from 312 specimens collected over the past 60 years. We provide guidelines quantifying reproductive parameters to assess specific maturation stages, as well as calculate body length-at-maturity (TL50) which was 2.84 +/- 0.06 m for males and 4.19 +/- 0.04 m for females. From the available information on the ovarian fecundity of Greenland sharks as well as a meta-analysis of Squaliform reproductive parameters, we estimate up to 200-324 pups per pregnancy (depending on maternal size) with a body length-at-birth of 35-45 cm. These estimates remain to be verified by future observations from gravid Greenland sharks.	[Nielsen, Julius; Hedeholm, Rasmus B.] Greenland Inst Nat Resources, Nuuk, Greenland; [Lynghammar, Arve; Christiansen, Jorgen S.] UiT Arctic Univ Norway, Fac Biosci Fisheries & Econ, Tromso, Norway; [McClusky, Leon M.] UiT Arctic Univ Norway, Fac Hlth Sci, Narvik, Norway; [Berland, Bjorn] Univ Bergen, Bergen, Norway; [Steffensen, John F.] Univ Copenhagen, Dept Biol, Helsingor, Denmark; [Christiansen, Jorgen S.] Abo Akad Univ, Environm & Marine Biol, Turku, Finland	Greenland Institute of Natural Resources; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University of Bergen; University of Copenhagen; Abo Akademi University	Nielsen, J (corresponding author), Greenland Inst Nat Resources, Nuuk, Greenland.	juliusnielsen88@gmail.com	Steffensen, John Fleng/F-6778-2010	Steffensen, John Fleng/0000-0002-4477-8039; Nielsen, Julius/0000-0002-6627-5424				Akhilesh KV, 2013, J FISH BIOL, V83, P1112, DOI 10.1111/jfb.12201; [Anonymous], 1944, SAMMENDRAG SAT OPLYS, VIII, P647; Augustine S, 2017, POLAR BIOL, V40, P2429, DOI 10.1007/s00300-017-2154-8; Avsar D, 2001, ESTUAR COAST SHELF S, V52, P269, DOI 10.1006/ecss.2000.0749; Banon R, 2008, J MAR BIOL ASSOC UK, V88, P411, DOI 10.1017/S0025315408000787; Banon R, 2006, J MAR BIOL ASSOC UK, V86, P843, DOI 10.1017/S0025315406013774; Bass AJ, 1976, SHARKS E COAST SO AF; Basusta Nuri, 2015, Journal of the Black Sea Mediterranean Environment, V21, P92; BIGELOW H. B., 1948, MEM SEARS FOUND MARINE RES [NEW HAVEN], V1, P59; Bjerkan P, 1957, NOTES GREENLAND SHAR, P3; Braccini JM, 2007, MAR BIOL, V150, P727, DOI 10.1007/s00227-006-0393-2; Braccini JM, 2006, MAR FRESHWATER RES, V57, P105, DOI 10.1071/MF05076; Burgess GH, 2015, IUCN RED LIST THREAT; Campana SE, 2015, DEEP-SEA RES PT II, V115, P109, DOI 10.1016/j.dsr2.2013.11.001; Capape C, 1999, CYBIUM, V23, P259; Capape C., 2001, B I NATL SCI TECHNIQ, V28, P55; Capape Christian, 2008, Pan-American Journal of Aquatic Sciences, V3, P355; Carlson L, 1958, HAKJERRINGA HAKJERRI, VIV; Carter AM, 2020, PLACENTA, V97, P26, DOI 10.1016/j.placenta.2020.05.014; Christiansen Jorgen S., 2012, P35; Clarke MW, 2001, J MAR BIOL ASSOC UK, V81, P1019, DOI 10.1017/S0025315401005008; Coelho R, 2008, J FISH BIOL, V73, P1419, DOI 10.1111/j.1095-8649.2008.02021.x; COMPAGNO L J V, 1984, FAO (Food and Agriculture Organization of the United Nations) Fisheries Synopsis, P1; Cotton CF, 2015, DEEP-SEA RES PT II, V115, P41, DOI 10.1016/j.dsr2.2014.10.009; Dulvy NK, 1997, P ROY SOC B-BIOL SCI, V264, P1309, DOI 10.1098/rspb.1997.0181; EBERT DA, 1987, CALIF FISH GAME, V73, P117; Edwards JE, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00087; Figueiredo I, 2008, J FISH BIOL, V73, P206, DOI 10.1111/j.1095-8649.2008.01927.x; Finucci B, 2016, J FISH BIOL, V89, P2326, DOI 10.1111/jfb.13116; Fisk AT, 2012, MAR ECOL PROG SER, V468, P255, DOI 10.3354/meps09962; Flisch R., 2009, AGRARFORSCHUNG, V16, P1; Frazer HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050196; Gilmore R. Grant Jr, 2005, P435; GILMORE RG, 1993, ENVIRON BIOL FISH, V38, P95, DOI 10.1007/BF00842907; Girard M, 1999, J MAR BIOL ASSOC UK, V79, P923, DOI 10.1017/S002531549800109X; Gotshall DW, 1965, FISH GAME, V4, P294; Graham KJ, 2011, MAR FRESHWATER RES, V62, P583, DOI 10.1071/MF10158; Guallart J, 2001, ENVIRON BIOL FISH, V61, P135, DOI 10.1023/A:1011080429625; Hamlett William C., 2005, P395; HANCHET S, 1988, NEW ZEAL J MAR FRESH, V22, P537, DOI 10.1080/00288330.1988.9516324; Heaton TJ, 2020, RADIOCARBON, V62, P779, DOI 10.1017/RDC.2020.68; Hedeholm R, 2019, J FISH BIOL, P1; Henderson AC, 2002, SARSIA, V87, P350, DOI 10.1080/0036482021000155805; Hussey NE, 2018, DEEP-SEA RES PT I, V134, P32, DOI 10.1016/j.dsr.2018.03.002; ICES, 2019, ICES SCI REPORTS, V1; Jakobsdottir KB, 2001, FISH RES, V51, P247, DOI 10.1016/S0165-7836(01)00250-8; Joel JJ, 1991, MARINE FISHERIES INF; JONES BC, 1977, J FISH RES BOARD CAN, V34, P1286, DOI 10.1139/f77-190; Jones TS, 2001, FISH B-NOAA, V99, P685; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; KETCHEN KS, 1972, J FISH RES BOARD CAN, V29, P1717, DOI 10.1139/f72-272; Koefoed E, 1957, NOTES GREENLAND SHAR, P8; Kondyurin V, 1983, J ICHTHYOL, V23, P140; Kukuev EI, 2002, J ICHTHYOL, V42, P377; Lutken C, 1879, VIDENSKABELIGE MEDDE; MacNeil MA, 2012, J FISH BIOL, V80, P991, DOI 10.1111/j.1095-8649.2012.03257.x; McLaughlin DM, 2005, J MAR BIOL ASSOC UK, V85, P1185, DOI 10.1017/S0025315405012282; Mecklenburg C.W., 2018, MARINE FISHES ARCTIC, VI; Megalofonou P, 2004, CYBIUM, V28, P105; Moura T, 2011, MAR BIOL, V158, P401, DOI 10.1007/s00227-010-1568-4; Musick John A., 2005, P45; Nakaya K, 1995, JPN J ICHTHYOL, V42, P325; NAMMACK MF, 1985, T AM FISH SOC, V114, P367, DOI 10.1577/1548-8659(1985)114<367:LHOSDO>2.0.CO;2; Nielsen J., 2018, THESIS; Nielsen J, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00125; Nielsen J, 2016, SCIENCE, V353, P702, DOI 10.1126/science.aaf1703; Nielsen J, 2014, POLAR BIOL, V37, P37, DOI 10.1007/s00300-013-1408-3; Nikolsky G V, 1961, SPECIAL ICHTHYOLOGY; OtterstrOm CV, 1917, FISK; Penfold LM, 2019, ADV EXP MED BIOL, V1200, P465, DOI 10.1007/978-3-030-23633-5_15; R Development Core Team, 2017, LANG ENV STAT COMP; Ranzi S., 1934, Pubblicazioni della Stazione Zoologica di Napoli, V13, P331; Severino Ricardo B., 2009, Arquipelago-Life and Marine Sciences, P57; Silva HM, 1988, GROWTH REPROD KITEFI; Stehmann MFW, 2002, ARCH FISH MAR RES, V50, P23; TANAKA S, 1990, JPN J ICHTHYOL, V37, P273; Tosti L, 2006, CHEM ECOL, V22, P335, DOI 10.1080/02757540600812016; Uchida S, 1996, GREAT WHITE SHARKS, P139, DOI 10.1016/B978-012415031-7/50015-X; Verissimo A, 2003, ICES J MAR SCI, V60, P1335, DOI 10.1016/S1054-3139(03)00146-2; Watson G, 1998, MAR FRESHWATER RES, V49, P695, DOI 10.1071/MF97255; Wetherbee BM, 1996, J FISH BIOL, V49, P1186, DOI 10.1111/j.1095-8649.1996.tb01788.x; YANO K, 1988, NIPPON SUISAN GAKK, V54, P167; Yano K, 2007, J FISH BIOL, V70, P374, DOI 10.1111/j.1095-8649.2007.01308.x; Yano K, 2004, ICHTHYOL RES, V51, P360, DOI 10.1007/s10228-004-0244-4; YANO K, 1995, J MAR BIOL ASSOC UK, V75, P285, DOI 10.1017/S002531540001818X	85	9	9	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0238986	10.1371/journal.pone.0238986	http://dx.doi.org/10.1371/journal.pone.0238986			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027263	Green Published, gold			2022-12-26	WOS:000581808000049
J	Alenko, A; Markos, Y; Fikru, C; Tadesse, E; Gedefaw, L				Alenko, Arefayne; Markos, Yohannes; Fikru, Chaltu; Tadesse, Eyasu; Gedefaw, Lealem			Association of serum cortisol level with severity of depression and improvement in newly diagnosed patients with major depressive disorder in Jimma medical center, Southwest Ethiopia	PLOS ONE			English	Article							SALIVARY CORTISOL; AWAKENING RESPONSE; STRESS; BRAIN	Background Major Depressive Disorder (MDD) is the leading psychiatric disorder in low- and middle-income countries, and is to be the second leading cause of burden of disease by 2020. Cortisol plays a significant role in pathophysiology of MDD. Depression can alter serum cortisol level. However, the change in serum cortisol level and its association with depressive symptom severity and improvement among patients with MDD is not well studied. Objective To outline change in serum cortisol levels and its association with severity and improvement of depressive symptoms in newly diagnosed patients with MDD. Method Hospital based longitudinal study was conducted among 34 newly diagnosed patients who met DSM-V criteria of MDD. Venous blood sample was performed twice; pre- and post- 8 weeks of treatment. Serum cortisol concentration was measured using an extracted radioimmunoassay. The 17-item Hamilton Depression Scale (HAM-D) was used to rate depression at baseline and after 8 weeks of treatment. Paired t-test was done to look the mean difference of serum cortisol level and HAM-D, before and after treatment. Pearson correlation was done to look the association between serum cortisol levels, HAM-D scores and, sociodemographic and clinical factors. Statistical significance was set at pResults There is no significant difference in cortisol concentrations at baseline and end line (t (33) = 2.02, p = 0.052). However, there is significant difference in HAM-D total score (t (33) = 5.67, p<0.001). Baseline and end line serum cortisol levels were significantly correlated (r = .561, p = .001). Monthly family income is correlated with baseline HAM-D total score (r = -0.373, p = .030). There is no significant relationship between baseline serum cortisol level and HAM-D score. There is also no significant relationship between end line serum cortisol level and HAM-D score. Conclusions The symptoms of MDD were reduced following treatment but there is no significant difference in serum cortisol levels. Baseline and end line serum cortisol levels were significantly correlated. We recommend further research based on large sample.	[Alenko, Arefayne] Jimma Univ, Inst Hlth, Dept Psychiat, Fac Med Sci, Jimma, Ethiopia; [Markos, Yohannes; Tadesse, Eyasu] Jimma Univ, Inst Hlth, Dept Biomed Sci, Fac Med Sci, Jimma, Ethiopia; [Fikru, Chaltu] Jimma Univ, Inst Hlth, Fac Publ Hlth, Dept Epidemiol, Jimma, Ethiopia; [Gedefaw, Lealem] Jimma Univ, Inst Hlth, Dept Lab Sci, Fac Med Sci, Jimma, Ethiopia	Jimma University; Jimma University; Jimma University; Jimma University	Alenko, A (corresponding author), Jimma Univ, Inst Hlth, Dept Psychiat, Fac Med Sci, Jimma, Ethiopia.	arefeaynealenko@gmail.com	Woldesenbet, yohannes/AAR-4491-2021	Woldesenbet, yohannes/0000-0003-0893-9306; Fikru Biyana, chaltu/0000-0002-9324-6055	Jimma University Institute of Health [IHRPGD/594/2019]	Jimma University Institute of Health	Name of author received award/fund: Arefayne Alenko This research work is funded by Jimma University Institute of Health Grant number/Ref. No: IHRPGD/594/2019. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2016, ACTA MED MARISIENSIS; Athari P, 2013, INT J PSYCHOL RES, V6, P98, DOI 10.21500/20112084.691; Bear M.F., 2007, NEUROSCIENCE; Beck J, 2015, NEUROPSYCHOBIOLOGY, V71, P97, DOI 10.1159/000370047; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Brody DJ., 2018, PREVALENCE DEPRESSIO; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Dziurkowska E, 2013, ARCH WOMEN MENT HLTH, V16, P139, DOI 10.1007/s00737-013-0329-z; FRERICHS RR, 1981, AM J EPIDEMIOL, V113, P691, DOI 10.1093/oxfordjournals.aje.a113149; Frodl T, 2013, NEUROBIOL DIS, V52, P24, DOI 10.1016/j.nbd.2012.03.012; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; Hardeveld F, 2014, PSYCHONEUROENDOCRINO, V50, P62, DOI 10.1016/j.psyneuen.2014.07.027; Hinkelmann K, 2012, PSYCHONEUROENDOCRINO, V37, P685, DOI 10.1016/j.psyneuen.2011.08.012; Islam MR, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118773953; Juruena MF, 2009, BRIT J PSYCHIAT, V194, P342, DOI 10.1192/bjp.bp.108.050278; Keating C, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-124; Khan QU, 2019, INT J MED RES HEALTH, V8, P21; Levine A, 2007, PHYSIOL BEHAV, V90, P43, DOI 10.1016/j.physbeh.2006.08.025; Linthorst ACE, 2008, PHARMACOL BIOCHEM BE, V90, P163, DOI 10.1016/j.pbb.2007.09.019; Lopez-Duran NL, 2009, PSYCHONEUROENDOCRINO, V34, P1272, DOI 10.1016/j.psyneuen.2009.03.016; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Matheson K, 2008, J IMMIGR MINOR HEALT, V10, P291, DOI 10.1007/s10903-007-9086-2; Melchior Maria, 2010, Depress Anxiety, V27, P1095, DOI 10.1002/da.20761; PAYKEL ES, 1978, COMPR PSYCHIAT, V19, P121, DOI 10.1016/0010-440X(78)90056-1; Subramaniam A, 2019, SCHIZOPHR RES, V213, P6, DOI 10.1016/j.schres.2019.06.023; Van Praag HM, 2005, WORLD J BIOL PSYCHIA, V6, P5, DOI [10.1080/15622970510030018, 10.1016/j.pnpbp.2004.05.031]; Vreeburg SA, 2013, PSYCHONEUROENDOCRINO, V38, P1494, DOI 10.1016/j.psyneuen.2012.12.017; WHO, 2017, DEPR OTH COMM MENT D; WHO, 2008, MHGAP MENTAL HLTH GA; Xie XX, 2020, J STEROID BIOCHEM, V200, DOI 10.1016/j.jsbmb.2020.105607; Xie XX, 2020, J AFFECT DISORDERS, V263, P166, DOI 10.1016/j.jad.2019.11.147; Xu YH, 2018, NEUROPSYCH DIS TREAT, V14, P459, DOI 10.2147/NDT.S152247; Zhao YN, 2017, SCI REP-UK, V7, DOI 10.1038/srep43192; Zhu JJ, 2018, BRAIN IMAGING BEHAV, V12, P1768, DOI 10.1007/s11682-018-9845-9	37	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240668	10.1371/journal.pone.0240668	http://dx.doi.org/10.1371/journal.pone.0240668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064754	gold, Green Published			2022-12-26	WOS:000585918300017
J	Castro, C; Muela, I; Doncel, P; Garcia-Fernandez, P				Castro, Candida; Muela, Ismael; Doncel, Pablo; Garcia-Fernandez, Pedro			Hazard Perception and Prediction test for walking, riding a bike and driving a car: "Understanding of the global traffic situation"	PLOS ONE			English	Article							ROAD USERS; BICYCLISTS; EXPERIENCE; ABILITIES; SAFETY	To "put oneself in the place of other road users" may improve understanding of the global traffic situation. It should be useful enabling drivers to anticipate and detect obstacles in time to prevent accidents to other road users, especially those most vulnerable. We created a pioneering Hazard Perception and Prediction test to explore this skill in different road users (pedestrians, cyclists and drivers), with videos recorded in naturalistic scenarios: walking, riding a bicycle and driving a car. There were 79 participants (30 pedestrians, 14 cyclists, 13 novice drivers and 22 experienced drivers). Sixty videos of hazardous traffic situations were presented, divided into 2 blocks of 30 videos each: 10 walking, 10 riding a bicycle, 10 driving a car. In each situation presented, we evaluated the performance of the participants carrying out the task of predicting the hazard and estimating the risk. In the second block, after they had carried out the task, we gave them feedback on their performance and let them see the whole video (i.e., checking what happened next). The results showed that the holistic test had acceptable psychometric properties (Cronbach's alpha = .846). The test was able to discriminate between the different conditions manipulated: a) between traffic hazards recorded from different perspectives: walking, riding a bicycle and driving a car; b) between participants with different user profiles: pedestrians, cyclists and drivers; c) between the two test blocks: the first evaluation only and the second combining evaluation with this complex intervention. We found modal bias effects in both Hazard Perception and Prediction; and in Risk Estimation.	[Castro, Candida; Muela, Ismael; Doncel, Pablo] Univ Granada, Fac Psychol, Mind Brain & Behav Res Ctr, CIMCYC, Granada, Spain; [Garcia-Fernandez, Pedro] Univ Granada, Elect & Comp Sci Dept, Fac Sci, Granada, Spain	University of Granada; University of Granada	Castro, C (corresponding author), Univ Granada, Fac Psychol, Mind Brain & Behav Res Ctr, CIMCYC, Granada, Spain.	candida@ugr.es	Castro, Candida/E-9111-2016; Garcia-Fernandez, Pedro/E-9236-2016	Castro, Candida/0000-0001-7348-5959; Garcia-Fernandez, Pedro/0000-0003-2184-2381; Muela, Ismael/0000-0002-3331-1679	State Research Agency (SRA) [PSI2016-75086]; European Regional Fund (ERDF)	State Research Agency (SRA); European Regional Fund (ERDF)	PSI2016-75086 has been supported by the State Research Agency (SRA) and European Regional Fund (ERDF).	Braess D, 2005, TRANSPORT SCI, V39, P446, DOI 10.1287/trsc.1050.0127; Brown TG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150227; Castro C, 2014, TRAFFIC INJ PREV, V15, P817, DOI 10.1080/15389588.2013.879125; Castro C, 2019, APPL ERGON, V81, DOI 10.1016/j.apergo.2019.102886; Castro C, 2016, SAFETY SCI, V82, P144, DOI 10.1016/j.ssci.2015.09.018; Crundall D, 2018, ACCIDENT ANAL PREV, V121, P335, DOI 10.1016/j.aap.2018.05.013; Crundall D, 2016, ACCIDENT ANAL PREV, V86, P47, DOI 10.1016/j.aap.2015.10.006; Crundall D, 2014, ACCIDENT ANAL PREV, V73, P81, DOI 10.1016/j.aap.2014.08.009; Crundall D, 2013, ACCIDENT ANAL PREV, V50, P456, DOI 10.1016/j.aap.2012.05.021; Crundall D, 2010, ACCIDENT ANAL PREV, V42, P2117, DOI 10.1016/j.aap.2010.07.001; ENDSLEY MR, 1995, HUM FACTORS, V37, P32, DOI 10.1518/001872095779049543; European Commission, 2018, ANN ACC REP 2018; Gugliotta A, 2017, TRANSPORT RES F-TRAF, V44, P168, DOI 10.1016/j.trf.2016.11.005; Harre N, 2005, BRIT J PSYCHOL, V96, P215, DOI 10.1348/000712605X36019; Haworth N, 2000, HAZARD PERCEPTION IN; Haworth N, 2006, P 2006 INT MOT SAF C; Herslund MB, 2003, ACCIDENT ANAL PREV, V35, P885, DOI 10.1016/S0001-4575(02)00095-7; Hodgson C, 2015, RES IMPACT BIKEABILI; Horswill M.S., 2004, COGNITIVE APPROACH S; Horswill MS, 2016, CURR DIR PSYCHOL SCI, V25, P425, DOI 10.1177/0963721416663186; Horswill MS, 2010, PSYCHOL AGING, V25, P464, DOI 10.1037/a0017306; Jackson L, 2009, ERGONOMICS, V52, P154, DOI 10.1080/00140130802030714; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; Lehtonen E, 2016, TRANSPORT RES F-TRAF, V41, P195, DOI 10.1016/j.trf.2015.04.006; Liu CC, 2009, TRANSPORT RES F-TRAF, V12, P325, DOI 10.1016/j.trf.2009.04.003; McKenna FP, 1991, BEHAV RES ROAD SAF P; Meir A, 2015, ACCIDENT ANAL PREV, V83, P101, DOI 10.1016/j.aap.2015.07.006; Meir A, 2013, TRANSPORT RES F-TRAF, V20, P90, DOI 10.1016/j.trf.2013.05.004; Michaels J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185909; Muela I, 2021, APPL ERGON, V90, DOI 10.1016/j.apergo.2020.103235; Psychology Software Tools Inc., 2016, E PRIM 3 0; Rosenbloom T, 2015, ACCIDENT ANAL PREV, V79, P160, DOI 10.1016/j.aap.2015.03.019; Sanocki T, 2015, ATTEN PERCEPT PSYCHO, V77, P1252, DOI 10.3758/s13414-015-0850-4; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; SOBER E, 1989, BEHAVIORISM, V17, P89; Sun J, 2016, ACCIDENT ANAL PREV, V95, P503, DOI 10.1016/j.aap.2015.12.011; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Vansteenkiste P, 2016, TRANSPORT RES F-TRAF, V41, P182, DOI 10.1016/j.trf.2016.05.001; Ventsislavova P, 2018, SAFETY SCI, V109, P246, DOI 10.1016/j.ssci.2018.06.004; Ventsislavova P, 2016, ACCIDENT ANAL PREV, V91, P43, DOI 10.1016/j.aap.2016.02.013; Vidotto G, 2008, ADV TRANSPORTATION B, V16, P51, DOI DOI 10.3389/FPSYG.2015.01653; White P, 2006, MEDICINE, EMOTION AND DISEASE, 1700-1950, P100; World Health Organisation, 2018, GLOB STAT REP ROAD S; Zeng Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082768; Zeng Q, 2019, ACCIDENT ANAL PREV, V127, P87, DOI 10.1016/j.aap.2019.02.029; Zeuwts LHRH, 2018, ACCIDENT ANAL PREV, V117, P449, DOI 10.1016/j.aap.2018.02.006	46	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0238605	10.1371/journal.pone.0238605	http://dx.doi.org/10.1371/journal.pone.0238605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064723	Green Published, gold			2022-12-26	WOS:000585918300033
J	Beasley, KL; Cristy, SA; Elmassry, MM; Dzvova, N; Colmer-Hamood, JA; Hamood, AN				Beasley, Kellsie L.; Cristy, Shane A.; Elmassry, Moamen M.; Dzvova, Nyaradzo; Colmer-Hamood, Jane A.; Hamood, Abdul N.			During bacteremia,Pseudomonas aeruginosaPAO1 adapts by altering the expression of numerous virulence genes including those involved in quorum sensing	PLOS ONE			English	Article							PSEUDOMONAS QUINOLONE SIGNAL; III SECRETION SYSTEM; AERUGINOSA INFECTION; SERUM-ALBUMIN; HOMOSERINE LACTONE; CHARCOAL TREATMENT; STATIONARY-PHASE; REGULATED GENES; BOVINE SERUM; PYOCYANIN	Pseudomonas aeruginosais a Gram-negative opportunistic pathogen that produces numerous virulence factors and causes serious infections in trauma patients and patients with severe burns. We previously showed that the growth ofP.aeruginosain blood from severely burned or trauma patients altered the expression of numerous genes. However, the specific influence of whole blood from healthy volunteers onP.aeruginosagene expression is not known. Transcriptome analysis ofP.aeruginosagrown for 4 h in blood from healthy volunteers compared to that when grown in laboratory medium revealed that the expression of 1085 genes was significantly altered. Quorum sensing (QS), QS-related, and pyochelin synthesis genes were downregulated, while genes of the type III secretion system and those for pyoverdine synthesis were upregulated. The observed effect on the QS and QS-related genes was shown to reside within serum fraction: growth of PAO1 in the presence of 10% human serum from healthy volunteers significantly reduced the expression of QS and QS-regulated genes at 2 and 4 h of growth but significantly enhanced their expression at 8 h. Additionally, the production of QS-regulated virulence factors, including LasA and pyocyanin, was also influenced by the presence of human serum. Serum fractionation experiments revealed that part of the observed effect resides within the serum fraction containing <10-kDa proteins. Growth in serum reduced the production of many PAO1 outer membrane proteins but enhanced the production of others including OprF, a protein previously shown to play a role in the regulation of QS gene expression. These results suggest that factor(s) within human serum: 1) impactP.aeruginosapathogenesis by influencing the expression of different genes; 2) differentially regulate the expression of QS and QS-related genes in a growth phase- or time-dependent mechanism; and 3) manipulate the production ofP.aeruginosaouter membrane proteins.	[Beasley, Kellsie L.; Dzvova, Nyaradzo; Colmer-Hamood, Jane A.; Hamood, Abdul N.] Texas Tech Univ, Hlth Sci Ctr, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA; [Cristy, Shane A.] Texas Tech Univ, Honors Coll, Lubbock, TX 79409 USA; [Elmassry, Moamen M.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Colmer-Hamood, Jane A.] Texas Tech Univ, Hlth Sci Ctr, Dept Med Educ, Lubbock, TX 79430 USA; [Hamood, Abdul N.] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Lubbock, TX 79430 USA; [Cristy, Shane A.] Univ Texas Houston, Hlth Sci Ctr, Dept Microbiol & Mol Genet, Houston, TX USA; [Cristy, Shane A.] UT Hlth, MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX USA; [Dzvova, Nyaradzo] Ind Microbes, Alameda, CA USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Hamood, AN (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA.; Hamood, AN (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Lubbock, TX 79430 USA.	abdul.hamood@ttuhsc.edu	Elmassry, Moamen M/J-9335-2015	Elmassry, Moamen M/0000-0002-1193-7822; Cristy, Shane/0000-0001-7316-9331; Colmer-Hamood, Jane/0000-0002-3768-5168				[Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; [Anonymous], 2015, RIV STORICA ITAL, V6, P1, DOI DOI 10.3389/fpls.2015.00951; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balyimez A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-269; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bleves S, 2005, J BACTERIOL, V187, P3898, DOI 10.1128/JB.187.11.3898-3902.2005; Bredenbruch F, 2006, ENVIRON MICROBIOL, V8, P1318, DOI 10.1111/j.1462-2920.2006.01025.x; BRITIGAN BE, 1992, J CLIN INVEST, V90, P2187, DOI 10.1172/JCI116104; BROCK JH, 1989, ACTA PAEDIATR SCAND, P31; Brutinel ED, 2008, MOL MICROBIOL, V68, P657, DOI 10.1111/j.1365-2958.2008.06179.x; Bucior I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002616; Cao ZM, 2009, ENDOCR RES, V34, P101, DOI 10.3109/07435800903204082; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carlson PE, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv061; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Choi S, 2004, CLIN CHIM ACTA, V339, P147, DOI 10.1016/j.cccn.2003.10.002; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Cole SJ, 2014, INFECT IMMUN, V82, P2048, DOI 10.1128/IAI.01652-14; Cornelis P, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00075; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Dang ZC, 2005, MOL CELL BIOCHEM, V268, P159, DOI 10.1007/s11010-005-3857-7; Dasgupta N, 2006, INFECT IMMUN, V74, P3334, DOI 10.1128/IAI.00090-06; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2002, J BACTERIOL, V184, P2576, DOI 10.1128/JB.184.10.2576-2586.2002; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Dong LM, 2020, VIRULENCE, V11, P57, DOI 10.1080/21505594.2019.1708052; Dong YH, 2005, MOL MICROBIOL, V58, P552, DOI 10.1111/j.1365-2958.2005.04851.x; Elmassry MM, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00312-18; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Farrow JM, 2008, J BACTERIOL, V190, P7043, DOI 10.1128/JB.00753-08; Farrow JM, 2015, J BACTERIOL, V197, P1988, DOI 10.1128/JB.00246-15; Fito-Boncompte L, 2011, INFECT IMMUN, V79, P1176, DOI 10.1128/IAI.00850-10; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; GAMBELLO MJ, 1993, INFECT IMMUN, V61, P1180, DOI 10.1128/IAI.61.4.1180-1184.1993; Ge SX, 2020, BIOINFORMATICS, V36, P2628, DOI 10.1093/bioinformatics/btz931; Gestal MC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01969; Gilbert KB, 2009, MOL MICROBIOL, V73, P1072, DOI 10.1111/j.1365-2958.2009.06832.x; Goldberg JB, 2000, TRENDS MICROBIOL, V8, P514, DOI 10.1016/S0966-842X(00)01872-2; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; Hall S, 2016, TOXINS, V8, DOI 10.3390/toxins8080236; Hamood AN, 1996, INFECT IMMUN, V64, P3154, DOI 10.1128/IAI.64.8.3154-3160.1996; Hari-Dass R, 2005, J BIOL CHEM, V280, P18562, DOI 10.1074/jbc.M500490200; HASSAN HM, 1980, J BACTERIOL, V141, P156, DOI 10.1128/JB.141.1.156-163.1980; HASSETT DJ, 1992, INFECT IMMUN, V60, P328, DOI 10.1128/IAI.60.2.328-336.1992; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; HAWIGER J, 1970, J LAB CLIN MED, V75, P93; Higgins S, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00252; Holder IA, 2001, BURNS, V27, P129, DOI 10.1016/S0305-4179(00)00142-X; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Hotterbeekx A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36507; Huang YC, 2002, PEDIATR INFECT DIS J, V21, P1049, DOI 10.1097/00006454-200211000-00015; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Jimenez PN, 2010, MICROBIOL-SGM, V156, P49, DOI 10.1099/mic.0.030973-0; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Kim TD, 2000, BIOCHEMISTRY-US, V39, P14839, DOI 10.1021/bi001441y; Kohler T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087814; Kostylev M, 2019, P NATL ACAD SCI USA, V116, P7027, DOI 10.1073/pnas.1819796116; Kruczek C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149229; Kruczek C, 2014, MICROBIOLOGYOPEN, V3, P64, DOI 10.1002/mbo3.147; Kruczek C, 2012, MICROBIOL-SGM, V158, P353, DOI 10.1099/mic.0.053371-0; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Ledgham F, 2003, MOL MICROBIOL, V48, P199, DOI 10.1046/j.1365-2958.2003.03423.x; Lee J, 2015, PROTEIN CELL, V6, P26, DOI 10.1007/s13238-014-0100-x; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Leeman M, 2018, ANAL BIOANAL CHEM, V410, P4867, DOI 10.1007/s00216-018-1127-2; Li XJ, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017315; Liang HH, 2014, NUCLEIC ACIDS RES, V42, P10307, DOI 10.1093/nar/gku586; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; McGrath S, 2004, FEMS MICROBIOL LETT, V230, P27, DOI 10.1016/S0378-1097(03)00849-8; McMackin EAW, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00209-19; Medina G, 2003, J BACTERIOL, V185, P5976, DOI 10.1128/JB.185.20.5976-5983.2003; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003143; Merlot AM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00299; Meynard JL, 1999, J INFECTION, V38, P176, DOI 10.1016/S0163-4453(99)90247-5; Miller JH, 1972, EXPT MOL GENETICS; Mishra M, 2015, INFECT IMMUN, V83, P3006, DOI 10.1128/IAI.00081-15; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Nestorovich EM, 2006, J BIOL CHEM, V281, P16230, DOI 10.1074/jbc.M600650200; Nikolaidis A, 2017, FOOD CHEM, V215, P235, DOI 10.1016/j.foodchem.2016.07.133; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; PRINCE RW, 1993, J BACTERIOL, V175, P2589, DOI 10.1128/JB.175.9.2589-2598.1993; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Recinos DA, 2012, P NATL ACAD SCI USA, V109, P19420, DOI 10.1073/pnas.1213901109; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; ROMBEL IT, 1995, MOL GEN GENET, V246, P519, DOI 10.1007/BF00290456; Rust L, 1996, J BACTERIOL, V178, P1134, DOI 10.1128/jb.178.4.1134-1140.1996; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Schuster M, 2004, MOL MICROBIOL, V51, P973, DOI 10.1046/j.1365-2958.2003.03886.x; Siehnel R, 2010, P NATL ACAD SCI USA, V107, P7916, DOI 10.1073/pnas.0908511107; Singh G, 2010, MICROB PATHOGENESIS, V49, P196, DOI 10.1016/j.micpath.2010.05.013; Sio CF, 2006, INFECT IMMUN, V74, P1673, DOI 10.1128/IAI.74.3.1673-1682.2006; Smith AC, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00116-17; STACHEL SE, 1985, EMBO J, V4, P891, DOI 10.1002/j.1460-2075.1985.tb03715.x; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Tjaden B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0572-2; TODER DS, 1991, MOL MICROBIOL, V5, P2003, DOI 10.1111/j.1365-2958.1991.tb00822.x; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; Whiteley M, 2001, J BACTERIOL, V183, P5529, DOI 10.1128/JB.183.19.5529-5534.2001; Wood TL, 2018, NPJ BIOFILMS MICROBI, V4, DOI 10.1038/s41522-018-0066-1; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yang HJ, 2007, J BACTERIOL, V189, P2599, DOI 10.1128/JB.01680-06; Zhao JR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002449	118	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240351	10.1371/journal.pone.0240351	http://dx.doi.org/10.1371/journal.pone.0240351			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057423	Green Published, gold			2022-12-26	WOS:000581814700048
J	Hu, XQ; Liao, ZY; Zhang, B; Yue, JJ; Wang, Z; Jie, X; Liu, J				Hu, Xiuqin; Liao, Zhenyang; Zhang, Bo; Yue, JingJing; Wang, Zhen; Jie, Xin; Liu, Juan			Transcriptome sequencing and screening of genes related to sex determination ofTrichosanthes kirilowiiMaxim	PLOS ONE			English	Article							POLLEN DEVELOPMENT; UNISEXUAL FLOWERS; DIFFERENTIAL GENE; EXPRESSION; ETHYLENE; AUXIN; BIOSYNTHESIS; MATURATION; TOOLKIT; TAPETAL	Trichosanthes kirilowiiMaxim. (TK) is a dioecious plant in the Cucurbitaceae for which different sexes have separate medicinal uses. In order to study the genes related to sex determination, transcriptome sequencing was performed on flower buds of male and female plants using the high-throughput sequencing technology. A total of 145,975 unigenes and 7110 DEGs were obtained. There were 6776 DEGs annotated to 1234 GO terms and enriched to 18 functional groups, including five biological processes related to sugar metabolism. KEGG pathway analysis indicated genes involved in hormone transduction, hormone synthesis and carbohydrate metabolism. Many DEGs ofTKare involved in reproductive organ formation, hormone signal transduction and regulatory networks. Combining the results of GO, KEGG and qRT-PCR, 11 sex determining candidate genes ofTKwere selected, includingMYB80,MYB108,CER1,CBL9,ABCB19,SERK1,HSP81-3,ACS9,SEP3,AUX1andYUC6. The results provide a foundation for the study of sex differentiation inTK.	[Hu, Xiuqin; Zhang, Bo; Wang, Zhen; Jie, Xin] Linyi Univ, Sch Pharm, Lunan Engn Technol Res Ctr Dev Tradit Chinese Med, Linyi, Shandong, Peoples R China; [Liao, Zhenyang; Yue, JingJing] Fujian Agr & Forestry Univ, FAFU & UIUC SIB Joint Ctr Genom & Biotechnol, Key Lab Genet Breeding & Multiple Utilizat Corps, Fujian Prov Key Lab Haixia Appl Plant Syst Biol,M, Fuzhou, Fujian, Peoples R China; [Liu, Juan] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China	Linyi University; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Jie, X (corresponding author), Linyi Univ, Sch Pharm, Lunan Engn Technol Res Ctr Dev Tradit Chinese Med, Linyi, Shandong, Peoples R China.; Liu, J (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China.	xinjiezhongyao@126.com; xinjie@lyu.edu.cn			foundation of National Natural Science Foundation [81803651, 31701889]; Shandong Provincial Natural Science Foundation [ZR2019PH088]	foundation of National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This work was supported by the foundation of National Natural Science Foundation of No. 81803651(Jie Xin) and 31701889 (Jingjing Yue) and Shandong Provincial Natural Science Foundation of No.ZR2019PH088(Jie Xin).	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; Acajjaoui S, 2013, ACTA CRYSTALLOGR F, V69, P997, DOI 10.1107/S174430911302006X; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai SL, 2004, PLANTA, V220, P230, DOI 10.1007/s00425-004-1342-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boualem A, 2015, SCIENCE, V350, P688, DOI 10.1126/science.aac8370; Cecchetti V, 2017, NEW PHYTOL, V213, P1194, DOI 10.1111/nph.14207; Cecchetti V, 2015, J INTEGR PLANT BIOL, V57, P1089, DOI 10.1111/jipb.12332; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo X.L., 2008, DETECTION FIRMICUTES; Phan HA, 2011, PLANT CELL, V23, P2209, DOI 10.1105/tpc.110.082651; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanika Karmakar, 2013, American Journal of Plant Sciences, V4, P494; Li DD, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01231; Li Y., 2005, THESIS ZHENGZHOU U Z; Li Z, 2017, PLANT PHYSIOL, DOI [10.1014/pp.16.01219, DOI 10.1014/PP.16.01219]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahs A, 2013, MOL PLANT, V6, P1149, DOI 10.1093/mp/sst095; Mandaokar A, 2009, PLANT PHYSIOL, V149, P851, DOI 10.1104/pp.108.132597; Pawelkowicz M, 2019, PLANT REPROD, V32, P193, DOI 10.1007/s00497-019-00362-z; Pawelkowicz ME, 2019, MOL BREEDING, V39, DOI 10.1007/s11032-019-0959-6; Phan HA, 2012, PLANT MOL BIOL, V78, P171, DOI 10.1007/s11103-011-9855-0; Qu YT, 2010, J ANHUI AGR SCI, DOI [10.3969/j.issn.0517-6611.2010.13.036, DOI 10.3969/J.ISSN.0517-6611.2010.13.036]; RUDICH J, 1972, PLANT PHYSIOL, V49, P998, DOI 10.1104/pp.49.6.998; Saminathan T, 2015, J EXP BOT, V66, P1369, DOI 10.1093/jxb/eru486; SHANNON S, 1969, NATURE, V223, P186, DOI 10.1038/223186a0; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sousa A, 2013, CYTOGENET GENOME RES, V139, P107, DOI 10.1159/000345370; Takahashi H, 1984, PHYTON, DOI DOI 10.1016/0031-9422(84)83062-9; Tian T, 2017, NUCLEIC ACIDS RES, V45, pW122, DOI 10.1093/nar/gkx382; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; TREBITSH T, 1987, PLANT GROWTH REGUL, V5, P105, DOI 10.1007/BF00024738; Tsuchisaka A, 2015, UNIQUE OVERLAPPING E, DOI [10.1104/pp.104.049999, DOI 10.1104/PP.104.049999]; van der Schuren A, 2018, NEW PHYTOL, V219, P1216, DOI 10.1111/nph.15332; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Xin Jie, 2018, Plant Science Journal, V36, P648, DOI 10.11913/PSJ.2095-0837.2018.50648; Xu Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0278-3; YABE N, 1994, PLANT CELL PHYSIOL, V35, P1207, DOI 10.1093/oxfordjournals.pcp.a078715; Yamasaki S, 2003, SEX PLANT REPROD, V16, P103, DOI 10.1007/s00497-003-0183-7; Yamasaki S, 2001, PLANT CELL PHYSIOL, V42, P608, DOI 10.1093/pcp/pce076; Ye WC, 2017, BIOINFORMATICS, V33, P1130, DOI 10.1093/bioinformatics/btw769; Yu FC, 2003, ZHEJIANG AGR J, DOI [10.3969/j.issn.1004-1524.2003.06.002, DOI 10.3969/J.ISSN.1004-1524.2003.06.002]	43	4	4	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0239230	10.1371/journal.pone.0239230	http://dx.doi.org/10.1371/journal.pone.0239230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057394	Green Submitted, gold, Green Published			2022-12-26	WOS:000581814700088
J	Siwinska, N; Paslawska, U; Bachor, R; Szczepankiewicz, B; Zak, A; Grocholska, P; Szewczuk, Z				Siwinska, Natalia; Paslawska, Urszula; Bachor, Remigiusz; Szczepankiewicz, Barbara; Zak, Agnieszka; Grocholska, Paulina; Szewczuk, Zbigniew			Evaluation of podocin in urine in horses using qualitative and quantitative methods	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EXPERIMENTAL MEMBRANOUS NEPHROPATHY; ACUTE KIDNEY INJURY; MASS-SPECTROMETRY; PODOCYTES; PHENYLBUTAZONE; PROTEINURIA; BIOMARKER; ELISA	No sensitive method for diagnosing early kidney dysfunction in horses has been identified so far. Many studies carried out in humans and small animals show that podocin can be useful to diagnose various kidney diseases, mainly affecting the glomeruli. The aim of this study was to perform a qualitative and quantitative analysis of podocin in urine samples obtained from healthy horses, horses with clinical kidney dysfunction and horses at risk of acute kidney injury. The study objectives aimed to assess: (1) whether the selected podocin tryptic peptide for LC-MS-MRM allows for podocin detection in horse; and (2) whether the species-specific ELISA test makes this detection possible as well;, (3) whether the chosen methods are sensitive enough to detect kidney dysfunction and glomerular injury, (4) whether the results of the tests applying both methods correspond with one another, (5) whether the results correlate with the hematological and biochemical data. The signals that may indicate the presence of trypsin fragments of podocin were found in three healthy horses, all the horses diagnosed with kidney dysfunction and half of the animals at risk for acute kidney injury. The concentration of podocin, diagnosed with the ELISA test was as follows: from 0.19 to 1.2 ng/ml in healthy animals, from 0.19 to 20.0 ng/ml in AKI horses, from 0.29 to 5.71 ng/ml in horses at risk for acute kidney injury. The results of both methods corresponded significantly. Podocin may be a potential biomarker of clinical kidney disease in horses and may be used in the detection of glomerular injury. However, its use is limited by the possibility of physiological podocyturia. LC-MS-MRM seems to be a more sensitive method to evaluate the presence of podocin than the ELISA test, whilst selected tryptic peptides of podocin appear to apply to horses. The ELISA test showed greater effectiveness in excluding the disease than in confirming it.	[Siwinska, Natalia; Paslawska, Urszula; Szczepankiewicz, Barbara; Zak, Agnieszka] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Internal Dis Clin Horses Dogs & Cats, Wroclaw, Poland; [Paslawska, Urszula] Nicolaus Copernicus Univ, Fac Biol & Vet Sci, Vet Inst, Torun, Poland; [Bachor, Remigiusz; Grocholska, Paulina; Szewczuk, Zbigniew] Univ Wroclaw, Fac Chem, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Nicolaus Copernicus University; University of Wroclaw	Siwinska, N (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Internal Dis Clin Horses Dogs & Cats, Wroclaw, Poland.	natalia.siwinska@upwr.edu.pl	Szewczuk, Zbigniew/A-2243-2013; Zak-Bochenek, Agnieszka/V-5182-2018	Grocholska, Paulina/0000-0001-7426-4146; Bachor, Remigiusz/0000-0003-1247-8709; Zak-Bochenek, Agnieszka/0000-0002-3532-6508	Wroclaw University of Environmental and Life Sciences [D220/0002/18]; National Science Centre, Poland [UMO-2016/23/B/ST4/01036]; Lead Research Team "AnimalTrans"	Wroclaw University of Environmental and Life Sciences; National Science Centre, Poland(National Science Centre, Poland); Lead Research Team "AnimalTrans"	This work was realized as part of a "Innovative PHD" Ph.D. research program (no. D220/0002/18) financially supported by the Wroclaw University of Environmental and Life Sciences. The chemistry part of the work was supported by the grant No. UMO-2016/23/B/ST4/01036 from the National Science Centre, Poland. The cost of the publication was covered by the Support of the Lead Research Team "AnimalTrans". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelbassit E., 2019, J NEPHROPATHOL, V8, P26, DOI [10.15171/jnp.2019.26, DOI 10.15171/JNP.2019.26]; Abe K, 2012, ASIA PACIFIC INTERDI; Aita K, 2009, NEPHRON CLIN PRACT, V112, pC65, DOI 10.1159/000213083; Arosalo BM, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-4; Bachor R, 2019, INT J MASS SPECTROM, V444, DOI 10.1016/j.ijms.2019.116174; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Camici M, 2007, BIOMED PHARMACOTHER, V61, P245, DOI 10.1016/j.biopha.2006.12.009; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Chan WC, 2000, FMOC SOLID PHASE PEP; COLLINS LG, 1984, J AM VET MED ASSOC, V184, P699; DIVERS TJ, 1987, EQUINE VET J, V19, P178, DOI 10.1111/j.2042-3306.1987.tb01370.x; Dixit M, 2010, PHARMACEUTICALS, V3, P1279, DOI 10.3390/ph3041279; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Faupel-Badger JM, 2010, CANCER EPIDEM BIOMAR, V19, P292, DOI 10.1158/1055-9965.EPI-09-0643; Garovic VD, 2013, NEPHROL DIAL TRANSPL, V28, P1555, DOI 10.1093/ndt/gfs074; Geor RJ, 2007, VET CLIN N AM-EQUINE, V23, P577, DOI 10.1016/j.cveq.2007.09.007; GRONWALL R, 1988, J EQUINE VET SCI, V8, P205, DOI 10.1016/S0737-0806(88)80003-0; GUNSON DE, 1983, VET PATHOL, V20, P603, DOI 10.1177/030098588302000512; Hollis AR, 2007, J VET INTERN MED, V21, P1099, DOI 10.1892/0891-6640(2007)21[1099:BGIHWA]2.0.CO;2; Ibrahim HMM, 2014, J EQUINE VET SCI, V34, P1205, DOI 10.1016/j.jevs.2014.08.002; Ichii O, 2011, HISTOL HISTOPATHOL, V26, P1243, DOI 10.14670/HH-26.1243; Izzedine H, 2006, EXPERT OPIN DRUG SAF, V5, P95, DOI 10.1517/14740338.5.1.95; Kelder TP, 2012, HYPERTENSION, V60, P1538, DOI 10.1161/HYPERTENSIONAHA.112.201681; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Lopes JA, 2013, CLIN KIDNEY J, V6, P8, DOI 10.1093/ckj/sfs160; MACALLISTER CG, 1993, J AM VET MED ASSOC, V202, P71; Mohammed Y, 2014, J PROTEOMICS, V106, P151, DOI 10.1016/j.jprot.2014.04.018; Nakamura T, 2000, AM J MED SCI, V320, P112, DOI 10.1097/00000441-200008000-00009; Perez-Hernandez J, 2016, NEPHROL DIAL TRANSPL, V31, P780, DOI 10.1093/ndt/gfw002; Petermann AT, 2003, KIDNEY INT, V64, P1222, DOI 10.1046/j.1523-1755.2003.00217.x; Preissner CM, 2003, J CLIN ENDOCR METAB, V88, P3069, DOI 10.1210/jc.2003-030122; Rahman HSA, 2019, ZUMJ, V25, P682; Ravnskov U, 1999, BRIT J CLIN PHARMACO, V47, P203, DOI 10.1046/j.1365-2125.1999.00869.x; Reiser J., 2016, F1000RESEARCH, V5, P5, DOI [10.12688/f1000research.7255.1, DOI 10.12688/F1000RESEARCH.7255.1]; Reiser J, 2013, ANNU REV MED, V64, P357, DOI 10.1146/annurev-med-050311-163340; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Sahoo S, 2013, INT J BIOASSAYS, V2, P667; Sato Y, 2009, J AM SOC NEPHROL, V20, P1041, DOI 10.1681/ASN.2007121328; Schott HC, 2020, VET CLIN N AM-EQUINE, V36, P121, DOI 10.1016/j.cveq.2019.12.003; SCHOTT HC, 1995, EQUINE VET J, V27, P67, DOI 10.1111/j.2042-3306.1995.tb03035.x; Schulze SW, 2004, PFERDEHEILKUNDE, V20, P118, DOI 10.21836/PEM20040201; Seanor JW, 1984, MOD VET PRACT, V65, P26; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Shankland SJ, 1997, KIDNEY INT, V52, P404, DOI 10.1038/ki.1997.347; Simon R, 2014, J PHARMACEUT BIOMED, V94, P84, DOI 10.1016/j.jpba.2014.01.019; Staatz CE, 2002, THER DRUG MONIT, V24, P607, DOI 10.1097/00007691-200210000-00005; Sun D, 2012, RENAL FAILURE, V34, P403, DOI 10.3109/0886022X.2011.649627; SWEENEY RW, 1988, EQUINE VET J, V20, P182, DOI 10.1111/j.2042-3306.1988.tb01494.x; Szczepankiewicz B, 2019, MOLECULES, V24, DOI 10.3390/molecules24173088; TANNER GA, 1982, KIDNEY INT, pS213; Thoen ME, 2011, J VET EMERG CRIT CAR, V21, P648, DOI 10.1111/j.1476-4431.2011.00689.x; Tyner GA, 2011, J VET INTERN MED, V25, P532, DOI 10.1111/j.1939-1676.2011.0700.x; Van Biervliet J, 2002, COMP CONT EDUC PRACT, V24, P892; van der Harst MR, 2005, VET RES COMMUN, V29, P247, DOI 10.1023/B:VERC.0000047492.05882.bb; Vashist SK, 2013, BIOSENS BIOELECTRON, V40, P297, DOI 10.1016/j.bios.2012.07.067; Volker LA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-102; Vogelmann SU, 2003, AM J PHYSIOL-RENAL, V285, pF40, DOI 10.1152/ajprenal.00404.2002; Waliczek M, 2019, ANAL CHIM ACTA, V1048, P96, DOI 10.1016/j.aca.2018.10.012; Waliczek M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37720; Wang G, 2007, NEPHRON CLIN PRACT, V106, P169, DOI 10.1159/000104428; Wig DA, 1978, J LAB DIN MED, V92, P239; Zheng M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020431	62	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240586	10.1371/journal.pone.0240586	http://dx.doi.org/10.1371/journal.pone.0240586			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057359	gold, Green Published			2022-12-26	WOS:000581814700097
J	Chelebian, E; Fuster-Garcia, E; Alvarez-Torres, MD; Juan-Albarracin, J; Garcia-Gomez, JM				Chelebian, Eduard; Fuster-Garcia, Elies; alvarez-Torres, Maria del Mar; Juan-Albarracin, Javier; Garcia-Gomez, Juan M.			Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype	PLOS ONE			English	Article							SURVIVAL; IDH1; CLASSIFICATION; PERFUSION; PREDICTION; LANDSCAPE; SYSTEM; TUMORS; GRADE; MRI	Background and purpose Genetic classifications are crucial for understanding the heterogeneity of glioblastoma. Recently, perfusion MRI techniques have demonstrated associations molecular alterations. In this work, we investigated whether perfusion markers within infiltrated peripheral edema were associated with proneural, mesenchymal, classical and neural subtypes. Materials and methods ONCOhabitats open web services were used to obtain the cerebral blood volume at the infiltrated peripheral edema for MRI studies of 50 glioblastoma patients from The Cancer Imaging Archive: TCGA-GBM. ANOVA and Kruskal-Wallis tests were carried out in order to assess the association between vascular features and the Verhaak subtypes. For assessing specific differences, Mann-Whitney U-test was conducted. Finally, the association of overall survival with molecular and vascular features was assessed using univariate and multivariate Cox models. Results ANOVA and Kruskal-Wallis tests for the maximum cerebral blood volume at the infiltrated peripheral edema between the four subclasses yielded false discovery rate corrected p-values of <0.001 and 0.02, respectively. This vascular feature was significantly higher (p = 0.0043) in proneural patients compared to the rest of the subtypes while conducting Mann-Whitney U-test. The multivariate Cox model pointed to redundant information provided by vascular features at the peripheral edema and proneural subtype when analyzing overall survival. Conclusions Higher relative cerebral blood volume at infiltrated peripheral edema is associated with proneural glioblastoma subtype suggesting underlying vascular behavior related to molecular composition in that area.	[Chelebian, Eduard; alvarez-Torres, Maria del Mar; Juan-Albarracin, Javier; Garcia-Gomez, Juan M.] Univ Politecn Valencia, Inst Univ Tecnol Informac & Comunicac, Valencia, Spain; [Chelebian, Eduard] Uppsala Univ, Dept Informat Technol, Uppsala, Sweden; [Fuster-Garcia, Elies] Oslo Univ Hosp, Dept Diagnost Phys, Oslo, Norway	Universitat Politecnica de Valencia; Uppsala University; University of Oslo	Chelebian, E (corresponding author), Univ Politecn Valencia, Inst Univ Tecnol Informac & Comunicac, Valencia, Spain.; Chelebian, E (corresponding author), Uppsala Univ, Dept Informat Technol, Uppsala, Sweden.	edchekoc@etsii.upv.es	; Fuster-Garcia, Elies/J-6187-2012	Chelebian, Eduard/0000-0001-6852-6605; Juan Albarracin, Javier/0000-0003-0680-0052; Fuster-Garcia, Elies/0000-0002-0716-8960	MTS4up project (National Plan for Scientific and Technical Research and Innovation) [DPI2016-80054-R]; H2020-SC1-2016CNECT Project [727560]; Fundacio Bancaria laCaixa [LCF/TR/CI16/10010016, H2020-SC1-BHC-2018-2020, 825750]; Ministerio de Ciencia e Innovacion [PID2019-104978RB-I00]; Programa Estatal de Promocion del Talento y su Empleabilidad en I+D +i [DPI2016-80054-R]; European Union [844646]	MTS4up project (National Plan for Scientific and Technical Research and Innovation); H2020-SC1-2016CNECT Project; Fundacio Bancaria laCaixa(La Caixa Foundation); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Programa Estatal de Promocion del Talento y su Empleabilidad en I+D +i; European Union(European Commission)	This work was partially supported by: MTS4up project (National Plan for Scientific and Technical Research and Innovation 2013-2016, No. DPI2016-80054-R) (JMGG); H2020-SC1-2016CNECT Project (No. 727560) (JMGG), Fundacio Bancaria laCaixa (LCF/TR/CI16/10010016) and H2020-SC1-BHC-2018-2020 (No. 825750) (JMGG); PID2019-104978RB-I00 (Ministerio de Ciencia e Innovacion) (JMGG). MAT was supported by DPI2016-80054-R (Programa Estatal de Promocion del Talento y su Empleabilidad en I+D +i). EFG was supported by the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 844646. There was no additional external funding received for this study.	Bai H, 2016, NAT GENET, V48, P59, DOI 10.1038/ng.3457; Barajas RF, 2010, RADIOLOGY, V254, P564, DOI 10.1148/radiol.09090663; Behnan J, 2019, BRAIN, V142, P847, DOI 10.1093/brain/awz044; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Carrillo JA, 2012, AM J NEURORADIOL, V33, P1349, DOI 10.3174/ajnr.A2950; Chen JR, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002583; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Alvarez-Torres MD, 2020, J MAGN RESON IMAGING, V51, P1478, DOI 10.1002/jmri.26958; Fedele M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112746; Fuster-Garcia E, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.4006; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Goldman M., 2018, UCSC XENA PLATFORM P; Guo L, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0702-y; He ZC, 2015, INT J CLIN EXP MED, V8, P20287; Hempel JM, 2019, CLIN NEURORADIOL, V29, P479, DOI 10.1007/s00062-018-0676-2; Hirai T, 2008, AM J NEURORADIOL, V29, P1505, DOI 10.3174/ajnr.A1121; Jain R, 2014, RADIOLOGY, V272, P484, DOI 10.1148/radiol.14131691; Jain R, 2013, RADIOLOGY, V267, P212, DOI 10.1148/radiol.12120846; Javier Juan-Albarracin, 2020, STAT COMPUT; Juan-Albarracin J, 2020, MULTIPLE SCLEROSIS S, P295; Juan-Albarracin J, 2019, INT J MED INFORM, V128, P53, DOI 10.1016/j.ijmedinf.2019.05.002; Juan-Albarracin J, 2018, RADIOLOGY, V287, P944, DOI 10.1148/radiol.2017170845; Juan-Albarracin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125143; Law M, 2008, RADIOLOGY, V247, P490, DOI 10.1148/radiol.2472070898; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Naeini KM, 2013, NEURO-ONCOLOGY, V15, P626, DOI 10.1093/neuonc/not008; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Olar A, 2014, J PATHOL, V232, P165, DOI 10.1002/path.4282; Price SJ, 2016, J MAGN RESON IMAGING, V43, P487, DOI 10.1002/jmri.24996; R Core Team, 2018, R LANG ENV STAT COMP; Romano A, 2018, J NEURO-ONCOL, V139, P455, DOI 10.1007/s11060-018-2887-4; Ryoo I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071704; Sandmann T, 2015, J CLIN ONCOL, V33, P2735, DOI 10.1200/JCO.2015.61.5005; Scarpace L., 2016, RADIOLOGY DATA CANC; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Tan WL, 2017, J MAGN RESON IMAGING, V45, P492, DOI 10.1002/jmri.25358; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Zinn PO, 2012, PLOS ONE, V7	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0232500	10.1371/journal.pone.0232500	http://dx.doi.org/10.1371/journal.pone.0232500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052913	Green Published, gold, Green Submitted			2022-12-26	WOS:000581820200028
J	Okuda, M; Fujita, Y; Takada-Takatori, Y; Sugimoto, H; Urakami, K				Okuda, Michiaki; Fujita, Yuki; Takada-Takatori, Yuki; Sugimoto, Hachiro; Urakami, Katsuya			Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MODEL; DEMENTIA; MEMORY; BRAIN; OIL; THERAPY; ORANGE	Alzheimer's disease (AD) is a progressive neurodegenerative disease and is known to be the most common cause of dementia. We previously described the benefits of aromatherapy on the cognitive function of patients with AD utilizing various aromatic essential oils; however, its mechanism of action remains poorly understood. Consequently, in the present study, this mechanism was thoroughly evaluated employing a dementia mice model, specifically the senescence-accelerated mouse prone 8. The mice were exposed to a mixture of lemon and rosemary oil at nighttime as well as to a mixture of lavender and orange oil in the daytime for 2 months. The cognitive function of the mice was assessed before and after treatment with the aromatic essential oils using the Y-maze test. Moreover, the brain levels of amyloid beta (A beta), abnormally phosphorylated tau, and brain-derived neurotrophic factor (BDNF) were measured following treatment. The benefits of aromatherapy on the cognitive function in mice were confirmed. It was also established that the brain levels of A beta and abnormally phosphorylated tau were considerably lower in the aromatherapy group, while the levels of BDNF were marginally higher. These results suggest that aromatherapy employing these aromatic essential oils is beneficial for the prevention and treatment of AD.	[Okuda, Michiaki; Fujita, Yuki; Sugimoto, Hachiro] Doshisha Univ, Grad Sch Brain Sci, Kizugawa, Kyoto, Japan; [Okuda, Michiaki; Fujita, Yuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Kyoto, Kyoto, Japan; [Takada-Takatori, Yuki] Doshisha Womens Coll, Fac Pharmaceut Sci, Kyotanabe, Kyoto, Japan; [Urakami, Katsuya] Tottori Univ, Fac Med, Sch Hlth Sci, Dept Regulat Biol, Yonago, Tottori, Japan; [Okuda, Michiaki; Fujita, Yuki; Sugimoto, Hachiro] Green Tech Co Ltd, Kyoto, Kyoto, Japan; [Sugimoto, Hachiro] Doshisha Univ, Fac Life & Med Sci, Kyotanabe, Kyoto, Japan	Doshisha University; Kyoto University; Tottori University; Doshisha University	Okuda, M (corresponding author), Doshisha Univ, Grad Sch Brain Sci, Kizugawa, Kyoto, Japan.; Okuda, M (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Kyoto, Kyoto, Japan.	okuda.michiaki.33r@st.kyoto-u.ac.jp		Okuda, Michiaki/0000-0002-0211-7144				[Anonymous], 2015, RES ALZH MED SETB ST; Ballard CG, 2002, J CLIN PSYCHIAT, V63, P553, DOI 10.4088/JCP.v63n0703; Bibari O, 2013, CURR ALZHEIMER RES, V10, P688, DOI 10.2174/15672050113109990147; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Camargo EC, 2016, J ALZHEIMERS DIS, V53, P1597, DOI 10.3233/JAD-160229; Chioca LR, 2013, J ETHNOPHARMACOL, V147, P412, DOI 10.1016/j.jep.2013.03.028; Cummings Jeffrey, 2018, Alzheimers Dement (N Y), V4, P195, DOI 10.1016/j.trci.2018.03.009; Farr SA, 2016, PHYSIOL BEHAV, V165, P328, DOI 10.1016/j.physbeh.2016.08.013; Filan SL, 2006, INT PSYCHOGERIATR, V18, P597, DOI 10.1017/S1041610206003322; Grassmann J, 2001, ARZNEIMITTEL-FORSCH, V51, P799; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hussain Syed Asif, 2002, Anc Sci Life, V22, P13; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jimbo D, 2009, PSYCHOGERIATRICS, V9, P173, DOI 10.1111/j.1479-8301.2009.00299.x; Koger SM, 1999, J MUSIC THER, V36, P2, DOI 10.1093/jmt/36.1.2; Lehrner J, 2005, PHYSIOL BEHAV, V86, P92, DOI 10.1016/j.physbeh.2005.06.031; Lewith GT, 2005, J ALTERN COMPLEM MED, V11, P631, DOI 10.1089/acm.2005.11.631; Maki T, 2014, ANN CLIN TRANSL NEUR, V1, P519, DOI 10.1002/acn3.79; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5; Morley JE, 2000, PEPTIDES, V21, P1761, DOI 10.1016/S0196-9781(00)00342-9; Nasermoaddeli Ali, 2005, Environmental Health and Preventive Medicine, V10, P171, DOI 10.1007/BF02897707; Okuda M, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2167-z; Okuda M, 2017, J ALZHEIMERS DIS, V59, P313, DOI 10.3233/JAD-161017; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Pengelly A, 2012, J MED FOOD, V15, P10, DOI 10.1089/jmf.2011.0005; Peters JM, 2003, AM J PSYCHIAT, V160, P1995, DOI 10.1176/appi.ajp.160.11.1995; Roberson Lynn, 2003, Home Healthc Nurse, V21, P16, DOI 10.1097/00004045-200301000-00004; Sakurai H, 2013, GERIATR GERONTOL INT, V13, P90, DOI 10.1111/j.1447-0594.2012.00866.x; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Shin BC, 2007, J ALTERN COMPLEM MED, V13, P247, DOI 10.1089/acm.2006.6189; Shinomiya M, 2012, ACTA MED OKAYAMA, V66, P111; Sigdell J E, 1982, Anc Sci Life, V1, P125; Smallwood J, 2001, INT J GERIATR PSYCH, V16, P1010, DOI 10.1002/gps.473; Sureda FX, 2006, EXP GERONTOL, V41, P360, DOI 10.1016/j.exger.2006.01.015; TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Wu N, 2013, J ALZHEIMERS DIS, V37, P699, DOI 10.3233/JAD-122443; YAGI H, 1988, BRAIN RES, V474, P86, DOI 10.1016/0006-8993(88)90671-3	39	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240378	10.1371/journal.pone.0240378	http://dx.doi.org/10.1371/journal.pone.0240378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052945	Green Published, gold			2022-12-26	WOS:000581820200040
J	Yamamoto, S; Nagamine, Y; Miyashita, T; Ito, S; Iwasawa, Y; Kawai, M; Saito, S; Tamai, T; Goto, T				Yamamoto, Saori; Nagamine, Yusuke; Miyashita, Tetsuya; Ito, Shiono; Iwasawa, Yurika; Kawai, Michihiko; Saito, Shinsaku; Tamai, Tomohisa; Goto, Takahisa			Perioperative and anesthetic risk factors of surgical site infection in patients undergoing pancreaticoduodenectomy: A retrospective cohort study	PLOS ONE			English	Article							POSTOPERATIVE OUTCOMES; COMPLICATIONS; CLASSIFICATION; SURVEILLANCE; SMOKING	Background Surgical site infection is a major perioperative issue. The morbidity of surgical site infection is high in major digestive surgery, such as pancreaticoduodenectomy. The comprehensive risk factors, including anesthetic factors, for surgical site infection in pancreaticoduodenectomy are unknown. The aim of this study was to investigate the perioperative and anesthetic risk factors of surgical site infection in pancreaticoduodenectomy. Methods This was a retrospective cohort study conducted in a single tertiary care center. A total of 326 consecutive patients who underwent pancreaticoduodenectomy between January 2009 and March 2018 were evaluated. Patients who underwent resection of other organs were excluded. The primary outcome was the incidence of surgical site infection, based on a Clavien-Dindo classification of grade 2 or higher. Multivariable logistic regression analysis was performed to investigate the association between surgical site infection and perioperative and anesthetic factors. Results Of the 326 patients, 116 (35.6%) were women. The median age was 70 years (interquartile range; 64-75). The median duration of surgery was 10.9 hours (interquartile range; 9.5-12.4). Surgical site infection occurred in 60 patients (18.4%). The multivariable analysis revealed that the use of desflurane as a maintenance anesthetic was associated with a significantly lower risk of surgical site infection than sevoflurane (odds ratio, 0.503; 95% confidence interval [CI], 0.260-0.973). In contrast, the duration of surgery (odds ratio, 1.162; 95% CI, 1.017-1.328), cerebrovascular disease (odds ratio, 3.544; 95% CI, 1.326-9.469), and ischemic heart disease (odds ratio, 10.839; 95% CI, 1.887-62.249) were identified as significant risk factors of surgical site infection. Conclusions Desflurane may be better than sevoflurane in preventing surgical site infection in pancreaticoduodenectomy. Cerebrovascular disease and ischemic heart disease are potential newly-identified risk factors of surgical site infection in pancreaticoduodenectomy.	[Yamamoto, Saori; Nagamine, Yusuke; Miyashita, Tetsuya; Ito, Shiono; Iwasawa, Yurika; Kawai, Michihiko; Saito, Shinsaku; Tamai, Tomohisa; Goto, Takahisa] Yokohama City Univ Med, Dept Anesthesiol & Crit Care Med, Yokohama, Kanagawa, Japan	Yokohama City University	Nagamine, Y (corresponding author), Yokohama City Univ Med, Dept Anesthesiol & Crit Care Med, Yokohama, Kanagawa, Japan.	ynagamin@yokohama-cu.ac.jp		Nagamine, Yusuke/0000-0002-0443-5007				Alexander JW, 2011, ANN SURG, V253, P1082, DOI 10.1097/SLA.0b013e31821175f8; Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; [Anonymous], **NON-TRADITIONAL**; Ban KA, 2017, J AM COLL SURGEONS, V224, P59, DOI 10.1016/j.jamcollsurg.2016.10.029; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Berrios SI, 2017, JAMA SURG, V152, P784, DOI 10.1001/jamasurg.2017.0904; Cheng H, 2017, SURG INFECT, V18, P722, DOI 10.1089/sur.2017.089; de Lissovoy G, 2009, AM J INFECT CONTROL, V37, P387, DOI 10.1016/j.ajic.2008.12.010; De Pastena M, 2017, SURGERY, V162, P792, DOI 10.1016/j.surg.2017.05.016; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Elliott IA, 2017, JAMA SURG, V152, P1023, DOI 10.1001/jamasurg.2017.2155; Fong ZV, 2016, JAMA SURG, V151, P432, DOI 10.1001/jamasurg.2015.4510; Funamizu N, 2018, MOL CLIN ONCOL, V9, P274, DOI 10.3892/mco.2018.1671; Haigh PI, 2011, ARCH SURG-CHICAGO, V146, P715, DOI 10.1001/archsurg.2011.115; Hopf HW, 1997, ARCH SURG-CHICAGO, V132, P997; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Katayama H, 2016, SURG TODAY, V46, P668, DOI 10.1007/s00595-015-1236-x; Kent TS, 2013, SURGERY, V153, P86, DOI 10.1016/j.surg.2012.03.026; Koo BW, 2016, KOREAN J ANESTHESIOL, V69, P332, DOI 10.4097/kjae.2016.69.4.332; Korol E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083743; Koutsogiannaki S, 2019, J SURG RES, V233, P323, DOI 10.1016/j.jss.2018.07.075; Morikane K, 2017, SURG TODAY, V47, P1208, DOI 10.1007/s00595-017-1503-0; Nolan MB, 2017, JAMA SURG, V152, P476, DOI 10.1001/jamasurg.2016.5704; Okano K, 2015, BRIT J SURG, V102, P1551, DOI 10.1002/bjs.9919; Poruk KE, 2016, HPB, V18, P893, DOI 10.1016/j.hpb.2016.07.011; Sharma A, 2013, ANN SURG, V258, P296, DOI 10.1097/SLA.0b013e3182708cc5; Shimizu K, 2010, J HOSP INFECT, V74, P129, DOI 10.1016/j.jhin.2009.10.011; Stollings LM, 2016, ANESTHESIOLOGY, V125, P399, DOI 10.1097/ALN.0000000000001195; Sugiura T, 2012, WORLD J SURG, V36, P2888, DOI 10.1007/s00268-012-1742-6; Takahashi Y, 2018, J INFECT CHEMOTHER, V24, P739, DOI 10.1016/j.jiac.2018.05.007; Takesue Y, 2012, J INFECT CHEMOTHER, V18, P816, DOI 10.1007/s10156-012-0509-1; Zhang LY, 2016, WORLD J SURG, V40, P2507, DOI 10.1007/s00268-016-3553-7; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	34	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240490	10.1371/journal.pone.0240490	http://dx.doi.org/10.1371/journal.pone.0240490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052944	Green Published, gold			2022-12-26	WOS:000581820200036
J	Chang, CH; Wang, YC; Shao, YT; Liu, SH				Chang, Chia-Hao; Wang, Yu-Chun; Shao, Yi Ta; Liu, Shih-Hui			Phylogenetic analysis and ontogenetic changes in the cone opsins of the western mosquitofish (Gambusia affinis)	PLOS ONE			English	Article							COLOR-VISION; VISUAL PIGMENTS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR EVOLUTION; BLUEFIN KILLIFISH; SENSITIVE OPSIN; FISH; EXPRESSION; LIGHT; PLASTICITY	To convert external light into internal neural signal, vertebrates rely on a special group of proteins, the visual opsins. Four of the five types of visual opsins-short-wavelength sensitive 1 (Sws1), short-wavelength sensitive 2 (Sws2), medium-wavelength sensitive (Rh2), and long-wavelength sensitive (Lws)-are expressed in cone cells for scotopic vision, with the fifth, rhodopsin (Rh1), being expressed in rod cells for photopic vision. Fish often display differing ontogenetic cone opsin expression profiles, which may be related to dietary and/or habitat ontogenetic shift. The western mosquitofish (Gambusia affinis) is an aggressive invader that has successfully colonized every continent except Antarctica. The strong invasiveness of this species may be linked to its visual acuity since it can inhabit turbid waters better than other fishes. By genome screening and transcriptome analysis, we identify seven cone opsin genes in the western mosquitofish, including onesws1, twosws2, onerh2, and threelws. The predicted maximal absorbance wavelength (lambda(max)) values of the respective proteins are 353 nm for Sws1, 449 nm for Sws2a, 408 nm for Sws2b, 516 nm for Rh2-1, 571 nm for Lws-1, and 519 nm for Lws-3. Retention of an intron in thelws-rtranscript likely renders this visual opsin gene non-functional. Our real-time quantitative PCR demonstrates that adult male and female western mosquitofish do not differ in their cone opsin expression profiles, but we do reveal an ontogenetic shift in cone opsin expression. Compared to adults, larvae express proportionally moresws1and lesslws-1, suggesting that the western mosquitofish is more sensitive to shorter wavelengths in the larval stage, but becomes more sensitive to longer wavelengths in adulthood.	[Chang, Chia-Hao] Tunghai Univ, TIGP Biodivers Program, Taichung, Taiwan; [Chang, Chia-Hao] Tunghai Univ, Ctr Ecol & Environm, Taichung, Taiwan; [Wang, Yu-Chun] Fisheries Res Inst, Planning & Informat Div, Keelung, Taiwan; [Shao, Yi Ta] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Liu, Shih-Hui] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan	Tunghai University; Tunghai University; Taiwan Fish Research Institute; National Taiwan Ocean University; National Sun Yat Sen University	Liu, SH (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan.	liushihhui@gmail.com	Liu, Shih-Hui/HHC-0223-2022	Liu, Shih-Hui/0000-0002-5429-6869	Ministry of Science and Technology, Taiwan [MOST 108-2621-B-029-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	C-H C was supported by the Ministry of Science and Technology, Taiwan (MOST 108-2621-B-029-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08822-w; Abrahams MV, 2017, T AM FISH SOC, V146, P1238, DOI 10.1080/00028487.2017.1353545; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Britt LL, 2001, J EXP BIOL, V204, P2581; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carleton K, 2009, INTEGR ZOOL, V4, P75, DOI 10.1111/j.1749-4877.2008.00137.x; Casner AM, 2016, ETHOLOGY, V122, P561, DOI 10.1111/eth.12507; Chang BSW, 1995, MOL PHYLOGENET EVOL, V4, P31, DOI 10.1006/mpev.1995.1004; Chang CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215376; Chang CH, 2009, ZOOL SCI, V26, P349, DOI 10.2108/zsj.26.349; Cheng CL, 2007, J EXP BIOL, V210, P4123, DOI 10.1242/jeb.009217; Cowing JA, 2002, BIOCHEMISTRY-US, V41, P6019, DOI 10.1021/bi025656e; Ehlman SM, 2015, J COMP PHYSIOL A, V201, P1125, DOI 10.1007/s00359-015-1041-4; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flamarique IN, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0058; Flamarique IN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2490; Fourment Mathieu, 2016, BMC Res Notes, V9, P106, DOI 10.1186/s13104-016-1927-4; Francis RA, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P1; Friesen CN, 2017, GEN COMP ENDOCR, V246, P200, DOI 10.1016/j.ygcen.2016.12.009; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fuller RC, 2003, J COMP PHYSIOL A, V189, P609, DOI 10.1007/s00359-003-0435-x; Fuller RC, 2004, J COMP PHYSIOL A, V190, P147, DOI 10.1007/s00359-003-0478-z; Fuller RC, 2011, MOL ECOL, V20, P3321, DOI 10.1111/j.1365-294X.2011.05180.x; Garcia-Berthou E, 1999, J FISH BIOL, V55, P135, DOI 10.1111/j.1095-8649.1999.tb00663.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hauser FE, 2017, CURR OPIN GENET DEV, V47, P110, DOI 10.1016/j.gde.2017.09.005; Hoffberg SL, 2018, G3-GENES GENOM GENET, V8, P1855, DOI 10.1534/g3.118.200101; Kasagi S, 2018, ECOL EVOL, V8, P1399, DOI 10.1002/ece3.3745; Kasagi S, 2015, GENE, V556, P182, DOI 10.1016/j.gene.2014.11.054; Kawamura S, 2016, VISION RES, V127, P67, DOI 10.1016/j.visres.2016.06.013; KIRK JTO, 1977, AUST J MAR FRESH RES, V28, P497, DOI 10.1071/MF9770497; KIRK JTO, 1977, AUST J MAR FRESH RES, V28, P9; Kodama I, 2008, ZOOL SCI, V25, P1199, DOI 10.2108/zsj.25.1199; Kranz AM, 2018, EVOLUTION, V72, P1656, DOI 10.1111/evo.13519; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laver CRJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-81; Lee F, 2018, ECOL FRESHW FISH, V27, P822, DOI 10.1111/eff.12395; Leech DM, 2009, LIMNOL OCEANOGR, V54, P1152, DOI 10.4319/lo.2009.54.4.1152; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lin JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15868-7; Locket NA, 1999, VERTEBRATE PHOTORECE; LOEW ER, 1993, CAN J ZOOL, V71, P384, DOI 10.1139/z93-053; Lythgoe J. N., 1979, ECOLOGY OF VISION; Madliger CL, 2012, BIODIVERS CONSERV, V21, P3277, DOI 10.1007/s10531-012-0363-6; Matsumoto T, 2016, FISHERIES SCI, V82, P17, DOI 10.1007/s12562-015-0936-x; Matsumoto Y, 2006, GENE, V371, P268, DOI 10.1016/j.gene.2005.12.005; Matsumoto Y, 2020, GENOME BIOL EVOL, V12, P911, DOI 10.1093/gbe/evaa111; MCFARLAND WN, 1994, VISION RES, V34, P1393, DOI 10.1016/0042-6989(94)90138-4; Musilova Z, 2019, SCIENCE, V364, P588, DOI 10.1126/science.aav4632; Nandamuri P, 2017, MOL ECOL, V26, P6036, DOI 10.1111/mec.14357; Polverino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054315; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; Ranwez V, 2018, MOL BIOL EVOL, V35, P2582, DOI 10.1093/molbev/msy159; Sandkam B, 2018, CURR ZOOL, V64, P535, DOI 10.1093/cz/zoy047; Sandkam B, 2015, MOL ECOL, V24, P596, DOI 10.1111/mec.13058; Sandkam BA, 2017, GENOME BIOL EVOL, V9, P3100, DOI 10.1093/gbe/evx228; Sandkam BA, 2016, J COMP PHYSIOL A, V202, P527, DOI 10.1007/s00359-016-1097-9; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shand J, 2002, J EXP BIOL, V205, P3661; SHAND J, 1988, J COMP PHYSIOL A, V163, P699, DOI 10.1007/BF00603854; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Tettamanti V, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.209916; Tsurui-Sato K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41858-y; Wakefield MJ, 2008, VISUAL NEUROSCI, V25, P257, DOI 10.1017/S0952523808080255; Wang FY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103953; Watson CT, 2011, J MOL EVOL, V72, P240, DOI 10.1007/s00239-010-9426-z; Watson CT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-87; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yokoyama S, 1998, MOL BIOL EVOL, V15, P560, DOI 10.1093/oxfordjournals.molbev.a025956; Yokoyama S, 2014, GENE, V534, P93, DOI 10.1016/j.gene.2013.09.114; Yourick MR, 2019, MOL ECOL RESOUR, V19, P1447, DOI 10.1111/1755-0998.13062	73	6	6	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240313	10.1371/journal.pone.0240313	http://dx.doi.org/10.1371/journal.pone.0240313			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048954	gold, Green Published			2022-12-26	WOS:000581813300005
J	Lee, SH; Lutz, D; Drexler, D; Frotscher, M; Shen, J				Lee, Sang Hun; Lutz, David; Drexler, Dagmar; Frotscher, Michael; Shen, Jie			Differential modulation of short-term plasticity at hippocampal mossy fiber and Schaffer collateral synapses by mitochondrial Ca2+	PLOS ONE			English	Article							POSTTETANIC POTENTIATION; AXONAL-TRANSPORT; ENDOPLASMIC-RETICULUM; CALCIUM; DYSFUNCTION; DETERMINANTS; TRANSMISSION; MOBILIZATION; ENHANCEMENT; DYNAMICS	Presynaptic mitochondrial Ca(2+)plays a critical role in the regulation of synaptic transmission and plasticity. The presynaptic bouton of the hippocampal mossy fiber (MF) is much larger in size than that of the Schaffer collateral (SC) synapse. Here we compare the structural and physiological characteristics of MF and SC presynaptic boutons to reveal functional and mechanistic differences between these two synapses. Our quantitative ultrastructural analysis using electron microscopy show many more mitochondria in MF presynaptic bouton cross-section profiles compared to SC boutons. Consistent with these results, post-tetanic potentiation (PTP), a form of presynaptic short-term plasticity dependent on mitochondrial Ca2+, is reduced by inhibition of mitochondrial Ca(2+)release at MF synapses but not at SC synapses. However, blockade of mitochondrial Ca(2+)release results in reduction of PTP at SC synapses by disynaptic MF stimulation. Furthermore, inhibition of mitochondrial Ca(2+)release selectively decreases frequency facilitation evoked by short trains of presynaptic stimulation at MF synapses, while having no effect at SC synapses. Moreover, depletion of ER Ca(2+)stores leads to reduction of PTP at MF synapses, but PTP is unaffected by ER Ca(2+)depletion at SC synapses. These findings show that MF and SC synapses differ in presynaptic mitochondrial content as well as mitochondrial Ca(2+)dependent synaptic plasticity, highlighting differential regulatory mechanisms of presynaptic plasticity at MF and SC synapses.	[Lee, Sang Hun; Shen, Jie] Harvard Med Sch, Dept Neurol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Lutz, David; Drexler, Dagmar; Frotscher, Michael] Univ Med Ctr Hamburg Eppendorf, Inst Struct Neurobiol, Ctr Mol Neurobiol Hamburg ZMNH, Hamburg, Germany; [Shen, Jie] Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA; [Lutz, David] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, Bochum, Germany; [Drexler, Dagmar] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Ctr Diagnost, Hamburg, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Harvard Medical School; Ruhr University Bochum; University of Hamburg; University Medical Center Hamburg-Eppendorf	Lee, SH (corresponding author), Harvard Med Sch, Dept Neurol, Brigham & Womens Hosp, Boston, MA 02115 USA.	slee82@bwh.harvard.edu	Lee, Sang Hun/C-1198-2015; Lutz, David/AAX-1607-2021; Shen, Jie/GXH-9449-2022	Lee, Sang Hun/0000-0002-0020-4631; Lutz, David/0000-0001-9171-4081	NINDS [R01NS041783]	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the NINDS (R01NS041783 to J.S.).	AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; ANDERSEN P, 1969, ACTA PHYSIOL SCAND, V76, pA4; BEHNISCH T, 1995, NEUROSCI LETT, V192, P185, DOI 10.1016/0304-3940(95)11641-9; Billups B, 2002, J NEUROSCI, V22, P5840; BLACKSTAD T, 1961, J COMP NEUROL, V117, P133, DOI 10.1002/cne.901170202; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Cho HJ, 2014, EMBO J, V33, P2314, DOI 10.15252/embj.201487807; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Evstratova A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00028; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Goethals J, 2017, EARLY MOD WOMEN, V12, P48, DOI 10.1353/emw.2017.0047; GRIFFITH WH, 1990, J NEUROPHYSIOL, V63, P491, DOI 10.1152/jn.1990.63.3.491; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; HAMLYN LH, 1962, J ANAT, V96, P112; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Herrick MK, 2019, NATURE, V571, P481, DOI 10.1038/d41586-019-02094-6; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; KARADJOV JS, 1986, CELL CALCIUM, V7, P115, DOI 10.1016/0143-4160(86)90014-X; Kesner RP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00078; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lee CW, 2008, MOL BIOL CELL, V19, P150, DOI 10.1091/mbc.E07-05-0515; Lee D, 2007, J NEUROSCI, V27, P13603, DOI 10.1523/JNEUROSCI.3985-07.2007; Lee JS, 2008, J NEUROSCI, V28, P7945, DOI 10.1523/JNEUROSCI.2165-08.2008; Lee SH, 2012, J NEUROSCI, V32, P5953, DOI 10.1523/JNEUROSCI.0465-12.2012; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lu Xiang-pei, 2011, Zhonghua Jie He He Hu Xi Za Zhi, V34, P515; Ma H, 2009, J NEUROSCI, V29, P13019, DOI 10.1523/JNEUROSCI.2517-09.2009; Mironov SL, 2006, J CELL SCI, V119, P4926, DOI 10.1242/jcs.03254; Okada K, 2009, BEHAV BRAIN RES, V200, P181, DOI 10.1016/j.bbr.2009.01.011; Pivovarova NB, 2002, J NEUROSCI, V22, P10653; REGEHR WG, 1994, J NEUROSCI, V14, P523; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; Rizzuto J, 2000, NETW COMPUT, V11, P18; Rizzuto R, 2003, J CELL BIOL, V163, P441, DOI 10.1083/jcb.200309111; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Sato I, 2011, NEUROSCI RES, V71, P183, DOI 10.1016/j.neures.2011.07.001; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shimizu H, 2008, P NATL ACAD SCI USA, V105, P11998, DOI 10.1073/pnas.0802175105; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Trancikova A, 2012, ANTIOXID REDOX SIGN, V16, P896, DOI 10.1089/ars.2011.4200; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; 2010, WEATHERWISE, V0002, P00139	57	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240610	10.1371/journal.pone.0240610	http://dx.doi.org/10.1371/journal.pone.0240610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33049001	Green Published, gold			2022-12-26	WOS:000581813300035
J	Valerio, LSA; Sugaya, K				Valerio, Luis Sebastian Alexis; Sugaya, Kiminobu			Xeno- and transgene-free reprogramming of mesenchymal stem cells toward the cells expressing neural markers using exosome treatments	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; INTEGRATION; GENERATION; SOX2	Neural stem cells (NSCs), capable of self-renew and differentiate into neural cells, hold promise for use in studies and treatments for neurological diseases. However, current approaches to obtain NSCs from a live brain are risky and invasive, since NSCs reside in the subventricular zone and the in the hippocampus dentate gyrus. Alternatively, mesenchymal stem cells (MSCs) could be a more available cell source due to their abundance in tissues and easier to access. However, MSCs are committed to producing mesenchymal tissue and are not capable of spontaneously differentiating into neural cells. Thus, the process of reprogramming of MSCs into neural cells to use in clinical and scientific settings has significantly impacted the advancement of regenerative medicine. Previously, our laboratory reported trans-differentiation of MSCs to neural cells through the induced pluripotent stem (iPS) cells state, which was produced by overexpression of the embryonic stem cell gene NANOG. In the current study, we demonstrate that treatment with exosomes derived from NSCs makes MSCs capable of expressing neural cell markers bypassing the generation of iPS cells. An epigenetic modifier, decitabine (5-aza-2'-deoxycytidine), enhanced the process. This novel Xeno and transgene-free trans-differentiation technology eliminates the issues associated with iPS cells, such as tumorigenesis. Thus, it may accelerate the development of neurodegenerative therapies andin vitroneurological disorder models for personalized medicine.	[Valerio, Luis Sebastian Alexis; Sugaya, Kiminobu] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Valerio, Luis Sebastian Alexis; Sugaya, Kiminobu] Inst Sci Res & Technol Serv INDICASAT, Panama City, Panama; [Valerio, Luis Sebastian Alexis] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, Andhra Pradesh, India	State University System of Florida; University of Central Florida; Acharya Nagarjuna University	Sugaya, K (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.; Sugaya, K (corresponding author), Inst Sci Res & Technol Serv INDICASAT, Panama City, Panama.	ksugaya@ucf.edu			SENACYT, Panama [KS FID14-203]	SENACYT, Panama	KS FID14-203 from SENACYT, Panama, https://www.senacyt.gob.pa. No contribution to the study design, data collection and analysis, decision to publish, or preparation of the manuscript by the funder.	Alexanian AR, 2013, INT J BIOCHEM CELL B, V45, P1633, DOI 10.1016/j.biocel.2013.04.022; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2018, LANCET ONCOL, V19, pe581; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2016, THE TOTAL AUDIENCE R; Azmitia L, 2018, METHODS MOL BIOL, V1842, P31, DOI 10.1007/978-1-4939-8697-2_2; Capetian P, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00245; Chen YC, 2017, STEM CELL RES, V23, P57, DOI 10.1016/j.scr.2017.06.002; Choi DH, 2017, INT J MOL SCI, V18, P1; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Gao M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0172-7; Gao M, 2017, STEM CELL RES, V23, P132, DOI 10.1016/j.scr.2017.07.015; Gao M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29955; Habich A, 2013, ACTA NEUROBIOL EXP, V73, P143; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hemmer K, 2014, STEM CELL REP, V3, P423, DOI 10.1016/j.stemcr.2014.06.017; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Kharizinejad E, 2016, MICROSC RES TECHNIQ, V79, P365, DOI 10.1002/jemt.22639; Kim JJ, 2017, INT J STEM CELLS, V10, P227, DOI 10.15283/ijsc17025; Kim SM, 2016, STEM CELL RES, V16, P460, DOI 10.1016/j.scr.2016.02.025; Kumar D, 2015, HISTOL HISTOPATHOL, V30, P1397, DOI 10.14670/HH-11-656; Kwon Jihye, 2012, Int J Stem Cells, V5, P140; Madhu V, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1035374; Martins-Taylor K, 2012, EPIGENETICS-US, V7, P71, DOI 10.4161/epi.7.1.18750; Okolie O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198596; Pauly MG, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00003; Qu TY, 2004, RESTOR NEUROL NEUROS, V22, P459; Smith Jason E., 2010, DECALAGES, V1.1, P1, DOI DOI 10.2202/2152-2812.1013; Sugaya K, 2005, Patent No. [US8192988, 8192988]; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeda YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135111; Uchugonova A, 2016, J BIOPHOTONICS, V9, P942, DOI 10.1002/jbio.201500240; Yamashita T, 2017, CELL TRANSPLANT, V26, P461, DOI 10.3727/096368916X692988	33	2	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240469	10.1371/journal.pone.0240469	http://dx.doi.org/10.1371/journal.pone.0240469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048978	Green Published, gold			2022-12-26	WOS:000581813300051
J	He, Q; Lin, ZY; Wang, ZH; Huang, WJ; Tian, D; Liu, M; Xia, LM				He, Qin; Lin, Zhuoying; Wang, Zhihui; Huang, Wenjie; Tian, Dean; Liu, Mei; Xia, Limin			SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET	ONCOGENE			English	Article							HEPATOCYTE GROWTH-FACTOR; THERAPEUTIC TARGET; CANCER; INHIBITOR; YAP/TAZ; THERAPIES; PROTEIN; EGFR; SIZE; AXIS	Metastasis is the main reason for high mortality in hepatocellular carcinoma (HCC) patients and the molecular mechanism remains unclear. Therefore, it is important to elucidate the mechanism underlying HCC metastasis. Here, we report a novel role of SIX homeobox 4 (SIX4), one of the SIX gene family, in promoting HCC metastasis. The elevated expression of SIX4 was positively correlated with loss of tumor encapsulation, microvascular invasion, higher TNM stage, and poor prognosis in human HCC. SIX4 expression was an independent and significant risk factor for the recurrence and survival in HCC patients. Upregulation of SIX4 promoted HCC invasion and metastasis, whereas downregulation of SIX4 decreased HCC invasion and metastasis. SIX4 transactivated Yes1 associated transcriptional regulator (YAP1) and MET proto-oncogene, receptor tyrosine kinase (MET) expression through directly binding to their promoters. Knockdown of YAP1 and c-MET inhibited SIX4-medicated HCC metastasis, while the stable overexpression of YAP1 and c-MET reversed the decreased metastasis induced by SIX4 knockdown. Hepatocyte growth factor (HGF), the specific ligand of c-MET, upregulated SIX4 expression through ERK/NF-kappa B pathway. Knockdown of SIX4 significantly decreased HGF-enhanced HCC metastasis. In human HCC tissues, SIX4 expression was positively correlated with nuclear YAP1, c-MET and HGF expression. Patients with positive coexpression of SIX4/ nuclear YAP1, SIX4/c-MET or HGF/SIX4 had the poorest prognosis. Moreover, the combination treatment of YAP1 inhibitor Verteporfin and c-MET inhibitor Capmatinib significantly suppressed SIX4-mediated HCC metastasis. In conclusion, SIX4 is a prognostic biomarker in HCC patients and targeting the HGF-SIX4-c-MET positive feedback loop may provide a promising strategy for the treatment of SIX4-driven HCC metastasis.	[He, Qin; Lin, Zhuoying; Wang, Zhihui; Tian, Dean; Liu, Mei; Xia, Limin] Huazhong Univ Sci & Technol, Dept Gastroenterol, Inst Liver & Gastrointestinal Dis, Tongji Hosp,Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Huang, Wenjie] Huazhong Univ Sci & Technol, Hepat Surg Ctr, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Huang, Wenjie] Clin Med Res Ctr Hepat Surg Hubei Prov, Wuhan 430030, Hubei, Peoples R China; [Huang, Wenjie] Minist Educ, Key Lab Organ Transplantat, Wuhan 430030, Hubei, Peoples R China; [Huang, Wenjie] Minist Publ Hlth, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, M; Xia, LM (corresponding author), Huazhong Univ Sci & Technol, Dept Gastroenterol, Inst Liver & Gastrointestinal Dis, Tongji Hosp,Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China.	fliumei@126.com; xialimin@tjh.tjmu.edu.cn		He, Qin/0000-0002-9887-9388; Xia, Limin/0000-0002-6327-6034	National Key Research and Development Program of China [2018YFC1312103]; National Natural Science Foundation of China [81871911, 81972237, 81772623]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Research was supported by grants from the National Key Research and Development Program of China 2018YFC1312103 (LX), National Natural Science Foundation of China No. 81871911 (WH), No. 81972237 (LX), and No. 81772623 (LX).	Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Bisso A, 2020, HEPATOLOGY, V72, P1430, DOI 10.1002/hep.31120; Bladt F, 2014, CANCERS, V6, P1736, DOI 10.3390/cancers6031736; Bouattour M, 2018, HEPATOLOGY, V67, P1132, DOI 10.1002/hep.29496; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen J, 2020, HEPATOLOGY, V71, P1712, DOI 10.1002/hep.30951; Chen RC, 2018, HEPATOLOGY, V67, P1823, DOI 10.1002/hep.29663; Christensen KL, 2008, ADV CANCER RES, V101, P93, DOI 10.1016/S0065-230X(08)00405-3; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Comoglio PM, 2018, NAT REV CANCER, V18, P341, DOI 10.1038/s41568-018-0002-y; Craig AJ, 2020, NAT REV GASTRO HEPAT, V17, P139, DOI 10.1038/s41575-019-0229-4; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dong QZ, 2019, CANCER RES, V79, P819, DOI 10.1158/0008-5472.CAN-18-1273; Faivre S, 2020, J HEPATOL, V72, P342, DOI 10.1016/j.jhep.2019.09.010; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Garcia-Vilas JA, 2018, WORLD J GASTROENTERO, V24, P3695, DOI 10.3748/wjg.v24.i33.3695; Gavini J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1989-z; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gibault F, 2017, CHEMMEDCHEM, V12, P954, DOI 10.1002/cmdc.201700063; Giordano S, 2014, J HEPATOL, V60, P442, DOI 10.1016/j.jhep.2013.09.009; Hu CT, 2017, CANCERS, V9, DOI 10.3390/cancers9060058; Lau EYT, 2016, CELL REP, V15, P1175, DOI 10.1016/j.celrep.2016.04.019; Li GD, 2017, PEERJ, V5, DOI 10.7717/peerj.3394; Li H, 2019, GASTROENTEROLOGY, V156, P1849, DOI 10.1053/j.gastro.2019.01.252; Li L, 2018, CANCER CELL, V33, P368, DOI 10.1016/j.ccell.2018.01.010; Liu XD, 2011, CLIN CANCER RES, V17, P7127, DOI 10.1158/1078-0432.CCR-11-1157; Liu Z, 2019, J DENT RES, V98, P572, DOI 10.1177/0022034519835204; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Mizuguchi T, 2009, J GASTROINTEST SURG, V13, P325, DOI 10.1007/s11605-008-0711-8; Oliphant MUJ, 2019, CANCER RES, V79, P720, DOI 10.1158/0008-5472.CAN-18-1791; Ono H, 2012, ONCOGENE, V31, P4923, DOI 10.1038/onc.2011.646; Ou SHI, 2017, J THORAC ONCOL, V12, P145, DOI 10.1016/j.jtho.2016.09.131; Papaccio F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113595; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Shah AM, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.043489; Shi C, 2018, REDOX BIOL, V14, P59, DOI 10.1016/j.redox.2017.08.013; Sun XL, 2020, AM J CANCER RES, V10, P224; Tang XP, 2019, BIOCHEM BIOPH RES CO, V516, P851, DOI 10.1016/j.bbrc.2019.06.114; Vejchapipat P, 2004, J GASTROENTEROL, V39, P1182, DOI 10.1007/s00535-004-1469-8; Wang CA, 2012, J CLIN INVEST, V122, P1895, DOI 10.1172/JCI59858; Wang HY, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00055; Xiang CA, 2017, CANCERS, V9, DOI 10.3390/cancers9050044; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Yang X, 2014, HEPATOLOGY, V59, P1874, DOI 10.1002/hep.26941; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Yu ZB, 2020, ONCOGENE, V39, P3163, DOI 10.1038/s41388-020-1206-7; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang SH, 2019, CURR OPIN CELL BIOL, V61, P64, DOI 10.1016/j.ceb.2019.07.006; Zhang XD, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0892-2; Zhang YZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0796-y; Zheng Y, 2018, THERANOSTICS, V8, P972, DOI 10.7150/thno.22328	54	15	15	1	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2020	39	50					7279	7295		10.1038/s41388-020-01500-y	http://dx.doi.org/10.1038/s41388-020-01500-y		OCT 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PD4HE	33046796				2022-12-26	WOS:000578784100001
J	Tiede, S; Kalathur, RKR; Luond, F; von Allmen, L; Szczerba, BM; Hess, M; Vlajnic, T; Muller, B; Murillo, JC; Aceto, N; Christofori, G				Tiede, Stefanie; Kalathur, Ravi Kiran Reddy; Luond, Fabiana; von Allmen, Luca; Szczerba, Barbara Maria; Hess, Mathias; Vlajnic, Tatjana; Mueller, Benjamin; Canales Murillo, James; Aceto, Nicola; Christofori, Gerhard			Multi-color clonal tracking reveals intra-stage proliferative heterogeneity during mammary tumor progression	ONCOGENE			English	Article							BREAST-CANCER; MUTATIONAL EVOLUTION; MOLECULAR PORTRAITS; MELANOMA-CELLS; KI67; EXPRESSION; SUBPOPULATION; STRATEGIES; DYNAMICS; MODEL	Despite major progress in breast cancer research, the functional contribution of distinct cancer cell clones to malignant tumor progression and metastasis remains largely elusive. We have assessed clonal heterogeneity within individual primary tumors and metastases and also during the distinct stages of malignant tumor progression using clonal tracking of cancer cells in the MMTV-PyMT mouse model of metastatic breast cancer. Comparative gene expression analysis of clonal subpopulations reveals a substantial level of heterogeneity across and also within the various stages of breast carcinogenesis. The intra-stage heterogeneity is primarily manifested by differences in cell proliferation, also found within invasive carcinomas of luminal A-, luminal B-, and HER2-enriched human breast cancer. Surprisingly, in the mouse model of clonal tracing of cancer cells, chemotherapy mainly targets the slow-proliferative clonal populations and fails to efficiently repress the fast-proliferative populations. These insights may have considerable impact on therapy selection and response in breast cancer patients.	[Tiede, Stefanie; Kalathur, Ravi Kiran Reddy; Luond, Fabiana; von Allmen, Luca; Szczerba, Barbara Maria; Hess, Mathias; Mueller, Benjamin; Canales Murillo, James; Aceto, Nicola; Christofori, Gerhard] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Kalathur, Ravi Kiran Reddy] Swiss Inst Bioinformat, CH-4053 Basel, Switzerland; [Vlajnic, Tatjana] Univ Hosp Basel, Inst Pathol, CH-4031 Basel, Switzerland	University of Basel; Swiss Institute of Bioinformatics; University of Basel	Tiede, S; Christofori, G (corresponding author), Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.	stefanie.tiede@unibas.ch; Gerhard.christofori@unibas.ch			SystemsX.ch MTD project MetastasiX; Swiss National Science Foundation; Swiss Cancer League; Krebsliga Beider Basel	SystemsX.ch MTD project MetastasiX; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Krebsliga Beider Basel	This work was supported by the SystemsX.ch MTD project MetastasiX, the Swiss National Science Foundation, the Swiss Cancer League, and the Krebsliga Beider Basel.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Cai Y, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3563-3; Casasent AK, 2018, CELL, V172, P205, DOI 10.1016/j.cell.2017.12.007; Chen J, 2017, NAT PROTOC, V12, P566, DOI 10.1038/nprot.2017.003; Chen K, 2015, MOL MED, V21, P792, DOI 10.2119/molmed.2015.00126; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cserni G, 2014, BREAST, V23, P259, DOI 10.1016/j.breast.2014.02.003; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Denkert C, 2015, BREAST, V24, pS67, DOI 10.1016/j.breast.2015.07.017; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Kim C, 2018, CELL, V173, P879, DOI 10.1016/j.cell.2018.03.041; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koren S, 2015, NATURE, V525, P114, DOI 10.1038/nature14669; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Macaulay IC, 2016, NAT PROTOC, V11, P36, DOI 10.1038/nprot.2016.138; Macaulay IC, 2015, NAT METHODS, V12, P519, DOI 10.1038/nmeth.3370; Maddipati R, 2015, CANCER DISCOV, V5, P1086, DOI 10.1158/2159-8290.CD-15-0120; Martinez RJ, 2015, J IMMUNOL METHODS, V424, P28, DOI 10.1016/j.jim.2015.04.018; Nguyen LV, 2015, NATURE, V528, P267, DOI 10.1038/nature15742; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Perego M, 2018, ONCOGENE, V37, P302, DOI 10.1038/onc.2017.341; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Reeves MQ, 2018, NAT CELL BIOL, V20, DOI 10.1038/s41556-018-0109-0; Rios AC, 2019, CANCER CELL, V35, P618, DOI 10.1016/j.ccell.2019.02.010; Rodriguez-Enriquez S, 2006, TOXICOL APPL PHARM, V215, P208, DOI 10.1016/j.taap.2006.02.005; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Szczerba BM, 2019, NATURE, V566, P553, DOI 10.1038/s41586-019-0915-y; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Tang YNJ, 2019, CELL REP, V28, P2837, DOI 10.1016/j.celrep.2019.08.029; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Wu FH, 2017, ONCOTARGET, V8, P78466, DOI 10.18632/oncotarget.19638; Yao CH, 2019, ELIFE, V8, DOI 10.7554/eLife.41351; Yates LR, 2017, CANCER CELL, V32, P169, DOI 10.1016/j.ccell.2017.07.005; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zomer A, 2013, STEM CELLS, V31, P602, DOI 10.1002/stem.1296	48	7	7	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					12	27		10.1038/s41388-020-01508-4	http://dx.doi.org/10.1038/s41388-020-01508-4		OCT 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33046799				2022-12-26	WOS:000578784100003
J	Ziakas, PD; Mylonakis, E				Ziakas, Panayiotis D.; Mylonakis, Eleftherios			Spatial association patterns between post-acute care services and acute care facilities in the United States	PLOS ONE			English	Article							COLOCATION QUOTIENT; POSTACUTE CARE; DISCHARGE	Background There is increasing demand for post-acute care services, which is amplified by the COVID-19 pandemic. Aims We studied the pattern of spatial association between post-acute care services and acute care facilities and evaluated how geographic variability could influence their use. Methods We compiled data on CMS-certified acute care and critical access hospitals and post-acute health care services (nursing homes, home health care services, inpatient rehabilitation facilities, long-term care hospitals, and hospice facilities). We used the colocation quotient (CLQ) to measure the magnitude and direction of association (clustering or segregation) between post-acute care providers and hospitals. This metric allows pairwise comparison of categorical data; a value 1 spatial clustering. Unity marks the lack of spatial dependence (random distribution). Results With the exception of nursing homes (CLQ 1.26), all other types of post-acute care providers are spatially segregated from rural critical access hospitals. Long-term care facilities ranked first (had the lowest global CLQ, 0.06), hospice facilities ranked last (had the highest global CLQ estimate, 0.54). Instead, post-acute care services either clustered with (inpatient rehabilitation 2.76, long-term care 2.10, nursing homes 1.37) or were only weakly segregated (home health care 0.86) from acute care hospitals. Home health care (1.44), hospice services (1.46), and nursing homes (1.08) spatially clustered with the same category of services. Results were robust in the sensitivity analysis and we provided illustrative examples of local variation for the states of MA and IA. Conclusion Post-acute care services are isolated from critical access hospitals, and have a clustering pattern with the same category services and acute care hospitals. Such misdistribution of resources may result in both underuse and a substitution effect on the type of post-acute care between rural and urban areas and undermine public health during increasing demand, such as the COVID-19 pandemic.	[Ziakas, Panayiotis D.; Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Mylonakis, E (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	emylonakis@lifespan.org		Ziakas, Panayiotis/0000-0002-5943-8635; Mylonakis, Eleftherios/0000-0002-4624-0777				Aad G, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2015)148; Amatya B, 2020, AM J PHYS MED REHAB, V99, P663, DOI 10.1097/PHM.0000000000001477; Anderson TK, 2009, ACCIDENT ANAL PREV, V41, P359, DOI 10.1016/j.aap.2008.12.014; [Anonymous], 2020, STAT AHIP BOARD DIR; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Buntin MB, 2005, HEALTH SERV RES, V40, P413, DOI 10.1111/j.1475-6773.2005.0i366.x; Burke Robert E, 2017, Am J Accountable Care, V5, P16; Burke RE, 2015, JAMA INTERN MED, V175, P295, DOI 10.1001/jamainternmed.2014.6383; Chandra A, 2013, HEALTH AFFAIR, V32, P864, DOI 10.1377/hlthaff.2012.1262; Cromley RG, 2014, PROF GEOGR, V66, P138, DOI 10.1080/00330124.2013.768130; Gadzinski AJ, 2014, JAMA SURG, V149, P671, DOI 10.1001/jamasurg.2013.5694; Hospital MA, 2020, CURR ONCOL REP, V22, DOI 10.1007/s11912-020-0869-0; Hu YJ, 2014, T GIS, V18, P911, DOI 10.1111/tgis.12076; Jones CD, 2015, J AM GERIATR SOC, V63, P1265, DOI 10.1111/jgs.13467; Kane RL, 2002, HEALTH SERV RES, V37, P667, DOI 10.1111/1475-6773.00043; Kane RL, 2006, GERONTOLOGIST, V46, P474, DOI 10.1093/geront/46.4.474; Kane RL, 2011, JAMA-J AM MED ASSOC, V305, P284, DOI 10.1001/jama.2010.2015; Kelejian HH, 2007, J ECONOMETRICS, V140, P131, DOI 10.1016/j.jeconom.2006.09.005; Kosar CM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.18738; Kronenfeld B., 2015, COLOCATION ANAL ENGI; Kronenfeld BJ, 2015, J GEOGR SYST, V17, P1, DOI 10.1007/s10109-014-0206-y; Lam O., 2018, FAR AM LIVE CLOSEST; Leslie TF, 2011, GEOGR ANAL, V43, P306, DOI 10.1111/j.1538-4632.2011.00821.x; Murray H, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22040378; Ouslander JG, 2016, J AM MED DIR ASSOC, V17, P839, DOI 10.1016/j.jamda.2016.05.021; Shang JJ, 2020, J AM MED DIR ASSOC, V21, P924, DOI 10.1016/j.jamda.2020.06.002; The Medicare Payment Advisory Commission (MedPAC), 2019, JUN 2019 DAT BOOK; The Medicare Payment Advisory Commission (MedPAC), 2020, HOSP SERV; Tumlinson A, 2020, J AM GERIATR SOC, V68, P1150, DOI 10.1111/jgs.16519; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wang FH, 2017, PROF GEOGR, V69, P22, DOI 10.1080/00330124.2016.1157498; Wang SY, 2017, MED CARE, V55, P848, DOI 10.1097/MLR.0000000000000776; Wang SY, 2016, J AM GERIATR SOC, V64, P314, DOI 10.1111/jgs.13939; Werner RM, 2018, JAMA-J AM MED ASSOC, V319, P1616, DOI 10.1001/jama.2018.2408; Yue H, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6100307; Zeigermann L., 2018, OPENCAGEGEO STATA MO; Ziakas PD, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004187	37	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240624	10.1371/journal.pone.0240624	http://dx.doi.org/10.1371/journal.pone.0240624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TU	33045016	Green Published, gold			2022-12-26	WOS:000581811700020
J	Abdu, N; Mosazghi, A; Teweldemedhin, S; Asfaha, L; Teshale, M; Kibreab, M; Anand, IS; Tesfamariam, EH; Russom, M				Abdu, Nuru; Mosazghi, Asmerom; Teweldemedhin, Samuel; Asfaha, Luwam; Teshale, Makda; Kibreab, Mikal; Anand, Indermeet Singh; Tesfamariam, Eyasu H.; Russom, Mulugeta			Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Usage and co-prescription with other potentially interacting drugs in elderly: A cross-sectional study	PLOS ONE			English	Article							PRESCRIBERS	Globally, usage of non-steroidal anti-inflammatory drugs (NSAIDs) in elderly with chronic pain has been reported as frequent. Though NSAIDs are fundamental in maintaining their quality of life, the risk of polypharmacy, drug interactions and adverse effects is of paramount importance as the elderly usually require multiple medications for their co-morbidities. If prescriptions are not appropriately monitored and managed, they are likely to expose patients to serious drug interactions and potentially fatal adverse effects. This study was conducted to assess the appropriateness of NSAIDs use and determine the risk of NSAIDs related potential interactions in elderly. An analytical cross-sectional study was conducted among elderly out-patients (aged 60 and above) who visited three hospitals in Asmara, Eritrea, between August 22 and September 29, 2018. A stratified random sampling design was employed and data was collected using an interview-based questionnaire and by abstracting information from patients' prescriptions and medical cards. Descriptive and analytical statistics including chi-square test and logistic regression were employed using IBM SPSS (version 22). A total of 285 respondents were enrolled in the study with similar male to female ratio. One in four of all respondents were chronic NSAIDs users and NSAIDs risk practice was reported in 24%. Using chronic NSAIDs without prophylactic gastro-protective agents, self-medication, polypharmacy and drug-drug interactions were the main problems identified. A total of 322 potential interactions in 205 patients were identified and of which, 97.2% were classified as moderate, 0.6% severe and the rest were mild. Those who involved in self-medication were more likely to be exposed to drug interactions. Diabetes (AOR = 2.39, 95% CI: 1.14, 5.02) and hypertension (AOR = 9.06, 95% CI: 4.00, 20.51) were associated with chronic NSAIDs use and incidence of potential drug interactions (AOR = 3.5, 95%CI: 1.68, 4.3; AOR = 2.81, 95%CI: 1.61, 4.9 respectively), while diabetes AOR = 4.5, 95% CI: 2.43, 8.35) and cardiac problems (AOR = 4.29, 95% CI: 1.17, 15.73) were more likely to be associated with incidence of polypharmacy. In conclusion, chronic use of NSAIDs without gastro-protective agents and therapeutic duplication of NSAIDs were commonly which requires attention from programmers, health facility managers and healthcare professionals to safeguard elderlies from preventable harm.	[Abdu, Nuru; Mosazghi, Asmerom; Teweldemedhin, Samuel; Asfaha, Luwam; Teshale, Makda; Kibreab, Mikal; Anand, Indermeet Singh] Asmara Coll Hlth Sci, Sch Pharm, Asmera, Eritrea; [Tesfamariam, Eyasu H.] Eritrean Inst Technol, Coll Sci, Biostat & Epidemiol Unit, Dept Stat, Mai Nefhi, Eritrea; [Russom, Mulugeta] Natl Medicines & Food Adm, Eritrean Pharmacovigilance Ctr, Asmera, Eritrea		Abdu, N (corresponding author), Asmara Coll Hlth Sci, Sch Pharm, Asmera, Eritrea.	pharmacistnuru@gmail.com	Russom, Mulugeta/ACM-0020-2022	Russom, Mulugeta/0000-0003-1939-5842; Abdu, Nuru/0000-0003-2426-4337				Abdulla A, 2013, AGE AGEING, V42, pI1, DOI 10.1093/ageing/afs200; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; [Anonymous], 2014, TRUSTS TRUSTEES, V20, P673; [Anonymous], 2018, 7 SER FPGAS DAT SHEE, V2, P1; Ateshim Y, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7020-x; Bahta M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228013; Bakhriansyah M, 2019, CLIN J AM SOC NEPHRO, V14, P1355, DOI 10.2215/CJN.14331218; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Chen YW, 2016, COGN COMPUT, V8, P114, DOI 10.1007/s12559-015-9346-8; Davies EA, 2015, BRIT J CLIN PHARMACO, V80, P796, DOI 10.1111/bcp.12596; Ely Luísa Scheer, 2015, Rev. bras. geriatr. gerontol., V18, P475, DOI 10.1590/1809-9823.2015.14141; Excellence NIfHaC, 2008, OST CAR MAN OST AD; Goudanavar P, 2016, ASIAN J BIOMEDICAL P, P6; Improvement IfCS, 2011, HLTH CAR GUID ASS MA; Ko Y, 2008, DRUG SAFETY, V31, P525, DOI 10.2165/00002018-200831060-00007; Ko Y, 2008, RES SOC ADMIN PHARM, V4, P355, DOI 10.1016/j.sapharm.2007.10.004; Lanas A, 2012, AM J GASTROENTEROL, V107, P707, DOI 10.1038/ajg.2012.13; Lanza FL, 2009, AM J GASTROENTEROL, V104, P728, DOI 10.1038/ajg.2009.115; Lima Tiago Aparecido Maschio de, 2016, Rev. bras. geriatr. gerontol., V19, P533, DOI 10.1590/1809-98232016019.150062; Raschi E, 2015, BRIT J CLIN PHARMACO, V80, P1411, DOI 10.1111/bcp.12754; Saedder EA, 2015, BRIT J CLIN PHARMACO, V80, P808, DOI 10.1111/bcp.12600; Schneider V, 2006, AM J EPIDEMIOL, V164, P881, DOI 10.1093/aje/kwj331; Stiftung Warentest, 2016, NON TRADITIONAL REF, V6, P54; Straube S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-41; Suh DC, 2008, RHEUMATOLOGY, V47, P458, DOI [10.1093/rheumatalogy/kem375, 10.1093/rheumatology/kem375]; U.S. Food and Drug Administration (FDA), 2015, FDA STRENGTHENS WARN; Vandraas KF, 2010, EUR J CLIN PHARMACOL, V66, P823, DOI 10.1007/s00228-010-0825-2	27	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0238868	10.1371/journal.pone.0238868	http://dx.doi.org/10.1371/journal.pone.0238868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035226	Green Published, gold			2022-12-26	WOS:000581817500057
J	Behe, BK; Huddleston, PT; Childs, KL; Chen, JP; Muraro, IS				Behe, Bridget K.; Huddleston, Patricia T.; Childs, Kevin L.; Chen, Jiaoping; Muraro, Iago S.			Seeing through the forest: The gaze path to purchase	PLOS ONE			English	Article							EYE-TRACKING; VISUAL-ATTENTION; CONSUMER PREFERENCES; CHOICE PROCESSES; TIME PRESSURE; INVOLVEMENT; MODEL; EXPLORATION; DECISIONS; KNOWLEDGE	Eye tracking studies have analyzed the relationship between visual attention to point of purchase marketing elements (price, signage, etc.) and purchase intention. Our study is the first to investigate the relationship between the gaze sequence in which consumers view a display (including gaze aversion away from products) and the influence of consumer (top down) characteristics on product choice. We conducted an in-lab 3 (display size: large, moderate, small) X 2 (price: sale, non-sale) within-subject experiment with 92 persons. After viewing the displays, subjects completed an online survey to provide demographic data, self-reported and actual product knowledge, and past purchase information. We employed a random forest machine learning approach via R software to analyze all possible three-unit subsequences of gaze fixations. Models comparing multiclass F1-macro score and F1-micro score of product choice were analyzed. Gaze sequence models that included gaze aversion more accurately predicted product choice in a lab setting for more complex displays. Inclusion of consumer characteristics generally improved model predictive F1-macro and F1-micro scores for less complex displays with fewer plant sizes Consumer attributes that helped improve model prediction performance were product expertise, ethnicity, and previous plant purchases.	[Behe, Bridget K.] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Huddleston, Patricia T.; Muraro, Iago S.] Michigan State Univ, Coll Commun Arts & Sci, Dept Advertising & Publ Relat, E Lansing, MI 48824 USA; [Childs, Kevin L.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Chen, Jiaoping] Michigan State Univ, Eli Broad Coll Business, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Behe, BK (corresponding author), Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA.	behe@msu.edu	Huddleston, Patricia/AAQ-9544-2021; Childs, Kevin/C-9513-2014	Behe, Bridget/0000-0002-7895-6235; Childs, Kevin/0000-0002-3680-062X	United States Department of Agriculture - Federal State Marketing Improvement Program [16FSMIPMI0007]; Horticultural Research Institute [6012448]	United States Department of Agriculture - Federal State Marketing Improvement Program; Horticultural Research Institute	The study was funded by the United States Department of Agriculture - Federal State Marketing Improvement Program Grant 16FSMIPMI0007 which was awarded to bkb, pth, and klc. Their website is located at https://www.ams.usda.gov/services/grants/fsmip.Additional funding was provided by the Horticultural Research Institute grant #6012448 and awarded to bkb, pth, and klc. Their website is located at https://www.hriresearch.org/.	ALBA JW, 1987, J CONSUM RES, V13, P411, DOI 10.1086/209080; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; [Anonymous], 2016, CANC DISCOV; [Anonymous], 2012, GERODONTOLOGY, V29, pe772; Armstrong T, 2012, CLIN PSYCHOL REV, V32, P704, DOI 10.1016/j.cpr.2012.09.004; Atalay AS, 2012, J CONSUM RES, V39, P848, DOI 10.1086/665984; Ballco P, 2019, FOOD RES INT, V116, P37, DOI 10.1016/j.foodres.2018.12.031; BEATTIE GW, 1981, BRIT J SOC PSYCHOL, V20, P243, DOI 10.1111/j.2044-8309.1981.tb00493.x; Behe BK, 2013, INT REV RETAIL DISTR, V23, P511, DOI 10.1080/09593969.2013.832695; Behe BK, 2015, J RETAIL CONSUM SERV, V24, P10, DOI 10.1016/j.jretconser.2015.01.002; Bialkova S, 2020, FOOD QUAL PREFER, V81, DOI 10.1016/j.foodqual.2019.103839; Brandmaier AM, 2013, PSYCHOL METHODS, V18, P71, DOI 10.1037/a0030001; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, MANUAL SETTING USING; Brennan M., 1994, FAST MOVING CONSUMER, V5, P47; Chandon P, 2009, J MARKETING, V73, P1, DOI 10.1509/jmkg.73.6.1; Chita-Tegmark M, 2016, RES DEV DISABIL, V48, P79, DOI 10.1016/j.ridd.2015.10.011; Clement J, 2013, J RETAIL CONSUM SERV, V20, P234, DOI 10.1016/j.jretconser.2013.01.003; Clement J, 2007, J MARKET MANAG-UK, V23, P917, DOI 10.1362/026725707X250395; Coco MI, 2014, Q J EXP PSYCHOL, V67, P1096, DOI 10.1080/17470218.2013.844843; Coltekin A, 2010, INT J GEOGR INF SCI, V24, P1559, DOI 10.1080/13658816.2010.511718; Datalicious and Econsultancy, 2016, WOULD YOU RAT EFF YO; Deng XY, 2016, J MARKETING RES, V53, P682, DOI 10.1509/jmr.13.0151; Dennis JH, 2007, HORTSCIENCE, V42, P262, DOI 10.21273/HORTSCI.42.2.262; Doherty-Sneddon G, 2002, DEV PSYCHOL, V38, P438, DOI 10.1037//0012-1649.38.3.438; Drusch G, 2011, P 23 C INT HOMM MACH, P1, DOI [10.1145/2044354.2044356, DOI 10.1145/2044354.2044356]; EFSA Panel on Additives and Products or Substances used in Animal Feed, 2015, EFSA Journal, V13, P4198; Forsdyke DR, 2019, BIOL J LINN SOC, V128, P239, DOI 10.1093/biolinnean/blz096; Glenberg AM, 1998, MEM COGNITION, V26, P651, DOI 10.3758/BF03211385; Greenacre L, 2016, J RETAIL CONSUM SERV, V32, P32, DOI 10.1016/j.jretconser.2016.06.006; Grewal D, 1998, J RETAILING, V74, P331, DOI 10.1016/S0022-4359(99)80099-2; Guralnick RM, 1998, TRENDS MATH, P81; Hendrickson K, 2014, REV MARKET RES, V11, P57, DOI 10.1108/S1548-643520140000011002; Huddleston P, 2015, INT J RETAIL DISTRIB, V43, P561, DOI 10.1108/IJRDM-06-2013-0120; Huddleston PT, 2018, J RETAIL CONSUM SERV, V43, P85, DOI 10.1016/j.jretconser.2018.03.006; Jones M., 2014, CURRENT TRENDS EYE T, P183, DOI DOI 10.1007/978-3-319-02868-2_14; Joo E, 2017, PRODUCT EXPERTISE IN; Josephson S, 2002, BEHAV RES METH INS C, V34, P539, DOI 10.3758/BF03195483; Keshvari S, 2016, J VISION, V16, DOI 10.1167/16.3.39; Khachatryan H, 2018, MARKET LETT, V29, P23, DOI 10.1007/s11002-018-9446-9; Lahey JN, 2016, AM ECON REV, V106, P309, DOI 10.1257/aer.p20161009; Liaw A., 2018, RANDOMFOREST BREIMAN; Lin LY, 2006, J CONSUM MARK, V23, P248, DOI 10.1108/07363760610681655; Manekar SC, 2019, CURR GENOMICS, V20, P2, DOI 10.2174/1389202919666181026101326; Mylopoulos M, 2007, MED EDUC, V41, P1159, DOI 10.1111/j.1365-2923.2007.02912.x; Neff G, 2017, ADAGE; Olson J.C., 1972, P 3 ANN C ASS CONS R, P167; Orquin CA, ACTA PSYCHOL AMST, V144, P190; Otterbring T, 2020, PERSPECT BEHAV SCI, V43, P451, DOI 10.1007/s40614-020-00242-2; Otterbring T, 2019, J RETAIL CONSUM SERV, V47, P177, DOI 10.1016/j.jretconser.2018.11.019; Otterbring T, 2018, PSYCHOL MARKET, V35, P454, DOI 10.1002/mar.21098; Otterbring T, 2014, J RETAIL CONSUM SERV, V21, P676, DOI 10.1016/j.jretconser.2014.05.002; Pieters R, 1999, INT J RES MARK, V16, P1, DOI 10.1016/S0167-8116(98)00022-6; Ravaja N, 2013, J NEUROSCI PSYCHOL E, V6, P1, DOI 10.1037/a0029949; Rebollar R, 2015, FOOD QUAL PREFER, V39, P251, DOI 10.1016/j.foodqual.2014.08.002; Reutskaja E, 2011, AM ECON REV, V101, P900, DOI 10.1257/aer.101.2.900; Rihn A, 2016, AGR ECON-BLACKWELL, V47, P599, DOI 10.1111/agec.12258; Rihn A, 2015, HORTSCIENCE, V50, P1524, DOI 10.21273/HORTSCI.50.10.1524; Rothkopf CA, 2007, J VISION, V7, DOI 10.1167/7.14.16; RUSSO JE, 1994, J CONSUM RES, V21, P274, DOI 10.1086/209397; Scarpi D, 2019, J RETAIL CONSUM SERV, V49, P267, DOI 10.1016/j.jretconser.2019.03.006; SHANTEAU J, 1992, ORGAN BEHAV HUM DEC, V53, P252, DOI 10.1016/0749-5978(92)90064-E; Shi SW, 2013, MANAGE SCI, V59, P1009, DOI 10.1287/mnsc.1120.1625; Smith EE, 2006, COGNITIVE PSYCHOL MI; STORY M, 1986, PHOTOGRAMM ENG REM S, V52, P397; Sundararajan RR, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00704; Tortora G, 2019, FOOD RES INT, V119, P605, DOI 10.1016/j.foodres.2018.10.038; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wastlund E, 2018, APPETITE, V120, P49, DOI 10.1016/j.appet.2017.08.024; Wedel M, 2008, EYE TRACKING VISUAL, V1, P266; Wei JM, 2010, EXPERT SYST APPL, V37, P3799, DOI 10.1016/j.eswa.2009.11.040; Wolfe JM, 2019, CURR OPIN PSYCHOL, V29, P19, DOI 10.1016/j.copsyc.2018.11.005; Yang SS, 2012, INT J HOSP MANAG, V31, P1021, DOI 10.1016/j.ijhm.2011.12.008; 2008, REV AGENCIA PLANECIO, V3, P9	76	5	5	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240179	10.1371/journal.pone.0240179	http://dx.doi.org/10.1371/journal.pone.0240179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3WA	33036020	gold, Green Published			2022-12-26	WOS:000581817500040
J	Zhang, LL; Qin, YQ; Wu, G; Wang, JY; Cao, JW; Wang, YQ; Wu, D; Yang, KY; Zhao, ZG; He, LC; Lyu, JX; Li, HZ; Gu, HH				Zhang, Lingling; Qin, Yaqian; Wu, Guang; Wang, Jieyi; Cao, Jiawei; Wang, Yaqi; Wu, Du; Yang, Kaiyan; Zhao, Zhiguang; He, Licai; Lyu, Jianxin; Li, Hongzhi; Gu, Haihua			PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1	ONCOGENE			English	Article							FOCAL ADHESION KINASE; MESENCHYMAL TRANSITION; AXON GUIDANCE; WAGR SYNDROME; PROTEINS; ROUNDABOUT; MIGRATION; PATHWAY; BINDING; FAMILY	Metastasis is responsible for the death of most breast cancer patients. Robo1 has been implicated as a tumor suppressor for various cancers including breast cancer. However, it is not well understood how Robo1 expression is regulated during tumorigenesis. In this study, we uncovered that the transmembrane proline rich gamma-carboxyglutamic acid protein 4 (PRRG4) promotes breast cancer metastasis by downregulating Robo1. Analysis of mRNA expression data in The Cancer Genome Atlas and immunohistochemistry assay on breast tumor samples showed that PRRG4 expression was higher in breast tumors than in normal breast tissues. Experiments with PRRG4 knockdown and overexpression revealed that PRRG4 promoted migration and invasion of breast cancer cells, and enhanced metastasis in an experimental metastasis model. Mechanistically, we found that PRRG4 via its LPSY and PPPY motifs recruited the E3 ubiquitin ligase NEDD4, which induced ubiquitination and degradation of Robo1, thus contributing to migration and invasion of breast cancer cells. In addition, PRRG4 interacted with and enhanced protein tyrosine kinase Src and FAK activation. Overall, our data support a model that PRRG4 via NEDD4 downregulates the Robo1, resulting in the activation of Src and FAK and promoting breast cancer metastasis. PRRG4 may be a novel target for treating metastatic breast cancer.	[Zhang, Lingling; Qin, Yaqian; Wu, Guang; Wang, Jieyi; Cao, Jiawei; Wang, Yaqi; Wu, Du; He, Licai; Lyu, Jianxin; Li, Hongzhi; Gu, Haihua] Wenzhou Med Univ, Sch Lab Med & Life Sci, Key Lab Lab Med, Minist Educ, Wenzhou 325035, Peoples R China; [Yang, Kaiyan] Wenzhou Med Univ, Dept Pathol, Affiliated Hosp 1, Wenzhou 325035, Peoples R China; [Zhao, Zhiguang] Wenzhou Med Univ, Dept Pathol, Affiliated Hosp 2, Wenzhou 325000, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Lyu, JX; Li, HZ; Gu, HH (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Key Lab Lab Med, Minist Educ, Wenzhou 325035, Peoples R China.	jxlu313@163.com; lhz@wmu.edu.cn; haihuagu@wmu.edu.cn	zhang, lingling/HDM-2189-2022	Wang, Jieyi/0000-0001-7444-0656; Cao, Jiawei/0000-0001-6268-5912	National Natural Science Foundation of China [81972463, 81772819]; Natural Science Foundation of Zhejiang Province, China [LY20C080001, LY18H080003]; Wenzhou Medical University Startup funds; Key Discipline of Zhejiang Province in Medical Technology (First Class, Category A)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Wenzhou Medical University Startup funds; Key Discipline of Zhejiang Province in Medical Technology (First Class, Category A)	We thank Dr. Weibao Jiao (Kunming Institute of Zoology, Academia Sinica) for kindly providing us the MDA-MB-231-luciferase cells, and Helen Gu (Department of Economics, Massachusetts Institute of Technology) for proofreading the paper. This work was supported by grants (81972463 and 81772819) from the National Natural Science Foundation of China, and grants (LY20C080001 and LY18H080003) from Natural Science Foundation of Zhejiang Province, China, and was supported in part by Wenzhou Medical University Startup funds and the Key Discipline of Zhejiang Province in Medical Technology (First Class, Category A).	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Ballard MS, 2012, ADV CANCER RES, V114, P187, DOI 10.1016/B978-0-12-386503-8.00005-3; Bhattacharya R, 2016, J GENET, V95, P551, DOI 10.1007/s12041-016-0678-2; Blockus H, 2016, DEVELOPMENT, V143, P3037, DOI 10.1242/dev.132829; Blockus H, 2014, CURR OPIN NEUROBIOL, V27, P82, DOI 10.1016/j.conb.2014.03.003; Boase NA, 2015, GENE, V557, P113, DOI 10.1016/j.gene.2014.12.020; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Juarez-Cruz JC, 2019, ENDOCR CONNECT, V8, P1539, DOI 10.1530/EC-19-0442; Chang PH, 2012, CANCER RES, V72, P4652, DOI 10.1158/0008-5472.CAN-12-0877; Dallol A, 2002, ONCOGENE, V21, P3020, DOI 10.1038/sj.onc.1205421; Dickinson RE, 2010, REPRODUCTION, V139, P697, DOI 10.1530/REP-10-0017; Diepenbruck M, 2014, J CELL SCI, V127, P1523, DOI 10.1242/jcs.139865; Fang ZH, 2019, EXP CELL RES, V382, DOI 10.1016/j.yexcr.2019.06.007; Fitzmaurice C, 2021, JAMA ONCOL, DOI 10.1001/jamaoncol.2020.8307; Gara RK, 2015, DRUG DISCOV TODAY, V20, P156, DOI 10.1016/j.drudis.2014.09.008; Gilestro GF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003798; Gorla M, 2019, CELL REP, V26, P3298, DOI 10.1016/j.celrep.2019.02.080; HE L, 2017, SCI REP UK, V7; Justice ED, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006865; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; Ke H, 2018, P NATL ACAD SCI USA, V115, pE3426, DOI 10.1073/pnas.1714573115; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kong RR, 2015, J CLIN INVEST, V125, P4407, DOI 10.1172/JCI81673; Kulman JD, 1997, P NATL ACAD SCI USA, V94, P9058, DOI 10.1073/pnas.94.17.9058; Kulman JD, 2001, P NATL ACAD SCI USA, V98, P1370, DOI 10.1073/pnas.98.4.1370; Lu W, 2019, DEV CELL, V49, P361, DOI 10.1016/j.devcel.2019.04.010; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Naser R, 2018, CANCERS, V10, DOI 10.3390/cancers10060196; Nayar U, 2019, NAT GENET, V51, P207, DOI 10.1038/s41588-018-0287-5; Ngan E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15059; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Patel A, 2016, LIFE SCI, V157, P52, DOI 10.1016/j.lfs.2016.05.036; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Qin F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09977; Schmid BC, 2007, BREAST CANCER RES TR, V106, P333, DOI 10.1007/s10549-007-9504-0; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Waks Adrienne G, 2019, JAMA, V321, P288, DOI 10.1001/jama.2018.19323; Wallace AG, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.168724; Wang Jing, 2011, Zhonghua Zhong Liu Za Zhi, V33, P447; Wang SZ, 2013, J NEUROSCI, V33, P12242, DOI 10.1523/JNEUROSCI.5736-12.2013; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Xia YW, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12606; Xu S, 2008, CYTOGENET GENOME RES, V122, P181, DOI 10.1159/000172086; Yamamoto T, 2014, AM J MED GENET A, V164, P634, DOI 10.1002/ajmg.a.36325; Yang N, 2012, CELL CYCLE, V11, P2922, DOI 10.4161/cc.21386; Yazicioglu MN, 2013, J BIOL CHEM, V288, P25908, DOI 10.1074/jbc.M113.484683; Yip KT, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-128; Yuan TC, 2017, BIOCHEM BIOPH RES CO, V488, P439, DOI 10.1016/j.bbrc.2017.04.072; Yuasa-Kawada J, 2009, P NATL ACAD SCI USA, V106, P14530, DOI 10.1073/pnas.0801262106; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	54	10	10	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2020	39	49					7196	7208		10.1038/s41388-020-01494-7	http://dx.doi.org/10.1038/s41388-020-01494-7		OCT 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PB0GA	33037408				2022-12-26	WOS:000578440800002
J	Baral, K; Coulman, B; Biligetu, B; Fu, YB				Baral, Kiran; Coulman, Bruce; Biligetu, Bill; Fu, Yong-Bi			Advancing crested wheatgrass [Agropyron cristatum(L.) Gaertn.] breeding through genotyping-by-sequencing and genomic selection	PLOS ONE			English	Article							GENETIC DIVERSITY ANALYSIS; AGROPYRON-CRISTATUM; PREDICTION ACCURACY; ASSOCIATION; RESISTANCE; REGRESSION; AFLP; MAP	Crested wheatgrass [Agropyron cristatum(L.) Gaertn.] provides high quality, highly palatable forage for early season grazing. Genetic improvement of crested wheatgrass has been challenged by its complex genome, outcrossing nature, long breeding cycle, and lack of informative molecular markers. Genomic selection (GS) has potential for improving traits of perennial forage species, and genotyping-by-sequencing (GBS) has enabled the development of genome-wide markers in non-model polyploid plants. An attempt was made to explore the utility of GBS and GS in crested wheatgrass breeding. Sequencing and phenotyping 325 genotypes representing 10 diverse breeding lines were performed. Bioinformatics analysis identified 827, 3,616, 14,090 and 46,136 single nucleotide polymorphism markers at 20%, 30%, 40% and 50% missing marker levels, respectively. Four GS models (BayesA, BayesB, BayesC pi, and rrBLUP) were examined for the accuracy of predicting nine agro-morphological and three nutritive value traits. Moderate accuracy (0.20 to 0.32) was obtained for the prediction of heading days, leaf width, plant height, clump diameter, tillers per plant and early spring vigor for genotypes evaluated at Saskatoon, Canada. Similar accuracy (0.29 to 0.35) was obtained for predicting fall regrowth and plant height for genotypes evaluated at Swift Current, Canada. The Bayesian models displayed similar or higher accuracy than rrBLUP. These findings show the feasibility of GS application for a non-model species to advance plant breeding.	[Baral, Kiran; Coulman, Bruce; Biligetu, Bill] Univ Saskatchewan, Dept Plant Sci, Coll Agr & Bioresources, Saskatoon, SK, Canada; [Fu, Yong-Bi] Agr & Agri Food Canada, Plant Gene Resources Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada	University of Saskatchewan; Agriculture & Agri Food Canada	Biligetu, B (corresponding author), Univ Saskatchewan, Dept Plant Sci, Coll Agr & Bioresources, Saskatoon, SK, Canada.; Fu, YB (corresponding author), Agr & Agri Food Canada, Plant Gene Resources Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada.	bill.biligetu@usask.ca; yong-bi.fu@canada.ca		Coulman, Bruce/0000-0001-9813-8435; Baral, Kiran/0000-0001-5498-1973; Fu, Yong-Bi/0000-0003-3106-1247	Beef Cattle Research Council of Canada; Agriculture and AgriFood Canada (AAFC)	Beef Cattle Research Council of Canada; Agriculture and AgriFood Canada (AAFC)(Agriculture & Agri Food Canada)	This project was funded by Beef Cattle Research Council of Canada. Agriculture and AgriFood Canada (AAFC) provides lab operation funding support to AAFC scientist YBF, where the DNA extraction was carried out.	Annicchiarico P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2212-y; [Anonymous], 2015, PULSE INT, V16, P1; Asay KH, 1986, CRESTED WHEATGRASS I, P53; Baral K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092587; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bouvet JM, 2016, HEREDITY, V116, P146, DOI 10.1038/hdy.2015.78; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Burgueno J, 2012, CROP SCI, V52, P707, DOI 10.2135/cropsci2011.06.0299; Che YH, 2015, PLANT SYST EVOL, V301, P163, DOI 10.1007/s00606-014-1062-4; Conaghan P, 2011, IRISH J AGR FOOD RES, V50, P47; Coulman B., 2013, Revitalising Grasslands to Sustain our Communities: Proceedings, 22nd International Grassland Congress, 15-19 September, 2013, Sydney, Australia, P290; Crossa J, 2017, TRENDS PLANT SCI, V22, P961, DOI 10.1016/j.tplants.2017.08.011; Dias KOD, 2018, HEREDITY, V121, P24, DOI 10.1038/s41437-018-0053-6; de Roos APW, 2009, GENETICS, V183, P1545, DOI 10.1534/genetics.109.104935; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; DONG YS, 1992, HEREDITAS, V116, P175, DOI 10.1111/j.1601-5223.1992.tb00224.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Faville M. J., 2016, Breeding in a world of scarcity. 31st Eucarpia Fodder Crops and Amenity Grasses Congress, Ghent, Belgium, 13-17 September 2015, P139; Faville MJ, 2018, THEOR APPL GENET, V131, P703, DOI 10.1007/s00122-017-3030-1; Fiedler JD, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1360-z; Fu YB, 2017, METHODS MOL BIOL, V1536, P169, DOI 10.1007/978-1-4939-6682-0_13; Fu YB, 2014, G3-GENES GENOM GENET, V4, P891, DOI 10.1534/g3.114.010942; Fu YB, 2011, PLANT GENOME-US, V4, P226, DOI 10.3835/plantgenome2011.08.0022; Gardner Kyle M, 2014, G3 (Bethesda), V4, P1681, DOI 10.1534/g3.114.011023; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Grinberg NF, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00133; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; Hayes BJ, 2013, PLANT BREEDING, V132, P133, DOI 10.1111/pbr.12037; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Henderson DC, 2005, BIOL INVASIONS, V7, P639, DOI 10.1007/s10530-004-6669-x; Henderson DC, 2005, ECOLOGY MANAGMENT CR; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Holland JB, 2002, PL BRED RE, V22, P9; Huang Yung-Fen, 2014, PLoS One, V9, pe102448, DOI 10.1371/journal.pone.0102448; HULL A. C., 1966, J RANGE MANAGE, V19, P5, DOI 10.2307/3895516; Hung HY, 2012, HEREDITY, V108, P490, DOI 10.1038/hdy.2011.103; Jia CJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01220; Kutner M., 2005, APPL LINEAR STAT MOD; LANDE R, 1990, GENETICS, V124, P743; Lenth RV., 2021, EMMEANS ESTIMATED MA; Lipka AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112227; LOOMAN J, 1973, CAN J PLANT SCI, V53, P501, DOI 10.4141/cjps73-097; Lopez-Cruz M, 2015, G3-GENES GENOM GENET, V5, P569, DOI 10.1534/g3.114.016097; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Massman JM, 2013, THEOR APPL GENET, V126, P13, DOI 10.1007/s00122-012-1955-y; Mellish A, 2002, CROP SCI, V42, P1662, DOI 10.2135/cropsci2002.1662; Meuwissen THE, 2001, GENETICS, V157, P1819; Oakey H, 2016, G3-GENES GENOM GENET, V6, P1313, DOI 10.1534/g3.116.027524; Ochoa V, 2015, EUPHYTICA, V201, P89, DOI 10.1007/s10681-014-1190-5; Pembleton LW, 2018, THEOR APPL GENET, V131, P1891, DOI 10.1007/s00122-018-3121-7; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Peterson G. W., 2014, Diversity, V6, P665, DOI 10.3390/d6040665; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Poudel HP, 2019, G3-GENES GENOM GENET, V9, P1921, DOI 10.1534/g3.119.400094; Rabier CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156086; Ramstein GP, 2016, G3-GENES GENOM GENET, V6, P1049, DOI 10.1534/g3.115.024950; Riedelsheimer C, 2013, GENETICS, V194, P493, DOI 10.1534/genetics.113.150227; ROGLER GA, 1983, J RANGE MANAGE, V36, P91, DOI 10.2307/3897991; SAS Institute Inc, 2013, SAS VERS 9 4; SHARMA HC, 1984, PHYTOPATHOL Z, V110, P143; Smoliak S, 1981, MANAGING CRESTED WHE, P19; Spindel JE, 2016, HEREDITY, V116, P395, DOI 10.1038/hdy.2015.113; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Tinker NA, 2016, G3-GENES GENOM GENET, V6, P857, DOI 10.1534/g3.115.024596; University of Saskatcehwan, 2019, EC SASK; Vaness BM, 2007, CAN J PLANT SCI, V87, P1023, DOI 10.4141/CJPS07120; Werner CR, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.09.0084; Wilkins PW, 2003, J AGR SCI-CAMBRIDGE, V140, P129, DOI 10.1017/S0021859603003058; Wurschum T, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-85; Yang MH, 2017, APPL PLANT SCI, V5, DOI 10.3732/apps.1700018; Yu XX, 2012, GENOME, V55, P327, DOI [10.1139/g2012-014, 10.1139/G2012-014]; Zeng FQ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110291; Zeng FQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177417; Zhang HH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00189; Zhang JP, 2015, GENOMICS, V106, P129, DOI 10.1016/j.ygeno.2015.04.003; Zhang XF, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.07.0059; Zhang Y, 2015, PLANTA, V242, P1335, DOI 10.1007/s00425-015-2372-7; Zhou SH, 2018, PLANT BIOTECHNOL J, V16, P818, DOI 10.1111/pbi.12831; 2015, DRUG SAFETY UPDATE, V8, P1	84	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239609	10.1371/journal.pone.0239609	http://dx.doi.org/10.1371/journal.pone.0239609			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031422	Green Published, gold			2022-12-26	WOS:000581809800006
J	Fadda, M; Chappuis, PO; Katapodi, MC; Pagani, O; Monnerat, C; Membrez, V; Unger, S; Zufferey, MC				Fadda, Marta; Chappuis, Pierre O.; Katapodi, Maria C.; Pagani, Olivia; Monnerat, Christian; Membrez, Veronique; Unger, Sheila; Caiata Zufferey, Maria			Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?	PLOS ONE			English	Article							HEALTH-CARE; AUTONOMY; PATIENT; GENOMICS	BRCA1/2genetic testing offers tremendous opportunities for prevention, diagnosis and treatment of breast and ovarian cancer. Women acquire valuable information that can help them to make informed decisions about their health. However, knowing one's susceptibility to developing cancer may be burdensome for several women, as this risk needs to be managed over time through a continuous dialogue with multiple healthcare professionals. We explored how communication between physicians and unaffected women carryingBRCA1/2germline pathogenic variants was experienced by women in relation to their genetic risk. Data came from qualitative interviews conducted in Switzerland with 32 unaffected women carryingBRCA1/2pathogenic variants and aware of their genetic status for at least 3 years. We identified three different types of message as conveyed by physicians to women: (1) a normative message, (2) an over-empowering message, and (3) a minimizing message. On one hand, we found that women are exposed to contradictory messages, often simultaneously, in their interactions with healthcare professionals during their post-genetic testing journey. On the other hand, women's reports highlighted the absence of shared decision-making in such interactions. The combination of these two findings resulted in a strong sense of disorientation, frustration, and powerlessness among participants. Healthcare professionals interacting with high cancer risk women are urged to align in favor of a both concerted and shared decision-making approach when discussing options for managing genetic risk.	[Fadda, Marta] Univ Svizzera italiana, Inst Publ Hlth, Fac Biomed Sci, Italiana, Switzerland; [Chappuis, Pierre O.] Geneva Univ Hosp, Div Genet Med, Geneva, Switzerland; [Chappuis, Pierre O.] Geneva Univ Hosp, Div Oncol, Geneva, Switzerland; [Katapodi, Maria C.] Univ Basel, Dept Clin Res, Fac Med, Basel, Switzerland; [Pagani, Olivia] Geneva Univ Hosp, Geneva, Switzerland; [Monnerat, Christian] Hop Jura, Serv Oncol, Delemont, Switzerland; [Membrez, Veronique] Hop Valais, Inst Cent ICH, Div Med Genet, Sion, Switzerland; [Unger, Sheila] CHU Vaudois, Serv Med Genet, Lausanne, Switzerland; [Caiata Zufferey, Maria] Univ Appl Sci & Arts Southern Switzerland, Manno, Switzerland	Universita della Svizzera Italiana; University of Geneva; University of Geneva; University of Basel; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Zufferey, MC (corresponding author), Univ Appl Sci & Arts Southern Switzerland, Manno, Switzerland.	maria.caiata@supsi.ch	Pagani, Olivia/ABF-3164-2020	Katapodi, Maria/0000-0003-3903-3750; Caiata-Zufferey, Maria/0000-0003-4197-8913; Fadda, Marta/0000-0003-3537-0346	Swiss National Science Foundation [PZ00P1_132633/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	MCZ was supported by the Swiss National Science Foundation, http://www.snf.ch/en/Pages/default.aspx (grant number PZ00P1_132633/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], **NON-TRADITIONAL**; Apostolou P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/747318; Balmana J, 2011, ANN ONCOL, V22, pvi31, DOI 10.1093/annonc/mdr373; Barnes-Kedar IM, 2002, OBSTET GYN CLIN N AM, V29, P341, DOI 10.1016/S0889-8545(01)00004-3; Blasimme A, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0149-6; Blazer KR, 2015, GENET TEST MOL BIOMA, V19, P657, DOI 10.1089/gtmb.2015.0061; Caiata-Zufferey M, 2015, GENET MED, V17, P726, DOI 10.1038/gim.2014.183; Charles C, 1999, BRIT MED J, V319, P780, DOI 10.1136/bmj.319.7212.780; Christensen KD, 2016, CLIN GENET, V89, P228, DOI 10.1111/cge.12626; Dove Edward S, 2017, Clin Ethics, V12, P150, DOI 10.1177/1477750917704156; Entwistle VA, 2010, J GEN INTERN MED, V25, P741, DOI 10.1007/s11606-010-1292-2; Godlee F., 2005, BMJ-BRIT MED J, V330, P7497; Greaves D, 2000, CAMB Q HEALTHC ETHIC, V9, P23, DOI 10.1017/S0963180100001043; Hauser D, 2018, HEALTH AFFAIR, V37, P793, DOI 10.1377/hlthaff.2017.1548; Hughes TM, 2018, AM J SURG, V216, P7, DOI 10.1016/j.amjsurg.2018.01.011; Keating NL, 2018, JAMA-J AM MED ASSOC, V319, P1814, DOI 10.1001/jama.2018.3388; Kreiner M. J., 2013, SOCIOLOGY HLTH ILLNE, V36, P870; Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112; Kurian AW, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.16.00066; Lau Y, 2009, J BIOETHIC INQ, V6, P495, DOI 10.1007/s11673-009-9188-8; Lowy I, 2008, SCI TECHNOL HUM VAL, V33, P299, DOI 10.1177/0162243907306855; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; McCuaig JM, 2018, J MED GENET, V55, P571, DOI 10.1136/jmedgenet-2018-105472; Met-Domestici Marie, 2020, Rev Med Suisse, V16, P374; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Muhr T, 2004, ATLAS TI VERSION 5; Parker L, 2017, EUR J CANCER, V85, P1, DOI 10.1016/j.ejca.2017.07.056; Petersen A., 1998, CRITICAL PUBLIC HLTH, V8, P59, DOI DOI 10.1080/09581599808409212; Rosenberg C, 2009, LANCET, V373, P802, DOI 10.1016/S0140-6736(09)60467-0; Seaman K, 2018, BREAST, V42, P81, DOI 10.1016/j.breast.2018.08.102; Shepherd RF, 2017, J GENET COUNS, V26, P283, DOI 10.1007/s10897-016-0022-2; Sosnay PR, 2014, THORAX, V69, P295, DOI 10.1136/thoraxjnl-2013-204903; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Stark Z, 2019, AM J HUM GENET, V104, P13, DOI 10.1016/j.ajhg.2018.11.014; Timmermans S, 2010, J HEALTH SOC BEHAV, V51, P408, DOI 10.1177/0022146510386794; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240054	10.1371/journal.pone.0240054	http://dx.doi.org/10.1371/journal.pone.0240054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TB	33031463	gold, Green Published			2022-12-26	WOS:000581809800069
J	Nyamu, GW; Kihara, JH; Oyugi, EO; Omballa, V; El-Busaidy, H; Jeza, VT				Nyamu, Gibson Waweru; Kihara, Jimmy Hussein; Oyugi, Elvis Omondi; Omballa, Victor; El-Busaidy, Hajara; Jeza, Victor Tunje			Prevalence and risk factors associated with asymptomatic Plasmodium falciparum infection and anemia among pregnant women at the first antenatal care visit: A hospital based cross-sectional study in Kwale County, Kenya	PLOS ONE			English	Article							MALARIA; CLINICS	Background Prevalence of Prevalence of malaria in pregnancy (MiP) in Kenya ranges from 9% to 18%. We estimated the prevalence and factors associated with MiP and anemia in pregnancy (AiP) among asymptomatic women attending antenatal care (ANC) visits. Methods We performed a cross-sectional study among pregnant women attending ANC at Msambweni Hospital, between September 2018 and February 2019. Data was collected and analyzed in Epi Info 7. Descriptive statistics were calculated and we compared MiP and AiP in asymptomatic cases to those without either condition. Adjusted prevalence Odds odds ratios (aPOR) and 95% confidence intervals (CI) were calculated to identify factors associated with asymptomatic MiP and AiP. Results We interviewed 308 study participants; their mean age was 26.6 years (+/- 5.8 years), mean gestational age was 21.8 weeks (+/- 6.0 weeks), 173 (56.2%) were in the second trimester of pregnancy, 12.9% (40/308) had MiP and 62.7% had AiP. Women who were aged <= 20 years had three times likelihood of developing MiP (aPOR = 3.1 Cl: 1.3-7.35) compared to those aged >20 years old. The likelihood of AiP was higher among women with gestational age >= 16 weeks (aPOR = 3.9, CI: 1.96-7.75), those with parasitemia (aPOR = 3.3, 95% CI: 1.31-8.18), those in third trimester of pregnancy (aPOR = 2.6, 95% CI:1.40-4.96) and those who reported eating soil as a craving during pregnancy (aPOR = 1.9, 95%CI:1.15-3.29). Conclusions Majority of the women had asymptomatic MiP and AiP. MiP was observed in one tenth of all study participants. Asymptomatic MiP was associated with younger age while AiP was associated with gestational age parasitemia, and soil consumption as a craving during pregnancy.	[Nyamu, Gibson Waweru; Jeza, Victor Tunje] Tech Univ Mombasa, Mombasa, Kenya; [Nyamu, Gibson Waweru; El-Busaidy, Hajara] Kwale Cty, Dept Hlth, Kwale, Kwale County, Kenya; [Kihara, Jimmy Hussein] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Oyugi, Elvis Omondi] Minist Hlth, Kenya Field Epidemiol & Lab Training Program, Nairobi, Kenya; [Omballa, Victor] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Nairobi, Kenya	Technical University of Mombasa; Kenya Medical Research Institute; Kenya Medical Research Institute	Nyamu, GW (corresponding author), Tech Univ Mombasa, Mombasa, Kenya.; Nyamu, GW (corresponding author), Kwale Cty, Dept Hlth, Kwale, Kwale County, Kenya.	wawerugibson2015@gmail.com	Jeza, Victor Tunje/AAX-4300-2021	Jeza, Victor Tunje/0000-0002-4437-1343; Nyamu, Gibson/0000-0002-0991-8040	Technical University of Mombasa, Kenya	Technical University of Mombasa, Kenya	We would like to thank the Technical University of Mombasa, Kenya, for their support during the study. Special thanks go to study participants and to the Kwale County Department of Health authorities for their collaboration. We also thank the many Vector Borne Disease Control Unit (VBDCU) Laboratory officers, including Said Lipi, Joyce Bandika, Peter Siema, Charles Ng'ang'a, and Elton Mzungu for their dedication and meticulous microscopy. We extend a special thank you to nurse Wendy Losier, for her assistance with the consenting process and data collection. We also thank Dr. Robert Perry, Dr. Elizabeth Wanja, and Dr. Shama Cash-Goldwasser for their valuable insight and comments on the manuscript.	Agan TU, 2010, ASIAN PAC J TROP MED, V3, P51, DOI 10.1016/S1995-7645(10)60032-6; Agomo CO, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-19; Alaku I., 2015, DEV COUNTRY STUDIES, V5; Bisanzio D, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1006-7; Bouyou-Akotet MK, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-18; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Cochran William G., 2007, SAMPLING TECHNIQUES; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dicko A, 2003, ACTA TROP, V89, P17, DOI 10.1016/j.actatropica.2003.07.001; Douamba Z., 2012, BIOMED RES INT; Enato EFO, 2009, J OBSTET GYNAECOL, V29, P301, DOI 10.1080/01443610902883320; Gajida A., 2010, ANN AFR MED, V9; Gedefaw L, 2015, ETHIOP J HEALTH SCI, V25, P155, DOI 10.4314/ejhs.v25i2.8; Glover-Amengor Mary, 2005, Ghana Med J, V39, P102; Helmy ME, 2018, MENOUFIA MED J, V31, P7, DOI [10.4103/1110-2098.234258, DOI 10.4103/1110-2098.234258]; Isah AY, 2011, ANN AFR MED, V10, P171, DOI 10.4103/1596-3519.82070; Ivoke N., 2013, INT J SCI ENG RES, V4, P1876; KNBS, 2019, KEN POP HOUS CENS, V1; Matangila JR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-132; Mathee A, 2014, SAMJ S AFR MED J, V104, P568, DOI [10.7196/samj.7466, 10.7196/SAMJ.7466]; McClure EM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002724; Melku M, 2014, ANEMIA, V2014, DOI 10.1155/2014/108593; MOH, 2020, MAL PREGN; MOH, 2015, KENYA MALARIA INDICA; MOH, 2015, FOC ANT CAR; Mwangi M.N., 2014, SAFETY EFFICACY IRON; Nega Desalegn, 2015, BMC Res Notes, V8, P110, DOI 10.1186/s13104-015-1081-4; Nega D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123630; Okube O.T., 2016, OPEN J OBSTET GYNECO, V6, P16; Olubukola A, 2011, ANN AFR MED, V10, P272, DOI 10.4103/1596-3519.87042; Ouma P, 2007, TROP MED INT HEALTH, V12, P1515, DOI 10.1111/j.1365-3156.2007.01960.x; Saute F, 2002, TROP MED INT HEALTH, V7, P19, DOI 10.1046/j.1365-3156.2002.00831.x; Stephen G, 2018, ANEMIA, V2018, DOI 10.1155/2018/1846280; Tarning J, 2012, ANTIMICROB AGENTS CH, V56, P1997, DOI 10.1128/AAC.05756-11; Tay S.C., 2013, MALARIA ANAEMIA PREG; Uneke CJ, 2007, J HEALTH POPUL NUTR, V25, P328; Waweru M., 2017, CAPITAL NEWS; WHO, 2017, INT PREV TREATM MAL; WHO, 2010, BAS MAL MICR; WHO, 2020, WORLD MAL REP 2019 1; Yakubu D., 2018, NOBLE INT J SCI RES, V2, P19; Zekarias B., 2017, HEAL SCI J, V11, P1, DOI [10.21767/1791-809x.1000529, DOI 10.21767/1791-809X.1000529, 10.21767/1791-8, DOI 10.21767/1791-809X.10005294]	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239578	10.1371/journal.pone.0239578	http://dx.doi.org/10.1371/journal.pone.0239578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031456	gold, Green Published			2022-12-26	WOS:000581809800020
J	Pereira, C; Bravo, J; Veiga, G; Marmeleira, J; Mendes, F; Almeida, G				Pereira, Catarina; Bravo, Jorge; Veiga, Guida; Marmeleira, Jose; Mendes, Felismina; Almeida, Gabriela			Stepping-forward affordance perception test cut-offs: Red-flags to identify community-dwelling older adults at high risk of falling and of recurrent falling	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SCREENING TOOL; PERFORMANCE; INJURIES; HEALTH	The stepping-forwardaffordanceperception test (SF-APT) fills an important gap within the screening of falls risk factors by considering the perception ofaffordances. The test showed to be a valid instrument for community-dwelling older adults falls risk assessment. The present study aimed to distinguish and test the key outcomes of the SF-APT usable for falls risk assessment in community-dwelling older adults to determine the respective cut-offs. This cross-sectional study enrolled 347 participants (73.1 +/- 6.2 years; non-fallers: 57.9%; fallers: 42.1%; recurrent-fallers: 17.9%). Falls occurrence and SF-APT outcomes were assessed. Analyses were performed using multivariate binary logistic regression analysis and receiver operating characteristic (ROC). The area under the ROC curve was computed (AUC) for each built model explaining falling or recurrent falling. Results distinguished the Estimated stepping-forward, and Absolute-error in interaction with Error-tendency as the SF-APT key outcomes for falls risk assessment [AUC(falling): 0.665 (CI 95%: 0.608-0.723); AUC(falling recurrently): 0.728 (CI 95%: 0.655-0.797)]. Computed cut-offs' analysis showed that (i) a boundary stepping-forward estimation >58 cm plus an underestimation bias >5 cm (>42(nd)percentile) avoid older adults to be recurrent-fallers, and (ii) a boundary stepping-forward estimation >62 cm plus an underestimation bias >6 cm (>54(th)percentile) avoid older adults to be fallers. In conclusion, results suggest that SF-APT is a valuable tool for falls risk assessment in community-dwelling older adults. Interventions targeting the prevention of falls should consider the above key outcomes and the respective cut-offs as alert red-flags.	[Pereira, Catarina; Bravo, Jorge; Veiga, Guida; Marmeleira, Jose; Almeida, Gabriela] Univ Evora, Dept Desporto & Saude, Escola Ciencias & Tecnol, Evora, Portugal; [Pereira, Catarina; Bravo, Jorge; Veiga, Guida; Marmeleira, Jose; Mendes, Felismina; Almeida, Gabriela] Comprehens Hlth Res Ctr, Lisbon, Portugal; [Mendes, Felismina] Univ Evora, Escola Super Enfermagem S Joao de Deus, Evora, Portugal	University of Evora; University of Evora	Pereira, C (corresponding author), Univ Evora, Dept Desporto & Saude, Escola Ciencias & Tecnol, Evora, Portugal.; Pereira, C (corresponding author), Comprehens Hlth Res Ctr, Lisbon, Portugal.	clnp@uevora.pt	Almeida, Gabriela/GXV-3687-2022; Veiga, Guida/F-3294-2019	Marmeleira, Jose/0000-0002-5534-9600; Pereira, Catarina/0000-0001-8111-1455; Veiga, Guida/0000-0002-0575-1757; Almeida, Gabriela/0000-0002-6716-2114; Bravo, Jorge/0000-0002-9009-5693	European Fund for regional development through Horizon 2020 - Portugal 2020 - Programa Operacional Regional do Alentejo [ALT20-03-0145-FEDER000007]	European Fund for regional development through Horizon 2020 - Portugal 2020 - Programa Operacional Regional do Alentejo	This work was supported by European Fund for regional development through Horizon 2020 - Portugal 2020 - Programa Operacional Regional do Alentejo (ALT20-03-0145-FEDER000007) with respect to the ESACA Portuguese study -Ageing Safety in Alentejo. Understanding for action. The sponsors had no role in the design, analysis, or preparation of this manuscript. There is no conflict of interest.	Almeida G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225118; Bhasin S, 2018, J GERONTOL A-BIOL, V73, P1053, DOI 10.1093/gerona/glx190; Butler AA, 2015, J GERONTOL A-BIOL, V70, P628, DOI 10.1093/gerona/glu201; Coughlin D, 2019, J APPL GERONTOL, V38, P805, DOI 10.1177/0733464817748776; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Etman A, 2012, AGE AGEING, V41, P190, DOI 10.1093/ageing/afr178; Fajen BR, 2011, HUM MOVEMENT SCI, V30, P504, DOI 10.1016/j.humov.2010.07.016; Fajen BR, 2009, INT J SPORT PSYCHOL, V40, P79; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gazibara T, 2017, PSYCHOGERIATRICS, V17, P215, DOI 10.1111/psyg.12217; Gibson J.J., 1977, PERCEIVING ACTING KN, P67; Gibson James J., 1979, ECOLOGICAL APPROACH, P127; Gill DP, 2009, ANN EPIDEMIOL, V19, P523, DOI 10.1016/j.annepidem.2009.03.012; Guerreiro M. P., 1994, REV PORTUGUESA NEURO, V1, P9, DOI DOI 10.1017/CB09781107415324.004; Hernandez D, 2008, ARCH PHYS MED REHAB, V89, P2309, DOI 10.1016/j.apmr.2008.05.020; Hou WH, 2017, J CLIN NURS, V26, P698, DOI 10.1111/jocn.13510; KONCZAK J, 1992, J EXP PSYCHOL HUMAN, V18, P691, DOI 10.1037/0096-1523.18.3.691; Lima CA, 2018, PHYSIOTHERAPY, V104, P383, DOI 10.1016/j.physio.2018.02.002; Lord SR, 2006, AGE AGEING, V35, P55, DOI 10.1093/ageing/afl088; Lusardi MM, 2017, J GERIATR PHYS THER, V40, P1, DOI 10.1519/JPT.0000000000000099; Luyat M, 2008, PSYCHOL NEUROPSYCHIA, V6, P287, DOI 10.1684/pnv.2008.0149; Luz C., 2017, J MOT LEARN DEV, V5, P193, DOI [10.1123/jmld.2016-0030, DOI 10.1123/JMLD.2016-0030]; Noel M, 2011, GERIATR PSYCHOL NEUR, V9, P287, DOI 10.1684/pnv.2011.0290; Palumbo P, 2019, AGING CLIN EXP RES, V31, P1069, DOI 10.1007/s40520-018-1051-5; Palumbo P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146247; Pereira C, 2016, REJUV RES, V19, P13, DOI 10.1089/rej.2015.1669; Pereira CLN, 2014, DISABIL REHABIL, V36, P117, DOI 10.3109/09638288.2013.782355; Pereira CLN, 2013, AM J PHYS MED REHAB, V92, P1095, DOI 10.1097/PHM.0b013e31829b49eb; Pieruccini-Faria F, 2019, J GERONTOL A-BIOL, V74, P1422, DOI 10.1093/gerona/gly254; Shimada H, 2009, GERONTOLOGY, V55, P532, DOI 10.1159/000236364; Stevens JA, 2013, HEALTH PROMOT PRACT, V14, P706, DOI 10.1177/1524839912463576; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Yang NP, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0779-2; Zaluska Wojciech, 2004, Przegl Lek, V61, P70	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239837	10.1371/journal.pone.0239837	http://dx.doi.org/10.1371/journal.pone.0239837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TB	33031391	Green Published, gold			2022-12-26	WOS:000581809800050
J	Kamau, A; Mtanje, G; Mataza, C; Malla, L; Bejon, P; Snow, RW				Kamau, Alice; Mtanje, Grace; Mataza, Christine; Malla, Lucas; Bejon, Philip; Snow, Robert W.			The relationship between facility-based malaria test positivity rate and community-based parasite prevalence	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; AFRICA	Introduction Malaria surveillance is a key pillar in the control of malaria in Africa. The value of using routinely collected data from health facilities to define malaria risk at community levels remains poorly defined. Methods Four cross-sectional parasite prevalence surveys were undertaken among residents at 36 enumeration zones in Kilifi county on the Kenyan coast and temporally and spatially matched to fever surveillance at 6 health facilities serving the same communities over 12 months. The age-structured functional form of the relationship between test positivity rate (TPR) and community-based parasite prevalence (PR) was explored through the development of regression models fitted by alternating the linear, exponential and polynomial terms for PR. The predictive ranges of TPR were explored for PR endemicity risk groups of control programmatic value using cut-offs of low (PR <5%) and high (PR >= 30%) transmission intensity. Results Among 28,134 febrile patients encountered for malaria diagnostic testing in the health facilities, 12,143 (43.2%: 95% CI: 42.6%, 43.7%) were positive. The overall community PR was 9.9% (95% CI: 9.2%, 10.7%) among 6,479 participants tested for malaria. The polynomial model was the best fitting model for the data that described the algebraic relationship between TPR and PR. In this setting, a TPR of >= 49% in all age groups corresponded to an age-standardized PR of >= 30%, while a TPR of < 40% corresponded to an age-standardized PR of < 5%. Conclusion A non-linear relationship was observed between the relative change in TPR and changes in the PR, which is likely to have important implications for malaria surveillance programs, especially at the extremes of transmission. However, larger, more spatially diverse data series using routinely collected TPR data matched to community-based infection prevalence data are required to explore the more practical implications of using TPR as a replacement for community PR.	[Kamau, Alice; Mtanje, Grace; Mataza, Christine; Malla, Lucas; Bejon, Philip; Snow, Robert W.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Kamau, Alice; Bejon, Philip; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Mataza, Christine] Kilifi Cty Govt, Minist Hlth, Kilifi, Kenya	University of Oxford	Kamau, A (corresponding author), KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.; Kamau, A (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.	akamau@kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088; Kamau, Alice/0000-0001-9846-5372	Wellcome Trust Principal Fellowship [103602, 212176]; DELTAS Africa Initiative [DEL-15-003]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa; UK government; New Partnership for Africa's Development Planning and Coordinating Agency from the Wellcome Trust [107769]	Wellcome Trust Principal Fellowship(Wellcome Trust); DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa; UK government; New Partnership for Africa's Development Planning and Coordinating Agency from the Wellcome Trust	This work was supported through support to RWS as part of his Wellcome Trust Principal Fellowship (103602 and 212176) and support to AK through the DELTAS Africa Initiative [DEL-15-003]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa and supported by the New Partnership for Africa's Development Planning and Coordinating Agency with funding from the Wellcome Trust [107769] and the UK government. All authors are grateful to the support of the Wellcome Trust to the Kenya Major Overseas Programme (203077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegana V.A., 2020, BMC MED, P2; Alegana VA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2127-y; [Anonymous], 2012, T3 TEST TREAT TRACK; [Anonymous], 2012, REGEN MED S3, V7, pS14; Ashton RA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2680-7; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Boyce MR, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4398-1; Brasseur P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-203; Brooker S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-231; Chacky F, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2601-1; Colborn JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231358; Division of Malaria Control, 2010, KEN NAT MAL POL; Doudou MH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-89; FOX E, 1987, T ROY SOC TROP MED H, V81, P115, DOI 10.1016/0035-9203(87)90300-2; Galatas B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1496-y; Gebretsadik D, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2654-6; Githinji S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1973-y; Githinji S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1638-2; Gitonga CW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-306; Global Malaria Programme, 2017, FRAM MAL EL; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Houngbedji CA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1775-z; Jemal A, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4329-6; Kamau A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01559-0; Kamau Alice, 2017, Wellcome Open Res, V2, P22, DOI 10.12688/wellcomeopenres.11073.1; Kapesa A, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0288-y; Kesteman T, 2016, MALARIA J, V15, P1; Macharia PM, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2489-9; Maina JK, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1413266; METSELAAR D., 1959, Tropical and Geographical Medicine, V11, P157; Ministry of Public Health and Sanitation M.o.M.S., 2010, GUID DET REG PROC GE; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Mweu Marshal M, 2019, Wellcome Open Res, V4, P67, DOI 10.12688/wellcomeopenres.15204.1; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; Oduro AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026305; Oduro AR, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2858-7; Okebe J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110926; Okech BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004050; Okello G, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-3061-y; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-99; OpenDocs, 2020, I DEV STUD, V19, P1; Plucinski MM, 2020, AM J TROP MED HYG, V102, P151, DOI 10.4269/ajtmh.19-0537; Plucinski MM, 2018, AM J TROP MED HYG, V99, P670, DOI 10.4269/ajtmh.18-0312; PULL JH, 1972, AM J TROP MED HYG, V21, P651, DOI 10.4269/ajtmh.1972.21.651; RAY A P, 1984, Journal of Communicable Diseases, V16, P197; Salvador F, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0540-z; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Snow RW, 2017, NATURE, V550, P515, DOI 10.1038/nature24059; Stresman G., 2020, LANCET INFECT DIS; Swana EK, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2297-2; Tesfa H, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2310-9; Thawer SG, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03250-4; Tukei BB, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1652-4; Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0; Weiss DJ, 2019, LANCET, V394, P322, DOI 10.1016/S0140-6736(19)31097-9; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2005, MAL IND SURV BAS DOC; World Health Organization, 2019, WORLD MALARIA REPORT; World Health Organization, 2018, HIGH BURD HIGH IMP T; World Health Organization, 2013, SEAS MAL CHEM SULF P; World Health Organization, 2018, MAL SURV MON EV REF; Yimer F, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0749-5	63	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240058	10.1371/journal.pone.0240058	http://dx.doi.org/10.1371/journal.pone.0240058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027313	Green Published, gold			2022-12-26	WOS:000581808000032
J	Koi, M; Okita, Y; Takeda, K; Koeppe, ES; Stoffel, EM; Galanko, JA; McCoy, AN; Keku, T; Carethers, JM				Koi, Minoru; Okita, Yoshiki; Takeda, Koki; Koeppe, Erika S.; Stoffel, Elena M.; Galanko, Joseph A.; McCoy, Amber N.; Keku, Temitope; Carethers, John M.			Co-morbid risk factors and NSAID use among white and black Americans that predicts overall survival from diagnosed colon cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; AFRICAN-AMERICANS; DIABETES-MELLITUS; AGE; PROGNOSIS; SMOKING; COMORBIDITY; ASSOCIATION; DISPARITIES; PREVENTION	Black Americans (BA) have higher incidence and higher mortality rates for colorectal cancers (CRC) as compared to White Americans (WA). While there are several identified risk factors associated with the development of CRC and evidence that high levels of adequate screening can reduce differences in incidence for CRC between BA and WA, there remains little data regarding patient co-morbid contributions towards survival once an individual has CRC. Here we set out to identify patient risk factors that influenced overall survival in a cohort of 293 BA and 348 WA with colon cancer. Amid our cohort, we found that patients' age, tobacco usage, and pre-diagnosed medical conditions such as hypertension and diabetes were associated with shorter overall survival (OS) from colon cancer. We identified pre-diagnosed hypertension and diabetes among BA were responsible for one-third of the colon cancer mortality disparity compared with WA. We also identified long-term regular use of non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin, was associated with shorter OS from colon cancer among WA >65 years of age, but not younger WA patients or any aged BA patients. Our results raise the importance of not only treating the colon cancer itself, but also taking into consideration co-morbid medical conditions and NSAID usage to enhance patient OS. Further evaluation regarding adequate treatment of co-morbidities and timing of NSAID continuance after cancer therapy will need to be studied.	[Koi, Minoru; Okita, Yoshiki; Takeda, Koki; Koeppe, Erika S.; Stoffel, Elena M.; Carethers, John M.] Univ Michigan, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA; [Galanko, Joseph A.; McCoy, Amber N.; Keku, Temitope] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Med, Chapel Hill, NC 27515 USA; [Galanko, Joseph A.; McCoy, Amber N.; Keku, Temitope] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Nutr, Chapel Hill, NC 27515 USA; [Carethers, John M.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Carethers, John M.] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Carethers, JM (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA.; Carethers, JM (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.; Carethers, JM (corresponding author), Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.	jcarethe@umich.edu	Koi, Minoru/G-9197-2014		United States Public Health Service (NIH) [CA206010]; A. Alfred Taubman Medical Research Institute of the University of Michigan	United States Public Health Service (NIH)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); A. Alfred Taubman Medical Research Institute of the University of Michigan	Supported by the United States Public Health Service (NIH grant CA206010 to John M. Carethers) and the A. Alfred Taubman Medical Research Institute of the University of Michigan (to John M. Carethers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashktorab H, 2017, GASTROENTEROLOGY, V153, P910, DOI 10.1053/j.gastro.2017.08.018; Basa RCB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156660; Brown JC, 2020, JNCI CANCER SPECT, V4, DOI 10.1093/jncics/pkz078; Carethers JM, 2020, GASTROENTEROLOGY, V158, P354, DOI 10.1053/j.gastro.2019.10.029; Carethers JM, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00531; Carethers JM, 2010, CURR COLORECT CANC R, V6, P24, DOI 10.1007/s11888-009-0038-1; Carethers JM, 2015, DIGEST DIS SCI, V60, P711, DOI 10.1007/s10620-014-3443-5; Carethers JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100461; Chan AT, 2019, GASTROENTEROLOGY, V156, P534, DOI 10.1053/j.gastro.2018.11.063; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P211, DOI 10.3322/caac.21555; Edelstein LC, 2013, NAT MED, V19, P1609, DOI 10.1038/nm.3385; El Brahimi S, 2019, INT J COLORECTAL DIS, V34, P1467, DOI 10.1007/s00384-019-03345-8; Grubbs SS, 2013, J CLIN ONCOL, V31, P1928, DOI 10.1200/JCO.2012.47.8412; Hong H, 2019, J CANCER, V10, P3021, DOI 10.7150/jca.30723; Hussain M, 2012, INT IMMUNOPHARMACOL, V12, P10, DOI 10.1016/j.intimp.2011.11.021; Kupfer SS, 2015, GASTROENTEROLOGY, V149, P1302, DOI 10.1053/j.gastro.2015.08.033; Lieu CH, 2014, J CLIN ONCOL, V32, P2975, DOI 10.1200/JCO.2013.54.9329; McNeil JJ, 2018, NEW ENGL J MED, V379, P1519, DOI 10.1056/NEJMoa1803955; McNeil JJ, 2021, JNCI-J NATL CANCER I, V113, P258, DOI 10.1093/jnci/djaa114; Mills KT, 2013, DIS COLON RECTUM, V56, P1304, DOI 10.1097/DCR.0b013e3182a479f9; Oakley R, 2014, AGING DIS, V5, P114, DOI 10.14336/AD.2014.0500114; Ordonez-Mena JM, 2018, ANN ONCOL, V29, P472, DOI 10.1093/annonc/mdx761; Polite BN, 2017, CANCER RES, V77, P4548, DOI [10.1158/0008-5472.CAN-17-0623, 10.1158/0008-5472.can-17-0623]; Sansbury LB, 2005, AM J EPIDEMIOL, V162, P548, DOI 10.1093/aje/kwi248; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Sineshaw HM, 2018, GASTROENTEROLOGY, V154, P906, DOI 10.1053/j.gastro.2017.11.005; Stein KB, 2010, DIGEST DIS SCI, V55, P1839, DOI 10.1007/s10620-009-0944-8; van Eeghen EE, 2015, J GASTROINTEST ONCOL, V6, P605, DOI 10.3978/j.issn.2078-6891.2015.070; Walter V, 2014, ANN ONCOL, V25, P1517, DOI 10.1093/annonc/mdu040; Yamano T, 2017, EUR J CANCER, V81, P90, DOI 10.1016/j.ejca.2017.05.024; Yang BY, 2015, J CLIN ONCOL, V33, P885, DOI 10.1200/JCO.2014.58.3831; Yang Y, 2013, CANCER-AM CANCER SOC, V119, P1512, DOI 10.1002/cncr.27923; Yokoyama K, 2018, RES PRACT THROMB HAE, V2, P274, DOI 10.1002/rth2.12097; Zavala VA, 2021, BRIT J CANCER, V124, P315, DOI 10.1038/s41416-020-01038-6; Zhang YY, 2020, CANCER RES, V80, P3345, DOI 10.1158/0008-5472.CAN-19-3533	35	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239676	10.1371/journal.pone.0239676	http://dx.doi.org/10.1371/journal.pone.0239676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027290	Green Published, gold			2022-12-26	WOS:000581808000058
J	Ouellette, DJ; Hsu, DL; Stefancin, P; Duong, TQ				Ouellette, David J.; Hsu, Dan-Ling; Stefancin, Patricia; Duong, Timothy Q.			Cortical thickness and functional connectivity changes in Chinese chess experts	PLOS ONE			English	Article							SUPRAMARGINAL GYRUS; PERFORMANCE; CORTEX; IMPACT	Background Repeated practice to acquire expertise could result in the structural and functional changes in relevant brain circuits as a result of long-term potentiation, neurogenesis, glial genesis, and remodeling. Purpose The goal of this study is to use surface-based morphology (SBM) to study cortical thickness differences in Chinese chess experts and novices, and to use regions of cortical thickness differences as seeds to guide a resting state connectivity analysis of the same population. Methods A raw public dataset from Huaxi MR Research Center consisting of 29 Chinese chess experts and 29 novices was used in this study, with both T1-weighted and resting state functional MRI. Surface based morphometry was performed on the T1 images with the Freesurfur pipeline, with a vertex significance threshold ofp<0.05 and a cluster false discovery rate of alpha < 0.05. Regions with significant differences were used in a seed-based comparison of resting state functional connectivity carried out with Statistical Parameter Mapping (SPM) and the Connectivity Toolbox (CONN). Regions of connectivity differences within groups were computed with a voxel significance threshold ofpResults Ten regions of the cortex of Chinese chess experts were found to be thinner than chess novices, including regions involved in visual processing, attention, working and episodic memory, and mental imagery, as well as several regions in the prefrontal cortex. There were no regions where experts' cortices were thicker than novices. Three of the thinner regions exhibited increased functional connectivity to distant brain regions in chess experts. Conclusions Brain regions that are structurally affected by chess training are associated with processes that would likely have a high utility in chess expertise. Using a hierarchical control model, we hypothesize that the functional changes linked with some of these structural changes are related to the professionally trained chess players' ability to perceive and use contextual information, visuospatial perception, and outcome prediction in the domain of chess, all contributing to their exceptional performance.	[Ouellette, David J.] SUNY Stony Brook, Biomed Engn, Stony Brook, NY 11794 USA; [Hsu, Dan-Ling; Stefancin, Patricia; Duong, Timothy Q.] SUNY Stony Brook, Radiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Duong, TQ (corresponding author), SUNY Stony Brook, Radiol, Stony Brook, NY 11794 USA.	timduong@stonybrookmedicine.edu	Duong, Tim/AAL-8357-2021	Duong, Tim/0000-0001-6403-2827; Ouellette, David/0000-0003-1922-5456				[Anonymous], 1978, THOUGHT CHOICE CHESS; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Badre D, 2018, TRENDS COGN SCI, V22, P170, DOI 10.1016/j.tics.2017.11.005; Bilalic M, 2016, CEREB CORTEX, V26, P1004, DOI 10.1093/cercor/bhu272; Bilalic M, 2011, J NEUROSCI, V31, P10206, DOI 10.1523/JNEUROSCI.5727-10.2011; CHARNESS N, 1992, PSYCHOL RES-PSYCH FO, V54, P4, DOI 10.1007/BF01359217; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; COHEN RL, 1981, SCAND J PSYCHOL, V22, P267, DOI 10.1111/j.1467-9450.1981.tb00402.x; Duan XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032532; Duan XJ, 2012, NEUROIMAGE, V60, P1280, DOI 10.1016/j.neuroimage.2012.01.047; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Hanggi J, 2014, NEUROPSYCHOLOGIA, V62, P152, DOI 10.1016/j.neuropsychologia.2014.07.019; Huntenburg JM, 2018, TRENDS COGN SCI, V22, P21, DOI 10.1016/j.tics.2017.11.002; Japee S, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00023; K Ericsson NC, 2006, CAMBRIDGE HDB EXPERT; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Macedonia M, 2011, HUM BRAIN MAPP, V32, P982, DOI 10.1002/hbm.21084; Machielsen WCM, 2000, HUM BRAIN MAPP, V9, P156, DOI 10.1002/(SICI)1097-0193(200003)9:3<156::AID-HBM4>3.0.CO;2-Q; Madan CR, 2012, COGN PROCESS, V13, P211, DOI 10.1007/s10339-012-0438-z; Parker JG, 2014, BRAIN BEHAV, V4, P227, DOI 10.1002/brb3.213; Silani G, 2013, J NEUROSCI, V33, P15466, DOI 10.1523/JNEUROSCI.1488-13.2013; Slotnick SD, 2006, NEUROPSYCHOLOGIA, V44, P1560, DOI 10.1016/j.neuropsychologia.2006.01.018; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; The Lancet HIV, 2015, LANCET HIV, V2, pe115; Tunik E, 2008, J NEUROSCI, V28, P14422, DOI 10.1523/JNEUROSCI.4734-08.2008; Wang HZ, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00027; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	28	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239822	10.1371/journal.pone.0239822	http://dx.doi.org/10.1371/journal.pone.0239822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3SJ	33027295	Green Published, gold			2022-12-26	WOS:000581808000040
J	Ahn, H; Kume, M; Terashima, Y; Ye, F; Kameyama, S; Miya, M; Yamashita, Y; Kasai, A				Ahn, Hyojin; Kume, Manabu; Terashima, Yuki; Ye, Feng; Kameyama, Satoshi; Miya, Masaki; Yamashita, Yoh; Kasai, Akihide			Evaluation of fish biodiversity in estuaries using environmental DNA metabarcoding	PLOS ONE			English	Article							CONSERVATION; EDNA	Biodiversity is an important parameter for the evaluation of the extant environmental conditions. Here, we used environmental DNA (eDNA) metabarcoding to investigate fish biodiversity in five different estuaries in Japan. Water samples for eDNA were collected from river mouths and adjacent coastal areas of two estuaries with high degrees of development (the Tama and Miya Rivers) and three estuaries with relatively low degrees of development (the Aka, Takatsu, and Sendai Rivers). A total of 182 fish species across 67 families were detected. Among them, 11 species occurred in all the rivers studied. Rare fishes including endangered species were successfully detected in rich natural rivers. Biodiversity was the highest in the Sendai River and lowest in the Tama River, reflecting the degree of human development along each river. Even though nutrient concentration was low in both the Aka and Sendai Rivers, the latter exhibited greater diversity, including many tropical or subtropical species, owing to its more southern location. Species composition detected by eDNA varied among rivers, reflecting the distribution and migration of fishes. Our results are in accordance with the ecology of each fish species and environmental conditions of each river.	[Ahn, Hyojin; Kume, Manabu; Terashima, Yuki; Ye, Feng; Yamashita, Yoh] Kyoto Univ, Humans & Oceans Unit, Connect Hills, Kyoto, Japan; [Ahn, Hyojin; Kasai, Akihide] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido, Japan; [Ye, Feng; Kameyama, Satoshi] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst, Ibaraki, Japan; [Miya, Masaki] Natl Hist Museum & Inst, Dept Ecol & Environm Sci, Chiba, Japan	Kyoto University; Hokkaido University; National Institute for Environmental Studies - Japan	Ahn, H (corresponding author), Kyoto Univ, Humans & Oceans Unit, Connect Hills, Kyoto, Japan.; Ahn, H (corresponding author), Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido, Japan.	ahn.hyojin.4a@kyoto-u.ac.jp	Kume, Manabu/AAI-7926-2020	Kume, Manabu/0000-0001-7287-029X	Nippon Foundation	Nippon Foundation(Nippon Foundation)	This study was conducted under the Link Again Program, part of Connectivity of Hills, Humans and Oceans, funded by the Nippon Foundation (www.nippon-foundation.or.jp), attained by YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Andruszkiewicz EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176343; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Barto K, 2019, MULTIMODEL INFERENCE, V1, P30; Barus V., 2001, FRESHWATER FISHES EU, P85; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Diana JS, 2009, BIOSCIENCE, V59, P27, DOI 10.1525/bio.2009.59.1.7; Durieux EDH, 2009, J FISH BIOL, V74, P921, DOI 10.1111/j.1095-8649.2009.02179.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Folke C, 1996, ECOL APPL, V6, P1018, DOI 10.2307/2269584; Fox J, 2019, COMPANION APPL REGRE, V2, P24; Fujii K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210357; Fujiwara A, 2016, FRESHW SCI, V35, P748, DOI 10.1086/685882; Ginsburg RN, 1994, P C GLOB ASP COR REE; Greenfield BK, 2010, ENVIRON POLLUT, V158, P2716, DOI 10.1016/j.envpol.2010.04.010; Hosoya K, 2015, FRESHWATER FISHES JA; Itakura H, 2019, AQUAT CONSERV, V29, P361, DOI 10.1002/aqc.3058; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kasai A, 2010, ESTUAR COAST SHELF S, V86, P408, DOI 10.1016/j.ecss.2009.06.001; Keskin E, 2014, BIOCHEM SYST ECOL, V56, P68, DOI 10.1016/j.bse.2014.05.003; KIMIZUKA Y, 1982, JPN J ICHTHYOL, V29, P305; Kotwicki L, 2005, BIODIVERS CONSERV, V14, P461, DOI 10.1007/10531-004-6272-6; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee KM, 2005, FISHERIES SCI, V71, P1324, DOI 10.1111/j.1444-2906.2005.01098.x; Merkes CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113346; Miya M, 2019, ENV DNA SAMPLING EXP, P55; Miya M, 2016, JOVE-J VIS EXP, DOI 10.3791/54741; Nakabo T., 2013, FISHES JAPAN PICTORI; Nakajima J, 2017, LOACHES JAPAN; Needles LA, 2015, ESTUAR COAST, V38, pS35, DOI 10.1007/s12237-013-9602-7; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Pfleger MO, 2016, GLOB ECOL CONSERV, V8, P99, DOI 10.1016/j.gecco.2016.08.008; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shen KN, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-83; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Smith GC, 2003, BIOSCIENCE, V53, P1048, DOI 10.1641/0006-3568(2003)053[1048:AEPOTB]2.0.CO;2; Smith GC, 2002, ESTUAR COAST SHELF S, V55, P347, DOI 10.1006/ecss.2001.0909; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Yamanaka Hiroki, 2016, Japanese Journal of Ecology (Otsu), V66, P601; Young J, 2005, BIODIVERS CONSERV, V14, P1641, DOI 10.1007/s10531-004-0536-z	52	8	10	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2020	15	10							e0231127	10.1371/journal.pone.0231127	http://dx.doi.org/10.1371/journal.pone.0231127			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OB4WW	33022692	gold, Green Published			2022-12-26	WOS:000578473000010
J	Natusch, DJD; Aust, PW; Khadiejah, S; Ithnin, H; Isa, A; Zamzuri, CK; Ganswindt, A; DeNardo, DF				Natusch, Daniel J. D.; Aust, Patrick W.; Khadiejah, Syarifah; Ithnin, Hartini; Isa, Ain; Zamzuri, Che Ku; Ganswindt, Andre; DeNardo, Dale F.			Behavioral and corticosterone responses to carbon dioxide exposure in reptiles	PLOS ONE			English	Article							PLASMA-CORTICOSTERONE; HORMONAL RESPONSES; EUTHANASIA; STRESS; LIZARD; SNAKE; RATS; CONFINEMENT; ANESTHESIA; AMPHIBIANS	The use of carbon dioxide (CO2) exposure as a means of animal euthanasia has received considerable attention in mammals and birds but remains virtually untested in reptiles. We measured the behavioral responses of four squamate reptile species (Homalopsis buccata,Malayopython reticulatus,Python bivitattus, andVaranus salvator) to exposure to 99.5% CO(2)for durations of 15, 30, or 90 minutes. We also examined alterations in plasma corticosterone levels ofM.reticulatusandV.salvatorbefore and after 15 minutes of CO(2)exposure relative to control individuals. The four reptile taxa showed consistent behavioral responses to CO(2)exposure characterized by gaping and minor movements. The time taken to lose responsiveness to stimuli and cessation of movements varied between 240-4260 seconds (4-71 minutes), with considerable intra- and inter-specific variation. Duration of CO(2)exposure influenced the likelihood of recovery, which also varied among species (e.g., from 0-100% recovery after 30-min exposure). Plasma corticosterone concentrations increased after CO(2)exposure in bothV.salvator(18%) andM.reticulatus(14%), but only significantly in the former species. Based on our results, CO(2)appears to be a mild stressor for reptiles, but the relatively minor responses to CO(2)suggest it may not cause considerable distress or pain. However, our results are preliminary, and further testing is required to understand optimal CO(2)delivery mechanisms and interspecific responses to CO(2)exposure before endorsing this method for reptile euthanasia.	[Natusch, Daniel J. D.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Natusch, Daniel J. D.] Epic Biodivers, Frogs Hollow, NSW, Australia; [Aust, Patrick W.] Univ Oxford, Dept Zool, Oxford, England; [Aust, Patrick W.] Bushtick Environm Serv, Grantham, Lincs, England; [Khadiejah, Syarifah; Ithnin, Hartini; Isa, Ain; Zamzuri, Che Ku] Peninsular Malaysia, Dept Wildlife & Natl Pk, Kuala Lumpur, Malaysia; [Ganswindt, Andre] Univ Pretoria, Fac Nat & Agr Sci, Dept Zool & Entomol, Endocrine Res Lab,Mammal Res Inst, Pretoria, South Africa; [Ganswindt, Andre] Univ Pretoria, Fac Vet Sci, Ctr Vet Wildlife Studies, Onderstepoort, South Africa; [DeNardo, Dale F.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Macquarie University; University of Oxford; University of Pretoria; University of Pretoria; Arizona State University; Arizona State University-Tempe	Natusch, DJD (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.; Natusch, DJD (corresponding author), Epic Biodivers, Frogs Hollow, NSW, Australia.	d.natusch@epicbiodiversity.com	Ithnin, Hartini/AAF-6267-2021; Ganswindt, Andre/G-9856-2014	Ithnin, Hartini/0000-0003-0339-5725; Ganswindt, Andre/0000-0002-1474-7602; Natusch, Daniel J. D./0000-0002-3275-518X	Southeast Asian Reptile Conservation Alliance; Swiss Federal Veterinary Office	Southeast Asian Reptile Conservation Alliance; Swiss Federal Veterinary Office	Daniel Natusch recieved funding from the Southeast Asian Reptile Conservation Alliance and the Swiss Federal Veterinary Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, ADAPT LEARN SYST SIG, DOI 10.1002/047084535X; Aust PW, 2019, WELFARE PRINCIPLES S; Boivin GP, 2017, J AM ASSOC LAB ANIM, V56, P491; Cavusoglu E, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10050787; CHAPPELL MA, 1987, J COMP PHYSIOL B, V157, P227, DOI 10.1007/BF00692367; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; COENEN AML, 1995, LAB ANIM, V29, P262, DOI 10.1258/002367795781088289; Cote J, 2006, HORM BEHAV, V49, P320, DOI 10.1016/j.yhbeh.2005.08.004; Cree A, 2000, COMP BIOCHEM PHYS A, V126, P275, DOI 10.1016/S1095-6433(00)00210-5; Dupoue A, 2016, J EXP BIOL, V219, P658, DOI 10.1242/jeb.132639; Eatwell K, 2010, IN PRACTICE, V32, P306, DOI 10.1136/inp.c3917; Finger JW, 2019, ARCH ENVIRON CON TOX, V77, P14, DOI 10.1007/s00244-019-00626-9; Hawkins P., 2006, NEWC CONS M CARB DIO, P1; HEWETT TA, 1993, LAB ANIM SCI, V43, P579; Hopkins WA, 2004, COMP BIOCHEM PHYS A, V137, P141, DOI 10.1016/j.cbpb.2003.09.017; Khadiejah S, 2019, WILDLIFE RES, V46, P265, DOI 10.1071/WR18166; Langkilde T, 2006, J EXP BIOL, V209, P1035, DOI 10.1242/jeb.02112; LASIEWSKI RC, 1966, COMP BIOCHEM PHYSIOL, V19, P445, DOI 10.1016/0010-406X(66)90153-8; Leary S, 2020, AVMA GUIDELINES EUTH; Lillywhite HB, 2017, BIOSCIENCE, V67, P52, DOI 10.1093/biosci/biw143; Mathies T, 2001, GEN COMP ENDOCR, V124, P106, DOI 10.1006/gcen.2001.7694; McKeegan DEF, 2006, APPL ANIM BEHAV SCI, V99, P271, DOI 10.1016/j.applanim.2005.11.002; Moore IT, 2000, ANIM BEHAV, V59, P529, DOI 10.1006/anbe.1999.1344; Murray D, 2009, ALL D LEM SWIN C, P114; Natusch DJD, 2019, BIOL CONSERV, V233, P83, DOI 10.1016/j.biocon.2019.02.016; Natusch DJD, 2014, IUCN SPECIES SURVIVA, V50; Reed B, 2009, ENDOCRINOLOGY, V150, P2934, DOI 10.1210/en.2008-1408; Seddon RJ, 2016, J EXP ZOOL PART A, V325, P491, DOI 10.1002/jez.2033; Sharp J, 2006, J AM ASSOC LAB ANIM, V45, P21; Shea SA, 1996, RESP PHYSIOL, V103, P113, DOI 10.1016/0034-5687(95)00086-0; Shine R, 2019, JAVMA-J AM VET MED A, V255, P48, DOI 10.2460/javma.255.1.48; Shine R, 2015, BIOL OPEN, V4, P760, DOI 10.1242/bio.012179; Swiss Expert Panel, 2013, AN HUM KILL METH REP; Sykes KL, 2009, J EXP ZOOL PART A, V311A, P172, DOI 10.1002/jez.515; Thaker M, 2010, AM NAT, V175, P50, DOI 10.1086/648558; THOMPSON GG, 1995, COMP BIOCHEM PHYS A, V111, P603, DOI 10.1016/0300-9629(95)00055-C; Warren Kristin, 2014, Pacific Conservation Biology, V20, P25; West JM, 2018, GEN COMP ENDOCR, V262, P71, DOI 10.1016/j.ygcen.2018.03.016; Withrock IC, 2015, THESIS; World Organisation for Animal Health, 2019, TERR AN HLTH COD; Xie SZ, 2017, PHYSIOL BIOCHEM ZOOL, V90, P348, DOI 10.1086/690484	41	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2020	15	10							e0240176	10.1371/journal.pone.0240176	http://dx.doi.org/10.1371/journal.pone.0240176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OB4WW	33022690	gold, Green Published			2022-12-26	WOS:000578473000029
J	Barrio-Nuevo, KM; Cunha, MS; Luchs, A; Fernandes, A; Rocco, IM; Mucci, LF; de Souza, RP; Medeiros-Sousa, ANR; Ceretti, W; Marrelli, MT				Barrio-Nuevo, Karolina Morales; Cunha, Mariana Sequetin; Luchs, Adriana; Fernandes, Aristides; Rocco, Iray Maria; Mucci, Luis Filipe; de Souza, Renato Pereira; Medeiros-Sousa, Antonio Ralph; Ceretti-Junior, Walter; Marrelli, Mauro Toledo			Detection of Zika and dengue viruses in wild-caught mosquitoes collected during field surveillance in an environmental protection area in Sao Paulo, Brazil	PLOS ONE			English	Article							CANTAREIRA STATE-PARK; METROPOLITAN-AREA; CULICIDAE; DIPTERA; POPULATION; ABUNDANCE; AMERICA; ECOLOGY; MALARIA; VECTOR	Species of the genus Flavivirus are widespread in Brazil and are a major public health concern. The country's largest city, Sao Paulo, is in a highly urbanized area with a few forest fragments which are commonly used for recreation. These can be considered to present a potential risk of flavivirus transmission to humans as they are home simultaneously to vertebrate hosts and mosquitoes that are potential flavivirus vectors. The aim of this study was to conduct flavivirus surveillance in field-collected mosquitoes in the Capivari-Monos Environmental Protection Area (EPA) and identify the flavivirus species by sequence analysis in flavivirus IFA-positive pools. Monthly mosquito collections were carried out from March 2016 to April 2017 with CO2-baited CDC light traps. Specimens were identified morphologically and grouped in pools of up to 10 individuals according to their taxonomic category. A total of 260 pools of non-engorged females were inoculated into C6/36 cell culture, and the cell suspensions were analyzed by indirect immunofluorescence assay (IFA) after the incubation period. IFA-positive pools were tested by qRT-PCR with genus-specific primers targeting the flavivirus NS5 gene to confirm IFA-positive results and sequenced to identify the species. Anopheles cruzii (19.5%) and Wyeomyia confusa (15.3%) were the most frequent vector species collected. IFA was positive for flaviviruses in 2.3% (6/260) of the sample pools. This was confirmed by qRT-PCR in five pools (83.3%). All five flavivirus-positive pools were successfully sequenced and the species identified. DENV serotype 2 (DENV-2) was detected in Culex spp. and Culex vaxus pools, while ZIKV was identified in An. cruzii, Limatus durhamii and Wy. confusa pools. To the best of our knowledge, detection of flavivirus species of medical importance has never previously been reported in these species of wild-caught mosquitoes. The finding of DENV-2 and ZIKV circulating in wild mosquitoes suggests the existence of an enzootic cycle in the area. In-depth studies of DENV-2 and ZIKV, including investigation of mosquito infection, vector competence and infection in sylvatic hosts, are needed to shed light on the transmission dynamics of these important viruses and the potential risk of future outbreaks of DENV-2 and ZIKV infections in the region.	[Barrio-Nuevo, Karolina Morales; Fernandes, Aristides; Medeiros-Sousa, Antonio Ralph; Ceretti-Junior, Walter; Marrelli, Mauro Toledo] Univ Sao Paulo, Sch Publ Hlth, Epidemiol Dept, Sao Paulo, Brazil; [Cunha, Mariana Sequetin; Rocco, Iray Maria; de Souza, Renato Pereira] Adolfo Lutz Inst, Virol Ctr, Vectorborne Dis Lab, Sao Paulo, Brazil; [Luchs, Adriana] Adolfo Lutz Inst, Virol Ctr, Enter Dis Lab, Sao Paulo, Brazil; [Mucci, Luis Filipe] State Hlth Dept, Superintendency Control Endem Dis, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Adolfo Lutz; Instituto Adolfo Lutz	Marrelli, MT (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Epidemiol Dept, Sao Paulo, Brazil.	mmarelli@usp.br	Cunha, Mariana/AAA-5340-2021; Marrelli, Mauro/AHB-7335-2022	Cunha, Mariana/0000-0001-8903-604X; 	Sao Paulo Research Foundation (FAPESP) [2014/50444-5, 2014/10919-4]; National Council for Scientific and Technological Development, Brazil (CNPq) [301466/2015-7]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development, Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by the Sao Paulo Research Foundation (FAPESP: grants nos. 2014/50444-5 and 2014/10919-4) and the National Council for Scientific and Technological Development, Brazil (CNPq: grant no. 301466/2015-7).	Aagaard-Hansen J, 2010, TROP MED INT HEALTH, V15, P1281, DOI 10.1111/j.1365-3156.2010.02629.x; [Anonymous], 2017, PHYS TEACH, V55, P204; [Anonymous], 2013, SAFIRANE NUR    0113, V7, P7; Batista WC, 2011, REV SOC BRAS MED TRO, V44, P528, DOI 10.1590/S0037-86822011000400028; Calzolari M, 2010, VECTOR-BORNE ZOONOT, V10, P875, DOI 10.1089/vbz.2009.0176; Cardosa J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000423; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Cunha MS, 2020, ARCH VIROL, V165, P1863, DOI 10.1007/s00705-020-04680-w; Cunha MS, 2020, ACTA TROP, V205, DOI 10.1016/j.actatropica.2020.105401; Cunha MS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41950-3; de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228; DEANE LM, 1970, T ROY SOC TROP MED H, V64, P647, DOI 10.1016/0035-9203(70)90088-X; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]; Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933; Fang Y, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0457-9; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Fernandes LN, 2016, ACTA TROP, V157, P73, DOI 10.1016/j.actatropica.2016.01.026; Ferreira Ivani B., 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P265, DOI 10.1590/S0036-46651994000300011; Ferreira-de-Lima VH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2643-9; Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4; Forattini OP, 2002, CULICIDOLOGIA MED; GOMES AD, 1985, REV SAUDE PUBL, V19, P190, DOI 10.1590/S0034-89101985000200009; Gu WD, 2004, AM J TROP MED HYG, V71, P636, DOI 10.4269/ajtmh.2004.71.636; Gubler DJ, 2001, ANN NY ACAD SCI, V951, P13; GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Iversson Lygia Busch, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P343, DOI 10.1590/S0036-46651994000400007; Karna AK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080434; Kato F, 2013, J GEN VIROL, V94, P2202, DOI 10.1099/vir.0.055343-0; Laporta GZ, 2014, BMC ECOL, V14, DOI 10.1186/s12898-014-0030-8; Laporta GZ, 2006, REV BRAS ENTOMOL, V50, P125, DOI 10.1590/S0085-56262006000100019; Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006791, 10.1590/s1518-8787.2016050006791]; LOPES J, 1995, REV SAUDE PUBL, V29, P183, DOI 10.1590/S0034-89101995000300005; Medeiros-Sousa AR, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2744-8; Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x; Michel C, 1984, DENGUE 2 SENEGAL ORI, V22, P313; Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030; Moraes OS, 2019, MED VET ENTOMOL, V33, P397, DOI 10.1111/mve.12374; Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849; Mucci LF, 2016, J AM MOSQUITO CONTR, V32, P329, DOI 10.2987/16-6587.1; Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140; Pan American Health Organization, 2019, CAS REP DENG AM; Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58; Ribeiro AF, 2012, J VECTOR ECOL, V37, P316, DOI 10.1111/j.1948-7134.2012.00233.x; Rocco Iray M., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P281, DOI 10.1590/S0036-46652005000500008; RUDNICK A, 1966, B WORLD HEALTH ORGAN, V35, P78; SALUZZO JF, 1986, B SOC PATHOL EXOT, V79, P313; Secretaria Municipal do Verde e do Meio Ambiente, PLAN MAN APA CAP MON; Segura MNO, 2007, ATL CUL AM BRAS; Taipe-Lagos CB, 2003, REV SAUDE PUBL, V37, P275, DOI 10.1590/S0034-89102003000300002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarifa JR, 2001, CLIMAS CIDADE SAO PA, P34; Teich V., 2017, J BRAS EC SAUDE, V9, P267, DOI DOI 10.21115/JBES.V9.N3.P267-76; Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trevelin LC, 2007, REV BRAS ZOOL, V24, P1071, DOI 10.1590/S0101-81752007000400026; Urbinatti PR, 2001, REV SAUDE PUBL, V35, P461, DOI 10.1590/S0034-89102001000500009; Valentine MJ, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3732-0; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P319, DOI 10.4269/ajtmh.1999.60.319; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; WHO.int, NEGL TROP DIS MOSQ B; World Health Organization, VECT BORN DIS	66	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0227239	10.1371/journal.pone.0227239	http://dx.doi.org/10.1371/journal.pone.0227239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064724	gold, Green Published			2022-12-26	WOS:000585918300036
J	Al-Shammari, H; Latif, N; Sarathchandra, P; McCormack, A; Rog-Zielinska, EA; Raja, S; Kohl, P; Yacoub, MH; Peyronnet, R; Chester, AH				Al-Shammari, Hessah; Latif, Najma; Sarathchandra, Padmini; McCormack, Ann; Rog-Zielinska, Eva A.; Raja, Shahzad; Kohl, Peter; Yacoub, Magdi H.; Peyronnet, Remi; Chester, Adrian H.			Expression and function of mechanosensitive ion channels in human valve interstitial cells	PLOS ONE			English	Article							ELEVATED CYCLIC STRETCH; MATRIX; STRESS; CALCIFICATION; STRAIN; TRPV4	Background The ability of heart valve cells to respond to their mechanical environment represents a key mechanism by which the integrity and function of valve cusps is maintained. A number of different mechanotransduction pathways have been implicated in the response of valve cells to mechanical stimulation. In this study, we explore the expression pattern of several mechanosensitive ion channels (MSC) and their potential to mediate mechanosensitive responses of human valve interstitial cells (VIC). Methods MSC presence and function were probed using the patch clamp technique. Protein abundance of key MSC was evaluated by Western blotting in isolated fibroblastic VIC (VICFB) and in VIC differentiated towards myofibroblastic (VICMB) or osteoblastic (VICOB) phenotypes. Expression was compared in non-calcified and calcified human aortic valves. MSC contributions to stretch-induced collagen gene expression and to VIC migration were assessed by pharmacological inhibition of specific channels. Results Two MSC types were recorded in VICFB: potassium selective and cation non-selective channels. In keeping with functional data, the presence of both TREK-1 and Kir6.1 (potassium selective), as well as TRPM4, TRPV4 and TRPC6 (cationic non-selective) channels was confirmed in VIC at the protein level. Differentiation of VIC(FB)into VIC(MB)or VIC(OB)phenotypes was associated with a lower expression of TREK-1 and Kir6.1, and a higher expression of TRPV4 and TRPC6. Differences in MSC expression were also seen in non-calcifiedvscalcified aortic valves where TREK-1, TRPM4 and TRPV4 expression were higher in calcified compared to control tissues. Cyclic stretch-induced expression of COL I mRNA in cultured VIC(FB)was blocked by RN-9893, a selective inhibitor of TRPV4 channels while having no effect on the stretch-induced expression of COL III. VIC(FB)migration was blocked with the non-specific MSC blocker streptomycin and by GSK417651A an inhibitor of TRPC6/3. Conclusion Aortic VIC express a range of MSC that play a role in functional responses of these cells to mechanical stimulation. MSC expression levels differ in calcified and non-calcified valves in ways that are in part compatible with the change in expression seen between VIC phenotypes. These changes in MSC expression, and associated alterations in the ability of VIC to respond to their mechanical environment, may form novel targets for intervention during aortic valvulopathies.	[Al-Shammari, Hessah; Latif, Najma; Sarathchandra, Padmini; Yacoub, Magdi H.; Chester, Adrian H.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Latif, Najma; McCormack, Ann; Yacoub, Magdi H.; Peyronnet, Remi; Chester, Adrian H.] Magdi Yacoub Inst, Heart Sci Ctr, Harefield, Middx, England; [Rog-Zielinska, Eva A.; Kohl, Peter; Peyronnet, Remi] Univ Heart Ctr Freiburg, Fac Med, Inst Expt Cardiovasc Med, Bad Krozingen, Germany; [Rog-Zielinska, Eva A.; Kohl, Peter; Peyronnet, Remi] Univ Freiburg, Fac Med, Freiburg, Germany; [Raja, Shahzad] Royal Brompton & Harefield NHS Fdn Trust, Harefield Hosp, Harefield, Middx, England	Imperial College London; Universitats Herzzentrum Freiburg; University of Freiburg; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital	Chester, AH (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.; Chester, AH (corresponding author), Magdi Yacoub Inst, Heart Sci Ctr, Harefield, Middx, England.	a.chester@imperial.ac.uk	Raja, Shahzad/ABG-8781-2021; LATIF, NAJMA/AAT-1973-2021	LATIF, NAJMA/0000-0002-5622-2150; Kohl, Peter/0000-0003-0416-6270; Chester, Adrian/0000-0001-7002-1075	Saudi Cultural Bureau; Imperial College Junior Research Fellowship; European Research Council Advanced Grant CardioNECT; DFG support within the Emmy Noether Programme; Magdi Yacoub Institute	Saudi Cultural Bureau; Imperial College Junior Research Fellowship; European Research Council Advanced Grant CardioNECT; DFG support within the Emmy Noether Programme; Magdi Yacoub Institute	HA was funded by a grant from the Saudi Cultural Bureau. RP was supported by an Imperial College Junior Research Fellowship. EAR-Z was an Immediate Post-Doctoral Fellow of the British Heart Foundation. PK acknowledges support by the European Research Council Advanced Grant CardioNECT. EAR-Z acknowledges DFG support within the Emmy Noether Programme. AHC, NL, PS & AMC were supported by the Magdi Yacoub Institute.	Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768; [Anonymous], 2017, LANCET PSYCHIAT, V4, P83, DOI 10.1016/S2215-0366(16)30443-6; [Anonymous], 2000, CIRCULATION S1, V102, pI12; [Anonymous], 1995, WALL STREET J, V60, pA1; [Anonymous], 2012, CLIN EXP RHEUMAT S70, V30, pS77; Balachandran K, 2012, CARDIOVASC PATHOL, V21, P206, DOI 10.1016/j.carpath.2011.07.005; Balachandran K, 2009, AM J PHYSIOL-HEART C, V296, pH756, DOI 10.1152/ajpheart.00900.2008; Bischoff J, 2019, CIRC RES, V124, P1163, DOI 10.1161/CIRCRESAHA.119.314813; Chen JH, 2011, CIRC RES, V108, P1510, DOI 10.1161/CIRCRESAHA.110.234237; Chester AH, 2007, PHILOS T R SOC B, V362, P1437, DOI 10.1098/rstb.2007.2126; Cooper PE, 2014, HUM MUTAT, V35, P809, DOI 10.1002/humu.22555; DECK JD, 1988, CARDIOVASC RES, V22, P7, DOI 10.1093/cvr/22.1.7; Dreger SA, 2002, J HEART VALVE DIS, V11, P875; GANNIER F, 1994, CARDIOVASC RES, V28, P1193, DOI 10.1093/cvr/28.8.1193; Hamill OP, 1996, PHARMACOL REV, V48, P231; Heckel E, 2015, CURR BIOL, V25, P1354, DOI 10.1016/j.cub.2015.03.038; Huang S, 2015, P I MECH ENG H, V229, P721, DOI 10.1177/0954411915604336; Kraning-Rush CM, 2012, METHOD CELL BIOL, V110, P139, DOI 10.1016/B978-0-12-388403-9.00006-0; Ku CH, 2006, CARDIOVASC RES, V71, P548, DOI 10.1016/j.cardiores.2006.03.022; Latif N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127844; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Lehmann S, 2009, ANN THORAC SURG, V88, P1476, DOI 10.1016/j.athoracsur.2009.07.025; Lewinsohn AD, 2011, P I MECH ENG H, V225, P821, DOI 10.1177/0954411911406340; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; Mazella J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000355; Mun GI, 2014, FEBS LETT, V588, P1024, DOI 10.1016/j.febslet.2014.02.012; Nichols CG, 2013, CIRC RES, V112, P1059, DOI 10.1161/CIRCRESAHA.112.300514; Osman L, 2006, CIRCULATION, V114, pI547, DOI 10.1161/CIRCULATIONAHA.105.001115; Peyronnet R, 2016, CIRC RES, V118, P311, DOI 10.1161/CIRCRESAHA.115.305043; Pierlot CM, 2014, ANN BIOMED ENG, V42, P2058, DOI 10.1007/s10439-014-1077-6; Pla AF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00311; Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Ranade SS, 2015, NEURON, V87, P1162, DOI 10.1016/j.neuron.2015.08.032; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Shetye A, 2016, HEARING BALANC COMMU, V14, P146, DOI 10.1080/21695717.2016.1209002; Suguitan Jr AL, 2011, PLOS ONE, V6; Taylor PM, 2000, J HEART VALVE DIS, V9, P150; Washburn DG, 2013, BIOORG MED CHEM LETT, V23, P4979, DOI 10.1016/j.bmcl.2013.06.047; Wei ZL, 2015, BIOORG MED CHEM LETT, V25, P4011, DOI 10.1016/j.bmcl.2015.06.098; Wylie-Sears J, 2011, ARTERIOSCL THROM VAS, V31, P598, DOI 10.1161/ATVBAHA.110.216184; Xu XP, 2013, BIOPHYS J, V104, p454A, DOI 10.1016/j.bpj.2012.11.2513; Yacoub MH, 2020, EUR J CARDIO-THORAC, V57, P977, DOI 10.1093/ejcts/ezaa019	43	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240532	10.1371/journal.pone.0240532	http://dx.doi.org/10.1371/journal.pone.0240532			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057457	gold, Green Published			2022-12-26	WOS:000581814700022
J	Ohmoto, M; Lei, WW; Yamashita, J; Hirota, J; Jiang, PH; Matsumoto, I				Ohmoto, Makoto; Lei, Weiwei; Yamashita, Junpei; Hirota, Junji; Jiang, Peihua; Matsumoto, Ichiro			SOX2 regulates homeostasis of taste bud cells and lingual epithelial cells in posterior tongue	PLOS ONE			English	Article							STEM/PROGENITOR CELLS; RECEPTOR-CELLS; PROGENITOR CELLS; STEM; EXPRESSION; LGR5	Taste bud cells arise from local epithelial stem cells in the oral cavity and are continuously replaced by newborn cells throughout an animal's life. However, little is known about the molecular and cellular mechanisms of taste cell turnover. Recently, it has been demonstrated that SOX2, a transcription factor expressed in epithelial stem/progenitor cells of the oral cavity, regulates turnover of anterior tongue epithelium including gustatory and non-gustatory papillae. Yet, the role of SOX2 in regulating taste cell turnover in the posterior tongue is unclear. Prompted by the fact that there are regional differences in the cellular and molecular composition of taste buds and stem/progenitor cells in the anterior and posterior portions of tongue, which are derived from distinct embryonic origins, we set out to determine the role of SOX2 in epithelial tissue homeostasis in the posterior tongue. Here we report the differential requirement of SOX2 in the stem/progenitor cells for the normal turnover of lingual epithelial cells in the posterior tongue.Sox2deletion in the stem/progenitor cells neither induced active caspase 3-mediated apoptotic cell death nor altered stem/progenitor cell population in the posterior tongue. Nevertheless, morphology and molecular feature of non-gustatory epithelial cells were impaired in the circumvallate papilla but not in the filiform papillae. Remarkably, taste buds became thinner, collapsed, and undetectable over time. Lineage tracing of Sox2-deleted stem/progenitor cells demonstrated an almost complete lack of newly generated basal precursor cells in the taste buds, suggesting mechanistically thatSox2is involved in determining stem/progenitor cells to differentiate to gustatory lineage cells. Together, these results demonstrate that SOX2 plays key roles in regulating epithelial tissue homeostasis in the posterior tongue, similar but not identical to its function in the anterior tongue.	[Ohmoto, Makoto; Lei, Weiwei; Yamashita, Junpei; Jiang, Peihua; Matsumoto, Ichiro] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Ohmoto, Makoto; Hirota, Junji] Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa, Japan; [Hirota, Junji] Tokyo Inst Technol, Dept Life Sci & Technol, Yokohama, Kanagawa, Japan	Monell Chemical Senses Center; Tokyo Institute of Technology; Tokyo Institute of Technology	Ohmoto, M; Matsumoto, I (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.; Ohmoto, M (corresponding author), Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa, Japan.	mohmoto@bio.titech.ac.jp; imatsumoto@monell.org			NIH/NIDCD [R01DC013807, R01DC015491, R01DC017503]; Lotte Shigemitsu Prize; NIH Core Grant [P30DC011735]	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Lotte Shigemitsu Prize; NIH Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH/NIDCD grant R01DC013807 (to P.J.) and R01DC015491 and R01DC017503 (to I.M.). M.O. is supported by the Lotte Shigemitsu Prize. We thank the Monell Genotyping, Phenotyping, and Histology and Cellular Localization Cores, supported in part by funding from NIH Core Grant P30DC011735 (to Robert F. Margolskee, Monell Chemical Senses Center), for facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoniadou CL, 2013, CELL STEM CELL, V13, P433, DOI 10.1016/j.stem.2013.07.004; [Anonymous], 2018, DEVELOPMENT, V145, pe0201; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gaillard D, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006990; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Jonker L, 2004, MECH DEVELOP, V121, P1313, DOI 10.1016/j.mod.2004.07.002; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsumoto I, 2013, SEMIN CELL DEV BIOL, V24, P210, DOI 10.1016/j.semcdb.2012.10.004; Matsumoto I, 2011, NAT NEUROSCI, V14, P685, DOI 10.1038/nn.2820; Miura H, 2014, NEUROSCI LETT, V580, P147, DOI 10.1016/j.neulet.2014.08.012; Nishiguchi Y, 2016, DEV BIOL, V416, P98, DOI 10.1016/j.ydbio.2016.06.001; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Ohmoto M, 2006, CHEM SENSES, V31, P739, DOI 10.1093/chemse/bjl016; Ohmoto M, 2017, CHEM SENSES, V42, P547, DOI 10.1093/chemse/bjx032; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Perea-Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053399; Peretz Y, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0277-y; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Ray S, 2016, STEM CELL REP, V7, P817, DOI 10.1016/j.stemcr.2016.09.010; Ren WW, 2014, P NATL ACAD SCI USA, V111, P16401, DOI 10.1073/pnas.1409064111; Rothova M, 2012, DEV DYNAM, V241, P1183, DOI 10.1002/dvdy.23804; Sarkar A, 2016, CELL REP, V16, P1929, DOI 10.1016/j.celrep.2016.07.034; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; STONE LM, 1995, P NATL ACAD SCI USA, V92, P1916, DOI 10.1073/pnas.92.6.1916; Suzuki Y, 2008, CELL TISSUE RES, V332, P393, DOI 10.1007/s00441-008-0600-1; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeda N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066314; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338; Zhang CX, 1996, DIFFERENTIATION, V61, P121, DOI 10.1046/j.1432-0436.1996.6120121.x; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	44	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240848	10.1371/journal.pone.0240848	http://dx.doi.org/10.1371/journal.pone.0240848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057384	Green Published, gold			2022-12-26	WOS:000581814700083
J	Yang, Y; Sun, J; Guo, X; Wang, KL; Liu, QH; Liu, QC				Yang, Yi; Sun, Jie; Guo, Xiao; Wang, Kuiling; Liu, Qinghua; Liu, Qingchao			Anther and ovule development ofClematis serratifolia(Ranunculaceae)-with new formation types in megaspore and nucellus	PLOS ONE			English	Article							CLEMATIS RANUNCULACEAE; MORPHOLOGY; EVOLUTION	Morphological indices of vegetative organs or reproductive organs, which are often used to analyze the evolution and classifyClematis, indicate thatClematis serratifoliaandC.glaucacould be related members at similar evolutionary levels. However, this assumption differs with phylogenetic studies based on genetics. Embryonic characteristics, which are more stable, are commonly used to estimate the phylogeny and evolution of angiosperms. We studied the microsporogenesis, microgametogenesis, megasporogenesis and macrogametogenesis development ofC.serratifolia, and compared the early embryological characteristics amongC.serratifolia,C.serratifoliaand otherClematisspecies reported to provide a reference for the taxonomy of the genusClematis. Our results showed thatC.serratifoliaandC.glaucadiffer in megaspore formation and nucellus types suggesting that they have originated from different ancestors. The differences amongClematiswere mainly found in the type of the anther wall development, tapetum, pollen grains, megaspore formation and nucellus types.	[Yang, Yi; Sun, Jie; Guo, Xiao; Wang, Kuiling; Liu, Qinghua; Liu, Qingchao] Qingdao Agr Univ, Coll Landscape Architecture & Forestry, Qingdao, Peoples R China	Qingdao Agricultural University	Liu, QC (corresponding author), Qingdao Agr Univ, Coll Landscape Architecture & Forestry, Qingdao, Peoples R China.	liuqingchao7205@126.com	Guo, Xiao/C-9237-2018	Guo, Xiao/0000-0003-2268-5090	Forestry Science and Technology Innovation Project of Shandong province, China [LYCX03-2018-15]; National Natural Science Foundation of China [31500264]	Forestry Science and Technology Innovation Project of Shandong province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Forestry Science and Technology Innovation Project of Shandong province, China (grant number LYCX03-2018-15), and the National Natural Science Foundation of China (grant number 31500264).	[Anonymous], 2000, CAN J CARDIOL SC, V16, p1C; Chen X. L, 2000, ACTA PHYTOTAXON SIN, V38, P337; Endress PK, 2000, INT J PLANT SCI, V161, pS211, DOI 10.1086/317572; Endress PK, 2000, INT J PLANT SCI, V161, pS237, DOI 10.1086/317571; ESSIG F B, 1991, SIDA Contributions to Botany, V14, P377; FRENCH JC, 1985, AM J BOT, V72, P472, DOI 10.2307/2443540; Guo YP., 2018, THESIS; Hardy CR, 2000, AM J BOT, V87, P1228, DOI 10.2307/2656715; Jang MY, 2005, J PLANT BIOL, V48, P128, DOI 10.1007/BF03030572; Kumazawa M., 1936, J JPN BOT, V8, P19; Liu P., 2006, THESIS; [钟满香 Manxiang Zhong], 2009, [植物学报, Chinese Bulletin of Botany], V44, P694; Miikeda O, 2006, BOT J LINN SOC, V152, P153, DOI 10.1111/j.1095-8339.2006.00551.x; Quan X. L, 2012, J LIAONING FOR SCI T, V1, P32; Sheidai M, 2009, ACTA BOT CROAT, V68, P67; Sheng L., 2015, THESIS; Sheng L, 2014, BRAZ J BOT, V37, P601, DOI 10.1007/s40415-014-0099-5; Shi JH, 2003, ACTA BOT SIN, V45, P257; Shi JH., 2003, THESIS; Song C.H., 2006, THESIS LANZHOU U; Song P., 2007, THESIS; TAMURA M, 1977, Journal of Japanese Botany, V52, P293; TAMURA MICHIO, 1965, SCI REP OSAKA UNIV, V14, P53; The Angiosperm Phylogeny Group II, 2003, BOT J LINN SOC, V141, P399, DOI [DOI 10.1046/J.1095-8339.2003.T01-1-00158.X, 10.1046/j.1095-8339.2003.t01-1-00158.x]; Tsou CH, 2007, AM J BOT, V94, P716, DOI 10.3732/ajb.94.5.716; Vijayaraghavan MR, 1970, FLORA BD, V159, P450; Wang Na, 2017, Acta Prataculturae Sinica, V26, P123; Wang WT, 2005, ACTA PHYTOTAXON SIN, V43, P431; Wang Z., 2008, THESIS; Wang ZF, 2008, ANN BOT-LONDON, V101, P447, DOI 10.1093/aob/mcm298; Xie L, 2012, PLANT SYST EVOL, V298, P1437, DOI 10.1007/s00606-012-0648-y; Xie L, 2011, SYST BOT, V36, P907, DOI 10.1600/036364411X604921; Xu Tao, 2011, Journal of Yunnan University - Natural Sciences Edition, V33, P96; Yamada T, 2001, BOT J LINN SOC, V137, P277, DOI 10.1006/bojl.2001.0487; [杨艺 Yang Yi], 2019, [植物学报, Chinese Bulletin of Botany], V54, P596; [杨艺 Yang Yi], 2019, [园艺学报, Acta Horticulturae Sinica], V46, P1565; [杨艺 Yang Yi], 2019, [园艺学报, Acta Horticulturae Sinica], V46, P87; Yang Y, 2019, FLORA, V253, P67, DOI 10.1016/j.flora.2019.03.008; Zhang AJ., 2006, THESIS; Zhang MinTao, 2016, Acta Botanica Boreali-Occidentalia Sinica, V36, P2213; 李铭, 2000, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V36, P186	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240432	10.1371/journal.pone.0240432	http://dx.doi.org/10.1371/journal.pone.0240432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057445	Green Published, gold			2022-12-26	WOS:000581814700004
J	Park, SH; Jeong, YM; Lee, HY; Kim, EY; Kim, JH; Park, HK; Ahn, HK				Park, So Hyun; Jeong, Yu Mi; Lee, Hee Young; Kim, Eun Young; Kim, Jeong Ho; Park, Heung Kyu; Ahn, Hee Kyung			Opportunistic use of chest CT for screening osteoporosis and predicting the risk of incidental fracture in breast cancer patients: A retrospective longitudinal study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; DEGENERATIVE CHANGES; COMPUTED-TOMOGRAPHY; ROUTINE CT; SPINE; HEALTH; SCANS; WOMEN	This study aimed to investigate the diagnostic performance of chest computed tomography (CT) for opportunistic screening and longitudinal follow-up of osteoporosis in breast cancer patients, compared to dual-energy X-ray absorptiometry (DXA). The association between L1 vertebral attenuation on chest CT and incidental fracture was also evaluated. We retrospectively reviewed 414 consecutive breast cancer patients who underwent both non-enhanced chest CT and DXA within a 3-month interval and had at least two DXA and two chest CT examinations over more than 1 year. The attenuation value of the L1 trabecular bone was measured on an axial CT image and compared to the corresponding DXA T-score. The diagnostic performance of L1 vertebral attenuation on CT for osteoporosis was calculated at different thresholds (90 HU, 100 HU, 110 HU), and the correlation between L1 vertebral attenuation values and DXA T-scores was statistically analyzed. Overall fracture-free survival was estimated and compared with the threshold of 90 HU on CT and -2.5 T-score on DXA. Of 414 patients (median age, 53.0 years), 88 (21.3%) had either vertebral or non-vertebral fractures. The median follow-up duration between initial and final DXA was 902.9 days. There was a moderate correlation between L1 vertebral attenuation value and DXA T-score (rho = 0.684, CI 0.653-0.712). Fracture-free survival was significantly lower in patients with attenuation values <= 90 HU on CT and T-scores <=-2.5 on DXA (P< .001). Multivariate analysis revealed that attenuation values <= 90 HU on CT (P< .001), T-scores <=-2.5 on DXA (P= .003), and age >= 65 years (P= .03) were independent significant prognostic factors associated with overall fracture-free survival. The sensitivities and specificities of L1 attenuation value were 54.9% and 85.8% at 90-HU threshold, 74.0% and78.4% at 100-HU threshold, and 83.9% and 70.1% at 110-HU threshold, respectively. In conclusion, CT can be used for predicting osteoporosis and discriminating incidental fracture risk in breast cancer patients.	[Park, So Hyun; Jeong, Yu Mi; Lee, Hee Young; Kim, Eun Young; Kim, Jeong Ho] Gachon Univ, Coll Med, Gil Med Ctr, Dept Radiol, Incheon, South Korea; [Park, Heung Kyu] Gachon Univ, Coll Med, Gil Med Ctr, Dept Surg,Breast Canc Ctr, Incheon, South Korea; [Ahn, Hee Kyung] Gachon Univ, Coll Med, Gil Med Ctr, Dept Oncol,Dept Internal Med, Incheon, South Korea	Gachon University; Gachon University; Gachon University	Lee, HY (corresponding author), Gachon Univ, Coll Med, Gil Med Ctr, Dept Radiol, Incheon, South Korea.	lhy0928@gmail.com	Kim, Jeong Ho/AAA-7538-2022	Lee, Hee Young/0000-0003-1461-3345	Gachon University [GCU2017-5256]	Gachon University	This research was supported by the Gachon University research fund of 2017 (GCU2017-5256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alacreu E, 2017, OSTEOPOROSIS INT, V28, P983, DOI 10.1007/s00198-016-3804-3; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], **NON-TRADITIONAL**; Buckens CF, 2015, EUR RADIOL, V25, P2074, DOI 10.1007/s00330-014-3584-0; Choksi Palak, 2018, Clin Diabetes Endocrinol, V4, P12, DOI 10.1186/s40842-018-0062-7; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Dull B, 2017, J NATL COMPR CANC NE, V15, P783, DOI 10.6004/jnccn.2017.0104; Fink HA, 2008, J CLIN DENSITOM, V11, P250, DOI 10.1016/j.jocd.2007.12.018; Garg M K, 2013, Indian J Endocrinol Metab, V17, P203, DOI 10.4103/2230-8210.109659; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Graffy PM, 2017, AM J ROENTGENOL, V209, P491, DOI 10.2214/AJR.17.17853; Gralow JR, 2013, J NATL COMPR CANC NE, V11, pS1; Hillner BE, 2003, J CLIN ONCOL, V21, P4042, DOI 10.1200/JCO.2003.08.017; Jang S, 2019, RADIOLOGY, V291, P359, DOI 10.1148/radiol.2019181648; Kalder M, 2014, BREAST CARE, V9, P312, DOI 10.1159/000368843; Lee SJ, 2018, J BONE MINER RES, V33, P860, DOI 10.1002/jbmr.3383; Leslie WD, 2007, J BONE MINER RES, V22, P476, DOI 10.1359/JBMR.061112; Lu Y, 2001, J BONE MINER RES, V16, P901, DOI 10.1359/jbmr.2001.16.5.901; LUENGO M, 1991, THORAX, V46, P803, DOI 10.1136/thx.46.11.803; Padlina I, 2017, OSTEOPOROSIS INT, V28, P909, DOI 10.1007/s00198-016-3829-7; Pickhardt PJ, 2013, ANN INTERN MED, V158, P588, DOI 10.7326/0003-4819-158-8-201304160-00003; Pickhardt PJ, 2011, J BONE MINER RES, V26, P2194, DOI 10.1002/jbmr.428; Ramin C, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1061-4; Rand T, 1997, CALCIFIED TISSUE INT, V60, P430, DOI 10.1007/s002239900258; Small Ralph E, 2005, MedGenMed, V7, P3; Tenne M, 2013, OSTEOPOROSIS INT, V24, P1419, DOI 10.1007/s00198-012-2048-0	26	10	10	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240084	10.1371/journal.pone.0240084	http://dx.doi.org/10.1371/journal.pone.0240084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052943	gold, Green Published			2022-12-26	WOS:000581820200016
J	Kovacs, L; Cabral, P; Chammas, R				Kovacs, Luciana; Cabral, Pablo; Chammas, Roger			Mannose receptor 1 expression does not determine the uptake of high-density mannose dendrimers by activated macrophages populations	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; PAMAM DENDRIMERS; POOR-PROGNOSIS; NANOPARTICLES; DELIVERY; DRUG; EXOCYTOSIS; RETENTION; MECHANISM; CORRELATE	The presence of a high number of macrophages within solid tumors is often significantly associated with poor prognosis and predict treatment failure for chemotherapy and radiotherapy. Macrophages are innate immune cells capable of performing diverse functions depending on the different signals from the microenvironment. The classically activated macrophage is commonly present during the early stages of tumor development while alternatively activated macrophages are associated with more advanced tumors. The distinction of the antitumoral macrophages from the pro-tumoral macrophages is not absolute. However, they have different cell surface markers such as mannose receptor (MRC1 or CD206) abundantly expressed by macrophages treated with interleukin-4 (IL-4). The important roles of macrophages in cancers suggest that it is important to develop novel therapies that target these cells. In the present study, we designed a probe using Polyamidoamine (PAMAM) fifth-generation (G5) dendrimers conjugated with mannose, Cyanine 7 (Cy7), and hydrazinonicotinamide (HYNIC) for target macrophages with high expression of MRC1 in the tumor. The intracellular uptake of(99m)Tc-HYNIC-dendrimer-mannose-Cy7 through the interaction with MRC1 in bone marrow-derived macrophages (BMDMs) untreated or treated with lipopolysaccharides (LPS) + interferon (IFN)gamma or IL-4 was analyzed. Our results show that high-density mannose dendrimers are preferentially bound by macrophages treated by IFN gamma and LPS that express lower levels of MRC1 than for macrophages treated by IL-4 that express high levels of MRC1. Furthermore, the intracellular(99m)Tc-HYNIC-dendrimer-mannose-Cy7 uptake in BMDMs was not inhibited in the presence of free mannose or glucose. This result suggests that(99m)Tc-HYNIC-dendrimer-mannose-Cy7 is not internalized via macrophage MRC1. Based on these findings, we concluded that MRC1 expression does not determine the uptake of high-density mannose dendrimers.	[Kovacs, Luciana; Chammas, Roger] Univ Sao Paulo, Ctr Invest Translac Oncol, Inst Canc Estado Sao Paulo, Fac Med, Sao Paulo, SP, Brazil; [Cabral, Pablo] Univ Republica, Dept Radiofarmacia, Ctr Invest Nucl, Fac Ciencias, Montevideo, Uruguay; [Chammas, Roger] Univ Sao Paulo, Dept Radiol & Oncol, Fac Med, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidad de la Republica, Uruguay; Universidade de Sao Paulo	Kovacs, L (corresponding author), Univ Sao Paulo, Ctr Invest Translac Oncol, Inst Canc Estado Sao Paulo, Fac Med, Sao Paulo, SP, Brazil.	luciana.kovacs@outlook.com	Kovacs, Luciana/N-7378-2013; Chammas, Roger/A-8004-2011; Cabral, Pablo/HDO-1170-2022	Kovacs, Luciana/0000-0002-3139-7528; Chammas, Roger/0000-0003-0342-8726; 	Sao Paulo Research Foundation (FAPESP) [2014/20746-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The work was supported by grant 2014/20746-0, Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi-Gaballu F, 2018, APPL MATER TODAY, V12, P177, DOI 10.1016/j.apmt.2018.05.002; ABRAMS MJ, 1990, J NUCL MED, V31, P2022; Albertazzi L, 2010, MOL PHARMACEUT, V7, P680, DOI 10.1021/mp9002464; [Anonymous], 2018, NAT REV GENET, V19, P1, DOI 10.1038/nrg.2017.141; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2018, SUSTAINABILITY; [Anonymous], 2016, EBIOMEDICINE, V14, P1, DOI DOI 10.2903/J.EFSA.2016.4418; Azad AK, 2015, J IMMUNOL, V195, P2019, DOI 10.4049/jimmunol.1402005; Bosnjakovic A, 2011, NANOMED-NANOTECHNOL, V7, P284, DOI 10.1016/j.nano.2010.10.008; Cheng Z, 2006, BIOCONJUGATE CHEM, V17, P662, DOI 10.1021/bc050345c; Chowdhury HH, 2018, BIOMATER SCI-UK, V6, P388, DOI 10.1039/c7bm00886d; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; He HL, 2018, TRANSL RES, V193, P13, DOI 10.1016/j.trsl.2017.10.008; Hoeffel G, 2018, CELL IMMUNOL, V330, P5, DOI 10.1016/j.cellimm.2018.01.001; Jiang C, 2017, MOL IMAGING, V16, P1, DOI 10.1177/1536012116689499; Klajnert-Maculewicz B, 2019, PHARM RES-DORDR, V36, P1; Kovacs L, 2014, CURR RADIOPHARM, V7, P115, DOI 10.2174/1874471007666140825121615; Kulhari H, 2016, SCI REP-UK, V6, DOI 10.1038/srep23179; Larionova I, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1596004; Li YC, 2020, ACS APPL BIO MATER, V3, P4335, DOI 10.1021/acsabm.0c00368; Lima L, 2014, UROL ONCOL-SEMIN ORI, V32, P449, DOI 10.1016/j.urolonc.2013.10.012; Loyher PL, 2018, J EXP MED, V215, P2536, DOI 10.1084/jem.20180534; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; Movahedi K, 2012, CANCER RES, V72, P4165, DOI 10.1158/0008-5472.CAN-11-2994; Mukherjee SP, 2013, NANOMED-NANOTECHNOL, V9, P202, DOI 10.1016/j.nano.2012.05.002; Nabeshima A, 2015, BRIT J CANCER, V112, P547, DOI 10.1038/bjc.2014.637; Naha PC, 2010, TOXICOL APPL PHARM, V246, P91, DOI 10.1016/j.taap.2010.04.014; Orecchioni M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01084; Petty AJ, 2017, IMMUNOTHERAPY-UK, V9, P289, DOI 10.2217/imt-2016-0135; Sakhtianchi R, 2013, ADV COLLOID INTERFAC, V201, P18, DOI 10.1016/j.cis.2013.10.013; Saovapakhiran A, 2009, BIOCONJUGATE CHEM, V20, P693, DOI 10.1021/bc8002343; Sharma A, 2018, J CONTROL RELEASE, V283, P175, DOI 10.1016/j.jconrel.2018.06.003; Shiao SL, 2015, CANCER IMMUNOL RES, V3, P518, DOI 10.1158/2326-6066.CIR-14-0232; Shigeoka M, 2013, CANCER SCI, V104, P1112, DOI 10.1111/cas.12188; Sugimura K, 2015, J SURG ONCOL, V111, P752, DOI 10.1002/jso.23881; Sun XL, 2015, THERANOSTICS, V5, P597, DOI 10.7150/thno.11546; Tassano MR, 2011, BIOORG MED CHEM LETT, V21, P5598, DOI 10.1016/j.bmcl.2011.06.079; Tiainen S, 2015, HISTOPATHOLOGY, V66, P873, DOI 10.1111/his.12607; Wangpradit O, 2016, ENVIRON SCI POLLUT R, V23, P2128, DOI 10.1007/s11356-015-5022-5; Zhang CR, 2017, THERANOSTICS, V7, P4276, DOI 10.7150/thno.20999; Zhang F, 2015, BIOMATERIALS, V52, P507, DOI 10.1016/j.biomaterials.2015.02.053; Zhang J, 2016, INT J NANOMED, V11, P3677, DOI 10.2147/IJN.S106418; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	45	1	1	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240455	10.1371/journal.pone.0240455	http://dx.doi.org/10.1371/journal.pone.0240455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048944	gold, Green Published			2022-12-26	WOS:000581813300036
J	Chung, GS; Hutton, DW				Chung, Grace S.; Hutton, David W.			Epidemiological impact and cost-effectiveness of universal meningitis b vaccination among college students prior to college entry	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; SEROGROUP-B	Objectives University students are at significantly higher risk of serogroup B meningococcal (MenB) infection, which can result in debilitating sequelae and excessive healthcare usage. This study aimed to elucidate the impact of universal pre-enrollment vaccination on MenB outbreak probability and the cost-effectiveness in outbreak-only scenarios. Methods We developed an infectious disease transmission model to determine the number of outbreaks averted under universal vaccination and a Markov model to simulate the costs accrued and QALYs lost associated with infection. The analysis was done on a hypothetical population of 40,000 college students over a four-year time frame. We used the outputs of these two models to calculate the incremental cost-effectiveness ratio (ICER) of universal MenB vaccination from a societal perspective. Results We find that the vaccination strategy was estimated to reduce MenB incidence by 63% and outbreak frequency rate by 90%. Under base case assumptions, the ICER of universal vaccination was $748,129 per QALY and in outbreak-only scenarios, it was cost-saving. Conclusions Universal vaccination is not cost-effective at the current low MenB incidence levels and vaccine price in the U.S., but it is cost-saving if outbreak is imminent.	[Chung, Grace S.; Hutton, David W.] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chung, GS (corresponding author), Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA.	sygrace@umich.edu			Agency for Healthcare Research and Quality Traineeship National Research Service Award	Agency for Healthcare Research and Quality Traineeship National Research Service Award	Grace S. Chung was funded by the Agency for Healthcare Research and Quality Traineeship National Research Service Award.	Al-Janabi H, 2016, HEALTH ECON, V25, P1529, DOI 10.1002/hec.3259; [Anonymous], 2016, LANCET INFECT DIS, V16, P385, DOI 10.1016/S1473-3099(16)00139-0; [Anonymous], 1996, COST EFFECTIVENESS H; Banzhoff Angelika, 2017, Ther Adv Vaccines, V5, P3, DOI 10.1177/2051013616681365; Batista RS, 2017, ASIAN PAC J TROP MED, V10, P1019, DOI 10.1016/j.apjtm.2017.10.004; Biswas HH, 2016, MMWR-MORBID MORTAL W, V65, P520, DOI 10.15585/mmwr.mm6520a3; Centers for Disease Control and Prevention, 2016, ENH MEN DIS SURV REP; Centers for Disease Control and Prevention, 2019, VACC PRIC LIST; Centers for Disease Control and Prevention, 2019, MEN VACC WHAT EV SHO; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P57; Centers for Disease Control and Prevention National Center for Health Statistics, FAST STATS A Z LIF E; Christensen H, 2017, VACCINE, V35, P208, DOI 10.1016/j.vaccine.2016.11.076; Christensen H, 2016, VACCINE, V34, P3412, DOI 10.1016/j.vaccine.2016.04.004; Christensen H, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5725; CMS, 2020, PHYS FEE SCHEDULE; Davis KL, 2011, HUM VACCINES, V7, P96, DOI 10.4161/hv.7.1.13692; GlaxoSmithKline, 2017, GET FACTS MEN B; Izquierdo G, 2015, HUM VACC IMMUNOTHER, V11, P875, DOI 10.1080/21645515.2015.1010885; Kuznik A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188595; Leeds IL, 2019, AM J PREV MED, V56, P196, DOI 10.1016/j.amepre.2018.09.020; Marshall GS, 2020, J PEDIAT INF DIS SOC, V9, P244, DOI 10.1093/jpids/piz024; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ortega-Sanchez IR, 2008, CLIN INFECT DIS, V46, P1, DOI 10.1086/524041; Ostergaard L, 2017, NEW ENGL J MED, V377, P2349, DOI 10.1056/NEJMoa1614474; Pace D, 2012, VACCINE, V30, pB3, DOI 10.1016/j.vaccine.2011.12.062; Poore KD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1015-8; Precision Vaccinations, 2018, IS MEN B VACC COST E; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Shepard CW, 2005, PEDIATRICS, V115, P1220, DOI 10.1542/peds.2004-2514; Soeters HM, 2019, EMERG INFECT DIS, V25, P434, DOI 10.3201/eid2503.181574; Stratton KR, 2000, VACCINES 21 CENTURY; Strauss D, 1999, DEV MED CHILD NEUROL, V41, P580, DOI 10.1017/S001216229900122X; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127; Trotter CL, 2006, EPIDEMIOL INFECT, V134, P556, DOI 10.1017/S0950268805005339; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Yaesoubi R, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002495	36	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239926	10.1371/journal.pone.0239926	http://dx.doi.org/10.1371/journal.pone.0239926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035260	Green Published, gold			2022-12-26	WOS:000581817500007
J	Ban, GY; Youn, DY; Ye, YM; Park, HS				Ban, Ga-Young; Youn, Dong-Ye; Ye, Young-Min; Park, Hae-Sim			Increased expression of serine palmitoyl transferase andORMDL3polymorphism are associated with eosinophilic inflammation and airflow limitation in aspirin-exacerbated respiratory disease	PLOS ONE			English	Article							ORMDL3 EXPRESSION; ASTHMA; POLYMORPHISM; METAANALYSIS; PREVALENCE; METABOLISM; CONTRIBUTE; SEVERITY; ONSET	Background Patients with aspirin-exacerbated respiratory disease (AERD) are known to have poor clinical outcomes. The pathogenic mechanisms have not yet been completely understood. Objective We aimed to assess the involvement of thede-novosynthetic pathway of sphingolipid metabolism in patients with AERD compared to those with aspirin tolerant asthma (ATA). Methods A total of 63 patients with AERD and 79 patients with ATA were enrolled in this study. Analysis of mRNA expression of serine palmitoyl transferase, long-chain base subunit 2 (SPTLC2) and genotyping ofORMDL3SNP (rs7216389) was performed. Results Significantly higher levels of SPTLC2 mRNA expression were noted in patients with AERD, which showed significant positive correlations with peripheral/sputum eosinophil counts and urine LTE4(allP<0.05). The levels of SPTLC2 mRNA expression showed significant negative correlations with the level of FEV(1)and FEV1/FVC (P= 0.033,r= -0.274;P= 0.019,r= -0.299, respectively). Genotype frequencies ofORMDL3SNP (rs7216389) showed no significant differences between the AERD and ATA groups. Patients with AERD carrying the TT genotype ofORMDL3had significantly lower levels of FVC (%) and PC(20)methacholine than those carrying the CT or CC genotype (P= 0.026 andP= 0.030).	[Ban, Ga-Young; Youn, Dong-Ye] Hallym Univ, Kangdong Sacred Heart Hosp, Coll Med, Dept Pulm Allergy & Crit Care Med, Seoul, South Korea; [Ban, Ga-Young] Hallym Univ, Coll Med, Allergy & Clin Immunol Res Ctr, Seoul, South Korea; [Ye, Young-Min; Park, Hae-Sim] Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon, South Korea	Hallym University; Hallym University; Ajou University	Ban, GY (corresponding author), Hallym Univ, Kangdong Sacred Heart Hosp, Coll Med, Dept Pulm Allergy & Crit Care Med, Seoul, South Korea.; Ban, GY (corresponding author), Hallym Univ, Coll Med, Allergy & Clin Immunol Res Ctr, Seoul, South Korea.; Park, HS (corresponding author), Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon, South Korea.	rkduddle@hanmail.net; hspark@ajou.ac.kr		Ban, Ga Young/0000-0002-7961-742X	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI16C0992]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2017R1A2B4010060, 2020R1I1A3051800]; Hallym University Research Fund	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) - Korea government (MSIP); Hallym University Research Fund	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI16C0992), the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No: 2017R1A2B4010060 and 2020R1I1A3051800) and Hallym University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; [Anonymous], **NON-TRADITIONAL**; Ban GY, 2017, CLIN EXP ALLERGY, V47, P37, DOI 10.1111/cea.12797; Choi Y, 2020, ALLERGY, V75, P2858, DOI 10.1111/all.14366; Choi Y, 2019, ALLERGY ASTHMA IMMUN, V11, P320, DOI 10.4168/aair.2019.11.3.320; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Hagan JB, 2017, J ALLER CL IMM-PRACT, V5, P990, DOI 10.1016/j.jaip.2016.11.004; Halapi E, 2010, EUR J HUM GENET, V18, P902, DOI 10.1038/ejhg.2010.38; James B, 2019, J ALLERGY CLIN IMMUN, V144, P634, DOI 10.1016/j.jaci.2019.07.023; Karandashova S, 2018, AM J PHYSIOL-LUNG C, V314, pL206, DOI 10.1152/ajplung.00322.2017; Kiefer K, 2015, J BIOL CHEM, V290, P2822, DOI 10.1074/jbc.M114.595116; Kim B, 2009, J ALLERGY CLIN IMMUN, V123, pS81, DOI 10.1016/j.jaci.2008.12.285; Kim SH, 2007, PHARMACOGENOMICS, V8, P1143, DOI 10.2217/14622416.8.9.1143; Kim SH, 2020, ALLERGY, V75, P1991, DOI 10.1111/all.14236; Kim SH, 2019, ALLERGY ASTHMA IMMUN, V11, P299, DOI 10.4168/aair.2019.11.3.299; Kowal K, 2019, ALLERGY ASTHMA IMMUN, V11, P330, DOI 10.4168/aair.2019.11.3.330; Liu T, 2018, J IMMUNOL, V200, P915, DOI 10.4049/jimmunol.1700603; McCracken JL, 2017, JAMA-J AM MED ASSOC, V318, P279, DOI 10.1001/jama.2017.8372; Miller M, 2017, J ALLERGY CLIN IMMUN, V139, P1373, DOI 10.1016/j.jaci.2016.08.053; Miller M, 2014, J IMMUNOL, V192, P3475, DOI 10.4049/jimmunol.1303047; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Morales DR, 2015, ALLERGY, V70, P828, DOI 10.1111/all.12629; Oyeniran C, 2015, J ALLERGY CLIN IMMUN, V136, P1035, DOI 10.1016/j.jaci.2015.02.031; PARK HS, 1995, CLIN EXP ALLERGY, V25, P38, DOI 10.1111/j.1365-2222.1995.tb01000.x; Paulenda T, 2016, ALLERGY, V71, P918, DOI 10.1111/all.12877; Perzanowski MS, 2017, AM J RESP CRIT CARE, V195, P1068, DOI 10.1164/rccm.201609-1884LE; Petrache I, 2016, ANNU REV PHYSIOL, V78, P463, DOI 10.1146/annurev-physiol-021115-105221; Rajan JP, 2015, J ALLERGY CLIN IMMUN, V135, P676, DOI 10.1016/j.jaci.2014.08.020; Reinke SN, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01740-2016; Salimi M, 2017, J ALLERGY CLIN IMMUN, V140, P1090, DOI 10.1016/j.jaci.2016.12.958; Sharma S, 2014, J ALLERGY CLIN IMMUN, V134, P1153, DOI 10.1016/j.jaci.2014.04.011; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Trinh HKT, 2016, SCI REP-UK, V6, DOI 10.1038/srep36599; Worgall TS, 2013, SCI TRANSL MED, V5; WTE and JHR, 2013, EUCONST, V9, P4	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240334	10.1371/journal.pone.0240334	http://dx.doi.org/10.1371/journal.pone.0240334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031402	gold, Green Published			2022-12-26	WOS:000581809800076
J	Lee, DC; Lee, SY				Lee, Dong Cheol; Lee, Se Youp			Analysis of astigmatism outcomes after horizontal rectus muscle surgery in patients with intermittent exotropia	PLOS ONE			English	Article							CORNEAL TOPOGRAPHIC CHANGES; STRABISMUS SURGERY; REFRACTIVE CHANGES; THICKNESS; RECESSION; MYOPIA	This study examined the factors affecting corneal curvature change after lateral rectus recession and medial rectus resection surgery in patients with intermittent exotropia. This was a retrospective cross-sectional study in intermittent exotropia patients who underwent rectus resection surgery. The study involved 41 male and 42 female patients (mean age: 9.55 +/- 5.03 years, range: 3-28 years). Corneal astigmatism analysis was performed using the Galilei G4 Dual Scheimpflug Analyzer. The values of simulated and ray tracing corneal keratometry (K) of astigmatism, including axis changes, were determined preoperatively and at 1 week and 3 months postoperatively. The factors found to affect corneal curvature change were sex, extent of surgery, and axial length. Simulated and ray tracing changes were significant preoperatively and at 1 week and 3 months after rectus resection surgery (p< 0.05); however, there were no differences in astigmatism (D) at any time. The spherical equivalent had a myopic change after rectus resection surgery with cycloplegic refraction, and in ray tracing mode, flat K was decreased at 1 week from baseline and increased 3 months later. Steep, mean K, and axis increased continuously from baseline to 1 week and 3 months. Astigmatism, in contrast, was increased at 1 week, but decreased at 3 months, with no return to baseline. Univariable linear regression analyses showed that the extent of surgery had an effect on flat K change and that sex had an effect on steep K and axis. Additionally, axial length affected steep K and astigmatism, while age had no effect on any variable. Ray tracing values were significantly different from simulated values. In ray tracing mode, rectus resection surgery may result in astigmatism shifted toward with-the-rule, and myopic changes may be caused by differences in thickness and flexibility of the sclera. Notably, age did not affect any variable.	[Lee, Dong Cheol; Lee, Se Youp] Keimyung Univ, Dept Ophthalmol, Sch Med, Daegu, South Korea; [Lee, Dong Cheol] Keimyung Univ, Inst Med Sci, Daegu, South Korea	Keimyung University; Keimyung University	Lee, DC (corresponding author), Keimyung Univ, Dept Ophthalmol, Sch Med, Daegu, South Korea.; Lee, DC (corresponding author), Keimyung Univ, Inst Med Sci, Daegu, South Korea.	tking33@naver.com		Lee, Dong Cheol/0000-0002-1570-3118	Keimyung University Dongsan Medical Center	Keimyung University Dongsan Medical Center	This work was supported by a researchpromoting grant from Keimyung University Dongsan Medical Center in 2018. No funding was received for the conduction of this study.	Bagheri A, 2003, J AAPOS, V7, P42, DOI 10.1016/S1091-8531(02)42007-1; Brum GS, 2011, ARQ BRAS OFTALMOL, V74, P24, DOI 10.1590/S0004-27492011000100006; Buckhurst HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132902; DENIS D, 1995, OPHTHALMOLOGICA, V209, P136, DOI 10.1159/000310599; DOTTAN SA, 1988, OPHTHALMIC SURG LAS, V19, P128; Elston J, 1997, PEDIAT OPHTHALMOLOGY, P925; Fix A, 1985, AM ORTHOPT J, V35, P59; Hainsworth DP, 1999, J AAPOS, V3, P80, DOI 10.1016/S1091-8531(99)70074-1; Hong Seung Woo, 2012, Korean J Ophthalmol, V26, P438, DOI 10.3341/kjo.2012.26.6.438; Killer HE, 1999, OPHTHALMOLOGICA, V213, P209, DOI 10.1159/000027422; Kim EJ, 2015, J CATARACT REFR SURG, V41, P2731, DOI 10.1016/j.jcrs.2015.07.035; KWITKO S, 1991, ARCH OPHTHALMOL-CHIC, V109, P873, DOI 10.1001/archopht.1991.01080060137042; KWITKO S, 1992, CORNEA, V11, P36, DOI 10.1097/00003226-199201000-00005; Loman J, 2002, OPHTHALMOLOGY, V109, P1032, DOI 10.1016/S0161-6420(02)01012-6; Marshall D, 1936, ARCH OPHTHALMOL-CHIC, V15, P1020; Matsumura H, 1999, SURV OPHTHALMOL, V44, pS109, DOI 10.1016/S0039-6257(99)00094-6; Menassa N, 2008, J CATARACT REFR SURG, V34, P1742, DOI 10.1016/j.jcrs.2008.06.024; Mohamed-Noor J, 2009, J GLAUCOMA, V18, P32, DOI 10.1097/IJG.0b013e31816b2fd1; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; Nardi M, 1997, J PEDIAT OPHTH STRAB, V34, P244; Norman RE, 2010, EXP EYE RES, V90, P277, DOI 10.1016/j.exer.2009.11.001; PRESLAN MW, 1992, J PEDIATR OPHTHALMOL, V29, P300; Rajavi Zhale, 2008, International Ophthalmology, V28, P83, DOI 10.1007/s10792-007-9116-z; Read SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33796; REYNOLDS RD, 1991, AM J OPHTHALMOL, V111, P371, DOI 10.1016/S0002-9394(14)72327-X; Schlatter B, 2015, J CATARACT REFR SURG, V41, P1073, DOI 10.1016/j.jcrs.2014.08.035; Siso-Fuertes I, 2015, J CATARACT REFR SURG, V41, P981, DOI 10.1016/j.jcrs.2014.08.038; SNIR M, 1989, OPHTHALMIC SURG LAS, V20, P57; Tay M T, 1992, Ann Acad Med Singap, V21, P785; THOMPSON WE, 1980, J PEDIAT OPHTH STRAB, V17, P372; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421	32	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240026	10.1371/journal.pone.0240026	http://dx.doi.org/10.1371/journal.pone.0240026			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031390	gold, Green Published			2022-12-26	WOS:000581809800044
J	Abbey, EJ; Khalifa, BAA; Oduwole, MO; Ayeh, SK; Nudotor, RD; Salia, EL; Lasisi, O; Bennett, S; Yusuf, HE; Agwu, AL; Karakousis, PC				Abbey, Enoch J.; Khalifa, Banda A. A.; Oduwole, Modupe O.; Ayeh, Samuel K.; Nudotor, Richard D.; Salia, Emmanuella L.; Lasisi, Oluwatobi; Bennett, Seth; Yusuf, Hasiya E.; Agwu, Allison L.; Karakousis, Petros C.			The Global Health Security Index is not predictive of coronavirus pandemic responses among Organization for Economic Cooperation and Development countries	PLOS ONE			English	Article								The ongoing COVID-19 pandemic has devastated many countries with ripple effects felt in various sectors of the global economy. In November 2019, the Global Health Security (GHS) Index was released as the first detailed assessment and benchmarking of 195 countries to prevent, detect, and respond to infectious disease threats. This paper presents the first comparison of Organization for Economic Cooperation and Development OECD countries' performance during the pandemic, with the pre-COVID-19 pandemic preparedness as determined by the GHS Index. Using a rank-based analysis, four indices were compared between select countries, including total cases, total deaths, recovery rate, and total tests performed, all standardized for comparison. Our findings suggest a discrepancy between the GHS index rating and the actual performance of countries during this pandemic, with an overestimation of the preparedness of some countries scoring highly on the GHS index and underestimation of the preparedness of other countries with relatively lower scores on the GHS index.	[Abbey, Enoch J.; Oduwole, Modupe O.; Ayeh, Samuel K.; Agwu, Allison L.; Karakousis, Petros C.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21205 USA; [Khalifa, Banda A. A.; Oduwole, Modupe O.; Salia, Emmanuella L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Nudotor, Richard D.] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD USA; [Salia, Emmanuella L.; Yusuf, Hasiya E.; Agwu, Allison L.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Lasisi, Oluwatobi] Wayne State Univ, Sch Med, Detroit, MI USA; [Bennett, Seth] CTI Clin Trial & Consulting, Covington, KY USA; [Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Wayne State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Agwu, AL; Karakousis, PC (corresponding author), Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21205 USA.; Agwu, AL (corresponding author), Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD 21205 USA.; Karakousis, PC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	ageorg10@jhmi.edu; petros@jhmi.edu	Abbey, Enoch/AAI-5563-2021; Khalifa, Banda/GRF-1928-2022	Abbey, Enoch/0000-0002-3286-0529; Khalifa, Banda Abdallah Abubakar/0000-0002-2525-5531	National Institute of Allergy and Infectious Diseases (NIAID) [K24AI143447]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Institute of Allergy and Infectious Diseases (NIAID) supported this study in the form of a grant awarded to PCK (K24AI143447). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], THE BALANCE; [Anonymous], 2020, MUCH DO WE KNOW COUN; [Anonymous], 2020, THE BALANCE; [Anonymous], WHAT GLOB HLTH SURV; [Anonymous], US COVID 19 LEAD WOR; COVID-19 Map, COVID 19 MAP; CSSEGISandData, 2020, CSSEGISANDDATA COVID; Dalglish SL, 2020, LANCET, V395, P1189, DOI 10.1016/S0140-6736(20)30739-X; GHS Index, 2020, US COVID 19 LEAD WOR; Gupta V, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020416; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Our World in Data, COR COVID 19 TEST ST; Scally G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1932; Semenza JC, 2019, TRANSBOUND EMERG DIS, V66, P1855, DOI 10.1111/tbed.13211; Varghese C, 2020, INFECT DIS HEALTH, V25, P242, DOI 10.1016/j.idh.2020.05.003	15	46	46	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239398	10.1371/journal.pone.0239398	http://dx.doi.org/10.1371/journal.pone.0239398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027257	Green Submitted, gold, Green Published			2022-12-26	WOS:000581808000054
J	Bottan, N; Hoffmann, B; Vera-Cossio, D				Bottan, Nicolas; Hoffmann, Bridget; Vera-Cossio, Diego			The unequal impact of the coronavirus pandemic: Evidence from seventeen developing countries	PLOS ONE			English	Article							INEQUALITY	The current coronavirus pandemic is an unprecedented public health challenge that is having a devastating economic impact on households. Using a sample of 230,540 respondents to an online survey from 17 countries in Latin America and the Caribbean, the study shows that the economic impacts are large and unequal: 45 percent of respondents report that a household member has lost their job and, among households owning small businesses, 59 percent of respondents report that a household member has closed their business. Among households with the lowest income prior to the pandemic, 71 percent report that a household member lost their job and 61 percent report that a household member has closed their business. Declines in food security and health are among the disproportionate impacts. The findings provide evidence that the current public health crisis will exacerbate economic inequality and provides some of the first estimates of the impact of the pandemic on the labor market and well-being in developing countries.	[Bottan, Nicolas] Cornell Univ, Policy Anal & Management, Ithaca, NY 14850 USA; [Hoffmann, Bridget; Vera-Cossio, Diego] Interamer Dev Bank, Res Dept, Washington, DC USA	Cornell University; Inter-American Development Bank	Bottan, N (corresponding author), Cornell Univ, Policy Anal & Management, Ithaca, NY 14850 USA.	nicolas.bottan@cornell.edu			InterAmerican Development Bank's Coronavirus research funds [RG-E1700]	InterAmerican Development Bank's Coronavirus research funds	This project was funded by the InterAmerican Development Bank's Coronavirus research funds (RG-E1700 - Coronavirus survey). The funder provided support in the form of salaries for authors Bridget Hoffmann and Diego VeraCossio, and provided funds to cover the cost of recruiting subjects via social media advertising, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section."	Adams-Prassl A, 2020, INEQUALITY IMPACT CO, DOI [10.13140/RG.2.2.11867.72482, DOI 10.13140/RG.2.2.11867.72482]; Allcott H, 2020, 26946 NBER; Alon T.M., 2020, NBER WORKING PAPER 2, DOI [10.3386/w26947, DOI 10.3386/W26947]; Amarante V, 2016, INEQUALITY LATIN AM, DOI [10.18356/bf11809a-en, DOI 10.18356/BF11809A-EN]; Baez JE, 2017, SHAKING EC PROGR AGG; Bartik Alexander W., 2020, NBER WORKING PAPERS, P26989; Bento AI, 2020, P NATL ACAD SCI; Berg AndrewG., 2011, FINANC DEV; Blackman A., 2020, POLITICA PUBLICA FRE, V810, DOI 10.18235/0002302; Briscese G, 2020, NATL BUREAU EC RES; Brzezinski M, 2018, ECON SYST, V42, P219, DOI 10.1016/j.ecosys.2017.07.003; Cingano F., 2014, TRENDS INCOME INEQUA; Fetzer T., 2020, CEPR DISCUSSION PAPE; Fetzer T, 2021, REV ECON STAT, V103, P968, DOI 10.1162/rest_a_00946; Gershon D., 2020, ARXIV200410324; Heathcote J, 2010, REV ECON DYNAM, V13, P15, DOI 10.1016/j.red.2009.10.010; Kohlscheen E., 2020, BIS B, V4, DOI [10.2139/ssrn.3569554, DOI 10.2139/SSRN.3569554]; Levy S, 2013, J ECON PERSPECT, V27, P193, DOI 10.1257/jep.27.2.193; Messina J, 2018, WAGE INEQUAITY LATIN; Milanovic B., 2016, GLOBAL INEQUALITY; Ostry J., 2014, REDISTRIBUTION INEQU; Piketty T, 2019, AM ECON REV, V109, P2469, DOI 10.1257/aer.20170973; Smeeding T, 2012, INCOME WEALTH DEBT G; Stiglitz JE, 2013, PRICEOF INEQUALITY T; Zaman K Taeen, 2020, COVID 19 PANDEMIC BU, DOI [10.20944/preprints202005.0461.v2, DOI 10.20944/PREPRINTS202005.0461.V2]; Zucman G, 2020, GLOBAL WEALTH INEQUA	26	46	46	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239797	10.1371/journal.pone.0239797	http://dx.doi.org/10.1371/journal.pone.0239797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3SJ	33027272	Green Submitted, Green Published, gold			2022-12-26	WOS:000581808000056
J	Weck, ML; Crawley, SW; Tyska, MJ				Weck, Meredith L.; Crawley, Scott W.; Tyska, Matthew J.			A heterologous in-cell assay for investigating intermicrovillar adhesion complex interactions reveals a novel protrusion length-matching mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						filopodia; microvilli; brush border; enterocyte; epithelia; actin; bundle; cytoskeleton; myosin; protocadherin; MYO10; MYO7B; CDHR2; CDHR5; USH1C; ANKS4B; adhesion; epithelial cell	USHER-SYNDROME PROTEINS; SENSORY HAIR-CELLS; TIP-LINK; BRUSH-BORDER; MYOSIN VIIA; CADHERIN-23; HARMONIN; FORM; LOCALIZATION; MICROVILLI	Solute transporting epithelial cells build arrays of microvilli on their apical surface to increase membrane scaffolding capacity and enhance function potential. In epithelial tissues such as the kidney and gut, microvilli are length-matched and assembled into tightly packed "brush borders," which are organized by similar to 50-nm thread-like links that form between the distal tips of adjacent protrusions. Composed of protocadherins CDHR2 and CDHR5, adhesion links are stabilized at the tips by a cytoplasmic tripartite module containing the scaffolds USH1C and ANKS4B and the actin-based motor MYO7B. Because several questions about the formation and function of this "intermicrovillar adhesion complex" remain open, we devised a system that allows one to study individual binary interactions between specific complex components and MYO7B. Our approach employs a chimeric myosin consisting of the MYO10 motor domain fused to the MYO7B cargo-binding tail domain. When expressed in HeLa cells, which do not normally produce adhesion complex proteins, this chimera trafficked to the tips of filopodia and was also able to transport individual complex components to these sites. Unexpectedly, the MYO10-MYO7B chimera was able to deliver CDHR2 and CDHR5 to distal tips in the absence of USH1C or ANKS4B. Cells engineered to localize high levels of CDHR2 at filopodial tips acquired interfilopodial adhesion and exhibited a striking dynamic length-matching activity that aligned distal tips over time. These findings deepen our understanding of mechanisms that promote the distal tip accumulation of intermicrovillar adhesion complex components and also offer insight on how epithelial cells minimize microvillar length variability.	[Weck, Meredith L.; Tyska, Matthew J.] Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Crawley, Scott W.] Univ Toledo, Dept Biol, Toledo, OH 43606 USA	Vanderbilt University; University System of Ohio; University of Toledo	Tyska, MJ (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	matthew.tyska@vanderbilt.edu		Tyska, Matthew/0000-0003-2238-6189; Crawley, Scott William/0000-0002-4121-5353	Vanderbilt Training Program in Stem Cell and Regenerative Developmental Biology; American Heart Association Predoctoral Fellowship; National Research Service Award Predoctoral Fellowship [F31DK108528]; American Heart Association Postdoctoral Fellowship; National Institutes of Health [R01-DK111949, R01-DK095811]	Vanderbilt Training Program in Stem Cell and Regenerative Developmental Biology; American Heart Association Predoctoral Fellowship(American Heart Association); National Research Service Award Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Vanderbilt Training Program in Stem Cell and Regenerative Developmental Biology (to M. L. W.), American Heart Association Predoctoral Fellowship (to M. L. W.), National Research Service Award Predoctoral Fellowship F31DK108528 (to M. L. W.), an American Heart Association Postdoctoral Fellowship (to S. W. C.), and National Institutes of Health Grants R01-DK111949 and R01-DK095811 (to M. J. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Bird JE, 2017, MOL BIOL CELL, V28, P463, DOI 10.1091/mbc.E16-08-0583; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Burke TA, 2014, CURR BIOL, V24, P579, DOI 10.1016/j.cub.2014.01.072; Choi MS, 2020, J BIOL CHEM, V295, P9281, DOI 10.1074/jbc.RA120.012820; Crawley SW, 2016, DEV CELL, V36, P190, DOI 10.1016/j.devcel.2015.12.022; Crawley SW, 2014, J CELL BIOL, V207, P441, DOI 10.1083/jcb.201407015; Crawley SW, 2014, CELL, V157, P433, DOI 10.1016/j.cell.2014.01.067; Delacour D, 2016, NAT REV GASTRO HEPAT, V13, P161, DOI 10.1038/nrgastro.2016.5; Faust JJ, 2019, CURR BIOL, V29, P3457, DOI 10.1016/j.cub.2019.08.051; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; He YY, 2019, CELL REP, V29, P974, DOI 10.1016/j.celrep.2019.09.027; Helander HF, 2014, SCAND J GASTROENTERO, V49, P681, DOI 10.3109/00365521.2014.898326; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Lentz J., 1993, GENEREVIEWS R; Li JC, 2017, P NATL ACAD SCI USA, V114, pE3776, DOI 10.1073/pnas.1702251114; Li JC, 2016, DEV CELL, V36, P179, DOI 10.1016/j.devcel.2015.12.020; Marshall WF, 2015, TRENDS CELL BIOL, V25, P760, DOI 10.1016/j.tcb.2015.08.008; Mazerik JN, 2012, J BIOL CHEM, V287, P13104, DOI 10.1074/jbc.M111.336313; MOOSEKER MS, 1975, J CELL BIOL, V67, P725, DOI 10.1083/jcb.67.3.725; Pan LF, 2009, P NATL ACAD SCI USA, V106, P5575, DOI 10.1073/pnas.0901819106; Pelaseyed T, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221853; Pena JF, 2016, EVODEVO, V7, DOI 10.1186/s13227-016-0050-x; Pinette JA, 2019, MOL BIOL CELL, V30, P108, DOI 10.1091/mbc.E18-09-0558; Rotty JD, 2015, DEV CELL, V32, P54, DOI 10.1016/j.devcel.2014.10.026; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Suarez C, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2016.106; Suarez C, 2015, DEV CELL, V32, P43, DOI 10.1016/j.devcel.2014.10.027; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weck ML, 2016, CURR BIOL, V26, P2717, DOI 10.1016/j.cub.2016.08.014; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; Yan J, 2010, P NATL ACAD SCI USA, V107, P4040, DOI 10.1073/pnas.0911385107; Yang Y, 2005, J BIOL CHEM, V280, P32061, DOI 10.1074/jbc.M506765200; Yu IM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15864; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136	47	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16191	16206		10.1074/jbc.RA120.015929	http://dx.doi.org/10.1074/jbc.RA120.015929			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	33051206	Green Published, hybrid			2022-12-26	WOS:000598519500002
J	Cai, B; Zhou, MH; Huang, HL; Zhou, AC; Chu, ZD; Huang, XD; Li, CW				Cai, Bin; Zhou, Min-hong; Huang, Hua-li; Zhou, A-cheng; Chu, Zheng-da; Huang, Xiao-dong; Li, Chun-wei			Protective effects of citrulline supplementation in ulcerative colitis rats	PLOS ONE			English	Article							ARGININE AVAILABILITY; INFLAMMATION; DISEASE; MCP-1	It has been reported that supplementing certain amino acids has therapeutic effects on ulcerative colitis (UC). We intend to explore whether citrulline (Cit) supplementation has protective effects on UC. Fifteen male Wistar rats were divided into normal control group (NC group), UC group and UC+Cit group, with five rats in each group. The UC model was established by TNBS/ethanol method. Rats in UC+Cit group were intragastrically administered with Cit for 7 consecutive days after modeling. All rats were sacrificed after 7 days. Blood samples were collected to detect the number of monocytes. Colon tissues were taken for HE staining. Immunohistochemistry staining for CD68 and p-STAT3 were performed to detect the infiltration of monocytes and the phosphorylation of STAT3 in colon tissues. The concentrations of MCP-1, IL-6 and IL-17A and the protein expression of p-STAT3 in colon tissues were measured by ELISA and western blot methods, respectively. The body weight of UC group rats decreased significantly after 7 days (p<0.05). However, the weight loss of UC+Cit group rats was not statistically significant (p>0.05). The number of peripheral blood monocytes in UC+Cit group was significantly lower than that in UC group (p<0.05), and the infiltration of CD68-positive monocytes in the colon tissue of UC+Cit group was significantly reduced than that in UC group. The concentrations of MCP-1, IL-6 and IL-17A and the expression of p-STAT3 in colon tissues of UC+Cit group rats were significantly lower than those in UC group (bothp<0.05). Our study suggests that Cit supplementation may be a potential therapy for UC.	[Cai, Bin; Huang, Hua-li; Zhou, A-cheng; Chu, Zheng-da; Huang, Xiao-dong; Li, Chun-wei] Wuxi Tradit Chinese Med Hosp, Dept Anorectal Surg, Wuxi, Jiangsu, Peoples R China; [Zhou, Min-hong] Wuxi Tradit Chinese Med Hosp, Dept Gastroenterol, Wuxi, Jiangsu, Peoples R China		Li, CW (corresponding author), Wuxi Tradit Chinese Med Hosp, Dept Anorectal Surg, Wuxi, Jiangsu, Peoples R China.	lichunweiwx@126.com			Natural Science Foundation of Jiangsu Province [BK20170212]; Six Talent Peaks Project in Jiangsu Province [WSN-190]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Six Talent Peaks Project in Jiangsu Province	This study was supported by the Natural Science Foundation of Jiangsu Province (Grant No. BK20170212). This study was also supported by the Six Talent Peaks Project in Jiangsu Province (Grant No. WSN-190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal U, 2017, J NUTR, V147, P596, DOI 10.3945/jn.116.240382; [Anonymous], 2001, OP O L C, V25; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Chatterjee PK, 2009, AM J PHYSIOL-CELL PH, V297, pC1294, DOI 10.1152/ajpcell.00160.2009; Cherfane CE, 2015, INFLAMM BOWEL DIS, V21, P1769, DOI 10.1097/MIB.0000000000000427; Coburn LA, 2016, INFLAMM BOWEL DIS, V22, P1847, DOI 10.1097/MIB.0000000000000790; Coburn LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033546; COOPER HS, 1993, LAB INVEST, V69, P238; Fragkos KC, 2018, UNITED EUR GASTROENT, V6, P181, DOI 10.1177/2050640617737632; Hwang YJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217642; Khan WI, 2006, AM J PHYSIOL-GASTR L, V291, pG803, DOI 10.1152/ajpgi.00069.2006; Kim CJ, 2010, J NUTR BIOCHEM, V21, P468, DOI 10.1016/j.jnutbio.2009.01.019; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Sharma A, 2020, EUR J NUTR, V59, P2663, DOI 10.1007/s00394-019-02114-1; Sido B, 2006, DIGEST DIS SCI, V51, P2170, DOI 10.1007/s10620-006-9473-x; Spoettl T, 2006, CLIN EXP IMMUNOL, V145, P190, DOI 10.1111/j.1365-2249.2006.03113.x; Suzuki T, 2017, BIOSCI BIOTECH BIOCH, V81, P372, DOI 10.1080/09168451.2016.1230007	21	7	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240883	10.1371/journal.pone.0240883	http://dx.doi.org/10.1371/journal.pone.0240883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064766	Green Published, gold			2022-12-26	WOS:000585918300028
J	Galvin, JE; Tolea, MI; Chrisphonte, S				Galvin, James E.; Tolea, Magdalena I.; Chrisphonte, Stephanie			Using a patient-reported outcome to improve detection of cognitive impairment and dementia: The patient version of the Quick Dementia Rating System (QDRS)	PLOS ONE			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; BRIEF INFORMANT INTERVIEW; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; DISEASE; SELF; DECLINE; TOOL; AD8; RECOMMENDATIONS	Introduction Community detection of mild cognitive impairment (MCI) and Alzheimer's disease and related disorders (ADRD) is a challenge. While Gold Standard assessments are commonly used in research centers, these methods are time consuming, require extensive training, and are not practical in most clinical settings or in community-based research projects. Many of these methods require an informant (e.g., spouse, adult child) to provide ratings of the patients' cognitive and functional abilities. A patient-reported outcome that captures the presence of cognitive impairment and corresponds to Gold Standard assessments could improve case ascertainment, clinical care, and recruitment into clinical research. We tested the patient version of the Quick Dementia Rating System (QDRS) as a patient-reported outcome to detect MCI and ADRD. Methods The patient QDRS was validated in a sample of 261 consecutive patient-caregiver dyads compared with the informant version of the QDRS, the Clinical Dementia Rating (CDR), neuropsychological tests, and Gold Standard measures of function, behavior, and mood. Psychometric properties including item variability, floor and ceiling effects, construct, concurrent, and known-groups validity, and internal consistency were determined. Results The patient QDRS strongly correlated with Gold Standard measures of cognition, function, mood, behavior, and global staging methods (p-values < .001) and had strong psychometric properties with excellent data quality and internal consistency (Cronbach alpha = 0.923, 95%CI:0.91-0.94). The patient QDRS had excellent agreement with the informant QDRS, the CDR and its sum of boxes (Intraclass Correlation Coefficients: 9.781-0.876). Receiver operator characteristic curves showed excellent discrimination between normal controls from CDR 0.5 (AUC:0.820;95% CI: 0.74-0.90) and for normal controls from any cognitive impairment (AUC:0.885;95% CI: 0.83-0.94). Discussion The patient QDRS validly and reliably differentiates individuals with and without cognitive impairment and can be completed by patients through all stages of dementia. The patient QDRS is highly correlated with Gold Standard measures of cognitive, function, behavior, and global staging. The patient QDRS provides a rapid method to screen patients for MCI and ADRD in clinical practice, determine study eligibility, improve case ascertainment in community studies.	[Galvin, James E.; Tolea, Magdalena I.; Chrisphonte, Stephanie] Univ Miami, Miller Sch Med, Dept Neurol, Comprehens Ctr Brain Hlth, Miami, FL 33136 USA	University of Miami	Galvin, JE (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Comprehens Ctr Brain Hlth, Miami, FL 33136 USA.	jeg200@miami.edu	Galvin, James/AAM-7492-2021		National Institute on Aging [R01 AG040211-A1, R01 NS101483-01A1]; Harry T. Mangurian Foundation; Leo and Anne Albert Charitable Trust	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Harry T. Mangurian Foundation; Leo and Anne Albert Charitable Trust	This study was supported by grants from the National Institute on Aging of JEG (R01 AG040211-A1 and R01 NS101483-01A1), the Harry T. Mangurian Foundation, and the Leo and Anne Albert Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; Berman SE, 2017, J ALZHEIMERS DIS REP, V1, P9, DOI 10.3233/ADR-170004; Black N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f167; Boeve BF, 2013, J CLIN SLEEP MED, V9, P471, DOI 10.5664/jcsm.2670; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; FLEISS JL, 1983, J PERIODONTAL RES, V18, P601, DOI 10.1111/j.1600-0765.1983.tb00397.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fowler W, 2019, ROU ST HIST AMERICAS, P1; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Galvin JE, 2007, ARCH NEUROL-CHICAGO, V64, P725, DOI 10.1001/archneur.64.5.725; Galvin JE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235534; Galvin JE, 2018, CURR GERIATR REP, V7, P19, DOI 10.1007/s13670-018-0236-2; Galvin James E, 2015, Alzheimers Dement (Amst), V1, P249; Galvin JE, 2014, NEURODEGENER DIS MAN, V4, P455, DOI [10.2217/nmt.14.47, 10.2217/NMT.14.47]; Galvin JE, 2011, PRION, V5, P16, DOI 10.4161/pri.5.1.14439; Galvin JE, 2010, BRAIN, V133, P3290, DOI 10.1093/brain/awq204; Galvin JE, 2006, NEUROLOGY, V67, P1942, DOI 10.1212/01.wnl.0000247042.15547.eb; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Ganguli M, 2006, AM J GERIAT PSYCHIAT, V14, P446, DOI 10.1097/01.JGP.0000199340.17808.77; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Harrawood A, 2018, CURR ALZHEIMER RES, V15, P51, DOI 10.2174/1567205014666170908100905; Hebert R, 2000, CAN J AGING, V19, P494, DOI 10.1017/S0714980800012484; Holmes MM, 2019, PATIENT-RELAT OUTCOM, V10, P385, DOI 10.2147/PROM.S178488; Holsinger T, 2007, JAMA-J AM MED ASSOC, V297, P2391, DOI 10.1001/jama.297.21.2391; James BD, 2005, AM J GERIAT PSYCHIAT, V13, P484, DOI 10.1176/appi.ajgp.13.6.484; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; JORM AF, 1991, PSYCHOL MED, V21, P785, DOI 10.1017/S0033291700022418; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Kelleher M, 2016, INT J GERIATR PSYCH, V31, P799, DOI 10.1002/gps.4394; Keller S, 2020, J GEN INTERN MED, V35, P2687, DOI 10.1007/s11606-020-05811-4; Li C, 2017, J ALZHEIMERS DIS, V60, P427, DOI 10.3233/JAD-161294; Marrero DG, 2019, DIABETES RES CLIN PR, V153, P23, DOI 10.1016/j.diabres.2019.05.016; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Monahan PO, 2014, CLIN INTERV AGING, V9, P2123, DOI 10.2147/CIA.S64140; Monahan PO, 2012, CLIN INTERV AGING, V7, P143, DOI 10.2147/CIA.S30663; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Olney NT, 2017, NEUROL CLIN, V35, P339, DOI [10.1016/j.ncl.2017.01.008, 10.1016/j.nc1.2017.01.008]; Pogatzki-Zahn E, 2019, CURR OPIN ANESTHESIO, V32, P616, DOI 10.1097/ACO.0000000000000780; Rattanabannakit C, 2016, J ALZHEIMERS DIS, V51, P1145, DOI 10.3233/JAD-150729; Reisberg B, 2007, INT PSYCHOGERIATR, V19, P421, DOI 10.1017/S1041610207005261; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Rosenbloom M, 2018, J GEN INTERN MED, V33, P1746, DOI 10.1007/s11606-018-4606-4; Scharre DW, 2010, ALZ DIS ASSOC DIS, V24, P64, DOI 10.1097/WAD.0b013e3181b03277; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Skrobot OA, 2017, ALZHEIMERS DEMENT, V13, P624, DOI 10.1016/j.jalz.2016.10.007; Smith AW, 2019, HEALTH PSYCHOL, V38, P347, DOI 10.1037/hea0000752; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Tappen RM, 2010, CLIN NEUROPSYCHOL, V24, P646, DOI 10.1080/13854040903482855; Weintraub S, 2018, ALZ DIS ASSOC DIS, V32, P10, DOI 10.1097/WAD.0000000000000223; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	55	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240422	10.1371/journal.pone.0240422	http://dx.doi.org/10.1371/journal.pone.0240422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057404	gold, Green Published			2022-12-26	WOS:000581814700036
J	Ishii, J; Kodaka, F; Miyata, H; Yamadera, W; Seto, H; Inamura, K; Higuchi, H; Tsuruoka, Y; Shigeta, M				Ishii, Junpei; Kodaka, Fumitoshi; Miyata, Hisatsugu; Yamadera, Wataru; Seto, Hikaru; Inamura, Keisuke; Higuchi, Hidejiro; Tsuruoka, Yoshiaki; Shigeta, Masahiro			Associations between parental bonding during childhood and functional recovery in patients with schizophrenia	PLOS ONE			English	Article							PSYCHOTIC SYMPTOMS; TRAUMA; METAANALYSIS; INSTRUMENT; ABUSE; RISK; AGES	Introduction Schizophrenia is believed to be etiologically associated with environmental factors. Poor parental bonding, especially arising from "low care" and "overprotection," may contribute to the prognosis in patients with psychosis. In the present study, we investigated the associations between the aforementioned two different parental bonding types and the prognosis, in terms of the functional recovery, of patients with schizophrenia. Methods A total of 89 patients with schizophrenia were recruited, and 79 patients were registered for the study. After the parental bonding types and representative childhood adverse events were assessed, specific items on the PANSS were assessed at 0 and 24 weeks of the study period to define the functional prognosis. Results At the end of the 24-week follow-up period, 36% of the patients were judged as showing recovery from schizophrenia. The score for "overprotective attitude," but not that for "low care," was found to be significantly higher in thenon-recovery(defined below) group. Exploratory logistic regression analysis identified only "overprotective attitude" of the parents as being predictive ofnon-recovery. Moreover, a significant negative correlation was found between "low care" and "overprotective attitude" only in thenon-recoverygroup. Conclusion In the present study, we showed that an overprotective attitude of the parents was associated withnon-recoveryin patients with schizophrenia.	[Ishii, Junpei; Yamadera, Wataru] Jikei Univ, Katsushika Med Ctr, Dept Psychiat, Katsushika Ku, Tokyo, Japan; [Kodaka, Fumitoshi; Miyata, Hisatsugu; Inamura, Keisuke; Shigeta, Masahiro] Jikei Univ, Sch Med, Dept Psychiat, Minato Ku, Tokyo, Japan; [Seto, Hikaru; Higuchi, Hidejiro] Sobu Hosp, Dept Psychiat, Funabashi, Chiba, Japan; [Tsuruoka, Yoshiaki] Otaki Hosp, Dept Psychiat, Chiba, Japan	Jikei University; Jikei University	Kodaka, F (corresponding author), Jikei Univ, Sch Med, Dept Psychiat, Minato Ku, Tokyo, Japan.	kodaka@jikei.ac.jp						Arseneault L, 2011, AM J PSYCHIAT, V168, P65, DOI 10.1176/appi.ajp.2010.10040567; Aspelmeier JE, 2007, CHILD ABUSE NEGLECT, V31, P549, DOI 10.1016/j.chiabu.2006.12.002; Bebbington PE, 2004, BRIT J PSYCHIAT, V185, P220, DOI 10.1192/bjp.185.3.220; Bobes J, 2009, SCHIZOPHR RES, V115, P58, DOI 10.1016/j.schres.2009.07.003; Butzlaff RL, 1998, ARCH GEN PSYCHIAT, V55, P547, DOI 10.1001/archpsyc.55.6.547; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Catalan A, 2017, PSYCHIAT RES, V251, P78, DOI 10.1016/j.psychres.2017.02.017; DONE DJ, 1994, BRIT MED J, V309, P699, DOI 10.1136/bmj.309.6956.699; Ferdinand RF, 2005, ADDICTION, V100, P612, DOI 10.1111/j.1360-0443.2005.01070.x; Fromm-Reichmann F, 1948, PSYCHIATR, V11, P263; Furukawa T, 1998, PSYCHIAT RES, V81, P353, DOI 10.1016/S0165-1781(98)00113-9; KITAMURA T, 1993, JPN J PSYCHIAT NEUR, V47, P29; Liberman RP, 2005, PSYCHIAT SERV, V56, P735, DOI 10.1176/appi.ps.56.6.735; LIDZ T, 1957, AM J PSYCHIAT, V114, P241, DOI 10.1176/ajp.114.3.241; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; PARKER G, 1981, J AFFECT DISORDERS, V3, P131, DOI 10.1016/0165-0327(81)90038-0; PARKER G, 1982, BRIT J PSYCHIAT, V141, P573, DOI 10.1192/bjp.141.6.573; PARKER G, 1984, SOC PSYCHIATR, V19, P75, DOI 10.1007/BF00583818; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Penner Justin D, 2007, Expert Rev Neurother, V7, P797, DOI 10.1586/14737175.7.7.797; Penttila M, 2014, BRIT J PSYCHIAT, V205, P88, DOI 10.1192/bjp.bp.113.127753; Prikryl R, 2013, COMPR PSYCHIAT, V54, P1111, DOI 10.1016/j.comppsych.2013.05.006; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; Read J, 1999, PSYCHIATR SERV, V50, P1467, DOI 10.1176/ps.50.11.1467; Robinson DG, 2004, AM J PSYCHIAT, V161, P473, DOI 10.1176/appi.ajp.161.3.473; Rosenthal D., 2002, J PSYCHIATR RES, V6, P377, DOI [10.1016/0022-3956(68)90028-9, DOI 10.1016/0022-3956(68)90028-9]; ROSS CA, 1994, HOSP COMMUNITY PSYCH, V45, P489; Segrin C, 2013, J SOC CLIN PSYCHOL, V32, P569, DOI 10.1521/jscp.2013.32.6.569; Trotta A, 2015, PSYCHOL MED, V45, P2481, DOI 10.1017/S0033291715000574; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Vogel PA, 1997, ACTA PSYCHIAT SCAND, V96, P469, DOI 10.1111/j.1600-0447.1997.tb09949.x; WENDER PH, 1974, ARCH GEN PSYCHIAT, V30, P121; Wilhelm K, 2005, PSYCHOL MED, V35, P387, DOI 10.1017/S0033291704003538; Wohl M, 2007, EUR PSYCHIAT, V22, P22, DOI 10.1016/j.eurpsy.2006.08.007; WYNNE LC, 1958, PSYCHIATR, V21, P205	35	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240504	10.1371/journal.pone.0240504	http://dx.doi.org/10.1371/journal.pone.0240504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057371	gold, Green Published			2022-12-26	WOS:000581814700061
J	Fielding-Miller, RK; Sundaram, ME; Brouwer, K				Fielding-Miller, Rebecca K.; Sundaram, Maria E.; Brouwer, Kimberly			Social determinants of COVID-19 mortality at the county level	PLOS ONE			English	Article								As of August 2020, the United States is the global epicenter of the COVID-19 pandemic. Emerging data suggests that "essential" workers, who are disproportionately more likely to be racial/ethnic minorities and immigrants, bear a disproportionate degree of risk. We used publicly available data to build a series of spatial autoregressive models assessing county level associations between COVID-19 mortality and (1) percentage of individuals engaged in farm work, (2) percentage of households without a fluent, adult English-speaker, (3) percentage of uninsured individuals under the age of 65, and (4) percentage of individuals living at or below the federal poverty line. We further adjusted these models for total population, population density, and number of days since the first reported case in a given county. We found that across all counties that had reported a case of COVID-19 as of July 12, 2020 (n = 3024), a higher percentage of farmworkers, a higher percentage of residents living in poverty, higher density, higher population, and a higher percentage of residents over the age of 65 were all independently and significantly associated with a higher number of deaths in a county. In urban counties (n = 115), a higher percentage of farmworkers, higher density, and larger population were all associated with a higher number of deaths, while lower rates of insurance coverage in a county was independently associated with fewer deaths. In non-urban counties (n = 2909), these same patterns held true, with higher percentages of residents living in poverty and senior residents also significantly associated with more deaths. Taken together, our findings suggest that farm workers may face unique risks of contracting and dying from COVID-19, and that these risks are independent of poverty, insurance, or linguistic accessibility of COVID-19 health campaigns.	[Fielding-Miller, Rebecca K.; Brouwer, Kimberly] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Sundaram, Maria E.] ICES Ontario, Toronto, ON, Canada	University of California System; University of California San Diego	Fielding-Miller, RK (corresponding author), Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA.	rfieldingmiller@health.ucsd.edu			National Institute of Mental Health [K01MH112436]; National Institute of Minority Health and Health Disparities Loan Repayment Contract	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Minority Health and Health Disparities Loan Repayment Contract	RFM was provided support by the National Institute of Mental Health, K01MH112436 and a National Institute of Minority Health and Health Disparities Loan Repayment Contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altan D, 2020, FRONTLINE, V54, P26; Analysis BoE, 2020, EMPL COUNT METR OTH; [Anonymous], 2020, WHO IS GETTING INFEC; [Anonymous], 2020, NY TIMES; [Anonymous], 2020, RAT CAS HOSP DEATHS; Bier D, 2020, IMMIGRANTS ARE 1 3 C; Borunda A, 2020, NATL GEOGRAPHIC; Bureau USC, 2017, POV STAT 12 MONTHS; [Bureau USC Estimate A-Y], 2014, AM COMMUNITY SURVEY; [Bureau USC Table A-YES], 2017, AM COMMUNITY SURVEY; Chausse P, 2010, J STAT SOFTW, V34, P1; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Philbin MM, 2018, SOC SCI MED, V199, P29, DOI 10.1016/j.socscimed.2017.04.007; Ratcliffe M., 2016, DEFINING RURAL US CE; USDA, 2020, FARM LAB; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; WHO, 2020, GLOBAL EXCESS DEATHS	17	54	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240151	10.1371/journal.pone.0240151	http://dx.doi.org/10.1371/journal.pone.0240151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052932	Green Published, Green Submitted, gold			2022-12-26	WOS:000581820200001
J	Kim, HY; Lee, H; Lee, JK; Kim, HV; Kim, KS; Kim, Y				Kim, Hye Yun; Lee, HeeYang; Lee, Jong Kook; Kim, Hyunjin Vincent; Kim, Key-Sun; Kim, YoungSoo			Bicine promotes rapid formation of beta-sheet-rich amyloid-beta fibrils	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PEPTIDE; A-BETA(1-40); ANGIOPATHY; FIBRILLOGENESIS; AGGREGATION; BUFFERS	Fibrillar aggregates of amyloid-beta (A beta) are the main component of plaques lining the cerebrovasculature in cerebral amyloid angiopathy. As the predominant A beta isoform in vascular deposits, A beta(40) is a valuable target in cerebral amyloid angiopathy research. However, the slow process of A beta(40) aggregationin vitrois a bottleneck in the search for A beta-targeting molecules. In this study, we sought a method to accelerate the aggregation of A beta(40) in vitro, to improve experimental screening procedures. We evaluated the aggregating ability of bicine, a biological buffer, using various in vitro methods. Our data suggest that bicine promotes the aggregation of A beta(40) with high speed and reproducibility, yielding a mixture of aggregates with significant beta-sheet-rich fibril formation and toxicity.	[Kim, Hye Yun; Lee, HeeYang; Kim, YoungSoo] Yonsei Univ, Dept Pharm, Incheon, South Korea; [Kim, Hye Yun; Lee, HeeYang; Kim, YoungSoo] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Incheon, South Korea; [Lee, HeeYang; Kim, YoungSoo] Yonsei Univ, Integrated Sci & Engn Div, Incheon, South Korea; [Lee, Jong Kook; Kim, Hyunjin Vincent; Kim, Key-Sun] Korea Inst Sci & Technol, Brain Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University; Korea Institute of Science & Technology (KIST)	Kim, Y (corresponding author), Yonsei Univ, Dept Pharm, Incheon, South Korea.; Kim, Y (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Incheon, South Korea.; Kim, Y (corresponding author), Yonsei Univ, Integrated Sci & Engn Div, Incheon, South Korea.	y.kim@yonsei.ac.kr	Kim, YoungSoo/AAO-1970-2020	Kim, YoungSoo/0000-0001-5029-7082	National Research Foundation of Korea [NRF-2018R1A6A1A03023718, NRF-2018R1D1A1B07048857]; POSCO Science Fellowship of POSCO TJ Park Foundation	National Research Foundation of Korea(National Research Foundation of Korea); POSCO Science Fellowship of POSCO TJ Park Foundation	This work was supported by National Research Foundation of Korea (NRF-2018R1A6A1A03023718 and NRF-2018R1D1A1B07048857), and POSCO Science Fellowship of POSCO TJ Park Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo NC, 1998, J NEUROPATH EXP NEUR, V57, P353, DOI 10.1097/00005072-199804000-00008; AZAB HA, 1994, J CHEM ENG DATA, V39, P599, DOI 10.1021/je00015a046; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Biffi A, 2011, J CLIN NEUROL, V7, P1, DOI 10.3988/jcn.2011.7.1.1; Choi JW, 2012, AMYLOID, V19, P133, DOI 10.3109/13506129.2012.700287; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Garvey M, 2011, BIOCHEM BIOPH RES CO, V409, P385, DOI 10.1016/j.bbrc.2011.04.141; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Haglund M, 2006, ACTA NEUROPATHOL, V111, P430, DOI 10.1007/s00401-006-0054-z; Harris JR, 2002, MICRON, V33, P609, DOI 10.1016/S0968-4328(02)00029-X; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Kim HY, 2010, J ALZHEIMERS DIS, V22, P73, DOI 10.3233/JAD-2010-100183; Kim W, 2005, J BIOL CHEM, V280, P35069, DOI 10.1074/jbc.M505763200; Klement K, 2007, J MOL BIOL, V373, P1321, DOI 10.1016/j.jmb.2007.08.068; Leuner K, 2012, MOL NEUROBIOL, V46, P194, DOI 10.1007/s12035-012-8300-y; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Rahimi Farid, 2009, J Vis Exp, DOI 10.3791/1071; SATO C, 1995, NEUROSCI LETT, V200, P105, DOI 10.1016/0304-3940(95)12089-M; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240608	10.1371/journal.pone.0240608	http://dx.doi.org/10.1371/journal.pone.0240608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048999	gold, Green Published			2022-12-26	WOS:000581813300042
J	Cho, HJ; Kang, YJ; Sung, SM; Ahn, SH; Jung, YH; Lee, KY; Seo, JH; Han, SW; Park, JH; Choi, HY; Kwon, JH; Kim, WJ; Park, HJ; Choi, JK; Nam, HS; Heo, JH; Kim, YD				Cho, Han-Jin; Kang, Yoon Jung; Sung, Sang Min; Ahn, Sung-Ho; Jung, Yo Han; Lee, Kyung-Yul; Seo, Jung Hwa; Han, Sang Won; Park, Joong Hyun; Choi, Hye-Yeon; Kwon, Jee-Hyun; Kim, Wook-Joo; Park, Hyung Jong; Choi, Jin Kyo; Nam, Hyo Suk; Heo, Ji Hoe; Kim, Young Dae			Effects of dabigatran and rivaroxaban on stroke severity according to the results of routine coagulation tests	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ASSAYS LABORATORY RECOMMENDATIONS; PARTIAL THROMBOPLASTIN TIME; DIRECT ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; THROMBIN INHIBITOR; PRACTICAL GUIDE; IMPACT	Introduction Prior use of direct oral anticoagulants has been associated with reduced stroke severity in patients with non-valvular atrial fibrillation (NVAF). The aim of this study was to investigate the impact of prothrombin time (PT) and activated partial thromboplastin time (aPTT) on stroke severity in patients who were receiving dabigatran or rivaroxaban at the time of stroke onset. Materials and methods We enrolled 107 patients with NVAF who developed acute ischemic stroke while on dabigatran or rivaroxaban and presented within 24 hours to nine hospitals between January 2014 and December 2018. The results of PT and aPTT assays were obtained within 24 hours of stroke onset in all patients. We analyzed PT and aPTT in relation to stroke severity and ischemic lesion volume using correlation and multivariable regression analyses. Results Of the 107 patients included, 46 (43.0%) were on dabigatran and 61 (57.0%) were on rivaroxaban. In patients with prior dabigatran use, while aPTT was inversely correlated with admission National Institutes of Health Stroke Scale (NIHSS) score (r = -0.369, p = 0.012) and ischemic lesion volume (r = -0.480, p = 0.005), there was no correlation between PT and either of these variables. Multivariable analysis confirmed the existence of a significant independent inverse relationship between aPTT and NIHSS score at admission (B, -0.201; 95% confidence interval [CI], -0.370 to -0.032; p = 0.005) and between aPTT and ischemic lesion volume (B, -0.076; 95% CI, -0.130 to -0.023; p = 0.007). In patients with prior rivaroxaban use, neither PT nor aPTT was associated with admission NIHSS score or ischemic lesion volume in the correlation and multivariable analyses. Conclusions In patients with NVAF who were receiving dabigatran, prolonged aPTT was associated with reduced stroke severity.	[Cho, Han-Jin; Kang, Yoon Jung; Sung, Sang Min] Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Neurol, Busan, South Korea; [Cho, Han-Jin; Kang, Yoon Jung; Sung, Sang Min] Biomed Res Inst, Busan, South Korea; [Ahn, Sung-Ho] Pusan Natl Univ, Yangsan Hosp, Sch Med, Dept Neurol, Yangsan, South Korea; [Jung, Yo Han] Changwon Fatima Hosp, Dept Neurol, Chang Won, South Korea; [Jung, Yo Han; Lee, Kyung-Yul] Yonsei Univ, Severance Inst Vasc & Metab Res, Gangnam Severance Hosp, Dept Neurol,Coll Med, Seoul, South Korea; [Seo, Jung Hwa] Inje Univ, Busan Paik Hosp, Coll Med, Dept Neurol, Busan, South Korea; [Han, Sang Won; Park, Joong Hyun] Inje Univ, Sanggye Paik Hosp, Coll Med, Dept Neurol, Seoul, South Korea; [Choi, Hye-Yeon] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Sch Med, Dept Neurol, Seoul, South Korea; [Kwon, Jee-Hyun; Kim, Wook-Joo] Ulsan Univ, Ulsan Univ Hosp, Coll Med, Dept Neurol, Ulsan, South Korea; [Park, Hyung Jong] Keimyung Univ, Sch Med, Brain Res Inst, Dept Neurol, Daegu, South Korea; [Choi, Jin Kyo; Nam, Hyo Suk; Heo, Ji Hoe; Kim, Young Dae] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Yonsei University; Yonsei University Health System; Inje University; Inje University; Kyung Hee University; Kyung Hee University Hospital; University of Ulsan; Ulsan University Hospital; Keimyung University; Yonsei University; Yonsei University Health System	Kim, YD (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	neuro05@yuhs.ac	Choi, Hye-Yeon/ABF-3086-2020	Kim, Young Dae/0000-0001-5750-2616; Heo, Ji Hoe/0000-0001-9898-3321; Lee, Kyung-Yul/0000-0001-5585-7739; NAM, HYO SUK/0000-0002-4415-3995	"Dongwha" Faculty Research Assistance Program of Yonsei University College of Medicine [6-2019-0191]	"Dongwha" Faculty Research Assistance Program of Yonsei University College of Medicine	This study was financially supported by the "Dongwha" Faculty Research Assistance Program of Yonsei University College of Medicine (6-2019-0191).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aguilar MI, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001927.pub2; Audebert HJ, 2010, CEREBROVASC DIS, V29, P476, DOI 10.1159/000297963; Ay H, 2008, ANN NEUROL, V64, P499, DOI 10.1002/ana.21456; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Brown KS, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1422-2; Cuker A, 2014, J AM COLL CARDIOL, V64, P1128, DOI 10.1016/j.jacc.2014.05.065; Douxfils J, 2018, J THROMB HAEMOST, V16, P209, DOI 10.1111/jth.13912; Douxfils J, 2012, THROMB RES, V130, P956, DOI 10.1016/j.thromres.2012.09.004; Douxfils J, 2012, THROMB HAEMOSTASIS, V107, P985, DOI 10.1160/TH11-11-0804; Dulli DA, 2003, NEUROEPIDEMIOLOGY, V22, P118, DOI 10.1159/000068743; Gosselin R, 2016, INT J LAB HEMATOL, V38, P505, DOI 10.1111/ijlh.12528; Hannon N, 2011, STROKE, V42, P2503, DOI 10.1161/STROKEAHA.110.602235; Hapgood G, 2013, THROMB HAEMOSTASIS, V110, P308, DOI 10.1160/TH13-04-0301; Hawes EM, 2013, J THROMB HAEMOST, V11, P1493, DOI 10.1111/jth.12308; Heidbuchel H, 2013, EUROPACE, V15, P625, DOI 10.1093/europace/eut083; Hellwig S, 2018, EUROPACE, V20, P569, DOI 10.1093/europace/eux087; Jung YH, 2018, THROMB HAEMOSTASIS, V118, P2145, DOI 10.1055/s-0038-1675602; Lin CH, 2015, J STROKE CEREBROVASC, V24, P2270, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.008; O'Donnell M, 2006, LANCET NEUROL, V5, P749, DOI 10.1016/S1474-4422(06)70536-1; Purrucker JC, 2017, STROKE, V48, P152, DOI 10.1161/STROKEAHA.116.014963; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Saxena R, 2004, COCHRANE DB SYST REV; Schwammenthal Y, 2010, AM J CARDIOL, V105, P411, DOI 10.1016/j.amjcard.2009.09.050; Silva VM, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029619835053; Stangier J, 2007, BRIT J CLIN PHARMACO, V64, P292, DOI 10.1111/j.1365-2125.2007.02899.x; Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136; Steger C, 2004, EUR HEART J, V25, P1734, DOI 10.1016/j.ehj.2004.06.030; Tomita H, 2015, J STROKE CEREBROVASC, V24, P1430, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.004; Tuttolomondo A, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1469-5; Tuttolomondo A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000813; Wouters A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00308	32	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240483	10.1371/journal.pone.0240483	http://dx.doi.org/10.1371/journal.pone.0240483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044991	gold, Green Published			2022-12-26	WOS:000581811700023
J	Galbusera, L; Bellement-Theroue, G; Urchueguia, A; Julou, T; van Nimwegen, E				Galbusera, Luca; Bellement-Theroue, Gwendoline; Urchueguia, Arantxa; Julou, Thomas; van Nimwegen, Erik			Using fluorescence flow cytometry data for single-cell gene expression analysis in bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; MICROBIAL-POPULATIONS; BATCH CULTURES; LIGHT SCATTER; SIZE; HETEROGENEITY; SENSITIVITY; MECHANISM; STRATEGY; LEVEL	Fluorescence flow cytometry is increasingly being used to quantify single-cell expression distributions in bacteria in high-throughput. However, there has been no systematic investigation into the best practices for quantitative analysis of such data, what systematic biases exist, and what accuracy and sensitivity can be obtained. We investigate these issues by measuring the sameE. colistrains carrying fluorescent reporters using both flow cytometry and microscopic setups and systematically comparing the resulting single-cell expression distributions. Using these results, we develop methods for rigorous quantitative inference of single-cell expression distributions from fluorescence flow cytometry data. First, we present a Bayesian mixture model to separate debris from viable cells using all scattering signals. Second, we show that cytometry measurements of fluorescence are substantially affected by autofluorescence and shot noise, which can be mistaken for intrinsic noise in gene expression, and present methods to correct for these using calibration measurements. Finally, we show that because forward- and side-scatter signals scale non-linearly with cell size, and are also affected by a substantial shot noise component that cannot be easily calibrated unless independent measurements of cell size are available, it is not possible to accurately estimate the variability in the sizes of individual cells using flow cytometry measurements alone. To aid other researchers with quantitative analysis of flow cytometry expression data in bacteria, we distributeE-Flow, an open-source R package that implements our methods for filtering debris and for estimating true biological expression means and variances from the fluorescence signal. The package is available at https://github.com/vanNimwegenLab/E-Flow.	[Galbusera, Luca; Bellement-Theroue, Gwendoline; Urchueguia, Arantxa; Julou, Thomas; van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland; [Galbusera, Luca; Bellement-Theroue, Gwendoline; Urchueguia, Arantxa; Julou, Thomas; van Nimwegen, Erik] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Basel; Swiss Institute of Bioinformatics	Julou, T; van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.; Julou, T; van Nimwegen, E (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.	thomas.julou@unibas.ch; erik.vannimwegen@unibas.ch	van Nimwegen, Erik/ABF-1085-2021; Urchueguia-Fornes, Arantxa/ABB-1946-2021	van Nimwegen, Erik/0000-0001-6338-1312; Urchueguia-Fornes, Arantxa/0000-0003-4689-9077	Swiss National Science Foundation [31003A 159673]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation in the form of a grant awarded to EvN (31003A 159673). Calculations were performed at sciCORE (http://scicore.unibas.ch/) scientific computing core facility of the University of Basel, and flow cytometry was performed at the FACS core facility of the Biozentrum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Ambriz-Avina V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/461941; Anand R, 2011, METHOD ENZYMOL, V497, P31, DOI 10.1016/B978-0-12-385075-1.00002-0; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; Sanchez-Romero MA, 2014, P NATL ACAD SCI USA, V111, P355, DOI 10.1073/pnas.1316084111; Baert J, 2015, BIOTECHNOL J, V10, P1316, DOI 10.1002/biot.201400537; Bahrudeen MNM, 2019, J MICROBIOL METH, V166, DOI 10.1016/j.mimet.2019.105745; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; BD, CYT SET TRACK BEADS; Belliveau NM, 2018, P NATL ACAD SCI USA, V115, pE4796, DOI 10.1073/pnas.1722055115; Carey LB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001528; CHRISTENSEN H, 1993, FEMS MICROBIOL ECOL, V102, P129, DOI 10.1111/j.1574-6968.1993.tb05804.x; CHUNG JD, 1994, J BACTERIOL, V176, P1977, DOI 10.1128/jb.176.7.1977-1984.1994; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Eberhardt EH, 1967, NOISE PHOTMULTIPLIER; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Hakkila K, 2003, J MICROBIOL METH, V54, P75, DOI 10.1016/S0167-7012(03)00008-3; Julia O, 2000, J MICROBIOL METH, V40, P57, DOI 10.1016/S0167-7012(99)00132-3; Kaiser M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02505-0; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; LOPEZAMOROS R, 1994, FEMS MICROBIOL LETT, V117, P225, DOI 10.1016/0378-1097(94)90199-6; Madar D, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-136; Miao H, 2009, J MICROBIOL METH, V76, P111, DOI 10.1016/j.mimet.2008.09.015; Muller S, 2010, FEMS MICROBIOL REV, V34, P554, DOI 10.1111/j.1574-6976.2010.00214.x; Nebe-Von-Caron G, 2009, CYTOM PART A, V75A, P86, DOI 10.1002/cyto.a.20696; Nordholt N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05871-3; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Razo-Mejia M, 2018, CELL SYST, V6, P456, DOI 10.1016/j.cels.2018.02.004; Rohlhill J, 2017, ACS SYNTH BIOL, V6, P1584, DOI 10.1021/acssynbio.7b00114; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sevastsyanovich Y, 2009, FEMS MICROBIOL LETT, V299, P86, DOI 10.1111/j.1574-6968.2009.01738.x; Shapiro M, 2003, NY TIMES BK REV, P34; Silander OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002443; STEEN HB, 1981, J BACTERIOL, V145, P1091, DOI 10.1128/JB.145.2.1091-1094.1981; Stepanauskas R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02128-5; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Urchueguia A., 2019, NOISE PROPAGATION SH, DOI [10.1101/795369, DOI 10.1101/795369]; Utratna M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/641647; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; Veal DA, 2000, J IMMUNOL METHODS, V243, P191, DOI 10.1016/S0022-1759(00)00234-9; Verwer B, CISC VIS NETW IND GL; VIVESREGO J, 1994, LETT APPL MICROBIOL, V19, P374, DOI 10.1111/j.1472-765X.1994.tb00479.x; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Wilson RL, 2001, INFECT IMMUN, V69, P5016, DOI 10.1128/IAI.69.8.5016-5024.2001; Winson MK, 2000, METHODS, V21, P231, DOI 10.1006/meth.2000.1003; Yan Q, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-017-0075-2; Yang LL, 2012, ANAL CHEM, V84, P1526, DOI 10.1021/ac2031332; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	54	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240233	10.1371/journal.pone.0240233	http://dx.doi.org/10.1371/journal.pone.0240233			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045012	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000581811700014
J	Curci, L; Brukman, NG; Munoz, MW; Rojo, D; Carvajal, G; Sulzyk, V; Gonzalez, SN; Rubinstein, M; Da Ros, VG; Cuasnicu, PS				Curci, L.; Brukman, N. G.; Weigel Munoz, M.; Rojo, D.; Carvajal, G.; Sulzyk, V.; Gonzalez, S. N.; Rubinstein, M.; Da Ros, V. G.; Cuasnicu, P. S.			Functional redundancy and compensation: Deletion of multiple murineCrispgenes reveals their essential role for male fertility	FASEB JOURNAL			English	Article						development; embryo; fertilization; protein family; sperm	RICH SECRETORY PROTEIN; SPERM-EGG FUSION; EPIDIDYMAL PROTEIN; COMPLEMENTARY SITES; GAMETE FUSION; FERTILIZATION; CRISP; MICE; SPERMATOZOA; MATURATION	Mammalian Cysteine-RIch Secretory Protein (CRISP) family includes four members present in sperm and reported to regulate Ca(2+)channels and fertilization. Based on our previous observations using single knockouts models and suggesting the existence of functional compensation among CRISP proteins, we investigated their relevance for male fertility by generating multipleCrispgene mutants by CRISPR/Cas9 technology. Whereas targeting ofCrisp1andCrisp3yielded subfertile males with early embryo developmental defects, the same deletion in zygotes from fertileCrisp2(-/-).Crisp4(-/-)mice led to the generation of both triple and quadruple knockout mice exhibiting a complete or severe disruption of male fertility due to a combination of sperm transport, fertilization, and embryo developmental defects linked to intracellular Ca(2+)dysregulation. These observations reveal that CRISP proteins are essential for male fertility and organize in functional modules that contribute distinctly to fertility success, bringing insights into the mechanisms underlying functional redundancy/compensation in protein families and emphasizing the importance of generating multiple and not just single knockout which might be masking the true functional relevance of family genes.	[Curci, L.; Brukman, N. G.; Weigel Munoz, M.; Carvajal, G.; Sulzyk, V.; Gonzalez, S. N.; Da Ros, V. G.; Cuasnicu, P. S.] Consejo Nacl Invest Cient & Tecn, IByME, Inst Biol & Med Expt, Vuelta Obligado 2490,C1428ADN, Buenos Aires, DF, Argentina; [Rojo, D.; Rubinstein, M.] Consejo Nacl Invest Cient & Tecn, INGEBI, Inst Invest Ingn Genet & Biol Mol, Buenos Aires, DF, Argentina; [Rubinstein, M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Cuasnicu, PS (corresponding author), Consejo Nacl Invest Cient & Tecn, IByME, Inst Biol & Med Expt, Vuelta Obligado 2490,C1428ADN, Buenos Aires, DF, Argentina.	pcuasnicu@gmail.com	Brukman, Nicolas/ABD-4071-2020	Rojo, Daniela/0000-0003-1750-9738; Da Ros, Vanina Gabriela/0000-0003-2367-0042	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2015-149]; MINCyT | Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2015-471]; MINCyT | ANPCyT | Fondo para la Investigacion Cientifica y Tecnologica (FonCyT) [PPL2/08 EBAL]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); MINCyT | Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); MINCyT | ANPCyT | Fondo para la Investigacion Cientifica y Tecnologica (FonCyT)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Grant/Award Number: PIP 2015-149; MINCyT | Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Grant/Award Number: (PICT 2015-471); MINCyT | ANPCyT | Fondo para la Investigacion Cientifica y Tecnologica (FonCyT), Grant/Award Number: PPL2/08 EBAL	Bray C, 2005, BIOL REPROD, V73, P807, DOI 10.1095/biolreprod.105.042184; Brown RL, 1999, P NATL ACAD SCI USA, V96, P754, DOI 10.1073/pnas.96.2.754; Brukman NG, 2016, MOL HUM REPROD, V22, P240, DOI 10.1093/molehr/gaw005; Busso D, 2007, BIOL REPROD, V77, P848, DOI 10.1095/biolreprod.107.061788; Busso D, 2007, BIOL REPROD, V76, P701, DOI 10.1095/biolreprod.106.056770; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; CAMEO MS, 1976, J ENDOCRINOL, V69, P47, DOI 10.1677/joe.0.0690047; Carvajal G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35719-3; Chung JJ, 2017, ELIFE, V6, DOI [10.7554/eLife.23082, 10.7547/elife.23082.001]; Cohen DJ, 2008, INT J DEV BIOL, V52, P737, DOI 10.1387/ijdb.072538dc; Cohen DJ, 2000, BIOL REPROD, V63, P462, DOI 10.1095/biolreprod63.2.462; Cohen DJ, 2000, MOL REPROD DEV, V56, P180, DOI 10.1002/(SICI)1098-2795(200006)56:2&lt;180::AID-MRD9&gt;3.0.CO;2-4; Cohen DJ, 2001, BIOL REPROD, V65, P1000, DOI 10.1095/biolreprod65.4.1000; Conine CC, 2018, DEV CELL, V46, P470, DOI 10.1016/j.devcel.2018.06.024; Da Ros VG, 2008, DEV BIOL, V320, P12, DOI 10.1016/j.ydbio.2008.03.015; Da Ros VG, 2015, ASIAN J ANDROL, V17, P711, DOI 10.4103/1008-682X.155769; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Ellerman DA, 2006, DEV BIOL, V297, P228, DOI 10.1016/j.ydbio.2006.05.013; ERBACH GT, 1994, BIOL REPROD, V50, P1027, DOI 10.1095/biolreprod50.5.1027; Ernesto JI, 2015, J CELL BIOL, V210, P1213, DOI 10.1083/jcb.201412041; Evans J, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127480; Fujihara Y, 2019, P NATL ACAD SCI USA, V116, P18498, DOI 10.1073/pnas.1908736116; Fujihara Y, 2018, EXP ANIM TOKYO, V67, P91, DOI 10.1538/expanim.17-0153; Gibbs GM, 2011, P NATL ACAD SCI USA, V108, P7034, DOI 10.1073/pnas.1015935108; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gibbs GM, 2006, J BIOL CHEM, V281, P4156, DOI 10.1074/jbc.M506849200; Gomez-Elias MD, 2016, HUM REPROD, V31, P53, DOI 10.1093/humrep/dev287; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Harris T, 2007, BIOL REPROD, V77, P376, DOI 10.1095/biolreprod.106.058669; Ho K, 2009, REPROD FERT DEVELOP, V21, P345, DOI 10.1071/RD08183; Hu JH, 2018, MOL HUM REPROD, V24, P111, DOI 10.1093/molehr/gay001; Hwang JY, 2019, CELL, V177, P1480, DOI 10.1016/j.cell.2019.03.047; Jalkanen J, 2005, BIOL REPROD, V72, P1268, DOI 10.1095/biolreprod.104.035758; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; KOHANE AC, 1980, BIOL REPROD, V23, P737, DOI 10.1095/biolreprod23.4.737; Kratzschmar J, 1996, EUR J BIOCHEM, V236, P827, DOI 10.1111/j.1432-1033.1996.t01-1-00827.x; Krutskikh A, 2012, FASEB J, V26, P4198, DOI 10.1096/fj.12-205211; La Spina FA, 2016, DEV BIOL, V411, P172, DOI 10.1016/j.ydbio.2016.02.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim S, 2019, ENDOCRINOLOGY, V160, P915, DOI 10.1210/en.2018-01076; Magdaleno L, 1997, FEBS LETT, V420, P179, DOI 10.1016/S0014-5793(97)01514-7; Maldera JA, 2014, MOL HUM REPROD, V20, P341, DOI 10.1093/molehr/gat092; Mata-Martinez E, 2013, JOVE-J VIS EXP, DOI 10.3791/50344; Miyata H, 2016, P NATL ACAD SCI USA, V113, P7704, DOI 10.1073/pnas.1608458113; Miyata H, 2015, SCIENCE, V350, P442, DOI 10.1126/science.aad0836; MORRISSETTE J, 1995, BIOPHYS J, V68, P2280, DOI 10.1016/S0006-3495(95)80410-8; Munoz MW, 2018, BIOL REPROD, V99, P373, DOI 10.1093/biolre/ioy048; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Navarrete FA, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00262; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; O'Bryan MK, 2001, MOL REPROD DEV, V58, P116, DOI 10.1002/1098-2795(200101)58:1&lt;116::AID-MRD14&gt;3.0.CO;2-8; Okabe M, 2018, BIOL REPROD, V99, P134, DOI 10.1093/biolre/ioy028; Okabe M, 2015, ASIAN J ANDROL, V17, P646, DOI 10.4103/1008-682X.153299; Olesen C, 2001, MOL HUM REPROD, V7, P11, DOI 10.1093/molehr/7.1.11; ORGEBINCRIST MC, 1967, ANN BIOL ANIM BIOCH, V7, P373, DOI 10.1051/rnd:19670403; Paoloni-Giacobino A, 2000, CLIN GENET, V58, P324, DOI 10.1034/j.1399-0004.2000.580411.x; Reddy T, 2008, DEV DYNAM, V237, P3313, DOI 10.1002/dvdy.21738; ROCHWERGER L, 1992, MOL REPROD DEV, V31, P34, DOI 10.1002/mrd.1080310107; ROCHWERGER L, 1992, DEV BIOL, V153, P83, DOI 10.1016/0012-1606(92)90093-V; Sheng J, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20182345; Toshimori K, 2015, KNOBIL NEILLS PHYSL, V1, P99; Turunen HT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092403; Udby L, 2002, J IMMUNOL METHODS, V263, P43, DOI 10.1016/S0022-1759(02)00033-9; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Munoz MW, 2019, ANDROLOGY-US, V7, P610, DOI 10.1111/andr.12638; Yamaguchi R, 2009, BIOL REPROD, V81, P142, DOI 10.1095/biolreprod.108.074021; Yamazaki Y, 2002, BIOCHEMISTRY-US, V41, P11331, DOI 10.1021/bi026132h; Yanagimachi R., 1994, P189	68	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15718	15733		10.1096/fj.202001406R	http://dx.doi.org/10.1096/fj.202001406R		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33037689				2022-12-26	WOS:000581163400001
J	Lattier, JM; De, A; Chen, ZH; Morales, JE; Lang, FF; Huse, JT; McCarty, JH				Lattier, John M.; De, Arpan; Chen, Zhihua; Morales, John E.; Lang, Frederick F.; Huse, Jason T.; McCarty, Joseph H.			Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment	ONCOGENE			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; STEM-LIKE CELLS; GLIALCAM MUTATIONS; PROTEIN; ASTROCYTES; CHANNEL; INTERACTS; SUBUNIT; GROWTH; DEFECT	Glioblastoma (GBM), or grade IV astrocytoma, is a malignant brain cancer that contains subpopulations of proliferative and invasive cells that coordinately drive primary tumor growth, progression, and recurrence after therapy. Here, we have analyzed functions for megalencephalic leukoencephalopathy with subcortical cysts 1 (Mlc1), an eight-transmembrane protein normally expressed in perivascular brain astrocyte end feet that is essential for neurovascular development and physiology, in the pathogenesis of GBM. We show that Mlc1 is expressed in human stem-like GBM cells (GSCs) and is linked to the development of primary and recurrent GBM. Genetically inhibiting MLC1 in GSCs using RNAi-mediated gene silencing results in diminished growth and invasion in vitro as well as impaired tumor initiation and progression in vivo. Biochemical assays identify the receptor tyrosine kinase Axl and its intracellular signaling effectors as important for MLC1 control of GSC invasive growth. Collectively, these data reveal key functions for MLC1 in promoting GSC growth and invasion, and suggest that targeting the Mlc1 protein or its associated signaling effectors may be a useful therapy for blocking tumor progression in patients with primary or recurrent GBM.	[Lattier, John M.; De, Arpan; Chen, Zhihua; Morales, John E.; Lang, Frederick F.; McCarty, Joseph H.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Huse, Jason T.] Univ Texas MD Anderson Canc Ctr, Translat Mol Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	McCarty, JH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA.	jhmccarty@mdanderson.org	De, Arpan/AAG-8512-2020	De, Arpan/0000-0001-8237-6703; Lattier, John/0000-0002-7680-668X	Cancer Prevention and Research Institute of Texas [RP180220]; National Institutes of Health [R01NS087635, R21NS103841, P50CA127001]; Brockman Foundation; Terry L. Chandler Foundation; NCI	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brockman Foundation; Terry L. Chandler Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the various members of the McCarty laboratory for insightful comments on the paper. This work was supported, in part, by grants to JHM from the Cancer Prevention and Research Institute of Texas (RP180220), the National Institutes of Health (R01NS087635, R21NS103841, and P50CA127001), the Brockman Foundation, and the Terry L. Chandler Foundation. The following NCI-funded Cancer Center Support Grant (CCSG) Core Facilities were instrumental in data acquisition: the shRNA and ORFeome Core, the Research Histopathology Facility, the Flow Cytometry and Cellular Imaging Facility, and the Sequencing and Microarray Facility.	Ambrosini E, 2008, MOL CELL NEUROSCI, V37, P480, DOI 10.1016/j.mcn.2007.11.003; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2019, CANCER RES, V79, P2810, DOI 10.1158/0008-5472.CAN-19-1185; Antony J, 2017, CANCER RES, V77, P3725, DOI 10.1158/0008-5472.CAN-17-0392; Antony J, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf8175; Balasubramaniyan V, 2015, ONCOTARGET, V6, P31007, DOI 10.18632/oncotarget.5219; Boor I, 2007, ACTA NEUROPATHOL, V114, P403, DOI 10.1007/s00401-007-0247-0; Boor PKI, 2005, J NEUROPATH EXP NEUR, V64, P412; Brignone MS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00106; Brignone MS, 2011, HUM MOL GENET, V20, P90, DOI 10.1093/hmg/ddq435; Capdevila-Nortes X, 2015, J PHYSIOL-LONDON, V593, P4165, DOI 10.1113/JP270467; Chen ZH, 2018, CANCER RES, V78, P3809, DOI 10.1158/0008-5472.CAN-18-0085; Dundar B, 2020, GLIA, V68, P2173, DOI 10.1002/glia.23813; Elorza-Vidal X, 2020, HUM MOL GENET, V29, P1107, DOI 10.1093/hmg/ddaa009; Gaitan-Penas H, 2017, J PHYSIOL-LONDON, V595, P6993, DOI 10.1113/JP275087; Garcia J, 2020, CANCER TREAT REV, V86, DOI 10.1016/j.ctrv.2020.102017; Gilbert A, 2019, BRAIN STRUCT FUNCT, V224, P1267, DOI 10.1007/s00429-019-01832-w; Guerrero PA, 2017, ONCOGENE, V36, P6568, DOI 10.1038/onc.2017.248; Hara A, 2019, J ONCOL, V2019, DOI 10.1155/2019/2964783; Hoegg-Beiler MB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4475; Hwang J, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0540-6; Jeworutzki E, 2012, NEURON, V73, P951, DOI 10.1016/j.neuron.2011.12.039; Jhaveri N, 2016, CANCER LETT, V380, P545, DOI 10.1016/j.canlet.2014.12.028; Lanciotti A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061425; Lanciotti A, 2016, HUM MOL GENET, V25, P1543, DOI 10.1093/hmg/ddw032; Lanciotti A, 2012, HUM MOL GENET, V21, P2166, DOI 10.1093/hmg/dds032; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Leegwater PAJ, 2002, HUM GENET, V110, P279, DOI 10.1007/s00439-002-0682-x; Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519; Leventoux N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62145-1; Lewis-Tuffin LJ, 2015, MOL ONCOL, V9, P1783, DOI 10.1016/j.molonc.2015.06.001; Lopez-Hernandez T, 2011, HUM MOL GENET, V20, P3266, DOI 10.1093/hmg/ddr238; Lopez-Hernandez T, 2011, AM J HUM GENET, V88, P422, DOI 10.1016/j.ajhg.2011.02.009; Ma W, 2015, MOL MED REP, V12, P1050, DOI 10.3892/mmr.2015.3492; McCarty JH, 2020, J CELL SCI, V133, DOI 10.1242/jcs.239434; Minata M, 2019, CELL REP, V26, P1893, DOI 10.1016/j.celrep.2019.01.076; Muir M, 2020, EXPERT OPIN THER TAR, V24, P605, DOI 10.1080/14728222.2020.1762568; Nishizuka SS, 2016, DRUG METAB PHARMACOK, V31, P35, DOI 10.1016/j.dmpk.2015.11.009; Onken J, 2017, ONCOTARGET, V8, P50403, DOI 10.18632/oncotarget.18468; Peglion F, 2019, CURR OPIN CELL BIOL, V60, P121, DOI 10.1016/j.ceb.2019.05.002; Rao L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16061-7; Reyes SB, 2013, MOL BIOL CELL, V24, P474, DOI 10.1091/mbc.E12-07-0521; Sadahiro H, 2018, CANCER RES, V78, P3002, DOI 10.1158/0008-5472.CAN-17-2433; Turner KL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0095; van der Knaap MS, 2012, LANCET NEUROL, V11, P973, DOI 10.1016/S1474-4422(12)70192-8; van der Knaap MS, 2010, ANN NEUROL, V67, P834, DOI 10.1002/ana.21980; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Waite A, 2012, TRENDS NEUROSCI, V35, P487, DOI 10.1016/j.tins.2012.04.004; Wen PY, 2020, NEURO-ONCOLOGY, V22, P1073, DOI 10.1093/neuonc/noaa106	49	4	4	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2020	39	50					7253	7264		10.1038/s41388-020-01503-9	http://dx.doi.org/10.1038/s41388-020-01503-9		OCT 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PD4HE	33040087	Green Accepted			2022-12-26	WOS:000576626800001
J	Agerskov, S; Arvidsson, J; Ziegelitz, D; Lagerstrand, K; Starck, G; Bjorkman-Burtscher, IM; Wikkelso, C; Tullberg, M				Agerskov, Simon; Arvidsson, Jonathan; Ziegelitz, Doerthe; Lagerstrand, Kerstin; Starck, Goran; Bjorkman-Burtscher, Isabella M.; Wikkelso, Carsten; Tullberg, Mats			MRI diffusion and perfusion alterations in the mesencephalon and pons as markers of disease and symptom reversibility in idiopathic normal pressure hydrocephalus	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; COEFFICIENT; DISTURBANCE	Introduction Core symptomatology in idiopathic normal pressure hydrocephalus (iNPH) points at dysfunction in the mesencephalon and pons indicating pathological changes in these regions, but only a few studies have addressed the issue. The aim of this study was to investigate diffusion (ADC) and perfusion patterns pre- and postoperatively in these areas in iNPH. Methods Twenty iNPH patients and 15 healthy controls were included. Patients underwent a clinical examination and brain MRI pre- and 3-6 months postoperatively. The MRI-scan included diffusion and dynamic susceptibility contrast perfusion weighted sequences. Regions of interest in the mesencephalon and pons were drawn on a FLAIR sequence and co-registered to ADC maps and perfusion data. Results There were no significant differences in pre or postoperative ADC compared to the control group, however postoperative ADC increased by 10% (p = 0.026) in the mesencephalon and 6% (p = 0.016) in the pons in all patients and also in the subgroup of shunt responders by 11% (p = 0.021) and 4% (p = 0.020), respectively. Preoperative relative cerebral blood flow (rCBF) was similar in iNPH patients and controls. Postoperatively, rCBF increased in shunt responders by 6% (p = 0.02) in the mesencephalon and 11% (p = 0.004) in the pons. This increase correlated with the degree of clinical improvement (r(s)= 0.80, p = 0.031 and r(s)= 0.66, p = 0.021, respectively). Conclusion The postoperative increase in ADC and the correlation between postoperative increase in rCBF and clinical improvement in the mesencephalon and pons shown in this study point at an involvement of these areas in the core pathophysiology and its reversibility in iNPH.	[Agerskov, Simon; Wikkelso, Carsten; Tullberg, Mats] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci,Hydrocephalus Res Unit, Gothenburg, Sweden; [Arvidsson, Jonathan; Lagerstrand, Kerstin; Starck, Goran] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Radiat Phys, Gothenburg, Sweden; [Ziegelitz, Doerthe; Bjorkman-Burtscher, Isabella M.] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Radiol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Agerskov, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci,Hydrocephalus Res Unit, Gothenburg, Sweden.	simon.agerskov@vgregion.se	Arvidsson, Jonathan/ABE-7316-2021	Arvidsson, Jonathan/0000-0002-6955-6360; Bjorkman-Burtscher, Isabella/0000-0002-9023-3363; Agerskov, Simon/0000-0001-6695-7049; Tullberg, Mats/0000-0003-4997-5266	Insamlingsstiftelsen for Neurologisk Forskning (ISNF); Stiftelsen Edith Jacobsons donationsfond	Insamlingsstiftelsen for Neurologisk Forskning (ISNF); Stiftelsen Edith Jacobsons donationsfond	SA received funding from "Insamlingsstiftelsen for Neurologisk Forskning (ISNF) and from "Stiftelsen Edith Jacobsons donationsfond". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerskov S, 2019, AM J NEURORADIOL, V40, P74, DOI 10.3174/ajnr.A5910; Agerskov S, 2018, J NEUROL SCI, V391, P54, DOI 10.1016/j.jns.2018.05.022; Aruga S, 2017, NEUROUROL URODYN; Arvidsson J, 2018, JOINT ANN M ISMRM ES; Aygok G, 2006, ACTA NEUROCHIR SUPPL, V96, P348; Benarroch EE, 2013, NEUROLOGY, V80, P1148, DOI 10.1212/WNL.0b013e3182886a76; Blomsterwall E, 2000, ACTA NEUROL SCAND, V102, P284, DOI 10.1034/j.1600-0404.2000.102005284.x; Calamante F, 2013, PROG NUCL MAG RES SP, V74, P1, DOI 10.1016/j.pnmrs.2013.04.002; Chen JJ, 2005, J MAGN RESON IMAGING, V22, P390, DOI 10.1002/jmri.20393; Corkill RG, 2003, CLIN NEUROL NEUROSUR, V105, P193, DOI 10.1016/S0303-8467(03)00010-6; Demura K, 2012, ACTA NEUROCHIR SUPPL, V113, P29, DOI 10.1007/978-3-7091-0923-6_6; Hashimoto M, 2010, FLUIDS BARRIERS CNS, V7, P2, DOI 10.1186/1743-8454-7-18; Hellstrom P, 2012, ACTA NEUROL SCAND, V126, P229, DOI 10.1111/j.1600-0404.2012.01677.x; Hiraoka K, 2011, J NEUROL, V258, P820, DOI 10.1007/s00415-010-5847-2; Jaraj D, 2014, NEUROLOGY, V82, P1449, DOI 10.1212/WNL.0000000000000342; Lee PH, 2005, J NEUROL, V252, P958, DOI 10.1007/s00415-005-0791-2; Lenfeldt N, 2011, NEUROSURGERY, V68, P1586, DOI 10.1227/NEU.0b013e31820f3401; Mataro M, 2007, J NEUROL NEUROSUR PS, V78, P395, DOI 10.1136/jnnp.2006.096164; MEIER P, 1954, J APPL PHYSIOL, V6, P731, DOI 10.1152/jappl.1954.6.12.731; Mocco J, 2006, NEUROSURGERY, V59, P847, DOI 10.1227/01.NEU.0000232655.78335.D5; Modat M, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.2.024003; Momjian S, 2004, BRAIN, V127, P965, DOI 10.1093/brain/awh131; Mori E, 2012, NEUROL MED-CHIR, V52, P775, DOI 10.2176/nmc.52.775; Mouridsen K, 2014, J CEREBR BLOOD F MET, V34, P1511, DOI 10.1038/jcbfm.2014.111; Ng SES, 2009, J MAGN RESON IMAGING, V30, P708, DOI 10.1002/jmri.21865; Owler BK, 2004, J CEREBR BLOOD F MET, V24, P17, DOI 10.1097/01.WCB.0000093326.88757.49; Reiss-Zimmermann M, 2014, ACTA RADIOL, V55, P622, DOI 10.1177/0284185113502334; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; Sugaya Kimio, 2005, Journal of Smooth Muscle Research, V41, P117, DOI 10.1540/jsmr.41.117; Tullberg M, 2004, ACTA NEUROL SCAND, V110, P322, DOI 10.1111/j.1600-0404.2004.00325.x; Tullberg M, 2009, ACTA NEUROL SCAND, V120, P226, DOI 10.1111/j.1600-0404.2009.01165.x; Tuniz F, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0072-3; Virhammar J, 2014, AM J NEURORADIOL, V35, P2311, DOI 10.3174/ajnr.A4046; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zare A, 2019, MOL NEUROBIOL, V56, P920, DOI 10.1007/s12035-018-1131-8; Ziegelitz D, 2016, J CEREBR BLOOD F MET, V36, P1755, DOI 10.1177/0271678X15608521; Ziegelitz D, 2015, J COMPUT ASSIST TOMO, V39, P531, DOI 10.1097/RCT.0000000000000254; Ziegelitz D, 2014, J MAGN RESON IMAGING, V39, P1533, DOI 10.1002/jmri.24292; [No title captured]; [No title captured]	40	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240327	10.1371/journal.pone.0240327	http://dx.doi.org/10.1371/journal.pone.0240327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031420	Green Published, gold			2022-12-26	WOS:000581809800085
J	Weldemhret, L; Hailu, A; Gebremedhn, G; Bekuretsion, H; Alemseged, G; Gebreegziabher, G; Tesfahuney, G; Berhe, T; Legesse, L; Kalayu, K; Tesfay, M; Mehari, K				Weldemhret, Letebrhan; Hailu, Ataklti; Gebremedhn, Goyitom; Bekuretsion, Hadish; Alemseged, Gebreselassie; Gebreegziabher, Gebremicheal; Tesfahuney, Gebrhiwot; Berhe, Tesfaye; Legesse, Lemlem; Kalayu, Kelali; Tesfay, Mesfin; Mehari, Kibrti			Blinded rechecking of sputum smear microscopy performance in public health facilities in Tigray region, Northern Ethiopia: Retrospective cross sectional study	PLOS ONE			English	Article								Introduction Tuberculosis disease is the leading cause of death worldwide along with HIV/AIDS. Sputum smear microscopy plays an essential role for initial TB diagnosis and treatment follow up. But, misdiagnosis of sputum smear microscopy revealed a high economical crisis and missing of active TB cases. This study was aimed to determine blinded rechecking of sputum smear microscopy performance in public health facilities in Tigray region, Northern Ethiopia. Materials and methods A cross sectional retrospective study was conducted from January, 2017 to December, 2018 year. Data was collected retrospectively using electronic and paper based in Tigray health research institute. The data was analyzed using the SPSS version 25 software. The sensitivity, specificity, positive predictive value, and negative predictive value of the smear readings were calculated using 2X2 contingency table. The reading agreement between the microscopic center and reference center was determined using kappa statistics. Results A total of 23,456 blinded rechecked smear results were reviewed. In average, the performances of sputum smear quality were 61%, 68%, 64%, 66%, 62% and 75% for specimen quality, staining quality, smear size, smear thickness, smear evenness and smear cleanliness respectively. Of the total error (0.48%) reported, 0.25%, 0.19% and 0.085% were false positive, false negative and quantification errors respectively. The concordance rate of health facilities for smear reading was increased to 90% by the end of 2018. Overall, the sensitivity, specificity, PPV, and NPV of the smear readings were 95%, 99.7%, 93% and 99.8% respectively. Likewise, the smear reading agreement was also perfect with kappa value, 0.87. Conclusion The overall performance of public health facilities for blinded rechecking of smear microscopy was satisfactory. But, the high false positive and false negative errors found calls for continuous evaluation and monitoring of the health facilities by reference center.	[Weldemhret, Letebrhan; Hailu, Ataklti; Gebremedhn, Goyitom; Bekuretsion, Hadish; Alemseged, Gebreselassie; Gebreegziabher, Gebremicheal; Tesfahuney, Gebrhiwot; Legesse, Lemlem; Kalayu, Kelali; Tesfay, Mesfin; Mehari, Kibrti] Tigray Hlth Res Inst, Lab Res Diagnost & Qual Assurance Directorate, Mekelle, Tigray, Ethiopia; [Berhe, Tesfaye] Challenge TB, Mekelle, Tigray, Ethiopia		Weldemhret, L (corresponding author), Tigray Hlth Res Inst, Lab Res Diagnost & Qual Assurance Directorate, Mekelle, Tigray, Ethiopia.	letinaweldemhret@gmail.com		Bekuretsion, Hadish/0000-0002-3172-8227				Addo KK, 2006, INT J TUBERC LUNG D, V10, P812; [Anonymous], 2016, COUNTERFUTURES, V1, P9, DOI DOI 10.1520/D4253-16; [Anonymous], 2002, EXT QUAL ASS AFD SME; Ayana Desalegn Admassu, 2015, BMC Res Notes, V8, P537, DOI 10.1186/s13104-015-1478-0; Central Statistics Agency, 2007, 2005 POP HOUS CENS E; Chang E, 2015, CENT ASIAN J GLOB HE, V4, DOI 10.5195/cajgh.2015.230; Desalegn Daniel Melese, 2018, BMC Res Notes, V11, P291, DOI 10.1186/s13104-018-3414-6; Ethiopian public health institute, 2009, GUID QUAL ASS SMEAR, P20; FMOH, 2012, GUID CLIN PROGR MAN, V5th, P52; FMOH Ethiopia, 2008, MAN TUB LEPR TB HIV, V4th, P45; Fujiki A, 2002, INT J TUBERC LUNG D, V6, P39; Mekonen A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198947; Melese M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151366; Mfinanga G.S., 2007, TANZANIA HLTH RES B, V9, P3; Murray R, 2013, MURRAY MED MICROBIOL, V7th, P586; Shiferaw MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138488; Sidiq Z, 2016, INT J TUBERC LUNG D, V20, P252, DOI 10.5588/ijtld.15.0481; Van Rie A, 2008, J CLIN MICROBIOL, V46, P897, DOI 10.1128/JCM.01553-07; WHO, 2019, GLOB TUB REP; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2015, WHO END TB STRAT; World Health Organization, 2003, QUAL ASS SPUT MICR D	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239342	10.1371/journal.pone.0239342	http://dx.doi.org/10.1371/journal.pone.0239342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027314	Green Published, gold			2022-12-26	WOS:000581808000026
J	Cevasco, KE; North, HM; Zeitoun, SA; Wofford, RN; Matulis, GA; Gregory, AF; Hassan, MH; Abdo, AD; Farris, D; Roess, AA; von Fricken, ME				Cevasco, Kevin E.; North, Hayley M.; Zeitoun, Sheryne A.; Wofford, Rachel N.; Matulis, Graham A.; Gregory, Abigail F.; Hassan, Maha H.; Abdo, Aya D.; Farris, David; Roess, Amira A.; von Fricken, Michael E.			COVID-19 observations and accompanying dataset of non-pharmaceutical interventions across US universities, March 2020	PLOS ONE			English	Article							OUTBREAKS	Background The Centers for Disease Control and Prevention (CDC) publishes COVID-19 non-pharmaceutical intervention (NPI) guidance for specific institutional audiences to limit community spread. Audiences include: business, clinical, public health, education, community, and state/local government. The swift, severe, and global nature of COVID-19 offers an opportunity to systematically obtain a national view of how larger institutions of higher education adopted NPI guidance at the onset of the pandemic. Method An original database of COVID-19-related university NPI policy changes was compiled. Survey team members manually combed university websites and official statements capturing implementation decisions and dates for five NPI variables from 575 U.S. universities, across 50 states and the District of Columbia, during March of 2020. The universities included in this study were selected from the Department of Education Integrated Postsecondary Education Data System (IPEDS), which provides a set of university explanatory variables. Using IPEDS as the basis for the organizational data allows consistent mapping to event-time and institutional characteristic variables including public health announcements, geospatial, census, and political affiliation. Results The dataset enables event-time analysis and offers a variety of variables to support institutional level study and identification of underlying biases like educational attainment. A descriptive analysis of the dataset reveals that there was substantial heterogeneity in the decisions that were made and the timing of these decisions as they temporally related to key state, national, and global emergency announcements. The WHO pandemic declaration coincided with the largest number of university decisions to implement NPIs. Conclusion This study provides descriptive observations and produced an original dataset that will be useful for future research focused on drivers and trends of COVID-19 NPIs for U.S. Universities. This preliminary analysis suggests COVID-19 university decisions appeared to be made largely at the university level, leading to major variations in the nature and timing of the responses both between and within states, which requires further study.	[Cevasco, Kevin E.; North, Hayley M.; Zeitoun, Sheryne A.; Wofford, Rachel N.; Gregory, Abigail F.; Hassan, Maha H.; Abdo, Aya D.; Roess, Amira A.; von Fricken, Michael E.] George Mason Univ, Dept Global & Community Hlth, Coll Hlth & Human Serv, Fairfax, VA 22030 USA; [Matulis, Graham A.] George Mason Univ, Dept Biol, Coll Sci, Fairfax, VA 22030 USA; [Farris, David] George Mason Univ, Environm Hlth & Safety Off, Fairfax, VA 22030 USA	George Mason University; George Mason University; George Mason University	von Fricken, ME (corresponding author), George Mason Univ, Dept Global & Community Hlth, Coll Hlth & Human Serv, Fairfax, VA 22030 USA.	mvonfric@gmu.edu		Farris, David/0000-0002-4412-3518; Roess, Amira/0000-0003-2321-1575				Adolph C, 2021, J HEALTH POLIT POLIC, V46, P211, DOI 10.1215/03616878-8802162; Beaton R, 2007, BIOSECUR BIOTERROR, V5, P327, DOI 10.1089/bsp.2007.0029; Centers for Disease Control and Prevention, 2007, INT PREP PLANN GUID; Centers for Disease Control and Prevention, 2017, GET YOUR SCH READ PA; Centers for Disease Control and Prevention, 2020, IMPL MIT STRAT COMM, P2021; Centers for Disease Control and Prevention, 2020, CDCS REC NEXT 30 DAY; Centers for Disease Control and Prevention, 2020, INT GUID ADM US I HI; Community Preventive Services Task Force, 2015, PREP RESP SCH DISM R; Crawford J., 2020, J APPL LEARNING TEAC, V3, P1, DOI [10.37074/jalt.2020.3.1.7, DOI 10.37074/JALT.2020.3.1.7]; Department of Education, 2020, GUID INT STUD REL CO; Goodman-Bacon A., 2020, USING DIFFERENCE IN; Pillemer FM, 2015, DISASTERS, V39, P125, DOI 10.1111/disa.12089; Qeadan F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176295; Rhodes T, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002914; Teasdale E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-589; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X	16	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240786	10.1371/journal.pone.0240786	http://dx.doi.org/10.1371/journal.pone.0240786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064753	gold, Green Published			2022-12-26	WOS:000585918300044
J	Samandari, T; Wiener, J; Huang, YLA; Hoover, KW; Siddiqi, AEA				Samandari, Taraz; Wiener, Jeffrey; Huang, Ya-Lin A.; Hoover, Karen W.; Siddiqi, Azfar-e-Alam			Impact of viral suppression among persons with HIV upon estimated HIV incidence between 2010 and 2015 in the United States	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TRANSMISSION; DISPARITIES; INFECTIONS; COVERAGE; CARE; MEN; SEX	Background The suppression of viremia among persons with HIV (PWH) using antiretroviral therapy has been hypothesized to reduce HIV incidence at the population level. We investigated the impact of state level viral suppression among PWH in the United States on estimated HIV incidence between 2010 and 2015. Methods Viral suppression data and HIV incidence estimates from the National HIV Surveillance System were available from 29 states and the District of Columbia. We assumed a one year delay for viral suppression to impact incidence. Poisson regression models were used to calculate the estimated annual percent change (EAPC) in incidence rate. We employed a multivariable mixed-effects Poisson regression model to assess the effects of state level race/ethnicity, socioeconomic status, percent men who have sex with men (MSM) and hepatitis C virus prevalence as a proxy for injection drug use on HIV incidence. Findings Fitted HIV incidence for 30 jurisdictions declined from 11.5 in 2010 to 10.0 per 100,000 population by 2015 corresponding with an EAPC of -2.67 (95% confidence interval [95%CI] -2.95, -2.38). Southern states experienced the highest estimated incidence by far throughout this period but upon adjustment for viral suppression and demographics there was a 36% lower incidence rate than Northeast states (adjusted rate ratio [aRR] 0.64; 95%CI 0.42, 0.99). For every 10 percentage point (pp) increase in viral suppression there was an adjusted 4% decline in HIV incidence rate in the subsequent year (aRR 0.96; 95%CI 0.93, 0.99). While controlling for viral suppression, HIV incidence rate increased by 42% (aRR 1.42 95%CI 1.31, 1.54) for every 5 pp increase in percent Black race and by 27% (aRR 1.27 95%CI 1.10, 1.48) for every 1 pp increase in percent MSM in states. Interpretation A decline in estimated HIV incidence from 2010 to 2015 was associated with increasing viral suppression in the United States. Race and sexual orientation were important HIV acquisition risk factors.	[Samandari, Taraz; Wiener, Jeffrey; Huang, Ya-Lin A.; Hoover, Karen W.; Siddiqi, Azfar-e-Alam] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Samandari, T (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	tts0@cdc.gov						Bradley H, 2016, CLIN INFECT DIS, V62, P90, DOI 10.1093/cid/civ708; Brewer RA, 2014, JAIDS-J ACQ IMM DEF, V65, P218, DOI 10.1097/01.qai.0000434953.65620.3d; Centers for Disease Control and Prevention, 2018, NEW CDC ANAL SHOWS S; Centers for Disease Control and Prevention, 2019, HIV SURVEILL S, V24; Centers for Disease Control and Prevention, 2014, 3 CDCP; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Crepaz N, 2017, ANN INTERN MED, V167, P446, DOI 10.7326/L17-0278; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Grey Jeremy A, 2016, JMIR Public Health Surveill, V2, pe14, DOI 10.2196/publichealth.5365; Hall HI, 2013, JAMA INT MED; Harper CR, 2018, SEX TRANSM DIS, V45, P400, DOI 10.1097/OLQ.0000000000000763; HRSA, 2018, RYAN WHITE HIV AIDS; Huang Y.-L. A., 2018, MMWR-MORBID MORTAL W, V67, P1147; Iqbal K, 2018, AIDS CARE, V30, P1128, DOI 10.1080/09540121.2018.1489099; Karim SSA, 2019, NEW ENGL J MED, V381, P286, DOI 10.1056/NEJMe1907279; Li Zihao, 2019, MMWR Morb Mortal Wkly Rep, V68, P267, DOI 10.15585/mmwr.mm6811e1; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Mandsager P, 2018, AM J PUBLIC HEALTH, V108, pS246, DOI [10.2105/AJPH.2018.304689, 10.2105/ajph.2018.304689]; McKnight L, 2019, IEEE GLOB HUMANIT C, P120; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Paz-Bailey G, 2016, AIDS, V30, P1985, DOI 10.1097/QAD.0000000000001139; Roemer M., 2013, UNINSURED AM FIRST P; Rosenberg ES, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6371; Smith DK, 2018, ANN EPIDEMIOL, V28, P850, DOI 10.1016/j.annepidem.2018.05.003; Solomon SS, 2016, LANCET HIV, V3, pE183, DOI 10.1016/S2352-3018(16)00019-9; Song RG, 2017, JAIDS-J ACQ IMM DEF, V74, P3, DOI 10.1097/QAI.0000000000001151; Sullivan PS, 2015, ANN EPIDEMIOL, V25, P445, DOI 10.1016/j.annepidem.2015.03.006; Van Handel MM, 2016, JAIDS-J ACQ IMM DEF, V73, P323, DOI 10.1097/QAI.0000000000001098; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Yehia BR, 2014, JAIDS-J ACQ IMM DEF, V67, P102, DOI 10.1097/QAI.0000000000000251	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240727	10.1371/journal.pone.0240727	http://dx.doi.org/10.1371/journal.pone.0240727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064746	Green Published, gold			2022-12-26	WOS:000585918300038
J	de Oliveira, GL; de Souza, AP; de Oliveira, FA; Zucchi, MI; de Souza, LM; Moura, MF				de Oliveira, Geovani Luciano; de Souza, Anete Pereira; de Oliveira, Fernanda Ancelmo; Zucchi, Maria Imaculada; de Souza, Livia Moura; Moura, Mara Fernandes			Genetic structure and molecular diversity of Brazilian grapevine germplasm: Management and use in breeding programs	PLOS ONE			English	Article							VITIS-VINIFERA L.; MICROSATELLITE MARKERS; SSR MARKERS; LINKAGE MAP; IDENTIFICATION; CULTIVARS; SOFTWARE; SET; POPULATIONS; RESISTANCE	The management of germplasm banks is complex, especially when many accessions are involved. Microsatellite markers are an efficient tool for assessing the genetic diversity of germplasm collections, optimizing their use in breeding programs. This study genetically characterizes a large collection of 410 grapevine accessions maintained at the Agronomic Institute of Campinas (IAC) (Brazil). The accessions were genotyped with 17 highly polymorphic microsatellite markers. Genetic data were analyzed to determine the genetic structure of the germplasm, quantify its allelic diversity, suggest the composition of a core collection, and discover cases of synonymy, duplication, and misnaming. A total of 304 alleles were obtained, and 334 unique genotypes were identified. The molecular profiles of 145 accessions were confirmed according to the literature and databases, and the molecular profiles of more than 100 genotypes were reported for the first time. The analysis of the genetic structure revealed different levels of stratification. The primary division was between accessions related toVitis viniferaandV.labrusca, followed by their separation from wild grapevine. A core collection of 120 genotypes captured 100% of all detected alleles. The accessions selected for the core collection may be used in future phenotyping efforts, in genome association studies, and for conservation purposes. Genetic divergence among accessions has practical applications in grape breeding programs, as the choice of relatively divergent parents will maximize the frequency of progeny with superior characteristics. Together, our results can enhance the management of grapevine germplasm and guide the efficient exploitation of genetic diversity to facilitate the development of new grape cultivars for fresh fruits, wine, and rootstock.	[de Oliveira, Geovani Luciano; Moura, Mara Fernandes] Agron Inst IAC, Adv Fruit Res Ctr, Jundiai, SP, Brazil; [de Souza, Anete Pereira; de Oliveira, Fernanda Ancelmo; de Souza, Livia Moura] Univ Campinas UNICAMP, Mol Biol & Genet Engn Ctr CBMEG, Campinas, SP, Brazil; [de Souza, Anete Pereira] Univ Campinas UNICAMP, Biol Inst, Dept Plant Biol, Campinas, SP, Brazil; [Zucchi, Maria Imaculada] Agribusiness Technol Dev Sao Paulo APTA, Lab Conservat Genet & Genom, Piracicaba, SP, Brazil	Universidade Estadual de Campinas	Moura, MF (corresponding author), Agron Inst IAC, Adv Fruit Res Ctr, Jundiai, SP, Brazil.	mouram@iac.sp.gov.br	DE SOUZA, ANETE PEREIRA/B-8663-2012; de Oliveira, Geovani Luciano/AAH-1123-2021; Moura, Mara/AGY-9987-2022; Zucchi, Maria Imaculada/D-2637-2012	DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; de Oliveira, Geovani Luciano/0000-0002-3478-0186; Moura, Mara/0000-0002-1327-5527; Zucchi, Maria Imaculada/0000-0002-4863-1843	Sao Paulo Research Foundation (FAPESP) [2018/13539-9]; Coordination for the Improvement of Higher Education Personnel (CAPES) [88882.444164/2019-01]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by the Sao Paulo Research Foundation (FAPESP, http://www.fapesp.br/), grant 2018/13539-9. Coordination for the Improvement of Higher Education Personnel (CAPES, http://www.capes.gov.br/) provided a master's fellowship to GLO, grant 88882.444164/2019-01. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Blondon AF, 2004, THEOR APPL GENET, V109, P1017, DOI 10.1007/s00122-004-1704-y; ALVES JD, 2012, MAGISTRA, V24, P116; Aradhya MK, 2003, GENET RES, V81, P179, DOI 10.1017/S0016672303006177; Bartsch D, 1999, MOL ECOL, V8, P1733, DOI 10.1046/j.1365-294x.1999.00769.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Boursiquot J. M., 1996, Journal International des Sciences de la Vigne et du Vin, P13; Boursiquot JM, 2009, AUST J GRAPE WINE R, V15, P144, DOI 10.1111/j.1755-0238.2008.00041.x; Bowers JE, 1999, AM J ENOL VITICULT, V50, P243; Bowers JE, 1996, GENOME, V39, P628, DOI 10.1139/g96-080; Boz Y, 2011, VITIS, V50, P99; Buhner-Zaharieva T, 2010, AM J ENOL VITICULT, V61, P557, DOI 10.5344/ajev.2010.09129; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Carrier G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032973; Arriel NHC, 2006, PESQUI AGROPECU BRAS, V41, P801, DOI 10.1590/S0100-204X2006000500012; CIPRIANI G, 1994, VITIS, V33, P211; Cipriani G, 2010, THEOR APPL GENET, V121, P1569, DOI 10.1007/s00122-010-1411-9; Costa A. F., 2017, GENET MOL RES, V16, P1; Crespan M, 2011, VITIS, V50, P21; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; de Andres MT, 2007, AM J ENOL VITICULT, V58, P75; De Beukelaer H, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2209-z; De Lorenzis G, 2014, SCI HORTIC-AMSTERDAM, V169, P189, DOI 10.1016/j.scienta.2014.02.028; De Lorenzis G, 2013, MOL BIOTECHNOL, V54, P634, DOI 10.1007/s12033-012-9605-9; Leao PCD, 2013, REV BRAS FRUTIC, V35, P799, DOI 10.1590/S0100-29452013000300017; Leao PCD, 2011, PESQUI AGROPECU BRAS, V46, P1035, DOI 10.1590/S0100-204X2011000900010; de Souza LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134607; DETTWEILER E, 1992, VITIS, V31, P117; Doligez A, 2002, THEOR APPL GENET, V105, P780, DOI 10.1007/s00122-002-0951-z; Doulati-Baneh H, 2013, SCI HORTIC-AMSTERDAM, V160, P29, DOI 10.1016/j.scienta.2013.05.029; DOYLE J, 1991, CHEMICAL CARCINOGENESIS 2, P289; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eibach R., 2015, GRAPEVINE BREEDING P, P3, DOI DOI 10.1016/B978-1-78242-075-0.00001-6; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fernandez L, 2010, PLANT J, V61, P545, DOI 10.1111/j.1365-313X.2009.04090.x; Ferri C. P., 1995, Scientia Agricola, V52, P107, DOI 10.1590/S0103-90161995000100019; Grando MS, 2003, THEOR APPL GENET, V106, P1213, DOI 10.1007/s00122-002-1170-3; Guo YS, 2014, BIOTECHNOL BIOTEC EQ, V28, P221, DOI 10.1080/13102818.2014.907996; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Ibanez J, 2003, AM J ENOL VITICULT, V54, P22; Ibanez J, 2012, AM J ENOL VITICULT, V63, P549, DOI 10.5344/ajev.2012.12012; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jombart T, 2010, BMC GENET, P11, DOI [10.1186/1471-2156-11-11, DOI 10.1186/1471-2156-11-11]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kellow AV, 2002, AUST J GRAPE WINE R, V8, P109, DOI 10.1111/j.1755-0238.2002.tb00219.x; Khadivi A, 2019, AGROFOREST SYST, V93, P435, DOI 10.1007/s10457-017-0134-1; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Lamboy WF, 1998, J AM SOC HORTIC SCI, V123, P182, DOI 10.21273/JASHS.123.2.182; Laucou V, 2011, THEOR APPL GENET, V122, P1233, DOI 10.1007/s00122-010-1527-y; Laucou V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192540; Le Cunff L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-31; Leao PCS, 2009, AM J ENOL VITICULT, V60, P517; Lefort Francois, 2000, Journal of Wine Research, V11, P233, DOI 10.1080/713684241; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Marsal G, 2016, AM J ENOL VITICULT, V67, P466, DOI 10.5344/ajev.2016.16013; Martin JP, 2003, GENOME, V46, P10, DOI 10.1139/G02-098; Merdinoglu D, 2005, MOL BREEDING, V15, P349, DOI 10.1007/s11032-004-7651-0; Migliaro D, 2019, AM J ENOL VITICULT, V70, P390, DOI 10.5344/ajev.2019.18054; Miller AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078680; Mohammadi SA, 2003, CROP SCI, V43, P1235, DOI 10.2135/cropsci2003.1235; Moura EF, 2013, ACTA AMAZON, V43, P461, DOI 10.1590/S0044-59672013000400008; Nass LL, 2012, CROP BREED APPL BIOT, V12, P75, DOI 10.1590/S1984-70332012000500009; OIV (Office International de la Vigne et du Vin ParisFrance), 2001, OIV DESCR LIST GRAP, V2nd; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pollefeys P, 2003, GENOME, V46, P1037, DOI 10.1139/G03-076; Pommer C V., 2003, UVA TECNOLOGIA PRODU; Pommer C V., 1993, MELHORAMENTO PLANTAS, P489; Popescu CF, 2017, VITIS, V56, P173, DOI 10.5073/vitis.2017.56.173-180; Porras-Hurtado Liliana, 2013, Frontiers in Genetics, V4, P98, DOI 10.3389/fgene.2013.00098; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Riaz S, 2008, J AM SOC HORTIC SCI, V133, P559, DOI 10.21273/JASHS.133.4.559; Rogers J. S., 1972, U TEXAS PUBL, V7213, P145; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Roychowdhury R, 2014, MOL MARKER ASSISTED, P241, DOI [10.13140/RG.2.1.2822.2560, DOI 10.13140/RG.2.1.2822.2560]; Saifert L, 2018, PESQUI AGROPECU BRAS, V53, P602, DOI [10.1590/S0100-204X2018000500009, 10.1590/s0100-204x2018000500009]; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneider A, 2014, AM J ENOL VITICULT, V65, P244, DOI 10.5344/ajev.2013.13082; Schuck MR, 2011, PESQUI AGROPECU BRAS, V46, P1480, DOI 10.1590/S0100-204X2011001100009; Schuck MR, 2009, PESQUI AGROPECU BRAS, V44, P487, DOI 10.1590/S0100-204X2009000500008; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sefc KM, 1999, GENOME, V42, P367, DOI 10.1139/gen-42-3-367; Sefc KM, 2000, THEOR APPL GENET, V100, P498, DOI 10.1007/s001220050065; SOUZA J.S.I., 2002, VITICULTURA BRASILEI; Summers K, 1997, BEHAV ECOL, V8, P260, DOI 10.1093/beheco/8.3.260; TECCHIO M.A., CULTIVO FRUTEIRAS CL, V2; Tessier C, 1999, THEOR APPL GENET, V98, P171, DOI 10.1007/s001220051054; This P, 2004, THEOR APPL GENET, V109, P1448, DOI 10.1007/s00122-004-1760-3; This P, 2003, ACTA HORTIC, P59, DOI 10.17660/ActaHortic.2003.603.3; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; THOMAS MR, 1993, THEOR APPL GENET, V86, P985, DOI 10.1007/BF00211051; Torregrosa L, 2015, METHODS MOL BIOL, V1224, P177, DOI 10.1007/978-1-4939-1658-0_15; Vaha JP, 2007, MOL ECOL, V16, P2638, DOI 10.1111/j.1365-294X.2007.03329.x; Manechini JRV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195623; Vignani R, 1996, SCI HORTIC-AMSTERDAM, V65, P163, DOI 10.1016/0304-4238(95)00865-9; Walker AR, 2006, PLANT MOL BIOL, V62, P623, DOI 10.1007/s11103-006-9043-9; Zarouri B, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0843-4; Zulini L, 2005, VITIS, V44, P35	103	5	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240665	10.1371/journal.pone.0240665	http://dx.doi.org/10.1371/journal.pone.0240665			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057449	Green Submitted, gold, Green Published			2022-12-26	WOS:000581814700034
J	Miyamoto, Y; Sasaki, M; Miyata, H; Monobe, Y; Nagai, M; Otani, M; Whiley, PAF; Morohoshi, A; Oki, S; Matsuda, J; Akagi, K; Adachi, J; Okabe, M; Ikawa, M; Yoneda, Y; Loveland, KL; Oka, M				Miyamoto, Yoichi; Sasaki, Mitsuho; Miyata, Haruhiko; Monobe, Yoko; Nagai, Masahiro; Otani, Mayumi; Whiley, Penny A. F.; Morohoshi, Akane; Oki, Shinya; Matsuda, Junichiro; Akagi, Ken-ichi; Adachi, Jun; Okabe, Masaru; Ikawa, Masahito; Yoneda, Yoshihiro; Loveland, Kate L.; Oka, Masahiro			Genetic loss of importin alpha 4 causes abnormal sperm morphology and impacts on male fertility in mouse	FASEB JOURNAL			English	Article						axoneme; Kpna; male infertility; nuclear transport; spermiogenesis	NUCLEAR IMPORT; MICE LACKING; NUCLEOCYTOPLASMIC TRANSPORT; CELL FATE; PROTEIN; SPERMIOGENESIS; LOCALIZATION; INHIBITION; CENTROSOME; MANCHETTE	Importin alpha proteins play a central role in the transport of cargo from the cytoplasm to the nucleus. In this study, we observed that male knock-out mice for importin alpha 4, which is encoded by theKpna4gene (Kpna4(-/-)), were subfertile and yielded smaller litter sizes than those of wild-type (WT) males. In contrast, mice lacking the closely related importin alpha 3 (Kpna3(-/-)) were fertile. In vitro fertilization and sperm motility assays demonstrated that sperm fromKpna4(-/-)mice had significantly reduced quality and motility. In addition, acrosome reaction was also impaired inKpna4(-/-)mice. Transmission electron microscopy revealed striking defects, including abnormal head morphology and multiple axoneme structures in the flagella ofKpna4(-/-)mice. A five-fold increase in the frequency of abnormalities inKpna4(-/-)mice compared toWTmice indicates the functional importance of importin alpha 4 in normal sperm development. Moreover, Nesprin-2, which is a component of the linker of nucleus and cytoskeleton complex, was expressed at lower levels in sperm fromKpna4(-/-)mice and was localized with abnormal axonemes, suggesting incorrect formation of the nuclear membrane-cytoskeleton structure during spermiogenesis. Proteomics analysis ofKpna4(-/-)testis showed significantly altered expression of proteins related to sperm formation, which provided evidence that genetic loss of importin alpha 4 perturbed chromatin status. Collectively, these findings indicate that importin alpha 4 is critical for establishing normal sperm morphology in mice, providing new insights into male germ cell development by highlighting the requirement of importin alpha 4 for normal fertility.	[Miyamoto, Yoichi; Otani, Mayumi; Oka, Masahiro] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Nucl Transport Dynam, 7-6-8 Saito Asagi, Ibaraki, Osaka, Japan; [Sasaki, Mitsuho; Matsuda, Junichiro] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Anim Models Human Dis, Osaka, Japan; [Miyata, Haruhiko; Morohoshi, Akane; Okabe, Masaru; Ikawa, Masahito] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan; [Monobe, Yoko; Akagi, Ken-ichi] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Sect Lab Equipment, Osaka, Japan; [Nagai, Masahiro] Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Osaka, Japan; [Whiley, Penny A. F.; Loveland, Kate L.] Hudson Inst Med Res, Ctr Reprod Hlth, Clayton, Vic, Australia; [Morohoshi, Akane; Ikawa, Masahito] Osaka Univ, Grad Sch Med, Osaka, Japan; [Oki, Shinya] Kyoto Univ, Grad Sch Med, Dept Drug Discovery Med, Kyoto, Japan; [Adachi, Jun] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Proteome Res, Osaka, Japan; [Yoneda, Yoshihiro] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Osaka, Japan; [Loveland, Kate L.] Monash Univ, Sch Clin Sci, Dept Mol & Translat Sci, Clayton, Vic, Australia	Osaka University; Osaka University; Hudson Institute of Medical Research; Osaka University; Kyoto University; Monash University	Miyamoto, Y; Oka, M (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Nucl Transport Dynam, 7-6-8 Saito Asagi, Ibaraki, Osaka, Japan.	ymiyamoto@nibiohn.go.jp; moka@nibiohn.go.jp	ikawa, masahito/A-5315-2009; Adachi, Jun/H-2813-2014; Oki, Shinya/J-7662-2019	ikawa, masahito/0000-0001-9859-6217; Adachi, Jun/0000-0003-1220-3246; Oki, Shinya/0000-0002-4767-3259; Miyamoto, Yoichi/0000-0003-4016-1119; AKAGI, Ken-ichi/0000-0002-7051-4598	MEXT | Japan Society for the Promotion of Science (JSPS) [15K07068, 16H04789, 17H03679, 20K06455]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 15K07068, 16H04789, 17H03679 and 20K06455	Adachi J, 2016, ANAL CHEM, V88, P7899, DOI 10.1021/acs.analchem.6b01232; Arjomand A, 2014, FASEB J, V28, P3480, DOI 10.1096/fj.13-244913; Baker SA, 2015, J BIOL CHEM, V290, P22485, DOI 10.1074/jbc.M115.658104; Bao JQ, 2011, MOL CELL ENDOCRINOL, V333, P134, DOI 10.1016/j.mce.2010.12.021; Castaneda JM, 2020, BIOL REPROD, V102, P852, DOI 10.1093/biolre/ioz226; Cheng Y, 2007, MOL CELL BIOL, V27, P2582, DOI 10.1128/MCB.01722-06; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fatima S, 2017, BBA-MOL CELL RES, V1864, P546, DOI 10.1016/j.bbamcr.2016.12.017; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Gob E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012072; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Hogarth CA, 2006, DEV DYNAM, V235, P253, DOI 10.1002/dvdy.20569; Hogarth CA, 2007, DEV DYNAM, V236, P2311, DOI 10.1002/dvdy.21238; Hu JJ, 2010, J BIOL CHEM, V285, P33113, DOI 10.1074/jbc.M110.117044; Ikawa M, 2011, J BIOL CHEM, V286, P5639, DOI 10.1074/jbc.M110.140152; Ito C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50516-2; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P131, DOI 10.1002/mrd.10164; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Loveland KL, 2015, ASIAN J ANDROL, V17, P537, DOI 10.4103/1008-682X.154310; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Miyamoto Y, 2016, J BIOCHEM, V160, P69, DOI 10.1093/jb/mvw036; Miyamoto Y, 2013, BBA-MOL CELL RES, V1833, P731, DOI 10.1016/j.bbamcr.2012.11.005; Miyamoto Y, 2012, BBA-GENE REGUL MECH, V1819, P616, DOI 10.1016/j.bbagrm.2012.01.015; Miyata H, 2015, SCIENCE, V350, P442, DOI 10.1126/science.aad0836; Mross C, 2018, NUCLEUS-PHILA, V9, P503, DOI 10.1080/19491034.2018.1523664; Muro Y, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135368; Nagai M, 2011, FEBS LETT, V585, P791, DOI 10.1016/j.febslet.2011.02.002; Oki S, 2018, EMBO REP, V19, DOI 10.15252/embr.201846255; Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Rajgor D, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.6; Satouh Y, 2012, J CELL SCI, V125, P4985, DOI 10.1242/jcs.100867; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Shen CL, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107086; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Tarnasky H, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-67; Ungricht R, 2017, NAT REV MOL CELL BIO, V18, P229, DOI 10.1038/nrm.2016.153; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Whiley PAF, 2012, INT J ANDROL, V35, P158, DOI 10.1111/j.1365-2605.2011.01202.x; Yamazaki D, 2016, J CELL SCI, V129, P1940, DOI 10.1242/jcs.182220; Yang K, 2018, HISTOCHEM CELL BIOL, V150, P49, DOI 10.1007/s00418-018-1668-7; Yasuda Y, 2012, EMBO J, V31, P83, DOI 10.1038/emboj.2011.360; Young JC, 2013, BBA-MOL CELL RES, V1833, P2348, DOI 10.1016/j.bbamcr.2013.06.007; Young SAM, 2016, REPRODUCTION, V152, P665, DOI 10.1530/REP-16-0150; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhu JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142296	54	7	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16224	16242		10.1096/fj.202000768RR	http://dx.doi.org/10.1096/fj.202000768RR		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058343				2022-12-26	WOS:000581160300001
J	Wang, DJ; You, YJ; Zhou, XL; Zong, ZY; Huang, H; Zhang, H; Yong, X; Cheng, YF; Yang, L; Guo, Q; Long, YL; Liu, Y; Huang, J; Du, L				Wang, Dijia; You, Yanjun; Zhou, Xiaoli; Zong, Zhiyong; Huang, Hao; Zhang, Hui; Yong, Xin; Cheng, Yifan; Yang, Liu; Guo, Qiong; Long, Youlin; Liu, Yan; Huang, Jin; Du, Liang			Selection of homemade mask materials for preventing transmission of COVID-19: A laboratory study	PLOS ONE			English	Article							RESPIRATORY PROTECTION; FILTER	The Coronavirus Disease 2019 (COVID-19) has swept the whole world with high mortality. Since droplet transmission is the main route of transmission, wearing a mask serves as a crucial preventive measure. However, the virus has spread quite quickly, causing severe mask shortage. Finding alternative materials for homemade masks while ensuring the significant performance indicators will help alleviate the shortage of masks. Referring to the national standard for the "Surgical Mask" of China, 17 materials to be selected for homemade masks were tested in four key indicators: pressure difference, particle filtration efficiency, bacterial filtration efficiency and resistance to surface wetting. Eleven single-layer materials met the standard of pressure difference (<= 49 Pa), of which 3 met the standard of resistance to surface wetting (>= 3), 1 met the standard of particle filtration efficiency (>= 30%), but none met the standard of bacterial filtration efficiency (>= 95%). Based on the testing results of single-layer materials, fifteen combinations of paired materials were tested. The results showed that three double-layer materials including double-layer medical non-woven fabric, medical non-woven fabric plus non-woven shopping bag, and medical non-woven fabric plus granular tea towel could meet all the standards of pressure difference, particle filtration efficiency, and resistance to surface wetting, and were close to the standard of the bacterial filtration efficiency. In conclusion, if resources are severely lacking and medical masks cannot be obtained, homemade masks using available materials, based on the results of this study, can minimize the chance of infection to the maximum extent.	[Wang, Dijia; Yong, Xin] Sichuan Univ, West China Hosp, Dept Equipment, Chengdu, Peoples R China; [You, Yanjun] Sichuan Testing Ctr Med Devices, Chengdu, Peoples R China; [Zhou, Xiaoli; Huang, Hao] Sichuan Univ, West China Hosp, Dept Nursing, Chengdu, Peoples R China; [Zong, Zhiyong; Zhang, Hui] Sichuan Univ, West China Hosp, Dept Infect Management, Chengdu, Peoples R China; [Cheng, Yifan; Yang, Liu; Guo, Qiong; Long, Youlin] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Peoples R China; [Liu, Yan] Sichuan Univ, West China Nursing Sch, Dept Emergency & Trauma Nursing, Emergency Dept,West China Hosp,Inst Disaster Med, Chengdu, Peoples R China; [Huang, Jin] Sichuan Univ, West China Hosp, Chengdu, Peoples R China; [Du, Liang] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Ctr Med Device Supervis & Evaluat, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Huang, J (corresponding author), Sichuan Univ, West China Hosp, Chengdu, Peoples R China.; Du, L (corresponding author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Ctr Med Device Supervis & Evaluat, Chengdu, Peoples R China.	michael_huangjin@163.com; duliang0606@vip.sina.com		Du, Liang/0000-0003-1855-9139; LONG, Youlin/0000-0002-5421-2645	West China Hospital of Sichuan University [HX2019-nCoV-024, HX-2019-nCoV-020, HX-2019nCoV-038]; Chengdu Science and Technology Bureau [2020-YF0500263-SN]	West China Hospital of Sichuan University(Sichuan University); Chengdu Science and Technology Bureau	The study was supported by science and technology project from West China Hospital of Sichuan University for tackling COVID-19 (No. HX2019-nCoV-024, HX-2019-nCoV-020, HX-2019nCoV-038), and joint fund of technology innovation project from Chengdu Science and Technology Bureau for tacking COVID-19 (No. 2020-YF0500263-SN).	[Anonymous], 2006, AUSTR HLTH MAN PLAN; [Anonymous], 2020, US CLOTH FAC COV HEL; [Anonymous], 2020, COMMUN BIOL, V3, P1; [Anonymous], 2007, NAT PLAN PERV CONTR; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2014, PREV CHRONIC DIS, V11, pE62; Brienen NCJ, 2010, RISK ANAL, V30, P1210, DOI 10.1111/j.1539-6924.2010.01428.x; China National Textile and Apparel Council, 2012, 47452012 GBT CHIN NA; COOPER DW, 1983, AM IND HYG ASSOC J, V44, P720, DOI 10.1202/0002-8894(1983)044<0720:CMFERP>2.3.CO;2; Dato VM, 2006, EMERG INFECT DIS, V12, P1033, DOI 10.3201/eid1206.051468; Davies A, 2013, DISASTER MED PUBLIC, V7, P413, DOI 10.1017/dmp.2013.43; Department of Health and Human Services, 2005, HHS PAND INFL PLAN; FURUHASHI M, 1978, Bulletin of Tokyo Medical and Dental University, V25, P7; GUYTON H G, 1959, AMA Arch Ind Health, V20, P91; Han L, 2020, J XIAN POLYTECHNIC U, V34, P1; Hou F, PRECIS CLIN MED, DOI [10.1093/pcmedi/pbaa024, DOI 10.1093/PCMEDI/PBAA024]; Li M, 2020, SHANDONG SCI; Lv Z., 2008, PLOS ONE, V3, pe3933; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; National Health Commission of People's Republic of China, 2020, NOT PRINT DISTR TECH; Oberg T, 2008, AM J INFECT CONTROL, V36, P276, DOI 10.1016/j.ajic.2007.07.008; Rengasamy S, 2010, ANN OCCUP HYG, V54, P789, DOI 10.1093/annhyg/meq044; Shimasaki N, 2018, BIOCONTROL SCI, V23, P61, DOI 10.4265/bio.23.61; State Food and Drug Administration, 2011, SURG MASK YY 0469 20; Viscusi DJ, 2009, ANN OCCUP HYG, V53, P815, DOI 10.1093/annhyg/mep070; World Health Organization, 2020, ADVICE USE MASKS CON; World Health Organization (WHO), 2020, STATEMENT 2 M INT HL; Wu HL, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100329; Wu W, 2016, CHINA PACKAGING, V36, P30; Zhou TJ, 2020, J METEOROL RES-PRC, V34, P1, DOI 10.1007/s13351-020-9164-0; Zhu L, 2018, MED INNOVATION CHINA, V10, P133; Zou X, 2012, CHINESE J INFECT CON, V5, P133	32	10	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240285	10.1371/journal.pone.0240285	http://dx.doi.org/10.1371/journal.pone.0240285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057355	Green Submitted, gold, Green Published			2022-12-26	WOS:000581814700010
J	Mogaka, JJO; Chimbari, MJ				Mogaka, John Jules O.; Chimbari, Moses J.			The mediating effects of public genomic knowledge in precision medicine implementation: A structural equation model approach	PLOS ONE			English	Article							DRUG DISCOVERY; BREAST-CANCER; GENETIC TESTS; RECOMMENDATIONS; ENGAGEMENT; STRATEGIES; BIOMARKERS; LESSONS; PROJECT; FUTURE	Precision medicine emphasizes predictive, preventive and personalized treatment on the basis of information gleaned from personal genetic and environmental data. Its implementation at health systems level is regarded as multifactorial, involving variables associated with omics technologies, public genomic awareness and adoption tendencies for new medical technologies. However, interrelationships of the various factors and their synergy has not been sufficiently quantified. Based on a survey of 270 participants involved in the use of molecular tests (omics-based biomarkers, OBMs), this study examined how characteristics of omics biomarkers influence precision medicine implementation outcomes (ImO) through an intermediary factor, public genomic awareness (represented by User Response, UsR). A structural equation modelling (SEM) approach was applied to develop and test a 3 latent variable mediation model; each latent variable being measured by a set of indicators ranging between three and six. Mediation analysis results confirmed a partial mediation effect (an indirect effect represented as the product of paths 'a' and 'b' (a*b)) of 0.36 at 90% confidence level, CI = [0.03, 9.94]. Results from the individual mediation paths 'a' and 'b' however, showed that these effects were negative(a = -0.38, b = -0.94). Path 'a' represents the effect of characteristics of OBMs on the mediator, UsR; 'b' represents the effect of the mediator, UsR on implementation outcomes, ImO, holding OBMs constant. The results have both theoretical and practice implications for biomedical genomics research and clinical genomics, respectively. For instance, the results imply better ways have to be devised to more effectively engage the public in addressing extended family support for extended family cascade screening, especially for monogenic hereditary conditions likeBRCA-related breast cancer and colorectal cancer in Lynch syndrome families. At basic biomedical research level, results suggest an integrated biomarker development pipeline, with early consideration of factors that may influence biomarker uptake. The results are also relevant at health systems level in indicating which factors should be addressed for successful.	[Mogaka, John Jules O.; Chimbari, Moses J.] Univ KwaZulu Natal, Dept Publ Hlth Med, Durban, South Africa	University of Kwazulu Natal	Mogaka, JJO (corresponding author), Univ KwaZulu Natal, Dept Publ Hlth Med, Durban, South Africa.	johnmogaka2@gmail.com	Mogaka, John J O/I-7004-2016	Mogaka, John J O/0000-0001-9902-865X	University of KwaZulu-Natal, College of Health Sciences Research office	University of KwaZulu-Natal, College of Health Sciences Research office	Authors would like to thank the University of KwaZulu-Natal, College of Health Sciences Research office for general support.	Aguilar-Martinez P, 2011, HAEMATOL-HEMATOL J, V96, P507, DOI 10.3324/haematol.2010.029751; [Anonymous], 2018, GEN ENGL POLL; [Anonymous], 2016, RUMIYAH         1111, V3, P24, DOI DOI 10.30897/IJEGEO.306468; Avard D, 2010, INT J CONSUM STUD, V34, P508, DOI 10.1111/j.1470-6431.2010.00914.x; Bakhtiar Ray, 2008, Journal of Pharmacological and Toxicological Methods, V57, P85, DOI 10.1016/j.vascn.2007.10.002; Bakhtiari MR, LAB DIAGNOSIS; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bartlett J., 2008, PANEL ANTIRETROVIRAL, P42; Bullock J.G., 2008, EXPT APPROACHE UNPUB; Bullock JG, 2010, J PERS SOC PSYCHOL, V98, P550, DOI 10.1037/a0018933; Burke W, 2001, AM J MED GENET, V106, P233, DOI 10.1002/ajmg.10011; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Cumming G, 2012, AUST J PSYCHOL, V64, P138, DOI 10.1111/j.1742-9536.2011.00037.x; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Devlieger I, 2017, METHODOLOGY; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Etchegary H, 2015, HEALTH EXPECT, V18, P1413, DOI 10.1111/hex.12122; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Feldstein AC, 2008, JT COMM J QUAL PATIE, V34, P228, DOI 10.1016/S1553-7250(08)34030-6; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Giardiello FM, 1997, NEW ENGL J MED, V336, P823, DOI 10.1056/NEJM199703203361202; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Glasgow RE, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170271; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Green RC, 2016, AM J HUM GENET, V98, P1051, DOI 10.1016/j.ajhg.2016.04.011; Hann KEJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4375-8; Holtzman NA, 2000, WILL GENETICS REVOLU; Hubbard R, 1996, PITFALLS GENETIC TES; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; JAMES LR, 1980, J APPL PSYCHOL, V65, P415, DOI 10.1037/0021-9010.65.4.415; Katsikatsou M, 2017, PACKAGE LAVAAN; Khoury MJ, 2008, HEALTH AFFAIR, V27, P1600, DOI 10.1377/hlthaff.27.6.1600; Kitson AL, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-1; Lefever S, 2007, BRIT J EDUC TECHNOL, V38, P574, DOI 10.1111/j.1467-8535.2006.00638.x; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Manolio TA, 2013, GENET MED, V15, P258, DOI 10.1038/gim.2012.157; McCabe LL, 2008, ANNU REV MED, V59, P163, DOI 10.1146/annurev.med.59.110106.132016; Mignani S, 2016, DRUG DISCOV TODAY, V21, P239, DOI 10.1016/j.drudis.2015.09.007; Newsom J, 2015, PRACTICAL APPROACHES; Novelli G, 2008, CLIN CASES MINER BON, V5, P149; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Rabe-Hesketh S, 2004, PSYCHOMETRIKA, V69, P167, DOI 10.1007/BF02295939; Revelle W., 2012, PROCEDURES PSYCHOL P, P9; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; Rosseel Y., 2012, PACKAGE LAVAAN R PAC; Rungtusanatham M, 2014, J OPER MANAG, V32, P99, DOI 10.1016/j.jom.2014.01.002; Rycroft-Malone J, 2004, J NURS CARE QUAL, V19, P297, DOI 10.1097/00001786-200410000-00002; Samuel G, 2018, AM J BIOETHICS, V18, P39, DOI 10.1080/15265161.2018.1431724; Samuel GN, 2018, PUBLIC UNDERST SCI, V27, P352, DOI 10.1177/0963662517747200; Schrag D, 2000, JAMA-J AM MED ASSOC, V283, P617, DOI 10.1001/jama.283.5.617; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Speerschneider KK, 2013, R US C USER JUL 10 1; Team RC, 2016, R LANG ENV STAT COMP; Warnich Louise, 2011, Current Pharmacogenomics & Personalized Medicine, V9, P191; Wechalekar AD, 2016, LANCET, V387, P2641, DOI 10.1016/S0140-6736(15)01274-X; Yu DH, 2000, BIOESSAYS, V22, P673, DOI 10.1002/1521-1878(200007)22:7<673::AID-BIES10>3.0.CO;2-A	59	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240585	10.1371/journal.pone.0240585	http://dx.doi.org/10.1371/journal.pone.0240585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052984	Green Published, gold			2022-12-26	WOS:000581820200063
J	Lamberti, MFT; Lopez, FE; Valdez, P; Bianchi, A; Medina, EB; Pescaretti, MD; Delgado, MA				Torrez Lamberti, Monica Florencia; Lopez, Fabian Enrique; Valdez, Patricia; Bianchi, Ana; Barrionuevo Medina, Evangelina; Pescaretti, Maria de las Mercedes; Delgado, Monica Alejandra			Epidemiological study of prevalent pathogens in the Northwest region of Argentina (NWA)	PLOS ONE			English	Article							MORTALITY	Northwest Argentina (NWA) is a poor economic-geographical region, with the highest rate of diarrhea diseases. At the moment, there are no reports showing the epidemiological status of this region that would allow to establish methods for prevention and control of these infections and to indicate of the prevalent pathogen that produces them. Therefore we carried out an epidemiological study of the gastroenteritis etiological agents and their incidence in the pediatric population. A total of 17 823 fecal samples were collected, 14 242 from HNJ-Tuc, 2,257 from CePSI-Stgo and 1,324 from HINEP-Cat. In 2,595 samples a bacterial agent was identified, the 93.64% corresponded toShigella/Salmonellaclinical isolates.Shigellagenus was the prevalent pathogen, beingShigella flexneri2 the most frequent serotype. Most of theShigellaclinical isolates presented themselves as multidrug-resistant (MDR), harboring 2 to 3 genetic resistance determinants. 50% of the affected patients were children under 4 years old. Here, we demonstrate that bacterial gastrointestinal diseases strongly affect the health of NWA population. The appearance of epidemic outbreaks, as happened during 2014, suggest that they may be related to the socio-economic poverty of NWA. Recently,Shigella flexneri2 has become the highest NWA ' s incidence infectious agent. The acquisition of new antibiotic resistance determinants may play an important role in their adaptation and persistence.	[Torrez Lamberti, Monica Florencia; Lopez, Fabian Enrique; Pescaretti, Maria de las Mercedes; Delgado, Monica Alejandra] UNT, CONICET, Inst Super Invest Biol INSIBIO, San Miguel De Tucuman, Tucuman, Argentina; [Torrez Lamberti, Monica Florencia; Lopez, Fabian Enrique; Pescaretti, Maria de las Mercedes; Delgado, Monica Alejandra] UNT, Fac Bioquim Quim & Farm, Inst Quim Biol Dr Bernabe Bloj, San Miguel De Tucuman, Tucuman, Argentina; [Valdez, Patricia] Hosp Int Ninos Eva Peron HINEP, San Fernando Valle Catam, Catamarca, Argentina; [Bianchi, Ana] Ctr Prov Salud Infantil Eva Peron CePSI, Santiago Del Estero, Argentina; [Barrionuevo Medina, Evangelina] Hosp Nino Jesus HNJ, San Miguel De Tucuman, Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Universidad Nacional de Tucuman	Pescaretti, MD; Delgado, MA (corresponding author), UNT, CONICET, Inst Super Invest Biol INSIBIO, San Miguel De Tucuman, Tucuman, Argentina.; Pescaretti, MD; Delgado, MA (corresponding author), UNT, Fac Bioquim Quim & Farm, Inst Quim Biol Dr Bernabe Bloj, San Miguel De Tucuman, Tucuman, Argentina.	monica.delgado@fbqf.unt.edu.ar; mpescaretti@fbqf.unt.edu.ar		Torrez Lamberti, Monica Florencia/0000-0001-8039-5732; Delgado, Monica/0000-0002-4283-6979	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT No:2014-0486]; Consejo de Investigacion de la Universidad Nacional de Tucuman [D641]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo de Investigacion de la Universidad Nacional de Tucuman	This work was supported by Grant PICT No:2015-1819 to investigator MAD from Agencia Nacional de Promocion Cientifica y Tecnologica; Grant PICT No:2014-0486 to investigator MMP from Agencia Nacional de Promocion Cientifica y Tecnologica; Grant PIUNT No D641 to investigator MAD from Consejo de Investigacion de la Universidad Nacional de Tucuman; and Grant PIP No 290 to investigator Monica A. Delgado from Consejo Nacional de Investigaciones Cienti ' ficas y Tecnologicas The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, J PROSTHET DENT, V115, P6; [Anonymous], 2014, EUROMET EMPIR CALL T, P1; Barry AL, 2011, METHODS DETERMINING; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Borruel M, 2010, ESTUDIO CARGA ENFERM, P320; Casabonne C, 2016, JPN J INFECT DIS, V69, P477, DOI 10.7883/yoken.JJID.2015.459; Chapur VF, 2017, ARCH ARGENT PEDIATR, V115, P462, DOI [10.5546/aap.2017.eng.462, 10.5546/aap.2017.462]; D'Souza RM, 2004, EPIDEMIOLOGY, V15, P86, DOI 10.1097/01.ede.0000101021.03453.3e; Farfan MJ, 2010, EPIDEMIOL INFECT, V138, P525, DOI 10.1017/S0950268809990823; INDEC, 2012, I NACL ESTADISTICA B, V2, P378; INDEC, 2016, INC POBR IND 31 AGL; Instituto Nacional de Estadistica y Censos de la Republica Argentina (INDEC), 2017, INC POBR IND 31 AGL; Koneman EK, 2008, DIAGNOSTICO MICROBIO; Kuchenmulller T, 2013, REV SCI TECH OIE, V32, P459; Liu G., 2004, J MAT SCI MAT MED, V15, P5; Marconi EH, 2014, ESTADISTICAS VITALES, V5, P150; MARTORELL R, 1980, AM J CLIN NUTR, V33, P345, DOI 10.1093/ajcn/33.2.345; Ministerio de Salud Gobierno Argentino, 2008, CONV HUM AN ZOON I Z, P11; Murray PR, 2013, MICROBIOLOGIA MED; Nielen MMJ, 2019, JMIR MED INF, V7, DOI 10.2196/11929; PRADO V, 1994, INFECT DIS CLIN N AM, V8, P77; Ray B, 2007, IMPORTANT FACTS FOOD, VFourth, P253; Rolfo F, 2012, J INFECT DEV COUNTR, V6, P324, DOI 10.3855/jidc.1977; Scherer CA, 2001, PRINCIPLES BACTERIAL, P266; Suarez MC, 2000, PRESENCIA SALMONELLA; United Nations International Children's Emergency Fund (UNICEF), 2017, SAL MAT INF JUV CIFR; Vallejos C, 2017, MANUAL MICROBIOLOGIA, P25; Vandepitte J, 2003, BASIC LAB PROCEDURES; Vargas MA, 2017, AGENTES ETIOLOGICOS, P16; Vizcaya Delgado L E, 1999, Rev Cubana Med Trop, V51, P14; WHO, 1996, WORLD HLTH REP 1996; World Health Organization (WHO), 2004, RISK ASS LIST MON RE; World Health Organization (WHO), 1996, B WHO, V71, P335; Zamanlou S, 2018, INFECT CHEMOTHER, V50, P29, DOI 10.3947/ic.2018.50.1.29	35	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240404	10.1371/journal.pone.0240404	http://dx.doi.org/10.1371/journal.pone.0240404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048937	gold, Green Published			2022-12-26	WOS:000581813300047
J	Wei, YX; Gao, J; Kou, YB; Liu, MN; Meng, LY; Zheng, XP; Xu, SH; Liang, M; Sun, HX; Liu, ZZ; Wang, YG				Wei, Yanxia; Gao, Jing; Kou, Yanbo; Liu, Mengnan; Meng, Liyuan; Zheng, Xingping; Xu, Shihong; Liang, Ming; Sun, Hongxiang; Liu, Zhuanzhuan; Wang, Yugang			The intestinal microbial metabolite desaminotyrosine is an anti-inflammatory molecule that modulates local and systemic immune homeostasis	FASEB JOURNAL			English	Article						desaminotyrosine; flavonoids; microbial metabolite; mucosal barrier; type I IFN	DIET-INDUCED OBESITY; GUT MICROBIOTA; INFLAMMATION; FLAVONOIDS; TRYPTOPHAN	It is considered that intestinal barrier dysfunction and systemic endotoxemia drive obesity and its related complications. However, what causes barrier dysfunction remains to be elucidated. Here, we showed that the gut microbiota from high-fat diet (HFD)-fed mice had impaired ability to degrade dietary flavonoids, and in correspondence, the microbial-derived flavonoid metabolite desaminotyrosine (DAT) was reduced. Supplementation of DAT in the drinking water was able to counter the HFD-induced body fat mass accumulation and body weight increment. This is correlated with the role of DAT in maintaining mucosal immune homeostasis to protect barrier integrity. DAT could attenuate dextran sodium sulfate (DSS)-induced mucosal inflammation in a type I interferon signal-dependent manner. Furthermore, intraperitoneal injection of DAT-protected mice from bacterial endotoxin-induced septic shock. Together, we identified DAT as a gut microbiota-derived anti-inflammatory metabolite that functions to modulate local and systemic immune homeostasis. Our data support the notion of dysbiosis being an important driving force of mucosal barrier dysfunction and systemic metabolic complications.	[Wei, Yanxia; Gao, Jing; Kou, Yanbo; Liu, Mengnan; Meng, Liyuan; Zheng, Xingping; Xu, Shihong; Liang, Ming; Sun, Hongxiang; Liu, Zhuanzhuan; Wang, Yugang] Xuzhou Med Univ, Lab Infect & Immun, Jiangsu Key Lab Immun & Metab, Dept Pathogen Biol & Immunol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University	Wang, YG (corresponding author), Xuzhou Med Univ, Dept Pathogen Biol & Immunol, Tongshan Rd 209, Xuzhou 221004, Jiangsu, Peoples R China.	wangyg@xzhmu.edu.cn		Wang, Yugang/0000-0002-0709-1924	National Natural Science Foundation of China [81770853, 81970730]; Jiangsu Higher Education Institutions [KYLX14-1448]; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province [16KJB310016]; Xuzhou Medical University [D2016029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Higher Education Institutions; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province; Xuzhou Medical University	National Natural Science Foundation of China, Grant/Award Number: 81770853 and 81970730; Jiangsu Higher Education Institutions, Grant/Award Number: KYLX14-1448; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, Grant/Award Number: 16KJB310016; Xuzhou Medical University, Grant/Award Number: D2016029	Adams JA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208681; Alsaggar M, 2017, GENE THER, V24, P60, DOI 10.1038/gt.2016.76; Braune A, 2016, GUT MICROBES, V7, P216, DOI 10.1080/19490976.2016.1158395; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Feng XJ, 2016, EBIOMEDICINE, V9, P61, DOI 10.1016/j.ebiom.2016.06.017; George IF, 2009, FEMS MICROBIOL LETT, V296, P159, DOI 10.1111/j.1574-6968.2009.01632.x; Hannibal TD, 2017, DIABETOLOGIA, V60, P2033, DOI 10.1007/s00125-017-4341-0; Hirota SA, 2012, INFECT IMMUN, V80, P4474, DOI 10.1128/IAI.00933-12; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kissig M, 2017, EMBO J, V36, P1528, DOI 10.15252/embj.201695588; Krishnan S, 2018, CELL REP, V23, P1099, DOI 10.1016/j.celrep.2018.03.109; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; LAMBERT MA, 1980, J CLIN MICROBIOL, V12, P291, DOI 10.1128/JCM.12.2.291-293.1980; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nieves-Ramirez ME, 2018, MSYSTEMS, V3, DOI [10.1128/mSystems.00007-18, 10.1128/msystems.00007-18]; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rodriguez-Mateos A, 2014, ARCH TOXICOL, V88, P1803, DOI 10.1007/s00204-014-1330-7; Sanmiguel C, 2015, CURR OBES REP, V4, P250, DOI 10.1007/s13679-015-0152-0; Saura-Calixto F, 2010, MOL NUTR FOOD RES, V54, P939, DOI 10.1002/mnfr.200900276; Schoefer L, 2003, APPL ENVIRON MICROB, V69, P5849, DOI 10.1128/AEM.69.10.5849-5854.2003; Selvanantham T, 2016, J IMMUNOL, V197, P4464, DOI 10.4049/jimmunol.1601410; Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336; Tang WHW, 2014, J CLIN INVEST, V124, P4204, DOI 10.1172/JCI72331; Thaiss CA, 2018, SCIENCE, V359, P1376, DOI 10.1126/science.aar3318; Tleugabulova MC, 2016, J IMMUNOL, V197, P3959, DOI 10.4049/jimmunol.1601382; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Wieser V, 2018, GUT, V67, P157, DOI 10.1136/gutjnl-2016-313155; Winer DA, 2016, CELL METAB, V23, P413, DOI 10.1016/j.cmet.2016.01.003	37	11	11	2	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16117	16128		10.1096/fj.201902900RR	http://dx.doi.org/10.1096/fj.201902900RR		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047367				2022-12-26	WOS:000581169400001
J	Chu, YJ; Chen, YP; Guo, HD; Li, MK; Wang, BC; Shi, DY; Cheng, XL; Guan, JX; Wang, XM; Xue, CH; Cheng, T; Shi, J; Yuan, WP				Chu, Yajing; Chen, Yangpeng; Guo, Huidong; Li, Mengke; Wang, Bichen; Shi, Deyang; Cheng, Xuelian; Guan, Jinxia; Wang, Xiaomin; Xue, Chenghai; Cheng, Tao; Shi, Jun; Yuan, Weiping			SUV39H1 regulates the progression ofMLL-AF9-induced acute myeloid leukemia	ONCOGENE			English	Article							HISTONE METHYLTRANSFERASE SUV39H1; STEM-CELL; NONSPECIFIC INHIBITOR; H3K79 METHYLATION; GENE-EXPRESSION; TARGET; CANCER; IDENTIFICATION; CHAETOCIN; PROTEINS	Epigenetic regulations play crucial roles in leukemogenesis and leukemia progression. SUV39H1 is the dominant H3K9 methyltransferase in the hematopoietic system, and its expression declines with aging. However, the role of SUV39H1 via its-mediated repressive modification H3K9me3 in leukemogenesis/leukemia progression remains to be explored. We found thatSUV39H1was down-regulated in a variety of leukemias, includingMLL-r AML, as compared with normal individuals. Decreased levels ofSuv39h1expression and genomic H3K9me3 occupancy were observed in LSCs fromMLL-r-induced AML mouse models in comparison with that of hematopoietic stem/progenitor cells.Suv39h1overexpression increased leukemia latency and decreased the frequency of LSCs inMLL-rAML mouse models, whileSuv39h1knockdown accelerated disease progression with increased number of LSCs. IncreasedSuv39h1expression led to the inactivation ofHoxb13andSix1, as well as reversion of Hoxa9/Meis1 downstream target genes, which in turn decelerated leukemia progression. Interestingly,Hoxb13expression is up-regulated inMLL-AF9-induced AML cells, while knockdown ofHoxb13inMLL-AF9leukemic cells significantly prolonged the survival of leukemic mice with reduced LSC frequencies. Our data revealed that SUV39H1 functions as a tumor suppressor inMLL-AF9-induced AML progression. These findings provide the direct link of SUV39H1 to AML development and progression.	[Chu, Yajing; Chen, Yangpeng; Guo, Huidong; Li, Mengke; Wang, Bichen; Shi, Deyang; Cheng, Xuelian; Wang, Xiaomin; Cheng, Tao; Shi, Jun; Yuan, Weiping] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Hematol Dis, Inst Hematol, Tianjin 300020, Peoples R China; [Chu, Yajing; Chen, Yangpeng; Guo, Huidong; Li, Mengke; Wang, Bichen; Shi, Deyang; Cheng, Xuelian; Wang, Xiaomin; Cheng, Tao; Shi, Jun; Yuan, Weiping] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin 300020, Peoples R China; [Guan, Jinxia; Xue, Chenghai] My Hlth Gene Technol Co Ltd, Serv Ctr Tianjin Chentang Sci & Technol Commercia, Tianjin 300220, Peoples R China; [Guo, Huidong] Peking Univ, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Inst Hematol, Natl Clin Res Ctr Hematol Dis,Peoples Hosp, Beijing 100044, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; Peking University	Chu, YJ; Shi, J; Yuan, WP (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Hematol Dis, Inst Hematol, Tianjin 300020, Peoples R China.; Chu, YJ; Shi, J; Yuan, WP (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin 300020, Peoples R China.	chuyajing@ihcams.ac.cn; shijun@ihcams.ac.cn; wpyuan@ihcams.ac.cn	Chu, Yajing/HDN-8398-2022	Guo, Huidong/0000-0003-3851-3656; Mengke, Li/0000-0001-7748-5307; Cheng, Tao/0000-0002-5925-2769	Ministry of Science and Technology of China [2017YFA0103402, 2018YFA0107801]; CAMS Innovation Fund for Medical Sciences [2016-I2M-1-017, 2017-I2M-3-015, 2017-I2M-3-018]; National Natural Science Foundation of China [81600136, 81670120, 81629001, 81770105]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); CAMS Innovation Fund for Medical Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Drs Peng Wu and Xiaowei Xie for their assistance with the bioinformatics analysis of RNA-seq. We would also like to thank the experimental pathology cell bank facility for the storage of human patient samples of SKLEH from IHBD. This work was partially supported by the funds from the Ministry of Science and Technology of China (2017YFA0103402 and 2018YFA0107801), CAMS Innovation Fund for Medical Sciences (2016-I2M-1-017, 2017-I2M-3-015 and 2017-I2M-3-018), National Natural Science Foundation of China (81600136, 81670120, 81629001, and 81770105).	Alharbi RA, 2013, LEUKEMIA, V27, P1000, DOI 10.1038/leu.2012.356; Bagger FO, 2016, NUCLEIC ACIDS RES, V44, pD917, DOI 10.1093/nar/gkv1101; Balgobind BV, 2009, HAEMATOL-HEMATOL J, V94, P1033, DOI 10.3324/haematol.2008.004564; Beebe-Dimmer JL, 2015, CANCER EPIDEM BIOMAR, V24, P1366, DOI 10.1158/1055-9965.EPI-15-0247; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Carbone R, 2006, MOL CELL BIOL, V26, P1288, DOI 10.1128/MCB.26.4.1288-1296.2006; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chaib H, 2012, LEUKEMIA, V26, P662, DOI 10.1038/leu.2011.271; Chen CW, 2015, NAT MED, V21, P335, DOI 10.1038/nm.3832; Cheng H, 2015, BLOOD, V126, P1302, DOI 10.1182/blood-2015-01-623645; Cherblanc FL, 2013, J MED CHEM, V56, P8616, DOI 10.1021/jm401063r; Cherblanc FL, 2013, NAT CHEM BIOL, V9, P136, DOI 10.1038/nchembio.1187; Chu YJ, 2019, CANCER SCI, V110, P2200, DOI 10.1111/cas.14033; Djeghloul D, 2016, STEM CELL REP, V6, P970, DOI 10.1016/j.stemcr.2016.05.007; Fong CY, 2014, HAEMATOLOGICA, V99, P1772, DOI 10.3324/haematol.2013.092007; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Goyama S, 2010, LEUKEMIA, V24, P81, DOI 10.1038/leu.2009.202; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Greiner D, 2013, NAT CHEM BIOL, V9, P137, DOI 10.1038/nchembio.1188; Guo HD, 2017, INT J CANCER, V141, P324, DOI 10.1002/ijc.30739; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hess JL, 2006, BLOOD, V108, P297, DOI 10.1182/blood-2005-12-5014; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jo SY, 2011, BLOOD, V117, P4759, DOI 10.1182/blood-2010-12-327668; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lai YS, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.37; Li L, 2018, CANCER CELL, V33, P368, DOI 10.1016/j.ccell.2018.01.010; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Monaghan L, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00705; Muller-Tidow C, 2010, BLOOD, V116, P3564, DOI 10.1182/blood-2009-09-240978; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Petti E, 2015, CELL CYCLE, V14, P1438, DOI 10.1080/15384101.2015.1021517; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Ropa J, 2020, HAEMATOLOGICA, V105, P2273, DOI 10.3324/haematol.2019.223883; Ropa James, 2018, Oncotarget, V9, P22123, DOI 10.18632/oncotarget.25204; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Tsai CT, 2017, ONCOGENE, V36, P1753, DOI 10.1038/onc.2016.315; Wang QF, 2011, BLOOD, V117, P6895, DOI 10.1182/blood-2010-12-324699; Williams TM, 2005, DEV BIOL, V277, P457, DOI 10.1016/j.ydbio.2004.10.004; Wong SHK, 2015, CANCER CELL, V28, P198, DOI 10.1016/j.ccell.2015.06.003; Yang YJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.98; Yang YJ, 2010, NUCLEIC ACIDS RES, V38, P382, DOI 10.1093/nar/gkp991; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zeisig Bernd B, 2012, Cancer Cell, V22, P698, DOI 10.1016/j.ccr.2012.10.017; Zheng Y, 2016, LEUKEMIA, V30, P2373, DOI 10.1038/leu.2016.112; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894	59	7	10	7	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2020	39	50					7239	7252		10.1038/s41388-020-01495-6	http://dx.doi.org/10.1038/s41388-020-01495-6		OCT 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PD4HE	33037410	Green Published, hybrid			2022-12-26	WOS:000578440800001
J	Kowitdamrong, E; Puthanakit, T; Jantarabenjakul, W; Prompetchara, E; Suchartlikitwong, P; Putcharoen, O; Hirankarn, N				Kowitdamrong, Ekasit; Puthanakit, Thanyawee; Jantarabenjakul, Watsamon; Prompetchara, Eakachai; Suchartlikitwong, Pintip; Putcharoen, Opass; Hirankarn, Nattiya			Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019	PLOS ONE			English	Article								Background A greater understanding of the antibody response to SARS-CoV-2 in an infected population is important for the development of a vaccination. Aim To investigate SARS-CoV-2 IgA and IgG antibodies in Thai patients with differing severities of COVID-19. Methods Plasma from the following patient groups was examined: 118 adult patients with confirmed SARS-CoV-2 infections, 49 patients under investigation (without confirmed infections), 20 patients with other respiratory infections, and 102 healthy control patients. Anti-SARS-CoV-2 enzyme-linked immunosorbent assay (ELISA) from EUROIMMUN was performed to assess for IgA and IgG antibodies. The optical density (OD) ratio cutoff for a positive result was 1.1 for IgA and 0.8 for IgG. Additionally, the association of the antibody response with both the severity of disease and the date after onset of symptoms was analyzed. Results A total of 289 participants were enrolled and 384 samples analyzed from March 10 to May 31, 2020. Patients were categorized, based on their clinical manifestations, as mild (n = 59), moderate (n = 27), or severe (n = 32). The overall sensitivity of IgA and IgG from the samples collected after day 7 of the symptoms was 87.9% (95% CI: 79.8-93.6) and 84.8% (95% CI: 76.2-91.3), respectively. Compared to the mild group, the severe group had significantly higher levels of spike 1 (S1) antigen-specific IgA and IgG. All patients in the moderate and severe groups had S1-specific IgG, while 20% of the patients in the mild group did not have any IgG detected after two weeks after the onset of symptoms. Interestingly, in the severe group, the SARS-CoV-2 IgG level was significantly higher in males than females (p=0.003). Conclusion The serological test for SARS-CoV-2 has a high sensitivity more than two weeks after the onset of illness. Additionally, the serological response differs among patients based on sex as well as the severity of infection.	[Kowitdamrong, Ekasit; Suchartlikitwong, Pintip; Hirankarn, Nattiya] Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok, Thailand; [Kowitdamrong, Ekasit] Chulalongkorn Univ, Appl Med Virol Res Unit, Bangkok, Thailand; [Puthanakit, Thanyawee; Jantarabenjakul, Watsamon] Chulalongkorn Univ, Dept Paediat, Fac Med, Bangkok, Thailand; [Puthanakit, Thanyawee; Jantarabenjakul, Watsamon; Suchartlikitwong, Pintip] Chulalongkorn Univ, Ctr Excellence Pediat Infect Dis & Vaccines, Bangkok, Thailand; [Jantarabenjakul, Watsamon; Putcharoen, Opass] King Chulalongkorn Mem Hosp, Thai Red Cross Emerging Infect Dis Clin Ctr, Bangkok, Thailand; [Prompetchara, Eakachai] Chulalongkorn Univ, Ctr Excellence Vaccine Res & Dev ChulaVRC, Bangkok, Thailand; [Prompetchara, Eakachai] Chulalongkorn Univ, Dept Lab Med, Fac Med, Bangkok, Thailand; [Putcharoen, Opass] Chulalongkorn Univ, Dept Med, Fac Med, Bangkok, Thailand; [Hirankarn, Nattiya] Chulalongkorn Univ, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Hirankarn, N (corresponding author), Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok, Thailand.; Hirankarn, N (corresponding author), Chulalongkorn Univ, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand.	Nattiya.H@chula.ac.th		Jantarabenjakul, Watsamon/0000-0003-4251-3499; Hirankarn, Nattiya/0000-0003-2224-6856; Puthanakit, Thanywee/0000-0003-1873-1867	Ratchadapisek Sompoch Fund, Faculty of Medicine, Chulalongkorn University	Ratchadapisek Sompoch Fund, Faculty of Medicine, Chulalongkorn University	This work was supported by funding to support Biobank from Ratchadapisek Sompoch Fund, Faculty of Medicine, Chulalongkorn University.	Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Euroimmun [package insert], 2020, EUR PACK INS ANT SAR; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Klein S, 2020, SEX AGE HOSPITALIZAT; Kohmer N, 2020, J MED VIROL, V92, P2243, DOI 10.1002/jmv.26145; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Montesinos Isabel, 2020, J Clin Virol, V128, P104413, DOI 10.1016/j.jcv.2020.104413; Nicol T, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104511; Ozcurumez MK, 2020, J ALLERGY CLIN IMMUN, V146, P35, DOI 10.1016/j.jaci.2020.05.020; Okada P, 2020, EUROSURVEILLANCE, V25, P6, DOI 10.2807/1560-7917.ES.2020.25.8.2000097; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8; Tang MS, 2020, CLIN CHEM, V66, P1055, DOI 10.1093/clinchem/hvaa120; Theel ES, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01243-20; Van Elslande J., 2020, CLIN MICROBIOL INFEC; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang XL, 2020, CLIN INFECT DIS, V71, P2688, DOI 10.1093/cid/ciaa721; Zhang YC, 2020, EMERG MICROBES INFEC, V9, P833, DOI 10.1080/22221751.2020.1756699	19	45	45	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240502	10.1371/journal.pone.0240502	http://dx.doi.org/10.1371/journal.pone.0240502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035234	gold, Green Published			2022-12-26	WOS:000581817500048
J	Madut, DB; Park, LP; Yao, J; Reddy, EA; Njau, B; Ostermann, J; Whetten, K; Thielman, NM				Madut, Deng B.; Park, Lawrence P.; Yao, Jia; Reddy, Elizabeth A.; Njau, Bernard; Ostermann, Jan; Whetten, Kathryn; Thielman, Nathan M.			Predictors of mortality in treatment experienced HIV-infected patients in northern Tanzania	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; SOCIOECONOMIC DIFFERENCES; SCALE-UP; DEPRESSION; POPULATION; EVENTS; PEOPLE; PHQ-9; INDICATORS	Background While factors that drive early mortality among people living with HIV (PLWH) initiating antiretroviral therapy (ART) in sub-Saharan Africa (SSA) have been described, less is known about the predictors of long-term mortality for those with ART experience. Methods PLWH and on ART attending two HIV treatment clinics in Moshi, Tanzania were enrolled from 2008 through 2009 and followed for 3.5 years. Demographic, psychosocial, and clinical information were collected at enrollment. Plasma HIV RNA measurements were collected annually. Cause of death was adjudicated by two independent reviewers based on verbal autopsy information and medical records. Bivariable and multivariable analyses were conducted using Cox proportional hazard models to identify predictors of mortality. Results The analysis included 403 participants. The median (IQR) age in years was 42 (36-48) and 277 (68.7%) participants were female. The proportion of participants virologically suppressed during the 4 collection time points was 88.5%, 94.7%, 91.5%, and 94.5%. During follow-up, 24 participants died; the overall mortality rate was 1.8 deaths per 100 person-years. Of the deaths, 14 (58.3%) were suspected to be HIV/AIDS related. Predictors of mortality (adjusted hazard ratio, 95% confidence interval) were male sex (2.63, 1.01-6.83), secondary or higher education (7.70, 3.02-19.60), receiving care at the regional referral hospital in comparison to the larger zonal referral hospital (6.33, 1.93-20.76), and moderate to severe depression symptoms (6.35, 1.69-23.87). Conclusions As ART coverage continues to expand in SSA, HIV programs should recognize the need for interventions to promote HIV care engagement for men and the integration of mental health screening and treatment with HIV care. Facility-level barriers may contribute to challenges faced by PLWH as they progress through the HIV care continuum, and further understanding of these barriers is needed. The association of higher educational attainment with mortality merits further investigation.	[Madut, Deng B.; Park, Lawrence P.; Thielman, Nathan M.] Duke Univ, Dept Med, Durham, NC 27708 USA; [Park, Lawrence P.; Whetten, Kathryn; Thielman, Nathan M.] Duke Global Hlth Inst, Durham, NC USA; [Yao, Jia; Whetten, Kathryn] Ctr Hlth Policy & Inequal Res, Durham, NC USA; [Yao, Jia; Whetten, Kathryn] Duke Univ, Duke Sanford Sch Publ Policy, Durham, NC USA; [Reddy, Elizabeth A.] SUNY Upstate Med Univ, Div Infect Dis, Syracuse, NY 13210 USA; [Njau, Bernard] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Ostermann, Jan] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Serv Policy & Management, Columbia, SC 29208 USA	Duke University; Duke University; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of South Carolina System; University of South Carolina Columbia	Madut, DB (corresponding author), Duke Univ, Dept Med, Durham, NC 27708 USA.	deng.madut@duke.edu	Ostermann, Jan/GQB-4743-2022	Madut, Deng/0000-0003-4023-3928	National Institute of Mental Health [5R01MH078756]; Duke Center for AIDS Research [5P30-AI064518]; Duke Interdisciplinary Research Training Program AIDS [T32 AI007392]; Vanderbilt-Emory-Cornell Duke Consortium for Global Health [D43TW009337]; Hubert-Yeargan Center for Global Health, Duke University; NIH Ruth L. Kirschstein National Research Service Award (NRSA) [T32AI007392]; US NIH Fogarty International Center [D43TW009337]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Duke Center for AIDS Research; Duke Interdisciplinary Research Training Program AIDS; Vanderbilt-Emory-Cornell Duke Consortium for Global Health; Hubert-Yeargan Center for Global Health, Duke University; NIH Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The CHAT study was funded by Grant 5R01MH078756 from the National Institute of Mental Health, with additional support from the Duke Center for AIDS Research, 5P30-AI064518; the Duke Interdisciplinary Research Training Program AIDS, T32 AI007392; the Vanderbilt-Emory-Cornell Duke Consortium for Global Health, D43TW009337; and the Hubert-Yeargan Center for Global Health, Duke University. DBM received support from the NIH Ruth L. Kirschstein National Research Service Award (NRSA) T32AI007392 and US NIH Fogarty International Center grant D43TW009337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas M, 2014, TROP MED INT HEALTH, V19, P1392, DOI 10.1111/tmi.12382; Adewuya AO, 2006, J AFFECT DISORDERS, V96, P89, DOI 10.1016/j.jad.2006.05.021; Anderegg N, 2017, AIDS, V31, pS31, DOI 10.1097/QAD.0000000000001321; [Anonymous], 2016, CLIN GUID MAN COMM C; Belenky NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095469; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Castelnuovo B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2016-015490; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; Cornell M, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21902; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Croxford S, 2017, LANCET PUBLIC HEALTH, V2, pE35, DOI 10.1016/S2468-2667(16)30020-2; Duncan GJ, 2002, AM J PUBLIC HEALTH, V92, P1151, DOI 10.2105/AJPH.92.7.1151; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Garenne M, 2006, B WORLD HEALTH ORGAN, V84, P164, DOI 10.2471/BLT.05.029124; Granich R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131353; Kabudula CW, 2017, LANCET GLOB HEALTH, V5, pE924, DOI 10.1016/S2214-109X(17)30297-8; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lahuerta M, 2013, J HEALTH CARE POOR U, V24, P359, DOI 10.1353/hpu.2013.0014; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Legarth RA, 2016, JAIDS-J ACQ IMM DEF, V71, P213, DOI 10.1097/QAI.0000000000000825; Linje G.O., 2015, CUSTOMER SATISFACTIO; Ministry of Health Community Development Gender Elderly and Children Tanzania and Ministry of Health Zanzibar. Tanzania, 2018, TANZ HIV IM SURV THI; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Nakimuli-Mpungu E, 2012, AIDS BEHAV, V16, P2101, DOI 10.1007/s10461-011-0087-8; Ostermann J, 2015, AIDS CARE, V27, P59, DOI 10.1080/09540121.2015.1090534; Ostermann J, 2014, AIDS CARE, V26, P1352, DOI 10.1080/09540121.2014.882493; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Pence BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036304; Probst C, 2016, TROP MED INT HEALTH, V21, P846, DOI 10.1111/tmi.12712; Rachlis B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159994; Reddy EA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1804-8; Teeraananchai S, 2017, HIV MED, V18, P256, DOI 10.1111/hiv.12421; Thielman NM, 2014, JAIDS-J ACQ IMM DEF, V65, pE104, DOI 10.1097/01.qai.0000437619.23031.83; Trickey A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160460; Tsai AC, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001906; UNAIDS, 2020, GLOB HIV AIDS STAT F; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Whetten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074771; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2007, VERB AUT STAND ASC A	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240293	10.1371/journal.pone.0240293	http://dx.doi.org/10.1371/journal.pone.0240293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TB	33031434	gold, Green Published			2022-12-26	WOS:000581809800070
J	Mason, SE; Scott, AJ; Markar, SR; Clarke, JM; Martin, G; Beatty, JW; Sounderajah, V; Yalamanchili, S; Denning, M; Arulampalam, T; Kinross, JM				Mason, Sam E.; Scott, Alasdair J.; Markar, Sheraz R.; Clarke, Jonathan M.; Martin, Guy; Winter Beatty, Jasmine; Sounderajah, Viknesh; Yalamanchili, Seema; Denning, Max; Arulampalam, Thanjakumar; Kinross, James M.		PanSurg Collaborative	Insights from a global snapshot of the change in elective colorectal practice due to the COVID-19 pandemic	PLOS ONE			English	Article							CANCER; DELAY; RISK	Background There is a need to understand the impact of COVID-19 on colorectal cancer care globally and determine drivers of variation. Objective To evaluate COVID-19 impact on colorectal cancer services globally and identify predictors for behaviour change. Design An online survey of colorectal cancer service change globally in May and June 2020. Participants Attending or consultant surgeons involved in the care of patients with colorectal cancer. Main outcome measures Changes in the delivery of diagnostics (diagnostic endoscopy), imaging for staging, therapeutics and surgical technique in the management of colorectal cancer. Predictors of change included increased hospital bed stress, critical care bed stress, mortality and world region. Results 191 responses were included from surgeons in 159 centers across 46 countries, demonstrating widespread service reduction with global variation. Diagnostic endoscopy was reduced in 93% of responses, even with low hospital stress and mortality; whilst rising critical care bed stress triggered complete cessation (p= 0.02). Availability of CT and MRI fell by 40-41%, with MRI significantly reduced with high hospital stress. Neoadjuvant therapy use in rectal cancer changed in 48% of responses, where centers which had ceased surgery increased its use (62vs30%,p= 0.04) as did those with extended delays to surgery (p<0.001). High hospital and critical care bed stresses were associated with surgeons forming more stomas (p<0.04), using more experienced operators (p<0.003) and decreased laparoscopy use (critical care bed stress only,p<0.001). Patients were also more actively prioritized for resection, with increased importance of co-morbidities and ICU need. Conclusions The COVID-19 pandemic was associated with severe restrictions in the availability of colorectal cancer services on a global scale, with significant variation in behaviours which cannot be fully accounted for by hospital burden or mortality.	[Mason, Sam E.; Scott, Alasdair J.; Markar, Sheraz R.; Martin, Guy; Winter Beatty, Jasmine; Sounderajah, Viknesh; Yalamanchili, Seema; Denning, Max; Kinross, James M.] Imperial Coll London, Dept Surg & Canc, London, England; [Clarke, Jonathan M.] Imperial Coll London, Ctr Math Precis Healthcare, London, England; [Arulampalam, Thanjakumar] Anglia Ruskin Univ, Dept Allied Hlth & Med, Cambridge, England	Imperial College London; Imperial College London; Anglia Ruskin University	Mason, SE (corresponding author), Imperial Coll London, Dept Surg & Canc, London, England.	sam.mason@imperial.ac.uk	Denning, Max/AAG-7659-2021	Denning, Max/0000-0001-6215-6885; Scott, Alasdair/0000-0003-4621-9756; Mason, Sam/0000-0003-3958-2856; Sounderajah, Viknesh/0000-0002-4595-8402; Kinross, James/0000-0002-0427-7643; Clarke, Jonathan/0000-0003-1495-7746; Martin, Guy/0000-0002-5759-962X				American College of Surgeons, LOC RES EL SURG GUID; [Anonymous], CLIN GUID MAN PAT RE; Bilimoria KY, 2013, J AM COLL SURGEONS, V217, P833, DOI 10.1016/j.jamcollsurg.2013.07.385; Burki TK, LANCET ONCOL; Cancer Research UK, COR IS IMP CANC SERV; Coccolini F, ANN SURG; Emanuel EJ, N ENGL J MED; European Association for Endoscopic Surgery, RES SMOK GAS EV OP L; European Society of Coloproctology, ESCP REC REG COVID 1; Fang Y, RADIOLOGY; Hanna TP, 2020, NAT REV CLIN ONCOL, V17, P268, DOI 10.1038/s41571-020-0362-6; International Agency for Research on Cancer, GLOB CANC OBS 2018; Korsgaard M, 2006, CANCER DETECT PREV, V30, P341, DOI 10.1016/j.cdp.2006.07.001; Kutikov A, ANN INTERN MED; Kwak HD, 2016, OCCUP ENVIRON MED, V73, P857, DOI 10.1136/oemed-2016-103724; Lai A, 2020, ESTIMATING EXCESS MO, DOI [10.1101/2020.05.27.20083287V1, DOI 10.1101/2020.05.27.20083287V1, 10.1101/2020.05.27.20083287v1]; Lefevre JH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-417; New South Wales Government, COVID 19 INT GUID EL; Petrelli F, 2016, ANN SURG, V263, P458, DOI 10.1097/SLA.0000000000000368; Pruitt SL, 2013, CANCER CAUSE CONTROL, V24, P961, DOI 10.1007/s10552-013-0172-6; Royal College of Radiologists and others, GUID PREOP CHEST CT; Royal College of Surgeons and others, URG INT GEN SURV GUI; RStudio Team, RSTUDIO INT DEV R; Seymour MT, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.3504; Shin DW, 2013, ANN SURG ONCOL, V20, P2468, DOI 10.1245/s10434-013-2957-y; Society of American Gastrointestinal and Endoscopic Surgeons European Association for Endoscopic Surgery and other Interventional Techniques, SAG EAES REC REG SUR; The Association of Coloproctology of Great Britain and Ireland, CONS MULT MAN PAT CO; The British Society of Gastroenterology, END ACT COVID 19 BSG; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]	29	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240397	10.1371/journal.pone.0240397	http://dx.doi.org/10.1371/journal.pone.0240397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031464	gold, Green Published			2022-12-26	WOS:000581809800004
J	Sato, K; Mano, T; Iwata, A; Toda, T				Sato, Kenichiro; Mano, Tatsuo; Iwata, Atsushi; Toda, Tatsushi			Autocorrelation-based method to identify disordered rhythm in Parkinson's disease tasks: A novel approach applicable to multimodal devices	PLOS ONE			English	Article							GAIT; ACCELEROMETRY; PARAMETER	Objective We aim to propose a novel method of evaluating the degree of rhythmic irregularity during repetitive tasks in Parkinson's disease (PD) by using autocorrelation to extract serial perturbation in the periodicity of body part movements as recorded by objective devices. Methods We used publicly distributed sequential joint movement data recorded during a leg agility task or pronation-supination task. The sequences of body part trajectory were processed to extract their short-time autocorrelation (STACF) matrices; the sequences of single task conducted by participants were then divided into two clusters according to their similarity in terms of their STACF representation. The Unified Parkinson's Disease Rating Scale sub-score rated for each task was compared with cluster membership to obtain the area under the curve (AUC) to evaluate the discrimination performance of the clustering. We compared the AUC with those obtained from the clustering of the raw sequence or short-time Fourier transform (STFT). Results In classifying the pose estimator-based trajectory data of the knee during the leg agility task, the AUC was the highest when the STACF sequence was used for clustering instead of other types of sequences with up to 0.815, being comparable to the results reported in the original analysis of the data using an approach different from ours. In addition, in classifying another dataset of accelerometer-based trajectory data of the wrist during a pronation-supination task, the AUC was again highest up to 0.785 when clustering was performed using the STACF rather than other types of sequence. Conclusion Our autocorrelation-based method achieved a fair performance in detecting sequences with irregular rhythm, suggesting that it might be used as another evaluation strategy that is potentially widely applicable to qualify the disordered rhythm of PD regardless of the kinds of task or the modality of devices, although further refinement is needed.	[Sato, Kenichiro; Mano, Tatsuo; Iwata, Atsushi; Toda, Tatsushi] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Iwata, Atsushi] Tokyo Metropolitan Geriatr Med Ctr Hosp, Dept Neurol, Tokyo, Japan	University of Tokyo	Sato, K; Iwata, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan.; Iwata, A (corresponding author), Tokyo Metropolitan Geriatr Med Ctr Hosp, Dept Neurol, Tokyo, Japan.	kenisatou-tky@umin.ac.jp; iwata@m.u-tokyo.ac.jp	Iwata, Atsushi/AAH-8924-2019; Iwata, Atsushi/A-9598-2013	Iwata, Atsushi/0000-0001-7308-5314; Iwata, Atsushi/0000-0001-7308-5314	Japan Society for the Promotion of Science (JSPS) KAKENHI [20J11009, 20H03587]; AMED [20dk0207048h0002]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 20J11009 (K.S) and 20H03587 (A.I), and also supported by AMED under Grant Number 20dk0207048h0002 (A.I).	[Anonymous], 2018, R PACKAGE VERSION 20; [Anonymous], 2016, SENSORS, V16, pC1, DOI 10.1109/JSEN.2016.2517933; Bachlin M, 2010, IEEE T INF TECHNOL B, V14, P436, DOI 10.1109/TITB.2009.2036165; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bennett TR, 2016, IEEE SIGNAL PROC MAG, V33, P28, DOI 10.1109/MSP.2015.2499314; Cancela J, 2011, IEEE ENG MED BIO, P2233, DOI 10.1109/IEMBS.2011.6090423; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Keenan D. Barry, 2005, V41, P329; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li MH, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0446-z; Lord S, 2008, GAIT POSTURE, V27, P357, DOI 10.1016/j.gaitpost.2007.04.001; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; Mera TO, 2012, J NEUROSCI METH, V203, P152, DOI 10.1016/j.jneumeth.2011.09.019; Montero P, 2014, J STAT SOFTW, V62, P1; Muro-de-la-Herran A, 2014, SENSORS-BASEL, V14, P3362, DOI 10.3390/s140203362; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sato K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223549; Shih-En Wei, ARXIV160200134; Tsipouras MG, 2012, ARTIF INTELL MED, V55, P127, DOI 10.1016/j.artmed.2012.03.003; Yang CC, 2011, SENSORS-BASEL, V11, P7314, DOI 10.3390/s110807314; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772; Yang K, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.09; Yokoe M, 2009, PARKINSONISM RELAT D, V15, P440, DOI 10.1016/j.parkreldis.2008.11.003; Zhe Cao, ARXIV161108050	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0238486	10.1371/journal.pone.0238486	http://dx.doi.org/10.1371/journal.pone.0238486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031372	Green Submitted, gold, Green Published			2022-12-26	WOS:000581809800022
J	Gilio, TAS; Hurtado-Gonzales, OP; Goncalves-Vidigal, MC; Valentini, G; Elias, JCF; Song, QJ; Pastor-Corrales, MA				Gilio, Thiago Alexandre Santana; Hurtado-Gonzales, Oscar P.; Goncalves-Vidigal, Maria Celeste; Valentini, Giseli; Ferreira Elias, Julio Cesar; Song, Qijian; Pastor-Corrales, Marcial A.			Fine mapping of an anthracnose-resistancelocusin Andean common bean cultivar Amendoim Cavalo	PLOS ONE			English	Article							CLATHRIN HEAVY-CHAIN; COLLETOTRICHUM-LINDEMUTHIANUM; PHASEOLUS-VULGARIS; GENETIC-CHARACTERIZATION; MOLECULAR DIVERSITY; MARKERS; IDENTIFICATION; ENDOCYTOSIS; GENOME; RACES	Anthracnose, caused by the fungal pathogenColletotrichum lindemuthianum, is one of the world's most destructive diseases of common bean. The use of resistant cultivars is the most cost-effective strategy to manage this disease; however, durable resistance is difficult to achieve due to the vast virulence diversity of the anthracnose pathogen. Finding new genes with broad-spectrum resistance increases the prospect of designing an effective anthracnose-management strategy. Genetic analysis confirmed the presence of a single, dominant anthracnose-resistancelocusin AC, which we provisionally namedCo-AC. Bulk segregant analysis and genetic mapping of two F(2)populations from the crosses AC x PI207262 and AC x G 2333 were used to determine the position of theCo-AC locusin a 631 Kbp genomic region flanked by the SNP markers SS56 and SS92 on the lower arm of chromosome Pv01. By genotyping 77 F(3)plants from the AC x PI207262 cross using nine additional markers, we fine-mapped theCo-AC locusto a significantly smaller genomic region (9.4 Kbp) flanked by the SNP markers SS102 and SS165. This 9.4 Kbp region harbors three predicted genes based on the common bean reference genome, notably including the gene model Phvul.001G244300, which encodes Clathrin heavy chain 1, a protein that supports specific stomatal regulation functions and might play a role in plant defense signaling. Because theCo-ACresistancelocusis linked incis, it can be selected with great efficiency using molecular markers. These results will be very useful for breeding programs aimed at developing bean cultivars with anthracnose resistance using marker-assisted selection. This study revealed the broad-spectrum resistance of AC toC.lindemuthianumand the existence of theCo-ACanthracnose-resistancelocus. Fine mapping positioned thislocusin a small genomic region on the lower end of chromosome Pv01 that contained three candidate genes for theCo-AC locus.	[Gilio, Thiago Alexandre Santana; Goncalves-Vidigal, Maria Celeste; Valentini, Giseli; Ferreira Elias, Julio Cesar] Univ Estadual Maringa, Dept Agron, Maringa, Parana, Brazil; [Gilio, Thiago Alexandre Santana] Univ Estado Mato Grosso, Programa Posgrad Genet & Melhoramento Plantas, Caceres, Mato Grosso, Brazil; [Hurtado-Gonzales, Oscar P.; Song, Qijian; Pastor-Corrales, Marcial A.] ARS, Soybean Genom & Improvement Lab, USDA, Beltsville, MD 20705 USA	Universidade Estadual de Maringa; Universidade do Estado de Mato Grosso; United States Department of Agriculture (USDA)	Gilio, TAS (corresponding author), Univ Estadual Maringa, Dept Agron, Maringa, Parana, Brazil.; Gilio, TAS (corresponding author), Univ Estado Mato Grosso, Programa Posgrad Genet & Melhoramento Plantas, Caceres, Mato Grosso, Brazil.; Pastor-Corrales, MA (corresponding author), ARS, Soybean Genom & Improvement Lab, USDA, Beltsville, MD 20705 USA.	thiago_gilio@hotmail.com; talo.pastor-corrales@ars.usda.gov	Hurtado-Gonzales, Oscar/AAX-6763-2021; Goncalves-Vidigal, Maria Celeste/O-2310-2013; Hurtado-Gonzales, Oscar/K-9203-2017	Goncalves-Vidigal, Maria Celeste/0000-0002-5157-6881; Hurtado-Gonzales, Oscar/0000-0002-9561-7016; Gilio, Thiago Alexandre Santana/0000-0003-4078-5407	CNPq; CAPES; Norman Borlaug Commemorative Research Initiative of the US Agency for International Development [0210-22310-004-96R]; US Department of Agriculture, Agricultural Research Services Project [8042-22000-286-00D]; Coordenacao de Aperfeicoamento de Pessoal de Nivel [99999.006984/2015]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Norman Borlaug Commemorative Research Initiative of the US Agency for International Development(United States Agency for International Development (USAID)); US Department of Agriculture, Agricultural Research Services Project; Coordenacao de Aperfeicoamento de Pessoal de Nivel	This research was supported in part by the Brazilian Federal Funding Institutions CNPq and CAPES. M.C. Goncalves-Vidigal is grateful for a grant from CNPq. This research was also supported by funding from the Norman Borlaug Commemorative Research Initiative of the US Agency for International Development, project number 0210-22310-004-96R, and by the US Department of Agriculture, Agricultural Research Services Project Number 8042-22000-286-00D (M. A. Pastor-Corrales). Also Thiago Alexandre Santana Gilio is grateful for the scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, 99999.006984/2015. The contents of this publication do not necessarily reflect the views or policies of the US Department of Agriculture, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzate-Marin AL, 2007, EUPHYTICA, V154, P1, DOI 10.1007/s10681-006-9253-x; Balardin RS, 1997, PHYTOPATHOLOGY, V87, P1184, DOI 10.1094/PHYTO.1997.87.12.1184; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Campa A, 2011, PHYTOPATHOLOGY, V101, P757, DOI 10.1094/PHYTO-11-10-0296; Chen ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169954; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; David P, 2008, MOL GENET GENOMICS, V280, P521, DOI 10.1007/s00438-008-0384-8; Castro SAD, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3685-7; del Rio LE, 2003, CAN J PLANT PATHOL, V25, P104; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Geffroy V, 1997, DISSECTION GENETIQUE; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Genchev D, 2010, BIOTECHNOL BIOTEC EQ, V24, P1814, DOI 10.2478/V10133-010-0047-X; GEPTS P, 1986, ECON BOT, V40, P469, DOI [10.1007/BF02859659, 10.1007/BF02859660]; Goncalves-Vidigal MC, 2013, THEOR APPL GENET, V126, P2245, DOI 10.1007/s00122-013-2131-8; Goncalves-Vidigal MC, 2009, CROP SCI, V49, P133, DOI 10.2135/cropsci2008.01.0004; Goncalves-Vidigal MC, 2008, PLANT BREEDING, V127, P592, DOI 10.1111/j.1439-0523.2008.01530.x; Goncalves-Vidigal MC, 2006, EUPHYTICA, V151, P411, DOI 10.1007/s10681-006-9164-x; Goncalves-Vidigal MC, 2012, PLANT BREEDING, V131, P423, DOI 10.1111/j.1439-0523.2011.01939.x; Goncalves-Vidigal MC, 2011, THEOR APPL GENET, V122, P893, DOI 10.1007/s00122-010-1496-1; Goncalves-Vidigal MC, 2016, ANN REP BEAN IMPROV, V59, P85; Gonqalves-Vidigal MC, 2007, GENET MOL BIOL, V30, P589, DOI 10.1590/S1415-47572007000400015; Goswami RS, 2011, PLANT DIS, V95, P408, DOI 10.1094/PDIS-06-10-0429; GUZMAN P, 1979, TURRIALBA, V29, P65; KAMI J, 1995, P NATL ACAD SCI USA, V92, P1101, DOI 10.1073/pnas.92.4.1101; KELLY JD, 1994, PLANT DIS, V78, P892, DOI 10.1094/PD-78-0892; Kelly JD, 2004, HORTSCIENCE, V39, P1196, DOI 10.21273/HORTSCI.39.6.1196; Lacanallo G. F., 2015, Australian Journal of Crop Science, V9, P394; Lamour K, 2006, MYCOLOGIA, V98, P514, DOI 10.3852/mycologia.98.3.514; Larson ER, 2017, PLANT PHYSIOL, V175, P708, DOI 10.1104/pp.17.00970; Mahuku GS, 2004, EUR J PLANT PATHOL, V110, P253, DOI 10.1023/B:EJPP.0000019795.18984.74; Malinovsky FG, 2014, PLANT PHYSIOL, V164, P1443, DOI 10.1104/pp.113.234625; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Mbengue M, 2016, P NATL ACAD SCI USA, V113, P11034, DOI 10.1073/pnas.1606004113; Meziadi C, 2016, PLANT SCI, V242, P351, DOI 10.1016/j.plantsci.2015.09.006; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Nanami DSY., 2017, AGRONOMY SCI BIOTECH, V3, P43, DOI DOI 10.33158/ASB.2017V3I1P43; Padder BA, 2017, J PLANT PATHOL, V99, P317; PASTOR-CORRALES M A, 1991, Phytopathology, V81, P694; Pastor-Corrales M.A., 1989, BEAN PRODUCTION PROB, P77; Pastor-Corrales M.A., 1996, ANN REP BEAN IMPROV, V39, P46; Pastor-Corrales MA, 2005, COMPENDIUM BEAN DIS, P25; PASTORCORRALES MA, 1995, PLANT DIS, V79, P63, DOI 10.1094/PD-79-0063; PASTORCORRALES MA, 1994, PLANT DIS, V78, P959, DOI 10.1094/PD-78-0959; PEARSE BMF, 1976, P NATL ACAD SCI USA, V73, P1255, DOI 10.1073/pnas.73.4.1255; Perini S, 2012, CURR OPIN PLANT BIOL, V15, P17, DOI 10.1016/j.pbi.2011.10.006; Richard MMS, 2014, THEOR APPL GENET, V127, P1653, DOI 10.1007/s00122-014-2328-5; Rodriguez-Suarez C, 2008, THEOR APPL GENET, V116, P807, DOI 10.1007/s00122-008-0714-6; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schwartz H.F., 1989, BEAN PRODUCTION PROB; SINGH SP, 1991, ECON BOT, V45, P379, DOI 10.1007/BF02887079; Singh SP, 1999, COMMON BEAN IMPROVEM, P1, DOI 10.1007/978-94-015-9211-6_1; Song QJ, 2015, G3-GENES GENOM GENET, V5, P2285, DOI 10.1534/g3.115.020594; Song QJ, 2010, CROP SCI, V50, P1950, DOI 10.2135/cropsci2009.10.0607; Sousa L. L., 2014, Australian Journal of Crop Science, V8, P317; Sousa LL, 2015, CROP SCI, V55, P1900, DOI 10.2135/cropsci2014.09.0604; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Trabanco N, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.10.0079; Van Schoonhoven A., 1987, STANDARD SYSTEM EVAL; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Young RA, 1998, THEOR APPL GENET, V96, P87, DOI 10.1007/s001220050713; Zeng MH, 2013, INT J MOL SCI, V14, P15179, DOI 10.3390/ijms140715179; Zuiderveen GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156391	64	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239763	10.1371/journal.pone.0239763	http://dx.doi.org/10.1371/journal.pone.0239763			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027258	Green Published, gold			2022-12-26	WOS:000581808000012
J	Yu, B; Wang, Z; Liu, SK; Liu, XM; Gou, RX				Yu, Bo; Wang, Zheng; Liu, Shangke; Liu, Xiaomin; Gou, Ruixin			The data dimensionality reduction and bad data detection in the process of smart grid reconstruction through machine learning	PLOS ONE			English	Article							DATA INJECTION ATTACKS	To detect false data injection attacks (FDIAs) in power grid reconstruction and solve the problem of high data dimension and bad abnormal data processing in the power system, thereby achieving safe and stable operation of the power grid system, this study introduces machine learning methods to explore the detection of FDIAs. First, through the utilization of the standard IEEE node system and the simulation of FDIAs under the condition of non-complete topology information, the construction of the attack data set is completed, and the MatPower tool is applied to simulate and analyze the data set. Second, based on the isolated Forest (iForest) abnormal score data processing algorithm combined with the Local Linear Embedding (LLE) data dimensionality reduction method, an algorithm for data feature extraction is constructed. Finally, based on the combination of the Convolutional Neural Network (CNN) and the Gated Recurrent Unit (GRU) network, an algorithm model for FDIAs detection is constructed. The results show that in the IEEE14-bus node and IEEE118-bus node systems, the overall distribution of the state estimated before and after the attack vector injection is consistent with the initial value. In the iFores algorithm, the number of iTree and the number of samples affect the extraction of abnormal score data. When the number of iTree n is determined to be 100, and the corresponding number of samples w is determined to be 10, the algorithm has the best detection effect. The FDIAs detection algorithm model based on CNN-GRU shows good detection effects under high attack intensity, with an accuracy rate of more than 95%, and its performance is better than other traditional detection algorithms. In this study, the bad data detection model based on deep learning has an active role in the realization of the safe and stable operation of the smart grid.	[Yu, Bo; Wang, Zheng; Liu, Shangke; Liu, Xiaomin; Gou, Ruixin] State Grid Ningxia Elect Power, Ecotech Res Inst, Yinchuan, Ningxia, Peoples R China		Gou, RX (corresponding author), State Grid Ningxia Elect Power, Ecotech Res Inst, Yinchuan, Ningxia, Peoples R China.	1409376851@qq.com						[Anonymous], J AM GERIATR SOC; [Anonymous], 2016, GLOBAL STATUS COMMER, V52, P1; [Anonymous], 2018, J JAES JSTS, V35, P1; ASHOK A, 2016, IEEE T SMART GRID, DOI DOI 10.1109/PESGM.2016.7741979; Basart J P, 2016, RADIO SCI, V21, P863; Beg OA, 2017, IEEE T IND INFORM, V13, P2693, DOI 10.1109/TII.2017.2656905; Che L, 2019, IEEE T POWER SYST, V34, P1513, DOI 10.1109/TPWRS.2018.2871345; Ganjkhani M, 2019, ENERGIES, V12, DOI 10.3390/en12112209; Geetha SJ, 2018, IET GENER TRANSM DIS, V12, P2299, DOI 10.1049/iet-gtd.2017.1733; Goncalves Francisco M P, 2016, PhytoKeys, P1, DOI 10.3897/phytokeys.65.8679; Krsman VD, 2017, IET GENER TRANSM DIS, V11, P2351, DOI 10.1049/iet-gtd.2016.1866; Li X, 2018, IET COMMUN, V11, P2800; McMullen JG, 2017, MICROBIOL-SGM, V163, P510, DOI 10.1099/mic.0.000449; Mohammadpourfard M, 2017, EXPERT SYST APPL, V84, P242, DOI 10.1016/j.eswa.2017.05.013; Moslemi R, 2018, IET GENER TRANSM DIS, V12, P1263, DOI 10.1049/iet-gtd.2017.0294; Schneider WF, 2018, J PHYS CHEM A, V122, P879, DOI 10.1021/acs.jpca.8b00034; Sorrentino E, 2016, ELECTR POW SYST RES, V140, P116, DOI 10.1016/j.epsr.2016.06.033; Tautz-Weinert J, 2017, IET RENEW POWER GEN, V11, P382, DOI 10.1049/iet-rpg.2016.0248; Umehara K, 2018, J DIGIT IMAGING, V31, P441, DOI 10.1007/s10278-017-0033-z; Wang G M, 2018, IEEE T AUTOMATION EN, P1; Wang Q, 2019, INT J ELEC POWER, V104, P169, DOI 10.1016/j.ijepes.2018.07.007; Wang XY, 2019, INT J ELEC POWER, V110, P208, DOI 10.1016/j.ijepes.2019.03.008; Zhang H, 2018, IEEE T CONTROL NETW, V5, P383, DOI 10.1109/TCNS.2016.2614099; Zhang JZ, 2018, IEEE T POWER SYST, V33, P4775, DOI 10.1109/TPWRS.2018.2818746; Zhang JX, 2016, INT J IMAGE DATA FUS, V7, P1, DOI 10.1080/19479832.2016.1122697; Zhang SC, 2018, IEEE T NEUR NET LEAR, V29, P1774, DOI 10.1109/TNNLS.2017.2673241; Zhou ZY, 2018, IEEE T IND INFORM, V14, P768, DOI 10.1109/TII.2017.2733001	27	1	1	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0237994	10.1371/journal.pone.0237994	http://dx.doi.org/10.1371/journal.pone.0237994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027298	Green Published, gold			2022-12-26	WOS:000581808000019
J	Li, QY; Hou, JH; Yan, P; Xu, L; Chen, Z; Yang, H; He, NP				Li, Qiuyue; Hou, Jihua; Yan, Pu; Xu, Li; Chen, Zhi; Yang, Hao; He, Nianpeng			Regional response of grassland productivity to changing environment conditions influenced by limiting factors	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; CLIMATE-CHANGE; LOESS PLATEAU; MONGOLIAN PLATEAU; PLANT DIVERSITY; COLD-TEMPERATE; ALPINE MEADOW; VEGETATION; PRECIPITATION; ASSOCIATION	Regional differences and regulatory mechanisms of vegetation productivity response to changing environmental conditions constitute a core issue in macroecological researches. To verify the main limiting factors of different macrosystems [temperature-limited Tibetan Plateau (TP), precipitation-limited Mongolian Plateau (MP), and nutrient-limited Loess Plateau (LP)], we conducted a comparative survey of the east-west grassland transects on the three plateaus and explored the factors limiting regional productivity and their underlying mechanisms. The results showed that aboveground net primary productivity (ANPP) of LP (109.10 +/- 16.76 g m(-2)yr(-1)) was significantly higher than that of MP (66.71 +/- 11.11 g m(-2)yr(-1)) and TP (57.02 +/- 10.59 g m(-2)yr(-1)). The response rate of ANPP with environmental changes was different among different plateaus, being closely related to the main limiting factors. On MP, this was precipitation, on LP it was temperature and nutrients, and on TP, it was non-specific, reflecting restriction by the extremely low temperature. After autocorrelation screening of environmental factors, different regions exhibited different productivity response mechanisms. MP was mainly influenced by temperature and precipitation, LP was influenced by temperature and nutrient, and TP was influenced by nutrient, reflecting the modifying effect of the main limiting factors. The effect of each regional environment on ANPP was 72.56% on average and only 27.18% after simple regional integration. The regional model could optimize the simulation error of the integrated model, and the relative deviations in MP, LP, and TP were reduced by 31.76%, 17.22%, and 2.23%, respectively. These findings indicate that the grasslands on the three plateaus may have different or even the opposite mechanisms to control productivity.	[Li, Qiuyue; Hou, Jihua] Beijing Forestry Univ, Sch Ecol & Nat Conservat, Beijing, Peoples R China; [Yan, Pu; Xu, Li; Chen, Zhi; Yang, Hao; He, Nianpeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Yan, Pu; He, Nianpeng] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China; [He, Nianpeng] Northeast Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Changchun, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northeast Normal University - China	Hou, JH (corresponding author), Beijing Forestry Univ, Sch Ecol & Nat Conservat, Beijing, Peoples R China.; He, NP (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.; He, NP (corresponding author), Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China.; He, NP (corresponding author), Northeast Normal Univ, Key Lab Vegetat Ecol, Minist Educ, Changchun, Peoples R China.	houjihua@bjfu.edu.cn; henp@igsnrr.ac.cn		Yan, Pu/0000-0001-5614-9355; he, nianpeng/0000-0002-0458-5953	National Natural Science Foundation of China [31961143022, 31870437]; National Key R&D Program of China [2017YFA0604803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	We received support for this research from National Natural Science Foundation of China, 31961143022, 31870437, National Key R&D Program of China, 2017YFA0604803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2017, KIDNEY INT S113, V76, pS1; Beck HE, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.214; Bussotti F, 2014, ENVIRON EXP BOT, V103, P80, DOI 10.1016/j.envexpbot.2013.09.013; Chai X, 2019, ECOL MODEL, V394, P66, DOI 10.1016/j.ecolmodel.2018.12.024; Chen D, 2013, ENVIRON DEV, V6, P69, DOI 10.1016/j.envdev.2013.03.007; Chen SP, 2018, P NATL ACAD SCI USA, V115, P4027, DOI 10.1073/pnas.1700298114; [戴黎聪 Dai Licong], 2019, [生态学报, Acta Ecologica Sinica], V39, P486; DeMarco J, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00281.1; Deng HJ, 2018, CLIMATIC CHANGE, V151, P379, DOI 10.1007/s10584-018-2325-9; Du EZ, 2020, NAT GEOSCI, V13, P221, DOI 10.1038/s41561-019-0530-4; Fan Y, 2016, J ARID ENVIRON, V129, P1, DOI 10.1016/j.jaridenv.2016.02.002; [冯险峰 Feng Xianfeng], 2014, [生态环境学报, Ecology and Environmental Sciences], V23, P496; Feng XM, 2016, NAT CLIM CHANGE, V6, P1019, DOI [10.1038/NCLIMATE3092, 10.1038/nclimate3092]; [高海东 Gao Haidong], 2017, [地理学报, Acta Geographica Sinica], V72, P863; [郭鑫年 Guo Xinnian], 2019, [中国土壤与肥料, Soil and Fertilizer Sciences in China], P154; Hu B, 2017, FOREST ECOL MANAG, V389, P46, DOI 10.1016/j.foreco.2016.12.011; Hu YF, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11051320; Huai JL, 2018, MOL PLANT, V11, P928, DOI 10.1016/j.molp.2018.04.005; Ilnitsky O. A., 2018, Russian Agricultural Sciences, V44, P224, DOI 10.3103/S1068367418030060; [焦翠翠 Jiao Cuicui], 2016, [地理学报, Acta Geographica Sinica], V71, P781; Jin Z, 2020, SCI TOTAL ENVIRON, V748, DOI 10.1016/j.scitotenv.2020.141375; Koch GW, 1995, VEGETATIO, V121, P53, DOI 10.1007/BF00044672; Li CL, 2018, ATMOSPHERE-BASEL, V9, DOI 10.3390/atmos9080322; Li G, 2019, SCI TOTAL ENVIRON, V660, P177, DOI 10.1016/j.scitotenv.2019.01.028; Li J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02413-9; Li Y, 2018, ECOL INDIC, V85, P383, DOI 10.1016/j.ecolind.2017.10.025; Liu Anrong, 2018, Biodiversity Science, V26, P972, DOI 10.17520/biods.2018119; Liu CC, 2018, FUNCT ECOL, V32, P20, DOI 10.1111/1365-2435.12973; Liu HX, 2018, J INDIAN SOC REMOTE, V46, P1081, DOI 10.1007/s12524-018-0769-z; Liu HY, 2018, P NATL ACAD SCI USA, V115, P4051, DOI 10.1073/pnas.1700299114; Liu LB, 2018, J GEOPHYS RES-BIOGEO, V123, P3603, DOI 10.1029/2018JG004760; Miao LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190313; Nystrom M, 2019, NATURE, V575, P98, DOI 10.1038/s41586-019-1712-3; Qin FY, 2018, J MT SCI-ENGL, V15, P992, DOI 10.1007/s11629-018-4837-1; Ren HY, 2017, ECOL MONOGR, V87, P457, DOI 10.1002/ecm.1262; Schleuss PM, 2020, ECOLOGY, V101, DOI 10.1002/ecy.3003; [沈海花 Shen Haihua], 2016, [科学通报, Chinese Science Bulletin], V61, P139; Shen MG, 2013, P NATL ACAD SCI USA, V110, pE2329, DOI 10.1073/pnas.1304625110; Shi WH, 2018, LAND DEGRAD DEV, V29, P2899, DOI 10.1002/ldr.3028; Smith MD, 2015, OECOLOGIA, V177, P935, DOI 10.1007/s00442-015-3230-9; Sun QL, 2020, AGR FOREST METEOROL, V284, DOI 10.1016/j.agrformet.2019.107896; Tian DS, 2019, NEW PHYTOL, V221, P807, DOI 10.1111/nph.15428; Tong SQ, 2018, J GEOGR SCI, V28, P595, DOI 10.1007/s11442-018-1493-x; Trabucco A., 2009, GLOBAL ARIDITY INDEX; Venables WN., 2002, MODERN APPL STAT S 4; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wang H.Y., 2012, THESIS; Wang H, 2020, ECOL LETT, V23, P701, DOI 10.1111/ele.13474; Wang XY, 2018, GLOBAL CHANGE BIOL, V24, P1651, DOI 10.1111/gcb.13930; Wei P, 2019, CATENA, V185, P104298; Wei T, 2017, R PACKAGE CORRPLOT V; Wu DH, 2018, BIOGEOSCIENCES, V15, P3421, DOI 10.5194/bg-15-3421-2018; Wu JS, 2019, J ENVIRON MANAGE, V231, P635, DOI 10.1016/j.jenvman.2018.10.097; Zhang Bin, 2014, Chinese Journal of Plant Ecology, V38, P1008, DOI 10.3724/SP.J.1258.2014.00095; Zhang JJ, 2020, LAND DEGRAD DEV, V31, P2185, DOI 10.1002/ldr.3603; Zhang T, 2018, AGR FOREST METEOROL, V256, P22, DOI 10.1016/j.agrformet.2018.02.027; Zhang Xin-Shi, 1997, Acta Botanica Sinica, V39, P785; Zhang XF, 2015, CATAL COMMUN, V60, P32, DOI 10.1016/j.catcom.2014.11.021; Zhang Y, 2017, J SUSTAIN FOREST, V36, P568, DOI 10.1080/10549811.2017.1314971; Zhang YH, 2018, OECOLOGIA, V188, P183, DOI 10.1007/s00442-018-4208-1; Zhang ZY, 2019, J PALAEOGEOG-ENGLISH, V8, DOI 10.1186/s42501-018-0016-0; Zhao F, 2019, INT J REMOTE SENS, V40, P2259, DOI 10.1080/01431161.2018.1516322; [周广胜 Zhou Guangsheng], 2012, [地球科学进展, Advance in Earth Sciences], V27, P563	66	3	3	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240238	10.1371/journal.pone.0240238	http://dx.doi.org/10.1371/journal.pone.0240238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064720	gold, Green Published			2022-12-26	WOS:000585918300003
J	Zhang, L; Wei, ZY; Liu, PC				Zhang, Lei; Wei, Zhengying; Liu, Pengcheng			An all-solid-state NO(3)(-)ion-selective electrode with gold nanoparticles solid contact layer and molecularly imprinted polymer membrane	PLOS ONE			English	Article							POTENTIOMETRIC SENSORS; NITRATE; IMMUNOSENSOR; CHROMATOGRAPHY; FILMS; WATER	To improve the single-layer all-solid-state ion selective electrode' defects including poor conductivity of PVC sensitive membrane and interference of water layer between substrate electrode and sensitive membrane, a double-layer all-solid-state ion selective electrode with nanomaterial as the solid contact layer and conductive polymer as the ion sensitive membrane was developed. A gold nanoparticles solid contact layer and a nitrate-doped polypyrrole molecularly imprinted polymer membrane were prepared by electrodeposition. The optimal parameters obtained by electrochemical performance test were 2.5 mmol/L HAuCl(4)electrolyte for solid contact layer and 1800s electrodeposition time for sensitive membrane. The new electrode exhibited a Nernstian response of -50.4 mV/decade and a low detection limit of 5.25x10(-5)mol/L. Potentiometric water layer test showed no water film formed between the gold nanoparticles solid contact layer and nitrate-doped polypyrrole molecularly imprinted polymer membrane. The contact angle between droplet and the surface of solid contact layer was 112.35 degrees and showed good hydrophobic property. Furthermore, the developed electrode exhibited fast response, excellent potential stability and long lifetime. This electrode is suitable for the detection of nitrate concentration in water and liquid fertilizer.	[Zhang, Lei; Wei, Zhengying; Liu, Pengcheng] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Peoples R China	Xi'an Jiaotong University	Zhang, L (corresponding author), Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Peoples R China.	zl870127@stu.xjtu.edu.cn			National Key Research and Development Plan of China [2017YFD0201500]	National Key Research and Development Plan of China	The financial support is provided by the National Key Research and Development Plan of China (No.2017YFD0201500).	Barak P, 1997, PLANT SOIL, V197, P61, DOI 10.1023/A:1004297607070; Bobacka J, 2008, CHEM REV, V108, P329, DOI 10.1021/cr068100w; CATTRALL RW, 1971, ANAL CHEM, V43, P1905, DOI 10.1021/ac60307a032; CAWSE PA, 1967, ANALYST, V92, P311, DOI 10.1039/an9679200311; CRAGGS A, 1974, J CHEM EDUC, V51, P541, DOI 10.1021/ed051p541; Fakhari AR, 2005, SENSOR ACTUAT B-CHEM, V104, P317, DOI 10.1016/j.snb.2004.05.024; Fattahi N, 2007, J CHROMATOGR A, V1157, P23, DOI 10.1016/j.chroma.2007.04.062; Freiser, 1980, ION SELECTIVE ELECTR, P85; Gabriel S, 2007, CHEM MATER, V19, P2364, DOI 10.1021/cm062450h; Guobis Z, 2012, J ORAL MAXILLOFAC RE, V3, pe2; Gupta VK, 2006, ANAL CHIM ACTA, V566, P5, DOI 10.1016/j.aca.2006.02.038; HARA H, 1993, ANALYST, V118, P549, DOI 10.1039/an9931800549; Haupt K, 2000, CHEM REV, V100, P2495, DOI 10.1021/cr990099w; HOGG G, 1994, SENSOR ACTUAT B-CHEM, V19, P376, DOI 10.1016/0925-4005(93)01001-K; Janata J., 2010, PRINCIPLES CHEM SENS; Li JH, 2017, SENSOR ACTUAT B-CHEM, V239, P438, DOI 10.1016/j.snb.2016.08.008; Liang PP, 2018, ACS APPL MATER INTER, V10, P4233, DOI 10.1021/acsami.7b16914; Ling SJ, 2009, BIOPROC BIOSYST ENG, V32, P407, DOI 10.1007/s00449-008-0260-2; Liu LF, 2013, J MEMBRANE SCI, V429, P252, DOI 10.1016/j.memsci.2012.11.066; Liu Y, ELECTROCHIMICA ACTA, P331; Liu YS, 2008, CHEM GEOL, V257, P34, DOI 10.1016/j.chemgeo.2008.08.004; Mikhelson K.N., 2013, ION SELECTIVE ELECTR; Mourzina YG, 2003, SENSOR ACTUAT B-CHEM, V91, P32, DOI 10.1016/S0925-4005(03)00063-7; Nagar B, 2019, BIOSENS BIOELECTRON, V129, P238, DOI 10.1016/j.bios.2018.09.073; Nie PC, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17051102; OTERO TF, 1988, POLYMER, V29, P1522, DOI 10.1016/0032-3861(88)90320-5; Silva NFD, 2019, TALANTA, V194, P134, DOI 10.1016/j.talanta.2018.10.024; Song RY, 2007, J POWER SOURCES, V166, P297, DOI 10.1016/j.jpowsour.2006.12.093; SOUBIRAN P, 1991, J ELECTROANAL CHEM, V303, P125, DOI 10.1016/0022-0728(91)85120-E; Vakilian KA, 2017, COMPUT ELECTRON AGR, V139, P153, DOI 10.1016/j.compag.2017.05.012; VOLOSCHIK IN, 1994, J CHROMATOGR A, V671, P205, DOI 10.1016/0021-9673(94)80240-8; Watanabe M, 2002, J APPL PHYS, V92, P4631, DOI 10.1063/1.1505674; Yang GM, 2009, ANAL CHIM ACTA, V644, P72, DOI 10.1016/j.aca.2009.04.021; Yin TJ, 2013, TRAC-TREND ANAL CHEM, V51, P79, DOI 10.1016/j.trac.2013.06.009; Yu K, 2017, ELECTROCHIM ACTA, V228, P66, DOI 10.1016/j.electacta.2017.01.009; Yuan DJ, 2015, ANAL CHEM, V87, P8640, DOI 10.1021/acs.analchem.5b01941; Zamani HA, 2007, J ANAL CHEM+, V62, P1080, DOI 10.1134/S1061934807110135; Zendler A., 2015, J COMPUT SCI-NETH, V11, P915; Zeng XZ, 2016, SENSOR ACTUAT B-CHEM, V234, P80, DOI 10.1016/j.snb.2016.04.153; ZHEN RG, 1992, J EXP BOT, V43, P131, DOI 10.1093/jxb/43.2.131; Zhuo Y, 2005, ELECTROCHEM COMMUN, V7, P355, DOI 10.1016/j.elecom.2005.02.001	41	4	4	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240173	10.1371/journal.pone.0240173	http://dx.doi.org/10.1371/journal.pone.0240173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057369	Green Published, gold			2022-12-26	WOS:000581814700072
J	Hayashi, T; Kobayashi, A; Takahashi, H; Oyakawa, I; Kato, N; Yamaguchi, T				Hayashi, Takahiko; Kobayashi, Akira; Takahashi, Hidenori; Oyakawa, Itaru; Kato, Naoko; Yamaguchi, Takefumi			Optical characteristics after Descemet membrane endothelial keratoplasty: 1-year results	PLOS ONE			English	Article							HIGHER-ORDER ABERRATIONS; CORNEAL SURFACE IRREGULARITY; REJECTION; ANTERIOR; EYES	Purpose To evaluate the corneal characteristics after Descemet membrane endothelial keratoplasty (DMEK) compared with normal corneas. Methods Patients who underwent DMEK at Yokohama Minami Kyosai Hospital were included and prospectively evaluated pre-operatively and at postoperative months 1, 3, 6, and 12, and compared to healthy controls. Corneal characteristics evaluated included corneal curvature (keratometric value [KV]; D), central corneal thickness (CCT), peripheral corneal thickness (PCT), and corneal higher-order aberrations [HOAs] at 6.0 mm diameter, calculated by anterior segment optical coherence tomography and logarithm of the minimal angle of resolution [logMAR]. Results A total of 30 eyes of 30 patients (6 men, 24 women, mean age 73.4 +/- 7.4 years) were included and compared with 31 age-matched healthy control eyes (13 men, 18 women; mean age 73.0 +/- 6.7 years). LogMAR after DMEK improved from 0.87 +/- 0.07 preoperatively to 0.04 +/- 0.07 at 12 months postoperatively (p<0.001). Although anterior KVs of DMEK eyes were similar to those of control eyes, posterior KVs were significantly larger (-6.4 +/- 0.3 D vs. -6.3 +/- 0.2 D; p = 0.02). Total HOAs after DMEK improved from 1.94 +/- 1.05 mu m preoperatively to 1.05 +/- 0.16 mu m at 12 months postoperatively (p<0.001), which was significantly higher than that in control eyes (0.63 +/- 0.06) (p<0.001). Despite the similar CCTs in the two groups, the PCT was significantly larger in DMEK eyes (704 +/- 41 mu m vs 669 +/- 38 mu m, p = 0.002) at 12 months. Conclusion Despite achieving good visual function and excellent corneal clarity, eyes that underwent DMEK showed a steeper posterior KV and higher corneal HOAs than normal eyes even at 12 months after surgery.	[Hayashi, Takahiko; Kato, Naoko] Yokohama Minami Kyosai Hosp, Dept Ophthalmol, Yokohama, Kanagawa, Japan; [Hayashi, Takahiko] Univ Cologne, Dept Ophthalmol, Cologne, Germany; [Hayashi, Takahiko; Takahashi, Hidenori] Jichi Med Univ, Dept Ophthalmol, Shimotsuke, Tochigi, Japan; [Hayashi, Takahiko] Yokohama City Univ, Sch Med, Dept Ophthalmol, Yokohama, Kanagawa, Japan; [Hayashi, Takahiko] Hiroshima Univ, Dept Technol & Design Thinking Med DT2M, Higashihiroshima, Japan; [Kobayashi, Akira] Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa, Japan; [Oyakawa, Itaru] Heart Life Hosp, Dept Ophthalmol, Okinawa, Japan; [Kato, Naoko] Minamiaoyama Eye Clin, Minato Ku, Tokyo, Japan; [Yamaguchi, Takefumi] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Ophthalmol, Chiba, Japan	University of Cologne; Jichi Medical University; Yokohama City University; Hiroshima University; Kanazawa University; Tokyo Dental College	Hayashi, T (corresponding author), Yokohama Minami Kyosai Hosp, Dept Ophthalmol, Yokohama, Kanagawa, Japan.; Hayashi, T (corresponding author), Univ Cologne, Dept Ophthalmol, Cologne, Germany.; Hayashi, T (corresponding author), Jichi Med Univ, Dept Ophthalmol, Shimotsuke, Tochigi, Japan.; Hayashi, T (corresponding author), Yokohama City Univ, Sch Med, Dept Ophthalmol, Yokohama, Kanagawa, Japan.; Hayashi, T (corresponding author), Hiroshima Univ, Dept Technol & Design Thinking Med DT2M, Higashihiroshima, Japan.	takamed@gmail.com	Yamaguchi, Takefumi/AEV-4169-2022	Takahashi, Hidenori/0000-0001-5331-4730; Kato, Naoko/0000-0002-6670-2043; Hayashi, Takahiko/0000-0001-8704-680X	Alexander von Humboldt Foundation; Japan Eye Bank Association	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Japan Eye Bank Association	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by Alexander von Humboldt Foundation (https://www.humboldt-foundation.de/web/home.html) and the Japan Eye Bank Association (http://www.j-eyebank.or.jp), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anshu A, 2012, OPHTHALMOLOGY, V119, P536, DOI 10.1016/j.ophtha.2011.09.019; Arnalich-Montiel F, 2019, CORNEA, V38, P535, DOI 10.1097/ICO.0000000000001875; Arnalich-Montiel F, 2013, GRAEF ARCH CLIN EXP, V251, P2575, DOI 10.1007/s00417-013-2460-y; Dapena I, 2011, CORNEA, V30, P1341, DOI 10.1097/ICO.0b013e31820d8540; Droutsas K, 2016, CORNEA, V35, P765, DOI 10.1097/ICO.0000000000000822; Duggan MJ, 2019, OPHTHALMOLOGY, V126, P946, DOI 10.1016/j.ophtha.2019.02.007; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Hayashi T, 2018, CORNEA, V37, P1185, DOI 10.1097/ICO.0000000000001606; Hayashi T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188832; Hayashi T, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9720389; Hos D, 2017, OPHTHALMOLOGY, V124, P512, DOI 10.1016/j.ophtha.2016.12.017; Jacobi C, 2011, AM J OPHTHALMOL, V152, P537, DOI 10.1016/j.ajo.2011.04.005; Kashizuka E, 2016, CORNEA, V35, P1562, DOI 10.1097/ICO.0000000000000910; Kwon RO, 2010, J REFRACT SURG, V26, P972, DOI 10.3928/1081597X-20100212-08; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Price MO, 2007, CURR OPIN OPHTHALMOL, V18, P290, DOI 10.1097/ICU.0b013e3281a4775b; Price MO, 2009, OPHTHALMOLOGY, V116, P2361, DOI 10.1016/j.ophtha.2009.07.010; Rudolph M, 2012, OPHTHALMOLOGY, V119, P528, DOI 10.1016/j.ophtha.2011.08.034; Schrittenlocher S, 2019, GRAEF ARCH CLIN EXP, V257, P321, DOI 10.1007/s00417-018-4193-4; Shimizu E, 2017, AM J OPHTHALMOL, V175, P148, DOI 10.1016/j.ajo.2016.12.014; Stechschulte SU, 2000, INT OPHTHALMOL CLIN, V40, P27, DOI 10.1097/00004397-200040010-00005; van Dijk K, 2014, AM J OPHTHALMOL, V158, P71, DOI 10.1016/j.ajo.2014.04.008; Yagi-Yaguchi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161075; Yamaguchi T, 2015, CORNEA, V34, pS128, DOI 10.1097/ICO.0000000000000589; Yamaguchi T, 2011, INVEST OPHTH VIS SCI, V52, P6222, DOI 10.1167/iovs.11-7647; Yamaguchi T, 2010, CORNEA, V29, P1086, DOI 10.1097/ICO.0b013e3181d0092c; Yamaguchi TD, 2009, J CATARACT REFR SURG, V35, P688, DOI 10.1016/j.jcrs.2008.11.062; Yuda K, 2019, CORNEA, V38, P970, DOI 10.1097/ICO.0000000000002015; Zirm E., 1906, A VONGRAEFES ARCH OP, V64, P580, DOI [10.1007/BF01949227, DOI 10.1007/BF01949227]	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240458	10.1371/journal.pone.0240458	http://dx.doi.org/10.1371/journal.pone.0240458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052928	Green Published, gold			2022-12-26	WOS:000581820200038
J	Reis, AC; Lokpo, K; Bojanic, M; Sperandei, S				Reis, Arianne C.; Lokpo, Komla; Bojanic, Matthew; Sperandei, Sandro			In search of a "vocabulary for recreation": Leisure-time physical activity among humanitarian migrants in regional Australia	PLOS ONE			English	Article							HEALTH; REFUGEES; EXPERIENCES; INTEGRATION; SPORT; PERSPECTIVES; MELBOURNE; COMMUNITY; BARRIERS; ASYLUM	This study provides an exploration of the meanings of leisure for humanitarian migrants in regional Australia and these meanings' implications for health. It uses mixed-methods to explore leisure-time physical activity participation and day-to-day experiences of leisure and health. A sample representing approximately one third of the Coffs Coast adult humanitarian migrant population completed the survey, as well as 32 individuals who participated in interviews and focus groups. Findings were organised into three themes and explored issues around mental health and time for leisure, cultural differences in experiencing leisure, and the connections with experiences of other disadvantaged groups. We conclude by arguing that leisure needs to be brought to the fore of discussions around service provision and policy making concerned with the wellbeing of the refugee migrant population, particularly focusing on support for the (re)development of a vocabulary for recreation, as a step forward in the journey to healing and belonging.	[Reis, Arianne C.] Western Sydney Univ, Sch Hlth Sci, Sydney, NSW, Australia; [Lokpo, Komla] Sanctuary Australia Fdn, Coffs Harbour, Australia; [Bojanic, Matthew] Western Sydney Univ, Sch Med, Sydney, NSW, Australia; [Sperandei, Sandro] Oswaldo Cruz Fdn FIOCRUZ, Inst Sci & Technol Commun & Informat Hlth, Rio De Janeiro, Brazil	Western Sydney University; Western Sydney University; Fundacao Oswaldo Cruz	Reis, AC (corresponding author), Western Sydney Univ, Sch Hlth Sci, Sydney, NSW, Australia.	a.reis@westernsydney.edu.au	Sperandei, Sandro/GQY-8785-2022; Sperandei, Sandro/M-7962-2014; Reis, Arianne/I-6805-2013	Sperandei, Sandro/0000-0001-5367-3397; Reis, Arianne/0000-0002-1630-8857				[Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; Australian Bureau of Statistics, 2018, NAT HLTH SURV 2017 1; Australian Bureau of Statistics (ABS), 2020, MICR AUSTR CENS MIGR; Bjertrup PJ, 2018, SOC SCI MED, V215, P53, DOI 10.1016/j.socscimed.2018.08.040; Borovica Tamara, 2019, LEISURE STUD, VXX, P1; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Caperchione CM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-26; Carr N, 2017, ANN LEIS RES, V20, P137, DOI 10.1080/11745398.2016.1206723; Casey M, 2011, ANN LEIS RES, V14, P1, DOI 10.1080/11745398.2011.575042; Clark A, 2014, AUST J PRIM HEALTH, V20, P92, DOI 10.1071/PY11118; Cleland V, 2010, SOC SCI MED, V70, P2011, DOI 10.1016/j.socscimed.2010.02.028; Correa-Velez I, 2010, SOC SCI MED, V71, P1399, DOI 10.1016/j.socscimed.2010.07.018; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Curtin KD, 2018, GLOB HEALTH PROMOT, V25, P25, DOI 10.1177/1757975916656347; De Grazia S., 1962, TIME WORK LEISURE; de Sousa-Mast FR, 2016, WOMEN HEALTH, V56, P595, DOI 10.1080/03630242.2015.1101745; Department of Immigration and Border Protection, 2017, DEP IMM BORD PROT AN; Doidge M, 2018, TRANSFORMING SPORT K, P23; Earl JK, 2015, LEISURE SCI, V37, P354, DOI 10.1080/01490400.2015.1021881; Evenson KR, 2002, WOMEN HEALTH, V36, P43, DOI 10.1300/J013v36n02_04; Fassaert T, 2009, INT J METH PSYCH RES, V18, P159, DOI 10.1002/mpr.288; Fenton L, 2017, LEISURE SCI, V39, P1, DOI 10.1080/01490400.2015.1120168; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Fullagar S, 2002, HEALTH-LONDON, V6, P69, DOI 10.1177/1363459302006001445; Goodale T., 1988, EVOLUTION LEISURE HI; Han JS, 2007, ANN LEIS RES, V10, P328, DOI 10.1080/11745398.2007.9686770; Hartley L, 2017, HEALTH SOC CARE COMM, V25, P1190, DOI 10.1111/hsc.12419; Henderson K.A., 2001, INTRO RECREATION LEI; Hurly J, 2019, LEISURE STUD, V38, P1, DOI 10.1080/02614367.2018.1515241; IPAQ Research Committee, 2005, IPAQ, P1; Iwasaki Y, 2000, LEISURE SCI, V22, P163, DOI 10.1080/01490409950121843; Johnston V, 2012, AUST J PRIM HEALTH, V18, P242, DOI 10.1071/PY11065; Juniu S, 2000, J LEISURE RES, V32, P69, DOI 10.1080/00222216.2000.11949888; Krueger R. A., 2000, FOCUS GROUPS PRACTIC, V3rd; Labys CA, 2017, TRANSCULT PSYCHIATRY, V54, P696, DOI 10.1177/1363461517705570; Lackey NQ, 2019, ANN LEISURE RES, P1; Lewis H, 2015, LEISURE STUD, V34, P42, DOI 10.1080/02614367.2014.966744; Ley C, 2018, QUAL HEALTH RES, V28, P491, DOI 10.1177/1049732317744533; Liamputtong P, 2018, CHILD YOUTH SERV REV, V85, P99, DOI 10.1016/j.childyouth.2017.12.020; Lincoln Y.S., 2011, SAGE HDB QUALITATIVE, V4th; Lincoln Y.S., 2011, SAGE HDB QUALITATIVE; Loukaitou-Sideris A, 2019, LEISURE STUD, V38, P43, DOI 10.1080/02614367.2018.1544656; Mata-Codesal D, 2015, LEISURE STUD, V34, P1, DOI 10.1080/02614367.2015.992620; Mathiowetz D, 2016, NEW POLIT SCI, V38, P241, DOI 10.1080/07393148.2016.1153193; McGee D, 2018, LEISURE STUD, V37, P22, DOI 10.1080/02614367.2017.1406979; Neulinger J, 1974, SPRINGFIELD, V11, P295, DOI [10.1080/00222216.1976.11970271, DOI 10.1080/00222216.1976.11970271]; Olliff L., 2008, Youth Studies Australia, V27, P52; OWENS J, 1981, CAN J PHILOS, V11, P713; Quirke L, 2015, J INT MIGR INTEGR, V16, P237, DOI 10.1007/s12134-014-0388-7; Russell RV, 1996, J LEISURE RES, V28, P108, DOI 10.1080/00222216.1996.11949764; Sangalang CC, 2019, J IMMIGR MINOR HEALT, V21, P909, DOI 10.1007/s10903-018-0826-2; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Semaan S., 2010, METHODOLOGICAL INNOV, V5, P60, DOI DOI 10.4256/MIO.2010.0019; Shawyer F, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1239-9; Snape R., 2008, Managing Leisure, V13, P23, DOI 10.1080/13606710701751377; Snape R, 2017, WORLD LEISURE J, V59, P184, DOI 10.1080/16078055.2017.1345483; Sofi F, 2007, EUR J CLIN INVEST, V37, P947, DOI 10.1111/j.1365-2362.2007.01884.x; Spaaij R, 2012, ETHNIC RACIAL STUD, V35, P1519, DOI 10.1080/01419870.2011.592205; Sperandei S, 2018, SOC NETWORKS, V52, P48, DOI 10.1016/j.socnet.2017.05.004; Sperandei S, 2014, BIOCHEM MEDICA, V24, P12, DOI 10.11613/BM.2014.003; Taylor J, 2018, AUST J PRIM HEALTH, V24, P14, DOI [10.1071/py16147, 10.1071/PY16147]; United Nations, UN DECL HUM RIGHTS 2; United Nations High Commissioner for Refugees, 2016, GLOB TRENDS FORC DIS; Veal AJ, 2016, LEISURE STUD, V35, P215, DOI 10.1080/02614367.2015.1036104; Veblen T., 1973, THEORY LEISURE CLASS, P154; Walseth K., 2006, Leisure Studies, V25, P75, DOI 10.1080/02614360500200722; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wieland ML, 2015, J IMMIGR MINOR HEALT, V17, P263, DOI 10.1007/s10903-013-9917-2; Yuen F, 2019, ANN LEISURE RES, P1	69	2	2	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0239747	10.1371/journal.pone.0239747	http://dx.doi.org/10.1371/journal.pone.0239747			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052914	Green Published, gold			2022-12-26	WOS:000581820200048
J	Carneros, D; Medina-Gomez, G; Giralt, M; Leon-Camacho, M; Campbell, M; Moreno-Aliaga, MJ; Villarroya, F; Bustos, M				Carneros, David; Medina-Gomez, Gema; Giralt, Marta; Leon-Camacho, Manuel; Campbell, Mark; Moreno-Aliaga, Maria J.; Villarroya, Francesc; Bustos, Matilde			Cardiotrophin-1 contributes to metabolic adaptations through the regulation of lipid metabolism and to the fasting-induced fatty acid mobilization	FASEB JOURNAL			English	Article						adipose tissue; fatty acid mobilization; food restriction; lipids; peroxisome proliferator-activated receptors	ADIPOSE-TISSUE; PPAR-ALPHA; LIPOLYSIS; LIVER; GAMMA; EXPRESSION; GLUCOSE; OBESITY; ACTIVATION; MECHANISMS	It is becoming clear that several human pathologies are caused by altered metabolic adaptations. During liver development, there are physiological changes, from the predominant utilization of glucose (fetal life) to the use of lipids (postnatal life). Fasting is another physiological stress that elicits well-known metabolic adjustments. We have reported the metabolic properties of cardiotrophin-1 (CT-1), a member of the interleukin-6 family of cytokines. Here, we aimed at analyzing the role of CT-1 in response to these metabolic changes. We used different in vivo models. Furthermore, a differential study was carried out with wild-type and CT-1 null mice in fed (ad libitum) and food-restricted conditions. We demonstrated thatCt-1is a metabolic gene induced in the liver via PPAR alpha in response to lipids in mice (neonates- and food-restricted adults). We found thatCt-1mRNA expression in white adipose tissue directly involved PPAR alpha and PPAR gamma. Finally, the physiological role of CT-1 in fasting is confirmed by the impaired food restriction-induced adipose tissue lipid mobilization in CT-1 null mice. Our findings support a previously unrecognized physiological role of CT-1 in metabolic adaptations, through the regulation of lipid metabolism and contributes to fasting-induced free fatty acid mobilization.	[Carneros, David; Bustos, Matilde] Univ Seville, Virgen del Rocio Univ Hosp, CSIC, Inst Biomed Seville IBiS,Area Liver Digest & Infl, Seville, Spain; [Medina-Gomez, Gema] Rey Juan Carlos Univ, Dept Basic Sci Hlth, Area Biochem & Mol Biol, Madrid, Spain; [Giralt, Marta; Villarroya, Francesc] Barcelona Univ, Dept Biochem & Mol Biomed, Barcelona, Spain; [Giralt, Marta; Moreno-Aliaga, Maria J.; Villarroya, Francesc] Inst Hlth Carlos III ISCIII, CIBERobn Physiopathol Obes & Nutr, Madrid, Spain; [Leon-Camacho, Manuel] Inst Grasa, CSIC, Dept Lipid Characterizat & Qual, Seville, Spain; [Campbell, Mark] Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, MRC MDU, Cambridge, England; [Moreno-Aliaga, Maria J.] Univ Navarra, Navarras Hlth Res Inst IdiSNA, Sch Pharm & Nutr, Ctr Nutr Res, Pamplona, Spain; [Moreno-Aliaga, Maria J.] Univ Navarra, Navarras Hlth Res Inst IdiSNA, Sch Pharm & Nutr, Dept Nutr Food Sci & Physiol, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Universidad Rey Juan Carlos; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Navarra; University of Navarra	Bustos, M (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, CSIC, Inst Biomed Sevilla IBIS, Avda Manuel Siurot S-N, Seville 41013, Spain.	mbustos-ibis@us.es	Giralt, Marta/A-4756-2013; Medina-Gomez, Gema/CAF-4668-2022; Medina-Gomez, Gema/CAI-1063-2022; Moreno-Aliaga, Maria J/M-7015-2018	Giralt, Marta/0000-0001-7968-4190; Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Moreno-Aliaga, Maria J/0000-0002-2018-6434	Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia) [P18-RT-4775]; Instituto de Salud Carlos III (ISCIII) [IFI 19/00048, PI16/01791]; MINECO/AE/FEDER,UE [PID2019-110587RB-100]	Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); MINECO/AE/FEDER,UE	Consejeria de Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia), Grant/Award Number: P18-RT-4775; Instituto de Salud Carlos III (ISCIII), Grant/Award Number: IFI 19/00048, PI16/01791 and MINECO/AE/FEDER,UE PID2019-110587RB-100	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Bougneres P, 1997, J CLIN INVEST, V99, P2568, DOI 10.1172/JCI119444; Carneros D, 2019, FASEB J, V33, P7578, DOI 10.1096/fj.201801563R; Castano D, 2014, J HEPATOL, V60, P1017, DOI 10.1016/j.jhep.2013.12.012; Cron L, 2016, J EXP BIOL, V219, P259, DOI 10.1242/jeb.129213; Enoksson S, 2000, DIABETES, V49, P2149, DOI 10.2337/diabetes.49.12.2149; FERRE P, 1978, PEDIATR RES, V12, P751, DOI 10.1203/00006450-197807000-00002; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Herrera E, 2000, DIABETES-METAB RES, V16, P202, DOI 10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.3.CO;2-R; Hondares E, 2014, METABOLISM, V63, P312, DOI 10.1016/j.metabol.2013.11.014; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Hung HC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17438; Hung HC, 2013, INT J CARDIOL, V169, pE33, DOI 10.1016/j.ijcard.2013.08.112; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Liu ML, 2012, BIOCHIMIE, V94, P2126, DOI 10.1016/j.biochi.2012.01.008; Lopez-Yoldi M, 2015, CYTOKINE GROWTH F R, V26, P523, DOI 10.1016/j.cytogfr.2015.07.009; Lopez-Yoldi M, 2014, J LIPID RES, V55, P2634, DOI 10.1194/jlr.M055335; Malavazos AE, 2008, HYPERTENSION, V51, pE8, DOI 10.1161/HYPERTENSIONAHA.107.105346; Marques JM, 2007, HEPATOLOGY, V45, P639, DOI 10.1002/hep.21508; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; MEHLER MF, 1995, INT J DEV NEUROSCI, V13, P213, DOI 10.1016/0736-5748(94)00060-G; Miyajima A, 2000, CYTOKINE GROWTH F R, V11, P177, DOI 10.1016/S1359-6101(00)00003-4; Montgomery MK, 2019, FASEB J, V33, P13267, DOI 10.1096/fj.201900909RR; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Natal C, 2008, AM J PHYSIOL-ENDOC M, V294, pE52, DOI 10.1152/ajpendo.00506.2007; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Preidis GA, 2017, J CLIN INVEST, V127, P1193, DOI [10.1172/jci88893, 10.1172/JCI88893]; Preite NZ, 2016, J ENDOCRINOL, V231, P259, DOI 10.1530/JOE-16-0199; Quehenberger O, 2011, BBA-MOL CELL BIOL L, V1811, P648, DOI 10.1016/j.bbalip.2011.07.006; REYNISDOTTIR S, 1994, DIABETOLOGIA, V37, P428, DOI 10.1007/s001250050128; Rodriguez-Cuenca S, 2012, MOL CELL BIOL, V32, P1555, DOI 10.1128/MCB.06154-11; Rogue A, 2014, TOXICOL APPL PHARM, V276, P73, DOI 10.1016/j.taap.2014.02.001; Stephens J, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020024; Targett-Adams P, 2005, BBA-GENE STRUCT EXPR, V1728, P95, DOI 10.1016/j.bbaexp.2005.01.017; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Vespasiani-Gentilucci U, 2013, ARCH MED SCI, V9, P635, DOI 10.5114/aoms.2013.37272; Viera-Alcaide I, 2007, ANAL CHIM ACTA, V596, P319, DOI 10.1016/j.aca.2007.06.026; Wei D, 2020, LIFE SCI, V247, DOI 10.1016/j.lfs.2020.117414; Wu JW, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006716; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Wueest S, 2014, AM J PHYSIOL-REG I, V306, pR861, DOI 10.1152/ajpregu.00533.2013; Xia B, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007110; Yubero P, 2004, ENDOCRINOLOGY, V145, P4268, DOI 10.1210/en.2004-0099; Zechner R, 2017, NAT REV MOL CELL BIO, V18, P671, DOI 10.1038/nrm.2017.76; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang YX, 2018, P NATL ACAD SCI USA, V115, pE6039, DOI 10.1073/pnas.1806366115	50	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15875	15887		10.1096/fj.202000109R	http://dx.doi.org/10.1096/fj.202000109R		OCT 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047392				2022-12-26	WOS:000581170500001
J	Gopal, A; Sharma, AJ; Subramanyam, MA				Gopal, Anvita; Sharma, Anupam Joya; Subramanyam, Malavika Ambale			Dynamics of psychological responses to COVID-19 in India: A longitudinal study	PLOS ONE			English	Article							SOCIAL-ISOLATION; ITEM MEASURE; SINGLE-ITEM; HEALTH; SCALE; RESILIENCE; ANXIETY; STRESS; WORK	The novel COVID-19 pandemic has created chaos around the globe. To curb its spread, the Government of India announced a nationwide lockdown on March 24th, 2020 for 21 days, which was extended further for a longer time. This long period of lockdown disrupted the routine of all citizens, affecting their psychological well-being. While recent studies showed the psychological burden of Indians during the pandemic, no study has assessed whether the psychological toll changed over time due to repeated extensions of the lockdown. We followed up 159 Indian adults during the first two months of the lockdown to assess any change in their anxiety, stress, and depressive symptoms. Multilevel linear regression models of repeated observations nested within individuals adjusted for sociodemographic covariates showed that anxiety (beta= 0.81, 95% CI: 0.03, 1.60), stress (beta= 0.51, CI: 0.32, 0.70), and depressive symptoms (beta= 0.37, CI: 0.13, 0.60) increased over time during the lockdown. This increase was higher among women than men independent of covariates. Individual resilience was negatively associated with adverse psychological outcomes. Our findings suggested that while the lockdown may help in effectively addressing this pandemic, the state and society at large need to be sensitive to the mental health impacts of a long-drawn-out lockdown. Such effects likely have long-term sequelae. The disproportionate impact on women needs immediate attention. Moreover, it behooves society to address the root causes driving the unequal distribution of psychological distress during such crises.	[Gopal, Anvita] Indian Inst Technol Gandhinagar, Cognit Sci, Gandhinagar, Gujarat, India; [Sharma, Anupam Joya; Subramanyam, Malavika Ambale] Indian Inst Technol Gandhinagar, Social Epidemiol, Gandhinagar, Gujarat, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Gandhinagar; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Gandhinagar	Gopal, A (corresponding author), Indian Inst Technol Gandhinagar, Cognit Sci, Gandhinagar, Gujarat, India.	anvita.gopal@iitgn.ac.in	Sharma, Anupam Joya/AAZ-6704-2020; Gopal, Anvita/AFT-3595-2022	Sharma, Anupam Joya/0000-0002-1726-9992; 				Chakraborty K, 2020, INDIAN J PSYCHIAT, V62, P266, DOI 10.4103/psychiatry.IndianJPsychiatry_276_20; Chandan JS, 2020, LANCET PUBLIC HEALTH, V5, pE309, DOI 10.1016/S2468-2667(20)30112-2; Daruvala R, 2019, INDIAN J MED PAEDIAT, V40, P111, DOI 10.4103/ijmpo.ijmpo_168_17; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Elo AL, 2003, SCAND J WORK ENV HEA, V29, P444, DOI 10.5271/sjweh.752; Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924; GEORGE LK, 1989, BRIT J PSYCHIAT, V154, P478, DOI 10.1192/bjp.154.4.478; Government of India, 2020, LAW PREV MIT HLTH RI, P1; Government of India, 2020, 4032020DMIA GOV IND, P1; Hoeppner BB, 2011, J SUBST ABUSE TREAT, V41, P305, DOI 10.1016/j.jsat.2011.04.005; Hui C. Ho Su, 2020, MENTAL HLTH STRATEGI; Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5; Kim Eui-Joong, 2007, Behav Sleep Med, V5, P256; Kowsalya R., 2017, MOJ PROTEOMICS BIOIN, V5; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Kumar Vijaya, 2018, Ind Psychiatry J, V27, P47, DOI 10.4103/ipj.ipj_72_17; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Lye MS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230363; Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1872; Mina S, 2015, INDIAN J DERMATOL, V60, DOI 10.4103/0019-5154.152564; Ministry of Health and G. of I. and Family Welfare, 2020, ADV MIND OUR MINDS C; Nigam S., 2020, COVID 19 INDIAS RESP; Ozamiz-Etxebarria N, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01491; Ozamiz-Etxebarria N, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00054020, 10.1590/0102-311x00054020]; Pieh C, 2020, THE J, DOI [10.2139/ssrn.3592372, DOI 10.2139/SSRN.3592372]; Polizzi C, 2020, CLIN NEUROPSYCHIATR, V17, P59, DOI 10.36131/CN20200204; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Rahul Krishna P., KNOWLEDGE BELIEFS GE; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Salminen S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-543; Seib C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-9; Sevilla-Sanz A, 2010, FEM ECON, V16, P137, DOI 10.1080/13545701.2010.531197; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; Sharma A. J., 2020, PSYCHOL IMPACT COVID; Sharma N, 2016, WORLD J PSYCHIATR, V6, P7, DOI 10.5498/wjp.v6.i1.7; Smith SG, 2018, HEALTH PSYCHOL, V37, P160, DOI 10.1037/hea0000541; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Srivastava A, 2020, POPUL DEV REV, V46, P249, DOI 10.1111/padr.12309; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tan WQ, 2020, BRAIN BEHAV IMMUN, V87, P84, DOI 10.1016/j.bbi.2020.04.055; Taub A, 2020, NEW YORK TIMES, V6; Vaishnavi S, 2007, PSYCHIAT RES, V152, P293, DOI 10.1016/j.psychres.2007.01.006; Varshney M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233874; Viglione G, 2020, NATURE, V581, P365, DOI 10.1038/d41586-020-01294-9; Waltz E., 1991, MEASUREMENT NURSING, V2nd; Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923921; Yang Y, 2020, LANCET PSYCHIAT, V7, pE19, DOI 10.1016/S2215-0366(20)30079-1; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	51	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240650	10.1371/journal.pone.0240650	http://dx.doi.org/10.1371/journal.pone.0240650			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	33048979	gold, Green Published, Green Submitted			2022-12-26	WOS:000581813300041
J	Segovia, J; Orellana, M; Sarmiento, JP; Carchi, D				Segovia, Joselin; Orellana, Mercy; Sarmiento, Juan Pablo; Carchi, Darwin			The effects of taxing sugar-sweetened beverages in Ecuador: An analysis across different income and consumption groups	PLOS ONE			English	Article							DEMAND SYSTEMS; CARDIOVASCULAR-DISEASE; SPATIAL VARIATION; PRICE ELASTICITY; ECONOMIC BURDEN; ENGEL CURVES; SOFT DRINKS; OBESITY; FOOD; QUANTITY	To analyze the effects of taxing sugar-sweetened beverages (SSBs) in Ecuador, this study estimates a Quadratic Almost Ideal Demand System model using data from the 2011-2012 National Survey of Income and Expenditure for Urban and Rural Households. We derive own- and cross-price elasticities by income quintiles and consumption deciles for five beverages, including two types of sugary drink: (i) milk, (ii) soft drinks, (iii) water, (iv) other sugary drinks, and (v) coffee and tea. Overall, results show that a 20% increase in the price of SSBs will decrease the consumption of soft drinks and other sugary drinks by 27% and 22%, respectively. Heterogeneous consumer behavior is revealed across income and consumption groups, as well as policy-relevant complementarity and substitution patterns. Policy impacts are simulated by considering an 18 cents per liter tax, implemented in Ecuador, and an ad-valorem 20% tax on the price. Estimated tax revenues and weight loss are larger for the latter. From a health perspective, high-income and heavy consumer households would benefit the most from this policy. Our study supports an evidence-based debate on how to correctly design and monitor food policy.	[Segovia, Joselin; Orellana, Mercy; Sarmiento, Juan Pablo] Univ Cuenca, Grp Invest Econ Reg GIER, Fac Ciencias Econ & Adm, Cuenca, Azuay, Ecuador; [Carchi, Darwin] Univ Cuenca, Fac Ciencias Econ & Adm, Cuenca, Azuay, Ecuador	Universidad de Cuenca; Universidad de Cuenca	Segovia, J (corresponding author), Univ Cuenca, Grp Invest Econ Reg GIER, Fac Ciencias Econ & Adm, Cuenca, Azuay, Ecuador.	joselin.segovias@ucuenca.edu.ec	Orellana, Mercy/ABG-1951-2021	Orellana, Mercy/0000-0002-7700-1947; Carchi M, Darwin/0000-0001-8858-8264; SEGOVIA, JOSELIN/0000-0002-3895-3814	Research Department of University of Cuenca (DIUC); Cuenca, Ecuador	Research Department of University of Cuenca (DIUC); Cuenca, Ecuador	Funding for this research was granted by the XVI call for research projects by the Research Department of University of Cuenca (DIUC), Cuenca, Ecuador. Funder website: https://www.ucuenca.edu.ec/investigacion.	Aepli M., 2014, AGR FOOD EC, V2, P15, DOI DOI 10.1186/s40100-014-0015-0; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; [Anonymous], 2017, REV PANAM SALUD PUBL, DOI DOI 10.26633/RPSP.2017.54; [Anonymous], 2013, ASAMBLEA MUNDIAL SAL; Colchero MA, 2017, HEALTH AFFAIR, V36, P564, DOI 10.1377/hlthaff.2016.1231; Banks J, 1997, REV ECON STAT, V79, P527, DOI 10.1162/003465397557015; Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163; Berardi N, 2016, APPL ECON, V48, P3976, DOI 10.1080/00036846.2016.1150946; Bonnet C, 2011, HEALTH ECON, V20, P1012, DOI 10.1002/hec.1721; Boysen O, 2016, S AFR J ECON, V84, P260, DOI 10.1111/saje.12093; BRIGGS ADM, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6189; Bronnmann J, 2019, EMPIR ECON, V57, P1469, DOI 10.1007/s00181-018-1491-y; Capacci S, 2011, J HEALTH ECON, V30, P87, DOI 10.1016/j.jhealeco.2010.10.006; Caro JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189026; Caro JC, 2017, FOOD POLICY, V71, P86, DOI 10.1016/j.foodpol.2017.08.001; Cawley J, 2015, INCIDENCE TAXES SUGA, DOI [10.3386/w21465, DOI 10.3386/W21465]; Censos IN de E y, ENC NAC INGR GAST HO; Colchero MA, 2015, ECON HUM BIOL, V19, P129, DOI 10.1016/j.ehb.2015.08.007; Crawford I, 2003, J ECONOMETRICS, V114, P221, DOI 10.1016/S0304-4076(03)00083-6; DEATON A, 1980, AM ECON REV, V70, P312; DEATON A, 1988, AM ECON REV, V78, P418; Deaton A., 1997, ANAL HOUSEHOLD SURVE, DOI [10.1596/0-8018-5254-4, DOI 10.1596/0-8018-5254-4]; Dharmasena S, 2012, HEALTH ECON, V21, P669, DOI 10.1002/hec.1738; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; Finkelstein EA, 2013, J HEALTH ECON, V32, P219, DOI 10.1016/j.jhealeco.2012.10.005; Freire WB, 2013, RESUMEN EJECUTIVO TO; Galvez P, 2016, ESTUD ECONOMIA, V43, P5, DOI 10.4067/S0718-52862016000100001; Gibson J, 2019, J DEV ECON, V137, P66, DOI 10.1016/j.jdeveco.2018.11.008; Goryakin Y, 2017, FOOD POLICY, V73, P88, DOI 10.1016/j.foodpol.2017.09.002; Grogger J, 2017, AM J AGR ECON, V99, P481, DOI 10.1093/ajae/aax024; HEIEN D, 1990, J BUS ECON STAT, V8, P365, DOI 10.2307/1391973; Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040; LAFRANCE JT, 1990, AUST J AGR ECON, V34, P118, DOI 10.1111/j.1467-8489.1990.tb00697.x; Majumder A, 2012, AM J AGR ECON, V94, P1218, DOI 10.1093/ajae/aas064; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Ministerio de Economia y Finanzas, 2017, JUST PROF PRES GEN E; Nakhimovsky SS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0163358, 10.1371/jour]; Narain A, 2016, INT J CLIN PRACT, V70, P791, DOI 10.1111/ijcp.12841; OPS/OMS, 2013, IMP REF BEB AZ COM M; Paraje G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152260; Popkin BM, 2018, OBES REV, V19, P1028, DOI 10.1111/obr.12694; Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2; Servicio de Rentas Internas del Ecuador, CESTADISTICAS GEN RE; Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070; Shonkwiler JS, 1999, AM J AGR ECON, V81, P972, DOI 10.2307/1244339; Smith T.A., 2010, TAXING CALORIC SWEET; Suarez-Varela M, 2020, J ENVIRON MANAGE, V261, DOI 10.1016/j.jenvman.2019.109921; Teng AM, 2019, OBES REV, V20, P1187, DOI 10.1111/obr.12868; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; Tremmel M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040435; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization, 2016, FISC POL DIET PREV N; Zhen C, 2014, AM J AGR ECON, V96, P1, DOI 10.1093/ajae/aat049	55	4	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240546	10.1371/journal.pone.0240546	http://dx.doi.org/10.1371/journal.pone.0240546			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	33048990	Green Published, gold			2022-12-26	WOS:000581813300052
J	Ishishita, S; Tatsumoto, S; Kinoshita, K; Nunome, M; Suzuki, T; Go, Y; Matsuda, Y				Ishishita, Satoshi; Tatsumoto, Shoji; Kinoshita, Keiji; Nunome, Mitsuo; Suzuki, Takayuki; Go, Yasuhiro; Matsuda, Yoichi			Transcriptome analysis revealed misregulated gene expression in blastoderms of interspecific chicken and Japanese quail F-1 hybrids	PLOS ONE			English	Article							PRIMITIVE STREAK FORMATION; UNIPARENTAL CHROMOSOME ELIMINATION; CELL HYBRIDS; POSTZYGOTIC ISOLATION; SEX-CHROMOSOMES; PATTERNS; SEQUENCE; INDUCTION; SEGREGATION; SPECIATION	Hybrid incompatibility, such as sterility and inviability, prevents gene flow between closely-related populations as a reproductive isolation barrier. F(1)hybrids between chickens and Japanese quail (hereafter, referred to as quail), exhibit a high frequency of developmental arrest at the preprimitive streak stage. To investigate the molecular basis of the developmental arrest at the preprimitive streak stage in chicken-quail F(1)hybrid embryos, we investigated chromosomal abnormalities in the hybrid embryos using molecular cytogenetic analysis. In addition, we quantified gene expression in parental species and chicken- and quail-derived allele-specific expression in the hybrids at the early blastoderm and preprimitive streak stages by mRNA sequencing. Subsequently, we compared the directions of change in gene expression, including upregulation, downregulation, or no change, from the early blastoderm stage to the preprimitive streak stage between parental species and their hybrids. Chromosome analysis revealed that the cells of the hybrid embryos contained a fifty-fifty mixture of parental chromosomes, and numerical chromosomal abnormalities were hardly observed in the hybrid cells. Gene expression analysis revealed that a part of the genes that were upregulated from the early blastoderm stage to the preprimitive streak stage in both parental species exhibited no upregulation of both chicken- and quail-derived alleles in the hybrids. GO term enrichment analysis revealed that these misregulated genes are involved in various biological processes, including ribosome-mediated protein synthesis and cell proliferation. Furthermore, the misregulated genes included genes involved in early embryonic development, such as primitive streak formation and gastrulation. These results suggest that numerical chromosomal abnormalities due to a segregation failure does not cause the lethality of chicken-quail hybrid embryos, and that the downregulated expression of the genes that are involved in various biological processes, including translation and primitive streak formation, mainly causes the developmental arrest at the preprimitive streak stage in the hybrids.	[Ishishita, Satoshi; Kinoshita, Keiji; Nunome, Mitsuo; Suzuki, Takayuki; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan; [Tatsumoto, Shoji; Go, Yasuhiro] Natl Inst Nat Sci, Cognit Genom Res Grp, Exploratory Res Ctr Life & Living Syst ExCELLs, Okazaki, Aichi, Japan; [Suzuki, Takayuki; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Anim Sci, Lab Avian Biosci,Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan	Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS); Nagoya University	Matsuda, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan.; Matsuda, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Anim Sci, Lab Avian Biosci,Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan.	yoimatsu@agr.nagoya-u.ac.jp	Go, Yasuhiro/AAD-3313-2020; Kinoshita, Keiji/GVS-4163-2022	Go, Yasuhiro/0000-0003-4581-0325; 	MEXT, Japan [23113004, 221S0002]; Avian Bioscience Research Center, Graduate School of Bioagricultural Sciences, Nagoya University through the National Bio-Resource Project (NBRP) `Chicken/Quail'; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED), Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Avian Bioscience Research Center, Graduate School of Bioagricultural Sciences, Nagoya University through the National Bio-Resource Project (NBRP) `Chicken/Quail'; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED), Japan(Japan Agency for Medical Research and Development (AMED))	This work was supported by a Grant-aid for Scientific Research from MEXT, Japan (No. 23113004 for Innovative Areas "Correlative gene system" and No. 221S0002 for Innovative Areas "Genome Science") to YM. URL: https://www.mext.go.jp/en/index.htm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kiyomi Imamura, Terumi Horiuchi, Sumio Sugano, and Yutaka Suzuki (the University of Tokyo) for supporting RNA sequencing analysis. Chicken fertilized eggs were provided by the Avian Bioscience Research Center, Graduate School of Bioagricultural Sciences, Nagoya University through the National Bio-Resource Project (NBRP) `Chicken/Quail' supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and Japan Agency for Medical Research and Development (AMED), Japan.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ASMUNDSON VS, 1957, POULTRY SCI, V36, P1323, DOI 10.3382/ps.0361323; BAMMI RK, 1966, CAN J GENET CYTOL, V8, P533, DOI 10.1139/g66-064; BENNETT MD, 1976, CHROMOSOMA, V54, P175, DOI 10.1007/BF00292839; Bertocchini F, 2004, DEVELOPMENT, V131, P3381, DOI 10.1242/dev.01178; Bhattacharyya T, 2013, P NATL ACAD SCI USA, V110, pE468, DOI 10.1073/pnas.1219126110; BLOOM SE, 1975, CHROMOSOMA, V51, P261; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; Brekke TD, 2016, EVOLUTION, V70, P2690, DOI 10.1111/evo.13085; Bressan M, 2015, METHODS MOL BIOL, V1214, P225, DOI 10.1007/978-1-4939-1462-3_14; Campbell P, 2013, GENETICS, V193, P819, DOI 10.1534/genetics.112.148635; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Coyne J.A., 2004, SPECIATION; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; Dobzhansky T, 1936, GENETICS, V21, P113; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; FINCH RA, 1983, CHROMOSOMA, V88, P386, DOI 10.1007/BF00285861; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; Fresard L, 2014, NUCLEIC ACIDS RES, V42, P3768, DOI 10.1093/nar/gkt1390; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Fujiwara A, 1997, CHROMOSOMA, V106, P44, DOI 10.1007/s004120050223; Gernand D, 2005, PLANT CELL, V17, P2431, DOI 10.1105/tpc.105.034249; Gibeaux R, 2018, NATURE, V553, P337, DOI 10.1038/nature25188; Good JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001148; GRAVES JAM, 1992, GENOME, V35, P537, DOI 10.1139/g92-079; Gregorova S, 2000, FOLIA BIOL-PRAGUE, V46, P31; Griffin DK, 1999, CYTOGENET CELL GENET, V87, P278, DOI 10.1159/000015449; Griffin JN, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.166181; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hardy KM, 2008, DEV BIOL, V320, P391, DOI 10.1016/j.ydbio.2008.05.546; Huxley J, 1940, NEW SYSTEMATICS, P185; Ishishita S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26369; IZPISUABELMONTE JC, 1993, CELL, V74, P645, DOI 10.1016/0092-8674(93)90512-O; Johnson NA, 2012, ANN NY ACAD SCI, V1256, pE1, DOI 10.1111/j.1749-6632.2012.06748.x; Johnson NA, 2010, TRENDS GENET, V26, P317, DOI 10.1016/j.tig.2010.04.005; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; KISPERT A, 1995, DEV BIOL, V168, P406, DOI 10.1006/dbio.1995.1090; Knezevic V, 1997, DEVELOPMENT, V124, P411; Kogo H, 2012, GENES CELLS, V17, P897, DOI 10.1111/gtc.12005; Laurie CC, 1997, GENETICS, V147, P937; Levin M, 2007, PROG BIOPHYS MOL BIO, V94, P186, DOI 10.1016/j.pbiomolbio.2007.03.005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MATSUDA Y, 1995, ELECTROPHORESIS, V16, P261, DOI 10.1002/elps.1150160142; Matsui S, 2003, CANCER GENET CYTOGEN, V142, P30, DOI 10.1016/S0165-4608(02)00730-6; MATZKE MA, 1990, CHROMOSOMA, V99, P131, DOI 10.1007/BF01735329; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Michalak P, 2003, MOL BIOL EVOL, V20, P1070, DOI 10.1093/molbev/msg119; Mikawa T, 2004, DEV DYNAM, V229, P422, DOI 10.1002/dvdy.10458; Mitsumoto K., 1958, JPN J ZOOTECH SCI, V29, P10; Muller HJ, 1942, BIOL S, V6, P71; Nishida-Umehara C, 2007, CHROMOSOME RES, V15, P721, DOI 10.1007/s10577-007-1157-7; Oka A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004301; OKAMOTO S, 1991, Animal Science and Technology, V62, P742; OLSEN MARLOW W., 1960, JOUR HEREDITY, V51, P69; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Price TD, 2002, EVOLUTION, V56, P2083; Rainkumar N, 2016, NAT CELL BIOL, V18, P1281, DOI 10.1038/ncb3442; REED KM, 1995, MOL REPROD DEV, V40, P408, DOI 10.1002/mrd.1080400404; Sakai C, 2007, CHROMOSOME RES, V15, P697, DOI 10.1007/s10577-007-1155-9; SANDNES GC, 1957, EVOLUTION, V11, P426, DOI 10.2307/2406063; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Schartl M, 1999, GENETICS, V153, P1385; Schilthuizen M, 2011, HEREDITY, V107, P95, DOI 10.1038/hdy.2010.170; Sheng GJ, 2014, DEV DYNAM, V243, P357, DOI 10.1002/dvdy.24087; Shibusawa M, 2001, CYTOGENET CELL GENET, V95, P103, DOI 10.1159/000057026; Skromne I, 2001, DEVELOPMENT, V128, P2915; STEIN S, 1995, MECH DEVELOP, V49, P37, DOI 10.1016/0925-4773(94)00300-C; Streit A, 1998, DEVELOPMENT, V125, P507; Suzuki T, 1999, CYTOGENET CELL GENET, V87, P32, DOI 10.1159/000015388; Sweetman D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-63; Tanabe Yuichi, 2000, Japanese Poultry Science, V37, P101; Tanaka K, 2000, J HERED, V91, P412, DOI 10.1093/jhered/91.5.412; Torlopp A, 2014, ELIFE, V3, DOI 10.7554/eLife.03743; Turner LM, 2014, ELIFE, V3, DOI 10.7554/eLife.02504; Valdez MB, 2009, EXP ANIM TOKYO, V58, P169, DOI 10.1538/expanim.58.169; van Tuinen M, 2004, MOL PHYLOGENET EVOL, V30, P74, DOI 10.1016/S1055-7903(03)00164-7; Voiculescu O, 2014, ELIFE, V3, DOI 10.7554/eLife.01817; WEISS MC, 1967, P NATL ACAD SCI USA, V58, P1104, DOI 10.1073/pnas.58.3.1104; WILCOX FH, 1961, J HERED, V52, P167, DOI 10.1093/oxfordjournals.jhered.a107057; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; Yamada K, 2006, CHROMOSOME RES, V14, P613, DOI 10.1007/s10577-006-1071-4; Yokomine T, 2005, GENOME RES, V15, P154, DOI 10.1101/gr.2609605; Yokomine T, 2001, CYTOGENET CELL GENET, V93, P109, DOI 10.1159/000056960; ZELESCO PA, 1987, GENOME, V29, P528, DOI 10.1139/g87-090; ZELESCO PA, 1988, J CELL SCI, V89, P49; Zidane N, 2013, BIOSCIENCE REP, V33, P113, DOI 10.1042/BSR20120103; Zinski J, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033274	100	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240183	10.1371/journal.pone.0240183	http://dx.doi.org/10.1371/journal.pone.0240183			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044996	gold, Green Published			2022-12-26	WOS:000581811700051
J	Le Meur, O; Le Pen, T; Cozot, R				Le Meur, Olivier; Le Pen, Tugdual; Cozot, Remi			Can we accurately predict where we look at paintings?	PLOS ONE			English	Article							VISUAL-ATTENTION; EYE-MOVEMENTS; SCENE; MODEL; SALIENCE	The objective of this study is to investigate and to simulate the gaze deployment of observers on paintings. For that purpose, we built a large eye tracking dataset composed of 150 paintings belonging to 5 art movements. We observed that the gaze deployment over the proposed paintings was very similar to the gaze deployment over natural scenes. Therefore, we evaluate existing saliency models and propose a new one which significantly outperforms the most recent deep-based saliency models. Thanks to this new saliency model, we can predict very accurately what are the salient areas of a painting. This opens new avenues for many image-based applications such as animation of paintings or transformation of a still painting into a video clip.	[Le Meur, Olivier; Le Pen, Tugdual] Univ Rennes, CNRS, IRISA, Rennes, France; [Cozot, Remi] Univ Cote Opale, Calais, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Le Meur, O (corresponding author), Univ Rennes, CNRS, IRISA, Rennes, France.	olemeur@irisa.fr		Le Meur, Olivier/0000-0001-9883-0296				Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2016, ABS161001563 CORR; Bannister K, 2018, P 5 WORKSH EMB NETW, P1; Bindemann M, 2010, VISION RES, V50, P2577, DOI 10.1016/j.visres.2010.08.016; Borji A, 2015, ARXIV150503581; Bruce N., 2010, J VISION, V7, P950, DOI [10.1167/7.9.950, DOI 10.1167/7.9.950]; Bruckert A, 2019, ARXIV190702336; Bylinskii Z, 2015, MIT SALIENCY BENCHMA; BYLINSKII Z, 2018, IEEE T PATTERN ANAL, V41, P3, DOI DOI 10.1109/TPAMI.2018.2815601; Callen Anthea, 2015, WORK ART PLEIN AIR P; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Cornia M., 2016, INT C PATT REC ICPR; Cornia M, 2018, IEEE T IMAGE PROCESS, V27, P5142, DOI 10.1109/TIP.2018.2851672; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fuchs I, 2011, COGN COMPUT, V3, P25, DOI 10.1007/s12559-010-9062-3; Garcia-Diaz A, 2012, J VISION, V12, DOI 10.1167/12.6.17; Gu YJ, 2019, 3RD INTERNATIONAL CONFERENCE ON INNOVATION IN ARTIFICIAL INTELLIGENCE (ICIAI 2019), P157, DOI 10.1145/3319921.3319932; Helo A, 2014, VISION RES, V103, P83, DOI 10.1016/j.visres.2014.08.006; Ho-Phuoc T, 2010, COGN COMPUT, V2, P344, DOI 10.1007/s12559-010-9078-8; Huang X, 2015, IEEE I CONF COMP VIS, P262, DOI 10.1109/ICCV.2015.38; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jiang M, 2015, PROC CVPR IEEE, P1072, DOI 10.1109/CVPR.2015.7298710; Judd T., 2012, MIT CSAIL TR; Judd T, 2009, IEEE I CONF COMP VIS, P2106, DOI 10.1109/ICCV.2009.5459462; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Koide N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117696; Kummerer M, LECT NOTES COMPUTER, P798; Le Meur O, 2017, IEEE T IMAGE PROCESS, V26, P4777, DOI 10.1109/TIP.2017.2722238; Le Meur O, 2016, VISION RES, V121, P72, DOI 10.1016/j.visres.2016.01.005; Le Meur O, 2015, VISION RES, V116, P152, DOI 10.1016/j.visres.2014.12.026; Le Meur O, 2013, BEHAV RES METHODS, V45, P251, DOI 10.3758/s13428-012-0226-9; Le Meur Olivier, 2011, P 19 ACM INT C MULT, P373, DOI DOI 10.1145/2072298.2072347; Li CL, 2019, 2019 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS (ISI), P206, DOI 10.1109/ISI.2019.8823324; Massaro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037285; Nothdurft HC, 2000, VISION RES, V40, P1183, DOI 10.1016/S0042-6989(00)00031-6; Nystrom M, 2008, J EYE MOVEMENT RES, V2; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Perrin AF, 2019, LECT NOTES COMPUT SC, V11678, P311, DOI 10.1007/978-3-030-29888-3_25; Reichert C, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00575; Riche N, 2012, IEEE IMAGE PROC, P641, DOI 10.1109/ICIP.2012.6466941; Tatler B.W., 2008, J EYE MOVEMENT RES, P1; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Walker F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178912; Wooding D. S., 2002, Proceedings ETRA 2002. Eye Tracking Research and Applications Symposium, P31, DOI 10.1145/507072.507078; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Zhang AT, 2018, IEEE IMAGE PROC, P2660, DOI 10.1109/ICIP.2018.8451219	51	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239980	10.1371/journal.pone.0239980	http://dx.doi.org/10.1371/journal.pone.0239980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035250	gold, Green Published			2022-12-26	WOS:000581817500036
J	Shen, H; Wang, GC; Li, X; Ge, X; Wang, M; Shi, ZM; Bhardwaj, V; Wang, ZX; Zinner, RG; Peiper, SC; Aplin, AE; Jiang, BH; He, J				Shen, Hua; Wang, Gao-Chan; Li, Xiang; Ge, Xin; Wang, Meng; Shi, Zhu-Mei; Bhardwaj, Vikas; Wang, Zi-Xuan; Zinner, Ralph G.; Peiper, Stephen C.; Aplin, Andrew E.; Jiang, Bing-Hua; He, Jun			S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer	ONCOGENE			English	Article							TYROSINE KINASE INHIBITORS; DRUG-RESISTANCE; P70S6K1 ACTIVATION; MAMMALIAN TARGET; BREAST-CANCER; GROWTH; MDM2; EXPRESSION; GEFITINIB; PROMOTES	The development of resistance to EGFR Tyrosine kinase inhibitors (TKIs) in NSCLC with activating EGFR mutations is a critical limitation of this therapy. In addition to genetic alterations such as EGFR secondary mutation causing EGFR-TKI resistance, compensatory activation of signaling pathways without interruption of genome integrity remains to be defined. In this study, we identified S6K1/MDM2 signaling axis as a novel bypass mechanism for the development of EGFR-TKI resistance. The observation of S6K1 as a candidate mechanism for resistance to EGFR TKI therapy was investigated by interrogation of public databases and a clinical cohort to establish S6K1 expression as a prognostic/predictive biomarker. The role of S6K1 in TKI resistance was determined in in vitro gain-and-loss of function studies and confirmed in subcutaneous and orthotopic mouse lung cancer models. Blockade of S6K1 by a specific inhibitor PF-4708671 synergistically enhanced the efficacy of TKI without showing toxicity. The mechanistic study showed the inhibition of EGFR caused nuclear translocation of S6K1 for binding with MDM2 in resistant cells. MDM2 is a downstream effector of S6K1-mediated TKI resistance. Taken together, we present evidence for the reversal of resistance to EGFR TKI by the addition of small molecule S6K1/MDM2 antagonists that could have clinical benefit.	[Shen, Hua] Nanjing Med Univ, Sir Run Run Hosp, Dept Oncol, Nanjing, Peoples R China; [Shen, Hua] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing, Peoples R China; [Wang, Gao-Chan; Li, Xiang; Wang, Meng; Wang, Zi-Xuan; Peiper, Stephen C.; He, Jun] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Li, Xiang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Thorac Surg, Xian, Peoples R China; [Ge, Xin; Shi, Zhu-Mei] Nanjing Med Univ, State Key Lab Reprod Med, Dept Pathol, Nanjing, Peoples R China; [Bhardwaj, Vikas] Thomas Jefferson Univ, Coll Pharm, Philadelphia, PA 19107 USA; [Zinner, Ralph G.] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA; [Aplin, Andrew E.] Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Jiang, Bing-Hua] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA USA	Nanjing Medical University; Nanjing Medical University; Jefferson University; Xi'an Jiaotong University; Nanjing Medical University; Jefferson University; Jefferson University; Jefferson University; University of Iowa	He, J (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	Jun.he@jefferson.edu		He, Jun/0000-0002-5162-6041; Bhardwaj, Vikas/0000-0003-3364-8711	National Cancer Institute [R00 CA 215316, R01 CA232587, R01 CA160495]; Natural Science Foundation of China [81874230]; Jiangsu Social Development Project (China) [BE2018726]; Natural Science Foundation of Jiangsu Province [BK20171484]; Project of Invigorating Health Care through Science, Technology, and Education (Jiangsu Provincial Medical Youth Talent) [QNRC2016856]; Summit of the Six Top Talents Program of Jiangsu Province [2017WSN-179]; NCI of the NIH [P30CA056036]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Social Development Project (China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Project of Invigorating Health Care through Science, Technology, and Education (Jiangsu Provincial Medical Youth Talent); Summit of the Six Top Talents Program of Jiangsu Province; NCI of the NIH	This work was supported by National Cancer Institute (R00 CA 215316, R01 CA232587, R01 CA160495), Natural Science Foundation of China (No. 81874230), Jiangsu Social Development Project (China, BE2018726), the Natural Science Foundation of Jiangsu Province (Grants No. BK20171484), the Project of Invigorating Health Care through Science, Technology, and Education (Jiangsu Provincial Medical Youth Talent QNRC2016856), the Summit of the Six Top Talents Program of Jiangsu Province (2017WSN-179). Research reported in this publication utilized the Flow Cytometry Facility at Sidney Kimmel Cancer Center at Jefferson Health, which was supported by the NCI of the NIH (P30CA056036).	Ashton JC, 2015, CANCER RES, V75, P2400, DOI 10.1158/0008-5472.CAN-14-3763; Bilanges Benoit, 2010, Biochem J, V431, pe1, DOI 10.1042/BJ20101445; Bostner J, 2015, ENDOCR-RELAT CANCER, V22, P331, DOI 10.1530/ERC-14-0513; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; de Bruin EC, 2014, CANCER DISCOV, V4, P606, DOI 10.1158/2159-8290.CD-13-0741; Desbois-Mouthon C, 2006, INT J CANCER, V119, P2557, DOI 10.1002/ijc.22221; Donev IS, 2011, CLIN CANCER RES, V17, P2260, DOI 10.1158/1078-0432.CCR-10-1993; Eischen CM, 2017, J MOL CELL BIOL, V9, P69, DOI 10.1093/jmcb/mjw052; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fang J, 2006, J CELL PHYSIOL, V209, P261, DOI 10.1002/jcp.20749; Feeley KP, 2017, CANCER RES, V77, P3823, DOI 10.1158/0008-5472.CAN-17-0809; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Fujita Y, 2012, J THORAC ONCOL, V7, P1640, DOI 10.1097/JTO.0b013e3182653d7f; Grasso S, 2014, NEOPLASIA, V16, P845, DOI 10.1016/j.neo.2014.08.011; Gray JE, 2019, CLIN CANCER RES, V25, P6644, DOI 10.1158/1078-0432.CCR-19-1126; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hollebecque A, 2014, EUR J CANCER, V50, P876, DOI 10.1016/j.ejca.2013.12.006; Ip CKM, 2014, ONCOTARGET, V5, P9133; Jacobsen K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00450-6; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Jiang XH, 2009, BIOCHEM BIOPH RES CO, V387, P521, DOI 10.1016/j.bbrc.2009.07.060; Ju LX, 2010, J CELL BIOCHEM, V111, P1565, DOI 10.1002/jcb.22888; Juchum M, 2015, DRUG RESIST UPDATE, V20, P12, DOI 10.1016/j.drup.2015.05.002; Khotskaya YB, 2014, AM J TRANSL RES, V6, P361; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; Lai KP, 2010, EMBO J, V29, P2994, DOI 10.1038/emboj.2010.166; Leonetti A, 2019, BRIT J CANCER, V121, P725, DOI 10.1038/s41416-019-0573-8; Lu QJ, 2015, ONCOL LETT, V10, P277, DOI 10.3892/ol.2015.3228; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Oxnard GR, 2011, CLIN CANCER RES, V17, P5530, DOI 10.1158/1078-0432.CCR-10-2571; Park HS, 2014, INT J CLIN ONCOL, V19, P842, DOI 10.1007/s10147-013-0639-1; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Phuchareon J, 2015, P NATL ACAD SCI USA, V112, pE3855, DOI 10.1073/pnas.1510733112; Qi HW, 2011, EXP THER MED, V2, P1091, DOI 10.3892/etm.2011.324; Qiu ZX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147185; Rolfo C, 2014, CANCER TREAT REV, V40, P990, DOI 10.1016/j.ctrv.2014.05.009; Romaniello D, 2018, CLIN CANCER RES, V24, P5610, DOI 10.1158/1078-0432.CCR-18-0450; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Tavares MR, 2015, LIFE SCI, V131, P1, DOI 10.1016/j.lfs.2015.03.001; Tolcher A, 2014, EUR J CANCER, V50, P867, DOI 10.1016/j.ejca.2013.11.039; Valovka T, 2003, MOL CELL BIOL, V23, P852, DOI 10.1128/MCB.23.3.852-863.2003; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6086; Wang Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0922-0; Wao H, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-10; Wykosky J, 2015, CANCER RES, V75, P394, DOI 10.1158/0008-5472.CAN-14-2004; Yu HA, 2018, CLIN CANCER RES, V24, P3108, DOI 10.1158/1078-0432.CCR-17-2961; Zhang CH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-184; Zhang Y, 2015, MOL CANCER THER, V14, P799, DOI 10.1158/1535-7163.MCT-14-0648; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	55	4	4	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2020	39	49					7181	7195		10.1038/s41388-020-01497-4	http://dx.doi.org/10.1038/s41388-020-01497-4		OCT 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PB0GA	33037411	Green Accepted			2022-12-26	WOS:000578440800004
J	Thompson, HM; Faig, W; VanKim, NA; Sharma, B; Afshar, M; Karnik, NS				Thompson, Hale M.; Faig, Walter; VanKim, Nicole A.; Sharma, Brihat; Afshar, Majid; Karnik, Niranjan S.			Differences in length of stay and discharge destination among patients with substance use disorders: The effect of Substance Use Intervention Team (SUIT) consultation service	PLOS ONE			English	Article							ADDICTION CONSULTATION; HOSPITALIZED-PATIENTS; CARE; BUPRENORPHINE; PERSPECTIVES; IMPACT; COSTS	Background Addiction medicine consultation services (ACS) may improve outcomes of hospitalized patients with substance use disorders (SUD). Our aim was to examine the difference in length of stay and the hazard ratio for a routine hospital discharge between SUD patients receiving and not receiving ACS. Methods Structured EHR data from 2018 of 1,900 adult patients with a SUD-related diagnostic code at an urban academic health center were examined among 35,541 total encounters. Cox proportional hazards regression models were fit using a cause-specific approach to examine differences in hospital outcome (i.e., routine discharge, leaving against medical advice, in-hospital death, or transfer to another level of care). Models were adjusted for age, sex, race, ethnicity, insurance status, and comorbidities. Results Length of stay was shorter among encounters with a SUD that received a SUIT consultation versus those admissions that did not receive one (5.77 v. 6.54 days, p<0.01). In adjusted analyses, admissions that received a SUIT consultation had a higher hazard of a routine discharge [hazard ratio (95% confidence interval): 1.16 (1.03-1.30)] compared to those not receiving a SUIT consultation. Conclusions The SUIT consultation service was associated with a reduced length of stay and an increased hazard of a routine discharge. The SUIT model may serve as a benchmark and inform other health systems attempting to improve outcomes in SUD patient cohorts.	[Thompson, Hale M.; Faig, Walter; Sharma, Brihat; Karnik, Niranjan S.] Rush Univ, Med Ctr, Dept Psychiat & Behav Sci, Sect Community Behav Hlth, Chicago, IL 60612 USA; [VanKim, Nicole A.] Univ Massachusetts Amherst, Dept Biostat & Epidemiol, Sch Publ Hlth & Hlth Sci, Amherst, MA USA; [Afshar, Majid] Loyola Univ, Div Pulm & Crit Care, Dept Publ Hlth Sci, Ctr Hlth Outcomes & Informat Res, Maywood, IL 60153 USA	Rush University; University of Massachusetts System; University of Massachusetts Amherst; Loyola University Chicago	Thompson, HM (corresponding author), Rush Univ, Med Ctr, Dept Psychiat & Behav Sci, Sect Community Behav Hlth, Chicago, IL 60612 USA.	Hale_Thompson@rush.edu	Karnik, Niranjan/N-4103-2019	Karnik, Niranjan/0000-0001-7650-3008; VanKim, Nicole/0000-0001-6711-9127; Thompson, Hale/0000-0002-9704-934X	ACCELERAT (A Chicago Center of Excellence in Learning Health Systems Research Training) from the Agency for Healthcare Research and Quality [K12-HS026385]; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [K23-AA024503]; National Center for Advancing Translational Sciences [UL1-TR002398, KL2-TR002387]; National Institute on Drug Abuse [R01-DA041071, UG1-DA049467]; Endowment Fund at Rush University Medical Center; Illinois Department of Human Services, Division of Substance Use Prevention and Recovery, as part of the Illinois Opioid-State Targeted Response grant from the U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis [TI-080231]	ACCELERAT (A Chicago Center of Excellence in Learning Health Systems Research Training) from the Agency for Healthcare Research and Quality; National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Endowment Fund at Rush University Medical Center; Illinois Department of Human Services, Division of Substance Use Prevention and Recovery, as part of the Illinois Opioid-State Targeted Response grant from the U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis	HT is supported by ACCELERAT (A Chicago Center of Excellence in Learning Health Systems Research Training) under grant number K12-HS026385 from the Agency for Healthcare Research and Quality. MA is supported by K23-AA024503 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA). NK is supported by the National Center for Advancing Translational Sciences (UL1-TR002398, KL2-TR002387), the National Institute on Drug Abuse (R01-DA041071, UG1-DA049467), and the Cynthia Oudejans Harris, MD, Endowment Fund at Rush University Medical Center. The SUIT services were supported in-part by a contract to Rush University Medical Center from the Illinois Department of Human Services, Division of Substance Use Prevention and Recovery, as part of the Illinois Opioid-State Targeted Response grant from the U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (TI-080231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AJ, 2017, AM J PUBLIC HEALTH, V107, P31, DOI 10.2105/AJPH.2016.303558; Afshar M, 2019, J AM MED INFORM ASSN, V26, P254, DOI 10.1093/jamia/ocy166; Alcala H. E., INSURANCE TYPES USUA, DOI [10.3122/jabfm.2020.04.190419, DOI 10.3122/JABFM.2020.04.190419]; Allison PD, 2018, CAUSAL ANAL COMPETIN; Andrews C, 2015, HEALTH AFFAIR, V34, P828, DOI 10.1377/hlthaff.2014.1330; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; [Anonymous], 2017, JAP CLASS ES CANC, V14, P1, DOI [DOI 10.1007/s10388-016-0551-7, DOI 10.1093/GERONT/GNY014]; [Anonymous], 2013, CAN J DIABETES S3, V37, pS357; Austin PC, 2017, STAT MED, V36, P4391, DOI 10.1002/sim.7501; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Blanchard J., 2019, SUBST USE MISUSE, V6084, P1; Buum HT, 2021, J INTERPROF CARE, V35, P641, DOI 10.1080/13561820.2019.1640190; Centers for Disease Control and Prevention, 2016, EXC ALC US, P3; Chicago Department of Public Health, 2017, EP BRIEF CHAR OP US, VIL, P2017; Ciccarone D, 2019, INT J DRUG POLICY, V71, P183, DOI 10.1016/j.drugpo.2019.01.010; Collins D, 2019, J GEN INTERN MED, DOI 10.1007/s11606-019-05311-0; Durante F, 2017, CURR OPIN PSYCHOL, V18, P43, DOI 10.1016/j.copsyc.2017.07.033; Englander H, 2019, J GEN INTERN MED, V34, P2796, DOI 10.1007/s11606-019-05251-9; Englander H, 2017, J HOSP MED, V12, P339, DOI 10.12788/jhm.2736; Fanucchi L, 2016, NEW ENGL J MED, V375, P811, DOI 10.1056/NEJMp1606157; FOX K, 1995, AM J PUBLIC HEALTH, V85, P48, DOI 10.2105/AJPH.85.1.48; Gryczynski J, 2013, AM J ADDICTION, V22, P285, DOI 10.1111/j.1521-0391.2012.12004.x; Hawk M, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0196-4; Hsu DJ, 2017, ADDICTION, V112, P1558, DOI 10.1111/add.13795; Hyshka E, 2019, DRUG ALCOHOL DEPEN, V204, DOI 10.1016/j.drugalcdep.2019.06.025; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Liebschutz JM, 2014, JAMA INTERN MED, V174, P1369, DOI 10.1001/jamainternmed.2014.2556; Mallow PJ, 2018, J PAIN RES, V11, P3079, DOI 10.2147/JPR.S184724; McNeil R, 2016, ADDICTION, V111, P685, DOI 10.1111/add.13214; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Norcross JC, 2011, J CLIN PSYCHOL, V67, P143, DOI 10.1002/jclp.20758; Priest KC, 2019, J ADDICT MED, V13, P104, DOI 10.1097/ADM.0000000000000496; Ronan MV, 2016, HEALTH AFFAIR, V35, P832, DOI 10.1377/hlthaff.2015.1424; Sledge WH, 2015, PSYCHOTHER PSYCHOSOM, V84, P208, DOI 10.1159/000379757; Trowbridge P, 2017, J SUBST ABUSE TREAT, V79, P1, DOI 10.1016/j.jsat.2017.05.007; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740; Wakeman SE, 2017, J GEN INTERN MED, V32, P909, DOI 10.1007/s11606-017-4077-z; Walley AY, 2012, J ADDICT MED, V6, P50, DOI 10.1097/ADM.0b013e318231de51; Wei J, 2015, J GEN INTERN MED, V30, P365, DOI 10.1007/s11606-014-2968-9	41	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239761	10.1371/journal.pone.0239761	http://dx.doi.org/10.1371/journal.pone.0239761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3WA	33035229	Green Published, gold			2022-12-26	WOS:000581817500010
J	Bond, MO; Gaoue, OG				Bond, Matthew O.; Gaoue, Orou G.			Prestige and homophily predict network structure for social learning of medicinal plant knowledge	PLOS ONE			English	Article							LOCAL ECOLOGICAL KNOWLEDGE; INDIGENOUS KNOWLEDGE; EVOLUTION; DIVERSITY; CULTURE; TRANSMISSION; BIODIVERSITY; COMMUNITY; PATTERNS; SCIENCE	Human subsistence societies have thrived in environmental extremes while maintaining biodiversity through social learning of ecological knowledge, such as techniques to prepare food and medicine from local resources. However, there is limited understanding of which processes shape social learning patterns and configuration in ecological knowledge networks, or how these processes apply to resource management and biological conservation. In this study, we test the hypothesis that the prestige (rarity or exclusivity) of knowledge shapes social learning networks. In addition, we test whether people tend to select who to learn from based on prestige (knowledge or reputation), and homophily (e.g., people of the same age or gender). We used interviews to assess five types of medicinal plant knowledge and how 303 people share this knowledge across four villages in Solomon Islands. We developed exponential random graph models (ERGMs) to test whether hypothesized patterns of knowledge sharing based on prestige and homophily are more common in the observed network than in randomly simulated networks of the same size. We found that prestige predicts five hypothesized network configurations and all three hypothesized learning patterns, while homophily predicts one of three hypothesized network configurations and five of the seven hypothesized learning patterns. These results compare the strength of different prestige and homophily effects on social learning and show how cultural practices such as intermarriage can affect certain aspects of prestige and homophily. By advancing our understanding of how prestige and homophily affect ecological knowledge networks, we identify which social learning patterns have the largest effects on biocultural conservation of ecological knowledge.	[Bond, Matthew O.; Gaoue, Orou G.] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Gaoue, Orou G.] Univ Tennessee Knoxville, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Gaoue, Orou G.] Univ Parakou, Fac Agron, Parakou, Benin; [Gaoue, Orou G.] Univ Johannesburg, Dept Geog Environm Management & Energy Studies, APK Campus, Johannesburg, South Africa	University of Hawaii System; University of Hawaii Manoa; University of Tennessee System; University of Tennessee Knoxville; University of Johannesburg	Bond, MO (corresponding author), Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA.	mb2286@hawaii.edu	; Gaoue, Orou G./B-4932-2011	Bond`, Matthew/0000-0001-7674-5787; Gaoue, Orou G./0000-0002-0946-2741	National Science Foundation Graduate Research Fellowship; American Philosophical Society Lewis & Clark Fund for Exploration Field Research; Garden Club of America Anne S. Chatham Fellowship in Medicinal Botany; National Science Foundation [1513354]; University of Tennessee Knoxville	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); American Philosophical Society Lewis & Clark Fund for Exploration Field Research; Garden Club of America Anne S. Chatham Fellowship in Medicinal Botany; National Science Foundation(National Science Foundation (NSF)); University of Tennessee Knoxville	MOB was funded by a National Science Foundation Graduate Research Fellowship (https://www.nsfgrfp.org), the American Philosophical Society Lewis & Clark Fund for Exploration & Field Research (https://www.amphilsoc.org/grants/lewis-and-clark-fund-exploration-and-fieldresearch), and the Garden Club of America Anne S. Chatham Fellowship in Medicinal Botany (https://www.gcamerica.org/scholarships/details/id/8).OGG was funded by a National Science Foundation Grant #1513354 (https://www.nsf.gov/index.jsp), and a start up grant from the University of Tennessee Knoxville (https://research.utk.edu/forms/start_up_funds/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Albuquerque UP., 2014, METHODS TECHNIQUES E, V1, DOI [10.1007/978-1-4614-8636-7, DOI 10.1007/978-1-4614-8636-7]; Altman A, 2019, HUM ECOL, V47, P483, DOI 10.1007/s10745-019-00090-y; Aswani S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195440; Atran S, 2002, CURR ANTHROPOL, V43, P421, DOI 10.1086/339528; Ban NC, 2013, FRONT ECOL ENVIRON, V11, P194, DOI 10.1890/110205; Barnes M., 2017, SSRN ELECT J, DOI [10.2139/ssrn.2932575, DOI 10.2139/SSRN.2932575]; Bodin O, 2006, ECOL SOC, V11, P2; Bond MO, 2019, PEOPLE NAT, V1, P87, DOI 10.1002/pan3.15; Bond MO, NETWORKS SOCIO UNPUB; Bond MO, REV; Brosi BJ, 2007, CONSERV BIOL, V21, P875, DOI 10.1111/j.1523-1739.2007.00654.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calvet-Mir L, 2016, ENVIRON SOC, V7, P107, DOI 10.3167/ares.2016.070107; Camara-Leret R, 2019, P NATL ACAD SCI USA, V116, P9913, DOI 10.1073/pnas.1821843116; Camara-Leret R, 2014, J ETHNOPHARMACOL, V158, P58, DOI 10.1016/j.jep.2014.10.009; Case RJ, 2005, ECON BOT, V59, P356, DOI 10.1663/0013-0001(2005)059[0356:FIMIKA]2.0.CO;2; Latorre EC, 2020, ECON BOT, V74, P195, DOI 10.1007/s12231-020-09491-3; Cost DS, 2015, ECOL SOC, V20, DOI 10.5751/ES-07757-200329; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Brito CD, 2019, ACTA BOT BRAS, V33, P370, DOI 10.1590/0102-33062018abb0340; de Ferranti J, 2016, DIGITAL ELEVATION DA; Diver S, 2017, ENVIRON SCI POLICY, V73, P1, DOI 10.1016/j.envsci.2017.03.001; Dray S., 2019, ADESPATIAL MULTIVARI, DOI DOI 10.1038/s41586-019-1111-9; Dudley N, 2009, CONSERV BIOL, V23, P568, DOI 10.1111/j.1523-1739.2009.01201.x; Dweba TP, 2011, INT J INFORM MANAGE, V31, P564, DOI 10.1016/j.ijinfomgt.2011.02.009; Ford J, 2017, ECON BOT, V71, P123, DOI 10.1007/s12231-017-9380-4; Gaoue O, 2017, ECON BOT, V71, P269, DOI 10.1007/s12231-017-9389-8; Garfield ZH., 2016, SOCIAL LEARNING INNO, P19; Garnett ST, 2018, NAT SUSTAIN, V1, P369, DOI 10.1038/s41893-018-0100-6; Goodreau Steven M, 2008, J Stat Softw, V24, P1; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Haselmair R, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-1; Henderson CP, 1988, GUIDE USEFUL PLANTS, V481; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Henrich J, 2011, PHILOS T R SOC B, V366, P1139, DOI 10.1098/rstb.2010.0323; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Iniesta-Arandia I, 2015, AMBIO, V44, P285, DOI 10.1007/s13280-014-0556-1; Joa B, 2018, LAND USE POLICY, V79, P520, DOI 10.1016/j.landusepol.2018.09.001; Jourdan C, 2014, LANG SOC, V43, P265, DOI 10.1017/S0047404514000190; Kalmijn M, 1998, ANNU REV SOCIOL, V24, P395, DOI 10.1146/annurev.soc.24.1.395; KEESING RM, 1968, AM ANTHROPOL, V70, P82, DOI 10.1525/aa.1968.70.1.02a00080; Keesing Roger M., 1991, MAN HALF ESSAYS PACI, P277; Kendal RL, 2018, TRENDS COGN SCI, V22, P651, DOI 10.1016/j.tics.2018.04.003; Koskinen J., 2013, EXPONENTIAL RANDOM G; Kwaioloa M, 2001, OUR FOREST KWARAAE O; Labeyrie V, 2016, P NATL ACAD SCI USA, V113, P98, DOI 10.1073/pnas.1513238112; Laumann EO, 1983, APPL NETWORK ANAL, P18; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Leonti M, 2011, J ETHNOPHARMACOL, V134, P542, DOI 10.1016/j.jep.2011.01.017; Levy MA, 2018, REG ENVIRON CHANGE, V18, P1235, DOI 10.1007/s10113-017-1258-6; McCarter J, 2015, ECON BOT, V69, P251, DOI 10.1007/s12231-015-9319-6; McCarter J, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-38; McDade TW, 2007, P NATL ACAD SCI USA, V104, P6134, DOI 10.1073/pnas.0609123104; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mesoudi A, 2019, HANDBOOK OF CULTURAL PSYCHOLOGY, 2 EDITION, P144; Mesoudi A, 2016, EVOL BIOL, V43, P481, DOI 10.1007/s11692-015-9320-0; Mesoudi A, 2016, TRENDS ECOL EVOL, V31, P215, DOI 10.1016/j.tree.2015.12.012; Mollee E, 2017, LAND USE POLICY, V63, P67, DOI 10.1016/j.landusepol.2017.01.020; Mulder MB, 2009, SCIENCE, V326, P682, DOI 10.1126/science.1178336; Natural Earth, 2018, FREE VECT RAST MAP D; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Zambrana NYP, 2018, NAT PLANTS, V4, P201, DOI 10.1038/s41477-018-0128-7; Paniagua-Zambrana NY, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0210-2; Reinaldo RCPD, 2015, J ETHNOPHARMACOL, V175, P39, DOI 10.1016/j.jep.2015.09.003; R Core Team, 2021, R LANGUAGE ENV STAT; Rendell L, 2010, EVOLUTION, V64, P534, DOI 10.1111/j.1558-5646.2009.00817.x; Reyes-Garcia V, 2008, EVOL HUM BEHAV, V29, P275, DOI 10.1016/j.evolhumbehav.2008.02.002; Reyes-Garcia V, 2016, CURR ANTHROPOL, V57, P761, DOI 10.1086/689307; Reyes-Garcia V, 2013, EVOL HUM BEHAV, V34, P249, DOI 10.1016/j.evolhumbehav.2013.03.002; Reyes-Garcia V, 2010, INT J EDUC DEV, V30, P305, DOI 10.1016/j.ijedudev.2009.11.007; Ross HM, 1973, ILLINOIS STUDIES ANT; Salali GD, 2016, CURR BIOL, V26, P2516, DOI 10.1016/j.cub.2016.07.015; Salpeteur M, 2015, CURR ANTHROPOL, V56, P471, DOI 10.1086/681006; Santoro FR, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04109; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Shen XL, 2012, BIOL CONSERV, V145, P160, DOI 10.1016/j.biocon.2011.10.027; Sobrevila C., 2008, ROLE INDIGENOUS PEOP; Solomon Islands National Statistics Office (SIMoHMS) Services SIM of H and M (SPC) Pacific Community, 2017, PAC CMM SOL ISL DEM; Song H, 2018, COMMUNIC RES, DOI [10.1177/0093650217705528, DOI 10.1177/0093650217705528]; Staub PO, 2015, J ETHNOPHARMACOL, V174, P514, DOI 10.1016/j.jep.2015.08.051; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Sterelny K, 2007, PHILOS T R SOC B, V362, P719, DOI 10.1098/rstb.2006.2006; Stevens M, 2014, IEEE PERVAS COMPUT, V13, P20, DOI 10.1109/MPRV.2014.37; Thomas E, 2007, ECON BOT, V61, P376, DOI 10.1663/0013-0001(2007)61[376:WWITFA]2.0.CO;2; Tipa G, 2009, NEW ZEAL GEOGR, V65, P95, DOI 10.1111/j.1745-7939.2009.01152.x; Torres-Avilez W, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/6592363; Ugulu Ilker, 2013, Journal of Human Ecology, V43, P151; UN, 2009, STAT WORLDS IND PEOP; Urama KC, 2006, ECOL ECON, V59, P24, DOI 10.1016/j.ecolecon.2005.09.022; Vennes C, 2019, PACKAGE GEOSPHERE; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wagner CS, 2005, RES POLICY, V34, P1608, DOI 10.1016/j.respol.2005.08.002; Waters CN, 2016, SCIENCE, V351, P137, DOI 10.1126/science.aad2622; Wehi PM, 2010, CONSERV BIOL, V24, P594, DOI 10.1111/j.1523-1739.2009.01376.x; Wei T., 2021, R PACKAGE CORRPLOT V; West P, 2006, CONSERV BIOL, V20, P609, DOI 10.1111/j.1523-1739.2006.00432.x; WHITMORE T, 1966, GUIDE FORESTS BRIT S; Willis KJ, 2016, STATE WORLDS PLANTS, V84; World Organization of Family Doctors, 2005, ICPC 2 R INT CLASS P	104	4	5	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239345	10.1371/journal.pone.0239345	http://dx.doi.org/10.1371/journal.pone.0239345			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TB	33031437	gold, Green Published			2022-12-26	WOS:000581809800089
J	Juge, N; Avci, F; Scott, NE; Creuzenet, C; Valvano, MA				Juge, Nathalie; Avci, Fikri; Scott, Nichollas E.; Creuzenet, Carole; Valvano, Miguel A.			2020 FASEB Science Research Conference on Microbial Glycobiology, July 13-14, 2020	FASEB JOURNAL			English	Article									[Juge, Nathalie] Quadram Inst Biosci, Gut Microbes & Hlth Inst Strateg Programme, Norwich Res Pk, Norwich, Norfolk, England; [Avci, Fikri] Univ Georgia, Ctr Mol Med, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Scott, Nichollas E.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Creuzenet, Carole] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Valvano, Miguel A.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University System of Georgia; University of Georgia; University of Melbourne; Western University (University of Western Ontario); Queens University Belfast	Valvano, MA (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	m.valvano@qub.ac.uk		Avci, Fikri/0000-0002-1902-7532	Chemical Biology (ACS Publications); Society for Glycobiology; Glycom (HOrsholm, Denmark); Journal of Biological Chemistry; VaxNewMo LLC (St. Louis, MO, USA); GLYcoDiag (Orleans, France); Microbiology Society; BBSRC [BBS/E/F/00044452] Funding Source: UKRI	Chemical Biology (ACS Publications); Society for Glycobiology; Glycom (HOrsholm, Denmark); Journal of Biological Chemistry; VaxNewMo LLC (St. Louis, MO, USA); GLYcoDiag (Orleans, France); Microbiology Society; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The FASEB Conference on Microbial Glycobiology received support from the following sponsors: Chemical Biology (ACS Publications), the Society for Glycobiology, Glycom (HOrsholm, Denmark), the Journal of Biological Chemistry, VaxNewMo LLC (St. Louis, MO, USA), GLYcoDiag (Orleans, France), and the Microbiology Society. The Organizing Committee thanks the sponsors for their support. Sponsorship also allowed the committee to provide four awards for the best short talks and poster presentations by junior researchers, which were given to: Andrew Bell (Quadram Institute Bioscience, Norwich, UK), Kelly Lee (University of Nottingham, Nottingham, UK), Sarah Tindall (University of York, York, UK), and Wouter van Bakel (Quadram Institute Bioscience).		0	0	0	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14069	14072		10.1096/fj.202002191	http://dx.doi.org/10.1096/fj.202002191		OCT 2020	4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	33031616				2022-12-26	WOS:000576979600001
J	Jung, BT; Kim, WH; Park, B; Lee, JH; Kim, B; Lee, JH				Jung, Bryan Taekyung; Kim, Won Hyeon; Park, Byungho; Lee, Jong-Ho; Kim, Bongju; Lee, Jee-Ho			Biomechanical evaluation of unilateral subcondylar fracture of the mandible on the varying materials: A finite element analysis	PLOS ONE			English	Article							SPLIT RAMUS OSTEOTOMY; CONDYLAR FRACTURES; BITE FORCES; OSTEOSYNTHESIS; SCREWS; STRESS; PLATES	Fixation materials used in the surgical treatment of subcondylar fractures contribute to successful clinical outcomes. In this study, we simulated the mechanical properties of four fixation materials [titanium (Ti), magnesium alloy (Mg alloy), poly-L-lactic acid (PLLA), and hydroxyapatite/poly-L-lactide (HA-PLLA)] in a finite-element analysis model of subcondylar fracture. Two four-hole plates were fixed on the anterior and posterior surfaces of the subcondyle of the mandible. In the simulation model of a subcondylar fracture, we evaluated the stress distribution and mechanical deformation of fixation materials. The stress distribution conspicuously appeared on the condylar neck of the non-fractured side and the center of the anterior plate for all materials. More stress distribution to the biologic component appeared with HA-PLLA than with Ti or Mg alloy, but its effects were less prominent than that of PLLA. The largest deformation was observed with PLLA, followed by HA-PLLA, Mg alloy, and Ti. The results of the present study imply the clinical potential of the HA-PLLA fixation material for open reduction of subcondylar fractures.	[Jung, Bryan Taekyung] Univ Detroit Mercy, Sch Dent, Detroit, MI 48221 USA; [Kim, Won Hyeon] Sejong Univ, Dept Mech Engn, Seoul, South Korea; [Kim, Won Hyeon; Lee, Jong-Ho; Kim, Bongju] Seoul Natl Univ, Clin Translat Res Ctr Dent Sci, Dent Hosp, Seoul, South Korea; [Park, Byungho; Lee, Jee-Ho] Univ Ulsan, Dept Oral & Maxillofacial Surg, Coll Med, Asan Med Ctr, Seoul, South Korea; [Lee, Jong-Ho] Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Seoul, South Korea	University of Detroit Mercy; Sejong University; Seoul National University (SNU); University of Ulsan; Seoul National University (SNU)	Kim, B (corresponding author), Seoul Natl Univ, Clin Translat Res Ctr Dent Sci, Dent Hosp, Seoul, South Korea.; Lee, JH (corresponding author), Univ Ulsan, Dept Oral & Maxillofacial Surg, Coll Med, Asan Med Ctr, Seoul, South Korea.	bjkim016@gmail.com; jeehoman@gmail.com	Kim, Wonhyeon/GOG-8940-2022; Kim, Won-Hyeon/AAZ-7903-2020	Kim, Won-Hyeon/0000-0002-9742-7945; Lee, Jee Ho/0000-0003-4232-2756	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [HI15C1535, 2016-569]; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea	This research was supported by a grant from the Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (Grant number: HI15C1535) and a Grant (No. 2016-569) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NUCLEIC ACIDS RES, V42, pD7; Bell RB, 2006, J ORAL MAXIL SURG, V64, P31, DOI 10.1016/j.joms.2005.09.010; CHAMPY M, 1978, J MAXILLOFAC SURG, V6, P14, DOI 10.1016/S0301-0503(78)80062-9; Cho BC, 2012, ARCH PLAST SURG-APS, V39, P190, DOI [10.5999/aps.2012.39.3.190, 10.5999/aps.2012.39.4.301]; Choi JP, 2010, J CRANIOFAC SURG, V21, P1104, DOI 10.1097/SCS.0b013e3181e1b449; El-Anwar MI., 2011, J GENET ENG BIOTECHN, V9, P77, DOI DOI 10.1016/J.JGEB.2011.05.007; Ferrario VF, 2004, J DENT, V32, P451, DOI 10.1016/j.jdent.2004.02.009; Gerlach KL, 2002, INT J ORAL MAX SURG, V31, P345, DOI 10.1054/ijom.2002.0290; Gilardino MS, 2009, CRANIOMAX TRAUM REC, V2, P49, DOI 10.1055/s-0029-1202591; Harada K, 2000, J ORAL MAXIL SURG, V58, P370, DOI 10.1016/S0278-2391(00)90913-3; Kim WH, 2019, MATERIALS, V12, DOI 10.3390/ma12020235; Koshy John C, 2010, Semin Plast Surg, V24, P357, DOI 10.1055/s-0030-1269765; Landes C, 2014, J ORAL MAXIL SURG, V72, P1328, DOI 10.1016/j.joms.2014.02.027; Lee JH, 2017, J CRANIO MAXILL SURG, V45, P1639, DOI 10.1016/j.jcms.2017.06.015; Lee JY, 2014, J ORAL MAXIL SURG, V72, DOI 10.1016/j.joms.2013.10.003; Maurer P, 2002, BRIT J ORAL MAX SURG, V40, P76, DOI 10.1054/bjom.2001.0752; Maurer P, 1999, J CRANIO MAXILL SURG, V27, P365, DOI 10.1054/jcms.1999.0069; Meyer C, 2006, J CRANIO MAXILL SURG, V34, P173, DOI 10.1016/j.jcms.2005.09.005; Meyer C, 2002, J CRANIO MAXILL SURG, V30, P160, DOI 10.1054/jcms.2002.0297; Pacifici L, 2017, ORAL IMPLANTOL RO S1, V9, P107; Park B, 2020, MATERIALS, V13, DOI 10.3390/ma13010228; Rallis G, 2003, QUINTESSENCE INT, V34, P45; Shash M, 2019, IRBM, V40, P313, DOI 10.1016/j.irbm.2019.07.001; SIM BK, 2017, LANCET HIV, V2017, DOI DOI 10.1155/2017/4842072; Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1; Song IS, 2019, J CRANIO MAXILL SURG, V47, P1752, DOI 10.1016/j.jcms.2019.07.033; THROCKMORTON GS, 1994, ARCH ORAL BIOL, V39, P853, DOI 10.1016/0003-9969(94)90017-5; Tominaga K, 2006, J ORAL MAXIL SURG, V64, P1510, DOI 10.1016/j.joms.2006.03.038; Wazeh Ahmad Mohamad, 2018, Open Access Maced J Med Sci, V6, P1702, DOI 10.3889/oamjms.2018.331; Zhang G, 2016, INT J DENT, V2016, DOI 10.1155/2016/4867402	30	4	4	7	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240352	10.1371/journal.pone.0240352	http://dx.doi.org/10.1371/journal.pone.0240352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031474	gold, Green Published			2022-12-26	WOS:000581809800053
J	Shiga, Y; Hosomi, N; Nezu, T; Nishi, H; Aoki, S; Nakamori, M; Ishikawa, K; Kinoshita, N; Imamura, E; Ueno, H; Shintani, T; Ohge, H; Kawaguchi, H; Kurihara, H; Wakabayashi, S; Maruyama, H				Shiga, Yuji; Hosomi, Naohisa; Nezu, Tomohisa; Nishi, Hiromi; Aoki, Shiro; Nakamori, Masahiro; Ishikawa, Kenichi; Kinoshita, Naoto; Imamura, Eiji; Ueno, Hiroki; Shintani, Tomoaki; Ohge, Hiroki; Kawaguchi, Hiroyuki; Kurihara, Hidemi; Wakabayashi, Shinichi; Maruyama, Hirofumi			Association between periodontal disease due to Campylobacter rectus and cerebral microbleeds in acute stroke patients	PLOS ONE			English	Article							SMALL VESSEL DISEASE; PORPHYROMONAS-GINGIVALIS; BRAIN; PATHOGENESIS; PROGRESSION; INFARCTION; DEMENTIA; AGE	Oral health conditions and cerebral small vessel disease, such as white matter lesions or cerebral microbleeds (CMBs), are associated with the incidence of stroke. The purpose of this study was to examine the associations between oral health conditions (serum IgG titers of periodontal pathogens) with the presence or severity of CMBs in acute stroke patients. From January 2013 to April 2016, acute stroke patients were registered in two hospitals. Serum samples were evaluated for antibody titers against 9 periodontal pathogens using the ELISA method. The cut-off points for reactivity (the positive decision point) to each antigen were defined as more than a mean ELISA unit + 1 standard deviation (after logarithmic transformation) in all subjects. CMBs were evaluated on T2*-weighted MRI. In all, 639 patients were evaluated (ischemic, n = 533 and hemorrhagic, n = 106; 73.1 +/- 12.9 years old). Among these patients, 627 were available for CMB evaluation. Among the 9 evaluated periodontal pathogens, only Campylobacter rectus(C. rectus) was associated with the presence of CMBs. the prevalence of positive serum antibody titers against C. rectus was higher among patients with CMBs than among those without CMBs (14.6% vs. 8.7%, P = 0.025). In addition, positive serum antibody titers against C. rectus remained one of the factors associated with the presence of CMBs in multivariate logistic analysis (odds ratio 2.03, 95% confidence interval 1.19-3.47, P = 0.010). A positive serum antibody titer against C. rectus was associated with the presence of CMBs in acute stroke patients.	[Shiga, Yuji; Nezu, Tomohisa; Aoki, Shiro; Nakamori, Masahiro; Ishikawa, Kenichi; Kinoshita, Naoto; Ueno, Hiroki; Maruyama, Hirofumi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Hosomi, Naohisa] Chikamori Hosp, Dept Neurol, Kochi, Japan; [Hosomi, Naohisa] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Hiroshima, Japan; [Nishi, Hiromi; Kawaguchi, Hiroyuki] Hiroshima Univ Hosp, Dept Gen Dent, Hiroshima, Japan; [Nakamori, Masahiro; Ishikawa, Kenichi; Imamura, Eiji] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan; [Shintani, Tomoaki] Hiroshima Univ Hosp, Ctr Oral Examinat, Hiroshima, Japan; [Ohge, Hiroki] Hiroshima Univ Hosp, Dept Infect Dis, Hiroshima, Japan; [Kurihara, Hidemi] Hiroshima Univ, Inst Biomed & Hlth Sci, Div Appl Life Sci, Dept Periodontal Med, Hiroshima, Japan; [Wakabayashi, Shinichi] Suiseikai Kajikawa Hosp, Dept Neurosurg, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University	Hosomi, N (corresponding author), Chikamori Hosp, Dept Neurol, Kochi, Japan.; Hosomi, N (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Hiroshima, Japan.	nhosomi@hiroshima-u.ac.jp	Maruyama, Hirofumi/B-9333-2011	Maruyama, Hirofumi/0000-0001-7613-8717; Aoki, Shiro/0000-0001-5348-5783; Shiga, Yuji/0000-0001-7881-570X	Japan Society for the Promotion 350 of Science KAKENHI [17K17350, 17K17907, 18K10746, 351 20K16579]	Japan Society for the Promotion 350 of Science KAKENHI	This study was supported by research grants from the Japan Society for the Promotion 350 of Science KAKENHI (Grant Numbers 17K17350, 17K17907, 18K10746, and 351 20K16579).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 1996, ANN PERIODONTOL, V1, P216; Del Brutto OH, 2016, EUR NEUROL, V76, P112, DOI 10.1159/000448839; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fornage M, 2008, STROKE, V39, P1952, DOI 10.1161/STROKEAHA.107.508135; Hosomi N, 2012, CEREBROVASC DIS, V34, P385, DOI 10.1159/000343659; Ihara M, 2016, STROKE, V47, P554, DOI 10.1161/STROKEAHA.115.009627; Lafon A, 2014, EUR J NEUROL, V21, P1155, DOI 10.1111/ene.12415; Leira Y, 2016, EUR J NEUROL, V23, P1572, DOI 10.1111/ene.13080; Liu WH, 2012, STROKE, V43, P2916, DOI 10.1161/STROKEAHA.112.658369; Mahendra Jaideep, 2015, Indian J Dent Res, V26, P189, DOI 10.4103/0970-9290.159164; Mahlen SD, 2009, J CLIN MICROBIOL, V47, P848, DOI 10.1128/JCM.01590-08; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Minn YK, 2013, J KOREAN MED SCI, V28, P929, DOI 10.3346/jkms.2013.28.6.929; Misaki T, 2018, NEPHRON, V139, P143, DOI 10.1159/000487103; Nakahara T, 2018, J GASTROENTEROL, V53, P269, DOI 10.1007/s00535-017-1368-4; Nambi V, 2009, STROKE, V40, P376, DOI 10.1161/STROKEAHA.107.513259; Nezu T, 2015, HYPERTENS RES, V38, P291, DOI 10.1038/hr.2015.4; Nishi H, 2020, CLIN EXP IMMUNOL, V200, P302, DOI 10.1111/cei.13430; Oka K, 2018, INTERNAL MED, V57, P3325, DOI 10.2169/internalmedicine.1025-18; Orlandi M, 2014, ATHEROSCLEROSIS, V236, P39, DOI 10.1016/j.atherosclerosis.2014.06.002; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Poggesi A, 2016, J CEREBR BLOOD F MET, V36, P72, DOI 10.1038/jcbfm.2015.116; Pussinen PJ, 2007, ATHEROSCLEROSIS, V193, P222, DOI 10.1016/j.atherosclerosis.2006.06.027; RAMS TE, 1993, ORAL MICROBIOL IMMUN, V8, P230, DOI 10.1111/j.1399-302X.1993.tb00565.x; Schmidt H, 2011, BRAIN, V134, P3384, DOI 10.1093/brain/awr252; Sen S, 2018, STROKE, V49, P355, DOI 10.1161/STROKEAHA.117.018990; Sobowale OA, 2016, STROKE, V47, P2160, DOI 10.1161/STROKEAHA.115.010001; Stevenson SF, 2010, STROKE, V41, pE434, DOI 10.1161/STROKEAHA.109.569855; Taguchi A, 2013, GERONTOLOGY, V59, P499, DOI 10.1159/000353707; Tonomura S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20074; Wang ZL, 2014, STROKE, V45, P2811, DOI 10.1161/STROKEAHA.114.004286; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239773	10.1371/journal.pone.0239773	http://dx.doi.org/10.1371/journal.pone.0239773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031428	gold, Green Published			2022-12-26	WOS:000581809800068
J	Petrone, P; Giordano, G; Vezzoli, E; Pensa, A; Castaldo, G; Graziano, V; Sirano, F; Capasso, E; Quaremba, G; Vona, A; Miano, MG; Savino, S; Niola, M				Petrone, Pierpaolo; Giordano, Guido; Vezzoli, Elena; Pensa, Alessandra; Castaldo, Giuseppe; Graziano, Vincenzo; Sirano, Francesco; Capasso, Emanuele; Quaremba, Giuseppe; Vona, Alessandro; Miano, Maria Giuseppina; Savino, Sergio; Niola, Massimo			Preservation of neurons in an AD 79 vitrified human brain	PLOS ONE			English	Article							VILLA-DEI-PAPIRI; HERCULANEUM VICTIMS; CRYO-SEM; VESUVIUS; ERUPTION; TISSUE; DEPOSITS; AGE	Detecting the ultrastructure of brain tissue in human archaeological remains is a rare event that can offer unique insights into the structure of the ancient central nervous system (CNS). Yet ancient brains reported in the literature show only poor preservation of neuronal structures. Using scanning electron microscopy (SEM) and advanced image processing tools, we describe the direct visualization of neuronal tissue in vitrified brain and spinal cord remains which we discovered in a male victim of the AD 79 eruption in Herculaneum. We show exceptionally well preserved ancient neurons from different regions of the human CNS at unprecedented resolution. This tissue typically consists of organic matter, as detected using energy-dispersive X-ray spectroscopy. By means of a self-developed neural image processing network, we also show specific details of the neuronal nanomorphology, like the typical myelin periodicity evidenced in the brain axons. The perfect state of preservation of these structures is due to the unique process of vitrification which occurred at Herculaneum. The discovery of proteins whose genes are expressed in the different region of the human adult brain further agree with the neuronal origin of the unusual archaeological find. The conversion of human tissue into glass is the result of sudden exposure to scorching volcanic ash and the concomitant rapid drop in temperature. The eruptive-induced process of natural vitrification, locking the cellular structure of the CNS, allowed us to study possibly the best known example in archaeology of extraordinarily well-preserved human neuronal tissue from the brain and spinal cord.	[Petrone, Pierpaolo; Graziano, Vincenzo; Capasso, Emanuele; Quaremba, Giuseppe; Niola, Massimo] Univ Napoli Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy; [Giordano, Guido; Pensa, Alessandra; Vona, Alessandro] Univ Roma Tre, Dipartimento Sci, Rome, Italy; [Vezzoli, Elena] Univ Milan, Dipartimento Sci Biomed Salute, Milan, Italy; [Castaldo, Giuseppe] CEINGE Biotecnol Avanzate Scarl, Naples, Italy; [Sirano, Francesco] Parco Archeol Ercolano, Naples, Italy; [Quaremba, Giuseppe; Savino, Sergio] Univ Napoli Federico II, Dipartimento Ingn Ind, Naples, Italy; [Miano, Maria Giuseppina] Consiglio Nazl Ric CNR, Ist Genet & Biofis Adriano Buzzati Traverso, Naples, Italy	University of Naples Federico II; Roma Tre University; University of Milan; CEINGE Biotecnologie Avanzate; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Petrone, P (corresponding author), Univ Napoli Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy.	pipetron@unina.it	Vona, Alessandro/H-1366-2012; Giuseppina, Miano Maria/B-9169-2015; Giordano, Guido/ABC-4130-2021; Castaldo, Giuseppe/AAC-6782-2022; Vona, Alessandro/AAH-8126-2021; Miano, Maria Giuseppina/E-9056-2011; Capassso, Emanuele/D-7989-2018	Vona, Alessandro/0000-0002-5483-5623; Castaldo, Giuseppe/0000-0002-4036-0874; Vona, Alessandro/0000-0002-5483-5623; Petrone, Pier Paolo/0000-0002-8897-8171; Savino, Sergio/0000-0002-1165-4451; Miano, Maria Giuseppina/0000-0003-1396-9673; Vezzoli, Elena/0000-0002-3342-3451; Capassso, Emanuele/0000-0001-9907-9078				Abdollahzadeh A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42648-2; AE K B, 2017, PEDIAT DERMATOL, V34, pS203, DOI 10.1111/pde.13142; [Anonymous], 2016, Med Lett Drugs Ther, V58, P109; [Anonymous], 1980, J HUM EVOL, V9, P517; Bender KJ, 2012, ANNU REV NEUROSCI, V35, P249, DOI 10.1146/annurev-neuro-062111-150339; Bouchet-Marquis C, 2007, BIOL CELL, V99, P45, DOI 10.1042/BC20060081; Buikstra Jane E., 1994, RES SERIES, V44; Capasso L, 2000, LANCET, V356, P1344, DOI 10.1016/S0140-6736(00)02827-0; Caricchi C, 2014, J VOLCANOL GEOTH RES, V289, P14, DOI 10.1016/j.jvolgeores.2014.10.016; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Cmejla R, 2007, HUM MUTAT, V28, P1178, DOI 10.1002/humu.20608; DORAN GH, 1986, NATURE, V323, P803, DOI 10.1038/323803a0; GERSZTEN PC, 1995, NEUROSURGERY, V36, P756, DOI 10.1227/00006123-199504000-00017; Giordano G, 2018, EARTH PLANET SC LETT, V490, P180, DOI 10.1016/j.epsl.2018.03.023; Guillabert-Gourgues A, 2016, MOL BIOL CELL, V27, P941, DOI 10.1091/mbc.E14-08-1332; Hrubanova K, 2018, MICRON, V110, P28, DOI 10.1016/j.micron.2018.04.006; Kim MJ, 2008, INT J OSTEOARCHAEOL, V18, P614, DOI 10.1002/oa.962; Liewald D, 2014, BIOL CYBERN, V108, P541, DOI 10.1007/s00422-014-0626-2; Lindersky J, 2007, SELECTED PAPERS, P179; Liu XB, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-42; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maiuri A, 1961, EXCAVATION J     FEB; Mastrolorenzo G, 2006, P NATL ACAD SCI USA, V103, P4366, DOI 10.1073/pnas.0508697103; Mastrolorenzo G, 2001, NATURE, V410, P769, DOI 10.1038/35071167; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Mitra S, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00073; Muller B, 2008, PROC SPIE, V7078, DOI 10.1117/12.794157; Nakatomi R, 2005, BRAIN RES PROTOC, V14, P100, DOI 10.1016/j.brainresprot.2004.12.004; Niola V, 2005, J MATER PROCESS TECH, V164, P1410, DOI 10.1016/j.jmatprotec.2005.02.169; O'Connor S, 2011, J ARCHAEOL SCI, V38, P1641, DOI 10.1016/j.jas.2011.02.030; Pagano M, 2003, STORIE UNERUZIONE PO, P124; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Papageorgopoulou C, 2010, NEUROIMAGE, V50, P893, DOI 10.1016/j.neuroimage.2010.01.029; Pensa A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42035-x; Petrone PP, 2011, J ANTHROPOL SCI, V89, P3, DOI 10.4436/jass.89008; Petrone P, 2020, NEW ENGL J MED, V382, P383, DOI 10.1056/NEJMc1909867; Petrone P, 2019, J ANTHROPOL SCI, V97, P69, DOI [10.4436/jass.97008, 10.4436/JASS.97008]; Petrone P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203210; Quarles RH, 1979, BIOCH BRAIN, P81; Reina-De La Torre F, 1998, ANAT RECORD, V251, P87, DOI 10.1002/(SICI)1097-0185(199805)251:1<87::AID-AR14>3.0.CO;2-7; Rosing FW, 2007, HOMO, V58, P75, DOI 10.1016/j.jchb.2005.07.002; ROYAL W, 1960, AM ANTIQUITY, V26, P285, DOI 10.2307/276213; Ruggiero M., 1885, STORIA SCAVI ERCOLAN; Salzer JL, 2016, CURR BIOL, V26, pR971, DOI 10.1016/j.cub.2016.07.074; Scarpati C, 2020, GEOL MAG, V157, P695, DOI 10.1017/S0016756819001560; Schmelzer JWP, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20020103; Schmid F, 2019, NEUROIMAGE, V197, P792, DOI 10.1016/j.neuroimage.2017.06.046; SIGURDSSON H, 1985, NATL GEOGR RES, V1, P332; SIGURDSSON H, 1982, AM J ARCHAEOL, V86, P39, DOI 10.2307/504292; Smol T, 2018, NEUROGENETICS, V19, P93, DOI 10.1007/s10048-018-0541-0; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127; TKOCZ I, 1979, AM J PHYS ANTHROPOL, V51, P197, DOI 10.1002/ajpa.1330510206; Ubelaker DH, 2011, FORENSIC SCI INT, V208, P167, DOI 10.1016/j.forsciint.2010.11.024; Utami KH, 2014, HUM MUTAT, V35, P1311, DOI 10.1002/humu.22636; Wang Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6823; Wojcik MH, 2018, AM J MED GENET A, V176, P2623, DOI 10.1002/ajmg.a.40493; Woody SK, 2016, J ALZHEIMERS DIS, V53, P1015, DOI 10.3233/JAD-160307	58	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2020	15	10							e0240017	10.1371/journal.pone.0240017	http://dx.doi.org/10.1371/journal.pone.0240017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OB4WW	33022024	gold, Green Published			2022-12-26	WOS:000578473000026
J	Barbosa, MD; de Souza, IBA; Schnaufer, ECD; da Silva, LF; Goncalves, CCM; Simionatto, S; Marchioro, SB				Barbosa, Marcelo dos Santos; Andrade de Souza, Iara Beatriz; Schnaufer, Erica Cristina dos Santos; da Silva, Liliane Ferreira; Maymone Goncalves, Crhistinne Carvalho; Simionatto, Simone; Marchioro, Silvana Beutinger			Prevalence and factors associated with Trichomonas vaginalis infection in indigenous Brazilian women	PLOS ONE			English	Article							DIAGNOSIS	There is a scarcity of studies on the prevalence ofTrichomonas vaginalis(TV) in indigenous populations of Brazil. We conducted a cross-sectional study between January and December 2018, on indigenous women living nearby an urban center of the Midwest region of Brazil and determined the prevalence of TV. Factors associated with TV infection and a comparison of molecular and direct microscopy diagnoses were determined. 241 indigenous women aged above 18 years participated in the study. Cervical and vaginal brush samples were collected to diagnose TV through polymerase chain reaction (PCR). Direct microscopy for detection of TV, and cellular changes was performed. A sociodemographic and behavioral questionnaire was applied at the beginning of the study. All the data were analyzed using Statistical Package for the Social Sciences. The result obtained showed that 27.8% [95% CI: 22.2-33.9] were positive for TV on PCR, while 7.41% [95% CI: 4.1-11] showed positive on direct microscopy. Direct microcopy also found 21 (8.71%) and 8 (3.31%) women infected with Gardnerella vaginalisand Candida albicans, respectively. In addition, 10 women presented atypical squamous cells of unknown significance and 14 lesions suggestive of HPV. Single women, under the age of 30 and who do not use condoms, were found to have a greater chance of getting TV infection. The high prevalence TV found in this population is comparable to highly vulnerable populations, as prisoners, sex workers and women in regions with low socioeconomic levels, moreover, seems to be an underdiagnosis of this infection. Therefore, a routine test program, as well as a review of the diagnostic method used, is encouraged for proper management.	[Barbosa, Marcelo dos Santos; Andrade de Souza, Iara Beatriz; Schnaufer, Erica Cristina dos Santos; Simionatto, Simone; Marchioro, Silvana Beutinger] Univ Fed Grande Dourados UFGD, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil; [da Silva, Liliane Ferreira] Dist Sanit Especial Indigena Mato Grosso do Sul, Campo Grande, MS, Brazil; [Maymone Goncalves, Crhistinne Carvalho] Secretaria Estadual Saude Mato Grosso do Sul, Campo Grande, MS, Brazil; [Marchioro, Silvana Beutinger] Univ Fed Bahia, Lab Imunol & Biol Mol, Inst Ciencias Saude, Salvador, BA, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Bahia	Marchioro, SB (corresponding author), Univ Fed Grande Dourados UFGD, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil.; Marchioro, SB (corresponding author), Univ Fed Bahia, Lab Imunol & Biol Mol, Inst Ciencias Saude, Salvador, BA, Brazil.	silmarchioro@hotmail.com	Marchioro, Silvana/H-7729-2012	Marchioro, Silvana/0000-0003-4282-5871; dos Santos Barbosa, Marcelo/0000-0001-8059-6630; Goncalves, Crhistinne/0000-0001-6953-4965; Andrade de Sousa, Iara Beatriz/0000-0002-5188-0568; Simionatto, Simone/0000-0003-2367-0915	National Council for Scientific and Technological Development (CNPq) [440245/2018-4]; Support Foundation for the Development of Education, Science and Technology of the State of Mato Grosso do Sul (FUNDECT) [092/2015, 041/2017]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES) [001]; Government of the State of Mato Grosso do Sul; Health Department of the state of Mato Grosso do Sul; Proex/Universidade Federal da Grande Dourados (UFGD)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Support Foundation for the Development of Education, Science and Technology of the State of Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Government of the State of Mato Grosso do Sul; Health Department of the state of Mato Grosso do Sul; Proex/Universidade Federal da Grande Dourados (UFGD)	This work was partially supported by the National Council for Scientific and Technological Development (CNPq grant 440245/2018-4), Support Foundation for the Development of Education, Science and Technology of the State of Mato Grosso do Sul (FUNDECT grants 092/2015 and 041/2017), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES, Finance code 001), Government of the State of Mato Grosso do Sul, Health Department of the state of Mato Grosso do Sul and Proex/Universidade Federal da Grande Dourados (UFGD). The sponsors had no role in the collection, analysis, and interpretation of data or the writing of the manuscript.; We thank the team of nurses from the basic health units of the Dourados/MS indigenous reserve for their support during the sample collection. We also appreciate the support of the Government of the State of Mato Grosso do Sul and, Health Department of the state of Mato Grosso do Sul.	[Anonymous], 2014, DREXEL L REV, V6, P409; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2013, CRIT CARE, V17, pR76; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2019, IMMUNE NETW, V19, pe34; Aslan DL, 2005, DIAGN CYTOPATHOL, V32, P341, DOI 10.1002/dc.20256; Carvalho NS, 2011, DST J BRAS DOENCAS S, V23, P142; de Oliveira ACA, 2020, ACTA CYTOL, P1; Donders GGG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0086266; Fichorova RN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0224359; Fonseca THS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5642535; Hobbs MM, 2013, SEX TRANSM INFECT, V89, P434, DOI 10.1136/sextrans-2013-051057; Jorge CA de S, 2015, INSEGURANCA ALIMENTA; Karaman U, ACTA PARASITOL TURC, V32, P309312; Lichtenstein B, 2008, WOMEN HEALTH ISS, V18, P369, DOI 10.1016/j.whi.2008.04.002; Logie CH, 2018, BMJ SEX REPROD HEAL, pbmjsrh; Lopez-Monteon A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/281892; Mabaso N, 2020, INT J STD AIDS, V31, P351, DOI 10.1177/0956462420907758; Mao M, 2015, PATHOG GLOB HEALTH, V109, P242, DOI 10.1179/2047773215Y.0000000020; Masha SC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225545; Norberg AN, 2010, CIENCIA TECNOLOGIA, V80; Nsagha D.S., 2015, AM J EPIDEMIOLOGY IN, V3, P28, DOI 10.12691/ajeid-3- 2-2; Oliveira AB, 2007, REV MED BELEM, V21, P47; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Pereira ER, 2014, REV BRAS PROMOC SAUD, V27, P445; Rowley J, 2019, B WORLD HEALTH ORGAN, V97, P548, DOI 10.2471/BLT.18.228486; SIASI/SESAI. Ministerio da Saude. Secretaria Especial de Saude Indigena. Sistema de InformacAo da AtencAo a Saude Indigena, 2014, QUANT POP IND CAD NO; Taborda W C, 2000, Rev Panam Salud Publica, V7, P92, DOI 10.1590/S1020-49892000000200004; Vieira-Baptista P, 2016, EUR J CLIN MICROBIOL, V35, P657, DOI 10.1007/s10096-016-2584-1; Wiringa AE, 2020, SEX TRANSM INFECT, V96, P436, DOI 10.1136/sextrans-2019-054079; World Health Organisation,, 2016, GLOB HLTH SECT STRAT	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240323	10.1371/journal.pone.0240323	http://dx.doi.org/10.1371/journal.pone.0240323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064733	gold, Green Published			2022-12-26	WOS:000585918300025
J	Sakyi, KS; Lartey, MY; Kennedy, CE; Denison, JA; Sacks, E; Owusu, PG; Hurley, EA; Mullany, LC; Surkan, PJ				Sakyi, Kwame S.; Lartey, Margaret Y.; Kennedy, Caitlin E.; Denison, Julie A.; Sacks, Emma; Owusu, Prince G.; Hurley, Emily A.; Mullany, Luke C.; Surkan, Pamela J.			Stigma toward small babies and their mothers in Ghana: A study of the experiences of postpartum women living with HIV	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; CARE; PRETERM; PHENOMENOLOGY; PERCEPTIONS; DEPRESSION; MORTALITY; INFECTION; CHILDREN; OUTCOMES	Infants born to HIV-infected mothers are more likely to be low birthweight (LBW) than other infants, a condition that is stigmatized in many settings worldwide, including sub-Saharan Africa. Few studies have characterized the social-cultural context and response to LBW stigma among mothers in sub-Saharan Africa or explored the views of women living with HIV (WLHIV) on the causes of LBW. We purposively sampled thirty postpartum WLHIV, who had given birth to either LBW or normal birthweight infants, from two tertiary hospitals in Accra, Ghana. Using semi-structured interviews, we explored women's understanding of the etiology of LBW, and their experiences of caring for a LBW infant. Interviews were analyzed using interpretive phenomenology. Mothers assessed their babies' smallness based on the baby's size, not hospital-recorded birthweight. Several participants explained that severe depression and a loss of appetite, linked to stigma following an HIV diagnosis during pregnancy, contributed to infants being born LBW. Women with small babies also experienced stigma due to the newborns' "undesirable" physical features and other people's unfamiliarity with their size. Consequently, mothers experienced blame, reluctance showing the baby to others, and social gossip. As a result of this stigma, women reported self-isolation and depressive symptoms. These experiences were layered on the burden of healthcare and infant feeding costs for LBW infants. LBW stigma appeared to attenuate with increased infant weight gain. A few of the women also did not breastfeed because they thought their baby's small size indicated pediatric HIV infection. Among WLHIV in urban areas in Ghana, mother and LBW infants may experience LBW-related stigma. A multi-component intervention that includes reducing LBW incidence, treating antenatal depression, providing psychosocial support after a LBW birth, and increasing LBW infants' weight gain are critically needed.	[Sakyi, Kwame S.; Sacks, Emma; Owusu, Prince G.; Hurley, Emily A.; Mullany, Luke C.; Surkan, Pamela J.] Ctr Learning & Childhood Dev Ghana, Accra, Ghana; [Sakyi, Kwame S.; Mullany, Luke C.] Oakland Univ, Sch Hlth Sci, Dept Publ & Environm Wellness, Rochester, MI 48063 USA; [Sakyi, Kwame S.; Kennedy, Caitlin E.; Denison, Julie A.; Sacks, Emma; Mullany, Luke C.; Surkan, Pamela J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Lartey, Margaret Y.] Univ Ghana, Sch Med & Dent, CHS Univ, Dept Med & Therapeut, Accra, Ghana; [Hurley, Emily A.] Childrens Mercy, Hlth Serv & Outcomes Res, Kansas City, MO USA	Oakland University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Ghana; Children's Mercy Hospital	Sakyi, KS (corresponding author), Ctr Learning & Childhood Dev Ghana, Accra, Ghana.; Sakyi, KS (corresponding author), Oakland Univ, Sch Hlth Sci, Dept Publ & Environm Wellness, Rochester, MI 48063 USA.; Sakyi, KS (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	ksakyi@oakland.edu		Kennedy, Caitlin/0000-0001-6820-063X; Sakyi, Kwame/0000-0001-5648-8744; Sacks, Emma/0000-0003-0743-7208; Denison, Julie/0000-0002-4670-093X	Johns Hopkins Center for Qualitative Studies into Health and Medicine	Johns Hopkins Center for Qualitative Studies into Health and Medicine	Data collection for this study was supported by funding from the Johns Hopkins Center for Qualitative Studies into Health and Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aagaard Hanne, 2008, J Pediatr Nurs, V23, pe26, DOI 10.1016/j.pedn.2007.02.003; Agorinya IA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206207; Amegah AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069181; Andreasen J., 2006, RICHS RES, V6; [Anonymous], 2013, LANCET GLOB HEALTH, V1, pe282; [Anonymous], 2014, PLOS ONE, V9, P8; Ansu-Kyeremeh K., 2000, RES REV, V16, P19, DOI DOI 10.4314/RRIAS.V16I2.22892; Ballot DE, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-11; Banchani E, 2020, MATERNAL CHILD HLTH, P1, DOI [10.1007/s10995-020-02899-2, DOI 10.1007/S10995-020-02899-2]; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Cruise SM, 2018, EPIDEMIOL PSYCH SCI, V27, P468, DOI 10.1017/S2045796017000026; Dreyfuss ML, 2001, AM J CLIN NUTR, V74, P814; Edmond KM, 2008, J PERINATOL, V28, P438, DOI 10.1038/jp.2008.19; Enweronu-Laryea CC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204410; Farmer P, 2004, CURR ANTHROPOL, V45, P305, DOI 10.1086/382250; Farmer P, 1996, DAEDALUS, V125, P261; Geis KJ, 1998, SOC PSYCHOL QUART, V61, P232, DOI 10.2307/2787110; Ghana Statistical Service Ghana Health Service & ICF International, 2014, GHAN DEM HLTH SURV 2; Giorgi A, 2000, SCAND J CARING SCI, V14, P11, DOI 10.1111/j.1471-6712.2000.tb00555.x; Goffman E, 2009, STIGMA NOTES MANAGEM; Gold KJ, 2013, PAEDIATR INT CHILD H, V33, P181, DOI 10.1179/2046905513Y.0000000063; Gold KJ, 2013, INT J GYNECOL OBSTET, V120, P228, DOI 10.1016/j.ijgo.2012.09.016; Heidari Haydeh, 2012, Med Arh, V66, P35; Holditch-Davis D, 2015, INFANT BEHAV DEV, V41, P154, DOI 10.1016/j.infbeh.2015.10.004; Hong R, 2007, J COMMUN HEALTH, V32, P21, DOI 10.1007/s10900-006-9032-6; James SE, 2003, AM J COMMUN PSYCHOL, V31, P129, DOI 10.1023/A:1023082822323; Jarde A, 2016, JAMA PSYCHIAT, V73, P826, DOI 10.1001/jamapsychiatry.2016.0934; Kambarami RA, 2002, TROP DOCT, V32, P131, DOI 10.1177/004947550203200303; Karatzias T., 2007, J PRENATAL PERINATAL, V21, P249; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kayode GA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-165; Kwon O, 1998, J KOREAN SOC NEONATO, V41, P307; Laar A. K., 2010, Journal of Public Health and Epidemiology, V2, P224; Landes Donald A., 2012, PHENOMENOLOGY PERCEP; Lee I, 2005, INT J NURS STUD, V42, P21, DOI 10.1016/j.ijnurstu.2004.05.004; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Lopez KA, 2004, QUAL HEALTH RES, V14, P726, DOI 10.1177/1049732304263638; Lupton D, 2013, CHILDHOOD, V20, P37, DOI 10.1177/0907568212447244; Malakouti J, 2013, MOTHERS EXPERIENCE H, DOI [10.1097/JPN.0b013e3182a983be, DOI 10.1097/JPN.0B013E3182A983BE]; Manyeh AK, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0956-2; Mmbando B P, 2008, Tanzan J Health Res, V10, P137; Ohene S, 2014, CHANGING TRENDS MENT, P47; Okyere E, 2010, ANN TROP PAEDIATR, V30, P321, DOI 10.1179/146532810X12858955921311; Parker R, 2012, CAD SAUDE PUBLICA, V28, P164, DOI 10.1590/S0102-311X2012000100017; Piechnik SK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-69; Raqib R, 2007, AM J CLIN NUTR, V85, P845, DOI 10.1093/ajcn/85.3.845; Reddy J., 2007, EXPERIENCES MOTHERS, DOI DOI 10.4102/CURATIONIS.V30I3.1104; Sakyi KS, 2019, AIDS BEHAV, V23, P433, DOI 10.1007/s10461-018-2194-2; Schenk Laura K, 2010, Adv Neonatal Care, V10, P88, DOI 10.1097/ANC.0b013e3181d28330; Scheper-Hughes Nancy, 1993, DEATH WEEPING VIOLEN; Schuler C, 2019, J PEDIATR NURS, V45, pE44, DOI 10.1016/j.pedn.2018.12.017; Smith JA, 2009, QUAL RES PSYCHOL; Taylor HG, 2000, CHILD DEV, V71, P1495, DOI 10.1111/1467-8624.00242; Tufford L, 2012, QUAL SOC WORK, V11, P80, DOI 10.1177/1473325010368316; Turan B, 2017, AIDS BEHAV, V21, P283, DOI 10.1007/s10461-016-1451-5; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; UNICEF WHO, 2004, LOW BIRTH WEIGHT COU; United Nations, 2013, ANN NUMB BIRTHS GHAN; Vesel L, 2013, TROP MED INT HEALTH, V18, P952, DOI 10.1111/tmi.12134; Waiswa P, 2010, TROP MED INT HEALTH, V15, P1140, DOI 10.1111/j.1365-3156.2010.02603.x; White Peter, 2015, Herv. teol. stud., V71, P01, DOI 10.4102/ HTS.V71I3.2762; Wingood GM, 2008, S AFR J SCI, V104, P237; Xiao PL, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0684-z; Yilgwan Christopher S, 2011, Niger J Med, V20, P349	64	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0239310	10.1371/journal.pone.0239310	http://dx.doi.org/10.1371/journal.pone.0239310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064737	gold, Green Published			2022-12-26	WOS:000585918300050
J	Gao, H; Huang, T; Pan, ZQ; Wu, J; Xu, JJ; Hong, J; Chen, W; Wu, HP; Kang, Q; Zhu, L; Fu, LL; Wang, LQ; Li, GG; Deng, ZH; Zhang, H; Xu, H; Zhao, QL; Liu, HS; Wang, LN; Chen, BH; Jin, XM; Huang, MH; Yang, JZ; Gao, MH; Zhou, WT; Xie, HP; Fu, Y; Wen, F; Fu, CB; Zhao, SZ; Yang, YN; Fu, YJ; Yao, T; Wang, CQ; Sun, XN; Gao, XW; Reziwan, M; Deng, YP; Li, J; Liu, LM; Zeng, B; Bao, LY; Wang, H; Zhang, LJ; Li, ZY; Yin, ZJ; Wen, YC; Zheng, X; Du, LQ; Huang, ZP; Sheng, XL; Zhang, H; Chen, LZ; Yan, XM; Liu, XW; Liu, WH; Liu, Y; Liang, L; Wu, PC; Qu, LJ; Cheng, JK; Zhang, H; Qi, QG; Tseten, Y; Ji, JP; Yuan, J; Jie, Y; Xiang, J; Huang, YF; Yang, YL; Li, Y; Hou, YY; Liu, T; Xie, LX; Shi, WY				Gao, Hua; Huang, Ting; Pan, Zhiqiang; Wu, Jie; Xu, Jianjiang; Hong, Jing; Chen, Wei; Wu, Huping; Kang, Qian; Zhu, Lei; Fu, Lingling; Wang, Liqiang; Li, Guigang; Deng, Zhihong; Zhang, Hong; Xu, Hui; Zhao, Qingliang; Liu, Hongshan; Wang, Linnong; Chen, Baihua; Jin, Xiuming; Huang, Minghai; Yang, Jizhong; Gao, Minghong; Zhou, Wentian; Xie, Hanping; Fu, Yao; Wen, Feng; Fu, Changbo; Zhao, Shaozhen; Yang, Yanning; Fu, Yanjiang; Yao, Tao; Wang, Chaoqing; Sun, Xiaonan; Gao, Xiaowei; Reziwan, Maimaitiming; Deng, Yingping; Li, Jian; Liu, Limei; Zeng, Bo; Bao, Lianyun; Wang, Hua; Zhang, Lijun; Li, Zhiyuan; Yin, Zhijian; Wen, Yuechun; Zheng, Xiao; Du, Liqun; Huang, Zhenping; Sheng, Xunlun; Zhang, Hui; Chen, Lizhong; Yan, Xiaoming; Liu, Xiaowei; Liu, Wenhui; Liu, Yuan; Liang, Liang; Wu, Pengcheng; Qu, Lijun; Cheng, Jinkui; Zhang, Hua; Qi, Qige; Tseten, Yangkyi; Ji, Jianping; Yuan, Jin; Jie, Ying; Xiang, Jun; Huang, Yifei; Yang, Yuli; Li, Ying; Hou, Yiyi; Liu, Tong; Xie, Lixin; Shi, Weiyun			Survey report on keratoplasty in China: A 5-year review from 2014 to 2018	PLOS ONE			English	Review							DEEP ANTERIOR LAMELLAR; PENETRATING KERATOPLASTY; VISION IMPAIRMENT; UNITED-STATES; BLINDNESS; TRENDS; KERATOCONUS; DISTANCE; SHANDONG	To provide the general information on corneal transplantation (CT) in China, China Cornea Society designed a questionnaire on CT from 2014 to 2018 and entrusted it to 31 committee members for implementation of the survey nationwide. This article presents the results of the survey and compares the indicators used in the survey and those in the annual statistical report released by the Eye Bank Association of America (EBAA). The number of corneal transplantations completed by the 64 hospitals from 2014 to 2018 was respectively 5377, 6394, 7595, 8270 and 8980, totally 36,616 (22,959 male and 13,657 female). The five largest hospitals by the number of corneal transplantations completed 15,994 surgeries in total, accounting for 43.68% of all the surgeries performed in the 64 hospitals. The most common indication for corneal transplantations was corneal leukoma (7683, 20.98%), followed by bacterial keratitis (4209, 11.49%), corneal dystrophies (4189, 11.44%), keratoconus (3578, 9.77%) and corneal perforation (2839, 7.75%). The main surgical techniques were penetrating keratoplasty (PK) (19,896, 54.34%), anterior lamellar keratoplasty (ALK) (13,869, 37.88%). The proportion of PK decreased from 57.97% in 2014 to 52.88% in 2018 while the proportion of ALK increased from 36.04% in 2014 to 37.92% in 2018. The geographical distribution of keratoplasties performed in China is unbalanced. PK and ALK were the main techniques of CT and corneal leukoma, bacterial keratitis and corneal dystrophies were the main indications for CT in China.	[Gao, Hua; Hou, Yiyi; Liu, Tong; Shi, Weiyun] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Dept Ophthalmol,Eye Hosp,Shandong Med Univ 1, Jinan, Peoples R China; [Gao, Hua; Huang, Ting; Pan, Zhiqiang; Wu, Jie; Xu, Jianjiang; Hong, Jing; Chen, Wei; Zhu, Lei; Wang, Liqiang; Li, Guigang; Zhang, Hong; Wang, Linnong; Chen, Baihua; Jin, Xiuming; Gao, Minghong; Xie, Hanping; Fu, Yao; Zhao, Shaozhen; Yang, Yanning; Gao, Xiaowei; Deng, Yingping; Wang, Hua; Zhang, Lijun; Zhang, Hui; Yan, Xiaoming; Yuan, Jin; Huang, Yifei; Yang, Yuli; Li, Ying; Xie, Lixin; Shi, Weiyun] Chinese Med Assoc China Cornea Soc, Corneal Dis Grp Ophthalmol Soc, Jinan, Peoples R China; [Huang, Ting; Ji, Jianping; Yuan, Jin] Sun Yat Sen Univ, Dept Ophthalmol, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China; [Pan, Zhiqiang; Jie, Ying] Capital Med Univ, Beijing Tongren Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Wu, Jie] 1 Hosp Xian City, Dept Ophthalmol, Xian, Peoples R China; [Xu, Jianjiang; Xiang, Jun] Fudan Univ, Eye & Ear Nose Throat Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Hong, Jing] Peking Univ Third Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Chen, Wei] Wenzhou Med Univ, Dept Ophthalmol, Eye Hosp, Wenzhou, Peoples R China; [Wu, Huping] Xiamen Univ, Dept Ophthalmol, Affiliated Xiamen Eye Ctr, Xiamen, Peoples R China; [Kang, Qian] Chengdu AiDi Eye Hosp, Dept Ophthalmol, Chengdu, Peoples R China; [Zhu, Lei] Henan Eye Hosp, Henan Eye Inst, Dept Ophthalmol, Zhengzhou, Peoples R China; [Fu, Lingling] Hefei Puri Ophthalmol Hosp, Dept Ophthalmol, Hefei, Peoples R China; [Wang, Liqiang; Huang, Yifei] Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Ophthalmol, Beijing, Peoples R China; [Li, Guigang] Huazhong Univ Sci & Technol, TongJi Hosp, Dept Ophthalmol, Tongji Med Coll, Wuhan, Peoples R China; [Deng, Zhihong] Cent South Univ, Dept Ophthalmol, Xiangya Hosp 3, Changsha, Peoples R China; [Zhang, Hong] Harbin Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Harbin, Peoples R China; [Xu, Hui] First Hosp Jilin Univ, Dept Ophthalmol, Changchun, Peoples R China; [Zhao, Qingliang] Suzhou Lixiang Eye Hosp, Dept Ophthalmol, Suzhou, Peoples R China; [Liu, Hongshan] Hainan Eye Hosp, Hainan Eye Inst, Dept Ophthalmol, Haikou, Hainan, Peoples R China; [Wang, Linnong] Nanjing Med Univ, Nanjing Hosp 1, Dept Ophthalmol, Nanjing, Peoples R China; [Chen, Baihua] Cent South Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Peoples R China; [Jin, Xiuming] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Ophthalmol, Hangzhou, Peoples R China; [Huang, Minghai] Nanning Aier Eye Hosp, Dept Ophthalmol, Nanning, Peoples R China; [Yang, Jizhong] Shanxi Eye Hosp, Dept Ophthalmol, Taiyuan, Peoples R China; [Gao, Minghong] Northern Theater Command Hosp, Dept Ophthalmol, Gen Hosp, Shenyang, Peoples R China; [Zhou, Wentian] Nanchang Univ, Dept Ophthalmol, Affiliated Eye Hosp, Nanchang, Jiangxi, Peoples R China; [Xie, Hanping; Yang, Yuli] Army Med Univ, Dept Ophthalmol, Hosp 1, Chongqing, Peoples R China; [Fu, Yao] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Ophthalmol, Sch Med, Shanghai, Peoples R China; [Wen, Feng] Ningbo Eye Hosp, Dept Ophthalmol, Ningbo, Peoples R China; [Fu, Changbo] Xuzhou Med Univ, Dept Ophthalmol, Xuzhou Municipal Hosp, Xuzhou, Jiangsu, Peoples R China; [Zhao, Shaozhen] Tianjin Med Univ, Dept Ophthalmol, Eye Hosp, Tianjin, Peoples R China; [Yang, Yanning] Wuhan Univ, Dept Ophthalmol, Renmin Hosp, Wuhan, Peoples R China; [Fu, Yanjiang] Daqing Ophthalmol Hosp, Dept Ophthalmol, Daqing, Peoples R China; [Yao, Tao] Shenyang He Eye Hosp, Dept Ophthalmol, Shenyang, Peoples R China; [Wang, Chaoqing] Jinan Mingshui Eye Hosp, Dept Ophthalmol, Jinan, Peoples R China; [Sun, Xiaonan] 4th Peoples Hosp Shenyang, Dept Ophthalmol, Shenyang, Peoples R China; [Gao, Xiaowei] 474 Hosp PLA, Dept Ophthalmol, Urumqi, Peoples R China; [Reziwan, Maimaitiming] Urumqi City Ophthalmol & Otolaryngol Hosp, Dept Ophthalmol, Urumqi, Peoples R China; [Deng, Yingping] Sichuan Univ, Dept Ophthalmol, West China Hosp, Chengdu, Peoples R China; [Li, Jian] Nanjing Med Univ, Jiangsu Prov Hosp, Dept Ophthalmol, Affiliated Hosp 1, Nanjing, Peoples R China; [Liu, Limei] Weifang Eye Hosp, Dept Ophthalmol, Weifang, Peoples R China; [Zeng, Bo] Gen Hosp Cent Theater Chinese Peoples Liberat Arm, Dept Ophthalmol, Wuhan, Peoples R China; [Bao, Lianyun] Nanjing Ningyi Eye Ctr, Dept Ophthalmol, Nanjing, Peoples R China; [Wang, Hua] Cent South Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Peoples R China; [Zhang, Lijun] Dalian Med Univ, Peoples Hosp Dalian 3, Dept Ophthalmol, Dalian, Peoples R China; [Li, Zhiyuan] Peoples 1 Hosp Chenzhou, Dept Ophthalmol, Chenzhou, Peoples R China; [Yin, Zhijian] Dali Univ, Dept Ophthalmol, Affiliated Hosp 1, Dali, Peoples R China; [Wen, Yuechun] Univ Sci & Technol China, Anhui Prov Hosp, Dept Ophthalmol, Affiliated Hosp 1, Hefei, Peoples R China; [Zheng, Xiao] Army Characterist Med Ctr, Dept Ophthalmol, Chongqing, Peoples R China; [Du, Liqun] Shandong Univ, Dept Ophthalmol, Qilu Hosp, Jinan, Peoples R China; [Huang, Zhenping] Nanjing Univ, Jinling Hosp, Dept Ophthalmol, Sch Med, Nanjing, Peoples R China; [Sheng, Xunlun] Ningxia Eye Hosp, Peoples Hosp Ningxia Hui Autonomous Reg, Dept Ophthalmol, Yinchuan, Ningxia, Peoples R China; [Zhang, Hui] Kunming Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Chen, Lizhong] Lunan Eye Hosp, Dept Ophthalmol, Linyi, Shandong, Peoples R China; [Yan, Xiaoming] Peking Univ First Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Liu, Xiaowei; Li, Ying] Chinese Acad Med Sci & Peking Union Med Coll, Dept Ophthalmol, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Liu, Wenhui] Wuxi Second Peoples Hosp, Dept Ophthalmol, Wuxi, Jiangsu, Peoples R China; [Liu, Yuan] Guizhou Jinglang Eye Hosp, Dept Ophthalmol, Guiyang, Peoples R China; [Liang, Liang] Yichang Cent Peoples Hosp, Dept Ophthalmol, Yichang, Peoples R China; [Wu, Pengcheng] Lanzhou Univ, Dept Ophthalmol, Hosp 2, Lanzhou, Peoples R China; [Qu, Lijun] Harbin Med Univ, Dept Ophthalmol, Affiliated Hosp 2, Harbin, Peoples R China; [Cheng, Jinkui] Jingzhou First Peoples Hosp, Dept Ophthalmol, Jingzhou, Peoples R China; [Zhang, Hua] Shijiazhuang 1 Hosp, Dept Ophthalmol, Shijiazhuang, Hebei, Peoples R China; [Qi, Qige] Hulunbuir Peoples Hosp, Dept Ophthalmol, Hulunbuir, Peoples R China; [Tseten, Yangkyi] Tibetan Tradit Tibet Med Hosp Tibet Autonomous Re, Dept Ophthalmol, Lhasa, Peoples R China; [Xie, Lixin] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Prov Key Lab Ophthalmol, Shandong Med Univ 1,State Key Lab Cultivat Base, Dept Ophthalmol,Shandong Eye Inst,Qingdao Eye Hos, Qingdao, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Sun Yat Sen University; Capital Medical University; Fudan University; Peking University; Wenzhou Medical University; Xiamen University; Chinese People's Liberation Army General Hospital; Huazhong University of Science & Technology; Central South University; Harbin Medical University; Jilin University; Nanjing Medical University; Central South University; Zhejiang University; Shanxi Medical University; Nanchang University; Army Medical University; Shanghai Jiao Tong University; Xuzhou Medical University; Tianjin Medical University; Wuhan University; Sichuan University; Nanjing Medical University; Central South University; Dalian Medical University; Dali University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Shandong University; Nanjing University; Kunming Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Lanzhou University; Harbin Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences	Shi, WY (corresponding author), Shandong First Med Univ & Shandong Acad Med Sci, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Dept Ophthalmol,Eye Hosp,Shandong Med Univ 1, Jinan, Peoples R China.; Xie, LX; Shi, WY (corresponding author), Chinese Med Assoc China Cornea Soc, Corneal Dis Grp Ophthalmol Soc, Jinan, Peoples R China.; Xie, LX (corresponding author), Shandong First Med Univ & Shandong Acad Med Sci, Shandong Prov Key Lab Ophthalmol, Shandong Med Univ 1,State Key Lab Cultivat Base, Dept Ophthalmol,Shandong Eye Inst,Qingdao Eye Hos, Qingdao, Peoples R China.	weiyunshi@163.com; wyshi@sdfmu.edu.cn	li, jian/GSE-0245-2022; Li, Jing/GYU-5036-2022; Li, Jin/GYQ-5363-2022; Xie, li/HGE-6052-2022; li, zhiyuan/HGD-9581-2022; Jin, Xiuming/AGO-9685-2022; LI, JIAN/GRY-2197-2022	Jin, Xiuming/0000-0001-7492-5143; 	National Natural Science Foundation of China [81570821, 81870639]; Key Project of National Natural Science Foundation of China [81530027]; Taishan Scholar Program [20150215, 201812150]; Innovation Project of Shandong Academy of Medical Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Program; Innovation Project of Shandong Academy of Medical Sciences	This study was supported by National Natural Science Foundation of China, grant number: 81570821 (HG), 81870639(HG); Key Project of National Natural Science Foundation of China, grant number: 81530027 (WS); Taishan Scholar Program, grant number: 20150215 (WS), 201812150(HG); and the Innovation Project of Shandong Academy of Medical Sciences (HG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland Peter, 2017, Community Eye Health, V30, P71; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2011, BUSINESS ENV 1, V22, P4; Borderie VM, 2012, OPHTHALMOLOGY, V119, P249, DOI 10.1016/j.ophtha.2011.07.057; Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0; Choi HJ, 2014, XENOTRANSPLANTATION, V21, P115, DOI [10.1111/xen.12075, 10.1111/xen.12082]; Darlington JK, 2006, OPHTHALMOLOGY, V113, P2171, DOI 10.1016/j.ophtha.2006.06.034; Eye bank association of America, 2019, 2018 EYE BANK STAT R; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Gao H, 2019, Zhonghua Yan Ke Za Zhi, V55, P625, DOI 10.3760/cma.j.issn.0412-4081.2019.08.016; Gomes JAP, 2015, CORNEA, V34, P359, DOI 10.1097/ICO.0000000000000408; Gordon-Shaag A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/795738; Guan Huai-jin, 2010, Zhonghua Yan Ke Za Zhi, V46, P938; Heindl LM, 2011, OPHTHALMOLOGY, V118, P294, DOI 10.1016/j.ophtha.2010.05.025; Hong Jia-Xu, 2007, Zhonghua Yan Ke Za Zhi, V43, P303; Huang T, 2012, AM J OPHTHALMOL, V154, P282, DOI 10.1016/j.ajo.2012.02.025; Li Su-xia, 2011, Zhonghua Yan Ke Za Zhi, V47, P837; Li SX, 2014, AM J OPHTHALMOL, V158, P26, DOI 10.1016/j.ajo.2014.03.011; Park CY, 2015, OPHTHALMOLOGY, V122, P2432, DOI 10.1016/j.ophtha.2015.08.017; Qu LJ, 2010, CHINESE MED J-PEKING, V123, P3268, DOI 10.3760/cma.j.issn.0366-6999.2010.22.018; Rong SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04393-2; Shi WY, 2010, OPHTHALMOLOGY, V117, P226, DOI 10.1016/j.ophtha.2009.07.005; Song XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113843; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Tur VM, 2017, SURV OPHTHALMOL, V62, P770, DOI 10.1016/j.survophthal.2017.06.009; Wang JY, 2011, INT J OPHTHALMOL-CHI, V4, P492, DOI 10.3980/j.issn.2222-3959.2011.05.07; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Xie L, 2009, BRIT J OPHTHALMOL, V93, P1291, DOI 10.1136/bjo.2008.148981; Xie Li-xin, 2006, Zhonghua Yan Ke Za Zhi, V42, P704; Xie LX, 2006, OPHTHALMOLOGY, V113, P1943, DOI 10.1016/j.ophtha.2006.05.035; Yan W, 2019, CLIN EXP OPHTHALMOL, V47, P453, DOI 10.1111/ceo.13430; Zhang CR, 2005, GRAEF ARCH CLIN EXP, V243, P1005, DOI 10.1007/s00417-005-1167-0; Zhang Ming-Chang, 2007, Zhonghua Yan Ke Za Zhi, V43, P289; Zhang S Y, 1992, Zhonghua Yan Ke Za Zhi, V28, P260; Zhang YN, 2018, CORNEA, V37, P1243, DOI 10.1097/ICO.0000000000001695; Zhao JL, 2018, AM J OPHTHALMOL, V193, P62, DOI 10.1016/j.ajo.2018.06.004	37	8	10	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0239939	10.1371/journal.pone.0239939	http://dx.doi.org/10.1371/journal.pone.0239939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057425	Green Published, gold			2022-12-26	WOS:000581814700067
J	Makino, Y; Ichinose, K; Yoshimura, M; Kawahara, Y; Yuge, L				Makino, Yoshio; Ichinose, Kanji; Yoshimura, Masatoshi; Kawahara, Yumi; Yuge, Louis			Efficient preservation of sprouting vegetables under simulated microgravity conditions	PLOS ONE			English	Article							MODIFIED ATMOSPHERE; FRUIT; STAGE	The effectiveness of a simulated microgravity environment as a novel method for preserving the freshness of vegetables was investigated. Three types of vegetables were selected: vegetable soybean, mung bean sprouts, and white radish sprouts. These selected vegetables were fixed on a three-dimensional rotary gravity controller, rotated slowly. The selected vegetables were stored at 25 degrees C and 66% of relative humidity for 9, 6, or 5 d while undergoing this process. The simulated microgravity was controlled utilizing a gravity controller around 0 m s(-2). The mung bean sprouts stored for 6 d under simulated microgravity conditions maintained higher thickness levels than the vegetable samples stored under normal gravity conditions (9.8 m s(-2)) for the same duration. The mass of all three items decreased with time without regard to the gravity environment, though the samples stored within the simulated microgravity environment displayed significant mass retention on and after 3 d for mung bean sprout samples and 1 d for white radish sprout samples. In contrast, the mass retention effect was not observed in the vegetable soybean samples. Hence, it was confirmed that the mass retention effect of microgravity was limited to sprout vegetables. As a result of analysis harnessing a mathematical model, assuming that the majority of the mass loss is due to moisture loss, a significant difference in mass reduction coefficient occurs among mung bean sprouts and white radish sprouts due to the microgravity environment, and the mass retention effect of simulated microgravity is quantitatively evaluated utilizing mathematical models. Simulated microgravity, which varies significantly from conventional refrigeration, ethylene control, and modified atmosphere, was demonstrated effective as a novel method for preserving and maintaining the freshness of sprout vegetables. This founding will support long-term space flight missions by prolonging shelf life of sprout vegetables.	[Makino, Yoshio; Ichinose, Kanji; Yoshimura, Masatoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Kawahara, Yumi; Yuge, Louis] Space Biolabs Co Ltd, Hiroshima, Japan; [Yuge, Louis] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	University of Tokyo; Hiroshima University	Makino, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	amakino@mail.ecc.u-tokyo.ac.jp	; Makino, Yoshio/A-3678-2015	Ichinose, Kunihiro/0000-0001-8794-7106; Makino, Yoshio/0000-0002-8635-8382				Akbudak B, 2007, J FOOD QUALITY, V30, P896, DOI 10.1111/j.1745-4557.2007.00168.x; [Anonymous], 2002, POSTHARVEST TECHNOLO; Bird RB, 1960, TRANSPORT PHENOMENA, P499; Boerzhijin S, 2020, FOOD PACKAGING SHELF, V23, DOI 10.1016/j.fpsl.2019.100427; Bovi GG, 2016, BIOSYST ENG, V150, P24, DOI 10.1016/j.biosystemseng.2016.07.013; Cia P, 2006, POSTHARVEST BIOL TEC, V42, P228, DOI 10.1016/j.postharvbio.2006.06.016; El Masri D, 2012, SOFT MATTER, V8, P6979, DOI 10.1039/c2sm07217c; Ferguson IB, 1998, AUST J PLANT PHYSIOL, V25, P155, DOI 10.1071/PP97093; Furukawa T, 2018, NPJ MICROGRAVITY, V4, DOI 10.1038/s41526-018-0045-0; Hirai H, 2009, ANN NY ACAD SCI, V1161, P166, DOI 10.1111/j.1749-6632.2009.04093.x; Kagawa A, 2020, STAND TABL FOOD COMP; KAILASAPATHY K, 1986, J AGR FOOD CHEM, V34, P259, DOI 10.1021/jf00068a026; Kitaya Y, 2004, ADV SPACE RES-SERIES, V34, P1466, DOI 10.1016/j.asr.2003.08.031; Koide S, 2015, AGRI FOOD PROCESS EN, P185; Leitz G, 2009, PLANT CELL, V21, P843, DOI 10.1105/tpc.108.065052; Li BB, 2020, IN VITRO CELL DEV-AN, V56, P200, DOI 10.1007/s11626-020-00435-8; Li H, 2018, FOOD QUAL SAF-OXFORD, V2, P111, DOI 10.1093/fqsafe/fyy016; Li L, 2015, J FOOD PROCESS PRES, V39, P2533, DOI 10.1111/jfpp.12504; Makino Y., 2016, Agricultural Sciences, V7, P327, DOI 10.4236/as.2016.76033; Makino Y, 2020, FOODS, V9, DOI 10.3390/foods9050558; Makino Y, 2020, FOODS, V9, DOI 10.3390/foods9040380; Makino Y, 2020, FOOD CHEM, V317, DOI 10.1016/j.foodchem.2020.126380; Nagano T., 1976, Journal of Agricultural Meteorology, V32, P67, DOI 10.2480/agrmet.32.67; NAKHASI S, 1991, J FOOD SCI, V56, P55, DOI 10.1111/j.1365-2621.1991.tb07974.x; Paul AL, 2013, AM J BOT, V100, P226, DOI 10.3732/ajb.1200338; Takahashi H, 2000, PLANTA, V210, P515, DOI 10.1007/s004250050039; Thompson A.K., 1998, CONTROLLED ATMOSPHER; Toyota M, 2013, PLANT PHYSIOL, V163, P543, DOI 10.1104/pp.113.223313; Uemura M, 2011, United States Patent, Patent No. [US 8,034,616 B2., 8034616]; Wang HW, 2017, J AGR FOOD CHEM, V65, P8538, DOI 10.1021/acs.jafc.7b02318; Watkins CB, 2006, BIOTECHNOL ADV, V24, P389, DOI 10.1016/j.biotechadv.2006.01.005; Xie JY, 2020, ACTA ASTRONAUT, V166, P567, DOI 10.1016/j.actaastro.2018.11.014; Xu DQ, 2013, PLANT PHYSIOL BIOCH, V66, P10, DOI 10.1016/j.plaphy.2013.01.021	33	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240809	10.1371/journal.pone.0240809	http://dx.doi.org/10.1371/journal.pone.0240809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057413	gold, Green Published			2022-12-26	WOS:000581814700027
J	Iizuka, O; Kawamura, S; Tero, A; Uemura, A; Miura, T				Iizuka, Osamu; Kawamura, Shotaro; Tero, Atsushi; Uemura, Akiyoshi; Miura, Takashi			Remodeling mechanisms determine size distributions in developing retinal vasculature	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; FRACTAL ANALYSIS; SCALING LAWS; BLOOD-VESSELS; PATTERN; PRINCIPLE; DISEASE; IMAGE; MODEL	The development of retinal blood vessels has extensively been used as a model to study vascular pattern formation. To date, various quantitative measurements, such as size distribution have been performed, but the relationship between pattern formation mechanisms and these measurements remains unclear. In the present study, we first focus on the islands (small regions subdivided by the capillary network). We quantitatively measured the island size distribution in the retinal vascular network and found that it tended to exhibit an exponential distribution. We were able to recapitulate this distribution pattern in a theoretical model by implementing the stochastic disappearance of vessel segments around arteries could reproduce the observed exponential distribution of islands. Second, we observed that the diameter distribution of the retinal artery segment obeyed a power law. We theoretically showed that an equal bifurcation branch pattern and Murray's law could reproduce this pattern. This study demonstrates the utility of examining size distribution for understanding the mechanisms of vascular pattern formation.	[Iizuka, Osamu; Kawamura, Shotaro] Kyushu Univ, Sch Med, Fukuoka, Fukuoka, Japan; [Tero, Atsushi] Kyushu Univ, Inst Math Ind, Fukuoka, Fukuoka, Japan; [Uemura, Akiyoshi] Nagoya City Univ, Grad Sch Med, Dept Retinal Vasc Biol, Nagoya, Aichi, Japan; [Miura, Takashi] Kyushu Univ, Grad Sch Med Sci, Dept Anat & Cell Biol, Fukuoka, Fukuoka, Japan	Kyushu University; Kyushu University; Nagoya City University; Kyushu University	Miura, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Anat & Cell Biol, Fukuoka, Fukuoka, Japan.	miura_t@anat1.med.kyushu-u.ac.jp	Miura, Takashi/AAF-3003-2021; Uemura, Akiyoshi/I-7510-2017	Miura, Takashi/0000-0002-9465-275X; Uemura, Akiyoshi/0000-0001-5574-5470	JSPS Kakenhi [15KT0018, JST188CREST, JPMJCR14W4]; Hayashi Eye Hospital Basic Medical Science Grant (2020, Kyushu University)	JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hayashi Eye Hospital Basic Medical Science Grant (2020, Kyushu University)	T. M. JSPS Kakenhi (Grant No. 15KT0018) T. M. JST188CREST (Grant No. JPMJCR14W4) Hayashi Eye Hospital Basic Medical Science Grant (2020, Kyushu University)	Aghamirmohammadali SMA, 2018, ROYAL SOC OPEN SCI, V5, DOI [10.1098/rsos.171639, DOI 10.1098/RS0S.17163929892362]; ASHTON N, 1970, BRIT MED BULL, V26, P103, DOI 10.1093/oxfordjournals.bmb.a070758; Cavallari M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019150; Cheung N, 2010, ANN NEUROL, V68, P107, DOI 10.1002/ana.22011; DD K., 1993, AM J PHYSIOL, V265, pH586; Doubal FN, 2010, NEUROLOGY, V74, P1102, DOI 10.1212/WNL.0b013e3181d7d8b4; FAMILY F, 1989, PHYSICA D, V38, P98, DOI 10.1016/0167-2789(89)90178-4; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Honda H, 1997, DEV GROWTH DIFFER, V39, P581; Hughes AFW, 1937, J ANAT, V72, P1; Huo YL, 2012, J R SOC INTERFACE, V9, P190, DOI 10.1098/rsif.2011.0270; Kassab GS, 2006, AM J PHYSIOL-HEART C, V290, pH894, DOI 10.1152/ajpheart.00579.2005; Liew G, 2011, EUR HEART J, V32, P422, DOI 10.1093/eurheartj/ehq431; Lim Shueh Wen, 2009, DIABETES CARE, V32, P2, DOI 10.2337/dc09-0719; Lorthois S, 2010, J THEOR BIOL, V262, P614, DOI 10.1016/j.jtbi.2009.10.037; Masters BR, 2004, ANNU REV BIOMED ENG, V6, P427, DOI 10.1146/annurev.bioeng.6.040803.140100; McDougall SR, 2012, B MATH BIOL, V74, P2272, DOI 10.1007/s11538-012-9754-9; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Murray CD, 1926, J GEN PHYSIOL, V9, P835, DOI 10.1085/jgp.9.6.835; Oka S, 1974, RHEOLOGY BIORHEOLOGY; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; Qi YX, 2011, P NATL ACAD SCI USA, V108, P1908, DOI 10.1073/pnas.1019219108; Rust R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40135-2; Sapieha P, 2012, BLOOD, V120, P2182, DOI 10.1182/blood-2012-04-396846; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semenza GL, 2000, GENE DEV, V14, P1983; Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Zhou J, 2014, ARTERIOSCL THROM VAS, V34, P2191, DOI 10.1161/ATVBAHA.114.303422	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0235373	10.1371/journal.pone.0235373	http://dx.doi.org/10.1371/journal.pone.0235373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052908	Green Published, Green Submitted, gold			2022-12-26	WOS:000581820200035
J	Kouakou, JL; Bi, SG; Bitty, EA; Kouakou, C; Yao, AK; Kasse, KB; Ouattara, S				Kouakou, Jean-Louis; Gonedele Bi, Sery; Bitty, Eloi Anderson; Kouakou, Celestin; Yao, Alphonse Kouassi; Kasse, Kouadio Benoitype; Ouattara, Soulemane			Ivory Coast without ivory: Massive extinction of African forest elephants in Cote d'Ivoire	PLOS ONE			English	Article							BIODIVERSITY; DEFORESTATION; LAND; DIET; WAR	In pre-colonial and colonial times Cote d'Ivoire probably hosted one of the largest elephant populations in West Africa, resulting in the country's name Cote d'Ivoire (in English Ivory Coast) by French settlers. Numbers declined and by the early 90s it was estimated that the total number of both savannah and forest elephants had reached 63 to 360 elephants in the entire country. Here we present updated information on the distribution and conservation status of forest elephant in Cote d'Ivoire based on multiple sources-dung counts on line transects, records of human-elephant conflict, media reports, sign and interview surveys-obtained during the period 2011-2017. We used Pearson correlation to determine the correlation between the presence of forest elephant and site variables (size of the forest, percentage of area converted into plantation, size of the forest left, size of human population inside the PA, poaching index, distance to the nearest road, population density in the Department, level of protection of the PA). To examine the effect of ecological traits on elephant extirpation, we used Principal Components Analysis (PCA) to check for multicollinearity among variables. Based on dung count elephant presence was confirmed in only 4 of the 25 protected areas surveyed. PAs with higher level of protection have higher probability to be home of elephant population. The viability of these populations is uncertain, since they have a small size and are isolated. Aggressive conservation actions including law enforcement for the protection of their remaining habitat and ranger patrolling are needed to protect the remaining forest elephant populations.	[Kouakou, Jean-Louis; Gonedele Bi, Sery; Bitty, Eloi Anderson; Yao, Alphonse Kouassi; Kasse, Kouadio Benoitype; Ouattara, Soulemane] Univ Felix Houphouet Boigny Abidjan Cocody, Lab Milieux Nat & Conservat Biodiversite, Abidjan, Cote Ivoire; [Gonedele Bi, Sery; Bitty, Eloi Anderson; Kouakou, Celestin] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Kouakou, Celestin] Univ Jean Lorougnon Guede, Unite Format & Rech Environm, Daloa, Cote Ivoire		Bi, SG (corresponding author), Univ Felix Houphouet Boigny Abidjan Cocody, Lab Milieux Nat & Conservat Biodiversite, Abidjan, Cote Ivoire.; Bi, SG (corresponding author), Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire.	sery.gonedele@univ-fhb.edu.ci		KOUAKOU, CELESTIN YAO/0000-0001-8439-4067; Gonedele, Sery/0000-0002-2760-2795				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Anderson DR, 2001, J WILDLIFE MANAGE, V65, P373, DOI 10.2307/3803088; [Anonymous], 2014, SAVE ELEPHANTS SITUA; [Anonymous], 2005, STRATEGIE GESTION DU; Barbieri C, 2012, TOURISM MANAGE, V33, P509, DOI 10.1016/j.tourman.2011.05.009; Barnes R., 1999, AFRICAN ELEPHANT DAT; Barnes RFW, 1999, AFRICAN ELEPHANT DAT, P22; Baskaran N, 2011, KARNATAKA ELEPHANT C; Bitty EA, 2015, TROP CONSERV SCI, V8, P95, DOI 10.1177/194008291500800110; Bitty EA, 2013, AM J PHYS ANTHROPOL, V150, P81; Blanc J.J., 2003, AFRICAN ELEPHANT STA; Bonfoh B, 2011, NATURE, V474, P569, DOI 10.1038/474569a; Bouche P, 2004, PACHYDERM, V37, P85; Brou YT, 1999, CONTRIBUTIONS ANAL I, VIIa, P833; BUCKLAND ST, 1992, BIOMETRICS, V48, P901, DOI 10.2307/2532356; Burn RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024165; Burnham K. P., 1980, WILDLIFE MONOGR, V72, P3, DOI DOI 10.2307/2981804; Burnham K. P., 1998, MODEL SELECTION INFE; Caspary HU, 1999, TOB SERIE, VN F-V/10f, P184; Chakravarty S, 2012, DEFORESTATION CAUSES; Chatterjee S., 2015, REGRESSION ANAL EXAM; CITES, 2012, CONV INT TRAD END SP; Douglas-Hamilton I, 1992, BATTLE ELEPHANTS; Dublin H.T., 1995, 4 YEARS CITES BAN IL; Dudley JP, 2002, CONSERV BIOL, V16, P319, DOI 10.1046/j.1523-1739.2002.00306.x; Eggert LS, 2002, P ROY SOC B-BIOL SCI, V269, P1993, DOI 10.1098/rspb.2002.2070; FEER F, 1995, AFR J ECOL, V33, P279, DOI 10.1111/j.1365-2028.1995.tb00808.x; Fischer F., 2004, PARKS, V14, P17; Fischer Frauke, 2005, Pachyderm, V38, P64; Gilbert N, 2010, NATURE, DOI [10.1038/news.2010.691, DOI 10.1038/NEWS.2010.691]; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Hanson T, 2009, CONSERV BIOL, V23, P578, DOI 10.1111/j.1523-1739.2009.01166.x; IUCN Red, 2015, IUCN RED LIST THREAT; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Martin E, 2010, PACHYDERM, P24; McPherson MA, 2000, CONTEMP ECON POLICY, V18, P14, DOI 10.1093/cep/18.1.14; Micklin Joan, 1989, AM FILM, V14, P22; Morris RJ, 2010, PHILOS T R SOC B, V365, P3709, DOI 10.1098/rstb.2010.0273; Nasi R, 2008, TECHNICAL SERIES, V50; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; OIPR, 2011, RAPP INV EL PARC NAT, P40; Okoumassou K., 1998, Pachyderm, V26, P52; Ouattara S, 2002, PACHYDERM, V32, P12; Powell J, 1997, THESIS; ROTH HH, 1991, MAMMALIA, V55, P489, DOI 10.1515/mamm.1991.55.4.489; Roth V.L., 1984, Journal of Vertebrate Paleontology, V4, P126; Rutagarama E, 2006, GEOGR J, V172, P291, DOI 10.1111/j.1475-4959.2006.00217.x; Scholte P, 2007, AFR J ECOL, V45, P431, DOI 10.1111/j.1365-2028.2007.00774.x; SHORT J, 1981, MAMMALIA, V45, P177, DOI 10.1515/mamm.1981.45.2.177; SPSS IBM, IBM STAT WIND VERS 2; Symstad AJ, 1998, OIKOS, V81, P389, DOI 10.2307/3547058; van Vliet N, 2007, AFR J ECOL, V45, P440, DOI 10.1111/j.1365-2028.2007.00783.x; Varma S, 2012, SYNCHRONIZED POPULAT; White GC, 2001, MODELING IN NATURAL RESOURCE MANAGEMENT: DEVELOPMENT INTERPRETATION AND APPLICATION, P35; WHITE LJT, 1993, AFR J ECOL, V31, P181, DOI 10.1111/j.1365-2028.1993.tb00532.x; Woods D, 2003, J MOD AFR STUD, V41, P641, DOI 10.1017/S0022278X03004427	56	1	1	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0232993	10.1371/journal.pone.0232993	http://dx.doi.org/10.1371/journal.pone.0232993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3XB	33052917	Green Published, gold			2022-12-26	WOS:000581820200045
J	Tan, H; Fulton, RE; Chou, WH; Birkholz, DA; Mannino, MP; Yamaguchi, DM; Aldrich, JC; Jacobsen, TL; Britt, SG				Tan, Hong; Fulton, Ruth E.; Chou, Wen-Hai; Birkholz, Denise A.; Mannino, Meridee P.; Yamaguchi, David M.; Aldrich, John C.; Jacobsen, Thomas L.; Britt, Steven G.			Drosophila R8 photoreceptor cell subtype specification requires hibris	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; AXONAL PROJECTIONS; PROTEIN; COLOR; R7; MELANOGASTER; SYSTEM; LOCUS; FATES	Cell differentiation and cell fate determination in sensory systems are essential for stimulus discrimination and coding of environmental stimuli. Color vision is based on the differential color sensitivity of retinal photoreceptors, however the developmental programs that control photoreceptor cell differentiation and specify color sensitivity are poorly understood. In Drosophila melanogaster, there is evidence that the color sensitivity of different photoreceptors in the compound eye is regulated by inductive signals between cells, but the exact nature of these signals and how they are propagated remains unknown. We conducted a genetic screen to identify additional regulators of this process and identified a novel mutation in the hibris gene, which encodes an irre cell recognition module protein (IRM). These immunoglobulin super family cell adhesion molecules include human KIRREL and nephrin (NPHS1). hibris is expressed dynamically in the developing Drosophila melanogaster eye and loss-of-function mutations give rise to a diverse range of mutant phenotypes including disruption of the specification of R8 photoreceptor cell diversity. We demonstrate that hibris is required within the retina, and that hibris over-expression is sufficient to disrupt normal photoreceptor cell patterning. These findings suggest an additional layer of complexity in the signaling process that produces paired expression of opsin genes in adjacent R7 and R8 photoreceptor cells.	[Tan, Hong; Fulton, Ruth E.; Birkholz, Denise A.; Mannino, Meridee P.; Yamaguchi, David M.] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Anschutz Med Campus, Aurora, CO USA; [Chou, Wen-Hai] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Aldrich, John C.; Jacobsen, Thomas L.; Britt, Steven G.] Univ Texas Austin, Med Sch, Dept Ophthalmol, Dept Neurol, Austin, TX 78712 USA; [Tan, Hong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Xian, Peoples R China; [Chou, Wen-Hai] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Austin; Xi'an Jiaotong University; National Health Research Institutes - Taiwan	Britt, SG (corresponding author), Univ Texas Austin, Med Sch, Dept Ophthalmol, Dept Neurol, Austin, TX 78712 USA.	steve.britt@austin.utexas.edu	Britt, Steven/GVT-1340-2022; Chou, Wen-Hai/H-1970-2016	Chou, Wen-Hai/0000-0002-7899-1129; Aldrich, John/0000-0002-4885-924X; Britt, Steven/0000-0001-7656-7984; Tan, Hong/0000-0002-8660-8222	National Institutes of Health, National Eye Institute [R01EY018376]	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	S.G.B. received National Institutes of Health, National Eye Institute grant R01EY018376 in support of this work. https://www.nei.nih.gov The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2017, ELIFE, V6, DOI 10.7554/eLife.29593; Artero RD, 2001, DEVELOPMENT, V128, P4251; Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Bao SJ, 2010, DEV BIOL, V344, P948, DOI 10.1016/j.ydbio.2010.06.013; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Bello B, 1998, DEVELOPMENT, V125, P2193; Birkholz DA, 2009, FLY, V3, P253, DOI 10.4161/fly.10546; Birkholz DA, 2009, J NEUROSCI, V29, P2666, DOI 10.1523/JNEUROSCI.5988-08.2009; BOSCHERT U, 1990, J NEUROGENET, V6, P153, DOI 10.3109/01677069009107107; BRAND AH, 1995, CURR OPIN NEUROBIOL, V5, P572, DOI 10.1016/0959-4388(95)80061-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Carmon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012319; Center BDS, BDSC CORNM FOOD 2017; Chandler CH, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007075; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Earl JB, 2006, GENE EXPR PATTERNS, V6, P687, DOI 10.1016/j.modgep.2006.01.003; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Fischbach KF, 2009, J NEUROGENET, V23, P48, DOI 10.1080/01677060802471668; Fleiss J., 2003, STAT METHODS RATES P, P760, DOI 10.1198/tech.2004.s812; FORTINI ME, 1991, CELL TISSUE RES, V265, P185, DOI 10.1007/BF00318153; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; Greenspan RJ, 2004, FLY PUSHING THEORY P, Vxiv, P191; Grillo-Hill BK, 2009, DEV DYNAM, V238, P2223, DOI 10.1002/dvdy.21981; HAY BA, 1994, DEVELOPMENT, V120, P2121; Helmstadter M, 2014, J NEUROGENET, V28, P264, DOI 10.3109/01677063.2014.918976; Holtzer H., 1968, EPITHELIAL MESENCHYM, P152; Hsiao HY, 2013, DEV BIOL, V381, P482, DOI 10.1016/j.ydbio.2013.07.001; Hummel Thomas, 2008, V420, P97, DOI 10.1007/978-1-59745-583-1_6; Jacobs GH, 1981, COMP COLOR VISION; Johnston RJ, 2011, CELL, V145, P956, DOI 10.1016/j.cell.2011.05.003; Jukam D, 2013, SCIENCE, V342, P211, DOI 10.1126/science.1238016; Jukam D, 2011, DEV CELL, V21, P874, DOI 10.1016/j.devcel.2011.10.004; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim MS, 1998, GENETICS, V150, P711; KIRSCHFELD K, 1978, J COMP PHYSIOL, V125, P275, DOI 10.1007/BF00656606; Linneweber GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128490; Lowry R, 2018, VASARSTATS WEBSITE S; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ni J, 2016, J BIOL CHEM, V291, P24406, DOI 10.1074/jbc.M116.745026; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Or Nick H. K., 2017, POLICY STUD J, V45, pS67; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; POECK B, 1993, MOL GEN GENET, V238, P325, DOI 10.1007/BF00291990; Ponomareff G, 2001, GENETICS, V159, P635; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; RIESGOESCOVAR J, 1992, J NEUROBIOL, V23, P947, DOI 10.1002/neu.480230803; Roberts DB, 1998, DROSOPHILA PRACTICAL, Vxxiv, P389; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Machado MCR, 2018, MECH DEVELOP, V154, P193, DOI 10.1016/j.mod.2018.07.006; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Singh J, 2012, DEV CELL, V23, P82, DOI 10.1016/j.devcel.2012.04.021; SPATZ HC, 1974, NATURE, V248, P359, DOI 10.1038/248359a0; Sugie A, 2010, DEVELOPMENT, V137, P3303, DOI 10.1242/dev.047332; Sun JT, 1999, MOL CELL BIOL, V19, P216; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; Thanawala SU, 2013, DEV CELL, V25, P93, DOI 10.1016/j.devcel.2013.02.016; Viets K, 2016, TRENDS GENET, V32, P638, DOI 10.1016/j.tig.2016.07.004; Waddington C. H, 1940, ORG AND GENES; Wells BS, 2017, ELIFE, V6, DOI 10.7554/eLife.25301; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; WIKLER KC, 1990, J NEUROSCI, V10, P3390; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Xie B, 2007, DEVELOPMENT, V134, P4243, DOI 10.1242/dev.012781; Yamaguchi S, 2010, P NATL ACAD SCI USA, V107, P5634, DOI 10.1073/pnas.0809398107; Yan J, 2017, DEVELOPMENT, V144, P844, DOI 10.1242/dev.144030	80	0	0	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240451	10.1371/journal.pone.0240451	http://dx.doi.org/10.1371/journal.pone.0240451			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052948	Green Submitted, Green Published, gold			2022-12-26	WOS:000581820200043
J	Rashid, V; Weijs, PJM; Engberink, MF; Verhoeff, AP; Nicolaou, M				Rashid, Viyan; Weijs, Peter J. M.; Engberink, Marielle F.; Verhoeff, Arnoud P.; Nicolaou, Mary			Beyond maternal education: Socio-economic inequalities in children's diet in the ABCD cohort	PLOS ONE			English	Article							PATTERNS; ASSOCIATIONS; POSITION; FOOD; AGE; DETERMINANTS; PREVALENCE; NUTRITION; KNOWLEDGE; QUALITY	Objective We examined whether the role of maternal education in children's unhealthy snacking diet is moderated by other socio-economic indicators. Methods Participants were selected from the Amsterdam Born Children and their Development cohort, a large ongoing community-based birth cohort. Validated Food Frequency Questionnaires (FFQ) (n = 2782) were filled in by mothers of children aged 5.7 +/- 0.5yrs. Based on these FFQs, a snacking dietary pattern was derived using Principal Component Analysis. Socio-economic indicators were: maternal and paternal education (low, middle, high; based on the highest education completed) household finance (low, high; based on ability to save money) and neighbourhood SES (composite score including educational level, household income and employment status of residents per postal code). Cross-sectional multivariable linear regression analysis was used to assess the association and possible moderation of maternal education and other socio-economic indicators on the snacking pattern score. Analyses were adjusted for children's age, sex and ethnicity. Results Low maternal education (B 0.95, 95% CI 0.83;1.06), low paternal education (B 0.36, 95% CI 0.20;0.52), lower household finance (B 0.18, 95% CI 0.11;0.26) and neighbourhood SES (B -0.09, 95% CI -0.11;-0.06) were independently associated with higher snacking pattern scores (p<0.001). The association between maternal education and the snacking pattern score was somewhat moderated by household finance (p = 0.089) but remained strong. Children from middle-high educated mothers (B 0.44, 95% CI 0.35;0.52) had higher snacking pattern scores when household finance was low (B 0.49, 95% CI 0.33;0.65). Conclusions All socio-economic indicators were associated with increased risk of unhealthy dietary patterns in young children, with low maternal education conferring the highest risk. Yet, within the group of middle-high educated mothers, lower household finance was an extra risk factor for unhealthy dietary patterns. Intervention strategies should therefore focus on lower educated mothers and middle-high educated mothers with insufficient levels of household finance.	[Rashid, Viyan; Weijs, Peter J. M.; Engberink, Marielle F.] Amsterdam Univ Appl Sci, Fac Sports & Nutr, Dept Nutr & Dietet, Amsterdam, Netherlands; [Weijs, Peter J. M.] Amsterdam Univ Med Ctr, Locat VUmc, Dept Nutr & Dietet, Amsterdam, Netherlands; [Verhoeff, Arnoud P.] Publ Hlth Serv Amsterdam, Dept Epidemiol Hlth Promot & Hlth Care Innovat, Amsterdam, Netherlands; [Verhoeff, Arnoud P.] Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands; [Nicolaou, Mary] Univ Amsterdam, Dept Publ Hlth, Amsterdam UMC, Amsterdam, Netherlands	Public Health Service Amsterdam; University of Amsterdam; University of Amsterdam	Rashid, V (corresponding author), Amsterdam Univ Appl Sci, Fac Sports & Nutr, Dept Nutr & Dietet, Amsterdam, Netherlands.	v.rashid@hva.nl		Rashid, Viyan/0000-0002-5287-4469; Weijs, Peter/0000-0001-8281-0426	Netherlands Organisation for Scientific Research (NWO) [023.002.105]; Public Health Service (GGD) in Amsterdam, The Netherlands	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Public Health Service (GGD) in Amsterdam, The Netherlands(Netherlands Government)	This work was supported by the Netherlands Organisation for Scientific Research (NWO) (V.R., grant number 023.002.105); The ABCD-study was supported by the Academic Medical Centre (AMC) in Amsterdam, The Netherlands and the Public Health Service (GGD) in Amsterdam, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beghin L, 2014, BRIT J NUTR, V111, P1303, DOI 10.1017/S0007114513003796; Camara S, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0285-2; CBS, 2016, STAND OND 2016 2017; CBS, 2010, BEV HUISH VIERC POST; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; De Bourdeaudhuij I, 1998, AM J HEALTH PROMOT, V13, P73, DOI 10.4278/0890-1171-13.2.73; de Jong E, 2011, INT J PEDIATR OBES, V6, P298, DOI 10.3109/17477166.2011.583659; Dutman AE, 2011, PUBLIC HEALTH NUTR, V14, P410, DOI 10.1017/S1368980010002119; Emmett PM, 2015, NUTR REV, V73, P207, DOI 10.1093/nutrit/nuv055; Fernandez-Alvira JM, 2014, EUR J CLIN NUTR, V68, P811, DOI 10.1038/ejcn.2014.78; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Gasser CE, 2017, J EPIDEMIOL COMMUN H, V71, P1152, DOI 10.1136/jech-2017-209641; Hrudey EJ, 2015, INT J ENV RES PUB HE, V12, P5561, DOI 10.3390/ijerph120505561; Hursti UKK, 1999, ANN MED, V31, P26, DOI 10.1080/07853890.1999.11904396; Iliescu C, 2008, INT J OBESITY, V32, pS19, DOI 10.1038/ijo.2008.178; Kiefte-de Jong JC, 2013, BRIT J NUTR, V109, P137, DOI 10.1017/S0007114512000682; Lehto E, 2015, PUBLIC HEALTH NUTR, V18, P89, DOI 10.1017/S136898001300339X; Leventakou V, 2016, EUR J CLIN NUTR, V70, P60, DOI 10.1038/ejcn.2015.93; Lioret S, 2015, J NUTR, V145, P775, DOI 10.3945/jn.114.201988; Lioret S, 2015, MATERN CHILD NUTR, V11, P936, DOI 10.1111/mcn.12031; Mackenbach JD, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092215; Mackenbach JD, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0445-3; McLeod ER, 2011, J AM DIET ASSOC, V111, P696, DOI 10.1016/j.jada.2011.02.011; Merchant AT, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-1; Northstone K, 2005, EUR J CLIN NUTR, V59, P751, DOI 10.1038/sj.ejcn.1602136; Northstone K, 2013, MATERN CHILD NUTR, V9, P533, DOI 10.1111/j.1740-8709.2012.00399.x; Pryer JA, 2009, PUBLIC HEALTH NUTR, V12, P957, DOI 10.1017/S1368980008003364; Ranjit N, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/1479-5868-12-S1-S4; Rashid V, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5014-0; Ravensbergen L, 2016, SOC SCI MED, V153, P81, DOI 10.1016/j.socscimed.2016.01.030; Robinson S, 2007, BRIT J NUTR, V98, P1029, DOI 10.1017/S0007114507750936; Shearer C, 2012, CAN J PUBLIC HEALTH, V103, pS55, DOI 10.1007/BF03403836; Shin KO, 2007, BRIT J NUTR, V98, P416, DOI 10.1017/S0007114507720226; Smithers LG, 2011, NUTR REV, V69, P449, DOI 10.1111/j.1753-4887.2011.00407.x; Sotos-Prieto M, 2015, PUBLIC HEALTH NUTR, V18, P275, DOI 10.1017/S1368980014000330; Tromp M, 2009, PAEDIATR PERINAT EP, V23, P264, DOI 10.1111/j.1365-3016.2009.01030.x; Turrell G, 2003, PUBLIC HEALTH NUTR, V6, P191, DOI 10.1079/PHN2002416; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Veldhuizen EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068790; Vereecken C, 2010, APPETITE, V54, P44, DOI 10.1016/j.appet.2009.09.005; Yancey AK, 2009, MILBANK Q, V87, P155, DOI 10.1111/j.1468-0009.2009.00551.x; Zarnowiecki DM, 2014, OBES REV, V15, P375, DOI 10.1111/obr.12139	42	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240423	10.1371/journal.pone.0240423	http://dx.doi.org/10.1371/journal.pone.0240423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	33048970	Green Published, gold			2022-12-26	WOS:000581813300053
J	Saah, FI; Amu, H				Saah, Farrukh Ishaque; Amu, Hubert			Sleep quality and its predictors among waiters in upscale restaurants: A descriptive study in the Accra Metropolis	PLOS ONE			English	Article							ANXIETY STRESS SCALES; DEPRESSION; EMPLOYEES; PATTERNS; STUDENTS; HOTEL; WORK	Introduction Poor mental and sleep health negatively affects work performance, turnover intention, and information retention. We examined the impact of waiting job in upscale restaurants on the sleep health of waiters. Materials and methods This was a descriptive study which collected cross-sectional data from waiters of upscale restaurants, using PSQI and DASS-21 questionnaires. Descriptive and inferential statistics comprising mean, frequency, percentage, chi-square, and logistic regression were adopted in presenting the results. Results Sleep quality was poor among 74% of the waiters. The predictors of sleep quality were sex (p = 0.002), role at restaurant (p = 0.004), non-prescription drug use (p<0.001), depression (p<0.001), anxiety (p<0.001), and stress (p<0.001). The prevalence of anxiety, depression, and stress among the waiters was 52.3%, 38.3%, and 34.4% respectively. Stationed (AOR = 4.72, 95%CI = 1.7-812.53, p = 0.002) and supervising (AOR = 3.08, 95%CI = 1.25-7.57, p = 0.014) waiters were more likely to have good sleep quality than headwaiters. Waiters who had depression, anxiety, and stress were, however, 8% (AOR = 0.92, 95%CI = 0.46-1.85, p = 0.819), 28% (AOR = 0.72, 95%CI = 0.38-1.36, p = 0.315), and 49% (AOR = 0.51, 95%CI = 0.24-1.07, p = 0.073) less likely to have a good sleep quality than those who respectively did not have depression, anxiety, and stress. Conclusions Sleep quality was poor among most of the waiters. If this persists, Ghana may not be able to meet the Sustainable Development Goal 3.4 target of promoting mental health and wellbeing. To improve sleep quality and accelerate progress towards achievement of the SDG target, there should be increased collaboration among stakeholders in the health and hospitality industries to develop innovative interventions to reduce poor sleep quality among workers.	[Saah, Farrukh Ishaque] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hohoe, Ghana; [Amu, Hubert] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Populat & Behav Sci, Hohoe, Ghana		Saah, FI (corresponding author), Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hohoe, Ghana.	fsaahpnur14@uhas.edu.gh	Amu, Hubert/H-9446-2019	Amu, Hubert/0000-0003-0218-3843; Saah, Farrukh Ishaque/0000-0001-8395-8369				Aday LA, 2006, DESIGNING CONDUCTING; Akerstedt T, 2003, OCCUP MED-OXFORD, V53, P89, DOI 10.1093/occmed/kqg046; [Anonymous], 2015, OB ESSENTIALS; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Anxiety and Depression Association of America (ADAA), 2016, SLEEP DISORDERS; Babakus E, 2008, INT J HOSP TOUR ADM, V9, P384, DOI 10.1080/15256480802427339; Brand S, 2008, IND HEALTH, V46, P199, DOI 10.2486/indhealth.46.199; Bush D., 2015, CBHSQ REPORT SUBSTAN; Buysse D J, 1989, Psychiatry Res, V28, P193; Caruso C, 2012, SLEEP WORK; Cheng SH, 2012, PSYCHIAT RES, V197, P270, DOI 10.1016/j.psychres.2011.08.011; Chiang Y., 2017, SLEEP HLTH RESOURCES; Chiang Y.-C., 2014, COLL STUDENT J, V48, P72; Cochran WG., 1963, SAMPLING TECHNIQUES; Constanti P, 2005, SERV IND J, V25, P103, DOI 10.1080/0264206042000302432; Dhande KK, 2011, HUM FACTOR ERGON MAN, V21, P260, DOI 10.1002/hfm.20231; Ebrahim IO, 2013, ALCOHOL CLIN EXP RES, V37, DOI 10.1111/acer.12006; Ghalichi L, 2013, ARCH IRAN MED, V16, P100, DOI 013162/AIM.0010; Giousmpasoglou C, 2018, INT J HOSP MANAG, V70, P59, DOI 10.1016/j.ijhm.2017.11.003; Gomes AA, 2011, CHRONOBIOL INT, V28, P786, DOI 10.3109/07420528.2011.606518; GSS (Ghana Statistical Services), 2014, 2010 POP HOUS CENS D; Hammami Mohammad Bakri Alaa, 2018, Journal of Caffeine and Adenosine Research, V8, P71, DOI 10.1089/caff.2017.0034; Hannerz H, 2002, EUR J PUBLIC HEALTH, V12, P192, DOI 10.1093/eurpub/12.3.192; Hershner SD, 2014, NAT SCI SLEEP, V6, P73, DOI 10.2147/NSS.S62907; Hochschild AR, 2012, MANAGED HEART: COMMERCIALIZATION OF HUMAN FEELING, P1; Hsieh Yi-Hsuan, 2011, Chang Gung Med J, V34, P278; Kline S., 2007, Journal of Human Resources in Hospitality & Tourism, V6, P69, DOI 10.1300/J171v06n01_04; Krystal AD, 2012, NEUROL CLIN, V30, P1389, DOI 10.1016/j.ncl.2012.08.018; Kumar S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224122; Lajoie P, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007327; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Maideen SFK, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0648-x; Masdek N. R. Nik Mohd, 2011, INT J EC MANAGEMENT, V5, P114; McKim WA, 2007, DRUGS BEHAV INTRO BE, P220; National Institute on Drug Abuse, 2014, NAT TRENDS; National Sleep Foundation-2011 Poll Task Force, 2011, SUMM FIND 2011 SLEEP; Neale J, 2017, WHAT IS ABSENTEEISM; Ng E. S., 2006, ED TRAINING; Osborn D., 2015, UNIVERSAL SUSTAINABL; Reese RJ, 2006, J CAREER ASSESSMENT, V14, P252, DOI 10.1177/1069072705274985; Rosenzweig M. R., 2005, BIOL PSYCHOL IINTRO, P424; Sipsma H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-288; Storm-Pallesen E., 2007, WORK RELATED STRESS; Tlapa CA, 2011, 2011 RESTAURANT FOOD; Trivellas P, 2013, PROCD SOC BEHV, V73, P718, DOI 10.1016/j.sbspro.2013.02.110; Tsai LL, 2004, J PSYCHOSOM RES, V56, P231, DOI 10.1016/S0022-3999(03)00507-5; UKEssays, 2013, CUST SAT REST IND; Wilson J., 2010, ESSENTIALS BUSINESS; Wirtz J., 2017, ESSENTIALS SERVICES; World Health Organisation, 2016, SUST DEV GOALS SDGS; Yang X, 2020, COMPR PSYCHIAT, V97, DOI 10.1016/j.comppsych.2019.152154; 2007, NANOTECHNOLOGY, V18, P9	53	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240599	10.1371/journal.pone.0240599	http://dx.doi.org/10.1371/journal.pone.0240599			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	33049002	gold, Green Published			2022-12-26	WOS:000581813300004
J	Sartori, CR; Pagliusi, M; Bonet, IJM; Tambeli, CH; Parada, CA				Sartori, Cesar Renato; Pagliusi, Marco, Jr.; Bonet, Ivan Jose Magayewski; Tambeli, Claudia Herrera; Parada, Carlos Amilcar			Running wheel exercise induces therapeutic and preventive effects on inflammatory stimulus-induced persistent hyperalgesia in mice	PLOS ONE			English	Article							LOW-INTENSITY EXERCISE; NEUROPATHIC PAIN; OXIDATIVE STRESS; SCIATIC-NERVE; FIBROMYALGIA; INJURY; RAT; PATHOPHYSIOLOGY; CONSTRICTION; ACTIVATION	Chronic pain affects significant portion of the world's population and physical exercise has been extensively indicated as non-pharmacological clinical intervention to relieve symptoms in chronic pain conditions. In general, studies on pain chronification and physical exercise intervention have focused on neuropathic pain, although chronic pain commonly results from an original inflammatory episode. Based on this, the objective of the present study was to investigate the therapeutic and preventive effect of the running wheel exercise on the persistent hyperalgesia induced by repetitive inflammatory stimulus, a rodent model that simulates clinical conditions of chronic pain that persist even with no more inflammatory stimulus present. To evaluate the therapeutic effect of physical exercise, we first induced persistent hyperalgesia through 14 days of PGE2 hind paw injections and, after that, mice have access to the regular voluntary running wheel. To evaluate the preventive effect of physical exercise, we first left the mice with access to the regular voluntary running wheel and, after that, we performed 14 days of PGE2 hind paw injection. Our results showed that voluntary running wheel exercise reduced persistent mechanical and chemical hyperalgesia intensity induced by repetitive inflammatory stimulus. In addition, we showed that this therapeutic effect is long-lasting and is observed even if started belatedly, i.e. two weeks after the development of hyperalgesia. Also, our results showed that voluntary running wheel exercise absolutely prevented persistent mechanical and chemical hyperalgesia induction. We can conclude that physical exercise has therapeutic and preventive effect on inflammatory stimulus-induced persistent hyperalgesia. Our data from animal experiments bypass placebo effects bias of the human studies and reinforce physical exercise clinical recommendations to treat and prevent chronic pain.	[Sartori, Cesar Renato; Pagliusi, Marco, Jr.; Bonet, Ivan Jose Magayewski; Tambeli, Claudia Herrera; Parada, Carlos Amilcar] Univ Estadual Campinas, Dept Struct & Funct Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas	Sartori, CR (corresponding author), Univ Estadual Campinas, Dept Struct & Funct Biol, Campinas, SP, Brazil.	sartoric@unicamp.br	Bonet, Ivan/AAC-8101-2022; Pagliusi, Marco O Finocchio/G-2016-2019; Parada, Carlos Amilcar/C-3974-2012; Tambeli, Claudia/AAQ-4409-2021	Pagliusi, Marco O Finocchio/0000-0002-8379-9131; Amilcar Parada, Carlos/0000-0001-5209-8853; Sartori, Cesar Renato/0000-0003-2713-3914; Bonet, Ivan/0000-0002-6008-3237	Sao Paulo Research Foundation (FAPESP) [2011/23531-6, 2012/08922-1]; Coordenacao de Aperfeicoamento de Pess oal de Nivel Superior - Brasil (CAPES) [001]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pess oal de Nivel Superior - Brasil (CAPES)	CRS, CAP and CHT was supported by the Sao Paulo Research Foundation (FAPESP - http://www.fapesp.br) #2011/23531-6 and #2012/08922-1. MPJr, and IJMB was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES - https://www.capes.gov.br) - Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Ahn AH, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0379-y; Almeida C, 2015, PAIN, V156, P504, DOI 10.1097/01.j.pain.0000460339.23976.12; Ambrose KR, 2015, BEST PRACT RES CL RH, V29, P120, DOI 10.1016/j.berh.2015.04.022; Ballantyne JC, 2017, ANESTH ANALG, V125, P1769, DOI 10.1213/ANE.0000000000002500; Batista ML, 2010, CYTOKINE, V49, P102, DOI 10.1016/j.cyto.2009.10.007; Bement MKH, 2005, ARCH PHYS MED REHAB, V86, P1736, DOI 10.1016/j.apmr.2005.03.029; Benatti FB, 2015, NAT REV RHEUMATOL, V11, P86, DOI 10.1038/nrrheum.2014.193; Birmann PT, 2019, J TRACE ELEM MED BIO, V54, P126, DOI 10.1016/j.jtemb.2019.04.014; Bobinski F, 2018, PAIN, V159, P437, DOI 10.1097/j.pain.0000000000001109; Bobinski F, 2015, PAIN, V156, P2595, DOI 10.1097/j.pain.0000000000000372; Boldt I, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009177.pub2; Booz GW, 2011, FREE RADICAL BIO MED, V51, P1054, DOI 10.1016/j.freeradbiomed.2011.01.007; Brandao AF, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01453; Brioche T, 2016, CURR PHARM DESIGN, V22, P2664, DOI 10.2174/1381612822666160219120531; Broom DM, 1998, ADV STUD BEHAV, V27, P371; Che L, 2017, ADV EXP MED BIOL, V999, P43, DOI 10.1007/978-981-10-4307-9_3; Chen YW, 2012, ANESTH ANALG, V114, P1330, DOI 10.1213/ANE.0b013e31824c4ed4; Cobianchi S, 2010, NEUROSCIENCE, V168, P273, DOI 10.1016/j.neuroscience.2010.03.035; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; de Moraes AA, 2018, NEUROL RES, V40, P955, DOI 10.1080/01616412.2018.1504180; Dias EV, 2015, EUR J NEUROSCI, V42, P2380, DOI 10.1111/ejn.13015; Ferrari LF, 2014, P NATL ACAD SCI USA, V111, P18363, DOI 10.1073/pnas.1420601111; FERREIRA SH, 1990, PAIN, V42, P365, DOI 10.1016/0304-3959(90)91149-D; Gatchel RJ, 2014, AM PSYCHOL, V69, P119, DOI 10.1037/a0035514; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Hauser W, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3002; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Hylands-White N, 2017, RHEUMATOL INT, V37, P29, DOI 10.1007/s00296-016-3481-8; Jones KD, 2009, RHEUM DIS CLIN N AM, V35, P373, DOI 10.1016/j.rdc.2009.05.004; Kim D, 2010, P NATL ACAD SCI USA, V107, P14851, DOI 10.1073/pnas.1009926107; Kroll HR, 2015, PHYS MED REH CLIN N, V26, P263, DOI 10.1016/j.pmr.2014.12.007; Kuphal KE, 2007, J PAIN, V8, P989, DOI 10.1016/j.jpain.2007.08.001; Lima L. V., 2017, PAIN; Mattson MP, 2012, AGEING RES REV, V11, P347, DOI 10.1016/j.arr.2012.01.007; Mazzardo-Martins L, 2010, J PAIN, V11, P1384, DOI 10.1016/j.jpain.2010.03.015; Moghetti P, 2016, FRONT HORM RES, V47, P44, DOI 10.1159/000445156; Nalk AK, 2006, EUR J PAIN, V10, P573, DOI 10.1016/j.ejpain.2005.08.006; Palandi J, 2020, NEUROSCI BIOBEHAV R, V108, P781, DOI 10.1016/j.neubiorev.2019.12.016; Pedersen BK, 2017, EUR J CLIN INVEST, V47, P600, DOI 10.1111/eci.12781; Ploner M, 2017, TRENDS COGN SCI, V21, P100, DOI 10.1016/j.tics.2016.12.001; Radak Z, 2008, AGEING RES REV, V7, P34, DOI 10.1016/j.arr.2007.04.004; Rooks DS, 2008, CURR OPIN RHEUMATOL, V20, P208, DOI 10.1097/BOR.0b013e3282f5687a; Sarifakioglu B, 2014, RHEUMATOL INT, V34, P1361, DOI 10.1007/s00296-014-2978-2; Smith C., 2010, J EVAL CLIN PRACT; Sommer C, 2018, PAIN, V159, P595, DOI 10.1097/j.pain.0000000000001122; Stagg NJ, 2011, ANESTHESIOLOGY, V114, P940, DOI 10.1097/ALN.0b013e318210f880; Tai HH, 2011, PROSTAG OTH LIPID M, V96, P37, DOI 10.1016/j.prostaglandins.2011.06.005; Thomas EN, 2010, RHEUMATOL INT, V30, P1143, DOI 10.1007/s00296-010-1369-6; Timmerman KL, 2008, J LEUKOCYTE BIOL, V84, P1271, DOI 10.1189/jlb.0408244; van Middelkoop M, 2010, BEST PRACT RES CL RH, V24, P193, DOI 10.1016/j.berh.2010.01.002; Vase L, 2019, BRIT J ANAESTH, V123, pE254, DOI 10.1016/j.bja.2019.01.040; Villarreal CF, 2009, BIOCHEM PHARMACOL, V77, P867, DOI 10.1016/j.bcp.2008.11.015; Watkins BA, 2018, MOL ASPECTS MED, V64, P68, DOI 10.1016/j.mam.2018.10.001; Whitehead RA, 2017, ANESTH ANALG, V124, P346, DOI 10.1213/ANE.0000000000001662	55	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240115	10.1371/journal.pone.0240115	http://dx.doi.org/10.1371/journal.pone.0240115			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048957	gold, Green Published			2022-12-26	WOS:000581813300006
J	de Morais, HRMM; Vidal, EID; Coeli, CM; Pinheiro, RS				de Morais, Helen Regina Mota Machareth; Vidal, Edison Iglesias de Oliveira; Coeli, Claudia Medina; Pinheiro, Rejane Sobrino			Is the number of previous hospitalizations associated with increased in-hospital mortality after hip fracture in a developing country?	PLOS ONE			English	Article							1-YEAR MORTALITY; RISK; ADJUSTMENT; PREDICTION; MORBIDITY; SURGERY; SCORE	Purpose We aimed to examine whether the number of previous hospitalizations and the main diagnoses of those hospitalizations are associated with increased in-hospital hip fracture mortality for older people. That assessment is relevant because if those variables are shown to be associated with increased mortality, that finding could support their use as proxies for comorbidity burden for case-mix adjustment in statistical models seeking to compare the performance of hospitals regarding hip fracture mortality in settings with limited hospital information systems. Methods In this retrospective cohort study of all public hospital admissions for older adults with hip fractures in the city of Rio de Janeiro between 2010 and 2011, we used data from the Hospital Admission Information System database to examine the association between in-hospital mortality and the number of hospitalizations in the previous two years and their main diagnoses through logistic regression. Results Among 1938 patients included in the study there were 103 (5.3%) in-hospital deaths. Although the presence of hospitalization episodes within the two years preceding the index hip fracture was associated with increased mortality (OR: 1.78, 95%CI: 1.07 to 2.97) we did not find evidence of a gradient of increased mortality with a growing number of previous hospitalizations. Additionally, several diseases recorded as main diagnoses of previous hospitalizations were not associated with increased mortality rates, as was expected based on existing knowledge on risk factors for decreased survival in older adults with hip fractures. Conclusions Our results suggest that, in settings where local hospital information systems have limited access to secondary diagnoses, the use of the number of previous hospitalizations or the main diagnoses associated with those hospitalizations as proxies for the profile of comorbidities of older adults with hip fractures may not be an effective way to adjust for case-mix when comparing in-hospital mortality rates among hospitals.	[de Morais, Helen Regina Mota Machareth; Coeli, Claudia Medina; Pinheiro, Rejane Sobrino] Univ Fed Rio de Janeiro, Inst Publ Hlth, Rio De Janeiro, Brazil; [Vidal, Edison Iglesias de Oliveira] Sao Paulo State Univ, Botucatu Med Sch, Botucatu, SP, Brazil	Universidade Federal do Rio de Janeiro; Universidade Estadual Paulista	Pinheiro, RS (corresponding author), Univ Fed Rio de Janeiro, Inst Publ Hlth, Rio De Janeiro, Brazil.	rejanesp07@gmail.com	Vidal, Edison Iglesias de Oliveira/G-1882-2012; Pinheiro, Rejane S/J-5129-2015	Vidal, Edison Iglesias de Oliveira/0000-0002-1573-4678; Pinheiro, Rejane S/0000-0002-3361-3626	National Council for Scientific and Technological Development [303295/2019-8, 481654/2012-7, 310173/2015-9, 307768/201800]; Carlos Chagas Filho Foundation [E-26-200.003/2019]	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation	CMC was partially supported by research fellowship grants from the National Council for Scientific and Technological Development (http://cnpq.br/) (Grant number 303295/2019-8) and Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (http://www.faperj.br/) (Grant number E-26-200.003/2019). RSP was supported by research grants and research fellowship grants from the National Council for Scientific and Technological Development (http://cnpq.br/) (Grant number 481654/2012-7, 310173/2015-9and 307768/201800).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner R, 2017, ARCH OSTEOPOROS, V12, DOI 10.1007/s11657-017-0327-2; [Anonymous], 2012, SAPERE AUDE REV DEP, V3, P182; [Anonymous], 2001, AHRQ QUAL IND GUID P; BLUMBERG MS, 1988, HEALTH AFFAIR, V7, P62, DOI 10.1377/hlthaff.7.1.62; Camargo K R Jr, 2000, Cad Saude Publica, V16, P439; Coutinho Evandro Silva Freire, 2006, Cad. Saúde Pública, V22, P2249, DOI 10.1590/S0102-311X2006001000031; Cree M, 2000, J AM GERIATR SOC, V48, P283, DOI 10.1111/j.1532-5415.2000.tb02647.x; de Camargo KR, 2015, CAD SAUDE PUBLICA, V31, P257, DOI 10.1590/0102-311X00041214; de Souza RC, 2008, CAD SAUDE PUBLICA, V24, P315, DOI 10.1590/S0102-311X2008000200010; Donabedian A., 1980, EXPLORATIONS QUALITY; DUBOIS RW, 1987, NEW ENGL J MED, V317, P1674, DOI 10.1056/NEJM198712243172626; El-Halees, 2007, ISLAMIC U J, V15, P167; Endo A, 2018, J ORTHOP TRAUMA, V32, P34, DOI 10.1097/BOT.0000000000001026; Folbert EC, 2017, OSTEOPOROSIS INT, V28, P269, DOI 10.1007/s00198-016-3711-7; Garcia Rosamaria, 2006, Clinics, V61, P539, DOI 10.1590/S1807-59322006000600009; Gdalevich M, 2004, ARCH ORTHOP TRAUM SU, V124, P334, DOI 10.1007/s00402-004-0662-9; GREEN J, 1990, JAMA-J AM MED ASSOC, V263, P241, DOI 10.1001/jama.263.2.241; Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981; Hu FK, 2012, INJURY, V43, P676, DOI 10.1016/j.injury.2011.05.017; Ireland AW, 2015, INJURY, V46, P1028, DOI 10.1016/j.injury.2015.03.006; Jiang HX, 2005, J BONE MINER RES, V20, P494, DOI 10.1359/JBMR.041133; Loures FB, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005172; Lucif N, 2004, REV SAUDE PUBL, V38, P780, DOI 10.1590/S0034-89102004000600005; Martins M, 2001, REV SAUDE PUBL, V35, P185, DOI 10.1590/S0034-89102001000200013; Marufu TC, 2016, ANAESTHESIA, V71, P515, DOI 10.1111/anae.13418; Meyer HE, 2000, OSTEOPOROSIS INT, V11, P228, DOI 10.1007/s001980050285; Norman G., 2014, BIOSTATISTICS BARE E, V4th; Pinheiro RS, 2016, CAD SAUDE COLET RIO, V14, P327; Pugely AJ, 2014, J ORTHOP TRAUMA, V28, P63, DOI 10.1097/BOT.0b013e3182a22744; Rath S, 2017, ARCH OSTEOPOROS, V12, DOI 10.1007/s11657-017-0344-1; Ribeiro TA, 2014, CLINICS, V69, P253, DOI 10.6061/clinics/2014(04)06; Sakaki Marcos Hideyo, 2004, Acta ortop. bras., V12, P242, DOI 10.1590/S1413-78522004000400008; Taylor PC, 2007, AFR AM REV, V41, P625, DOI 10.2307/25426981; Travassos C, CIEN SAUDE COLET, V4, P367; van Zeeland MLP, 2011, J TRAUMA, V70, pE67, DOI 10.1097/TA.0b013e3181edbf7a; Vidal EIO, 2006, OSTEOPOROSIS INT, V17, P1569, DOI 10.1007/s00198-006-0173-3; von Friesendorff M, 2016, OSTEOPOROSIS INT, V27, P2945, DOI 10.1007/s00198-016-3616-5	37	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240229	10.1371/journal.pone.0240229	http://dx.doi.org/10.1371/journal.pone.0240229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3WA	33035236	gold, Green Published			2022-12-26	WOS:000581817500009
J	Kerkhoff, AD; Sachdev, D; Mizany, S; Rojas, S; Gandhi, M; Peng, J; Black, D; Jones, D; Rojas, S; Jacobo, J; Tulier-Laiwa, V; Petersen, M; Martinez, J; Chamie, G; Havlir, DV; Marquez, C				Kerkhoff, Andrew D.; Sachdev, Darpun; Mizany, Sara; Rojas, Susy; Gandhi, Monica; Peng, James; Black, Douglas; Jones, Diane; Rojas, Susana; Jacobo, Jon; Tulier-Laiwa, Valerie; Petersen, Maya; Martinez, Jackie; Chamie, Gabriel; Havlir, Diane V.; Marquez, Carina			Evaluation of a novel community-based COVID-19 'Test-to-Care' model for low-income populations	PLOS ONE			English	Article							HEALTH WORKER INTERVENTIONS; ANTIRETROVIRAL THERAPY; COUNTRIES; SUPPORT; PEOPLE; MIDDLE	Background After a COVID-19 diagnosis, vulnerable populations face considerable logistical and financial challenges to isolate and quarantine. We developed and evaluated a novel, community-based approach ('Test-to-Care' Model) designed to address these barriers for socioeconomically vulnerable Latinx individuals with newly diagnosed COVID-19 and their households. Methods This three-week demonstration project was nested within an epidemiologic surveillance study in a primarily Latinx neighborhood in the Mission district of San Francisco, California. The Test-to-Care model was developed with input from community members and public health leaders. Key components included: (1) provision of COVID-19-related education and information about available community resources, (2) home deliveries of material goods to facilitate safe isolation and quarantine (groceries, personal protective equipment and cleaning supplies), and (3) longitudinal clinical and social support. Newly SARS-CoV-2 PCR-positive participants were eligible to participate. Components of the model were delivered by the Test-to-Care team, which was comprised of healthcare providers and community health workers (CHWs) who provided longitudinal clinic- and community-based support for the duration of the isolation period to augment existing services from the Department of Public Health (DPH). We evaluated the Test-to-Care Model using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) Framework and drew upon multiple data sources including: programmatic data, informal interviews with participants and providers/CHWs and structured surveys among providers/CHWs. Results Overall, 83 participants in the surveillance study were diagnosed with COVID-19, of whom 95% (79/83) were Latinx and 88% (65/74) had an annual household income <$50,000. Ninety-six percent (80/83) of participants were reached for results disclosure, needs assessment and DPH linkage for contact tracing. Among those who underwent an initial needs assessment, 45% (36/80) were uninsured and 55% (44/80) were not connected to primary care. Sixty-seven percent (56/83) of participants requested community-based CHW support to safely isolate at their current address and 65% (54/83) of all COVID-19 participants received ongoing community support via CHWs for the entire self-isolation period. Participants reported that the intervention was highly acceptable and that their trust increased over time-this resulted in 9 individuals who disclosed a larger number of household members than first reported, and 6 persons who requested temporary relocation to a hotel room for isolation despite initially declining this service; no unintended harms were identified. The Test-to-Care Model was found to be both acceptable and feasible to providers and CHWs. Challenges identified included a low proportion of participants linked to primary care despite support (approximately 10% after one month), and insufficient access to financial support for wage replacement. Conclusions The Test-to-Care Model is a feasible and acceptable intervention for supporting self-isolation and quarantine among newly diagnosed COVID-19 patients and their households by directly addressing key barriers faced by socioeconomically vulnerable populations.	[Kerkhoff, Andrew D.; Gandhi, Monica; Peng, James; Black, Douglas; Jones, Diane; Martinez, Jackie; Chamie, Gabriel; Havlir, Diane V.; Marquez, Carina] Univ Calif San Francisco, Dept Med, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA; [Sachdev, Darpun] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Mizany, Sara; Rojas, Susy; Rojas, Susana; Jacobo, Jon; Tulier-Laiwa, Valerie] San Francisco Latino Task Force COVID 19, San Francisco, CA USA; [Petersen, Maya] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; San Francisco Department of Public Health; University of California System; University of California Berkeley	Kerkhoff, AD (corresponding author), Univ Calif San Francisco, Dept Med, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA.	andrew.kerkhoff@ucsf.edu		Mizany, Sara/0000-0003-3147-253X	Chan Zuckerberg Biohub; UCSF; Program for Breakthrough Biomedical Research award	Chan Zuckerberg Biohub; UCSF; Program for Breakthrough Biomedical Research award	The study was supported by the Chan Zuckerberg Biohub, UCSF, and a Program for Breakthrough Biomedical Research award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2020, SAN FRANCISCO LATINO; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Brownstein JN, 2007, AM J PREV MED, V32, P435, DOI 10.1016/j.amepre.2007.01.011; Calo WA, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200165; Centers for Disease Control and Prevention, 2014, POL EV ASS REP COMM; Christopoulos KA, 2011, AIDS PATIENT CARE ST, V25, P439, DOI 10.1089/apc.2011.0041; Coffey S, 2019, AIDS, V33, P825, DOI 10.1097/QAD.0000000000002124; Drahota A, 2016, MILBANK Q, V94, P163, DOI 10.1111/1468-0009.12184; Gil RM, 2020, J INFECT DIS, V222, P1592, DOI 10.1093/infdis/jiaa474; Haines A, 2020, LANCET, V395, P1173, DOI 10.1016/S0140-6736(20)30735-2; Havlir DV, 2019, NEW ENGL J MED, V381, P219, DOI 10.1056/NEJMoa1809866; Kangovi S., 2020, WANT HELP BATTLE COV; Kangovi S, 2017, AM J PUBLIC HEALTH, V107, P1660, DOI [10.2105/AJPH.2017.303985, 10.2105/ajph.2017.303985]; Kenya S, 2011, HIV MED, V12, P525, DOI 10.1111/j.1468-1293.2011.00921.x; Kim K, 2016, AM J PUBLIC HEALTH, V106, pE3, DOI 10.2105/AJPH.2015.302987; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P1151, DOI 10.1016/S1473-3099(20)30457-6; Landers S, 2016, AM J PUBLIC HEALTH, V106, P591, DOI 10.2105/AJPH.2016.303099; Michie S, 2014, BEHAV CHANGE WHEEL G, DOI DOI 10.1186/s13012-015-0322-1; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Palmas W, 2015, J GEN INTERN MED, V30, P1004, DOI 10.1007/s11606-015-3247-0; Parekh TM, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0878-7; Penn Center for Community Health Workers, 2020, CALL ACT; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; POWER TJ, 1995, J DEV BEHAV PEDIATR, V16, P238; Rajan S, 2020, J ROY SOC MED, V113, P245, DOI 10.1177/0141076820939395; San Francisco Chronicle, 2020, SAN FRANCISCO CHRONI; San Francisco Department of Public Health, 2020, POP CHAR COVID 19 CA; Schwab D, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1234, DOI 10.1093/CID/CIAA123432821935]; Siegler AJ, 2020, WILLINGNESS SEEK LAB, V2020, DOI 10.1101/2020.05.06.20093005.; Smith DO, 2020, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20200504.336184/full/, DOI 10.1377/HBL0G20200504.336184/FULL/]; Smith DO, WHAT YOU NEED KNOW C; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Trump LJ, 2017, FAM SYST HEALTH, V35, P320, DOI 10.1037/fsh0000283; U.S. Citezenship and Immigration Services, 2020, PUBL CHARG; Urban Displacement Project, 2018, RIS HOUS COSTS RE SE; Weaver A, 2018, J HEALTH CARE POOR U, V29, P159, DOI 10.1353/hpu.2018.0011; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Weiner BJ, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0635-3	41	26	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239400	10.1371/journal.pone.0239400	http://dx.doi.org/10.1371/journal.pone.0239400			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3WA	33035216	Green Submitted, Green Published, gold			2022-12-26	WOS:000581817500011
J	Achakkagari, SR; Kyriakidou, M; Tai, HH; Anglin, NL; Ellis, D; Stromvik, MV				Achakkagari, Sai Reddy; Kyriakidou, Maria; Tai, Helen H.; Anglin, Noelle L.; Ellis, David; Stromvik, Martina V.			Complete plastome assemblies from a panel of 13 diverse potato taxa	PLOS ONE			English	Article							CHLOROPLAST GENOME SEQUENCES; SOLANUM-TUBEROSUM; SOMATIC HYBRIDS; DNA; DIFFERENTIATION; EVOLUTION; WILD	The chloroplasts are a crucial part of photosynthesizing plant cells and are extensively utilized in phylogenetic studies mainly due to their maternal inheritance. Characterization and analysis of complete plastome sequences is necessary to understand their diversity and evolutionary relationships. Here, a panel of thirteen plastomes from various potato taxa are presented. Though they are highly similar with respect to gene order and content, there is also a great extent of SNPs and InDels between them, with one of theSolanum bukasoviiplastomes (BUK2) having the highest number of SNPs and InDels. Five different potato plastome types (C, S, A, W, W2) are present in the panel. Interestingly, theS.tuberosumsubsp.tuberosum(TBR) accession has a W-type plastome, which is not commonly found in this species. The S-type plastome has a conserved 48 bp deletion not found in other types, which is responsible for the divergence of the S-type from the C-type plastome. Finally, a phylogenetic analysis shows that these plastomes cluster according to their types. Congruence between the nuclear genome and the plastome phylogeny of these accessions was seen, however with considerable differences, supporting the hypothesis of introgression and hybridization between potato species.	[Achakkagari, Sai Reddy; Kyriakidou, Maria; Stromvik, Martina V.] McGill Univ, Dept Plant Sci, Montreal, PQ, Canada; [Tai, Helen H.] Agr & Agri Food Canada, Fredericton Res & Dev Ctr, Fredericton, NB, Canada; [Anglin, Noelle L.; Ellis, David] Int Potato Ctr, Lima, Peru	McGill University; Agriculture & Agri Food Canada; CGIAR; International Potato Center (CIP)	Stromvik, MV (corresponding author), McGill Univ, Dept Plant Sci, Montreal, PQ, Canada.	martina.stromvik@mcgill.ca		Stromvik, Martina/0000-0002-0501-3703; Ellis, David/0000-0002-0209-2784; Achakkagari, Sai Reddy/0000-0002-5554-6110	Nouvelles Initiatives (Project International) grant from the Centre SEVE (Fonds de recherche du Quebec - Nature et technologies (FRQ-NT)); Compute/Calcul Canada Resource Allocations for Research Portals and Platforms (The Potato Genome Diversity Portal); Natural Sciences and Engineering Research Council of Canada (NSERC); Genome Quebec [GQ-AAC-2019-2]; Agriculture and Agri-Food Canada; CGIAR Genebank Platform; Federal Ministry of Economic Cooperation and Development, Germany	Nouvelles Initiatives (Project International) grant from the Centre SEVE (Fonds de recherche du Quebec - Nature et technologies (FRQ-NT)); Compute/Calcul Canada Resource Allocations for Research Portals and Platforms (The Potato Genome Diversity Portal)(CGIAR); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Quebec; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); CGIAR Genebank Platform(CGIAR); Federal Ministry of Economic Cooperation and Development, Germany	The authors acknowledge funding through a Nouvelles Initiatives (Project International) grant from the Centre SEVE (Fonds de recherche du Quebec -Nature et technologies (FRQ-NT) to M.V.S., N.A., D.E., and H.H.T.; Compute/Calcul Canada Resource Allocations for Research Portals and Platforms (The Potato Genome Diversity Portal), a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) and a Genome Quebec (GQ-AAC-2019-2) award to M.V.S.; A-base funding from Agriculture and Agri-Food Canada to H.H.T. from the Management Directed Genomics Call. The authors also gratefully acknowledge the support of the CGIAR Genebank Platform and appreciatively express thanks to the financial support for the sequencing by GIZ on behalf of the Federal Ministry of Economic Cooperation and Development, Germany. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amiryousefi A, 2018, BIOINFORMATICS, V34, P3030, DOI 10.1093/bioinformatics/bty220; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19591-9; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradshaw JE, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, P1, DOI 10.1016/B978-0-12-374349-7.00001-5; Cho KS, 2016, PLANT CELL REP, V35, P2113, DOI 10.1007/s00299-016-2022-y; Chung HJ, 2006, PLANT CELL REP, V25, P1369, DOI 10.1007/s00299-006-0196-4; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Dong WP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08348; Greiner S, 2019, NUCLEIC ACIDS RES, V47, pW59, DOI 10.1093/nar/gkz238; HAWKES JG, 1990, POTATO EVOLUTION BIO; HOSAKA K, 1988, THEOR APPL GENET, V76, P333, DOI 10.1007/BF00265332; HOSAKA K, 1986, THEOR APPL GENET, V72, P606, DOI 10.1007/BF00288998; HOSAKA K, 1995, THEOR APPL GENET, V90, P356, DOI 10.1007/BF00221977; Hosaka K, 2009, GENES GENET SYST, V84, P371, DOI 10.1266/ggs.84.371; Huang BQ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40790-5; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; JOHNSTON SA, 1980, THEOR APPL GENET, V57, P5, DOI 10.1007/BF00276002; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kraemer L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-41; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Kyriakidou M, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0428-4; Kyriakidou M, 2020, THEOR APPL GENET, V133, P951, DOI 10.1007/s00122-019-03519-6; Liu EX, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37456-z; PAUP* (Phylogenetic Analysis Using Parsimony (and Other Methods)), DICT BIOINFORMATICS; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rodriguez F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-191; San Millan Rosario Maria, 2013, BMC Res Notes, V6, P513, DOI 10.1186/1756-0500-6-513; Sanetomo R, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0545-y; Spooner DM, 2014, BOT REV, V80, P283, DOI 10.1007/s12229-014-9146-y; Sukhotu T, 2004, GENOME, V47, P46, DOI [10.1139/g03-105, 10.1139/G03-105]; Thode VA, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00796; Tillich M, 2017, NUCLEIC ACIDS RES, V45, pW6, DOI 10.1093/nar/gkx391; Tiwari JK, 2016, AGR RES, V5, P22, DOI 10.1007/s40003-015-0197-z; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158	36	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240124	10.1371/journal.pone.0240124	http://dx.doi.org/10.1371/journal.pone.0240124			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031462	gold, Green Published			2022-12-26	WOS:000581809800063
J	Endo, Y; Baldino, K; Li, B; Zhang, YT; Sakthivel, D; MacArthur, M; Panayi, AC; Kip, P; Spencer, DJ; Jasuja, R; Bagchi, D; Bhasin, S; Nuutila, K; Neppl, RL; Wagers, AJ; Sinha, I				Endo, Yori; Baldino, Kodi; Li, Bin; Zhang, Yuteng; Sakthivel, Dharaniya; MacArthur, Michael; Panayi, Adriana C.; Kip, Peter; Spencer, Daniel J.; Jasuja, Ravi; Bagchi, Debalina; Bhasin, Shalender; Nuutila, Kristo; Neppl, Ronald L.; Wagers, Amy J.; Sinha, Indranil			Loss of ARNT in skeletal muscle limits muscle regeneration in aging	FASEB JOURNAL			English	Article						aging; hypoxia signaling; muscle regeneration	ARYL-HYDROCARBON RECEPTOR; SATELLITE CELLS; STEM-CELLS; HYPOXIA; HOMEOSTASIS	The ability of skeletal muscle to regenerate declines significantly with aging. The expression of aryl hydrocarbon receptor nuclear translocator (ARNT), a critical component of the hypoxia signaling pathway, was less abundant in skeletal muscle of old (23-25 months old) mice. This loss of ARNT was associated with decreased levels of Notch1 intracellular domain (N1ICD) and impaired regenerative response to injury in comparison to young (2-3 months old) mice. Knockdown of ARNT in a primary muscle cell line impaired differentiation in vitro. Skeletal muscle-specific ARNT deletion in young mice resulted in decreased levels of whole muscle N1ICD and limited muscle regeneration. Administration of a systemic hypoxia pathway activator (ML228), which simulates the actions of ARNT, rescued skeletal muscle regeneration in both old and ARNT-deleted mice. These results suggest that the loss of ARNT in skeletal muscle is partially responsible for diminished myogenic potential in aging and activation of hypoxia signaling holds promise for rescuing regenerative activity in old muscle.	[Endo, Yori; Baldino, Kodi; Li, Bin; Zhang, Yuteng; Panayi, Adriana C.; Nuutila, Kristo; Sinha, Indranil] Harvard Med Sch, Brigham & Womens Hosp, Div Plast Surg, Boston, MA 02115 USA; [Li, Bin; Zhang, Yuteng] Southern Med Univ, Nanfang Hosp, Dept Plast & Aesthet Surg, Guangzhou, Peoples R China; [Sakthivel, Dharaniya] Baylor Coll Med, Div Human Genet, Houston, TX 77030 USA; [MacArthur, Michael] Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA USA; [MacArthur, Michael; Kip, Peter] Brigham & Womens Hosp, Div Vasc & Endovasc Surg, 75 Francis St, Boston, MA 02115 USA; [Spencer, Daniel J.; Jasuja, Ravi; Bhasin, Shalender] Brigham & Womens Hosp, Div Endocrinol, 75 Francis St, Boston, MA 02115 USA; [Bagchi, Debalina; Neppl, Ronald L.] Brigham & Womens Hosp, Dept Orthoped Surg, 75 Francis St, Boston, MA 02115 USA; [Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Wagers, Amy J.] Harvard Stem Cell Inst, Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA USA; [Wagers, Amy J.] Harvard Med Sch, Paul F Glenn Ctr Biol Aging, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Southern Medical University - China; Baylor College of Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard University; Harvard Medical School	Sinha, I (corresponding author), Brigham & Womens Hosp, Div Plast Surg, 45 Francis St, Boston, MA 02115 USA.	isinha@bwh.harvard.edu	Endo, Yori/AAY-8962-2020; Panayi, Adriana C./AAF-1817-2020; MacArthur, Michael Robert/AAA-3173-2022	Endo, Yori/0000-0002-9282-8811; Panayi, Adriana C./0000-0003-4053-9855; MacArthur, Michael Robert/0000-0003-3593-6995; Spencer, Daniel/0000-0003-1547-2935	HHS \ NIH \ National Institute on Aging (NIA) [K76AG059996, P30AG031679]; National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK036836]; Glenn Foundation for Medical Research	HHS \ NIH \ National Institute on Aging (NIA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Glenn Foundation for Medical Research	HHS vertical bar NIH vertical bar National Institute on Aging (NIA), Grant/Award Number: K76AG059996 and P30AG031679; National Institute of Diabetes and Digestive and Kidney Diseases, Grant/Award Number: P30 DK036836; Glenn Foundation for Medical Research	Badin PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168457; Bi PP, 2016, ELIFE, V5, DOI 10.7554/eLife.17355; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chakravarthy MV, 2001, CELL MOL LIFE SCI, V58, P1150, DOI 10.1007/PL00000929; Chen HL, 2017, EXP THER MED, V13, P861, DOI 10.3892/etm.2017.4049; Cirillo F, 2017, FASEB J, V31, P2146, DOI 10.1096/fj.201600878R; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; DeCarolis NA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025874; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Engin F, 2009, HUM MOL GENET, V18, P1464, DOI 10.1093/hmg/ddp057; Feige P, 2018, CELL STEM CELL, V23, P653, DOI 10.1016/j.stem.2018.10.006; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; Hendrickse P, 2019, J MUSCLE RES CELL M, V40, P127, DOI 10.1007/s10974-019-09520-2; Huang XX, 2018, CURR STEM CELL REP, V4, P149, DOI 10.1007/s40778-018-0127-7; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Liu L, 2018, CELL STEM CELL, V23, P544, DOI 10.1016/j.stem.2018.08.019; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Mandl M, 2014, MOL MED, V20, P215, DOI 10.2119/molmed.2014.00032; Oh J, 2016, AGING-US, V8, P2871, DOI 10.18632/aging.101098; Pawlikowski B, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0067-1; Sacco A, 2015, CELL STEM CELL, V16, P585, DOI 10.1016/j.stem.2015.05.007; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sinha I, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00153; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Theriault JR, 2012, BIOORG MED CHEM LETT, V22, P76, DOI 10.1016/j.bmcl.2011.11.077; Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674; Verma M, 2018, CELL STEM CELL, V23, P530, DOI 10.1016/j.stem.2018.09.007; Xie LW, 2018, J CLIN INVEST, V128, P2339, DOI 10.1172/JCI96208; Yang X, 2017, J BIOL CHEM, V292, P5981, DOI 10.1074/jbc.M116.756312; Yeo EJ, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0233-3	37	2	2	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16086	16104		10.1096/fj.202000761RR	http://dx.doi.org/10.1096/fj.202000761RR		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33064329	Green Published, hybrid			2022-12-26	WOS:000581154300001
J	Forlano, R; Mullish, BH; Mukherjee, SK; Nathwani, R; Harlow, C; Crook, P; Judge, R; Soubieres, A; Middleton, P; Daunt, A; Perez-Guzman, P; Selvapatt, N; Lemoine, M; Dhar, A; Thursz, MR; Nayagam, S; Manousou, P				Forlano, Roberta; Mullish, Benjamin H.; Mukherjee, Sujit K.; Nathwani, Rooshi; Harlow, Cristopher; Crook, Peter; Judge, Rebekah; Soubieres, Anet; Middleton, Paul; Daunt, Anna; Perez-Guzman, Pablo; Selvapatt, Nowlan; Lemoine, Maud; Dhar, Ameet; Thursz, Mark R.; Nayagam, Shevanthi; Manousou, Pinelopi			In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19	PLOS ONE			English	Article							RISK	Background & aims Although metabolic risk factors are associated with more severe COVID-19, there is little evidence on outcomes in patients with non-alcoholic fatty liver disease (NAFLD). We here describe the clinical characteristics and outcomes of NAFLD patients in a cohort hospitalised for COVID-19. Methods This study included all consecutive patients admitted for COVID-19 between February and April 2020 at Imperial College Healthcare NHS Trust, with either imaging of the liver available dated within one year from the admission or a known diagnosis of NAFLD. Clinical data and early weaning score (EWS) were recorded. NAFLD diagnosis was based on imaging or past medical history and patients were stratified for Fibrosis-4 (FIB-4) index. Clinical endpoints were admission to intensive care unit (ICU)and in-hospital mortality. Results 561 patients were admitted. Overall, 193 patients were included in the study. Fifty nine patients (30%) died, 9 (5%) were still in hospital, and 125 (65%) were discharged. The NAFLD cohort (n = 61) was significantly younger (60 vs 70.5 years, p = 0.046) at presentation compared to the non-NAFLD (n = 132). NAFLD diagnosis was not associated with adverse outcomes. However, the NAFLD group had higher C reactive protein (CRP) (107 vs 91.2 mg/L, p = 0.05) compared to non-NAFLD(n = 132). Among NAFLD patients, male gender (p = 0.01), ferritin (p = 0.003) and EWS (p = 0.047) were associated with in-hospital mortality, while the presence of intermediate/high risk FIB-4 or liver cirrhosis was not. Conclusion The presence of NAFLDper sewas not associated with worse outcomes in patients hospitalised for COVID-19. Though NAFLD patients were younger on admission, disease stage was not associated with clinical outcomes. Yet, mortality was associated with gender and a pronounced inflammatory response in the NAFLD group.	[Forlano, Roberta; Mullish, Benjamin H.; Mukherjee, Sujit K.; Nathwani, Rooshi; Harlow, Cristopher; Crook, Peter; Judge, Rebekah; Soubieres, Anet; Middleton, Paul; Daunt, Anna; Selvapatt, Nowlan; Lemoine, Maud; Dhar, Ameet; Thursz, Mark R.; Nayagam, Shevanthi; Manousou, Pinelopi] Imperial Coll London, Fac Med, Dept Metab Digest & Reprod, Liver Unit,Div Digest Dis, London, England; [Perez-Guzman, Pablo; Nayagam, Shevanthi] Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Global Infect Dis Anal, London, England	Imperial College London; Imperial College London	Manousou, P (corresponding author), Imperial Coll London, Fac Med, Dept Metab Digest & Reprod, Liver Unit,Div Digest Dis, London, England.	p.manousou@imperial.ac.uk	Forlano, Roberta/K-5121-2019; Mullish, Benjamin H/O-9524-2017; Middleton, Paul/AAF-2572-2021	Forlano, Roberta/0000-0003-4746-7065; Mullish, Benjamin H/0000-0001-6300-3100; Middleton, Paul/0000-0002-8070-2138; Judge, Rebekah/0000-0003-3288-8297; Thursz, Mark/0000-0002-8218-192X; Crook, Peter/0000-0002-9094-6558; Nayagam, Amanda Shevanthi/0000-0002-8030-3380; Daunt, Anna/0000-0001-6480-8867	EASL PhD fellowship Juan Rodes; NIHR Academic Clinical Lectureship; MRC GIDA fellowship; NIHR Imperial Biomedical Research Centre (BRC); MRC [MR/R015600/1, MC_PC_19012] Funding Source: UKRI	EASL PhD fellowship Juan Rodes; NIHR Academic Clinical Lectureship; MRC GIDA fellowship; NIHR Imperial Biomedical Research Centre (BRC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RF is the recipient of the EASL PhD fellowship Juan Rodes. BHM is the recipient of an NIHR Academic Clinical Lectureship. SN is supported by an MRC GIDA fellowship. The Division of Digestive Diseases at Imperial College London receives financial from the NIHR Imperial Biomedical Research Centre (BRC).	Abeles RD, 2019, ALIMENT PHARM THER, V49, P1077, DOI 10.1111/apt.15192; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; [Anonymous], 2020, LANCET INFECT DIS, V20, P383, DOI 10.1016/S1473-3099(20)30180-8; Carey IM, 2018, DIABETES CARE, V41, P513, DOI 10.2337/dc17-2131; Chen J, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.004; Crossan C, 2019, LIVER INT, V39, P2052, DOI 10.1111/liv.14198; De Jong A, 2015, BRIT J ANAESTH, V114, P297, DOI 10.1093/bja/aeu373; Dietz W, 2020, OBESITY, V28, P1005, DOI 10.1002/oby.22818; England N, 2020, CLIN MAN PERS ADM HO; Forlano R, 2021, CURR VASC PHARMACOL, V19, P269, DOI 10.2174/1570161118666200318103001; Glen J, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4428; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ji D, 2020, J HEPATOL, V73, P451, DOI 10.1016/j.jhep.2020.03.044; Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758; Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Pandyarajan Vijay, 2019, Gastroenterol Hepatol (N Y), V15, P357; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Prins GH, 2020, LIVER INT, V40, P2568, DOI 10.1111/liv.14484; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Younossi ZM, 2019, TRANSPLANTATION, V103, P22, DOI 10.1097/TP.0000000000002484; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	26	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240400	10.1371/journal.pone.0240400	http://dx.doi.org/10.1371/journal.pone.0240400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031439	Green Published, gold			2022-12-26	WOS:000581809800061
J	Laleye, AT; Abolnik, C				Laleye, Agnes Tinuke; Abolnik, Celia			Emergence of highly pathogenic H5N2 and H7N1 influenza A viruses from low pathogenic precursors by serial passage in ovo	PLOS ONE			English	Article							HEMAGGLUTININ CLEAVAGE SITE; AVIAN INFLUENZA; CHORIOALLANTOIC MEMBRANE; POTENTIAL PATHOGENICITY; VIRAL PATHOGENICITY; FOWL PLAGUE; RECOMBINATION; GENES; NEURAMINIDASE; MUTATIONS	Highly pathogenic (HPAI) strains emerge from their low pathogenic (LPAI) precursors and cause severe disease in poultry with enormous economic losses, and zoonotic potential. Understanding the mechanisms involved in HPAI emergence is thus an important goal for risk assessments. In this study ostrich-origin H5N2 and H7N1 LPAI progenitor viruses were serially passaged seventeen times in 14-day old embryonated chicken eggs and Ion Torrent ultra-deep sequencing was used to monitor the incremental changes in the consensus genome sequences. Both virus strains increased in virulence with successive passages, but the H7N1 virus attained a virulent phenotype sooner. Mutations V63M, E228V and D272G in the HA protein, Q357K in the nucleoprotein (NP) and H155P in the neuraminidase protein correlated with the increased pathogenicity of the H5N2 virus; whereas R584H and L589I substitutions in the polymerase B2 protein, A146T and Q220E in HA plus D231N in the matrix 1 protein correlated with increased pathogenicity of the H7N1 virus in embryos. Enzymatic cleavage of HA protein is the critical virulence determinant, and HA cleavage site motifs containing multibasic amino acids were detected at the sub-consensus level. The motifs PQERRR/GLF and PQRERR/GLF were first detected in passages 11 and 15 respectively of the H5N2 virus, and in the H7N1 virus the motifs PELPKGKK/GLF and PELPKRR/GLF were detected as early as passage 7. Most significantly, a 13 nucleotide insert of unknown origin was identified at passage 6 of the H5N2 virus, and at passage 17 a 42 nucleotide insert derived from the influenza NP gene was identified. This is the first report of non-homologous recombination at the HA cleavage site in an H5 subtype virus. This study provides insights into how HPAI viruses emerge from low pathogenic precursors and demonstrated the pathogenic potential of H5N2 and H7N1 strains that have not yet been implicated in HPAI outbreaks.	[Laleye, Agnes Tinuke] Natl Vet Res Inst, Vom, Nigeria; [Laleye, Agnes Tinuke; Abolnik, Celia] Univ Pretoria, Fac Vet Sci, Dept Prod Anim Studies, Pretoria, South Africa	University of Pretoria	Abolnik, C (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Prod Anim Studies, Pretoria, South Africa.	celia.abolnik@up.ac.za		Abolnik, Celia/0000-0003-3044-465X; Laleye, Agnes/0000-0002-2363-1548	South African Exotic Leather Cluster grant "Healthy Flocks-Quality Leather"; NRF-DSI SARChI grant [N77705-114612]	South African Exotic Leather Cluster grant "Healthy Flocks-Quality Leather"; NRF-DSI SARChI grant	The study was funded by the South African Exotic Leather Cluster grant "Healthy Flocks-Quality Leather". CA is funded by NRF-DSI SARChI grant #N77705-114612.	Abdelwhab EM, 2016, J VIROL, V90, P400, DOI 10.1128/JVI.02082-15; Abolnik C, 2012, AVIAN DIS, V56, P865, DOI 10.1637/10171-041012-Reg.1; Abolnik C, 2017, ARCH VIROL, V162, P2219, DOI 10.1007/s00705-017-3337-x; Abolnik C, 2016, AVIAN DIS, V60, P286, DOI 10.1637/11110-042815-Reg; Abolnik C, 2009, INFLUENZA OTHER RESP, V3, P63, DOI 10.1111/j.1750-2659.2009.00074.x; [Anonymous], 2003, JSHT, V10, P177; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Beerens N, 2020, J VIROL, V94, DOI 10.1128/JVI.01818-19; Besser J, 2018, CLIN MICROBIOL INFEC, V24, P335, DOI 10.1016/j.cmi.2017.10.013; Brugh M, 2003, AVIAN DIS, V47, P166; Dreier C, 2019, EMERG MICROBES INFEC, V8, P1324, DOI 10.1080/22221751.2019.1663131; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Han GZ, 2011, VIRUSES-BASEL, V3, P1358, DOI 10.3390/v3081358; HARDY CT, 1995, VIROLOGY, V211, P302, DOI 10.1006/viro.1995.1405; HORIMOTO T, 1995, VIROLOGY, V206, P755, DOI 10.1016/S0042-6822(95)80004-2; Horimoto T, 1998, J VET MED SCI, V60, P273, DOI 10.1292/jvms.60.273; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Khaliq Z, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0465-x; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Lee CW, 2007, AVIAN DIS, V51, P260, DOI 10.1637/7572-033106R.1; Lopez-Martinez I, 2013, EMERG INFECT DIS, V19, P1531, DOI 10.3201/eid1909.130087; Luczo JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29944-z; Luczo JM, 2015, REV MED VIROL, V25, P406, DOI 10.1002/rmv.1846; Manvell RJ, 2005, P 3 INT RAT SCI S WP, P14; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Maurer-Stroh S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-139; Monne I, 2014, J VIROL, V88, P4375, DOI 10.1128/JVI.03181-13; Nao N, 2017, MBIO, V8, DOI 10.1128/mBio.02298-16; NCBI, 2020, BAS LOC AL SEARCH TO; OIE (World Organisation for Animal Health), 2015, AV INFL INF AV INFL; ORLICH M, 1994, VIROLOGY, V204, P462, DOI 10.1006/viro.1994.1555; Pasick J, 2005, J GEN VIROL, V86, P727, DOI 10.1099/vir.0.80478-0; Pasick J, 2009, REV SCI TECH OIE, V28, P349, DOI 10.20506/rst.28.1.1875; Perdue M., 2003, AVIAN DIS, V47, P182; Perdue ML, 1996, VIRUS GENES, V12, P77, DOI 10.1007/BF00370003; Perdue ML, 2000, VET MICROBIOL, V74, P77, DOI 10.1016/S0378-1135(00)00168-1; PERDUE ML, 1990, VIRUS RES, V16, P137, DOI 10.1016/0168-1702(90)90018-7; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richard M, 2017, MECH RISK FACTORS MU; ROTT R, 1976, J VIROL, V19, P54, DOI 10.1128/JVI.19.1.54-60.1976; ROTT R, 1980, ARCH VIROL, V65, P123, DOI 10.1007/BF01317323; SCHOLTISSEK C, 1988, J GEN VIROL, V69, P2155, DOI 10.1099/0022-1317-69-9-2155; SCHOLTISSEK C, 1977, VIROLOGY, V81, P74, DOI 10.1016/0042-6822(77)90059-9; Seekings AH, 2017, THESIS; Spackman E, 2005, AVIAN DIS, V49, P313; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Suttie A, 2019, VIRUS GENES, V55, P739, DOI 10.1007/s11262-019-01700-z; Uchida Y, 2011, VET MICROBIOL, V147, P1, DOI 10.1016/j.vetmic.2010.05.037; VEY M, 1992, VIROLOGY, V188, P408, DOI 10.1016/0042-6822(92)90775-K; Wang L, 2008, VACCINE, V26, P3580, DOI 10.1016/j.vaccine.2008.05.001; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Zarkov I. S., 2006, Bulgarian Journal of Veterinary Medicine, V9, P43	54	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240290	10.1371/journal.pone.0240290	http://dx.doi.org/10.1371/journal.pone.0240290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031421	gold, Green Published			2022-12-26	WOS:000581809800072
J	Protsenko, E; Rehkopf, D; Prather, AA; Epel, E; Lin, J				Protsenko, Ekaterina; Rehkopf, David; Prather, Aric A.; Epel, Elissa; Lin, Jue			Are long telomeres better than short? Relative contributions of genetically predicted telomere length to neoplastic and non-neoplastic disease risk and population health burden	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; CANCER; HERITABILITY; LOCUS; TERC; METAANALYSIS; CELLS; BIOMARKER; BIOLOGY	Background Mendelian Randomization (MR) studies exploiting single nucleotide polymorphisms (SNPs) predictive of leukocyte telomere length (LTL) have suggested that shorter genetically determined telomere length (gTL) is associated with increased risks of degenerative diseases, including cardiovascular and Alzheimer's diseases, while longer gTL is associated with increased cancer risks. These varying directions of disease risk have long begged the question: when it comes to telomeres, is it better to be long or short? We propose to operationalize and answer this question by considering the relative impact of long gTL vs. short gTL on disease incidence and burden in a population. Methods and findings We used odds ratios (OR) of disease associated with gTL from a recently published MR meta-analysis to approximate the relative contributions of gTL to the incidence and burden of neoplastic and non-neoplastic disease in a European population. We obtained incidence data of the 9 cancers associated with long gTL and 4 non-neoplastic diseases associated with short gTL from the Institute of Health Metrics (IHME). Incidence rates of individual cancers from SEER, a database of United States cancer records, were used to weight the ORs in order to align with the available IHME data. These data were used to estimate the excess incidences due to long vs. short gTL, expressed as per 100,000 persons per standard deviation (SD) change in gTL. To estimate the population disease burden, we used the Disability Adjusted Life Years (DALY) metric from the IHME, a measure of overall disease burden that accounts for both mortality and morbidity, and similarly calculated the excess DALY associated with long vs. short gTL. Results Our analysis shows that, despite the markedly larger ORs of neoplastic disease, the large incidence of degenerative diseases causes the excess incidence attributable to gTL to balance that of neoplastic diseases. Long gTL is associated with an excess incidence of 94.04 cases/100,000 persons/SD (45.49-168.84, 95%CI) from the 9 cancer, while short gTL is associated with an excess incidence of 121.49 cases/100,000 persons/SD (48.40-228.58, 95%CI) from the 4 non-neoplastic diseases. When considering disease burden using the DALY metric, long gTL is associated with an excess 1255.25 DALYs/100,000 persons/SD (662.71-2163.83, 95%CI) due to the 9 cancers, while short gTL is associated with an excess 1007.75 DALYs/100,000 persons/SD (411.63-1847.34, 95%CI) due to 4 non-neoplastic diseases. Conclusions Our results show that genetically determined long and short telomere length are associated with disease risk and burden of approximately equal magnitude. These results provide quantitative estimates of the relative impact of genetically-predicted short vs. long TL in a human population, and provide evidence in support of the cancer-aging paradox, wherein human telomere length is balanced by opposing evolutionary forces acting to minimize both neoplastic and non-neoplastic diseases. Importantly, our results indicate that odds ratios alone can be misleading in different clinical scenarios, and disease risk should be assessed from both an individual and population level in order to draw appropriate conclusions about the risk factor's role in human health.	[Protsenko, Ekaterina] UCSF Sch Med, San Francisco, CA USA; [Rehkopf, David] Stanford Dept Primary Care & Populat Hlth, Stanford, CA USA; [Prather, Aric A.; Epel, Elissa] UCSF Dept Psychiat, San Francisco, CA USA; [Lin, Jue] UCSF Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Lin, J (corresponding author), UCSF Dept Biochem & Biophys, San Francisco, CA 94158 USA.	jue.lin@ucsf.edu		Rehkopf, David/0000-0002-7597-6513				Al Khaldi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145721; Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; [Anonymous], 2011, KHARTOUM MED J, V4, P514; Aviv A, 2020, FASEB J, V34, P7247, DOI 10.1096/fj.202001025; Aviv A, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0436; Benetos A, 2013, AGING CELL, V12, P615, DOI 10.1111/acel.12086; Bilgili H, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081232; Bischoff C, 2005, TWIN RES HUM GENET, V8, P433, DOI 10.1375/twin.8.5.433; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Broer L, 2013, EUR J HUM GENET, V21, P1163, DOI 10.1038/ejhg.2012.303; Cao Y, 2002, ONCOGENE, V21, P3130, DOI 10.1038/sj.onc.1205419; Cheng Y, 2017, CANCER EPIDEMIOL, V50, P39, DOI 10.1016/j.canep.2017.07.011; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; De Meyer T, 2018, J AM COLL CARDIOL, V72, P805, DOI 10.1016/j.jacc.2018.06.014; De Meyer T, 2014, EUR J HUM GENET, V22, P10, DOI 10.1038/ejhg.2013.255; Delgado DA, 2019, HUM GENET, V138, P49, DOI 10.1007/s00439-018-1964-2; Delgado DA, 2018, J MED GENET, V55, P64, DOI 10.1136/jmedgenet-2017-104922; Dugdale HL, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0450; Entringer S, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0151; Faul JD, 2016, BIODEMOGR SOC BIOL, V62, P73, DOI 10.1080/19485565.2015.1120645; Gable DL, 2019, GENE DEV, V33, P1381, DOI 10.1101/gad.326785.119; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Hoffman TW, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00809-2019; Horvath K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36923-x; Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588; Jafri MA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0324-x; Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772; Kachuri L, 2019, INT J EPIDEMIOL, V48, P751, DOI 10.1093/ije/dyy140; Keefe DL, 2016, REPROD SCI, V23, P1612, DOI 10.1177/1933719116676397; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040504; Levinson BM, 2013, J ANC JUD, V4, P310, DOI 10.13109/jaju.2013.4.3.310; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Li C, 2020, AM J HUM GENET, V106, P389, DOI 10.1016/j.ajhg.2020.02.006; Liu Y, 2014, REGION ANESTH PAIN M, V9, pe85043, DOI 10.1371/journal.pone.0085043; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Ma LJ, 2017, J PATHOL, V243, P407, DOI 10.1002/path.4961; Machiela MJ, 2017, EUR UROL, V72, P747, DOI 10.1016/j.eururo.2017.07.015; Mangino M, 2009, J MED GENET, V46, P451, DOI 10.1136/jmg.2008.064956; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; Mangino M, 2012, HUM MOL GENET, V21, P5385, DOI 10.1093/hmg/dds382; Martinez P, 2017, J CELL BIOL, V216, P875, DOI 10.1083/jcb.201610111; Maubaret CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083122; Mirabello L, 2010, HUM MUTAT, V31, P1050, DOI 10.1002/humu.21314; Njajou OT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013048; Rangel-Zuniga OA, 2016, EXP GERONTOL, V83, P56, DOI 10.1016/j.exger.2016.07.015; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pooley KA, 2013, HUM MOL GENET, V22, P5056, DOI 10.1093/hmg/ddt355; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Saxena R, 2014, CIRC-CARDIOVASC GENE, V7, P287, DOI 10.1161/CIRCGENETICS.113.000412; Shen Q, 2011, EUR J HUM GENET, V19, P721, DOI 10.1038/ejhg.2011.4; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Stone RC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006144; Ter Kuile Wissink, 2015, CML REV, V52, P157; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Walsh KM, 2015, ONCOTARGET, V6, P42468, DOI 10.18632/oncotarget.6468; Walsh KM, 2014, NAT GENET, V46, P731, DOI 10.1038/ng.3004; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Worheide G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-24; Xu XF, 2017, HUM REPROD, V32, P201, DOI 10.1093/humrep/dew283; Zhang CA, 2015, HUM MOL GENET, V24, P5356, DOI 10.1093/hmg/ddv252; Zhang X, 2017, CANCER EPIDEM BIOMAR, V26, P1381, DOI 10.1158/1055-9965.EPI-16-0968; Zhou YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33147; 2011, GMBI, V2, P19	69	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240185	10.1371/journal.pone.0240185	http://dx.doi.org/10.1371/journal.pone.0240185			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031470	Green Published, gold			2022-12-26	WOS:000581809800090
J	Akinyemi, JO; Afolabi, RF; Awolude, OA				Akinyemi, Joshua Odunayo; Afolabi, Rotimi Felix; Awolude, Olutosin Alaba			Semi-parametric model for timing of first childbirth after HIV diagnosis among women of childbearing age in Ibadan, Nigeria	PLOS ONE			English	Article							INFECTED WOMEN; INTENTIONS; PREGNANCY	Background HIV diagnosis is a watershed in women's childbearing experience. It is usually accompanied by the fear of death and stigmatisation. Women diagnosed of HIV are often sceptical about pregnancy. Meanwhile, availability of antiretroviral treatments has impacted positively on childbearing experience among women living with HIV. We therefore investigated the timing of first childbirth after HIV diagnosis and its determinants among women in Ibadan, Nigeria. Methods We extracted and analysed data from a 2015 cross-sectional study on childbearing progression among 933 women living with HIV and receiving care at University College Hospital, Ibadan, Nigeria. Extended Cox proportional hazards regression, a semi-parametric event history model was used at 5% significance level. Results The women's mean age was 38.1 (+/- SD = 6.1) years and the median time to first birth after HIV diagnosis (FBI_HIV) was 8 years. The likelihood of first birth after HIV diagnosis was lower among women who desired more children (HR = 0.63, CI: 0.51-0.78). Women whose partners had primary and secondary education respectively were about 2.3 times more likely to shorten FBI_HIV compared to those whose partners had no formal education. Knowledge of partner's HIV-positive status (HR = 1.42, CI: 1.04,1.93) increased the likelihood of having a first birth after HIV diagnosis. Older age, longer duration on ART and a higher number of children at diagnosis were associated with a declined hazard of first birth after HIV diagnosis. Conclusions The median time to first childbirth after HIV diagnosis was long. Partner's HIV-positive status and higher educational attainment were associated with early childbearing after HIV diagnosis.	[Akinyemi, Joshua Odunayo; Afolabi, Rotimi Felix] Univ Ibadan, Dept Epidemiol & Med Stat, Coll Med, Ibadan, Nigeria; [Akinyemi, Joshua Odunayo] Univ Witwatersrand, Demog & Populat Studies, Sch Publ Hlth, Johannesburg, South Africa; [Akinyemi, Joshua Odunayo] Univ Witwatersrand, Demog & Populat Studies, Sch Social Sci, Johannesburg, South Africa; [Afolabi, Rotimi Felix] North West Univ, Fac Humanities, Populat & Hlth Res Ent, Vanderbijlpark, South Africa; [Awolude, Olutosin Alaba] Univ Ibadan, Coll Med, Dept Obstet & Gynaecol, Ibadan, Nigeria	University of Ibadan; University of Witwatersrand; University of Witwatersrand; North West University - South Africa; University of Ibadan	Afolabi, RF (corresponding author), Univ Ibadan, Dept Epidemiol & Med Stat, Coll Med, Ibadan, Nigeria.; Afolabi, RF (corresponding author), North West Univ, Fac Humanities, Populat & Hlth Res Ent, Vanderbijlpark, South Africa.	rotimifelix@yahoo.com	Afolabi, Rotimi Felix/ABA-1796-2021; Awolude, Olutosin A./U-5349-2019	Afolabi, Rotimi Felix/0000-0002-0744-1787; Awolude, Olutosin A./0000-0003-3365-0256				Annotation Rice, 2007, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm97818089549; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2017, UNAIDS DAT 2017; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2015, ORBITAL DEBRIS Q NEW, V19, P14; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Chen I, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.02.002; Claye LJ, 2018, INT J WOMENS HEALTH, V10, P623, DOI 10.2147/IJWH.S165958; Cliffe S, 2011, AIDS CARE, V23, P1093, DOI 10.1080/09540121.2011.554515; de Jonge HCC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0427-6; Diabetes Poland, 2011, DIABETOLOGIA DOSW SA, V11, P1; Evens E, 2015, CULT HEALTH SEX, V17, P374, DOI 10.1080/13691058.2014.968806; Haddad LB, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.079; Hernando V, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000005991, 10.1097/md.0000000000005991]; In J, 2019, KOREAN J ANESTHESIOL, V72, P441, DOI 10.4097/kja.19183; Kaida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063411; Kawale P, 2014, AIDS CARE, V26, P769, DOI 10.1080/09540121.2013.855294; Kleinbaum DG, 2012, STAT BIOL HEALTH, P241, DOI 10.1007/978-1-4419-6646-9_6; Mohammed F, 2016, DETERMINANTS DESIRE; National Agency for the Control of AIDS, 2019, REV NAT HIV AIDS STR; National Population Commission (NPC) [Nigeria] and ICF International, 2019, NIG DEM HLTH SURV 20; National Population Commission of Nigeria, 2014, NIG DEM HLTH SURV 20; Onubogu CU., 2013, J PAEDIAT, V40, P264, DOI DOI 10.4314/NJP.V40I3; Pilecco FB, 2015, CIENC SAUDE COLETIVA, V20, P1520, DOI 10.1590/1413-81232015205.13002014; Shiferaw T, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4190-7; Tolosie K, 2014, APPL COX PROPORTIONA, DOI [10.1155/2014/536976, DOI 10.1155/2014/536976]; UNAIDS, 2019, UNAIDS DAT 2019; Van Ommen CE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211434; Zhang Y, 2017, J EXP MED, V214, P2523, DOI 10.1084/jem.20161427	29	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240247	10.1371/journal.pone.0240247	http://dx.doi.org/10.1371/journal.pone.0240247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3SJ	33027315	Green Published, gold			2022-12-26	WOS:000581808000016
J	Stopyra, JP; Snavely, AC; Smith, LM; Harris, RD; Nelson, RD; Winslow, JE; Alson, RL; Pomper, GJ; Riley, RF; Ashburn, NP; Hendley, NW; Gaddy, J; Woodrum, T; Fornage, L; Conner, D; Alvarez, M; Pflum, A; Koehler, LE; Miller, CD; Mahler, SA				Stopyra, Jason P.; Snavely, Anna C.; Smith, Lane M.; Harris, R. David; Nelson, Robert D.; Winslow, James E.; Alson, Roy L.; Pomper, Gregory J.; Riley, Robert F.; Ashburn, Nicklaus P.; Hendley, Nella W.; Gaddy, Jeremiah; Woodrum, Tyler; Fornage, Louis; Conner, David; Alvarez, Manrique; Pflum, Adam; Koehler, Lauren E.; Miller, Chadwick D.; Mahler, Simon A.			Prehospital use of a modified HEART Pathway and point-of-care troponin to predict cardiovascular events	PLOS ONE			English	Article							HIGH-SENSITIVITY TROPONIN; EMERGENCY-DEPARTMENT PATIENTS; ACUTE CHEST-PAIN; MYOCARDIAL-INFARCTION; DIAGNOSIS; PERFORMANCE; TRIAL; ASSAY; RULE; TIME	The HEART Pathway is a validated risk stratification protocol for Emergency Department patients with chest pain that has yet to be tested in the prehospital setting. This study seeks to test the performance of a prehospital modified HEART Pathway (PMHP). A prospective cohort study of adults with chest pain without ST-segment elevation myocardial infarction was conducted at three EMS agencies between 12/2016-1/2018. To complete a PMHP assessment, paramedics drew blood, measured point-of-care (POC) troponin (i-STAT; Abbott Point of Care) and calculated a HEAR score. Patients were stratified into three groups: high-risk based on an elevated troponin, low-risk based on a HEAR score <4 with a negative troponin, or moderate risk for a HEAR score >= 4 with a negative troponin. Sensitivity, specificity, negative and positive predictive values of the PMHP for detection of major adverse cardiac events (MACE: cardiac death, MI, or coronary revascularization) at 30-days were calculated. A total of 506 patients were accrued, with PMHP completed in 78.1% (395/506). MACE at 30-days occurred in 18.7% (74/395). Among these patients, 7.1% (28/395) were high risk yielding a specificity and PPV for 30-day MACE of 96.6% (95%CI: 94.0-98.3%) and 60.7% (95%CI: 40.6-78.6%) respectively. Low-risk assessments occurred in 31.4% (124/395), which were 90.5% (95%CI: 81.5-96.1%) sensitive for 30-day MACE with a NPV of 94.4% (95%CI: 88.7-97.7%). Moderate-risk assessments occurred in 61.5% (243/395), of which 20.6% had 30-day MACE. The PMHP is able to identify high-risk and low-risk groups with high specificity and negative predictive value for 30-day MACE.	[Stopyra, Jason P.; Smith, Lane M.; Nelson, Robert D.; Winslow, James E.; Alson, Roy L.; Ashburn, Nicklaus P.; Hendley, Nella W.; Gaddy, Jeremiah; Woodrum, Tyler; Koehler, Lauren E.; Miller, Chadwick D.; Mahler, Simon A.] Wake Forest Univ, Bowman Gray Sch Med, Dept Emergency Med, Winston Salem, NC 27109 USA; [Snavely, Anna C.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat, Winston Salem, NC USA; [Harris, R. David] Forsyth Cty Govt, Forsyth Cty Emergency Serv, Winston Salem, NC USA; [Pomper, Gregory J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27103 USA; [Riley, Robert F.] Christ Hosp, Dept Cardiol, Heart & Vasc Ctr, Cincinnati, OH 45219 USA; [Fornage, Louis] Washington Univ, Sch Med, Dept Emergency Med, St Louis, MO USA; [Conner, David] Duke Univ, Dept Emergency Med, Durham, NC USA; [Alvarez, Manrique; Pflum, Adam] Wake Forest Univ, Bowman Gray Sch Med, Dept Cardiol, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Christ Hospital - Ohio; Washington University (WUSTL); Duke University; Wake Forest University; Wake Forest Baptist Medical Center	Stopyra, JP (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Emergency Med, Winston Salem, NC 27109 USA.	jstopyra@wakehealth.edu		Ashburn, Nicklaus/0000-0002-3466-8813; Stopyra, Jason/0000-0001-7457-3969	Abbott Point of Care; Wake Forest School of Medicine	Abbott Point of Care; Wake Forest School of Medicine	Abbott Point of Care provided funding for this study. Wake Forest School of Medicine received this funding to provide Dr. Stopyra & Mahler with time to complete the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts GWA, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034403; Aldous S, 2014, INT J CARDIOL, V177, P182, DOI 10.1016/j.ijcard.2014.09.026; Aldous S, 2012, EMERG MED J, V29, P805, DOI 10.1136/emermed-2011-200222; Alghamdi A, 2019, EUR J EMERG MED, V26, P356, DOI 10.1097/MEJ.0000000000000575; Backus Barbra E, 2010, Crit Pathw Cardiol, V9, P164, DOI 10.1097/HPC.0b013e3181ec36d8; Ducas RA, 2012, CAN J CARDIOL, V28, P432, DOI 10.1016/j.cjca.2012.04.008; Erhardt L, 2002, EUR HEART J, V23, P1153, DOI 10.1053/euhj.2002.3194; Ezekowitz JA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002859; Ezekowitz JA, 2014, CAN J CARDIOL, V30, P1208, DOI 10.1016/j.cjca.2014.04.012; Havas S, 2009, ARCH INTERN MED, V169, P150, DOI 10.1001/archinternmed.2008.518; Ishak M, 2018, EUR HEART J-ACUTE CA, V7, P102, DOI 10.1177/2048872616687116; JP S., 2020, SAEM 2020; Kerr D, 2006, EMERG MED J, V23, P948, DOI 10.1136/emj.2006.038414; Li GQ, 2016, CLIN CHEM LAB MED, V54, P133, DOI 10.1515/cclm-2014-0776; Lynn Jeremy S, 2011, ISRN Cardiol, V2011, P364728, DOI 10.5402/2011/364728; Mahler SA, 2018, CIRCULATION, V138, P2456, DOI 10.1161/CIRCULATIONAHA.118.036528; Mahler SA, 2015, CIRC-CARDIOVASC QUAL, V8, P195, DOI 10.1161/CIRCOUTCOMES.114.001384; Mahler SA, 2013, INT J CARDIOL, V168, P795, DOI 10.1016/j.ijcard.2012.10.010; Mahler Simon A, 2011, Crit Pathw Cardiol, V10, P128, DOI 10.1097/HPC.0b013e3182315a85; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Six AJ, 2008, NETH HEART J, V16, P191, DOI 10.1007/BF03086144; Sorensen JT, 2011, AM J CARDIOL, V107, P1436, DOI 10.1016/j.amjcard.2011.01.014; Stengaard C, 2013, AM J CARDIOL, V112, P1361, DOI 10.1016/j.amjcard.2013.06.026; Stopyra JP, 2018, PREHOSP DISASTER MED, V33, P58, DOI 10.1017/S1049023X17007154; Stopyra JP, 2017, ACAD EMERG MED, V24, P1165, DOI 10.1111/acem.13221; Stopyra Jason P, 2016, Crit Pathw Cardiol, V15, P46, DOI 10.1097/HPC.0000000000000072; Stopyra Jason P, 2015, Crit Pathw Cardiol, V14, P134, DOI 10.1097/HPC.0000000000000059; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; van Dongen DN, 2018, AM J CARDIOL, V122, P1610, DOI 10.1016/j.amjcard.2018.07.037; Venge P, 2017, CLIN CHIM ACTA, V469, P119, DOI 10.1016/j.cca.2017.03.023; Wilson RE, 2013, AM J EMERG MED, V31, P1098, DOI 10.1016/j.ajem.2013.04.013; [No title captured]	32	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239460	10.1371/journal.pone.0239460	http://dx.doi.org/10.1371/journal.pone.0239460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027260	gold, Green Published			2022-12-26	WOS:000581808000023
J	Zauner, J; Plischke, H; Stijnen, H; Schwarz, UT; Strasburger, H				Zauner, Johannes; Plischke, Herbert; Stijnen, Hanna; Schwarz, Ulrich T.; Strasburger, Hans			Influence of common lighting conditions and time-of-day on the effort-related cardiac response	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; HUMAN MELATONIN; HEART-RATE; PERFORMANCE; ALERTNESS; SENSITIVITY; TEMPERATURE; SLEEPINESS; QUALITY; TASK	Melanopic stimuli trigger diverse non-image-forming effects. However, evidence of a melanopic contribution to acute effects on alertness and performance is inconclusive, especially under common lighting situations. Effects on cognitive performance are likely mediated by effort-related physiological changes. We assessed the acute effects of lighting in three scenarios, at two times of day, on effort-related changes to cardiac contraction as indexed by the cardiac pre-ejection period (PEP). In a within-subject design, twenty-seven participants performed a cognitive task thrice during a morning and a late-afternoon session. We set the lighting at 500 lux in all three lighting scenarios, measured horizontally at the desk level, but with 54 lux, 128 lux, or 241 lux melanopic equivalent daylight illuminance at the eye level. Impedance cardiography and electrocardiography measurements were used to calculate PEP, for the baseline and task period. A shorter PEP during the task represents a sympathetic heart activation and therefore increased effort. Data were analysed with linear mixed-effect models. PEP changes depended on both the light scene and time of day (p = 0.01 and p = 0.002, respectively). The highest change (sympathetic activation) occurred for the medium one of the three stimuli (128 lux) during the late-afternoon session. However, effect sizes for the singular effects were small, and only for the combined effect of light and time of day middle-sized. Performance scores or self-reported scores on alertness and task demand did not change with the light scene. In conclusion, participants reached the same performance most efficiently at both the highest and lowest melanopic setting, and during the morning session. The resulting U-shaped relation between melanopic stimulus intensity and PEP is likely not dependent solely on intrinsic ipRGC stimuli, and might be moderated by extrinsic cone input. Since lighting situations were modelled according to current integrative lighting strategies and real-life indoor light intensities, the result has implications for artificial lighting in a work environment.	[Zauner, Johannes; Plischke, Herbert] Munich Univ Appl Sci, Munich, Germany; [Stijnen, Hanna; Schwarz, Ulrich T.] Tech Univ Chemnitz, Inst Phys, Chemnitz, Germany; [Strasburger, Hans] Ludwig Maximilians Univ Munchen, Inst Med Psychol, Munich, Germany	University of Munich; Technische Universitat Chemnitz; University of Munich	Zauner, J (corresponding author), Munich Univ Appl Sci, Munich, Germany.	zauner@me.com	; Schwarz, Ulrich/B-1797-2010	Strasburger, Hans/0000-0001-7156-5111; Zauner, Johannes/0000-0003-2171-4566; Schwarz, Ulrich/0000-0002-1889-2188	Open Access Publication Fund of the Munich University of Applied Sciences (MUAS)	Open Access Publication Fund of the Munich University of Applied Sciences (MUAS)	The Open Access Publication Fund of the Munich University of Applied Sciences (MUAS) provided financial support for the publication of this work. Lumitech Lighting Solution GmbH, Austria provided materials (lighting and control components) for this study, as well as funding for the payment of participants and the material costs of disposable strip electrodes. Lumitech and MUAS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari P, 2015, INVEST OPHTH VIS SCI, V56, P3838, DOI 10.1167/iovs.14-16233; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Allen Micah, 2019, Wellcome Open Res, V4, P63, DOI 10.12688/wellcomeopenres.15191.1; American Diabetes Association, 2014, DIABETES CARE S, V37, P1; Andre N, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00079; [Anonymous], 2017, LANCET HIV, V4, pE51; [Anonymous], 2019, CO POS STAT PROP LIG; [Anonymous], 2013, AM J OCCUP THER, V68, pS1; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bellia L, 2017, LIGHTING RES TECHNOL, V49, P33, DOI 10.1177/1477153515594654; Berntson GG, 2004, PSYCHOPHYSIOLOGY, V41, P333, DOI 10.1111/j.1469-8986.2004.00156.x; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Boivin DB, 1996, NATURE, V379, P540, DOI 10.1038/379540a0; BREHM JW, 1989, ANNU REV PSYCHOL, V40, P109, DOI 10.1146/annurev.ps.40.020189.000545; Brown TM, 2020, J PINEAL RES, V69, DOI 10.1111/jpi.12655; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Carrington M, 2003, J SLEEP RES, V12, P213, DOI 10.1046/j.1365-2869.2003.00364.x; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Chellappa SL, 2011, PROG BRAIN RES, V190, P119, DOI 10.1016/B978-0-444-53817-8.00007-4; Christensen R., 2019, ORDINAL REGRESSION M; CIE, 2018, S0262018 CIE; DEBSKI TT, 1993, BIOL PSYCHOL, V36, P63, DOI 10.1016/0301-0511(93)90081-I; Dijk DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000145; DIN, 2011, 124641201108 DIN EN; DIN, 2013, 67600201304 DIN SPEC; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Figueiro MG, 2016, BIOL RES NURS, V18, P90, DOI 10.1177/1099800415572873; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Goldstein D, 2007, PERS INDIV DIFFER, V42, P431, DOI 10.1016/j.paid.2006.07.008; Goodman SN, 2001, EPIDEMIOLOGY, V12, P295, DOI 10.1097/00001648-200105000-00006; Griefahn B, 2001, SOMNOLOGIE, V5, P71, DOI [10.1046/j.1439-054X.2001.01149.x, DOI 10.1046/J.1439-054X.2001.01149.X]; HART S G, 1988, P139; Hart S.G., 2006, P HUM FACT ERG SOC A, DOI [10.1177/154193120605000909, DOI 10.1177/154193120605000909]; Holmes A L, 2001, J Hum Ergol (Tokyo), V30, P223; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; KRAUCHI K, 1994, AM J PHYSIOL, V267, pR819, DOI 10.1152/ajpregu.1994.267.3.R819; Lasauskaite R, 2018, BIOL PSYCHOL, V132, P64, DOI 10.1016/j.biopsycho.2017.11.005; Laszewska K, 2018, ADV COGN PSYCHOL, V14, P192, DOI 10.5709/acp-0250-0; Lockley SW, 2006, SLEEP, V29, P161; Lozano DL, 2007, PSYCHOPHYSIOLOGY, V44, P113, DOI 10.1111/j.1469-8986.2006.00468.x; Lucassen EA, 2016, CURR BIOL, V26, P1843, DOI 10.1016/j.cub.2016.05.038; MCCUBBIN JA, 1983, PSYCHOPHYSIOLOGY, V20, P102, DOI 10.1111/j.1469-8986.1983.tb00910.x; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; MCINTYRE IM, 1989, PSYCHONEUROENDOCRINO, V14, P187, DOI 10.1016/0306-4530(89)90016-4; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Munch M, 2012, INVEST OPHTH VIS SCI, V53, P4546, DOI 10.1167/iovs.12-9494; OBRIST PA, 1976, PSYCHOPHYSIOLOGY, V13, P95, DOI 10.1111/j.1469-8986.1976.tb00081.x; Oldham MA, 2014, CHRONOBIOL INT, V31, P305, DOI 10.3109/07420528.2013.833935; Pachito DV, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012243.pub2; Plitnick B, 2010, LIGHTING RES TECHNOL, V42, P449, DOI 10.1177/1477153509360887; Prayag AS, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00126; R Core Team, 2021, R LANGUAGE ENV STAT; Revell VL, 2006, NEUROSCI LETT, V399, P96, DOI 10.1016/j.neulet.2006.01.032; Richter M, 2008, PSYCHOPHYSIOLOGY, V45, P869, DOI 10.1111/j.1469-8986.2008.00688.x; Richter M, 2009, PSYCHOPHYSIOLOGY, V46, P451, DOI 10.1111/j.1469-8986.2009.00795.x; Satish U, 2012, ENVIRON HEALTH PERSP, V120, P1671, DOI 10.1289/ehp.1104789; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schachinger H, 2001, PSYCHOSOM MED, V63, P788, DOI 10.1097/00006842-200109000-00012; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Seppanen O., 2006, 5 INT C COLD CLIMATE; SHERWOOD A, 1990, PSYCHOPHYSIOLOGY, V27, P1, DOI 10.1111/j.1469-8986.1990.tb02171.x; Sheskin D., 2011, HDB PARAMETRIC NONPA, Vfifth, DOI [DOI 10.1201/9781420036268, 10.2307/2685909]; Sikka G, 2014, P NATL ACAD SCI USA, V111, P17977, DOI 10.1073/pnas.1420258111; Silvestrini N, 2011, BIOL PSYCHOL, V87, P209, DOI 10.1016/j.biopsycho.2011.02.017; Spitschan M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00941; Stern M, 2018, EUR J PREV CARDIOL, V25, P1875, DOI 10.1177/2047487318800072; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; van Eekelen APJ, 2004, CHRONOBIOL INT, V21, P107, DOI 10.1081/CBI-120027983; Vandewalle G, 2007, CEREB CORTEX, V17, P2788, DOI 10.1093/cercor/bhm007; WALLACE AG, 1963, CIRC RES, V12, P611, DOI 10.1161/01.RES.12.6.611; Wright RA, 2001, ADV EXP SOC PSYCHOL, V33, P255, DOI 10.1016/S0065-2601(01)80007-1; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x	81	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239553	10.1371/journal.pone.0239553	http://dx.doi.org/10.1371/journal.pone.0239553			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3SJ	33027252	Green Published, gold			2022-12-26	WOS:000581808000052
J	Lei, F; Wang, W; Fu, YT; Wang, J; Zheng, Y				Lei, Fang; Wang, Wen; Fu, Yating; Wang, Ji; Zheng, Yu			Mitochondrial K(ATP)channels contribute to the protective effects of hydrogen sulfide against impairment of central chemoreception of rat offspring exposed to maternal cigarette smoke	PLOS ONE			English	Article							SENSITIVE POTASSIUM CHANNELS; SELF-REPORTED SMOKING; K+ CHANNEL; OXIDATIVE STRESS; RETROTRAPEZOID NUCLEUS; MYOCARDIAL-INFARCTION; CA2+ OVERLOAD; ACTIVATION; CARDIOPROTECTION; MECHANISM	We previously reported that maternal cigarette smoke (CS) exposure resulted in impairment of central chemoreception and induced mitochondrial dysfunction in offspring parafacial respiratory group (pFRG), the kernel for mammalian central chemoreception. We also found that hydrogen sulfide (H2S) could attenuate maternal CS exposure-induced impairment of central chemoreception in the rat offspringin vivo. Mitochondrial ATP sensitive potassium (mitoK(ATP)) channel has been reported to play a significant role in mitochondrial functions and protect against apoptosis in neurons. Thus, we hypothesize here that mitoK(ATP)channel plays a role in the protective effects of H2S on neonatal central chemoreception in maternal CS-exposed rats. Our findings revealed that pretreatment with NaHS (donor of H2S, 22.4mM) reversed the central chemosensitivity decreased by maternal CS exposure, and also inhibited cell apoptosis in offspring pFRG, however, 5-HD (blocker of mitoK(ATP)channels, 19mM) attenuated the protective effects of NaHS. In addition, NaHS declined pro-apoptotic proteins related to mitochondrial pathway apoptosis in CS rat offspring pFRG, such as Bax, Cytochrome C, caspase9 and caspase3. NaHS or 5-HD alone had no significant effect on above indexes. These results suggest that mitoK(ATP)channels play an important role in the protective effect of H2S against impairment of central chemoreception via anti-apoptosis in pFRG of rat offspring exposed to maternal CS.	[Lei, Fang] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China; [Lei, Fang; Wang, Wen; Fu, Yating; Wang, Ji; Zheng, Yu] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Physiol, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Zheng, Y (corresponding author), Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Physiol, Chengdu, Sichuan, Peoples R China.	yzheng@scu.edu.cn	LEI, FANG/AGZ-4959-2022		National Natural Science Foundation of China [31471096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	YZ received the National Natural Science Foundation of China, grant number: 31471096, URL: http://www.nsfc.gov.cn/.The funder plays no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; [Anonymous], 2017, NAT CLIM CHANGE, V7, P455; [Anonymous], 2001, AM J PHYSL HEART CIR, V280, pH2674; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Arabian M, 2018, ADV MED SCI-POLAND, V63, P213, DOI 10.1016/j.advms.2017.11.003; Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Bajgar R, 2001, J BIOL CHEM, V276, P33369, DOI 10.1074/jbc.M103320200; BULTERYS MG, 1990, PEDIATRICS, V86, P535; Chrcanovic, 2012, ORAL MAXILLOFAC SURG, V17, P95; Coddou C, 2009, PHILOS T R SOC B, V364, P2527, DOI 10.1098/rstb.2009.0078; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Fryer RM, 1999, CIRC RES, V84, P846; Guyenet PG, 2008, J PHYSIOL-LONDON, V586, P2043, DOI 10.1113/jphysiol.2008.150870; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Heinzel FR, 2005, CIRC RES, V97, P583, DOI 10.1161/01.RES.0000181171.65293.65; Heusch G, 2011, EUR HEART J, V32, P1184, DOI 10.1093/eurheartj/ehq511; HOFFMAN HJ, 1988, ANN NY ACAD SCI, V533, P13, DOI 10.1111/j.1749-6632.1988.tb37230.x; Holmuhamedov EL, 1999, J PHYSIOL-LONDON, V519, P347, DOI 10.1111/j.1469-7793.1999.0347m.x; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Kida K, 2011, ANTIOXID REDOX SIGN, V15, P343, DOI 10.1089/ars.2010.3671; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Klebanoff MA, 1998, AM J EPIDEMIOL, V148, P259; Lavezzi AM, 2012, AUTON NEUROSCI-BASIC, V170, P12, DOI 10.1016/j.autneu.2012.06.005; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Lei F, 2018, FREE RADICAL BIO MED, V129, P169, DOI 10.1016/j.freeradbiomed.2018.09.003; Li XY, 2019, J CELL BIOCHEM, V120, P4385, DOI 10.1002/jcb.27724; Liu YG, 2016, PHARMACOL BIOCHEM BE, V150, P207, DOI 10.1016/j.pbb.2016.11.002; Minners J, 2003, CARDIOVASC RES, V59, P1, DOI 10.1016/S0008-6363(03)00337-7; Murata M, 2001, CIRC RES, V89, P891, DOI 10.1161/hh2201.100205; Nakagawa I, 2005, NEUROSURGERY, V57, P334, DOI 10.1227/01.NEU.0000166681.88736.86; Nie LH, 2013, RESP PHYSIOL NEUROBI, V188, P29, DOI 10.1016/j.resp.2013.05.001; Nozawa Y, 2003, BASIC RES CARDIOL, V98, P50, DOI 10.1007/s00395-003-0378-y; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Penna C, 2006, BASIC RES CARDIOL, V101, P180, DOI 10.1007/s00395-006-0584-5; Shao SX, 2012, ANAT REC, V295, P632, DOI 10.1002/ar.22410; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Szewczyk A, 1996, ACTA BIOCHIM POL, V43, P713; Takashi E, 1999, CIRC RES, V85, P1146; Testai L, 2016, PHARMACOL RES, V113, P290, DOI 10.1016/j.phrs.2016.09.006; Valavanidis A, 2009, INT J ENV RES PUB HE, V6, P445, DOI 10.3390/ijerph6020445; Vasankari T, 2011, SCAND J PUBLIC HEALT, V39, P547, DOI 10.1177/1403494811401474; Virgili N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075189, 10.1371/annotation/0e045706-ea24-41db-be90-27d1cbcd35b1]; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang YY, 2020, BIOTECHNOL LETT, V42, P375, DOI 10.1007/s10529-019-02782-3; Watanabe M, 2008, BRAIN RES, V1238, P199, DOI 10.1016/j.brainres.2008.08.038; Yan XF, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00007; Yong QC, 2010, NEUROCHEM INT, V56, P508, DOI 10.1016/j.neuint.2009.12.011; Yu KY, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0416-y; Zhang SF, 2017, RESP PHYSIOL NEUROBI, V243, P1, DOI 10.1016/j.resp.2017.04.009; Zhang XZ, 2014, ACS CHEM NEUROSCI, V5, P876, DOI 10.1021/cn500185g; Zhou X, 2014, APOPTOSIS, V19, P998, DOI 10.1007/s10495-014-0978-z	55	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0237643	10.1371/journal.pone.0237643	http://dx.doi.org/10.1371/journal.pone.0237643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064729	Green Published, gold			2022-12-26	WOS:000585918300039
J	Liu, XB; Xia, EH; Li, M; Cui, YY; Wang, PM; Zhang, JX; Xie, BG; Xu, JP; Yan, JJ; Li, J; Nagy, LG; Yang, ZL				Liu, Xiao-Bin; Xia, En-Hua; Li, Meng; Cui, Yang-Yang; Wang, Pan-Meng; Zhang, Jin-Xia; Xie, Bao-Gui; Xu, Jian-Ping; Yan, Jun-Jie; Li, Jing; Nagy, Laszlo G.; Yang, Zhu L.			Transcriptome data reveal conserved patterns of fruiting body development and response to heat stress in the mushroom-forming fungus Flammulina filiformis	PLOS ONE			English	Article							POSTREPLICATION REPAIR GENE; WINTER MUSHROOM; COPRINUS-CINEREUS; GENOME SEQUENCE; FAMILY PROTEINS; VELUTIPES; MORPHOGENESIS; AQUAPORINS; ECTOMYCORRHIZAL; PURIFICATION	Mushroom-forming fungi are complex multicellular organisms that form the basis of a large industry, yet, our understanding of the mechanisms of mushroom development and its responses to various stresses remains limited. The winter mushroom (Flammulina filiformis) is cultivated at a large commercial scale in East Asia and is a species with a preference for low temperatures. This study investigated fruiting body development in F. filiformis by comparing transcriptomes of 4 developmental stages, and compared the developmental genes to a 200-genome dataset to identify conserved genes involved in fruiting body development, and examined the response of heat sensitive and -resistant strains to heat stress. Our data revealed widely conserved genes involved in primordium development of F. filiformis, many of which originated before the emergence of the Agaricomycetes, indicating co-option for complex multicellularity during evolution. We also revealed several notable fruiting-specific genes, including the genes with conserved stipe-specific expression patterns and the others which related to sexual development, water absorption, basidium formation and sporulation, among others. Comparative analysis revealed that heat stress induced more genes in the heat resistant strain (M1) than in the heat sensitive one (XR). Of particular importance are the hsp70, hsp90 and fes1 genes, which may facilitate the adjustment to heat stress in the early stages of fruiting body development. These data highlighted novel genes involved in complex multicellular development in fungi and aid further studies on gene function and efforts to improve the productivity and heat tolerance in mushroom-forming fungi.	[Liu, Xiao-Bin; Cui, Yang-Yang; Wang, Pan-Meng; Li, Jing; Yang, Zhu L.] Chinese Acad Sci, Kunming Inst Bot, CAS Key Lab Plant Div & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Liu, Xiao-Bin; Cui, Yang-Yang; Wang, Pan-Meng; Li, Jing; Yang, Zhu L.] Yunnan Key Lab Fungal Div & Green Dev, Kunming, Yunnan, Peoples R China; [Xia, En-Hua] Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Hefei, Anhui, Peoples R China; [Li, Meng] Yunnan Tobacco Sci Res Inst, Kunming, Yunnan, Peoples R China; [Zhang, Jin-Xia] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [Zhang, Jin-Xia] Minist Agr & Rural Affairs, Key Lab Microbial Resources, Beijing, Peoples R China; [Xie, Bao-Gui; Yan, Jun-Jie] Fujian Agr & Forestry Univ, Coll Life Sci, Mycol Res Ctr, Fuzhou, Peoples R China; [Xu, Jian-Ping] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Li, Jing] Yunnan Univ, Key Lab Conservat & Utilizat Bioresources, Minist Educ, Kunming, Yunnan, Peoples R China; [Li, Jing] Yunnan Univ, Key Lab Microbial Div Southwest China, Minist Educ, Kunming, Yunnan, Peoples R China; [Nagy, Laszlo G.] Biol Res Ctr, Inst Biochem, Synthet & Syst Biol Unit, Szeged, Hungary	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Anhui Agricultural University; China National Tobacco Corporation; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Fujian Agriculture & Forestry University; McMaster University; Yunnan University; Yunnan University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Yang, ZL (corresponding author), Chinese Acad Sci, Kunming Inst Bot, CAS Key Lab Plant Div & Biogeog East Asia, Kunming, Yunnan, Peoples R China.; Yang, ZL (corresponding author), Yunnan Key Lab Fungal Div & Green Dev, Kunming, Yunnan, Peoples R China.	fungi@mail.kib.ac.cn	Xia, Enhua/AAV-4999-2021	Xia, Enhua/0000-0003-3411-9117	Strategic Priority Research Program of Chinese Academy of Sciences [XDB31000000]; Yunnan Ten-Thousand-Talents Plan - Yunling Scholar Project; National Basic Research Program of China (973 Program) [2014CB138305]; European Research Council [758161]; National Research, Development and Innovation office [Ginop-2.3.2-1500001]	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Yunnan Ten-Thousand-Talents Plan - Yunling Scholar Project; National Basic Research Program of China (973 Program)(National Basic Research Program of China); European Research Council(European Research Council (ERC)European Commission); National Research, Development and Innovation office(National Research, Development & Innovation Office (NRDIO) - Hungary)	This study was supported by the Strategic Priority Research Program of Chinese Academy of Sciences (No. XDB31000000); Yunnan Ten-Thousand-Talents Plan - Yunling Scholar Project; and the National Basic Research Program of China (973 Program, No. 2014CB138305). LGN acknowledges support from the European Research Council (grant no. 758161 to L.G.N.) and the National Research, Development and Innovation office (Contract No. Ginop-2.3.2-1500001, to LGN).	Almsi E, 2019, NEW PHYTOL, V224, P902, DOI 10.1111/nph.16032; Anders S., 2010, MOL BIOL+, V43, P1, DOI DOI 10.1186/GB-2010-11-10-R106; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Arima T, 2004, FUNGAL GENET BIOL, V41, P805, DOI 10.1016/j.fgb.2004.04.003; BINNINGER DM, 1987, EMBO J, V6, P835, DOI 10.1002/j.1460-2075.1987.tb04828.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chae E, 2008, DEVELOPMENT, V135, P1235, DOI 10.1242/dev.015842; Chen Y, 2014, ENVIRON MICROBIOL, V16, P788, DOI 10.1111/1462-2920.12204; de Padula M, 2004, NUCLEIC ACIDS RES, V32, P5003, DOI 10.1093/nar/gkh831; Dietz S, 2011, NEW PHYTOL, V190, P927, DOI 10.1111/j.1469-8137.2011.03651.x; Fukuda K, 2008, BIOSCI BIOTECH BIOCH, V72, P3107, DOI 10.1271/bbb.80213; FULTZ SA, 1988, APPL ENVIRON MICROB, V54, P2460, DOI 10.1128/AEM.54.10.2460-2463.1988; Gaderer R, 2014, APPL MICROBIOL BIOT, V98, P4795, DOI 10.1007/s00253-014-5690-y; Gehrmann T, 2018, P NATL ACAD SCI USA, V115, P4429, DOI 10.1073/pnas.1721381115; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Gowda NKC, 2013, P NATL ACAD SCI USA, V110, P5975, DOI 10.1073/pnas.1216778110; Hamlett CAE, 2011, PLANTA, V234, P1267, DOI 10.1007/s00425-011-1475-z; Herzog R, 2019, MOL GENET GENOMICS, V294, P663, DOI 10.1007/s00438-018-01528-6; Ishizaki T, 2000, FEMS MICROBIOL LETT, V193, P111, DOI 10.1111/j.1574-6968.2000.tb09411.x; Kaur JN, 2016, SCI REP-UK, V6, DOI 10.1038/srep23638; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kim HI, 2016, MYCOSCIENCE, V57, P320, DOI 10.1016/j.myc.2016.04.004; Knapp DG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24686-4; Konno N, 2011, APPL MICROBIOL BIOT, V91, P1365, DOI 10.1007/s00253-011-3295-2; Krizsan K, 2019, P NATL ACAD SCI USA, V116, P7409, DOI 10.1073/pnas.1817822116; Kruger M, 1998, EMBO J, V17, P204, DOI 10.1093/emboj/17.1.204; Kues U, 2015, FUNGAL BIOL REV, V29, P63, DOI 10.1016/j.fbr.2015.05.001; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liu JY, 2017, J AGR FOOD CHEM, V65, P5091, DOI 10.1021/acs.jafc.7b01120; Liu XB, 2017, HEREDITAS, V155, DOI 10.1186/s41065-017-0038-0; Liu XB, 2016, GENE, V591, P227, DOI 10.1016/j.gene.2016.07.009; Lomascolo A, 1999, TRENDS BIOTECHNOL, V17, P282, DOI 10.1016/S0167-7799(99)01313-X; Luti S, 2020, FUNGAL BIOL REV, V34, P13, DOI 10.1016/j.fbr.2019.10.001; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Merenyi Z, 2020, MOL BIOL EVOL; Mizuno R, 2009, BIOSCI BIOTECH BIOCH, V73, P1671, DOI 10.1271/bbb.90099; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Muraguchi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141586; Nagy LG, 2018, BIOL REV, V93, P1778, DOI 10.1111/brv.12418; Narai A, 2004, BIOSCI BIOTECH BIOCH, V68, P2230, DOI 10.1271/bbb.68.2230; Navarro-Rodenas A, 2015, PLANT CELL ENVIRON, V38, P2475, DOI 10.1111/pce.12552; Ohm RA, 2011, MOL MICROBIOL, V81, P1433, DOI 10.1111/j.1365-2958.2011.07776.x; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Ota K, 2013, BIOCHIMIE, V95, P1855, DOI 10.1016/j.biochi.2013.06.012; Panevska A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41450-4; Park YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093560; Pelkmans JF, 2016, MYCOTA, P387; Pelkmans JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00483-3; Pelkmans JF, 2016, APPL MICROBIOL BIOT, V100, P7151, DOI 10.1007/s00253-016-7574-9; Pellegrin C, 2019, ENVIRON MICROBIOL, V21, P3765, DOI 10.1111/1462-2920.14727; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pettersson N, 2005, BIOL CELL, V97, P487, DOI 10.1042/BC20040144; Sakamoto Y, 2002, MYCOL RES, V106, P222, DOI 10.1017/S095375620100541X; Sakamoto Y, 2001, MYCOL RES, V105, P177, DOI 10.1017/S0953756200003336; Sakamoto Y, 2018, FUNGAL BIOL REV, V32, P236, DOI 10.1016/j.fbr.2018.02.003; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sipos G, 2017, NAT ECOL EVOL, V1, P1931, DOI 10.1038/s41559-017-0347-8; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Tao YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097789; Tayyrov A, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01549-19; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; van der Laan R, 2000, GENOMICS, V69, P86, DOI 10.1006/geno.2000.6220; van Peer AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022249; Varga T, 2019, NAT ECOL EVOL, V3, P668, DOI 10.1038/s41559-019-0834-1; Verkade HM, 2001, MOL GENET GENOMICS, V265, P993, DOI 10.1007/s004380100494; Walti MA, 2006, EUKARYOT CELL, V5, P732, DOI 10.1128/EC.5.4.732-744.2006; Wang GZ, 2018, CELL PHYSIOL BIOCHEM, V50, P1617, DOI 10.1159/000494784; Wang LQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004185; Wang PM, 2018, MYCOL PROG, V17, P1013, DOI 10.1007/s11557-018-1409-2; Wang WX, 2016, PROCEEDINGS OF THE 8TH (2016) INTERNATIONAL CONFERENCE ON FINANCIAL RISK AND CORPORATE FINANCE MANAGEMENT, P6; Wang YZ, 2018, GENE, V641, P326, DOI 10.1016/j.gene.2017.10.061; Wu BJ, 2018, GENOME BIOL EVOL, V10, P3250, DOI 10.1093/gbe/evy246; Wu TJ, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01735-19; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Xu H, 2016, MYCORRHIZA, V26, P19, DOI 10.1007/s00572-015-0643-6; Xu H, 2013, BOTANY, V91, P495, DOI 10.1139/cjb-2013-0041; Xu JP, 2016, GENOME, V59, P913, DOI 10.1139/gen-2016-0046; Yamada M, 2006, FEMS MICROBIOL LETT, V254, P165, DOI 10.1111/j.1574-6968.2005.00023.x; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zhang X, 2016, APPL ENVIRON MICROB, V82, P4112, DOI 10.1128/AEM.01036-16; Zhou YJ, 2015, MICROBIOL-SGM, V161, P1978, DOI 10.1099/mic.0.000143; Zurga S, 2014, FEBS J, V281, P3489, DOI 10.1111/febs.12875	86	10	11	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0239890	10.1371/journal.pone.0239890	http://dx.doi.org/10.1371/journal.pone.0239890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064719	gold, Green Published, Green Accepted			2022-12-26	WOS:000585918300020
J	Chan, HF; Brumpton, M; Macintyre, A; Arapoc, J; Savage, DA; Skali, A; Stadelmann, D; Torgler, B				Chan, Ho Fai; Brumpton, Martin; Macintyre, Alison; Arapoc, Jefferson; Savage, David A.; Skali, Ahmed; Stadelmann, David; Torgler, Benno			How confidence in health care systems affects mobility and compliance during the COVID-19 pandemic	PLOS ONE			English	Article							PUBLIC TRUST	Confidence in the health care system implies an expectation that sufficient and appropriate treatments will be provided if needed. The COVID-19 public health crisis is a significant, global, and (mostly) simultaneous test of the behavioral implications arising from this confidence. We explore whether populations reporting low levels of confidence in the health care system exhibit a stronger behavioral reaction to the COVID-19 pandemic. We track the dynamic responses to the COVID-19 pandemic across 38 European countries and 621 regions by employing a large dataset on human mobility generated between February 15 and June 5, 2020 and a broad range of contextual factors (e.g., deaths or policy implementations). Using a time-dynamic framework we find that societies with low levels of health care confidence initially exhibit a faster response with respect to staying home. However, this reaction plateaus sooner, and after the plateau it declines with greater magnitude than does the response from societies with high health care confidence. On the other hand, regions with higher confidence in the health care system are more likely to reduce mobility once the government mandates that its citizens are not to leave home except for essential trips, compared to those with lower health care system confidence. Regions with high trust in the government but low confidence in the health care system dramatically reduce their mobility, suggesting a correlation for trust in the state with respect to behavioral responses during a crisis.	[Chan, Ho Fai; Brumpton, Martin; Stadelmann, David; Torgler, Benno] Queensland Univ Technol, Sch Econ & Finance, Brisbane, Qld, Australia; [Chan, Ho Fai; Brumpton, Martin; Macintyre, Alison; Savage, David A.; Torgler, Benno] Ctr Behav Econ Soc & Technol BEST, Brisbane, Qld, Australia; [Arapoc, Jefferson; Savage, David A.] Univ Newcastle, Newcastle Business Sch, Callaghan, NSW, Australia; [Skali, Ahmed] Deakin Univ, Burwood, Vic, Australia; [Stadelmann, David] Univ Bayreuth, Bayreuth, Germany; [Stadelmann, David; Torgler, Benno] CREMA Ctr Res Econ Management & Arts, Zurich, Switzerland	Queensland University of Technology (QUT); University of Newcastle; Deakin University; University of Bayreuth	Chan, HF (corresponding author), Queensland Univ Technol, Sch Econ & Finance, Brisbane, Qld, Australia.; Chan, HF (corresponding author), Ctr Behav Econ Soc & Technol BEST, Brisbane, Qld, Australia.	hofai.chan@qut.edu.au	Torgler, Benno/W-4556-2019; Chan, Ho Fai/G-9541-2015; Stadelmann, David/I-1116-2019	Torgler, Benno/0000-0002-9809-963X; Chan, Ho Fai/0000-0002-7281-5212; Stadelmann, David/0000-0002-1211-9936; Savage, David/0000-0002-2110-4023; Skali, Ahmed/0000-0002-4753-3280	German Research Foundation (DFG); University of Bayreuth	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth	This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing.	Allcott H., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Antinyan A, 2020, TRUST HEALTHCARE SYS; Bargain O., 2020, POVERTY COVID 19 DEV; Bargain O, 2020, J PUBLIC ECON, V192, DOI 10.1016/j.jpubeco.2020.104316; Brodeur A., 2020, LIT REV EC COVID 19; Brzezinski Adam, 2020, 202056 BECK FREIDM I, DOI [DOI 10.2139/SSRN.3587990, 10.2139/ssrn.3587990]; Bunton V, 2013, HEALTH SOCIOL REV, V22, P88, DOI 10.5172/hesr.2013.22.1.88; Calnan MW, 2004, QUAL SAF HEALTH CARE, V13, P92, DOI 10.1136/qshc.2003.009001; Capraro V, 2020, PRIMING REASONING IN; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Chan HF, 2020, WORKING PAPER; Chan HF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76763-2; Chan HF, 2021, SOC PSYCHOL PERS SCI, V12, P1018, DOI 10.1177/1948550620952572; Clots-Figueras I, 2016, ECON LETT, V147, P168, DOI 10.1016/j.econlet.2016.08.019; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; Deb P, 2020, DP15086 CEPR; Di Paolo R, 2020, EFFECT NORM BASED ME, DOI DOI 10.31234/OSF.IO/7863G; Drake TM, 2020, LANCET DIGIT HEALTH, V2, pE385, DOI 10.1016/S2589-7500(20)30134-5; Dulleck U, 2006, J ECON LIT, V44, P5, DOI 10.1257/002205106776162717; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Everett J.A., 2020, EFFECTIVENESS MORAL, DOI [10.31234/osf.io/9yqs8, DOI 10.31234/OSF.IO/9YQS8]; Falk A., 2016, 9674 IZA; Falk A, 2018, Q J ECON, V133, P1645, DOI 10.1093/qje/qjy013; Friedson A. I., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts), DOI 10.3386/w26992; Gilbert T, 1998, J ADV NURS, V27, P1010, DOI 10.1046/j.1365-2648.1998.00578.x; Gille F, 2015, J HEALTH SERV RES PO, V20, P62, DOI 10.1177/1355819614543161; Grootaert C, 2002, UNDERSTANDING MEASUR; Heffner J., 2020, EMOTIONAL RESPONSES; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; Jordan J., 2020, DONT GET IT DONT SPR, DOI DOI 10.31234/OSF.IO/YUQ7X; Kooistra E.B., 2020, 202019 AMST LAW SCH, P1, DOI [DOI 10.2139/SSRN.3598221, 10.2139/ssrn.3598221]; Latham M., 2000, ONLY MEN WERE ANGELS, V2000, P192; Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7; Norris P., 2007, TRUST CRISIS HEALTHC; Painter M., 2020, COVID EC, V4, P103, DOI [10.2139/ssrn.3569098, DOI 10.2139/SSRN.3569098]; Pfattheicher S., 2020, EMOTIONAL PATH ACTIO, DOI 10.31234/osf.io/y2cg5; Putintseva YA, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-07061-4; Raihani N, 2020, FACTORS ASS BEHAV PO; Smith Carole, 2005, J Appl Philos, V22, P299, DOI 10.1111/j.1468-5930.2005.00312.x; Straten GFM, 2002, SOC SCI MED, V55, P227, DOI 10.1016/S0277-9536(01)00163-0; Torgler B., 2010, PARTICIPATION ENV OR; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Van Rooij B., 2020, 202021 AMST LAW SCH; Zhao DH, 2019, INT J HEALTH PLAN M, V34, P130, DOI 10.1002/hpm.2597	45	57	58	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240644	10.1371/journal.pone.0240644	http://dx.doi.org/10.1371/journal.pone.0240644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057450	Green Published, Green Submitted, gold			2022-12-26	WOS:000581814700064
J	Wang, EM; Hu, TH; Huang, CC; Chang, YC; Yang, SM; Huang, ST; Wu, JC; Ma, YL; Chan, HH; Liu, LF; Lu, WB; Kung, ML; Wen, ZH; Wang, JC; Ko, CY; Tsai, WL; Chu, TH; Tai, MH				Wang, E-Ming; Hu, Tsung-Hui; Huang, Chao-Cheng; Chang, Yi-Chen; Yang, Shih-Ming; Huang, Shih-Tsung; Wu, Jian-Ching; Ma, Yi-Ling; Chan, Hoi-Hung; Liu, Li-Feng; Lu, Wen-Bin; Kung, Mei-Lang; Wen, Zhi-Hong; Wang, Jui-Chu; Ko, Chou-Yuan; Tsai, Wei-Lun; Chu, Tian-Huei; Tai, Ming-Hong			Hepatoma-derived growth factor participates in concanavalin A-induced hepatitis	FASEB JOURNAL			English	Article						acute hepatitis; concanavalin A; hepatoma-derived growth factor; neutrophils	NECROSIS-FACTOR-ALPHA; NEUTROPHIL MIGRATION; FACTOR HDGF; TNF-ALPHA; LIVER; INFLAMMATION; CELLS; HEPATOCYTES; EXPRESSION; AUTOPHAGY	Hepatitis is an important health problem worldwide. Novel molecular targets are in demand for detection and management of hepatitis. Hepatoma-derived growth factor (HDGF) has been delineated to participate in hepatic fibrosis and liver carcinogenesis. However, the relationship between hepatitis and HDGF remains unclear. This study aimed to elucidate the role of HDGF during hepatitis using concanavalin A (ConA)-induced hepatitis model. In cultured hepatocytes, ConA treatment-elicited HDGF upregulation at transcriptional level and promoted HDGF secretion while reducing intracellular HDGF protein level and cellular viability. Similarly, mice receiving ConA administration exhibited reduced hepatic HDGF expression and elevated circulating HDGF level, which was positively correlated with serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels. By using HDGF knockout (KO) mice, it was found the ConA-evoked cell death was prominently alleviated in KO compared with control. Besides, it was delineated HDGF ablation conferred protection by suppressing the ConA-induced neutrophils recruitment in livers. Above all, the ConA-mediated activation of tumor necrosis factor-alpha (TNF-alpha)/interleukin-1 beta (IL-1 beta)/interleukin-6 (IL-6)/cyclooxygenase-2 (COX-2) inflammatory signaling was significantly abrogated in KO mice. Treatment with recombinant HDGF (rHDGF) dose-dependently stimulated the expression of TNF-alpha/IL-1 beta/IL-6/COX-2 in hepatocytes, further supporting the pro-inflammatory function of HDGF. Finally, application of HDGF antibody not only attenuated the ConA-mediated inflammatory cascade in hepatocytes, but also ameliorated the ConA-induced hepatic necrosis and AST elevation in mice. In summary, HDGF participates in ConA-induced hepatitis via neutrophils recruitment and may constitute a therapeutic target for acute hepatitis.	[Wang, E-Ming; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Wang, E-Ming; Tsai, Wei-Lun] Kaohsiung Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Kaohsiung, Taiwan; [Hu, Tsung-Hui] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol,Dept Internal Med, Kaohsiung, Taiwan; [Huang, Chao-Cheng; Wu, Jian-Ching; Chu, Tian-Huei] Kaohsiung Chang Gung Mem Hosp, Biobank & Tissue Bank, Kaohsiung, Taiwan; [Huang, Chao-Cheng; Wu, Jian-Ching; Wang, Jui-Chu] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Huang, Chao-Cheng; Wu, Jian-Ching; Wang, Jui-Chu] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chang, Yi-Chen; Huang, Shih-Tsung; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan; [Chang, Yi-Chen; Huang, Shih-Tsung; Tai, Ming-Hong] Acad Sinica, Kaohsiung, Taiwan; [Yang, Shih-Ming; Lu, Wen-Bin; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, 70 Lien Hai Rd, Kaohsiung 80424, Taiwan; [Huang, Shih-Tsung] LabTurbo Biotech Corp, Taipei, Taiwan; [Ma, Yi-Ling] Kaohsiung Vet Gen Hosp, Div Nephrol, Kaohsiung, Taiwan; [Chan, Hoi-Hung] Conde S Januario Hosp, Dept Med, Div Gastroenterol, Macau, Peoples R China; [Liu, Li-Feng] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan; [Kung, Mei-Lang] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Wen, Zhi-Hong] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Ko, Chou-Yuan] Kaohsiung Armed Forces Gen Hosp, Dept Gastroenterol, Kaohsiung, Taiwan; [Chu, Tian-Huei] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, 123 Ta Pei Rd, Kaohsiung 83301, Taiwan; [Tai, Ming-Hong] Natl Sun Yat Sen Univ, Ctr Neurosci, Kaohsiung, Taiwan; [Tai, Ming-Hong] Kaohsiung Med Univ, Regenerat Med & Cell Therapy Res Ctr, Kaohsiung, Taiwan	National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; Academia Sinica - Taiwan; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; I Shou University; Kaohsiung Veterans General Hospital; National Sun Yat Sen University; Chang Gung Memorial Hospital; National Sun Yat Sen University; Kaohsiung Medical University	Tai, MH (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, 70 Lien Hai Rd, Kaohsiung 80424, Taiwan.; Chu, TH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Med Res, 123 Ta Pei Rd, Kaohsiung 83301, Taiwan.	skbboyz0817@gmail.com; minghongtai@gmail.com		Chu, Tian-Huei/0000-0003-1197-5754	Ministry of Science and Technology, Taiwan [MOST108-2314-B-110-003-MY2]; Kaohsiung Veterans General Hospital, Taiwan [VGHKS100-025, VGHKS109-004]; Chang Gung Medical Foundation [CMRPG8D0642, CMRPG8G0031, CLRPG8I0032]; Kaohsiung Armed Forces General Hospital [108-36, 109-07]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital, Taiwan; Chang Gung Medical Foundation; Kaohsiung Armed Forces General Hospital	This work was supported by grants from Ministry of Science and Technology, Taiwan (MOST108-2314-B-110-003-MY2), Kaohsiung Veterans General Hospital, Taiwan (VGHKS100-025, VGHKS109-004), Chang Gung Medical Foundation (CMRPG8D0642, CMRPG8G0031, CLRPG8I0032), and Kaohsiung Armed Forces General Hospital (108-36,109-07). The authors thank Dr Sebastian Franken (Institute of Physiological Chemistry, University of Bonn, Bonn, Germany) for sharing HDGF KO mice. We thank the Biobank and Tissue Bank, Kaohsiung Chang Gung Memorial Hospital for technical support.	Bandala-Sanchez E, 2018, P NATL ACAD SCI USA, V115, P7783, DOI 10.1073/pnas.1722056115; Barbier L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02014; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45; Botros Mona, 2013, Clin Biochem Rev, V34, P117; Callejas NA, 2000, GASTROENTEROLOGY, V119, P493, DOI 10.1053/gast.2000.9374; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Chen SC, 2015, ONCOTARGET, V6, P16253, DOI 10.18632/oncotarget.3608; Chu TH, 2019, ONCOGENE, V38, P6461, DOI 10.1038/s41388-019-0886-3; Chu TH, 2018, CANCER MED-US, V7, P2567, DOI 10.1002/cam4.1487; Chu TH, 2014, ONCOTARGET, V5, P1475, DOI 10.18632/oncotarget.1745; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Crossin KL, 1997, P NATL ACAD SCI USA, V94, P2687, DOI 10.1073/pnas.94.6.2687; Desjarlais M, 2014, GENE REGUL SYST BIO, V8, P63, DOI 10.4137/GRSB.S13946; DOYLE MV, 1985, BIOCHEM BIOPH RES CO, V130, P768, DOI 10.1016/0006-291X(85)90482-6; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Gallitzendoerfer R, 2008, DEV DYNAM, V237, P1875, DOI 10.1002/dvdy.21589; Giri K, 2016, APOPTOSIS, V21, P329, DOI 10.1007/s10495-015-1200-7; Heneghan MA, 2002, HEPATOLOGY, V35, P7, DOI 10.1053/jhep.2002.30991; Heymann F, 2015, LAB ANIM-UK, V49, P12, DOI 10.1177/0023677215572841; Hsu SS, 2012, J NEURO-ONCOL, V107, P101, DOI 10.1007/s11060-011-0733-z; Hu TH, 2003, CANCER-AM CANCER SOC, V98, P1444, DOI 10.1002/cncr.11653; Kao YH, 2010, J HEPATOL, V52, P96, DOI 10.1016/j.jhep.2009.10.002; Lemos HP, 2009, P NATL ACAD SCI USA, V106, P5954, DOI 10.1073/pnas.0812782106; Luan JY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00758; Malchow S, 2011, BBA-MOL BASIS DIS, V1812, P290, DOI 10.1016/j.bbadis.2010.11.009; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; NAKAMURA H, 1989, CLIN CHIM ACTA, V183, P273, DOI 10.1016/0009-8981(89)90361-6; Oliveira SHP, 2008, INFLAMMATION, V31, P36, DOI 10.1007/s10753-007-9047-x; Ray A, 2015, J IMMUNOL, V195, P3071, DOI 10.4049/jimmunol.1500153; Shetty A., 2016, UROL ONCOL, V34, P483; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; SMART SJ, 1994, AM J PHYSIOL, V266, pL238, DOI 10.1152/ajplung.1994.266.3.L238; Sun AM, 2015, CYTOKINE, V72, P31, DOI 10.1016/j.cyto.2014.12.001; Swamydas Muthulekha, 2015, Curr Protoc Immunol, V110, DOI 10.1002/0471142735.im0320s110; Takano M, 2012, J PERIODONTAL RES, V47, P89, DOI 10.1111/j.1600-0765.2011.01408.x; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Wang CF, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/189785; Wei YP, 2020, HEPATOLOGY, V71, P130, DOI 10.1002/hep.30795; Yoon JH, 2011, J PROTEOME RES, V10, P5315, DOI 10.1021/pr200573b; Zhang GR, 2017, TOHOKU J EXP MED, V242, P101, DOI 10.1620/tjem.242.101; Zheng CH, 2018, CELL MOL IMMUNOL, V15, P260, DOI 10.1038/cmi.2016.57; Zhou RR, 2012, EXP MOL PATHOL, V93, P213, DOI 10.1016/j.yexmp.2012.05.006	45	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16163	16178		10.1096/fj.202000511RR	http://dx.doi.org/10.1096/fj.202000511RR		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33063394				2022-12-26	WOS:000581422500001
J	Bai, L; Chang, HM; Zhang, L; Zhu, YM; Leung, PCK				Bai, Long; Chang, Hsun-Ming; Zhang, Liang; Zhu, Yi-Min; Leung, Peter C. K.			BMP2 increases the production of BDNF through the upregulation of proBDNF and furin expression in human granulosa-lutein cells	FASEB JOURNAL			English	Article						ALK; BMP2; BDNF; human granulosa cells; furin; oocyte maturation	BONE MORPHOGENETIC PROTEIN-2; HUMAN OOCYTE MATURATION; EPIDERMAL-GROWTH-FACTOR; NEUROTROPHIC FACTOR; FOLLICULAR-FLUID; GENE-EXPRESSION; RECEPTOR; OVARY; FERTILIZATION; MECHANISMS	Locally produced in human granulosa cells of the developing follicle, bone morphogenetic protein 2 (BMP2) plays a crucial role in the regulation of ovarian folliculogenesis and luteal formation. Brain-derived neurotrophic factor (BDNF) is an intraovarian neurotrophic factor that has been shown to promote oocyte maturation and subsequent fertilization competency. At present, little is known regarding the intracellular regulation, assembly and secretion of endogenous BDNF in human granulosa cells. The aim of this study was to explore the effect of BMP2 on the expression and production of BDNF in human granulosa cells and the molecular mechanisms underlying this effect. An immortalized human granulosa cell line (SVOG) and primary human granulosa-lutein (hGL) cells were utilized as in vitro study models. Our results showed that BMP2 significantly increased the mRNA and secreted levels of BDNF. Additionally, BMP2 upregulated the expression of furin at the transcriptional and translational levels. Knockdown of endogenous furin partially attenuated the BMP2-induced increase in BDNF production, indicating that furin is involved in the maturation process of BDNF. Using pharmacological (kinase receptor inhibitors) and siRNA-mediated inhibition approaches, we demonstrated that BMP2-induced upregulation of BDNF and furin expression is most likely mediated by the activin receptor-like kinase (ALK)2/ALK3-SMAD4 signaling pathway. Notably, analysis using clinical samples revealed that there was a positive correlation between follicular fluid concentrations of BMP2 and those of BDNF. These results indicate that BMP2 increases the production of mature BDNF by upregulating the precursor BDNF and promoting the proteolytic processing of mature BDNF. Finally, we also investigated the effects of BMP2 on ovarian steroidogenesis and the results showed that BMP2 treatment significantly increased the accumulated level of estradiol (by upregulating the expression of FSH receptor and cytochrome P450 aromatase), whereas it decreased the accumulated level of progesterone (by downregulating the expression of LH receptors and steroidogenic acute regulatory protein) in primary hGL cells. Our findings provide a novel paracrine mechanism underlying the regulation of an intraovarian growth factor in human granulosa cells.	[Bai, Long; Zhu, Yi-Min; Leung, Peter C. K.] Zhejiang Univ, Womens Hosp, Sch Med, Dept Reprod Endocrinol, Hangzhou 310006, Zhejiang, Peoples R China; [Bai, Long; Chang, Hsun-Ming; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [Zhang, Liang] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Peoples R China	Zhejiang University; University of British Columbia; Zhejiang Academy of Agricultural Sciences	Zhu, YM; Leung, PCK (corresponding author), Zhejiang Univ, Womens Hosp, Sch Med, Dept Reprod Endocrinol, Hangzhou 310006, Zhejiang, Peoples R China.; Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	zhuyim@zju.edu.cn; peter.leung@ubc.ca		Leung, Peter/0000-0003-3152-3800	National Key Research and Development Program of China [2018YFC1003201]; Natural Science Foundation of Zhejiang province, China [LQ20C17000]; CIHR Foundation [143317]	National Key Research and Development Program of China; Natural Science Foundation of Zhejiang province, China(Natural Science Foundation of Zhejiang Province); CIHR Foundation(Canadian Institutes of Health Research (CIHR))	National Key Research and Development Program of China, Grant/Award Number: 2018YFC1003201; Natural Science Foundation of Zhejiang province, China, Grant/Award Number: LQ20C17000; CIHR Foundation, Grant/Award Number: 143317	Anderson RA, 2010, FERTIL STERIL, V93, P1394, DOI 10.1016/j.fertnstert.2009.04.007; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bai L, 2019, CELL SIGNAL, V53, P201, DOI 10.1016/j.cellsig.2018.10.009; Bai L, 2017, ENDOCRINOLOGY, V158, P3501, DOI 10.1210/en.2017-00436; Bai L, 2017, CELL SIGNAL, V37, P52, DOI 10.1016/j.cellsig.2017.05.017; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Chakraborty P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12664; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chang HM, 2019, HUM REPROD UPDATE, V25, P224, DOI 10.1093/humupd/dmy047; Chang HM, 2017, HUM REPROD UPDATE, V23, P1, DOI 10.1093/humupd/dmw039; Chang HM, 2016, MOL CELL ENDOCRINOL, V422, P9, DOI 10.1016/j.mce.2015.11.009; Chang HM, 2015, J CLIN ENDOCR METAB, V100, pE375, DOI 10.1210/jc.2014-3026; Chang HM, 2014, J CLIN ENDOCR METAB, V99, pE1922, DOI 10.1210/jc.2014-1223; Chen Y, 2015, J NEUROSCI RES, V93, P189, DOI 10.1002/jnr.23455; DISSEN GA, 1995, ENDOCRINOLOGY, V136, P4681, DOI 10.1210/en.136.10.4681; Franks S, 2008, HUM REPROD UPDATE, V14, P367, DOI 10.1093/humupd/dmn015; Gratacos E, 2001, J NEUROCHEM, V79, P747, DOI 10.1046/j.1471-4159.2001.00570.x; Harel S, 2006, MOL HUM REPROD, V12, P357, DOI 10.1093/molehr/gal033; Haugen MJ, 2010, REPRODUCTION, V140, P551, DOI 10.1530/REP-10-0211; Hsieh M, 2009, SEMIN REPROD MED, V27, P52, DOI 10.1055/s-0028-1108010; Kawamura K, 2005, P NATL ACAD SCI USA, V102, P9206, DOI 10.1073/pnas.0502442102; Kelty BP, 2010, BIOL REPROD, V83, P147, DOI 10.1095/biolreprod.109.079947; Lie BL, 1996, MOL CELL ENDOCRINOL, V120, P169, DOI 10.1016/0303-7207(96)03835-X; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Meng TG, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.231; Messinis IE, 2010, ANN NY ACAD SCI, V1205, P5, DOI 10.1111/j.1749-6632.2010.05660.x; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nio-Kobayashi J, 2015, ENDOCRINOLOGY, V156, P1494, DOI 10.1210/en.2014-1704; Paredes A, 2004, DEV BIOL, V267, P430, DOI 10.1016/j.ydbio.2003.12.001; Qiao J, 2011, HUM REPROD UPDATE, V17, P17, DOI 10.1093/humupd/dmq032; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Rossi RODS, 2016, HISTOL HISTOPATHOL, V31, P339, DOI 10.14670/HH-11-674; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Seifer DB, 2006, AM J OBSTET GYNECOL, V194, P1129, DOI 10.1016/j.ajog.2005.12.022; Seifer DB, 2003, FERTIL STERIL, V79, P451, DOI 10.1016/S0015-0282(02)04669-1; Selvaraju S, 2013, DOMEST ANIM ENDOCRIN, V44, P115, DOI 10.1016/j.domaniend.2012.10.002; Shi J, 2011, AM J REPROD IMMUNOL, V65, P421, DOI 10.1111/j.1600-0897.2010.00917.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Skaper Stephen D, 2012, Methods Mol Biol, V846, P1, DOI 10.1007/978-1-61779-536-7_1; Streiter S, 2016, MOL HUM REPROD, V22, P3, DOI 10.1093/molehr/gav057; Sugiyama R, 2010, HUM CELL, V23, P83, DOI 10.1111/j.1749-0774.2010.00088.x; Takahashi C, 2008, FERTIL STERIL, V89, P586, DOI 10.1016/j.fertnstert.2007.03.080; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; Wang X, 2011, J ASSIST REPROD GEN, V28, P1053, DOI 10.1007/s10815-011-9635-4; Wu YT, 2017, MOL HUM REPROD, V23, P155, DOI 10.1093/molehr/gaw078; Yin JW, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010185; Yu Y, 2012, HUM REPROD, V27, P2146, DOI 10.1093/humrep/des099; Zhang XY, 2019, CELL SIGNAL, V55, P109, DOI 10.1016/j.cellsig.2019.01.002; Zhao HJ, 2018, ENDOCRINOLOGY, V159, P2815, DOI 10.1210/en.2018-00301; Zhao P, 2011, HUM REPROD, V26, P695, DOI 10.1093/humrep/deq390	55	8	8	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16129	16143		10.1096/fj.202000940R	http://dx.doi.org/10.1096/fj.202000940R		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047388				2022-12-26	WOS:000581169300001
J	Buchheim, JI; Ghislin, S; Ouzren, N; Albuisson, E; Vanet, A; Matzel, S; Ponomarev, S; Rykova, M; Chouker, A; Frippiat, JP				Buchheim, Judith-Irina; Ghislin, Stephanie; Ouzren, Nassima; Albuisson, Eliane; Vanet, Anne; Matzel, Sandra; Ponomarev, Sergey; Rykova, Marina; Chouker, Alexander; Frippiat, Jean-Pol			Plasticity of the human IgM repertoire in response to long-term spaceflight	FASEB JOURNAL			English	Article						antibody; cosmonaut; spaceflight; stress; V(D)J recombination	LATENT VIRUSES; STRESS; REACTIVATION; COSMONAUTS; IMMUNITY	Immune dysregulation is among the main adverse outcomes of spaceflight. Despite the crucial role of the antibody repertoire in host protection, the effects of spaceflight on the human antibody repertoire are unknown. Consequently, using high-throughput sequencing, we examined the IgM repertoire of five cosmonauts 25 days before launch, after 64 +/- 11 and 129 +/- 20 days spent on the International Space Station (ISS), and at 1, 7, and 30 days after landing. This is the first study of this kind in humans. Our data revealed that the IgM repertoire of the cosmonauts was different from that of control subjects (n = 4) prior to launch and that two out the five analyzed cosmonauts presented significant changes in their IgM repertoire during the mission. These modifications persisted up to 30 days after landing, likely affected the specificities of IgM binding sites, correlated with changes in the V(D)J recombination process responsible for creating antibody genes, and coincided with a higher stress response. These data confirm that the immune system of approximately half of the astronauts who spent 6 months on the ISS is sensitive to spaceflight conditions, and reveal individual responses indicating that personalized approaches should be implemented during future deep-space exploration missions that will be of unprecedented durations.	[Buchheim, Judith-Irina; Matzel, Sandra; Chouker, Alexander] Hosp Ludwig Maximilians Univ, Dept Anesthesiol, Lab Translat Res Stress & Immun, Munich, Germany; [Ghislin, Stephanie; Ouzren, Nassima; Frippiat, Jean-Pol] Lorraine Univ, Fac Med, Stress Immun Pathogens Lab, EA 7300, 9 Ave Foret Haye, F-54500 Vandoeuvre Les Nancy, France; [Albuisson, Eliane] Nancy Univ Hosp, Data Management & Stat UMDS, Methodol Unit, DRCI,MPI Dept, Vandoeuvre Les Nancy, France; [Vanet, Anne] Univ Paris, Paris, France; [Vanet, Anne] CNRS, Jacques Monod Inst, Genoinformat Ctr, UMR7592, Paris, France; [Ponomarev, Sergey; Rykova, Marina] Russian Acad Sci, Inst Biomed Problems, Moscow, Russia	University of Munich; Universite de Lorraine; CHU de Nancy; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences	Frippiat, JP (corresponding author), Lorraine Univ, Fac Med, Stress Immun Pathogens Lab, EA 7300, 9 Ave Foret Haye, F-54500 Vandoeuvre Les Nancy, France.	jean-pol.frippiat@univ-lorraine.fr	Ponomarev, Sergey/AAB-2794-2020	Ponomarev, Sergey/0000-0002-5364-7815; Vanet, Anne/0000-0002-6018-3158	Centre National d'Etudes Spatiales (CNES) [DAR 4800000894, 4800000950, 4800001008]; French Ministry of Higher Education and Research; Universite de Lorraine (UL); French State-Region Project; Deutsches Zentrum fur Luft- und Raumfahrt (DLR) [BMWi 50WB0719, 50WB0919, 50WB1319]; European Space Agency (ESA) [ELIPS 3, ELIPS 4]; Roscosmos; IBMP	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); French Ministry of Higher Education and Research; Universite de Lorraine (UL); French State-Region Project; Deutsches Zentrum fur Luft- und Raumfahrt (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); European Space Agency (ESA)(European Space AgencyEuropean Commission); Roscosmos; IBMP	Centre National d'Etudes Spatiales (CNES), Grant/Award Number: DAR 4800000894, 4800000950 and 4800001008; French Ministry of Higher Education and Research; Universite de Lorraine (UL); French State-Region Project Contract; Deutsches Zentrum fur Luft- und Raumfahrt (DLR), Grant/Award Number: BMWi 50WB0719, 50WB0919 and 50WB1319; European Space Agency (ESA), Grant/Award Number: ELIPS 3 and 4 programs; Roscosmos; IBMP, Grant/Award Number: theme 65.1	Agha NH, 2020, J APPL PHYSIOL, V128, P264, DOI 10.1152/japplphysiol.00560.2019; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Bascove M, 2011, FASEB J, V25, P2947, DOI 10.1096/fj.11-185215; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; Buchheim JI, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00085; Campbell JP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00648; Chouker A, 2001, J APPL PHYSIOL, V90, P1736, DOI 10.1152/jappl.2001.90.5.1736; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crucian B, 2016, INT J GEN MED, V9, P383, DOI 10.2147/IJGM.S114188; Crucian B, 2015, NPJ MICROGRAVITY, V1, DOI 10.1038/npjmgrav.2015.13; Crucian BE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01437; Crucian BE, 2014, J INTERF CYTOK RES, V34, P778, DOI 10.1089/jir.2013.0129; Fonte C, 2019, FASEB J, V33, P896, DOI 10.1096/fj.201800969R; Frippiat JP, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.40; Frippiat JP, 2013, MOL IMMUNOL, V56, P434, DOI 10.1016/j.molimm.2013.06.011; Ghislin S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09318; Globus RK, 2016, J APPL PHYSIOL, V120, P1196, DOI 10.1152/japplphysiol.00997.2015; Gueguinou N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071579; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hong BB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00128; Horie K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44067-9; Huin-Schohn C, 2013, FASEB J, V27, P333, DOI 10.1096/fj.12-217547; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kimzey SL, 1977, BIOMEDICAL RESULTS S, P248; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Laakko T, 2002, IMMUNOLOGY, V105, P111, DOI 10.1046/j.1365-2567.2002.01346.x; Lange MD, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00345; Ledo A, 2020, BRAIN BEHAV IMMUN, V83, P135, DOI 10.1016/j.bbi.2019.09.024; Lescale C, 2015, FASEB J, V29, P455, DOI 10.1096/fj.14-259770; Liu LY, 2003, IMMUNOGENETICS, V55, P336, DOI 10.1007/s00251-003-0583-8; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mackworth-Young CG, 2003, CLIN EXP IMMUNOL, V134, P420, DOI 10.1111/j.1365-2249.2003.02319.x; Maki KA, 2020, PHYSIOL GENOMICS, V52, P280, DOI 10.1152/physiolgenomics.00039.2020; Martin V, 2015, ANN NY ACAD SCI, V1362, P153, DOI 10.1111/nyas.12823; Mehta SK, 2014, BRAIN BEHAV IMMUN, V41, P210, DOI 10.1016/j.bbi.2014.05.014; Mehta SK, 2013, CYTOKINE, V61, P205, DOI 10.1016/j.cyto.2012.09.019; Mehta SK, 2007, MICROGRAVITY SCI TEC, V19, P215, DOI 10.1007/BF02919485; Mehta SK, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0015-y; Mehta SK, 2004, J MED VIROL, V72, P174, DOI 10.1002/jmv.10555; Novoselova EG, 2015, IMMUNOBIOLOGY, V220, P500, DOI 10.1016/j.imbio.2014.10.021; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rettig TA, 2019, LIFE SCI SPACE RES, V22, P16, DOI 10.1016/j.lssr.2019.06.001; Rettig TA, 2019, FASEB BIOADV, V1, P6, DOI 10.1096/fba.1017; Rettig TA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210284; Rettig TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190982; Rettig Trisha A, 2017, Gravit Space Res, V5, P2; Rooney BV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00016; Rykova MP, 2008, ACTA ASTRONAUT, V63, P697, DOI 10.1016/j.actaastro.2008.03.016; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Shearer WT, 2009, J ALLERGY CLIN IMMUN, V123, P900, DOI 10.1016/j.jaci.2008.12.016; Spielmann G, 2019, J APPL PHYSIOL, V126, P469, DOI 10.1152/japplphysiol.00789.2018; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Tascher G, 2019, FASEB J, V33, P3772, DOI 10.1096/fj.201801463R; van Dijk-Hard I, 2002, IMMUNOLOGY, V107, P136, DOI 10.1046/j.1365-2567.2002.01466.x; VOSS EW, 1984, SCIENCE, V225, P214, DOI 10.1126/science.6729476; Ward C, 2018, LIFE SCI SPACE RES, V16, P63, DOI 10.1016/j.lssr.2017.11.003; Wu GC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13838; Zhang ZX, 2004, IMMUNOL REV, V197, P231, DOI 10.1111/j.0105-2896.2004.0107.x	59	9	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16144	16162		10.1096/fj.202001403RR	http://dx.doi.org/10.1096/fj.202001403RR		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047384	Green Submitted			2022-12-26	WOS:000581171300001
J	Nagel, S; Pommerenke, C; Meyer, C; MacLeod, RAF; Drexler, HG				Nagel, Stefan; Pommerenke, Claudia; Meyer, Corinna; MacLeod, Roderick A. F.; Drexler, Hans G.			Aberrant expression of NKL homeobox genes HMX2 and HMX3 interferes with cell differentiation in acute myeloid leukemia	PLOS ONE			English	Article							INNER-EAR; THERAPEUTIC TARGET; KAPPA-B; MLL; CANCER; TRANSFORMATION; PROTEINS; NKX5-1; FUSION; CLASSIFICATION	The NKL-code describes normal expression patterns of NKL homeobox genes in hematopoiesis. Aberrant expression of NKL homeobox gene subclass members have been reported in several hematopoietic malignancies including acute myeloid leukemia (AML). Here, we analyzed the oncogenic role of the HMX-group of NKL homeobox genes in AML. Public expression profiling data-available for HMX1 and HMX2-indicate aberrant activity of HMX2 in circa 2% AML patients overall, rising to 31% in those with KMT2A/MLL rearrangements whereas HMX1 expression remains inconspicuous. AML cell lines EOL-1, MV4-11 and MOLM-13 expressed both, HMX2 and neighboring HMX3 genes, and harbored KMT2A aberrations, suggesting their potential functional association. Surprisingly, knockdown experiments in these cell lines demonstrated that KMT2A inhibited HMX2/3 which, in turn, did not regulate KMT2A expression. Furthermore, karyotyping and genomic profiling analysis excluded rearrangements of the HMX2/3 locus in these cell lines. However, comparative expression profiling and subsequent functional analyses revealed that IRF8, IL7- and WNT-signalling activated HMX2/3 expression while TNFa/NFkB- signalling proved inhibitory. Whole genome sequencing of EOL-1 identified two mutations in the regulatory upstream regions of HMX2/3 resulting in generation of a consensus ETS-site and transformation of a former NFkB-site into an SP1-site. Reporter-gene assays demonstrated that both mutations contributed to HMX2/3 activation, modifying ETS1/ELK1- and TNFalpha-mediated gene regulation. Moreover, DMSO-induced eosinophilic differentiation of EOL-1 cells coincided with HMX2/3 downregulation while knockdown of HMX2 induced cell differentiation, collectively supporting a fundamental role for these genes in myeloid differentiation arrest. Finally, target genes of HMX2/3 were identified in EOL-1 and included suppression of differentiation gene EPX, and activation of fusion gene FIP1L1-PDGFRA and receptor-encoding gene HTR7, both of which enhanced oncogenic ERK-signalling. Taken together, our study documents a leukemic role for deregulated NKL homeobox genes HMX2 and HMX3 in AML, revealing molecular mechanisms of myeloid differentiation arrest.	[Nagel, Stefan; Pommerenke, Claudia; Meyer, Corinna; MacLeod, Roderick A. F.; Drexler, Hans G.] Leibniz Inst DSMZ, German Collect Microorganisms & Cell Cultures, Dept Human & Anim Cell Lines, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Nagel, S (corresponding author), Leibniz Inst DSMZ, German Collect Microorganisms & Cell Cultures, Dept Human & Anim Cell Lines, Braunschweig, Germany.	sna@dsmz.de						Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Alasti F, 2009, J MED GENET, V46, P361, DOI 10.1136/jmg.2008.062158; Amendt BA, 1999, J BIOL CHEM, V274, P11635, DOI 10.1074/jbc.274.17.11635; [Anonymous], 2018, CELL DEATH DIS, V9, P742, DOI [10.1038/s41419-018-0793-5, DOI 10.1038/S41419-018-0793-5]; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Boulling A, 2013, MOL VIS, V19, P1779; Brendolan A, 2005, DEVELOPMENT, V132, P3113, DOI 10.1242/dev.01884; Brown ST, 2005, J COMP NEUROL, V483, P48, DOI 10.1002/cne.20418; Campos LW, 2019, CANCERS, V11, DOI 10.3390/cancers11121952; Charrot S, 2020, BRIT J HAEMATOL, V188, P49, DOI 10.1111/bjh.16356; Cools J, 2004, BLOOD, V103, P2802, DOI 10.1182/blood-2003-07-2479; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Doyle AD, 2013, BLOOD, V122, P781, DOI 10.1182/blood-2013-01-473405; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eklund E. A., 2011, Critical Reviews in Oncogenesis, V16, P65; Fu JF, 2019, NEOPLASIA, V21, P469, DOI 10.1016/j.neo.2019.03.006; Graux C, 2006, LEUKEMIA, V20, P1496, DOI 10.1038/sj.leu.2404302; Hadrys T, 1998, DEVELOPMENT, V125, P33; Hassani M, 2020, HAEMATOLOGICA, V105, pE52, DOI 10.3324/haematol.2019.219048; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Klein HU, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-422; LANGE B, 1987, BLOOD, V70, P192; MacLeod RAF, 2011, METHODS MOL BIOL, V731, P57, DOI 10.1007/978-1-61779-080-5_6; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; MAYUMI M, 1992, LEUKEMIA LYMPHOMA, V7, P243, DOI 10.3109/10428199209053629; Mennerich D, 1999, BIOL CHEM, V380, P1041, DOI 10.1515/BC.1999.130; Metzelder SK, 2015, LEUKEMIA, V29, P1470, DOI 10.1038/leu.2015.95; Meyer C, 2018, LEUKEMIA, V32, P273, DOI 10.1038/leu.2017.213; Miesner M, 2010, BLOOD, V116, P2742, DOI 10.1182/blood-2010-04-279794; Mori Y, 2009, J EXP MED, V206, P183, DOI 10.1084/jem.20081756; Nagel S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226212; Nagel S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205537; Nagel S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197194; Nagel S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171164; Noel LA, 2014, MOL ONCOL, V8, P728, DOI 10.1016/j.molonc.2014.02.003; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Pigazzi M, 2011, LEUKEMIA, V25, P560, DOI 10.1038/leu.2010.316; Poppe B, 2004, BLOOD, V103, P229, DOI 10.1182/blood-2003-06-2163; Quentmeier H, 2003, LEUKEMIA, V17, P980, DOI 10.1038/sj.leu.2402911; Quentmeier H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44491-x; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Reiter A, 2017, BLOOD, V129, P704, DOI 10.1182/blood-2016-10-695973; Rheinbay E, 2020, NATURE, V578, P102, DOI 10.1038/s41586-020-1965-x; RinkwitzBrandt S, 1996, HEARING RES, V99, P129, DOI 10.1016/S0378-5955(96)00093-7; Rosin JM, 2016, DEVELOPMENT, V143, P2582, DOI 10.1242/dev.133736; SAITO H, 1985, BLOOD, V66, P1233; Sangu Noriko, 2016, Hum Genome Var, V3, P16008, DOI 10.1038/hgv.2016.8; Speranza L, 2013, NEUROPHARMACOLOGY, V67, P155, DOI 10.1016/j.neuropharm.2012.10.026; Starkova J, 2011, HAEMATOL-HEMATOL J, V96, P820, DOI 10.3324/haematol.2010.031179; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Sugimoto Y, 2015, CANCER GENET-NY, V208, P508, DOI 10.1016/j.cancergen.2015.07.001; Tamura T, 2015, INT J HEMATOL, V101, P342, DOI 10.1007/s12185-015-1761-9; Wang WD, 2004, DEV CELL, V7, P439, DOI 10.1016/j.devcel.2004.06.016; Wang WD, 2001, DEVELOPMENT, V128, P5017; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wotton KR, 2009, DEV GENES EVOL, V219, P481, DOI 10.1007/s00427-009-0311-y; Xing YJ, 2013, FUNCT INTEGR GENOMIC, V13, P143, DOI 10.1007/s10142-012-0305-0; Yoshiura K, 1998, GENOMICS, V50, P61, DOI 10.1006/geno.1998.5284; Zhang HX, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0776-0	66	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240120	10.1371/journal.pone.0240120	http://dx.doi.org/10.1371/journal.pone.0240120			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048949	gold, Green Published			2022-12-26	WOS:000581813300016
J	Ramos-Arredondo, RI; Carvajal-Gamez, BE; Gendron, D; Gallegos-Funes, FJ; Mujica-Vargas, D; Rosas-Fernandez, JB				Ramos-Arredondo, Rosa I.; Carvajal-Gamez, Blanca E.; Gendron, Diane; Gallegos-Funes, Francisco J.; Mujica-Vargas, Dante; Rosas-Fernandez, J. B.			PhotoId-Whale: Blue whale dorsal fin classification for mobile devices	PLOS ONE			English	Article							PHOTOIDENTIFICATION; IDENTIFICATION; ALGORITHM; SOFTWARE; PROGRAM; ECOLOGY	Photo-identification (photo-id) is a method used in field studies by biologists to monitor animals according to their density, movement patterns and behavior, with the aim of predicting and preventing ecological risks. However, these methods can introduce subjectivity when manually classifying an individual animal, creating uncertainty or inaccuracy in the data as a result of the human criteria involved. One of the main objectives in photo-id is to implement an automated mechanism that is free of biases, portable, and easy to use. The main aim of this work is to develop an autonomous and portable photo-id system through the optimization of image classification algorithms that have high statistical dependence, with the goal of classifying dorsal fin images of the blue whale through offline information processing on a mobile platform. The new proposed methodology is based on the Scale Invariant Feature Transform (SIFT) that, in conjunction with statistical discriminators such as the variance and the standard deviation, fits the extracted data and selects the closest pixels that comprise the edges of the dorsal fin of the blue whale. In this way, we ensure the elimination of the most common external factors that could affect the quality of the image, thus avoiding the elimination of relevant sections of the dorsal fin. The photo-id method presented in this work has been developed using blue whale images collected off the coast of Baja California Sur. The results shown have qualitatively and quantitatively validated the method in terms of its sensitivity, specificity and accuracy on the Jetson Tegra TK1 mobile platform. The solution optimizes classic SIFT, balancing the results obtained with the computational cost, provides a more economical form of processing and obtains a portable system that could be beneficial for field studies through mobile platforms, making it available to scientists, government and the general public.	[Ramos-Arredondo, Rosa I.] Inst Politecn Nacl, SEPI Culhuacan, Mexico City, DF, Mexico; [Carvajal-Gamez, Blanca E.] Inst Politecn Nacl, SEPI ESCOM, Mexico City, DF, Mexico; [Gendron, Diane] Inst Politecn Nacl, CICIMAR, Mexico City, DF, Mexico; [Gallegos-Funes, Francisco J.] Inst Politecn Nacl, SEPI Zacatenco, Mexico City, DF, Mexico; [Mujica-Vargas, Dante] Tecnol Nacl Mexico, Dept Ciencias Computac, Cuernavaca, Morelos, Mexico; [Rosas-Fernandez, J. B.] Secretaria Educ Ciencia Tecnol & Innovac, Mexico City, DF, Mexico; [Ramos-Arredondo, Rosa I.] ESIME Culhuacan, SEPI Culhuacan, Mexico City, DF, Mexico; [Carvajal-Gamez, Blanca E.] ESCOM, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Carvajal-Gamez, BE (corresponding author), Inst Politecn Nacl, SEPI ESCOM, Mexico City, DF, Mexico.; Carvajal-Gamez, BE (corresponding author), ESCOM, Mexico City, DF, Mexico.	becarvajal@ipn.mx	Mujica-Vargas, Dante/N-4226-2019	Mujica-Vargas, Dante/0000-0001-8665-4096; Ramos-Arredondo, Rosa-Isela/0000-0002-0989-8377	Instituto Politecnico Nacional for the SIP project [20200736]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [221284]; Comision de Operacion y Promocion de Actividades Academicas from the IPN	Instituto Politecnico Nacional for the SIP project; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Comision de Operacion y Promocion de Actividades Academicas from the IPN	This study was financed by the Instituto Politecnico Nacional for the SIP project number 20200736, the Consejo Nacional de Ciencia y Tecnologia (CONACYT) with project number 221284, and the Comision de Operacion y Promocion de Actividades Academicas from the IPN to BECG. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Adams Jeffrey D., 2006, Aquatic Mammals, V32, P374, DOI 10.1578/AM.32.3.2006.374; [Anonymous], 2017, Future Oncol, V13, P1, DOI 10.2217/fon-2017-0071; [Anonymous], 2017, DZIENNIK USTAW RZECZ, V6, P2; Ardovini A, 2008, PATTERN RECOGN, V41, P1867, DOI 10.1016/j.patcog.2007.11.010; Armstrong Asia O., 2019, Marine Biodiversity Records, V12, P14, DOI 10.1186/s41200-019-0173-6; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Beekmans Bas W. P. M., 2005, Aquatic Mammals, V31, P243, DOI 10.1578/AM.31.2.2005.243; Bertulli CG, 2016, J MAR BIOL ASSOC UK, V96, P807, DOI 10.1017/S0025315415000284; Bigg M., 1982, REP INT WHALING COMM, V32, P655; Bolger DT, 2012, METHODS ECOL EVOL, V3, P813, DOI 10.1111/j.2041-210X.2012.00212.x; Buehler P, 2019, ECOL INFORM, V50, P191, DOI 10.1016/j.ecoinf.2019.02.003; Calambokidis J, 2001, MAR MAMMAL SCI, V17, P769, DOI 10.1111/j.1748-7692.2001.tb01298.x; Caldwell D. K., 1955, Journal of Mammalogy, V36, P467, DOI 10.2307/1375705; Chater A, 2020, TELKOMNIKA, V18, P695, DOI [10.12928/TELKOMNIKA.v18i2.13726, DOI 10.12928/TELKOMNIKA.V18I2.13726]; Damm Philip E., 2010, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V64, P125; Donnelly A, 2014, INT J BIOMETEOROL, V58, P1237, DOI 10.1007/s00484-013-0717-0; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Gamble L, 2008, J APPL ECOL, V45, P170, DOI 10.1111/j.1365-2664.2007.01368.x; Gendron D., 2012, Journal of Cetacean Research and Management, V12, P79; Gope C, 2005, PATTERN RECOGN, V38, P125, DOI 10.1016/j.patcog.2004.06.005; Grellier K, 2003, CAN J ZOOL, V81, P1421, DOI 10.1139/Z03-132; Hammond P.S., 1986, P253; Hartog J, 2007, INTERACTIVE INDIVIDU; Kelly MJ, 2001, J MAMMAL, V82, P440, DOI 10.1644/1545-1542(2001)082<0440:CAPMIS>2.0.CO;2; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Lu D, 2007, INT J REMOTE SENS, V28, P823, DOI 10.1080/01431160600746456; Mann J, 2001, J BIOGEOGR, V6, P814; McCoy E, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00271; Meek PD, 2015, AUST MAMMAL, V37, P13, DOI 10.1071/AM14023; Mittal S, 2019, J SYST ARCHITECT, V97, P428, DOI 10.1016/j.sysarc.2019.01.011; Molloy SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154161; Moya O, 2015, ECOL INFORM, V27, P64, DOI 10.1016/j.ecoinf.2015.03.003; NVIDIA, 2020, JETS TK1 MOB EMB SUP; Parsons K, 2005, MARINE MONITORING HD; Preece J, 2016, INT J HUM-COMPUT INT, V32, P585, DOI 10.1080/10447318.2016.1194153; Qu XZ, 2016, INT ARCH PHOTOGRAMM, V41, P685, DOI 10.5194/isprsarchives-XLI-B3-685-2016; Raj A, 2016, 3 INT C COMP SUST GL, P335; SHANE SH, 1986, MAR MAMMAL SCI, V2, P34, DOI 10.1111/j.1748-7692.1986.tb00026.x; Sherley Richard B., 2010, Endangered Species Research, V11, P101, DOI 10.3354/esr00267; Sheth A, 2009, IEEE INTERNET COMPUT, V13, P87, DOI 10.1109/MIC.2009.77; Suriyamongkol T, 2018, COPEIA, V106, P646, DOI 10.1643/CH-18-101; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Swann DE, 2004, WILDLIFE SOC B, V32, P357, DOI 10.2193/0091-7648(2004)32[357:ICFDWA]2.0.CO;2; Teacher AGF, 2013, ECOL EVOL, V3, P5268, DOI 10.1002/ece3.888; Town C, 2013, ECOL EVOL, V3, P1902, DOI 10.1002/ece3.587; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; Weideman HJ, 2017, ARXIV170807785; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43; Yao H, 2013, MATH COMPUT MODEL, V58, P784, DOI 10.1016/j.mcm.2012.12.025; Zhao F, 2014, EXPERT SYST APPL, V41, P4083, DOI 10.1016/j.eswa.2014.01.003	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0237570	10.1371/journal.pone.0237570	http://dx.doi.org/10.1371/journal.pone.0237570			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044975	Green Published, gold			2022-12-26	WOS:000581811700052
J	Gutierrez, JP; Bertozzi, SM				Gutierrez, Juan Pablo; Bertozzi, Stefano M.			Non-communicable diseases and inequalities increase risk of death among COVID-19 patients in Mexico	PLOS ONE			English	Article								Background The SARS-CoV-2 pandemic compounds Mexico's pre-existing challenges: very high levels of both non-communicable diseases (NCD) and social inequity. Methods and findings Using data from national reporting of SARS-CoV-2 tested individuals, we estimated odds of hospitalization, intubation, and death based on pre-existing non-communicable diseases and socioeconomic indicators. We found that obesity, diabetes, and hypertension are positively associated with the three outcomes in a synergistic manner. The municipal poverty level is also positively associated with hospitalization and death. Conclusions Mexico's response to COVID-19 is complicated by a synergistic double challenge: raging NCDs and extreme social inequity. The response to the current pandemic must take both into account both to be effective and to ensure that the burden of COVID-19 not falls disproportionately on those who are already disadvantaged.	[Gutierrez, Juan Pablo] Univ Nacl Autonoma Mexico, Sch Med, Ctr Policy Populat & Hlth Res, Mexico City, DF, Mexico; [Bertozzi, Stefano M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Bertozzi, Stefano M.] Univ Washington, Seattle, WA 98195 USA; [Bertozzi, Stefano M.] Mexico INSP, Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; Instituto Nacional de Salud Publica	Gutierrez, JP (corresponding author), Univ Nacl Autonoma Mexico, Sch Med, Ctr Policy Populat & Hlth Res, Mexico City, DF, Mexico.	jpgutierrez@unam.mx	Gutierrez, Juan Pablo/A-4253-2010	Gutierrez, Juan Pablo/0000-0002-0557-5562; Bertozzi, Stefano M/0000-0002-1723-7085				[Anonymous], 2013, MED LETT DRUGS THER, V55, pe44; Baqui P, 2020, LANCET GLOB HEALTH, V8, P1018, DOI 10.1016/S2214-109X(20)30285-0; Basto-Abreu A, 2019, SALUD PUBLICA MEXICO, V62, P50, DOI [10.21149/10752, DOI 10.21149/1075231869561]; Campos-Nonato I, 2013, SALUD PUBLICA MEXICO, V55, pS144, DOI 10.21149/spm.v55s2.5110; Chokshi DA, 2018, JAMA-J AM MED ASSOC, V319, P1312, DOI 10.1001/jama.2018.2521; Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3; CONEVAL, POV MUN LEV 2010 201; CONEVAL, 2018, REP EV SOC POL 2018; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Farsalinos K, 2020, INTERN EMERG MED, V15, P845, DOI 10.1007/s11739-020-02355-7; Carrillo-Vega MF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238905; Gutierrez JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201333; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; IHME (Institute for Health Metrics and Evaluation), 2020, GBD COMPARE; INEGI, 2018, NAT HLTH NUTR SURV 2; Kass DA, 2020, LANCET, V395, P1544, DOI 10.1016/S0140-6736(20)31024-2; Kirby T, 2020, LANCET RESP MED, V8, P547, DOI 10.1016/S2213-2600(20)30228-9; Kruk ME, 2018, LANCET, V392, P2170, DOI 10.1016/S0140-6736(18)31668-4; McDonald J.H., 2014, HDB BIOL STAT; MoH, 2020, OP DAT COVID 19; MoH, 2020, STAND GUID EP LAB SU; Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020; Niessen LW, 2018, LANCET, V391, P2036, DOI [10.1016/S0140-6736(18)30482-3, 10.1016/s0140-6736(18)30482-3]; OECD, INC IN IND; OECD, 2017, OB UPD 2017; Gutierrez JP, 2016, SALUD PUBLICA MEXICO, V58, P666, DOI 10.21149/spm.v58i6.7923; Plummer MP, 2020, CRIT CARE RESUSC; Schwalbe N, 2020, LANCET GLOB HEALTH, V8, P974, DOI 10.1016/S2214-109X(20)30276-X; Shadmi E, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01218-z; Stefan N, 2020, NAT REV ENDOCRINOL, V16, P341, DOI 10.1038/s41574-020-0364-6; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Williamson E, 2020, MEDRXIV, V7, P1, DOI [10.1101/2020.05.06.20092999v1, 10.1101/2020.05.06.20092999]; Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021	34	27	27	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240394	10.1371/journal.pone.0240394	http://dx.doi.org/10.1371/journal.pone.0240394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031467	gold, Green Submitted, Green Published			2022-12-26	WOS:000581809800001
J	Borregaard, B; Dahl, JS; Ekholm, O; Fosbol, E; Riber, LPS; Sibilitz, KL; Pedersen, SM; Rothberg, TPH; Nielsen, MH; Berg, SK; Moller, JE				Borregaard, Britt; Dahl, Jordi S.; Ekholm, Ola; Fosbol, Emil; Riber, Lars P. S.; Sibilitz, Kirstine L.; Pedersen, Sasja M.; Rothberg, Thomas P. H.; Nielsen, Maiken H.; Berg, Selina K.; Moller, Jacob E.			Employment status before and after open heart valve surgery: A cohort study	PLOS ONE			English	Article							FOLLOW-UP; RETURN; WORKFORCE	Objective Detachment from the workforce following open heart valve surgery is a burden for the patient and society. The objectives were to examine patterns of employment status at different time points and to investigate factors associated with a lower likelihood of returning to the workforce within six months. Methods A cohort study of patients aged 18-63 undergoing valvular surgery at a Danish tertiary centre from 2013-2017. Return to the workforce was defined as being employed, unemployed (still capable of working) or receiving paid leave of absence. The association between demographic-, clinical characteristics (including a surgical risk evaluation, EuroScore), and return to the workforce were investigated with a multivariable logistic regression model. Results In total, 1,395 consecutive patients underwent surgery, 347 were between 18 and 63 years and eligible for inclusion. Of those, 282 were attached to the workforce before surgery and included in the study. At the time of surgery, 79% were on paid sick leave. After six months, 21% of the patients (being part of the workforce before surgery), were still on sick leave. In the regression model, prolonged sick leave prior to surgery (OR 0.43, 95% CI 0.23-0.79) and EuroScore >= 2.3 (OR 0.39, 95% CI 0.21-0.74) significantly reduced the likelihood of returning to the workforce. Conclusion One-fifth of patients in the working-age were on sick leave six months after surgery. Prolonged sick leave prior to surgery and a EuroScore >= 2.3 were associated with a lower likelihood of returning to the workforce.	[Borregaard, Britt; Riber, Lars P. S.] Odense Univ Hosp, Dept Cardiothorac & Vasc Surg, Odense, Denmark; [Borregaard, Britt] Odense Univ Hosp, OPEN, Odense Patient Data Explorat Network, Odense, Denmark; [Borregaard, Britt; Dahl, Jordi S.; Riber, Lars P. S.; Nielsen, Maiken H.; Moller, Jacob E.] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Borregaard, Britt; Dahl, Jordi S.; Nielsen, Maiken H.; Moller, Jacob E.] Odense Univ Hosp, Dept Cardiol, Odense, Denmark; [Ekholm, Ola] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Fosbol, Emil; Sibilitz, Kirstine L.; Berg, Selina K.; Moller, Jacob E.] Copenhagen Univ Hosp, Rigshosp, Heart Ctr, Copenhagen, Denmark; [Pedersen, Sasja M.; Rothberg, Thomas P. H.] Univ Southern Denmark, Fac Business & Social Sci, Odense, Denmark; [Berg, Selina K.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Rigshospitalet; University of Copenhagen; University of Southern Denmark; University of Copenhagen	Borregaard, B (corresponding author), Odense Univ Hosp, Dept Cardiothorac & Vasc Surg, Odense, Denmark.; Borregaard, B (corresponding author), Odense Univ Hosp, OPEN, Odense Patient Data Explorat Network, Odense, Denmark.; Borregaard, B (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark.; Borregaard, B (corresponding author), Odense Univ Hosp, Dept Cardiol, Odense, Denmark.	britt.borregaard@rsyd.dk	Riber, Lars Peter Schødt/GRR-9540-2022; Borregaard, Britt/O-8040-2015; Riber, Lars/GWZ-4712-2022	Riber, Lars Peter Schødt/0000-0001-6898-2715; Borregaard, Britt/0000-0003-2702-0231; Fosbol, Emil/0000-0002-2048-4167; Pedersen, Sasja Maria/0000-0002-2011-4625	Helsefonden; Odense University Hospital PhD foundation; Ove William Buhl Olesen; Edith Buhl Olesen Foundation; Kurt Bonnelycke and Grethe Bonnelycke Foundation	Helsefonden; Odense University Hospital PhD foundation; Ove William Buhl Olesen; Edith Buhl Olesen Foundation; Kurt Bonnelycke and Grethe Bonnelycke Foundation	Helsefonden, The Odense University Hospital PhD foundation, Ove William Buhl Olesen and Edith Buhl Olesen Foundation and Kurt Bonnelycke and Grethe Bonnelycke Foundation funded this research. The funders had no role in either concept, design or interpretation of the study results.	[Anonymous], 2018, INT J CARDIOL; [Anonymous], 2011, CANC DISCOV; Berg SK, 2013, BMC NURS, V12, DOI 10.1186/1472-6955-12-23; Borregaard B., 2019, QUAL LIFE RES; Borregaard B, 2019, INT J CARDIOL, V289, P30, DOI 10.1016/j.ijcard.2019.02.056; Borregaard B, 2018, EUR J CARDIOVASC NUR, V17, P246, DOI 10.1177/1474515117731391; Butt JH, 2018, AM HEART J, V195, P130, DOI 10.1016/j.ahj.2017.09.009; Butt JH, 2018, INT J CARDIOL, V251, P15, DOI 10.1016/j.ijcard.2017.10.032; Committee NM-S, 2011, NOMESCO CLASS SURG P; Fonager K, 2014, REHABIL RES PRACT, V2014, DOI 10.1155/2014/631842; Hallberg V, 2009, SCAND CARDIOVASC J, V43, P277, DOI 10.1080/14017430802506601; Hansen TB, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000288; Hegewald J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010748.pub2; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; Kausto J., 2015, SICKNESS ABSENCE NOR; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; Oterhals K, 2015, EUR J CARDIO-THORAC, V48, P283, DOI 10.1093/ejcts/ezu425; Price AE, 2004, HEART, V90, P1077, DOI 10.1136/hrt.2003.029298; Rorth R, 2016, CIRCULATION, V134, P999, DOI 10.1161/CIRCULATIONAHA.116.021859; Schmidt Morten, 2010, Clin Epidemiol, V2, P137; Sibilitz KL, 2015, INT J CARDIOL, V189, P96, DOI 10.1016/j.ijcard.2015.04.078; Stapelfeldt CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-661; Trooboff S.W., 2019, J CARD SURG; World Medical Association (WMA), 1964, DECL HELS	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240210	10.1371/journal.pone.0240210	http://dx.doi.org/10.1371/journal.pone.0240210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027303	Green Published, gold			2022-12-26	WOS:000581808000033
J	Arbel, Y; Fialkoff, C; Kerner, A				Arbel, Yuval; Fialkoff, Chaim; Kerner, Amichai			The cause and effect problem: Is there mutual obesity among Arab Israeli couples?	PLOS ONE			English	Article							BODY-MASS INDEX	The influence of the health-related behavior of one spouse on that of the other is an important research question with public policy reprecussions. Yet, we are unaware of any previous study, which considered endogeneity problems between couples. Moreover, only a few studies considered ethnic origin differences among couples. Based on the 2016 wave of the Israeli longitudinal survey, we observe the cross-sectional correlation between the married couples'BMI, age, and accumulated wealth. TheBMI(=kgmeter2) is a conventional measure of obesity, whereBMI >= 25 is considered overweight. Using a 3SLS methodology (in an effort to correct the endogeneity problem associated withBMIcouples), the analysis tests the mutual obesity hypothesis among married couples. This hypothesis states that theBMIof the male influences that of a female and vice versa. Results indicate that on the one hand, a one-percentBMIincrease among Arab Israeli males is associated with a projected 0.969 percent BMI increase among Arab Israeli females (p= 0.017); and in the case that an Arab Israeli male suffers from overweight, the projected probability of his Arab Israeli female counterpart to suffer from overweight as wellrises(p= 0.050). On the other hand, one cannot reject the null hypothesis that projectedBMIof the Arab Israeli male is unaffected by that of his Arab Israeli female counterpart (p= 0.907 andp= 0.853). As for the Jewish Israeli population, in the case that the 3SLS methodology is employed, so that the endogeneity problem among couples is considered, a one-percentBMIincrease among Jewish Israeli females is associated with a projected 0.639 percentBMIincrease among Jewish Israeli males (p= 0.091). Unlike Arab Israeli couples, no support is found to indicate the influence in the other direction, namely, theBMIof the male influences that of the female spouse. Research findings may thus be of relevance to public health and policy planners. Two limitations of this research lie in: 1) the self-reportedBMI(which might be different from the measuredBMI); and 2) missing confounders, such as regional dummies, which are not available in the dataset.	[Arbel, Yuval] Western Galilee Coll, Sir Harry Solomon Sch Econ & Management, Akko, Israel; [Fialkoff, Chaim] Hebrew Univ Jerusalem, Inst Urban & Reg Studies, Jerusalem, Israel; [Kerner, Amichai] Netanya Acad Coll, Sch Real Estate, Netanya, Israel	Hebrew University of Jerusalem	Arbel, Y (corresponding author), Western Galilee Coll, Sir Harry Solomon Sch Econ & Management, Akko, Israel.	YuvalAr@wgalil.ac.il		Arbel, Yuval/0000-0003-4365-6280				Adachi-Mejia AM, 2017, PREV MED, V100, P33, DOI 10.1016/j.ypmed.2017.03.018; [Anonymous], 2018, LANCET PUBLIC HEALTH, V3, pE153, DOI 10.1016/S2468-2667(18)30053-7; Arbel Y, 2020, J REAL ESTATE FINANC, V61, P576, DOI 10.1007/s11146-019-09737-5; Arbel Y, 2018, ECON BULL, V38, P1313; Avicenna Between, 2015, DOCUMENTI STUDI TRAD, V26, P211; Cobb LK, 2016, AM J EPIDEMIOL, V183, P435, DOI 10.1093/aje/kwv112; Falba TA, 2008, HEALTH SERV RES, V43, P96, DOI 10.1111/j.1475-6773.2007.00754.x; Greene H., 2003, ECONOMETRIC ANAL; Hermesch AC, 2016, OBSTET GYNECOL, V128, P1033, DOI 10.1097/AOG.0000000000001678; Israeli Central Bureau of Statistics, 2018, FAM DAY FAM FAM ISR; Jeffery RW, 2002, OBES RES, V10, P809, DOI 10.1038/oby.2002.109; Johnston J., 1997, ECONOMETRICS METHODS, V4th ed.; Katzmarzyk PT, 1999, OBES RES, V7, P545, DOI 10.1002/j.1550-8528.1999.tb00712.x; Kmenta Jan, 1997, ELEMENTS ECONOMETRIC, VSecond, DOI DOI 10.3998/MPUB.15701; OECD, 2018, OV OB POP MEAS SELF; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Organisation for Economic Cooperation and Development (OECD), 2016, HLTH GLANCE EUROPE 2, DOI [10.1787/9789264265592-en, DOI 10.1787/9789264265592-EN]; Rice T, 1999, GENET EPIDEMIOL, V16, P316; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Shamriz O, 2017, CANCER CAUSE CONTROL, V28, P331, DOI [10.1007/s10552-017-0863-5, 10.1007/s10552-017-086]; Stark JH, 2014, PREV MED, V64, P63, DOI 10.1016/j.ypmed.2014.03.026; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization, OB OV; Yan YK, 2017, J HYPERTENS, V35, P47, DOI [10.1097/HJH.0000000000001118, 10.1097/hjh.0000000000001118]; Yoon SH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1839-6	27	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240034	10.1371/journal.pone.0240034	http://dx.doi.org/10.1371/journal.pone.0240034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064722	Green Published, gold			2022-12-26	WOS:000585918300009
J	Yang, QH; Gruenbacher, DM; Stamm, JLH; Amrine, DE; Brase, GL; DeLoach, SA; Scoglio, CM				Yang, Qihui; Gruenbacher, Don M.; Heier Stamm, Jessica L.; Amrine, David E.; Brase, Gary L.; DeLoach, Scott A.; Scoglio, Caterina M.			Impact of truck contamination and information sharing on foot-and-mouth disease spreading in beef cattle production systems	PLOS ONE			English	Article							SIMULATION-MODEL; NETWORK ANALYSIS; EPIDEMIC; TRANSMISSION; STRATEGIES; DAIRY	As cattle movement data in the United States are scarce due to the absence of mandatory traceability programs, previous epidemic models for U.S. cattle production systems heavily rely on contact rates estimated based on expert opinions and survey data. These models are often based on static networks and ignore the sequence of movement, possibly overestimating the epidemic sizes. In this research, we adapt and employ an agent-based model that simulates beef cattle production and transportation in southwest Kansas to analyze the between-premises transmission of a highly contagious disease, foot-and-mouth disease. First, we assess the impact of truck contamination on the disease transmission with the truck agent following an independent clean-infected-clean cycle. Second, we add an information-sharing functionality such that producers/packers can trace back and forward their trade records to inform their trade partners during outbreaks. Scenario analysis results show that including indirect contact routes between premises via truck movements can significantly increase the amplitude of disease spread, compared with equivalent scenarios that only consider animal movement. Mitigation strategies informed by information sharing can effectively mitigate epidemics, highlighting the benefit of promoting information sharing in the cattle industry. In addition, we identify salient characteristics that must be considered when designing an information-sharing strategy, including the number of days to trace back and forward in the trade records and the role of different cattle supply chain stakeholders. Sensitivity analysis results show that epidemic sizes are sensitive to variations in parameters of the contamination period for a truck or a loading/unloading area of premises, and indirect contact transmission probability and future studies can focus on a more accurate estimation of these parameters.	[Yang, Qihui; Gruenbacher, Don M.; Scoglio, Caterina M.] Kansas State Univ, Dept Elect & Comp Engn, Manhattan, KS 66506 USA; [Heier Stamm, Jessica L.] Kansas State Univ, Dept Ind & Mfg Syst Engn, Manhattan, KS 66506 USA; [Amrine, David E.] Kansas State Univ, Coll Vet Med, Beef Cattle Inst, Manhattan, KS 66506 USA; [Brase, Gary L.] Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA; [DeLoach, Scott A.] Kansas State Univ, Dept Comp Sci, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University; Kansas State University; Kansas State University	Yang, QH (corresponding author), Kansas State Univ, Dept Elect & Comp Engn, Manhattan, KS 66506 USA.	qihui@ksu.edu		Brase, Gary/0000-0002-9613-5529; Scoglio, Caterina/0000-0003-4486-9229	United States National Science Foundation [CMMI-1744812]	United States National Science Foundation(National Science Foundation (NSF))	This work was supported by United States National Science Foundation under Grant Award CMMI-1744812. https://www.nsf.gov/awardsearch/showAward?AWD_ID=1744812 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; Bates TW, 2003, AM J VET RES, V64, P195, DOI 10.2460/ajvr.2003.64.195; Bates TW, 2001, AM J VET RES, V62, P1121, DOI 10.2460/ajvr.2001.62.1121; Behnke K, 2020, INT J INFORM MANAGE, V52, DOI 10.1016/j.ijinfomgt.2019.05.025; Bernini A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223652; Bertram MR, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00174; Boklund A, 2013, PREV VET MED, V111, P206, DOI 10.1016/j.prevetmed.2013.05.008; Bradhurst RA, 2016, ENVIRON MODELL SOFTW, V77, P1, DOI 10.1016/j.envsoft.2015.11.015; Brennan ML, 2008, PREV VET MED, V84, P242, DOI 10.1016/j.prevetmed.2007.12.009; Caro M.P., 2018, 2018 IOT VERTICAL TO, P1, DOI [10.1109/IOT-TUSCANY.2018.8373021, DOI 10.1109/IOT-TUSCANY.2018.8373021]; Dorea FC, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00118; Feng Tian, 2016, 2016 13th International Conference on Service Systems and Service Management (ICSSSM), P1, DOI 10.1109/ICSSSM.2016.7538424; Garner MG, 2005, AUST VET J, V83, P758, DOI 10.1111/j.1751-0813.2005.tb11589.x; Granell C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.128701; Green DM, 2006, P ROY SOC B-BIOL SCI, V273, P2729, DOI 10.1098/rspb.2006.3648; Halasa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092521; Harvey N, 2007, PREV VET MED, V82, P176, DOI 10.1016/j.prevetmed.2007.05.019; Hayama Y, 2013, PREV VET MED, V112, P183, DOI 10.1016/j.prevetmed.2013.08.010; Kansas Department of Agriculture, SEC BEEF SUPPL PLAN; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kim Eu-Tteum, 2018, [Journal of Preventive Veterinary Medicine, 예방수의학회지], V42, P99, DOI 10.13041/jpvm.2018.42.3.99; Kim M, 2017, INT J PROD ECON, V187, P42, DOI 10.1016/j.ijpe.2017.02.007; Lentz HHK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155196; Lin J, 2018, PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON CROWD SCIENCE AND ENGINEERING (ICCSE 2018), DOI 10.1145/3265689.3265692; Liu H, 2012, PROCEDIA COMPUT SCI, V9, P857, DOI 10.1016/j.procs.2012.04.092; Mansley LM, 2011, REV SCI TECH OIE, V30, P483; Namatovu A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114811; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Viet NQ, 2018, COMPUT IND ENG, V120, P68, DOI 10.1016/j.cie.2018.04.034; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Pendell DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129134; Pendell DL, 2010, AM J AGR ECON, V92, P927, DOI 10.1093/ajae/aaq037; Porphyre T, 2020, TRANSBOUND EMERG DIS, V67, DOI 10.1111/tbed.13459; Rossi G, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005301; Rossi G, 2015, EPIDEMICS-NETH, V11, P62, DOI 10.1016/j.epidem.2015.02.007; Sahneh FD, 2014, MATH MODEL NAT PHENO, V9, P136, DOI 10.1051/mmnp/20149209; Sahneh FD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00632; SANSON RL, 1993, NEW ZEAL VET J, V41, P21, DOI 10.1080/00480169.1993.35730; Schroeder T. C., 2015, Journal of Agricultural and Applied Economics, V47, P47; Sterchi M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217974; Stevenson MA, 2013, PREV VET MED, V109, P10, DOI 10.1016/j.prevetmed.2012.08.015; Thakur KK, 2015, VET MICROBIOL, V180, P212, DOI 10.1016/j.vetmic.2015.09.010; Tian F, 2017, I C SERV SYST SERV M; USDA, 2014, USDA APHIS FOOT AND; Wang ZJ, 2020, AUTOMAT CONSTR, V111, DOI 10.1016/j.autcon.2019.103063; Wiltshire SW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194013; World Perspectives Inc, COMPR FEAS STUD US B; Yadav S, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00263; Yang QH, 2019, PHYSICA A, V526, DOI 10.1016/j.physa.2019.04.092; Yi C, 2020, UNDERSTANDING EFFECT, DOI [10.1101/2020.04.27.063735, DOI 10.1101/2020.04.27.063735]; Zheng CY, 2018, J PARALLEL DISTR COM, V115, P20, DOI 10.1016/j.jpdc.2018.01.001	53	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240819	10.1371/journal.pone.0240819	http://dx.doi.org/10.1371/journal.pone.0240819			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064750	Green Submitted, gold, Green Published			2022-12-26	WOS:000585918300051
J	Berry, BJ; Baldzizhar, A; Nieves, TO; Wojtovich, AP				Berry, Brandon J.; Baldzizhar, Aksana; Nieves, Tyrone O.; Wojtovich, Andrew P.			Neuronal AMPK coordinates mitochondrial energy sensing and hypoxia resistance inC. elegans	FASEB JOURNAL			English	Article						anoxia; metabolism; optogenetics; uncoupling	REPERFUSION INJURY; INNER MEMBRANE; C-ELEGANS; PROTEIN; HEART; CONDUCTANCE; METABOLISM; KINASE; TISSUE; SIGNAL	Organisms adapt to their environment through coordinated changes in mitochondrial function and metabolism. The mitochondrial protonmotive force (PMF) is an electrochemical gradient that powers ATP synthesis and adjusts metabolism to energetic demands via cellular signaling. It is unknown how or where transient PMF changes are sensed and signaled due to the lack of precise spatiotemporal control in vivo. We addressed this by expressing a light-activated proton pump in mitochondria to spatiotemporally "turn off" mitochondrial function through PMF dissipation in tissues with light. We applied our construct-mitochondria-OFF (mtOFF)-to understand how metabolic status impacts hypoxia resistance, a response that relies on mitochondrial function. Activation of mtOFF induced starvation-like behavior mediated by AMP-activated protein kinase (AMPK). We found prophylactic mtOFF activation increased survival following hypoxia, and that protection relied on neuronal AMPK. Our study links spatiotemporal control of mitochondrial PMF to cellular metabolic changes that mediate behavior and stress resistance.	[Berry, Brandon J.; Wojtovich, Andrew P.] Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, 575 Elmwood Ave, Rochester, NY 14642 USA; [Baldzizhar, Aksana; Nieves, Tyrone O.; Wojtovich, Andrew P.] Univ Rochester, Med Ctr, Dept Anesthesiol & Perioperat Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Wojtovich, AP (corresponding author), Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, 575 Elmwood Ave, Rochester, NY 14642 USA.	andrew_wojtovich@urmc.rochester.edu	Berry, Brandon/GWQ-5878-2022; Berry, Brandon/ABC-9821-2021	Berry, Brandon/0000-0002-2206-7615	National Institutes of Health [R01 NS092558, R01 NS115906]; American Heart Association Predoctoral Fellowship [18PRE33990054]; NIH Office of Research Infrastructure Programs [P40 OD010440]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	APW is supported by grants from the National Institutes of Health (R01 NS092558, R01 NS115906). BJB is supported by an American Heart Association Predoctoral Fellowship (18PRE33990054). We thank Dr Richard Roy (McGill University) for providing plasmid pMR729. We also thank the Mitochondrial Research & Innovation Group at the University of Rochester Medical Center for helpful discussions and guidance. Some strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).	Ahmadi B, 2016, 2016 FOURTH INTERNATIONAL CONFERENCE ON MILLIMETER-WAVE AND TERAHERTZ TECHNOLOGIES (MMWATT), P5, DOI 10.1109/MMWaTT.2016.7869863; Aldakkak M, 2010, AM J PHYSIOL-CELL PH, V298, pC530, DOI 10.1152/ajpcell.00468.2009; Bartok A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11646-3; Berry BJ, 2020, EMBO REP, V21, DOI 10.15252/embr.201949113; Berry BJ, 2018, J MOL BIOL, V430, P3873, DOI 10.1016/j.jmb.2018.03.025; Bleasdale EE, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00124; BRENNER S, 1974, GENETICS, V77, P71; Chen X, 2018, METABOLISM, V83, P256, DOI 10.1016/j.metabol.2018.03.004; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; De Magalhaes CD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02934-5; Dufayet L, 2020, INT J LEGAL MED, V134, P1003, DOI 10.1007/s00414-020-02268-2; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Ernst P, 2019, BIOPHYS J, V117, P631, DOI 10.1016/j.bpj.2019.06.038; Escorcia W, 2018, JOVE-J VIS EXP, DOI 10.3791/57352; Fagan KA, 2018, CURR BIOL, V28, P902, DOI 10.1016/j.cub.2018.02.029; Goedeke L, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aay0284; Hoerter J, 2004, CIRCULATION, V110, P528, DOI 10.1161/01.CIR.0000137824.30476.0E; Husson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040937; IMAI Y, 2019, COMMUN BIOL, V2; Iranon NN, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008242; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; JUNG DW, 1989, ANAL BIOCHEM, V178, P348, DOI 10.1016/0003-2697(89)90651-9; Kaufman DM, 2015, CURR BIOL, V25, P2171, DOI 10.1016/j.cub.2015.06.062; Kim AS, 2011, J MOL CELL CARDIOL, V51, P24, DOI 10.1016/j.yjmcc.2011.03.003; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Komlodi T, 2018, J BIOENERG BIOMEMBR, V50, P355, DOI 10.1007/s10863-018-9766-8; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Larue BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016790; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Li PA, 2017, J NEUROSCI RES, V95, P2025, DOI 10.1002/jnr.24042; Lim Y, 2019, DEV BIOL, V454, P15, DOI 10.1016/j.ydbio.2019.06.016; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McElroy GS, 2017, EXP CELL RES, V356, P217, DOI 10.1016/j.yexcr.2017.03.034; MEISNER H, 1972, BIOCHEMISTRY-US, V11, P949, DOI 10.1021/bi00756a002; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mitchell P, 2011, BBA-BIOENERGETICS, V1807, P1507, DOI 10.1016/j.bbabio.2011.09.018; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; NICHOLLS DG, 1977, EUR J BIOCHEM, V77, P349, DOI 10.1111/j.1432-1033.1977.tb11674.x; Nishino Y, 2004, CARDIOVASC RES, V61, P610, DOI 10.1016/j.cardiores.2003.10.022; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Onukwufor JO, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080285; Otani H, 2004, ANTIOXID REDOX SIGN, V6, P449, DOI 10.1089/152308604322899521; Ozcan C, 2013, AM J PHYSIOL-HEART C, V304, pH1192, DOI 10.1152/ajpheart.00592.2012; Paggio A, 2019, NATURE, V572, P609, DOI 10.1038/s41586-019-1498-3; Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2; Pena S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159989; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Philip NS, 2019, G3-GENES GENOM GENET, V9, P2629, DOI 10.1534/g3.119.400399; Rolland SG, 2019, CELL REP, V28, P1659, DOI 10.1016/j.celrep.2019.07.049; Ryan DA, 2014, CURR BIOL, V24, P2509, DOI 10.1016/j.cub.2014.09.032; Sack MN, 2006, CARDIOVASC RES, V72, P210, DOI 10.1016/j.cardiores.2006.07.010; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schneider F, 2013, BIOPHYS J, V105, P91, DOI 10.1016/j.bpj.2013.05.042; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Seager Richard, 2020, Neuronal Signal, V4, pNS20200008, DOI 10.1042/NS20200008; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Tkatch T, 2017, P NATL ACAD SCI USA, V114, pE5167, DOI 10.1073/pnas.1703623114; To TL, 2019, CELL, V179, P1222, DOI 10.1016/j.cell.2019.10.032; Trewin AJ, 2019, ANTIOXID REDOX SIGN, V31, P594, DOI 10.1089/ars.2018.7681; Trewin AJ, 2018, FREE RADICAL BIO MED, V128, P157, DOI 10.1016/j.freeradbiomed.2018.02.002; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Velazquez AFC, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00303-18; Wang XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182777; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; Westermann B, 2010, SEMIN CELL DEV BIOL, V21, P542, DOI 10.1016/j.semcdb.2009.12.003; Wojtovich AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028287; Wolf C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040815; Xie X, 2020, DOSE-RESPONSE, V18, DOI 10.1177/1559325820935329; Yang MY, 2017, J PHOTOCH PHOTOBIO B, V173, P325, DOI 10.1016/j.jphotobiol.2017.06.014; Yin SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074011; Yurgel ME, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006409; Zhang Q, 2018, CELL, V174, P870, DOI 10.1016/j.cell.2018.06.029; Zhang Y, 2019, ELIFE, V8, DOI 10.7554/eLife.49158	77	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16333	16347		10.1096/fj.202001150RR	http://dx.doi.org/10.1096/fj.202001150RR		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058299	hybrid, Green Published			2022-12-26	WOS:000581159400001
J	Eriksen, AMH; Nielsen, TK; Matthiesen, H; Caroe, C; Hansen, LH; Gregory, DJ; Turner-Walker, G; Collins, MJ; Gilbert, MTP				Eriksen, Anne Marie Hoier; Nielsen, Tue Kjaergaard; Matthiesen, Henning; Caroe, Christian; Hansen, Lars Hestbjerg; Gregory, David John; Turner-Walker, Gordon; Collins, Matthew James; Gilbert, M. Thomas P.			Bone biodeterioration-The effect of marine and terrestrial depositional environments on early diagenesis and bone bacterial community	PLOS ONE			English	Article							BIOEROSION; SUCCESSION; COLLAGEN; TUNNELS; DEATH; TIME	Bacteria play an important role in the degradation of bone material. However, much remains to be learnt about the structure of their communities in degrading bone, and how the depositional environment influences their diversity throughout the exposure period. We genetically profiled the bacterial community in an experimental series of pig bone fragments (femur and humeri) deposited at different well-defined environments in Denmark. The bacterial community in the bone fragments and surrounding depositional environment were studied over one year, and correlated with the bioerosion damage patterns observed microscopically in the bones. We observed that the bacterial communities within the bones were heavily influenced by the local microbial community, and that the general bone microbial diversity increases with time after exposure. We found the presence of several known collagenase producing bacterial groups, and also observed increases in the relative abundance of several of these in bones with tunneling. We anticipate that future analyses using shotgun metagenomics on this and similar datasets will be able to provide insights into mechanisms of microbiome driven bone degradation.	[Eriksen, Anne Marie Hoier; Matthiesen, Henning; Gregory, David John] Natl Museum Denmark, Environm Archaeol & Mat Sci, Conservat & Nat Sci, Copenhagen, Denmark; [Eriksen, Anne Marie Hoier; Caroe, Christian; Collins, Matthew James; Gilbert, M. Thomas P.] Univ Copenhagen, GLOBE Inst, Copenhagen, Denmark; [Nielsen, Tue Kjaergaard; Hansen, Lars Hestbjerg] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark; [Turner-Walker, Gordon] Natl Yunlin Univ Sci & Technol, Dept Cultural Heritage Conservat, Touliu, Yunlin, Taiwan; [Collins, Matthew James] McDonald Inst Archaeol Res, Cambridge, England; [Gilbert, M. Thomas P.] Norwegian Univ Sci & Technol, Univ Museum, Trondheim, Norway; [Gilbert, M. Thomas P.] Univ Copenhagen, GLOBE Inst, Ctr Evolutionary Hologen, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; National Yunlin University Science & Technology; University of Cambridge; Norwegian University of Science & Technology (NTNU); University of Copenhagen	Eriksen, AMH (corresponding author), Natl Museum Denmark, Environm Archaeol & Mat Sci, Conservat & Nat Sci, Copenhagen, Denmark.; Eriksen, AMH (corresponding author), Univ Copenhagen, GLOBE Inst, Copenhagen, Denmark.	anne.marie.hoeier.eriksen@natmus.dk	Gregory, David/AAT-9030-2021; Gilbert, Marcus/A-8936-2013	Gilbert, Marcus/0000-0002-5805-7195; Nielsen, Tue/0000-0001-6610-8450; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Hoier Eriksen, Anne Marie/0000-0001-5243-5207	Danish Council for Independent Research [DFF-4090-00037]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Council for Independent Research grant DFF-4090-00037 (AMHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abinandan S, 2019, CRIT REV BIOTECHNOL, V39, P981, DOI 10.1080/07388551.2019.1654972; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2020, CLIN DIABETOLOGY, V9, P1; ARNAUD G, 1978, J HUM EVOL, V7, P409; Balzer A, 1997, ARCHAEOMETRY, V39, P415, DOI 10.1111/j.1475-4754.1997.tb00817.x; BELL LS, 1991, SCANNING, V13, P173, DOI 10.1002/sca.4950130204; Booth TJ, 2020, BIOARCHAEOL SOC THEO, P193, DOI 10.1007/978-3-030-27393-4_11; Cai JF, 2018, FORENSIC ECOGENOMICS: THE APPLICATION OF MICROBIAL ECOLOGY ANALYSES IN FORENSIC CONTEXTS, P113, DOI 10.1016/B978-0-12-809360-3.00005-9; CANALEPAROLA E, 1978, ANNU REV MICROBIOL, V32, P69, DOI 10.1146/annurev.mi.32.100178.000441; Caroe C, 2020, MOL ECOL RESOUR, V20, P1620, DOI 10.1111/1755-0998.13227; Carter DO, 2015, FORENSIC SCI MED PAT, V11, P202, DOI 10.1007/s12024-015-9667-7; CEN-Standard, 2011, DSEN9331 CEN; Chater Keith F, 2016, F1000Res, V5, P2795; Chowdhury MP, 2019, ARCHAEOMETRY, V61, P1382, DOI 10.1111/arcm.12492; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; Damann FE., 2017, FORENSIC MICROBIOLOG, P312, DOI 10.1002/9781119062585.ch12; Damann FE, 2015, J FORENSIC SCI, V60, P844, DOI 10.1111/1556-4029.12744; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161, 10.1101/2020.05.12.088096]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emmons AL, 2019, BIORXIV; Eriksen AMH, 2020, ARCHAEOMETRY; Eriksen AMH, 2020, SCI TECHNOL ARCHAEOL, V6, P1, DOI 10.1080/20548923.2020.1738115; Froslev TG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01312-x; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Grupe G, 1993, PREHISTORIC HUMAN BO, P257, DOI DOI 10.1007/978-3-662-02894-0; HACKETT CJ, 1981, MED SCI LAW, V21, P243, DOI 10.1177/002580248102100403; Hauther KA, 2015, J FORENSIC SCI, V60, P1234, DOI 10.1111/1556-4029.12828; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; Hedlund BP., 2010, BERGEYS MANUAL SYSTE, V4, P785; Hyde ER, 2015, INT J LEGAL MED, V129, P661, DOI 10.1007/s00414-014-1128-4; Jaeger KE, 2014, METHODS MOL BIOL, V1149, P111, DOI 10.1007/978-1-4939-0473-0_12; Jans MME, 2004, J ARCHAEOL SCI, V31, P87, DOI 10.1016/j.jas.2003.07.007; Kadnikov VV, 2019, EXTREMOPHILES, V23, P189, DOI 10.1007/s00792-018-01073-5; Kendall C, 2018, PALAEOGEOGR PALAEOCL, V491, P21, DOI 10.1016/j.palaeo.2017.11.041; Kolde R., PHEATMAP PRETTY HEAT; LEETHORP JA, 1989, J ARCHAEOL SCI, V16, P585, DOI 10.1016/0305-4403(89)90024-1; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lambri ML, 2018, MATERIA-BRAZIL, V23, DOI [10.1590/s1517-707620180002.0424, 10.1590/S1517-707620180002.0424]; Margaryan A, 2018, ECOL EVOL, V8, P3534, DOI 10.1002/ece3.3924; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Metcalf JL, 2016, SCIENCE, V351, P158, DOI 10.1126/science.aad2646; Peterson B.G., 2020, PACKAGE PERFORMANCEA; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; SCHOELLMANN G, 1966, BIOCHIM BIOPHYS ACTA, V122, P557, DOI 10.1016/0926-6593(66)90052-X; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Skriver C., 2018, DANISH J ARCHAEOLOGY, V7, P195; Skriver C, 2017, SEA ARCHAEOLOGY PALA; Spring S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00862; Taylor PG, 1996, MOL BIOL EVOL, V13, P283, DOI 10.1093/oxfordjournals.molbev.a025566; Turner-Walker G, 2002, ARCHAEOMETRY, V44, P461, DOI 10.1111/1475-4754.t01-1-00078; Turner-Walker G, 2008, PALAEOGEOGR PALAEOCL, V266, P227, DOI 10.1016/j.palaeo.2008.03.024; Turner-Walker G, 2019, PALAEOGEOGR PALAEOCL, V529, P24, DOI 10.1016/j.palaeo.2019.05.020; Turner-Walker G, 2012, NEUES JAHRB GEOL P-A, V265, P165, DOI 10.1127/0077-7749/2012/0253; van Hoesel A, 2019, J ARCHAEOL SCI-REP, V28, DOI 10.1016/j.jasrep.2019.102033; Ward I, 2019, J ARCHAEOL SCI, V102, P11, DOI 10.1016/j.jas.2018.12.009; Warinner C, 2017, ANNU REV GENOM HUM G, V18, P321, DOI 10.1146/annurev-genom-091416-035526; White L, 2014, FORENSIC SCI INT, V239, P92, DOI 10.1016/j.forsciint.2014.03.024; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; YOSHINO M, 1991, FORENSIC SCI INT, V49, P143, DOI 10.1016/0379-0738(91)90074-S; Zaremba-Niedzwiedzka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062799; Ziesemer KA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16498	70	9	9	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240512	10.1371/journal.pone.0240512	http://dx.doi.org/10.1371/journal.pone.0240512			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057402	Green Published, gold			2022-12-26	WOS:000581814700051
J	Lima, BSD; Esteves, BB; Fialho, LC; Mendes, TAD; Pires, SD; Chapeourouge, A; Perales, J; de Andrade, HM				Lima, Bruna Soares de Souza; Esteves, Barbara Beiral; Fialho-Junior, Luiz Carlos; Mendes, Tiago Antonio de Oliveira; Pires, Simone da Fonseca; Chapeourouge, Alexander; Perales, Jonas; de Andrade, Helida Monteiro			Study of the differentially abundant proteins amongLeishmania amazonensis,L.braziliensis, andL.infantum	PLOS ONE			English	Article							PROTOZOAN PARASITE LEISHMANIA; TRYPANOTHIONE REDUCTASE; CUTANEOUS LEISHMANIASIS; ANTIMONY-RESISTANT; PROTEOMIC APPROACH; GENE-EXPRESSION; INFANTUM; PROMASTIGOTES; ARGINASE; IDENTIFICATION	Leishmaniasis has been considered as emerging and re-emerging disease, and its increasing global incidence has raised concerns. The great clinical diversity of the disease is mainly determined by the species. In several American countries, tegumentary leishmaniasis (TL) is associated with bothLeishmania amazonensisandL.braziliensis, while visceral leishmaniasis (VL) is associated withL.(L.) infantum. The major molecules that determine the most diverse biological variations are proteins. In the present study, through a DIGE approach, we identified differentially abundant proteins among the species mentioned above. We observed a variety of proteins with differential abundance among the studied species; and the biological networks predicted for each species showed that many of these proteins interacted with each other. The prominent proteins included the heat shock proteins (HSPs) and the protein network involved in oxide reduction process inL.amazonensis, the protein network of ribosomes inL.braziliensis, and the proteins involved in energy metabolism inL.infantum. The important proteins, as revealed by the PPI network results, enrichment categories, and exclusive proteins analysis, were arginase, HSPs, and trypanothione reductase inL.amazonensis; enolase, peroxidoxin, and tryparedoxin1 inL.braziliensis; and succinyl-CoA ligase [GDP -forming] beta-chain and transaldolase inL.infantum.	[Lima, Bruna Soares de Souza] Fac Dinam Vale Piranga FADIP, Dept Med, Ponte Nova, MG, Brazil; [Lima, Bruna Soares de Souza; Esteves, Barbara Beiral; Fialho-Junior, Luiz Carlos; Pires, Simone da Fonseca; de Andrade, Helida Monteiro] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Leishmanioses, Dept Parasitol, Belo Horizonte, MG, Brazil; [Mendes, Tiago Antonio de Oliveira] Univ Fed Vicosa UFV, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil; [Chapeourouge, Alexander; Perales, Jonas] Fiocruz MS, Inst Oswaldo Cruz, Lab Toxinol, Rio De Janeiro, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Vicosa; Fundacao Oswaldo Cruz	de Andrade, HM (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Leishmanioses, Dept Parasitol, Belo Horizonte, MG, Brazil.	helidandrade@gmail.com	Mendes, Tiago/AAG-1709-2021	Mendes, Tiago/0000-0002-5569-4893; , Barbara/0000-0001-7446-632X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [PPM00129-17]; Instituto Nacional de Ciencia e Tecnologia de Vacinas [CNPq-573547/2008-4/FAPEMIG/MS-CBB, APQ 00077-09]; Rede Mineira de Biomoleculas [CCBRED0001214]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia de Vacinas; Rede Mineira de Biomoleculas	This research was supported by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [PPM00129-17], Instituto Nacional de Ciencia e Tecnologia de Vacinas [CNPq-573547/2008-4/FAPEMIG/MS-CBB, APQ 00077-09] and Rede Mineira de Biomoleculas [CCBRED0001214]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolea PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164344; Alcolea PJ, 2016, ACTA TROP, V158, P240, DOI 10.1016/j.actatropica.2016.03.015; Alcolea PJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-849; Alcolea PJ, 2010, INT J PARASITOL, V40, P1497, DOI 10.1016/j.ijpara.2010.05.013; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2015, J ENDOUROL S1, V29, pP1, DOI 10.1089/end.2015.29003.abstracts; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Avilan Luisana, 2011, Enzyme Res, V2011, P932549, DOI 10.4061/2011/932549; Badirzadeh A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005774; Banuls AL, 1999, INT J PARASITOL, V29, P1137, DOI 10.1016/S0020-7519(99)00083-1; Bass JJ, 2017, SCAND J MED SCI SPOR, V27, P4, DOI 10.1111/sms.12702; BELLI AA, 1994, PARASITOLOGY, V109, P435, DOI 10.1017/S0031182000080689; Bente M, 2003, PROTEOMICS, V3, P1811, DOI 10.1002/pmic.200300462; Bogdan C, 2012, ANN RHEUM DIS, V71, P60, DOI 10.1136/annrheumdis-2011-200596; Brobey RKB, 2006, EXP PARASITOL, V114, P94, DOI 10.1016/j.exppara.2006.02.021; Broeders, 2007, INT SOCIOLOGY, V22, P71; Brotherton MC, 2012, J PROTEOME RES, V11, P3974, DOI 10.1021/pr201248h; Carnielli JBT, 2014, J PROTEOMICS, V108, P198, DOI 10.1016/j.jprot.2014.05.010; Castilho-Martins EA, 2015, ELECTROPHORESIS, V36, P2314, DOI 10.1002/elps.201500114; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Castro-Pinto DB, 2004, J ENZYM INHIB MED CH, V19, P57, DOI 10.1080/14756360310001624966; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Core Team R, 2013, LANG ENV STAT COMP; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Costa MM, 2011, J PROTEOME RES, V10, P2172, DOI 10.1021/pr101286y; Couto NF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005657; da Silva Maria Fernanda Laranjeira, 2014, Subcell Biochem, V74, P103, DOI 10.1007/978-94-007-7305-9_4; Das P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000899; David CV, 2009, DERMATOL THER, V22, P491, DOI 10.1111/j.1529-8019.2009.01272.x; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Drummelsmith J, 2003, MOL CELL PROTEOMICS, V2, P146, DOI 10.1074/mcp.M200085-MCP200; El Fakhry Y, 2002, PROTEOMICS, V2, P1007, DOI 10.1002/1615-9861(200208)2:8<1007::AID-PROT1007>3.0.CO;2-G; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Folgueira C, 2007, FEMS MICROBIOL REV, V31, P359, DOI 10.1111/j.1574-6976.2007.00069.x; Gaur U, 2007, J IMMUNOL, V179, P8446, DOI 10.4049/jimmunol.179.12.8446; Gongora Rafael, 2003, Biomedica, V23, P153; Gupta R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086073; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; KRAUTHSIEGEL RL, 1987, EUR J BIOCHEM, V164, P123, DOI 10.1111/j.1432-1033.1987.tb11002.x; Kropf P, 2005, FASEB J, V19, P1000, DOI 10.1096/fj.04-3416fje; Lima BSS, 2017, J PROTEOMICS, V151, P174, DOI 10.1016/j.jprot.2016.05.017; Lynn MA, 2013, J PROTEOMICS, V82, P179, DOI 10.1016/j.jprot.2013.02.010; Martinez E, 2002, T ROY SOC TROP MED H, V96, P529, DOI 10.1016/S0035-9203(02)90428-1; Matrangolo FSV, 2013, MOL BIOCHEM PARASIT, V190, P63, DOI 10.1016/j.molbiopara.2013.06.006; McNicoll F, 2006, PROTEOMICS, V6, P3567, DOI 10.1002/pmic.200500853; Moreira DD, 2015, PROTEOMICS, V15, P2999, DOI 10.1002/pmic.201400611; Mukbel RM, 2007, AM J TROP MED HYG, V76, P669, DOI 10.4269/ajtmh.2007.76.669; Muleme HM, 2009, J IMMUNOL, V183, P8068, DOI 10.4049/jimmunol.0803979; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Peysselon F, 2013, BBA-PROTEINS PROTEOM, V1834, P2653, DOI 10.1016/j.bbapap.2013.09.015; Pires SD, 2014, J PROTEOME RES, V13, P1860, DOI 10.1021/pr400923g; Reguera RM, 2009, MOL BIOCHEM PARASIT, V165, P48, DOI 10.1016/j.molbiopara.2009.01.001; Romao S, 2009, INT J PARASITOL, V39, P703, DOI 10.1016/j.ijpara.2008.11.009; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Thiel M, 2001, MED MICROBIOL IMMUN, V190, P33, DOI 10.1007/s004300100075; Turrens Julio F., 2004, Molecular Aspects of Medicine, V25, P211, DOI 10.1016/j.mam.2004.02.021; Vasconcelos EJR, 2012, MOL BIOCHEM PARASIT, V183, P140, DOI 10.1016/j.molbiopara.2012.02.009; Waki K, 2007, EUKARYOT CELL, V6, P198, DOI 10.1128/EC.00282-06; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380	65	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240612	10.1371/journal.pone.0240612	http://dx.doi.org/10.1371/journal.pone.0240612			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057350	Green Published, gold			2022-12-26	WOS:000581814700074
J	Napyo, A; Tylleskar, T; Mukunya, D; Tumuhamye, J; Musaba, MW; Arach, AAO; Waako, P; Tumwine, JK; Ndeezi, G				Napyo, Agnes; Tylleskar, Thorkild; Mukunya, David; Tumuhamye, Josephine; Musaba, Milton W.; Ojok Arach, Anna Agnes; Waako, Paul; Tumwine, James K.; Ndeezi, Grace			Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda	PLOS ONE			English	Article							TO-CHILD TRANSMISSION	Background Sub-optimal adherence to infant prophylaxis has been associated with mother-to-child-transmission of HIV. However, the factors associated have not been well characterised in different settings. This study describes barriers and enablers of adherence to infant prophylaxis among 6-week-old HIV exposed infants in Lira district, Northern Uganda. Methods This prospective cohort study was conducted from 2018-2020 at the PMTCT clinic at Lira Regional Referral Hospital and included 472 mother-infant pairs. HIV-infected pregnant women were recruited, followed up at delivery and 6 weeks postpartum. We used a structured questionnaire to obtain data on socio-demographic, reproductive-related, HIV-related characteristics and adherence. Data were analysed using Stata to estimate adjusted risk ratios using Poisson regression models to ascertain barriers and enablers of adherence to infant nevirapine prophylaxis. Results Barriers to infant adherence are maternal characteristics including: younger age (<= 20 years adjusted risk ratio (ARR) = 1.55; 95% CI: 1.1-2.2), missing a viral load test during pregnancy (ARR: 1.4; 95% CI: 1.1-1.7) and not receiving nevirapine syrup for the baby after childbirth (ARR = 6.2; 95% CI: 5.1-7.6). Enablers were: having attained >= 14 years of schooling (ARR = 0.7; 95% CI: 0.5-0.9), taking a nevirapine-based regimen (ARR = 0.6; 95% CI: 0.4-0.9), long-term ART (>= 60 months ARR = 0.75; 95% CI: 0.6-0.9), accompanied by a husband to hospital during labour and childbirth (ARR = 0.5; 95% CI: 0.4-0.7) and labour starting at night (ARR = 0.7; 95% CI: 0.6-0.8). Conclusion and recommendations Despite mothers receiving nevirapine syrup from the health workers for the infant, non-adherence rates still prevail at 14.8%. The health system needs to consider giving HIV infected pregnant women the nevirapine syrup before birth to avoid delays and non-adherence. There is need to pay particular attention to younger women and those who recently started ART.	[Napyo, Agnes; Musaba, Milton W.] Busitema Univ, Dept Publ Hlth, Fac Hlth Sci, Mbale, Uganda; [Napyo, Agnes; Tylleskar, Thorkild; Mukunya, David; Tumuhamye, Josephine] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Napyo, Agnes; Ojok Arach, Anna Agnes; Tumwine, James K.; Ndeezi, Grace] Makerere Univ, Dept Paediat & Child Hlth, Kampala, Uganda; [Musaba, Milton W.] Busitema Univ, Dept Obstet & Gynaecol, Fac Hlth Sci, Mbale, Uganda; [Ojok Arach, Anna Agnes] Lira Univ, Dept Nursing, Lira, Uganda; [Waako, Paul] Busitema Univ, Dept Pharmacol, Fac Hlth Sci, Mbale, Uganda	University of Bergen; Makerere University	Napyo, A (corresponding author), Busitema Univ, Dept Publ Hlth, Fac Hlth Sci, Mbale, Uganda.; Napyo, A (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.; Napyo, A (corresponding author), Makerere Univ, Dept Paediat & Child Hlth, Kampala, Uganda.	napyoagnes@gmail.com	Tylleskär, Thorkild/S-5529-2017	Tylleskär, Thorkild/0000-0003-4801-4324; Musaba, Milton/0000-0003-4145-4044; Agnes, Napyo/0000-0003-4333-3588	Norwegian Programme for Capacity Development in Higher Education and Research for Development (NORHED) by the Norwegian Agency for Development Cooperation (Norad), Norway through the Survival Pluss Project at Makerere University [UGA-13-0030]	Norwegian Programme for Capacity Development in Higher Education and Research for Development (NORHED) by the Norwegian Agency for Development Cooperation (Norad), Norway through the Survival Pluss Project at Makerere University	The study was funded by the Norwegian Programme for Capacity Development in Higher Education and Research for Development (NORHED) by the Norwegian Agency for Development Cooperation (Norad), Norway through the Survival Pluss Project at Makerere University (no. UGA-13-0030).	Albrecht S, 2006, JAIDS-J ACQ IMM DEF, V41, P114, DOI 10.1097/01.qai.0000179425.27036.d7; Beyene GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3217-3; Bukenya D, 2019, AIDS RES THER, V16, DOI 10.1186/s12981-018-0214-y; Buregyeya E, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1276-x; Colombini M, 2014, AIDS CARE, V26, P914, DOI 10.1080/09540121.2013.869539; Desmond AC, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0340-9; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2016, UNAIDS DAT EST, P2; Katirayi L, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20919; Kuonza LR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-218; Larsen A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4341-4; Mazanderani AH, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25284; Ministry of Health Uganda (MOH)., 2016, CONSOLIDATED GUIDELI; Mirkuzie AH, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-50; Mugasha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115171; Mukunya D, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16101723; Okoko NA, 2017, INT J STD AIDS, V28, P1215, DOI 10.1177/0956462417693735; Stirratt MJ, 2015, TRANSL BEHAV MED, V5, P470, DOI 10.1007/s13142-015-0315-2; Uganda AIDS Commission, 2014, HIV AIDS UG COUNTR P; UNAIDS, 2015, UND FAST TRACK; Vreeman Rachel C, 2014, J Int AIDS Soc, V17, P19227, DOI 10.7448/IAS.17.1.19227; World Health Organization, 2016, CONS GUID US ANT DRU, Vsecond, DOI [10.1097/00022744-199706000-00003, DOI 10.1097/00022744-199706000-00003]; World Health Organization, 2012, PROGR UPD US ANT DRU; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240529	10.1371/journal.pone.0240529	http://dx.doi.org/10.1371/journal.pone.0240529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057393	Green Published, gold			2022-12-26	WOS:000581814700024
J	Wei, XB; Zhang, LL; Zhang, RJ; Wu, RJ; Si, DY; Ahmad, B; Petitte, JN; Mozdziak, PE; Li, ZX; Guo, HA; Zhang, MY				Wei, Xubiao; Zhang, Lulu; Zhang, Rijun; Wu, Rujuan; Si, Dayong; Ahmad, Baseer; Petitte, James N.; Mozdziak, Paul E.; Li, Zhongxuan; Guo, Henan; Zhang, Manyi			A highly efficient hybrid peptide ameliorates intestinal inflammation and mucosal barrier damage by neutralizing lipopolysaccharides and antagonizing the lipopolysaccharide-receptor interaction	FASEB JOURNAL			English	Article						in silico; NF-kappa B signaling; peptide drug; proinflammatory cytokine; tight junction; Toll-like receptor	CECROPIN A(1-8)-MAGAININ 2(1-12); TIGHT JUNCTION PROTEINS; TOLL-LIKE RECEPTORS; BOWEL-DISEASE; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR-DISEASE; CELL SELECTIVITY; OXIDATIVE STRESS; IMMUNE-RESPONSES; IN-VIVO	Intestinal inflammatory disorders, such as inflammatory bowel disease, are major contributors to mortality and morbidity in humans and animals worldwide. While some native peptides have great potential as therapeutic agents against intestinal inflammation, potential cytotoxicity, anti-inciting action, and suppression of anti-inflammatory activity may limit their development as anti-inflammatory agents. Peptide hybridization is an effective approach for the design and engineering of novel functional peptides because hybrid peptides combine the advantages and benefits of various native peptides. In the present study, a novel hybrid anti-inflammatory peptide that combines the active center of Cecropin A (C) and the core functional region of LL-37 (L) was designed [C-L peptide; C (1-8)-L (17-30)] through in silico analysis to reduce cytotoxicity and improve the anti-inflammatory activity of the parental peptides. The resulting C-L peptide exhibited lower cytotoxicity than either C or L peptides alone. C-L also exerted a protective effect against lipopolysaccharide (LPS)-induced inflammatory responses in RAW264.7 macrophages and in the intestines of a mouse model. The hybrid peptide exhibited increased anti-inflammatory activity compared to the parental peptides. C-L plays a role in protecting intestinal tissue from damage, LPS-induced weight loss, and leukocyte infiltration. In addition, C-L reduces the expression levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), IL-1 beta, and interferon-gamma (IFN-gamma), as well as reduces cell apoptosis. It also reduced mucosal barrier damage caused by LPS. The anti-inflammatory effects of the hybrid peptide were mainly attributed to its LPS-neutralizing activity and antagonizing the activation of LPS-induced Toll-like receptor 4-myeloid differentiation factor 2 (TLR4/MD2). The peptide also affected the TLR4-(nuclear factor kappa B) signaling pathway, modulating the inflammatory response upon LPS stimulation. Collectively, these findings suggest that the newly designed peptide, C-L, could be developed into a novel anti-inflammatory agent for animals or humans.	[Wei, Xubiao; Zhang, Lulu; Zhang, Rijun; Wu, Rujuan; Si, Dayong; Ahmad, Baseer; Li, Zhongxuan; Guo, Henan; Zhang, Manyi] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China; [Petitte, James N.; Mozdziak, Paul E.] North Carolina State Univ, Coll Agr & Life Sci, Raleigh, NC USA	China Agricultural University; University of North Carolina; North Carolina State University	Zhang, RJ (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	rjzhang@cau.edu.cn	zhang, lu/GRO-2969-2022; Ahmad, Baseer/ABG-5769-2021	mozdziak, paul/0000-0002-1575-3123; , Baseer/0000-0002-8177-0271; Petitte, James/0000-0003-2764-6007	National Key Research and Development Program of China [2018YFD0500600]; National Natural Science Foundation of China [31572442, 31272476]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Key Research and Development Program of China (grant number 2018YFD0500600) and National Natural Science Foundation of China (grant numbers 31572442 and 31272476).	Akiyama T, 2014, J INNATE IMMUN, V6, P739, DOI 10.1159/000362789; Anders E, 2018, BIOCHEM BIOPH RES CO, V501, P280, DOI 10.1016/j.bbrc.2018.04.235; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Banerjee S, 2016, MUCOSAL IMMUNOL, V9, P1418, DOI 10.1038/mi.2016.9; Barlow PG, 2006, J LEUKOCYTE BIOL, V80, P509, DOI 10.1189/jlb.1005560; Beaugerie L, 2015, NEW ENGL J MED, V373, P195, DOI 10.1056/NEJMc1505689; Brandenburg K, 2011, APPL MICROBIOL BIOT, V90, P799, DOI 10.1007/s00253-011-3185-7; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Burrin DG, 2005, ENDOCRINOLOGY, V146, P22, DOI 10.1210/en.2004-1119; Chen H, 2014, GUT, V63, P711, DOI 10.1136/gutjnl-2012-303731; Chen X, 2013, BIOCHEM BIOPH RES CO, V433, P532, DOI 10.1016/j.bbrc.2013.03.024; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P484; Choudhary S, 2001, DIGEST DIS SCI, V46, P2222, DOI 10.1023/A:1011975218006; Chubinskiy-Nadezhdin VI, 2013, CELL BIOL INT, V37, P617, DOI 10.1002/cbin.10079; Citi S, 2018, SCIENCE, V359, P1097, DOI 10.1126/science.aat0835; COOPER HS, 1993, LAB INVEST, V69, P238; da Silva VC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124016; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong N, 2014, BIOMATERIALS, V35, P8028, DOI 10.1016/j.biomaterials.2014.06.005; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; Foit L, 2016, BIOMATERIALS, V100, P67, DOI 10.1016/j.biomaterials.2016.05.021; Fork C, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0439-4; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Gao Y, 2013, J ANIM SCI, V91, P5614, DOI 10.2527/jas.2013-6528; Gibson PR, 2004, GUT, V53, P1724, DOI 10.1136/gut.2004.047092; Goluszko P, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.051; Guo ST, 2011, BIOMATERIALS, V32, P4283, DOI 10.1016/j.biomaterials.2011.02.034; Gupta K, 2016, INNATE IMMUN-LONDON, V22, P21, DOI 10.1177/1753425915610643; Han FF, 2015, J IMMUNOL, V194, P1882, DOI 10.4049/jimmunol.1402300; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Heinbockel L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01704; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hering NA, 2009, DIGEST DIS, V27, P450, DOI 10.1159/000233283; Ince C, 2004, CRIT CARE MED, V32, P1963, DOI 10.1097/01.CCM.0000139617.88704.B9; Ishida W, 2016, INVEST OPHTH VIS SCI, V57, P30, DOI [10.1167/ iovs.15-17652, 10.1167/iovs.15-17652]; Jonsson D, 2012, J PERIODONTAL RES, V47, P330, DOI 10.1111/j.1600-0765.2011.01436.x; Kandiel A, 2005, GUT, V54, P1121, DOI 10.1136/gut.2004.049460; Koberlin MS, 2016, CURR OPIN CELL BIOL, V39, P28, DOI 10.1016/j.ceb.2016.01.010; Lee E, 2015, ARCH INSECT BIOCHEM, V88, P31, DOI 10.1002/arch.21193; Lee JH, 2019, J MICROBIOL BIOTECHN, V29, P687, DOI 10.4014/jmb.1809.09031; Li QR, 2009, J CELL MOL MED, V13, P4061, DOI 10.1111/j.1582-4934.2009.00975.x; Li RL, 2012, PLANT CELL, V24, P2105, DOI 10.1105/tpc.112.095695; Li TH, 2017, ACS APPL MATER INTER, V9, P17681, DOI 10.1021/acsami.7b04718; Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Liu H, 2020, J DIGEST DIS, V21, P385, DOI 10.1111/1751-2980.12909; Lopes PH, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00636; Lopez-Rojas R, 2011, EUR J CLIN MICROBIOL, V30, P1391, DOI 10.1007/s10096-011-1233-y; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Ma Z, 2015, BIOMATERIALS, V52, P517, DOI 10.1016/j.biomaterials.2015.02.063; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Martellini JA, 2009, FASEB J, V23, P3609, DOI 10.1096/fj.09-131961; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Matricon J, 2010, M S-MED SCI, V26, P405, DOI 10.1051/medsci/2010264405; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mu LX, 2017, AMINO ACIDS, V49, P1571, DOI 10.1007/s00726-017-2449-7; Neu J, 2006, SEMIN PERINATOL, V30, P77, DOI 10.1053/j.semperi.2006.02.007; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Oh D, 2000, BIOCHEMISTRY-US, V39, P11855, DOI 10.1021/bi000453g; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Park EJ, 2010, J PEDIATR GASTR NUTR, V50, P321, DOI 10.1097/MPG.0b013e3181ae2ba0; Park S, 2017, BIOMATERIALS, V126, P49, DOI 10.1016/j.biomaterials.2017.02.023; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Pathak AK, 2019, J CHEM THEORY COMPUT, V15, P2706, DOI 10.1021/acs.jctc.9b00005; Pi DA, 2014, J NUTR BIOCHEM, V25, P456, DOI 10.1016/j.jnutbio.2013.12.006; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Plociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI 10.1007/s00018-014-1762-5; Qi W, 2004, FASEB J, V18, pA15; Rajasekaran G, 2017, BBA-BIOMEMBRANES, V1859, P722, DOI 10.1016/j.bbamem.2017.01.037; Rangel-Frausto MS, 2005, ARCH MED RES, V36, P672, DOI 10.1016/j.arcmed.2005.06.006; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Saugar JM, 2002, ANTIMICROB AGENTS CH, V46, P875, DOI 10.1128/AAC.46.3.875-878.2002; Scott MG, 1999, INFECT IMMUN, V67, P2005; Segui J, 2005, INFLAMM BOWEL DIS, V11, P872, DOI 10.1097/01.MIB.0000183420.25186.7a; Semple F, 2011, EUR J IMMUNOL, V41, P3291, DOI 10.1002/eji.201141648; Senthilkumar B, 2017, J CLUST SCI, V28, P2549, DOI 10.1007/s10876-017-1240-y; Sigman T, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-29; Siti HN, 2015, VASC PHARMACOL, V71, P40, DOI 10.1016/j.vph.2015.03.005; Song YS, 2014, BIOTECHNOL BIOPROC E, V19, P404, DOI 10.1007/s12257-014-0131-4; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stallmach Andreas, 2004, Int J Colorectal Dis, V19, P308, DOI 10.1007/s00384-003-0554-4; Stanbury RM, 1998, BRIT J OPHTHALMOL, V82, P704, DOI 10.1136/bjo.82.6.704; Stein C, 2012, CURR PHARM DESIGN, V18, P6053, DOI 10.2174/138161212803582513; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Sun Y, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/167572; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Varshney P, 2016, IMMUNOLOGY, V149, P13, DOI 10.1111/imm.12617; Velkov T, 2018, PHARMACOL THERAPEUT, V181, P85, DOI 10.1016/j.pharmthera.2017.07.012; Vieira ELM, 2012, J NUTR BIOCHEM, V23, P430, DOI 10.1016/j.jnutbio.2011.01.007; Ba VAP, 2018, ACS APPL MATER INTER, V10, P17100, DOI 10.1021/acsami.8b04287; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; Wang B, 2016, J NUTR, V146, P501, DOI 10.3945/jn.115.224857; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang ZL, 2018, MAR DRUGS, V16, DOI 10.3390/md16020057; Wei L, 2013, J MED CHEM, V56, P3546, DOI 10.1021/jm4004158; Whitehouse MW, 2005, CURR MED CHEM, V12, P2931, DOI 10.2174/092986705774462879; Wicke C, 2000, ARCH SURG-CHICAGO, V135, P1265, DOI 10.1001/archsurg.135.11.1265; Wu BC, 2017, J IMMUNOL, V199, P3592, DOI 10.4049/jimmunol.1700985; Wu RJ, 2014, MOL BIOL REP, V41, P4163, DOI 10.1007/s11033-013-2900-0; Yu HN, 2015, SCI REP-UK, V5, DOI 10.1038/srep11082; Yu HT, 2020, FASEB J, V34, P1018, DOI 10.1096/fj.201901717R; Yu J, 2007, J IMMUNOL, V179, P7684, DOI 10.4049/jimmunol.179.11.7684; Zhang D, 2009, INT J COLORECTAL DIS, V24, P5, DOI 10.1007/s00384-008-0544-7; Zhang YL, 2018, EUR J MED CHEM, V148, P291, DOI 10.1016/j.ejmech.2018.02.008; Zong X, 2016, BIOCHEM PHARMACOL, V104, P74, DOI 10.1016/j.bcp.2016.01.009; Zou DY, 2020, EBIOMEDICINE, V52, DOI 10.1016/j.ebiom.2020.102652	115	3	3	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16049	16072		10.1096/fj.201903263RRR	http://dx.doi.org/10.1096/fj.201903263RRR		OCT 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058296				2022-12-26	WOS:000581158000001
J	Bhura, M; Ariff, S; Qazi, SA; Qazi, Z; Ahmed, I; Nisar, YB; Suhag, Z; Soomro, AW; Soofi, SB				Bhura, Maria; Ariff, Shabina; Qazi, Shamim Ahmad; Qazi, Zaitoon; Ahmed, Imran; Nisar, Yasir bin; Suhag, Zamir; Soomro, Abdul Wahab; Soofi, Sajid Bashir			Evaluating implementation of "management of Possible Serious Bacterial Infection (PSBI) when referral is not feasible" in primary health care facilities in Sindh province, Pakistan	PLOS ONE			English	Article							INJECTABLE PROCAINE BENZYLPENICILLIN; SIMPLIFIED ANTIBIOTIC REGIMENS; YOUNG INFANTS; OPEN-LABEL; PLUS GENTAMICIN; CLINICAL SIGNS; LOW-INCOME; INTERVENTION; STRATEGIES; QUALITY	Background The World Health Organization (WHO) launched a guideline in 2015 for managing Possible Serious Bacterial Infection (PSBI) when referral is not feasible in young infants aged 0-59 days. This guideline was implemented across 303 Basic Health Unit (BHU) Plus primary health care (PHC) facilities in peri-urban and rural settings of Sindh, Pakistan. We evaluated the implementation of PSBI guideline, and the quality of care provided to sick young infants at these facilities. Methods Thirty (10%) out of 303 BHU Plus facilities were randomly selected for evaluation. A survey team visited each facility for one day, assessed the health system support, observed the management of sick young infants by health care providers (HCP), validated their management, interviewed HCPs and caretakers of sick infants. HCPs who were unable to see a young infant on the day of survey were evaluated using pre-prepared case scenarios. Results Thirty (100%) BHU Plus facilities had oral amoxicillin, injectable gentamicin, thermometers, baby weighing scales and respiratory timers available; 29 (97%) had disposable syringes and needles; 28 (93%) had integrated management of childhood illness (IMCI)/PSBI chart booklets and job aids and 18 (60%) had a functional ambulance. Each facility had at least one HCP trained in PSBI, and 21 (70%) facilities had been visited by a supervisor in the preceding six months. Of 42 HCPs, 19 (45.3%) were trained within the preceding 12 months. During the survey, 26 sick young infants were identified in 18 facilities. HCPs asked about history of breastfeeding in 23 (89%) infants, history of vomiting in 17 (65%), and history of convulsions in 14 (54%); weighed 25 (97%) infants; measured respiratory rate in all (100%) and temperature in 24 (92%); assessed 20 (77%) for movement and 14 (54%) for chest indrawing. HCPs identified two infants with fast breathing pneumonia and managed them correctly per IMCI/PSBI protocol. HCPs identified six (23%) infants with clinical severe infection (CSI), two of them were referred to a higher-level facility, only one accepted the referral advice. Only one CSI patient was managed correctly per IMCI/PSBI protocol at the outpatient level. HCPs described the PSBI danger signs to eight (31%) caretakers. Caretakers of five infants with CSI and two with pneumonia were not counselled for PSBI danger signs. Five of the six CSI cases categorized by HCPs were validated as CSI on re-examination, whereas one had pneumonia. Similarly, one of the two pneumonia patients categorized by HCPs had CSI and one identified as local bacterial infection was classified as CSI upon re-examination. Conclusion Health system support was adequate but clinical management and counselling by HCPs was sub-optimal particularly with CSI cases who are at higher risk of adverse outcomes. Scaling up PSBI management is potentially feasible in PHC facilities in Pakistan, provided that HCPs are trained well and mentored, receive refresher training to appropriately manage sick young infants, and have adequate supplies and counselling skills.	[Bhura, Maria; Ahmed, Imran; Soofi, Sajid Bashir] Aga Khan Univ, Ctr Excellance Women & Child Hlth, Karachi, Pakistan; [Ariff, Shabina; Soofi, Sajid Bashir] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan; [Qazi, Shamim Ahmad] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Nisar, Yasir bin] WHO, Dept Maternal Newborn Child Adolescent Hlth & Agi, Geneva, Switzerland; [Suhag, Zamir; Soomro, Abdul Wahab] Peoples Primary Healthcare Initiat, Sindh, Pakistan	Aga Khan University; Aga Khan University; World Health Organization; World Health Organization	Soofi, SB (corresponding author), Aga Khan Univ, Ctr Excellance Women & Child Hlth, Karachi, Pakistan.; Soofi, SB (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.	sajid.soofi@aku.edu	Nisar, Yasir Bin/AFO-2407-2022	soofi, sajid/0000-0003-4192-8406	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by the Bill and Melinda Gates Foundation through a grant to the World Health Organization, Geneva, Switzerland. The funder provided support in the form of salary [ZQ] and to conduct the study, none of the other authors were provided any salary from the study. Funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study hired independent consultant ZQ for development of methods by Aga Khan University, Pakistan has no other commercial affiliation or role in the study. The contents, conclusions and interpretation are solely the responsibility of the authors and do not necessarily represent the official views of The Bill and Melinda Gates Foundation or World Health Organization or PPHI, Sindh, Pakistan or The Aga Khan University, Pakistan.	Aboubaker S, 2014, J GLOB HEALTH, V4, P32, DOI 10.7189/jogh.04.020302; Applegate JA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229988; Applegate JA, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001643; Ariff S, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-319; Ayaz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013783; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2015, LANCET GLOB HEALTH, V3, pE279, DOI 10.1016/S2214-109X(14)70347-X; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Birhanu Z, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-78; Bright T, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2180-9; Degefa N., 2019, KNOWLEDGE NEONATAL D, V2019; Editorial, 2015, EUCONST, V11, P1, DOI DOI 10.1186/s12917-014-0312-6; Gera T, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010123.pub2; Gogia S, 2016, J PERINATOL, V36, pS54, DOI 10.1038/jp.2016.33; Government of Pakistan, 2018, PROV SUMM RES 6 POP; Hoque DME, 2014, HEALTH POLICY PLANN, V29, P753, DOI 10.1093/heapol/czt059; Howe LD, 2011, PAEDIATR PERINAT EP, V25, P192, DOI 10.1111/j.1365-3016.2010.01178.x; Larson E, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014888; Macarayan EK, 2018, LANCET GLOB HEALTH, V6, pE1176, DOI 10.1016/S2214-109X(18)30440-6; Mir F, 2017, LANCET GLOB HEALTH, V5, pE177, DOI [10.1016/s2214-109x(16)30335-7, 10.1016/S2214-109X(16)30335-7]; Nguyen DTK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066030; People's Primary Healthcare Initiative (PPHI) Sindh, 2019, PPHI SINDH ANN REP 2; Rowe AK, 2018, LANCET GLOB HEALTH, V6, pE1163, DOI 10.1016/S2214-109X(18)30398-X; Rowe AK, 2012, HEALTH POLICY PLANN, V27, P179, DOI 10.1093/heapol/czr033; Simen-Kapeu A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S6; Son H, 2017, JPN J NURS SCI, V14, P27, DOI 10.1111/jjns.12132; Trimmer C, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-018-3857-4; Tshefu A, 2015, LANCET, V385, P1767, DOI 10.1016/S0140-6736(14)62284-4; Tshefu A, 2015, LANCET, V385, P1758, DOI 10.1016/S0140-6736(14)62285-6; UNICEF WHO World Bank Group UN, 2020, LEVELS TRENDS CHILD; UNICEF World Health Organization World Bank Group United Nations, 2017, LEV TRENDS CHILD MOR; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x; WHO, 2003, HLTH FAC SURV TOOL E; World Health Organization, 2015, MAN POSS SER BACT IN; World Health Organization unicef Save the Children, 2017, OPERATIONALIZING MAN; Yaya S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2745-7; Zaidi AKM, 2012, PEDIATR INFECT DIS J, V31, P667, DOI 10.1097/INF.0b013e318256f86c; Zaidi S, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0041-8	39	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240688	10.1371/journal.pone.0240688	http://dx.doi.org/10.1371/journal.pone.0240688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052981	Green Published, gold			2022-12-26	WOS:000581820200019
J	Brederecke, J; Zimmermann, T				Brederecke, Jan; Zimmermann, Tanja			Psychometric properties of the German version of the Self Image Scale (SIS-D) in a sample of cancer patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; BODY-IMAGE; BREAST-CANCER; IMPACT; DEPRESSION; SEXUALITY; SURVIVORS; DISTRESS; CONTEXT; WOMEN	Background A cancer disease can affect the satisfaction with the physical appearance, so that the standardized assessment of the body image is important in cancer patients. The German version of the Self-Image Scale is a self-report measure that uses two subscales to assess appearance satisfaction (self-acceptance) and perceptions of partners' acceptance of their appearance (partner-acceptance). The present study aimed to validate the Self-Image Scale's two-factor structure in a sample of cancer patients with a variety of different diagnoses to further increase its utility. Methods Confirmatory factor analysis methods were used to examine the two-factor model in a sample of cancer patients (N= 278). Scale reliability and validity were then assessed through internal consistency measures and correlations with external criteria such as depressiveness, anxiety, distress, and relationship satisfaction. Results The proposed factor structure was supported by the results and the internal consistencies were good with alpha = .83 for the self-acceptance scale and alpha = .88 for the partner-acceptance scale while additional correlations with external criteria were observed as expected. Conclusions The results support the use of the German version of the Self-Image Scale in cancer patients in general. Future research directions include validation across further entities of cancer, the in-depth investigation of sex differences, and research in other diseases that might impact body image.	[Brederecke, Jan; Zimmermann, Tanja] Hannover Med Sch, Dept Psychosomat Med & Psychotherapy, Hannover, Germany; [Brederecke, Jan] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany	Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf	Brederecke, J (corresponding author), Hannover Med Sch, Dept Psychosomat Med & Psychotherapy, Hannover, Germany.; Brederecke, J (corresponding author), Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany.	Brederecke.Jan@mh-hannover.de		Brederecke, Jan/0000-0003-1457-9255	German Research Foundation (DFG); Open Access Publication Fund of Hannover Medical School (MHH)	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Hannover Medical School (MHH)	We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Fund of Hannover Medical School (MHH).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bober SL, 2012, J CLIN ONCOL, V30, P3712, DOI 10.1200/JCO.2012.41.7915; Bollen KA, 1989, STRUCTURAL EQUATIONS; Boyes AD, 2007, J FAM PSYCHOL, V21, P764, DOI 10.1037/0893-3200.21.4.764; Brauer K, 2019, ENCY PERSONALITY IND, P1; Brederecke J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230331; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Choi EK, 2014, PSYCHO-ONCOLOGY, V23, P1103, DOI 10.1002/pon.3531; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Collins KK, 2011, BREAST CANCER RES TR, V126, P167, DOI 10.1007/s10549-010-1077-7; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DeFrank Jessica T, 2007, Oncol Nurs Forum, V34, pE36; Drigotas SM, 1999, J PERS SOC PSYCHOL, V77, P293, DOI 10.1037/0022-3514.77.2.293; Eisenberg ME, 2006, J PSYCHOSOM RES, V61, P521, DOI 10.1016/j.jpsychores.2006.05.007; Feingold A, 1998, PSYCHOL SCI, V9, P190, DOI 10.1111/1467-9280.00036; Fingeret MC, 2014, CANCER-AM CANCER SOC, V120, P633, DOI 10.1002/cncr.28469; Fingeret Michelle Cororve, 2013, Head Neck, V35, P354, DOI 10.1002/hed.22980; GERBING DW, 1984, J CONSUM RES, V11, P572, DOI 10.1086/208993; Goins LB, 2012, AM J MENS HEALTH, V6, P240, DOI 10.1177/1557988311431007; Greer S, 1994, PSYCHO-ONCOLOGY, V3, P87, DOI [DOI 10.1002/P0N.2960030203, DOI 10.1002/PON.2960030203]; Halford WK, 2001, PSYCHOL COUPLES ILLN, P135; Harrington JM, 2009, ONCOL NURS FORUM, V36, P167, DOI 10.1188/09.ONF.167-172; Hedges LV, 1981, J EDUC STAT, V6, P107, DOI [10.2307/1164588, DOI 10.2307/1164588, 10.3102/10769986006002107]; Herschbach P., 2003, Z MED PSYCHOL, V12, P69; Higano Celestia, 2003, Clin Prostate Cancer, V2, P22; Hopwood P, 2001, EUR J CANCER, V37, P189, DOI 10.1016/S0959-8049(00)00353-1; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jorgensen TD, 2018, PACKAGE SEMTOOLS; Karazsia BT, 2017, PSYCHOL BULL, V143, P293, DOI 10.1037/bul0000081; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lehmann V, 2015, J CANCER SURVIV, V9, P339, DOI 10.1007/s11764-014-0414-y; Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7; Muzzatti B, 2017, SUPPORT CARE CANCER, V25, P1019, DOI 10.1007/s00520-016-3538-y; Neises M, 1995, PSYCHOSOMATISCHE GYN, P232; Nishi H, 2016, PROTEIN SCI, V25, P316, DOI 10.1002/pro.2845; O'Connor KM, 2006, BJU INT, V97, P22, DOI 10.1111/j.1464-410X.2006.05865.x; Przezdziecki A, 2013, PSYCHO-ONCOLOGY, V22, P1872, DOI 10.1002/pon.3230; R Core Team, 2021, R LANGUAGE ENV STAT; Ross L, 2007, SUPPORT CARE CANCER, V15, P505, DOI 10.1007/s00520-006-0177-8; Roy M, 2012, ARCH GERONTOL GERIAT, V55, P505, DOI 10.1016/j.archger.2012.04.007; Rubin DB., 2004, MULTIPLE IMPUTATION; Satorra A, 2000, ADV ST THEO, V36, P233; Scott JL, 2004, J CONSULT CLIN PSYCH, V72, P1122, DOI 10.1037/0022-006X.72.6.1122; Sharpe L, 2011, J PSYCHOSOM RES, V70, P395, DOI 10.1016/j.jpsychores.2010.11.003; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sprangers MAG, 1996, J CLIN ONCOL, V14, P2756, DOI 10.1200/JCO.1996.14.10.2756; Steiger JH, 1980, ANN M PSYCH SOC IOW; Taghian NR, 2014, CRIT REV ONCOL HEMAT, V92, P227, DOI 10.1016/j.critrevonc.2014.06.004; Teo I, 2016, PSYCHO-ONCOLOGY, V25, P1106, DOI 10.1002/pon.3952; Traeen B, 2017, INT J SEX HEALTH, V29, P11, DOI 10.1080/19317611.2016.1227012; van Buuren S, 2011, J STAT SOFTW, V45, P1; van den Brink F, 2018, J FAMILY PSYCHOL; Whelan TJ, 2000, CANCER-AM CANCER SOC, V88, P2260, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2260::AID-CNCR9>3.3.CO;2-D; Wimberly SR, 2005, J CONSULT CLIN PSYCH, V73, P300, DOI 10.1037/0022-006X.73.2.300; Zhang XJ, 2016, EDUC PSYCHOL MEAS, V76, P357, DOI 10.1177/0013164415596421; Zimmermann T, 2019, ONKOLOGE, V25, P451, DOI 10.1007/s00761-018-0506-9; Zimmermann T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212758; Zimmermann T, 2010, PSYCHO-ONCOLOGY, V19, P1061, DOI 10.1002/pon.1660	60	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240619	10.1371/journal.pone.0240619	http://dx.doi.org/10.1371/journal.pone.0240619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3XB	33052971	Green Published, gold			2022-12-26	WOS:000581820200064
J	van Putten, S; O'Meara, C; Wartmann, F; Yager, J; Villette, J; Mazzuca, C; Bieling, C; Burenhult, N; Purves, R; Majid, A				van Putten, Saskia; O'Meara, Carolyn; Wartmann, Flurina; Yager, Joanne; Villette, Julia; Mazzuca, Claudia; Bieling, Claudia; Burenhult, Niclas; Purves, Ross; Majid, Asifa			Conceptualisations of landscape differ across European languages	PLOS ONE			English	Article							CATEGORY NORMS; AGE	Policies aimed at sustainable landscape management recognise the importance of multiple cultural viewpoints, but the notion of landscape itself is implicitly assumed to be homogeneous across speech communities. We tested this assumption by collecting data about the concept of "landscape" from speakers of seven languages of European origin. Speakers were asked to freely list exemplars to "landscape" (a concrete concept for which the underlying conceptual structure is unclear), "animals" (a concrete and discrete concept) and "body parts" (a concrete concept characterised by segmentation). We found, across languages, participants considered listing landscape terms the hardest task, listed fewest exemplars, had the least number of shared exemplars, and had fewer common co-occurrence pairs (i.e., pairs of exemplars listed adjacently). We also found important differences between languages in the types of exemplars that were cognitively salient and, most importantly, in how the exemplars are connected to each other in semantic networks. Overall, this shows that "landscape" is more weakly structured than other domains, with high variability both within and between languages. This diversity suggests that for sustainable landscape policies to be effective, they need to be better tailored to local conceptualisations.	[van Putten, Saskia] Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands; [O'Meara, Carolyn] Univ Nacl Autonoma Mexico, Philol Res Inst, Mexico City, DF, Mexico; [Wartmann, Flurina] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Yager, Joanne; Burenhult, Niclas] Lund Univ, Ctr Languages & Literature, Lund, Sweden; [Villette, Julia; Purves, Ross] Univ Zurich, Dept Geog, Zurich, Switzerland; [Mazzuca, Claudia; Majid, Asifa] Univ York, Dept Psychol, York, N Yorkshire, England; [Bieling, Claudia] Univ Hohenheim, Societal Transit & Agr, Stuttgart, Germany; [Burenhult, Niclas] Lund Univ, Humanities Lab, Lund, Sweden; [Purves, Ross] Univ Zurich, Univ Res Prior Programme Language & Space, Zurich, Switzerland	Radboud University Nijmegen; Universidad Nacional Autonoma de Mexico; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Lund University; University of Zurich; University of York - UK; University Hohenheim; Lund University; University of Zurich	van Putten, S (corresponding author), Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands.	s.vanputten@let.ru.nl	Wartmann, Flurina/AAJ-7760-2020; Majid, Asifa/A-7906-2008	Wartmann, Flurina/0000-0003-4788-2963; MAZZUCA, CLAUDIA/0000-0002-1568-2425; Majid, Asifa/0000-0003-0132-216X	Bank of Sweden Tercentenary Foundation Jubilee Initiative Grant [NHS14-1665:1]	Bank of Sweden Tercentenary Foundation Jubilee Initiative Grant	This work was funded by a Bank of Sweden Tercentenary Foundation Jubilee Initiative Grant (https://www.rj.se/en), grant ref. NHS14-1665:1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, RES METHODS ANTHR QU; [Anonymous], 2011, LANDSCAPE LANGUAGE T; Antrop M, 2019, ROUTL COMPANIONS, P1; Arivazhagan N, 2019, ARXIV190705019CS; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bolukbasi T, 2016, ADV NEUR IN, V29; Brysbaert M, 2014, BEHAV RES METHODS, V46, P904, DOI 10.3758/s13428-013-0403-5; Burenhult N, 2008, LANG SCI, V30, P135, DOI 10.1016/j.langsci.2006.12.028; Castilho S., 2019, P MACHINE TRANSLATIO, P179; Council of Europe, 2000, EUR TREAT SER; Crowe SJ, 2003, INT J BEHAV DEV, V27, P467, DOI 10.1080/01650250344000091; Fukuda-Parr S, 2019, GLOB POLICY, V10, P5, DOI 10.1111/1758-5899.12604; HENLEY NM, 1969, J VERB LEARN VERB BE, V8, P176, DOI 10.1016/S0022-5371(69)80058-7; Majid A, 2017, HDB MEREOLOGY; Malt BC, 2013, WIRES COGN SCI, V4, P583, DOI 10.1002/wcs.1251; Niles D, 2018, NAT SUSTAIN, V1, P540, DOI 10.1038/s41893-018-0124-y; Macias LP, 2020, OPEN LINGUIST, V6, P68, DOI 10.1515/opli-2020-0004; Prates MOR, 2020, NEURAL COMPUT APPL, V32, P6363, DOI 10.1007/s00521-019-04144-6; Robbins P, 2001, ENVIRON PLANN A, V33, P161, DOI 10.1068/a3379; Schrauf RW, 2008, J GERONTOL B-PSYCHOL, V63, pS385, DOI 10.1093/geronb/63.6.S385; Smith B, 2001, INT J GEOGR INF SCI, V15, P591, DOI 10.1080/13658810110061199; Smith JJ., 1997, J LINGUIST ANTHROPOL, V7, P208, DOI [10.1525/jlin.1997.7.2.208, DOI 10.1525/JLIN.1997.7.2.208]; Stanovsky G, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P1679; Sutrop Urmas, 2001, FIELD METHOD, V13, P263; van Zanten BT, 2016, P NATL ACAD SCI USA, V113, P12974, DOI 10.1073/pnas.1614158113; Vieira LN, 2021, INFORM COMMUN SOC, V24, P1515, DOI 10.1080/1369118X.2020.1776370; Wartmann FM, 2015, LECT NOTES COMPUT SC, V9368, P224, DOI 10.1007/978-3-319-23374-1_11; Wierzbicka A., 2014, IMPRISONED ENGLISH H; Yoon C, 2004, PSYCHOL AGING, V19, P379, DOI 10.1037/0882-7974.19.3.379; Zipf George, 1935, PSYCHOBIOLOGY LANGUA	32	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0239858	10.1371/journal.pone.0239858	http://dx.doi.org/10.1371/journal.pone.0239858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3XB	33052934	Green Published, Green Accepted, gold			2022-12-26	WOS:000581820200029
J	Barton, JC; Barton, JC; Bertoli, LF; Acton, RT				Barton, James C.; Barton, Jackson C.; Bertoli, Luigi F.; Acton, Ronald T.			Characterization of adult patients with IgG subclass deficiency and subnormal IgG2	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; LYMPHOCYTE SUBPOPULATIONS; IMMUNOGLOBULIN; INFECTIONS; ANTIBODIES; CHILDREN; POLYSACCHARIDE; ALABAMA	Background Adults with IgG subclass deficiency (IgGSD) with subnormal IgG2 are inadequately characterized. Methods We retrospectively analyzed observations in unrelated adults with IgGSD evaluated in a single hematology clinic (1991-2019) and selected those with subnormal serum IgG2 (<117 mg/dL (<1.2 g/L)) without corticosteroid therapy to describe: age; prevalence of women; upper/lower respiratory infection; autoimmune condition(s); atopy; other allergy; frequent or severe respiratory tract infection in first-degree relatives; IgG, IgG subclasses, IgA, and IgM; blood lymphocyte subpopulations; human leukocyte antigen (HLA)-A and -B types and haplotypes; and 23-valent pneumococcal polysaccharide vaccination (PPSV23) responses. We determined the prevalence of subnormal IgG2 among unrelated adults with IgGSD without corticosteroid therapy and compared general characteristics of those with and without subnormal IgG2. Results There were 18 patients (94.4% women) with subnormal IgG2. Mean age was 52 +/- 11 y. Upper/lower respiratory infection occurred in 94.4%/74.8%, respectively. Autoimmune condition(s), atopy, other allergy, and frequent or severe respiratory infection in first-degree relatives occurred in 44.4%, 44.4%, 61.1%, and 22.2%, respectively. Median IgG2 was 105 mg/dL (83, 116). Subnormal IgG, IgG1, IgG3, IgG4, IgA, and IgM was observed in 66.7%, 50.0%, 100.0%, 5.6%, 33.3%, and 0%, respectively. Lymphocyte subpopulations were normal in most patients. HLA frequencies were similar in patients and controls. Three of 4 patients had no protectiveS.pneumoniaeserotype-specific IgG levels before or after PPSV23. These 18 patients represent 7.6% of 236 adults with IgGSD. Prevalence of subnormal IgG, subnormal IgG3, and subnormal IgA was significantly greater in 18 adults with subnormal IgG2 than 218 adults without subnormal IgG2. Prevalence of subnormal IgM was significantly lower in patients with subnormal IgG2. Conclusions Characteristics of adults with IgGSD with subnormal IgG2 include female predominance, other immunologic abnormalities, subnormal IgG3 and/or IgG1, lack of HLA-A and -B association, and suboptimal PPSV23 response.	[Barton, James C.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Barton, James C.; Barton, Jackson C.; Acton, Ronald T.] Southern Iron Disorders Ctr, Birmingham, AL 35209 USA; [Barton, James C.; Bertoli, Luigi F.] Brookwood Med Ctr, Dept Med, Birmingham, AL 35211 USA; [Acton, Ronald T.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Barton, JC (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.; Barton, JC (corresponding author), Southern Iron Disorders Ctr, Birmingham, AL 35209 USA.; Barton, JC (corresponding author), Brookwood Med Ctr, Dept Med, Birmingham, AL 35211 USA.	bartonjames336@gmail.com		Barton, James/0000-0003-2876-8276; Barton, Jackson/0000-0002-2646-4466				Abinun A, 2019, ESID REGISTRY WORKIN, P1; Abrahamian F, 2010, CLIN EXP IMMUNOL, V159, P344, DOI 10.1111/j.1365-2249.2009.04062.x; ACTON RT, 1993, TRANSPLANT P, V25, P2404; Aghamohmmadi A., 2008, PREDOMINANTLY ANTIBO, P97, DOI DOI 10.1007/S10875-021-00980-1; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Apoil PA, 2017, CELL IMMUNOL, V314, P42, DOI 10.1016/j.cellimm.2017.02.001; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; AUCOUTURIER P, 1994, ANN BIOL CLIN-PARIS, V52, P53; BARRETT DJ, 1986, CLIN EXP IMMUNOL, V63, P127; Barton James C, 2003, BMC Med Genet, V4, P3, DOI 10.1186/1471-2350-4-3; Barton JC, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1405950; Barton JC, 2016, CELL IMMUNOL, V299, P50, DOI 10.1016/j.cellimm.2015.09.004; Barton JC, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/542706; Barton JC, 2003, BLOOD CELL MOL DIS, V31, P102, DOI 10.1016/S1079-9796(03)00116-5; Bartonid J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216940; Bonilla FA, 2008, IMMUNOL ALLERGY CLIN, V28, P803, DOI 10.1016/j.iac.2008.06.006; Bousfiha A, 2018, J CLIN IMMUNOL, V38, P129, DOI 10.1007/s10875-017-0465-8; BRACONIER JH, 1984, SCAND J INFECT DIS, V16, P407, DOI 10.3109/00365548409073969; CELINSKA E, 1976, Z IMMUNITATSFORSCH, V151, P455, DOI 10.1016/S0340-904X(76)80029-2; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Dine G, 2017, CLIN CASE REP, V5, P792, DOI 10.1002/ccr3.936; FRENCH MAH, 1984, CLIN EXP IMMUNOL, V56, P473; FRENCH MAH, 1995, CLIN EXP IMMUNOL, V100, P47; Guimaraes JT, 2020, BLOOD CELLS MOL DIS, P12345; Gupta S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01056; HAMMARSTROM L, 1983, CLIN EXP IMMUNOL, V51, P600; Hashira S, 2000, PEDIATR INT, V42, P337, DOI 10.1046/j.1442-200x.2000.01245.x; Khokar A, 2019, ARCH IMMUNOL THER EX, V67, P325, DOI 10.1007/s00005-019-00556-3; Kim JH, 2016, J KOREAN MED SCI, V31, P1560, DOI 10.3346/jkms.2016.31.10.1560; Kuijpers T W, 1992, Allergol Immunopathol (Madr), V20, P28; Lacombe C, 1997, CLIN IMMUNOL IMMUNOP, V84, P194, DOI 10.1006/clin.1997.4386; Latiff AHA, 2007, ANN CLIN BIOCHEM, V44, P131, DOI 10.1258/000456307780117993; LEFRANC G, 1983, EUR J IMMUNOL, V13, P240, DOI 10.1002/eji.1830130312; LEFRANC MP, 1982, NATURE, V300, P760, DOI 10.1038/300760a0; Lenexa, 1998, HLA 1998, P57; Lock RJ, 2003, ANN CLIN BIOCHEM, V40, P143, DOI 10.1258/000456303763046067; MADASSERY JV, 1988, CLIN CHEM, V34, P1407; NAHM MH, 1990, J ALLERGY CLIN IMMUN, V85, P769, DOI 10.1016/0091-6749(90)90197-C; Orange JS, 2012, J ALLERGY CLIN IMMUN, V130, pS1, DOI 10.1016/j.jaci.2012.07.002; Oxelius V A, 1986, Monogr Allergy, V20, P106; OXELIUS VA, 1981, NEW ENGL J MED, V304, P1476, DOI 10.1056/NEJM198106113042408; OXELIUS VA, 1974, CLIN EXP IMMUNOL, V17, P19; Parker Antony, 2017, J Immunoassay Immunochem, V38, P514, DOI 10.1080/15321819.2017.1340897; Parker AR, 2019, BMC IMMUNOL, V20, DOI 10.1186/s12865-019-0310-3; PFREUNDSCHUH M, 1980, Z RHEUMATOL, V39, P348; Schauer U, 2003, CLIN DIAGN LAB IMMUN, V10, P202, DOI 10.1128/CDLI.10.2.202-207.2003; Schauer U, 2003, CLIN CHEM, V49, P1924, DOI 10.1373/clinchem.2003.022350; Schroeder HW, 1998, MOL MED, V4, P72, DOI 10.1007/BF03401731; Schwartz RA, 2020, IMMUNOGLOBULIN G DEF; SHACKELFORD PG, 1986, J PEDIATR-US, V108, P647, DOI 10.1016/S0022-3476(86)81035-6; SIBER GR, 1980, NEW ENGL J MED, V303, P178, DOI 10.1056/NEJM198007243030402; Slade CA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00694; SODERSTROM T, 1987, INT ARCH ALLER A IMM, V82, P476, DOI 10.1159/000234258; STANLEY PJ, 1984, CLIN EXP IMMUNOL, V58, P703; Stapleton NM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40731-2; Tashita H, 1998, J CLIN INVEST, V101, P677, DOI 10.1172/JCI1672; URBANIAK SJ, 1973, CLIN EXP IMMUNOL, V15, P345; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x	59	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240522	10.1371/journal.pone.0240522	http://dx.doi.org/10.1371/journal.pone.0240522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048985	Green Published, gold			2022-12-26	WOS:000581813300020
J	Danes, JM; de Abreu, ALP; Kerketta, R; Huang, YP; Palma, FR; Gantner, BN; Mathison, AJ; Urrutia, RA; Bonini, MG				Danes, Jeanne M.; de Abreu, Andre L. P.; Kerketta, Romica; Huang, Yunping; Palma, Flavio R.; Gantner, Benjamin N.; Mathison, Angela J.; Urrutia, Raul A.; Bonini, Marcelo G.			Inorganic arsenic promotes luminal to basal transition and metastasis of breast cancer	FASEB JOURNAL			English	Article						arsenic; breast cancer; environmental exposures; estrogen receptor	ESTROGEN-RECEPTOR-ALPHA; EXPRESSION; DATABASE	Inorganic arsenic (iAs/As2O32-) is an environmental toxicant found in watersheds around the world including in densely populated areas. iAs is a class I carcinogen known to target the skin, lungs, bladder, and digestive organs, but its role as a primary breast carcinogen remains controversial. Here, we examined a different possibility: that exposure to iAs promotes the transition of well-differentiated epithelial breast cancer cells characterized by estrogen and progesterone receptor expression (ER+/PR+), to more basal phenotypes characterized by active proliferation, and propensity to metastasis in vivo. Our results indicate two clear phenotypic responses to low-level iAs that depend on the duration of the exposure. Short-term pulses of iAs activate ER signaling, consistent with its reported pseudo-estrogen activity, but longer-term, chronic treatments for over 6 months suppresses both ER and PR expression and signaling. In fact, washout of these chronically exposed cells for up to 1 month failed to fully reverse the transcriptional and phenotypic effects of prolonged treatments, indicating durable changes in cellular physiologic identity. RNA-seq studies found that chronic iAs drives the transition toward more basal phenotypes characterized by impaired hormone receptor signaling despite the conservation of estrogen receptor expression. Because treatments for breast cancer patients are largely designed based on the detection of hormone receptor expression, our results suggest greater scrutiny of ER+ cancers in patients exposed to iAs, because these tumors may spawn more aggressive phenotypes than unexposed ER+ tumors, in particular, basal subtypes that tend to develop therapy resistance and metastasis.	[Danes, Jeanne M.; Huang, Yunping; Palma, Flavio R.; Bonini, Marcelo G.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Med,Div Hematol Oncol, 303 E Super St,Suite 7-123, Chicago, IL 60611 USA; [de Abreu, Andre L. P.] Univ Illinois, Dept Med, Chicago, IL USA; [Kerketta, Romica; Mathison, Angela J.; Urrutia, Raul A.] Med Coll Wisconsin, Dept Surg, Gen Sci & Precis Med Ctr GSPMC, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Gantner, Benjamin N.] Med Coll Wisconsin, Dept Med, Div Endocrinol, Milwaukee, WI 53226 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical College of Wisconsin; Medical College of Wisconsin	Bonini, MG (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Med,Div Hematol Oncol, 303 E Super St,Suite 7-123, Chicago, IL 60611 USA.	marcelo.bonini@northwestern.edu		Palma, Flavio/0000-0003-4350-2708	HHS | NIH | National Cancer Institute (NCI) [RO1CA216882]; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [RO1ES028149]; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [RO1AI131267]; Advancing a Healthier Wisconsin Endowment; DOD | United States Army | RDECOM | Army Research Office (ARO) [71138LS]	HHS | NIH | National Cancer Institute (NCI); HHS | NIH | National Institute of Environmental Health Sciences (NIEHS); HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID); Advancing a Healthier Wisconsin Endowment; DOD | United States Army | RDECOM | Army Research Office (ARO)	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: RO1CA216882; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: RO1ES028149; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: RO1AI131267; Advancing a Healthier Wisconsin Endowment; DOD | United States Army | RDECOM | Army Research Office (ARO), Grant/Award Number: 71138LS	Al-Eryani L, 2018, TOXICOL SCI, V162, P645, DOI 10.1093/toxsci/kfx292; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Cardoso APF, 2018, TOXICOL SCI, V165, P284, DOI 10.1093/toxsci/kfy128; Carlin DJ, 2016, ENVIRON HEALTH PERSP, V124, P890, DOI 10.1289/ehp.1510209; Chatterjee K, 2018, SOUTH ASIAN J CANCER, V7, P5, DOI 10.4103/sajc.sajc_60_17; Chen GC, 2002, ANTICANCER RES, V22, P633; Davey JC, 2007, TOXICOL SCI, V98, P75, DOI 10.1093/toxsci/kfm013; Garcia-Esquinas E, 2013, CANCER EPIDEM BIOMAR, V22, P1944, DOI 10.1158/1055-9965.EPI-13-0234-T; Gupta PB, 2019, CELL STEM CELL, V24, P65, DOI 10.1016/j.stem.2018.11.011; Hart PC, 2016, ONCOTARGET, V7, P308, DOI 10.18632/oncotarget.5687; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Khanjani N, 2017, REV ENVIRON HEALTH, V32, P267, DOI 10.1515/reveh-2016-0068; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lopez-Carrillo L, 2020, ENVIRON RES, V184, DOI 10.1016/j.envres.2020.109361; Luo M, 2015, CURR PHARM DESIGN, V21, P1301, DOI 10.2174/1381612821666141211120604; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Rahman M, 2015, Gulf J Oncolog, V1, P34; Ruiz-Ramos R, 2009, TOXICOL APPL PHARM, V241, P269, DOI 10.1016/j.taap.2009.09.006; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Selmin OI, 2019, INT J ONCOL, V54, P869, DOI 10.3892/ijo.2019.4687; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stoica A, 2000, ENDOCRINOLOGY, V141, P3595, DOI 10.1210/en.141.10.3595; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tang BW, 2015, STEM CELL REP, V4, P155, DOI 10.1016/j.stemcr.2014.11.002; Telli ML, 2011, BREAST CANCER RES TR, V127, P471, DOI 10.1007/s10549-010-1173-8; Xie H, 2014, MUTAT RES-GEN TOX EN, V760, P33, DOI 10.1016/j.mrgentox.2013.11.001; Xu Y, 2014, ARCH TOXICOL, V88, P263, DOI 10.1007/s00204-013-1131-4; Zhang YX, 2019, CHEM-BIOL INTERACT, V310, DOI 10.1016/j.cbi.2019.06.032; Zimmermann MT, 2019, PEERJ, V7, DOI 10.7717/peerj.6994	30	5	5	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16034	16048		10.1096/fj.202001192R	http://dx.doi.org/10.1096/fj.202001192R		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047385	Green Accepted			2022-12-26	WOS:000581167800001
J	Patterson, L; Allen, J; Posey, I; Shaw, JJP; Costa-Pinheiro, P; Walker, SJ; Gademsey, A; Wu, XN; Wu, SG; Zachos, NC; Fox, TE; Sears, CL; Kester, M				Patterson, Logan; Allen, Jawara; Posey, Isabella; Shaw, Jeremy Joseph Porter; Costa-Pinheiro, Pedro; Walker, Susan J.; Gademsey, Alexis; Wu, Xinqun; Wu, Shaoguang; Zachos, Nicholas C.; Fox, Todd E.; Sears, Cynthia L.; Kester, Mark			Glucosylceramide production maintains colon integrity in response toBacteroides fragilistoxin-induced colon epithelial cell signaling	FASEB JOURNAL			English	Article						Bacteroides fragilistoxin; glucosylceramides; organoids; permeability; tight junctions	ENTEROTOXIGENIC BACTEROIDES-FRAGILIS; SPHINGOLIPID METABOLISM; TIGHT JUNCTIONS; INTESTINAL PHYSIOLOGY; HUMAN COMMENSAL; CANCER-CELLS; MODEL; ADHERENS; COLITIS; GLYCOSPHINGOLIPIDS	EnterotoxigenicBacteroides fragilis(ETBF) is a commensal bacterium of great importance to human health due to its ability to induce colitis and cause colon tumor formation in mice through the production ofB. fragilistoxin (BFT). The formation of tumors is dependent on a pro-inflammatory signaling cascade, which begins with the disruption of epithelial barrier integrity through cleavage of E-cadherin. Here, we show that BFT increases levels of glucosylceramide, a vital intestinal sphingolipid, both in mice and in colon organoids (colonoids) generated from the distal colons of mice. When colonoids are treated with BFT in the presence of an inhibitor of glucosylceramide synthase (GCS), the enzyme responsible for generating glucosylceramide, colonoids become highly permeable, lose structural integrity, and eventually burst, releasing their contents into the extracellular matrix. By increasing glucosylceramide levels in colonoids via an inhibitor of glucocerebrosidase (GBA, the enzyme that degrades glucosylceramide), colonoid permeability was reduced, and bursting was significantly decreased. In the presence of BFT, pharmacological inhibition of GCS caused levels of tight junction protein 1 (TJP1) to decrease. However, when GBA was inhibited, TJP1 levels remained stable, suggesting that BFT-induced production of glucosylceramide helps to stabilize tight junctions. Taken together, our data demonstrate a glucosylceramide-dependent mechanism by which the colon epithelium responds to BFT.	[Patterson, Logan; Shaw, Jeremy Joseph Porter; Costa-Pinheiro, Pedro] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Allen, Jawara; Wu, Xinqun; Wu, Shaoguang; Zachos, Nicholas C.; Sears, Cynthia L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Posey, Isabella] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Walker, Susan J.; Gademsey, Alexis; Fox, Todd E.; Kester, Mark] Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave,Pinn Hall,POB 800735, Charlottesville, VA 22908 USA	University of Virginia; Johns Hopkins University; University of Virginia; University of Virginia	Kester, M (corresponding author), Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave,Pinn Hall,POB 800735, Charlottesville, VA 22908 USA.	mkester@virginia.edu	Kester, Mark/ABG-4615-2020; Zachos, Nicholas/GWC-7914-2022	Patterson, Logan/0000-0002-4825-0565; Allen, Jawara/0000-0002-6274-0499	Bloomberg Philanthropies; Integrated Physiology and Imaging Cores of the Hopkins Conte Digestive Disease Basic and Translational Research Core Center [NIH DK-089502, S10 OD025244]	Bloomberg Philanthropies; Integrated Physiology and Imaging Cores of the Hopkins Conte Digestive Disease Basic and Translational Research Core Center	This work was supported by Bloomberg Philanthropies (to CLS). The authors also wish to acknowledge the Integrated Physiology and Imaging Cores of the Hopkins Conte Digestive Disease Basic and Translational Research Core Center (NIH DK-089502) for providing growth factor conditioned media for colonoids and use of Olympus FV3000RS confocal microscope (S10 OD025244).	Allen J, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00447-18; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; An DD, 2011, P NATL ACAD SCI USA, V108, P4666, DOI 10.1073/pnas.1001501107; Ando-Akatsuka Y, 1999, J CELL PHYSIOL, V179, P115, DOI 10.1002/(SICI)1097-4652(199905)179:2<115::AID-JCP1>3.0.CO;2-T; Arai K, 2015, J OLEO SCI, V64, P737, DOI 10.5650/jos.ess15005; Beckham TH, 2013, ADV CANCER RES, V117, P1, DOI 10.1016/B978-0-12-394274-6.00001-7; Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Campbell HK, 2017, EXP CELL RES, V358, P39, DOI 10.1016/j.yexcr.2017.03.061; Chambers FG, 1997, INFECT IMMUN, V65, P3561, DOI 10.1128/IAI.65.9.3561-3570.1997; Chan JL, 2019, MUCOSAL IMMUNOL, V12, P164, DOI 10.1038/s41385-018-0085-5; Chung L, 2018, CELL HOST MICROBE, V23, P203, DOI [10.1016/j.chom.2018.01.007, 10.1016/j.chom.2018.02.004]; Co JY, 2019, CELL REP, V26, P2509, DOI 10.1016/j.celrep.2019.01.108; Daniotti JL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00306; Deng ZB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7956; Duan RD, 2009, PROG LIPID RES, V48, P62, DOI 10.1016/j.plipres.2008.04.003; Franco AA, 2005, INFECT IMMUN, V73, P5273, DOI 10.1128/IAI.73.8.5273-5277.2005; Franco AA, 2002, MOL MICROBIOL, V45, P1067, DOI 10.1046/j.1365-2958.2002.03077.x; Garcia-Barros M, 2014, BBA-MOL CELL BIOL L, V1841, P773, DOI 10.1016/j.bbalip.2013.09.007; Gouaze V, 2004, MOL CANCER THER, V3, P633; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hadi LA, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3827684; Hakomori S, 1998, GLYCOBIOLOGY, V8, pXI; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Heaver SL, 2018, CURR OPIN MICROBIOL, V43, P92, DOI 10.1016/j.mib.2017.12.011; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Housseau F, 2010, CELL CYCLE, V9, P3, DOI 10.4161/cc.9.1.10352; Ichikawa S, 1998, TRENDS CELL BIOL, V8, P198, DOI 10.1016/S0962-8924(98)01249-5; In J, 2016, CELL MOL GASTROENTER, V2, P48, DOI 10.1016/j.jcmgh.2015.10.001; In JG, 2019, JOVE-J VIS EXP, DOI 10.3791/59357; In JG, 2016, NAT REV GASTRO HEPAT, V13, P633, DOI 10.1038/nrgastro.2016.142; Itier JM, 2014, J INHERIT METAB DIS, V37, P1013, DOI 10.1007/s10545-014-9724-5; Jennemann R, 2012, J BIOL CHEM, V287, P32598, DOI 10.1074/jbc.M112.371005; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Landy J, 2016, WORLD J GASTROENTERO, V22, P3117, DOI 10.3748/wjg.v22.i11.3117; Liu LX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67104-4; Machala M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236051; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Morjani H, 2001, INT J CANCER, V94, P157, DOI 10.1002/ijc.1449; MYERS LL, 1987, AM J VET RES, V48, P774; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Pearson JM, 2020, MOL CANCER RES, V18, P352, DOI 10.1158/1541-7786.MCR-19-0619; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schnaar RL, 2017, ESSENTIALS GLYCOBIOL, V3rd, P2015, DOI 10.1101/glycobiology.3e.011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sears CL, 2001, TOXICON, V39, P1737, DOI 10.1016/S0041-0101(01)00160-X; Shayman JA, 2006, SPHINGOLIPID BIOL, P83, DOI DOI 10.1007/2F4-431-34200-1_6; Vardi A, 2016, J PATHOL, V239, P496, DOI 10.1002/path.4751; von Gerichten J, 2017, J LIPID RES, V58, P1247, DOI 10.1194/jlr.D076190; Wells CL, 1996, GASTROENTEROLOGY, V110, P1429, DOI 10.1053/gast.1996.v110.pm8613048; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2002, INFECT IMMUN, V70, P2463, DOI 10.1128/IAI.70.5.2463-2471.2002; Wu SG, 2006, INFECT IMMUN, V74, P5382, DOI 10.1128/IAI.00060-06; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Zachos NC, 2016, J BIOL CHEM, V291, P3759, DOI 10.1074/jbc.R114.635995; Zigmond E, 2007, GUT, V56, P82, DOI 10.1136/gut.2006.095497; Zschiebsch K, 2016, J CROHNS COLITIS, V10, P965, DOI 10.1093/ecco-jcc/jjw056	63	12	12	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15922	15945		10.1096/fj.202001669R	http://dx.doi.org/10.1096/fj.202001669R		OCT 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047400	Green Accepted			2022-12-26	WOS:000581170800001
J	Xu, XH; Zhang, CK				Xu, Xinghan; Zhang, Chengkun			Estimation of ground-level PM(2.5)concentration using MODIS AOD and corrected regression model over Beijing, China	PLOS ONE			English	Article							AEROSOL OPTICAL DEPTH; PARTICULATE MATTER PM2.5; AIR-POLLUTION; THICKNESS	To establish a new model for estimating ground-level PM(2.5)concentration over Beijing, China, the relationship between aerosol optical depth (AOD) and ground-level PM(2.5)concentration was derived and analysed firstly. Boundary layer height (BLH) and relative humidity (RH) were shown to be two major factors influencing the relationship between AOD and ground-level PM(2.5)concentration. Thus, they are used to correct MODIS AOD to enhance the correlation between MODIS AOD and PM2.5. When using corrected MODIS AOD for modelling, the correlation between MODIS AOD and PM(2.5)was improved significantly. Then, normalized difference vegetation index (NDVI), surface temperature (ST) and surface wind speed (SPD) were introduced as auxiliary variables to further improve the performance of the corrected regression model. The seasonal and annual average distribution of PM(2.5)concentration over Beijing from 2014 to 2016 were mapped for intuitively analysing. Those can be regarded as important references for monitoring the ground-level PM(2.5)concentration distribution. It is obviously that the PM(2.5)concentration distribution over Beijing revealed the trend of "southeast high and northwest low", and showed a significant decrease in annual average PM(2.5)concentration from 2014 to 2016.	[Xu, Xinghan] Kyoto Univ, Dept Environm Engn, Kyoto, Japan; [Zhang, Chengkun] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Peoples R China	Kyoto University; Dalian University of Technology	Zhang, CK (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Peoples R China.	zhangchengkundon@mail.dlut.edu.cn						Bilal M, 2017, IEEE J-STARS, V10, P3448, DOI 10.1109/JSTARS.2017.2693289; Butt MJ, 2017, ENVIRON POLLUT, V231, P143, DOI 10.1016/j.envpol.2017.07.104; Dabass A, 2018, ENVIRON RES, V161, P485, DOI 10.1016/j.envres.2017.11.042; Eck TF, 2018, J GEOPHYS RES-ATMOS, V123, P5560, DOI 10.1029/2018JD028313; Geng GN, 2015, REMOTE SENS ENVIRON, V166, P262, DOI 10.1016/j.rse.2015.05.016; GRIGGS M, 1975, JAPCA J AIR WASTE MA, V25, P622, DOI 10.1080/00022470.1975.10470118; Guo YJ, 2014, INT J REMOTE SENS, V35, P6522, DOI 10.1080/01431161.2014.958245; Guo YX, 2017, REMOTE SENS ENVIRON, V198, P140, DOI 10.1016/j.rse.2017.06.001; Hoff RM, 2009, J AIR WASTE MANAGE, V59, P645, DOI 10.3155/1047-3289.59.6.645; Huang TH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201364; Koelemeijer RBA, 2006, ATMOS ENVIRON, V40, P5304, DOI 10.1016/j.atmosenv.2006.04.044; Lee HJ, 2011, ATMOS CHEM PHYS, V11, P7991, DOI 10.5194/acp-11-7991-2011; Li XM, 2019, ENVIRON POLLUT, V246, P972, DOI 10.1016/j.envpol.2018.12.083; Lin CQ, 2015, REMOTE SENS ENVIRON, V156, P117, DOI 10.1016/j.rse.2014.09.015; Ma ZW, 2014, ENVIRON SCI TECHNOL, V48, P7436, DOI 10.1021/es5009399; Schafer K, 2008, ATMOS ENVIRON, V42, P4036, DOI 10.1016/j.atmosenv.2008.01.060; Tai APK, 2010, ATMOS ENVIRON, V44, P3976, DOI 10.1016/j.atmosenv.2010.06.060; Tsai TC, 2011, ATMOS ENVIRON, V45, P4777, DOI 10.1016/j.atmosenv.2009.10.006; Wang QX, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19051207; Wang W, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9080858; Wei J, 2019, ATMOS ENVIRON, V201, P428, DOI 10.1016/j.atmosenv.2018.12.004; Xie YY, 2015, ENVIRON SCI TECHNOL, V49, P12280, DOI 10.1021/acs.est.5b01413; Xin JY, 2014, ATMOS RES, V138, P179, DOI 10.1016/j.atmosres.2013.11.001; You W, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030184; You W, 2015, SCI TOTAL ENVIRON, V505, P1156, DOI 10.1016/j.scitotenv.2014.11.024; Zhang Q, 2019, P NATL ACAD SCI USA, V116, P24463, DOI 10.1073/pnas.1907956116; Zhang XY, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9090908; Zhao R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201011; Zheng YX, 2016, ATMOS ENVIRON, V124, P232, DOI 10.1016/j.atmosenv.2015.06.046	29	7	7	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240430	10.1371/journal.pone.0240430	http://dx.doi.org/10.1371/journal.pone.0240430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048987	gold, Green Published			2022-12-26	WOS:000581813300009
J	Bruk, LA; Dunkelberger, KE; Khampang, P; Hong, WZ; Sadagopan, S; Alper, CM; Fedorchak, MV				Bruk, Liza A.; Dunkelberger, Katherine E.; Khampang, Pawjai; Hong, Wenzhou; Sadagopan, Srivatsun; Alper, Cuneyt M.; Fedorchak, Morgan V.			Controlled release of ciprofloxacin and ceftriaxone from a single ototopical administration of antibiotic-loaded polymer microspheres and thermoresponsive gel	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; 3-DAY INTRAMUSCULAR CEFTRIAXONE; IN-VITRO; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; DRUG-DELIVERY; ANTIMICROBIAL AGENTS; CLINICAL-EFFICACY; HEARING-LOSS; SUSCEPTIBILITIES	Acute otitis media (AOM) is the main indication for pediatric antibiotic prescriptions, accounting for 25% of prescriptions. While the use of topical drops can minimize the administered dose of antibiotic and adverse systemic effects compared to oral antibiotics, their use has limitations, partially due to low patient compliance, high dosing frequency, and difficulty of administration. Lack of proper treatment can lead to development of chronic OM, which may require invasive interventions. Previous studies have shown that gel-based drug delivery to the ear is possible with intratympanic injection or chemical permeation enhancers (CPEs). However, many patients are reluctant to accept invasive treatments and CPEs have demonstrated toxicity to the tympanic membrane (TM). We developed a novel method of delivering therapeutics to the TM and middle ear using a topical, thermoresponsive gel depot containing antibiotic-loaded poly(lactic-co-glycolic acid) microspheres. Ourin vitroandex vivoresults suggest that the sustained presentation can safely allow therapeutically relevant drug concentrations to penetrate the TM to the middle ear for up to 14 days. Animal results indicate sufficient antibiotic released for treatment from topical administration 24h after bacterial inoculation. However, animals treated 72h after inoculation, a more clinically relevant treatment practice, displayed spontaneous clearance of infection as is also often observed in the clinic. Despite this variability in the disease model, data suggest the system can safely treat bacterial infection, with future studies necessary to optimize microsphere formulations for scaled up dosage of antibiotic as well as further investigation of the influence of spontaneous bacterial clearance and of biofilm formation on effectiveness of treatment. To our knowledge, this study represents the first truly topical drug delivery system to the middle ear without the use of CPEs.	[Bruk, Liza A.; Dunkelberger, Katherine E.; Sadagopan, Srivatsun; Fedorchak, Morgan V.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Khampang, Pawjai; Hong, Wenzhou] Med Coll Wisconsin, Dept Otolaryngol & Commun Sci, Milwaukee, WI 53226 USA; [Sadagopan, Srivatsun] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Alper, Cuneyt M.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Alper, Cuneyt M.] UPMC Childrens Hosp Pittsburgh, Div Pediat Otolaryngol, Pittsburgh, PA 15224 USA; [Alper, Cuneyt M.; Fedorchak, Morgan V.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA; [Fedorchak, Morgan V.] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Fedorchak, Morgan V.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical College of Wisconsin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fedorchak, MV (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Fedorchak, MV (corresponding author), Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA.; Fedorchak, MV (corresponding author), Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA.; Fedorchak, MV (corresponding author), Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.	fedorchak@pitt.edu		Bruk, Liza/0000-0003-1202-1629	University of Pittsburgh Center for Medical Innovation; Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness; NIH [CORE P30 EY008098]	University of Pittsburgh Center for Medical Innovation; Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding to MVF from the University of Pittsburgh Center for Medical Innovation (https://www.engineering.pitt.edu/cmi/), the Eye and Ear Foundation of Pittsburgh (https://eyeandear.org/), an unrestricted grant from Research to Prevent Blindness (https://www.rpbusa.org/rpb/), and NIH CORE P30 EY008098 (https://www.nei.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS AM, 1994, CLIN OTOLARYNGOL, V19, P138, DOI 10.1111/j.1365-2273.1994.tb01198.x; Ahn JY, 2008, CLIN EXP OTORHINOLAR, V1, P139, DOI 10.3342/ceo.2008.1.3.139; Al-mahallawi AM, 2014, INT J PHARMACEUT, V472, P304, DOI 10.1016/j.ijpharm.2014.06.041; Albuquerque Agnes Afrodite Sumarelli, 2009, Rev. Bras. Otorrinolaringol., V75, P43, DOI 10.1590/S0034-72992009000100007; Amali Amin, 2017, Electron Physician, V9, P3823, DOI 10.19082/3823; [Anonymous], 2018, LANCET PUBLIC HEALTH, V3, pE153, DOI 10.1016/S2468-2667(18)30053-7; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 1987, CETR; [Anonymous], 2018, OECD GUIDELINES TEST; Bakaletz LO, 2007, PEDIATR INFECT DIS J, V26, pS17, DOI 10.1097/INF.0b013e318154b273; Belfield K, 2015, INT J PEDIATR OTORHI, V79, P296, DOI 10.1016/j.ijporl.2015.01.003; Bluestone CD, 1998, INT J PEDIATR OTORHI, V42, P207, DOI 10.1016/S0165-5876(97)00147-X; Bolt P, 2008, ARCH DIS CHILD, V93, P40, DOI 10.1136/adc.2006.110429; Cohen R, 1999, PEDIATR INFECT DIS J, V18, P403, DOI 10.1097/00006454-199905000-00002; da Costa SS, 2009, EUR ARCH OTO-RHINO-L, V266, P221, DOI 10.1007/s00405-008-0739-0; Daniel M, 2012, ARCH OTOLARYNGOL, V138, P942, DOI 10.1001/archotol.2013.238; England RJA, 2000, J LARYNGOL OTOL, V114, P24, DOI 10.1258/0022215001903834; Fedorchak MV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09379-8; Fedorchak MV, 2014, EXP EYE RES, V125, P210, DOI 10.1016/j.exer.2014.06.013; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Fradis M, 1997, ARCH OTOLARYNGOL, V123, P1057; Furue M, 2015, BRIT J DERMATOL, V172, P272, DOI 10.1111/bjd.13377; Gan CW, 2013, LARYNGOSCOPE, V123, P1770, DOI 10.1002/lary.23895; Gates GA, 2001, PEDIATR INFECT DIS J, V20, P104, DOI 10.1097/00006454-200101000-00038; Gates GA, 1996, OTOLARYNG HEAD NECK, V114, P525, DOI 10.1016/S0194-5998(96)70243-7; Gehanno P, 1999, ANTIMICROB AGENTS CH, V43, P16, DOI 10.1128/AAC.43.1.16; Gimeno M, 2015, EUR J PHARM BIOPHARM, V96, P264, DOI 10.1016/j.ejpb.2015.08.007; Gray RF, 2005, CLIN OTOLARYNGOL, V30, P105, DOI 10.1111/j.1365-2273.2004.00950.x; GREEN SM, 1993, PEDIATRICS, V91, P23; Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027; Hoberman A, 2016, NEW ENGL J MED, V375, P2446, DOI 10.1056/NEJMoa1606043; Hong WZ, 2007, INFECT IMMUN, V75, P958, DOI 10.1128/IAI.01691-06; Hong WZ, 2019, INT J PEDIATR OTORHI, V125, P134, DOI 10.1016/j.ijporl.2019.07.002; Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937; Jang CH, 2003, INT J PEDIATR OTORHI, V67, P313, DOI 10.1016/S0165-5876(03)00033-8; Jensen RG, 2013, INT J PEDIATR OTORHI, V77, P1530, DOI 10.1016/j.ijporl.2013.06.025; Karande P, 2005, P NATL ACAD SCI USA, V102, P4688, DOI 10.1073/pnas.0501176102; Khoo XJ, 2013, BIOMATERIALS, V34, P1281, DOI 10.1016/j.biomaterials.2012.10.025; Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025; Kundu B, 2010, PHARM RES-DORDR, V27, P1659, DOI 10.1007/s11095-010-0166-y; Kurabi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30031-6; Kurabi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22663; Leibovitz E, 2000, PEDIATR INFECT DIS J, V19, P1040, DOI 10.1097/00006454-200011000-00003; Leibovitz E, 1998, PEDIATR INFECT DIS J, V17, P1126, DOI 10.1097/00006454-199812000-00005; Li WJ, 2015, BIOMED REP, V3, P617, DOI 10.3892/br.2015.481; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Lim D. J., 1995, Acta Oto-Rhino-Laryngologica Belgica, V49, P101; Mair EA, 2016, ANN OTO RHINOL LARYN, V125, P105, DOI 10.1177/0003489415599001; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mammen A, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.6.12; Minovi Amir, 2014, GMS Curr Top Otorhinolaryngol Head Neck Surg, V13, pDoc11, DOI 10.3205/cto000114; Mittal R, 2014, INT J INFECT DIS, V29, P259, DOI 10.1016/j.ijid.2014.10.015; Mujica-Mota MA, 2015, LARYNGOSCOPE, V125, P1444, DOI 10.1002/lary.25080; Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014; Nwokoye NN, 2015, J LARYNGOL OTOL, V129, P779, DOI 10.1017/S0022215115001127; Onusko E, 2004, AM FAM PHYSICIAN, V70, P1713; Pacifici GM, 2017, INT J PEDIATR-MASSHA, V5, P6383, DOI 10.22038/ijp.2017.26942.2320; Pichichero ME, 2013, PEDIATR CLIN N AM, V60, P391, DOI 10.1016/j.pcl.2012.12.007; Piu F, 2011, OTOL NEUROTOL, V32, P171, DOI 10.1097/MAO.0b013e3182009d29; Pollock JF, 2010, ACTA BIOMATER, V6, P1307, DOI 10.1016/j.actbio.2009.11.027; Prasad S, 2008, J FAM PRACTICE, V57, P370; Rothstein SN, 2011, J MATER CHEM, V21, P29, DOI 10.1039/c0jm01668c; Samarei R, 2014, Glob J Health Sci, V6, P144, DOI 10.5539/gjhs.v6n7p144; SHANKS JE, 1981, J SPEECH HEAR RES, V24, P557, DOI 10.1044/jshr.2404.557; Siegel RM, 2010, PEDIATRICS, V125, P384, DOI 10.1542/peds.2009-3208; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Thornsberry C, 1999, ANTIMICROB AGENTS CH, V43, P2612, DOI 10.1128/AAC.43.11.2612; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Wang XB, 2014, OTOL NEUROTOL, V35, P459, DOI 10.1097/MAO.0000000000000261; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wilson SL, 2015, TOXICOLOGY, V327, P32, DOI 10.1016/j.tox.2014.11.003; Yang R, 2019, MOL PHARMACEUT, V16, P1555, DOI 10.1021/acs.molpharmaceut.8b01235; Yang R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4363; Yokell Z, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4030410	74	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240535	10.1371/journal.pone.0240535	http://dx.doi.org/10.1371/journal.pone.0240535			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045028	Green Published, gold			2022-12-26	WOS:000581811700041
J	Carrillo-Larco, RM; Bennett, JE; Di Cesare, M; Gregg, EW; Bernabe-Ortiz, A				Carrillo-Larco, Rodrigo M.; Bennett, James E.; Di Cesare, Mariachiara; Gregg, Edward W.; Bernabe-Ortiz, Antonio			The contribution of specific non-communicable diseases to the achievement of the Sustainable Development Goal 3.4 in Peru	PLOS ONE			English	Article								Background Non-communicable diseases (NCDs) have received political attention and commitment, yet surveillance is needed to measure progress and set priorities. Building on global estimates suggesting that Peru is not on target to meet the Sustainable Development Goal 3.4, we estimated the contribution of various NCDs to the change in unconditional probability of dying from NCDs in 25 regions in Peru. Methods Using national death registries and census data, we estimated the unconditional probability of dying between ages 30 and 69 from any and from each of the following NCDs: cardiovascular, cancer, diabetes, chronic respiratory diseases and chronic kidney disease. We estimated the contribution of each NCD to the change in the unconditional probability of dying from any of these NCDs between 2006 and 2016. Results The overall unconditional probability of dying improved for men (21.4%) and women (23.3%). Cancer accounted for 10.9% in men and 13.7% in women of the overall reduction; cardiovascular diseases also contributed substantially: 11.3% in men) and 9.8% in women. Consistently in men and women and across regions, diabetes moved in the opposite direction of the overall reduction in the unconditional probability of dying from any selected NCD. Diabetes contributed a rise in the unconditional probability of 3.6% in men and 2.1% in women. Conclusions Although the unconditional probability of dying from any selected NCD has decreased, diabetes would prevent Peru from meeting international targets. Policies are needed to prevent diabetes and to strengthen healthcare to avoid diabetes-related complications and delay mortality.	[Carrillo-Larco, Rodrigo M.; Bennett, James E.; Gregg, Edward W.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Carrillo-Larco, Rodrigo M.; Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, CRON Ctr Excellence Chron Dis, Lima, Peru; [Di Cesare, Mariachiara] Middlesex Univ, London, England; [Bernabe-Ortiz, Antonio] Univ Cient Sur, Lima, Peru	Imperial College London; Universidad Peruana Cayetano Heredia; Middlesex University; Universidad Cientifica del Sur (CIENTIFICA)	Carrillo-Larco, RM (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.; Carrillo-Larco, RM (corresponding author), Univ Peruana Cayetano Heredia, CRON Ctr Excellence Chron Dis, Lima, Peru.	rcarrill@ic.ac.uk		Bernabe-Ortiz, Antonio/0000-0002-6834-1376; Gregg, Edward/0000-0003-2381-6822	Wellcome Trust-Imperial College Centre for Global Health Research [100693/Z/12/Z]; Imperial College London Wellcome Trust [294834/Z/16/Z ISSF ICL]; Wellcome Trust International Training Fellowship [214185/Z/18/Z]	Wellcome Trust-Imperial College Centre for Global Health Research; Imperial College London Wellcome Trust; Wellcome Trust International Training Fellowship	Rodrigo M. Carrillo-Larco has been supported by Strategic Award, Wellcome Trust-Imperial College Centre for Global Health Research (100693/Z/12/Z), and Imperial College London Wellcome Trust Institutional Strategic Support Fund [Global Health Clinical Research Training Fellowship] (294834/Z/16/Z ISSF ICL). Rodrigo M Carrillo-Larco is supported by a Wellcome Trust International Training Fellowship (214185/Z/18/Z).	2018 Clinical Practice Guidelines Committees, 2018, CAN J DIABETES S1, V42, pS1; Álvarez-Dongo Doris, 2012, Rev. perú. med. exp. salud publica, V29, P303; anamerican Health Organization (PAHO), NCD GLOB MON FRAM IN; [Anonymous], 2017, INT J MOL SCI, V18, pE961; [Anonymous], CENS NAC 2007 11 POB; [Anonymous], PER EST PROYECC POBL; [Anonymous], CENS NAC 2017 12 POB; [Anonymous], 2017, INT J MOL SCI, V18, pE961; [Anonymous], 2003, J S I METALLURGY, V24, P1; Bennett JE, 2020, LANCET, V396, P918, DOI 10.1016/S0140-6736(20)31761-X; Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5; Bennett JE, 2015, LANCET, V386, P163, DOI 10.1016/S0140-6736(15)60296-3; Bernabe-Ortiz A, 2016, DIABETES RES CLIN PR, V121, P135, DOI 10.1016/j.diabres.2016.09.007; Bixby H, 2019, NATURE, V569, P260, DOI 10.1038/s41586-019-1171-x; Carrillo-Larco RM, 2019, DIABETIC MED, V36, P1573, DOI 10.1111/dme.14114; Carrillo-Larco Rodrigo M, 2019, Rev. perú. med. exp. salud publica, V36, P26, DOI 10.17843/rpmesp.2019.361.4027; Carrillo-Larco Rodrigo M, 2018, Rev. perú. med. exp. salud publica, V35, P409, DOI 10.17843/rpmesp.2018.353.3633; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; Department of Health Statistics and information Systems WHO G, 2014, WHO METH LIF EXP HLT; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Jarvis JD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220781; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Mathers CD, 2015, LANCET, V385, P540, DOI 10.1016/S0140-6736(14)60569-9; Ministerio de Salud del Peru, 1986, AN CAUS MORT PER; Ministerio de Salud del Peru, 2015, AN SIT ENF REN CRON; NCD Risk Factor Collaboration (NCD-RisC), 2017, Lancet, V389, P37, DOI 10.1016/S0140-6736(16)31919-5; NCD Risk Factor Collaboration (NCD-RisC), 2016, Lancet, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8; Seclen SN, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2017-000401; Pollard Suzanne L, 2018, Energy Sustain Dev, V46, P82, DOI 10.1016/j.esd.2018.06.001; Preston S., 2000, DEMOGRAPHY MEASURING; Rosengren A, 2019, LANCET GLOB HEALTH, V7, pE748, DOI 10.1016/S2214-109X(19)30045-2; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Tarqui-Mamani C, 2017, REV ESP NUTR HUM DIE, V21, P137, DOI 10.14306/renhyd.21.2.312; The Lancet Global Health, 2016, LANCET GLOB HEALTH, V4, pe427; The World Bank, DATA; United Nations, SUST DEV GOALS; Vargas-Herrera Javier, 2018, Rev. perú. med. exp. salud publica, V35, P505, DOI 10.17843/rpmesp.2018.353.3913; Wilmoth JR, 2007, METHODS PROTOCOL HUM; World Health Organization, UN HIGH LEV M NONC D; World Health Organization, PER TUB PROF; World Health Organization, NCD GLOB MON FRAM; World Health Organization, 3 UN HIGH LEV M NCDS; World Health Organization (WHO), GLOB MON FRAM NCDS; ZAFRATANAKA JH, 2020, PLOS ONE, V15, DOI DOI 10.1371/JOURNAL.PONE.0228867	44	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240494	10.1371/journal.pone.0240494	http://dx.doi.org/10.1371/journal.pone.0240494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045034	Green Published, gold, Green Accepted			2022-12-26	WOS:000581811700036
J	Li, YH; Wang, Y; Fan, LL; Wang, F; Liu, XL; Zhang, HZ; Zhou, JZ				Li, Yahui; Wang, Ying; Fan, Linlin; Wang, Fan; Liu, Xiaoli; Zhang, Hongzhi; Zhou, Jianzhong			Assessment of beta-D-glucosidase activity andbglgene expression ofOenococcus oeniSD-2a	PLOS ONE			English	Article							OENOCOCCUS-OENI STRAINS; LACTIC-ACID BACTERIA; BOUND FLAVOR COMPOUNDS; GLYCOSIDASE ACTIVITIES; WINE AROMA; LACTOBACILLUS-PLANTARUM; MALOLACTIC FERMENTATION; NATURAL PRECURSORS; CABERNET-SAUVIGNON; QUANTITATIVE PCR	Glycosidases enhance flavor during wine-making by mediating the enzymatic release of aroma molecules. In order to better understand the aroma enhancement potential ofOenococcus oeniSD-2a,beta-D-glucosidase (beta G) activities in the culture supernatant, whole cells, and disrupted cell lysate were assessed at mid log, late log and stationary growth phase. The enzymatic activity was also compared further from cell cultures with 5 different carbon sources (glucose, cellobiose, arbutin, glucose and cellobiose, glucose and arbutin) at late log phase. Correspondingly, expression levels of 3bglgenes,OEOE-0224,OEOE-1210, andOEOE-1569were investigated from cell cultures of the 3 growth phases, and the 5 cell cultures with different carbon sources. Finally, the volatile aroma compounds released byO.oeniSD-2a in synthetic wines with natural glycosides were evaluated by GC-MS. Results showed beta G ofO.oeniSD-2a was not extracellular enzyme, and the location of it didn't change with the change of growth phase and carbon source studied.beta G activities in the whole cells and disrupted cell lysate were similar and constant at the 3 growth phases. As for the carbon sources,beta G activities of whole cells and disrupted lysate were positively affected by cellobiose. While arbutin displayed positive and negative effect on beta G activity of whole cells and disrupted lysate, respectively. It is probably thatbglgenesOEOE-0224andOEOE-1210were related to beta G activity of SD-2a whole cells, whileOEOE-1569was responsible for beta G activity of disrupted lysate. More kinds of volatile compounds and higher total concentration were released by SD-2a in synthetic wine compared with control. Thus, SD-2a showed a great potential for flavor enhancement under wine-like conditions. This study provides more information for further study of beta G activity fromO.oeniSD-2a.	[Li, Yahui; Wang, Ying; Fan, Linlin; Wang, Fan; Liu, Xiaoli; Zhang, Hongzhi; Zhou, Jianzhong] Jiangsu Acad Agr Sci, Inst Agroprod Proc, Nanjing, Jiangsu, Peoples R China; [Li, Yahui; Wang, Ying; Liu, Xiaoli; Zhou, Jianzhong] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Jiangsu University	Liu, XL (corresponding author), Jiangsu Acad Agr Sci, Inst Agroprod Proc, Nanjing, Jiangsu, Peoples R China.; Liu, XL (corresponding author), Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu, Peoples R China.	liuxljaas@hotmail.com	Liu, Xiaoli/HGE-7614-2022		Natural Science Foundation of Jiangsu Province, China [BK20170603, 31901675]; National Natural Science Foundation of China	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Author: Yahui Li Grant numbers: BK20170603 and 31901675 Names of funder: Natural Science Foundation of Jiangsu Province, China and National Natural Science Foundation of China. URL of funder website: http://std.jiangsu.gov.cn/http://www.nsfc.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, INT BLOOD PLASM 0333, V8, P110; Barbagallo RN, 2004, ENZYME MICROB TECH, V34, P292, DOI 10.1016/j.enzmictec.2003.11.013; Belda I, 2017, MOLECULES, V22, DOI 10.3390/molecules22020189; Bloem A, 2008, FOOD MICROBIOL, V25, P99, DOI 10.1016/j.fm.2007.07.009; Brizuela NS, 2018, FOOD RES INT, V106, P22, DOI 10.1016/j.foodres.2017.12.032; Campbell-Sills H, 2016, INT J MASS SPECTROM, V397, P42, DOI 10.1016/j.ijms.2016.02.001; Capaldo A, 2011, J MOL CATAL B-ENZYM, V69, P27, DOI 10.1016/j.molcatb.2010.12.006; Capaldo A, 2011, FOOD CHEM, V125, P476, DOI 10.1016/j.foodchem.2010.09.036; Cappello MS, 2017, INT J FOOD MICROBIOL, V243, P16, DOI 10.1016/j.ijfoodmicro.2016.11.025; Claus H, 2018, FERMENTATION, V4, P1; D'Incecco N, 2004, FOOD MICROBIOL, V21, P257, DOI 10.1016/j.fm.2003.09.003; Desroche N, 2005, J MICROBIOL METH, V60, P325, DOI 10.1016/j.mimet.2004.10.010; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dong M, 2014, EUR FOOD RES TECHNOL, V239, P995, DOI 10.1007/s00217-014-2296-7; Gagne S, 2011, J APPL MICROBIOL, V110, P218, DOI 10.1111/j.1365-2672.2010.04878.x; Gambetta JM, 2017, AM J ENOL VITICULT, V68, P39, DOI 10.5344/ajev.2016.16058; Grimaldi A, 2005, INT J FOOD MICROBIOL, V105, P233, DOI 10.1016/j.ijfoodmicro.2005.04.011; Grimaldi A, 2005, J APPL MICROBIOL, V99, P1061, DOI 10.1111/j.1365-2672.2005.02707.x; Grimaldi A, 2000, AM J ENOL VITICULT, V51, P362; Iorizzo M, 2016, LWT-FOOD SCI TECHNOL, V73, P557, DOI 10.1016/j.lwt.2016.06.062; Jiang B, 2010, MOLECULES, V15, P9184, DOI 10.3390/molecules15129184; Li YH, 2012, S AFR J ENOL VITIC, V33, P144; Li YH, 2016, POL J MICROBIOL, V65, P209, DOI 10.5604/17331331.1204481; Li YH, 2016, CZECH J FOOD SCI, V34, P16, DOI 10.17221/216/2015-CJFS; Maicas S, 2016, BEVERAGES, V2, DOI 10.3390/beverages2030020; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Mansfield AK, 2002, AM J ENOL VITICULT, V53, P303; Maria Jesus CB, 2013, J FOOD SCI, V78, P507; Mateo JJ, 1997, FOOD MICROBIOL, V14, P583, DOI 10.1006/fmic.1997.0122; Maturano C, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2316-4; McMahon H, 1999, J IND MICROBIOL BIOT, V23, P198, DOI 10.1038/sj.jim.2900720; Mesas JM, 2012, LETT APPL MICROBIOL, V55, P247, DOI 10.1111/j.1472-765X.2012.03285.x; Michlmayr H, 2010, J APPL MICROBIOL, V108, P550, DOI 10.1111/j.1365-2672.2009.04461.x; Michlmayr H, 2012, MITT KLOSTERNEUBURG, V62, P87; Michlmayr H, 2012, FOOD CHEM, V135, P80, DOI 10.1016/j.foodchem.2012.04.099; Michlmayr H, 2010, WORLD J MICROB BIOT, V26, P1281, DOI 10.1007/s11274-009-0299-5; Mtshali PS, 2012, WORLD J MICROB BIOT, V28, P1443, DOI 10.1007/s11274-011-0944-7; Olguin N, 2011, AM J ENOL VITICULT, V62, P99, DOI 10.5344/ajev.2010.10044; Palmeri R, 2007, ENZYME MICROB TECH, V40, P382, DOI 10.1016/j.enzmictec.2006.07.007; Perez-Martin F, 2015, EUR FOOD RES TECHNOL, V240, P609, DOI 10.1007/s00217-014-2361-2; Perez-Martin F, 2012, WORLD J MICROB BIOT, V28, P1423, DOI 10.1007/s11274-011-0942-9; Saguir F.M., 2009, INT J WINE RES, P175, DOI 10.2147/IJWR.S4567; Sumby KM, 2012, APPL MICROBIOL BIOT, V96, P1039, DOI 10.1007/s00253-012-4409-1; Ugliano M, 2003, J AGR FOOD CHEM, V51, P5073, DOI 10.1021/jf0342019; Vincenzi S, 2015, J AGR FOOD CHEM, V63, P2314, DOI 10.1021/jf505657h; Zhang GQ, 2012, AFR J MICROBIOL RES, V6, P1478, DOI 10.5897/AJMR11.1336; Zhang Y, 2019, J AGR FOOD CHEM, V67, P5169, DOI 10.1021/acs.jafc.9b00863	47	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240484	10.1371/journal.pone.0240484	http://dx.doi.org/10.1371/journal.pone.0240484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035240	Green Published, gold			2022-12-26	WOS:000581817500028
J	Xu, XM; Li, LS; Zhang, YM; Lu, XH; Lin, W; Wu, SS; Qin, X; Xu, RQ; Lin, WJ				Xu, Xiaomei; Li, Lisha; Zhang, Yamin; Lu, Xuehua; Lin, Wei; Wu, Shuangshuang; Qin, Xia; Xu, Rongqing; Lin, Wenjin			Hypolipidemic effect ofAlisma orientale(Sam.) Juzep on gut microecology and liver transcriptome in diabetic rats	PLOS ONE			English	Article							REV-ERB-ALPHA; GENE; MELLITUS; RNA; MICROBIOTA; EXPRESSION; NOCTURNIN; INSIG-1; PROTEIN; TISSUE	Alisma orientale(Sam.) Juzep (A.orientale) is a traditional herb that is often used to treat disease including edema and hyperlipidemia. However, the molecular mechanism by whichAlisma orientale(Sam.) Juzep exerts its hypolipidemic effects remains unclear. In this study, a diabetic rat model was established by feeding a high-fat and high-sugar diet combined with a low-dose streptozotocin injection (HFS). Then the rats were treated with anA.orientalewater extract (AOW), anA.orientaleethanolic extract (AOE) or metform (MET). The gut microflora and liver transcriptome were analyzed by high-throughput next-generation sequencing. Ultra-performance liquid chromatography-triple quadrupole-mass spectrometry was employed to analyze the major compounds in the AOE. The results showed that the serum total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) levels in rats of the AOE group (2.10 g/kg/day, 14 days) were significantly lower than those in the HFS group (p<0.01). Moreover, AOE treatment altered the gut microecology, particularly modulating the relative abundance of gut microflora involved in lipid metabolism compared with the HFS group. Furthermore, compared with the HFS group, the mRNA expression levels of Fam13a, Mapk7, Mpp7, Chac1, Insig1, Mcpt10, Noct, Greb1l, Fabp12 and Hba-a3 were upregulated after the administration of AOE. In contrast, the mRNA expression levels of Lox, Mybl1, Arrdc3, Cyp4a2, Krt20, Vxn, Ggt1, Nr1d1 and S100a9 were downregulated. Moreover, AOE treatment for two weeks markedly promoted the relative abundance ofLachnospiraceae(p= 0.0013). The triterpenoids contents in AOE were alisol A, alisol A 24-acetate, alisol B, alisol B 23-acetate, alisol C 23-acetate, alisol F, alisol F 24-acetate, and alisol G. Our findings above illustrated that the hypolipidemic effect of the triterpenoids ofA.orientaleis mediated mainly through alteration of the gut microecology and the regulation of genes involved in cholesterol metabolism, especially Insig1.	[Xu, Xiaomei; Li, Lisha; Zhang, Yamin; Lu, Xuehua; Wu, Shuangshuang; Qin, Xia; Xu, Rongqing; Lin, Wenjin] Fujian Acad Med Sci, Fujian Key Lab Med Measurement, Fuzhou, Peoples R China; [Lin, Wei] Fujian Med Univ, Fujian Prov Hosp, Shengli Clin Med Coll, Dept Endocrinol, Fuzhou, Peoples R China	Fujian Medical University; Fujian Provincial Hospital	Lin, WJ (corresponding author), Fujian Acad Med Sci, Fujian Key Lab Med Measurement, Fuzhou, Peoples R China.	Lwj680@139.com		Lin, Wenjin/0000-0002-4568-486X	Basic Research Project of Fujian Provincial Public Welfare Research Institute, China [2017R1031-2, 2018R1031-3, 2019R1011-5]; Medical Innovation Project of Fujian Provincial Health and Family Planning Commission, China [2018-CX-15]; High-Level Hospital grants from Fujian Provincial Hospital, Fujian province, China [2017GL-001]	Basic Research Project of Fujian Provincial Public Welfare Research Institute, China; Medical Innovation Project of Fujian Provincial Health and Family Planning Commission, China; High-Level Hospital grants from Fujian Provincial Hospital, Fujian province, China	This work was supported by the Basic Research Project of Fujian Provincial Public Welfare Research Institute, China (2017R1031-2, 2018R1031-3 and 2019R1011-5), Medical Innovation Project of Fujian Provincial Health and Family Planning Commission, China (2018-CX-15), and High-Level Hospital grants from Fujian Provincial Hospital, Fujian province, China (2017GL-001). The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author Wei Lin received a salary from the funder of Fujian Provincial Hospital, Fujian province, China. The authors received no specific funding for this work.	Abshire ET, 2018, NUCLEIC ACIDS RES, V46, P6257, DOI 10.1093/nar/gky412; Aierken A, 2017, J SCI FOOD AGR, V97, P4557, DOI 10.1002/jsfa.8323; [Anonymous], 2019, LANCET GLOB HEALTH, V7, pE1, DOI 10.1016/S2214-109X(18)30536-9; [Anonymous], 2019, CIRCULATION, V2019; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Arya A, 2012, J ETHNOPHARMACOL, V144, P22, DOI 10.1016/j.jep.2012.08.014; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1993, BIOMETRIKA, V80, P193, DOI 10.2307/2336768; CHAWLA A, 1993, J BIOL CHEM, V268, P16265; Chen YP, 2016, J ETHNOPHARMACOL, V194, P850, DOI 10.1016/j.jep.2016.10.079; Cheng FR, 2019, MOLECULES, V24, DOI 10.3390/molecules24081454; Cui HX, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01423; Dai B, 2016, J ETHNOPHARMACOL, V192, P382, DOI 10.1016/j.jep.2016.07.024; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ding Chen-yi, 2015, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V37, P451, DOI 10.3881/j.issn.1000-503X.2015.04.015; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ellis KL, 2017, PHARMACOGENOMICS J, V17, P76, DOI 10.1038/tpj.2015.84; Estrella MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10125-z; Franks PW, 2016, SCIENCE, V354, P69, DOI 10.1126/science.aaf5094; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Gholizadeh P, 2019, MICROB PATHOGENESIS, V127, P48, DOI 10.1016/j.micpath.2018.11.031; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gomez-Arango LF, 2016, DIABETES, V65, P2214, DOI 10.2337/db16-0278; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Hee SW, 2012, OBESITY, V20, P1558, DOI 10.1038/oby.2012.37; Hoch U, 2000, J BIOL CHEM, V275, P26952; Janowski BA, 2002, P NATL ACAD SCI USA, V99, P12675, DOI 10.1073/pnas.202471599; Jiao YK, 2017, J ETHNOPHARMACOL, V199, P119, DOI 10.1016/j.jep.2017.02.003; Jones RD, 2012, AM J PHYSIOL-GASTR L, V303, pG263, DOI 10.1152/ajpgi.00111.2012; Katsiki N, 2019, CURR PHARM DESIGN, V25, P2051, DOI 10.2174/1381612825666190708192134; Kim Y, 2016, AM J CHINESE MED, V44, P1639, DOI 10.1142/S0192415X16500920; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lang S, 2020, CELL HOST MICROBE, V28, P233, DOI 10.1016/j.chom.2020.07.007; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Li S, 2016, J ETHNOPHARMACOL, V177, P10, DOI 10.1016/j.jep.2015.11.017; Liao ML, 2018, PHYTOMEDICINE, V45, P93, DOI 10.1016/j.phymed.2018.04.006; Liapis CD, 2009, EUR J VASC ENDOVASC, V37, pS1, DOI 10.1016/j.ejvs.2008.11.006; Lin WJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48806-w; Liu RZ, 2008, GENOMICS, V92, P436, DOI 10.1016/j.ygeno.2008.08.003; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martel J, 2017, NAT REV ENDOCRINOL, V13, P149, DOI 10.1038/nrendo.2016.142; Munoz-Garach A, 2016, ENDOCRINOL NUTR, V63, P560, DOI 10.1016/j.endonu.2016.07.008; Ohashi K, 2003, J BIOL CHEM, V278, P42936, DOI 10.1074/jbc.M307228200; Pang GM, 2019, CHINESE MED J-PEKING, V132, P78, DOI 10.1097/CM9.0000000000000006; Pascale A, 2018, ENDOCRINE, V61, P357, DOI 10.1007/s12020-018-1605-5; Ren RB, 2015, SCIENCE, V349, P187, DOI 10.1126/science.aab1091; Rom S, 2019, MOL NEUROBIOL, V56, P1883, DOI 10.1007/s12035-018-1195-5; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stubblefield JJ, 2012, TRENDS ENDOCRIN MET, V23, P326, DOI 10.1016/j.tem.2012.03.007; SUNDSETH SS, 1992, J BIOL CHEM, V267, P3915; Szopa M, 2010, AM J CLIN NUTR, V92, P252, DOI 10.3945/ajcn.2010.29422; Tang Y, 2018, INT J MOL MED, V41, P251, DOI 10.3892/ijmm.2017.3245; Wang C, 2019, DIABETES OBES METAB, V21, P1111, DOI 10.1111/dom.13624; Willinger T, 2019, J INTERN MED, V285, P367, DOI 10.1111/joim.12855; Xie WD, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/726723; Xu DQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9100; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yuan X, 2019, PHARMACOL RES, V141, P310, DOI 10.1016/j.phrs.2019.01.010; Zeng Z, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900457; Zhang YY, 2016, J ETHNOPHARMACOL, V192, P256, DOI 10.1016/j.jep.2016.07.002; Zhang YC, 2015, BIOCHEM J, V470, P181, DOI 10.1042/BJ20141494; Zhu W, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00586; Zhuang MJ, 2018, DRUG DES DEV THER, V12, DOI 10.2147/DDDT.S153898	67	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240616	10.1371/journal.pone.0240616	http://dx.doi.org/10.1371/journal.pone.0240616			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035272	Green Published, gold			2022-12-26	WOS:000581817500055
J	Graul, I; Marintschev, I; Hackenbroch, C; Palm, HG; Friemert, B; Lang, P				Graul, Isabel; Marintschev, Ivan; Hackenbroch, Carsten; Palm, Hans-Georg; Friemert, Benedikt; Lang, Patricia			Modified therapy concepts for fragility fractures of the pelvis after additional MRI	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; INSUFFICIENCY FRACTURES; STRESS; CT; OSTEOPOROSIS; MORTALITY	Background Fractures of the pelvic ring in elderly patients have increased in frequency over time. These injuries are associated with a high morbidity and have a socio-economic impact. The diagnostic procedures and their influence of therapy decisions are still controversial. Methods In a retrospective study, we investigate the value of additional MRI examination on therapy decision of fragility fractures of the pelvis. The evaluation of all patients with pelvic fractures without adequate trauma and with performed CT and MRI was conducted at three large German hospitals. The imaging procedure took place within a maximum interval of 4 weeks. After evaluation of the imaging, the resulting therapeutic consequences either based on CT alone or on CT and MRI were reviewed by experienced pelvic surgeons. Results Of 754 patients with pelvic injuries, 67 (age 80 +/- 9.7 years, f: m 54:13) could be included. The detection of vertical fractures in CT (n = 40 unilateral, n = 11 bilateral) could be increased by the additional MRI (n = 44 unilateral, n = 23 bilateral). A horizontal fracture component was identified in CT in 9.0% (n = 6) vs. MRI in 25.4% (n = 17) of the cases. An anterior pelvic ring injury was detected in 71.6% (n = 44; 4x bilateral) in CT, in 80.6% in MRI (n = 50, 4 bilateral). Additive MRI imaging increased the decision rate for surgical therapy from 20.9% (n = 14) to 31.3% (n = 21). Conclusions The results of this study further support the value of bone marrow edema detection by MRI diagnostics (or dual source CT which showed promising initial results) for the detection of pelvic ring fractures. For the first time, the study identifies an additional therapeutic consequence by an increased rate of surgical procedures.	[Graul, Isabel; Marintschev, Ivan] Univ Hosp Jena, Dept Trauma Hand & Reconstruct Surg, Jena, Germany; [Hackenbroch, Carsten] Ulm Army Hosp, Dept Radiol & Neuroradiol, Ulm, Germany; [Palm, Hans-Georg] Univ Klinikum Erlangen, Dept Orthopaed & Trauma Surg, Erlangen, Germany; [Friemert, Benedikt; Lang, Patricia] Ulm Army Hosp, Dept Trauma Surg & Orthopaed, Reconstruct & Sept Surg, Sports Traumatol, Ulm, Germany	Friedrich Schiller University of Jena; University of Erlangen Nuremberg	Graul, I (corresponding author), Univ Hosp Jena, Dept Trauma Hand & Reconstruct Surg, Jena, Germany.	Isabel.graul@med.uni-jena.de			German Research Foundation [433052568]	German Research Foundation(German Research Foundation (DFG))	The authors thank the Pelvic Injury Register of the German Trauma Society for support. We acknowledge support by the German Research Foundation and the Open Access Publication Fund of the Thueringer Universitaets-und Landesbibliothek Jena Projekt-Nr. 433052568.	Arduini M, 2015, AGING CLIN EXP RES, V27, pS61, DOI 10.1007/s40520-015-0430-4; Cabarrus MC, 2008, AM J ROENTGENOL, V191, P995, DOI 10.2214/AJR.07.3714; Graul I, 2021, GLOB SPINE J, V11, P1197, DOI 10.1177/2192568220941821; Hackenbroch C, 2017, Z ORTHOP UNFALLCHIR, V155, P708, DOI 10.1055/s-0043-117738; Hackenbroch C, 2017, Z ORTHOP UNFALLCHIR, V155, P27, DOI 10.1055/s-0042-110208; Henes FO, 2012, EUR J RADIOL, V81, P2337, DOI 10.1016/j.ejrad.2011.07.012; Hoch A, 2019, INT ORTHOP; Hopf JC, 2015, INJURY, V46, P1631, DOI 10.1016/j.injury.2015.04.036; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Lassus J, 2002, ACTA ORTHOP SCAND, V73, P359, DOI 10.1080/000164702320155392; Lyders EM, 2010, AM J NEURORADIOL, V31, P201, DOI 10.3174/ajnr.A1666; Marrinan S, 2015, AGE AGEING, V44, P258, DOI 10.1093/ageing/afu123; Nuchtern JV, 2015, INJURY, V46, P315, DOI 10.1016/j.injury.2014.10.050; Pickhardt PJ, 2013, ANN INTERN MED, V158, P588, DOI 10.7326/0003-4819-158-8-201304160-00003; Polytrauma Guideline Update Group, 2018, Eur J Trauma Emerg Surg, V44, P3, DOI 10.1007/s00068-018-0922-y; Pulley BR, 2018, J ORTHOP TRAUMA, V32, P617, DOI 10.1097/BOT.0000000000001308; Rangger C, 1998, ACTA ORTHOP SCAND, V69, P291, DOI 10.3109/17453679809000933; Rommens PM, 2017, JBJS REV, V5, DOI 10.2106/JBJS.RVW.16.00057; Rommens PM, 2013, INJURY, V44, P1733, DOI 10.1016/j.injury.2013.06.023; Scheyerer MJ, 2019, UNFALLCHIRURG; Spiegl UJA, 2019, Z ORTHOP UNFALLCHIR, V157, P144, DOI 10.1055/a-0640-8933; Taillandier J, 2003, JOINT BONE SPINE, V70, P287, DOI 10.1016/S1297-319X(03)00015-0; Thiryayi WA, 2008, EUR J RADIOL, V67, P62, DOI 10.1016/j.ejrad.2008.01.056; Tins BJ, 2015, INSIGHTS IMAGING, V6, P97, DOI 10.1007/s13244-014-0371-z; Wagner D, 2018, ARCH ORTHOPAEDIC TRA	25	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0238773	10.1371/journal.pone.0238773	http://dx.doi.org/10.1371/journal.pone.0238773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031459	Green Published, Green Submitted, gold			2022-12-26	WOS:000581809800088
J	Hasumi, A; Maeda, H; Yoshida, KI				Hasumi, Akihiro; Maeda, Hideyuki; Yoshida, Ken-ichi			Analyzing cannabinoid-induced abnormal behavior in a zebrafish model	PLOS ONE			English	Article							5-HT1A RECEPTORS; CANNABIDIOL; DELTA(9)-TETRAHYDROCANNABINOL; CATALEPSY; EXPOSURE; CB1; HALOPERIDOL; WIN55,212-2; ACTIVATION; DOPAMINE	In this study, we investigated locomotor activity and responses to repeated light and dark stimuli to assess cannabinoid-induced abnormal behavior in zebrafish larvae (Danio rerio), as an alternative to standard rodent models. To induce the desired responses, we used cannabidiol and WIN55,212-2, two major cannabinoid components. A repeated light and dark test was used to assess how drug exposure influences locomotory responses. Larvae were examined after moderate cannabidiol and WIN55,212-2 exposure and at 24 h after transfer to untreated water. We found that cannabidiol did not produce a dose-dependent inhibitory effect on locomotor activity, with both 0.5 and 10 mu g/mL concentrations reducing movement velocity and the total distance moved. However, 10 mu g/mL cannabidiol was observed to attenuate the responses of larvae exposed to darkness. No differences were detected between the control and cannabidiol-treated groups after 24 h in fresh water. Fish treated with WIN55,212-2 at 0.5 and 1 mu g/mL showed virtually no activity, even in darkness, whereas a concentration of 10 mu g/mL induced mortality. A 24-h period in fresh water had the effect of reversing most of the drug-induced immobilization, even in the WIN55,212-2-treated groups. Larvae were also evaluated for their responses to cannabidiol subsequent to an initial exposure to WIN55,212-2, and it was accordingly found that treatment with cannabidiol could attenuate WIN55,212-2-induced abnormal immobilization, whereas equivalent doses of cannabidiol and WIN55,212-2 produced a mixed response. In conclusion, the behavioral effects of the two cannabinoids cannabidiol and WIN55,212-2 appear to be ratio dependent. Furthermore, the repeated light and dark test could serve as a suitable method for assaying drug-induced behavior.	[Hasumi, Akihiro; Maeda, Hideyuki; Yoshida, Ken-ichi] Tokyo Med Univ, Dept Forens Med, Shinjyuku Ku, Tokyo, Japan	Tokyo Medical University	Maeda, H (corresponding author), Tokyo Med Univ, Dept Forens Med, Shinjyuku Ku, Tokyo, Japan.	hmaeda@tokyo-med.ac.jp	MAEDA, Hideyuki/AAZ-9450-2021	Hasumi, Akihiro/0000-0002-4542-2376; /0000-0002-1820-5253	Departments of Forensic Medicine and Pathophysiology at Tokyo Medical University	Departments of Forensic Medicine and Pathophysiology at Tokyo Medical University	This study was supported by the Departments of Forensic Medicine and Pathophysiology at Tokyo Medical University. We gratefully acknowledge their support.	Andreza BS, 2016, BEHAV BRAIN RES, V309, P22, DOI [10.1016/j.bbr.2016.04.042, DOI 10.1016/J.BBR.2016.04.042]; Araya KA, 2007, EUR J PHARMACOL, V572, P32, DOI 10.1016/j.ejphar.2007.06.013; Bartlett D, 2017, CRIT CARE NURSE, V37, P49, DOI 10.4037/ccn2017169; Basnet RM, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7010023; Bruni G, 2016, NAT CHEM BIOL, V12, P559, DOI [10.1038/NCHEMBIO.2097, 10.1038/nchembio.2097]; Carty DR, 2018, TOXICOL SCI, V162, P137, DOI 10.1093/toxsci/kfx232; Connors KA, 2014, AQUAT TOXICOL, V151, P105, DOI 10.1016/j.aquatox.2013.12.005; Corroon J, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-1059-8; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P425, DOI 10.1016/j.ntt.2012.03.002; Devinsky O, 2017, NEW ENGL J MED, V376, P2011, DOI 10.1056/NEJMoa1611618; Eddins D, 2010, NEUROTOXICOL TERATOL, V32, P99, DOI 10.1016/j.ntt.2009.02.005; Egashira N, 2007, J PHARMACOL SCI, V105, P361, DOI 10.1254/jphs.FP0071247; Ellis LD, 2018, BEHAV BRAIN RES, V337, P151, DOI 10.1016/j.bbr.2017.09.028; Farrell TC, 2011, NEUROBIOL DIS, V44, P9, DOI 10.1016/j.nbd.2011.05.016; Flinn L, 2008, J NEUROCHEM, V106, P1991, DOI 10.1111/j.1471-4159.2008.05463.x; Fukushiro DF, 2008, BRAIN RES BULL, V77, P124, DOI 10.1016/j.brainresbull.2008.05.004; Galanopoulos A, 2011, BEHAV BRAIN RES, V224, P65, DOI 10.1016/j.bbr.2011.05.018; Gomes FV, 2013, PROG NEURO-PSYCHOPH, V46, P43, DOI 10.1016/j.pnpbp.2013.06.005; Irons TD, 2013, PHARMACOL BIOCHEM BE, V103, P792, DOI 10.1016/j.pbb.2012.12.010; Jeong S, 2019, CANCER LETT, V447, P12, DOI 10.1016/j.canlet.2019.01.011; Krug RG, 2015, GENE, V570, P168, DOI 10.1016/j.gene.2015.07.036; Lawston J, 2000, BRAIN RES, V877, P407, DOI 10.1016/S0006-8993(00)02739-6; Lindstrom NM, 2015, CLIN LAB MED, V35, P629, DOI 10.1016/j.cll.2015.05.011; Liu YW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02822-w; Maeda H, 2018, FORENSIC TOXICOL, V36, P313, DOI 10.1007/s11419-018-0405-1; Makhija DT, 2014, J PHARMACOL PHARMACO, V5, P39, DOI 10.4103/0976-500X.124422; McCarroll MN, 2016, ACS CHEM BIOL, V11, P842, DOI 10.1021/acschembio.5b00800; Oomen PP, 2018, BEHAV PHARMACOL, V29, P605, DOI 10.1097/FBP.0000000000000426; Magno LDP, 2015, PHARMACOL BIOCHEM BE, V135, P169, DOI 10.1016/j.pbb.2015.05.014; Pittman JT, 2014, PHYSIOL BEHAV, V123, P174, DOI 10.1016/j.physbeh.2013.10.023; Polissidis A, 2013, INT J NEUROPSYCHOPH, V16, P393, DOI 10.1017/S1461145712000156; Priya M, 2012, BEHAV BRAIN RES, V219, P234; Resstel LBM, 2009, BRIT J PHARMACOL, V156, P181, DOI 10.1111/j.1476-5381.2008.00046.x; Rice C, 2011, AQUAT TOXICOL, V105, P600, DOI 10.1016/j.aquatox.2011.08.014; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Sim-Selley LJ, 2002, J PHARMACOL EXP THER, V303, P36, DOI 10.1124/jpet.102.035618; Sonego AB, 2016, BEHAV BRAIN RES, V309, P22, DOI 10.1016/j.bbr.2016.04.042; Stewart AM, 2014, BRAIN RES, V1543, P109, DOI 10.1016/j.brainres.2013.11.002; Tierney KB, 2011, BBA-MOL BASIS DIS, V1812, P381, DOI 10.1016/j.bbadis.2010.10.011; Tran S, 2016, PSYCHOPHARMACOLOGY, V233, P1445, DOI 10.1007/s00213-016-4240-y; Vaz RL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00347; Zehra A, 2018, J NEUROIMMUNE PHARM, V13, P438, DOI 10.1007/s11481-018-9782-9	42	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0236606	10.1371/journal.pone.0236606	http://dx.doi.org/10.1371/journal.pone.0236606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031370	gold, Green Submitted, Green Published			2022-12-26	WOS:000581809800048
J	Meng, LL; He, XX; Zhang, X; Zhang, XB; Wei, YT; Wu, B; Li, W; Li, J; Xiao, YY				Meng, Liangliang; He, Xiaoxi; Zhang, Xiao; Zhang, Xiaobo; Wei, Yingtian; Wu, Bin; Li, Wei; Li, Jing; Xiao, Yueyong			Predicting the clinical outcome of melanoma using an immune-related gene pairs signature	PLOS ONE			English	Article							DABRAFENIB; TRAMETINIB; IPILIMUMAB; NIVOLUMAB; SURVIVAL; BLOCKADE; PLACEBO	Objective Melanoma is rare but dangerous skin cancer, and it can spread rather quickly in the advanced stages of the tumor. Abundant evidence suggests the relationship between tumor development and progression and the immune system. A robust gene risk model could provide an accurate prediction of clinical outcomes. The present study aimed to explore a robust signature of immune-related gene pairs (IRGPs) for estimating overall survival (OS) in malignant melanoma. Methods Clinical and genetic data of skin cutaneous melanoma (SKCM) patients from The Cancer Genome Atlas (TCGA) was performed as a training dataset to identify candidate IRGPs for the prognosis of melanoma. Two independent datasets from the Gene Expression Omnibus (GEO) database (GSE65904) and TCGA dataset (TCGA-UVM) were selected for external validation. Univariate and multivariate Cox regression analyses were then performed to explore the prognostic power of the IRGPs signature and other clinical factors. CIBERSORTx was applied to estimate the fractions of infiltrated immune cells in bulk tumor tissues. Results A signature consisted of 33 IRGPs was established which was significantly associated with patients' survival in the TCGA-SKCM dataset (P = 2.0x10(-16), Hazard Ratio (HR) = 4.220 (2.909 to 6.122)). We found the IRGPs signature exhibited an independent prognostic factor in all the three independent cohorts in both the univariate and multivariate Cox analysis (P<0.01). The prognostic efficacy of the signature remained unaffected regardless of whetherBRAForNRASwas mutated. As expected, the results were verified in the GSE65904 dataset and the TCGA-UVM dataset. We found an apparent shorter OS in patients of the high-risk group in the GSE65904 dataset (P = 2.1x10(-3); HR = 1.988 (1.309 to 3.020)). The trend in the results of the survival analysis in TCGA-UVM was as we expected, but the result was not statistically significant (P = 0.117, HR = 4.263 (1.407 to 12.91)). CD8 T cells, activated dendritic cells (DCs), regulatory T cells (Tregs), and activated CD4 memory T cells presented a significantly lower fraction in the high-risk group in the TCGA-SKCM dataset(P <0.01). Conclusion The results of the present study support the IRGPs signature as a promising marker for prognosis prediction in melanoma.	[Meng, Liangliang] Chinese PLA, Sch Med, Beijing, Peoples R China; [Meng, Liangliang; Zhang, Xiao; Zhang, Xiaobo; Wei, Yingtian; Li, Jing; Xiao, Yueyong] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Radiol, Beijing, Peoples R China; [Meng, Liangliang; Wu, Bin; Li, Wei] Chinese PAP Beijing Corps Hosp, Dept Radiol, Beijing, Peoples R China; [He, Xiaoxi] Tianjin Med Univ Canc Inst & Hosp, Dept Radiol, Natl Clin Res Ctr Canc, Tianjin, Peoples R China	Chinese People's Liberation Army General Hospital; Tianjin Medical University	Xiao, YY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Radiol, Beijing, Peoples R China.	yueyongxiao@yahoo.com	Meng, Liang/ABG-4839-2020	Meng, Liangliang/0000-0003-2267-9803				Albittar AA, 2020, ADV EXP MED BIOL, V1244, P51, DOI 10.1007/978-3-030-41008-7_3; Ashton TM, 2018, CLIN CANCER RES, V24, P2482, DOI 10.1158/1078-0432.CCR-17-3070; Besser MJ, 2020, MOL CARCINOGEN, V59, P736, DOI 10.1002/mc.23193; Chae YK, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0349-3; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Chen XJ, 2017, J DERMATOL SCI, V85, P226, DOI 10.1016/j.jdermsci.2016.12.006; Cursons J, 2019, CANCER IMMUNOL RES, V7, P1162, DOI 10.1158/2326-6066.CIR-18-0500; Dancsok AR, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1747340; Duane M, 2016, J AM BOARD FAM MED, V29, P508, DOI 10.3122/jabfm.2016.04.160022; Dummer R, 2020, LANCET ONCOL, V21, P358, DOI 10.1016/S1470-2045(20)30062-0; Fisher PB, 2007, TOXICOL APPL PHARM, V224, P300, DOI 10.1016/j.taap.2006.11.021; Guo WN, 2019, ELIFE, V8, DOI 10.7554/eLife.44310; Hassel JC, 2016, LANCET ONCOL, V17, P1471, DOI 10.1016/S1470-2045(16)30409-0; Ivashkiv LB, 2018, NAT REV IMMUNOL, V18, P545, DOI 10.1038/s41577-018-0029-z; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; La Porta CAM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002316; Lemos H, 2019, NAT REV CANCER, V19, P162, DOI 10.1038/s41568-019-0106-z; Li BL, 2017, JAMA ONCOL, V3, P1529, DOI 10.1001/jamaoncol.2017.1609; Lim B, 2018, NAT REV CANCER, V18, P485, DOI 10.1038/s41568-018-0010-y; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Luke JJ, 2017, NAT REV CLIN ONCOL, V14, P463, DOI 10.1038/nrclinonc.2017.43; Mahoney KM, 2015, CLIN THER, V37, P764, DOI 10.1016/j.clinthera.2015.02.018; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Newman AM, 2019, NAT BIOTECHNOL, V37, P773, DOI 10.1038/s41587-019-0114-2; Puzanov I, 2015, INVEST NEW DRUG, V33, P159, DOI 10.1007/s10637-014-0167-5; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Roncati L, 2020, INT J DERMATOL, V59, P763, DOI 10.1111/ijd.14945; Samson JM, 2019, CHEM-BIOL INTERACT, V314, DOI 10.1016/j.cbi.2019.108822; Sheng Y, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00206; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Sun XY, 2020, CANCER MED-US, V9, P2868, DOI 10.1002/cam4.2921; Testori A, 2017, EJSO-EUR J SURG ONC, V43, P544, DOI 10.1016/j.ejso.2016.10.005; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Tucci M, 2014, EXPERT REV CLIN IMMU, V10, P1395, DOI 10.1586/1744666X.2014.955851; Uryvaev A, 2018, MED ONCOL, V35, DOI 10.1007/s12032-018-1080-0; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wu JP, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1596715; Yang SC, 2018, INT J ONCOL, V52, P1178, DOI 10.3892/ijo.2018.4268; Z K, 2015, SPORT SCI, V8, P41; Zhang LY, 2019, ONCOTARGETS THER, V12, P7005, DOI 10.2147/OTT.S200191; Zhou Y, 2019, AM J PATHOL, V189, P2138, DOI 10.1016/j.ajpath.2019.08.002	41	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240331	10.1371/journal.pone.0240331	http://dx.doi.org/10.1371/journal.pone.0240331			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031392	gold, Green Published			2022-12-26	WOS:000581809800081
J	Monmai, C; Rod-in, W; Jang, AY; Lee, SM; Jung, SK; You, SG; Park, WJ				Monmai, Chaiwat; Rod-in, Weerawan; Jang, A-yeong; Lee, Sang-min; Jung, Seok-Kyu; You, SangGuan; Park, Woo Jung			Immune-enhancing effects of anionic macromolecules extracted fromCodium fragilecoupled with arachidonic acid in RAW264.7 cells	PLOS ONE			English	Article							NF-KAPPA-B; FATTY-ACIDS; CODIUM-FRAGILE; MACROPHAGE POLARIZATION; DOCOSAHEXAENOIC ACID; SULFATED GALACTAN; ACTIVATION; POLYSACCHARIDES; OMEGA-3-FATTY-ACIDS; MECHANISM	Arachidonic acid (ARA) is an integral constituent of the biological cell membrane, conferring it with fluidity and flexibility, which are necessary for the function of all cells, especially nervous system, skeletal muscle, and immune system.Codiumspecies biosynthesize sulfated polysaccharides with very distinct structural features. Some of them have different biological activities with great potential in pharmaceutical applications. In this study, anionic macromolecules extracted fromCodium fragilewere investigated for their cooperative immune-enhancing activities with ARA. The cooperation between ARA and Codium resulted in increased, dose-dependent nitric oxide production and iNOS gene expression. In addition, co-treatment of ARA and Codium effectively increased pro-inflammatory cytokines (IL-1 beta, IL-6, and TNF-alpha), compared with Codium alone. We also demonstrated that the expression of COX-2 mRNA was also increased, which is responsible for the production of inflammatory mediator prostaglandins and their metabolites. Compared to the Codium group, the co-treatment of Codium with ARA enhanced the phosphorylation of nuclear factor-kappa B p-65, p38, and extracellular signal-related kinase 1/2, indicating that this combination stimulated immune response through nuclear factor-kappa B and mitogen-activated protein kinase pathways. These results indicated that the coordination of arachidonic acid with polysaccharide extracted from seaweed may be a potential source of immunomodulatory molecules.	[Monmai, Chaiwat; Rod-in, Weerawan; You, SangGuan; Park, Woo Jung] Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Kangnung, Gangwon, South Korea; [Jang, A-yeong] Gangneung Wonju Natl Univ, Dept Wellness Bio Ind, Kangnung, Gangwon, South Korea; [Lee, Sang-min] Gangneung Wonju Natl Univ, Dept Marine Biotechnol, Kangnung, Gangwon, South Korea; [Jung, Seok-Kyu] Daegu Catholic Univ, Dept Hort, Gyongsan, Gyeongbuk, South Korea	Kangnung Wonju National University; Kangnung Wonju National University; Kangnung Wonju National University; Catholic University of Daegu	Park, WJ (corresponding author), Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Kangnung, Gangwon, South Korea.	pwj0505@gwnu.ac.kr		Monmai, Chaiwat/0000-0002-9267-3047	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2019R1A2B5B01070542]; University Emphasis Research Institute Support Program from the National Research Foundation of Korea [2018R1A61A03023584]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); University Emphasis Research Institute Support Program from the National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2019R1A2B5B01070542). This research project was also supported by the University Emphasis Research Institute Support Program (No.2018R1A61A03023584) from the National Research Foundation of Korea.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BELL JG, 1995, FISH PHYSIOL BIOCHEM, V14, P139, DOI 10.1007/BF00002457; Calder PC, 2002, P NUTR SOC, V61, P345, DOI 10.1079/PNS2002166; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Cao RA, 2014, INT J BIOL MACROMOL, V67, P303, DOI 10.1016/j.ijbiomac.2014.03.019; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Ciancia M, 2007, INT J BIOL MACROMOL, V41, P641, DOI 10.1016/j.ijbiomac.2007.08.007; Dantagnan P, 2017, AQUACULT NUTR, V23, P710, DOI 10.1111/anu.12438; Dragano NRV, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0869-7; Ganapathy S, 2009, INDIAN PEDIATR, V46, P785; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Haller I, 2006, ANESTHESIOLOGY, V105, P1024, DOI 10.1097/00000542-200611000-00025; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; HWANG D, 1989, FASEB J, V3, P2052, DOI 10.1096/fasebj.3.9.2501132; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Im DS, 2016, EUR J PHARMACOL, V785, P36, DOI 10.1016/j.ejphar.2015.03.094; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Kang CH, 2012, J MED FOOD, V15, P44, DOI 10.1089/jmf.2010.1540; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Kim HS, 2013, FOOD CHEM TOXICOL, V55, P241, DOI 10.1016/j.fct.2012.12.007; Kim JK, 2011, INT J BIOL MACROMOL, V49, P1051, DOI 10.1016/j.ijbiomac.2011.08.032; Kim JB, 2007, BIOL PHARM BULL, V30, P2345, DOI 10.1248/bpb.30.2345; Lee H, 2014, J MED FOOD, V17, P189, DOI 10.1089/jmf.2013.2917; Lee JH, 2017, POULTRY SCI, V96, P3872, DOI 10.3382/ps/pex205; Lee JB, 2010, CARBOHYD RES, V345, P1452, DOI 10.1016/j.carres.2010.02.026; Li Y, 2017, INT IMMUNOPHARMACOL, V49, P38, DOI 10.1016/j.intimp.2017.05.017; Lv R, 2017, MOL MED REP, V16, P9111, DOI 10.3892/mmr.2017.7719; Manosroi A, 2003, J ETHNOPHARMACOL, V89, P155, DOI 10.1016/S0378-8741(03)00278-2; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mocca B, 2012, J BACTERIOL, V194, P4059, DOI 10.1128/JB.00476-12; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullen A, 2010, J NUTR BIOCHEM, V21, P444, DOI 10.1016/j.jnutbio.2009.02.008; Narayanan BA, 2003, CANCER RES, V63, P972; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ohta Y, 2009, BIOL PHARM BULL, V32, P892, DOI 10.1248/bpb.32.892; Rahat MA, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00144; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Seo JY, 2011, AQUAC RES, V42, P623, DOI 10.1111/j.1365-2109.2010.02653.x; Sevag MG, 1938, J BIOL CHEM, V124, P0425; Tabarsa M, 2013, INT J BIOL MACROMOL, V59, P1, DOI 10.1016/j.ijbiomac.2013.04.022; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Uemura E, 2016, J NANOPART RES, V18, DOI 10.1007/s11051-016-3475-1; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Verbruggen H, 2007, MOL PHYLOGENET EVOL, V44, P240, DOI 10.1016/j.ympev.2007.01.009; Villegas-Comonfort S, 2017, PROSTAG LEUKOTR ESS, V117, P1, DOI 10.1016/j.plefa.2017.01.013; Xia YL, 2010, GLIA, V58, P244, DOI 10.1002/glia.20921; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zhang XR, 2016, CARBOHYD POLYM, V149, P186, DOI 10.1016/j.carbpol.2016.04.097; 이수경, 2015, [Journal of Life Science, 생명과학회지], V25, P1377	52	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239422	10.1371/journal.pone.0239422	http://dx.doi.org/10.1371/journal.pone.0239422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031432	Green Published, gold			2022-12-26	WOS:000581809800038
J	Terrill, JR; Al-Mshhdani, BA; Duong, MN; Wingate, CD; Abbas, Z; Baustista, AP; Bettis, AK; Balog-Alvarez, CJ; Kornegay, JN; Nghiem, PP; Grounds, MD; Arthur, PG				Terrill, Jessica R.; Al-Mshhdani, Basma A.; Duong, Marisa N.; Wingate, Catherine D.; Abbas, Zahra; Baustista, Angelo P.; Bettis, Amanda K.; Balog-Alvarez, Cynthia J.; Kornegay, Joe N.; Nghiem, Peter P.; Grounds, Miranda D.; Arthur, Peter G.			Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy	PLOS ONE			English	Article							THIOL OXIDATION; TITIN FRAGMENT; MUSCLE; STRESS; INFLAMMATION; MODEL; MYELOPEROXIDASE; IDENTIFICATION; PATHOLOGY; RESPONSES	Duchenne muscular dystrophy (DMD) is a lethal, X-chromosome linked muscle-wasting disease affecting about 1 in 3500-6000 boys worldwide. Myofibre necrosis and subsequent loss of muscle mass are due to several molecular sequelae, such as inflammation and oxidative stress. We have recently shown increased neutrophils, highly reactive oxidant hypochlorous acid (HOCl) generation by myeloperoxidase (MPO), and associated oxidative stress in muscle from the GRMD dog and mdx mouse models for DMD. These findings have led us to hypothesise that generation of HOCl by myeloperoxidase released from neutrophils has a significant role in dystropathology. Since access to muscle from DMD patients is limited, the aim of this study was to develop methods to study this pathway in urine. Using immunoblotting to measure markers of protein oxidation, we show increased labelling of proteins with antibodies to dinitrophenylhydrazine (DNP, oxidative damage) and DiBrY (halogenation by reactive oxidants from myeloperoxidase) in GRMD and mdx urine. A strong positive correlation was observed between DiBrY labelling in dog urine and muscle. A strong positive correlation was also observed when comparing DNP and DiBrY labelling (in muscle and urine) to markers of dystropathology (plasma creatine kinase) and neutrophil presence (muscle MPO). Our results indicate the presence of neutrophil mediated oxidative stress in both models, and suggest that urine is a suitable bio-fluid for the measurement of such biomarkers. These methods could be employed in future studies into the role of neutrophil mediated oxidative stress in DMD and other inflammatory pathologies.	[Terrill, Jessica R.; Al-Mshhdani, Basma A.; Duong, Marisa N.; Wingate, Catherine D.; Abbas, Zahra; Baustista, Angelo P.; Arthur, Peter G.] Univ Western Australia, Sch Mol Sci, Perth, WA, Australia; [Bettis, Amanda K.; Balog-Alvarez, Cynthia J.; Kornegay, Joe N.; Nghiem, Peter P.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA; [Grounds, Miranda D.] Univ Western Australia, Sch Human Sci, Perth, WA, Australia	University of Western Australia; Texas A&M University System; Texas A&M University College Station; University of Western Australia	Terrill, JR (corresponding author), Univ Western Australia, Sch Mol Sci, Perth, WA, Australia.	jessica.terrill@uwa.edu.au	Arthur, Peter/H-8765-2014	Arthur, Peter/0000-0002-1257-8200; Wingate, Catherine/0000-0002-4951-0410; Duong, Marisa/0000-0001-5075-5936; Bautista, Angelo Patrick/0000-0002-0640-3156; Kornegay, Joe/0000-0002-5594-1882; Terrill, Jessica/0000-0001-5484-5373; Abbas, Zahra/0000-0002-1751-6930; Grounds, Miranda/0000-0002-4530-9402	Muscular Dystrophy Western Australia; French Muscular Dystrophy Association (AFM-Telethon); Save Our Sons Duchenne Foundation; Duchenne UK	Muscular Dystrophy Western Australia(Muscular Dystrophy Association); French Muscular Dystrophy Association (AFM-Telethon); Save Our Sons Duchenne Foundation; Duchenne UK	Muscular Dystrophy Western Australia (JT & PA) The French Muscular Dystrophy Association (AFM-Telethon) (JT) Save Our Sons Duchenne Foundation (PA & MG) Duchenne UK (PA & MG).; We thank Proteomics International for the use of mass spectrometry equipment, and James Lui and Scott Bringans for technical advice.	Abstracts of the ESC (European Society of Cardiology) Congress, 2013, EUR HEART J S1, V34, P1; Allen DG, 2016, PHYSIOL REV, V96, P253, DOI 10.1152/physrev.00007.2015; [Anonymous], 2009, TULSA LAW REV, V44, P67; [Anonymous], 1999, AM J PHYS, V276, pF122; [Anonymous], 2005, AM J PHYSIOL-HEART C, V288, pH2869; Arthur PG, 2008, CURR OPIN CLIN NUTR, V11, P408, DOI 10.1097/MCO.0b013e328302f3fe; Awano H, 2018, CLIN CHIM ACTA, V476, P111, DOI 10.1016/j.cca.2017.11.024; Barnes J, 2006, STATUTE LAW REV, V27, P83, DOI 10.1093/slr/hml004; Brown KL, 2015, DIABETES, V64, P2242, DOI 10.2337/db14-1001; Bruschi M, 2013, BBA-GEN SUBJECTS, V1830, P5473, DOI 10.1016/j.bbagen.2013.04.017; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Chapman ALP, 2000, ARCH BIOCHEM BIOPHYS, V377, P95, DOI 10.1006/abbi.2000.1744; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Davies MJ, 2020, ANTIOXID REDOX SIGN, V32, P957, DOI 10.1089/ars.2020.8030; El-Shafey AF, 2011, FREE RADICAL RES, V45, P991, DOI 10.3109/10715762.2011.590136; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Falzarano MS, 2015, MOLECULES, V20, P18168, DOI 10.3390/molecules201018168; FEHSKE KJ, 1980, ARCH BIOCHEM BIOPHYS, V205, P217, DOI 10.1016/0003-9861(80)90101-0; Garrood P, 2008, NEUROMUSCULAR DISORD, V18, P71, DOI 10.1016/j.nmd.2007.07.006; Grounds MD, 2008, CELL MOL LIFE SCI, V65, P1621, DOI 10.1007/s00018-008-7574-8; Grounds MD, 2011, BIOESSAYS, V33, P458, DOI 10.1002/bies.201000136; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Haycock JW, 1996, NEUROREPORT, V8, P357, DOI 10.1097/00001756-199612200-00070; Hortin GL, 2008, PROTEOM CLIN APPL, V2, P950, DOI 10.1002/prca.200780145; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Ishitsuka Y, 2007, PHOTOCHEM PHOTOBIOL, V83, P698, DOI 10.1562/2006-07-24-RA-978; Kato Y, 2005, FREE RADICAL BIO MED, V38, P24, DOI 10.1016/j.freeradbiomed.2004.09.013; Kharraz Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965631; Kolisetty N, 2013, TOXICOL APPL PHARM, V272, P391, DOI 10.1016/j.taap.2013.06.018; Kornegay JN, 2012, MAMM GENOME, V23, P85, DOI 10.1007/s00335-011-9382-y; Margonis K, 2007, FREE RADICAL BIO MED, V43, P901, DOI 10.1016/j.freeradbiomed.2007.05.022; Partridge TA, 2013, FEBS J, V280, P4177, DOI 10.1111/febs.12267; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Radak Z, 2003, EUR J CLIN INVEST, V33, P726, DOI 10.1046/j.1365-2362.2003.01202.x; Renjini R, 2012, NEUROCHEM RES, V37, P885, DOI 10.1007/s11064-011-0683-z; Robertson AS, 2017, NEUROMUSCULAR DISORD, V27, P635, DOI 10.1016/j.nmd.2017.05.009; Rouillon J, 2014, NEUROMUSCULAR DISORD, V24, P563, DOI 10.1016/j.nmd.2014.03.012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider SM, 2018, MOL IMAGING BIOL, V20, P780, DOI 10.1007/s11307-018-1174-2; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Takagi T, 2011, J CLIN BIOCHEM NUTR, V48, P178, DOI 10.3164/jcbn.10-93; Terrill JR, 2016, REDOX BIOL, V9, P276, DOI 10.1016/j.redox.2016.08.016; Terrill JR, 2016, J PHYSIOL-LONDON, V594, P3095, DOI 10.1113/JP271418; Terrill JR, 2013, FEBS J, V280, P4149, DOI 10.1111/febs.12142; Tidball JG, 2018, COMPR PHYSIOL, V8, P1313, DOI 10.1002/cphy.c170052; Weller R, 2003, AM J PHYSIOL-CELL PH, V284, pC1140, DOI 10.1152/ajpcell.00462.2002.; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Yan LJ, 1998, ANAL BIOCHEM, V263, P67, DOI 10.1006/abio.1998.2799	49	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240317	10.1371/journal.pone.0240317	http://dx.doi.org/10.1371/journal.pone.0240317			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031394	Green Published, gold			2022-12-26	WOS:000581809800019
J	Hoffmann, P; Behnisch, R; Gsenger, J; Schnitzler, P; Gauss, A				Hoffmann, Peter; Behnisch, Rouven; Gsenger, Julia; Schnitzler, Paul; Gauss, Annika			Hepatitis E seroprevalence in a German cohort of patients with inflammatory bowel diseases	PLOS ONE			English	Article							E VIRUS-INFECTION	Background and aims The incidence of hepatitis E virus (HEV)-infections in industrialized nations has been increasing over the past years. Patients suffering from inflammatory bowel diseases (IBD) may be more prone to transmission. Data on HEV seroprevalence in IBD patients is scarce and has not been reported in German IBD patients. The German Health Examination Survey for Adults 2008-2011, which included 4.422 samples, found a HEV seroprevalence of 16.8%, increasing with age. The aim of the present study was to determine the seroprevalence of anti-HEV IgG in a German cohort of IBD patients, and to explore which parameters have an impact on HEV seroprevalence. Material and methods This is an uncontrolled, cross-sectional, retrospective monocentric study. Among the patients visiting the IBD outpatient clinic between 25 January, 2019 and 24 September, 2019, 328 patients with Crohn's disease (CD) and 150 patients with ulcerative colitis (UC) were included in the study. IgG antibodies against HEV were determined by enzyme-linked immunosorbent assay. Positive antibody titers were verified using immunoblot analysis. Medical records were reviewed for demographic and clinical parameters to identify potential risk factors for HEV infection. Results The prevalence of anti-HEV IgG antibodies was 17.4% in CD patients and 24.7% in UC patients. No patient with positive HEV PCR was detected. Greater age of CD und UC patients and longer duration of anti-interleukin 12/23 treatment in CD patients were associated with higher anti-HEV IgG antibody rates. Conclusions In summary, we conclude that patients with UC have a higher anti-HEV IgG antibody prevalence than the general population in Germany, and that immunosuppressive therapy may carry no higher risk for HEV infection.	[Hoffmann, Peter; Gauss, Annika] Heidelberg Univ Hosp, Dept Gastroenterol & Hepatol, Heidelberg, Germany; [Behnisch, Rouven] Heidelberg Univ Hosp, Inst Med Biometry & Informat, Dept Med Biometry, Heidelberg, Germany; [Gsenger, Julia; Schnitzler, Paul] Heidelberg Univ Hosp, Ctr Infect Dis, Virol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hoffmann, P (corresponding author), Heidelberg Univ Hosp, Dept Gastroenterol & Hepatol, Heidelberg, Germany.	peter.hoffmann@med.uni-heidelberg.de						Alberts CJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208522; Brost S, 2010, J CLIN VIROL, V47, P89, DOI 10.1016/j.jcv.2009.10.011; Cordts SE, 2018, PEDIATR NEPHROL, V33, P1215, DOI 10.1007/s00467-018-3905-7; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a; Faber MS, 2012, EMERG INFECT DIS, V18, P1654, DOI 10.3201/eid1810.111756; Hogema BM, 2016, TRANSFUSION, V56, P722, DOI 10.1111/trf.13402; Juhl D, 2014, TRANSFUSION, V54, P49, DOI 10.1111/trf.12121; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2011, GASTROENTEROLOGY, V140, P1481, DOI 10.1053/j.gastro.2011.02.050; Li PF, 2020, LIVER INT, V40, P1516, DOI 10.1111/liv.14468; Maaser C, 2019, J CROHNS COLITIS, V13, P144, DOI 10.1093/ecco-jcc/jjy113; Mooij SH, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3078-9; Pas SD, 2013, J CLIN VIROL, V58, P629, DOI 10.1016/j.jcv.2013.10.010; Pischke S, 2019, VIRUSES, V11; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Senosiain C, 2016, GASTROENT HEPAT-BARC, V39, P185, DOI 10.1016/j.gastrohep.2015.06.004; Slot E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176414; Tabatabai J, 2014, J CLIN VIROL, V61, P170, DOI 10.1016/j.jcv.2014.06.008; Westholter D, 2018, J HEPATOL, V69, P36, DOI 10.1016/j.jhep.2018.02.031; Wilhelm B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216826; Wong L, 2020, ZOONOSES PUBLIC HLTH, V67, P263, DOI 10.1111/zph.12681	23	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239825	10.1371/journal.pone.0239825	http://dx.doi.org/10.1371/journal.pone.0239825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027305	gold, Green Published			2022-12-26	WOS:000581808000034
J	Huang, SK; Huang, CY; Lin, CH; Cheng, BW; Chiang, YT; Lee, YC; Yeh, SN; Chan, CI; Chua, WK; Lee, YJ; Ting, WH				Huang, Shih-Kang; Huang, Chi-Yu; Lin, Chao-Hsu; Cheng, Bi-Wen; Chiang, Ya-Ting; Lee, Yi-Chen; Yeh, Shu-Nin; Chan, Chon-In; Chua, Wei-Kian; Lee, Yann-Jinn; Ting, Wei-Hsin			Acute kidney injury is a common complication in children and adolescents hospitalized for diabetic ketoacidosis	PLOS ONE			English	Article							RISK	Diabetic ketoacidosis (DKA) is associated with dehydration and which can cause acute kidney injury (AKI). The proportion of AKI in children and adolescents with DKA has not been reported in East Asian population. This study aimed to identify the prevalence of AKI and to determine whether there is an association between AKI severity and recovery time from metabolic acidosis in children and adolescents with DKA. Medical records of children and adolescents (aged <18 years) presenting with type 1 or type 2 diabetes mellitus and DKA between 2000-2017 at the MacKay Children's Hospital were retrospectively reviewed. AKI was defined by an admission creatinine level >1.5 times the calculated expected baseline creatinine level. Patients were divided into three groups based on AKI severity: no AKI, mild AKI, and severe AKI. In total, 170 (56.5%) patients with DKA presented AKI (mild AKI, 116 [38.5%]; severe AKI, 54 [18.0%]). Heart rate and laboratory parameters related to dehydration, such as corrected sodium level and blood urea nitrogen, were strongly associated with AKI development (P<0.01). Blood pH, plasma glucose, and potassium levels were also associated with AKI. A negative correlation with borderline significance between the estimated glomerular filtration rate (eGFR) and recovery time from metabolic acidosis was observed in the severe AKI group. AKI was highly prevalent in children and adolescents with DKA. An association between AKI and biomarkers indicating dehydration was noted. The recovery time from metabolic acidosis following treatment may be longer in children with a decreased eGFR who present with severe AKI. AKI is a common complication in children with DKA.	[Huang, Shih-Kang; Huang, Chi-Yu; Chiang, Ya-Ting; Lee, Yi-Chen; Yeh, Shu-Nin; Chan, Chon-In; Chua, Wei-Kian; Lee, Yann-Jinn; Ting, Wei-Hsin] MacKay Childrens Hosp, Dept Pediat Endocrinol, Taipei, Taiwan; [Huang, Chi-Yu; Lee, Yann-Jinn; Ting, Wei-Hsin] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Lin, Chao-Hsu; Cheng, Bi-Wen] Hsinchu MacKay Mem Hosp, Dept Pediat Endocrinol, Hsinchu, Taiwan; [Lin, Chao-Hsu] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chiang, Ya-Ting] Ditmanson Med Fdn Chia Yi Christian Hosp, Dept Pediat Endocrinol, Chiayi, Taiwan; [Yeh, Shu-Nin] St Pauls Hosp, Dept Pediat, Taoyuan, Taiwan; [Chan, Chon-In] Ctr Hosp Conde Sao Januario, Dept Pediat, Macau, Taiwan; [Lee, Yann-Jinn] Tamsui MacKay Mem Hosp, Dept Med Res, New Taipei, Taiwan; [Lee, Yann-Jinn] Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan; [Lee, Yann-Jinn] MacKay Med Coll, Inst Biomed Sci, New Taipei, Taiwan; [Ting, Wei-Hsin] MacKay Jr Coll Med Nursing & Management, New Taipei, Taiwan	Mackay Medical College; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management	Ting, WH (corresponding author), MacKay Childrens Hosp, Dept Pediat Endocrinol, Taipei, Taiwan.; Ting, WH (corresponding author), MacKay Med Coll, Dept Med, New Taipei, Taiwan.; Ting, WH (corresponding author), MacKay Jr Coll Med Nursing & Management, New Taipei, Taiwan.	Stczge@ms27.hinet.net		Yeh, Shu-Nin/0000-0002-4378-9764; Huang, Shih Kang/0000-0002-3271-0328				ADROGUE HJ, 1984, KIDNEY INT, V25, P591, DOI 10.1038/ki.1984.62; Al-Matrafi J, 2009, SAUDI J KIDNEY DIS T, V20, P831; Alkandari O, 2011, CRIT CARE, V15, DOI 10.1186/cc10269; [Anonymous], 2012, Bonekey Rep, V1, P19, DOI 10.1038/bonekey.2012.20; Avner ED, 2009, MANAGEMENT CHRONIC K, V6ed, P1662; Baalaaji M, 2018, INDIAN PEDIATR, V55, P311, DOI 10.1007/s13312-018-1274-8; Basu RK, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0016-6; Chan James C M, 2002, Pediatr Rev, V23, P47, DOI 10.1542/pir.23-2-47; Donaghue KC, 2018, PEDIATR DIABETES, V19, P262, DOI 10.1111/pedi.12742; Edge JA, 2016, DIABETIC MED, V33, P1352, DOI 10.1111/dme.13065; Fitzgerald JC, 2016, CRIT CARE MED, V44, P2241, DOI 10.1097/CCM.0000000000002007; Greenberg JH, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-184; Hursh BE, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.0020; Jabbour SA, 2001, CLIN LAB MED, V21, P99; Jefferies CA, 2015, PEDIATR CLIN N AM, V62, P857, DOI 10.1016/j.pcl.2015.04.002; Kaddourah A, 2017, NEW ENGL J MED, V376, P11, DOI 10.1056/NEJMoa1611391; Kawata Hitomi, 2006, J Anesth, V20, P129, DOI 10.1007/s00540-005-0385-2; Kemperman FAW, 2000, J INTERN MED, V248, P511, DOI 10.1046/j.1365-2796.2000.00768.x; Kliegman R., 2015, ACID BASE BALANCE, V20th, P375; Kliegman R., 2015, TYPE 1 DIABETES MELL, V20th, P2773; Koves IH, 2004, DIABETES CARE, V27, P2485, DOI 10.2337/diacare.27.10.2485; Lee MH, 2018, INTERN MED J, V48, P529, DOI 10.1111/imj.13735; Mammen C, 2012, AM J KIDNEY DIS, V59, P523, DOI 10.1053/j.ajkd.2011.10.048; MURDOCH IA, 1993, ACTA PAEDIATR, V82, P498, DOI 10.1111/j.1651-2227.1993.tb12734.x; Newton CA, 2004, ARCH INTERN MED, V164, P1925, DOI 10.1001/archinte.164.17.1925; Ongun EA, 2019, CUMHUR MED J, V41, P42, DOI [10.7197/223.vi.540887, DOI 10.7197/223.VI.540887, 10.7197/223.VI.540887]; Orban JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110925; Raghupathy P, 2015, Indian J Endocrinol Metab, V19, pS55, DOI 10.4103/2230-8210.155403; Razavi Zahra, 2010, Oman Med J, V25, P114, DOI 10.5001/omj.2010.31; Schwartz GJ, 2009, CLIN J AM SOC NEPHRO, V4, P1832, DOI 10.2215/CJN.01640309; Slocum JL, 2012, TRANSL RES, V159, P277, DOI 10.1016/j.trsl.2012.01.014; Toto Robert D, 2004, J Clin Hypertens (Greenwich), V6, P2, DOI 10.1111/j.1524-6175.2004.4064.x; Uber AM, 2020, PEDIATR NEPHROL, V35, P213, DOI 10.1007/s00467-018-4128-7; Viaud M, 2012, PEDIATR NEPHROL, V27, P151, DOI 10.1007/s00467-011-2016-5; von Oettingen JE, 2018, DIABETES RES CLIN PR, V135, P76, DOI 10.1016/j.diabres.2017.09.011; Weissbach A, 2019, PEDIATR CRIT CARE ME, V20, pE10, DOI 10.1097/PCC.0000000000001758; Wolfsdorf J, 2006, DIABETES CARE, V29, P1150, DOI 10.2337/dc06-9909; Wolfsdorf JI, 2018, PEDIATR DIABETES, V19, P155, DOI 10.1111/pedi.12701	38	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239160	10.1371/journal.pone.0239160	http://dx.doi.org/10.1371/journal.pone.0239160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027293	Green Published, gold			2022-12-26	WOS:000581808000003
J	Shulman, HC; Bullock, OM				Shulman, Hillary C.; Bullock, Olivia M.			Don't dumb it down: The effects of jargon in COVID-19 crisis communication	PLOS ONE			English	Article							SCIENCE; METACOGNITION; LANGUAGE	Experts are typically advised to avoid jargon when communicating with the general public, but previous research has not established whether avoiding jargon is necessary in a crisis. Using the ongoing COVID-19 pandemic as a backdrop, this online survey experiment (N= 393) examined the effect of jargon use across three different topics that varied in situational urgency: COVID-19 (high urgency), flood risk (low urgency), and federal emergency policy (control). Results revealed that although the use of jargon led to more difficult processing and reduced persuasion for the two less-urgent topics (flood risk, emergency policy), there was no effect of jargon in the COVID-19 condition. Theoretically, these findings suggest that the motivation to process information is an important moderator for crisis communication in particular and science communication in general. Practically, these findings suggest that science communicators, during times of crisis, do not need to "dumb down" their language in the same way they should during non-crises.	[Shulman, Hillary C.; Bullock, Olivia M.] Ohio State Univ, Sch Commun, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Shulman, HC (corresponding author), Ohio State Univ, Sch Commun, Columbus, OH 43210 USA.	shulman.36@osu.edu	Shulman, Hillary/AAN-8625-2021	Shulman, Hillary/0000-0001-7525-8119; Bullock, Olivia/0000-0001-5403-7149	School of Communication at Ohio State University	School of Communication at Ohio State University	this research was funded through the lead author's personal research funds, granted through the School of Communication at Ohio State University. That said, it remains that the funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript. Moreover, neither author received a salary for this work	Alter AL, 2009, PERS SOC PSYCHOL REV, V13, P219, DOI 10.1177/1088868309341564; [Anonymous], 2009, Aust Nurs J, V16, P30; [Anonymous], 2006, TRAINING, V43, P20; Appelman A, 2016, J MASS COMMUN Q, V93, P59, DOI 10.1177/1077699015606057; Bullock OM, 2019, PUBLIC UNDERST SCI, V28, P845, DOI 10.1177/0963662519865687; Chmielewski M, 2020, SOC PSYCHOL PERS SCI, V11, P464, DOI 10.1177/1948550619875149; David YBB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0222250; Dragojevic M, 2020, COMMUN MONOGR, V87, P158, DOI 10.1080/03637751.2019.1663543; Halliday MAK, 2003, WRITING SCI LIT DISC; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171394; Krieger JL, 2017, J LANG SOC PSYCHOL, V36, P3, DOI 10.1177/0261927X16663256; Litman L, 2017, BEHAV RES METHODS, V49, P433, DOI 10.3758/s13428-016-0727-z; Merriam-Webster.com, 2016, JARG; Nisbet EC, 2015, ANN AM ACAD POLIT SS, V658, P36, DOI 10.1177/0002716214555474; Petty R.E., 1986, COMMUN PERSUATION, P123; Petty R.E., 2007, SOCIAL PSYCHOL HDB B, V2nd ed., P254, DOI DOI 10.1016/J.EPLEPSYRES.2008.03.002; Schwarz N., 2011, HDB THEORIES SOCIAL, VOne, P289; Schwarz N., 2015, APA HDB PERSONALITY, V1, P203, DOI [10.1037/14341-006, DOI 10.1037/14341-006]; Scrimshaw SC, 2019, P NATL ACAD SCI USA, V116, P7650, DOI 10.1073/pnas.1807218116; Shulman HC, 2020, J LANG SOC PSYCHOL, V39, P579, DOI 10.1177/0261927X20902177; Shulman HC, 2018, HUM COMMUN RES, V44, P155, DOI 10.1093/hcr/hqx006; Shulman HC, 2018, J LANG SOC PSYCHOL, V37, P224, DOI 10.1177/0261927X17707557; Slater Michael D, 2015, Commun Yearb, V39, P3; Sweitzer MD, 2018, PUBLIC OPIN QUART, V82, P745, DOI 10.1093/poq/nfy034	26	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239524	10.1371/journal.pone.0239524	http://dx.doi.org/10.1371/journal.pone.0239524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3SJ	33027268	gold, Green Published			2022-12-26	WOS:000581808000007
J	van de Groep, S; Zanolie, K; Green, KH; Sweijen, SW; Crone, EA				van de Groep, Suzanne; Zanolie, Kiki; Green, Kayla H.; Sweijen, Sophie W.; Crone, Eveline A.			A daily diary study on adolescents' mood, empathy, and prosocial behavior during the COVID-19 pandemic	PLOS ONE			English	Article							FAIRNESS	Adolescence is a formative phase for social development. The COVID-19 pandemic and associated regulations have led to many changes in adolescents' lives, including limited opportunities for social interactions. The current exploratory study investigated the effect of the first weeks of COVID-19 pandemic lockdown on Dutch adolescents' (N= 53 with attrition, N= 36 without attrition) mood, empathy, and prosocial behavior. Longitudinal analyses comparing pre-pandemic measures to a three-week peri-pandemic daily diary study showed (i) decreases in empathic concern, opportunities for prosocial actions, and tension, (ii) stable levels of social value orientation, altruism, and dire prosociality, and (iii) increased levels of perspective-taking and vigor during the first weeks of lockdown. Second, this study investigated peri-pandemic effects of familiarity, need, and deservedness on giving behavior. To this end, we utilized novel hypothetical Dictator Games with ecologically valid targets associated with the COVID-19 pandemic. Adolescents showed higher levels of giving to a friend (a familiar other, about 51% of the total share), a doctor in a hospital (deserving target, 78%), and individuals with COVID-19 or a poor immune system (targets in need, 69 and 63%, respectively) compared to an unfamiliar peer (39%) This suggests that during the pandemic need and deservedness had a greater influence on adolescent giving than familiarity. Overall, this study demonstrates detrimental effects of the first weeks of lockdown on adolescents' empathic concern and opportunities for prosocial actions, which are important predictors of healthy socio-emotional development. However, adolescents also showed marked resilience and a willingness to benefit others as a result of the lockdown, as evidenced by improved perspective-taking and mood, and high sensitivity to need and deservedness in giving to others.	[van de Groep, Suzanne; Green, Kayla H.; Sweijen, Sophie W.; Crone, Eveline A.] Erasmus Univ, Erasmus Sch Social & Behav Sci, Rotterdam, Netherlands; [van de Groep, Suzanne; Zanolie, Kiki; Green, Kayla H.; Sweijen, Sophie W.; Crone, Eveline A.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Zanolie, Kiki] Leiden Univ, Inst Psychol, Dept Dev & Educ Psychol, Leiden, Netherlands	Erasmus University Rotterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	van de Groep, S (corresponding author), Erasmus Univ, Erasmus Sch Social & Behav Sci, Rotterdam, Netherlands.; van de Groep, S (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	s.vandegroep@essb.eur.nl	Green, Kayla/AAC-4618-2022; van de Groep, Suzanne/ABH-3488-2020	Green, Kayla/0000-0001-6962-4047; van de Groep, Suzanne/0000-0001-6135-0053; Zanolie, Kiki/0000-0001-6101-1000	European Research Council [ERC CoG PROSOCIAL 681632]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by an innovative ideas grant of the European Research Council (ERC CoG PROSOCIAL 681632 to E.A.C.)	[Anonymous], 2020, GEL OND DRUK PROF; Asscheman JS, 2020, INT J BEHAV DEV, V44, P412, DOI 10.1177/0165025420911094; Bilancini E., 2020, PSYARXIV; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blankenstein NE, 2020, CHILD DEV, V91, pE665, DOI 10.1111/cdev.13292; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Branas-Garza P., 2020, PSYARXIV; Brooks S, 2020, BMJ MILITARY HEALTH, V166, P52, DOI 10.1136/jramc-2017-000876; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Campos-Mercade P, 2020, SSRN ELECT J; Cappelen AW, 2020, SSRN ELECT J; Carlo G, 2003, J EARLY ADOLESCENCE, V23, P107, DOI 10.1177/0272431602239132; Chi C.K., DUAL APPROACH AGENCY, DOI [10.2139/ssrn.4128083, DOI 10.2139/SSRN.4128083, DOI 10.2139/SSRN.3409146]; Crone EA, 2020, ANNU REV PSYCHOL, V71, P447, DOI 10.1146/annurev-psych-010419-050937; Crone EA, 2013, CHILD DEV PERSPECT, V7, P97, DOI 10.1111/cdep.12022; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Everett JAC, 2020, PSYARXIV; Franzen A, 2013, EXP ECON, V16, P155, DOI 10.1007/s10683-012-9337-5; Fried E, 2020, MENTAL HLTH SOCIAL C; Fuligni AJ, 2019, PERSPECT PSYCHOL SCI, V14, P331, DOI 10.1177/1745691618805437; Galizzi MM, 2019, MANAGE SCI, V65, P976, DOI 10.1287/mnsc.2017.2908; Guroglu B, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00291; KAHNEMAN D, 1986, J BUS, V59, pS285, DOI 10.1086/296367; Masten Ann S, 2020, Advers Resil Sci, V1, P95, DOI 10.1007/s42844-020-00010-w; Matthews GA, 2019, ANN NY ACAD SCI, V1457, P5, DOI 10.1111/nyas.14016; McDonald NM, FREE WILL EMOTIONS M, P36; Murphy RO, 2011, 1804189 SOC SCI RES; Muth C, 2016, EDUC PSYCHOL MEAS, V76, P64, DOI 10.1177/0013164415580432; Orben A, 2020, LANCET CHILD ADOLESC; Poulin F, 2010, DEV REV, V30, P257, DOI 10.1016/j.dr.2009.01.001; Salmela-Aro K, 2012, J ADOLESCENCE, V35, P929, DOI 10.1016/j.adolescence.2012.01.001; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Swango D, 2014, INT HIST REV, V36, P210, DOI 10.1080/07075332.2013.866152; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; van de Groep S, 2020, J RES ADOLESCENCE, V30, P290, DOI 10.1111/jora.12491; van Hoorn J, 2016, CURR OPIN BEHAV SCI, V10, P59, DOI 10.1016/j.cobeha.2016.05.007; Wald F, 1990, NED TIJDSCHR PSYCHOL; Wang CS, 2018, PERS SOC PSYCHOL B, V44, P928, DOI 10.1177/0146167218757453; Will GJ, 2016, STUD NEUROSCI, P293, DOI 10.1007/978-3-642-35923-1_15; Yeager DS, 2018, PERSPECT PSYCHOL SCI, V13, P101, DOI 10.1177/1745691617722620; Zettler I., 2020, PSYARXIV	43	51	51	8	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240349	10.1371/journal.pone.0240349	http://dx.doi.org/10.1371/journal.pone.0240349			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3SJ	33027308	gold, Green Published			2022-12-26	WOS:000581808000006
J	Zhang, QQ; Shi, FJ; Abdullahi, NM; Shao, LQ; Huo, XX				Zhang, Qiangqiang; Shi, Fanji; Abdullahi, Nazir Muhammad; Shao, Liqun; Huo, Xuexi			An empirical study on spatial-temporal dynamics and influencing factors of apple production in China	PLOS ONE			English	Article							FARMERS; IMPACTS	In the context of supply-side structural reform, revealing the characteristics of spatial-temporal dynamics and influencing factors of China's apple production layout is of great significance to ensure apple supply and demand balance and timely adjustment of industrial policies and regional layout strategies. Based on national and provincial apple production data from 1978 to 2016, this study used the apple production concentration index to analyse the evolution characteristics of regional apple production patterns in China. A theoretical analysis framework was established and a spatial econometric model was used to quantitatively explore the influencing factors of China's apple production layout. The results showed that, first, since the reform and opening-up policy, a general trend of fluctuating growth was found for apple production in China. The centre of apple production layout moved in the southwest direction, with the shift from the Bohai Bay region to the Loess Plateau region. Second, apple production had a significant spatial correlation, while the degree of spatial agglomeration gradually decreased. Third, these changes were significantly influenced by apple comparative income, infrastructure, policies, and climatic conditions. Therefore, it is necessary to continue optimizing and adjusting the apple spatial layout to enhance the technological progress and economic effect of the apple industry and to ensure the stability and balance of regional supply and demand.	[Zhang, Qiangqiang; Abdullahi, Nazir Muhammad; Shao, Liqun; Huo, Xuexi] Northwest A&F Univ, Coll Econ & Management, Yangling, Shaanxi, Peoples R China; [Zhang, Qiangqiang; Abdullahi, Nazir Muhammad; Shao, Liqun; Huo, Xuexi] Northwest A&F Univ, Ctr Western Rural Dev, Yangling, Shaanxi, Peoples R China; [Shi, Fanji] Univ Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; University of Chinese Academy of Sciences, CAS	Huo, XX (corresponding author), Northwest A&F Univ, Coll Econ & Management, Yangling, Shaanxi, Peoples R China.; Huo, XX (corresponding author), Northwest A&F Univ, Ctr Western Rural Dev, Yangling, Shaanxi, Peoples R China.	xuexihuo@nwafu.edu.cn	Abdullahi, Nazir Muhammad/AHB-9200-2022; Zhang, Qiangqiang/CAJ-5422-2022; Huo, Xuexi/GPG-3739-2022	Zhang, Qiangqiang/0000-0002-5270-9957; Huo, Xuexi/0000-0002-8263-9101; Abdullahi, Nazir Muhammad/0000-0003-2149-0638	earmarked fund of China Agriculture Research System [CARS-28]; National Natural Science Foundation of China [71573211, 71603207]; Projects of Humanities and Social Sciences [16YJC790085]; National Modern Apple Industry Technology System of the China Agriculture Research System, Center of Western Rural Development-Northwest AF University	earmarked fund of China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of Humanities and Social Sciences; National Modern Apple Industry Technology System of the China Agriculture Research System, Center of Western Rural Development-Northwest AF University	This study was funded by the earmarked fund of China Agriculture Research System (No. CARS-28), the National Natural Science Foundation of China (No.71573211 and No.71603207), and the Projects of Humanities and Social Sciences (No.16YJC790085). Financial and personnel support also comes from the National Modern Apple Industry Technology System of the China Agriculture Research System, Center of Western Rural Development-Northwest A&F University and all the participants.	[Anonymous], 2012, INT J SPORTS MED, V33, P36; [Anonymous], 1971, AGR DEV INT PERSPECT; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 2001, AM J AGR ECON, V83, P705, DOI 10.1111/0002-9092.00194; Anselin L, 2007, SOC INDIC RES, V82, P287, DOI 10.1007/s11205-006-9034-x; Anselin L, 2010, PAP REG SCI, V89, P3, DOI 10.1111/j.1435-5957.2010.00279.x; Ates HC, 2017, LAND USE POLICY, V69, P298, DOI 10.1016/j.landusepol.2017.09.029; Bai X.G., 2015, ECON GEOGR, V35, P130, DOI [10.15957/j.cnki.jjdl.2015.06.018, DOI 10.15957/J.CNKI.JJDL.2015.06.018]; Birthal PS, 2019, AGR SYST, V173, P345, DOI 10.1016/j.agsy.2019.03.005; Cai R, 2016, BRIT FOOD J, V118, P858, DOI 10.1108/BFJ-11-2015-0456; Canavari M., 2002, British Food Journal, V104, P220, DOI 10.1108/00070700210425688; Deng X, 2018, MODERN AGR EQUIPMENT, P13; Ditlevsen K, 2020, APPETITE, V147, DOI 10.1016/j.appet.2019.104544; Dobbs M, 2006, BRIT FOOD J, V108, P574, DOI 10.1108/00070700610676389; Dubin RA, 1998, J HOUS ECON, V7, P304, DOI 10.1006/jhec.1998.0236; Feng XiaoLong, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P204; Fleary SA, 2020, APPETITE, V147, DOI 10.1016/j.appet.2019.104546; Gallardo RK, 2015, AGRIC FINANCE REV, V75, P514, DOI 10.1108/AFR-05-2015-0022; Griffith D, 1988, ADV SPATIAL STAT; Gupta R, 2019, AGR SYST, V173, P1, DOI 10.1016/j.agsy.2019.01.009; Hurgobin Y, 2020, FOOD QUAL PREFER, V81, DOI 10.1016/j.foodqual.2019.103860; INOUYE A., 2019, FRESH DECIDUOUS FRUI; Jin G, 2019, ECOL INDIC, V105, P591, DOI 10.1016/j.ecolind.2018.05.073; Khan I, 2019, ENVIRON SCI POLLUT R, V26, P33076, DOI 10.1007/s11356-019-06448-5; Khan I, 2018, ECOL INDIC, V93, P627, DOI 10.1016/j.ecolind.2018.05.018; Lin JYF, 1997, FOOD POLICY, V22, P201, DOI 10.1016/S0306-9192(97)00009-2; LIU HC, 2018, SUSTAINABILITY-BASEL, V10, DOI DOI 10.3390/SU10093037; Liu RF, 2019, FOOD POLICY, V88, DOI 10.1016/j.foodpol.2019.101768; Ma WL, 2016, CHINA AGR ECON REV, V8, P2, DOI 10.1108/CAER-04-2015-0035; Marette S, 2012, FOOD POLICY, V37, P151, DOI 10.1016/j.foodpol.2011.12.001; Mergenthaler M, 2009, FOOD POLICY, V34, P426, DOI 10.1016/j.foodpol.2009.03.009; Min M, 2014, IEEE J-STARS, V7, P4453, DOI 10.1109/JSTARS.2014.2325898; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; National Bureau of Statistics of China (NBSC), 1996, CHINA STAT YEAR; National Bureau of Statistics of China (NBSC), 1985, CHIN RUR STAT YEAR; Poole ND, 2007, FOOD POLICY, V32, P175, DOI 10.1016/j.foodpol.2006.05.004; Porsch A, 2018, AGRIC FINANCE REV, V78, P532, DOI 10.1108/AFR-07-2017-0062; Samani R. E., 2015, International Journal of Agricultural Management and Development, V5, P235; Sridharan S, 2007, SOC SCI MED, V65, P1942, DOI 10.1016/j.socscimed.2007.05.052; [王伟新 Wang Weixin], 2017, [农业现代化研究, Research of Agricultural Modernization], V38, P493; Xia CQ, 2020, LAND USE POLICY, V90, DOI 10.1016/j.landusepol.2019.104276; Xiao Z, 2018, J GEOGR SCI, V28, P275, DOI 10.1007/s11442-018-1472-2; Yang H, 1999, WORLD DEV, V27, P2137, DOI 10.1016/S0305-750X(99)00107-2; Yu X, 2019, J CLEAN PROD, V212, P610, DOI 10.1016/j.jclepro.2018.12.063; [张聪颖 Zhang Congying], 2018, [经济地理, Economic Geography], V38, P141; ZHANG CY, 2019, SUSTAINABILITY BASEL, DOI DOI 10.3390/SU11195411; Zhang F., 2017, J AGROTECHNICAL EC, V5, P57, DOI [DOI 10.13246/J.CNKI.JAE.2017.05.006, 10.13246/j.cnki.jae.2017.05.006]; Zhang QQ, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10124525; ZHANG Y., 2018, J AGROTECHNICAL EC, P112, DOI DOI 10.13246/J.CNKI.JAE.2018.09.010	50	9	9	20	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240140	10.1371/journal.pone.0240140	http://dx.doi.org/10.1371/journal.pone.0240140			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3SJ	33027300	Green Published, gold			2022-12-26	WOS:000581808000042
J	Auger, J; Markel, J; Pecoski, DD; Leiva-Molano, N; Talavage, TM; Leverenz, L; Shen, FC; Nauman, EA				Auger, Joshua; Markel, Justin; Pecoski, Dimitri D.; Leiva-Molano, Nicolas; Talavage, Thomas M.; Leverenz, Larry; Shen, Francis; Nauman, Eric A.			Factors affecting peak impact force during soccer headers and implications for the mitigation of head injuries	PLOS ONE			English	Article							HIGH-SCHOOL; UNITED-STATES; CONCUSSIONS; FOOTBALL; PERFORMANCE; PLAYERS	It has been documented that up to 22% of all soccer injuries are concussions. This is in part due to players purposely using their head to direct the ball during play. To provide a more complete understanding of head trauma in soccer athletes, this study characterized the effects of four soccer ball characteristics (size, inflation pressure, mass, velocity) on the resulting peak impact force as it relates to the potential for incurring neurophysiological changes. A total of six hundred trials were performed on size 4 and 5 soccer balls as well as a novel lightweight soccer ball. Impact force was measured with a force plate and ball velocity was determined using motion capture. These data were used, in conjunction with dimensional analysis to relate impact force to ball size, mass, velocity, and pressure. Reasonable reductions in allowable ball parameters resulted in a 19.7% decrease in peak impact force. Adjustments to ball parameters could reduce a high cumulative peak translational acceleration soccer athlete down into a previously defined safer low loading range. In addition, it was noted that water absorption by soccer balls can result in masses that substantially increase impact force and quickly surpass the NCAA weight limit for game play. Additional research is required to determine whether varying soccer ball characteristics will enable soccer players to avoid persistent neurophysiological deficits or what additional interventions may be necessary and the legal implications of these data are discussed.	[Auger, Joshua; Markel, Justin; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Pecoski, Dimitri D.; Leiva-Molano, Nicolas; Talavage, Thomas M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Leverenz, Larry; Nauman, Eric A.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Shen, Francis] Univ Minnesota, Sch Law, Minneapolis, MN 55455 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Minnesota System; University of Minnesota Twin Cities; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Nauman, EA (corresponding author), Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA.; Nauman, EA (corresponding author), Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA.; Nauman, EA (corresponding author), Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA.	enauman@purdue.edu		Auger, Joshua/0000-0003-4281-8591; Talavage, Thomas/0000-0003-4977-6398; Leiva-Molano, Nicolas/0000-0002-8734-8813				Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Andres K, 2016, NCAA 2016 2017 MENS; [Anonymous], 2016, MATLAB VERS R2016B; [Anonymous], **NON-TRADITIONAL**; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barenblatt G.I, 2003, SCALING; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Breedlove K.M., 2014, ATHL TRAIN SPORT HEA, V6, P119, DOI [10.3928/19425864-20140507-02, DOI 10.3928/19425864-20140507-02]; Broglio SP, 2003, J ATHL TRAINING, V38, P220; com F, 2007, COM F FIFA BIG COUNT; COTTER SC, 1974, J ROY STAT SOC B MET, V36, P267; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Elbin RJ, 2015, RES SPORTS MED, V23, P203, DOI 10.1080/15438627.2015.1005293; FIFA, 2015, GAME ARSBERETNING 20; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koizumi A, 2014, PROCEDIA ENGINEER, V72, P423, DOI 10.1016/j.proeng.2014.06.074; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1111/j.1553-2712.2003.tb01983.x; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Schuff MM, 2013, J MATH BIOL, V67, P1307, DOI 10.1007/s00285-012-0544-7; Soccer USY, 2017, RUL GAM; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, BRAIN IMAGING BEHAV; Taha Z, 2015, SADHANA-ACAD P ENG S, V40, P1567, DOI 10.1007/s12046-015-0383-5; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512	36	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240162	10.1371/journal.pone.0240162	http://dx.doi.org/10.1371/journal.pone.0240162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064732	gold, Green Published			2022-12-26	WOS:000585918300021
J	King, LE; Zhang, HH; Gould, CM; Thomas, DW; Whitehead, LW; Simpson, KJ; Burgess, AW; Faux, MC				King, Lauren E.; Zhang, Hui-Hua; Gould, Cathryn M.; Thomas, Daniel W.; Whitehead, Lachlan W.; Simpson, Kaylene J.; Burgess, Antony W.; Faux, Maree C.			Genes regulating membrane-associated E-cadherin and proliferation in adenomatous polyposis coli mutant colon cancer cells: High content siRNA screen	PLOS ONE			English	Article							MIR-200 FAMILY; PROTEIN; EXPRESSION; REVEALS; TARGET; DIFFERENTIATION; IDENTIFICATION; RESTORATION; TRANSITION; INHIBITION	Truncating mutations in the tumour suppressor gene APC occur frequently in colorectal cancers and result in the deregulation of Wnt signalling as well as changes in cell-cell adhesion. Using quantitative imaging based on the detection of membrane-associated E-cadherin, we undertook a protein coding genome-wide siRNA screen to identify genes that regulate cell surface E-cadherin in the APC-defective colorectal cancer cell line SW480. We identified a diverse set of regulators of E-cadherin that offer new insights into the regulation of cell-cell adhesion, junction formation and genes that regulate proliferation or survival of SW480 cells. Among the genes whose depletion promotes membrane-associated E-cadherin, we identified ZEB1, the microRNA200 family, and proteins such as a ubiquitin ligase UBE2E3, CDK8, sorting nexin 27 (SNX27) and the matrix metalloproteinases, MMP14 and MMP19. The screen also identified 167 proteins required for maintaining E-cadherin at cell-cell adherens junctions, including known junctional proteins,CTNND1 and CTNNA1, as well as signalling enzymes, DUSP4 and MARK2, and transcription factors, TEAD3, RUNX2 and TRAM2. A better understanding of the post-translational regulation of E-cadherin provides new opportunities for restoring cell-cell adhesion in APC-defective cells.	[King, Lauren E.; Zhang, Hui-Hua; Whitehead, Lachlan W.; Burgess, Antony W.; Faux, Maree C.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [King, Lauren E.; Zhang, Hui-Hua; Whitehead, Lachlan W.; Burgess, Antony W.; Faux, Maree C.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Gould, Cathryn M.; Thomas, Daniel W.] Peter MacCallum Canc Ctr, Victorian Ctr Funct Genom, Melbourne, Vic, Australia; [Simpson, Kaylene J.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia; [Burgess, Antony W.] Univ Melbourne, RMH, Dept Surg, Parkville, Vic, Australia; [Thomas, Daniel W.] St Vincents Inst Med Res, Fitzroy, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; St. Vincent's Institute of Medical Research	Burgess, AW; Faux, MC (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.; Burgess, AW; Faux, MC (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.; Burgess, AW (corresponding author), Univ Melbourne, RMH, Dept Surg, Parkville, Vic, Australia.	faux@wehi.edu.au; tburgess@wehi.edu.au			Ludwig Institute for Cancer Research; National Health and Medical Research Council (NH&MRC) Australia Program [487922]; Walter and Eliza Hall Institute; Australian Cancer Research Foundation (ACRF); Australian Phenomics Network (APN) through the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS) program; Peter MacCallum Cancer Centre Foundation	Ludwig Institute for Cancer Research; National Health and Medical Research Council (NH&MRC) Australia Program(National Health and Medical Research Council (NHMRC) of Australia); Walter and Eliza Hall Institute; Australian Cancer Research Foundation (ACRF); Australian Phenomics Network (APN) through the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS) program; Peter MacCallum Cancer Centre Foundation	This work was supported by the Ludwig Institute for Cancer Research, the National Health and Medical Research Council (NH&MRC) Australia Program grant #487922 and the Walter and Eliza Hall Institute. The Victorian Centre for Functional Genomics (K.J.S.) is funded by the Australian Cancer Research Foundation (ACRF), the Australian Phenomics Network (APN) through funding from the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS) program and the Peter MacCallum Cancer Centre Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal M, 2004, ONCOGENE, V23, P1737, DOI 10.1038/sj.onc.1207299; BIRCHMEIER W, 1995, CANCER SURV, V24, P129; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Carothers AM, 2001, J BIOL CHEM, V276, P39094, DOI 10.1074/jbc.M103450200; Chen Y, 2017, EUR REV MED PHARMACO, V21, P2617; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DOLF G, 1991, GENE CHROMOSOME CANC, V3, P48, DOI 10.1002/gcc.2870030109; Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033; Ducharme NA, 2006, MOL BIOL CELL, V17, P3625, DOI 10.1091/mbc.E05-08-0736; Falkenberg KJ, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.17; Faux MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014127; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Ferraro A, 2014, EPIGENETICS-US, V9, P129, DOI 10.4161/epi.26842; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Groschl B, 2013, INT J CANCER, V132, P1537, DOI 10.1002/ijc.27834; Heuberger J, 2009, COLD SPRING HARBOR P, pa002915; Huels DJ, 2015, EMBO J, V34, P2321, DOI 10.15252/embj.201591739; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; King LE, 2016, GENOM DATA, V7, P293, DOI 10.1016/j.gdata.2016.02.001; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Lin H, 2017, BIOMED PHARMACOTHER, V92, P340, DOI 10.1016/j.biopha.2017.05.072; Maier VK, 2015, MOL CELL PROTEOMICS, V14, P1435, DOI 10.1074/mcp.M114.044586; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Minamida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108032; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Serrao A, 2018, ONCOGENE, V37, P4792, DOI 10.1038/s41388-018-0316-y; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Smits R, 2000, GASTROENTEROLOGY, V119, P1045, DOI 10.1053/gast.2000.18162; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Sultan AS, 2005, ONCOGENE, V24, P746, DOI 10.1038/sj.onc.1208203; Toret CP, 2014, J CELL BIOL, V204, P265, DOI 10.1083/jcb.201306082; Wang J, 2017, GASTROENTEROLOGY, V153, P1082, DOI 10.1053/j.gastro.2017.06.008; Zhu XL, 2015, INT J BIOCHEM CELL B, V61, P103, DOI 10.1016/j.biocel.2015.02.005; Zimmerman SP, 2013, BIOCHEM J, V455, P95, DOI 10.1042/BJ20121755	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240746	10.1371/journal.pone.0240746	http://dx.doi.org/10.1371/journal.pone.0240746			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057364	gold, Green Published			2022-12-26	WOS:000581814700060
J	Wendt, R; Nickel, O; Botsch, A; Lindner, M; Bethge, A; Marx, K; Ruf, BR; Beige, J; Lubbert, C				Wendt, Ralph; Nickel, Olaf; Botsch, Almut; Lindner, Margareta; Bethge, Angela; Marx, Kathrin; Ruf, Bernhard R.; Beige, Joachim; Luebbert, Christoph			Low colonization rates with Multidrug-resistant Gram-negative bacteria in a German hospital-affiliated hemodialysis center	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; MORTALITY; PREVALENCE; ORGANISMS; CARE; INFECTION; MDRO	Background Multidrug-resistant Gram-negative bacteria (MDRGN) are found with rising prevalence in non-hemodialysis risk populations as well as hemodialysis (HD) cohorts in Asia, Europe and North America. At the same time, colonization and consecutive infections with such pathogens may increase mortality and morbidity of affected individuals. We aimed to monitor intestinal MDRGN colonization in a yet not investigated German HD population. Methods We performed cross-sectional point-prevalence testing with 12 months follow-up and selected testing of relatives in an out-patient HD cohort of n = 77 patients by using microbiological cultures from fresh stool samples, combined with Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF-MS) and antimicrobial susceptibility testing. Results We detected MDRGN in 8 out of 77 patients (10.4%) and 1 out of 22 relatives (4.5%), indicating only colonization and no infections. At follow-up, 2 patients showed phenotypic persistence of MDRGN colonization, and in 6 other patients de-novo MDRGN colonization could be demonstrated. Pathogens includedEscherichia coliandKlebsiella pneumoniae(with extended-spectrum beta-lactamase [ESBL]-production as well as fluoroquinolone resistance),Stenotrophomonas maltophiliaandEnterobacter cloacae. Conclusions In a single-center study, MDRGN colonization rates were below those found in non-HD high-risk populations and HD units in the US, respectively. Reasons for this could be high hygiene standards and a strict antibiotic stewardship policy with evidence of low consumption of fluoroquinolones and carbapenems in our HD unit and the affiliated hospital.	[Wendt, Ralph; Botsch, Almut; Ruf, Bernhard R.; Beige, Joachim; Luebbert, Christoph] Hosp St Georg, Dept Infect Dis Trop Med Nephrol & Rheumatol, Leipzig, Germany; [Wendt, Ralph; Beige, Joachim] Hosp St Georg, Kuratorium Dialysis & Transplantat KfH, Renal Unit, Leipzig, Germany; [Nickel, Olaf; Lindner, Margareta; Bethge, Angela] Hosp St Georg, Dept Lab Med & Microbiol, Leipzig, Germany; [Marx, Kathrin] Hosp St Georg, Hosp Pharm, Leipzig, Germany; [Beige, Joachim] Martin Luther Univ Halle Wittenberg, Halle, Germany; [Luebbert, Christoph] Leipzig Univ Hosp, Dept Oncol Gastroenterol Hepatol Pneumol & Infect, Div Infect Dis & Trop Med, Leipzig, Germany; [Luebbert, Christoph] Leipzig Univ Hosp, Interdisciplinary Ctr Infect Dis, Leipzig, Germany	Martin Luther University Halle Wittenberg; Leipzig University; Leipzig University	Lubbert, C (corresponding author), Hosp St Georg, Dept Infect Dis Trop Med Nephrol & Rheumatol, Leipzig, Germany.; Lubbert, C (corresponding author), Leipzig Univ Hosp, Dept Oncol Gastroenterol Hepatol Pneumol & Infect, Div Infect Dis & Trop Med, Leipzig, Germany.; Lubbert, C (corresponding author), Leipzig Univ Hosp, Interdisciplinary Ctr Infect Dis, Leipzig, Germany.	christoph.luebbert@medizin.uni-leipzig.de	Wendt, Ralph/AAC-6878-2022; Nickel, Olaf/AAB-5506-2022; Beige, Joachim/A-3446-2017	Wendt, Ralph/0000-0003-1600-6581; Beige, Joachim/0000-0002-1907-825X	German Research Foundation (DFG); Leipzig University	German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	The authors acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, BUNDESGESUNDHEITSBLA, V56, P580, DOI DOI 10.1007/S00103-013-1705-6; [Anonymous], **NON-TRADITIONAL**; Benson L, 2007, INFECT CONT HOSP EP, V28, P880, DOI 10.1086/518454; D'Agata EMC, 2018, CLIN J AM SOC NEPHRO, V13, P666, DOI 10.2215/CJN.13781217; Doi Y, 2017, J TRAVEL MED, V24, pS44, DOI 10.1093/jtm/taw102; Foley RN, 1998, J NEPHROL, V11, P239; Grunewald T, 2013, INT J HYG ENVIR HEAL, V216, P751, DOI 10.1016/j.ijheh.2013.02.005; Hogardt M, 2015, EUROSURVEILLANCE, V20, P23, DOI 10.2807/1560-7917.ES2015.20.26.21171; Kern W, KRANKENHAUSVERGLEICH; Kommission fur Krankenhaushygiene und Infektionspravention beim Robert Koch-Institut, 2011, EPIDEMIOL B, P337; Kommission fur Krankenhaushygiene und Infektionspravention (KRINKO) beim Robert Koch-Institut (RKI), 2012, BUNDESGESUNDHEITSBLA, V55, P1311, DOI DOI 10.1007/S00103-012-1549-5; Lacson E, 2009, AM J KIDNEY DIS, V53, P79, DOI 10.1053/j.ajkd.2008.07.031; Lentino JR, 2000, INFECTION, V28, P355, DOI 10.1007/s150100070005; Lubbert C, 2015, INT J MED MICROBIOL, V305, P148, DOI 10.1016/j.ijmm.2014.12.001; Lubbert C, 2014, AM J INFECT CONTROL, V42, P376, DOI 10.1016/j.ajic.2013.12.001; Maechler F, 2015, INFECTION, V43, P163, DOI 10.1007/s15010-014-0701-6; Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764; Meurs L, 2020, TRAVEL MED INFECT DI, V33, DOI 10.1016/j.tmaid.2019.101521; Murray EC, 2015, NEPHROL DIAL TRANSPL, V30, P1202, DOI 10.1093/ndt/gfv205; Neumann N, 2016, BUNDESGESUNDHEITSBLA, V59, P292, DOI 10.1007/s00103-015-2290-7; Ny S, 2018, EUR J CLIN MICROBIOL, V37, P2347, DOI 10.1007/s10096-018-3382-8; O'Fallon E, 2009, INFECT CONT HOSP EP, V30, P1172, DOI 10.1086/648453; Pop-Vicas A, 2008, CLIN J AM SOC NEPHRO, V3, P752, DOI 10.2215/CJN.04651107; Vardakas KZ, 2013, J INFECTION, V66, P401, DOI 10.1016/j.jinf.2012.10.028; Warren DK, 2004, CRIT CARE MED, V32, P2450, DOI 10.1097/01.CCM.0000147685.79487.28; Wendt S, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taz068	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240314	10.1371/journal.pone.0240314	http://dx.doi.org/10.1371/journal.pone.0240314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057439	gold, Green Published			2022-12-26	WOS:000581814700003
J	Gawlik, D; Ruppelt-Lorz, A; Muller, E; Reissig, A; Hotzel, H; Braun, SD; Soderquist, B; Ziegler-Cordts, A; Stein, C; Pletz, MW; Ehricht, R; Monecke, S				Gawlik, Darius; Ruppelt-Lorz, Antje; Mueller, Elke; Reissig, Annett; Hotzel, Helmut; Braun, Sascha D.; Soederquist, Bo; Ziegler-Cordts, Albrecht; Stein, Claudia; Pletz, Mathias W.; Ehricht, Ralf; Monecke, Stefan			Molecular investigations on a chimeric strain ofStaphylococcus aureussequence type 80	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PVL-POSITIVE MRSA; EMERGENCE; CLONE; EPIDEMIOLOGY; PREVALENCE; SEQUENCE; GENES	A PVL-positive, methicillin-susceptibleStaphylococcus aureuswas cultured from pus from cervical lymphadenitis of a patient of East-African origin. Microarray hybridisation assigned the isolate to clonal complex (CC) 80 but revealed unusual features, including the presence of the ORF-CM14 enterotoxin homologue and of an ACME-III element as well as the absence ofetDandedinB. The isolate was subjected to both, Illumina and Nanopore sequencing allowing characterisation of deviating regions within the strain ' s genome. Atypical features of this strain were attributable to the presence of two genomic regions that originated from otherS.aureuslineages and that comprised, respectively, 3% and 1.4% of the genome. One deviating region extended fromwalJtosirB. It comprised ORF-CM14 and the ACME-III element. A homologous but larger fragment was also found in an atypicalS.aureusCC1/ST567 strain whose lineage might have served as donor of this genomic region. This region itself is a chimera comprising fragments from CC1 as well as fragments of unknown origin. The other deviating region comprised the region fromhtsBtoecfA2,i.e., another 3% of the genome. It was very similar to CC1 sequences. Either this suggests an incorporation of CC1 DNA into the study strain, or alternatively a recombination event affecting "canonical" CC80. Thus, the study strain bears witness of several recombination events affecting supposedly core genomic genes. Although the exact mechanism is not yet clear, such chimerism seems to be an additional pathway in the evolution ofS.aureus. This could facilitate also a transmission of virulence and resistance factors and therefore offer an additional evolutionary advantage.	[Gawlik, Darius; Stein, Claudia; Pletz, Mathias W.] Univ Hosp, Inst Infect Dis & Infect Control, Jena, Germany; [Gawlik, Darius] PTC Phage Technol Ctr GmbH, Bonen, Germany; [Ruppelt-Lorz, Antje; Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany; [Mueller, Elke; Reissig, Annett; Braun, Sascha D.; Ehricht, Ralf; Monecke, Stefan] Leibniz Inst Photon Technol IPHT, Jena, Germany; [Mueller, Elke; Reissig, Annett; Braun, Sascha D.; Ehricht, Ralf; Monecke, Stefan] InfectoGnost Res Campus, Jena, Germany; [Hotzel, Helmut] Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany; [Soederquist, Bo] Orebro Univ, Sch Med Sci, Dept Lab Med, Clin Microbiol,Fac Med & Hlth, Orebro, Sweden; [Ziegler-Cordts, Albrecht] T Syst Multimedia Solut GmbH, Dresden, Germany; [Ehricht, Ralf] Jena Univ, Inst Phys Chem, Jena, Germany	Friedrich Schiller University of Jena; Technische Universitat Dresden; Leibniz Institut fur Photonische Technologien; Friedrich Loeffler Institute; Orebro University	Monecke, S (corresponding author), Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany.; Monecke, S (corresponding author), Leibniz Inst Photon Technol IPHT, Jena, Germany.; Monecke, S (corresponding author), InfectoGnost Res Campus, Jena, Germany.	stefan.monecke@leibniz-ipht.de	Pletz, Mathias Wilhelm/H-9782-2019	Pletz, Mathias Wilhelm/0000-0001-8157-2753; Soderquist, Bo/0000-0001-5939-2932				Antri K, 2011, CLIN MICROBIOL INFEC, V17, P526, DOI 10.1111/j.1469-0691.2010.03273.x; Basset P, 2015, J INFECT DEV COUNTR, V9, P206, DOI 10.3855/jidc.4620; Ben Nejma M, 2013, DIAGN MICR INFEC DIS, V77, P20, DOI 10.1016/j.diagmicrobio.2008.02.010; Ben Slama K, 2011, EUR J CLIN MICROBIOL, V30, P499, DOI 10.1007/s10096-010-1109-6; Boswihi SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162744; Budd KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134592; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P2027, DOI 10.1128/JCM.41.5.2027-2032.2003; Djoudi F, 2013, NEW MICROBIOL, V36, P49; Driebe EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130955; Dunne WM, 2018, INFECT GENET EVOL, V63, P332, DOI 10.1016/j.meegid.2017.09.019; Everitt RG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4956; Faria NA, 2005, J CLIN MICROBIOL, V43, P1836, DOI 10.1128/JCM.43.4.1836-1842.2005; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Fetsch A, 2017, CLIN INFECT DIS, V64, P102, DOI 10.1093/cid/ciw687; Fuoad Sura Ali, 2014, RRJDS, V2, P100; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Herrmann M, 2013, FUTURE MICROBIOL, V8, P17, DOI [10.2217/fmb.12.126, 10.2217/FMB.12.126]; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Krziwanek K, 2007, EUR J CLIN MICROBIOL, V26, P931, DOI 10.1007/s10096-007-0391-4; Maier J, 2005, EUR J CLIN MICROBIOL, V24, P637, DOI 10.1007/s10096-005-0008-8; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01436; Monecke S, 2018, VET MICROBIOL, V217, P36, DOI 10.1016/j.vetmic.2018.02.024; Monecke S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162654; Monecke S, 2014, APMIS, V122, P580, DOI 10.1111/apm.12181; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nimmo GR, 2015, CLIN MICROBIOL INFEC, V21, P444, DOI 10.1016/j.cmi.2014.12.018; Otter JA, 2008, CLIN MICROBIOL INFEC, V14, P670, DOI 10.1111/j.1469-0691.2008.02017.x; Robinson DA, 2005, J BACTERIOL, V187, P8312, DOI 10.1128/JB.187.24.8312-8321.2005; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Schaumburg F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001150; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; Shittu AO, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01160; Spoor LE, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000036; Stegger M, 2014, MBIO, V5, DOI 10.1128/mBio.01044-14; Strauss L, 2016, J CLIN MICROBIOL, V54, P1008, DOI 10.1128/JCM.03022-15; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Udo EE, 2010, J MED MICROBIOL, V59, P193, DOI 10.1099/jmm.0.013268-0; Vourli S, 2005, Euro Surveill, V10, P78; Watanabe S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005714; Wildeman P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62751-z	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0232071	10.1371/journal.pone.0232071	http://dx.doi.org/10.1371/journal.pone.0232071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052925	Green Submitted, Green Published, gold			2022-12-26	WOS:000581820200037
J	Hassan, S; Peluso, J; Chalhoub, S; Gillet, YI; Benkirane-Jessel, N; Rochel, N; Fuhrmann, G; Ubeaud-Sequier, G				Hassan, Sarah; Peluso, Jean; Chalhoub, Sandra; Idoux Gillet, Ysia; Benkirane-Jessel, Nadia; Rochel, Natacha; Fuhrmann, Guy; Ubeaud-Sequier, Genevieve			Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1 alpha and MDR1	PLOS ONE			English	Article							PANCREATIC-CANCER; INTERVENTION; EXPRESSION	The impact of cancer on lifespan is significantly increasing worldwide. Enhanced activity of drug efflux pumps and the incidences of the tumor microenvironment such as the apparition of a hypoxic gradient inside of the bulk tumor, are the major causes of chemotherapy failure. For instance, expression of Hypoxia-inducible factor (HIF-1 alpha) has been associated with metastasis, resistance to chemotherapy and reduced survival rate. One of the current challenges to fight against cancer is therefore to find new molecules with therapeutic potential that could overcome this chemoresistance. In the present study, we focused on the bioactive plant flavonoid quercetin, which has strong antioxidant and anti-proliferative properties. We examined the efficacy of combined treatments of quercetin and the anti-cancer drugs gemcitabine and doxorubicin, known to specifically act on human pancreatic and hepatic cancer cells, respectively. Moreover, our study aimed to investigate more in-depth the implication of the multidrug transporter MDR1 and HIF-1 alpha n chemoresistance and if quercetin could act on the activity of the drug efflux pumps and the hypoxia-associated effects. We observed that the anti-cancer drugs, were more effective when administered in combination with quercetin, as shown by an increased percentage of dead cells up to 60% in both 2D and 3D cultures. In addition, our results indicated that the combination of anti-cancer drugs and quercetin down-regulated the expression of HIF-1 alpha and increased the expression levels of the regulator of apoptosis p53. Moreover, we observed that quercetin could inhibit the efflux activity of MDR1. Finally, our in vitro study suggests that the efficiency of the chemotherapeutic activity of known anti-cancer drugs might be significantly increased upon combination with quercetin. This flavonoid may therefore be a promising pharmacological agent for novel combination therapy since it potentializes the cytotoxic activity of gemcitabine and doxorubicin on by targeting the chemoresistance developed by the pancreatic and liver cancer cells respectively.	[Hassan, Sarah; Idoux Gillet, Ysia; Benkirane-Jessel, Nadia; Fuhrmann, Guy; Ubeaud-Sequier, Genevieve] Univ Strasbourg, Regenerat Nanomed, INSERM UMR 1260, FMTS, Strasbourg, France; [Hassan, Sarah; Peluso, Jean; Ubeaud-Sequier, Genevieve] Univ Strasbourg, Fac Pharm, Platform EBiocyt UPS1401, Strasbourg, France; [Chalhoub, Sandra; Rochel, Natacha] Univ Strasbourg, Dept Integrat Struct Biol, Inst Genet & & Biol Mol Cellulaire, INSERM,U964,CNRS,UMR 7104, Strasbourg, France; [Ubeaud-Sequier, Genevieve] Strasbourg Univ Hosp, Dept Pharm, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hassan, S (corresponding author), Univ Strasbourg, Regenerat Nanomed, INSERM UMR 1260, FMTS, Strasbourg, France.; Hassan, S (corresponding author), Univ Strasbourg, Fac Pharm, Platform EBiocyt UPS1401, Strasbourg, France.	sarah.w.hassan@gmail.com	Rochel, Natacha/A-5718-2016	Rochel, Natacha/0000-0002-3573-5889; Idoux-Gillet, Ysia/0000-0002-0436-1968; hassan, sarah/0000-0002-0025-2895				Abdallah HM, 2015, J ADV RES, V6, P45, DOI 10.1016/j.jare.2014.11.008; Adcock A., 2015, J ANAL BIOANAL TECH, V6, P3; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Barannyk LL, 2012, MATH COMPUT SIMULAT, V82, P1008, DOI 10.1016/j.matcom.2010.11.015; Berrouet C, 2020, BIORXIV; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; Breslin S, 2016, ONCOTARGET, V7, P45745, DOI 10.18632/oncotarget.9935; Brito AF, 2015, CURR MED CHEM, V22, P3025, DOI 10.2174/0929867322666150812145435; Chang JE, 2012, PHARM RES-DORDR, V29, P795, DOI 10.1007/s11095-011-0603-6; Duval K, 2017, PHYSIOLOGY, V32, P266, DOI 10.1152/physiol.00036.2016; Eales KL, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.50; Griffiths Keith, 2016, Diseases, V4, DOI 10.3390/diseases4030028; Guo JH, 2017, CHINESE MED J-PEKING, V130, P203, DOI 10.4103/0366-6999.198003; Hassan S, 2017, INT J CURR ADV RES S, V6, P7275; Herrmann D, 2014, CARCINOGENESIS, V35, P1671, DOI 10.1093/carcin/bgu108; Kanji ZS, 2018, ANN SURG ONCOL, V25, P1052, DOI 10.1245/s10434-018-6334-8; Kee JY, 2016, PHYTOMEDICINE, V23, P1680, DOI 10.1016/j.phymed.2016.09.011; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Lee YH, 2017, ONCOL LETT, V14, P171, DOI 10.3892/ol.2017.6132; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Mohammed A, 2015, CANCERS, V7, P1499, DOI 10.3390/cancers7030850; Mokhtari RB, 2017, ONCOTARGET, V8, P38022, DOI 10.18632/oncotarget.16723; Nadia Salem Alrawaiq, 2014, International Journal of PharmTech Research, V6, P933; Nakagawa T, 2009, CANCER LETT, V273, P250, DOI 10.1016/j.canlet.2008.08.004; Polya G., 1921, Math. Ann., V84, P149, DOI DOI 10.1007/BF01458701; Pratheeshkumar P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/324021; Pratheeshkumar P, 2014, TOXICOL APPL PHARM, V281, P230, DOI 10.1016/j.taap.2014.10.008; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Senthebane DA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071586; Seo K, 2014, INFLAMMATION, V37, P712, DOI 10.1007/s10753-013-9789-6; Seo S, 2016, BIOL PHARM BULL, V39, P1830, DOI 10.1248/bpb.b16-00414; Thani NAA, 2014, J CLIN PATHOL, V67, P949, DOI 10.1136/jclinpath-2013-202075; Wong S, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0159-3; Zhao Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132746; Zhao Yu-pei, 2011, Zhonghua Wai Ke Za Zhi, V49, P771	39	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240676	10.1371/journal.pone.0240676	http://dx.doi.org/10.1371/journal.pone.0240676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052979	Green Published, gold			2022-12-26	WOS:000581820200002
J	Walawalkar, S; Joshi, M; Khattry, N; Sapra, BK; Khan, A; Pujari, PK; Mohan, L; Srivastava, SP; Naresh, C; Badwe, R; Gupta, S				Walawalkar, Sachin; Joshi, Manish; Khattry, Navin; Sapra, Balvinder Kaur; Khan, Arshad; Pujari, Pradeep Kumar; Mohan, Lalit; Srivastava, Sushil Prasad; Naresh, Chital; Badwe, Rajendra; Gupta, Sudeep			Particle removal from air by face masks made from Sterilization Wraps: Effectiveness and Reusability	PLOS ONE			English	Article								Wearing face masks is highly recommended to prevent SARS-CoV-2 transmission in health care workers and for the general public. The demand for high quality face masks has seen an upsurge in the recent times, leading to exploration of alternative economic and easily available options, without compromising on the quality. Particle removal from air in terms of capture efficiency of the filter media or the face mask is a crucial parameter for testing and quality assurance. Short-term reusability of the face masks is also an important aspect as the demand for masks will potentially outstrip the supply in future. Sterilization Wraps, which are used to wrap sterile surgical instruments, have shown a promising performance in terms of removal of particles from air. In this study, we evaluate the particle filtration characteristics of face masks made of 2 different metric weights [45 and 60 gram per square metre (GSM)] respectively, using locally available Sterilization Wraps. The aerosol filtration characteristics were also studied after sterilisation by different techniques such as heat with 50% humidity (thermal treatment), ethylene oxide (ETO), steam and radiation dose of 30kGy. We found that 60 GSM face mask had particle capture efficiency of 94% for total particles greater than 0.3 microns and this capture efficiency was maintained even after sterilisation with ETO and thermal treatment. The cost of producing these masks was 30 US cents/mask at our institute. Our study suggests that sterilization wrap material made of non-woven polypropylene spunbond-meltblown-spunbond (SMS) fibres could be an appropriate readily available inexpensive material for making face masks or N95 respirators.	[Walawalkar, Sachin; Khattry, Navin; Naresh, Chital; Badwe, Rajendra; Gupta, Sudeep] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc ACTREC, Navi Mumbai, India; [Joshi, Manish; Sapra, Balvinder Kaur; Khan, Arshad] Bhabha Atom Res Ctr BARC, Radiol Phys & Advisory Div, Mumbai, Maharashtra, India; [Khattry, Navin; Sapra, Balvinder Kaur; Pujari, Pradeep Kumar; Mohan, Lalit; Srivastava, Sushil Prasad; Badwe, Rajendra; Gupta, Sudeep] Homi Bhabha Natl Inst, Mumbai, Maharashtra, India; [Pujari, Pradeep Kumar] Bhabha Atom Res Ctr BARC, Radiat Chem & Isotope Grp, Mumbai, Maharashtra, India; [Mohan, Lalit; Srivastava, Sushil Prasad] Bhabha Atom Res Ctr BARC, Ctr Design & Mfg CDM, Mumbai, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Bhabha Atomic Research Center (BARC); Homi Bhabha National Institute; Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC)	Khattry, N (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc ACTREC, Navi Mumbai, India.; Khattry, N (corresponding author), Homi Bhabha Natl Inst, Mumbai, Maharashtra, India.	nkhattry@gmail.com		Sapra, B.K./0000-0002-1666-5635				ASTM international, 2018, F210011 ASTM ASTM IN; Aydin O., 2020, PERFORMANCE FABRICS; Bureau of Indian standards, 2014, 162892014 IS BUR IND; Ferioli M, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0068-2020; Joshi M, 2020, QUICK LAB METHODOLOG; Jung H, 2014, AEROSOL AIR QUAL RES, V14, P991, DOI 10.4209/aaqr.2013.06.0201; Kampf G, 2020, J HOSP INFECT, V105, P348, DOI 10.1016/j.jhin.2020.03.025; Konda A, 2020, ACS NANO, V14, P6339, DOI 10.1021/acsnano.0c03252; Lin TH, 2020, AEROSOL AIR QUAL RES, V20, P833, DOI 10.4209/aaqr.2019.12.0620; Liu JY, 2020, EMERG INFECT DIS, V26, P1320, DOI 10.3201/eid2606.200239; Meijer JH, 2020, USING SURG WRAPPING, DOI 10.1101/2020.04.10.20060632; Rengasamy S, 2010, ANN OCCUP HYG, V54, P789, DOI 10.1093/annhyg/meq044; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Sookne K, 2020, 2 LIFE STERILE WRAP; WHO, 2020, RAT US PERS PROT EQ; Woolverton CJ, 2020, APPL BIOSAF, V25, P127, DOI 10.1177/1535676020925958; Wu D, 2020, INT J INFECT DIS, V94, P44, DOI 10.1016/j.ijid.2020.03.004	17	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240398	10.1371/journal.pone.0240398	http://dx.doi.org/10.1371/journal.pone.0240398			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052962	Green Published, gold			2022-12-26	WOS:000581820200003
J	Long, KD; Woodburn, EV; Berg, IC; Chen, V; Scott, WS				Long, Kenneth D.; Woodburn, Elizabeth V.; Berg, Ian C.; Chen, Valerie; Scott, William S.			Measurement of filtration efficiencies of healthcare and consumer materials using modified respirator fit tester setup	PLOS ONE			English	Article							FILTER; MASKS	During the current SARS-CoV-2 pandemic there is unprecedented demand for personal protective equipment (PPE), especially N95 respirators and surgical masks. The ability of SARS-CoV-2 to be transmitted via respiratory droplets from asymptomatic individuals has necessitated increased usage of both N95 respirators in the healthcare setting and masks (both surgical and homemade) in public spaces. These precautions rely on two fundamental principles of transmission prevention: particle filtration and droplet containment. The former is the focus of NIOSH N95 testing guidelines, and the latter is an FDA guideline for respirators and surgical masks. While studies have investigated droplet containment to provide guidance for homemade mask production, limited work has been done to characterize the filtration efficiency (FE) of materials used in home mask making. In this work, we demonstrate the low-cost (<$300) conversion of standard equipment used to fit-test respirators in hospital and industrial settings into a setup that measures quantitative FEs of materials based on NIOSH N95 guidelines, and subsequently measure FEs of materials found in healthcare and consumer spaces. These materials demonstrate significant variability in filtration characteristics, even for visually similar materials. We demonstrate a FE of 96.49% and pressure drop of 25.4 mmH(2)0 for a double-layer of sterilization wrap used in surgical suites and a FE of 90.37% for a combination of consumer-grade materials. The excellent filtration characteristics of the former demonstrate potential utility for emergent situations when N95 respirators are not available, while those of the latter demonstrate that a high FE can be achieved using publicly available materials.	[Long, Kenneth D.; Berg, Ian C.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Long, Kenneth D.; Scott, William S.] Univ Illinois, Coll Med Urbana, Urbana, IL 61801 USA; [Woodburn, Elizabeth V.; Chen, Valerie; Scott, William S.] Carle Illinois Coll Med, Champaign, IL USA; [Scott, William S.] Carle Fdn Hosp, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Long, KD (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.; Long, KD (corresponding author), Univ Illinois, Coll Med Urbana, Urbana, IL 61801 USA.	long6@illinois.edu		Chen, Valerie/0000-0002-4141-2920; Woodburn, Elizabeth/0000-0001-7350-9949; Berg, Ian/0000-0003-2302-7006	Carle-Illinois College of Medicine Innovation Pathway Grant; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [T32EB019944]	Carle-Illinois College of Medicine Innovation Pathway Grant; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work described was supported by a Carle-Illinois College of Medicine Innovation Pathway Grant (medicine.illinois.edu). IB was supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (www.nibib.nih.gov/) under Award Number T32EB019944. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, INTERIM INFECT PREVE; [Anonymous], 2020, MODES TRANSMISSION V; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; [Anonymous], 2020, HK MASK MAN; [Anonymous], 2015, HOSP RESP PROTECTION; [Anonymous], 2017, 22518006 MOU; Aydin O, 2020, EXTREME MECH LETT, V40, DOI 10.1016/j.eml.2020.100924; Bailar JC, 2006, REUSABILITY FACEMASK, P1; Brooks, 2020, HEAT BASED DECONTAMI; Cai CJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12099; Chen V, 2020, J HOSP INFECT, V105, P412, DOI 10.1016/j.jhin.2020.04.032; Cramer A, 2020, ANAL STERAMIST IONIZ; Cramer A, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9961; Daeschler SC, 2020, THERMAL DISINFECTION; Dato VM, 2006, EMERG INFECT DIS, V12, P1033, DOI 10.3201/eid1206.051468; Dave N, 2020, CHARACTERIZATION NOV; Davies A, 2013, DISASTER MED PUBLIC, V7, P413, DOI 10.1017/dmp.2013.43; Duling AZ, 2020, RESPIRATOR MODELS RE; Fischer EP, 2020, SCI ADV, V3083; Forsyth B, 1998, AEROSOL SCI TECH, V28, P489, DOI 10.1080/02786829808965540; Greenawald LA, 2020, PPE CASE PERSONAL PR; Hilton DM, 2020, IMPORTED NON NIOSH A; John AR, 2020, SCALABLE IN HOSPITAL; Karki T, 2020, INFECT PREVENTION CO; Konda A, 2020, ACS NANO, V14, P6339, DOI 10.1021/acsnano.0c03252; Larson EL, 2011, PREVENTING TRANSMISSION OF PANDEMIC INFLUENZA AND OTHER VIRAL RESPIRATORY DISEASES: PERSONAL PROTECTIVE EQUIPMENT FOR HEALTHCARE PERSONNEL: UPDATE 2010, P113; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Li T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237691; Livingston E, 2020, JAMA-J AM MED ASSOC, V323, P1912, DOI 10.1001/jama.2020.5317; Ma T., 2020, NY TIMES; Manning EP, 2020, DISINFECTION N95 RES; McCormick E., 2020, GUARDIAN; Mittal R, 2020, J FLUID MECH, V894, DOI 10.1017/jfm.2020.330; National Institute for Occupational Safety and Health (NIOSH), 2019, DET PART FILT EFF LE; Nemer M.B., 2020, ALTERNATIVE MAT MASK; Ni F, 2020, SOTERA HLTH CO SPONS; Oberg T, 2008, AM J INFECT CONTROL, V36, P276, DOI 10.1016/j.ajic.2007.07.008; Oral E, 2020, VAPOR H 2 0 2 STERIL; Ou QS, 2020, J AEROSOL SCI, V150, DOI 10.1016/j.jaerosci.2020.105609; Parshley L., 2020, VOX, DOI 1354325/coronavirus-face-mask-mandate-enforcement; Rengasamy S, 2017, J OCCUP ENVIRON HYG, V14, P92, DOI 10.1080/15459624.2016.1225157; Rengasamy S, 2010, ANN OCCUP HYG, V54, P789, DOI 10.1093/annhyg/meq044; Sanchez AL, 2013, AEROSOL SCI TECH, V47, P606, DOI 10.1080/02786826.2013.778384; Sandaradura I, 2020, J HOSP INFECT, V104, P529, DOI 10.1016/j.jhin.2020.01.006; Songer J, 2020, SURGE MAKERMASK; Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y; TSI Incorporated, 2012, PART GEN MOD 8026 SP; Wigginton KR, 2020, VALIDATION N95 FILTE; Wilson AM, 2020, J HOSP INFECT, V105, P640, DOI 10.1016/j.jhin.2020.05.036; Zangmeister CD, FILTRATION EFFICIENC	50	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240499	10.1371/journal.pone.0240499	http://dx.doi.org/10.1371/journal.pone.0240499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048980	Green Published, gold			2022-12-26	WOS:000581813300037
J	Merckaert, T; Zwaenepoel, O; Gevaert, K; Gettemans, J				Merckaert, Tijs; Zwaenepoel, Olivier; Gevaert, Kris; Gettemans, Jan			Development and characterization of protein kinase B/AKT isoform-specific nanobodies	PLOS ONE			English	Article							DISTINCT ROLES; CANCER; BREAST; AKT; PATHWAY; SUBSTRATE; TARGET; DOMAIN	The serine/threonine protein kinase AKT is frequently over-activated in cancer and is associated with poor prognosis. As a central node in the PI3K/AKT/mTOR pathway, which regulates various processes considered to be hallmarks of cancer, this kinase has become a prime target for cancer therapy. However, AKT has proven to be a highly complex target as it comes in three isoforms (AKT1, AKT2 and AKT3) which are highly homologous, yet non-redundant. The isoform-specific functions of the AKT kinases can be dependent on context (i.e. different types of cancer) and even opposed to one another. To date, there is no isoform-specific inhibitor available and no alternative to genetic approaches to study the function of a single AKT isoform. We have developed and characterized nanobodies that specifically interact with the AKT1 or AKT2 isoforms. These new tools should enable future studies of AKT1 and AKT2 isoform-specific functions. Furthermore, for both isoforms we obtained a nanobody that interferes with the AKT-PIP3-interaction, an essential step in the activation of the kinase. The nanobodies characterized in this study are a new stepping stone towards unravelling AKT isoform-specific signalling.	[Merckaert, Tijs; Zwaenepoel, Olivier; Gevaert, Kris; Gettemans, Jan] Univ Ghent, Fac Med & Hlth Sci, Dept Biomol Med, Ghent, Belgium; [Merckaert, Tijs; Gevaert, Kris] Univ Gent VIB, Ctr Med Biotechnol, Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Gettemans, J (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Biomol Med, Ghent, Belgium.	jan.gettemans@ugent.be	Gevaert, Kris/D-6489-2017	Gevaert, Kris/0000-0002-4237-0283	Fonds Wetenschappelijk Onderzoek [1S 127 16N]; Ghent University [30322401]	Fonds Wetenschappelijk Onderzoek(FWO); Ghent University(Ghent University)	This study was supported by Fonds Wetenschappelijk Onderzoek (https://www.fwo.be/) in the form of a grant awarded to TM (1S 127 16N) and Ghent University (https://www.ugent.be/) in the form of a grant also awarded to TM (30322401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, AM J TRANSPLANT, V18, P10, DOI 10.1111/ajt.14556; [Anonymous], 2009, JBL, V128, P178; [Anonymous], 2010, ENG TECHNOL, V5, P9; Arboleda MJ, 2003, CANCER RES, V63, P196; Beaver JA, 2013, CLIN CANCER RES, V19, P5413, DOI 10.1158/1078-0432.CCR-13-0884; Beghein E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00771; Bertier L, 2018, BIOMED PHARMACOTHER, V102, P230, DOI 10.1016/j.biopha.2018.03.064; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Cariaga-Martinez AE, 2013, CELL SIGNAL, V25, P1586, DOI 10.1016/j.cellsig.2013.03.019; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chaichan M. T, 2017, INT J RENEWABLE ENER, V7, P12, DOI DOI 10.3390/ANI7020012; Chin YR, 2011, CELL ADHES MIGR, V5, P211, DOI 10.4161/cam.5.3.15790; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Clark AR, 2014, BIOCHEM SOC T, V42, P1349, DOI 10.1042/BST20140160; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Decanniere K, 2000, J MOL BIOL, V300, P83, DOI 10.1006/jmbi.2000.3839; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Fulcher LJ, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170066; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kumar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064364; Lawson ADG, 2012, NAT REV DRUG DISCOV, V11, P519, DOI 10.1038/nrd3756; Liu J, NANO RES, V11, DOI [10.1007/s12274-020-2633-z, DOI 10.1007/S12274-020-2633-ZW0S:000507801500001]; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Molife LR, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-1; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nitulescu GM, 2016, INT J ONCOL, V48, P869, DOI 10.3892/ijo.2015.3306; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Parikh C, 2012, P NATL ACAD SCI USA, V109, P19368, DOI 10.1073/pnas.1204384109; Peres J, 2015, ONCOTARGET, V6, P1821, DOI 10.18632/oncotarget.2782; Quevedo CE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05707-2; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; Santi SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014614; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Song MQ, 2019, CANCER RES, V79, P1019, DOI 10.1158/0008-5472.CAN-18-2738; Thueng-in K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049254; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Uhlenbrock N, 2019, CHEM SCI, V10, P3573, DOI 10.1039/c8sc05212c; Van Audenhove I, 2016, EBIOMEDICINE, V8, P40, DOI 10.1016/j.ebiom.2016.04.028; Van Impe K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3585; Vasylieva N, 2019, ANAL CHIM ACTA, V1057, P106, DOI 10.1016/j.aca.2018.12.060; Vincke C, 2012, GENERATION SINGLE DO, V907, P145; Wang Q, 2017, BRIT J CANCER, V117, P159, DOI 10.1038/bjc.2017.153; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870	48	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240554	10.1371/journal.pone.0240554	http://dx.doi.org/10.1371/journal.pone.0240554			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045011	Green Published, gold, Green Submitted			2022-12-26	WOS:000581811700010
J	Burger, J; Malyshev, AV; Colbach, N				Buerger, Jana; Malyshev, Andrey V.; Colbach, Nathalie			Populations of arable weed species show intra-specific variability in germination base temperature but not in early growth rate	PLOS ONE			English	Article							ALOPECURUS-MYOSUROIDES GERMINATION; CAPSELLA-BURSA-PASTORIS; INTRASPECIFIC VARIABILITY; EUROPEAN POPULATIONS; SEEDLING GROWTH; THERMAL TIME; EMERGENCE; DORMANCY; TRAITS; MODEL	Key plant traits affecting growth performance can differ among and within species, influencing competitive plant community dynamics. We determined the intra-specific variability of germination base temperature among 13 arable weed species and the seedlings' early post-emergence relative growth rate among 21 species in climate chamber and green house experiments. Intra-specific variability was quantified with two seed populations (originating from contrasting climate in Germany & France) for the germination base temperature of 6 species and for the early growth rate of 16 species. Inter-specific variability for both traits was always higher than intra-specific variability. Within a given species, we found that germination base temperatures were higher in seeds stemming from colder climate populations. Seedling relative growth rates did not differ between seed populations. Models simulating weed growth should reflect these differences in germination traits among populations, especially when they are used for weed community assembly studies in a local to regional extent.	[Buerger, Jana] Univ Rostock, Fac Agr & Environm Sci, Crop Hlth, Rostock, Germany; [Malyshev, Andrey V.] Univ Greifswald, Inst Bot & Landscape Ecol, Expt Plant Ecol, Greifswald, Germany; [Colbach, Nathalie] Univ Bourgogne Franche Comte, Univ Borgogne, INRAE, AgroSup Dijon,Agroecol, Dijon, France	University of Rostock; Ernst Moritz Arndt Universitat Greifswald; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Burger, J (corresponding author), Univ Rostock, Fac Agr & Environm Sci, Crop Hlth, Rostock, Germany.	jana.buerger@uni-rostock.de	Colbach, Nathalie/C-6677-2014	Colbach, Nathalie/0000-0002-3791-037X	Deutsche Forschungsgemeinschaft [BU 3097/1-1]; Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE)	JB was funded by Deutsche Forschungsgemeinschaft (https://www.dfg.de/) under the grant number BU 3097/1-1. NC acknowledges past and current funding by Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE,). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; [Anonymous], 2014, PEERJ, V2, pe447; ARNOLD CHARLES Y., 1959, PROC AMER SOC HORT SCI, V74, P430; Barberi P, 2018, WEED RES, V58, P76, DOI 10.1111/wre.12283; Baskin CC, 2004, WEED RES, V44, P60, DOI 10.1046/j.1365-3180.2003.00373.x; BASKIN JM, 1989, WEED RES, V29, P205, DOI 10.1111/j.1365-3180.1989.tb00860.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benvenuti S., 1993, Agricoltura Mediterranea, V123, P252; Bischoff A, 2006, BASIC APPL ECOL, V7, P347, DOI 10.1016/j.baae.2005.07.009; Bischoff A, 2010, OIKOS, V119, P445, DOI 10.1111/j.1600-0706.2009.17776.x; Borgy B, 2016, WEED RES, V56, P102, DOI 10.1111/wre.12190; Bourgeois B, 2019, AM J BOT, V106, P90, DOI 10.1002/ajb2.1213; Cici SZH, 2009, CAN J PLANT SCI, V89, P575, DOI 10.4141/CJPS08131; Cochrane A, 2015, GLOBAL ECOL BIOGEOGR, V24, P12, DOI 10.1111/geb.12234; Colbach N, 2003, WEED SCI, V51, P708, DOI 10.1614/P2002-051; Colbach N, 2002, WEED RES, V42, P210, DOI 10.1046/j.0043-1737.2002.00279.x; Colbach N, 2020, EUROPEAN J AGRONOMY; Fayaud B, 2014, EUR J AGRON, V52, P180, DOI 10.1016/j.eja.2013.09.009; FENNER M, 1983, NEW PHYTOL, V95, P697, DOI 10.1111/j.1469-8137.1983.tb03533.x; Fenner M., 2005, ECOLOGY SEEDS; Forcella F, 2000, FIELD CROP RES, V67, P123, DOI 10.1016/S0378-4290(00)00088-5; Gaba S, 2017, WEED RES, V57, P123, DOI 10.1111/wre.12245; Gardarin A, 2015, WEED RES, V55, P14, DOI 10.1111/wre.12121; Gardarin A, 2010, EUR J AGRON, V32, P162, DOI 10.1016/j.eja.2009.09.006; Gardarin A, 2009, WEED RES, V49, P117, DOI 10.1111/j.1365-3180.2008.00683.x; Gardarin A, 2012, ECOL MODEL, V240, P123, DOI 10.1016/j.ecolmodel.2012.05.004; Gardarin A, 2011, ECOL MODEL, V222, P626, DOI 10.1016/j.ecolmodel.2010.10.005; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grundy AC, 2000, NEW PHYTOL, V148, P433, DOI 10.1046/j.1469-8137.2000.00778.x; Guillemin JP, 2017, WEED RES, V57, P361, DOI 10.1111/wre.12267; Guillemin JP, 2013, WEED RES, V53, P76, DOI 10.1111/wre.12000; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Hunt R, 1997, NEW PHYTOL, V135, P395, DOI 10.1046/j.1469-8137.1997.00671.x; Izquierdo J, 2009, WEED SCI, V57, P660, DOI 10.1614/WS-09-043.1; JANA S, 1988, CAN J BOT, V66, P635, DOI 10.1139/b88-089; Karlsson LM, 2008, FLORA, V203, P409, DOI 10.1016/j.flora.2007.08.001; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lenth RV., 2021, EMMEANS ESTIMATED MA; Loddo D, 2014, WEED RES, V54, P356, DOI 10.1111/wre.12083; Loddo D, 2018, PLANT PROTECT SCI, V54, P60, DOI 10.17221/92/2016-PPS; Loddo D, 2013, WEED SCI, V61, P443, DOI 10.1614/WS-D-12-00162.1; Malyshev AV, 2016, GLOBAL CHANGE BIOL, V22, P449, DOI 10.1111/gcb.13114; Masin R, 2005, WEED SCI, V53, P193, DOI 10.1614/WS-04-066R1; Masin R, 2010, WEED SCI, V58, P216, DOI 10.1614/WS-D-09-00066.1; Onofri A, 2010, WEED RES, V50, P5, DOI 10.1111/j.1365-3180.2009.00758.x; Perronne R, 2014, ACTA BOT GALLICA, V161, P243, DOI 10.1080/12538078.2013.868320; PETERS NCB, 1982, WEED RES, V22, P205, DOI 10.1111/j.1365-3180.1982.tb00165.x; Prieto I, 2017, AM J BOT, V104, P62, DOI 10.3732/ajb.1600354; R Core Team, 2021, R LANGUAGE ENV STAT; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Ritz C, 2013, EUR J AGRON, V45, P1, DOI 10.1016/j.eja.2012.10.003; Rosbakh S, 2015, FUNCT ECOL, V29, P5, DOI 10.1111/1365-2435.12304; Royo-Esnal A, 2012, WEED RES, V52, P458, DOI 10.1111/j.1365-3180.2012.00939.x; Saatkamp A, 2019, NEW PHYTOL, V221, P1764, DOI 10.1111/nph.15502; Shipley B, 2016, OECOLOGIA, V180, P923, DOI 10.1007/s00442-016-3549-x; Siefert A, 2015, ECOL LETT, V18, P1406, DOI 10.1111/ele.12508; Steinmaus SJ, 2000, J EXP BOT, V51, P275, DOI 10.1093/jexbot/51.343.275; Storkey J, 2015, WEED RES, V55, P206, DOI 10.1111/wre.12126; Storkey J, 2004, ANN BOT-LONDON, V93, P681, DOI 10.1093/aob/mch095; Storkey J, 2000, WEED SCI, V48, P467, DOI 10.1614/0043-1745(2000)048[0467:RBTATE]2.0.CO;2; THOMPSON PA, 1975, ANN BOT-LONDON, V39, P1; Tozzi E, 2014, WEED RES, V54, P178, DOI 10.1111/wre.12065; Trnka M, 2011, GLOBAL CHANGE BIOL, V17, P2298, DOI 10.1111/j.1365-2486.2011.02396.x; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; Vellend M, 2014, MOL ECOL, V23, P2890, DOI 10.1111/mec.12756; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Zakharova L, 2019, ECOL MODEL, V407, DOI 10.1016/j.ecolmodel.2019.05.008; Zhang H, 2003, GENETICS, V164, P347	71	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240538	10.1371/journal.pone.0240538	http://dx.doi.org/10.1371/journal.pone.0240538			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035273	gold, Green Published			2022-12-26	WOS:000581817500056
J	Gupta, A; Kennedy, K; Perales-Puchalt, J; Drew, D; Beddhu, S; Sarnak, M; Burns, J				Gupta, Aditi; Kennedy, Kevin; Perales-Puchalt, Jaime; Drew, David; Beddhu, Srinivasan; Sarnak, Mark; Burns, Jeffrey		Alzheimer's Dis Neuroimaging	Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; COMPOSITE SCORE; RENAL-FUNCTION; AGING KIDNEY; AGE; DEMENTIA; DECLINE; EQUATIONS	Background Chronic kidney disease (CKD) is associated with cognitive impairment and dementia. We examined whether this relationship hold true in older adults, who have a higher prevalence of both CKD and dementia. Design, setting, participants, and measurements We conducted a cross-sectional secondary analysis of an established observational cohort. We analyzed data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), an NIH funded, multicenter longitudinal observational study, which includes participants with normal and impaired cognition and assesses cognition with a comprehensive battery of neuropsychological tests. We included a non-probability sample of all ADNI participants with serum creatinine measurements at baseline (N = 1181). Using multivariable linear regression analysis, we related the CKD Epidemiology Collaboration equation eGFR with validated composite scores for memory (ADNI-mem) and executive function (ADNI-EF). Results For the 1181 ADNI participants, the mean age was 73.7 +/- 7.1 years. Mean estimated glomerular filtration rate (eGFR) was 76.4 +/- 19.7; 6% had eGFR<45, 22% had eGFR of 45 to <60, 51% had eGFR of 60-90 and 21% had eGFR>90 ml/min/1.73 m(2). The mean ADNI-Mem score was 0.241 +/- 0.874 and mean ADNI-EF score was 0.160 +/- 1.026. In separate multivariable linear regression models, adjusted for age, sex, race education and BMI, there was no association between each 10 ml/ min/1.73 m(2)higher eGFR and ADNI-Mem (beta -0.02, 95% CI -0.04, 0.02, p = 0.56) or ADNI-EF (beta 0.01, 95% CI -0.03, 0.05, p = 0.69) scores. Conclusion We did not observe an association between eGFR and cognition in the older ADNI participants.	[Gupta, Aditi] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA; [Gupta, Aditi] Univ Kansas, Med Ctr, Div Nephrol & Hypertens, Kansas City, KS 66103 USA; [Gupta, Aditi; Perales-Puchalt, Jaime; Burns, Jeffrey] Univ Kansas, Med Ctr, Alzheimers Dis Ctr, Kansas City, KS 66103 USA; [Kennedy, Kevin] Univ Kansas, Med Ctr, Kansas City Vet Affairs, Kansas City, KS 66103 USA; [Perales-Puchalt, Jaime; Burns, Jeffrey] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; [Drew, David; Sarnak, Mark] Tufts Med Ctr, Div Nephrol & Hypertens, Boston, MA 02111 USA; [Beddhu, Srinivasan] Univ Utah, Salt Lake City, UT USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Tufts Medical Center; Utah System of Higher Education; University of Utah	Gupta, A (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA.; Gupta, A (corresponding author), Univ Kansas, Med Ctr, Div Nephrol & Hypertens, Kansas City, KS 66103 USA.; Gupta, A (corresponding author), Univ Kansas, Med Ctr, Alzheimers Dis Ctr, Kansas City, KS 66103 USA.	agupta@kumc.edu	Gupta, Aditi/HGD-9632-2022	Gupta, Aditi/0000-0002-6286-802X	NIH [K23 AG055666, P30 AG035982]; NIH CTSA grant [UL1 TR000001]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CTSA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is supported by NIH K23 AG055666 (AG) Cognitive Impairment in End Stage Renal Disease, NIH CTSA grant UL1 TR000001 (KUMC), and NIH P30 AG035982 (KU ADC). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org).The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.]	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Bremer BA, 1997, ANN BEHAV MED, V19, P348, DOI 10.1007/BF02895153; Burns CM, 2017, J GERONTOL A-BIOL, V73, P393; Crane PK, 2012, BRAIN IMAGING BEHAV, V6, P502, DOI 10.1007/s11682-012-9186-z; Drew DA, 2017, AM J KIDNEY DIS, V69, P780, DOI 10.1053/j.ajkd.2016.11.015; Drew DA, 2015, AM J KIDNEY DIS, V65, P303, DOI 10.1053/j.ajkd.2014.07.009; Ellam T, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6559; Fan L, 2015, J AM SOC NEPHROL, V26, P1982, DOI 10.1681/ASN.2014060607; Gabin JM, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1425-8; Gibbons LE, 2012, BRAIN IMAGING BEHAV, V6, P517, DOI 10.1007/s11682-012-9176-1; Glassock R, 2015, JAMA-J AM MED ASSOC, V314, P559, DOI 10.1001/jama.2015.6731; Glassock RJ, 2012, KIDNEY INT, V82, P270, DOI 10.1038/ki.2012.65; Gupta A, 2020, J AM SOC NEPHROLOGY, V2020081119, P2020; Gupta A, 2019, CLIN J AM SOC NEPHRO, V14, P567, DOI 10.2215/CJN.11010918; Gupta A, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0570-1; Hailpern SM, 2007, J AM SOC NEPHROL, V18, P2205, DOI 10.1681/ASN.2006101165; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Helmer C, 2011, NEUROLOGY, V77, P2043, DOI 10.1212/WNL.0b013e31823b4765; Hommos MS, 2018, KIDNEY INT, V93, P1175, DOI 10.1016/j.kint.2017.09.028; Knopman DS, 2014, MAYO CLIN PROC, V89, P1452, DOI 10.1016/j.mayocp.2014.06.019; Kremers WK, 2015, NEPHROL DIAL TRANSPL, V30, P2034, DOI 10.1093/ndt/gfv072; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Lipnicki DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065841; Lopez-Vargas PA, 2014, NEPHROLOGY, V19, P234, DOI 10.1111/nep.12206; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Miller WG, 2018, ADV CHRONIC KIDNEY D, V25, P7, DOI 10.1053/j.ackd.2017.09.013; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; O'Hare AM, 2012, J AM GERIATR SOC, V60, P2215, DOI 10.1111/j.1532-5415.2012.04238.x; Obi Y, 2010, CLIN J AM SOC NEPHRO, V5, P1558, DOI 10.2215/CJN.08061109; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Rule AD, 2013, CLIN J AM SOC NEPHRO, V8, P1414, DOI 10.2215/CJN.01240213; Schaeffner ES, 2012, ANN INTERN MED, V157, P471, DOI 10.7326/0003-4819-157-7-201210020-00003; Slinin Y, 2008, J AM GERIATR SOC, V56, P2082, DOI 10.1111/j.1532-5415.2008.01936.x; Stevens LA, 2010, ADV CHRONIC KIDNEY D, V17, P293, DOI 10.1053/j.ackd.2010.03.010; Tamura MK, 2008, AM J KIDNEY DIS, V52, P227, DOI 10.1053/j.ajkd.2008.05.004; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Yaffe K, 2010, J AM GERIATR SOC, V58, P338, DOI 10.1111/j.1532-5415.2009.02670.x	45	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239871	10.1371/journal.pone.0239871	http://dx.doi.org/10.1371/journal.pone.0239871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3WA	33036021	gold, Green Published			2022-12-26	WOS:000581817500060
J	Supeleto, FA; Santos, BF; Basilio, LA; Aguiar, AP				Supeleto, Fernanda A.; Santos, Bernardo F.; Basilio, Leandro A.; Aguiar, Alexandre P.			Species delimitation, environmental cline and phylogeny for a new Neotropical genus of Cryptinae (Ichneumonidae)	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; DESICCATION RESISTANCE; HYMENOPTERA; RICHNESS; MELANISM; DIVERSITY; SELECTION; RATES; PAPER	A morphologically unusual Cryptini,Cryptoxenodongen.nov. Supeleto, Santos & Aguiar, is described and illustrated, with a single species,C.metamorphussp.nov. Supeleto, Santos & Aguiar, apparently occurring in two disjunct populations in northern and southeastern South America. The highly dimorphic female and male are described and illustrated. The phylogenetic relationships of the new genus are investigated using a matrix with 308 other species of Cryptini in 182 genera, based on 109 morphological characters and molecular data from seven loci. The analyses clearly supportCryptoxenodongen.nov. as a distinct genus, closest toDebilosTownes andDiapetimorphaViereck. Species limits and definition are investigated, but despite much morphological variation the analyses at the specimen level do not warrant the division of the studied populations into separate species. The considerable morphological variation is explored with principal component analyses of mixed features, and a new procedure is proposed for objective analysis of colors. The relationship of color and structural variation with altitude and latitude is demonstrated and discussed, representing an important case study for Ichneumonidae. Externally,Cryptoxenodongen.nov. can be recognized mainly by its unusually large mandibles, but other diagnostic features include clypeus wide; sternaulus complete, distinct and crenulate throughout; areolet closed, about as long as pterostigma width; petiole anteriorly with distinct triangular projection on each side, spiracle near posterior 0.25; propodeum without posterior transverse carina; and propodeal apophyses conspicuously projected.	[Supeleto, Fernanda A.; Basilio, Leandro A.; Aguiar, Alexandre P.] Univ Fed Espirito Santo, Depto Ciencias Biol, Vitoria, ES, Brazil; [Santos, Bernardo F.] Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA	Universidade Federal do Espirito Santo; Smithsonian Institution; Smithsonian National Museum of Natural History	Aguiar, AP (corresponding author), Univ Fed Espirito Santo, Depto Ciencias Biol, Vitoria, ES, Brazil.	alexandre.aguiar@ufes.br	Santos, Bernardo/ABG-6757-2021		Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES) [001]; National Science Foundation [1501802]; Buck Global Genome Initiative postdoctoral fellowship (Smithsonian Institution)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Science Foundation(National Science Foundation (NSF)); Buck Global Genome Initiative postdoctoral fellowship (Smithsonian Institution)	This publication represents part of the results of the Master's work of FAS, financed by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES) [Finance Code 001], and was partially supported by research funds provided by a Doctoral Dissertation Improvement Grant for BFS, from the National Science Foundation (Award no. 1501802). BFS is currently supported by a Buck Global Genome Initiative postdoctoral fellowship (Smithsonian Institution). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2013, WIRES COMPUT STAT, V5, P149, DOI 10.1002/wics.1246; Abe Y, 2013, EUR J ENTOMOL, V110, P627, DOI 10.14411/eje.2013.085; Aggarwal Rakesh, 2016, Perspect Clin Res, V7, P187; Aguiar AP, 2013, ZOOTAXA, V3609, P593, DOI 10.11646/zootaxa.3609.6.5; Aguiar AP, 2005, ZOOTAXA, P31; Ahmed UAM, 2007, APPL ENTOMOL ZOOL, V42, P383, DOI 10.1303/aez.2007.383; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Archer MA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P386, DOI 10.1086/518354; BAUER HARRY L., 1936, ECOL MONOGR, V6, P409, DOI 10.2307/1943220; Blumthaler M, 1997, J PHOTOCH PHOTOBIO B, V39, P130, DOI 10.1016/S1011-1344(96)00018-8; Brecko J, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.464.8615; BRUES CHARLES T., 1928, PSYCHE, V35, P205, DOI 10.1155/1928/47573; Chavent M, 2017, PACKAGE PCAMIXDATA V; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; CRAMER H, 1946, MATH METHODS STAT, P282; De Oliveira CM, 2004, ENVIRON ENTOMOL, V33, P1192, DOI 10.1603/0046-225X-33.5.1192; DeJong PW, 1996, J EXP BIOL, V199, P2655; Dillon N, 1996, INSECT MOL BIOL, V5, P21, DOI 10.1111/j.1365-2583.1996.tb00036.x; DOWNING HA, 1986, INSECT SOC, V33, P422, DOI 10.1007/BF02223949; Drasgow F., 1986, ENCY STAT SCI, VVol. 7, P68, DOI DOI 10.1002/0471667196.ESS2014.PUB2.ACCESSED; Ellers J, 2004, BIOL J LINN SOC, V82, P79, DOI 10.1111/j.1095-8312.2004.00319.x; ESCOFIER B, 1994, COMPUT STAT DATA AN, V18, P121, DOI 10.1016/0167-9473(94)90135-X; Finley D. Rex, 2006, HSP COLOR MODEL ALTE; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaston KJ, 1996, J BIOGEOGR, V23, P105, DOI 10.1046/j.1365-2699.1996.00978.x; Gauld Ian, 2002, Memoirs of the American Entomological Institute (Gainesville), V66, P1; GAULD ID, 1986, ECOL ENTOMOL, V11, P155, DOI 10.1111/j.1365-2311.1986.tb00290.x; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harris RM, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.5101; Hebert P.D., 2003, P ROYAL SOC LONDON S, V270, P313, DOI [10.1098/rspb.2002.2218, DOI 10.1093/molbev/msy096]; Ilin A, 2010, J MACH LEARN RES, V11, P1957; JANZEN DH, 1981, ECOLOGY, V62, P532, DOI 10.2307/1937717; JEANNE RL, 1979, ECOLOGY, V60, P1211, DOI 10.2307/1936968; MANI M. S., 1968, Ser. ent., V4; Masner Lubomir, 1995, P209; NEFF NA, 1986, SYST ZOOL, V35, P110, DOI 10.2307/2413295; OLSSON U, 1982, PSYCHOMETRIKA, V47, P337, DOI 10.1007/BF02294164; OWEN DF, 1974, NATURE, V249, P583, DOI 10.1038/249583a0; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Quicke DLJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032101; Rajpurohit S, 2012, BIOL J LINN SOC, V106, P287, DOI 10.1111/j.1095-8312.2012.01870.x; Ramniwas S, 2013, J EXP BIOL, V216, P1244, DOI 10.1242/jeb.076166; Rebijith KB, 2014, FLA ENTOMOL, V97, P1328, DOI 10.1653/024.097.0407; Reinhard E, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.946629; Reinhard E., 2008, COLOR IMAGING FUNDAM; Rohlf FJ., 2006, TPSDIG VERSION 2 10; ROLAND J, 1982, OECOLOGIA, V53, P214, DOI 10.1007/BF00545666; ROSE MR, 1992, EXP GERONTOL, V27, P241, DOI 10.1016/0531-5565(92)90048-5; Rull J, 2009, ENVIRON ENTOMOL, V38, P588, DOI 10.1603/022.038.0310; Saaksjarvi IE, 2004, ECOL ENTOMOL, V29, P735, DOI 10.1111/j.0307-6946.2004.00656.x; Santos BF, 2018, MITOCHONDRIAL DNA A, V29, P1284, DOI 10.1080/24701394.2018.1445242; Santos BF, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2352; Santos BF, 2017, SYST ENTOMOL, V42, P650, DOI 10.1111/syen.12238; Santos BF, 2013, ZOOTAXA, V3634, P3, DOI 10.11646/zootaxa.3634.1.1; Scherrer MV, 2014, ZOOTAXA, V3797, P207, DOI 10.11646/zootaxa.3797.1.15; Shapiro B.A., 2000, Agricultural and Forest Entomology, V2, P39, DOI 10.1046/j.1461-9563.2000.00048.x; Sheskin D., 2011, HDB PARAMETRIC NONPA, Vfifth, DOI [DOI 10.1201/9781420036268, 10.2307/2685909]; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TOWNES H, 1958, J ECON ENTOMOL, V51, P650, DOI 10.1093/jee/51.5.650; Townes H., 1969, Memoirs of the American Entomological Institute, V11, P1; Townes H., 1971, Memoirs Am Ent Inst, V17, P1; TOWNES H., 1970, MEMOIRS AM ENTOMOLOG, V12, P1; Townes HK, 1972, P TALL TIMBERS C ECO, V3, P235; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Wang G, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039700, 10.1371/journal.pone.0051764, 10.1371/journal.pone.0047051]; WATT WB, 1968, EVOLUTION, V22, P437, DOI 10.1111/j.1558-5646.1968.tb03985.x; WCISLO WT, 1987, BIOL REV, V62, P515, DOI 10.1111/j.1469-185X.1987.tb01640.x; YOUNG DK, 1990, GREAT LAKES ENTOMOL, V23, P1; Yu D.S.K., 2016, DATABASE FLASH DRIVE; Zwickl D. J, 2006, GENETIC ALGORITHM AP; Zychlinski S, 2018, DYTHON SET DATA ANAL	77	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0237233	10.1371/journal.pone.0237233	http://dx.doi.org/10.1371/journal.pone.0237233			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035225	gold, Green Published			2022-12-26	WOS:000581817500032
J	Vendelbo, NM; Sarup, P; Orabi, J; Kristensen, PS; Jahoor, A				Vendelbo, Nikolaj M.; Sarup, Pernille; Orabi, Jihad; Kristensen, Peter S.; Jahoor, Ahmed			Genetic structure of a germplasm for hybrid breeding in rye (Secale cereale L.)	PLOS ONE			English	Article							MALE-FERTILITY RESTORATION; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; COMBINING ABILITY; MALE-STERILITY; PAMPA CMS; DIVERSITY; YIELD; SELECTION; ASSOCIATION	Rye (Secale cereale L.) responds strongly to changes in heterozygosity with hybrids portraying strong heterosis effect on all developmental and yielding characteristics. In order to achieve the highest potential heterosis effect parental lines must originate from genetically distinct gene pools. Here we report the first comprehensive SNP-based population study of an elite germplasm using fertilization control system for hybrid breeding in rye that is genetically different to the predominating P-type. In total 376 inbred lines from Nordic Seed Germany GmbH were genotyped for 4419 polymorphic SNPs. The aim of this study was to confirm and quantify the genetic separation of parental populations, unveil their genetic characteristics and investigate underlying population structures. Through a palette of complimenting analysis, we confirmed a strong genetic differentiation (F-ST = 0.332) of parental populations validating the germplasms suitability for hybrid breeding. These were, furthermore, found to diverge considerably in several features with the maternal population portraying a strong population structure characterized by a narrow genetic profile, small effective population size and high genome-wise linkage disequilibrium. We propose that the employed male-sterility system putatively constitutes a population determining parameter by influencing the rate of introducing novel genetic variation to the parental populations. Functional analysis of linkage blocks led to identification of a conserved segment on the distal 4RL chromosomal region annotated to the Rfp3 male-fertility restoration 'Pampa' type gene. Findings of our study emphasized the immediate value of comprehensive population studies on elite breeding germplasms as a pre-requisite for application of genomic-based breeding techniques, introgression of novel material and to support breeder decision-making.	[Vendelbo, Nikolaj M.; Sarup, Pernille; Orabi, Jihad; Jahoor, Ahmed] Nord Seed AS, Odder, Denmark; [Vendelbo, Nikolaj M.] Aarhus Univ, Dept Agroecol, Slagelse, Denmark; [Kristensen, Peter S.] Nord Seed Germany GmbH, Nienstadt, Germany; [Jahoor, Ahmed] Swedish Univ Agr Sci, Dept Plant Breeding, Alnarp, Sweden	Aarhus University; Swedish University of Agricultural Sciences	Vendelbo, NM (corresponding author), Nord Seed AS, Odder, Denmark.; Vendelbo, NM (corresponding author), Aarhus Univ, Dept Agroecol, Slagelse, Denmark.	nive@nordicseed.com	Orabi, Jihad/ABB-1020-2020	Vendelbo, Nikolaj Meisner/0000-0001-7433-9793	Innovation Fund Denmark [8053-00085B]; Nordic Seed A/S; Pajbjergfoundation	Innovation Fund Denmark; Nordic Seed A/S; Pajbjergfoundation	The research was funded by Innovation Fund Denmark (grant no. 8053-00085B), Pajbjergfoundation, and Nordic Seed A/S. The funder provided support in the form of salaries for authors NMV, PMS, JO, PSK, and, AJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2003, CRIT CARE MED, V31, pS417; [Anonymous], 2008, BIBLIOTECA ESTUDIO I, V23, P75; [Anonymous], 2011, QUALITY EXPLORATION, V11, P6; Auinger HJ, 2016, THEOR APPL GENET, V129, P2043, DOI 10.1007/s00122-016-2756-5; Baker K, 2014, PLANT J, V79, P981, DOI 10.1111/tpj.12600; Balestre M, 2008, GENET MOL RES, V7, P65, DOI 10.4238/vol7-1gmr403; Bauer E, 2017, PLANT J, V89, P853, DOI 10.1111/tpj.13436; BECK DL, 1990, MAYDICA, V35, P279; Bevan MW, 2017, NATURE, V543, P346, DOI 10.1038/nature22011; Bolibok-Bragoszewska H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-184; Bolibok-Bragoszewska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-578; Borner A, 1998, THEOR APPL GENET, V97, P99, DOI 10.1007/s001220050871; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Clayton D., 2019, SNPSTATS SNPMATRIX X; COVARRUBIASPAZARAN, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0156744; CROSSA J, 1987, THEOR APPL GENET, V73, P445, DOI 10.1007/BF00262514; Dwivedi SL, 2016, TRENDS PLANT SCI, V21, P31, DOI 10.1016/j.tplants.2015.10.012; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falke KC, 2008, THEOR APPL GENET, V117, P641, DOI 10.1007/s00122-008-0808-1; Falke KC, 2009, THEOR APPL GENET, V118, P1225, DOI 10.1007/s00122-009-0976-7; FAO, 2018, FAO STAT DAT; Fischer S, 2010, THEOR APPL GENET, V120, P291, DOI 10.1007/s00122-009-1124-0; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frederiksen S, 1998, NORD J BOT, V18, P399, DOI 10.1111/j.1756-1051.1998.tb01517.x; Frisch M, 2010, THEOR APPL GENET, V120, P441, DOI 10.1007/s00122-009-1204-1; Fu Y, 2015, THEOR APPL GENET, V128, P1029, DOI 10.1007/s00122-015-2487-z; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Geiger H. H., 2009, V3, P157; Geiger HH, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P439; GEIGER HH, 1970, CROP SCI, V10, P590, DOI 10.2135/cropsci1970.0011183X001000050043x; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Granato ISC, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-018-0844-8; Guo X, 1999, LINKAGE INFORM CONTE; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; Hackauf B, 2017, THEOR APPL GENET, V130, P1179, DOI 10.1007/s00122-017-2879-3; Haseneyer G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-131; He ZZ, 2012, RICE SCI, V19, P193, DOI 10.1016/S1672-6308(12)60040-7; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Hillman G., 1978, ANATOL STUD, V28, P157, DOI [DOI 10.2307/3642748, 10.2307/3642748]; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; LUNDQVIST A, 1956, HEREDITAS, V42, P293, DOI 10.1111/j.1601-5223.1956.tb03021.x; Ma JX, 2007, TRENDS GENET, V23, P134, DOI 10.1016/j.tig.2007.01.004; Maraci O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200825; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; MELZ G, 1991, THEOR APPL GENET, V82, P761, DOI 10.1007/BF00227322; Melz Gi., 2003, Plant Breeding and Seed Science, V47, P47; Miedaner T, 2000, THEOR APPL GENET, V101, P1226, DOI 10.1007/s001220051601; Milczarski P, 2016, J APPL GENET, V57, P439, DOI 10.1007/s13353-016-0347-4; Monteiro F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01334; Morrell PL, 2005, P NATL ACAD SCI USA, V102, P2442, DOI 10.1073/pnas.0409804102; Murdoc D, 2019, RGL 3D VISUALIZATION; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Persson K, 2001, HEREDITAS, V134, P237, DOI 10.1111/j.1601-5223.2001.00237.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2020, R LANG ENV STAT COMP; Rabanus-Wallace MT, 2019, BIORXIV201920122011, DOI 10.1101/2019.12.11.869693; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rasheed A, 2017, MOL PLANT, V10, P1047, DOI 10.1016/j.molp.2017.06.008; Reif JC, 2003, THEOR APPL GENET, V107, P947, DOI 10.1007/s00122-003-1333-x; Reif JC, 2003, CROP SCI, V43, P1275, DOI 10.2135/cropsci2003.1275; Rstudio Team, 2015, RSTUDIO INT DEV R; Schlegel R., 2016, RUSS J GENET+, V6, P569, DOI [10.1134/S2079059716050105, DOI 10.1134/S2079059716050105]; Schlegel R.H., 2013, RYE GENETICS BREEDIN; Schreiber M, 2019, EVOL APPL, V12, P66, DOI 10.1111/eva.12624; Schulthess AW, 2016, THEOR APPL GENET, V129, P273, DOI 10.1007/s00122-015-2626-6; Shin J.-H., 2006, J STAT SOFTWARE, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Stracke S, 2003, THEOR APPL GENET, V106, P1184, DOI 10.1007/s00122-002-1153-4; Targonska M, 2016, PLANT MOL BIOL REP, V34, P37, DOI 10.1007/s11105-015-0896-4; Van Inghelandt D, 2011, THEOR APPL GENET, V123, P11, DOI 10.1007/s00122-011-1562-3; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wang Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-556; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Zhang XH, 2016, ELECTRON COMMER R A, V17, P1, DOI 10.1016/j.elerap.2016.02.002	81	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239541	10.1371/journal.pone.0239541	http://dx.doi.org/10.1371/journal.pone.0239541			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035208	Green Published, gold			2022-12-26	WOS:000581817500046
J	Guo, H; Li, W; Huang, YY; Li, XY; Li, Z; Zhou, HX; Sun, EH; Li, L; Li, JS				Guo, Hui; Li, Wei; Huang, Yingying; Li, Xiaoyan; Li, Zhi; Zhou, Hongxia; Sun, Enhua; Li, Li; Li, Jisheng			Increased microbial loading in aerosols produced by non-contact air-puff tonometer and relative suggestions for the prevention of coronavirus disease 2019 (COVID-19)	PLOS ONE			English	Article							INACTIVATION	Objective To evaluate the microbial loading in aerosols produced after air-puff by non-contact tonometer (NCT) as well as the effect of alcohol disinfection on the inhibition of microbes and thus to provide suggestions for the prevention and control of COVID-19 in ophthalmic departments of hospitals or clinics during the great pandemics. Methods A cross-sectional study was carried out in this study. A NIDEK NCT was used for intraocular pressure (IOP) measurement for patients who visited Department of Ophthalmology in Qilu Hospital of Shandong University during March 18-25 2020. After ultra-violate (UV) light disinfection, the room air was sampled for 5 minutes. Before and after alcohol disinfection, the air samples and nozzle surface samples were respectively collected by plate exposure method and sterile moist cotton swab technique after predetermined times of NCT air-puff. Microbial colony counts were calculated after incubation for 48 hours. Finally, mass spectrometry was performed for the accurate identification of microbial species. Results Increased microbial colonies were detected from air samples close to NCT nozzle after air-puff compared with air samples at a distance of 1 meter from the nozzle (p= 0.001). Interestingly, none microbes were detected on the surface of NCT nozzle. Importantly, after 75% alcohol disinfection less microbes were detected in the air beside the nozzle (p= 0.003). Microbial species identification showed more than ten strains of microbes, all of which were non-pathogenic. Conclusion Aerosols containing microbes were produced by NCT air-puff in the ophthalmic consultation room, which may be a possible virus transmission route in the department of ophthalmology during the COVID-19 pandemic. Alcohol disinfection for the nozzle and the surrounding air was efficient at decreasing the microbes contained in the aerosols and theoretically this prevention measure could also inhibit the virus. This will give guidance for the prevention of virus transmission and protection of hospital staff and patients.	[Guo, Hui; Huang, Yingying; Li, Xiaoyan; Li, Zhi] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Cheeloo Coll Med, Jinan, Shandong, Peoples R China; [Li, Wei; Zhou, Hongxia; Sun, Enhua] Shandong Univ, Qilu Hosp, Dept Clin Lab, Cheeloo Coll Med, Jinan, Shandong, Peoples R China; [Li, Li; Li, Jisheng] Shandong Univ, Qilu Hosp, Dept Med Oncol, Cheeloo Coll Med, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Li, JS (corresponding author), Shandong Univ, Qilu Hosp, Dept Med Oncol, Cheeloo Coll Med, Jinan, Shandong, Peoples R China.	lijisheng@sdu.edu.cn	Li, Wei/GLU-8496-2022	Li, Jisheng/0000-0002-4186-6228	Natural Science Foundation of Shandong Province [ZR2017MH022]; Key Technology Research and Development Program of Shandong Province [2015GGH318025]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Key Technology Research and Development Program of Shandong Province	H.G. received the Natural Science Foundation of Shandong Province grant support (ZR2017MH022). http://cloud.sdstc.gov.cn/L.L.received the Key Technology Research and Development Program of Shandong Province grant support (2015GGH318025). http://cloud.sdstc.gov. cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari U, 2019, RISK ANAL, V39, P2608, DOI 10.1111/risa.13389; [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; BRITT JM, 1991, ARCH OPHTHALMOL-CHIC, V109, P225, DOI 10.1001/archopht.1991.01080020071046; Chan WM, 2004, BRIT J OPHTHALMOL, V88, P968, DOI 10.1136/bjo.2003.039461; Darnell MER, 2006, TRANSFUSION, V46, P1770, DOI 10.1111/j.1537-2995.2006.00976.x; Hindawi SI, 2018, TRANSFUSION, V58, P52, DOI 10.1111/trf.14422; Hui KPY, 2020, LANCET RESP MED, V8, P687, DOI 10.1016/S2213-2600(20)30193-4; Junk AK, 2017, OPHTHALMOLOGY, V124, P1867, DOI 10.1016/j.ophtha.2017.05.033; Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022; Kratzel A, 2020, EMERG INFECT DIS, V26, P1592, DOI 10.3201/eid2607.200915; [李纯纯 Li Chunchun], 2020, [中华实验眼科杂志, Chinese Journal of Experimental Ophthalmology], V38, P212; Lian KY, 2017, CLIN EXP OPTOM, V100, P341, DOI 10.1111/cxo.12544; Liu K, 2020, CLIN INFECT DIS, V71, P2045, DOI 10.1093/cid/ciaa422; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Wang J, 2020, IRISH J MED SCI, V189, P1143, DOI 10.1007/s11845-020-02218-2; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Xia JH, 2020, J MED VIROL, V92, P589, DOI 10.1002/jmv.25725; Ye GM, 2020, J INFECTION, V81, pE1, DOI 10.1016/j.jinf.2020.04.034; Yu AY, 2020, EYE VISION, V7, DOI 10.1186/s40662-020-00187-2; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867; Zhang HN, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-204	22	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240421	10.1371/journal.pone.0240421	http://dx.doi.org/10.1371/journal.pone.0240421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031477	Green Published, gold			2022-12-26	WOS:000581809800045
J	Misistia, A; Skotak, M; Cardenas, A; Alay, E; Chandra, N; Kamimori, GH				Misistia, Anthony; Skotak, Maciej; Cardenas, Arturo; Alay, Eren; Chandra, Namas; Kamimori, Gary H.			Sensor orientation and other factors which increase the blast overpressure reporting errors	PLOS ONE			English	Article							EXPOSURE	This study compared the response of the wearable sensors tested against the industry-standard pressure transducers at blast overpressure (BOP) levels typically experienced in training. We systematically evaluated the effects of the sensor orientation with respect to the direction of the incident shock wave and demonstrated how the averaging methods affect the reported pressure values. The evaluated methods included averaging peak overpressure and impulse of all four sensors mounted on a helmet, taking the average of the three sensors, or isolating the incident pressure equivalent using two sensors. The experimental procedures were conducted in controlled laboratory conditions using the shock tube, and some of the findings were verified in field conditions with live fire charges during explosive breaching training. We used four different orientations (0 degrees, 90 degrees, 180 degrees, and 270 degrees) of the headform retrofitted with commonly fielded helmets (ACH, ECH, Ops-Core) with four B3 Blast Gauge sensors. We determined that averaging the peak overpressure values overestimates the actual dosage experienced by operators, which is caused by the reflected pressure contribution. This conclusion is valid despite the identified limitation of the B3 gauges that consistently underreport the peak reflected overpressure, compared to the industry-standard sensors. We also noted consistent overestimation of the impulse. These findings demonstrate that extreme caution should be exercised when interpreting occupational blast exposure results without knowing the orientation of the sensors. Pure numerical values without the geometrical, training-regime specific information such as the position of the sensors, the distance and orientation of the trainee to the source of the blast wave, and weapon system used will inevitably lead to erroneous estimation of the individual and cumulative blast overpressure (BOP) dosages. Considering that the 4 psi (similar to 28 kPa) incident BOP is currently accepted as the threshold exposure safety value, a misinterpretation of exposure level may lead to an inaccurate estimation of BOP at the minimum standoff distance (MSD), or exclusion criteria.	[Misistia, Anthony; Skotak, Maciej; Cardenas, Arturo; Kamimori, Gary H.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Dept, Silver Spring, MD 20910 USA; [Misistia, Anthony; Cardenas, Arturo] Cherokee Nation Assurance, Catoosa, OK USA; [Skotak, Maciej; Alay, Eren; Chandra, Namas] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Alay, Eren] Stevens Inst Technol, Dept Comp Sci, Hoboken, NJ 07030 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); New Jersey Institute of Technology; Stevens Institute of Technology	Kamimori, GH (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Dept, Silver Spring, MD 20910 USA.; Skotak, M (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	maciej.skotak.ctr@mail.mil; gary.h.kamimori.civ@mail.mil	Skotak, Maciej/H-4769-2019	Skotak, Maciej/0000-0003-2584-7294	U.S. Army MRMC MOMRP (RAD 3) grant "Environmental Sensors in Training" (ESiT); Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-16-2-0001]	U.S. Army MRMC MOMRP (RAD 3) grant "Environmental Sensors in Training" (ESiT); Office of the Assistant Secretary of Defense for Health Affairs	This work was supported by U.S. Army MRMC MOMRP (RAD 3) grant "Environmental Sensors in Training" (ESiT), and Office of the Assistant Secretary of Defense for Health Affairs, award no. W81XWH-16-2-0001 (PI: Dr. Gary H. Kamimori). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alay E, 2018, SHOCK WAVES, V28, P51, DOI 10.1007/s00193-017-0762-4; Ben-Dor G, 2006, SHOCK WAVES, V15, P277, DOI 10.1007/s00193-006-0036-z; Ben-Dor G, 2007, SHOCK WAVE HIGH PRES, P1; Ben-Dor G., 1992, Shock Waves, V2, P211, DOI 10.1007/BF01414757; Ben-Dor G., 1988, Progress in Aerospace Sciences, V25, P329, DOI 10.1016/0376-0421(88)90009-7; Bogosian D, 2016, P 24 MIL ASP BLAST S; Bogosian D., 2002, MEASURING UNCERTAINT; Borkholder DA, 2019, GOOGLE PATENTS; Boutte AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221036; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Cormie D., 2019, BLAST EFFECTS BUILDI, DOI 10.1680/beob2e.35218.fm; Draganic H, 2012, TEH VJESN, V19, P643; Federal Emergency Management Agency (FEMA), 2003, 426 FEMA; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; LaValle CR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00949; Ngo T, 2007, ELECT J STRUCT ENG, V7; Skotak M, 2019, HIGH VELOCITY IMPACT; Skotak M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00797; Skotak M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198968; Skotak M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00052; USDD, 2008, US DEP DEF STRUCT RE; Walter PL, 2004, SOUND VIB, V38, P10; Wang ZY, 2020, J NEUROTRAUM, V37, P1221, DOI 10.1089/neu.2019.6742; Zhao H, 1999, SHOCK WAVES, V9, P419, DOI 10.1007/s001930050172	30	3	3	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240262	10.1371/journal.pone.0240262	http://dx.doi.org/10.1371/journal.pone.0240262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031423	Green Published, gold			2022-12-26	WOS:000581809800039
J	Werbin, ZR; Heidari, L; Buckley, S; Brochu, P; Butler, LJ; Connolly, C; Bloemendaal, LH; McCabe, TD; Miller, TK; Hutyra, LR				Werbin, Zoey R.; Heidari, Leila; Buckley, Sarabeth; Brochu, Paige; Butler, Lindsey J.; Connolly, Catherine; Houttuijn Bloemendaal, Lucila; McCabe, Tempest D.; Miller, Tara K.; Hutyra, Lucy R.			A tree-planting decision support tool for urban heat mitigation	PLOS ONE			English	Article							VULNERABILITY INDEX; ECOSYSTEM SERVICES; TEMPERATURE; STREET; PERFORMANCE; PROGRAMS; CITIES; CITY	Heat poses an urgent threat to public health in cities, as the urban heat island (UHI) effect can amplify exposures, contributing to high heat-related mortality and morbidity. Urban trees have the potential to mitigate heat by providing substantial cooling, as well as co-benefits such as reductions in energy consumption. The City of Boston has attempted to expand its urban canopy, yet maintenance costs and high tree mortality have hindered successful canopy expansion. Here, we present an interactive web application calledRight Place,Right Tree-Bostonthat aims to support informed decision-making for planting new trees. To highlight priority regions for canopy expansion, we developed a Boston-specific Heat Vulnerability Index (HVI) and present this alongside maps of summer daytime land surface temperatures. We also provide information about tree pests and diseases, suitability of species for various conditions, land ownership, maintenance tips, and alternatives to tree planting. This web application is designed to support decision-making at multiple spatial scales, to assist city officials as well as residents who are interested in expanding or maintaining Boston's urban forest.	[Werbin, Zoey R.; Miller, Tara K.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Heidari, Leila; Brochu, Paige; Butler, Lindsey J.; Connolly, Catherine] Boston Univ, Dept Environm Hlth, Boston, MA 02215 USA; [Buckley, Sarabeth; Houttuijn Bloemendaal, Lucila; McCabe, Tempest D.; Hutyra, Lucy R.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Werbin, ZR (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	zrwerbin@bu.edu	BITOUN, RACHEL Elisabeth/AAC-9538-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Heidari, Leila/0000-0003-1853-5778; Brochu, Paige/0000-0001-8174-2273	BU URBAN Program - National Science Foundation Research Traineeship (NRT) [DGE 1735087]; National Institute on Minority Health and Health Disparities [P50MD010428]; U.S. Environmental Protection Agency [RD-836156]	BU URBAN Program - National Science Foundation Research Traineeship (NRT); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); U.S. Environmental Protection Agency(United States Environmental Protection Agency)	TDM, PB, SB, LHB, LJB, LH, CC, TKM, and LRH are supported by the BU URBAN Program, funded by a National Science Foundation Research Traineeship (NRT) grant to Boston University (DGE 1735087). The HVI work conducted by LH was supported by the following grants: National Institute on Minority Health and Health Disparities (Award No. P50MD010428) and U.S. Environmental Protection Agency (Award No. RD-836156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel D., 2012, BOSTON GLOBE; Abel David, 2018, BOSTON GLOBE; [Anonymous], **DATA OBJECT**; [Anonymous], 2012, NATL LAND COVER DATA; [Anonymous], **DATA OBJECT**; [Anonymous], 2018, AM COMM SURV; [Anonymous], SPEAK TREES BOST; [Anonymous], SAS VERS 9 4; Bao JZ, 2015, INT J ENV RES PUB HE, V12, P7220, DOI 10.3390/ijerph120707220; Carinanos P, 2016, J ENVIRON QUAL, V45, P244, DOI 10.2134/jeq2015.02.0075; Carmichael CE, 2019, SOC NATUR RESOUR, V32, P588, DOI 10.1080/08941920.2018.1550229; Chang W, 2019, WEB APPL FRAMEWORK R; Cheng J, 2021, MET MATER INT, V27, P545, DOI 10.1007/s12540-019-00503-z; Chuang WC, 2015, ENVIRON HEALTH PERSP, V123, P606, DOI 10.1289/ehp.1307868; City of Cambridge, CAMBR URB FOR TREE P; Coutts Erin, 2015, PLANNING URBAN HEAT, DOI [10.1007/s00484-014-0946-x, DOI 10.1007/S00484-014-0946-X25567543]; Davis M., 2010, BOSTON GLOBE; Del Tredici P., 2014, HARDY URBAN TREES NE; DeNardo JC, 2005, T ASAE, V48, P1491, DOI 10.13031/2013.19181; Fitzpatrick MC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08540-3; Harlan SL, 2013, ENVIRON HEALTH PERSP, V121, P197, DOI 10.1289/ehp.1104625; Hondula DM, 2015, ENVIRON RES, V138, P439, DOI 10.1016/j.envres.2015.02.033; i-Tree Software Suite, I TREE SPEC UT; I-Tree Software Suite, 2018, I TREE CAN; Jennings V, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020196; Kumar R, 2005, BUILD ENVIRON, V40, P1505, DOI 10.1016/j.buildenv.2004.11.015; Landry SM, 2009, ENVIRON PLANN A, V41, P2651, DOI 10.1068/a41236; Livesley SJ, 2016, J ENVIRON QUAL, V45, P119, DOI 10.2134/jeq2015.11.0567; Loughner CP, 2012, J APPL METEOROL CLIM, V51, P1775, DOI 10.1175/JAMC-D-11-0228.1; Maier G, 2014, WEATHER CLIM SOC, V6, P253, DOI 10.1175/WCAS-D-13-00037.1; McDonald R., 2016, PLANTING HLTH AIR GL; Moss JL, 2019, URBAN FOR URBAN GREE, V37, P65, DOI 10.1016/j.ufug.2018.07.023; Narango DL, 2018, P NATL ACAD SCI USA, V115, P11549, DOI 10.1073/pnas.1809259115; Nayak SG, 2018, PUBLIC HEALTH, V161, P127, DOI 10.1016/j.puhe.2017.09.006; Norton BA, 2015, LANDSCAPE URBAN PLAN, V134, P127, DOI 10.1016/j.landurbplan.2014.10.018; Nowak DJ, 2013, ENVIRON POLLUT, V178, P229, DOI 10.1016/j.envpol.2013.03.019; Oke T.R., 2017, URBAN CLIMATES, V1st, P197, DOI 10.1017/9781139016476; Orsini F, 2014, FOOD SECUR, V6, P781, DOI 10.1007/s12571-014-0389-6; Parker LE, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/034001; Pazzanese C., 2011, BOSTON GLOBE; Pincetl S, 2013, GEOJOURNAL, V78, P475, DOI 10.1007/s10708-012-9446-x; R Core Team, 2020, R LANG ENV STAT COMP; Roy S, 2012, URBAN FOR URBAN GREE, V11, P351, DOI 10.1016/j.ufug.2012.06.006; San Francisco Urban Forestry Council, 2018, ANN URB FOR REP; Savarani S., 2019, REV GREEN ROOF LAWS; Schwartz A., 2011, GOTHAM GAZ; Schwarz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122051; Smith IA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215846; Solecki W.D., 2005, ENVIRON HAZARDS-UK, V6, P39, DOI [10.1016/j.hazards.2004.12.002, DOI 10.1016/J.HAZARDS.2004.12.002]; Trlica A, 2017, EARTHS FUTURE, V5, P1084, DOI 10.1002/2017EF000569; University of Vermont Spatial Analysis Lab, 2014, BOST LAND COV; van Westen C.J, 2014, CARRIBEAN HDB RISK I; Walker K, 2018, TIGRIS LOAD CENSUS T; Walsh MMJ, 2016, CLIMATE READY BOSTON; Wang JA, 2017, J APPL METEOROL CLIM, V56, P817, DOI 10.1175/JAMC-D-16-0325.1; Wolf T, 2015, INT J ENV RES PUB HE, V12, P13321, DOI 10.3390/ijerph121013321; Xie Y., 2019, DT WRAPPER JAVASCRIP	57	12	12	8	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0224959	10.1371/journal.pone.0224959	http://dx.doi.org/10.1371/journal.pone.0224959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TB	33031384	gold, Green Published			2022-12-26	WOS:000581809800093
J	Szigeti, R; Kellermayer, D; Trakimas, G; Kellermayer, R				Szigeti, Reka; Kellermayer, Domos; Trakimas, Giedrius; Kellermayer, Richard			BCG epidemiology supports its protection against COVID-19? A word of caution	PLOS ONE			English	Article							CORONAVIRUS; GUIDE	The COVID-19 pandemic, caused by type 2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), puts all of us to the test. Epidemiologic observations could critically aid the development of protective measures to combat this devastating viral outbreak. Recent observations, linked nation based universal Bacillus Calmette-Guerin (BCG) vaccination to potential protection against morbidity and mortality from SARS-CoV-2, and received much attention in public media. We wished to validate the findings by examining the country based association between COVID-19 mortality per million population, or daily rates of COVID-19 case fatality (i.e. Death Per Case/Days of the endemic [dpc/d]) and the presence of universal BCG vaccination before 1980, or the year of the establishment of universal BCG vaccination. These associations were examined in multiple regression modeling based on publicly available databases on both April 3(rd)and May 15(th)of 2020. COVID-19 deaths per million negatively associated with universal BCG vaccination in a country before 1980 based on May 15(th)data, but this was not true for COVID-19 dpc/d on either of days of inquiry. We also demonstrate possible arbitrary selection bias in such analyses. Consequently, caution should be exercised amidst the publication surge on COVID-19, due to political/economical-, arbitrary selection-, and fear/anxiety related biases, which may obscure scientific rigor. We argue that global COVID-19 epidemiologic data is unreliable and therefore should be critically scrutinized before using it as a nidus for subsequent hypothesis driven scientific discovery.	[Szigeti, Reka] Houston Methodist Hosp, Dept Pathol & Genom Med, Houston, TX 77030 USA; [Kellermayer, Domos] Univ Houston, Houston, TX USA; [Trakimas, Giedrius] Vilnius Univ, Inst Biosci, Vilnius, Latvia; [Trakimas, Giedrius] Daugavpils Univ, Inst Life Sci & Technol, Daugavpils, Latvia; [Kellermayer, Richard] Texas Childrens Hosp, Sect Pediat Gastroenterol, Houston, TX 77030 USA; [Kellermayer, Richard] Baylor Coll Med, Houston, TX 77030 USA; [Kellermayer, Richard] USDA ARS, Childrens Nutr Res Ctr, Houston, TX USA	The Methodist Hospital System; The Methodist Hospital - Houston; University of Houston System; University of Houston; University of Daugavpils; Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA)	Kellermayer, R (corresponding author), Texas Childrens Hosp, Sect Pediat Gastroenterol, Houston, TX 77030 USA.; Kellermayer, R (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.; Kellermayer, R (corresponding author), USDA ARS, Childrens Nutr Res Ctr, Houston, TX USA.	kellerma@bcm.edu	Trakimas, Giedrius/B-8462-2008	Trakimas, Giedrius/0000-0001-6294-0194; Kellermayer, Richard/0000-0002-4146-1335				[Anonymous], 2010, NEPHROL THER, V6, pS27; [Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; [Anonymous], 2005, HAEMATOLOGICA, V90; [Anonymous], 2020, YEMEN COVID 19 FEARS; [Anonymous], 2020, CORONAVIRUS HUNGARY; Centers for Disease Control and Prevention, 2020, CENT DIS CONTROL PRE; Clay CC, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-4; Cleasby IR, 2011, BEHAV ECOL SOCIOBIOL, V65, P2361, DOI 10.1007/s00265-011-1254-7; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Escobar Luis E, 2020, medRxiv, DOI [10.1073/pnas.2008410117, 10.1101/2020.05.05.20091975]; Fjallbrant H, 2008, SCAND J INFECT DIS, V40, P387, DOI 10.1080/00365540701732905; Giamarellos-Bourboulis EJ, 2020, CELL, V183, P315, DOI 10.1016/j.cell.2020.08.051; Hamiel U, 2020, JAMA-J AM MED ASSOC, V323, P2340, DOI 10.1001/jama.2020.8189; Han CQ, 2020, AM J GASTROENTEROL, V115, P916, DOI 10.14309/ajg.0000000000000664; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Heneghan RSJBAPC, 2020, DOES BCG VACC PROT A; Lescure FX, 2020, LANCET INFECT DIS, V20, P697, DOI 10.1016/S1473-3099(20)30200-0; Meena J, 2020, INDIAN J PEDIATR, V87, P749, DOI 10.1007/s12098-020-03371-3; Melcher T, 2012, ACTA PSYCHOL, V139, P507, DOI 10.1016/j.actpsy.2012.01.012; Miyasaka M, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012661; Qiu HY, 2020, LANCET INFECT DIS, V20, P689, DOI 10.1016/S1473-3099(20)30198-5; Santarpia JL., 2020, TRANSMISSION POTENTI, DOI [10.1101/2020.03.23.20039446, DOI 10.1101/2020.03.23.20039446]; Sigurdsson Sigurdur, 2005, Laeknabladid, V91, P69; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Thabet F, 2015, SAUDI MED J, V36, P484, DOI 10.15537/smj.2015.4.10243; Tyler AD, 2014, AM J GASTROENTEROL, V109, P983, DOI 10.1038/ajg.2014.73; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786; Whittaker E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33499-4; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	33	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240203	10.1371/journal.pone.0240203	http://dx.doi.org/10.1371/journal.pone.0240203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027297	Green Published, gold			2022-12-26	WOS:000581808000015
J	Cardona, G; Pujol-Nadal, R				Cardona, Gabriel; Pujol-Nadal, Ramon			OTSun, a python package for the optical analysis of solar-thermal collectors and photovoltaic cells with arbitrary geometry	PLOS ONE			English	Article								Ray tracing software systems are commonly used to analyze the optics of solar energy devices, since they allow to predict the energy gains of devices in real conditions, and also to compare them with other systems constantly emerging in the market. However, the available open-source packages apply excessive simplifications to the model of light-matter interaction, making that the optical behaviour of the systems can not be properly characterized, which in turn implies disagreements between physical experiments and computer simulations. We present here the open source python package OTSun, which applies the Fresnel equations in their most general form, without further simplifications, and is suitable for the simulation of both solar-thermal and photovoltaic systems. The geometrical objects used in this package are created using the parametric 3D modeler FreeCAD, which is also a free and open source program and allows for the construction of arbitrary geometries that can be analyzed with OTSun. These, and other software capabilities, make OTSun extremely flexible and accurate for the optical analysis of solar devices with arbitrary geometry. Additionally, OTSun has a companion webtool, OTSunWebApp, that allows for the usage of certain features of the package without the need to install anything locally. We also show here two numerical experiments that we performed in order to validate the model and implementation: The analysis of the optical efficiency of a Linear Fresnel Reflector (with moving objects), and of a second surface mirror (with variable wavelengths). In each case, the numerical computations had deviations of less than 0.25% from reference models (either computed with another program or with exact formulas).	[Cardona, Gabriel] Univ Illes Balears, Dept Ciencies Matemat & Informat, Palma De Mallorca, Spain; [Cardona, Gabriel] Univ Montpellier, Inst Sci Evolut, Montpellier, France; [Pujol-Nadal, Ramon] Univ Illes Balears, Dept Engn Ind & Construccio, Palma De Mallorca, Spain	Universitat de les Illes Balears; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universitat de les Illes Balears	Pujol-Nadal, R (corresponding author), Univ Illes Balears, Dept Engn Ind & Construccio, Palma De Mallorca, Spain.	ramon.pujol@uib.es	Nadal, Ramon Pujol/E-9625-2013; Cardona, Gabriel/K-4019-2014	Nadal, Ramon Pujol/0000-0003-0523-6904; Cardona, Gabriel/0000-0001-8845-4290	Spanish Ministry of Economy and Competitiveness [ENE2015-68339-R]; AEI; European Regional Development Fund, European Union	Spanish Ministry of Economy and Competitiveness(Spanish Government); AEI; European Regional Development Fund, European Union	The work was funded by the Spanish Ministry of Economy and Competitiveness [grant number ENE2015-68339-R], AEI and the European Regional Development Fund, European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; Blanco M, 2011, P 17 SOLARPACES INT; Bonnin-Ripoll F, 2019, SOL ENERG MAT SOL C, V200, DOI 10.1016/j.solmat.2019.110050; Bos-Coenraad J, 2017, SOL ENERGY, V155, P1188, DOI 10.1016/j.solener.2017.07.003; Bos-Coenraad J, 2020, SCIENTRACE; Breault Research Organization Inc. ASAP, 2020, ASAP; Buie D, 2003, SOL ENERGY, V74, P417, DOI 10.1016/S0038-092X(03)00156-7; Byrnes S., 2017, TMM 0 1 7 PYTHON PAC; Byrnes S. J., 2016, ARXIV PREPRINT ARXIV, P1; Cardona G, 2020, OTSUNWEBAPP TUTORIAL; Cruz NC, 2017, RENEW SUST ENERG REV, V72, P1001, DOI 10.1016/j.rser.2017.01.032; Google Inc, 2013, HOPS HEL OPT SIM; Lambda Research Corp, 2020, TRACEPRO; Lipovek B, 2019, CROWM; Macleod HA, 2010, SER OPT OPTOELECTRON, P1, DOI 10.1201/9781420073034; Magnin V, 2014, SOL ENERGY, V110, P378, DOI 10.1016/j.solener.2014.09.025; Malinowski M, 2017, P IEEE, V105, P2132, DOI 10.1109/JPROC.2017.2690343; Osorio T, 2016, AIP CONF PROC, V1734, DOI 10.1063/1.4949041; Riegel J, 2020, FREECAD; Tesfamichael T, 2000, SOL ENERGY, V68, P335, DOI 10.1016/S0038-092X(00)00029-3; Verma RK, 2006, RAY OPTICS; Wendelin T., 2003, INT SOL EN C, V36762, P253	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240735	10.1371/journal.pone.0240735	http://dx.doi.org/10.1371/journal.pone.0240735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052977	gold, Green Published			2022-12-26	WOS:000581820200068
J	Fei, XW; Zhang, Y; Ding, LL; Li, YJ; Deng, XD				Fei, Xiaowen; Zhang, Yang; Ding, Lili; Li, Yajun; Deng, Xiaodong			Controlling the development of the dengue vector Aedes aegypti using HR3 RNAi transgenicChlamydomonas	PLOS ONE			English	Article							NUCLEAR TRANSFORMATION; METEOROLOGICAL FACTORS; GENE-EXPRESSION; RECEPTOR; TRIACYLGLYCEROLS; BIOSYNTHESIS; INTERFERENCE; TRANSMISSION; ECDYSONE; LARVAL	TheAedes aegyptimosquito plays an important role in the spread of diseases, including epidemic ones, such as dengue fever, Zika virus disease, yellow fever, and chikungunya disease. To control the population ofAe.aegypti, we transferred an HR3 RNAi fragment into the microalgaeChlamydomonas, which serves as food forAe.aegyptilarvae. Results showed that the HR3 RNAi transgenic algal strains were lethal toAe.aegypti. The integumentary system of larvae fed with HR3 RNAi transgenic algal strains was severely damaged. Muscles of the larvae were unevenly distributed and disordered, and their midgut showed disintegration of the intestinal cavity. RNA-Seq results demonstrated that on the 4th day of inoculation with the transgenic algae, the abundance of early expressed genes in the 20E signal transduction pathway of larvae fed with the HR3 RNAi transgenic algal strain significantly reduced. These genes include E74, E75, E93, and 20E receptor complex EcR/USP and FTZ-F1 gene regulated by HR3. In later experiments, a scale test of 300Ae.aegyptieggs per group was carried out for 30 days, and the survival rate ofAe.aegyptifed with the HR3 RNAi transgenic strain was only 1.3%. These results indicate that the HR3 RNAi transgenic strain exerts obvious insecticidal effect.	[Fei, Xiaowen; Zhang, Yang; Ding, Lili] Hainan Med Coll, Dept Biochem & Mol Biol, Haikou, Hainan, Peoples R China; [Li, Yajun; Deng, Xiaodong] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China; [Li, Yajun; Deng, Xiaodong] Hainan Prov Key Lab Funct Components Res & Utiliz, Haikou, Hainan, Peoples R China	Hainan Medical University; Chinese Academy of Tropical Agricultural Sciences	Deng, XD (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China.; Deng, XD (corresponding author), Hainan Prov Key Lab Funct Components Res & Utiliz, Haikou, Hainan, Peoples R China.	dengxiaodong@itbb.org.cn	fei, xiaowen/GRJ-8141-2022		Key Projects of Hainan Province [ZDYF2018124]; National Natural Science Foundation of China [31870344]; Financial Fund of the Ministry of Agriculture and Rural Affairs, P.R.China [NFZX2018]; Special fund for basic scientific research business of the Chinese Academy of Tropical Agricultural Sciences [1630052018001, 19CXTD-32]	Key Projects of Hainan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Financial Fund of the Ministry of Agriculture and Rural Affairs, P.R.China; Special fund for basic scientific research business of the Chinese Academy of Tropical Agricultural Sciences	This study was supported by the Key Projects of Hainan Province (ZDYF2018124), the National Natural Science Foundation of China (31870344) and Financial Fund of the Ministry of Agriculture and Rural Affairs, P.R.China (NFZX2018), Special fund for basic scientific research business of the Chinese Academy of Tropical Agricultural Sciences (NO.19CXTD-32, 1630052018001) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	[Anonymous], 2014, GLOB BRIEF VECT BORN; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026086; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699; Bian GW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002250; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Cordaux R., 2010, J EVOLUTIONARY BIOL, V14, P237; Coy MR, 2012, J APPL ENTOMOL, V136, P741, DOI 10.1111/j.1439-0418.2012.01713.x; Curtis Z, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003999; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; Deng XD, 2012, MOL PLANT, V5, P945, DOI 10.1093/mp/sss040; Deng XD, 2014, BIOTECHNOL LETT, V36, P2199, DOI 10.1007/s10529-014-1593-3; Deng XD, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-38; Dong Peng, 2004, Zoological Research, V25, P456; Fan J, 2014, EPIDEMIOL INFECT, V142, P634, DOI 10.1017/S0950268813001519; Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Huo LP, 2016, PEOPLES DAILY, P23; Huo LP, 2016, PEOPLES DAILY, P3; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Kapitskaya MZ, 2000, MOL CELL ENDOCRINOL, V160, P25, DOI 10.1016/S0303-7207(99)00253-1; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Lam GT, 1997, DEVELOPMENT, V124, P1757; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu FR, 2016, NAT PHOTONICS, V10, P1; Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754; Mane-Padros D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045019; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Palucka AK, 2000, NAT MED, V6, P748, DOI 10.1038/77470; PaulrajM G, 2016, APPADURAI D REEGAN, V7, P193; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Shen JC, 2015, BIOMED ENVIRON SCI, V28, P321, DOI 10.3967/bes2015.046; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Xue L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006666; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x	40	5	5	10	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240223	10.1371/journal.pone.0240223	http://dx.doi.org/10.1371/journal.pone.0240223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052930	Green Published, gold			2022-12-26	WOS:000581820200062
J	Formanowicz, D; Krawczyk, JB				Formanowicz, Dorota; Krawczyk, Jacek B.			Controlling the thickness of the atherosclerotic plaque by statin medication	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK-FACTORS; CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; MATHEMATICAL-MODEL; CAROTID-ARTERY; MYOCARDIAL-INFARCTION	Atherosclerosis, a chronic inflammatory disorder of the arterial wall, is a complex process whose dynamics are affected by multiple factors. The disease control consists of restraining it by administering statins. Slowing down or halting the plaque growth depends on the patient age at which the statin treatment begins and on the thickness of the intima-media (IMT) at that time. In this paper, we propose a mathematical model to estimate the sets of atherosclerosis states, from which the use of statins can restrain the disease. Our model is control-theoretic, and the estimated sets are theviability kernels, in the parlance of viability theory. To our best knowledge, this way of modelling the atherosclerosis progression is original. We compute two viability kernels, each for a different statin-treatment dose. Each kernel is composed of the vector [age, IMT] from which the disease can be restrained. By extension, the disease can't be restrained from the kernel complements, this being mainly because of the disease and patient-age advancement. The kernels visualise tradeoffs between early and late treatments, which helps the clinician to decide when to start the statin treatment and which statin dose may be sufficient.	[Formanowicz, Dorota] Poznan Univ Med Sci, Dept Clin Biochem & Lab Med, Poznan, Poland; [Krawczyk, Jacek B.] Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia	Poznan University of Medical Sciences; University of Sydney	Formanowicz, D (corresponding author), Poznan Univ Med Sci, Dept Clin Biochem & Lab Med, Poznan, Poland.; Krawczyk, JB (corresponding author), Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia.	doforman@ump.edu.pl; jacek.krawczyk@sydney.edu.au	Formanowicz, Dorota/V-3901-2019	Formanowicz, Dorota/0000-0001-6691-3863	National Science Centre (Poland) [2012/07/B/ST6/01537]; Poznan University of Medical Sciences	National Science Centre (Poland)(National Science Centre, Poland); Poznan University of Medical Sciences	This research has been partially supported by the National Science Centre (Poland) Grant No. 2012/07/B/ST6/01537 (DF) and by the statutory funds of Poznan University of Medical Sciences (DF).	Al-Mallah MH, 2009, CARDIOL J, V16, P227; Aubin JP, 2011, VIABILITY THEORY: NEW DIRECTIONS, SECOND EDITION, P1, DOI 10.1007/978-3-642-16684-6; Bartels S., 2012, PERSPECTIVES MED, V1, P139, DOI 10.1016/j.permed.2012.01.006; Benfante R, 1992, Ann Epidemiol, V2, P273; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Bohula EA, 2015, CIRCULATION, V132, P1224, DOI 10.1161/CIRCULATIONAHA.115.018381; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Buljan Krunoslav, 2015, Coll Antropol, V39, P779; Calvez Vincent, 2010, ESAIM Proceedings, V30, P1, DOI 10.1051/proc/2010002; Chalmers AD, 2015, J MATH BIOL, V71, P1451, DOI 10.1007/s00285-015-0864-5; Conti P, 2015, CENT EUR J IMMUNOL, V40, P380, DOI 10.5114/ceji.2015.54603; CORTI MC, 1995, JAMA-J AM MED ASSOC, V274, P539, DOI 10.1001/jama.274.7.539; Corti MC, 1997, ANN INTERN MED, V126, P753, DOI 10.7326/0003-4819-126-10-199705150-00001; Curb JD, 2004, J AM GERIATR SOC, V52, P1975, DOI 10.1111/j.1532-5415.2004.52551.x; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Diamantis E, 2017, CURR CARDIOL REV, V13, P209, DOI 10.2174/1573403X13666170426104611; El Khatib N, 2019, MATH MODEL NAT PHENO, V14, DOI 10.1051/mmnp/2019050; El Khatib N, 2009, PHILOS T R SOC A, V367, P4877, DOI 10.1098/rsta.2009.0142; Formanowicz D, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030785; Formanowicz D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113476; Friedman A, 2015, B MATH BIOL, V77, P758, DOI 10.1007/s11538-014-0010-3; Gaeta G, 2000, NEW ENGL J MED, V343, P840, DOI 10.1056/NEJM200009213431203; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Homma S, 2001, STROKE, V32, P830, DOI 10.1161/01.STR.32.4.830; Hong Young Mi, 2010, Korean Circ J, V40, P1, DOI 10.4070/kcj.2010.40.1.1; Horne BD, 2000, J AM COLL CARDIOL, V36, P1774, DOI 10.1016/S0735-1097(00)00950-5; Ibragimov AI, 2005, MATH MED BIOL, V22, P305, DOI 10.1093/imammb/dqi011; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; Jones NL, 2000, ARTERIOSCL THROM VAS, V20, P773, DOI 10.1161/01.ATV.20.3.773; Juonala M, 2008, EUR HEART J, V29, P1198, DOI 10.1093/eurheartj/ehm556; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Khan HA, 2013, BIOMARK INSIGHTS, V8, P1, DOI 10.4137/BMI.S11015; Kim SW, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00103; Koga M, 2018, STROKE, V49, P107, DOI 10.1161/STROKEAHA.117.018387; Koushki K, 2021, CLIN REV ALLERG IMMU, V60, P175, DOI 10.1007/s12016-020-08791-9; Krawczyk J.B., 2013, MATH APPL, V41, P97, DOI DOI 10.14708/MA.V41I1.409; Krawczyk JB, 2012, COMPUT MANAG SCI, V9, P233, DOI 10.1007/s10287-012-0141-7; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; Kwon D, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017013; Laufs Ulrich, 2003, Curr Atheroscler Rep, V5, P372, DOI 10.1007/s11883-003-0008-z; Loboz-Rudnicka M, 2016, CLIN INTERV AGING, V11, P721, DOI 10.2147/CIA.S103521; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Migrino RQ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-37; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Paraskevas KI, 2007, J VASC SURG, V46, P373, DOI 10.1016/j.jvs.2007.03.035; Quispe R, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.013600; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Ravnskov U, 2018, EXPERT REV CLIN PHAR, V11, P959, DOI 10.1080/17512433.2018.1519391; Ravnskov U, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010401; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, CIRC-CARDIOVASC QUAL, V2, P279, DOI 10.1161/CIRCOUTCOMES.109.868299; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085; ROSS R, 1977, AM J PATHOL, V86, P675; Rzosinska K, 2017, ARCH CONTROL SCI, V27, P331, DOI 10.1515/acsc-2017-0022; Sachdeva A, 2009, AM HEART J, V157, P111, DOI 10.1016/j.ahj.2008.08.010; Salvayre R, 2016, BIOCHIMIE, V125, P281, DOI 10.1016/j.biochi.2015.12.014; Schmidt-Trucksass A, 1999, ARTERIOSCL THROM VAS, V19, P1091, DOI 10.1161/01.ATV.19.4.1091; Silva T, 2013, C PAPERS MATH, V2013; Sinning C, 2011, AM J CARDIOL, V107, P1841, DOI 10.1016/j.amjcard.2011.02.318; Soulaidopoulos S, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00024; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Tanaka M, 2012, J STROKE CEREBROVASC, V21, P47, DOI 10.1016/j.jstrokecerebrovasdis.2010.03.018; Taqueti VR, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.117.006676; Tikhonoff V, 2005, J AM GERIATR SOC, V53, P2159, DOI 10.1111/j.1532-5415.2005.00492.x; Tsoupras A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050604; Tuzcu EM, 2001, CIRCULATION, V103, P2705; Ulmer H, 2004, J WOMENS HEALTH, V13, P41, DOI 10.1089/154099904322836447; Wu Y, 2016, J STROKE CEREBROVASC, V25, P259, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.026; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089269; Yang XY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00600	73	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0239953	10.1371/journal.pone.0239953	http://dx.doi.org/10.1371/journal.pone.0239953			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048950	Green Published, gold			2022-12-26	WOS:000581813300058
J	Interdonato, R; Bourgoin, J; Grislain, Q; Zignani, M; Gaito, S; Giger, M				Interdonato, Roberto; Bourgoin, Jeremy; Grislain, Quentin; Zignani, Matteo; Gaito, Sabrina; Giger, Markus			The parable of arable land: Characterizing large scale land acquisitions through network analysis	PLOS ONE			English	Article							FOOD SECURITY; INVESTMENTS; IMPACTS; RUSH; DISPLACEMENT; GOVERNANCE; ECONOMY; INCOME	Land is a scarce resource and its depletion is related to a combination of demographic and economic factors. Hence, the changes in dietary habits and increase in world population that upturn the food demand, are intertwined with a context of increasing oil prices and rise of green capitalism that in turn impacts the demand in biofuel. A visible indicator of these phenomena is the increase, in recent years, of Large Scale Land Acquisitions (LSLAs) by private companies or states. Such land investments often lead to conflicts with local population and have raised issues regarding people's rights, the role of different production models and land governance. The aim of this work is to show how publicly available data about LSLAs can be modeled into complex network structures, thus showing how the application of advanced network analysis techniques can be used to better understand land trade dynamics. We use data collected by the Land Matrix Initiative on LSLAs to model three land trade networks: amulti-sectornetwork, a network centered on theminingsector and a network centered on theagricultureone. Then we provide an extended analysis of such networks which includes: (i) a structural analysis, (ii) the definition of a score, namelyLSLA-score, which allows to rank the countries based on their investing/target role in the land trade network, (iii) an analysis of the land trade context which takes into account theLSLA-scoreranking and the correlation between network features and several country development indicators, (iv) an analysis centered on the discover and analysis of network motifs (i.e., recurring patterns in the land trade network), which provides insights into complex and diverse relations between countries. Our analyses showed how the land trade market is massively characterized by a Global North-Global South dynamic, even if the investing power of emerging economies also has a major impact in creating relations between different sub-regions of the world. Moreover, the analyses on the mining and agriculture sectors highlighted how the role of several countries in the trade network may drastically change depending of the investment sector, showing diverse hierarchies between investor, intermediate and target countries.	[Interdonato, Roberto; Bourgoin, Jeremy; Grislain, Quentin] TETIS, Cirad, Montpellier, France; [Interdonato, Roberto; Bourgoin, Jeremy; Grislain, Quentin] Univ Montpellier, TETIS, APT, Cirad,CNRS,INRAE, Montpellier, France; [Zignani, Matteo; Gaito, Sabrina] Univ Milan, Dipartimento Informat, Milan, Italy; [Giger, Markus] Univ Bern, Ctr Dev & Environm CDE, Bern, Switzerland	AgroParisTech; CIRAD; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CIRAD; INRAE; Universite de Montpellier; University of Milan; University of Bern	Interdonato, R (corresponding author), TETIS, Cirad, Montpellier, France.; Interdonato, R (corresponding author), Univ Montpellier, TETIS, APT, Cirad,CNRS,INRAE, Montpellier, France.	roberto.interdonato@cirad.fr	Interdonato, Roberto/ABC-3468-2021	Interdonato, Roberto/0000-0002-0536-6277	Land Matrix initiative	Land Matrix initiative	This paper is supported by the Land Matrix initiative.	ACHPR, 2017, REP AFR COMM WORK GR; Adbib R., 2012, LARGE SCALE FOREIGN; [Anonymous], 2010, WORLDWIDE GOVERNANCE; Anseeuw W., 2012, TRANSNATIONAL LAND D; Anseeuw W, 2013, S AFR J INT AFF, V20, P159, DOI 10.1080/10220461.2013.780326; Arezki R, 2015, WORLD BANK ECON REV, V29, P207, DOI 10.1093/wber/lht034; Bank W, 2010, RISING GLOBAL INTERE; Baumgartner P, 2015, WORLD DEV, V72, P175, DOI 10.1016/j.worlddev.2015.02.017; Boamah F, 2016, DEV CHANGE, V47, P98, DOI 10.1111/dech.12213; Borras SM, 2011, J PEASANT STUD, V38, P209, DOI 10.1080/03066150.2011.559005; Bottazzi P, 2016, J PEASANT STUD, V43, P971, DOI 10.1080/03066150.2015.1119119; Bourgoin J, 2019, LAND-BASEL, V8, DOI 10.3390/land8030042; Breu T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150901; Chen B, 2018, SCI TOTAL ENVIRON, V613, P931, DOI 10.1016/j.scitotenv.2017.09.138; Chen GQ, 2015, LAND USE POLICY, V49, P118, DOI 10.1016/j.landusepol.2015.07.023; Conceicao P, 2019, HUMAN DEV REPORT 201; Conesa P, 2016, DOCTEUR SAOUD MISTER; Cotula L., 2013, HUMAN RIGHTS NATURAL; Cotula L., 2009, LAND GRAB DEV OPPORT; Cotula L, 2012, J PEASANT STUD, V39, P649, DOI 10.1080/03066150.2012.674940; De Schutter O, 2011, J PEASANT STUD, V38, P249, DOI 10.1080/03066150.2011.559008; Deininger K, 2011, J PEASANT STUDIES; Dell'Angelo J, 2017, WORLD DEV, V92, P1, DOI 10.1016/j.worlddev.2016.11.005; Dell'Angelo J, 2016, MT RES DEV, V36, P102, DOI 10.1659/MRD-JOURNAL-D-15-00040.1; Economist T, 2019, ECONOMIST T; Escobar A, 2015, SUSTAIN SCI, V10, P451, DOI 10.1007/s11625-015-0297-5; Friis-Hansen E., 2000, AGR POLICY AFRICA AD; Giger M, 2019, 13 IMPACTS LARGE SCA; GRAIN, 2012, ACC TERR SOUV AL AFR; Grin J., 2010, TRANSITIONS SUSTAINA, DOI 10.4324/9780203856598; Interdonato R, 2019, P 8 INT C COMPL NETW, P152; International T, 2019, CORR PERC IND 2019; Lay J, 2018, J ECON GEOGR, V18, P59, DOI 10.1093/jeg/lbx011; Liao C, 2020, LAND DEGRAD DEV, V31, P1241, DOI 10.1002/ldr.3544; Mavrodieva AV, 2019, CLIMATE, V7, DOI 10.3390/cli7100122; MEADOWS D H, 1972, P205; Mechiche-Alami A, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab2e4b; Messerli P, 2014, APPL GEOGRAPHY, V31, P1241; Meyfroidt P, 2013, CURR OPIN ENV SUST, V5, P438, DOI 10.1016/j.cosust.2013.04.003; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Network GF, 2009, EC FOOTPR STAND 2009; Nolte K, 2013, J PEASANT STUDIES, V40, P521; Nolte K., 2016, FRESH INSIGHTS LAND; Nolte K, 2017, WORLD DEV, V98, P430, DOI 10.1016/j.worlddev.2017.05.012; Oberlack C, 2016, GLOBAL ENVIRON CHANG, V41, P153, DOI 10.1016/j.gloenvcha.2016.10.001; OECD, 2020, NAT ACC OECD COUNTR, DOI DOI 10.1787/2221433X; Oya C, 2013, J PEASANT STUD, V40, P503, DOI 10.1080/03066150.2013.799465; Peluso NL, 2011, J PEASANT STUD, V38, P667, DOI 10.1080/03066150.2011.607692; Pitron G., 2018, GUERRE METAUX RARES; Ribeiro P, 2010, P 2010 ACM S APPL CO, P1559, DOI DOI 10.1145/1774088.1774422; Rulli MC, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064030; Schiffman R, 2013, ETHICS INT AFF, V27, P239, DOI 10.1017/S0892679413000208; Schoneveld GC, 2011, ECOLOGY SOC, P16; Schoneveld GC, 2017, GEOFORUM, V83, P119, DOI 10.1016/j.geoforum.2016.12.007; SCOONES I, 2013, J PEASANT STUD, V40, P469, DOI DOI 10.1080/03066150.2013.801341; Scoones I, 2019, GEOFORUM, V101, P231, DOI 10.1016/j.geoforum.2018.06.006; Seaquist JW, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/114006; Shete M, 2015, LAND USE POLICY, V47, P282, DOI 10.1016/j.landusepol.2015.01.034; Stiglitz J. E., 2016, POLIT Q, P134, DOI [DOI 10.1111/1467-923X.12237, 10.1111/1467-923X.12237]; UNCTAD, 2019, WORLD INV REP 2019, P237; United Nations Environment Programme, 2011, GREEN EC PATHW SUST; Voget-Kleschin L, 2013, J AGR ENVIRON ETHIC, V26, P1059, DOI 10.1007/s10806-013-9450-2; Weinzettel J, 2013, GLOBAL ENVIRON CHANG, V23, P433, DOI 10.1016/j.gloenvcha.2012.12.010; Wily LA, 2012, J PEASANT STUD, V39, P751, DOI 10.1080/03066150.2012.674033; Wu XD, 2018, LAND USE POLICY, V76, P201, DOI 10.1016/j.landusepol.2018.05.005; Zoomers A, 2016, GEOFORUM, V69, P147, DOI 10.1016/j.geoforum.2015.11.017; Zoomers EB, 2017, GEOFORUM, V83, P164, DOI 10.1016/j.geoforum.2017.01.009	68	4	4	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240051	10.1371/journal.pone.0240051	http://dx.doi.org/10.1371/journal.pone.0240051			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	33048955	Green Published, gold			2022-12-26	WOS:000581813300031
J	Lam, FW; Brown, CA; Valladolid, C; Emebo, DC; Palzkill, TG; Cruz, MA				Lam, Fong Wilson; Brown, Cameron August; Valladolid, Christian; Emebo, Dabel Cynthia; Palzkill, Timothy Gerald; Cruz, Miguel Angel			The vimentin rod domain blocks P-selectin-P-selectin glycoprotein ligand 1 interactions to attenuate leukocyte adhesion to inflamed endothelium	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; PLATELET-ADHESION; LIVER-INJURY; NEUTROPHIL; RECRUITMENT; ALPHA; CELL	Acute inflammation begins with leukocyte P-selectin glycoprotein ligand-1 (PSGL-1) binding to P-selectin on inflamed endothelium and platelets. In pathologic conditions, this process may contribute to secondary organ damage, like sepsis-induced liver injury. Therefore, developing novel therapies to attenuate inflammation may be beneficial. We previously reported that recombinant human vimentin (rhVim) binds P-selectin to block leukocyte adhesion to endothelium and platelets. In this study, we used SPOT-peptide arrays to identify the rod domain as the active region within rhVim that interacts with P-selectin. Indeed, recombinant human rod domain of vimentin (rhRod) binds to P-selectin with high affinity, within silicomodeling suggesting that rhRod binds P-selectin at or near the PSGL-1 binding site. Using bio-layer interferometry, rhRod decreases PSGL-1 binding to immobilized P-selectin, corroborating thein silicodata. Under parallel-plate flow, rhRod blocks leukocyte adhesion to fibrin(ogen)-captured platelets, P-selectin/Fc-coated channels, and IL-1 beta/IL-4-co-stimulated human umbilical vein endothelial cells. Finally, using intravital microscopy in endotoxemic C57Bl/6 mice, rhRod co-localizes with P-selectin in the hepatic sinusoids and decreases neutrophil adhesion to hepatic sinusoids. These data suggest a potential role for rhRod in attenuating inflammation through directly blocking P-selectin-PSGL-1 interactions.	[Lam, Fong Wilson; Emebo, Dabel Cynthia] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lam, Fong Wilson; Valladolid, Christian; Emebo, Dabel Cynthia; Cruz, Miguel Angel] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA; [Brown, Cameron August; Palzkill, Timothy Gerald] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA; [Valladolid, Christian; Cruz, Miguel Angel] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lam, FW (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Lam, FW (corresponding author), Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA.	flam@bcm.edu		Lam, Fong/0000-0003-2034-2625; Brown, Cameron/0000-0002-8886-1328	NIH/NIGMS [GM-112806, NIH/NIGMS GM-123261]; NIH/NINDS [NS094280]; PHS [P30DK056338]; NIH/NHLBI [HL-116524]; Department of Veterans Affairs [I01 BX002551, NIH/NIGMS T32 GM-120011]	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the following: NIH/NIGMS GM-112806 (MAC), NIH/NIGMS GM-123261 (FWL), NIH/NINDS NS094280 (MAC), and in part by PHS grant P30DK056338. Research support was also funded by NIH/NHLBI HL-116524 and the Department of Veterans Affairs I01 BX002551 (Equipment, Personnel, Supplies), CAB was supported by training grant NIH/NIGMS T32 GM-120011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaduzzaman M, 2009, CRIT CARE MED, V37, P1389, DOI 10.1097/CCM.0b013e31819ceb71; Chernyatina AA, 2012, J STRUCT BIOL, V177, P46, DOI 10.1016/j.jsb.2011.11.014; Chernyatina AA, 2012, P NATL ACAD SCI USA, V109, P13620, DOI 10.1073/pnas.1206836109; Da Q, 2018, MICROCIRCULATION, V25, DOI 10.1111/micc.12457; Da Q, 2015, BLOOD, V126, P2338, DOI 10.1182/blood-2015-05-648030; Da Q, 2014, BLOOD, V123, P2715, DOI 10.1182/blood-2013-10-530428; Diacovo TG, 1996, BLOOD, V88, P146; DORE M, 1993, VET PATHOL, V30, P213, DOI 10.1177/030098589303000301; Essani NA, 1998, J LEUKOCYTE BIOL, V63, P288, DOI 10.1002/jlb.63.3.288; Fernandes LS, 2003, THROMB RES, V111, P171, DOI 10.1016/j.thromres.2003.08.017; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Ise H, 2010, GLYCOBIOLOGY, V20, P843, DOI 10.1093/glycob/cwq039; JONES DA, 1993, BIOPHYS J, V65, P1560, DOI 10.1016/S0006-3495(93)81195-0; Klintman D, 2004, CLIN DIAGN LAB IMMUN, V11, P56, DOI 10.1128/CDLI.11.1.56-62.2004; Kobashi H, 2013, HEPATOL RES, V43, P255, DOI 10.1111/j.1872-034X.2012.01069.x; Konstantopoulos K, 1998, CIRCULATION, V98, P873, DOI 10.1161/01.CIR.98.9.873; Lam FW, 2018, J IMMUNOL, V200, P1718, DOI 10.4049/jimmunol.1700784; Lam FW, 2011, AM J PHYSIOL-HEART C, V300, pH468, DOI 10.1152/ajpheart.00491.2010; Law AMK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15885-6; Marques PE, 2015, NAT PROTOC, V10, P258, DOI 10.1038/nprot.2015.006; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; Mor-Vaknin N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01045; Pang AH, 2018, FEBS J, V285, P2888, DOI 10.1111/febs.14585; Park I, 2018, BIOMED OPT EXPRESS, V9, P2383, DOI 10.1364/BOE.9.002383; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; SMITH CW, 1988, J CLIN INVEST, V82, P1746, DOI 10.1172/JCI113788; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wang YM, 2005, CIRCULATION, V112, P2993, DOI 10.1161/CIRCULATIONAHA.105.571315; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240164	10.1371/journal.pone.0240164	http://dx.doi.org/10.1371/journal.pone.0240164			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048962	gold, Green Published			2022-12-26	WOS:000581813300015
J	Liu, B; Zeng, RH; Guo, TT; Zhang, YZ; Leng, J; Ge, JH; Yu, G; Xu, YN; Zhou, YB				Liu, Bin; Zeng, Ruhui; Guo, Tingting; Zhang, Yingzhan; Leng, Jing; Ge, Jiahui; Yu, Gang; Xu, Yineng; Zhou, Yingbi			Differential properties of E prostanoid receptor-3 and thromboxane prostanoid receptor in activation by prostacyclin to evoke vasoconstrictor response in the mouse renal vasculature	FASEB JOURNAL			English	Article						EP3; IP; PGI(2); renal vasoresponse; TP	ENDOTHELIUM-DEPENDENT CONTRACTIONS; PROSTAGLANDIN E-2; NITRIC-OXIDE; HYPERTENSIVE-RATS; ARTERIES; AORTA; CYCLOOXYGENASE-2; ALDOSTERONE; DYSFUNCTION; RELAXATION	Vasomotor reactions of prostacyclin (prostaglandin I-2; PGI(2)) can be collectively modulated by thromboxane prostanoid receptor (TP), E-prostanoid receptor-3 (EP3), and the vasodilator I prostanoid receptor (IP). This study aimed to determine the direct effect of PGI(2)on renal arteries and/or the whole renal vasculature and how each of these receptors is involved. Experiments were performed on vessels or perfused kidneys of wild-type mice and/or mice with deficiency in TP (TP-/-) and/or EP3. Here we show that PGI(2)did not evoke relaxation, but instead resulted in contraction of main renal arteries (from similar to 0.001-0.01 mu M) or reduction of flow in perfused kidneys (from similar to 1 mu M); either of them was reversed into a dilator response in TP-/-/EP3(-/-)counterparts. Also, we found that in renal arteries although it has a lesser effect than TP(-/-)on the maximal contraction to PGI(2)(10 mu M), EP3(-/-)but not TP(-/-)resulted in relaxation to the prostanoid at 0.01-1 mu M. Meanwhile, TP(-/-)only significantly reduced the contractile activity evoked by PGI(2)at >= 0.1 mu M. These results demonstrate that PGI(2)may evoke an overall vasoconstrictor response in the mouse renal vasculature, reflecting activities of TP and EP3 outweighing that of the vasodilator IP. Also, our results suggest that EP3, on which PGI(2)can have a potency similar to that on IP, plays a major role in the vasoconstrictor effect of the prostanoid of low concentrations (<= 1 mu M), while TP, on which PGI(2)has a lower potency but higher efficacy, accounts for a larger part of its maximal contractile activity.	[Liu, Bin; Zeng, Ruhui; Guo, Tingting; Zhang, Yingzhan; Leng, Jing; Ge, Jiahui; Yu, Gang; Xu, Yineng; Zhou, Yingbi] Shantou Univ, Coll Med, Cardiovasc Res Ctr, 22 Xin Ling Rd, Shantou 515041, Peoples R China; [Zeng, Ruhui] Shantou Univ, Med Coll, Affiliated Hosp 1, Dept Gynecol & Obstet, Shantou, Peoples R China	Shantou University; Shantou University	Zhou, YB (corresponding author), Shantou Univ, Coll Med, Cardiovasc Res Ctr, 22 Xin Ling Rd, Shantou 515041, Peoples R China.	yz_sumc@163.com			National Natural Science Foundation of China (NSFC) [31771272, 81970433, 81770678]; Major Research Program for Universities of Guangdong Province [2017KZDXM037]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major Research Program for Universities of Guangdong Province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771272, 81970433 and 81770678; the Major Research Program for Universities of Guangdong Province, Grant/Award Number: 2017KZDXM037	Benyahia C, 2013, PROSTAG OTH LIPID M, V107, P48, DOI 10.1016/j.prostaglandins.2013.07.001; Blanco-Rivero J, 2005, HYPERTENSION, V46, P107, DOI 10.1161/01.HYP.0000171479.36880.17; BUNTING S, 1976, PROSTAG OTH LIPID M, V12, P897, DOI 10.1016/0090-6980(76)90125-8; DAI FX, 1992, HYPERTENSION, V19, P795, DOI 10.1161/01.HYP.19.6.795; Davidge ST, 2001, CIRC RES, V89, P650, DOI 10.1161/hh2001.098351; DUSTING GJ, 1977, EUR J PHARMACOL, V45, P301, DOI 10.1016/0014-2999(77)90014-0; Dzeshka MS, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0688-8; Eskildsen MP, 2014, HYPERTENSION, V64, P551, DOI 10.1161/HYPERTENSIONAHA.113.03051; Feletou M, 2009, BRIT J PHARMACOL, V156, P563, DOI 10.1111/j.1476-5381.2008.00060.x; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Hu CJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01247; Ihara E, 2000, BRIT J PHARMACOL, V129, P943, DOI 10.1038/sj.bjp.0703141; INSCHO EW, 1990, AM J PHYSIOL, V259, pF157, DOI 10.1152/ajprenal.1990.259.1.F157; Kirkby NS, 2018, HYPERTENSION, V71, P297, DOI 10.1161/HYPERTENSIONAHA.117.09906; Kirkby NS, 2012, P NATL ACAD SCI USA, V109, P17597, DOI 10.1073/pnas.1209192109; LEVY JV, 1980, PROSTAG OTH LIPID M, V19, P517, DOI 10.1016/S0090-6980(80)80002-5; LEVY JV, 1978, PROSTAG OTH LIPID M, V16, P93, DOI 10.1016/0090-6980(78)90205-8; Li SS, 2016, CLIN EXP PHARMACOL P, V43, P67, DOI 10.1111/1440-1681.12501; Li Z, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.17; Liu B, 2020, FASEB J, V34, P2568, DOI 10.1096/fj.201901611R; Liu B, 2019, FASEB J, V33, P2451, DOI 10.1096/fj.201801064RR; Liu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09288-w; Liu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136738; Liu B, 2013, AM J PHYSIOL-RENAL, V305, pF1315, DOI 10.1152/ajprenal.00332.2013; Liu B, 2012, EXP PHYSIOL, V97, P895, DOI 10.1113/expphysiol.2011.063784; Liu B, 2012, AM J PHYSIOL-RENAL, V302, pF1133, DOI 10.1152/ajprenal.00604.2011; Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034; Liu DL, 2015, AM J PHYSIOL-HEART C, V309, pH804, DOI 10.1152/ajpheart.00150.2015; Longrois D, 2012, EUR J PHARMACOL, V681, P55, DOI 10.1016/j.ejphar.2012.01.041; Luo WH, 2016, EUR J PHARMACOL, V780, P148, DOI 10.1016/j.ejphar.2016.03.043; Meurer M, 2018, PFLUG ARCH EUR J PHY, V470, P1691, DOI 10.1007/s00424-018-2183-3; Michel F, 2008, AM J PHYSIOL-RENAL, V294, pF120, DOI 10.1152/ajprenal.00111.2007; Mitchell JA, 2008, EXP PHYSIOL, V93, P141, DOI 10.1113/expphysiol.2007.038588; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nasrallah R, 2005, AM J PHYSIOL-RENAL, V289, pF235, DOI 10.1152/ajprenal.00454.2004; NEEDLEMAN P, 1976, NATURE, V261, P558, DOI 10.1038/261558a0; Norel X, 2004, PROSTAG OTH LIPID M, V74, P101, DOI 10.1016/j.prostaglandins.2004.07.003; Norel X, 2004, BRIT J PHARMACOL, V142, P788, DOI 10.1038/sj.bjp.0705843; Rapoport RM, 1996, HYPERTENSION, V28, P64, DOI 10.1161/01.HYP.28.1.64; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SCHOR N, 1981, HYPERTENSION, V3, P81, DOI 10.1161/01.HYP.3.6_Pt_2.II-81; Scotland RS, 2005, CIRCULATION, V111, P796, DOI 10.1161/01.CIR.0000155238.70797.4E; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Tang EHC, 2008, CARDIOVASC RES, V78, P130, DOI 10.1093/cvr/cvm112; Vachiery JL, 2011, ADV THER, V28, P251, DOI 10.1007/s12325-011-0005-5; van Rodijnen WF, 2007, AM J PHYSIOL-RENAL, V292, pF1094, DOI 10.1152/ajprenal.00351.2005; Vanhoutte PM, 2011, HYPERTENSION, V57, P526, DOI 10.1161/HYPERTENSIONAHA.110.165100; WILLIAMS SP, 1994, AM J PHYSIOL, V267, pH796, DOI 10.1152/ajpheart.1994.267.2.H796; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770; Xavier FE, 2008, BRIT J PHARMACOL, V154, P1225, DOI 10.1038/bjp.2008.200; Yu H, 1998, HYPERTENSION, V32, P287, DOI 10.1161/01.HYP.32.2.287; Zhao YJ, 1996, J APPL PHYSIOL, V81, P2595, DOI 10.1152/jappl.1996.81.6.2595; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005; Zhu NX, 2014, AM J PHYSIOL-HEART C, V307, pH319, DOI 10.1152/ajpheart.00022.2014	56	3	3	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16105	16116		10.1096/fj.202000845RR	http://dx.doi.org/10.1096/fj.202000845RR		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047360				2022-12-26	WOS:000581168700001
J	Trifiletti, E; D'Ascenzo, S; Lugli, L; Cocco, VM; Di Bernardo, GA; Iani, C; Rubichi, S; Nicoletti, R; Vezzali, L				Trifiletti, Elena; D'Ascenzo, Stefania; Lugli, Luisa; Cocco, Veronica Margherita; Di Bernardo, Gian Antonio; Iani, Cristina; Rubichi, Sandro; Nicoletti, Roberto; Vezzali, Loris			Truth and lies in your eyes: Pupil dilation of White participants in truthful and deceptive responses to White and Black partners	PLOS ONE			English	Article							OWN-RACE BIAS; ATTENTION; INGROUP; SIZE; OUTGROUP; MIMICRY; THREAT; BRAIN; PUPILLOMETRY; INFORMATION	In the present study, we examined the pupillary response of White participants who were asked to tell the truth or lie to White or Black partners. Research on cues to deception has assumed that lying is more cognitively demanding that truth telling. In line with this assumption, previous studies have shown that lying is associated with greater pupil dilation, a behavioral cue that typically manifests itself under conditions of stress or cognitive effort. In accordance with these results, we predicted greater pupil dilation when lying than when telling the truth. Furthermore, pupil dilation was expected to be greater when responding to White than Black partners. Finally, we hypothesized that pupil dilation would be greater when lying to White than Black partners. Participants were instructed to answer a set of questions, half truthfully and half deceptively. They were led to believe that White vs. Black partners (one male and one female) would ask the questions via computer connection. Indeed, we used feminine and masculine synthetic voices. Pupil dilation was assessed with a remote eye-tracking system. Results provided support for the first two hypotheses. However, the predicted interaction between race of partners and truth status of message (lying vs. telling the truth) was nonsignificant. Our findings highlight the importance of considering race in the study of truthful and deceptive communications.	[Trifiletti, Elena] Univ Verona, Dipartimento Sci Umane, Verona, Italy; [D'Ascenzo, Stefania; Lugli, Luisa; Nicoletti, Roberto] Univ Bologna, Dipartimento Filosofia & Comunicaz, Bologna, Italy; [Cocco, Veronica Margherita; Di Bernardo, Gian Antonio] Univ Modena & Reggio Emilia, Dipartimento Educ & Sci Umane, Reggio Emilia, Italy; [Iani, Cristina; Vezzali, Loris] Univ Modena & Reggio Emilia, Dipartimento Chirurg Med Odontoiatr & Sci Morfol, Reggio Emilia, Italy; [Iani, Cristina; Rubichi, Sandro] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Metab & Neurosci, Reggio Emilia, Italy; [Rubichi, Sandro] Univ Modena & Reggio Emilia, Ctr Interdipartimentale Neurosci & Neurotecnol, Reggio Emilia, Italy	University of Verona; University of Bologna; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Trifiletti, E (corresponding author), Univ Verona, Dipartimento Sci Umane, Verona, Italy.	elena.trifiletti@univr.it	Lugli, Luisa/AAG-1408-2021; Iani, Cristina/D-1652-2009	Iani, Cristina/0000-0002-7220-6337; Trifiletti, Elena/0000-0002-9203-507X				Abrams D, 2014, DEV PSYCHOL, V50, P258, DOI 10.1037/a0032461; Amnesty International, 2018, AMN INT REP 2017 18; Azevedo RT, 2013, HUM BRAIN MAPP, V34, P3168, DOI 10.1002/hbm.22133; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Berrien FK, 1943, J EXP PSYCHOL, V32, P443, DOI 10.1037/h0063488; Bodenhausen G., 2012, SAGE HDB SOCIAL COGN; Bond CF, 2006, PERS SOC PSYCHOL REV, V10, P214, DOI 10.1207/s15327957pspr1003_2; BRADSHAW J, 1967, NATURE, V216, P515, DOI 10.1038/216515a0; Brewer M., 1988, ADV SOCIAL COGNITION, P1; Christ SE, 2009, CEREB CORTEX, V19, P1557, DOI 10.1093/cercor/bhn189; Cole T, 2001, J SOC PERS RELAT, V18, P107, DOI 10.1177/0265407501181005; D'Ascenzo S, 2018, Q J EXP PSYCHOL, V71, P917, DOI 10.1080/17470218.2017.1307429; D'Ascenzo S, 2016, INT J PSYCHOPHYSIOL, V110, P187, DOI 10.1016/j.ijpsycho.2016.08.002; Dalmaso M, 2012, BIOL LETTERS, V8, P450, DOI 10.1098/rsbl.2011.0881; DePaulo BM, 1998, J PERS SOC PSYCHOL, V74, P63, DOI 10.1037/0022-3514.74.1.63; DePaulo BM, 1996, J PERS SOC PSYCHOL, V70, P979, DOI 10.1037/0022-3514.70.5.979; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; DePaulo BM, 1989, MOTIVATIONAL IMPAIRM, P51; Dickter CL, 2007, SOC COGN AFFECT NEUR, V2, P189, DOI 10.1093/scan/nsm012; Dionisio DP, 2001, PSYCHOPHYSIOLOGY, V38, P205, DOI 10.1017/S0048577201990717; Donders NC, 2008, J EXP SOC PSYCHOL, V44, P1328, DOI 10.1016/j.jesp.2008.04.002; Ekman I, 2008, PROCEEDINGS OF THE EYE TRACKING RESEARCH AND APPLICATIONS SYMPOSIUM (ETRA 2008), P115, DOI 10.1145/1344471.1344501; Ekman P., 2009, TELLING LIES CLUES D; Engelmann JM, 2013, DEVELOPMENTAL SCI, V16, P952, DOI 10.1111/desc.12086; Everett JAC, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00015; Farah MJ, 2014, NAT REV NEUROSCI, V15, P123, DOI 10.1038/nrn3665; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferrari V, 2016, BIOL PSYCHOL, V113, P75, DOI 10.1016/j.biopsycho.2015.11.008; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; Gitelman DR, 2002, BEHAV RES METH INS C, V34, P605, DOI 10.3758/BF03195488; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Goldinger SD, 2009, J EXP PSYCHOL LEARN, V35, P1105, DOI 10.1037/a0016548; GOLDWATER BC, 1972, PSYCHOL BULL, V77, P340, DOI 10.1037/h0032456; Gonzalez-Billandon J, 2019, FRONT ROBOT AI, V6, DOI 10.3389/frobt.2019.00064; Granhag P. A., 2004, DETECTION DECEPTION, DOI DOI 10.1017/CBO9780511490071; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Hartwig M, 2011, PSYCHOL BULL, V137, P643, DOI 10.1037/a0023589; HEILVEIL I, 1976, J CLIN PSYCHOL, V32, P675, DOI 10.1002/1097-4679(197607)32:3<675::AID-JCLP2270320340>3.0.CO;2-A; HESS EH, 1975, SCI AM, V233, P110, DOI 10.1038/scientificamerican1175-110; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Hochman G, 2016, J BEHAV DECIS MAKING, V29, P322, DOI 10.1002/bdm.1932; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Ito TA, 2009, TRENDS COGN SCI, V13, P524, DOI 10.1016/j.tics.2009.10.002; Jensen LA, 2004, J YOUTH ADOLESCENCE, V33, P101, DOI 10.1023/B:JOYO.0000013422.48100.5a; Kawakami K, 2014, J PERS SOC PSYCHOL, V107, P1, DOI 10.1037/a0036838; Kret ME, 2015, PSYCHOL SCI, V26, P1401, DOI 10.1177/0956797615588306; Kuligowska K., 2018, INT J RES ENG TECHNO, V7, P234; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Lakin JL, 2008, PSYCHOL SCI, V19, P816, DOI 10.1111/j.1467-9280.2008.02162.x; Lavin C, 2014, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00218; Leavitt K, 2015, ACAD MANAGE REV, V40, P587, DOI 10.5465/amr.2013.0167; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; Lloyd EP, 2017, PSYCHOL SCI, V28, P1125, DOI 10.1177/0956797617705399; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Lu HJ, 2014, EVOL PSYCHOL-US, V12, P635; Lubow RE, 1996, J EXP PSYCHOL-APPL, V2, P164, DOI 10.1037/1076-898X.2.2.164; Marques JM, 1998, J PERS SOC PSYCHOL, V75, P976, DOI 10.1037/0022-3514.75.4.976; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Mendes WB, 2002, PERS SOC PSYCHOL B, V28, P939; Miles LK, 2011, EXP BRAIN RES, V211, P495, DOI 10.1007/s00221-011-2641-z; Pew Research Center, 2018, BEING CHRIST W EUR; Porter S, 2010, LEGAL CRIMINOL PSYCH, V15, P57, DOI 10.1348/135532509X433151; RANKIN R E, 1955, J Abnorm Psychol, V51, P30, DOI 10.1037/h0041539; Ratcliff NJ, 2011, PERS SOC PSYCHOL B, V37, P1003, DOI 10.1177/0146167211407210; Richeson JA, 2008, PSYCHOL SCI, V19, P98, DOI 10.1111/j.1467-9280.2008.02052.x; Sporer SL, 2007, PSYCHOL PUBLIC POL L, V13, P1, DOI 10.1037/1076-8971.13.1.1; Trawalter S, 2008, J EXP SOC PSYCHOL, V44, P1322, DOI 10.1016/j.jesp.2008.03.006; Trifiletti E, 2018, YOUR LIES ARE UNPUB; Trovillo PV, 1939, J CRIM LAW CRIM, V29, P848, DOI 10.2307/1136489; van der Wel P, 2018, PSYCHON B REV, V25, P2005, DOI 10.3758/s13423-018-1432-y; Vrij Aldert, 2010, Psychol Sci Public Interest, V11, P89, DOI 10.1177/1529100610390861; Wang JTY, 2010, AM ECON REV, V100, P984, DOI 10.1257/aer.100.3.984; Weiss B, 2006, J APPL SOC PSYCHOL, V36, P1070, DOI 10.1111/j.0021-9029.2006.00055.x; Willadsen-Jensen EC, 2008, GROUP PROCESS INTERG, V11, P182, DOI 10.1177/1368430207088037; Wu EXW, 2012, SOC NEUROSCI-UK, V7, P202, DOI 10.1080/17470919.2011.596946; Yamanaka K, 2009, INT J OCCUP SAF ERGO, V15, P447, DOI 10.1080/10803548.2009.11076824; Yin LJ, 2016, BRAIN COGNITION, V102, P13, DOI 10.1016/j.bandc.2015.11.007; Zhongguo Qingshaonian Yanjiu Zhongxin Ketizu, 2005, ZHONGGUO QINGNIAN YA, V5, P21; [No title captured]	81	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0239512	10.1371/journal.pone.0239512	http://dx.doi.org/10.1371/journal.pone.0239512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	33048934	Green Published, gold			2022-12-26	WOS:000581813300059
J	Zerdo, Z; Van Geertruyden, JP; Massebo, F; Biresaw, G; Shewangizawu, M; Tunje, A; Chisha, Y; Yohanes, T; Bastiaens, H; Anthierens, S				Zerdo, Zerihun; Van Geertruyden, Jean-Pierre; Massebo, Fekadu; Biresaw, Gelila; Shewangizawu, Misgun; Tunje, Abayneh; Chisha, Yilma; Yohanes, Tsegaye; Bastiaens, Hilde; Anthierens, Sibyl			Parents' perception on cause of malaria and their malaria prevention experience among school-aged children in Kutcha district, Southern Ethiopia; qualitative study	PLOS ONE			English	Article							COMMUNITY; KNOWLEDGE	Introduction School-aged children become a highly vulnerable group for malaria, yet they are less likely to use malaria prevention interventions. Previous studies exploring perception on cause of malaria mainly focused on pregnant mothers or parents of children under age five years. Exploring parent's perception on cause of malaria and their experiences on the prevention of malaria and associated challenges among school-aged children is important to develop a malaria prevention education package for school-aged children to reduce malaria and malaria related morbidities among school-aged children. Methods A descriptive qualitative study is conducted in Kutcha district by recruiting 19 parents of school-aged children for semi-structured interviews, 6 key informants and 6 focus group discussion which consists of parents, health development army and health extension workers. A semi-structured interview guide is used to guide the interview process. The collected data is analyzed thematically with a focus on the three major areas of concern: perceived cause of malaria, experience of malaria prevention and challenges of bed net use for prevention of malaria. Results Five causes of malaria were identified, namely hunger, mosquito bite, exposure to hot sunshine, poor sanitation and hygiene and eating some sweet foods and unripe maize. Participants perceived that eating sweet foods and unripe maize lead to enlargement of the spleen that ends in malaria while poor hygiene and sanitation leads to either development of the ova of mosquito and the landing of the housefly to contaminate food for consumption. The experiences of malaria prevention were largely influenced by their perceived cause of malaria. The malaria prevention measures undertaken by parents were vectors control measures, homemade herbal remedies and restricting children from eating sweet foods. The challenges of malaria prevention by using bed nets were related to a negative attitude, sleeping behaviors of children; use of bed nets for unintended purposes, shortage of bed nets and delays in the distribution of bed nets. Conclusion There were misconceptions about the cause of malaria and associated experiences of malaria prevention. Control of malaria among school-aged children need health education targeting the challenges and correcting identified misconceptions by parents in Kutcha district and in other similar settings.	[Zerdo, Zerihun; Biresaw, Gelila; Yohanes, Tsegaye] Arba Minch Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Arba Minch, Ethiopia; [Zerdo, Zerihun; Van Geertruyden, Jean-Pierre] Antwerp Univ, Global Hlth Inst, Antwerp, Belgium; [Massebo, Fekadu] Arba Minch Univ, Coll Nat Sci, Dept Biol, Arba Minch, Ethiopia; [Shewangizawu, Misgun; Tunje, Abayneh; Chisha, Yilma] Arba Minch Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Arba Minch, Ethiopia; [Bastiaens, Hilde; Anthierens, Sibyl] Univ Antwerp, Dept Family Med & Populat Hlth, Antwerp, Belgium	Arba Minch University; University of Antwerp; Arba Minch University; Arba Minch University; University of Antwerp	Zerdo, Z (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Arba Minch, Ethiopia.; Zerdo, Z (corresponding author), Antwerp Univ, Global Hlth Inst, Antwerp, Belgium.	zedozerihun@gmail.com	Chisha, Yilma/GOH-2697-2022; Massebo, Fekadu/CAG-5111-2022	Massebo, Fekadu/0000-0002-1442-9567; Bastiaens, Hilde/0000-0002-5509-3406; Zerdo, Zerihun/0000-0002-6509-4672; Anthierens, Sibyl/0000-0003-4762-1907; Yohanes, Tsegaye/0000-0003-4847-9631				Adhikari B, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4070-9; Adongo PB, 2005, TROP MED INT HEALTH, V10, P366, DOI 10.1111/j.1365-3156.2005.01361.x; AGYEPONG IA, 1992, SOC SCI MED, V35, P131, DOI 10.1016/0277-9536(92)90160-R; [Anonymous], 2016, THE TOTAL AUDIENCE R; Ashton RA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-25; Attu H, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2291-8; Birhanu Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160234; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Chacky F, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2601-1; CSA, CENS 2007 TABL SO NA; Doda Z, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2209-5; Dori G., 2012, MALARIA J, V3; EPHI, 2015, ADD AB ETH; Federal Ministry of Health, 2012, NAT MAL GUID, V3rd; Fernando SD, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-366; Gakpey K, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1328-5; Gobena T, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20461; Loha E, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2775-1; Lover AA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-199; Ministry of Health, 2017, EFY 2009 2016 17 VER; Mitiku I, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1798-8; Musoke D, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1369-4; Muula Adamson S, 2004, Afr J Health Sci, V11, P98; Nakitende AJ, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2514-z; Nankabirwa J, 2014, TROP MED INT HEALTH, V19, P1294, DOI 10.1111/tmi.12374; Newell I, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2177-9; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Pilkington H, 2004, J EPIDEMIOL COMMUN H, V58, P826, DOI 10.1136/jech.2003.016089; Sifft KC, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1606-x; Solomon T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210578; Strachan CE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1101-4; Sumari D, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1870-4; Taffese HS, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0487-3; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Tine Roger C K, 2012, BMC Res Notes, V5, P565, DOI 10.1186/1756-0500-5-565; USAID, 2006, SO NAT NAT PEOPL REG; Vitor-Silva S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-230; Walldorf JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134061; WHO, 2018, WORLD MAL REP 2018; WHO, 2015, GLOB TECHN STRAT MAL; 2013, WORLD MAL REP 2013, P1	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0239728	10.1371/journal.pone.0239728	http://dx.doi.org/10.1371/journal.pone.0239728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048941	Green Published, gold			2022-12-26	WOS:000581813300014
J	Cameron, K; El Hassan, M; Sabbagh, R; Freed, DH; Nobes, DS				Cameron, Katie; El Hassan, Mouhammad; Sabbagh, Reza; Freed, Darren H.; Nobes, David S.			Experimental investigation into the effect of compliance of a mock aorta on cardiac performance	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; DONOR HEART; PRESERVATION; PERFUSION; FLOW; PRESSURE; TRANSPLANTATION; STRAIN	Demand for heart transplants far exceeds supply of donated organs. This is attributed to the high percentage of donor hearts that are discarded and to the narrow six-hour time window currently available for transplantation. Ex-vivo heart perfusion (EVHP) provides the opportunity for resuscitation of damaged organs and extended transplantation time window by enabling functional assessment of the hearts in a near-physiologic state. Present work investigates the fluid mechanics of the ex-vivo flow loop and corresponding impact on cardiac performance. A mechanical flow loop is developed that is analogous to the region of the EVHP system that mimics in-vivo systemic circulation, including the body's largest and most compliant artery, the aorta. This investigation is focused on determining the effect of mock aortic tubing compliance on pump performance. A custom-made silicone mock aorta was developed to simulate a range of in-vivo conditions and a physiological flow was generated using a commercial ventricular assist device (VAD). Monitored parameters, including pressure, tube distension and downstream velocity, acquired using time-resolved particle imaging velocimetry (PIV), were applied to an unsteady Bernoulli analysis of the flow in a novel way to evaluate pump performance as a proxy for cardiac workload. When compared to the rigid case, the compliant mock aorta case demonstrated healthier physiologic pressure waveforms, steadier downstream flow and reduced energetic demands on the pump. These results provide experimental verification of Windkessel theory and support the need for a compliant mock aorta in the EVHP system.	[Cameron, Katie] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [El Hassan, Mouhammad] Prince Mohammad Bin Fahd Univ, Al Khobar, Saudi Arabia; [El Hassan, Mouhammad; Sabbagh, Reza; Nobes, David S.] Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada; [Freed, Darren H.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Freed, Darren H.] Univ Alberta, Dept Physiol & Biomed Engn, Edmonton, AB, Canada	University of Alberta; Prince Mohammad Bin Fahd University; University of Alberta; University of Alberta; University of Alberta	Nobes, DS (corresponding author), Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada.	dnobes@ualberta.ca		Sabbagh, Reza/0000-0001-6446-6676	Natural Sciences and Engineering Research Council (NSERC) of Canada (DSN); Canadian Foundation for Innovation (DSN); Canadian National Transplant Research Program (DHF); University Hospital Foundation (DHF)	Natural Sciences and Engineering Research Council (NSERC) of Canada (DSN)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (DSN); Canadian National Transplant Research Program (DHF); University Hospital Foundation (DHF)	Financial support for this project was provided by the Natural Sciences and Engineering Research Council (NSERC) of Canada (DSN), Canadian Foundation for Innovation (DSN), Canadian National Transplant Research Program (DHF), and University Hospital Foundation (DHF).	Amatya DM, 2010, J FLUID STRUCT, V26, P218, DOI 10.1016/j.jfluidstructs.2009.12.001; [Anonymous], 1996, CHINESE LAW GOV, V29, P13; [Anonymous], 2017, CIRC-CARDIOVASC IMAG; [Anonymous], 2017, INDIAN J HEMATOL BLO, V33, pS113; [Anonymous], 2016, ECOFLEX 00 50; [Anonymous], 2001, FLL, V12, P163; Ardehali A, 2015, LANCET, V385, P2577, DOI 10.1016/S0140-6736(15)60261-6; Avolio AP, 2009, HYPERTENSION, V54, P375, DOI 10.1161/HYPERTENSIONAHA.109.134379; BELZ GG, 1995, CARDIOVASC DRUG THER, V9, P73, DOI 10.1007/BF00877747; BENBRAHIM A, 1994, J VASC SURG, V20, P184, DOI 10.1016/0741-5214(94)90005-1; Chen CH, 1997, CIRCULATION, V95, P1827; Collins MJ, 2008, EUR J CARDIO-THORAC, V34, P318, DOI 10.1016/j.ejcts.2008.03.043; FARRAR DJ, 1986, IEEE ENG MED BIOL, V5, P19, DOI 10.1109/MEMB.1986.5006251; Freed DH, 2015, LANCET, V385, P2552, DOI 10.1016/S0140-6736(15)60614-6; Geoghegan PH, 2013, EXP FLUIDS, V54, DOI 10.1007/s00348-013-1528-0; Geoghegan PH, 2012, EXP FLUIDS, V52, P1331, DOI 10.1007/s00348-011-1258-0; Geoghegan PH, 2010, 15 INT S LAS TECHN F; Grimes R Y, 1995, J Am Soc Echocardiogr, V8, P631, DOI 10.1016/S0894-7317(05)80376-1; Gulan U, 2012, EXP FLUIDS, V53, P1469, DOI 10.1007/s00348-012-1371-8; HICKLER RB, 1990, CLIN CARDIOL, V13, P317, DOI 10.1002/clc.4960130504; Huetter Larissa, 2015, IFAC - Papers Online, V48, P407, DOI 10.1016/j.ifacol.2015.10.174; Hughes Alun D., 2013, PLOS ONE, V8, P1; Khoshdel AR, 2007, CLIN MED RES, V5, P45, DOI 10.3121/cmr.2007.708; Koeppen BM, 2017, BERNE LEVY PHYSL, P706; Langlois WE, 2014, SLOW VISCOUS FLOW, P1; Loudon C, 1998, J THEOR BIOL, V191, P63, DOI 10.1006/jtbi.1997.0564; Macdonald PS, 2016, CURR OPIN ORGAN TRAN, V21, P336, DOI 10.1097/MOT.0000000000000309; Manning TS, 2002, HYPERTENSION, V39, P963, DOI 10.1161/01.HYP.0000016920.96457.7C; McAnulty JF, 2010, CRYOBIOLOGY, V60, pS13, DOI 10.1016/j.cryobiol.2009.06.004; McDonald DA, 1974, EDWARD ARNOLD PUBL, V12, P399; McGhee Beate H, 2002, Crit Care Nurse, V22, P60; Messer S, 2015, TRANSPL INT, V28, P634, DOI 10.1111/tri.12361; Messer SJ, 2016, J HEART LUNG TRANSPL, V35, P1443, DOI 10.1016/j.healun.2016.07.004; Minasian SM, 2015, INTERACT CARDIOV TH, V20, P510, DOI 10.1093/icvts/ivu432; MURGO JP, 1980, CIRCULATION, V62, P105, DOI 10.1161/01.CIR.62.1.105; PASIPOULARIDES A, 1984, AM J PHYSIOL, V246, pH542, DOI 10.1152/ajpheart.1984.246.4.H542; Pibarot P, 2009, CIRCULATION, V119, P1034, DOI 10.1161/CIRCULATIONAHA.108.778886; Piersol AG, 2010, RANDOM DATA ANAL MEA, P640; Pontrelli G, 1998, COMPUT FLUIDS, V27, P367, DOI 10.1016/S0045-7930(97)00041-8; PRASAD AK, 1992, EXP FLUIDS, V13, P105, DOI 10.1007/BF00218156; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Raghav V, 2018, CARDIOVASC ENG TECHN, V9, P273, DOI 10.1007/s13239-018-0348-z; Redheuil A, 2011, J AM COLL CARDIOL, V58, P1262, DOI 10.1016/j.jacc.2011.06.012; Redheuil A, 2010, HYPERTENSION, V55, P319, DOI 10.1161/HYPERTENSIONAHA.109.141275; Repse S, 2010, J HEART LUNG TRANSPL, V29, P747, DOI 10.1016/j.healun.2010.02.009; Reusz GS, 2010, HYPERTENSION, V56, P217, DOI 10.1161/HYPERTENSIONAHA.110.152686; Rosenbaum DH, 2007, J SURG RES, V140, P243, DOI 10.1016/j.jss.2007.03.033; SEGADAL L, 1987, CIRCULATION, V76, P90, DOI 10.1161/01.CIR.76.1.90; Segers P, 2012, ARTERY RES, V6, P7, DOI 10.1016/j.artres.2012.01.005; Song Z, 2015, J BIOMECH ENG, V137, P1; Stalder AF, 2011, J MAGN RESON IMAGING, V33, P839, DOI 10.1002/jmri.22512; Swillens A, 2008, ARTERY RES, V2, P122, DOI 10.1016/j.artres.2008.05.001; Taylor CA, 2004, ANNU REV FLUID MECH, V36, P197, DOI 10.1146/annurev.fluid.36.050802.121944; Voges I, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-77; Westerweel J, 1992, DIGITAL PARTICLE IMA; White CW, 2016, J HEART LUNG TRANSPL, V35, pS186, DOI 10.1016/j.healun.2016.01.518; White CW, 2016, AM J TRANSPLANT, V16, P773, DOI 10.1111/ajt.13574; White C. W., 2015, CANADIAN J CARDIOLOG, V31, ps202; White C, 2017, ANN THORAC SURG, V103, P122, DOI 10.1016/j.athoracsur.2016.05.084; White CW, 2015, CAN J PHYSIOL PHARM, V93, P893, DOI 10.1139/cjpp-2014-0474; White CW, 2015, J HEART LUNG TRANSPL, V34, P113, DOI 10.1016/j.healun.2014.09.021; White CW, 2013, J HEART LUNG TRANSPL, V32, P734, DOI 10.1016/j.healun.2013.04.016; White CW, 2016, CAN J CARDIOL, V32, pS173, DOI [10.1016/j.cjca.2016.07.270, DOI 10.1016/J.CJCA.2016.07.270]; WOMERSLEY JR, 1955, J PHYSIOL-LONDON, V127, P553, DOI 10.1113/jphysiol.1955.sp005276; Wood NB, 1999, J THEOR BIOL, V199, P137, DOI 10.1006/jtbi.1999.0953; Yee A, 2006, ANN BIOMED ENG, V34, P593, DOI 10.1007/s10439-006-9078-8; Yip R, 2011, P CAN ENG ED ASS, P1; Zhalmuratova D, 2019, ACS APPL MATER INTER, V11, P33323, DOI 10.1021/acsami.9b10524	68	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0239604	10.1371/journal.pone.0239604	http://dx.doi.org/10.1371/journal.pone.0239604			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044976	Green Published, gold			2022-12-26	WOS:000581811700017
J	Kawai, T; Kayama, K; Tatsumi, S; Akter, S; Miyawaki, N; Okochi, Y; Abe, M; Sakimura, K; Yamamoto, H; Kihara, S; Okamura, Y				Kawai, Takafumi; Kayama, Kento; Tatsumi, Shoki; Akter, Sharmin; Miyawaki, Nana; Okochi, Yoshifumi; Abe, Manabu; Sakimura, Kenji; Yamamoto, Hiroyasu; Kihara, Shinji; Okamura, Yasushi			Regulation of hepatic oxidative stress by voltage-gated proton channels (Hv1/VSOP) in Kupffer cells and its potential relationship with glucose metabolism	FASEB JOURNAL			English	Article						blood glucose; Kupffer cell; voltage-gated proton channels	PHOSPHOENOLPYRUVATE CARBOXYKINASE; SUPEROXIDE-PRODUCTION; LIVER; GLUCONEOGENESIS; INTOLERANCE; VSOP/HV1; ASSAY	Voltage-gated proton channels (Hv1/VSOP), encoded byHvcn1, are important regulator of reactive oxygen species (ROS) production in many types of immune cells. While in vitro studies indicate that Hv1/VSOP regulates ROS production by maintaining pH homeostasis, there are few studies investigating the functional importance of Hv1/VSOP in vivo. In the present study, we first show that Hv1/VSOP is functionally expressed in liver resident macrophage, Kupffer cells, regulating the hepatic oxidative stress in vivo. Our immunocytochemistry and electrophysiology data showed thatHvcn1is specifically expressed in Kupffer cells, but not in hepatocytes. Furthermore,Hvcn1-deficiency drastically altered the hepatic oxidative stress. TheHvcn1-deficient mice showed high blood glucose and serum insulin but normal insulin sensitivity, indicating that these phenotypes were not linked to insulin resistance. Transcriptome analysis indicated that the gene expression ofglycogen phosphorylase (Pygl)andGlucose-6-phosphatase, catalytic subunit (G6pc)were upregulated inHvcn1-deficient liver tissues, and quantitative PCR confirmed the result forPygl. Furthermore, we observed higher amount of glucose-6-phosphate, a key sugar intermediate for glucose inHvcn1-deficient liver than WT, suggesting that glucose production in liver is accelerated inHvcn1-deficient mice. The present study sheds light on the functional importance of Kupffer cells in hepatic oxidative stress and its potential relationship with glucose metabolism.	[Kawai, Takafumi; Kayama, Kento; Tatsumi, Shoki; Akter, Sharmin; Miyawaki, Nana; Okochi, Yoshifumi; Okamura, Yasushi] Osaka Univ, Grad Sch Med & Frontier Biosci, Integrat Physiol, Suita, Osaka, Japan; [Kayama, Kento; Tatsumi, Shoki; Yamamoto, Hiroyasu; Kihara, Shinji] Osaka Univ, Div Hlth Sci, Dept Biomed Informat, Grad Sch Med, Suita, Osaka, Japan; [Abe, Manabu; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Japan	Osaka University; Osaka University; Niigata University	Kihara, S (corresponding author), Osaka Univ, Div Hlth Sci, Dept Biomed Informat, Grad Sch Med, Suita, Osaka, Japan.; Okamura, Y (corresponding author), Osaka Univ, Grad Sch Med, Lab Integrat Physiol, Suita, Osaka, Japan.	skihara@sahs.med.osaka-u.ac.jp; vsop1@me.com	Abe, Manabu/A-9221-2008	Akter, Sharmin/0000-0001-6901-3377	MEXT \ Japan Society for the Promotion of Science (JSPS) [12J01957, 15K18575, 21229003, 25253016]; Takeda Medical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24111529, 26111712]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Medical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 12J01957, 15K18575, 21229003 and 25253016; Takeda Medical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant/Award Number: 24111529 and 26111712	Aibara D, 2020, ENDOCR J, V67, P9, DOI 10.1507/endocrj.EJ19-0276; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Butterfield DA, 2019, NAT REV NEUROSCI, V20, P148, DOI 10.1038/s41583-019-0132-6; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; DeCoursey TE, 2013, PHYSIOL REV, V93, P599, DOI 10.1152/physrev.00011.2012; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; Feingold KR, 2012, INNATE IMMUN-LONDON, V18, P231, DOI 10.1177/1753425911398678; HORTON RA, 1994, BIOCHEM J, V299, P735, DOI 10.1042/bj2990735; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jiang Joy X, 2014, Adv Hepatol, V2014; Kawai T, 2018, CHANNELS, V12, P1, DOI 10.1080/19336950.2017.1385684; Kawai T, 2017, J NEUROCHEM, V142, P686, DOI 10.1111/jnc.14106; Kim H, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00048-17; Kimura K, 2016, CELL REP, V14, P2362, DOI 10.1016/j.celrep.2016.02.032; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; Li PZ, 2014, IMMUNOL LETT, V158, P52, DOI 10.1016/j.imlet.2013.12.002; MOTTA PM, 1984, ARCH HISTOL JAPON, V47, P1, DOI 10.1679/aohc.47.1; Naito M, 1997, MICROSC RES TECHNIQ, V39, P350, DOI 10.1002/(SICI)1097-0029(19971115)39:4<350::AID-JEMT5>3.0.CO;2-L; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Pang HM, 2020, J BIOL CHEM, V295, P3601, DOI 10.1074/jbc.RA119.010489; Petheo GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014081; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Sasaki M, 2013, BIOCHEM J, V450, P295, DOI 10.1042/BJ20121188; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Taylor KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056181; Tu H, 2010, NEUROSCIENCE, V165, P39, DOI 10.1016/j.neuroscience.2009.10.002; WAKE K, 1989, INT REV CYTOL, V118, P173; Wilson LH, 2019, HEPATOL COMMUN, V3, P1544, DOI 10.1002/hep4.1426; WISSE E, 1974, J ULTRA MOL STRUCT R, V46, P393, DOI 10.1016/S0022-5320(74)90064-1; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; Xue Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075240; YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1; Yamazaki Tsuyoshi, 2011, Trop Med Health, V39, P41, DOI 10.2149/tmh.2011-08; Ye ZW, 2015, BBA-GEN SUBJECTS, V1850, P1607, DOI 10.1016/j.bbagen.2014.11.010; Yerkovich ST, 2004, INT J BIOCHEM CELL B, V36, P1462, DOI 10.1016/j.biocel.2003.10.022	40	6	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15805	15821		10.1096/fj.202001056RRR	http://dx.doi.org/10.1096/fj.202001056RRR		OCT 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33040408				2022-12-26	WOS:000576980100001
J	Gonzalez, T; de la Rubia, MA; Hincz, KP; Comas-Lopez, M; Subirats, L; Fort, S; Sacha, GM				Gonzalez, T.; de la Rubia, M. A.; Hincz, K. P.; Comas-Lopez, M.; Subirats, Laia; Fort, Santi; Sacha, G. M.			Influence of COVID-19 confinement on students' performance in higher education	PLOS ONE			English	Article							REGULATED LEARNING-STRATEGIES; SELF-REGULATION; ONLINE; MOTIVATION; EFFICACY	This study analyzes the effects of COVID-19 confinement on the autonomous learning performance of students in higher education. Using a field experiment with 458 students from three different subjects at Universidad Autonoma de Madrid (Spain), we study the differences in assessments by dividing students into two groups. The first group (control) corresponds to academic years 2017/2018 and 2018/2019. The second group (experimental) corresponds to students from 2019/2020, which is the group of students that had their face-to-face activities interrupted because of the confinement. The results show that there is a significant positive effect of the COVID-19 confinement on students' performance. This effect is also significant in activities that did not change their format when performed after the confinement. We find that this effect is significant both in subjects that increased the number of assessment activities and subjects that did not change the student workload. Additionally, an analysis of students' learning strategies before confinement shows that students did not study on a continuous basis. Based on these results, we conclude that COVID-19 confinement changed students' learning strategies to a more continuous habit, improving their efficiency. For these reasons, better scores in students' assessment are expected due to COVID-19 confinement that can be explained by an improvement in their learning performance.	[Gonzalez, T.] Univ Autonoma Madrid, Fac Med, Biochem Dept, Madrid, Spain; [de la Rubia, M. A.] Univ Autonoma Madrid, Fac Sci, Chem Engn Dept, Madrid, Spain; [Hincz, K. P.; Comas-Lopez, M.; Sacha, G. M.] Univ Autonoma Madrid, Escuela Politecn Super, Madrid, Spain; [Subirats, Laia; Fort, Santi] Eurecat, Ctr Tecnol Catalunya, Barcelona, Spain; [Subirats, Laia] Univ Oberta Catalunya, ADaS Lab, Barcelona, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Autonomous University of Madrid; UOC Universitat Oberta de Catalunya	Sacha, GM (corresponding author), Univ Autonoma Madrid, Escuela Politecn Super, Madrid, Spain.	sacha.gomez@uam.es	, angeles/E-8673-2016; Subirats, Laia/C-3642-2018	, angeles/0000-0002-7411-5236; Subirats, Laia/0000-0001-8646-5463; Fort, Santi/0000-0003-2189-6830	ADeAPTIVE (Advanced Design of e-Learning Applications Personalizing Teaching to Improve Virtual Education) project; Erasmus + programme of the European Union [2017-1-ES01-KA203-038266]; ACCIO, Spain (Pla d'Actuacio de Centres Tecnologics 2019) under the project Augmented Workplace; Fondo Supera COVID-19 (Project: Development of tools for the assessment in higher education in the COVID-19 confinement)	ADeAPTIVE (Advanced Design of e-Learning Applications Personalizing Teaching to Improve Virtual Education) project; Erasmus + programme of the European Union; ACCIO, Spain (Pla d'Actuacio de Centres Tecnologics 2019) under the project Augmented Workplace; Fondo Supera COVID-19 (Project: Development of tools for the assessment in higher education in the COVID-19 confinement)	This research was funded by ADeAPTIVE (Advanced Design of e-Learning Applications Personalizing Teaching to Improve Virtual Education) project with the support of the Erasmus + programme of the European Union (grant number 2017-1-ES01-KA203-038266). This study was also funded by ACCIO, Spain (Pla d'Actuacio de Centres Tecnologics 2019) under the project Augmented Workplace. This study was also funded by the Fondo Supera COVID-19 (Project: Development of tools for the assessment in higher education in the COVID-19 confinement).	Caballero-Hernandez JA, 2020, INT J ENG EDUC, V36, P470; Bellhauser H, 2016, INTERNET HIGH EDUC, V31, P87, DOI 10.1016/j.iheduc.2016.07.002; Biasutti M, 2017, COMPUT EDUC, V111, P158, DOI 10.1016/j.compedu.2017.04.006; Boyd A. M., 2003, THESIS; Broadbent J, 2017, INTERNET HIGH EDUC, V33, P24, DOI 10.1016/j.iheduc.2017.01.004; Castro-Schez JJ, 2014, J NETW COMPUT APPL, V41, P65, DOI 10.1016/j.jnca.2013.10.011; CORNO L, 1986, CONTEMP EDUC PSYCHOL, V11, P333, DOI 10.1016/0361-476X(86)90029-9; DAGOSTIN.R, 1973, BIOMETRIKA, V60, P613, DOI 10.1093/biomet/60.3.613; de la Rubia MA, 2020, INT J ENG EDUC, V36, P411; Ebner M, 2020, FUTURE INTERNET, V12, DOI 10.3390/fi12060094; Eggen T.J.H.M., 2001, MEASUREMENT RES DEP; Favale T, 2020, COMPUT NETW, V176, DOI 10.1016/j.comnet.2020.107290; Gaevi D, 2019, J COMPUTER ASSISTED, V36, P70; Gohiya P., 2020, RES SQUARE, P4, DOI [10.21203/rs.3.rs-29575/v1, DOI 10.21203/RS.3.RS-29575/V1]; Hambleton R. K., 1991, FUNDAMENTALS ITEM RE; Garcia-Penalvo FJ, 2020, EDUC KNOWL SOC, V21, DOI 10.14201/eks.23013; Jovanovic J, 2019, COMPUT EDUC, V134, P156, DOI 10.1016/j.compedu.2019.02.011; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lord F.M., 1980, APPL ITEM RESPONSE T; Lu H, 2016, COMPUT EDUC, V100, P45, DOI 10.1016/j.compedu.2016.04.012; Maldonado-Mahauad J, 2018, COMPUT HUM BEHAV, V80, P179, DOI 10.1016/j.chb.2017.11.011; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martin AJ, 2018, J EDUC PSYCHOL, V110, P27, DOI 10.1037/edu0000205; McAuley A., 2010, MOOC MODEL DIGITAL P; Molins-Ruano P, 2016, COMPUT HUM BEHAV, V61, P378, DOI 10.1016/j.chb.2016.03.044; Molins-Ruano P, 2015, INT J ENG EDUC, V31, P764; Molins-Ruano P, 2014, COMPUT HUM BEHAV, V31, P571, DOI 10.1016/j.chb.2013.06.013; Narciss S, 2014, COMPUT EDUC, V71, P56, DOI 10.1016/j.compedu.2013.09.011; Ozyurt O, 2015, COMPUT HUM BEHAV, V52, P349, DOI 10.1016/j.chb.2015.06.020; Palomo-Duarte M, 2014, INTERACT LEARN ENVIR, V22, P444, DOI 10.1080/10494820.2012.680969; Panadero E, 2019, EUR J PSYCHOL EDUC, V34, P535, DOI 10.1007/s10212-018-0407-8; Rizvi S, 2020, J COMPUT HIGH EDUC, V32, DOI 10.1007/s12528-019-09231-0; Rodrigues H, 2019, COMPUT EDUC, V136, P87, DOI 10.1016/j.compedu.2019.03.007; Sabitha AS, 2017, EDUC INF TECHNOL, V22, P1673, DOI 10.1007/s10639-016-9516-7; Tsai YS, 2019, BRIT J EDUC TECHNOL, V50, P2839, DOI 10.1111/bjet.12846; van der Linden WJ, 2003, PSYCHOMETRIKA, V68, P251, DOI 10.1007/BF02294800; Veldkamp BP, 2017, COMPUT HUM BEHAV, V76, P693, DOI 10.1016/j.chb.2017.04.060; Wainer H., 2000, COMPUTERIZED ADAPTIV, V2, P335, DOI [10.4324/9781410605931, DOI 10.4324/9781410605931]; Wainer H.W., 1990, COMPUTERIZED ADAPTIV; Wang TH, 2011, COMPUT EDUC, V57, P1801, DOI 10.1016/j.compedu.2011.01.003; Winne PH, 2018, BRIT J EDUC PSYCHOL, V88, P9, DOI 10.1111/bjep.12173; Zimmerman BJ, 2008, AM EDUC RES J, V45, P166, DOI 10.3102/0002831207312909; Zimmerman BJ, 2014, CONTEMP EDUC PSYCHOL, V39, P145, DOI 10.1016/j.cedpsych.2014.03.004; ZIMMERMAN BJ, 1990, J EDUC PSYCHOL, V82, P51, DOI 10.1037/0022-0663.82.1.51	44	237	242	12	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239490	10.1371/journal.pone.0239490	http://dx.doi.org/10.1371/journal.pone.0239490			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3WA	33035228	Green Submitted, gold, Green Published			2022-12-26	WOS:000581817500015
J	Yosef, N; Xi, YX; McCarty, JH				Yosef, Nejla; Xi, Yuanxin; McCarty, Joseph H.			Isolation and transcriptional characterization of mouse perivascular astrocytes	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; DIFFERENTIAL EXPRESSION; NEUROVASCULAR UNIT; G-PROTEIN; INTEGRIN; MFSD2A; MICE; GENE; ANGIOGENESIS; DISRUPTION	In the post-natal mammalian brain perivascular astrocytes (PAs) ensheath blood vessels to regulate their unique permeability properties known as the blood-brain barrier (BBB). Very little is known about PA-expressed genes and signaling pathways that mediate contact and communication with endothelial cells (ECs) to regulate BBB physiology. This is due, in part, to lack of suitable models to distinguish PAs from other astrocyte sub-populations in the brain. To decipher the unique biology of PAs, we used in vivo gene knock-in technology to fluorescently label these cells in the adult mouse brain followed by fractionation and quantitative single cell RNA sequencing. In addition, PAs and non-PAs were also distinguished with transgenic fluorescent reporters followed by gene expression comparisons using bulk RNA sequencing. These efforts have identified several genes and pathways in PAs with potential roles in contact and communication with brain ECs. These genes encode various extracellular matrix (ECM) proteins and adhesion receptors, secreted growth factors, and intracellular signaling enzymes. Collectively, our experimental data reveal a set of genes that are expressed in PAs with putative roles in BBB physiology.	[Yosef, Nejla; McCarty, Joseph H.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Xi, Yuanxin] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	McCarty, JH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA.	jhmccarty@mdanderson.org			Cancer Prevention and Research Institute of Texas [RP180220]; National Institutes of Health [R01NS087635, R21NS103841, P50CA127001]; Brockman Foundation; Terry L. Chandler Foundation	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brockman Foundation; Terry L. Chandler Foundation	This work was supported by grants from the Cancer Prevention and Research Institute of Texas (RP180220), the National Institutes of Health (R01NS087635, R21NS103841, and P50CA127001), the Brockman Foundation, and the Terry L. Chandler Foundation.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Joseph McCarty received salary from the Cancer Prevention and Research Institute of Texas (RP180220), the National Institutes of Health (R01NS087635, R21NS103841, and P50CA127001), the Brockman Foundation, and the Terry L. Chandler Foundation. Nejla Yosef received salary from the Brockman Foundation. .	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alto LT, 2017, METHODS MOL BIOL, V1493, P1, DOI 10.1007/978-1-4939-6448-2_1; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnold TD, 2014, DEVELOPMENT, V141, P4489, DOI 10.1242/dev.107193; Aspalter IM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8264; Beck TF, 2013, HUM MOL GENET, V22, P1026, DOI 10.1093/hmg/dds507; Ben-Gigi L, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0078-14.2015; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Boor PKI, 2005, J NEUROPATH EXP NEUR, V64, P412; Bragg AD, 2010, NEUROREPORT, V21, P695, DOI 10.1097/WNR.0b013e32833b0a3b; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Chen MY, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-1; Cuis J., 2008, ECONOMIST, V19, P1; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Flintoff-Dye NL, 2005, DEV DYNAM, V234, P11, DOI 10.1002/dvdy.20462; Gautam J, 2019, TRANSL STROKE RES, V10, P705, DOI 10.1007/s12975-019-0688-5; Grimmer C, 2006, AM J PATHOL, V169, P491, DOI 10.2353/ajpath.2006.050738; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; Guo DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170005; Heng JS, 2019, P NATL ACAD SCI USA, V116, P9103, DOI 10.1073/pnas.1821122116; Hirota S, 2015, DEVELOPMENT, V142, P4363, DOI 10.1242/dev.113746; Hirota S, 2011, DEVELOPMENT, V138, P5157, DOI 10.1242/dev.069153; Hu SH, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01236; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jamieson AR, 2010, MED PHYS, V37, P339, DOI 10.1118/1.3267037; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kitagawa M, 2016, J BIOCHEM, V159, P287, DOI 10.1093/jb/mvv123; Kobayashi N, 2020, CANCERS, V12, DOI 10.3390/cancers12020363; Kofler N, 2016, CURR OPIN HEMATOL, V23, P260, DOI 10.1097/MOH.0000000000000233; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Langen UH, 2019, ANNU REV CELL DEV BI, V35, P591, DOI 10.1146/annurev-cellbio-100617-062608; Li S, 2015, NAT NEUROSCI, V18, P1737, DOI 10.1038/nn.4146; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lien CF, 2012, J BIOL CHEM, V287, P41374, DOI 10.1074/jbc.M112.400044; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Ma S, 2017, DEV CELL, V41, P366, DOI 10.1016/j.devcel.2017.04.014; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; McCarty JH, 2020, J CELL SCI, V133, DOI 10.1242/jcs.239434; Mishra A, 2016, NAT NEUROSCI, V19, P1619, DOI 10.1038/nn.4428; Muhle Christiane, 2007, Hum Genet, V122, P549; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Nathanson J, 2013, AM J MED GENET A, V161A, P473, DOI 10.1002/ajmg.a.35736; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Octeau JC, 2018, NEURON, V98, P49, DOI 10.1016/j.neuron.2018.03.003; Paredes I, 2018, DEV CELL, V45, P10, DOI 10.1016/j.devcel.2018.01.023; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Pavlakis E, 2011, INT J BIOCHEM CELL B, V43, P487, DOI 10.1016/j.biocel.2010.12.016; Pesch M, 2017, J INVEST DERMATOL, V137, P332, DOI 10.1016/j.jid.2016.07.040; Posokhova E, 2015, CELL REP, V10, P123, DOI 10.1016/j.celrep.2014.12.020; Pouliot N, 2013, CELL ADHES MIGR, V7, P142, DOI 10.4161/cam.22125; Qin Y, 2018, CELL, V174, P156, DOI 10.1016/j.cell.2018.05.027; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rousselle P, 2013, CELL ADHES MIGR, V7, P122, DOI 10.4161/cam.23132; Sakane A, 2012, J BIOL CHEM, V287, P42455, DOI 10.1074/jbc.M112.383653; Sakane A, 2010, MOL CELL BIOL, V30, P1077, DOI 10.1128/MCB.01067-09; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Tiwary S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26636-6; Toutounchian JJ, 2017, GENESIS, V55, DOI 10.1002/dvg.23071; Umlauf BJ, 2019, CURR OPIN BIOTECH, V60, P146, DOI 10.1016/j.copbio.2019.01.013; Urata Y, 2020, DEV GROWTH DIFFER, V62, P35, DOI 10.1111/dgd.12643; van der Knaap MS, 2012, LANCET NEUROL, V11, P973, DOI 10.1016/S1474-4422(12)70192-8; Vanhollebeke B, 2015, ELIFE, V4, DOI 10.7554/eLife.06489; Waite A, 2012, TRENDS NEUROSCI, V35, P487, DOI 10.1016/j.tins.2012.04.004	70	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240035	10.1371/journal.pone.0240035	http://dx.doi.org/10.1371/journal.pone.0240035			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031376	gold, Green Published			2022-12-26	WOS:000581809800003
J	Chen, BS; Bing, L; Chen, CX; Song, JX; Zhu, SL; Li, CL; Yang, SQ; Luo, CX				Chen Bishan; Bing, Li; Chen Chixin; Song Junxia; Zhu Shulin; Li Cailang; Yang Siqiao; Luo Chuanxiu			Relationship between airborne pollen assemblages and major meteorological parameters in Zhanjiang, South China	PLOS ONE			English	Article							CLIMATE-CHANGE; BIRCH; AIR	Pollen is an important component of bioaerosol and the distribution of pollen and its relationship with meteorological parameters can be analyzed to better prevent hay fever. Pollen assemblages can also provide basic data for analyzing the relationship between bioaerosol and PM. We collected 82 samples of airborne pollen using a TSP large flow pollen collector from June 1, 2015 to June 1, 2016, from central Zhanjiang city in South China. We also conducted a survey of the nearby vegetation at the same time, in order to characterize the major plant types and their flowering times. We then used data on daily temperature, relative humidity, precipitation, vapor pressure and wind speed from a meteorological station in the center of Zhanjiang City to assess the relationship between the distribution of airborne pollen and meteorological parameters. Our main findings and conclusions are as follows: (1) We identified 15 major pollen types, includingPinus,Castanopsis,Myrica, Euphorbiaceae, Compositae, Gramineae,Microlepiaand Polypodiaceae. From the vegetation survey, we found that the pollen from these taxa represented more than 75% of local pollen, while the pollen ofPodocarpus,Dacrydiumand other regional pollen types represented less than 25%. (2) The pollen concentrations varied significantly in different seasons. The pollen concentrations were at a maximum in spring, consisting mainly of tree pollen; the pollen concentrations were at an intermediate level in autumn and winter, consisting mainly of herb pollen and fern spores; and the pollen concentrations in summer were the lowest, consisting mainly of fern spores. (3) Analysis of the relationship between airborne pollen concentrations and meteorological parameters showed that variations in the pollen concentrations were mainly affected by temperature and relative humidity. In addition, there were substantial differences in these relationships in different seasons. In spring, pollen concentrations were mainly affected by temperature; in summer, they were mainly affected by the direction of the maximum wind speed; in autumn, they were mainly affected by relative humidity and temperature; and in winter, they were mainly affected by relative humidity and wind speed. Temperature and relative humidity promote plant growth and flowering. Notably, the variable wind direction in summer and the increased wind speed in winter and spring are conductive to pollen transmission. (4) Of the 15 major pollen types, Moraceae,Artemisiaand Gramineae are the main allergenic pollen types, with peaks in concentration during April-May, August-September, and October-December, respectively. (5) Atypical weather conditions have substantial effects on pollen dispersal. In South China, the pollen concentrations in the sunny day were usually significantly higher than that of the rainy day. The pollen concentrations increased in short rainy days, which usually came from the Herb and Fern pollen. The pollen concentrations decreased in continuous rainy days especially for the Tree and Shrub pollen. the pollen concentrations in the sunny days were usually significantly higher than that in the rainy days. The pollen concentrations increased in short and strong rainfall.	[Chen Bishan; Song Junxia; Zhu Shulin; Li Cailang; Yang Siqiao] Lingnan Normal Univ, Sch Geog Sci, Zhanjiang, Peoples R China; [Bing, Li] Hebei Normal Univ, Sch Resources & Environm Sci, Shijiazhuang, Hebei, Peoples R China; [Bing, Li] Key Lab Environm Change & Ecol Dev Hebei Prov, Shijiazhuang, Hebei, Peoples R China; [Chen Chixin] Guangzhou Marine Geol Survey, Guangzhou, Peoples R China; [Luo Chuanxiu] South China Sea Inst Oceanol, Guangzhou, Peoples R China	LingNan Normal University; Hebei Normal University; China Geological Survey; Guangzhou Marine Geological Survey; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Bing, L (corresponding author), Hebei Normal Univ, Sch Resources & Environm Sci, Shijiazhuang, Hebei, Peoples R China.; Bing, L (corresponding author), Key Lab Environm Change & Ecol Dev Hebei Prov, Shijiazhuang, Hebei, Peoples R China.	17733838911@163.com			National Natural Science Foundation of China [41606053, 41701230]; Natural science foundation of Guangdong province [2016A030310364]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural science foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This research was supported by the National Natural Science Foundation of China (Grant Nos. 41606053 and 41701230) and by the Natural science foundation of Guangdong province (Grant No. 2016A030310364).	Acharya R, 2008, ARTECH HSE BIOINF BI, P1; [Anonymous], 2005, REVIJA SOCIJALNU POL, V2, P189; [Anonymous], 2016, L STUD, V36, P136; [Anonymous], 2003, INT J BIOMETEOROL, V48, P1; Barnes C., 2001, AEROBIOLOGIA, V17, P61, DOI DOI 10.1023/A:1007693032090; Bellanger AP, 2012, BIOL TRACE ELEM RES, V150, P391, DOI 10.1007/s12011-012-9485-7; Caisse nationale de l'assurance maladie des travailleurs salaries, 2010, POINTS REPERE, V31, P1; Chakraborty P, 1998, GRANA, V37, P53, DOI 10.1080/00173139809362640; Chen M X, 2001, CHINA ENV SCI, V21, P97; Detweiler HK, 1930, J ALLERGY, V1, P334; Ediger V., 1997, Bollettino di Geofisica, Teorica ed Applicata, V38, P307; Fang YM, 2018, J GEOPHYS RES-ATMOS, V123, P10842, DOI 10.1029/2018JD029026; Fang YM, 2015, STUDY LAW AIRBORNE P; Fichera D, 2012, BMC Systems Biology, V6, P10; Frei T, 1998, GRANA, V37, P172, DOI 10.1080/00173139809362662; Frenguelli G, 1989, AEROBIOLOGIA, V5, P64, DOI [10.1007/BF02446489, DOI 10.1007/BF02446489]; GALAN C, 1995, GRANA, V34, P189, DOI 10.1080/00173139509429042; Garcia-Mozo H, 2016, SCI TOTAL ENVIRON, V548, P221, DOI 10.1016/j.scitotenv.2016.01.005; Gu DG, 2003, METEOR BUR HUBEI, V22, P36; Guo ZD, 2018, ENVIRON SCI POLLUT R, V25, P34540, DOI 10.1007/s11356-018-3355-6; Haberle SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097925; Ispir N, 2016, MATH COMMUN, V21, P31; [蒋素雪 Jiang Suxue], 2010, [古地理学报, Journal of Palaeogeography], V12, P629; Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021; Li J, 2015, LAT MED INF, V15, P28; [李俊 LI Jun], 2008, [环境与健康杂志, Journal of Environment and Health], V25, P510; [李英 Li Ying], 2014, [生态学报, Acta Ecologica Sinica], V34, P1575; [李月从 Li Yuecong], 2014, [地理研究, Geographical Research], V33, P2367; [李政 Li Zheng], 2009, [极地研究, Chinese Journal of Polar Research], V21, P151; Linkosalo T, 2010, AGR FOREST METEOROL, V150, P1579, DOI 10.1016/j.agrformet.2010.08.007; Lu SQ, 2013, AIRBORNE POLLEN ASSE; Luo CX, 2015, INT J BIOMETEOROL, V59, P397, DOI 10.1007/s00484-014-0852-2; Meng Xiang-bin, 2016, Huanjing Kexue, V37, P4147, DOI 10.13227/j.hjkx.201605074; Nelle O, 2010, J ARCHAEOL SCI, V37, P2126, DOI 10.1016/j.jas.2010.02.010; Ning XL, 2011, GUANGXI MED U, V33, P443; Oduber F, 2019, AGR FORE METEOR, P6; Okuyama Y, 2007, ATMOS ENVIRON, V41, P253, DOI 10.1016/j.atmosenv.2006.08.009; Peternel R, 2006, AEROBIOLOGIA, V22, P161, DOI 10.1007/s10453-006-9028-9; Puc M, 2004, ANN AGR ENV MED, V11, P53; Qiao BS, 2014, ATLAS CHINESE AIRBOR, P1; Rahman A, 2019, ATMOS ENVIRON, V212, P290, DOI 10.1016/j.atmosenv.2019.05.049; Rahman M. A., 2019, Journal of Biodiversity Conservation and Bioresource Management, V5, P1, DOI 10.3329/jbcbm.v5i2.44909; Recio M, 2018, AGR FOREST METEOROL, V250, P308, DOI 10.1016/j.agrformet.2017.11.028; Ritenberga O, 2016, AGR FOREST METEOROL, V226, P96, DOI 10.1016/j.agrformet.2016.05.016; Scheifinger H., 2013, ALLERGENIC POLLEN, P71, DOI DOI 10.1007/978-94-007-4881-1_4; Sikoparija B, 2018, ATMOS ENVIRON, V192, P13, DOI 10.1016/j.atmosenv.2018.08.040; Sikoparija B, 2018, AEROBIOLOGIA, V34, P203, DOI 10.1007/s10453-018-9507-9; Sofia G, 2017, INT J BIOMETEOROL, V61, P149, DOI 10.1007/s00484-016-1198-8; Sofiev M, 2015, ATMOS CHEM PHYS, V15, P8115, DOI 10.5194/acp-15-8115-2015; Sofiev M, 2013, ALLERGENIC POLLEN RE; [宋杰鲲 Song Jiekun], 2012, [资源科学, Resources Science], V34, P35; Wang F.X., 1995, POLLEN FLORA CHINA, P1, DOI DOI 10.1016/J.TECTO.2011.04.006; Wang Jin, 2016, Acta Botanica Boreali-Occidentalia Sinica, V36, P542; Wang JT, 2017, STUDY RELATIONSHIP M; Wang XJ, 2018, J INT MED RES, V46, P802, DOI 10.1177/0300060517724710; [王赞红 WANG Zanhong], 2006, [地理研究, Geographical Research], V25, P262; Yan J, 2015, STUDY HIST ECOLOGICA; Yang Y, 2007, STUDY URBAN TREES PO; [杨振京 Yang Zhenjing], 2011, [干旱区地理, Arid Land Geography], V34, P880; Zhang J, 2012, J ARID LAND, V4, P357, DOI 10.3724/SP.J.1227.2012.00357; ZHANG S L, 2003, METROROLOGICAL SCI T, V31, P406	61	6	7	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240160	10.1371/journal.pone.0240160	http://dx.doi.org/10.1371/journal.pone.0240160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027306	Green Published, gold			2022-12-26	WOS:000581808000013
J	Iommi, M; Rosa, S; Fusaroli, M; Rucci, P; Fantini, MP; Poluzzi, E				Iommi, Marica; Rosa, Simona; Fusaroli, Michele; Rucci, Paola; Fantini, Maria Pia; Poluzzi, Elisabetta			Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions	PLOS ONE			English	Article							ADMINISTRATIVE DATABASES; COMORBIDITY; MORTALITY; HEALTH	Background Estimating the morbidity of a population is strategic for health systems to improve healthcare. In recent years administrative databases have been increasingly used to predict health outcomes. In 1992, Von Korff proposed a Chronic Disease Score (CDS) to predict 1-year mortality by only using drug prescription data. Because pharmacotherapy underwent many changes over the last 3 decades, the original version of the CDS has limitations. The aim of this paper is to report on the development of the modified version of the CDS. Methods The modified CDS (M-CDS) was developed using 33 variables (from drug prescriptions within two-year before 01/01/2018) to predict one-year mortality in Bologna residents aged >= 50 years. The population was split into training and testing sets for internal validation. Score weights were estimated in the training set using Cox regression model with LASSO procedure for variables selection. The external validation was carried out on the Imola population. The predictive ability of M-CDS was assessed using ROC analysis and compared with that of the Charlson Comorbidity Index (CCI), that is based on hospital data only, and of the Multisource Comorbidity Score (MCS), which uses hospital and pharmaceutical data. Results The predictive ability of M-CDS was similar in the training and testing sets (AUC 95% CI: training [0.760-0.770] vs. testing [0.750-0.772]) and in the external population (Imola AUC 95% CI [0.756-0.781]). M-CDS was significantly better than CCI (M-CDS AUC = 0.761, 95% CI [0.750-0.772] vs. CCI-AUC = 0.696, 95% CI [0.681-0.711]). No significant difference was found between M-CDS and MCS (MCS AUC = 0.762, 95% CI [0.749-0.775]). Conclusions M-CDS, using only drug prescriptions, has a better performance than the CCI score in predicting 1-year mortality, and is not inferior to the multisource comorbidity score. M-CDS can be used for population risk stratification, for risk-adjustment in association studies and to predict the individual risk of death.	[Iommi, Marica; Rosa, Simona; Rucci, Paola; Fantini, Maria Pia] Univ Bologna, Hyg & Biostat Unit, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Fusaroli, Michele; Poluzzi, Elisabetta] Univ Bologna, Pharmacol Unit, Dept Med & Surg Sci, Bologna, Italy	University of Bologna; University of Bologna	Iommi, M (corresponding author), Univ Bologna, Hyg & Biostat Unit, Dept Biomed & Neuromotor Sci, Bologna, Italy.	marica.iommi2@unibo.it	Fusaroli, Michele/AAK-6107-2021; Fusaroli, Michele/AAJ-6956-2021	Fusaroli, Michele/0000-0002-0254-2212; Fusaroli, Michele/0000-0002-0254-2212; Iommi, Marica/0000-0003-4589-3474; POLUZZI, ELISABETTA/0000-0002-7209-0426; Rucci, Paola/0000-0002-7704-0831				Ahlgren-Rimpilainen AJ, 2020, PSYCHIAT RES, V286, DOI 10.1016/j.psychres.2020.112801; Chang W, 2020, SCHIZOPHR B, DOI [10.1093/schbul/sbaa013/5743103, DOI 10.1093/SCHBUL/SBAA013/5743103]; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chini F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-688; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; Corrao G, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019503; Dudoit S, 2005, STAT METHODOL, V2, P131, DOI [10.1016/j.stamet.2005.02.003, DOI 10.1016/J.STAMET.2005.02.003]; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ellis R.P., 2018, RISK ADJUSTMENT RISK, P55, DOI [10.1016/B978-0-12-811325-7.00003-8, DOI 10.1016/B978-0-12-811325-7.00003-8]; Gallo JJ, 2005, AM J GERIAT PSYCHIAT, V13, P748, DOI 10.1176/appi.ajgp.13.9.748; Heila H, 2005, PSYCHOL MED, V35, P725, DOI 10.1017/S0033291704004118; Huber CA, 2013, J CLIN EPIDEMIOL, V66, P1118, DOI 10.1016/j.jclinepi.2013.04.011; Kass GV, 1980, J R STAT SOC C-APPL, P119; Leal JR, 2010, CLIN MICROBIOL INFEC, V16, P715, DOI 10.1111/j.1469-0691.2009.02867.x; Mehta HB, 2016, MED CARE, V54, P519, DOI 10.1097/MLR.0000000000000517; Needham DM, 2005, J CRIT CARE, V20, P12, DOI 10.1016/j.jcrc.2004.09.007; Payne RA, 2020, CAN MED ASSOC J, V192, pE107, DOI 10.1503/cmaj.190757; Preen DB, 2004, J CLIN EPIDEMIOL, V57, P1295, DOI 10.1016/j.jclinepi.2004.03.016; Robusto F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149203; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; Stirland LE, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m160; Strom BL, 2013, TEXTBOOK OF PHARMACOEPIDEMIOLOGY, 2ND EDITION, P118; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502; Zielinski A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-347	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240899	10.1371/journal.pone.0240899	http://dx.doi.org/10.1371/journal.pone.0240899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064757	Green Published, gold			2022-12-26	WOS:000585918300049
J	Cherrak, SA; Merzouk, H; Mokhtari-Soulimane, N				Cherrak, Sabri Ahmed; Merzouk, Hafida; Mokhtari-Soulimane, Nassima			Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies	PLOS ONE			English	Article							IN-VITRO; GLYCOSIDES; RUTIN; VIVO	A novel coronavirus responsible of acute respiratory infection closely related to SARS-CoV has recently emerged. So far there is no consensus for drug treatment to stop the spread of the virus. Discovery of a drug that would limit the virus expansion is one of the biggest challenges faced by the humanity in the last decades. In this perspective, to test existing drugs as inhibitors of SARS-CoV-2 main protease is a good approach. Among natural phenolic compounds found in plants, fruit, and vegetables; flavonoids are the most abundant. Flavonoids, especially in their glycosylated forms, display a number of physiological activities, which makes them interesting to investigate as antiviral molecules. The flavonoids chemical structures were downloaded from PubChem and protease structure 6LU7 was from the Protein Data Bank site. Molecular docking study was performed using AutoDock Vina. Among the tested moleculesshowed the highest binding affinity (-9,7 kcal/mol). Docking studies showed that glycosylated flavonoids are good inhibitors for the SARS-CoV-2 protease and could be further investigated by in vitro and in vivo experiments for further validation. MD simulations were further performed to evaluate the dynamic behavior and stability of the protein in complex with the three best hits of docking experiments. Our results indicate that the rutin is a potential drug to inhibit the function of Chymotrypsin-like protease (3CL pro) of Coronavirus.	[Cherrak, Sabri Ahmed; Merzouk, Hafida; Mokhtari-Soulimane, Nassima] Univ Tlemcen, Fac Nat & Life Sci, Lab Physiol Physiopathol & Biochem Nutr, Dept Biol,Earth & Univere, Tilimsen, Algeria	Universite Abou Bekr Belkaid	Cherrak, SA (corresponding author), Univ Tlemcen, Fac Nat & Life Sci, Lab Physiol Physiopathol & Biochem Nutr, Dept Biol,Earth & Univere, Tilimsen, Algeria.	cherraksabri@gmail.com	Cherrak, Sabri Ahmed/ABD-6356-2020	nassima, mokhtari soulimane/0000-0002-6934-5168; Cherrak, Sabri Ahmed/0000-0002-5079-9661				Abraham LCN, 2008, FOOD CHEM, V109, P415, DOI 10.1016/j.foodchem.2007.12.069; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ahmadpour SS, 2020, J SUPERCOMPUT, V76, P10155, DOI 10.1007/s11227-020-03249-3; Amaretti A, 2015, NUTRIENTS, V7, P2788, DOI 10.3390/nu7042788; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; Benson NC, 2012, J PHYS CHEM B, V116, P8722, DOI 10.1021/jp302103t; Bhardwaj VK, 2021, J BIOMOL STRUCT DYN, V39, P3449, DOI 10.1080/07391102.2020.1766572; Bobone S, 2017, J VIROL, V91, DOI 10.1128/JVI.00267-17; de Oliveira OV, 2021, J BIOMOL STRUCT DYN, V39, P3924, DOI 10.1080/07391102.2020.1772885; Dou J, 2011, ARCH VIROL, V156, P793, DOI 10.1007/s00705-011-0917-z; El Mekabaty A, 2021, J NEUROINTERV SURG, V13, DOI 10.1136/neurintsurg-2020-015949; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Feng ZC, 2020, EARLY PREDICTION DIS; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Gupta S, 2021, J BIOMOL STRUCT DYN, V39, P4334, DOI 10.1080/07391102.2020.1776157; Hemida MG, 2020, ONE HEALTH-AMSTERDAM, V10, DOI 10.1016/j.onehlt.2020.100127; Hofer CT, 2019, BBA-BIOMEMBRANES, V1861, P1123, DOI 10.1016/j.bbamem.2019.03.013; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Khalil H, 2019, J MED VIROL, V91, P45, DOI 10.1002/jmv.25295; Khan A, 2021, J BIOMOL STRUCT DYN, V39, P4659, DOI 10.1080/07391102.2020.1779128; Khan A, 2020, INTERDISCIP SCI, V12, P335, DOI 10.1007/s12539-020-00381-9; Khan MT, 2021, J BIOMOL STRUCT DYN, V39, P3627, DOI 10.1080/07391102.2020.1769733; Khan S, 2021, J BIOMOL STRUCT DYN, V39, P970, DOI 10.1080/07391102.2020.1722240; Kumar A, 2021, J BIOMOL STRUCT DYN, V39, P1155, DOI 10.1080/07391102.2020.1726816; Kumar DA, 2021, J AMB INTEL HUM COMP, V12, P7063, DOI 10.1007/s12652-020-02371-7; Kumar M, 2010, FITOTERAPIA, V81, P234, DOI 10.1016/j.fitote.2009.09.003; Kumar S, 2020, CURR TOP MED CHEM, V20, P599, DOI 10.2174/1568026620999200305144319; Kumar V., 2020, J NEUROCHEM, V1, DOI DOI 10.1111/jnc.15119; Kutzner C, 2019, J COMPUT CHEM, V40, P2418, DOI 10.1002/jcc.26011; Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301; Li HZ, 2013, TOXICOL APPL PHARM, V272, P180, DOI 10.1016/j.taap.2013.05.011; Li SG, 2010, CANCER LETT, V298, P222, DOI 10.1016/j.canlet.2010.07.009; Liu ZM, 2005, J CHEM INF MODEL, V45, P10, DOI 10.1021/ci049809b; Mittal L, 2021, J BIOMOL STRUCT DYN, V39, P3662, DOI 10.1080/07391102.2020.1768151; Morse JS, 2020, CHEMBIOCHEM, V21, P730, DOI 10.1002/cbic.202000047; Nyakas M, 2019, CLIN EXP IMMUNOL, V197, P74, DOI 10.1111/cei.13283; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powers CN, 2016, COMB CHEM HIGH T SCR, V19, P516, DOI 10.2174/1386207319666160506123715; Reutrakul V, 2007, PLANTA MED, V73, P683, DOI 10.1055/s-2007-981538; Sati P, 2019, J TRADIT COMPL MED, V9, P15, DOI 10.1016/j.jtcme.2017.10.003; Serseg T, 2021, CURR COMPUT-AID DRUG, V17, P469, DOI 10.2174/1573409916666200422075440; Sk MF, 2021, J BIOMOL STRUCT DYN, V39, P3649, DOI 10.1080/07391102.2020.1768149; Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4; Tao J, 2007, ANTIVIR RES, V75, P227, DOI 10.1016/j.antiviral.2007.03.008; Tasdemir D, 2006, ANTIMICROB AGENTS CH, V50, P1352, DOI 10.1128/AAC.50.4.1352-1364.2006; Thi THN, 2012, BIOTECHNOL LETT, V34, P831, DOI 10.1007/s10529-011-0845-8; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Phan T, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104260; Umesh, 2021, J BIOMOL STRUCT DYN, V39, P3428, DOI 10.1080/07391102.2020.1763202; Valentova K, 2014, FOOD CHEM TOXICOL, V68, P267, DOI 10.1016/j.fct.2014.03.018; Wahedi HM, 2021, J BIOMOL STRUCT DYN, V39, P3225, DOI 10.1080/07391102.2020.1762743; Wen LR, 2017, FREE RADICAL BIO MED, V110, P92, DOI 10.1016/j.freeradbiomed.2017.05.027; Wu WJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010006; Xiao JB, 2017, CRIT REV FOOD SCI, V57, P1874, DOI 10.1080/10408398.2015.1032400; Xiao JB, 2016, CRIT REV FOOD SCI, V56, pS29, DOI 10.1080/10408398.2015.1067595; Xu G, 2010, BIOL PHARM BULL, V33, P238, DOI 10.1248/bpb.33.238; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zhu LL, 2011, ANTIVIR RES, V92, P204, DOI 10.1016/j.antiviral.2011.08.001	60	76	76	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240653	10.1371/journal.pone.0240653	http://dx.doi.org/10.1371/journal.pone.0240653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057452	Green Published, gold			2022-12-26	WOS:000581814700021
J	Cunha, EN; de Souza, MFB; Lanza, DCF; Lima, JPMS				Cunha, Eduardo Nogueira; de Souza, Maria Fernanda Bezerra; Lanza, Daniel Carlos Ferreira; Lima, Joao Paulo Matos Santos			A low-cost smart system for electrophoresis-based nucleic acids detection at the visible spectrum	PLOS ONE			English	Article							ETHIDIUM-BROMIDE; MOLECULAR DIAGNOSTICS; AGAROSE GELS; SYBR GOLD; DNA; DECONTAMINATION; FLUORESCENCE	Nucleic acid detection by electrophoresis is still a quick and accessible technique for many diagnosis methods, primarily at research laboratories or at the point of care units. Standard protocols detect DNA/RNA molecules through specific bound chemical dyes using a UV-transilluminator or UV-photo documentation system. However, the acquisition costs and availability of these devices, mainly the ones with photography and internet connection capabilities, can be prohibitive, especially in developing countries public health units. Also, ultraviolet radiation is a common additional risk factor to professionals that use electrophoresis-based nucleic acid detection. With that in mind, this work describes the development of a low-cost DNA/RNA detection smart system capable of obtaining qualitative and semi-quantitative data from gel analysis. The proposed device explores the visible light absorption range of commonly used DNA/RNA dyes using readily available parts, and simple manufacturing processes, such as light-emitting diodes (LEDs) and 3D impression. By applying IoT techniques, our system covers a wide range of color spectrum in order to detect bands from various commercially used dyes, using Bluetooth communication and a smartphone for hardware control, image capturing, and sharing. The project also enables process scalability and has low manufacturing and maintenance costs. The use of LEDs at the visible spectrum can achieve very reproducible images, providing a high potential for rapid and point-of-care diagnostics as well as applications in several fields such as healthcare, agriculture, and aquaculture.	[Cunha, Eduardo Nogueira; Lanza, Daniel Carlos Ferreira; Lima, Joao Paulo Matos Santos] Univ Fed Rio Grande Norte UFRN, Programa Posgrad Bioinformat PPg Bioinfo, IMD, Natal, RN, Brazil; [Cunha, Eduardo Nogueira; Lima, Joao Paulo Matos Santos] Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, Lab Sistemas Metab & Bioinformat LASIS, Natal, RN, Brazil; [Cunha, Eduardo Nogueira; Lima, Joao Paulo Matos Santos] Univ Fed Rio Grande do Norte, Inst Med Trop Rio Grande Norte IMT RN, Natal, RN, Brazil; [de Souza, Maria Fernanda Bezerra; Lanza, Daniel Carlos Ferreira; Lima, Joao Paulo Matos Santos] Univ Fed Rio Grande do Norte, Ctr Biociencias, Programa Posgrad Bioquim, Natal, RN, Brazil; [de Souza, Maria Fernanda Bezerra; Lanza, Daniel Carlos Ferreira] Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, Lab Biol Mol Aplicada LAPLIC, Natal, RN, Brazil; [Lima, Joao Paulo Matos Santos] Univ Fed Rio Grande do Norte, Bioinformat Multidisciplinary Environm BioME, IMD, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Lima, JPMS (corresponding author), Univ Fed Rio Grande Norte UFRN, Programa Posgrad Bioinformat PPg Bioinfo, IMD, Natal, RN, Brazil.; Lima, JPMS (corresponding author), Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, Lab Sistemas Metab & Bioinformat LASIS, Natal, RN, Brazil.; Lima, JPMS (corresponding author), Univ Fed Rio Grande do Norte, Inst Med Trop Rio Grande Norte IMT RN, Natal, RN, Brazil.; Lima, JPMS (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Programa Posgrad Bioquim, Natal, RN, Brazil.; Lima, JPMS (corresponding author), Univ Fed Rio Grande do Norte, Bioinformat Multidisciplinary Environm BioME, IMD, Natal, RN, Brazil.	jpmslima@imd.ufrn.br	Lima, João Paulo Matos Santos/AAS-7878-2021	Lima, João Paulo Matos Santos/0000-0002-6113-8834; Cunha, Eduardo Nogueira/0000-0001-6991-7296	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq [447222/2014-7]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MFB Souza was supported by a scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES -www.capes.gov.br).JPMSL had financial support from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq (www.cnpq.br), grant number 447222/2014-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; ANDERSON DJ, 1989, CLIN CHEM, V35, P2152; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Bourzac KM, 2003, J CHEM EDUC, V80, P1292, DOI 10.1021/ed080p1292; Chan K, 2018, ANAL BIOCHEM, V545, P4, DOI 10.1016/j.ab.2018.01.008; Cheng ZL, 2018, SENSOR ACTUAT B-CHEM, V258, P1302, DOI 10.1016/j.snb.2017.12.158; FLORES N, 1992, BIOTECHNIQUES, V13, P203; Haines AM, 2015, ELECTROPHORESIS, V36, P941, DOI 10.1002/elps.201400496; Huang KC, 2011, IEEE IMTC P, P134; Huang Q, 2010, CLIN LAB, V56, P149; Huo F, 2011, ANALYST, V136, P2234, DOI 10.1039/c0an00772b; Hurth C, 2008, APPL PHYS B-LASERS O, V93, P693, DOI 10.1007/s00340-008-3218-9; Kirsanov KI, 2010, MUTAT RES-GEN TOX EN, V699, P1, DOI 10.1016/j.mrgentox.2010.04.014; Klaschik S, 2002, MOL BIOTECHNOL, V22, P231, DOI 10.1385/MB:22:3:231; Lee Pei Yun, 2012, Jove-Journal of Visualized Experiments, pe3923, DOI 10.3791/3923; Lerchner J, 2002, THERMOCHIM ACTA, V382, P65, DOI 10.1016/S0040-6031(01)00738-9; Li ZQ, 2018, SENSOR ACTUAT B-CHEM, V254, P153, DOI 10.1016/j.snb.2017.07.064; LUNN G, 1987, ANAL BIOCHEM, V162, P453, DOI 10.1016/0003-2697(87)90419-2; Maier A, 2017, PROCEEDINGS OF THE 2017 7TH INTERNATIONAL CONFERENCE INTERNET TECHNOLOGIES AND APPLICATIONS (ITA), P143, DOI 10.1109/ITECHA.2017.8101926; Maksimovic Mirjana, 2016, J INFORM SYSTEMS ENG, V1, P25, DOI DOI 10.20897/LECTIT0.201607; Millar BC, 2007, CURR ISSUES MOL BIOL, V9, P21; Nolvak H, 2012, SCI TOTAL ENVIRON, V426, P351, DOI 10.1016/j.scitotenv.2012.03.054; OIE OEOZZ, 2006, MAN DIAGN TESTS AQ A; Roth C, 2004, ENCY ANALYTICALSCIEN, VSecond, P456; Sambrook J., 2001, MOL CLONING LAB MANU; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHARP PA, 1973, BIOCHEMISTRY-US, V12, P3055, DOI 10.1021/bi00740a018; Shaw MM, 2003, PROTEOMICS, V3, P1408, DOI 10.1002/pmic.200300471; Stellwagen NC, 2009, ELECTROPHORESIS, V30, pS188, DOI 10.1002/elps.200900052; Thomaz S., 2009, P FRONTIERS ED C, DOI [10.1109/FIE.2009.5350439, DOI 10.1109/FIE.2009.5350439]; Tuma RS, 1999, ANAL BIOCHEM, V268, P278, DOI 10.1006/abio.1998.3067; Zabzdyr JL, 2001, J CHROMATOGR A, V911, P269, DOI 10.1016/S0021-9673(00)01189-4	33	4	4	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240536	10.1371/journal.pone.0240536	http://dx.doi.org/10.1371/journal.pone.0240536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057447	Green Submitted, Green Published, gold			2022-12-26	WOS:000581814700047
J	Velayutham, B; Jayabal, L; Watson, B; Jagadeesan, S; Angamuthu, D; Rebecca, P; Devaleenal, B; Nair, D; Tripathy, S; Selvaraju, S				Velayutham, Banurekha; Jayabal, Lavanya; Watson, Basilea; Jagadeesan, Saraswathy; Angamuthu, Dhanalakshmi; Rebecca, Priscilla; Devaleenal, Bella; Nair, Dina; Tripathy, Srikanth; Selvaraju, Sriram			Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting	PLOS ONE			English	Article							CHEMOPROPHYLAXIS	Background Household contacts (HHC) of tuberculosis (TB) patients are at risk of TB infection and disease. The study assessed the utility of "Household contact card and register" for screening of HHC of pulmonary TB (PTB) patients for TB and explored the reasons for HHC not being screened and followed-up. Methods The "Household contact card and register" was implemented by the Health Care Workers (HCW) of the TB Control Programme in Chennai District for screening HHC of index PTB patients initiated on treatment between June and August, 2018. Contacts were required to be screened within 2 months of treatment initiation of the index patient. Details collected included age, gender, smoking, alcohol use, immunosuppressive conditions and TB treatment. Symptom screening along with chest radiograph and or sputum examination was attempted. Follow-up TB screening at 6 and 12 months were performed. Screening of HHC was compared pre and post implementation phase. Proportions were computed for the data analysed. Results HHC information was documented for 93% (1268/1364) of Index PTB patients. The main reasons of non-listing of HHC in 96 PTB patients were HCW non-availability or non-co-operation of the HHC. There were 2150 (80%) contacts who were screened for TB. Inconvenient time, feeling healthy, stigma, out-station visit were the main reasons for 537 contacts not undergoing TB screening. Anti-TB treatment was initiated in 21 (1%) of contacts diagnosed with TB. Preventive therapy was initiated in 59% (81/138) of contacts aged Conclusion "Household contact card and register" is a useful tool for HCWs for TB screening in HHC of PTB patients. Reasons for non-adherence to contact screening needs to be addressed.	[Velayutham, Banurekha; Watson, Basilea; Jagadeesan, Saraswathy; Angamuthu, Dhanalakshmi; Rebecca, Priscilla; Devaleenal, Bella; Nair, Dina; Tripathy, Srikanth; Selvaraju, Sriram] ICMR Natl Inst Res TB, Chennai, Tamil Nadu, India; [Jayabal, Lavanya] Natl TB Eliminat Programme, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Velayutham, B (corresponding author), ICMR Natl Inst Res TB, Chennai, Tamil Nadu, India.	bhannu@gmail.com	Watson, Basilea/AGH-6965-2022	Selvaraju, Sriram/0000-0003-0369-6640; Tripathy, Srikanth/0000-0002-8363-2606	United States Agency for International Development (USAID) through Tuberculosis Health Action and Learning initiative (THALI) grant/STOP TB Partnership/United Nations Office for Project Services (UNOPS) under the TB free Chennai initiative	United States Agency for International Development (USAID) through Tuberculosis Health Action and Learning initiative (THALI) grant/STOP TB Partnership/United Nations Office for Project Services (UNOPS) under the TB free Chennai initiative	The study was funded by United States Agency for International Development (USAID) through Tuberculosis Health Action and Learning initiative (THALI) grant/STOP TB Partnership/United Nations Office for Project Services (UNOPS) under the TB free Chennai initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dhingra V.K., 2004, INDIAN J MED, V29, P44; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Fox GJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0816-0; Gebregergs GB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125767; Gupta M, 2016, LUNG INDIA, V33, P159, DOI 10.4103/0970-2113.177445; Htet KKK, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3586-7; Nair D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162090; Ramos JM, 2013, INT J MYCOBACT, V2, P240, DOI 10.1016/j.ijmyco.2013.10.001; Rekha B, 2013, INT J TUBERC LUNG D, V17, P163, DOI 10.5588/ijtld.12.0415; Rekha VVB, 2009, INT J TUBERC LUNG D, V13, P1507; Revised National TB Control Programme, TECHN OP GUID 2016; Shiferaw DA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4695-7; Singh J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069730; Tornee Songpol, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P331; WHO, 2019, GLOB TUB REP, P1; World Health Organisation, WHOHTMTB20129; World Health Organisation, END TB STRAT GLOB ST	17	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240594	10.1371/journal.pone.0240594	http://dx.doi.org/10.1371/journal.pone.0240594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057399	gold, Green Published, Green Accepted			2022-12-26	WOS:000581814700055
J	Kubota, M; Kobayashi, N; Sugizaki, T; Shimoda, M; Kawahara, M; Tanaka, K				Kubota, Maho; Kobayashi, Nahoko; Sugizaki, Toshifumi; Shimoda, Mikako; Kawahara, Masahiro; Tanaka, Ken-ichiro			Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in anin vitromodel of Parkinson's disease	PLOS ONE			English	Article							ZINC-INDUCED NEUROTOXICITY; EXPRESSION; ALZHEIMERS; PROTECTION; PATHWAYS; INJURY; COPPER; DAMAGE; BRAIN; DNA	Parkinson's disease is a progressive neurodegenerative disease for which prevention and effective treatments are lacking. The pathogenesis of Parkinson's disease is not clearly understood. It is thought to be caused by oxidative stress-dependent loss of dopamine neurons in the substantia nigra and the promotion of inflammatory responses by microglia at the lesion site. In addition, cell loss occurs in the hypothalamus of Parkinson's disease patients. Carnosine is an endogenous dipeptide that can exert many beneficial effects, including an antioxidant action, metal ion chelation, proton buffering capacity, and inhibition of protein carbonylation and glycolysis. Previously, we found that carnosine inhibits trace metal-induced death of immortalized hypothalamic neuronal GT1-7 cells. In this study, we analyzed the efficacy of carnosine on 6-hydroxydopamine (6-OHDA)-dependent GT1-7 cell death and inflammatory responses. We found that carnosine significantly prevented 6-OHDA-dependent GT1-7 cell death in a dose-dependent manner. Moreover, carnosine significantly suppressed the expression of 6-OHDA-induced integrated stress response (ISR)-related factors and pro-inflammatory cytokines. Carnosine also significantly inhibited 6-OHDA-dependent reactive oxygen species (ROS) production and c-Jun amino-terminal kinase (JNK) pathway activation in GT1-7 cells. These results indicate that carnosine inhibits hypothalamic neuronal cell death and inflammatory responses by inhibiting the ROS-JNK pathway. We therefore suggest that carnosine may be effective in preventing the onset or the exacerbation of Parkinson's disease.	[Kubota, Maho; Kobayashi, Nahoko; Sugizaki, Toshifumi; Shimoda, Mikako; Kawahara, Masahiro; Tanaka, Ken-ichiro] Musashino Univ, Lab Bioanalyt Chem, Pharmaceut Sci Res Inst, Fac Pharm, Tokyo, Japan		Kawahara, M; Tanaka, K (corresponding author), Musashino Univ, Lab Bioanalyt Chem, Pharmaceut Sci Res Inst, Fac Pharm, Tokyo, Japan.	k-tana@musashino-u.ac.jp; makawa@musashino-u.ac.jp		Tanaka, Ken-ichiro/0000-0003-1893-0751	Research Foundation for Pharmaceutical Sciences; Japan Society for the Promotion of Science (JSPS) (KAKENHI KIBAN (C)) [18K06669]	Research Foundation for Pharmaceutical Sciences; Japan Society for the Promotion of Science (JSPS) (KAKENHI KIBAN (C))	This research was supported by grants from The Research Foundation for Pharmaceutical Sciences, and also in part by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) (KAKENHI KIBAN (C) 18K06669).	Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Alsheblak MM, 2016, EUR CYTOKINE NETW, V27, P6, DOI 10.1684/ecn.2016.0372; American Academy of Ophthalmology, 2016, BCSC BASIC CLIN SCI, V10, P129; [Anonymous], 2015, INT J COMPUTER APPL, V130, P25; BELLOMO G, 1991, J NEUROL, V238, P19, DOI 10.1007/BF00319704; Bermudez ML, 2019, NEUROSCIENCE, V411, P270, DOI 10.1016/j.neuroscience.2019.05.026; Bernstein AI, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-2; Boldyrev A, 2008, REJUV RES, V11, P821, DOI 10.1089/rej.2008.0716; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Burns MJ, 2007, ORG LETT, V9, P5397, DOI 10.1021/ol702291r; Callio J, 2005, J BIOL CHEM, V280, P18536, DOI 10.1074/jbc.M413224200; Chen HC, 2018, MOL MED REP, V18, P4913, DOI 10.3892/mmr.2018.9509; Dhanasekaran Danny N, 2017, Genes Cancer, V8, P682, DOI 10.18632/genesandcancer.155; Erekat N.S., 2018, PARKINSONS DIS PATHO; Giguere N, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00455; Ham S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00614-w; Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kawahara M, 2002, CELL MOL NEUROBIOL, V22, P87, DOI 10.1023/A:1015345813075; Kawahara M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020147; Kawahara M, 2011, METALLOMICS, V3, P726, DOI 10.1039/c1mt00015b; Kim Y, 2012, INT J NEUROSCI, V122, P641, DOI 10.3109/00207454.2012.702821; Konnova EA., 2018, PARKINSONS DIS PATHO, DOI 10.15586/codonpublications.parkinsonsdisease.2018.ch5; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Macchi B, 2015, CNS NEUROL DISORD-DR, V14, P313, DOI 10.2174/1871527314666150225124928; Medeiros MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146129; Mizuno D, 2015, METALLOMICS, V7, P1233, DOI 10.1039/c5mt00049a; Monti DA, 2019, CLIN PHARMACOL THER, V106, P884, DOI 10.1002/cpt.1548; Pagano G, 2016, NEUROLOGY, V86, P1400, DOI 10.1212/WNL.0000000000002461; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Park SY, 2014, NEUROTOXICOLOGY, V44, P160, DOI 10.1016/j.neuro.2014.06.011; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; TANAKA K, 2019, CIRCULATION, DOI DOI 10.1155/2019/9693726; Tanaka KI, 2020, CURR MED CHEM, V27, P1714, DOI 10.2174/0929867326666190712140545; Tanaka KI, 2019, TOXICOL SCI, V169, P293, DOI 10.1093/toxsci/kfz043; Tanaka K, 2018, INT J PHARMACEUT, V535, P140, DOI 10.1016/j.ijpharm.2017.11.012; Tanaka K, 2018, BIOCHEM BIOPH RES CO, V495, P1335, DOI 10.1016/j.bbrc.2017.11.152; Tanaka K, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00058; Tanaka KI, 2017, SCI REP-UK, V7, DOI 10.1038/srep42813; Thannickal TC, 2007, BRAIN, V130, P1586, DOI 10.1093/brain/awm097; Trist BG, 2019, AGING CELL, V18, DOI 10.1111/acel.13031; Tsai SJ, 2010, J AGR FOOD CHEM, V58, P11510, DOI 10.1021/jf103258p; Wang S, 2014, J CLIN NEUROSCI, V21, P810, DOI 10.1016/j.jocn.2013.08.017; Yoritaka A, 2015, PARKINSONISM RELAT D, V21, P911, DOI 10.1016/j.parkreldis.2015.05.022; Zahoor I.S.A., 2018, PARKINSONS DIS PATHO; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5	47	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240448	10.1371/journal.pone.0240448	http://dx.doi.org/10.1371/journal.pone.0240448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052927	gold, Green Published			2022-12-26	WOS:000581820200050
J	Sreekantha, S; Wang, Y; Sakurai, R; Liu, J; Rehan, VK				Sreekantha, Sreevidya; Wang, Ying; Sakurai, Reiko; Liu, Jie; Rehan, Virender K.			Maternal food restriction-induced intrauterine growth restriction in a rat model leads to sex-specific adipogenic programming	FASEB JOURNAL			English	Article						adipocytes; adipogenesis; obesity; preadipocytes; white adipose tissue	METABOLIC SYNDROME; PPAR-GAMMA; OBESITY; CHILDHOOD; DIFFERENTIATION; ASSOCIATION; MORTALITY; RISK; FAT	Intrauterine growth restriction (IUGR) leads to offspring obesity. In a maternal food restriction (MFR) during pregnancy-related IUGR rat model, bone marrow stem cells showed enhanced adipogenic programming; however, the effect of IUGR on white adipose tissue (WAT) progenitors is unknown. Here, by mRNA and functional profiling, we determined sex-specific adipogenic programming of WAT progenitors isolated from pups on the postnatal day (PND) 1 and 21. On PND1, PPAR gamma and Pref-1 expression was significantly downregulated in preadipocytes of both MFR males and females; however, at PND21, preadipocytes of MFR males showed upregulation in these genes. Even following adipogenic induction, both male and female MFR adipocytes exhibited lower PPAR gamma, ADRP, and adiponectin levels at PND1; however, at PND21 MFR male adipocytes showed an upward trend in the expression of these genes. An adipogenesis-specific RT-PCR array showed that male MFR adipocytes were programmed to exhibit stronger adipogenic propensity than females. Last, serum sex hormone and adipocyte estrogen/testosterone receptor expression profiles provide preliminary insights into the possible mechanism underlying sex-specific adipogenic programming in the IUGR offspring. In summary, IUGR programs WAT preadipocytes to greater adipogenic potential in males. Although the altered adipogenic programming following MFR was detectable at PND1, the changes were more pronounced at PND21, suggesting a potential role of postnatal nutrition in facilitating the sex-specific adipogenic programming in the IUGR offspring.	[Sreekantha, Sreevidya; Wang, Ying; Sakurai, Reiko; Liu, Jie; Rehan, Virender K.] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Dept Pediat, 1124 West Carson St, Torrance, CA 90502 USA; [Sreekantha, Sreevidya; Wang, Ying; Sakurai, Reiko; Liu, Jie; Rehan, Virender K.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rehan, VK (corresponding author), Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Dept Pediat, 1124 West Carson St, Torrance, CA 90502 USA.	vrehan@lundquist.org			HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HD058948, HL151769, HL152915, HL107118, HD071731, HD127237]; Tobacco-Related Disease Research Program (TRDRP) [23RT-0018, 27IP-0050, T29IR0737]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); Tobacco-Related Disease Research Program (TRDRP)(University of California System)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HD058948, HL151769, HL152915, HL107118, HD071731 and HD127237; Tobacco-Related Disease Research Program (TRDRP), Grant/Award Number: 23RT-0018, 27IP-0050 and T29IR0737	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; BARKER DJP, 1986, LANCET, V1, P1077; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Cnattingius S, 2012, INT J OBESITY, V36, P1320, DOI 10.1038/ijo.2011.248; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; de Onis M, 1998, EUR J CLIN NUTR, V52, pS5; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2008, REPROD SCI, V15, P785, DOI 10.1177/1933719108318597; Desai M, 2007, AM J OBSTET GYNECOL, V196, P555, DOI 10.1016/j.ajog.2006.11.036; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Garver WS, 2013, GENES NUTR, V8, P271, DOI 10.1007/s12263-013-0339-5; Gong M, 2016, INT J OBESITY, V40, P1768, DOI 10.1038/ijo.2016.157; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Harding JE, 2001, INT J EPIDEMIOL, V30, P15, DOI 10.1093/ije/30.1.15; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S1; Karadag A, 2009, PEDIATR PULM, V44, P635, DOI 10.1002/ppul.21030; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Malhotra A, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00055; Martin RJ, 1998, P SOC EXP BIOL MED, V219, P200; Misra A, 1997, OBES RES, V5, P93, DOI 10.1002/j.1550-8528.1997.tb00648.x; Newell-Fugate AE, 2017, REPRODUCTION, V153, pR133, DOI 10.1530/REP-16-0417; Nobili Valerio, 2008, Pediatr Endocrinol Rev, V6, P241; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Paek DS, 2015, REPROD SCI, V22, P207, DOI 10.1177/1933719114537712; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Puttabyatappa M, 2018, REPROD SCI, V25, P1010, DOI 10.1177/1933719117746767; Rehan VK, 2014, REPROD SCI, V21, P517, DOI 10.1177/1933719113503404; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Tarantal AF, 2014, NUTRIENTS, V6, P1725, DOI 10.3390/nu6041725; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; Yee JK, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-62; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	35	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16073	16085		10.1096/fj.202000985RR	http://dx.doi.org/10.1096/fj.202000985RR		OCT 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047380	Green Accepted			2022-12-26	WOS:000581168400001
J	Eymard-Vernain, E; Luche, S; Rabilloud, T; Lelong, C				Eymard-Vernain, Elise; Luche, Sylvie; Rabilloud, Thierry; Lelong, Cecile			ZnO and TiO(2)nanoparticles alter the ability ofBacillus subtilisto fight against a stress	PLOS ONE			English	Article							ZINC-OXIDE NANOPARTICLES; BACILLUS-SUBTILIS; OXIDATIVE STRESS; IN-VITRO; SPX; METHYLGLYOXAL; MECHANISMS; IMPACTS; PPGPP	Due to the physicochemical properties of nanoparticles, the use of nanomaterials increases over time in industrial and medical processes. We herein report the negative impact of nanoparticles, using solid growth conditions mimicking a biofilm, on the ability ofBacillus subtilisto fight against a stress. Bacteria have been exposed to sublethal doses of nanoparticles corresponding to conditions that bacteria may meet in their natural biotopes, the upper layer of soil or the gut microbiome. The analysis of the proteomic data obtained by shotgun mass spectrometry have shown that several metabolic pathways are affected in response to nanoparticles, n-ZnO or n-TiO2, or zinc salt: the methyglyoxal and thiol metabolisms, the oxidative stress and the stringent responses. Nanoparticles being embedded in the agar medium, these impacts are the consequence of a physiological adaptation rather than a physical cell injury. Overall, these results show that nanoparticles, by altering bacterial physiology and especially the ability to resist to a stress, may have profound influences on a "good bacteria",Bacillus subtilis, in its natural biotope and moreover, on the global equilibrium of this biotope.	[Eymard-Vernain, Elise; Luche, Sylvie; Rabilloud, Thierry; Lelong, Cecile] Univ Grenoble Alpes, CNRS, CEA, IRIG,CBM,UMR 5249, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Lelong, C (corresponding author), Univ Grenoble Alpes, CNRS, CEA, IRIG,CBM,UMR 5249, Grenoble, France.	cecile.lelong@univ-grenoble-alpes.fr			CNRS, The University of Grenoble Alpes; "Investissements d'Avenir" French Government program of the French National Research Agency (ANR) through the A.MIDEX project [ANR-11LABX-0064, ANR-11-IDEX-0001-02]	CNRS, The University of Grenoble Alpes; "Investissements d'Avenir" French Government program of the French National Research Agency (ANR) through the A.MIDEX project(French National Research Agency (ANR))	This work was funded by the CNRS, The University of Grenoble Alpes. This work is a contribution to the Labex Serenade (no ANR-11LABX-0064) funded by the "Investissements d'Avenir" French Government program of the French National Research Agency (ANR) through the A.MIDEX project (no ANR-11-IDEX-0001-02).	Al-Sagan AA, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00124; [Anonymous], 2020, CANC DISCOV, V10, pOF8; Antelmann H, 2000, J BACTERIOL, V182, P4478, DOI 10.1128/JB.182.16.4478-4490.2000; Aude-Garcia C, 2016, J PROTEOMICS, V134, P174, DOI 10.1016/j.jprot.2015.12.013; Auger S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30719-9; Bakshi MS, 2020, ENVIRON RES, V182, DOI 10.1016/j.envres.2019.109099; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; Booth IR, 2003, BIOCHEM SOC T, V31, P1406; Boyes WK, 2020, CHEM RES TOXICOL, V33, P1121, DOI 10.1021/acs.chemrestox.0c00050; Catto C, 2019, ENVIRON POLLUT, V245, P754, DOI 10.1016/j.envpol.2018.11.019; Cornu R, 2020, TOXICOLOGY, V430, DOI 10.1016/j.tox.2019.152344; Corrigan RM, 2016, P NATL ACAD SCI USA, V113, pE1710, DOI 10.1073/pnas.1522179113; Courtois P, 2019, ENVIRON POLLUT, V253, P578, DOI 10.1016/j.envpol.2019.07.053; Dalzon B, 2019, PROTEOMES, V7, DOI 10.3390/proteomes7020026; Dong YX, 2020, PROBIOTICS ANTIMICRO, V12, P1385, DOI 10.1007/s12602-020-09643-w; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Eymard-Vernain E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21402-0; Ferdous Z, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072375; GRIFFITH R, 1989, J DAIRY SCI, V72, P604, DOI 10.3168/jds.S0022-0302(89)79150-5; Hammer O, 2001, PAST PALEONTOLOGICAL, V9; Hoseinzadeh E, 2017, CURR DRUG METAB, V18, P120, DOI 10.2174/1389200217666161201111146; Hussein EOS, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030507; Jimenez-Avalos JA, 2021, CRIT REV FOOD SCI, V61, P234, DOI 10.1080/10408398.2020.1724075; Kheiri S, 2019, COLLOID SURFACE B, V184, DOI 10.1016/j.colsurfb.2019.110550; Khezerlou A, 2018, MICROB PATHOGENESIS, V123, P505, DOI 10.1016/j.micpath.2018.08.008; Lamas B, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00349-z; Larsson JT, 2007, MOL MICROBIOL, V66, P669, DOI 10.1111/j.1365-2958.2007.05949.x; Lee NK, 2019, FOOD SCI BIOTECHNOL, V28, P1297, DOI 10.1007/s10068-019-00691-9; Li M, 2011, ENVIRON SCI TECHNOL, V45, P1977, DOI 10.1021/es102624t; Luche S, 2016, J PROTEOMICS, V135, P170, DOI 10.1016/j.jprot.2015.07.018; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Nisar P, 2019, J BIOL INORG CHEM, V24, P929, DOI 10.1007/s00775-019-01717-7; Paunovic J, 2020, CHEM-BIOL INTERACT, V316, DOI 10.1016/j.cbi.2019.108935; Pelgrift RY, 2013, ADV DRUG DELIVER REV, V65, P1803, DOI 10.1016/j.addr.2013.07.011; Riediker M, 2019, PART FIBRE TOXICOL, V16, DOI 10.1186/s12989-019-0302-8; Rojas-Tapias DF, 2019, ADV MICROB PHYSIOL, V75, P279, DOI 10.1016/bs.ampbs.2019.05.003; Rojas-Tapias DF, 2018, MOL MICROBIOL, V107, P659, DOI 10.1111/mmi.13906; Rosenfeld CS, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00396; Runde S, 2014, MOL MICROBIOL, V91, P1036, DOI 10.1111/mmi.12521; Schafer H, 2019, CURR GENET, V65, P871, DOI 10.1007/s00294-019-00950-6; Shin SM, 2017, INT J BIOCHEM CELL B, V91, P14, DOI 10.1016/j.biocel.2017.08.005; Siddiqi KS, 2018, NANOSCALE RES LETT, V13, DOI 10.1186/s11671-018-2532-3; Siddiqi KS, 2018, J NANOBIOTECHNOL, V16, DOI 10.1186/s12951-018-0334-5; Sizentsov AN, 2018, ENVIRON SCI POLLUT R, V25, P15765, DOI 10.1007/s11356-018-1761-4; Tiwari P, 2016, MOL BIOCHEM PARASIT, V207, P89, DOI 10.1016/j.molbiopara.2016.06.005; Triboulet S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124496; Triboulet S, 2014, NANOSCALE, V6, P6102, DOI 10.1039/c4nr00319e; Yoshida KI, 2008, J BIOL CHEM, V283, P10415, DOI 10.1074/jbc.M708043200; Zhang P, 2013, BIOSENS BIOELECTRON, V49, P433, DOI 10.1016/j.bios.2013.05.056; Zhu Y, 2019, CHEMOSPHERE, V237, DOI 10.1016/j.chemosphere.2019.124403; Zorraquin-Pena I, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8010132	51	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240510	10.1371/journal.pone.0240510	http://dx.doi.org/10.1371/journal.pone.0240510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045025	Green Published, gold			2022-12-26	WOS:000581811700011
J	Thong, P; Sahoo, UK; Thangjam, U; Pebam, R				Thong, Pentile; Sahoo, Uttam Kumar; Thangjam, Uttam; Pebam, Rocky			Pattern of forest recovery and carbon stock following shifting cultivation in Manipur, North-East India	PLOS ONE			English	Article							SLASH-AND-BURN; LAND-USE; SECONDARY SUCCESSION; ALTITUDINAL GRADIENT; ABOVEGROUND BIOMASS; AGRICULTURE; MOUNTAINS; DIVERSITY; ALTERNATIVES; VEGETATION	Shifting cultivation has resulted in large-scale deforestation and forest degradation in the tropics; however the abandoned fallows are known to have high potential for carbon capture. The paper is an attempt to determine the forest recovery patterns following shifting cultivation by evaluating the tree species composition, diversity and abundance with respect to topographical factors in Manipur, India. We also used ordination analysis to understand the change in species composition with regard to environmental variables. The living woody biomass carbon of each fallow was quantified, and the factors affecting the recovery of carbon stock along an increasing fallow gradient was assessed. Our results showed that the species richness and basal area recovered relatively with time since abandonment, and the north-facing lower elevation fallow sites displayed higher species richness and stem density than those in higher elevations. Environmental variables had no impact on the regeneration ofElaeocarpus floribundusBlume andCastanopsis hystrixHook. f. & Thomson ex A. DC. which suggests that they may be capable of effective restoration of degraded forest areas. As these species appear naturally in the forests, it would facilitate quicker rehabilitation and reinstate the soil nutrients making the soil reusable in a short term. We also found that fallow age plays a vital role in recovering above-ground biomass carbon from living woody species followed by the aspect of the site. The total living woody biomass carbon ranged from 0.98 Mg ha(-1)in 5 years fallow to 142.58 Mg ha(-1)in 20 years fallow. The above-ground biomass carbon recovery of the oldest fallow was 39% to 40% of the reference undisturbed forest and the estimated time for the shifting cultivation fallows to reach that of the undisturbed forest level was approximately 39 years to 41 years.	[Thong, Pentile; Sahoo, Uttam Kumar; Thangjam, Uttam] Mizoram Univ, Dept Forestry, Aizawl, Mizoram, India; [Pebam, Rocky] North Eastern Space Applicat Ctr, Umiam, Meghalaya, India	Mizoram University; Department of Space (DoS), Government of India; North Eastern Space Applications Centre (NESAC)	Sahoo, UK (corresponding author), Mizoram Univ, Dept Forestry, Aizawl, Mizoram, India.	uttams64@gmail.com	Sahoo, Uttam Kumar/AAY-7076-2021	Sahoo, Uttam kumar/0000-0002-6524-1775				Ali A, 2015, SILVA FENN, V49; [Anonymous], 2017, IND STAT FOR REP; [Anonymous], 2016, BIOMED RES INT, V3, P1; AWETO AO, 1981, J ECOL, V69, P601, DOI 10.2307/2259686; Bonner MTL, 2013, FOREST ECOL MANAG, V291, P73, DOI 10.1016/j.foreco.2012.11.024; Brady NC, 1996, AGR ECOSYST ENVIRON, V58, P3, DOI 10.1016/0167-8809(96)00650-0; BROWN S, 1989, FOREST SCI, V35, P881; Brown S, 1997, ESTIMATING BIOMASS B, V134, P55; Brown S, 1992, WORLD RESOURCE REV, V4, P366; Brown SL, 1999, FOREST ECOL MANAG, V123, P81, DOI 10.1016/S0378-1127(99)00017-1; Budiharta S, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/114020; Chambers JQ, 2001, FOREST ECOL MANAG, V152, P73, DOI 10.1016/S0378-1127(00)00591-0; Chan N, 2016, NEW FOREST, V47, P565, DOI 10.1007/s11056-016-9531-y; Chaturvedi A. N., 1992, WASTELAND NEWS, V7, P40; Dehuri S, 2010, NEURAL COMPUT APPL, V19, P187, DOI 10.1007/s00521-009-0288-5; Fearnside PM, 2000, CLIMATIC CHANGE, V46, P115, DOI 10.1023/A:1005569915357; FERGUSON BG, 2001, GUATEMALA CONSERV BI, V17, P818; FSI, 1996, VOL EQ FOR IND; Geiger R., 2003, CLIMATE NEAR GROUND; Heinimann A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184479; Higuchi N, 2016, ECOL STUD-ANAL SYNTH, V227, P171, DOI 10.1007/978-3-662-49902-3_9; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; Hughes RF, 2000, ECOL APPL, V10, P515, DOI 10.1890/1051-0761(2000)010[0515:ESIODA]2.0.CO;2; Indian Space Research Organisation, 2020, POL SAT LAUNCH VEH; Intergovernmental Panel on Climate Change, 2003, GOOD PRACTICE GUIDAN; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [10.5169/seals.266450, DOI 10.5169/SEALS.266450, DOI 10.5169/SEALS-266450]; Jepsen MR, 2006, FOREST ECOL MANAG, V225, P287, DOI 10.1016/j.foreco.2006.01.005; Kammesheidt L, 1998, PLANT ECOL, V139, P155, DOI 10.1023/A:1009763402998; Kikvidze Z, 2006, J VEG SCI, V17, P77, DOI 10.1111/j.1654-1103.2006.tb02425.x; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Kotto-Same J, 1997, AGR ECOSYST ENVIRON, V65, P245, DOI 10.1016/S0167-8809(97)00060-1; Lippok D, 2013, FOREST ECOL MANAG, V295, P69, DOI 10.1016/j.foreco.2013.01.011; Lohbeck M, 2012, PERSPECT PLANT ECOL, V14, P89, DOI 10.1016/j.ppees.2011.10.002; Lovett JC, 2006, AFR J ECOL, V44, P478, DOI 10.1111/j.1365-2028.2006.00660.x; Maren IE, 2015, J ARID ENVIRON, V121, P112, DOI 10.1016/j.jaridenv.2015.06.004; Margalef R., 1968, PERSPECTIVES ECOLOGI; Mertz O, 2002, AGROFOREST SYST, V55, P149, DOI 10.1023/A:1020507631848; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Mueller-Dombois D., 1974, AIMS METHODS VEGETAT; Mukul SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep22483; Nath AJ, 2019, FORESTS, V10, DOI 10.3390/f10020103; Njana MA, 2017, SOUTH FORESTS, V79, P41, DOI 10.2989/20702620.2016.1233753; Odland A, 1999, ECOGRAPHY, V22, P548, DOI 10.1111/j.1600-0587.1999.tb01285.x; Pelletier J, 2012, GLOBAL CHANGE BIOL, V18, P3581, DOI 10.1111/j.1365-2486.2012.02788.x; Pena-Claros M, 2003, BIOTROPICA, V35, P450, DOI 10.1111/j.1744-7429.2003.tb00602.x; Poorter L, 2016, NATURE, V530, P211, DOI 10.1038/nature16512; Ramakrishnan PS, UNESCO MAP SERIES; Shannon C. E., 1949, MATH THEORY COMMUNIC; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Thong P, 2019, REMOTE SENS APPL, V14, P126, DOI 10.1016/j.rsase.2019.03.001; Thong P, 2018, J INDIAN SOC REMOTE, V46, P1713, DOI 10.1007/s12524-018-0832-9; Titshall L. W., 2000, African Journal of Range and Forage Science, V17, P70, DOI 10.2989/10220110009485742; Toledo M, 2006, BIOTROPICA, V38, P161, DOI 10.1111/j.1744-7429.2006.00120.x; UHL C, 1987, J ECOL, V75, P377, DOI 10.2307/2260425; Vittoz P, 2010, J VEG SCI, V21, P1035, DOI 10.1111/j.1654-1103.2010.01216.x; Waikhom AC, 2018, J FORESTRY RES, V29, P425, DOI 10.1007/s11676-017-0439-y; WHITFORD PB, 1949, ECOLOGY, V30, P199, DOI 10.2307/1931186; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Zanne AE, 2009, GLOBAL WOOD DENSITY; Zhang JT, 2007, BOT STUD, V48, P339	60	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239906	10.1371/journal.pone.0239906	http://dx.doi.org/10.1371/journal.pone.0239906			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031401	Green Published, gold			2022-12-26	WOS:000581809800082
J	Abdel-Sattar, M; Haikal, AM; Hammad, SE				Abdel-Sattar, Mahmoud; Haikal, Amr M.; Hammad, Sandy E.			Meloidogyne incognitapopulation control and nutritional status and productivity of Thompson seedless grapevines managed with different treatments	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; NEMATOCIDAL ACTIVITY; CHITOSAN; BORON; CHITIN; FERTILIZER; ACETYLCHOLINESTERASE; RHIZOBACTERIA; AGRICULTURE; NUTRIENTS	A two-year field trial was conducted in a vineyard (northern Egypt)cultivated with Thompson seedless grapevines to evaluate the effectiveness of four "alternative" (biological/chemical) treatments,Bacillus megaterium, boric acid, calcium nitrate and chitosan, against the root-knot nematodeMeloidogyne incognita(Mi), compared to that of the nematicide oxamyl. The influence of these treatments on plant nutritional status and fruit yield and quality was also assessed. All treatments significantly inhibitedMireproduction parameters in both seasons, decreasing the numbers of nematode galls and egg masses (roots) and of second-stage juveniles (soil). Oxamyl application resulted in the highest reductions inMi-reproduction parameters, followed by boric acid, which also showed the highest relative nematicidal efficacy (respect to oxamyl). In the 1st season, the highest fruit yield (10.34 kg/grapevine) was recorded from boric acid-treated plants, followed by that from oxamyl-treated plants (7.50 kg/grapevine); in the subsequent season (2019), oxamyl use led to the highest yield, followed by boric acid + chitosan use (10.04 and 8.62 kg/grapevine, respectively). In both seasons, application of boric acid alone and combined with chitosan enhanced the total soluble solids (TSS)/total acidity ratio in grape juice. All treatments led to higher nutrient contents (leaf petioles) and chlorophyll levels (leaves) as well as enhanced fruit size and weight. We conclude that the tested treatments can be safely applied for nematode management in Thompson seedless grapevines, with positive effects on fruit yield and quality.	[Abdel-Sattar, Mahmoud] King Saud Univ, Coll Food Sci & Agr, Dept Plant Prod, Riyadh, Saudi Arabia; [Abdel-Sattar, Mahmoud] Alexandria Univ, Fac Agr, Pomol Dept, Alexandria, Egypt; [Haikal, Amr M.] Damanhour Univ, Fac Agr, Hort Dept, Damanhour, Egypt; [Hammad, Sandy E.] Agr Res Ctr, Plant Pathol Res Inst, Dept Plant Nematol Res, Giza, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Damanhour University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Abdel-Sattar, M (corresponding author), King Saud Univ, Coll Food Sci & Agr, Dept Plant Prod, Riyadh, Saudi Arabia.; Abdel-Sattar, M (corresponding author), Alexandria Univ, Fac Agr, Pomol Dept, Alexandria, Egypt.	mmarzouk1@ksu.edu.sa		Abdel-Sattar, Mahmoud/0000-0002-9317-109X				Aballay E, 2013, EUR J PLANT PATHOL, V135, P137, DOI 10.1007/s10658-012-0073-7; Abou-Zaid EAA, 2019, MIDDLE E J AGR RES, V8, P654; Akula Venu, 2014, International Journal of Tropical Agriculture, V32, P331; [Anonymous], 2011, P ROTH STUDIES, V7, P171; [Anonymous], 2017, COMMUN MATH STAT, V5, P1, DOI DOI 10.1007/S40304-017-0103-Z; Couto EAA, 2016, ACTA AGR SCAND B-S P, V66, P346, DOI 10.1080/09064710.2015.1118154; Association of Official Agricultural Chemists, 1995, OFF METH AN AOAC, V14th, P490; Batukaev A, 2016, BIO WEB CONF, V7, DOI 10.1051/bioconf/20160701030; Belal BEA, 2017, J PLANT PRODUCTION, V8, P19; BESSIS R., 1960, Compte Rendu Hebdomadaire des Seances de l'Academie d'Agriculture de France, V46, P828; Brown D. J. F., 1993, P427; BROWN JG, 1946, P AM SOC HORTIC SCI, V48, P341; Carneiro Rui G., 2002, Fitopatologia Brasileira, V27, P141, DOI 10.1590/S0100-41582002000200004; Chandrkrachang S., 2002, ADV CHITIN SCI, V5, P458; Corradini E, 2010, EXPRESS POLYM LETT, V4, P509, DOI 10.3144/expresspolymlett.2010.64; Cottenie A., 1982, LAB ANALYTICAL AGROC; Coyne DL, 2004, EXP AGR, V40, P245, DOI 10.1017/S0014479703001595; Daykin M. E., 1985, An advanced treatise on Meloidogyne.Volume II: Methodology., P39; Dell B, 2002, BORON IN PLANT AND ANIMAL NUTRITION, P103; Dordas C, 2008, AGRON SUSTAIN DEV, V28, P33, DOI 10.1051/agro:2007051; Ekbic HB, 2018, ACTA SCI POL-HORTORU, V17, P149, DOI 10.24326/asphc.2018.1.14; El-Saedy MAM, 2019, JPLANTSCIPHYTOPATHOL, V3, P111, DOI [10.29328/journal.jpsp.1001041, DOI 10.29328/JOURNAL.JPSP.1001041]; El-Sayed S. M., 2015, International Journal of ChemTech Research, V7, P1985; El-Sherif A. G, 2014, EGYPT J AGRONEMATOL, V13, P44, DOI DOI 10.21608/EJAJ.2014.63630; ELSAEDY MAM, 2015, AM-EURASIAN J AGRIC, V15, P1710, DOI DOI 10.5829/idosi.aejaes.2015.15.9.12779; Er F, 2011, BULG J AGRIC SCI, V17, P544; Escudero N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01415; Franklin M. T., 1949, Journal of Helminthology, V23, P175, DOI 10.1017/S0022149X0003251X; Gaser Aisha S. A., 2017, EGYPTIAN JOURNAL OF HORTICULTURE, V44, P183, DOI 10.21608/EJOH.2017.1825.1022; German E., 2019, Journal of Applied Biosciences, V136, P13896, DOI 10.4314/jab.v136i1.6; Gomez K. A., 1984, J STAT PROCEDURES, V2, P680, DOI DOI 10.1017/S0014479700014496; Gornik Krzysztof, 2008, Journal of Fruit and Ornamental Plant Research, V16, P333; Gunes A, 2015, TURK J AGRIC FOR, V39, P742, DOI 10.3906/tar-1412-13; Gurjar MK, 2015, INT J SCI RES, V4, P207; Habes D, 2006, PESTIC BIOCHEM PHYS, V84, P17, DOI 10.1016/j.pestbp.2005.05.002; Hassan O., 2017, ASIAN J PLANT PATHOL, V11, P53, DOI [10.3923/ajppaj.2017.53.70, DOI 10.3923/AJPPAJ.2017.53.70]; HATCHER JT, 1950, ANAL CHEM, V22, P567, DOI 10.1021/ac60040a017; Hendershot W. H., 1993, SOIL SAMPLING METHOD, P141; Hirano S, 1996, J ENVIRON POLYM DEGR, V4, P261, DOI 10.1007/BF02070695; Hirschmann H., 1985, An advanced treatise on Meloidogyne. Volume 1: Biology and control., P79; Huang Y, 2010, EUR J PLANT PATHOL, V126, P417, DOI 10.1007/s10658-009-9550-z; Hurchanik D, 2003, NEMATROPICA, V33, P55; Jehangir I. A., 2017, INT J CURR MICROBIOL, V6, P5347, DOI DOI 10.20546/IJCMAS.2017.611.510; Jiang P, 2016, N HORTI, V5, P22; Khalil AE, 2012, EGYPT J AGRONEMATOLO, V11, P320; Khalil AEM, 2007, J AGR SCI, V32, P8705; Khalil MS, 2012, PLANT PROTECT SCI, V48, P170, DOI 10.17221/46/2011-PPS; Lamberti F, 1988, P INT S PLANT PROT P, P163; Li LL, 2018, BIOCONTROL SCI TECHN, V28, P1128, DOI 10.1080/09583157.2018.1514587; Lopez-Bucio J, 2007, MOL PLANT MICROBE IN, V20, P207, DOI 10.1094/MPMI-20-2-0207; Mills HA, 1996, PLANT ANAL HDB, P185; Mohamed M. M., 2009, International Journal of Nematology, V19, P229; Mohamed M. M. M., 2017, Egyptian Journal of Agronematology, V16, P85; Mostafa FAM, 2018, EGYPT J BIOL PEST CO, V28, DOI 10.1186/s41938-018-0068-6; MULLA MS, 1971, J ECON ENTOMOL, V64, P300, DOI 10.1093/jee/64.1.300; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Neipp PW, 1999, J NEMATOL, V31, P54; Nijjar GS, 1985, NUTR FRUIT TREES, P80; Oliveira DF, 2007, EUR J PLANT PATHOL, V119, P477, DOI 10.1007/s10658-007-9176-y; Oostenbrink M., 1966, MEDEDEELINGEN LANDBO, V66, P1; OPPERMAN CH, 1990, J NEMATOL, V22, P481; Padgham JL, 2007, CROP PROT, V26, P971, DOI 10.1016/j.cropro.2006.09.004; Patil J, 2013, NEMATOLOGY, V15, P483, DOI 10.1163/15685411-00002694; Preethi M, 2017, INT J CURRENT MICROB, V6, P2081, DOI [10.20546/ijcmas.2017.609.255, DOI 10.20546/IJCMAS.2017.609.255]; Pregl F., 1945, QUANTITATIVE ORGANIC, V4th; Radwan MA, 2012, BIOL FERT SOILS, V48, P463, DOI 10.1007/s00374-011-0632-7; Radwan SM, 1983, THESIS, P184; Ramsdell DC, 1996, PLANT DIS, V80, P334, DOI 10.1094/PD-80-0334; RODRIGUEZKABANA R, 1984, NEMATROPICA, V14, P10; Santana-Gomes S. de M., 2013, African Journal of Agricultural Research, V8, P2413; SAS Institute Inc, 2008, SAS SYSTEM WINDOWS V; Sharif R, 2018, MOLECULES, V23, DOI 10.3390/molecules23040872; Sharp RG, 2013, AGRONOMY-BASEL, V3, P757, DOI 10.3390/agronomy3040757; Singh C., 2002, INDIAN J HORTIC, V59, P258; Singh S, 2015, PROCEDIA ENVIRON SCI, V29, P215, DOI 10.1016/j.proenv.2015.07.270; Southey JF., 1986, LAB METHODS WORK PLA, P202; Spann TM, 2009, PROC FL STATE HORTIC, V122, P169; Statistics Agriculture, 2016, HORTICULTURAL CROPS; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Stefanakis, 2015, INT J GEOGRAPHICAL I, V29, P1; Swanepoel M, 2007, S AFR J ENOL VITIC, V28, P140; Wang R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222104; Wu L, 2008, CARBOHYD POLYM, V72, P240, DOI 10.1016/j.carbpol.2007.08.020; YADAVA UL, 1986, HORTSCIENCE, V21, P1449; Yermiyahu U, 2006, HORTSCIENCE, V41, P1698, DOI 10.21273/HORTSCI.41.7.1698; Youssef M. M. A., 2017, Agricultural Engineering International: CIGR Journal, V19, P293; [张晓煜 ZHANG XiaoYu], 2007, [生态学报, Acta Ecologica Sinica], V27, P740	87	7	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2020	15	10							e0239993	10.1371/journal.pone.0239993	http://dx.doi.org/10.1371/journal.pone.0239993			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OB4WW	33022025	gold, Green Published			2022-12-26	WOS:000578473000050
J	Agyei-Baffour, P; Asare, M; Lanning, B; Koranteng, A; Millan, C; Commeh, ME; Montealegre, JR; Mamudu, HM				Agyei-Baffour, Peter; Asare, Matthew; Lanning, Beth; Koranteng, Adofo; Millan, Cassandra; Commeh, Mary E.; Montealegre, Jane R.; Mamudu, Hadii M.			Human papillomavirus vaccination practices and perceptions among Ghanaian Healthcare Providers: A qualitative study based on multi-theory model	PLOS ONE			English	Article							HPV VACCINATION; RECOMMENDATIONS; ADOLESCENTS; BARRIERS; COMMUNICATION; KNOWLEDGE; ATTITUDES; SERIES; GIRLS	Background Healthcare providers' (HCPs) recommendations for the Human Papillomavirus (HPV) vaccine are likely to increase the vaccination uptake. However, little is known about Ghanaian HCPs' general practices regarding HPV vaccination. We used Multi-Theory Model (MTM) constructs (i.e. participatory dialogue, behavioral confidence, environment, social and emotional transformation) to examine Ghanaian HCPs' attitudes towards HPV vaccination and their vaccination recommendation practices. Methods We conducted three, 60-minute focus group discussions (FGDs) with HCP in the second-largest government hospital in Ghana. Sixteen semi-structured open-ended questions based on MTM constructs were used to guide the FGDs. We explored HCPs' general knowledge about HPV, vaccination recommendation behavior, physical environment, and socio-cultural factors associated with the HPV vaccination. Data from the FGDs were transcribed and thematically coded using NVivo software. Results The sample of (n = 29) HCPs consisting of males (n = 15) and females (n = 14) between the ages of 29 and 42 years participated in the FGDs. Our analyses showed that HCPs (a) rarely offered HPV vaccination recommendations, (b) showed varied understanding about who should be vaccinated regarding age eligibility, gender, and infection status. Perceived barriers to HPV vaccination include (a) low urgency for vaccination education due to competing priorities such as malaria and HIV/AIDS; (b) lack of data on HPV vaccination; (c) lack of awareness about the vaccine safety and efficacy; (c) lack of HPV vaccine accessibility and (d) stigma, misconceptions and religious objections. HCPs expressed that their motivation for counseling their clients about HPV vaccination would be increased by having more knowledge about the vaccine's efficacy and safety, and the involvement of the parents, chiefs, churches, and opinion leaders in the vaccination programs. Conclusion The study's findings underscore the need for a comprehensive HPV vaccination education for HCPs in Ghana. Future HPV vaccination education programs should include information about the efficacy of the vaccine and effective vaccination messages to help mitigate HPV vaccine-related stigma.	[Agyei-Baffour, Peter; Koranteng, Adofo] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana; [Asare, Matthew; Lanning, Beth; Millan, Cassandra] Baylor Univ, Dept Publ Hlth, Waco, TX 76798 USA; [Commeh, Mary E.] Ghana Hlth Serv, Noncommunicable Dis Control, Accra, Ghana; [Montealegre, Jane R.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA; [Mamudu, Hadii M.] East Tennessee State Univ, Dept Hlth Serv Management & Policy, Coll Publ Hlth, Johnson City, TN USA	Kwame Nkrumah University Science & Technology; Baylor University; Ghana Health Service; Baylor College of Medicine; East Tennessee State University	Asare, M (corresponding author), Baylor Univ, Dept Publ Hlth, Waco, TX 76798 USA.	matt_asare@baylor.edu	Commeh, Mary Efua/GQP-8320-2022					AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; American Cancer Society, 2020, HPV VACC; [Anonymous], 2017, Obstet Gynecol, V129, P1, DOI 10.1097/AOG.0000000000002111; [Anonymous], 2015, INT J INFORM TECHNOL, V7, P3; [Anonymous], 2006, EXAMINATION PHENOMEN; [Anonymous], 2020, ZHONGHUA JIE HE HE H, V17, DOI 10.3760/cma.j.issn.1001-0939.2020.0020; [Anonymous], 1981, BIOGRAPHY SOC LIFE H; Bandura A., 1986, SOCIAL FDN THOUGHT A; Berkowitz Z, 2016, PREV MED, V87, P128, DOI 10.1016/j.ypmed.2016.02.030; Damnjanovic K, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00735; Dilley SE, 2018, PREV MED, V113, P124, DOI 10.1016/j.ypmed.2018.05.021; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Edwin A K, 2010, Ghana Med J, V44, P70; Farias AJ, 2017, PREV MED, V105, P219, DOI 10.1016/j.ypmed.2017.07.016; Freire P., 2013, PEDAGOGY OPPRESSED T; Gallagher KE, 2017, PAPILLOMAVIRUS RES, V4, P72, DOI 10.1016/j.pvr.2017.09.001; Gallagher KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177773; GAVI, GHAN GAVI SUPP GHAN; Gilkey MB, 2016, VACCINE, V34, P1187, DOI 10.1016/j.vaccine.2016.01.023; Glaser BG, 2017, DISCOVERY GROUNDED T; Goleman D, 2020, EMOTIONAL INTELLIGEN, V25th; Hoque ME, 2016, AFR HEALTH SCI, V16, P567, DOI 10.4314/ahs.v16i2.26; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hudson SM, 2016, VACCINE, V34, P3515, DOI 10.1016/j.vaccine.2016.02.066; Humiston SG, 2013, CLIN PEDIATR, V52, P710, DOI 10.1177/0009922813483359; Javanbakht M, 2012, VACCINE, V30, P4511, DOI 10.1016/j.vaccine.2012.04.062; Jim CC, 2012, J WOMENS HEALTH, V21, P372, DOI 10.1089/jwh.2011.3417; Kahn JA, 2005, J ADOLESCENT HEALTH, V37, P502, DOI 10.1016/j.jadohealth.2005.07.014; Kahn JA, 2009, CANCER EPIDEM BIOMAR, V18, P2325, DOI 10.1158/1055-9965.EPI-09-0184; Kasting ML, 2016, VACCINE, V34, P1331, DOI 10.1016/j.vaccine.2016.01.050; Laryea DO, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-362; Lazcano-Ponce E, 2014, VACCINE, V32, P725, DOI 10.1016/j.vaccine.2013.11.059; Leung S.O.A., 2019, VACCINE, VX, P37; McCave EL, 2010, J COMMUN HEALTH, V35, P645, DOI 10.1007/s10900-010-9255-4; [Merck Merck], 2013, PHAS 3 STUD; Mullins TLK, 2013, VACCINE, V31, P4894, DOI 10.1016/j.vaccine.2013.07.033; Nartey Y, 2017, J GLOB ONCOL, V3, P782, DOI 10.1200/JGO.2016.005744; National Cancer Institute, HUM PAP HPV VACC; Orenstein WA, 2013, PUBLIC HEALTH REP, V128, P78; Palefsky JM, 2010, J ADOLESCENT HEALTH, V46, pS12, DOI 10.1016/j.jadohealth.2010.01.010; Perkins RB, 2016, HUM VACC IMMUNOTHER, V12, P1528, DOI 10.1080/21645515.2015.1118594; Prochaska J. O., 1979, SYSTEMS PSYCHOTHERAP; Riedesel J M, 2005, J Pediatr Adolesc Gynecol, V18, P391, DOI 10.1016/j.jpag.2005.09.004; Rosen BL, 2018, ACAD PEDIATR, V18, pS53, DOI 10.1016/j.acap.2017.10.007; Rosen BL, 2017, PSYCHOL HEALTH MED, V22, P535, DOI 10.1080/13548506.2016.1173710; Schmidt-Grimminger D, 2013, J CANCER EDUC, V28, P357, DOI 10.1007/s13187-013-0468-y; Serrano B., 2021, HUMAN PAPILLOMAVIRUS; Sharma M, 2017, J Prev Med Hyg, V58, pE203; Suryadevara M, 2015, VACCINE, V33, P6629, DOI 10.1016/j.vaccine.2015.10.096; Vadaparampil ST, 2014, AM J PREV MED, V46, P80, DOI 10.1016/j.amepre.2013.07.009; White Leah, 2016, Pediatr Nurs, V42, P21; World Health Organization, 2014, EV BAS REC HUM PAP V; World Health Organization: International Agency for Research on Cancer, 2019, AFR; World Hlth Org, 2017, VACCINE, V35, P5753, DOI 10.1016/j.vaccine.2017.05.069	55	3	4	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240657	10.1371/journal.pone.0240657	http://dx.doi.org/10.1371/journal.pone.0240657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064718	Green Published, gold			2022-12-26	WOS:000585918300048
J	Scott, S; Pant, A; Nguyen, PH; Shinde, S; Menon, P				Scott, Samuel; Pant, Anjali; Nguyen, Phuong Hong; Shinde, Sachin; Menon, Purnima			Demographic, nutritional, social and environmental predictors of learning skills and depression in 20,000 Indian adolescents: Findings from the UDAYA survey	PLOS ONE			English	Article							ACADEMIC-PERFORMANCE; HEALTH; EDUCATION; QUALITY; OUTCOMES; STRESS; WOMEN	Objectives Adolescent wellbeing is critical to breaking the intergenerational cycle of poverty and one in five of the world's adolescents live in India. We explored predictors of learning skills and depression in Indian adolescents. Methods Data on adolescents aged 10-19y (three groups: 5,840 unmarried males, 8,953 unmarried females, 4,933 married females) were available from the state-representative Understanding the Lives of Adolescents and Young Adults survey in Uttar Pradesh and Bihar. Multivariable logistic regression models adjusted for cluster sampling design and state fixed effects were used to examine factors (demographic, health/nutrition, social, and environmental) associated with three outcomes: reading proficiency, math proficiency, and depressive symptoms. Findings Learning skills were poor (28-61% lacked basic reading and math skills depending on adolescent group and outcome) and depression was common (8-26%). Better learning skills were predicted by greater household wealth (AOR 1.72-2.55 depending on group) and household head education (AOR 1.03-1.07 per year), being in school (AOR 4.19-18.65), parental support (AOR 1.11-1.39), having gender equal attitudes (AOR 1.56-2.67), number of food groups consumed at least weekly (unmarried females: AOR 1.11), and having an improved latrine (AOR 1.33-1.51). Poorer learning skills were predicted by family substance use (AOR 0.68-0.74), underweight (males: AOR 0.74), witnessing parental violence (AOR 0.66-0.78). Depressive symptoms were predicted by witnessing parental violence (AOR 1.51-1.92) and experiencing sexual abuse (AOR 2.30-6.16). Conclusion Factors across multiple life dimensions are associated with learning skills and depression in Indian adolescents. Adolescent-focused policies and programs should consider health/nutrition, social, and environmental aspects of life in vulnerable individuals.	[Scott, Samuel; Nguyen, Phuong Hong; Menon, Purnima] Int Food Policy Res Inst, Washington, DC 20036 USA; [Scott, Samuel; Pant, Anjali; Menon, Purnima] Int Food Policy Res Inst, New Delhi, India; [Shinde, Sachin] Populat Council, New Delhi, India	CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI)	Scott, S (corresponding author), Int Food Policy Res Inst, Washington, DC 20036 USA.; Scott, S (corresponding author), Int Food Policy Res Inst, New Delhi, India.	samuel.scott@cgiar.org			Bill and Melinda Gates Foundation; David and Lucile Packard Foundation; Bill & Melinda Gates Foundation through POSHAN [OPP1150189]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Bill & Melinda Gates Foundation through POSHAN	The primary data collection for the UDAYA survey was supported by the Bill and Melinda Gates Foundation and the David and Lucile Packard Foundation through a grant to the Population Council. This secondary analysis was supported by the Bill & Melinda Gates Foundation through POSHAN, led by IFPRI (grant number OPP1150189).	Agrifrance, 2018, AGR 2018 RUR REP; [Anonymous], 2007, INT J TOXICOL, V26, P1, DOI 10.1080/10915810701351186; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; ASER Centre, 2015, TRENDS TIM 2006 2014; ASER Centre, 2017, ANN STAT ED REP RUR; Banerjee AV, 2007, Q J ECON, V122, P1235, DOI 10.1162/qjec.122.3.1235; Carvajal-Aguirre L, 2019, MEASUREMENT MENTAL H; Chatterjee I, 2018, WORLD DEV, V106, P99, DOI 10.1016/j.worlddev.2018.01.016; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Correa-Burrows P, 2016, B WORLD HEALTH ORGAN, V94, P185, DOI 10.2471/BLT.15.161315; Dahl RE, 2018, NATURE, V554, P441, DOI 10.1038/nature25770; Duflo E, 2012, AM ECON REV, V102, P1241, DOI 10.1257/aer.102.4.1241; Fry D, 2018, CHILD ABUSE NEGLECT, V75, P6, DOI 10.1016/j.chiabu.2017.06.021; Ganguly S, 2013, J ADOLESCENT HEALTH, V52, P546, DOI 10.1016/j.jadohealth.2012.09.012; Gururaj G, 2016, NATL MENTAL HLTH SUR; Hale DR, 2018, J EPIDEMIOL COMMUN H, V72, P465, DOI 10.1136/jech-2017-209605; He F, 2008, TEACH ENGLISH INDIA; Jha V, 2017, INDIA DEV REV ED EDI; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Masino S, 2016, INT J EDUC DEV, V48, P53, DOI 10.1016/j.ijedudev.2015.11.012; Mousteri V, 2019, SOC SCI MED, V222, P305, DOI 10.1016/j.socscimed.2018.12.030; Muralidharan K, 2010, ECON J, V120, pF187, DOI 10.1111/j.1468-0297.2010.02373.x; Murshid NS, 2017, CHILD YOUTH SERV REV, V79, P160, DOI 10.1016/j.childyouth.2017.06.018; Nasreen HE, 2016, J CHILD ADOL PS NURS, V29, P135, DOI 10.1111/jcap.12150; Pandey R, 2020, AUST NZ J PSYCHIAT, V54, P496, DOI 10.1177/0004867420909524; Patel Y, 2018, MATER RELIG, V14, P1, DOI 10.1080/17432200.2017.1417215; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Roy K, 2019, SOC PSYCHIAT PSYCHIA; S BE, 2018, J CROHNS COLITIS, V12, pS049; Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031; Santhya KG, 2015, INT J EDUC DEV, V41, P35, DOI 10.1016/j.ijedudev.2014.12.002; Santhya KG., 2016, UNDERSTANDING LIVES; Scott SP, 2017, J NUTR, V147, P104, DOI 10.3945/jn.116.240192; Shaikh BM, 2018, INDIAN J PUBLIC HLTH, V62, P311, DOI 10.4103/ijph.IJPH_174_17; Sheehan P, 2017, LANCET, V390, P1792, DOI 10.1016/S0140-6736(17)30872-3; United Nations Department of Economic and Social Affairs Population Division, 2017, ESAPWP248 UN DEP EC; UNOSSC, 2017, S S ACT CIT FRIENDL; Vagh S, 2010, VALIDATING ASER TEST; WHO, 2011, WHO TECH REP SER, V959, P1; WHO Consultation, 2000, WHO TECH REP SER, V894, P1	40	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240843	10.1371/journal.pone.0240843	http://dx.doi.org/10.1371/journal.pone.0240843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064744	gold, Green Published			2022-12-26	WOS:000585918300022
J	Dunnill, C; Ibraheem, K; Peake, M; Ioannou, M; Palmer, M; Smith, A; Collett, A; Georgopoulos, NT				Dunnill, Christopher; Ibraheem, Khalidah; Peake, Michael; Ioannou, Myria; Palmer, Megan; Smith, Adrian; Collett, Andrew; Georgopoulos, Nikolaos T.			Cooling-mediated protection from chemotherapy drug-induced cytotoxicity in human keratinocytes by inhibition of cellular drug uptake	PLOS ONE			English	Article							INDUCED ALOPECIA; ADRIAMYCIN UPTAKE; BREAST-CANCER; HAIR; DOXORUBICIN; TEMPERATURE; CELLS; LOCALIZATION; CULTIVATION; RESISTANCE	Chemotherapy-induced alopecia (CIA) represents the most distressing side-effect for cancer patients. Scalp cooling is currently the only treatment to combat CIA, yet little is known about its cytoprotective effects in human hair follicles (HF). We have previously established in vitro human keratinocyte models to study the effects of taxanes and anthracyclines routinely-used clinically and reported that cooling markedly-reduced or even completely-prevented cytotoxicity in a temperature dependent manner. Using these models (including HF-derived primary keratinocytes), we now demonstrate that cooling markedly attenuates cellular uptake of the anthracyclines doxorubicin and epirubicin to reduce or prevent drug-mediated human keratinocyte cytotoxicity. We show marked reduction in drug uptake and nuclear localization qualitatively by fluorescence microscopy. We have also devised a flow cytometry-based methodology that permitted semi-quantitative analysis of differences in drug uptake, which demonstrated that cooling can reduce drug uptake by up to similar to 8-fold in comparison to normal/physiological temperature, an effect that was temperature-dependent. Our results provide evidence that attenuation of cellular drug uptake represents at least one of the mechanisms underpinning the ability of cooling to rescue human keratinocytes from chemotherapy drug-cytotoxicity, thus supporting the clinical efficacy of scalp cooling.	[Dunnill, Christopher; Ibraheem, Khalidah; Peake, Michael; Ioannou, Myria; Palmer, Megan; Collett, Andrew; Georgopoulos, Nikolaos T.] Univ Huddersfield, Sch Appl Sci, Dept Biol Sci, Huddersfield, W Yorkshire, England; [Smith, Adrian] Calderdale & Huddersfield NHS Fdn Trust, Dept Gen Surg, Huddersfield, W Yorkshire, England; [Georgopoulos, Nikolaos T.] Univ Huddersfield, Inst Skin Integr & Infect, Huddersfield, W Yorkshire, England	University of Huddersfield; University of Huddersfield	Georgopoulos, NT (corresponding author), Univ Huddersfield, Sch Appl Sci, Dept Biol Sci, Huddersfield, W Yorkshire, England.; Georgopoulos, NT (corresponding author), Univ Huddersfield, Inst Skin Integr & Infect, Huddersfield, W Yorkshire, England.	N.Georgopoulos@hud.ac.uk		Georgopoulos, Nik/0000-0002-6330-4947; Palmer, Megan/0000-0002-5188-792X	Paxman Coolers Ltd	Paxman Coolers Ltd	Authors CD and KI were financially supported by funding from Paxman Coolers Ltd (paxmanscalpcooling.com). This does not alter our adherence to PLOS ONE policies on sharing data and materials. No other authors were supported by funding from Paxman. The authors declare that the sponsors were not involved in the design of the study; in the collection, analysis and interpretation of data; in the writing of the manuscript; nor were the sponsors involved in the decision to submit the paper for publication.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Al-Tameemi W, 2014, TOXICOL IN VITRO, V28, P1366, DOI 10.1016/j.tiv.2014.07.011; [Anonymous], 2018, CANC DISCOV, V8, pOF6; BATES DA, 1985, CANCER LETT, V28, P213, DOI 10.1016/0304-3835(85)90077-1; Bodo E, 2005, AM J PATHOL, V166, P985, DOI 10.1016/S0002-9440(10)62320-6; Bodo E, 2007, AM J PATHOL, V171, P1153, DOI 10.2353/ajpath.2007.061164; Breed W. P. M., 2011, EXPERT REV DERMATOLO, DOI [10.1586/edm.10.76, DOI 10.1586/EDM.10.76]; Choi EK, 2014, PSYCHO-ONCOLOGY, V23, P1103, DOI 10.1002/pon.3531; Decorti G, 1998, J PHARMACOL EXP THER, V286, P525; Du LP, 2008, IJBRA, V4, P49; Duffy PM, 1996, BRIT J UROL, V77, P824, DOI 10.1046/j.1464-410X.1996.09539.x; Dunnill CJ, 2018, ONCOLOGIST, V23, P84, DOI 10.1634/theoncologist.2017-0263; Georgopoulos NT, 2014, J CELL SCI, V127, P2967, DOI 10.1242/jcs.150888; Haslam IS, 2017, J INVEST DERMATOL, V137, P295, DOI 10.1016/j.jid.2016.08.035; Janssen FPEM, 2007, PHYSIOL MEAS, V28, P829, DOI 10.1088/0967-3334/28/8/006; Kauffman Melinda K, 2016, React Oxyg Species (Apex), V2, P432, DOI 10.20455/ros.2016.873; LANE P, 1987, CANCER RES, V47, P4038; LIMAT A, 1986, J INVEST DERMATOL, V87, P485, DOI 10.1111/1523-1747.ep12455548; Luu AZ, 2018, JACC-BASIC TRANSL SC, V3, P861, DOI 10.1016/j.jacbts.2018.06.005; MESCHINI S, 1994, J MICROSC-OXFORD, V176, P204, DOI 10.1111/j.1365-2818.1994.tb03516.x; Mitry MA, 2016, IJC HEART VASC, V10, P17, DOI 10.1016/j.ijcha.2015.11.004; Nangia J, 2018, J ONCOL PRACT, V14, P157, DOI 10.1200/JOP.18.00033; Nangia J, 2017, JAMA-J AM MED ASSOC, V317, P596, DOI 10.1001/jama.2016.20939; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; OSBORNE EJ, 1987, CANCER LETT, V37, P213, DOI 10.1016/0304-3835(87)90165-0; Paus R, 2013, LANCET ONCOL, V14, pE50, DOI 10.1016/S1470-2045(12)70553-3; Pickard-Holley S, 1995, Semin Oncol Nurs, V11, P235, DOI 10.1016/S0749-2081(05)80003-8; Purba TS, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201911031; Rubenwolf PC, 2009, EUR UROL, V56, P1013, DOI 10.1016/j.eururo.2008.08.013; SAKAGUCHI Y, 1994, CANCER CHEMOTH PHARM, V33, P371, DOI 10.1007/BF00686265; Sakurai T, 2005, EXP CELL RES, V309, P264, DOI 10.1016/j.yexcr.2005.06.002; Shin H, 2015, INT J CANCER, V136, pE442, DOI 10.1002/ijc.29115; SPEELMANS G, 1994, BIOCHEMISTRY-US, V33, P13761, DOI 10.1021/bi00250a029; Thakkar N, 2015, AAPS J, V17, P535, DOI 10.1208/s12248-015-9740-x; van den Hurk CJ, 2012, ACTA ONCOL, V51, P497, DOI 10.3109/0284186X.2012.658966; Xie GJ, 2015, J INVEST DERMATOL, V135, P690, DOI 10.1038/jid.2014.409; Zhao YZ, 2013, CANCER LETT, V330, P74, DOI 10.1016/j.canlet.2012.11.031	37	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240454	10.1371/journal.pone.0240454	http://dx.doi.org/10.1371/journal.pone.0240454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057448	Green Published, gold			2022-12-26	WOS:000581814700081
J	Teixeira, GCM; Prado, RD; Rocha, AMS; Piccolo, MD				Teixeira, Gelza Carliane Marques; Prado, Renato de Mello; Rocha, Antonio Marcio Souza; Piccolo, Marisa de Cassia			Root- and foliar-applied silicon modifies C: N: P ratio and increases the nutritional efficiency of pre-sprouted sugarcane seedlings under water deficit	PLOS ONE			English	Article							ANTIOXIDANT RESPONSES; STRESS; GROWTH; CONDUCTANCE; TOLERANCE; IMPROVES; PLANTS	Water deficit limits the establishment of sugarcane plants from pre-sprouted seedlings (PSS). Silicon (Si) can mitigate such stress, and your supply in plants with the active absorption mechanism is carried out through roots. However, foliar spraying has been practiced to supply Si in PSS production nurseries. Althought it is known that Si via roots can alter C: N: P ratios, nothing has been reported about its supply via foliar spraying, nor whether such changes interfere with structural nutrient use efficiency and with plant physiological responses. Thus, this study aimes to asses whether Si foliar spraying changes C: N: P ratios and increases the nutritional efficiency of PSS, as well as whether water deficiency interferes with such a relationships. For these purposes, three experiments were carried out. In experiment I, treatments consisted of two sugarcane cultivars (CTC 4 and RB 966928) and three Si supply forms (in nutrient solution via roots [SiR], via foliar spraying [SiL], and one control with the absence of Si [-Si]). The same Si supply forms were used in the other two experiments. In experiment II, a short-term water deficit was induced by polyethylene glycol addition to nutrient solution (-0.6 MPa) for three days. In experiment III, a long-term water deficit was imposed using levels of soil water retention capacity (70% [no water deficit], 50% [moderate water deficit], and 30% [severe water deficit] for 30 days. Our findings revealed that Si supply decreased C concentrations regardless of water conditions and that N and P concentrations varied with Si supply form and water deficit level. Moreover, root- and foliar-applied Si modified the C: N: P stoichiometry and increased C use efficiency in PSS, which thus increased N and P use efficiencies. Such an increased nutritional performance helped adjust physiological parameters and increase dry matter yield in PSS, both under water stress and non-stress conditions. Further, Si foliar spraying promoted structural effects on PSS regardless of water conditions, even if sugarcane has an active absorption via roots. In conclusion, foliar spraying can be used to supply Si in PSS production nurseries.	[Teixeira, Gelza Carliane Marques; Prado, Renato de Mello] Sao Paulo State Univ UNESP, Dept Soils & Fertilizers, Lab Plant Nutr, Jaboticabal, SP, Brazil; [Rocha, Antonio Marcio Souza] Sao Paulo State Univ UNESP, Dept Technol, Lab Biogeochem, Jaboticabal, SP, Brazil; [Piccolo, Marisa de Cassia] Univ Sao Paulo, Ctr Nucl Energy Agr CENA, Lab Nutrient Cycling, Piracicaba, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo	Teixeira, GCM (corresponding author), Sao Paulo State Univ UNESP, Dept Soils & Fertilizers, Lab Plant Nutr, Jaboticabal, SP, Brazil.	gelzacarliane@hotmail.com	de Mello Prado, Renato/K-9947-2015; Teixeira, Gelza Carliane Marques/ABG-9313-2020; piccolo, marisa de Cássia/D-6149-2012; Rocha, Antonio Márcio Souza/ABG-9325-2020	de Mello Prado, Renato/0000-0003-1998-6343; Teixeira, Gelza Carliane Marques/0000-0002-8062-482X; piccolo, marisa de Cássia/0000-0003-2163-5630; Rocha, Antonio Márcio Souza/0000-0003-0038-8503	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior - Brasil (CAPES) - Finance Code 001 (Author benefited GCMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahmed M, 2011, AFR J AGR RES, V6, P594; [Anonymous], 2017, KIDNEY INT, V7, P3, DOI DOI 10.1038/SREP45137; BABIKER AGT, 1974, WEED RES, V14, P375, DOI 10.1111/j.1365-3180.1974.tb01078.x; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bataglia O. C., 1983, METODOS ANALISE QUIM; BIRCHALL JD, 1995, CHEM SOC REV, V24, P351, DOI 10.1039/cs9952400351; Boaretto LF, 2014, PLANT PHYSIOL BIOCH, V74, P165, DOI 10.1016/j.plaphy.2013.11.016; Brouder SM, 2008, PHYSIOL PLANTARUM, V133, P705, DOI 10.1111/j.1399-3054.2008.01136.x; CAVALCANTE VS, 2016, AGROCIENCIA, V0050, P00867; DAROS E., 2015, 45 ANOS VARIEDADES R; de Camargo MS, 2019, J SOIL SCI PLANT NUT, V19, P81, DOI 10.1007/s42729-019-0012-1; Detmann KC, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22523; Detmann KC, 2012, NEW PHYTOL, V196, P752, DOI 10.1111/j.1469-8137.2012.04299.x; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Embrapa, 1997, 1 EMBR; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Fageria NK, 2005, ADV AGRON, V88, P97, DOI 10.1016/S0065-2113(05)88004-6; Fernandez V, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00289; Figueiredo P, 2012, SISTEMA MULTIPLICACA; Gong HJ, 2005, PLANT SCI, V169, P313, DOI 10.1016/j.plantsci.2005.02.023; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P29; Hurtado AC, 2020, SAUDI J BIOL SCI, DOI [10.1016/j.sjbs.2020.08.017, DOI 10.1016/J.SJBS.2020.08.017]; Kaya C, 2006, J PLANT NUTR, V29, P1469, DOI 10.1080/01904160600837238; Korndorfer G.H., 2004, ANALISE SILICIO SOLO, V2nd ed.; Kraska JE, 2010, COMMUN SOIL SCI PLAN, V41, P2075, DOI 10.1080/00103624.2010.498537; Kudryavtsev PG, 2016, NANOTECHNOL CONSTR, V8, P16, DOI 10.15828/2075-8545-2016-8-1-16-56; Li ZC, 2018, AGRON SUSTAIN DEV, V38, DOI 10.1007/s13593-018-0496-4; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Bezerra BKL, 2019, ACTA PHYSIOL PLANT, V41, DOI 10.1007/s11738-019-2980-0; de Oliveira RLL, 2019, J SOIL SCI PLANT NUT, V19, P948, DOI 10.1007/s42729-019-00092-1; Liu P, 2014, J EXP BOT, V65, P4747, DOI 10.1093/jxb/eru220; MA JF, 1990, PLANT SOIL, V126, P115, DOI 10.1007/BF00041376; Teixeira GCM, 2020, J SOIL SCI PLANT NUT, V20, P849, DOI 10.1007/s42729-019-00170-4; Martins A.P.C., 2015, J AGRON SCI, V4, P301; Matsuoka S, 2017, J SCI ACHIEV, V2, P1; Mitani N, 2009, PLANT CELL PHYSIOL, V50, P5, DOI 10.1093/pcp/pcn110; Murozuka E, 2014, BIOMASS BIOENERG, V64, P291, DOI 10.1016/j.biombioe.2014.03.034; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Viciedo DO, 2019, SCI TOTAL ENVIRON, V681, P267, DOI 10.1016/j.scitotenv.2019.05.108; Pei ZF, 2010, J PLANT GROWTH REGUL, V29, P106, DOI 10.1007/s00344-009-9120-9; Raij B.V., 2001, B TECNICO; RAVEN JA, 1983, BIOL REV, V58, P179, DOI 10.1111/j.1469-185X.1983.tb00385.x; Santos HG, 2018, BRAZILIAN SOIL CLASS, V5th; Santos L, 2020, SUGAR TECH, DOI [10.1007/s12355-020-00846-7, DOI 10.1007/S12355-020-00846-7]; Santos LS, 2020, SUGAR TECH, V22, P675, DOI 10.1007/s12355-020-00798-y; Schaller J, 2012, PLANT BIOLOGY, V14, P392, DOI 10.1111/j.1438-8677.2011.00537.x; Schoelynck J, 2010, NEW PHYTOL, V186, P385, DOI 10.1111/j.1469-8137.2009.03176.x; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; VILLELA FA, 1991, PESQUI AGROPECU BRAS, V26, P1957	49	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240847	10.1371/journal.pone.0240847	http://dx.doi.org/10.1371/journal.pone.0240847			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057406	gold, Green Published			2022-12-26	WOS:000581814700084
J	Adhikari, P; Goodrich, E; Fernandes, SB; Lipka, AE; Tranel, P; Brown, P; Jamann, TM				Adhikari, Pragya; Goodrich, Emma; Fernandes, Samuel B.; Lipka, Alexander E.; Tranel, Patrick; Brown, Patrick; Jamann, Tiffany M.			Genetic variation associated with PPO-inhibiting herbicide tolerance in sorghum	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; CONFERS RESISTANCE; AMARANTH; MUTATION; METABOLISM; MECHANISMS	Herbicide application is crucial for weed management in most crop production systems, but for sorghum herbicide options are limited. Sorghum is sensitive to residual protoporphyrinogen oxidase (PPO)-inhibiting herbicides, such as fomesafen, and a long re-entry period is required before sorghum can be planted after its application. Improving sorghum for tolerance to such residual herbicides would allow for increased sorghum production and the expansion of herbicide options for growers. In this study, we observed sorghum tolerance to residual fomesafen. To investigate the underlying tolerance mechanism a genome-wide association mapping study was conducted using field-collected sorghum biomass panel (SBP) data, and a greenhouse assay was developed to confirm the field phenotypes. A total of 26 significant SNPs (FDR<0.05), spanning a 215.3 kb region on chromosome 3, were detected. The ten most significant SNPs included two in genic regions (Sobic.003G136800, and Sobic.003G136900) and eight SNPs in the intergenic region encompassing the genes Sobic.003G136700, Sobic.003G136800, Sobic.003G137000, Sobic.003G136900, and Sobic.003G137100. The gene Sobic.003G137100 (PPXI), which encodes the PPO1 enzyme, one of the targets of PPO-inhibiting herbicides, was located 12kb downstream of the significant SNP S03_13152838. We found thatPPXIis highly conserved in sorghum and expression does not significantly differ between tolerant and sensitive sorghum lines. Our results suggest thatPPXImost likely does not underlie the observed herbicide tolerance. Instead, the mechanism underlying herbicide tolerance in the SBP is likely metabolism-based resistance, possibly regulated by the action of multiple genes. Further research is necessary to confirm candidate genes and their functions.	[Adhikari, Pragya; Goodrich, Emma; Fernandes, Samuel B.; Lipka, Alexander E.; Tranel, Patrick; Jamann, Tiffany M.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Brown, Patrick] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis	Jamann, TM (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	tjamann@illinois.edu	Tranel, Patrick J/AGW-1507-2022; Fernandes, Samuel/AFA-9552-2022; Jamann, Tiffany/S-7392-2019	Tranel, Patrick J/0000-0003-0666-4564; Fernandes, Samuel/0000-0001-8269-535X; Jamann, Tiffany/0000-0002-7288-0866	Department of Energy (DOE); Office of Biological Research [DE-SC0012400]	Department of Energy (DOE)(United States Department of Energy (DOE)); Office of Biological Research	This research is supported by the Department of Energy (DOE; www.energy.gov/): Office of Biological Research through the grant DE-SC0012400 to PJB and TMJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2007, R PACKAGE VERSION, P74, DOI DOI 10.18637/JSS.V067.I01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besancon T, 2017, AGRON J, V109, P1642, DOI 10.2134/agronj2016.06.0363; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cai Y, 2014, PLANT PHYSIOL, V165, P1328, DOI 10.1104/pp.114.238378; Chahal P.S., 2015, HERBICIDES AGRONOMIC, P1, DOI DOI 10.5772/61512; Cobucci T, 1998, WEED SCI, V46, P258, DOI 10.1017/S0043174500090500; Concenco G, 2018, EMBRAPA CLIMA TEMPER; Cornelius CD, 2017, WEED TECHNOL, V31, P21, DOI 10.1614/WT-D-16-00062.1; Cui Y, 2018, FRONTIERS PLANT SCI, P9, DOI [10.3389/fpls.2018.00009, DOI 10.3389/FPLS.2018.00009]; Dayan FE, 1997, WEED SCI, V45, P634; Dayan FE, 2018, PEST MANAG SCI, V74, P2226, DOI 10.1002/ps.4744; de Mendiburu F, 2019, R PACKAGE; Dear BS, 2003, AUST J AGR RES, V54, P203, DOI 10.1071/AR02134; Delye C, 2015, WEED SCI, V63, P91, DOI 10.1614/WS-D-13-00096.1; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; Edwards R, 1996, PHYSIOL PLANTARUM, V98, P594, DOI 10.1111/j.1399-3054.1996.tb05716.x; Fall LA, 2019, MYCOLOGIA, V111, P563, DOI 10.1080/00275514.2019.1607135; Fernandes SB, 2018, THEOR APPL GENET, V131, P747, DOI 10.1007/s00122-017-3033-y; FREAR DS, 1983, PESTIC BIOCHEM PHYS, V20, P299, DOI 10.1016/0048-3575(83)90104-9; Jugulam M, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8100417; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee RM, 2008, WEED SCI, V56, P371, DOI 10.1614/WS-07-194.1; Lermontova I, 2000, PLANT PHYSIOL, V122, P75, DOI 10.1104/pp.122.1.75; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Mahmood K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01160; McCormick RF, 2018, PLANT J, V93, P338, DOI 10.1111/tpj.13781; Patzoldt WL, 2006, P NATL ACAD SCI USA, V103, P12329, DOI 10.1073/pnas.0603137103; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, LANG ENV STAT COMP; Rangani G, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00568; Reddy PS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00529; Rousonelos SL, 2012, WEED SCI, V60, P335, DOI 10.1614/WS-D-11-00152.1; Salas RA, 2016, PEST MANAG SCI, V72, P864, DOI 10.1002/ps.4241; Salas-Perez RA, 2017, WEED SCI, V65, P718, DOI 10.1017/wsc.2017.41; Skipsey M, 1997, FEBS LETT, V409, P370, DOI 10.1016/S0014-5793(97)00554-1; Tang Y, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.11.0120; Thinglum KA, 2011, WEED SCI, V59, P22, DOI 10.1614/WS-D-10-00085.1; Thurber CS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r68; Valluru R, 2019, GENETICS, V211, P1075, DOI 10.1534/genetics.118.301742; Varanasi VK, 2018, WEED SCI, V66, P149, DOI 10.1017/wsc.2017.68; Werle R, 2017, ECOL MODEL, V343, P131, DOI 10.1016/j.ecolmodel.2016.10.023; Yu Q, 2014, PLANT PHYSIOL, V166, P1106, DOI 10.1104/pp.114.242750; Zhang XY, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-2275-z; 2015, DRUG SAFETY UPDATE, V8, P1	47	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0233254	10.1371/journal.pone.0233254	http://dx.doi.org/10.1371/journal.pone.0233254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052910	Green Submitted, gold, Green Published			2022-12-26	WOS:000581820200074
J	Nu, UT; Pervin, J; Rahman, AMQ; Rahman, M; Rahman, A				Nu, U. Tin; Pervin, Jesmin; Rahman, A. M. Q.; Rahman, Monjur; Rahman, Anisur			Determinants of care-seeking practice for neonatal illnesses in rural Bangladesh: A community-based cross-sectional study	PLOS ONE			English	Article							HEALTH; BEHAVIOR; DISTRICT	Background Proper utilization of skilled care services in neonatal illnesses is crucial to reduce neonatal morbidity and mortality. The study aimed to evaluate the level and factors associated with seeking care from skilled healthcare service providers for reported neonatal illnesses in rural Matlab, Bangladesh. Methods This community based cross-sectional study was based on data from a randomly selected sample comprised of 2223 women who delivered live-born babies in 2014. Data were collected from June to October 2015 through a structured questionnaire. We used a multivariable logistic regression model and presented the results by adjusted odds ratios (AOR) with 95% confidence intervals (CI). Results Of the neonates, 1361 (61.2%) suffered from at least one complication, and among these, 479 (35.2%) sought care from skilled healthcare service providers. In the multivariable logistic regression analysis, the participants' husbands' educational level, number of antenatal care visits, and place of childbirth were significantly associated with seeking skilled care for reported neonatal illnesses. The care-seeking from skilled healthcare service providers for neonatal illness was more than two times higher (AOR = 2.26, 95% CI = 1.51-3.39) in the group in which the participants' husband had attended school for more than 10 years as compared to the group in which they had attended school for less than six years. The AORs of seeking skilled care were 1.93 (95% CI = 1.42-2.62) and 2.26 (95% CI = 1.51-3.39) with the mothers receiving two to three and four or more antenatal care services, respectively, compared to the mothers with no or one antenatal care visit. Women who gave birth at a health facility were three times (AOR = 3.24, 95% CI = 2.50-4.19) more likely to seek skilled care for sick neonates compared to those who gave birth at home. Conclusion The utilization of skilled care for neonatal sicknesses was low in this rural setting in Bangladesh. The participants' husbands' higher school attendance, increased number of ANC visits, and facility delivery were positively associated with care-seeking from skilled healthcare providers for neonatal illness. The husbands with low school attendance should be targeted for intervention, and continue efforts to increase ANC coverage and facility delivery to improve neonatal health in this country's rural area.	[Nu, U. Tin; Pervin, Jesmin; Rahman, A. M. Q.; Rahman, Monjur; Rahman, Anisur] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Pervin, J (corresponding author), Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Dhaka, Bangladesh.	jpervin@icddrb.org		Rahman, Md Monjur/0000-0002-7877-858X	USAID through Partnerships for Enhanced Engagement in Research (PEER) Health [01122]	USAID through Partnerships for Enhanced Engagement in Research (PEER) Health	This work was supported by the USAID through Partnerships for Enhanced Engagement in Research (PEER) Health, Grant Number: 01122 (https://www.usaid.gov/bd; http://sites.nationalacademies.org/pga/peer/index.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, J TROP PEDIATRICS, V47, P98, DOI 10.1093/tropej/47.2.98; Ahsan KZ, 2019, BANGLADESH DEMOGRAPH; Anmut W, 2017, J BIOMEDICAL SCI, V06; [Anonymous], 2017, INT J INFORM TECHNOL, V9, P85; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bekele F, 2020, J NEONATAL NURSING; Bulto GA, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4583-7; Chowdhury HR, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-88; Chowdhury SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204902; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; Diabetes Poland, 2011, DIABETOLOGIA DOSW SA, V11, P1; Dongre AR, 2008, INDIAN J PEDIATR, V75, P325, DOI 10.1007/s12098-008-0032-7; Dongre AR, 2009, INDIAN J PEDIATR, V76, P45, DOI 10.1007/s12098-009-0028-y; Herbert HK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001183; Khanum P, 2002, USE OBSTET CARE SERV; Lama TP, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0123-z; Lassi Zohra S, 2019, F1000Res, V8, P200, DOI 10.12688/f1000research.17828.1; NIPORT ACPR ICF International, 2016, BANGL HLTH FAC SURV; NIPORT Mitra and Associates & ICF International, 2014, BANGL DEM HLTH SURV; Nunu WN, 2019, MIDWIFERY, V68, P15, DOI 10.1016/j.midw.2018.09.013; Ogunlesi TA, 2010, J TROP PEDIATRICS, V56, P379, DOI 10.1093/tropej/fmq009; Pervin J, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-111; Shah R, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-417; Syed U, 2008, J PERINATOL, V28, pS9, DOI 10.1038/jp.2008.165; UNICEF WHO World Bank Group UN, 2020, LEVELS TRENDS CHILD; World Health Organization, 2012, CAR NEWB HOM TRAIN C; World Health Organization, 2015, HLTH 2015 MDGS MILL, DOI 10.1007/BF01918387	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240316	10.1371/journal.pone.0240316	http://dx.doi.org/10.1371/journal.pone.0240316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052973	Green Published, gold			2022-12-26	WOS:000581820200033
J	Sha, DX; Miao, X; Lan, H; Stewart, K; Ruan, SY; Tian, YF; Tian, YY; Yang, CW				Sha, Dexuan; Miao, Xin; Lan, Hai; Stewart, Kathleen; Ruan, Shiyang; Tian, Yifei; Tian, Yuyang; Yang, Chaowei			Spatiotemporal analysis of medical resource deficiencies in the US under COVID-19 pandemic	PLOS ONE			English	Article							MECHANICAL VENTILATORS; CARE	Coronavirus disease 2019 (COVID-19) was first identified in December 2019 in Wuhan, China as an infectious disease, and has quickly resulted in an ongoing pandemic. A data-driven approach was developed to estimate medical resource deficiencies due to medical burdens at county level during the COVID-19 pandemic. The study duration was mainly from February 15, 2020 to May 1, 2020 in the U.S. Multiple data sources were used to extract local population, hospital beds, critical care staff, COVID-19 confirmed case numbers, and hospitalization data at county level. We estimated the average length of stay from hospitalization data at state level, and calculated the hospitalized rate at both state and county level. Then, we developed two medical resource deficiency indices that measured the local medical burden based on the number of accumulated active confirmed cases normalized by local maximum potential medical resources, and the number of hospitalized patients that can be supported per ICU bed per critical care staff, respectively. Data on medical resources, and the two medical resource deficiency indices are illustrated in a dynamic spatiotemporal visualization platform based on ArcGIS Pro Dashboards. Our results provided new insights into the U.S. pandemic preparedness and local dynamics relating to medical burdens in response to the COVID-19 pandemic.	[Sha, Dexuan; Lan, Hai; Tian, Yifei; Yang, Chaowei] George Mason Univ, NSF Spatiotemporal Innovat Ctr, Fairfax, VA 22030 USA; [Sha, Dexuan; Ruan, Shiyang; Yang, Chaowei] George Mason Univ, Dept Geog & GeoInformat Sci, Fairfax, VA 22030 USA; [Miao, Xin] Missouri State Univ, Dept Geog Geol & Planning, Springfield, MO 65897 USA; [Lan, Hai; Stewart, Kathleen] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Tian, Yuyang] Mercy Clin Family Med, Springfield, MO USA	George Mason University; George Mason University; Missouri State University; University System of Maryland; University of Maryland College Park	Miao, X (corresponding author), Missouri State Univ, Dept Geog Geol & Planning, Springfield, MO 65897 USA.	xinxiao@missouristate.edu		Miao, Xin/0000-0001-8732-9105; Sha, Dexuan/0000-0001-6161-6050	NSF [CNS-1841520, CSSI-1835507, CSSI-1835512]	NSF(National Science Foundation (NSF))	X.M. acknowledges support from NSF CSSI-1835512. C.Y. is supported by NSF CNS-1841520 and CSSI-1835507. (www.nsf.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajao A, 2015, DISASTER MED PUBLIC, V9, P634, DOI 10.1017/dmp.2015.105; [Anonymous], 2020, MISSISSIPPI COVID 19; [Anonymous], 2020, LARGE SPIKE CORONAVI; [Anonymous], 2020, ESTIMATING COVID 19; [Anonymous], 2020, US ICU RESOURCE AVAI; [Anonymous], 2020, LAB CONFIRMED COVID; [Anonymous], 2020, US HOSP BEDS; [Anonymous], 2020, VENT STOCKP AV US; [Anonymous], 2020, ICU BEDS AR; [Anonymous], 2020, COVID TRACKING PROJE; [Anonymous], 2019, HOSPITALS; [Anonymous], 2020, PREPARED IS US RESPO; [Anonymous], 2020, CORONAVIRUS LOCATION; [Anonymous], 2020, ADVOCATE; Branas CC., 2020, FLATTENING CURVE IT, DOI [10.1101/2020.04.01.20049759, DOI 10.1101/2020.04.01.20049759]; Colias-Pete M, 2020, CHICAGO TRIBUNE; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Giannakeas V, 2020, ANN INTERN MED, V173, P407, DOI 10.7326/M20-1169; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang HC, 2017, EMERG INFECT DIS, V23, P914, DOI 10.3201/eid2306.161417; Liu Q, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12101576; Malatino EM, 2008, RESP CARE, V53, P91; Marema T, 2020, THE DAILY YONDER; NPPES, 2020, NDI REG DAT; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Rubinson L, 2010, DISASTER MED PUBLIC, V4, P199, DOI 10.1001/dmp.2010.18; U.S. Census Bureau, 2020, TIGER LIN SHAP TIGER; Wallace DJ, 2015, AM J RESP CRIT CARE, V191, P410, DOI 10.1164/rccm.201409-1746OC; Yang CW, 2020, INT J DIGIT EARTH, V13, P1186, DOI 10.1080/17538947.2020.1809723; Yang CW, 2020, INT J GEOGR INF SCI, V34, P1075, DOI 10.1080/13658816.2019.1698743	30	11	11	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240348	10.1371/journal.pone.0240348	http://dx.doi.org/10.1371/journal.pone.0240348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052956	Green Published, Green Submitted, gold			2022-12-26	WOS:000581820200057
J	Torices, S; Roberts, SA; Park, M; Malhotra, A; Toborek, M				Torices, Silvia; Roberts, Samantha A.; Park, Minseon; Malhotra, Arun; Toborek, Michal			Occludin, caveolin-1, and Alix form a multi-protein complex and regulate HIV-1 infection of brain pericytes	FASEB JOURNAL			English	Article						Alix; blood-brain barrier; caveolin-1; HIV-1; pericytes	CEREBROSPINAL-FLUID; TIGHT JUNCTIONS; EXPRESSION; BINDING; ALIX/AIP1; DISRUPTS; TSG101; HEALTH; DOMAIN; P6	HIV-1 enters the brain by altering properties of the blood-brain barrier (BBB). Recent evidence indicates that among cells of the BBB, pericytes are prone to HIV-1 infection. Occludin (ocln) and caveolin-1 (cav-1) are critical determinants of BBB integrity that can regulate barrier properties of the BBB in response to HIV-1 infection. Additionally, Alix is an early acting endosomal factor involved in HIV-1 budding from the cells. The aim of the present study was to evaluate the role of cav-1, ocln, and Alix in HIV-1 infection of brain pericytes. Our results indicated that cav-1, ocln, and Alix form a multi-protein complex in which they cross-regulate each other's expression. Importantly, the stability of this complex was affected by HIV-1 infection. Modifications of the complex resulted in diminished HIV-1 infection and alterations of the cytokine profile produced by brain pericytes. These results identify a novel mechanism involved in HIV-1 infection contributing to a better understanding of the HIV-1 pathology and the associated neuroinflammatory responses.	[Torices, Silvia; Roberts, Samantha A.; Park, Minseon; Malhotra, Arun; Toborek, Michal] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 528 Gautier Bldg,1011 NW 15th St, Miami, FL 33136 USA	University of Miami	Torices, S; Toborek, M (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 528 Gautier Bldg,1011 NW 15th St, Miami, FL 33136 USA.	sxt736@med.miami.edu; mtoborek@med.miami.edu			HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL126559]; HHS | NIH | National Institute of Mental Health (NIMH) [MH122235, MH072567]; HHS | NIH | National Institute on Drug Abuse (NIDA) [DA039576, DA040537, DA044579, DA047157, DA050528]; American Heart Association (AHA) [20POST35211181]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); HHS | NIH | National Institute of Mental Health (NIMH); HHS | NIH | National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); American Heart Association (AHA)(American Heart Association)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL126559; HHS | NIH | National Institute of Mental Health (NIMH), Grant/Award Number: MH122235 and MH072567; HHS | NIH | National Institute on Drug Abuse (NIDA), Grant/Award Number: DA039576, DA040537, DA044579, DA047157 and DA050528; American Heart Association (AHA), Grant/Award Number: 20POST35211181	Armulik A, 2011, THER DELIV, V2, P419, DOI 10.4155/TDE.11.23; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bertrand L, 2019, BRAIN, V142, P502, DOI 10.1093/brain/awy339; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Blasig IE, 2011, ANTIOXID REDOX SIGN, V15, P1195, DOI 10.1089/ars.2010.3542; Bohannon DG, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1463-y; Boneberg EM, 2002, INFLAMM RES, V51, P119, DOI 10.1007/PL00000283; Bordoni V, 2020, CYTOKINE, V125, DOI 10.1016/j.cyto.2019.154839; Castro V, 2018, J CEREBR BLOOD F MET, V38, P317, DOI 10.1177/0271678X17720816; Castro V, 2016, FASEB J, V30, P1234, DOI 10.1096/fj.15-277673; Cho HJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00410; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Dowlatshahi DP, 2012, DEV CELL, V23, P1247, DOI 10.1016/j.devcel.2012.10.023; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Gargalovic P, 2003, J LIPID RES, V44, P1622, DOI 10.1194/jlr.M300140-JLR200; Giovannoni G, 1998, J NEUROL SCI, V156, P53, DOI 10.1016/S0022-510X(98)00021-5; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Guerra DAP, 2018, ANGIOGENESIS, V21, P667, DOI 10.1007/s10456-018-9621-x; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hill J, 2014, J NEUROIMMUNE PHARM, V9, P591, DOI 10.1007/s11481-014-9557-x; Huang QY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1387-y; Kamouchi M, 2011, CELL MOL NEUROBIOL, V31, P175, DOI 10.1007/s10571-010-9605-x; Ku PI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096950; Lamaze C, 2015, BIOMED J, V38, P367, DOI 10.4103/2319-4170.164229; Lin SS, 2010, J VIROL, V84, P9487, DOI 10.1128/JVI.00763-10; Llano M, 2002, J VIROL, V76, P9152, DOI 10.1128/JVI.76.18.9152-9164.2002; Lynch RD, 2007, EXP CELL RES, V313, P2597, DOI 10.1016/j.yexcr.2007.05.009; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; MCARTHUR JC, 1992, NEUROLOGY, V42, P1707, DOI 10.1212/WNL.42.9.1707; Mergia A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060129; Miller NM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00287; Munshi UM, 2007, J BIOL CHEM, V282, P3847, DOI 10.1074/jbc.M607489200; Nakagawa S, 2012, J CELL MOL MED, V16, P2950, DOI 10.1111/j.1582-4934.2012.01622.x; Nemeth CL, 2015, NEUROSCIENCE, V302, P165, DOI 10.1016/j.neuroscience.2014.09.016; Nusrat A, 2000, J CELL SCI, V113, P1771; Park M, 2012, J CELL MOL MED, V16, P362, DOI 10.1111/j.1582-4934.2011.01320.x; Persidsky Y, 2016, J CEREBR BLOOD F MET, V36, P794, DOI 10.1177/0271678X15606149; Piekna-Przybylska D, 2019, J NEUROVIROL, V25, P114, DOI 10.1007/s13365-018-0693-6; Sa-Pereira I, 2012, MOL NEUROBIOL, V45, P327, DOI 10.1007/s12035-012-8244-2; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Sena IFG, 2018, CANCER MED-US, V7, P1232, DOI 10.1002/cam4.1375; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Van Duyne R, 2019, P NATL ACAD SCI USA, V116, P9040, DOI 10.1073/pnas.1820333116; Van Itallie CM, 2012, ANN NY ACAD SCI, V1257, P103, DOI 10.1111/j.1749-6632.2012.06535.x; Wang XM, 2011, J VIROL, V85, P5483, DOI 10.1128/JVI.00254-11; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459; Wood S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091574; Zhong Y, 2008, J NEUROSCI, V28, P7788, DOI 10.1523/JNEUROSCI.0061-08.2008; Zou HF, 2011, MECH AGEING DEV, V132, P533, DOI 10.1016/j.mad.2011.11.001; Zou M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3403206	67	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16319	16332		10.1096/fj.202001562R	http://dx.doi.org/10.1096/fj.202001562R		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058236	hybrid, Green Published			2022-12-26	WOS:000581161200001
J	Vilades, E; Perez-del Palomar, A; Cegonino, J; Obis, J; Satue, M; Orduna, E; Pablo, LE; Cipres, M; Garcia-Martin, E				Vilades, Elisa; Perez-del Palomar, Amaya; Cegonino, Jose; Obis, Javier; Satue, Maria; Orduna, Elvira; Pablo, Luis E.; Cipres, Marta; Garcia-Martin, Elena			Physiological changes in retinal layers thicknesses measured with swept source optical coherence tomography	PLOS ONE			English	Article							HEALTHY-SUBJECTS; BLOOD-FLOW; SEGMENTATION; AGE; PARAMETERS	Purpose To evaluate the physiological changes related with age of all retinal layers thickness measurements in macular and peripapillary areas in healthy eyes. Methods Wide protocol scan (with a field of view of 12x9 cm) from Triton SS-OCT instrument (Topcon Corporation, Japan) was performed 463 heathy eyes from 463 healthy controls. This protocol allows to measure the thickness of the following layers: Retina, Retinal nerve fiber layer (RNFL), Ganglion cell layer (GCL +), GCL++ and choroid. In those layers, mean thickness was compared in four groups of ages: Group 1 (71 healthy subjects aged between 20 and 34 years); Group 2 (65 individuals aged 35-49 years), Group 3 (230 healthy controls aged 50-64 years) and Group 4 (97 healthy subjects aged 65-79 years). Results The most significant thinning of all retinal layers occurs particularly in the transition from group 2 to group 3, especially in temporal superior quadrant at RNFL, GCL++ and retinal layers (p <= 0.001), and temporal superior, temporal inferior, and temporal half in choroid layer (p<0.001). Curiously group 2 when compared with group 1 presents a significant thickening of RNFL in temporal superior quadrant (p = 0.001), inferior (p<0.001) and temporal (p = 0.001) halves, and also in nasal half in choroid layer (p = 0.001). Conclusions Excepting the RNFL, which shows a thickening until the third decade of life, the rest of the layers seem to have a physiological progressive thinning.	[Vilades, Elisa; Obis, Javier; Satue, Maria; Orduna, Elvira; Pablo, Luis E.; Cipres, Marta; Garcia-Martin, Elena] Miguel Servet Univ Hosp, Dept Ophthalmol, Zaragoza, Spain; [Vilades, Elisa; Perez-del Palomar, Amaya; Cegonino, Jose; Satue, Maria; Orduna, Elvira; Pablo, Luis E.; Cipres, Marta; Garcia-Martin, Elena] Univ Zaragoza, Aragon Inst Hlth Res IIS Aragon, Zaragoza, Spain; [Perez-del Palomar, Amaya; Cegonino, Jose] Univ Zaragoza, Aragon Inst Engn Res, Dept Mech Engn, Zaragoza, Spain	Miguel Servet University Hospital; University of Zaragoza; University of Zaragoza	Garcia-Martin, E (corresponding author), Miguel Servet Univ Hosp, Dept Ophthalmol, Zaragoza, Spain.; Garcia-Martin, E (corresponding author), Univ Zaragoza, Aragon Inst Hlth Res IIS Aragon, Zaragoza, Spain.	egmvivax@yahoo.com		Pablo, Luis/0000-0003-2389-8282; GARCIA-MARTIN, ELENA/0000-0001-6258-2489; Cegonino Banzo, Jose/0000-0002-2967-6747	EGM [PI17/01726, MAT201783858-C2-2]; MINECO/AEI/FEDER, UE [DPI201679302R]	EGM; MINECO/AEI/FEDER, UE	EGM PI17/01726 (https://www.isciii.es/QueHacemos/Financiacion/Paginas/default.aspx) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EGM MAT201783858-C2-2 MINECO/AEI/FEDER, UE, DPI201679302R (https://www.isciii.es/QueHacemos/Financiacion/Paginas/default.aspx) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191977; Adhi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133080; Ahmad M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175691; Akhtar Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197457; Almotiri J, 2018, IEEE J TRANSL ENG HE, V6, DOI 10.1109/JTEHM.2018.2835315; Chalam K V, 2016, J Ophthalmic Vis Res, V11, P84, DOI 10.4103/2008-322X.180709; Colak HN, 2016, ARQ BRAS OFTALMOL, V79, P78, DOI 10.5935/0004-2749.20160024; Costa VP, 1997, OPHTHALMOLOGY, V104, P1994, DOI 10.1016/S0161-6420(97)30066-9; Ekinci M, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-75; Falavarjani KG, 2018, J OPHTHAL VIS RES, V13, P260, DOI 10.4103/jovr.jovr_173_17; Foroozan R, 2002, OPHTHALMOLOGY, V109, P744, DOI 10.1016/S0161-6420(01)01011-9; Garcia-Martin E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177163; Hanumunthadu D, 2018, INT J OPHTHALMOL-CHI, V11, P681, DOI 10.18240/ijo.2018.04.24; Hanumunthadu D, 2017, CLIN EXP OPHTHALMOL, V45, P270, DOI 10.1111/ceo.12868; Higashiyama T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172168; Keane PA, 2009, INVEST OPHTH VIS SCI, V50, P3378, DOI 10.1167/iovs.08-2728; Mazzaferri J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42112; Michalewski J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/639160; Modrzejewska M, 2015, CURR EYE RES, V40, P729, DOI 10.3109/02713683.2014.954675; Nateras OS, 2014, CURR EYE RES, V39, P1059, DOI 10.3109/02713683.2014.892997; Nikolopoulou E, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6724818; Pandolfi A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2982251; Schutte S, 2006, VISION RES, V46, P1724, DOI 10.1016/j.visres.2005.11.022; Shin A, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037562; Steigerwalt RD, 1998, RETINA-J RET VIT DIS, V18, P539; Ulusoy MO, 2018, INDIAN J OPHTHALMOL, V66, P428, DOI 10.4103/ijo.IJO_877_17; Venhuizen FG, 2017, BIOMED OPT EXPRESS, V8, P3292, DOI 10.1364/BOE.8.003292; Wakatsuki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144156; Waldstein SM, 2015, BRIT J OPHTHALMOL, V99, P794, DOI 10.1136/bjophthalmol-2014-305573; Zhao J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22745-4	30	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240441	10.1371/journal.pone.0240441	http://dx.doi.org/10.1371/journal.pone.0240441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052946	Green Published, gold			2022-12-26	WOS:000581820200026
J	Wu, L; Lan, JB; Xiang, XX; Xiang, HY; Jin, Z; Khan, S; Liu, YQ				Wu, Lin; Lan, Jianbin; Xiang, Xiaoxue; Xiang, Haiyang; Jin, Zhao; Khan, Sadia; Liu, Yiqing			Transcriptome sequencing and endogenous phytohormone analysis reveal new insights in CPPU controlling fruit development in kiwifruit (Actinidia chinensis)	PLOS ONE			English	Article							TOMATO SOLANUM-LYCOPERSICON; HORMONAL-REGULATION; GROWTH; SIZE; PLANT; QUALITY; GENE; PARTHENOCARPY; DIVERSITY; MECHANISM	Kiwifruit (Actinidia chinensis) is a rich nutritious fruit crop owing to a markedly higher content of vitamin C and minerals. To promote fruit set and to increase the yield of kiwifruit, forchlorfenuron (CPPU) has been widely applied. However, the molecular details regarding CPPU controlling kiwifruit development, especially at the fastest fruit growth stage, remain unknown. In the present study, we measured the effect of CPPU on developmental regulation in red-fleshed kiwifruit (Actinidia chinensis'Hongyang'). Additionally, a cytological analysis was performed to clarify the precise changes in the cell structure of the CPPU-treated kiwifruits. Moreover, the concentration of endogenous phytohormones, including indoleacetic acid (IAA), zeatin (ZT), gibberellic acid 3 (GA(3)), and abscisic acid (ABA), were measured by Enzyme-linked Immunosorbent Assay (ELISA). Furthermore, RNA-Seq was performed to dissect the complicated molecular mechanisms, with a focus on biosynthesis, metabolism, and signaling compounds, such as endogenous hormones, sugars, and L-ascorbic acid. Our results demonstrated that CPPU treatment not only regulates the size and weight of a single fruit but also improves the quality in 'Hongyang' kiwifruit through the accumulation of both soluble sugar and vitamin C. It was also seen that CPPU regulates kiwifruit development by enhancing cell expansion of epidermal cells and parenchyma cells, while, promoting cell division of subepidermal cells. Additionally, CPPU significantly increased the gibberellin and cytokinin biosynthetic pathway and signaling, while repressing auxin and ABA biosynthetic pathway; thus, signaling plays an essential role in CPPU controlling kiwifruit development. Notably, transcriptomic analysis revealed that a total of 2244 genes, including 352 unannotated genes, were differentially expressed in kiwifruits because of CPPU treatment, including 127 transcription factors. These genes are mainly enriched in plant hormone signal transduction, photosynthesis, MAPK signaling pathway, starch and sucrose metabolism, and phenylpropanoid biosynthesis. Overall, our results highlight that CPPU regulation of kiwifruit development is mainly associated with an antagonistic and/or synergistic regulatory role of endogenous phytohormones, and enhancing the energy supply. This provides new insights into the molecular details of CPPU controlling kiwifruit development at the fastest fruit growth stage, which is of agricultural importance for kiwifruit breeding and crop improvement.	[Wu, Lin; Lan, Jianbin; Xiang, Xiaoxue; Xiang, Haiyang; Jin, Zhao] Chongqing Univ Arts & Sci, Inst Special Plants, Chongqing Key Lab Econ Plant Biotechnol, Chongqing, Peoples R China; [Khan, Sadia] Univ Toronto, Dept Biol Sci, Scarborough, ON, Canada; [Liu, Yiqing] Yangtze Univ, Inst Hort Plants, Coll Hort & Gardening, Jingzhou, Hubei, Peoples R China	Chongqing University of Arts & Sciences; University of Toronto; University Toronto Scarborough; Yangtze University	Wu, L (corresponding author), Chongqing Univ Arts & Sci, Inst Special Plants, Chongqing Key Lab Econ Plant Biotechnol, Chongqing, Peoples R China.; Liu, YQ (corresponding author), Yangtze Univ, Inst Hort Plants, Coll Hort & Gardening, Jingzhou, Hubei, Peoples R China.	wulin@cau.edu.cn; liung906@163.com		Wu, Lin/0000-0001-5190-2926	National Natural Science Foundation of China [31670688]; Science and Technology Research Program of Chongqing Municipal Education Commission [KJ15011125, KJQN201801318, KJZD-K202001304]; Science and Technology Research Program of Chongqing Science and Technology Bureau [cstc2018jscxmsybX0196, CQYC201903201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Program of Chongqing Municipal Education Commission; Science and Technology Research Program of Chongqing Science and Technology Bureau	This work was supported by the National Natural Science Foundation of China in the form of a grant awarded to YL (31670688), the Science and Technology Research Program of Chongqing Municipal Education Commission in the form of grants awarded to JL (KJ15011125, KJQN201801318, KJZD-K202001304), and the Science and Technology Research Program of Chongqing Science and Technology Bureau in the form of grants awarded to JL (cstc2018jscxmsybX0196) and LW (CQYC201903201).	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2018, NAT REV GENET, V19, P1, DOI 10.1038/nrg.2017.141; Azzi L, 2015, J EXP BOT, V66, P1075, DOI 10.1093/jxb/eru527; Bangerth FK, 1997, ACTA HORTIC, P77; Burbidge A, 1999, PLANT J, V17, P427, DOI 10.1046/j.1365-313X.1999.00386.x; Chung MY, 2010, PLANT J, V64, P936, DOI 10.1111/j.1365-313X.2010.04384.x; Devoghalaere F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-7; Famiani F, 1999, J HORTIC SCI BIOTECH, V74, P375, DOI 10.1080/14620316.1999.11511124; Fei LY, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10020245; Silva GFFE, 2014, PLANT J, V78, P604, DOI 10.1111/tpj.12493; Flaishman MA, 2001, J HORTIC SCI BIOTECH, V76, P145, DOI 10.1080/14620316.2001.11511341; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Garcia-Hurtado N, 2012, J EXP BOT, V63, P5803, DOI 10.1093/jxb/ers229; Goetz M, 2007, PLANT PHYSIOL, V145, P351, DOI 10.1104/pp.107.104174; Hallett IC, 2005, INT J PLANT SCI, V166, P693, DOI 10.1086/431232; Huang SX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3640; Ishikawa T., 2018, ANTIOXIDANTS ANTIOXI, P163, DOI DOI 10.1007/978-3-319-75088-0_8; IWAHORI S, 1988, SCI HORTIC-AMSTERDAM, V35, P109, DOI 10.1016/0304-4238(88)90042-8; Jo YS, 2002, 5 INT S KIW, V610, P539, DOI [10.17660/ActaHortic.2003.610.72, DOI 10.17660/ACTAHORTIC.2003.610.72]; Karlova R, 2014, J EXP BOT, V65, P4527, DOI 10.1093/jxb/eru316; Kim JG, 2006, SCI HORTIC-AMSTERDAM, V110, P219, DOI 10.1016/j.scienta.2006.06.017; Kumar R, 2014, J EXP BOT, V65, P4561, DOI 10.1093/jxb/eru277; LEDGER SE, 1994, PLANT MOL BIOL, V25, P877, DOI 10.1007/BF00028882; Lee JM, 2012, PLANT J, V70, P191, DOI 10.1111/j.1365-313X.2011.04863.x; Lin ZF, 2008, PLANT J, V55, P301, DOI 10.1111/j.1365-313X.2008.03505.x; Lotter JDV, 1991, 2 INT S KIW, V297, P357, DOI [10.17660/ActaHortic.1992.297.48, DOI 10.17660/ACTAHORTIC.1992.297.48]; Luo J, 2017, FOOD RES INT, V102, P666, DOI 10.1016/j.foodres.2017.09.051; Marti C, 2007, PLANT J, V52, P865, DOI 10.1111/j.1365-313X.2007.03282.x; Matsuo S, 2012, J EXP BOT, V63, P5569, DOI 10.1093/jxb/ers207; McAtee P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00079; Mignolli F, 2019, PHYSIOL PLANTARUM, V165, P768, DOI 10.1111/ppl.12770; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Nishyama L, 2008, FOOD SCI TECHNOL RES, V14, P67; Nitsch L, 2012, J PLANT PHYSIOL, V169, P878, DOI 10.1016/j.jplph.2012.02.004; Obroucheva NV, 2014, RUSS J DEV BIOL+, V45, P11, DOI 10.1134/S1062360414010068; Pabon-Mora N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00300; Pattison RJ, 2012, PLANT J, V70, P585, DOI 10.1111/j.1365-313X.2011.04895.x; Ren ZX, 2011, J EXP BOT, V62, P2815, DOI 10.1093/jxb/erq455; Renaudin JP, 2017, J EXP BOT, V68, P1613, DOI 10.1093/jxb/erx058; Schaart JG, 2013, NEW PHYTOL, V197, P454, DOI 10.1111/nph.12017; Seymour GB, 2013, ANNU REV PLANT BIOL, V64, P219, DOI 10.1146/annurev-arplant-050312-120057; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Stern RA, 2003, J HORTIC SCI BIOTECH, V78, P297, DOI 10.1080/14620316.2003.11511621; Tang N, 2018, POSTHARVEST BIOL TEC, V145, P61, DOI [10.1016/j.po, 10.1016/j.postharvbio.2018.06.007]; Tang W, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz027; Tang W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00335; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936; Vriezen WH, 2008, NEW PHYTOL, V177, P60, DOI 10.1111/j.1469-8137.2007.02254.x; Wang LH, 2019, PLANT J, V99, P359, DOI 10.1111/tpj.14330; Wu L, 2020, PAK J BOT, V52, P147, DOI 10.30848/PJB2020-1(10); Wu L, 2019, ACTA PHYSIOL PLANT, V41, DOI 10.1007/s11738-019-2903-0; Wu L, 2017, PLANT PHYSIOL, V173, P853, DOI 10.1104/pp.16.01064; Zabadal TJ, 2006, HORTSCIENCE, V41, P154, DOI 10.21273/HORTSCI.41.1.154; Zou J, 2018, POSTHARVEST BIOL TEC, V135, P57, DOI 10.1016/j.postharvbio.2017.08.017; 2019, CAN J KIDNEY HLTH DI, V6, P1	57	11	11	9	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240355	10.1371/journal.pone.0240355	http://dx.doi.org/10.1371/journal.pone.0240355			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044982	gold, Green Published			2022-12-26	WOS:000581811700012
J	Luo, L; Kang, HN; Li, XC; Ness, SA; Stidley, CA				Luo, Li; Kang, Huining; Li, Xichen; Ness, Scott A.; Stidley, Christine A.			Two-step mixed model approach to analyzing differential alternative RNA splicing	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; FALSE DISCOVERY RATE; EXPRESSION ANALYSIS; UP-REGULATION; GENE; LANDSCAPE; PERIOSTIN; SWITCHES; PREDICTS; REVEALS	Changes in gene expression can correlate with poor disease outcomes in two ways: through changes in relative transcript levels or through alternative RNA splicing leading to changes in relative abundance of individual transcript isoforms. The objective of this research is to develop new statistical methods in detecting and analyzing both differentially expressed and spliced isoforms, which appropriately account for the dependence between isoforms and multiple testing corrections for the multi-dimensional structure of at both the gene- and isoform- level. We developed a linear mixed effects model-based approach for analyzing the complex alternative RNA splicing regulation patterns detected by whole-transcriptome RNA-sequencing technologies. This approach thoroughly characterizes and differentiates three types of genes related to alternative RNA splicing events with distinct differential expression/splicing patterns. We applied the concept of appropriately controlling for the gene-level overall false discovery rate (OFDR) in this multi-dimensional alternative RNA splicing analysis utilizing a two-step hierarchical hypothesis testing framework. In the initial screening test we identify genes that have differentially expressed or spliced isoforms; in the subsequent confirmatory testing stage we examine only the isoforms for genes that have passed the screening tests. Comparisons with other methods through application to a whole transcriptome RNA-Seq study of adenoid cystic carcinoma and extensive simulation studies have demonstrated the advantages and improved performances of our method. Our proposed method appropriately controls the gene-level OFDR, maintains statistical power, and is flexible to incorporate advanced experimental designs.	[Luo, Li; Kang, Huining; Ness, Scott A.; Stidley, Christine A.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Luo, Li; Kang, Huining; Ness, Scott A.] Univ New Mexico, Comprehens Canc Ctr, Albuquerque, NM 87131 USA; [Li, Xichen] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico	Kang, HN (corresponding author), Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA.; Kang, HN (corresponding author), Univ New Mexico, Comprehens Canc Ctr, Albuquerque, NM 87131 USA.	HuKang@salud.unm.edu	Kang, Huining/AAM-7506-2021	Kang, Huining/0000-0002-4415-3573	National Institutes of Health National Cancer Institute [R01CA170250]; National Institutes of Health, National Institute of Dental and Craniofacial Research [R01DE023222]; UNM Comprehensive Cancer Center Support Grant NCI [P30CA118100]	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); UNM Comprehensive Cancer Center Support Grant NCI	This work was supported by grants from the National Institutes of Health (https://www.nih.gov/) National Cancer Institute (R01CA170250 to S.A.N.), National Institute of Dental and Craniofacial Research (R01DE023222 to S.A.N.), and was partially supported by UNM Comprehensive Cancer Center Support Grant NCI P30CA118100, the Biostatistics Shared Resource, and Analytical and Translational Genomics Shared Resource. The computational resources used in this work were provided by the University of New Mexico Center for Advanced Research Computing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; [Anonymous], 2014, NUCLEIC ACIDS RES, V42, pD7; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; Bender RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061788; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2008, BIOMETRICS, V64, P1215, DOI 10.1111/j.1541-0420.2007.00984.x; Biselli-Chicote PM, 2012, J CANCER RES CLIN, V138, P363, DOI 10.1007/s00432-011-1073-2; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Brayer KJ, 2016, CANCER DISCOV, V6, P176, DOI 10.1158/2159-8290.CD-15-0859; Farrar JE, 2016, CANCER RES, V76, P2197, DOI 10.1158/0008-5472.CAN-15-1015; Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172; Gao PK, 2014, TUMOR BIOL, V35, P9585, DOI 10.1007/s13277-014-2228-y; Goldie SJ, 2012, CANCER RES, V72, P3424, DOI 10.1158/0008-5472.CAN-12-0423; Halekoh U, 2014, J STAT SOFTW, V59, P1; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; Hassan MK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191377; Heller R, 2009, BIOINFORMATICS, V25, P1019, DOI 10.1093/bioinformatics/btp076; Hirano H, 2014, BRAIN TUMOR PATHOL, V31, P85, DOI 10.1007/s10014-013-0153-1; Hu Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1026; Kang HN, 2012, BLOOD, V119, P1872, DOI 10.1182/blood-2011-10-382861; Kang HN, 2010, BLOOD, V115, P1394, DOI 10.1182/blood-2009-05-218560; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Kwok OM, 2007, MULTIVAR BEHAV RES, V42, P557, DOI 10.1080/00273170701540537; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Li J, 2012, BIOSTATISTICS, V13, P523, DOI 10.1093/biostatistics/kxr031; Li YH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-108; Li ZW, 2015, INT J MOL SCI, V16, P12108, DOI 10.3390/ijms160612108; Liu Y, 2015, J NEURO-ONCOL, V121, P505, DOI 10.1007/s11060-014-1678-9; Maae E, 2012, BREAST CANCER RES TR, V133, P257, DOI 10.1007/s10549-012-1957-0; O'Rourke JP, 2008, MOL CELL BIOL, V28, P2091, DOI 10.1128/MCB.01870-07; Pan Y, 2015, BRIT J CANCER, V113, P763, DOI 10.1038/bjc.2015.260; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryner L, 2015, CLIN CANCER RES, V21, P2941, DOI 10.1158/1078-0432.CCR-14-3111; Sebestyen E, 2015, NUCLEIC ACIDS RES, V43, P1345, DOI 10.1093/nar/gku1392; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079448; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van den Berge K, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1277-0; Vitting-Seerup K, 2019, BIOINFORMATICS, V35, P4469, DOI 10.1093/bioinformatics/btz247; Vitting-Seerup K, 2017, MOL CANCER RES, V15, P1206, DOI 10.1158/1541-7786.MCR-16-0459; Wang X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S16; Zhang ZF, 2013, GENOME MED, V5, DOI 10.1186/gm437; Zhou YE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022880	48	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0232646	10.1371/journal.pone.0232646	http://dx.doi.org/10.1371/journal.pone.0232646			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035235	gold, Green Published, Green Submitted			2022-12-26	WOS:000581817500053
J	Sayedi, SM; Seddiq, MK; Rashidi, MK; Qader, G; Ikram, N; Melese, M; Suarez, PG				Sayedi, Said Mirza; Seddiq, Mohammad Khaled; Rashidi, Mohammad K.; Qader, Ghulam; Ikram, Naser; Melese, Muluken; Suarez, Pedro G.			Active household contact screening for tuberculosis and provision of isoniazid preventive therapy to under-five children in Afghanistan	PLOS ONE			English	Article							YIELD	Objectives This observational study analyzed the performance of the National TB Control Program (NTP) in Afghanistan in household contact screening from 2011 to 2018 and its use as an entry point for isoniazid preventive therapy (IPT), as well as the IPT completion rates for children under age five. Methods From 2011 to 2018, the Afghanistan NTP released guidelines for passive and active contact screening of bacteriologically confirmed TB cases. Health workers were trained in contact screening. Presumptive TB cases gave sputum for AFB smear microscopy; other diagnostics were used if patients could not produce sputum. Children under five (excluding those with active TB) were treated for latent TB infection. We calculated the yield and the number needed to screen and number needed to test to find a case of TB, as well as the rates of IPT initiation and completion. Results From 2011 to 2018, 142,797 bacteriologically confirmed TB cases were diagnosed in Afghanistan. The number of household members eligible for screening was estimated to be 856,782, of whom 586,292 (81%) were screened for TB and 117,643 (20.1%) were found to be presumptive TB cases. Among the cases screened, 10,896 TB cases (all forms) were diagnosed (1.85%, 95% CI 1.82-1.89), 54.4% in females. The number needed to screen to diagnose a single case of TB (all forms) was 53.8; the number needed to test was 10.7. Out of all children under five, 101,084 (85.9%) were initiated on IPT, and 69,273 (68.5%) completed treatment. Conclusions Program performance in contact screening in Afghanistan is high, at 81%, and the yield of TB is also high-close to 10 times higher than the national TB incidence rate. IPT initiation and completion rates are also high as compared to those of many other countries but need further improvement, especially for completion.	[Sayedi, Said Mirza; Rashidi, Mohammad K.; Qader, Ghulam] Management Sci Hlth, Challenge TB Project, Kabul, Afghanistan; [Seddiq, Mohammad Khaled] Minist Publ Hlth, Natl TB Program, Kabul, Afghanistan; [Ikram, Naser] US Agcy Int Dev, Off Hlth & Nutr, Kabul, Afghanistan; [Melese, Muluken; Suarez, Pedro G.] Management Sci Hlth, Arlington, VA USA	United States Agency for International Development (USAID)	Sayedi, SM (corresponding author), Management Sci Hlth, Challenge TB Project, Kabul, Afghanistan.	msayedi1980@gmail.com	Suarez, Pedro G/AAD-2278-2019	Suarez, Pedro G/0000-0001-9825-1761	United States Agency for International Development (USAID) [AID-OAA-A-14-00029]; USAID through Public Health Institute (PHI)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); USAID through Public Health Institute (PHI)	The United States Agency for International Development (USAID) funded this study through the Challenge TB project under cooperative agreement number AID-OAA-A-14-00029. The contents of the article are the responsibility of the authors alone and do not necessarily reflect the views of USAID or the US government. The publication fee is covered by the USAID funded Sustainable Technical and Analytic Resources (STAR) project, through Public Health Institute (PHI).	Becerra MC, 2005, PUBLIC HEALTH REP, V120, P271, DOI 10.1177/003335490512000309; Beyanga M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3036-6; Cavany SM, 2017, THORAX, V72, P736, DOI 10.1136/thoraxjnl-2016-209677; Enos M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209098; Fatima R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165813; Fox GJ, 2018, NEW ENGL J MED, V378, P221, DOI 10.1056/NEJMoa1700209; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; Habte D, 2016, INT J INFECT DIS, V49, P179, DOI 10.1016/j.ijid.2016.07.002; Hasam R, 2018, RGLC MONITORING REPO; Hopewell P, 2012, RECOMMENDATIONS INVE; Islamic Republic of Afghanistan Central Statistics Organisation (CSO), 2018, AFGH LIV COND SURV 2; Islamic Republic of Afghanistan Ministry of Public Health General Directorate of Preventive Medicine Control of Communicable Diseases Directorate National TB Program, NAT STRAT PLAN TUB C; Jerene D, 2015, INT J TUBERC LUNG D, V19, P898, DOI 10.5588/ijtld.14.0978; Little KM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3193-7; Muyoyeta M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2388-7; Ohene SA, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0396-5; Sanaie A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163813; Saunders MJ, 2014, INT J TUBERC LUNG D, V18, P640, DOI 10.5588/ijtld.13.0486; Thanh THT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-713; WHO, 2019, GLOB TUB REP; World Health Organisation, 2015, GUID MAN LAT TUB INF; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2015, SYSTEMATIC SCREENING	23	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240031	10.1371/journal.pone.0240031	http://dx.doi.org/10.1371/journal.pone.0240031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035249	Green Published, gold			2022-12-26	WOS:000581817500001
J	Ahonkhai, AA; Regan, S; Idigbe, I; Adeniyi, O; Aliyu, MH; Okonkwo, P; Adeola, J; Losina, E; Musa, Z; Ezechi, O; Freedberg, KA				Ahonkhai, Aima A.; Regan, Susan; Idigbe, Ifeoma; Adeniyi, Olayemi; Aliyu, Muktar H.; Okonkwo, Prosper; Adeola, Juliet; Losina, Elena; Musa, Zaidat; Ezechi, Oliver; Freedberg, Kenneth A.			The impact of user fees on uptake of HIV services and adherence to HIV treatment: Findings from a large HIV program in Nigeria	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY PROGRAMS; OF-POCKET COSTS; CARE	Background Global HIV funding cutbacks have been accompanied by the adoption of user fees to address funding gaps in treatment programs. Our objective was to assess the impact of user fees on HIV care utilization and medication adherence in Nigeria. Methods We conducted a retrospective analysis of patients enrolled in care before (October 2012-September 2013) and after (October 2014-September 2015) the introduction of user fees in a Nigerian clinic. We assessed pre- vs. post-user fee patient characteristics and enrollment trends, and determined risk of care interruption, loss to follow-up, and optimal medication adherence. Results After fees were instituted, there was a 66% decline in patient enrollment and 75% decline in number of ART doses dispensed. There was no difference in the proportion of female clients (64% vs 63%, p = 0.46), average age (36 vs. 37 years, p = 0.15), or median baseline CD4 (220/ul vs. 222/uL, p = 0.24) in pre- and post-fee cohorts. There was an increase in clients employed and/or had tertiary education (24% vs. 32%, p<0.001). Compared to pre-fee patients, the post-fee period had a 48% decreased risk of care interruption (aRR = 0.52, 95%CI:0.39-0.69), 22% decreased LTFU risk (aRR = 0.64, 95%CI:0.96), and 27% decreased odds of optimal medication adherence (aOR = 0.7, 3 95%CI 0.59-0.89). Conclusions Patients enrolled in care after introduction of user fees in Nigeria were more likely to be educated or employed, and effectively retained in care after starting ART. However, fees were accompanied by a drastic reduction in new patient enrollment, suggesting that many patients may have been marginalized from HIV care.	[Ahonkhai, Aima A.] Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37235 USA; [Ahonkhai, Aima A.; Aliyu, Muktar H.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Regan, Susan; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Idigbe, Ifeoma; Adeniyi, Olayemi; Musa, Zaidat; Ezechi, Oliver] Nigerian Inst Med Res, Lagos, Nigeria; [Aliyu, Muktar H.] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Nashville, TN USA; [Okonkwo, Prosper; Adeola, Juliet] APIN Publ Hlth Initiat APIN, Abuja, Nigeria; [Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Losina, Elena] Harvard Med Sch, Boston, MA 02115 USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, 75 Francis St, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res CFAR, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA	Vanderbilt University; Vanderbilt University; Harvard University; Massachusetts General Hospital; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Ahonkhai, AA (corresponding author), Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37235 USA.; Ahonkhai, AA (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA.	aimalohi.a.ahonkhai@vumc.org		Ahonkhai, Aimalohi/0000-0003-0666-4767	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [K23 AI106406, R01 AI058736-09S1, R01 MH108427, P30AI060354]; US Centers for Disease Control and Prevention [5U2GPS001058]; President and Fellows of Harvard College	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); President and Fellows of Harvard College	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Numbers: K23 AI106406, R01 AI058736-09S1, R01 MH108427, and P30AI060354. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study was also supported in part by cooperative agreement number 5U2GPS001058 from the US Centers for Disease Control and Prevention, and by the President and Fellows of Harvard College.	Ahonkhai AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032993; Ahonkhai Aimalohi A, 2017, J Int Assoc Provid AIDS Care, V16, P98, DOI 10.1177/2325957416672010; Ahonkhai AA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1137-z; [Anonymous], 2018, NIG COR INFL RAT 200; [Anonymous], 2016, THEOLOGICAL STUDIES, V72, pa4210, DOI 10.4102/hts.v72i1.4210; [Anonymous], 2016, J DEMOCR, V27, P3; Banigbe B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221809; Bisson GP, 2006, AIDS, V20, P1333, DOI 10.1097/01.aids.0000232245.36039.2b; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Doshi JA, 2018, J CLIN ONCOL, V36, P476, DOI 10.1200/JCO.2017.74.5091; Emenyonu N, 2010, CASH TRANSFERS COVER; Etiaba E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167117; Foundation KF, 2014, FIN RESP HIV LOW MID; Foundation KF, 2014, US PRES EM PLAN AIDS; Geng EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021797; Grimsrud A, 2014, TROP MED INT HEALTH, V19, P1029, DOI 10.1111/tmi.12346; Group TWB, 2014, OUT POCK HLTH EXP PR; HIV/AIDS Division Federal Ministry of Health, 2014, NAT OP PLAN EL MOTH; Hong SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056307; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; James CD, 2006, APPL HEALTH ECON HEA, V5, P137, DOI 10.2165/00148365-200605030-00001; Kranzer K, 2011, TROP MED INT HEALTH, V16, P1297, DOI 10.1111/j.1365-3156.2011.02828.x; Lagarde M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009094; Lagarde M, 2008, B WORLD HEALTH ORGAN, V86, P839, DOI 10.2471/BLT.07.049197; Mosoko JJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-32; MSF, 2016, OUT FOC MILL PEOPL W; Nau DP, PROPORTION DAYS COVE; PEPFAR, 2010, SUMM HIV AIDS PARTN; PEPFAR, 2014, C BUDG JUST SUPPL FI; PEPFAR, 2015, FY 2015 NIG COUNTR O; PEPFAR, 2016, SUST HIV EP CONTR PE; Rabkin M, 2017, B WORLD HEALTH ORGAN, V95, P353, DOI [10.2471/BLT.16.180646, 10.2471/blt.16.180646]; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Strategies for Management of Anti-retroviral Therapy/INSIGHT, 2008, AIDS, V22, pF17; Strategies for Management of Anti-retroviral Therapy/INSIGHT, 2008, AIDS, V22, pF17; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; UNAIDS, 2017, ENDING AIDS PROGR 90; UNAIDS, 2014, 90 90 90 AMB TREATM; WHO, 2007, FACT SHEET PAYING HL; Witter S., 2005, UNNECESSARY EVIL USE; Yates R, 2009, LANCET, V373, P2078, DOI 10.1016/S0140-6736(09)60258-0; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6	42	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0238720	10.1371/journal.pone.0238720	http://dx.doi.org/10.1371/journal.pone.0238720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031440	gold, Green Published			2022-12-26	WOS:000581809800066
J	Osinski, M; Mantaj, U; Kedzia, M; Gutaj, P; Wender-Ozegowska, E				Osinski, Maciej; Mantaj, Urszula; Kedzia, Malgorzata; Gutaj, Pawel; Wender-Ozegowska, Ewa			Poor glycaemic control contributes to a shift towards prothrombotic and antifibrinolytic state in pregnant women with type 1 diabetes mellitus	PLOS ONE			English	Article							MEAN PLATELET VOLUME; FLOW-CHAMBER SYSTEM; CARDIOVASCULAR-DISEASE; ATRIAL-FIBRILLATION; INSULIN-RESISTANCE; THROMBUS FORMATION; RISK-FACTOR; THROMBOEMBOLISM; ASPIRIN	Ojectives Thrombotic and antifibrinolytic influence of Diabetes mellitus type 1 (T1DM) on haemostasis have been well demonstrated. There has been no research assessing the influence of poor glycemic control on thrombus formation under flow conditions in vitro or in pregnant type 1 diabetic women to date. Patients/Methods This study compared singleton pregnant T1DM women (n = 21) and control pregnant subjects without any metabolic disease (n = 15). The T1DM group was divided into two subgroups of sufficient (SGC-DM; Hb(A1c)<= 6,5%,n = 15) and poor glycaemic control (PGC-DM; Hb(A1c)>6,5%,n = 6). Evaluation of the whole blood thrombogenicity we assessed using T-TAS(R)at a shear rate of 240 s-1 (Total-Thrombus Analysis System, Zacros, Japan). Results Blood clot formation initiation time (T10) was significantly shortened in PGC-DM subgroup when compared to SGC-DM subgroup (p = 0,03). The area under the curve (AUC30) of blood clot time formation and the MPV (mean platelet volume) values were substantially higher in the PGC-DM subgroup in comparison to the SGC-DM group (p = 0,03). Negative correlations were noted between Hb(A1c)and T10 values (p = 0,02) and between T10 and MPV values in the T1DM group (p = 0,04). Conclusions Poor glycaemic control in T1DM subjects triggers a shift towards a prothrombotic and antifibrinolytic state. This phenomenon can be detected using the novel system for quantitative assessment of the platelet thrombus formation process under flow conditions in vitro. The alteration of T-TAS values in PGC-DM subgroup proves that a poor glycemic control-related shift of the equilibrium toward thrombogenesis occurs in this group of patients. Our findings need a further elucidation in research on more massive data sets to be confirmed.	[Osinski, Maciej; Mantaj, Urszula; Kedzia, Malgorzata; Gutaj, Pawel; Wender-Ozegowska, Ewa] Poznan Univ Med Sci, Dept Reprod, Chair Obstet Gynaecol & Oncol, Poznan, Poland	Poznan University of Medical Sciences	Osinski, M (corresponding author), Poznan Univ Med Sci, Dept Reprod, Chair Obstet Gynaecol & Oncol, Poznan, Poland.	maciejosinski@me.com		Mantaj, Urszula/0000-0002-0042-778X				AAH A., 2019, BRIT J ANAESTH, V122, pe136; Ajjan RA, 2013, BLOOD, V122, P134, DOI 10.1182/blood-2013-04-494641; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; American Diabetes Association, 2017, Diabetes Care, V40, pS114; Angiolillo DJ, 2005, DIABETES, V54, P2430, DOI 10.2337/diabetes.54.8.2430; Assert R, 2001, DIABETOLOGIA, V44, P188, DOI 10.1007/s001250051598; Barna B, 2018, ORVOSI HETILAP, V159, P1335, DOI 10.1556/650.2018.31130; Braekkan SK, 2010, J THROMB HAEMOST, V8, P157, DOI 10.1111/j.1538-7836.2009.03498.x; Bray PF, 2007, HEMATOL ONCOL CLIN N, V21, P633, DOI 10.1016/j.hoc.2007.06.002; Bremme KA, 2003, BEST PRACT RES CL HA, V16, P153, DOI 10.1016/S1521-6926(03)00021-5; Brown A, 2010, NAT REV CARDIOL, V7, P369, DOI 10.1038/nrcardio.2010.35; Coban E, 2005, INT J CLIN PRACT, V59, P981, DOI 10.1111/j.1742-1241.2005.00500.x; Colak E, 2020, J MATERN-FETAL NEO M, V33, P3689, DOI 10.1080/14767058.2019.1583730; ELKHAWAND C, 1993, DIABETES CARE, V16, P1137, DOI 10.2337/diacare.16.8.1137; Endler G, 2002, BRIT J HAEMATOL, V117, P399, DOI 10.1046/j.1365-2141.2002.03441.x; Fangel MV, 2018, INT J CARDIOL, V268, P137, DOI 10.1016/j.ijcard.2018.05.037; Fangel MV, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.118.007030; Hekimsoy Z, 2004, J DIABETES COMPLICAT, V18, P173, DOI 10.1016/S1056-8727(02)00282-9; Henry P, 2011, THROMB HAEMOSTASIS, V105, P336, DOI 10.1160/TH10-02-0082; Hori Y, 2002, J CLIN ENDOCR METAB, V87, P660, DOI 10.1210/jc.87.2.660; Hosokawa K, 2011, J THROMB HAEMOST, V9, P2029, DOI 10.1111/j.1538-7836.2011.04464.x; Hosokawa K, 2012, MICROVASC RES, V83, P154, DOI 10.1016/j.mvr.2011.11.007; ISHII M, 1987, DIABETES RES CLIN PR, V4, P45, DOI 10.1016/S0168-8227(87)80032-3; Kearney K, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0515-9; Lados-Krupa A, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/456189; Lipets EN, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0038-0; Liu J, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180214; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Neergaard-Petersen S, 2015, PLOS ONE, V10; Ogawa S, 2012, HAEMOPHILIA, V18, P926, DOI 10.1111/j.1365-2516.2012.02867.x; Overvad TF, 2015, STROKE, V46, P2168, DOI 10.1161/STROKEAHA.115.009371; Picard F, 2017, Ann Cardiol Angeiol (Paris), V66, P385, DOI 10.1016/j.ancard.2017.10.011; Radha RKN, 2016, J CLIN DIAGN RES, V10, pEC22, DOI 10.7860/JCDR/2016/21499.8353; Schuette C, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0182-7; Tripodi A, 2011, J THROMB THROMBOLYS, V31, P165, DOI 10.1007/s11239-010-0506-0; Varol E, 2010, J CARDIOL, V56, P154, DOI 10.1016/j.jjcc.2010.03.005; Vinik AI, 2001, DIABETES CARE, V24, P1476, DOI 10.2337/diacare.24.8.1476; Wender-Ozegowska E, 2018, GINEKOL POL, V89, P341, DOI 10.5603/GP.a2018.0059; WINOCOUR PD, 1992, THROMB HAEMOSTASIS, V68, P577; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	40	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0237843	10.1371/journal.pone.0237843	http://dx.doi.org/10.1371/journal.pone.0237843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031385	Green Published, gold			2022-12-26	WOS:000581809800087
J	Honda, Y; Kosugi, K; Fuchikami, C; Kuramoto, K; Numakura, Y; Kuwano, K				Honda, Yohei; Kosugi, Keiji; Fuchikami, Chiaki; Kuramoto, Kazuya; Numakura, Yuki; Kuwano, Keiichi			The selective PGI(2) receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats	PLOS ONE			English	Article							VASODILATOR RESPONSES; SIGNAL-TRANSDUCTION; THROMBOXANE A(2); PROSTACYCLIN; LESIONS; MRE-269	Pulmonary arterial hypertension (PAH) is a lethal disease characterized by a progressive increase in pulmonary artery pressure due to an increase in vessel tone and occlusion of vessels. The endogenous vasodilator prostacyclin and its analogs are used as therapeutic agents for PAH. However, their pharmacological effects on occlusive vascular remodeling have not been elucidated yet. Selexipag is a recently approved, orally available and selective prostacyclin receptor agonist with a non-prostanoid structure. In this study, we investigated the pharmacological effects of selexipag on the pathology of chronic severe PAH in Sprague-Dawley and Fischer rat models in which PAH was induced by a combination of injection with the vascular endothelial growth factor receptor antagonist Sugen 5416 and exposure to hypoxia (SuHx). Oral administration of selexipag for three weeks significantly improved right ventricular systolic pressure and right ventricular (RV) hypertrophy in Sprague-Dawley SuHx rats. Selexipag attenuated the proportion of lung vessels with occlusive lesions and the medial wall thickness of lung arteries, corresponding to decreased numbers of Ki-67-positive cells and a reduced expression of collagen type 1 in remodeled vessels. Administration of selexipag to Fischer rats with SuHx-induced PAH reduced RV hypertrophy and mortality caused by RV failure. These effects were probably based on the potent prostacyclin receptor agonistic effect of selexipag on pulmonary vessels. Selexipag has been approved and is used in the clinical treatment of PAH worldwide. It is thought that these beneficial effects of prostacyclin receptor agonists on multiple aspects of PAH pathology contribute to the clinical outcomes in patients with PAH.	[Honda, Yohei; Fuchikami, Chiaki; Numakura, Yuki] Nippon Shinyaku Co Ltd, Discovery Res Labs, Kyoto, Japan; [Kosugi, Keiji; Kuramoto, Kazuya; Kuwano, Keiichi] Nippon Shinyaku Co Ltd, R&D Adm Div, Kyoto, Japan	Nippon Shinyaku Co Ltd; Nippon Shinyaku Co Ltd	Honda, Y (corresponding author), Nippon Shinyaku Co Ltd, Discovery Res Labs, Kyoto, Japan.	y.honda@po.nippon-shinyaku.co.jp						Abe K, 2016, CARDIOVASC RES, V111, P16, DOI 10.1093/cvr/cvw070; Abe K, 2011, AM J RESP CELL MOL, V45, P804, DOI 10.1165/rcmb.2010-0371OC; Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Asaki T, 2015, J MED CHEM, V58, P7128, DOI 10.1021/acs.jmedchem.5b00698; Badejo AM, 2008, AM J PHYSIOL-LUNG C, V295, pL828, DOI 10.1152/ajplung.00042.2008; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Bogaard HJ, 2020, AM J RESP CRIT CARE, V201, P621, DOI 10.1164/rccm.201910-1983LE; Bogaard HJ, 2019, AM J RESP CRIT CARE, V200, P1447, DOI 10.1164/rccm.201906-1200LE; Bonnet S, 2017, AM J RESP CRIT CARE, V195, P583, DOI 10.1164/rccm.201607-1515PP; Chaudhary KR, 2018, BRIT J PHARMACOL, V175, P3976, DOI 10.1111/bph.14472; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Fuchikami C, 2017, EUR J PHARMACOL, V795, P75, DOI 10.1016/j.ejphar.2016.11.057; Galie N, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01889-2018; Gatfield J, 2017, J PHARMACOL EXP THER, V362, P186, DOI 10.1124/jpet.116.239665; Gomez-Arroyo J, 2015, EUR RESPIR J, V45, P449, DOI 10.1183/09031936.00188013; Humbert M, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01887-2018; Jernigan NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180455; Kato F, 2017, AM J PHYSIOL-LUNG C, V313, pL899, DOI 10.1152/ajplung.00527.2016; Kaufmann P, 2015, AM J CARDIOVASC DRUG, V15, P195, DOI 10.1007/s40256-015-0117-4; Kuwano K, 2008, J PHARMACOL EXP THER, V326, P691, DOI 10.1124/jpet.108.138305; Kuwano K, 2007, J PHARMACOL EXP THER, V322, P1181, DOI 10.1124/jpet.107.124248; Legchenko E, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao0303; Liu PP, 2015, INT J MOL MED, V35, P901, DOI 10.3892/ijmm.2015.2110; Mair KM, 2014, AM J RESP CRIT CARE, V190, P456, DOI 10.1164/rccm.201403-0483OC; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Nakamura A, 2007, BIOORGAN MED CHEM, V15, P7720, DOI 10.1016/j.bmc.2007.08.052; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; Olschewski H, 2004, PHARMACOL THERAPEUT, V102, P139, DOI 10.1016/j.pharmthera.2004.01.003; Orellana R, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2017.01.005; Pankey EA, 2011, AM J PHYSIOL-HEART C, V300, pH792, DOI 10.1152/ajpheart.00953.2010; Sakao S, 2010, AM J RESP CELL MOL, V43, P629, DOI 10.1165/rcmb.2009-0389TR; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Shinohara T, 2015, AM J PHYSIOL-LUNG C, V308, pL523, DOI 10.1152/ajplung.00129.2014; Simonneau G, 2012, EUR RESPIR J, V40, P874, DOI 10.1183/09031936.00137511; Sitbon O, 2015, NEW ENGL J MED, V373, P2522, DOI 10.1056/NEJMoa1503184; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Tamura Y, 2018, CIRC J, V82, P275, DOI 10.1253/circj.CJ-17-0139; Voelkel NF, 2012, EUR RESPIR J, V40, P1555, DOI 10.1183/09031936.00046612; Yamamoto K, 1995, GEN PHARMACOL-VASC S, V26, P1489, DOI 10.1016/0306-3623(95)00025-9; Yi ES, 2000, AM J RESP CRIT CARE, V162, P1577, DOI 10.1164/ajrccm.162.4.9912131; Zmajkovicova K, 2019, AM J RESP CELL MOL, V60, P578, DOI 10.1165/rcmb.2018-0142OC	43	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240692	10.1371/journal.pone.0240692	http://dx.doi.org/10.1371/journal.pone.0240692			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057388	Green Published, gold			2022-12-26	WOS:000581814700070
J	Ingraham, LR; Oswald, SA; Son, E; Arnold, JM				Ingraham, Laura R.; Oswald, Stephen A.; Son, Eunice; Arnold, Jennifer M.			Opportunistic predation of birds by breeding Herring Gulls (Larus argentatus)	PLOS ONE			English	Article							SKUAS STERCORARIUS-SKUA; GREAT SKUAS; INDIVIDUAL SPECIALIZATION; REPRODUCTIVE-PERFORMANCE; DIET; ECOLOGY; CONSERVATION; SEABIRDS; SUCCESS; COLONY	Dietary specialization, exploiting a small fraction of available food resources, is commonly reported for gulls and skuas. Predation of birds by these species is usually considered a specialist strategy employed by the minority of the population but non-specialists also predate birds and may actually have a greater impact on the prey species. To date, most studies have focused on predatory bird-specialists, down-playing the possible importance of opportunistic predation by non-specialists. We addressed this by studying diet (regurgitated pellets and prey remains) and behavior of breeding Herring Gulls (Larus argentatus) over three summers at Gull Island, a mixed-species breeding colony in Lake Ontario. One-third of all pellets analyzed contained bird remains, primarily the most numerous breeding bird: Ring-billed Gull (L.delawarensis) chicks (51%) and adults (36%). Although all but one pair of Herring Gulls ate birds, all pairs maintained broad and mostly similar diets, with birds accounting for at most one-third of prey. Behavior also indicated that Herring Gulls at Gull Island were not predatory bird-specialists because predation was too infrequent to meet energetic requirements, was largely unsuccessful and was only ever observed when Ring-billed Gulls strayed into Herring Gull breeding territories. Instead, bird predation appeared mainly opportunistic, increasing with seasonal availability, access to shoreline, proximity to nesting Ring-billed Gulls and breeding territory size. Compared with predatory specialist Herring Gulls in the same region, individuals that predated birds at Gull Island did not display specialist behaviors and killed six times fewer birds (0.1-0.4 per day, on average) but were over 20 times more numerous (98% of the population versus 4%). Thus, our results indicate that opportunistic predation by non-specialists may have important consequences for prey species. Since opportunistic predation cannot be effectively managed using techniques widely advocated for specialist predators, it is essential to investigate cause of predation by large gulls prior to lethal management.	[Ingraham, Laura R.; Oswald, Stephen A.; Son, Eunice; Arnold, Jennifer M.] Penn State Univ, Div Sci, Reading, PA 19610 USA; [Ingraham, Laura R.] EA Engn Sci & Technol Inc, PBC, Hunt Valley, MD 21031 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Arnold, JM (corresponding author), Penn State Univ, Div Sci, Reading, PA 19610 USA.	jma25@psu.edu			Penn State University 2016 Erickson Discovery Grant	Penn State University 2016 Erickson Discovery Grant	Penn State University 2016 Erickson Discovery Grant to LRI. https://undergradresearch.psu.edu/resources/opportunities/ericksondiscovery-grants The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No funding or salary for this project was provided by EA Engineering.	ANDERSSON M, 1976, IBIS, V118, P208, DOI 10.1111/j.1474-919X.1976.tb03066.x; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Barton K, 2016, **DATA OBJECT**, V1, P6; Besnard A, 2006, WATERBIRDS, V29, P481, DOI 10.1675/1524-4695(2006)29[481:FQCOAB]2.0.CO;2; Blodget BG, 1991, P E WILDL DAMAGE CON, V5, P212; Blokpoel H, 1997, COLON WATERBIRD, V20, P98, DOI 10.2307/1521769; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Burger J, 1996, HDB BIRDS WORLD, V3, P572; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Ceia FR, 2015, MAR BIOL, V162, P1923, DOI 10.1007/s00227-015-2735-4; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; Finney SK, 2003, J APPL ECOL, V40, P545, DOI 10.1046/j.1365-2664.2003.00810.x; Furness R. W., 1996, HDB BIRDS WORLD HOAT, V3, P556; HARIO M, 1994, ORNIS FENNICA, V71, P1; HATCH JJ, 1970, AUK, V87, P244, DOI 10.2307/4083918; HUNT GL, 1972, ECOLOGY, V53, P1051, DOI 10.2307/1935417; Jenkins CN, 2016, BIOL CONSERV, V204, P333, DOI 10.1016/j.biocon.2016.10.005; Mazerolle MJ, 2017, AICCMODAVG R PACKAGE; Nisbet ICT, 2017, BIRDS N AM ONLINE; Oswald SA, 2013, WATERBIRDS, V36, P385, DOI 10.1675/063.036.0318; PARNELL JF, 1988, COLON WATERBIRD, V11, P129, DOI 10.2307/1520996; PARSONS J, 1971, British Birds, V64, P528; PETRAITIS PS, 1979, ECOLOGY, V60, P703, DOI 10.2307/1936607; Phillips RA, 1999, J APPL ECOL, V36, P218, DOI 10.1046/j.1365-2664.1999.00391.x; Phillips RA, 1997, MAR ECOL PROG SER, V152, P285, DOI 10.3354/meps152285; Pichegru L, 2013, BIRD CONSERV INT, V23, P296, DOI 10.1017/S0959270912000135; Pierotti R., 1987, P417; PIEROTTI R, 1991, ECOLOGY, V72, P319, DOI 10.2307/1938925; PIETZ PJ, 1987, AUK, V104, P617, DOI 10.1093/auk/104.4.617; Sanz-Aguilar A, 2009, BIOL CONSERV, V142, P424, DOI 10.1016/j.biocon.2008.11.004; Sargeant BL, 2007, OIKOS, V116, P1431, DOI 10.1111/j.2007.0030-1299.15833.x; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Scopel LC, 2017, J WILDLIFE MANAGE, V81, P572, DOI 10.1002/jwmg.21233; Southern W.E., 1984, Colonial Waterbirds, V7, P105, DOI 10.2307/1521088; Spatz DR, 2014, CONSERV BIOL, V28, P1282, DOI 10.1111/cobi.12279; SPEAR LB, 1993, J ANIM ECOL, V62, P399, DOI 10.2307/5190; SWENNEN C, 1989, ARDEA, V77, P21; Szigeti V, 2019, OIKOS, V128, P649, DOI 10.1111/oik.05400; van Donk S, 2017, ECOL EVOL, V7, P4620, DOI 10.1002/ece3.3018; VELARDE E, 1992, COLON WATERBIRD, V15, P8, DOI 10.2307/1521349; Votier SC, 2004, J APPL ECOL, V41, P1117, DOI 10.1111/j.0021-8901.2004.00974.x; Votier SC, 2004, CONDOR, V106, P275, DOI 10.1650/7261; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Votier SC, 2001, BIRD STUDY, V48, P373, DOI 10.1080/00063650109461237; Votier SC, 2007, J AVIAN BIOL, V38, P234, DOI 10.1111/j.0908-8857.2007.03893.x; Votier SC, 2006, J ORNITHOL, V147, P405, DOI 10.1007/s10336-005-0021-9; WATANUKI Y, 1992, CONDOR, V94, P159, DOI 10.2307/1368805	49	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0239180	10.1371/journal.pone.0239180	http://dx.doi.org/10.1371/journal.pone.0239180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057336	Green Published, gold			2022-12-26	WOS:000581814700079
J	Sayed, AM; Shousha, MA; Islam, MDB; Eleiwa, TK; Kashem, R; Abdel-Mottaleb, M; Ozcan, E; Tolba, M; Cook, JC; Parrish, RK				Sayed, Ahmed M.; Shousha, Mohamed Abou; Baharul Islam, M. D.; Eleiwa, Taher K.; Kashem, Rashed; Abdel-Mottaleb, Mostafa; Ozcan, Eyup; Tolba, Mohamed; Cook, Jane C.; Parrish, Richard K., II			Mobility improvement of patients with peripheral visual field losses using novel see-through digital spectacles	PLOS ONE			English	Article							GLAUCOMA; DEVICE	Purpose To evaluate see-through Augmented Reality Digital spectacles (AR DSpecs) for improving the mobility of patients with peripheral visual field (VF) losses when tested on a walking track. Design Prospective Case Series. Participants 21 patients with peripheral VF defects in both eyes, with the physical ability to walk without assistance. Methods We developed the AR DSpecs as a wearable VF aid with an augmented reality platform. Image remapping algorithms produced personalized visual augmentation in real time based on the measured binocular VF with the AR DSpecs calibration mode. We tested the device on a walking track to determine if patients could more accurately identify peripheral objects. Main outcome measures We analyzed walking track scores (number of recognized/avoided objects) and eye tracking data (six gaze parameters) to measure changes in the kinematic and eye scanning behaviors while walking, and assessed a possible placebo effect by deactivating the AR DSpecs remapping algorithms in random trials. Results Performance, judged by the object detection scores, improved with the AR DSpecs (P<0.001, Wilcoxon rank sum test) with an average improvement rate of 18.81%. Two gaze parameters improved with the activated algorithm (P<0.01, paired t-test), indicating a more directed gaze on the central path with less eye scanning. Determination of the binocular integrated VF with the DSpecs correlated with the integrated standard automated perimetry (R = 0.86, P<0.001), mean sensitivity difference 0.8 +/- 2.25 dB (Bland-Altman). Conclusions AR DSpecs may improve walking maneuverability of patients with peripheral VF defects by enhancing detection of objects in a testing environment.	[Sayed, Ahmed M.] Helwan Univ, Dept Biomed Engn, Helwan, Egypt; [Sayed, Ahmed M.; Shousha, Mohamed Abou; Baharul Islam, M. D.; Eleiwa, Taher K.; Kashem, Rashed; Ozcan, Eyup; Tolba, Mohamed; Cook, Jane C.; Parrish, Richard K., II] Univ Miami, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Sayed, Ahmed M.] MSOE Univ, Elect Engn & Comp Sci, Milwaukee, WI 53202 USA; [Shousha, Mohamed Abou; Abdel-Mottaleb, Mostafa] Univ Miami, Dept Elect & Comp Engn, Miami, FL 33136 USA; [Shousha, Mohamed Abou] Univ Miami, Dept Biomed Engn, Miami, FL 33136 USA; [Baharul Islam, M. D.] Amer Univ Malta, Dept Comp Sci, Bml, Malta; [Eleiwa, Taher K.] Benha Univ, Dept Ophthalmol, Fac Med, Banha, Egypt; [Ozcan, Eyup] Net Eye Med Ctr, Gaziantep, Turkey	Egyptian Knowledge Bank (EKB); Helwan University; Bascom Palmer Eye Institute; University of Miami; Milwaukee School Engineering; University of Miami; University of Miami; Egyptian Knowledge Bank (EKB); Benha University	Sayed, AM (corresponding author), Helwan Univ, Dept Biomed Engn, Helwan, Egypt.; Sayed, AM; Shousha, MA (corresponding author), Univ Miami, Bascom Palmer Eye Inst, Miami, FL 33136 USA.; Sayed, AM (corresponding author), MSOE Univ, Elect Engn & Comp Sci, Milwaukee, WI 53202 USA.; Shousha, MA (corresponding author), Univ Miami, Dept Elect & Comp Engn, Miami, FL 33136 USA.; Shousha, MA (corresponding author), Univ Miami, Dept Biomed Engn, Miami, FL 33136 USA.	Mshousha@med.miami.edu; a.sayed@h-eng.helwan.edu.eg	Eleiwa, Taher/AAW-4546-2020; Sayed, Ahmed/AAM-4829-2021; Sayed, Ahmed/GQP-7743-2022; Islam, Baharul/R-3751-2019	Eleiwa, Taher/0000-0003-3107-2106; Islam, Baharul/0000-0002-9928-5776; Abou Shousha, Mohamed/0000-0002-4508-0492; Abdulhameed Sayed, Ahmed Mohamed/0000-0002-7477-9016; Parrish, Richard/0000-0001-8219-0271; Tolba, Mohamed Y/0000-0002-6431-0361	National Institute of Health (NIH), United States [K23 KEY026118A]; NEI core center grant, United Stated [P30 EY014801]; Research to Prevent Blindness (RPB), United States	National Institute of Health (NIH), United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI core center grant, United Stated; Research to Prevent Blindness (RPB), United States(Research to Prevent Blindness (RPB))	This research has been partially supported by the National Institute of Health (NIH, https://grants.nih.gov/funding/index.htm), United States, under Grant #K23 KEY026118A (MAS), NEI core center grant, United Stated, to the University of Miami (P30 EY014801), and Research to Prevent Blindness (RPB, https://www. rpbusa.org/rpb/?), United States. Research and its contents are solely the responsibility of the authors and do not necessarily represent the official view of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbaum H, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.6.8; Bengtsson B, 2008, AM J OPHTHALMOL, V145, P343, DOI 10.1016/j.ajo.2007.09.038; Bowers AR, 2004, OPHTHAL PHYSL OPT, V24, P296, DOI 10.1111/j.1475-1313.2004.00228.x; BRUNS G, 1992, SAFETY OF COMPUTER CONTROL SYSTEMS 1992 (SAFECOMP'92), P1; Chung DC, 2018, CLIN EXP OPHTHALMOL, V46, P247, DOI 10.1111/ceo.13022; Crabb DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009710; Crabb DP, 1998, BRIT J OPHTHALMOL, V82, P1236, DOI 10.1136/bjo.82.11.1236; de Haan GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134459; Deemer AD, 2018, OPTOMETRY VISION SCI, V95, P694, DOI 10.1097/OPX.0000000000001278; Dijkerman HC, 2003, EXP BRAIN RES, V153, P220, DOI 10.1007/s00221-003-1595-1; Ehrlich JR, 2017, AM J OPHTHALMOL, V176, P26, DOI 10.1016/j.ajo.2016.12.021; Hilkes R, 2020, European patent specification, Patent No. [EP2674805B1, 267485]; Houston KE, 2018, OPTOMETRY VISION SCI, V95, P795, DOI 10.1097/OPX.0000000000001280; Houston KE, 2015, INVEST OPHTH VIS SCI, V56, P4135, DOI 10.1167/iovs.14-15492; Hwang AD, 2014, OPTOMETRY VISION SCI, V91, P1021, DOI 10.1097/OPX.0000000000000326; Kotecha A, 2013, INVEST OPHTH VIS SCI, V54, P5408, DOI 10.1167/iovs.12-12026; Lajoie K, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.4.10; Luo G, 2006, INVEST OPHTH VIS SCI, V47, P4152, DOI 10.1167/iovs.05-1672; Luo G, 2009, INVEST OPHTH VIS SCI, V50, P4509, DOI 10.1167/iovs.08-2916; Markowitz SN, 2016, CAN J OPHTHALMOL, V51, P59, DOI 10.1016/j.jcjo.2015.11.002; Mihailovic A, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.3.23; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Ng M, 2012, J GLAUCOMA, V21, P551, DOI 10.1097/IJG.0b013e31821dac66; Olsen A, 2012, P S EYE TRACKING RES, P317, DOI [DOI 10.1145/2168556.2168625, 10.1145/2168556.2168625]; Patla AE, 2004, CAN J PHYSIOL PHARM, V82, P682, DOI 10.1139/Y04-058; Patodia Y, 2017, CLIN OPHTHALMOL, V11, P683, DOI 10.2147/OPTH.S128425; Sayed AM, 2020, AM J OPHTHALMOL, V210, P125, DOI 10.1016/j.ajo.2019.10.006; Sayed AM, 2020, AM J OPHTHALMOL, V210, P136, DOI 10.1016/j.ajo.2019.10.005; STOFFREGEN TA, 1987, PERCEPTION, V16, P113, DOI 10.1068/p160113; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Trese MGJ, 2016, OSLI RETINA, V47, P486, DOI 10.3928/23258160-20160419-15; Vega RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077294; Wittich W, 2018, OPTOMETRY VISION SCI, V95, P774, DOI 10.1097/OPX.0000000000001262; 2015, EPILEPSIA, V0056	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240509	10.1371/journal.pone.0240509	http://dx.doi.org/10.1371/journal.pone.0240509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052969	gold, Green Published			2022-12-26	WOS:000581820200007
J	Kim, SH; Jung, JH; Shin, HJ; Hahm, SC; Cho, HY				Kim, Sung-Hyeon; Jung, Jin-Hwa; Shin, Ho-jin; Hahm, Suk-Chan; Cho, Hwi-young			The impact of smartphone use on gait in young adults: Cognitive load vs posture of texting	PLOS ONE			English	Article							LOCAL DYNAMIC STABILITY; DRIVER DISTRACTION; VISUAL INFORMATION; OBSTACLE; PARAMETERS; ATTENTION; WALKING; STEP	Many researches have reported that the use of smartphones has a negative impact on gait variability and speed of pedestrians by dispersion of cognition, but the influence of factors other than cognitive function on gait is still unclear. The purpose of this study was to investigate the impact of smartphone use on spatiotemporal gait parameters in healthy young people while walking. 42 healthy young adults were recruited and instructed to walk in four conditions (walking without using a smartphone, typing on a smartphone with both hands, typing on a smartphone with one hand, and texting posture with non-task). All spatiotemporal gait parameters were measured using the GAITRite walkway. Compared to walking without using a smartphone, the subjects walked with a slower cadence and velocity and changed stride length and gait cycle and spent more time in contact with the ground when using a smartphone (p < 0.05). In addition, even if a texting posture was taken without performing a task, a similar change was observed when using a smartphone (p < 0.05). This study found that a cautious gait pattern occurred due to smartphone use, and that a change in gait appeared just by taking a posture without using smartphone.	[Kim, Sung-Hyeon; Shin, Ho-jin] Gachon Univ, Grad Sch, Dept Hlth Sci, Incheon, South Korea; [Jung, Jin-Hwa] Semyung Univ, Dept Occupat Therapy, Jecheon, South Korea; [Hahm, Suk-Chan] CHA Univ, Grad Sch Integrat Med, Seongnam, South Korea; [Cho, Hwi-young] Gachon Univ, Dept Phys Therapy, Incheon, South Korea	Gachon University; Semyung University; Pochon Cha University; Gachon University	Hahm, SC (corresponding author), CHA Univ, Grad Sch Integrat Med, Seongnam, South Korea.; Cho, HY (corresponding author), Gachon Univ, Dept Phys Therapy, Incheon, South Korea.	skchanhahmu@gmail.com; hwiyoung@gachon.ac.kr		Jung, Jin Hwa/0000-0002-3687-7096; Hahm, Suk-Chan/0000-0003-4067-3149; Cho, Hwi-young/0000-0003-0465-9665; kim, sung-hyeon/0000-0002-4725-4396	JH Jung National Research Foundation of Korea [NRF-2018R1C1B5041760]	JH Jung National Research Foundation of Korea(National Research Foundation of Korea)	JH Jung National Research Foundation of Korea (NRF-2018R1C1B5041760) https://www.nrf.re.kr/index The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese LD, 2014, GAIT POSTURE, V40, P658, DOI 10.1016/j.gaitpost.2014.07.017; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Fajen BR, 2003, J EXP PSYCHOL HUMAN, V29, P343, DOI 10.1037/0096-1523.29.2.343; Helbostad JL, 2009, GAIT POSTURE, V30, P233, DOI 10.1016/j.gaitpost.2009.05.004; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Jeon S, 2016, WORK, V53, P241, DOI 10.3233/WOR-152115; Kim HJ, 2017, J BEHAV ADDICT, V6, P699, DOI 10.1556/2006.6.2017.070; Lamberg EM, 2012, GAIT POSTURE, V35, P688, DOI 10.1016/j.gaitpost.2011.12.005; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Lee JD, 2004, HUM FACTORS, V46, P583, DOI 10.1518/hfes.46.4.583.56811; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Marigold DS, 2008, EXP BRAIN RES, V188, P23, DOI 10.1007/s00221-008-1335-7; Martin CL, 2006, MULT SCLER J, V12, P620, DOI 10.1177/1352458506070658; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; McPhee LC, 2004, HUM FACTORS, V46, P674, DOI 10.1518/hfes.46.4.674.56817; Mohagheghi AA, 2004, EXP BRAIN RES, V155, P459, DOI 10.1007/s00221-003-1751-7; Newzoo, 2018, TOP 50 COUNTR MARK S; Ortiz C, 2018, ACCIDENT ANAL PREV, V117, P239, DOI 10.1016/j.aap.2018.04.018; Patla AE, 2006, NEUROSCI LETT, V397, P110, DOI 10.1016/j.neulet.2005.12.016; Patla AE, 2003, EXP BRAIN RES, V148, P133, DOI 10.1007/s00221-002-1246-y; Punt M, 2015, GAIT POSTURE, V41, P504, DOI 10.1016/j.gaitpost.2014.12.002; Roche B, 2018, GAIT POSTURE, V66, P45, DOI 10.1016/j.gaitpost.2018.08.017; Schabrun SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084312; St George RJ, 2011, J PHYSIOL-LONDON, V589, P807, DOI 10.1113/jphysiol.2010.197665; Statista.com, 2018, SMARTPH US PEN PERC; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Strayer DL, 2006, HUM FACTORS, V48, P381, DOI 10.1518/001872006777724471; Strayer DL, 2004, HUM FACTORS, V46, P640, DOI 10.1518/hfes.46.4.640.56806; Strayer DL, 2003, J EXP PSYCHOL-APPL, V9, P23, DOI 10.1037/1076-898X.9.1.23; Wu Y, 2016, HUM MOVEMENT SCI, V45, P102, DOI 10.1016/j.humov.2015.10.005; Yang HS, 2015, GAIT POSTURE, V42, P430, DOI 10.1016/j.gaitpost.2015.07.010; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Yogev-Seligmann G, 2012, GAIT POSTURE, V35, P641, DOI 10.1016/j.gaitpost.2011.12.016	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240118	10.1371/journal.pone.0240118	http://dx.doi.org/10.1371/journal.pone.0240118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TU	33044974	Green Published, gold			2022-12-26	WOS:000581811700031
J	Niu, JQ; Ma, M; Yin, XN; Liu, XL; Dong, T; Sun, WT; Yang, FX				Niu, Junqiang; Ma, Ming; Yin, Xiaoning; Liu, Xinglu; Dong, Tie; Sun, Wentai; Yang, Fuxia			Transcriptional and physiological analyses of reduced density in apple provide insight into the regulation involved in photosynthesis	PLOS ONE			English	Article							PHOTOSYSTEM-II; POLYPHENOL OXIDASE; MISSING LINK; LIGHT; ARABIDOPSIS; PROTEINS; FAMILY; PHOSPHATASES; EVOLUTION; RESPONSES	Different densities have a great influence on the physiological process and growth of orchard plants. Exploring the molecular basis and revealing key candidate genes for different densities management of orchard has great significance for production capacity improvement. In this study, transcriptome sequencing of apple trees was carried out at three different sampling heights to determine gene expression patterns under high density(HD) and low density(LD) and the physiological indices were measured to determine the effect of density change on plants. As a result, physiological indexes showed that the content of Chlorophyll, ACC, RUBP and PEP in the LD was apparently higher than that in control group(high density, HD). While the content of PPO and AO in the LD was noticeably lower than that in the HD. There were 3808 differentially expressed genes (DEGs) were detected between HD and LD, of which 1935, 2390 and 1108 DEGs were found in the three comparisons(middle-upper, lower-outer and lower-inner), respectively. 274 common differentially expressed genes (co-DEGs) were contained in all three comparisons. Functional enrichment and KEGG pathway analysis found these genes were involved in Carbon fixation in photosynthetic organisms, Circadian rhythm, Photosynthesis - antenna proteins, Photosynthesis, chlorophyll metabolism, Porphyrin, sugar metabolism and so on. Among these genes,LHCBfamily participated in photosynthesis as parts of photosystem II. In addition,SPA1,rbcL,SNRK2,MYC2,BSK,SAURandPP2Care involved in Circadian rhythm, the expression of genes related to glycometabolism and hormone signaling pathway is also changed. The results revealed that the decrease of plant density changed the photosynthetic efficiency of leaves and the expression of photosynthesis-related genes, which provide a theoretical basis for the actual production regulation of apples.	[Niu, Junqiang; Ma, Ming; Yin, Xiaoning; Liu, Xinglu; Dong, Tie; Sun, Wentai; Yang, Fuxia] Gansu Acad Agr Sci, Inst Fruit & Floriculture Res, Lanzhou, Gansu, Peoples R China		Niu, JQ (corresponding author), Gansu Acad Agr Sci, Inst Fruit & Floriculture Res, Lanzhou, Gansu, Peoples R China.	niujq222@163.com			Discipline construction fund project of National Natural Science Foundation of China [31760556]; Agricultural science and technology innovation project of Gansu Academy of Agricultural Sciences [2016GAAS14]; National key Research and Development plan project [2016YFD001135]; Science and technology research project of apple industry in Gansu Province [GPCK2011-1]; Fruit tree science observation station project in Northwest China of Ministry of agriculture [10218020]	Discipline construction fund project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural science and technology innovation project of Gansu Academy of Agricultural Sciences; National key Research and Development plan project; Science and technology research project of apple industry in Gansu Province; Fruit tree science observation station project in Northwest China of Ministry of agriculture	This research was supported by Discipline construction fund project of National Natural Science Foundation of China (31760556), Agricultural science and technology innovation project of Gansu Academy of Agricultural Sciences (2016GAAS14); National key Research and Development plan project (2016YFD001135); Science and technology research project of apple industry in Gansu Province (GPCK2011-1); Fruit tree science observation station project in Northwest China of Ministry of agriculture (10218020).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Aleman F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28941; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Bartoli CG, 2006, J EXP BOT, V57, P1621, DOI 10.1093/jxb/erl005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betterle N, 2010, ARCH BIOCHEM BIOPHYS, V504, P67, DOI 10.1016/j.abb.2010.05.016; Boeckx T, 2015, ANN BOT-LONDON, V116, P529, DOI 10.1093/aob/mcv081; Bolger ME, 2018, BRIEF BIOINFORM, V19, P437, DOI 10.1093/bib/bbw135; Chen JW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-571; Chen YZ, 2014, J INTEGR PLANT BIOL, V56, P133, DOI 10.1111/jipb.12127; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; de Bianchi S, 2011, PLANT CELL, V23, P2659, DOI 10.1105/tpc.111.087320; Ding ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep31673; Ellis BE, 2012, GENETIC ENG PLANT SE; Evkaikina AI, 2017, GENOME BIOL EVOL, V9, P2444, DOI 10.1093/gbe/evx169; Ferraz AC, 2018, AN ACAD BRAS CIENC, V90, P255, DOI 10.1590/0001-3765201720150453; Fuchs S, 2014, P NATL ACAD SCI USA, V111, P5741, DOI 10.1073/pnas.1322085111; Guan HY, 2015, IEEE T INTELL TRANSP, V16, P194, DOI 10.1109/TITS.2014.2328589; Han M, 2008, FRONTIERS AGR CHINA, V2, P93, DOI [10.1007/s11703-008-0017-3, DOI 10.1007/S11703-008-0017-3]; JANAS PS, 1988, FOREST CHRON, V64, P320, DOI 10.5558/tfc64320-4; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Lin JC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21510-x; Liu WY, 2017, FOREST POLICY ECON, V78, P51, DOI 10.1016/j.forpol.2017.01.002; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Luo T, 2013, PLANT PHYSIOL BIOCH, V65, P17, DOI 10.1016/j.plaphy.2013.01.006; Ma J, 2018, J EXP BOT, V69, P5077, DOI 10.1093/jxb/ery282; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; McElhiney J, 2001, TOXICON, V39, P1411, DOI 10.1016/S0041-0101(01)00100-3; Moreno-Gutierrez C, 2011, PLANT CELL ENVIRON, V34, P1009, DOI 10.1111/j.1365-3040.2011.02300.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mujeeb-ur-Rahman, 2007, Pak J Biol Sci, V10, P4531, DOI 10.3923/pjbs.2007.4531.4534; Ning K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217066; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pietrzykowska M, 2014, PLANT CELL, V26, P3646, DOI 10.1105/tpc.114.127373; Reganold JP, 2001, NATURE, V410, P926, DOI 10.1038/35073574; Robles MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111092; Song TT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210672; Spartz AK, 2014, PLANT CELL, V26, P2129, DOI 10.1105/tpc.114.126037; Suorsa M, 2006, J BIOL CHEM, V281, P145, DOI 10.1074/jbc.M510600200; Trebst A, 1995, PHOTOSYNTH RES, V46, P41, DOI 10.1007/BF00020414; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang PC, 2013, P NATL ACAD SCI USA, V110, P11205, DOI 10.1073/pnas.1308974110; Wang YX, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4846-z; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu XD, 2019, P NATL ACAD SCI USA, V116, P20218, DOI 10.1073/pnas.1907540116; Zhu JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047593; Zuo ZC, 2011, CURR BIOL, V21, P841, DOI 10.1016/j.cub.2011.03.048	52	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0239737	10.1371/journal.pone.0239737	http://dx.doi.org/10.1371/journal.pone.0239737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044972	Green Published, gold			2022-12-26	WOS:000581811700030
J	Chen, CH; Patel, R; Bortolami, A; Sesti, F				Chen, Chih-Hsiung; Patel, Rahul; Bortolami, Alessandro; Sesti, Federico			A novel assay for drug screening that utilizes the heat shock response ofCaenorhabditis elegansnematodes	PLOS ONE			English	Article							C. ELEGANS; LIFE-SPAN; PROTEINS; ANTIDEPRESSANT; DISCOVERY; STRESS; HSP70	Biological organisms respond to environmental stressors by recruiting multiple cellular cascades that act to mitigate damage and ultimately enhance survival. This implies that compounds that interact with any of those pathways might improve organism's survival. Here, we report on an initial attempt to develop a drug screening assay based on the heat shock (HS) response ofCaenorhabditis elegansnematodes. The protocol works by subjecting the worms to two HS conditions in the absence/presence of the test compounds. Post-heat shock survival is quantified manually or in semi-automatic manner by analyzing z-stack pictures. We blindly screened a cassette of 72 compounds in different developmental stages provided by Eli Lilly through their Open Innovation Drug Discovery program. The analysis indicated that, on average, therapeutically useful drugs increase survival to HS compared to compounds used in non-clinical settings. We developed a formalism that estimates the probability of a compound to enhance survival based on a comparison with a set of parameters calculated from a pool of 35 FDA-approved drugs. The method correctly identified the developmental stages of the Lilly compounds based on their relative abilities to enhance survival to the HS. Taken together these data provide proof of principle that an assay that measures the HS response ofC.eleganscan offer physiological and pharmacological insight in a cost- and time-efficient manner.	[Chen, Chih-Hsiung; Bortolami, Alessandro; Sesti, Federico] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Patel, Rahul] Univ N Carolina, Neurosci Ctr, Chapel Hill, NC 27515 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Sesti, F (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA.	federico.sesti@rutgers.edu		Patel, Rahul/0000-0002-5398-2496	National Science Foundation [1826496]; National Institutes of Health [R01AG060919]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a National Science Foundation grant (1826496) and by a National Institutes of Health grant (R01AG060919) to FS.	Anderson EN, 2016, MECH AGEING DEV, V154, P30, DOI 10.1016/j.mad.2016.01.004; [Anonymous], 2007, NAT REV DRUG DISCOV, V6, P853, DOI 10.1038/nrd2460; [Anonymous], 1989, SELECTED WORKS J NEH, V8, P233; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2014, ACME INT E J CRITICA, V13, P206; Bolhassani A, 2019, CLIN CHIM ACTA, V498, P90, DOI 10.1016/j.cca.2019.08.015; Butler KV, 2017, J CHEM INF MODEL, V57, P2699, DOI 10.1021/acs.jcim.7b00343; Cai SQ, 2005, NAT NEUROSCI, V8, P1503, DOI 10.1038/nn1557; Carretero M, 2017, CURR TOP MED CHEM, V17, P2067, DOI 10.2174/1568026617666170131114401; Cotella D, 2013, FASEB J, V27, P1381, DOI 10.1096/fj.12-222778; Cruz-Corchado J, 2020, G3-GENES GENOM GENET, V10, P1225, DOI 10.1534/g3.120.401088; Ding Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073919, 10.1371/journal.pone.0056877]; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Feldman N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085964; Flavel MR, 2018, G3-GENES GENOM GENET, V8, P567, DOI 10.1534/g3.117.300325; Gillman PK, 2007, BRIT J PHARMACOL, V151, P737, DOI 10.1038/sj.bjp.0707253; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; HESCHL MFP, 1990, COMP BIOCHEM PHYS B, V96, P633, DOI 10.1016/0305-0491(90)90206-9; Ikwegbue PC, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010002; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jones Quinton, 2011, Inflammation & Allergy Drug Targets, V10, P247, DOI 10.2174/187152811796117726; Kong DX, 2009, J CHEM INF MODEL, V49, P2376, DOI 10.1021/ci900229c; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; MacRae CA, 2015, NAT REV DRUG DISCOV, V14, P721, DOI 10.1038/nrd4627; O'Reilly LP, 2014, ADV DRUG DELIVER REV, V69, P247, DOI 10.1016/j.addr.2013.12.001; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Patel R, 2017, BIOCHEM BIOPH RES CO, V492, P338, DOI 10.1016/j.bbrc.2017.08.112; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; San Gil R, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0208-6; Sharp FR, 2013, TRANSL STROKE RES, V4, P685, DOI 10.1007/s12975-013-0271-4; Stegeman GW, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0510-z; Tatum MC, 2015, CURR BIOL, V25, P163, DOI 10.1016/j.cub.2014.11.040; Xiong HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10454-3; Zevian SC, 2014, METHODS, V68, P450, DOI 10.1016/j.ymeth.2014.04.015	36	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240255	10.1371/journal.pone.0240255	http://dx.doi.org/10.1371/journal.pone.0240255			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035268	gold, Green Published			2022-12-26	WOS:000581817500038
J	Buanafina, MMD; Buanafina, MF; Dalton, S; Morris, P; Kowalski, M; Yadav, MK; Capper, L				de O. Buanafina, Marcia M.; Buanafina, M. Fernanda; Dalton, Sue; Morris, Phillip; Kowalski, Marissa; Yadav, Manav K.; Capper, Lindsay			Probing the role of cell wall feruloylation during maize development by differential expression of an apoplast targeted fungal ferulic acid esterase	PLOS ONE			English	Article							DIFERULATE CROSS-LINKS; TALL FESCUE; COUPLING-PRODUCTS; DIGESTIBILITY; WHEAT; RICE; INTERNODE; COMPLEX; PLANT; GLUCURONOARABINOXYLANS	While many aspects of the growth of maize are well understood, the role of cell wall feruloylation particularly during internode elongation has not been firmly established, but results so far indicate that it has significant implications for both biofuel feedstock conversion and for crop yield. The growth of the cell wall is achieved by synthesis, integration and cross-linking between wall polymers. As ferulate oxidative coupling of arabinoxylan side chains constitutes a significant type of cross-link in grass cell walls, it is expected to have a crucial role in plant growth. Making use of plants expressing an apoplast targetedAspergillus nigerFAEA under the control of either a constitutive or an inducible promoter, the role of cell wall feruloylation in maize internode expansion was investigated. Analysis of FAEA expressing plants showed that where FAEA was targeted to the apoplast under a constitutive promoter, plants varied in stature either from semi-dwarf plants with a 40-60% height reduction, to extreme dwarf mutants with over 90% reduction in plant heights compared to controls. Results indicate that disruption of cell wall feruloylation by FAEA occurs before the start of rapid internode expansion is initiated and affects the normal course of internode elongation, resulting in short internodes and dwarfed plants. In contrast, when under the inducibleLm See1senescence promoter, FAEA activity was found to be low up to the VT stage of development but increased significantly at the VR stage as plants began to senesce, strongly suggesting that normal cell wall feruloylation is required for the process of internode expansion. In addition, with apoplast targeted expression of FAEA under control of the senescence enhanced promoter it was possible to demonstrate decreased cell wall feruloylation without affecting internode expansion or other aspects of plant development.	[de O. Buanafina, Marcia M.; Buanafina, M. Fernanda; Kowalski, Marissa; Yadav, Manav K.; Capper, Lindsay] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Dalton, Sue; Morris, Phillip] Inst Grassland & Environm Res, Aberystwyth, Dyfed, Wales	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Aberystwyth University	Buanafina, MMD (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	mmb26@psu.edu			U.S. Department of Agriculture (USDA) [2009-35318-o513]; Office of Science Engagement; Center of Excellence in Industrial Biotechnology; Eberly College of Science	U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Office of Science Engagement; Center of Excellence in Industrial Biotechnology; Eberly College of Science	Authors who received award: MMdOB Grants awarded: U.S. Department of Agriculture (USDA), grant number 2009-35318-o513, the Office of Science Engagement, Eberly College of Science and the Center of Excellence in Industrial Biotechnology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CT, 2010, PLANT PHYSIOL, V152, P787, DOI 10.1104/pp.109.150128; Appeldoorn MM, 2013, CARBOHYD RES, V381, P33, DOI 10.1016/j.carres.2013.08.024; BERGVINSON DJ, 1994, CAN J BOT, V72, P1243, DOI 10.1139/b94-152; Bidhendi AJ, 2016, J EXP BOT, V67, P449, DOI 10.1093/jxb/erv535; Bily AC, 2003, PHYTOPATHOLOGY, V93, P712, DOI 10.1094/PHYTO.2003.93.6.712; Bollhoner B, 2012, J EXP BOT, V63, P1081, DOI 10.1093/jxb/err438; Buanafina MMDO, 2008, PLANT BIOTECHNOL J, V6, P264, DOI 10.1111/j.1467-7652.2007.00317.x; Buanafina MMD, 2006, APPL BIOCHEM BIOTECH, V130, P416; Buanafina MMD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185312; Buanafina MMD, 2015, PLANTA, V242, P97, DOI 10.1007/s00425-015-2288-2; Buanafina MMDO, 2012, PLANTA, V236, P1757, DOI 10.1007/s00425-012-1724-9; Buanafina MMD, 2012, PLANTA, V236, P513, DOI 10.1007/s00425-012-1625-y; Buanafina MMD, 2010, PLANT BIOTECHNOL J, V8, P316, DOI 10.1111/j.1467-7652.2009.00485.x; Bunzel M, 2004, J AGR FOOD CHEM, V52, P6496, DOI 10.1021/jf040204p; Bunzel M, 2001, J SCI FOOD AGR, V81, P653, DOI 10.1002/jsfa.861; Chiniquy D, 2012, P NATL ACAD SCI USA, V109, P17117, DOI 10.1073/pnas.1202079109; de Souza WR, 2018, NEW PHYTOL, V218, P81, DOI 10.1111/nph.14970; DEVI SR, 1992, J CHEM ECOL, V18, P1981, DOI 10.1007/BF00981921; deVries RP, 1997, APPL ENVIRON MICROB, V63, P4638, DOI 10.1128/AEM.63.12.4638-4644.1997; Frame BR, 2000, IN VITRO CELL DEV-PL, V36, P21, DOI 10.1007/s11627-000-0007-5; Fry SC, 2000, PLANTA, V211, P679, DOI 10.1007/s004250000330; Fry Stephen C., 2004, Phytochemistry Reviews, V3, P97, DOI 10.1023/B:PHYT.0000047808.74647.43; Funk C, 2005, PHYTOCHEMISTRY, V66, P363, DOI 10.1016/j.phytochem.2004.12.008; Grabber JH, 1998, J SCI FOOD AGR, V77, P193, DOI 10.1002/(SICI)1097-0010(199806)77:2<193::AID-JSFA25>3.0.CO;2-A; Grabber JH, 2000, J AGR FOOD CHEM, V48, P6106, DOI 10.1021/jf0006978; HARRIS PJ, 1980, BIOCHEM SYST ECOL, V8, P153, DOI 10.1016/0305-1978(80)90008-3; HARRIS PJ, 1976, NATURE, V259, P508, DOI 10.1038/259508a0; Hu WJ, 1999, NAT BIOTECHNOL, V17, P808, DOI 10.1038/11758; Huisman MMH, 2000, CARBOHYD POLYM, V43, P269, DOI 10.1016/S0144-8617(00)00154-5; ITOH T, 1976, BOT MAG TOKYO, V89, P291, DOI 10.1007/BF02493305; JACQUET G, 1995, J AGR FOOD CHEM, V43, P2746, DOI 10.1021/jf00058a037; Jones AM, 2001, PROGR BIOTECHNOL, V18, P29, DOI 10.1016/S0921-0423(01)80053-8; Jung HG, 2011, J DAIRY SCI, V94, P5124, DOI 10.3168/jds.2011-4495; Jung HJG, 2003, PHYTOCHEMISTRY, V63, P543, DOI 10.1016/S0031-9422(03)00221-8; Kende H, 1998, PLANT PHYSIOL, V118, P1105, DOI 10.1104/pp.118.4.1105; Konishi T, 2011, PHYTOCHEMISTRY, V72, P1962, DOI 10.1016/j.phytochem.2011.07.012; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Li Q, 2004, PLANT CELL REP, V22, P816, DOI 10.1007/s00299-004-0762-6; MacAdam JW, 2002, PLANTA, V215, P785, DOI 10.1007/s00425-002-0812-7; MARKWALDER HU, 1976, PHYTOCHEMISTRY, V15, P836, DOI 10.1016/S0031-9422(00)94474-1; Martin Randy, 1992, SOCIAL TEXT, V33, P103; Martinez-Rubio R, 2020, PHYTOCHEMISTRY, V170, DOI 10.1016/j.phytochem.2019.112219; Mastrangelo L, 2009, PLANTA, V229, P343, DOI 10.1007/s00425-008-0834-x; MORRISON TA, 1994, CROP SCI, V34, P1055, DOI 10.2135/cropsci1994.0011183X003400040040x; Ng A, 1998, J AGR FOOD CHEM, V46, P3365, DOI 10.1021/jf9711101; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Obel N, 2003, PLANTA, V216, P620, DOI 10.1007/s00425-002-0863-9; Obro J, 2004, PHYTOCHEMISTRY, V65, P1429, DOI 10.1016/j.phytochem.2004.05.002; Pellny TK, 2020, PLANT BIOTECHNOL J, V18, P2316, DOI 10.1111/pbi.13393; RALPH J, 1995, CARBOHYD RES, V275, P167, DOI 10.1016/0008-6215(95)00237-N; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Ritchie SW, 1986, 48 IW STAT U SCI TEC; SAS, 2015, SAS SYST SAS ONL DOC; SCALBERT A, 1985, PHYTOCHEMISTRY, V24, P1359, DOI 10.1016/S0031-9422(00)81133-4; Schopfer P, 2006, AM J BOT, V93, P1415, DOI 10.3732/ajb.93.10.1415; SCHUNMANN PHD, 1994, PLANT CELL ENVIRON, V17, P1315, DOI 10.1111/j.1365-3040.1994.tb00533.x; SCOBBIE L, 1993, J SCI FOOD AGR, V61, P217, DOI 10.1002/jsfa.2740610213; SIEMER EG, 1969, AGRON J, V61, P14, DOI 10.2134/agronj1969.00021962006100010005x; TOKI S, 1992, PLANT PHYSIOL, V100, P1503, DOI 10.1104/pp.100.3.1503; VERBRUGGEN MA, 1995, J CEREAL SCI, V21, P271, DOI 10.1006/jcrs.1995.0030; Vermerris W, 2010, J EXP BOT, V61, P2479, DOI 10.1093/jxb/erq093; Vissenberg K, 2005, J EXP BOT, V56, P673, DOI 10.1093/jxb/eri048; Waldron Keith W., 2007, V25, P183; Waterstraat M, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00190; WEYERS JDB, 1981, J EXP BOT, V32, P837, DOI 10.1093/jxb/32.4.837; Zhang QS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-27; Zhang Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219923	67	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240369	10.1371/journal.pone.0240369	http://dx.doi.org/10.1371/journal.pone.0240369			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035255	Green Published, gold			2022-12-26	WOS:000581817500017
J	Nouri, H; Moghimi, H; Marashi, SA; Elahi, E				Nouri, Hoda; Moghimi, Hamid; Marashi, Sayed-Amir; Elahi, Elahe			Impact of hfq and sigE on the tolerance of Zymomonas mobilis ZM4 to furfural and acetic acid stresses	PLOS ONE			English	Article							ETHANOL-PRODUCTION; STRAIN; HYDROLYSATE; IMPROVEMENT; INHIBITORS; DISCOVERY; SUGARS; GENE; PCR	Zymomonas mobilis, as an ethanologenic microorganism with many desirable industrial features, faces crucial obstacles in the lignocellulosic ethanol production process. A significant hindrance occurs during the pretreatment procedure that not only produces fermentable sugars but also releases severe toxic compounds. As diverse parts of regulation networks are involved in different aspects of complicated tolerance to inhibitors, we developed ZM4-hfq and ZM4-sigE strains, in which hfq and sigE genes were overexpressed, respectively. ZM4-hfq is a transcription regulator and ZM4-sigE is a transcription factor that are involved in multiple stress responses. In the present work, by overexpressing these two genes, we evaluated their impact on the Z. mobilis tolerance to furfural, acetic acid, and sugarcane bagasse hydrolysates. Both recombinant strains showed increased growth rates and ethanol production levels compared to the parental strain. Under a high concentration of furfural, the growth rate of ZM4-hfq was more inhibited compared to ZM4-sigE. More precisely, fermentation performance of ZM4-hfq revealed that the yield of ethanol production was less than that of ZM4-sigE, because more unused sugar had remained in the medium. In the case of acetic acid, ZM4-sigE was the superior strain and produced four and two-fold more ethanol compared to the parental strain and ZM4-hfq, respectively. Comparison of inhibitor tolerance between single and multiple toxic inhibitors in the fermentation of sugarcane bagasse hydrolysate by ZM4-sigE strain showed similar results. In addition, ethanol production performance was considerably higher in ZM4-sigE as well. Finally, the results of the qPCR analysis suggested that under both furfural and acetic acid treatment experiments, overproduction of both hfq and sigE improves the Z. mobilis tolerance and its ethanol production capability. Overall, our study showed the vital role of the regulatory elements to overcome the obstacles in lignocellulosic biomass-derived ethanol and provide a platform for further improvement by directed evolution or systems metabolic engineering tools.	[Nouri, Hoda; Moghimi, Hamid] Univ Tehran, Sch Biol, Dept Microbial Biotechnol, Coll Sci, Tehran, Iran; [Marashi, Sayed-Amir] Univ Tehran, Dept Biotechnol, Coll Sci, Tehran, Iran; [Elahi, Elahe] Univ Tehran, Sch Biol, Coll Sci, Tehran, Iran	University of Tehran; University of Tehran; University of Tehran	Moghimi, H (corresponding author), Univ Tehran, Sch Biol, Dept Microbial Biotechnol, Coll Sci, Tehran, Iran.	hmoghimi@ut.ac.ir	Marashi, Sayed-Amir/A-5384-2008	Marashi, Sayed-Amir/0000-0001-9801-7449; Moghimi, Hamid/0000-0002-9454-7474				Agrawal M, 2011, BIOTECHNOL LETT, V33, P2127, DOI 10.1007/s10529-011-0677-6; [Anonymous], 2016, KARDIOVASKULYARNAYA, V15, P4, DOI DOI 10.15829/1728-8800-2016-2-4-19; Bartkiene A, 2019, RETHINKING ECOLOGICAL CITIZENSHIP, P1, DOI 10.1080/00344087.2019.1581873; Cho SH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02432; Cho SH, 2014, APPL ENVIRON MICROB, V80, P4189, DOI 10.1128/AEM.00429-14; Dong HW, 2013, BIOTECHNOL BIOENG, V110, P2395, DOI 10.1002/bit.24897; Feng Quanzhou, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P37; Haning K, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02987; He MX, 2012, APPL MICROBIOL BIOT, V95, P189, DOI 10.1007/s00253-012-4155-4; Huang SZ, 2018, APPL MICROBIOL BIOT, V102, P3337, DOI 10.1007/s00253-018-8817-8; Jennings EW, 2011, BIORESOURCE TECHNOL, V102, P1240, DOI 10.1016/j.biortech.2010.08.024; Jeon YJ, 2010, LETT APPL MICROBIOL, V51, P518, DOI 10.1111/j.1472-765X.2010.02923.x; Joachimstahl E, 1998, BIOTECHNOL LETT, V20, P137, DOI 10.1023/A:1005320306410; Krishnan MS, 2000, 21 S BIOT FUELS CHEM; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mohagheghi A, 2004, BIOTECHNOL LETT, V26, P321, DOI 10.1023/B:BILE.0000015451.96737.96; Nouri H., 2020, SCI REP-UK, V10, P1; Nouri H, 2018, ENVIRON PROG SUSTAIN, V37, P1169, DOI 10.1002/ep.12769; Nouri H, 2017, ANN MICROBIOL, V67, P633, DOI 10.1007/s13213-017-1292-0; Sambrook J., 2001, MOL CLONING LAB MANU; Bocanegra CLS, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0431-7; Schell DJ, 2016, BIORESOURCE TECHNOL, V205, P153, DOI 10.1016/j.biortech.2016.01.024; Seo JS, 2005, NAT BIOTECHNOL, V23, P63, DOI 10.1038/nbt1045; Serate J, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0356-2; Shui ZX, 2015, APPL MICROBIOL BIOT, V99, P5739, DOI 10.1007/s00253-015-6616-z; Tan FR, 2015, APPL MICROBIOL BIOT, V99, P5363, DOI 10.1007/s00253-015-6577-2; Wang W., 2019, BIOTECHNOL BIOFUELS, V12, P1; Wang X, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0714-3; Wang Y, 2008, DEV ACETIC ACID TOLE; Wu B, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-018-1348-9; Xia J, 2019, TRENDS BIOTECHNOL; Yang S, 2013, PLOS ONE, V8; Yang SH, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00013; Yang SH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00246; Yang SH, 2010, P NATL ACAD SCI USA, V107, P10395, DOI 10.1073/pnas.0914506107; Yang SH, 2010, BMC MICROBIOL, V10, DOI [10.1186/1471-2180-10-135, 10.1186/1471-2229-10-85]; Yang YF, 2018, BIORESOUR BIOPROCESS, V5, DOI 10.1186/s40643-018-0193-9; Yi X, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0333-9; Zhang K, 2019, APPL MICROBIOL BIOT, V103, P2087, DOI 10.1007/s00253-019-09620-6; Zhang Y, 2010, J MICROBIOL BIOTECHN, V20, P1156, DOI 10.4014/jmb.0912.12036; Zhao N, 2014, BIOTECHNOL J, V9, P362, DOI 10.1002/biot.201300367	41	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240330	10.1371/journal.pone.0240330	http://dx.doi.org/10.1371/journal.pone.0240330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035245	gold, Green Published			2022-12-26	WOS:000581817500041
J	Allender, MC; Ravesi, MJ; Haynes, E; Ospina, E; Petersen, C; Phillips, CA; Lovich, R				Allender, Matthew C.; Ravesi, Michael J.; Haynes, Ellen; Ospina, Emilie; Petersen, Christopher; Phillips, Christopher A.; Lovich, Robert			Ophidiomycosis, an emerging fungal disease of snakes: Targeted surveillance on military lands and detection in the western US and Puerto Rico	PLOS ONE			English	Article							MASSASAUGA SISTRURUS-CATENATUS; OPHIODIICOLA INFECTION; PYGMY RATTLESNAKES; CAUSATIVE AGENT; HUMAN HEALTH; BIODIVERSITY; PREVALENCE; THREATS	Wildlife disease surveillance and pathogen detection are fundamental for conservation, population sustainability, and public health. Detection of pathogens in snakes is often overlooked despite their essential roles as both predators and prey within their communities. Ophidiomycosis (formerly referred to as Snake Fungal Disease, SFD), an emergent disease on the North American landscape caused by the fungusOphidiomyces ophiodiicola, poses a threat to snake population health and stability. We tested 657 individual snakes representing 58 species in 31 states from 56 military bases in the continental US and Puerto Rico forO.ophiodiicola.Ophidiomyces ophiodiicolaDNA was detected in samples from 113 snakes for a prevalence of 17.2% (95% CI: 14.4-20.3%), representing 25 species from 19 states/territories, including the first reports of the pathogen in snakes in Idaho, Oklahoma, and Puerto Rico. Most animals were ophidiomycosis negative (n = 462), withOphidiomycesdetected by qPCR (n = 64), possible ophidiomycosis (n = 82), and apparent ophidiomycosis (n = 49) occurring less frequently. Adults had 2.38 times greater odds than juveniles of being diagnosed with ophidiomycosis. Snakes from Georgia, Massachusetts, Pennsylvania, and Virginia all had greater odds of ophidiomycosis diagnosis, while snakes from Idaho were less likely to be diagnosed with ophidiomycosis. The results of this survey indicate that this pathogen is endemic in the eastern US and identified new sites that could represent emergence or improved detection of endemic sites. The direct mortality of snakes with ophidiomycosis is unknown from this study, but the presence of numerous individuals with clinical disease warrants further investigation and possible conservation action.	[Allender, Matthew C.; Haynes, Ellen; Ospina, Emilie] Univ Illinois, Dept Vet Clin Med, Coll Vet Med, Wildlife Epidemiol Lab,Vet Diagnost Lab, Urbana, IL 61801 USA; [Allender, Matthew C.; Phillips, Christopher A.] Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Ravesi, Michael J.] Sess Woods WMA, Connecticut Dept Energy & Environm Protect, Wildlife Div, Burlington, CT USA; [Petersen, Christopher] Naval Facil Engn Command Atlantic, Norfolk, VA USA; [Lovich, Robert] Naval Facil Engn Command Southwest, San Diego, CA USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Allender, MC (corresponding author), Univ Illinois, Dept Vet Clin Med, Coll Vet Med, Wildlife Epidemiol Lab,Vet Diagnost Lab, Urbana, IL 61801 USA.; Allender, MC (corresponding author), Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Champaign, IL 61820 USA.	mcallend@illinois.edu		Allender, Matthew/0000-0001-9067-1964; Haynes, Ellen/0000-0002-0033-0304	Legacy Resource Management Program [17-838]	Legacy Resource Management Program	Legacy Resource Management Program 17-838.	Agugliaro J, 2020, FUNCT ECOL, V34, P486, DOI 10.1111/1365-2435.13487; Allender MC, 2016, J WILDLIFE DIS, V52, P694, DOI 10.7589/2015-12-333; Allender MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140193; Allender MC, 2015, FUNGAL ECOL, V17, P187, DOI 10.1016/j.funeco.2015.05.003; Allender MC, 2015, J VET DIAGN INVEST, V27, P217, DOI 10.1177/1040638715573983; Allender MC, 2011, EMERG INFECT DIS, V17, P2383, DOI 10.3201/eid1712.110240; [Anonymous], 2019, MODEL SELECTION MULT; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Archer GA, 2017, J ZOO WILDLIFE MED, V48, P1127, DOI 10.1638/2017-0148r.1; Aycrigg JL, 2015, CONSERV LETT, V8, P306, DOI 10.1111/conl.12197; BAKER SJ, 2019, HERPETOL REV, V50, P279; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Bayles BR, 2016, ECOHEALTH, V13, P443, DOI 10.1007/s10393-016-1137-5; Benton N., 2008, CONSERVING BIODIVERS; Burbrink FT, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701387; Chongsuvivatwong V., 2018, **DATA OBJECT**; Clark RW, 2011, BIOL CONSERV, V144, P886, DOI 10.1016/j.biocon.2010.12.001; Crawford JA, 2017, J FISH WILDL MANAG, V8, P344, DOI 10.3996/012017-JFWM-003; Crother B. I., 2017, SSAR HERPETOLOGICAL; Dolinski Amanda C., 2014, Journal of Herpetological Medicine and Surgery, V24, P7, DOI 10.5818/1529-9651-24.1.7; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Figueroa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161070; Franklinos LHV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03352-1; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; Harfoot MBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001841; Hileman ET, 2018, J WILDLIFE MANAGE, V82, P173, DOI 10.1002/jwmg.21345; Kabay E, 2013, P EC SOC AM ANN C 98; Lannoo MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022211; Lind CM, 2019, J ZOOL, V307, P104, DOI 10.1111/jzo.12628; Lind CM, 2019, J HERPETOL, V53, P282, DOI 10.1670/18-147; Lind CM, 2018, J WILDLIFE DIS, V54, P352, DOI 10.7589/2017-05-109; Lorch JM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0457; Lorch JM, 2015, MBIO, V6, DOI 10.1128/mBio.01534-15; Lovich RE, 2015, STRATEGIC PLAN AMPHI; McBride MP, 2015, J ZOO WILDLIFE MED, V46, P86, DOI 10.1638/2012-0248R2.1; Mccoy CM, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cow077; McKenzie JM, 2019, ECOHEALTH, V16, P141, DOI 10.1007/s10393-018-1384-8; Molyneux DH, 2018, PARASITOLOGY, V145, P1647, DOI [10.1017/S0031182018000069, 10.1017/s0031182018000069]; Myers SS, 2013, P NATL ACAD SCI USA, V110, P18753, DOI 10.1073/pnas.1218656110; Myers SS, 2009, ANNU REV ENV RESOUR, V34, P223, DOI 10.1146/annurev.environ.033108.102650; Nguyen VM, 2017, CONSERV BIOL, V31, P789, DOI 10.1111/cobi.12857; O'Dea MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165209; Ostfeld RS, 2004, FRONT ECOL ENVIRON, V2, P13, DOI 10.1890/1540-9295(2004)002[0013:APGFYH]2.0.CO;2; Pecl GT, 2017, SCIENCE, V355, DOI 10.1126/science.aai9214; Petersen CE, 2018, HERPETOL CONSERV BIO, V13, P652; Petersen CE, 2016, ECOHEALTH, V13, P368, DOI 10.1007/s10393-016-1101-4; Pontremoli C, 2018, INFECT GENET EVOL, V64, P212, DOI 10.1016/j.meegid.2018.06.031; Reino L, 2018, SCI TOTAL ENVIRON, V625, P1596, DOI 10.1016/j.scitotenv.2018.01.007; Robertson J, 2016, J ZOO WILDLIFE MED, V47, P337, DOI 10.1638/2014-0222.1; Rzadkowska M, 2016, J WILDLIFE DIS, V52, P759, DOI 10.7589/2016-01-012; Sigler L, 2013, J CLIN MICROBIOL, V51, P3338, DOI 10.1128/JCM.01465-13; Stein BA, 2008, BIOSCIENCE, V58, P339, DOI 10.1641/B580409; Tetzlaff SJ, 2017, HERPETOL CONSERV BIO, V12, P624; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Titeux N, 2016, GLOBAL CHANGE BIOL, V22, P2505, DOI 10.1111/gcb.13272; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	58	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240415	10.1371/journal.pone.0240415	http://dx.doi.org/10.1371/journal.pone.0240415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031451	Green Published, gold			2022-12-26	WOS:000581809800049
J	van de Vossenberg, BTLH; Visser, M; Bruinsma, M; Koenraadt, HMS; Westenberg, M; Botermans, M				van de Vossenberg, Bart T. L. H.; Visser, Michael; Bruinsma, Maaike; Koenraadt, Harrie M. S.; Westenberg, Marcel; Botermans, Marleen			Real-time tracking of Tomato brown rugose fruit virus (ToBRFV) outbreaks in the Netherlands using Nextstrain	PLOS ONE			English	Article								Tomato brown rugose fruit virus (ToBRFV) is aTobamovirusthat was first observed in 2014 and 2015 on tomato plants in Israel and Jordan respectively. Since the first description, the virus has been reported from all continents except Oceania and Antarctica, and has been found infecting both tomato and pepper crops. In October 2019, the Dutch National Plant Protection Organization received a ToBRFV infected tomato sample as part of a generic survey targeting tomato pests. Presence of the virus was verified using Illumina sequencing. A follow-up survey was initiated to determine the extent of ToBRFV presence in the Dutch tomato horticulture and identify possible linkages between ToBRFV genotypes, companies and epidemiological traits. Nextstrain was used to visualize these potential connections. By November 2019, 68 companies had been visited of which 17 companies were found to be infected. The 50 ToBRFV genomes from these outbreak locations group in three main clusters, which are hypothesized to represent three original sources. No correlation was found between genotypes, companies and epidemiological traits, and the source(s) of the Dutch ToBRFV outbreak remain unknown. This paper describes a Nextstrain build containing ToBRFV genomes up to and including November 2019. Sharing data with this interactive online tool will enable the plant virology field to better understand and communicate the diversity and spread of this new virus. Organizations are invited to share data or materials for inclusion in the Nextstrain build, which can be accessed at https://nextstrain.nrcnvwa.nl/ToBRFV/20191231.	[van de Vossenberg, Bart T. L. H.; Visser, Michael; Westenberg, Marcel; Botermans, Marleen] Dutch Natl Plant Protect Org, Natl Reference Ctr Plant Hlth, Wageningen, Netherlands; [Bruinsma, Maaike; Koenraadt, Harrie M. S.] Naktuinbouw, Roelofarendsveen, Netherlands		van de Vossenberg, BTLH (corresponding author), Dutch Natl Plant Protect Org, Natl Reference Ctr Plant Hlth, Wageningen, Netherlands.	b.t.l.h.vandevossenberg@nvwa.nl		van de Vossenberg, Bart T.L.H./0000-0003-1205-6119				Adams TM, 2020, TRACKING WHEAT YELLO, DOI [10.5281/zenodo.3758079, DOI 10.5281/ZENODO.3758079]; Alkowni R, 2019, J PLANT PATHOL, V101, P719, DOI 10.1007/s42161-019-00240-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amer M, 2020, INT J THERMOPHYS, V41, DOI 10.1007/s10765-020-02723-7; [Anonymous], 2019, OFFICIAL J EUROPEAN, V250, P91; [Anonymous], 2020, VALITEST DELIVERABLE; Botermans M, 2013, J VIROL METHODS, V187, P43, DOI 10.1016/j.jviromet.2012.09.004; BROADBENT L, 1963, ANN APPL BIOL, V52, P233, DOI 10.1111/j.1744-7348.1963.tb03747.x; Camacho-Beltran E, 2019, PLANT DIS, V103, P1440, DOI 10.1094/PDIS-11-18-1974-PDN; Fidan H., 2019, New Disease Reports, V39, DOI 10.5197/j.2044-0588.2019.039.018; Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Grad YH, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0538-4; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ISF, 2019, DET INF TOM BROWN RU, P11; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Levitzky N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210871; Ling KS, 2019, PLANT DIS, V103, P1439, DOI 10.1094/PDIS-11-18-1959-PDN; Luria N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170429; Cambrón-Crisantos José Manuel, 2019, Rev. mex. fitopatol, V37, P185, DOI [10.18781/R.MEX.FIT.1810-5, 10.18781/r.mex.fit.1810-5]; Menzel W., 2019, New Disease Reports, V39, DOI 10.5197/j.2044-0588.2019.039.001; OEPP/EPPO, 2019, 1 REP TOM BROWN RUG; OEPP/EPPO, 2019, EPPO REPORTING SERVI, V11; OEPP/EPPO, 2019, EPPO AL LIST TOM BRO; OEPP/EPPO, 2020, 22020037 OEPPEPPO; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Panno S., 2020, New Disease Reports, V41, DOI 10.5197/j.2044-0588.2020.041.020; Panno S, 2019, PLANT DIS, V103, P1443, DOI 10.1094/PDIS-12-18-2254-PDN; Panno S, 2019, PEERJ, V7, DOI 10.7717/peerj.7928; Rodriguez-Mendoza J, 2019, IDENTIFICATION TOMAT, V37, P346; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Salem N, 2016, ARCH VIROL, V161, P503, DOI 10.1007/s00705-015-2677-7; Salem NM, 2020, PLANT DIS, V104, P601, DOI 10.1094/PDIS-06-19-1189-PDN; Skelton A., 2019, New Disease Reports, V40, DOI 10.5197/j.2044-0588.2019.040.012; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Wohl S, 2016, ANNU REV VIROL, V3, P173, DOI 10.1146/annurev-virology-110615-035747; Yan ZY, 2019, PLANT DIS, V103, P2973, DOI 10.1094/PDIS-05-19-1045-PDN	38	10	11	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0234671	10.1371/journal.pone.0234671	http://dx.doi.org/10.1371/journal.pone.0234671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031371	Green Submitted, gold, Green Published			2022-12-26	WOS:000581809800008
J	Iqbal, A; He, L; Ali, I; Ullah, S; Khan, A; Khan, A; Akhtar, K; Wei, SQ; Zhao, Q; Zhang, J; Jiang, LG				Iqbal, Anas; He, Liang; Ali, Izhar; Ullah, Saif; Khan, Ahmad; Khan, Aziz; Akhtar, Kashif; Wei, Shangqin; Zhao, Quan; Zhang, Jing; Jiang, Ligeng			Manure combined with chemical fertilizer increases rice productivity by improving soil health, post-anthesis biomass yield, and nitrogen metabolism	PLOS ONE			English	Article							INORGANIC FERTILIZERS; ORGANIC AMENDMENTS; CROPPING SYSTEM; USE EFFICIENCY; GRAIN-YIELD; DRY-MATTER; IMPACT; MAIZE; WHEAT; CARBON	Excessive reliance on chemical fertilizer (CF) in conventional farming is a serious concern owing to its negative effects on soil health, the environment, and crop productivity. Organic manure is an alternative source of fertilizer to reduce the amount of CF usage in agriculture, decrease environmental pollution, and ensure sustainable crop production. This study assessed the integrated effect of poultry manure (PM) and cattle manure (CM) with CF on soil properties, plant physiology, and rice grain yield. Additionally, the difference in pre-and post-anthesis dry matter (DM) and nitrogen (N) accumulation and their relationship with grain yield was also determined. Pot experiments were performed in the early and late growing season at the experimental station of Guangxi University, China, in 2018. A total of six treatments, i.e., T-1-CF0; T-2-100% CF; T-3-60% CM + 40% CF; T-4-30% CM + 70% CF; T-5-60% PM + 40% CF, and T-6-30% PM + 70% CF were used in this pot experiment. Results showed that T(6)enhanced leaf photosynthetic efficiency by 11% and 16%, chlorophyll content by 8% and 11%, panicle number by 12% and 16%, and grain yield by 11% and 15% in the early and late seasons, respectively, compared to T-2. Similarly1, post-anthesis N and DM accumulation, N uptake, and soil properties (i.e., soil organic carbon, total N, and bulk density) were improved with integrated CF and manure treatments over the sole CF treatments. Interestingly, increases in post-anthesis N uptake and DM production were further supported by enhanced N-metabolizing enzyme activities (i.e., nitrate reductase, glutamine synthetase, and glutamate oxoglutarate aminotransferase during the grain-filling period in combined treatments. In-addition, the linear regression analysis showed that post-anthesis DM (R-2= 0.95) and N (R-2= 0.96) accumulation were highly associated with grain yield of rice. Thus, the combination of 30% N from PM or CM with 70% N from CF (i.e., urea) is a promising option for improvement of soil quality and rice grain yield. Furthermore, our study provides a sustainable nutrient management plan to increase rice yield with high N use efficiency.	[Iqbal, Anas; He, Liang; Ali, Izhar; Ullah, Saif; Khan, Aziz; Wei, Shangqin; Zhao, Quan; Zhang, Jing; Jiang, Ligeng] Guangxi Univ, Coll Agr, Key Lab Crop Cultivat & Farming Syst, Nanning, Peoples R China; [Iqbal, Anas; Ali, Izhar; Khan, Ahmad] Univ Agr Peshawar, Dept Agron, Peshawar, Pakistan; [Akhtar, Kashif] Zhejiang Univ, Coll Agr & Biotechnol, Inst Nucl Agr Sci, Hangzhou, Peoples R China	Guangxi University; Zhejiang University	Jiang, LG (corresponding author), Guangxi Univ, Coll Agr, Key Lab Crop Cultivat & Farming Syst, Nanning, Peoples R China.	jiang@gxu.edu.cn	Iqbal, Anas/AAD-3297-2022; Ali, Izhar/AAV-5940-2020; Iqbal, Anas/AAS-1535-2021	Iqbal, Anas/0000-0002-4088-3886; Ali, Izhar/0000-0002-9161-9145; Ullah, Saif/0000-0002-7237-4138	National Key Research and Development Project of China [2016YFD030050902]	National Key Research and Development Project of China	National Key Research and Development Project of China Grant Number: 2016YFD030050902.	Adekiya AO, 2019, SCI HORTIC-AMSTERDAM, V243, P457, DOI 10.1016/j.scienta.2018.08.048; Akhtar K, 2019, SOIL USE MANAGE, V35, P526, DOI 10.1111/sum.12478; Akhtar K, 2019, ENVIRON INT, V132, DOI 10.1016/j.envint.2019.105092; Akhtar K, 2019, AGR WATER MANAGE, V211, P16, DOI 10.1016/j.agwat.2018.09.031; Ali I, 2020, FOOD ENERGY SECUR, V9, DOI 10.1002/fes3.208; Anil Mahajan, 2008, SAARC Journal of Agriculture, V6, P149; [Anonymous], 2002, SSSA BOOK SER 4, DOI DOI 10.2136/SSSAB00KSER5.4.C9; Bao SJAPHoC, 2000, AGRO CHEM ANAL SOIL; Baum C, 2013, PLANT SOIL ENVIRON, V59, P95, DOI 10.17221/548/2012-PSE; Bitew Yayeh, 2017, Asian Journal of Plant Sciences, V16, P109, DOI 10.3923/ajps.2017.109.131; BuchananWollaston V, 1997, J EXP BOT, V48, P181, DOI 10.1093/jxb/48.2.181; Cai AD, 2018, NUTR CYCL AGROECOSYS, V111, P61, DOI 10.1007/s10705-018-9918-6; Carrijo DR, 2017, FIELD CROP RES, V203, P173, DOI 10.1016/j.fcr.2016.12.002; Ceusters N, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01012; Chauhan BS, 2017, RICE PRODUCTION WORL, DOI DOI 10.1007/978-3-319-47516-5; Chen L, 2019, RICE, V12, DOI 10.1186/s12284-019-0333-7; DORICH RA, 1984, SOIL SCI SOC AM J, V48, P72, DOI 10.2136/sssaj1984.03615995004800010013x; Franzluebbers AJ, 2000, SOIL BIOL BIOCHEM, V32, P469, DOI 10.1016/S0038-0717(99)00176-5; Geng YH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219512; Huang JL, 2008, FIELD CROP RES, V105, P70, DOI 10.1016/j.fcr.2007.07.006; Ibrahim M, 2020, SOIL TILL RES, V200, DOI 10.1016/j.still.2020.104631; Iqbal A, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9100651; Jackson MJM, 1956, SOIL CHEM ANAL ADV C, V895; Khan A, 2019, AGRON J, V111, P2600, DOI 10.2134/agronj2019.02.0100; Khan A, 2019, INT J AGRIC BIOL, V21, P1117, DOI 10.17957/IJAB/15.1001; Khan A, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9120859; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Kosteckas R., 2009, Agronomy Research, V7, P355; Kwiatkowska-Malina J, 2018, J SOIL SEDIMENT, V18, P2801, DOI 10.1007/s11368-017-1891-1; Lal R, 2015, SUSTAINABILITY-BASEL, V7, P5875, DOI 10.3390/su7055875; Landrine H, 2016, TOB CONTROL, V25, pe142; Lea P, 1990, INORGANIC NITROGEN P, P115; Lin WW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217018; Liu JR, 2008, PLANT PROD SCI, V11, P271, DOI 10.1626/pps.11.271; Luo GW, 2018, SOIL BIOL BIOCHEM, V124, P105, DOI 10.1016/j.soilbio.2018.06.002; Mahmood F, 2017, J SOIL SCI PLANT NUT, V17, P22; Makoto K, 2007, PHOTOSYNTHETICA, V45, P99, DOI 10.1007/s11099-007-0015-3; Mangalassery S, 2019, SOIL TILL RES, V187, P144, DOI 10.1016/j.still.2018.12.008; McGuire S, 2015, ADV NUTR, V6, P623, DOI 10.3945/an.115.009936; Mehasen S. A. S., 2012, Asian Journal of Biological Sciences, V5, P171; Morone P, 2019, J CLEAN PROD, V208, P563, DOI 10.1016/j.jclepro.2018.10.075; Muhammad Arif, 2014, Journal of Agricultural Research (Lahore), V52, P197; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nkoa R, 2014, AGRON SUSTAIN DEV, V34, P473, DOI 10.1007/s13593-013-0196-z; Ohyama T., 2004, Bulletin of the Faculty of Agriculture, Niigata University, V57, P33; Pal R, 2017, FIELD CROP RES, V206, P138, DOI 10.1016/j.fcr.2017.01.025; Panda D, 2013, PHYSIOL MOL BIOL PLA, V19, P43, DOI 10.1007/s12298-012-0142-6; PAPAKOSTA DK, 1991, AGRON J, V83, P864, DOI 10.2134/agronj1991.00021962008300050018x; Pathak RR, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P209; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Purakayastha TJ, 2008, GEODERMA, V144, P370, DOI 10.1016/j.geoderma.2007.12.006; Shang QY, 2014, BIOL FERT SOILS, V50, P715, DOI 10.1007/s00374-013-0891-6; SINGH RP, 1986, PHYSIOL PLANTARUM, V66, P413, DOI 10.1111/j.1399-3054.1986.tb05944.x; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Stockmann U, 2013, AGR ECOSYST ENVIRON, V164, P80, DOI 10.1016/j.agee.2012.10.001; Sun YJ, 2012, FIELD CROP RES, V127, P85, DOI 10.1016/j.fcr.2011.11.015; Tubiello FN, 2015, GLOBAL CHANGE BIOL, V21, P2655, DOI 10.1111/gcb.12865; [王寅 Wang Yin], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P518; Wittmann C, 2001, BASIC APPL ECOL, V2, P145, DOI 10.1078/1439-1791-00047; Wu W, 2013, EUR J AGRON, V45, P75, DOI 10.1016/j.eja.2012.10.009; Yadav RL, 2000, FIELD CROP RES, V65, P15, DOI 10.1016/S0378-4290(99)00066-0; Yadav SK, 2013, INT J AGRON, V2013, DOI 10.1155/2013/718145; Yang B, 2015, ECOL ENG, V81, P289, DOI 10.1016/j.ecoleng.2015.04.071; Yang JC, 2001, FIELD CROP RES, V71, P47, DOI 10.1016/S0378-4290(01)00147-2; Yue SC, 2012, AGRON J, V104, P1687, DOI 10.2134/agronj2012.0232; Yue XL, 2016, EUR J SOIL BIOL, V77, P34, DOI 10.1016/j.ejsobi.2016.10.002; Zhang M, 2018, FIELD CROP RES, V227, P102, DOI 10.1016/j.fcr.2018.08.010; Zhang XY, 2020, GLOBAL CHANGE BIOL, V26, P888, DOI 10.1111/gcb.14826; Zhang X, 2015, NATURE, V528, P51, DOI 10.1038/nature15743; Zou CM, 2018, GEODERMA, V325, P49, DOI 10.1016/j.geoderma.2018.03.017	70	27	32	6	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0238934	10.1371/journal.pone.0238934	http://dx.doi.org/10.1371/journal.pone.0238934			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027309	Green Published, gold			2022-12-26	WOS:000581808000035
J	Lu, P; Wang, WN; Zhang, GX; Li, W; Jiang, AJ; Cao, MJ; Zhang, XY; Xing, K; Peng, X; Yuan, B; Feng, ZZ				Lu, Peng; Wang, Weinan; Zhang, Guangxi; Li, Wen; Jiang, Anjie; Cao, Mengjiao; Zhang, Xiaoyan; Xing, Ke; Peng, Xue; Yuan, Bo; Feng, Zhaozhong			Isolation and characterization marine bacteria capable of degrading lignin-derived compounds	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SP-NOV.; ORGANIC-MATTER; GENE; DEGRADATION; CATABOLISM; DISCOVERY; PATHWAYS	Lignin, a characteristic component of terrestrial plants. Rivers transport large amounts of vascular plant organic matter into the oceans where lignin can degrade over time; however, microorganisms involved in this degradation have not been identified. In this study, several bacterial strains were isolated from marine samples using the lignin-derived compound vanillic acid (4-hydroxy-3-methoxybenzoic acid) as the sole carbon and energy source. The optimum growth temperature for all isolates ranged from 30 to 35 degrees C. All isolates grew well in a wide NaCl concentration range of 0 to over 50 g/L, with an optimum concentration of 22.8 g/L, which is the same as natural seawater. Phylogenetic analysis indicates that these strains are the members of Halomonas, Arthrobacter, Pseudoalteromonas, Marinomonas,and Thalassospira. These isolates are also able to use other lignin-derived compounds, such as 4-hydroxybenzoic acid, ferulic acid, syringic acid, and benzoic acid. Vanillic acid was detected in all culture media when isolates were grown on ferulic acid as the sole carbon source; however, no 4-hydroxy-3-methoxystyrene was detected, indicating that ferulic acid metabolism by these strains occurs via the elimination of two side chain carbons. Furthermore, the isolates exhibit 3,4-dioxygenase or 4,5-dioxygenase activity for protocatechuic acid ring-cleavage, which is consistent with the genetic sequences of related genera. This study was conducted to isolate and characterize marine bacteria of degrading lignin-derived compounds, thereby revealing the degradation of aromatic compounds in the marine environment and opening up new avenues for the development and utilization of marine biological resources.	[Lu, Peng] Anhui Normal Univ, Coll Life Sci, Wuhu, Peoples R China; [Wang, Weinan; Zhang, Guangxi; Li, Wen; Jiang, Anjie; Cao, Mengjiao; Zhang, Xiaoyan; Xing, Ke; Peng, Xue; Yuan, Bo; Feng, Zhaozhong] Jiangsu Normal Univ, Sch Life Sci, Xuzhou, Jiangsu, Peoples R China	Anhui Normal University; Jiangsu Normal University	Yuan, B; Feng, ZZ (corresponding author), Jiangsu Normal Univ, Sch Life Sci, Xuzhou, Jiangsu, Peoples R China.	boyuan@jsnu.edu.cn; fzz2012@jsnu.edu.cn			National Natural Science Foundation of China [31800327, 31570028]; Anhui National Natural Science Foundation [1708085QC67]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Postgraduate Research and Practice Innovation Program of Jiangsu Province, China [KYCX18_2138, KYCX17_1618]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui National Natural Science Foundation; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Postgraduate Research and Practice Innovation Program of Jiangsu Province, China	This study was supported by National Natural Science Foundation of China (31800327, 31570028), the project funded by Grant from Anhui National Natural Science Foundation (1708085QC67), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Postgraduate Research and Practice Innovation Program of Jiangsu Province, China (KYCX18_2138, KYCX17_1618). The authors declare that they have no conflicts of interest with the contents of this article.	Acolombri U, 2014, BIOCHEMISTRY-US, V53, P5473, DOI 10.1021/bi500853s; Bowman JP, 1998, INT J SYST BACTERIOL, V48, P1037, DOI 10.1099/00207713-48-3-1037; Chen M, 2005, ARCH MICROBIOL, V183, P301, DOI 10.1007/s00203-005-0772-y; Chimetto LA, 2011, INT J SYST EVOL MICR, V61, P1170, DOI 10.1099/ijs.0.024661-0; Dittmar T, 2001, GEOCHIM COSMOCHIM AC, V65, P1417, DOI 10.1016/S0016-7037(00)00619-0; Goble AM, 2011, ACS CHEM BIOL, V6, P1036, DOI 10.1021/cb200198c; HEDGES JI, 1979, GEOCHIM COSMOCHIM AC, V43, P1803, DOI 10.1016/0016-7037(79)90028-0; Hernes PJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001421; Hernes PJ, 2002, DEEP-SEA RES PT I, V49, P2119, DOI 10.1016/S0967-0637(02)00128-0; ITTEKKOT V, 1988, NATURE, V332, P436, DOI 10.1038/332436a0; Kallimanis A, 2011, STAND GENOMIC SCI, V4, P123, DOI 10.4056/sigs.1393494; Kasai D, 2009, J BACTERIOL, V191, P6758, DOI 10.1128/JB.00840-09; Kuzyk ZZA, 2008, MAR CHEM, V112, P215, DOI 10.1016/j.marchem.2008.08.001; Labeeuw L, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0052-y; Lai QL, 2012, J BACTERIOL, V194, P6957, DOI 10.1128/JB.01904-12; Leveau JHJ, 2008, FEMS MICROBIOL ECOL, V65, P238, DOI 10.1111/j.1574-6941.2008.00436.x; Li XG, 2012, J OCEAN U CHINA, V11, P501, DOI 10.1007/s11802-012-1834-9; Loh PS, 2008, J ENVIRON MONITOR, V10, P1187, DOI 10.1039/b808970a; Lopez-Lopez A, 2002, INT J SYST EVOL MICR, V52, P1277, DOI 10.1099/ijs.0.01928-0; Lucas-Elio P, 2012, STAND GENOMIC SCI, V7, P31, DOI 10.4056/sigs.2976373; Lucas-Elio P, 2012, STAND GENOMIC SCI, V6, P63, DOI 10.4056/sigs.2545743; Maejima Y, 2018, BIOSCI BIOTECH BIOCH, V82, P1260, DOI 10.1080/09168451.2018.1456317; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Matsuyama H, 2014, INT J SYST EVOL MICR, V64, P101, DOI 10.1099/ijs.0.055558-0; Mongodin EF, 2006, PLOS GENET, V2, P2094, DOI 10.1371/journal.pgen.0020214; Monnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015489; Ni J, 2018, ANGEW CHEM INT EDIT, V57, P1214, DOI 10.1002/anie.201710793; Nogi Y, 2014, INT J SYST EVOL MICR, V64, P1149, DOI 10.1099/ijs.0.058321-0; Peng X, 2005, APPL ENVIRON MICROB, V71, P5014, DOI 10.1128/AEM.71.9.5014-5021.2005; Peng X, 2003, APPL ENVIRON MICROB, V69, P1417, DOI 10.1128/AEM.69.3.1417-1427.2003; Pollegioni L, 2015, FEBS J, V282, P1190, DOI 10.1111/febs.13224; Romanenko LA, 2003, INT J SYST EVOL MICR, V53, P1105, DOI 10.1099/ijs.0.02564-0; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Sahoo NK, 2014, BIODEGRADATION, V25, P705, DOI 10.1007/s10532-014-9693-2; Sanchez-Porro C, 2010, INT J SYST EVOL MICR, V60, P2768, DOI 10.1099/ijs.0.020628-0; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Tian J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03115; Woo HL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00922; Wrobel AM, 2014, J APPL TOXICOL, V34, P1041, DOI 10.1002/jat.2978; Zhan H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00098; Zhao KX, 2010, J BACTERIOL, V192, P1565, DOI 10.1128/JB.01338-09	41	6	6	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240187	10.1371/journal.pone.0240187	http://dx.doi.org/10.1371/journal.pone.0240187			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027312	gold, Green Published			2022-12-26	WOS:000581808000047
J	Nolte, S; van Londen, M; Elting, JWJ; de Greef, BTA; Kuks, JBM; Faber, CG; Nolte, IM; Groen, RJM; Bakker, SJL; Groothof, D; Lesman-Leegte, I; Berger, SP; Drost, G				Nolte, Svea; van Londen, Marco; Elting, Jan Willem J.; de Greef, Bianca T. A.; Kuks, Jan B. M.; Faber, Catharina G.; Nolte, Ilja M.; Groen, Rob J. M.; Bakker, Stephan J. L.; Groothof, Dion; Lesman-Leegte, Ivonne; Berger, Stefan P.; Drost, Gea			Vibration threshold in non-diabetic subjects	PLOS ONE			English	Article							AGE; POLYNEUROPATHY; SYSTEM	Measuring vibration perception threshold (VPT) accurately classifies and quantifies the severity of loss of vibration perception. A biothesiometer (Bio-thesiometer (R); Bio Medical Instrument Co, Ohio, USA) appears to be the most suitable tool to determine VPT due to its low inter-rater variability and low occurence of adaption to the sensation. Different VPT values for a biothesiometer have been described, however, specification on age, height and different measurement locations is currently lacking. The objective of our study was to identify determinants of vibration perception in non-diabetic subjects, in order to provide individualized normal values of VPTs for clinical practice. Measurements of the vibration perception were performed on the big toes, insteps, lateral malleoli, and wrists. A total of 205 healthy subjects were included (108 (52.7%) males) with a median [interquartile range] age of 59 [51;64] (range 21-80) years. Mean height was 174.45 +/- 9.20 cm and mean weight was 82.94 +/- 14.84 kg, resulting in a mean BMI of 27.19 +/- 4.00 kg/m(2). In stepwise forward linear regression analyses, age (st. beta = 0.51, p < 0.001) and height (st. beta = 0.43, p < 0.001) were found to be the independent unmodifiable determinants of the VPT at the big toe. Regression coefficients for quantiles of the determinants age and height were incorporated in the corresponding regression equations. This study provides equations to calculate age- and height-specific normal values for VPT that can be used in clinical practice and in large research studies.	[Nolte, Svea; Groen, Rob J. M.; Lesman-Leegte, Ivonne; Drost, Gea] Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands; [Nolte, Svea; van Londen, Marco; Elting, Jan Willem J.; Kuks, Jan B. M.; Nolte, Ilja M.; Groen, Rob J. M.; Bakker, Stephan J. L.; Groothof, Dion; Lesman-Leegte, Ivonne; Berger, Stefan P.; Drost, Gea] Univ Groningen, Groningen, Netherlands; [van Londen, Marco; Groothof, Dion; Berger, Stefan P.] Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Elting, Jan Willem J.; Drost, Gea] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [de Greef, Bianca T. A.; Faber, Catharina G.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands; [de Greef, Bianca T. A.; Faber, Catharina G.] Maastricht Univ, Maastricht, Netherlands; [de Greef, Bianca T. A.] Maastricht Univ, Med Ctr, Klin Epidemiol Med Technol Assessment KEMTA, Maastricht, Netherlands; [Nolte, Ilja M.] Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; Maastricht University; Maastricht University; Maastricht University; University of Groningen	Nolte, S (corresponding author), Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands.; Nolte, S (corresponding author), Univ Groningen, Groningen, Netherlands.	s.nolte@umcg.nl	; Bakker, Stephan/J-4023-2015	Groen, Rob J.M./0000-0003-3067-763X; Nolte, Svea/0000-0003-4742-1446; Drost, Gea/0000-0002-3546-4548; Bakker, Stephan/0000-0003-3356-6791; Groothof, Dion/0000-0002-1886-4451				[Anonymous], 2016, J CHIROPR MED, V15, P155, DOI DOI 10.1016/J.JCM.2016.02.012; Bentham J, 2016, ELIFE, V5, DOI 10.7554/eLife.13410.001; Bio-Medical Instrument Company, BIOTH INSTR OP; BLOOM S, 1984, BRIT MED J, V288, P1793, DOI 10.1136/bmj.288.6433.1793; Callaghan BC, 2015, JAMA-J AM MED ASSOC, V314, P2172, DOI 10.1001/jama.2015.13611; CERIMELE D, 1990, BRIT J DERMATOL, V122, P13, DOI 10.1111/j.1365-2133.1990.tb16120.x; Deshpande N, 2008, NEUROBIOL AGING, V29, P765, DOI 10.1016/j.neurobiolaging.2006.12.002; Eisenga MF, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-024502; Furno M, 2011, J EDUC BEHAV STAT, V36, P105, DOI 10.3102/1076998610379134; Jones Graham, 2008, Clin Biochem Rev, V29 Suppl 1, pS93; Kerner W, 2014, EXP CLIN ENDOCR DIAB, V122, P384, DOI 10.1055/s-0034-1366278; Knox C.A., 1994, CLIN NEUROLOGY AGING, Vsecond, P68; Lin YH, 2005, J PERIPHER NERV SYST, V10, P269, DOI 10.1111/j.1085-9489.2005.10305.x; Maffei Laura, 2014, J Diabetes Sci Technol, V8, P621, DOI 10.1177/1932296814527818; Marcuzzi A, 2019, MUSCLE NERVE, V59, P229, DOI 10.1002/mus.26373; Martina ISJ, 1998, J NEUROL NEUROSUR PS, V65, P743, DOI 10.1136/jnnp.65.5.743; MEH D, 1995, J NEUROL SCI, V134, P136, DOI 10.1016/0022-510X(95)00230-9; Pare M, 2007, J COMP NEUROL, V501, P543, DOI 10.1002/cne.21262; Pearson GHJ, 1928, ARCH NEURO PSYCHIATR, V20, P482, DOI 10.1001/archneurpsyc.1928.02210150042003; Rinkel WD, 2017, MUSCLE NERVE, V56, P399, DOI 10.1002/mus.25512; Rogers William., 1992, STATA TECHNICAL B, V9, P16; ROOS D, 1977, ACTA NEUROL SCAND, V56, P551; Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083; Sherwood Ben, 2016, Alzheimers Dement (Amst), V2, P12, DOI 10.1016/j.dadm.2015.11.005; Shirk SD, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt94; Shy ME, 2003, NEUROLOGY, V60, P898, DOI 10.1212/01.WNL.0000058546.16985.11; Sorond FA, 2015, J GERONTOL A-BIOL, V70, P1526, DOI 10.1093/gerona/glv130; Stavros K, 2014, CURR HIV-AIDS REP, V11, P195, DOI 10.1007/s11904-014-0211-2; Svendsen TD, 2020, BASIC CLIN PHARMACOL, V126, P203, DOI 10.1111/bcpt.13320; TENCKHOF.HA, 1965, J AMER MED ASSOC, V192, P1121, DOI 10.1001/jama.1965.03080260009003; Teunissen LL, 2000, J NEUROL, V247, P195, DOI 10.1007/s004150050562; TJONATSIEN AML, 1995, DIABETES RES CLIN PR, V27, P211, DOI 10.1016/0168-8227(95)01049-J; VERRILLO RT, 1980, J GERONTOL, V35, P185, DOI 10.1093/geronj/35.2.185; Visser NA, 2015, NEUROLOGY, V84, P259, DOI 10.1212/WNL.0000000000001160; Warendorf JK, 2019, NEUROLOGY, V92, pE2136, DOI [10.1212/WNL.0000000000007148, 10.1212/wnl.0000000000007148]	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0237733	10.1371/journal.pone.0237733	http://dx.doi.org/10.1371/journal.pone.0237733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027294	Green Published, gold			2022-12-26	WOS:000581808000051
J	Runnebohm, AM; Richards, KA; Irelan, CB; Turk, SM; Vitali, HE; Indovina, CJ; Rubenstein, EM				Runnebohm, Avery M.; Richards, Kyle A.; Irelan, Courtney Broshar; Turk, Samantha M.; Vitali, Halie E.; Indovina, Christopher J.; Rubenstein, Eric M.			Overlapping function of Hrd1 and Ste24 in translocon quality control provides robust channel surveillance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum&#8211; associated degradation (ERAD); Ste24; Hrd1; E3 ubiquitin ligase; protein translocation; protein quality control; translocon quality control; Saccharomyces cerevisiae; yeast genetics	UBIQUITIN-LIGASE; ENDOPLASMIC-RETICULUM; PROTEIN TRANSLOCATION; MEMBRANE-PROTEINS; DEGRADATION; SEC61P; POLYPEPTIDES; ORGANIZATION; MECHANISMS; PATHWAY	Translocation of proteins across biological membranes is essential for life. Proteins that clog the endoplasmic reticulum (ER) translocon prevent the movement of other proteins into the ER. Eukaryotes have multiple translocon quality control (TQC) mechanisms to detect and destroy proteins that persistently engage the translocon. TQC mechanisms have been defined using a limited panel of substrates that aberrantly occupy the channel. The extent of substrate overlap among TQC pathways is unknown. In this study, we found that two TQC enzymes, the ER-associated degradation ubiquitin ligase Hrd1 and zinc metalloprotease Ste24, promote degradation of characterized translocon-associated substrates of the other enzyme in Saccharomyces cerevisiae. Although both enzymes contribute to substrate turnover, our results suggest a prominent role for Hrd1 in TQC. Yeast lacking both Hrd1 and Ste24 exhibit a profound growth defect, consistent with overlapping function. Remarkably, two mutations that mildly perturb post-translational translocation and reduce the extent of aberrant translocon engagement by a model substrate diminish cellular dependence on TQC enzymes. Our data reveal previously unappreciated mechanistic complexity in TQC substrate detection and suggest that a robust translocon surveillance infrastructure maintains functional and efficient translocation machinery.	[Runnebohm, Avery M.; Richards, Kyle A.; Irelan, Courtney Broshar; Turk, Samantha M.; Vitali, Halie E.; Indovina, Christopher J.; Rubenstein, Eric M.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA; [Runnebohm, Avery M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Irelan, Courtney Broshar] Eli Lilly & Co, Diabet & Complicat Therapeut Area, Indianapolis, IN 46285 USA; [Vitali, Halie E.] Eli Lilly & Co, Dept Invest Toxicol, Indianapolis, IN 46285 USA; [Indovina, Christopher J.] Thermo Fisher Sci, Life Sci Solut, Grand Isl, NY USA	Ball State University; Indiana University System; Indiana University Bloomington; Eli Lilly; Eli Lilly; Thermo Fisher Scientific	Rubenstein, EM (corresponding author), Ball State Univ, Dept Biol, Muncie, IN 47306 USA.	emrubenstein@bsu.edu		Runnebohm, Avery/0000-0001-6798-6407	Ball State University ASPiRE Research Awards; Indiana Academy of Science Senior Research Grants; National Institutes of Health [GM111713]	Ball State University ASPiRE Research Awards; Indiana Academy of Science Senior Research Grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Ball State University ASPiRE Research Awards (to A. M. R., K. A. R., and C. B. I.), Indiana Academy of Science Senior Research Grants (to E. M. R. and K. A. R.), and National Institutes of Health Grant GM111713 (to E. M. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arakawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30795; Ast T, 2016, CELL, V164, P103, DOI 10.1016/j.cell.2015.11.053; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Avci D, 2015, TRENDS CELL BIOL, V25, P611, DOI 10.1016/j.tcb.2015.07.003; Aviram N, 2017, J CELL SCI, V130, P4079, DOI 10.1242/jcs.204396; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Buchanan BW, 2019, J BIOL CHEM, V294, P19814, DOI 10.1074/jbc.RA119.010295; Buchanan BW, 2016, JOVE-J VIS EXP, DOI 10.3791/53975; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Choi J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-105; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Crowder JJ, 2015, J BIOL CHEM, V290, P18454, DOI 10.1074/jbc.M115.663559; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; Engle SM, 2017, PEERJ, V5, DOI 10.7717/peerj.3728; Fisher EA, 2011, J LIPID RES, V52, P1170, DOI 10.1194/jlr.M011726; Guthrie C., 2004, GUIDE YEAST GENETICS, P1; Harada Y, 2011, J BIOL CHEM, V286, P2956, DOI 10.1074/jbc.M110.159517; HJELM H, 1972, FEBS LETT, V28, P73, DOI 10.1016/0014-5793(72)80680-X; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Itskanov S, 2019, SCIENCE, V363, P84, DOI 10.1126/science.aav6740; Izawa T, 2012, CELL REPORTS, V2, P447, DOI 10.1016/j.celrep.2012.08.010; Joazeiro CAP, 2019, NAT REV MOL CELL BIO, V20, P368, DOI 10.1038/s41580-019-0118-2; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kadowaki H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25724-x; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Kayatekin C, 2018, CELL, V173, P62, DOI 10.1016/j.cell.2018.02.026; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Lyman SK, 1997, CELL, V88, P85, DOI 10.1016/S0092-8674(00)81861-9; Marek A, 2013, EVOLUTION, V67, P3077, DOI 10.1111/evo.12196; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Prinz A, 2000, BIOL CHEM, V381, P1025, DOI 10.1515/BC.2000.126; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tripathi A, 2017, J BIOL CHEM, V292, P8007, DOI 10.1074/jbc.M116.761122; von der Malsburg K, 2015, MOL BIOL CELL, V26, P2168, DOI 10.1091/mbc.E15-01-0040; Voorhees RM, 2016, CURR OPIN CELL BIOL, V41, P91, DOI 10.1016/j.ceb.2016.04.009; Wang LH, 2020, CELL RES, V30, DOI 10.1038/s41422-019-0236-6; Watts SG, 2015, JOVE-J VIS EXP, DOI 10.3791/52428; Willer M, 2008, J BIOL CHEM, V283, P33883, DOI 10.1074/jbc.M803054200; Wu XD, 2019, NATURE, V566, P136, DOI 10.1038/s41586-018-0856-x	51	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					16113	16120		10.1074/jbc.AC120.016191	http://dx.doi.org/10.1074/jbc.AC120.016191			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	33033070	hybrid, Green Published			2022-12-26	WOS:000595657900026
J	Gao, YR; Sengupta, A; Li, MW; Zu, ZL; Rogers, BP; Anderson, AW; Ding, ZH; Gore, JC				Gao, Yurui; Sengupta, Anirban; Li, Muwei; Zu, Zhongliang; Rogers, Baxter P.; Anderson, Adam W.; Ding, Zhaohua; Gore, John C.		Alzheimer's Dis Neuroimaging	Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease	PLOS ONE			English	Article							RESTING-STATE FMRI; POSTERIOR CINGULATE; MEMORY DEFICITS; TEMPORAL-LOBE; RATING-SCALE; DIFFUSION; DEMENTIA; CORTEX; DAMAGE; MRI	Objective In vivofunctional changes in white matter during the progression of Alzheimer's disease (AD) have not been previously reported. Our objectives are to measure changes in white matter functional connectivity (FC) in an elderly population undergoing cognitive decline as AD develops, to establish their relationship to neuropsychological scores of cognitive abilities, and to assess the performance in prediction of AD using white matter FC measures as features. Methods Analyses were conducted using resting state functional MRI and neuropsychological data from 383 ADNI participants, including 136 cognitive normal (CN) controls, 46 with significant memory concern, 83 with early mild cognitive impairment (MCI), 37 with MCI, 46 with late MCI, and 35 with AD dementia. FC metrics between segregated white matter tracts and discrete gray matter volumes or between white matter tracts were quantitatively analyzed and characterized, along with their relationships to 6 cognitive measures. Finally, supervised machine learning was implemented on white matter FCs to classify the participants and performance of the classification was evaluated. Results Significant decreases in FC measures were found in white matter with prominent, specific, regional deficits appearing in late MCI and AD dementia patients from CN. These changes significantly correlated with neuropsychological measurements of impairments in cognition and memory. The sensitivity and specificity of distinguishing AD dementia and CN using white matter FCs were 0.83 and 0.81 respectively. Conclusions and relevance The white matter FC decreased in late MCI and AD dementia patients compared to CN participants, and this decrease was correlated with cognitive measures. White matter FC is valuable in the prediction of AD. All these findings suggest that white matter FC may be a promising avenue for understanding functional impairments in white matter tracts during AD progression.	[Gao, Yurui; Sengupta, Anirban; Li, Muwei; Zu, Zhongliang; Rogers, Baxter P.; Anderson, Adam W.; Ding, Zhaohua; Gore, John C.] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Nashville, TN USA; [Gao, Yurui; Anderson, Adam W.; Ding, Zhaohua; Gore, John C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Sengupta, Anirban; Li, Muwei; Zu, Zhongliang; Rogers, Baxter P.; Anderson, Adam W.; Gore, John C.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Ding, Zhaohua] Vanderbilt Univ, Dept Elect Engn & Comp Sci, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Gao, YR (corresponding author), Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Nashville, TN USA.; Gao, YR (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	yurui.gao@vanderbilt.edu	Ding, Zhaohua/AHC-7551-2022	Ding, Zhaohua/0000-0002-1805-2955; Rogers, Baxter/0000-0002-5666-2797; Gao, Yurui/0000-0002-4339-5351	NIH [R01 NS093669, R01 NS113832]; Vanderbilt University [600670]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University	The project is supported by the NIH grant R01 NS093669 and R01 NS113832 received by J.C.G. The full name of this funder is National Institute of Neurological Disorders and Stroke (https://www.ninds.nih.gov/).This project is also supported by Vanderbilt University Discovery Grant 600670, received by Y.G. and B.P.R. The full name of this funder is Vanderbilt University (https://www.vanderbilt.edu/provost/internal-funding/discoverygrants/).The two funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2016, BRAIN, V139, P1877, DOI 10.1093/brain/aww083; Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Arvanitakis Z, 2016, LANCET NEUROL, V15, P934, DOI 10.1016/S1474-4422(16)30029-1; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barber R, 1999, J NEUROL NEUROSUR PS, V67, P66, DOI 10.1136/jnnp.67.1.66; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binnewijzend MAA, 2012, NEUROBIOL AGING, V33, P2018, DOI 10.1016/j.neurobiolaging.2011.07.003; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Cohen J.E., 1988, STAT POWER ANAL BEHA; DELAMONTE SM, 1989, ANN NEUROL, V25, P450, DOI 10.1002/ana.410250506; Dennis EL, 2014, NEUROPSYCHOL REV, V24, P49, DOI 10.1007/s11065-014-9249-6; Ding ZH, 2018, P NATL ACAD SCI USA, V115, P595, DOI 10.1073/pnas.1711567115; Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gao Y, 2020, DECLINED FUNCTIONAL, DOI [10.1101/2020.05.16.20091397, DOI 10.1101/2020.05.16.20091397]; Gao Y, 2019, BIOMED CIRC SYST C; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gore JC, 2019, MAGN RESON IMAGING, V63, P1, DOI 10.1016/j.mri.2019.07.017; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Guo H, 2013, WHITE MATTER FMRI AC; Hanyu H, 1997, GERONTOLOGY, V43, P343, DOI 10.1159/000213874; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jo T, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00220; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee S, 2016, ANN NEUROL, V79, P929, DOI 10.1002/ana.24647; Lee TMC, 2002, EPILEPSIA, V43, P283, DOI 10.1046/j.1528-1157.2002.09901.x; Li MW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09076-2; Loh WY, 2002, STAT SINICA, V12, P361; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mayo CD, 2017, NEUROIMAGE-CLIN, V13, P330, DOI 10.1016/j.nicl.2016.12.012; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mohanty R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57915-w; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nasrabady SE, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0515-3; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Pievani M, 2010, HUM BRAIN MAPP, V31, P1862, DOI 10.1002/hbm.20978; Pillon B, 1999, CORTEX, V35, P561, DOI 10.1016/S0010-9452(08)70819-0; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Rose SE, 2006, J NEUROL NEUROSUR PS, V77, P1122, DOI 10.1136/jnnp.2005.074336; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Ruiz DS, 2009, ANN NEUROL, V66, P271, DOI 10.1002/ana.21754; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; SCHELTENS P, 1995, NEUROLOGY, V45, P883, DOI 10.1212/WNL.45.5.883; Sengupta A, 2019, J MAGN RESON IMAGING, V50, P1295, DOI 10.1002/jmri.26704; Song X, 2013, FUNCTIONAL MRI ACTIV; Uylings HBM, 2002, BRAIN COGNITION, V49, P268, DOI 10.1006/brcg.2001.1500; Vann SD, 2015, PROG BRAIN RES, V219, P163, DOI 10.1016/bs.pbr.2015.03.006; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; Wechsler D, 1987, WMS R WECHSLER MEMOR; Weiner M., 2016, STUDY POPULATION; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Zadrozny B., 2003, 3 IEEE INT C DAT MIN; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006; 2012, ACTA PHYS SIN, V61, P273	73	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240513	10.1371/journal.pone.0240513	http://dx.doi.org/10.1371/journal.pone.0240513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064765	Green Submitted, gold, Green Published			2022-12-26	WOS:000585918300001
J	Brooks, EB; Coulston, JW; Riitters, KH; Wear, DN				Brooks, Evan B.; Coulston, John W.; Riitters, Kurt H.; Wear, David N.			Using a hybrid demand-allocation algorithm to enable distributional analysis of land use change patterns	PLOS ONE			English	Article							CONTERMINOUS UNITED-STATES; CLIMATE-CHANGE; COVER DATABASE; MODEL; SIMULATION; UNCERTAINTY; COMPLETION; EXPANSION; CARBON; MAPS	Future land use projections are needed to inform long-term planning and policy. However, most projections require downscaling into spatially explicit projection rasters for ecosystem service analyses. Empirical demand-allocation algorithms input coarse-level transition quotas and convert cells across the raster, based on a modeled probability surface. Such algorithms typically employ contagious and/or random allocation approaches. We present a hybrid seeding approach designed to generate a stochastic collection of spatial realizations for distributional analysis, by 1) randomly selecting a seed cell from a sample ofncells, then 2) converting patches of neighboring cells based on transition probability and distance to the seed. We generated a collection of realizations from 2001-2011 for the conterminous USA at 90m resolution based on varying the value ofn, then computed forest area by fragmentation class and compared the results with observed 2011 forest area by fragmentation class. We found that realizations based on values ofn <= 256 generally covered observed forest fragmentation at regional scales, for approximately 70% of assessed cases. We also demonstrate the potential of the seeding algorithm for distributional analysis by generating 20 trajectories of realizations from 2020-2070 from a single example scenario. Generating a library of such trajectories from across multiple scenarios will enable analysis of projected patterns and downstream ecosystem services, as well as their variation.	[Brooks, Evan B.] Virginia Tech, Dept Forest Resources & Environm Conservat, Blacksburg, VA 24061 USA; [Coulston, John W.] USDA Forest Serv, Southern Res Stn, Blacksburg, VA USA; [Riitters, Kurt H.] USDA Forest Serv, Southern Res Stn, Res Triangle Pk, NC USA; [Wear, David N.] Resources Future Inc, Washington, DC USA	Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; Resources for the Future	Brooks, EB (corresponding author), Virginia Tech, Dept Forest Resources & Environm Conservat, Blacksburg, VA 24061 USA.	evbrooks@vt.edu	BITOUN, RACHEL Elisabeth/AAC-9538-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Brooks, Evan/0000-0001-7338-1279	USDA Forest Service [14-JV-11330145-108]; Virginia Tech. [14-JV-11330145-108]	USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Virginia Tech.	E.B.B was funded through the Joint Venture Agreement 14-JV-11330145-108 between the USDA Forest Service and Virginia Tech. J.W.C, K.H.R, and D.N.W were supported by the USDA Forest Service.	Aguejdad R, 2017, ENVIRON MODEL ASSESS, V22, P591, DOI 10.1007/s10666-017-9564-4; Ahmed B, 2013, ISPRS INT GEO-INF, V2, P577, DOI 10.3390/ijgi2030577; Alig R. J., 2003, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; [Anonymous], 2013, LANCET GLOB HLTH; [Anonymous], 2020, US FOR SERV RMRS-GTR, DOI DOI 10.2737/RMRS-GTR-412; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2020, US FOR SERV GEN TECH; Aquilue N, 2017, ECOL MODEL, V344, P73, DOI 10.1016/j.ecolmodel.2016.11.005; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown JF, 2020, REMOTE SENS ENVIRON, V238, DOI 10.1016/j.rse.2019.111356; Caldas MM, 2016, J LAND USE SCI, V11, P579, DOI 10.1080/1747423X.2016.1215563; Clerici N, 2019, SCI TOTAL ENVIRON, V685, P1181, DOI 10.1016/j.scitotenv.2019.06.275; Coulston JW, 2016, PHOTOGRAMM ENG REM S, V82, P189, DOI 10.14358/PERS.82.3.189; Coulston JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08002; Coulston JW, 2014, FORESTRY, V87, P267, DOI 10.1093/forestry/cpt056; d'Amour CB, 2017, P NATL ACAD SCI USA, V114, P8939, DOI 10.1073/pnas.1606036114; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gergely K.J., 2013, FACT SHEET, P2; Gounaridis D, 2019, SCI TOTAL ENVIRON, V646, P320, DOI 10.1016/j.scitotenv.2018.07.302; Hijmans R.J., 2016, RASTER GEOGRAPHIC DA; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Homer C, 2020, ISPRS J PHOTOGRAMM, V162, P184, DOI 10.1016/j.isprsjprs.2020.02.019; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Irwin EG, 2001, AGR ECOSYST ENVIRON, V85, P7, DOI 10.1016/S0167-8809(01)00200-6; Joyce L. A., 2020, General Technical Report - Rocky Mountain Research Station, USDA Forest Service, DOI 10.2737/RMRS-GTR-413; Kaushal S.S., 2017, LAND USE CLIMATE WAT; Langhammer M, 2019, ECOL MODEL, V393, P135, DOI 10.1016/j.ecolmodel.2018.12.010; Loh WY, 2014, INT STAT REV, V82, P329, DOI 10.1111/insr.12016; Martin KL, 2017, ECOHYDROLOGY, V10, DOI 10.1002/eco.1870; Mas JF, 2012, ECOL COMPLEX, V11, P38, DOI 10.1016/j.ecocom.2012.01.004; Mihiar C., 2019, ECONOMETRIC ANAL IMP; Pielke RA, 2005, SCIENCE, V310, P1625, DOI 10.1126/science.1120529; Pontius RG, 2010, SUSTAIN SCI, V5, P39, DOI 10.1007/s11625-009-0095-z; Ren YJ, 2019, EARTH-SCI REV, V190, P398, DOI 10.1016/j.earscirev.2019.01.001; Riitters K.H., 2011, FOREST HLTH MONITORI, P71; Riitters KH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00653; Rosa IMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077231; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Sohl T, 2019, ENVIRON MODELL SOFTW, V120, DOI 10.1016/j.envsoft.2019.104495; Sohl T, 2016, J LAND USE SCI, V11, P476, DOI 10.1080/1747423X.2016.1147619; Sohl TL, 2014, ECOL APPL, V24, P1015, DOI 10.1890/13-1245.1; Sohl TL, 2007, J LAND USE SCI, V2, P103, DOI 10.1080/17474230701218202; Sorensen R, 2006, HYDROL EARTH SYST SC, V10, P101, DOI 10.5194/hess-10-101-2006; Titeux N., 2017, GLOBAL SCENARIOS BIO; U.S. Department of Agriculture, 2012, FUT AM FOR RANG, P198; van Vuuren DP, 2014, CLIMATIC CHANGE, V122, P373, DOI 10.1007/s10584-013-0906-1; Verburg PH, 2015, ANTHROPOCENE, V12, P29, DOI 10.1016/j.ancene.2015.09.004; Verburg PH, 2010, LANDSCAPE ECOL, V25, P217, DOI 10.1007/s10980-009-9347-7; Verburg PH, 2002, ENVIRON MANAGE, V30, P391, DOI 10.1007/s00267-002-2630-x; Wear D.N., 2013, SRSGTR178 USDA FOR S, P542, DOI [10.2737/SRS-GTR-178, DOI 10.2737/SRS-GTR-178]; Wear D.N, 2013, 2013 SO FOREST FUTUR, V178, P45, DOI DOI 10.1017/CB09781107415324.004; Wear DN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219242; Yang J, 2019, GISCI REMOTE SENS, V56, P388, DOI 10.1080/15481603.2018.1533680; Yang J, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5070106	58	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240097	10.1371/journal.pone.0240097	http://dx.doi.org/10.1371/journal.pone.0240097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057344	gold, Green Published			2022-12-26	WOS:000581814700017
J	Hernandez-Valencia, JC; Rincon, DS; Marin, A; Naranjo-Diaz, N; Correa, MM				Hernandez-Valencia, Juan C.; Rincon, Daniel S.; Marin, Alba; Naranjo-Diaz, Nelson; Correa, Margarita M.			Effect of land cover and landscape fragmentation on anopheline mosquito abundance and diversity in an important Colombian malaria endemic region	PLOS ONE			English	Article							MARK-RELEASE-RECAPTURE; DIPTERA-CULICIDAE; SPECIES RICHNESS; GENETIC DIVERSITY; LARVAL HABITATS; VECTOR; DEFORESTATION; DARLINGI; BEHAVIOR; DISCRIMINATION	Landscape structure influences the distribution and abundance of anopheline mosquitoes and has an indirect impact on malaria transmission. This work aimed to determine the effect of land cover and landscape fragmentation on anopheline mosquito abundance and diversity in an important Colombian malaria endemic area, the Bajo Cauca region. Diversity indices were calculated forAnophelesmosquitoes collected in various localities of the region. Land cover types were characterized using orthorectified aerial photographs to estimate landscape metrics. The relationship between landscape fragmentation and species diversity was evaluated by regression analysis. The correlation between species abundance and land cover types was determined using canonical correspondence analyses. Results showed a statistically significant tendency for a lower diversity of theAnophelescommunity in landscapes with higher patch number, patch density and effective mesh size. For most species, there was evidence of a significant relationship between species abundance and land covers modified by anthropic activities which generate forest loss. These results indicate that activities that modify the landscape structure and land cover composition generate changes that affect the spatial distribution and composition of epidemiologically-importantAnopheles species, which may impact malaria distribution in a region. This information is useful to guide control interventions that promote unfavorable landscapes for malaria vector propagation.	[Hernandez-Valencia, Juan C.; Rincon, Daniel S.; Naranjo-Diaz, Nelson; Correa, Margarita M.] Univ Antioquia, Escuela Microbiol, Grp Microbiol Mol, Medellin, Colombia; [Marin, Alba] Univ Antioquia, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia	Correa, MM (corresponding author), Univ Antioquia, Escuela Microbiol, Grp Microbiol Mol, Medellin, Colombia.	margarita.correao@udea.edu.co	Correa, Margarita/AAW-8277-2020	Correa, Margarita/0000-0003-2419-7269; Rincon, Daniel/0000-0002-2614-3881	Departamento Administrativo de Ciencia, Tecnologia e Innovacion - Colciencias; Universidad de Antioquia - UdeA [753-2018]; Colciencias; program Jovenes Investigadores e Innovadores of Colciencias [812-2018]; Colciencias, Colombia [511]; UdeA [596-2013]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion - Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Antioquia - UdeA; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); program Jovenes Investigadores e Innovadores of Colciencias; Colciencias, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); UdeA	This work was derived from a study supported by the Departamento Administrativo de Ciencia, Tecnologia e Innovacion - Colciencias and Universidad de Antioquia - UdeA, project code No. 753-2018 to MMC; it also included samples collected under the project funded by Colciencias and UdeA code No. 596-2013 to MMC. JCHV received support from the program Jovenes Investigadores e Innovadores, grant 812-2018 of Colciencias. NND received financial support for their doctoral studies from Colciencias, Colombia, grant No. 511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee NL, 2007, J AM MOSQUITO CONTR, V23, P276, DOI 10.2987/8756-971X(2007)23[276:AMSTDT]2.0.CO;2; Achee NL, 2005, J AM MOSQUITO CONTR, V21, P366, DOI 10.2987/8756-971X(2006)21[366:AMSUAN]2.0.CO;2; Adde A, 2017, J MED ENTOMOL, V54, P597, DOI 10.1093/jme/tjx031; Adde A, 2016, MEM I OSWALDO CRUZ, V111, P750, DOI 10.1590/0074-02760160272; Afrane YA, 2008, EMERG INFECT DIS, V14, P1533, DOI 10.3201/eid1410.070781; Altamiranda-Saavedra M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179093; Alvarez N, 2018, INFECT GENET EVOL, V64, P76, DOI 10.1016/j.meegid.2018.06.018; Argota RC, 2017, REV INT COOP DESARRO, V4, P46, DOI [10.21500/23825014.3116, DOI 10.21500/23825014.3116]; Beketov MA, 2010, J MED ENTOMOL, V47, P129, DOI 10.1603/ME09150; Brochero Helena, 2006, Biomed., V26, P269; Gonzalez JJC, 2009, SIST BIBLIO INF SOC, P2; Camara de Comercio de Medellin para Antioquia, 2014, PERF SOC SUBR ANT; Carmona-Fonseca Jaime, 2017, Rev. Univ. Ind. Santander. Salud, V49, P577, DOI 10.18273/revsal.v49n4-2017007; Castellanos A, 2016, MEM I OSWALDO CRUZ, V111, P59, DOI 10.1590/0074-02760150382; Chaparro P, 2012, BIOMEDICA, V32, P95, DOI 10.1590/S0120-41572012000500011; Chaves LF, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00088.1; Cienfuegos AV, 2011, ACTA TROP, V118, P128, DOI 10.1016/j.actatropica.2011.02.004; Colwell RK, 2014, ECOGRAPHY, V37, P609, DOI 10.1111/ecog.00814; Conn JE, 2002, AM J TROP MED HYG, V66, P18, DOI 10.4269/ajtmh.2002.66.18; da Silva-Vasconcelos A, 2002, MEM I OSWALDO CRUZ, V97, P151, DOI 10.1590/S0074-02762002000200002; Dale P. E. R., 2008, Wetlands Ecology and Management, V16, P255, DOI 10.1007/s11273-008-9098-2; Eisen L, 2008, J MED ENTOMOL, V45, P800, DOI 10.1603/0022-2585(2008)45[800:MSRCAA]2.0.CO;2; ELLIOTT R, 1972, AM J TROP MED HYG, V21, P755, DOI 10.4269/ajtmh.1972.21.755; Environmental Systems Research Institute (ESRI), 2014, ARCGIS REL 10 2; Espinosa-Velez Y, 2020, TROP MED INT HEALTH, V25, P861, DOI 10.1111/tmi.13399; FARAN M E, 1981, Mosquito Systematics, V13, P1; Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002; Gatti RC, 2015, ECOL RES, V30, P119, DOI 10.1007/s11284-014-1217-3; Gomez G, 2013, MOL ECOL RESOUR, V13, P1082, DOI 10.1111/1755-0998.12126; Goodman H, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2779-7; Gutierrez LA, 2010, MEM I OSWALDO CRUZ, V105, P1019, DOI 10.1590/S0074-02762010000800011; Gutierrez LA, 2009, MEM I OSWALDO CRUZ, V104, P1117, DOI 10.1590/S0074-02762009000800008; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hunter P, 2007, EMBO REP, V8, P316, DOI 10.1038/sj.embor.7400951; Instituto Nacional de Salud, 2019, VIG RUT 2019; Keven JB, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2038-3; Knoblauch AM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-194; Kweka EJ, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00238; Laporta GZ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002139; Lee JM, 2020, ECOHEALTH, V17, P52, DOI 10.1007/s10393-019-01457-9; Loaiza JR, 2012, INFECT GENET EVOL, V12, P1, DOI 10.1016/j.meegid.2011.08.004; LOPES J, 1995, REV SAUDE PUBL, V29, P183, DOI 10.1590/S0034-89101995000300005; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mayi MPA, 2019, J VECTOR ECOL, V44, P271, DOI 10.1111/jvec.12359; Mohlmann TWR, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2481-1; Moreno JE, 2015, B MALARIOL SALUD AMB, V55, P117; Muturi EJ, 2008, J AM MOSQUITO CONTR, V24, P349, DOI 10.2987/5675.1; Naranjo-Diaz N, 2020, INFECT GENET EVOL, V78, DOI 10.1016/j.meegid.2019.104114; Naranjo-Diaz N, 2016, INFECT GENET EVOL, V45, P56, DOI 10.1016/j.meegid.2016.08.019; Naranjo-Diaz N, 2016, INFECT GENET EVOL, V39, P64, DOI 10.1016/j.meegid.2016.01.004; Naranjo-Diaz N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-61; Obsomer V, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-136; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Overgaard HJ, 2003, LANDSCAPE ECOL, V18, P605, DOI 10.1023/A:1026074910038; R Core Team, 2018, R LANG ENV STAT COMP; Ribeiro AF, 2012, J VECTOR ECOL, V37, P316, DOI 10.1111/j.1948-7134.2012.00233.x; Rondon XJ, 2012, INT J FOR RES, P170974, DOI [10.1155/2012/170974, DOI 10.1155/2012/170974]; Rosero DA, 2012, AM J TROP MED HYG, V87, P910, DOI 10.4269/ajtmh.2012.12-0285; Rosero DA, 2010, REV COLOMB ENTOMOL, V36, P260; Samson DM, 2015, J VECTOR ECOL, V40, P46, DOI 10.1111/jvec.12131; Schuller B, 2003, INT CONF ACOUST SPEE, P1; Silva-Do-Nascimento TF, 2006, J MED ENTOMOL, V43, P455, DOI 10.1603/0022-2585(2006)43[455:MCOTSS]2.0.CO;2; Gil LHS, 2015, REV INST MED TROP SP, V57, P263, DOI 10.1590/S0036-46652015000300014; Srivastava AK, 2013, J VECTOR DIS, V50, P121; Stefani A, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-65; Stein M, 2016, ACTA TROP, V156, P57, DOI 10.1016/j.actatropica.2015.12.002; Stein M, 2011, MEM I OSWALDO CRUZ, V106, P400, DOI 10.1590/S0074-02762011000400004; Tadei Wanderli Pedro, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P87, DOI 10.1590/S0036-46652000000200005; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Thomas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068679; Thongsripong P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002507; Subiros JV, 2006, DOC ANAL GEOGR, V48, P151; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Weitzel T, 2015, PARASITOL RES, V114, P289, DOI 10.1007/s00436-014-4193-1; WHO, 2019, WORLD MALARIA REPORT; World Wildlife Fund (WWF), 2001, VIS BIOD AND NORT; Zapata MA, 2007, AM J TROP MED HYG, V77, P67, DOI 10.4269/ajtmh.2007.77.67; Zittra C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2140-6	79	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240207	10.1371/journal.pone.0240207	http://dx.doi.org/10.1371/journal.pone.0240207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057442	gold, Green Published			2022-12-26	WOS:000581814700086
J	Muloiwa, R; Dube, FS; Nicol, MP; Hussey, GD; Zar, HJ				Muloiwa, Rudzani; Dube, Felix S.; Nicol, Mark P.; Hussey, Gregory D.; Zar, Heather J.			Risk factors forBordetella pertussisdisease in hospitalized children	PLOS ONE			English	Article							MATERNAL HIV-INFECTION; TIME PCR ASSAY; BORDETELLA-PERTUSSIS; INFANT PERTUSSIS; IMMUNE-RESPONSES; IMMUNIZATION; PARAPERTUSSIS; SURVEILLANCE; VACCINATION; PREGNANCY	Introduction Despite a resurgence of disease, risk factors for pertussis in children in low and middle-income countries are poorly understood. This study aimed to investigate risk factors for pertussis disease in African children hospitalized with severe LRTI. Methods A prospective study of children hospitalized with severe LRTI in Cape Town, South Africa was conducted over a one-year period. Nasopharyngeal and induced sputum samples from child and nasopharyngeal sample from caregiver were tested forBordetella pertussisusing PCR (IS481+/hIS1001). History and clinical details were documented. Results 460 children with a median age of 8 (IQR 4-18) months were enrolled.B.pertussisinfection was confirmed in 32 (7.0%). The adjusted risk of confirmed pertussis was significantly increased if infants were younger than two months [aRR 2.37 (95% CI 1.03-5.42]), HIV exposed but uninfected (aRR 3.53 [95% CI 1.04-12.01]) or HIV infected (aRR 4.35 [95% CI 1.24-15.29]). Mild (aRR 2.27 [95% CI 1.01-5.09]) or moderate (aRR 2.70 [95% CI 1.13-6.45]) under-nutrition in the children were also associated with higher risk. The highest adjusted risk occurred in children whose caregivers hadB.pertussisdetected from nasopharyngeal swabs (aRR 13.82 [95% CI 7.76-24.62]). Completion of the primary vaccine schedule (three or more doses) was protective (aRR 0.28 [95% CI 0.10-0.75]). Conclusions HIV exposure or infection, undernutrition as well as detection of maternal nasalB.pertussiswere associated with increased risk of pertussis in African children, especially in young infants. Completed primary vaccination was protective. There is an urgent need to improve primary pertussis vaccine coverage in low and middle-income countries. Pertussis vaccination of pregnant women, especially those with HIV infection should be prioritized.	[Muloiwa, Rudzani] Univ Cape Town, Groote Schuur Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa; [Dube, Felix S.] Univ Cape Town, Dept Mol & Cell Biol, Fac Sci, Cape Town, South Africa; [Dube, Felix S.; Hussey, Gregory D.] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Dube, Felix S.; Nicol, Mark P.] Univ Western Australia, Sch Biomed Sci, Div Infect & Immun, Perth, WA, Australia; [Nicol, Mark P.] Univ Cape Town, Div Med Microbiol, Fac Hlth Sci, Cape Town, South Africa; [Hussey, Gregory D.] Univ Cape Town, Div Med Microbiol, Vaccines Africa Initiat, Cape Town, South Africa; [Zar, Heather J.] Univ Cape Town, SA MRC Unit Child & Adolescent Lung Hlth, Cape Town, South Africa; [Zar, Heather J.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat Child Hlth, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Western Australia; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Muloiwa, R (corresponding author), Univ Cape Town, Groote Schuur Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa.	Rudzani.Muloiwa@uct.ac.za	Zar, Heather/GZL-5350-2022; Muloiwa, Rudzani/AAG-8139-2021; Nicol, Mark/J-4987-2014; Mashiya, Nombeko Monica/AET-3950-2022	Zar, Heather/0000-0002-9046-759X; Nicol, Mark/0000-0002-1366-4805; Muloiwa, Rudzani/0000-0002-4527-0827; Mashiya, Nombeko Monica/0000-0003-0124-9118	Sanofi Pasteur	Sanofi Pasteur	The authors acknowledge financial support to their institution by Sanofi Pasteur for the submitted work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3; [Anonymous], 2014, Harv Mens Health Watch, V18, P8; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; Anukam KC, 2004, WORLD J MICROB BIOT, V20, P231, DOI 10.1023/B:WIBI.0000023825.36332.f1; Barger-Kamate B, 2016, CLIN INFECT DIS, V63, pS187, DOI 10.1093/cid/ciw546; Centers for Disease Control and Prevention, 1993, JAMA-J AM MED ASSOC, V269, P460; Cherry JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003418; Clark TA, 2014, J INFECT DIS, V209, P978, DOI 10.1093/infdis/jiu001; Corrigall J, 2008, SAMJ S AFR MED J, V98, P41; Dabrera G, 2015, CLIN INFECT DIS, V60, P333, DOI 10.1093/cid/ciu821; Delamonica E, 2005, B WORLD HEALTH ORGAN, V83, P384; Edwards KM, 2014, J INFECT DIS, V209, pS10, DOI 10.1093/infdis/jit560; Farrell DJ, 1999, J CLIN MICROBIOL, V37, P606, DOI 10.1128/JCM.37.3.606-610.1999; Gaayeb L, 2014, VACCINE, V32, P3431, DOI 10.1016/j.vaccine.2014.03.086; Gill CJ, 2016, CLIN INFECT DIS, V63, pS154, DOI 10.1093/cid/ciw526; Heininger U, 2014, PEDIATR INFECT DIS J, V33, P147, DOI 10.1097/01.inf.0000435503.44620.74; Jardine A, 2010, COMMUN DIS INTELL, V34, P116; Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100; Juretzko P, 2002, CLIN INFECT DIS, V35, P162, DOI 10.1086/341027; Kabami J, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-81; Kayina V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123240; Kidzeru EB, 2014, AIDS, V28, P1421, DOI 10.1097/QAD.0000000000000292; Lim GH, 2014, EUROSURVEILLANCE, V19, P26, DOI 10.2807/1560-7917.ES2014.19.5.20688; Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071; Muloiwa R, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01699-3; Muloiwa R, 2018, VACCINE, V36, P2385, DOI 10.1016/j.vaccine.2018.03.025; Muloiwa R, 2016, PEDIATR INFECT DIS J, V35, P611, DOI 10.1097/INF.0000000000001132; Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633; National Department of Health of South Africa (NDoH), 2019, 2019 ART CLIN GUID M; Nunes MC, 2016, CLIN INFECT DIS, V63, pS174, DOI 10.1093/cid/ciw527; Reischl U, 2001, J CLIN MICROBIOL, V39, P1963, DOI 10.1128/JCM.39.5.1963-1966.2001; Skowronski DM, 2012, CLIN INFECT DIS, V54, P318, DOI 10.1093/cid/cir836; Soofie N, 2016, CLIN INFECT DIS, V63, pS165, DOI 10.1093/cid/ciw545; Sutcliffe CG, 2010, LANCET INFECT DIS, V10, P630, DOI 10.1016/S1473-3099(10)70116-X; Tan TN, 2015, PEDIATR INFECT DIS J, V34, pE222, DOI 10.1097/INF.0000000000000795; Tatti KM, 2011, J CLIN MICROBIOL, V49, P4059, DOI 10.1128/JCM.00601-11; Tejiokem MC, 2009, CLIN VACCINE IMMUNOL, V16, P479, DOI 10.1128/CVI.00312-08; Tejiokem MC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001260; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; UNICEF, 2020, PROGR CHILDR WORLD F; Vanker A, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00052-2018; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; World Health Organization (WHO), 2020, IMM VACC BIOL; World Health Organization (WHO), 2020, CHILD GROWTH STAND; Zar HJ, 2015, THORAX, V70, P592, DOI 10.1136/thoraxjnl-2014-206242	46	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240717	10.1371/journal.pone.0240717	http://dx.doi.org/10.1371/journal.pone.0240717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057415	gold, Green Published			2022-12-26	WOS:000581814700014
J	Oyarzo-Miranda, C; Latorre, N; Meynard, A; Rivas, J; Bulboa, C; Contreras-Porcia, L				Oyarzo-Miranda, Carolina; Latorre, Nicolas; Meynard, Andres; Rivas, Jorge; Bulboa, Cristian; Contreras-Porcia, Loretto			Coastal pollution from the industrial park Quintero bay of central Chile: Effects on abundance, morphology, and development of the kelpLessonia spicata(Phaeophyceae)	PLOS ONE			English	Article							LESSONIA-TRABECULATA LAMINARIALES; COPPER MINE TAILINGS; HEAVY-METALS; TRACE-ELEMENTS; NIGRESCENS PHAEOPHYCEAE; ANTIOXIDANT RESPONSES; MARINE-SEDIMENTS; NORTHERN CHILE; KELP; EXPOSURE	The industrial park of Quintero Bay (QB) in the central coast of Chile was established in the 1960s, presents high levels of pollution due to the industrial activity, and it is known as one of the five Chilean "sacrifice zones".Lessonia spicatais the most important habitat-forming kelp species in the intertidal along the central and south shores of Chile, and currently there are no morphometric and population studies ofL.spicata(or other seaweed species) nor studies about the effects of pollution on its development in QB and neighbouring sites. In this context, the aims of this study were (i) to register the abundance and morphological features ofL.spicatapopulations from Ventanas, Horcon and Cachagua (sites with different pollution histories and located only up to 40 km from the QB); ii) to determine the heavy metals (HMs) concentration in seawater and marine sediments; and (iii) to evaluatein vitrothe effects of exposure to seawater from the three sampling sites on spore release and early developmental stages, up to the juvenile sporophyte. Results showed that the chronically exposed Ventanas kelp population had the smallest adult individuals in comparison with the other sites. Ventanas and Horcon registered high HMs concentration in the seawater and marine sediments exceeding the international permissible limits (e.g in seawater Cu 20-859 mu g L-1; sediments Cu > 50,000 mu g kg(-1)). Unexpectedly in Cachagua, a site often considered unpolluted, high concentrations of Cu and As were also registered in the seawater (859 and 1,484 mu g L-1, respectively) and of As in marine sediments (20,895 mu g kg(-1)). Exposure of gametophytes to the seawater from Ventanas resulted in a developmental delay compared to the other treatments; however, low sporophyte production was determined in all treatments. Our results indicate that QB, more notably Ventanas, induce highly negative effects on individual development, and consequently on seaweed populations, which suggest a long-term negative impact on the community structure of these marine zones. Furthermore, the high concentrations of HMs reported here at Cachagua suggest a recent expansion of pollution along the central coast of Chile, evidencing effects on the marine ecosystem health even on sites far from the pollution source.	[Oyarzo-Miranda, Carolina; Latorre, Nicolas; Meynard, Andres; Rivas, Jorge; Bulboa, Cristian; Contreras-Porcia, Loretto] Univ Andres Bello, Fac Ciencias Vida, Dept Ecol & Biodiversidad, Santiago, Chile; [Oyarzo-Miranda, Carolina; Latorre, Nicolas; Meynard, Andres; Rivas, Jorge; Bulboa, Cristian; Contreras-Porcia, Loretto] Univ Andres Bello, Fac Ciencias Vida, Ctr Invest Marina Quintay CIMARQ, Santiago, Chile; [Oyarzo-Miranda, Carolina; Latorre, Nicolas; Meynard, Andres; Contreras-Porcia, Loretto] Ctr Appl Ecol & Sustainabil CAPES, Santiago, Chile; [Latorre, Nicolas] Univ Andres Bello, Fac Ciencias Vida, Programa Doctorado Med Conservac, Santiago, Chile	Universidad Andres Bello; Universidad Andres Bello; Universidad Andres Bello	Contreras-Porcia, L (corresponding author), Univ Andres Bello, Fac Ciencias Vida, Dept Ecol & Biodiversidad, Santiago, Chile.; Contreras-Porcia, L (corresponding author), Univ Andres Bello, Fac Ciencias Vida, Ctr Invest Marina Quintay CIMARQ, Santiago, Chile.; Contreras-Porcia, L (corresponding author), Ctr Appl Ecol & Sustainabil CAPES, Santiago, Chile.	lorettocontreras@unab.cl	Contreras-Porcia, Loretto/F-9593-2016	Contreras-Porcia, Loretto/0000-0002-6511-2244; Oyarzo, Carolina/0000-0003-3871-0721	ANID FONDECYT [1170881]; ANID PIA/BASAL [FB0002]	ANID FONDECYT; ANID PIA/BASAL	This work was supported ANID FONDECYT No 1170881 to LC-P as PI and ANID PIA/BASAL FB0002.	Vega JMA, 2014, J APPL PHYCOL, V26, P791, DOI 10.1007/s10811-013-0167-4; Alvarez-Campos P, 2017, SYST BIODIVERS, V15, P520, DOI 10.1080/14772000.2017.1285364; Aminina N. M., 2012, Research in Plant Biology, V2, P32; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 1995, REQ RES FISH REQ MUS; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2000, LEIDEN J INT LAW, V13, P2; Casares FA, 2016, EVOL ECOL, V30, P953, DOI 10.1007/s10682-016-9849-0; Bernalte E, 2015, INT J ENVIRON SCI TE, V12, P817, DOI 10.1007/s13762-013-0461-3; Bond PR, 1999, EUR J PHYCOL, V34, P513, DOI 10.1080/09541449910001718871; CASTILLA JC, 1983, MAR POLLUT BULL, V14, P459, DOI 10.1016/0025-326X(83)90046-2; Celis JE, 2014, ENVIRON MONIT ASSESS, V186, P1815, DOI 10.1007/s10661-013-3495-6; Chandia C, 2012, MAR POLLUT BULL, V64, P2254, DOI 10.1016/j.marpolbul.2012.06.030; Chen CW, 2007, CHEMOSPHERE, V66, P1431, DOI 10.1016/j.chemosphere.2006.09.030; CHUNG IK, 1986, MAR POLLUT BULL, V17, P213, DOI 10.1016/0025-326X(86)90603-X; Coelho Susana M., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P317, DOI 10.1023/A:1009916129009; Comision de Recursos Naturales Bienes Nacionales y Medio Ambiente, 2011, INF COM REC NAT BIEN; Contreras, 2013, ANALISIS RIESGO ECOL; Contreras L, 2005, J PHYCOL, V41, P1184, DOI 10.1111/j.1529-8817.2005.00151.x; Contreras L, 2007, ENVIRON POLLUT, V145, P75, DOI 10.1016/j.envpol.2006.03.051; Contreras-Porcia L., 2017, SYSTEMS BIOL MARINE, P35, DOI [10.1007/978-3-319-62094-7_3, DOI 10.1007/978-3-319-62094-7_3]; Contreras-Porcia L, ANID FONDECYT, V1170881, P2017; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; DeGregori I, 1996, ENVIRON POLLUT, V92, P359, DOI 10.1016/0269-7491(95)00077-1; Evans La Kenya, 2011, Algae, V26, P265, DOI 10.4490/algae.2011.26.3.265; Farias DR, 2018, MAR POLLUT BULL, V128, P175, DOI 10.1016/j.marpolbul.2018.01.023; Farina JM, 2001, MAR POLLUT BULL, V42, P554, DOI 10.1016/S0025-326X(00)00201-0; Fertah M, 2017, ARAB J CHEM, V10, pS3707, DOI 10.1016/j.arabjc.2014.05.003; Fink LA, 2011, MAR POLLUT BULL, V62, P2619, DOI 10.1016/j.marpolbul.2011.09.035; Flórez-Leiva Lennin, 2010, Bol. Invest. Mar. Cost., V39, P41; HOPKIN R, 1978, ESTUAR COAST MAR SCI, V7, P531, DOI 10.1016/0302-3524(78)90063-4; Larsson N., 2020, WIRED MAGAZINE; Leal PP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32899-w; Leal PP, 2016, PHYCOLOGIA, V55, P12, DOI 10.2216/15-87.1; Lovazzano C, 2013, PHYSIOL PLANTARUM, V149, P378, DOI 10.1111/ppl.12047; Mabin CJT, 2019, J PHYCOL, V55, P380, DOI 10.1111/jpy.12820; Medina M, 2005, MAR POLLUT BULL, V50, P396, DOI 10.1016/j.marpolbul.2004.11.022; Mineur F, 2015, J SEA RES, V98, P91, DOI 10.1016/j.seares.2014.11.004; Mohring MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065310; Moreno-Garrido I, 2015, MAR ENVIRON RES, V111, P60, DOI 10.1016/j.marenvres.2015.05.008; Munoz AA, 2019, SCI TOTAL ENVIRON, V696, DOI 10.1016/j.scitotenv.2019.133915; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Nelson WA, 2005, J APPL PHYCOL, V17, P23, DOI 10.1007/s10811-005-5521-8; O y arzUN un Pablo, 2016, BAUDELAIRE MODERNIDA; Oppliger LV, 2007, J PHYCOL, V43, P1295, DOI 10.1111/j.1529-8817.2007.00408.x; Oppliger LV, 2011, J PHYCOL, V47, P5, DOI 10.1111/j.1529-8817.2010.00930.x; Oppliger LV, 2010, THESIS; Ortega KJ, 2014, REV BIOL MAR OCEANOG, V49, P129, DOI 10.4067/S0718-19572014000100014; Parra S, 2015, MAR POLLUT BULL, V99, P256, DOI 10.1016/j.marpolbul.2015.07.066; Pastene M, 2019, MAR POLLUT BULL, V142, P76, DOI 10.1016/j.marpolbul.2019.03.005; Perez Leonardo Valenzuela, 2016, COPPERED LIVES CHILE; Ratkevicius N, 2003, PLANT CELL ENVIRON, V26, P1599, DOI 10.1046/j.1365-3040.2003.01073.x; Reid MK, 2009, ENVIRON POLLUT, V157, P2275, DOI 10.1016/j.envpol.2009.03.033; Ritter A, 2010, PROTEOMICS, V10, P2074, DOI 10.1002/pmic.200900004; Roleda MY, 2016, POLAR BIOL, V39, P1967, DOI 10.1007/s00300-015-1813-x; Rueda-Holgado F, 2016, CHEMOSPHERE, V144, P1788, DOI 10.1016/j.chemosphere.2015.10.079; Saez CA, 2015, AQUAT TOXICOL, V159, P81, DOI 10.1016/j.aquatox.2014.11.019; Saez CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050170; Salmani-Ghabeshi S, 2016, ENVIRON POLLUT, V218, P322, DOI 10.1016/j.envpol.2016.07.007; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Sfakianakis DG, 2015, ENVIRON RES, V137, P246, DOI 10.1016/j.envres.2014.12.014; Stuart-Smith RD, 2015, MAR POLLUT BULL, V95, P324, DOI 10.1016/j.marpolbul.2015.03.023; Sulmon C, 2015, ENVIRON POLLUT, V202, P66, DOI 10.1016/j.envpol.2015.03.013; Tala F, 2005, AQUAT BOT, V82, P39, DOI 10.1016/j.aquabot.2005.02.009; Tala F, 2007, PHYCOLOGIA, V46, P467, DOI 10.2216/06-56.1; Tala F, 2007, PHYCOL RES, V55, P66, DOI 10.1111/j.1440-1835.2006.00447.x; Thiel M, OCEANOGR MAR BIOL AN, V45, P195; Thompson SA, 2010, MAR ECOL PROG SER, V413, P17, DOI 10.3354/meps08705; US EPA, 1996, 3050B USEPA; US EPA, 1999, US EPA NATL RECOMMEN; US EPA (Environmental Protection Agency), 1974, METH CHEM AN WAT WAS; V?squez JA., 1984, REV CHIL HIST NAT, V57, P131; Oppliger LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039289; Vasquez JA, 2012, J APPL PHYCOL, V24, P417, DOI 10.1007/s10811-012-9794-4; Villegas MJ, 2008, HELGOLAND MAR RES, V62, pS33, DOI 10.1007/s10152-007-0096-1; Walker C.H., 2012, PRINCIPLES ECOTOXICO; Whitehead A, 2017, EVOL APPL, V10, P762, DOI 10.1111/eva.12470; Wong MH, 2003, CHEMOSPHERE, V50, P775, DOI 10.1016/S0045-6535(02)00232-1; Zaldivar JR, 2015, HOMOLOGACION CATEGOR; Zhou QF, 2008, ANAL CHIM ACTA, V606, P135, DOI 10.1016/j.aca.2007.11.018	80	13	13	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240581	10.1371/journal.pone.0240581	http://dx.doi.org/10.1371/journal.pone.0240581			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057390	Green Published, gold			2022-12-26	WOS:000581814700089
J	Vishnyakova, TG; Bocharov, AV; Baranova, IN; Kurlander, R; Drake, SK; Chen, ZG; Amar, M; Sviridov, D; Vaisman, B; Poliakov, E; Remaley, AT; Eggerman, TL; Patterson, AP				Vishnyakova, Tatyana G.; Bocharov, Alexander V.; Baranova, Irina N.; Kurlander, Roger; Drake, Steven K.; Chen, Zhigang; Amar, Marcelo; Sviridov, Denis; Vaisman, Boris; Poliakov, Eugenia; Remaley, Alan T.; Eggerman, Thomas L.; Patterson, Amy P.			SR-BI mediates neutral lipid sorting from LDL to lipid droplets and facilitates their formation	PLOS ONE			English	Article							CHOLESTERYL ESTER UPTAKE; SCAVENGER RECEPTOR-BI; SELECTIVE UPTAKE; DENSITY-LIPOPROTEINS; CELLS; METABOLISM; PATHWAY; BINDING; MICE; LOCALIZATION	SR-BI binds various lipoproteins, including HDL, LDL as well as VLDL, and mediates selective cholesteryl ester (CE) uptake. HDL derived CE accumulates in cellular lipid droplets (LDs), which also store triacylglycerol (TAG). We hypothesized that SR-BI could significantly facilitate LD formation, in part, by directly transporting LDL derived neutral lipids (NL) such as CE and TAG into LDs without lipolysis andde novolipid synthesis. SR-BI overexpression greatly increased LDL uptake and LD formation in stably transfected HeLa cells (SR-BI-HeLa). LDs isolated from SR-BI-HeLa contained 4- and 7-times more CE and TAG, respectively, than mock-transfected HeLa (Mock-HeLa). In contrast, LDL receptor overexpression in HeLa (LDLr-HeLa) greatly increased LDL uptake, degradation with moderate 1.5- and 2-fold increases of CE and TAG, respectively. Utilizing CE and TAG analogs, BODIPY-TAG (BP-TAG) and BODIPY-CE (BP-CE), for tracking LDL NL, we found that after initial binding of LDL to SR-BI-HeLa, apoB remained at the cell surface, while BP-CE and BP-TAG were sorted and simultaneously transported together to LDs. Both lipids demonstrated limited internalization to lysosomes or endoplasmic reticulum in SR-BI-HeLa. In LDLr-HeLa, NLs demonstrated clear lysosomal sequestration without their sorting to LDs. An inhibition of TAG and CEde novosynthesis by 90-95% only reduced TAG and CE LD content by 45-50%, and had little effect on BP-CE and BP-TAG transport to LDs in SR-BI HeLa. Furthermore, intravenous infusion of 1-2 mg of LDL increased liver LDs in normal (WT) but not in SR-BI KO mice. Mice transgenic for human SR-BI demonstrated higher liver LD accumulation than WT mice. Finally, Electro Spray Infusion Mass Spectrometry (ESI-MS) using deuterated d-CE found that LDs accumulated up to 40% of unmodified d-CE LDL. We conclude that SR-BI mediates LDL-induced LD formationin vitroandin vivo. In addition to cytosolic NL hydrolysis andde novolipid synthesis, this process includes selective sorting and transport of LDL NL to LDs with limited lysosomal NL sequestration and the transport of LDL CE, and TAG directly to LDs independently ofde novosynthesis.	[Vishnyakova, Tatyana G.; Bocharov, Alexander V.; Baranova, Irina N.; Kurlander, Roger; Drake, Steven K.; Chen, Zhigang; Eggerman, Thomas L.; Patterson, Amy P.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Amar, Marcelo; Sviridov, Denis; Vaisman, Boris; Remaley, Alan T.; Patterson, Amy P.] NHLBI, Bldg 10, Bethesda, MD 20892 USA; [Poliakov, Eugenia] NEI, Bethesda, MD 20892 USA; [Eggerman, Thomas L.] NIDDK, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bocharov, AV (corresponding author), NIH, Ctr Clin, Bethesda, MD 20892 USA.	abocharov@mail.cc.nih.gov						Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Azhar S, 2002, MOL CELL ENDOCRINOL, V195, P1, DOI 10.1016/S0303-7207(02)00222-8; Azhar S, 1999, J CELL PHYSIOL, V180, P190, DOI 10.1002/(SICI)1097-4652(199908)180:2<190::AID-JCP7>3.0.CO;2-Z; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Chen JZ, 2013, INVEST OPHTH VIS SCI, V54, P5730, DOI 10.1167/iovs.12-10317; Connelly MA, 2009, MOL CELL ENDOCRINOL, V300, P83, DOI 10.1016/j.mce.2008.09.011; Cox RA., 1990, CLIN METHODS HIST PH, V3rd, P153; Dagher G, 2003, J LIPID RES, V44, P1811, DOI 10.1194/jlr.M300267-JLR200; Eveland SS, 2007, ANAL BIOCHEM, V368, P239, DOI 10.1016/j.ab.2007.06.003; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Foger B, 1999, J BIOL CHEM, V274, P36912, DOI 10.1074/jbc.274.52.36912; Frolov A, 2000, J BIOL CHEM, V275, P12769, DOI 10.1074/jbc.275.17.12769; GREEN SR, 1991, J LIPID RES, V32, P667; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; Hoekstra M, 2010, WORLD J GASTROENTERO, V16, P5916, DOI 10.3748/wjg.v16.i47.5916; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Hussain MM, 2001, FRONT BIOSCI, V6, pD417, DOI 10.2741/Hussain1; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kraemer FB, 2004, MOL ENDOCRINOL, V18, P549, DOI 10.1210/me.2003-0179; Kraemer FB, 2007, MOL CELL ENDOCRINOL, V265, P42, DOI 10.1016/j.mce.2006.12.001; Krieger M, 1999, CURR OPIN LIPIDOL, V10, P491, DOI 10.1097/00041433-199912000-00003; Le Lay S, 2009, PROG LIPID RES, V48, P191, DOI 10.1016/j.plipres.2009.03.001; MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Nieland TJF, 2005, BBA-MOL CELL BIOL L, V1734, P44, DOI 10.1016/j.bbalip.2005.02.007; Okumura T, 2011, J PHYSIOL BIOCHEM, V67, P629, DOI 10.1007/s13105-011-0110-6; Out R, 2005, J LIPID RES, V46, P1172, DOI 10.1194/jlr.M400361-JLR200; Poppelreuther M, 2012, J LIPID RES, V53, P888, DOI 10.1194/jlr.M024562; REAVEN E, 1995, J LIPID RES, V36, P1602; Reaven E, 1996, J BIOL CHEM, V271, P16208, DOI 10.1074/jbc.271.27.16208; Reaven E, 2000, J LIPID RES, V41, P343; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; RINNINGER F, 1988, J LIPID RES, V29, P1179; RINNINGER F, 1987, J LIPID RES, V28, P1313; Robenek H, 2009, J CELL MOL MED, V13, P4657, DOI 10.1111/j.1582-4934.2009.00950.x; Schmitz G, 2009, BBA-MOL CELL BIOL L, V1791, P524, DOI 10.1016/j.bbalip.2008.12.007; SINN HJ, 1988, ANAL BIOCHEM, V170, P186, DOI 10.1016/0003-2697(88)90107-8; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200; Van Eck M, 2008, J LIPID RES, V49, P136, DOI 10.1194/jlr.M700355-JLR200; Vishnyakova TG, 2003, J BIOL CHEM, V278, P22771, DOI 10.1074/jbc.M211032200; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Williams DL, 2000, ENDOCR RES, V26, P639, DOI 10.3109/07435800009048584; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Xie CL, 2006, J LIPID RES, V47, P953, DOI 10.1194/jlr.M500534-JLR200; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zhang Y, 2007, J LIPID RES, V48, P405, DOI 10.1194/jlr.M600326-JLR200	59	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240659	10.1371/journal.pone.0240659	http://dx.doi.org/10.1371/journal.pone.0240659			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057430	Green Published, gold			2022-12-26	WOS:000581814700044
J	Hulse, EJ; Smith, SH; Wallace, WA; Dorward, DA; Simpson, AJ; Drummond, G; Clutton, RE; Eddleston, M				Hulse, Elspeth J.; Smith, Sionagh H.; Wallace, William A.; Dorward, David A.; Simpson, A. John; Drummond, Gordon; Clutton, Richard E.; Eddleston, Michael			Development of a histopathology scoring system for the pulmonary complications of organophosphorus insecticide poisoning in a pig model	PLOS ONE			English	Article							RESPIRATORY-FAILURE; LUNG; TOXICITY; PREDICTORS; MORBIDITY; MORTALITY; DAMAGE; NERVE; RATS	Organophosphorus (OP) insecticide self-poisoning causes over 100,000 global deaths annually. Around a third of patients are intubated and up to half of these can die. Post-mortem analysis of OP poisoned patients' lungs reveals consolidation, edema and hemorrhage, suggesting that direct or indirect lung damage may contribute to mortality. The lung injury caused by these formulated agricultural preparations is poorly characterised in humans, and a valid histopathology scoring system is needed in a relevant animal model to further investigate the disease and potential treatments. We conducted two pilot studies in anesthetized minipigs, which are commonly used for toxicological studies. In the first, pigs were given 2.5 mL/kg of either OP (n = 4) or saline (n = 2) by gavage and compared with positive controls (iv oleic acid n = 2). The second study simulated ingestion followed by gastric content aspiration: mixtures of OP (n = 3) or saline (n = 2) (0.63-0.71mL/kg) were placed in the stomach, and then small volumes of the gastric content were placed in the lung. At post-mortem examination, lungs were removed and inflation-fixed with 10% neutral buffered formalin. Samples (n = 62) were taken from cranial and caudal regions of both lungs. Two experienced lung histopathologists separately scored these samples using 8 proposed features of damage and their scores related (Kendall rank order). Two elements had small and inconsistent scores. When these were removed, the correlation increased from 0.74 to 0.78. Eight months later, a subset of samples (n = 35) was re-scored using the modified system by one of the previous histopathologists, with a correlation of 0.88. We have developed a reproducible pulmonary histopathology scoring system for OP poisoning in pigs which will assist future toxicological research and improve understanding and treatment of human OP poisoning.	[Hulse, Elspeth J.; Eddleston, Michael] Univ Edinburgh, Ctr Cardiovasc Sci, Pharmacol Toxicol & Therapeut, Edinburgh, Midlothian, Scotland; [Hulse, Elspeth J.; Simpson, A. John] Univ Edinburgh, Royal Dick Sch Vet Med, Translat & Clin Res Inst, Newcastle Univ, Edinburgh, Midlothian, Scotland; [Smith, Sionagh H.] Univ Edinburgh, Easter Bush Pathol, Royal Dick Sch Vet Med, Edinburgh, Midlothian, Scotland; [Wallace, William A.; Simpson, A. John] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Wallace, William A.; Dorward, David A.] Univ Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland; [Drummond, Gordon] Univ Edinburgh, Anaesthesia Crit Care & Pain Med, Div Hlth Sci, Edinburgh, Midlothian, Scotland; [Clutton, Richard E.] Univ Edinburgh, Royal Dick Sch Vet Med, Wellcome Crit Care Lab Large Anim, Edinburgh, Midlothian, Scotland	University of Edinburgh; Newcastle University - UK; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Smith, SH (corresponding author), Univ Edinburgh, Easter Bush Pathol, Royal Dick Sch Vet Med, Edinburgh, Midlothian, Scotland.	Sionagh.Smith@ed.ac.uk	Drummond, Gordon/ABH-1772-2020	Wallace, William/0000-0002-4752-7956	Wellcome Trust [085979, 090886, 104972]; Lister Research Prize Fellowship; Scottish Senior Clinical Fellowship; MRC [MR/M024075/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Lister Research Prize Fellowship; Scottish Senior Clinical Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The studies were funded by grants 085979, 090886 and 104972 from the Wellcome Trust, as well as by a Lister Research Prize Fellowship and Scottish Senior Clinical Fellowship awarded to Professor Michael Eddleston, University of Edinburgh.	Alahakoon C, 2020, CLIN TOXICOL, V58, P466, DOI 10.1080/15563650.2019.1660782; [Anonymous], 2004, AM J PHYSIOL-HEART C, V286, pH1573; [Anonymous], 2018, LOOK FERTILIZER PEST; Atis S, 2002, INHAL TOXICOL, V14, P199, DOI 10.1080/089583701753403999; Atwood D., 2017, PESTICIDES IND SALES; Banday TH, 2015, N AM J MED SCI, V7, P259, DOI 10.4103/1947-2714.159331; Ben Amara I, 2012, BIOMED ENVIRON SCI, V25, P340, DOI 10.3967/0895-3988.2012.03.013; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bode G, 2010, J PHARMACOL TOX MET, V62, P196, DOI 10.1016/j.vascn.2010.05.009; Burden N, 2015, J AM ASSOC LAB ANIM, V54, P198; Chang C, 2020, AJRCCM, V201, pA5354; Dorandeu F, 2007, TOXICOLOGY, V233, P128, DOI 10.1016/j.tox.2006.09.013; Drummond GB, 2012, BRIT J PHARMACOL, V166, P1977, DOI 10.1111/j.1476-5381.2012.01999.x; Eddleston M, 2008, NETH J MED, V66, P146; Eddleston M, 2006, QJM-INT J MED, V99, P513, DOI 10.1093/qjmed/hcl065; Eddleston M, 2019, ANNU REV PHARMACOL, V59, P341, DOI 10.1146/annurev-pharmtox-010818-021842; Eddleston M, 2012, TOXICOLOGY, V294, P94, DOI 10.1016/j.tox.2012.02.005; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; He XH, 2012, CHINESE MED J-PEKING, V125, P3612, DOI 10.3760/cma.j.issn.0366-6999.2012.20.003; Hulse EJ, 2014, AM J RESP CRIT CARE, V190, P1342, DOI 10.1164/rccm.201406-1150CI; Judge EP, 2014, AM J RESP CELL MOL, V51, P334, DOI 10.1165/rcmb.2013-0453TR; Kamat S R, 1989, J Postgrad Med, V35, P123; Li B, 2005, BIOCHEM PHARMACOL, V70, P1673, DOI 10.1016/j.bcp.2005.09.002; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Meers CM, 2011, J SURG RES, V166, pE195, DOI 10.1016/j.jss.2010.10.015; Mew EJ, 2017, J AFFECT DISORDERS, V219, P93, DOI 10.1016/j.jad.2017.05.002; Muley A, 2014, INDIAN J CRIT CARE M, V18, P297, DOI 10.4103/0972-5229.132488; NAMBA T, 1971, AM J MED, V50, P475, DOI 10.1016/0002-9343(71)90337-8; Patocka Jiri, 2004, Acta Medica (Hradec Kralove), V47, P215; Rotta AT, 1999, J CRIT CARE, V14, P84, DOI 10.1016/S0883-9441(99)90019-9; Sahin O, 2006, PATHOLOGY, V38, P58, DOI 10.1080/00313020500464904; Siegel S, 1988, NONPARAMETRIC STAT B, P245; Yavuz Y, 2008, CLIN TOXICOL, V46, P711, DOI 10.1080/15563650701584111; Yurumez Y, 2007, BASIC CLIN PHARMACOL, V100, P323, DOI 10.1111/j.1742-7843.2007.00049.x	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240563	10.1371/journal.pone.0240563	http://dx.doi.org/10.1371/journal.pone.0240563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052985	gold, Green Published			2022-12-26	WOS:000581820200023
J	Thiblin, I; Andersson, J; Wester, K; Wikstrom, J; Hogberg, G; Hogberg, U				Thiblin, Ingemar; Andersson, Jacob; Wester, Knut; Wikstrom, Johan; Hogberg, Goran; Hogberg, Ulf			Medical findings and symptoms in infants exposed to witnessed or admitted abusive shaking: A nationwide registry study	PLOS ONE			English	Article							SHAKEN BABY SYNDROME; HEAD TRAUMA; WHITE MATTER; BRAIN-DAMAGE; CHILD-ABUSE; INJURY; CLEFTS; FALLS	Background Many physicians regard the combination of encephalopathy, subdural haemorrhage (SDH), retinal haemorrhage (RH), rib fractures, and classical metaphyseal lesions (CML) as highly specific for abusive head trauma (AHT). However, without observed abuse or other criteria that are independent of these findings, bias risk is high. Methods Infants subjected for examination under the suspicion of maltreatment during the period 1997-2014 were identified in the National Patient Registry, International Classification of Diseases (ICD-10 SE). The medical records were scrutinized for identification of cases of witnessed or admitted physical abuse by shaking. The main outcome measures were occurrence of SDH, RH, fractures and skin lesions. Results All identified 36 infants had been shaken, and for 6, there was information indicating blunt force impact immediately after shaking. In 30 cases, there were no findings of SDH or RH, rib fractures, or CMLs. Six infants had finding(s) suggestive of physical abuse, two with possible acute intracranial pathology. One infant with combined shaking and impact trauma had hyperdense SDH, hyperdense subarachnoid haemorrhage, suspected cortical vein thrombosis, RH, and bruises. Another infant abused by shaking had solely an acute subarachnoid haemorrhage. Both had pre-existing vulnerability. The first was born preterm and had non-specific frontal subcortical changes. The other had bilateral chronic SDH/hygroma. Conclusions The present findings do not support the hypothesis that acute SDH or RH can be caused by isolated shaking of a healthy infant. However, they do suggest that abuse by shaking may cause acute intracranial haemorrhage with RH in infants with certain risk factors.	[Thiblin, Ingemar; Andersson, Jacob; Wikstrom, Johan] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Wester, Knut] Univ Bergen, Dept Clin Med K1, Bergen, Norway; [Hogberg, Ulf] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Hogberg, Ulf] Umea Univ, Dept Epidemiol & Global Hlth, Umea, Sweden	Uppsala University; University of Bergen; Uppsala University; Umea University	Hogberg, U (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.; Hogberg, U (corresponding author), Umea Univ, Dept Epidemiol & Global Hlth, Umea, Sweden.	ulf.hogberg@kbh.uu.se	/ABC-6294-2021; /AGX-8250-2022	Hogberg, Ulf/0000-0002-2121-7511				Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; [Anonymous], 2013, INT PERIODICAL LANGU, V8, P179; [Anonymous], 2019, ACTA PAEDIAT; [Anonymous], 2019, MEDCALC SOFTW; Atkinson N, 2018, PEDIATR EMERG CARE, V34, P837, DOI 10.1097/PEC.0000000000001186; Binenbaurn G, 2016, J AAPOS, V21, P23, DOI 10.1016/j.jaapos.2016.10.004; Binney NR, 2018, ARCH DIS CHILD, V103, DOI 10.1136/archdischild-2018-315381; CAFFEY J, 1974, PEDIATRICS, V54, P396; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Cory CZ, 2003, MED SCI LAW, V43, P317, DOI 10.1258/rsmmsl.43.4.317; Debelle GD, 2018, ARCH DIS CHILD, V103, P606, DOI 10.1136/archdischild-2017-313855; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Einboden RD, 2017, NOWHERE STAND CRITIC; Elinder G, 2018, ACTA PAEDIATR, V107, P3, DOI 10.1111/apa.14473; Findley KA, 2019, WISC LAW REV, P1211; Girard N, 2007, J NEURORADIOLOGY, V34, P167, DOI 10.1016/j.neurad.2007.04.003; Gohara M., 2006, LIE LIE FALSE CONFES, V33, P101; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; HAUSDORF G, 1984, NEUROPEDIATRICS, V15, P110, DOI 10.1055/s-2008-1052351; Hauser D, 1996, AM J OPHTHALMOL, V122, P592, DOI 10.1016/S0002-9394(14)72130-0; Himanshu T., 2016, BIOCERAM DEV APPL, V6, P1, DOI [10.4172/2090-5025.100090, DOI 10.4172/2090-5025.100090]; Hogberg U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208033; Hogberg U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206340; Hogberg U, 2018, EUR J PUBLIC HEALTH, V28, P641, DOI 10.1093/eurpub/cky062; Intrapiromkul J, 2013, J NEURORADIOLOGY, V40, P81, DOI 10.1016/j.neurad.2012.03.006; JASPAN T, 1992, PEDIATR RADIOL, V22, P237, DOI 10.1007/BF02019848; KLEINMAN PK, 1988, AM J ROENTGENOL, V150, P635, DOI 10.2214/ajr.150.3.635; Larsen KB, 2019, FORENSIC SCI INT, V296, P115, DOI 10.1016/j.forsciint.2019.01.011; Lynoe N, 2019, PEDIATR RADIOL, V49, P422, DOI 10.1007/s00247-019-04344-1; Lynoe N, 2018, ARCH DIS CHILD, V103, P714, DOI 10.1136/archdischild-2018-315380; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; Melville JD, 2019, PEDIATR EMERG CARE, V35, P245, DOI 10.1097/PEC.0000000000001096; Offiah A, 2009, PEDIATR RADIOL, V39, P461, DOI 10.1007/s00247-009-1157-1; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; ORDIA IJ, 1981, J NEUROSURG, V54, P696, DOI 10.3171/jns.1981.54.5.0696; Palifka LA, 2016, AM J NEURORADIOL, V37, P163, DOI 10.3174/ajnr.A4519; Piatt J H Jr, 1999, Neurosurg Focus, V7, pe4; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Reece RM, 2008, AM J PREV MED, V34, pS116, DOI 10.1016/j.amepre.2007.11.005; ROBERTSON WC, 1979, J PEDIATR-US, V94, P382, DOI 10.1016/S0022-3476(79)80575-2; Tegern G, 2012, ATT FOREBYGGA SKAKVA; Tuerkheimer D, 2009, WASH U L REV, V87, P1; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; Wiig US, 2017, PEDIATR NEUROL, V73, P36, DOI 10.1016/j.pediatrneurol.2017.04.018; Winnicki M, 2018, SURF ENG, V34, P235, DOI 10.1080/02670844.2016.1271579; 2010, AUSTR NZ J PUBLIC HL, P00003	50	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240182	10.1371/journal.pone.0240182	http://dx.doi.org/10.1371/journal.pone.0240182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	33048994	Green Published, gold			2022-12-26	WOS:000581813300049
J	Guta, A; Areri, HA; Anteab, K; Abera, L; Umer, A				Guta, Alemu; Areri, Habtamu Abera; Anteab, Kirubel; Abera, Legesse; Umer, Abdurezak			HIV-positive status disclosure and associated factors among children in public health facilities in Dire Dawa, Eastern Ethiopia: A cross-sectional study	PLOS ONE			English	Article							DIAGNOSIS; PREVALENCE; PARENTS	Introduction HIV status disclosure in children is one of acontroversial issue in current health. Over 44,000 children in Ethiopia were living with HIV in the year 2019 with a variable level of disclosure, which ranges from 16.3% to 49%. Therefore, this study aimed to assess HIV-positive status disclosure and associated factors among HIV-infected children. Methods A cross-sectional study was conducted in ten public health facilities providing pediatric antiretroviral therapy services. Systematic random sampling was used to select 221 caregivers of children aged 6-15 years. Face-to-face interviews were employed to generate the data. Binary logistic regression was used to analyze the association between HIV-positive status disclosure to children and independent variables with statistical significance set at p-value <0.05. Results Out of the total, 134 (60.6%) of HIV-infected children knew about their HIV status. The mean age at disclosure was 10.71 years. Children aged older than 10 years [AOR = 22, 95% CI: 5.3-79.2], female children [AOR = 3; 95% CI = 1.2-8.7], children lost their family member by HIV [AOR = 3.5, 95% CI: 1.2-10], caregiver's perception of child did not get stigmatized [AOR = 4, 95% CI: 1.6-11], and children's responsible for anti-retroviral therapy [AOR = 16, 95% CI: 5-50] were significantly associated with HIV positive status disclosure compared to their counterpart respectively. Children who stayed on anti-retroviral for 10-15 years were [AOR = 7; 95% CI: 2-27] more likely to know their HIV positive status compared to those staying on anti-retroviral therapy for < 6 years. Conclusion The proportion of disclosure of HIV-positive status among HIV-infected children was low. Factors associated were the age of the child, sex, existence of parent, stigma, ART duration, and responsibility of the child for his/her drugs. HIV care providers should consider these factors while supporting disclosure.	[Guta, Alemu; Anteab, Kirubel; Abera, Legesse; Umer, Abdurezak] Dire Dawa Univ, Coll Med & Hlth Sci, Dept Midwifery, Dire Dawa, Ethiopia; [Areri, Habtamu Abera] Addis Ababa Univ, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University	Guta, A (corresponding author), Dire Dawa Univ, Coll Med & Hlth Sci, Dept Midwifery, Dire Dawa, Ethiopia.	chelsea0061@gmail.com	Umer, Abdurezak/ABC-1091-2021; Guta, Alemu/AAI-6771-2021	Umer, Abdurezak/0000-0001-6806-5378; Guta, Alemu/0000-0002-0353-2817; Abera, Legesse/0000-0003-3686-8445	Dire Dawa University [DDU/RTI/5029/2019]	Dire Dawa University	Dire Dawa University has supported the study with grant number: DDU/RTI/5029/2019. The University has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; First and for most, we would like to thank Dire Dawa University Research and Technology Interchange, College of Medicine and Health Sciences, and all respective Health Bureau for their support and collaborations. Secondly, we would like to thank all data collectors and supervisors for their valuable contribution during the data collection. Lastly, we would like to thank the study participants.	Abebe W, 2012, AIDS CARE, V24, P1097, DOI 10.1080/09540121.2012.656565; Abegaz BF, 2019, J INFECT PUBLIC HEAL, V12, P873, DOI 10.1016/j.jiph.2019.05.018; Alemu A, 2013, J AIDS CLIN RES, V4, P1; ANECCA [African network for the care of children affected by HIV/AIDS HoPAiA] Re<prime>seau Africain pour les soins aux enfants affecte<prime>s par le SIDA, 2006, RES AFR SOINS ENF AF; [Anonymous], 2007, COMP LABOR LAW POLIC, V28, P155; [Anonymous], 2020, GLOBAL HIV STAT AIDS; Biadgilign S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017572; Boon-Yasidhi Vitharon, 2005, J Med Assoc Thai, V88 Suppl 8, pS100; Britto C, 2016, J DEV BEHAV PEDIATR, V37, P496, DOI 10.1097/DBP.0000000000000303; Collaborative Study Group on Perioperative ScvO2 Monitoring, 2006, CRIT CARE, V10, pR158; Corby N, 2005, CALLS ACTION CHILDRE; Fiyona GK, 2005, J TROPICAL PEDIAT, V51, P285, DOI [10.1093/tropej/fmi014, DOI 10.1093/TR0PEJ/FMI01416014763]; Flanagan-Klygis E, 2002, AIDS PUBLIC POLICY J, V17, P3; Kallem S, 2011, AIDS BEHAV, V15, P1121, DOI 10.1007/s10461-010-9741-9; Kusnierz-Cabala B, 2015, PANCREATOLOGY, V15, P344, DOI 10.1016/j.pan.2015.05.475; Madiba S., 2012, WORLD J AIDS, V2, P212, DOI [10.4236/wja.2012.23027, DOI 10.4236/WJA.2012.23027]; Maria MP, 2013, J TROPICAL PEDIAT, V59, P84, DOI [10.1093/tropej/fms052, DOI 10.1093/TR0PEJ/FMS05223070738]; Meless GD, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18569; Mellins CA., 2002, CLIN CHILD PSYCHOL P, V7, P101, DOI [10.1177/1359104502007001008, DOI 10.1177/1359104502007001008]; Mengesha MM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019554; Murphy Debra A, 2008, Clin Child Psychol Psychiatry, V13, P105, DOI 10.1177/1359104507087464; Negese Digsu, 2012, ISRN AIDS, V2012, P485720, DOI 10.5402/2012/485720; Nostlinger C, 2004, AIDS CARE, V16, P641, DOI 10.1080/09540120410001716432; Tamir Y, 2015, QUALITY PRIMARY CARE, V23, P223; WHO and UNICEF, 2008, SCAL UP HIV REL PREV; WIENER L, 1994, AM J ORTHOPSYCHIAT, V64, P485, DOI 10.1037/h0079539; Wiener LS, 1996, PEDIATR AIDS HIV INF, V7, P310; Wilson-Wright A, 2013, HEBR BIBLE ANC ISR, V2, P136, DOI 10.1628/219222713X13757034787757; World Health Organization, 2011, GUID HIV DISCL COUNS; World Health Organization, 2010, ANT THER HIV INF INF	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0239767	10.1371/journal.pone.0239767	http://dx.doi.org/10.1371/journal.pone.0239767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TU	33044968	Green Published, gold			2022-12-26	WOS:000581811700022
J	Mojtabai, R; Mauro, C; Wall, MM; Barry, CL; Olfson, M				Mojtabai, Ramin; Mauro, Christine; Wall, Melanie M.; Barry, Colleen L.; Olfson, Mark			Private health insurance coverage of drug use disorder treatment: 2005-2018	PLOS ONE			English	Article							AFFORDABLE CARE ACT; SUBSTANCE-ABUSE TREATMENT; MENTAL-HEALTH; FEDERAL PARITY; MEDICAID; INDIVIDUALS; DISPARITIES; EXPANSION; BARRIERS; ALCOHOL	Many privately insured adults with drug use disorders in the United States do not have health care coverage for drug use treatment. The Affordable Care Act sought to redress this gap by including substance use treatments as essential health benefits under new plans offered. This study used data from 11,732 privately insured adult participants of the 2005-2018 National Survey on Drug Use and Health with drug use disorders to examine trends in drug use treatment coverage and the association of coverage with receiving treatment. 37.6% of the participants with drug use disorders did not know whether their plan covered drug use treatment, with little change over time. Among those who knew, coverage increased modestly between the 2005-2013 and 2014-2018 periods (73.5% vs. 77.5%, respectively,p= .015). Coverage was associated with receiving drug use treatment (adjusted odds ratio = 2.09, 95% confidence interval = 1.61-2.72,p< .001). However, even among participants with coverage, only 13.4% received treatment. Broader coverage of drug use treatment could potentially improve treatment rates.	[Mojtabai, Ramin] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21218 USA; [Mojtabai, Ramin] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD 21218 USA; [Mauro, Christine; Wall, Melanie M.; Olfson, Mark] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Wall, Melanie M.; Olfson, Mark] Columbia Univ, Dept Psychiat, Vagelos Coll Phys & Surg, New York, NY USA; [Barry, Colleen L.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Barry, Colleen L.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Columbia University; Columbia University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mojtabai, R (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21218 USA.; Mojtabai, R (corresponding author), Johns Hopkins Univ, Dept Psychiat, Baltimore, MD 21218 USA.	rmojtab1@jhu.edu	Olfson, Mark/AAA-8547-2021		National Institute on Drug Abuse [R01DA039137]	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	All authors were supported in this project by grant R01DA039137 from the National Institute on Drug Abuse (https://www.drugabuse.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, Vxxvii; Andrews CM, 2019, J SUBST ABUSE TREAT, V102, P1, DOI 10.1016/j.jsat.2019.04.002; Ban YL, 2014, IEEE ANTENN WIREL PR, V13, P31, DOI 10.1109/LAWP.2013.2295623; Barry CL, 2016, HEALTH AFFAIR, V35, P1009, DOI 10.1377/hlthaff.2015.1653; Barry CL, 2011, NEW ENGL J MED, V365, P973, DOI 10.1056/NEJMp1108649; Buck JA, 2011, HEALTH AFFAIR, V30, P1402, DOI 10.1377/hlthaff.2011.0480; Burns A, 2019, CBO JCT ANALYZED COV; Busch SH, 2014, AM J MANAG CARE, V20, P76; Center for Behavioral Health Statistics and Quality, 2018, 2016 NAT SURV DRUG U; Cowell AJ, 2018, HEALTH AFFAIR, V37, P1153, DOI 10.1377/hlthaff.2017.1517; Cummings JR, 2014, PSYCHIAT SERV, V65, P1070, DOI 10.1176/appi.ps.201300443; Dafny LS, 2017, HEALTH AFFAIR, V36, P1606, DOI 10.1377/hlthaff.2016.1669; Freyer J, 2004, J STUD ALCOHOL, V65, P801, DOI 10.15288/jsa.2004.65.801; Goldman HH, 2006, NEW ENGL J MED, V354, P1378, DOI 10.1056/NEJMsa053737; Grant BF, 2016, JAMA PSYCHIAT, V73, P39, DOI 10.1001/jamapsychiatry.2015.2132; Grogan CM, 2016, HEALTH AFFAIR, V35, P2289, DOI 10.1377/hlthaff.2016.0623; Hadley J, 2003, INQUIRY-J HEALTH CAR, V40, P323, DOI 10.5034/inquiryjrnl_40.4.323; Han B, 2015, AM J PUBLIC HEALTH, V105, P1982, DOI 10.2105/AJPH.2014.302521; Harris PAWE, 2018, PATIENTS NEED POLICY; Huskamp HA., 2020, PALGRAVE HDB AM MENT, P367, DOI DOI 10.1007/978-3-030-11908-9_13; Jordan BK, 2008, ADDICT BEHAV, V33, P782, DOI 10.1016/j.addbeh.2007.12.007; Jost TS, 2018, HEALTH AFFAIR, V37, P523, DOI 10.1377/hlthaff.2018.0259; Kaiser Family Foundation, 2017, EMPL HLTH BEN SURV 2; Maclean JC, 2019, J POLICY ANAL MANAG, V38, P366, DOI 10.1002/pam.22112; Mojtabai R, 2019, PSYCHIAT SERV, V70, P617, DOI 10.1176/appi.ps.201900025; Mojtabai R, 2014, J SUBST ABUSE TREAT, V46, P268, DOI 10.1016/j.jsat.2013.07.012; Pellitt S, 2018, TRUMP ADM LOOSENS RE; Perron BE, 2009, SUBST ABUSE TREAT PR, V4, DOI 10.1186/1747-597X-4-3; Priester MA, 2016, J SUBST ABUSE TREAT, V61, P47, DOI 10.1016/j.jsat.2015.09.006; Reif S, 2017, J PSYCHOACTIVE DRUGS, V49, P102, DOI 10.1080/02791072.2017.1300360; Richmond LM, 2019, APA APPEALS COURT DE, DOI [10.1176/appi.pn.2019.8b32, DOI 10.1176/APPI.PN.2019.8B32]; Saloner B, 2020, HEALTH AFFAIR, V39, P453, DOI 10.1377/hlthaff.2019.01428; Saloner B, 2019, HEALTH AFFAIR, V38, P633, DOI 10.1377/hlthaff.2018.05049; Saloner B, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1588; Saloner B, 2013, HEALTH AFFAIR, V32, P135, DOI 10.1377/hlthaff.2011.0983; Sawyer AN, 2018, AM J HEALTH PROMOT, V32, P906, DOI 10.1177/0890117117736091; Smith BT, 2018, AM J DRUG ALCOHOL AB, V44, P426, DOI 10.1080/00952990.2017.1411934; Stewart MT, 2018, PSYCHIAT SERV, V69, P315, DOI 10.1176/appi.ps.201700098; Substance Abuse and Mental Health Services Administration, 2010, REL KEY MEAS NAT SUR; The American Association for Public Opinion Research, 2015, STAND DEF FIN DISP C; U.S. Department of Labor, 2014, NAT COMP SURV HLTH R; Wells K, 2001, AM J PSYCHIAT, V158, P2027, DOI 10.1176/appi.ajp.158.12.2027; Zemore SE, 2014, J SUBST ABUSE TREAT, V46, P174, DOI 10.1016/j.jsat.2013.06.011; Zhu JM, 2017, HEALTH AFFAIR, V36, P1625, DOI 10.1377/hlthaff.2017.0325	44	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240298	10.1371/journal.pone.0240298	http://dx.doi.org/10.1371/journal.pone.0240298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3WA	33035265	gold, Green Published			2022-12-26	WOS:000581817500043
J	Wan, KS; Moy, FM; Yusof, KM; Mustapha, FI; Ali, ZM; Hairi, NN				Wan, Kim Sui; Moy, Foong Ming; Mohd Yusof, Khalijah; Mustapha, Feisul Idzwan; Mohd Ali, Zainudin; Hairi, Noran Naqiah			Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study	PLOS ONE			English	Article							TREATMENT INTENSIFICATION; THERAPY; PEOPLE; HYPERGLYCEMIA; ADHERENCE	Background Clinical inertia can lead to poor glycemic control among type 2 diabetes patients. However, there is paucity of information on clinical inertia in low- and middle-income countries including Malaysia. This study aimed to determine the time to treatment intensification among T2D patients with HbA1c of >= 7% (>= 53 mmol/mol) in Malaysian public health clinics. The proportion of patients with treatment intensification and its associated factors were also determined. Material and methods This was a five-year retrospective open cohort study using secondary data from the National Diabetes Registry. The study setting was all public health clinics (n = 47) in the state of Negeri Sembilan, Malaysia. Time to treatment intensification was defined as the number of years from the index year until the addition of another oral antidiabetic drug or initiation of insulin. Life table survival analysis based on best-worst case scenarios was used to determine the time to treatment intensification. Discrete-time proportional hazards model was fitted for the factors associated with treatment intensification. Results The mean follow-up duration was 2.6 (SD 1.1) years. Of 7,646 patients, the median time to treatment intensification was 1.29 years (15.5 months), 1.58 years (19.0 months) and 2.32 years (27.8 months) under the best-, average- and worst-case scenarios respectively. The proportion of patients with treatment intensification was 45.4% (95% CI: 44.2-46.5), of which 34.6% occurred only after one year. Younger adults, overweight, obesity, use of antiplatelet medications and poorer HbA1c were positively associated with treatment intensification. Patients treated with more oral antidiabetics were less likely to have treatment intensification. Conclusion Clinical inertia is present in the management of T2D patients in Malaysian public health clinics. We recommend further studies in lower- and middle-income countries to explore its causes so that targeted strategies can be developed to address this issue.	[Wan, Kim Sui; Moy, Foong Ming; Hairi, Noran Naqiah] Univ Malaya, Fac Med, Ctr Epidemiol & Evidence Based Practice, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Wan, Kim Sui; Mohd Yusof, Khalijah; Mohd Ali, Zainudin] State Hlth Dept Negeri Sembilan, Seremban, Malaysia; [Mustapha, Feisul Idzwan] Minist Hlth, Dis Control Div, Putrajaya, Malaysia; [Mohd Yusof, Khalijah] State Hlth Dept Johor, Johor Baharu, Malaysia	Universiti Malaya; Kementerian Kesihatan Malaysia	Moy, FM (corresponding author), Univ Malaya, Fac Med, Ctr Epidemiol & Evidence Based Practice, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	moyfm@ummc.edu.my	HAIRI, NORAN/B-9339-2010; Moy, Foong Ming/B-7899-2010; Wan, Kim Sui/ABC-1576-2021	HAIRI, NORAN/0000-0002-2692-9016; Moy, Foong Ming/0000-0002-0306-4419; Wan, Kim Sui/0000-0002-0859-1648				American Diabetes Association, 2018, Diabetes Care, V41, pS55, DOI 10.2337/dc18-S006; [Anonymous], 2019, BMJ-BRIT MED J, V367, pl6131; [Anonymous], 2015, WORLD POP AG 2015 HI; Aris T, 2015, NATL HLTH MORBIDITY, VII; Arnold RJG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199011; Cahn A, 2015, DIABETES CARE, V38, P2293, DOI 10.2337/dc15-0187; Department of statistics, 2020, DEM STAT 1 Q; Department of Statistics Malaysia, 2019, ABR LIF TABL MAL 201; Fu AZ, 2011, DIABETES OBES METAB, V13, P765, DOI 10.1111/j.1463-1326.2011.01405.x; Garcia-Perez LE, 2013, DIABETES THER, V4, P175, DOI 10.1007/s13300-013-0034-y; Hair R. L., 2010, MULTIVARIATE DATA AN, V7th; Higgins JPT, 2008, CLIN TRIALS, V5, P225, DOI 10.1177/1740774508091600; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Kallenbach L, 2018, ENDOCR PRACT, V24, P805, DOI 10.4158/EP-2017-0261; Khunti K, 2016, DIABETES OBES METAB, V18, P401, DOI 10.1111/dom.12626; Khunti K, 2018, DIABETES OBES METAB, V20, P427, DOI 10.1111/dom.13088; Malaysia MoH, 2015, CLIN PRACTICE GUIDEL, V5th; Masnoon N, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0621-2; McEwen LN, 2009, DIABETES CARE, V32, P971, DOI 10.2337/dc08-1911; Ministry of Health Malaysia, 2013, NATL DIABETES REGIST, V1; Ministry of Health Malaysia, 2008, MAN PENGG AUD KLIN D; Pantalone KM, 2018, DIABETES CARE, V41, pE113, DOI 10.2337/dc18-0116; Pantalone KM, 2016, DIABETES CARE, V39, P1527, DOI 10.2337/dc16-0227; Paul SK, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0178-3; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Pirela DV, 2019, ENDOCR PRACT, V25, P1317, DOI 10.4158/EP-2019-0303; Reach G, 2017, DIABETES METAB, V43, P501, DOI 10.1016/j.diabet.2017.06.003; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Stone MA, 2013, DIABETES CARE, V36, P2628, DOI 10.2337/dc12-1759; Tunceli K., 2015, DIABETES MANAGEMENT, V5, P17, DOI DOI 10.2217/DIABETEST.14.45; Wong ND, 2016, DIABETES CARE, V39, P668, DOI 10.2337/dc15-2439; World Health Organization, 2000, WHO TECHN REP SER, V894	34	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240531	10.1371/journal.pone.0240531	http://dx.doi.org/10.1371/journal.pone.0240531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035261	Green Published, gold			2022-12-26	WOS:000581817500039
J	Becker, AS; Zellweger, C; Bacanovic, S; Franckenberg, S; Nagel, HW; Frick, L; Schawkat, K; Eberhard, M; Bluthgen, C; Volbracht, J; Moos, R; Wolfrum, C; Burger, IA				Becker, Anton S.; Zellweger, Caroline; Bacanovic, Sara; Franckenberg, Sabine; Nagel, Hannes W.; Frick, Lukas; Schawkat, Khoschy; Eberhard, Matthias; Bluethgen, Christian; Volbracht, Joerk; Moos, Rudolf; Wolfrum, Christian; Burger, Irene A.			Brown fat does not cause cachexia in cancer patients: A large retrospective longitudinal FDG-PET/CT cohort study	PLOS ONE			English	Article							ADIPOSE-TISSUE ACTIVITY; TUMOR-NECROSIS-FACTOR; LIPID-METABOLISM; OUTDOOR TEMPERATURE; THERMOGENESIS; PREVALENCE; LIPOLYSIS; ACTIVATION; WHITE; CELL	Background Brown adipose tissue (BAT) is a specialized form of adipose tissue, able to increase energy expenditure by heat generation in response to various stimuli. Recently, its pathological activation has been implicated in the pathogenesis of cancer cachexia. To establish a causal relationship, we retrospectively investigated the longitudinal changes in BAT and cancer in a large FDG-PET/CT cohort. Methods We retrospectively analyzed 13 461 FDG-PET/CT examinations of n = 8 409 patients at our institution from the winter months of 2007-2015. We graded the activation strength of BAT based on the anatomical location of the most caudally activated BAT depot into three tiers, and the stage of the cancer into five general grades. We validated the cancer grading by an interreader analysis and correlation with histopathological stage. Ambient temperature data (seven-day average before the examination) was obtained from a meteorological station close to the hospital. Changes of BAT, cancer, body mass index (BMI) and temperature between the different examinations were examined with Spearman's test and a mixed linear model for correlation, and with a causal inference algorithm for causality. Results We found n = 283 patients with at least two examinations and active BAT in at least one of them. There was no significant interaction between the changes in BAT activation, cancer burden or BMI. Temperature changes exhibited a strong negative correlation with BAT activity (rho = -0.57, p<0.00001). These results were confirmed with the mixed linear model. Causal inference revealed a link of Temperature -> BAT in all subjects and also of BMI -> BAT in subjects who had lost weight and increased cancer burden, but no role of cancer and no causal links of BAT -> BMI. Conclusions Our data did not confirm the hypothesis that BAT plays a major role in cancer-mediated weight loss. Temperature changes are the main driver of incidental BAT activity on FDG-PET scans.	[Becker, Anton S.; Wolfrum, Christian] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Schwerzenbach, Switzerland; [Becker, Anton S.; Wolfrum, Christian] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland; [Becker, Anton S.; Franckenberg, Sabine; Schawkat, Khoschy; Eberhard, Matthias; Bluethgen, Christian] Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Becker, Anton S.; Zellweger, Caroline; Bacanovic, Sara; Nagel, Hannes W.; Burger, Irene A.] Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland; [Frick, Lukas] Univ Hosp Zurich, Dept Pathol & Mol Pathol, Zurich, Switzerland; [Volbracht, Joerk; Moos, Rudolf] Univ Hosp Zurich, Div Controlling & Data Management, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Becker, AS (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Schwerzenbach, Switzerland.; Becker, AS (corresponding author), Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland.; Becker, AS (corresponding author), Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland.; Becker, AS (corresponding author), Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland.	anton.becker@usz.ch	Franckenberg, Sabine/AAN-7127-2021; Blüthgen, Christian/I-3050-2019	Franckenberg, Sabine/0000-0002-8326-0777; Blüthgen, Christian/0000-0001-7321-5676; Frick, Lukas/0000-0002-2147-5369; Wolfrum, Christian/0000-0002-3862-6805; Becker, Anton/0000-0001-8372-6496	Starr foundation	Starr foundation	This study was partly funded by the Starr foundation (CW, grant number not applicable) http://starrfoundation.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; ARBEENY CM, 1995, AM J PHYSIOL-ENDOC M, V268, pE678, DOI 10.1152/ajpendo.1995.268.4.E678; Arruda AP, 2010, ENDOCRINOLOGY, V151, P683, DOI 10.1210/en.2009-0865; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Becker AS, 2017, EUR J RADIOL, V91, P41, DOI 10.1016/j.ejrad.2017.03.012; Beijer E, 2012, ONCOL REV, V6, P88, DOI 10.4081/oncol.2012.e11; BIANCHI A, 1989, HORM METAB RES, V21, P640, DOI 10.1055/s-2007-1009308; Bos SA, 2018, SKELETAL RADIOLOGY, V71, P2455; BROOKS SL, 1981, BIOSCIENCE REP, V1, P509, DOI 10.1007/BF01121584; Cohade C, 2003, J NUCL MED, V44, P1267; COOMBES RC, 1987, BIOSCIENCE REP, V7, P791, DOI 10.1007/BF01116752; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DeWys W, WEIGHT LOSS NUTR ABN, P251; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Gilsanz V, 2012, AM J ROENTGENOL, V198, P909, DOI 10.2214/AJR.11.7488; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; Huang YC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-238; Kim S, 2006, CLIN NUCL MED, V31, P127, DOI 10.1097/01.rlu.0000200601.29042.ce; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; Lee P, 2010, AM J PHYSIOL-ENDOC M, V299, pE601, DOI 10.1152/ajpendo.00298.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LopezSoriano J, 1997, CANCER LETT, V116, P159, DOI 10.1016/S0304-3835(97)00173-0; LopezSoriano J, 1997, MOL CELL ENDOCRINOL, V132, P93, DOI 10.1016/S0303-7207(97)00125-1; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Oudart H, 1995, CAN J PHYSIOL PHARM, V73, P1625, DOI 10.1139/y95-724; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Perdikari A, 2018, CELL REP, V25, P784, DOI 10.1016/j.celrep.2018.09.044; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Rohm M, 2016, NAT MED, V22, P1120, DOI 10.1038/nm.4171; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Rousseau C, 2006, EUR J NUCL MED MOL I, V33, P785, DOI 10.1007/s00259-006-0066-x; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Ryden M, 2008, CANCER-AM CANCER SOC, V113, P1695, DOI 10.1002/cncr.23802; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seelaender MCL, 1996, BIOCHEM MOL BIOL INT, V39, P1037; Senn JR, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01184; SHELLOCK FG, 1986, J CANCER RES CLIN, V111, P82, DOI 10.1007/BF00402783; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tsoli M, 2012, CANCER RES, V72, P4372, DOI 10.1158/0008-5472.CAN-11-3536; Vaitkus JA, 2017, EXP BIOL MED, V242, P473, DOI 10.1177/1535370216683282; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239990	10.1371/journal.pone.0239990	http://dx.doi.org/10.1371/journal.pone.0239990			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031379	Green Published, Green Accepted, gold			2022-12-26	WOS:000581809800092
J	Correale, P; Caracciolo, M; Bilotta, F; Conte, M; Cuzzola, M; Falcone, C; Mangano, C; Falzea, AC; Iuliano, E; Morabito, A; Foti, G; Armentano, A; Caraglia, M; De Lorenzo, A; Sitkovsky, M; Macheda, S				Correale, Pierpaolo; Caracciolo, Massimo; Bilotta, Federico; Conte, Marco; Cuzzola, Maria; Falcone, Carmela; Mangano, Carmelo; Falzea, Antonella Consuelo; Iuliano, Eleonora; Morabito, Antonella; Foti, Giuseppe; Armentano, Antonio; Caraglia, Michele; De Lorenzo, Antonino; Sitkovsky, Michail; Macheda, Sebastiano			Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia	PLOS ONE			English	Article							MECHANISMS; RECEPTORS; PURINES	Background SARS-Cov2 infection may trigger lung inflammation and acute-respiratory-distress-syndrome (ARDS) that requires active ventilation and may have fatal outcome. Considering the severity of the disease and the lack of active treatments, 14 patients with Covid-19 and severe lung inflammation received inhaled adenosine in the attempt to therapeutically compensate for the oxygen-related loss of the endogenous adenosine -> A2A adenosine receptor (A2AR)-mediated mitigation of the lung-destructing inflammatory damage. This off label-treatment was based on preclinical studies in mice with LPS-induced ARDS, where inhaled adenosine/A2AR agonists protected oxygenated lungs from the deadly inflammatory damage. The treatment was allowed, considering that adenosine has several clinical applications. Patients and treatment Fourteen consecutively enrolled patients with Covid19-related interstitial pneumonitis and PaO2/FiO(2)ratio<300 received off-label-treatment with 9 mg inhaled adenosine every 12 hours in the first 24 hours and subsequently, every 24 days for the next 4 days. Fifty-two patients with analogue features and hospitalized between February and April 2020, who did not receive adenosine, were considered as a historical control group. Patients monitoring also included hemodynamic/hematochemical studies, CTscans, and SARS-CoV2-tests. Results The treatment was well tolerated with no hemodynamic change and one case of moderate bronchospasm. A significant increase (> 30%) in the PaO2/FiO(2)-ratio was reported in 13 out of 14 patients treated with adenosine compared with that observed in 7 out of52 patients in the control within 15 days. Additionally, we recorded a mean PaO2/FiO(2)-ratio increase (215 +/- 45 vs. 464 +/- 136, P = 0.0002) in patients receiving adenosine and no change in the control group (210 +/- 75 vs. 250 +/- 85 at 120 hours, P>0.05). A radiological response was demonstrated in 7 patients who received adenosine, while SARS-CoV-2 RNA load rapidly decreased in 13 cases within 7 days while no changes were recorded in the control group within 15 days. There was one Covid-19 related death in the experimental group and 11in the control group. Conclusion Our short-term analysis suggests the overall safety and beneficial therapeutic effect of inhaled adenosine in patients with Covid-19-inflammatory lung disease suggesting further investigation in controlled clinical trials.	[Correale, Pierpaolo; Falzea, Antonella Consuelo; Iuliano, Eleonora] Grand Metropolitan Hosp, Med Oncol Unit, Covid19 Sci Task Force, Reggio Di Calabria, Italy; [Caracciolo, Massimo] Grand Metropolitan Hosp, Unit Post Surg Intens Therapy USDO, Covid19 Sci Task Force, Reggio Di Calabria, Italy; [Bilotta, Federico] Sapienza Univ Rome, Dept Anesthesiol Crit Care & Pain Med, Policlin Umberto I, Rome, Italy; [Conte, Marco; Cuzzola, Maria] Grand Metropolitan Hosp, Microbiol Unit, Covid19 Sci Task Force, Reggio Di Calabria, Italy; [Falcone, Carmela] Grand Metropolitan Hosp, Radiol Unit, Covid19 Sci Task Force, Reggio Di Calabria, Italy; [Mangano, Carmelo; Foti, Giuseppe] Grand Metropolitan Hosp, Infect Dis Unit, Covid19 Sci Task Force, Reggio Di Calabria, Italy; [Morabito, Antonella] Grand Metropolitan Hosp, Unit Pharm, Covid19 Sci Task Force, Reggio Di Calabria, Italy; [Armentano, Antonio] Grand Metropolitan Hosp, Unit Neuroradiol, Covid19 Sci Task Force, Reggio Di Calabria, Italy; [Caraglia, Michele] Univ Campania L Vanvitelli, Dept Precis Med, Naples, Italy; [Caraglia, Michele] BiogemScarl, Inst Genet Res, Lab Precis & Mol Oncol, Ariano Irpino, Italy; [De Lorenzo, Antonino] Univ Roma Tor Vergata, Sect Clin Nutr & Nutrigen, Dept Biomed & Prevent, Rome, Italy; [Sitkovsky, Michail] Northeastern Univ, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA; [Macheda, Sebastiano] Grand Metropolitan Hosp, Unit Intens Therapy & Resuscitat, Covid19 Sci Task Force, Reggio Di Calabria, Italy	Sapienza University Rome; University Hospital Sapienza Rome; Universita della Campania Vanvitelli; University of Rome Tor Vergata; Northeastern University	Bilotta, F (corresponding author), Sapienza Univ Rome, Dept Anesthesiol Crit Care & Pain Med, Policlin Umberto I, Rome, Italy.; Sitkovsky, M (corresponding author), Northeastern Univ, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA.	federico.bilotta@uniroma1.it; m.sitkovsky@northeastern.edu	Correale, Pierpaolo/K-7015-2019; Caraglia, Michele/AFY-9729-2022; Correale, Pierpaolo/K-1640-2016	Correale, Pierpaolo/0000-0003-2154-6734; Caraglia, Michele/0000-0003-2408-6091; Correale, Pierpaolo/0000-0003-2154-6734; De Lorenzo, Antonino/0000-0001-6524-4493				Aggarwal NR, 2013, AM J RESP CELL MOL, V48, P635, DOI 10.1165/rcmb.2012-0351OC; [Anonymous], 2012, JAMA-J AM MED ASSOC, DOI 10.1001/jama.2012.5669; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Coombs MRP, 2011, EXPERT REV ANTI-INFE, V9, P261, DOI [10.1586/eri.10.158, 10.1586/ERI.10.158]; Cron RQ, 2020, J RHEUMATOL, V47, P639, DOI 10.3899/jrheum.200334; Cronstein BN, 2017, NAT REV RHEUMATOL, V13, P41, DOI 10.1038/nrrheum.2016.178; CUSHLEY MJ, 1983, BRIT J CLIN PHARMACO, V15, P161, DOI 10.1111/j.1365-2125.1983.tb01481.x; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Gualtieri P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134670; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo T, JAMA CARDIOL; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; HOLGATE ST, 1986, ARCH INT PHARMACOD T, V280, P240; Jacobson KA, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00124; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Michot JM, ANN ONCOL; Nowak-Machen M, 2013, AM J RESP CELL MOL, V48, P601, DOI 10.1165/rcmb.2012-0180OC; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Seo SU, 2019, CURR OPIN VIROL, V37, P63, DOI 10.1016/j.coviro.2019.06.003; Shi S, 2020, JAMA CARDIOL; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Spicuzza L, 2006, EUR J PHARMACOL, V533, P77, DOI 10.1016/j.ejphar.2005.12.056; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; van der Wiel E, 2017, LANCET HIV, V4, P1369328; Wang D, JAMA; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu Z, JAMA; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhang XH, 2020, BLOOD ADV, V4, P1307, DOI 10.1182/bloodadvances.2020001907	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239692	10.1371/journal.pone.0239692	http://dx.doi.org/10.1371/journal.pone.0239692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031409	Green Published, gold			2022-12-26	WOS:000581809800011
J	Ingle, L; Rigby, A; Brodie, D; Sandercock, G				Ingle, Lee; Rigby, Alan; Brodie, David; Sandercock, Gavin			Normative reference values for estimated cardiorespiratory fitness in apparently healthy British men and women	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; METABOLICALLY HEALTHY; CARDIOVASCULAR RISK; REFERENCE INTERVALS; REFERENCE-STANDARDS; PHYSICAL-ACTIVITY; CENTILE CURVES; EXERCISE; ADULTS; PHENOTYPE	Objectives To develop normative reference standards for estimated cardiorespiratory fitness (eCRF) measured from treadmill-based incremental exercise testing in similar to 12 000 British men and women. Methods Cross-sectional study using retrospectively collected eCRF data from five preventative health screening clinics in the United Kingdom. Reference centiles were developed using a parametric approach by fitting fractional polynomials. We selected the 'best' powers by considering both the smallest deviance, and clinical knowledge from the following set ofa prioridecided powers (-2,-1,-0.5, 0, 0.5,1,2,3). A series of fractional polynomials (FPs) were investigated with three-parameters (median, standard deviation and skewness). The following reference centiles were plotted (3, 5, 10, 25, 50, 75, 90, 95, 97). Results We included 9 204 males (median [25(th),75(th)centiles] age 48 [44, 53] years; BMI 27 {25, 29] kg.m(-2); peak VO2 36.9 [30.5, 44.7] ml.kg(-1).min(-1)) and 2 687 females (age 48, [41, 51] years; BMI 24 {22, 27] kg.m(-2); peak VO2 36.5 [30.1, 44.8] ml.kg(-1).min(-1)) in our analysis to develop the normative values. Conclusion Reference values and nomograms for eCRF were derived from a relatively large cohort of preventative health care screening examinations of apparently healthy British men and women. Age- and sex-specific eCRF percentiles were similar to data from international cohort studies. The adoption of submaximal exercise testing protocols reduces individual risk when exercise history is unknown and testing is conducted in a community-based setting. Our findings can be used by health professionals to help guide clinical decision making.	[Ingle, Lee] Univ Hull, Dept Sport Hlth & Exercise Sci, Kingston Upon Hull, N Humberside, England; [Rigby, Alan] Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Brodie, David] Buckinghamshire New Univ, Dept Hlth, Wycombe, Bucks, England; [Sandercock, Gavin] Univ Essex, Ctr Sport & Exercise Sci, Colchester, Essex, England	University of Hull; University of Hull; University of York - UK; Buckinghamshire New University; University of Essex	Ingle, L (corresponding author), Univ Hull, Dept Sport Hlth & Exercise Sci, Kingston Upon Hull, N Humberside, England.	l.ingle@hull.ac.uk	Rigby, Alan/AFM-1194-2022	Rigby, Alan/0000-0001-8331-3907; Ingle, Lee/0000-0001-6155-5577; Sandercock, Gavin/0000-0002-5443-6518				Addoh O, 2016, MAYO CLIN PROC, V91, P1320, DOI 10.1016/j.mayocp.2016.06.008; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; [Anonymous], ACSMS GUIDELINES EXE; Arena R, 2018, CIRC RES, V122, P804, DOI 10.1161/CIRCRESAHA.118.312849; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; Cole TJ, 2006, FOOD NUTR BULL, V27, pS237, DOI 10.1177/15648265060274S507; Cole TJ, 2019, STAT MED, V38, P3571, DOI 10.1002/sim.8129; COLE TJ, 1988, J R STAT SOC A STAT, V151, P385, DOI 10.2307/2982992; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Dominelli PB, 2015, J PHYSIOL-LONDON, V593, P1965, DOI 10.1113/jphysiol.2014.285965; Edvardsen E, 2013, CHEST, V144, P241, DOI 10.1378/chest.12-1458; Frith E, 2017, CLIN CARDIOL, V40, P469, DOI 10.1002/clc.22679; Guenette JA, 2009, AM J PHYSIOL-REG I, V297, pR166, DOI 10.1152/ajpregu.00078.2009; Ingle L, 2017, PREV MED, V94, P7, DOI 10.1016/j.ypmed.2016.11.001; Kaminsky LA, 2017, MAYO CLIN PROC, V92, P228, DOI 10.1016/j.mayocp.2016.10.003; Kaminsky LA, 2015, MAYO CLIN PROC, V90, P1515, DOI 10.1016/j.mayocp.2015.07.026; Koch B, 2009, EUR RESPIR J, V33, P389, DOI 10.1183/09031936.00074208; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Loe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064319; Loprinzi PD, 2018, EUR J APPL PHYSIOL, V118, P629, DOI 10.1007/s00421-018-3803-5; Miller RJ Jnr, 1977, ANOVA BASICS APPL ST; O'Donovan G, 2013, PREV MED, V57, P201, DOI 10.1016/j.ypmed.2013.05.022; Ortega FB, 2015, PROG CARDIOVASC DIS, V58, P76, DOI 10.1016/j.pcad.2015.05.001; Rapp D, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018697; Roberson LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-14; Robsahm TE, 2017, CANCER MED-US, V6, P865, DOI 10.1002/cam4.1043; Neto JMR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209897; Royston P, 1998, J R STAT SOC A STAT, V161, P79, DOI 10.1111/1467-985X.00091; Shah RV, 2016, JAMA INTERN MED, V176, P87, DOI 10.1001/jamainternmed.2015.6309; Wright EM, 1997, STAT MED, V16, P2785, DOI 10.1002/(SICI)1097-0258(19971230)16:24<2785::AID-SIM797>3.0.CO;2-Z	33	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240099	10.1371/journal.pone.0240099	http://dx.doi.org/10.1371/journal.pone.0240099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031457	Green Published, Green Accepted, gold			2022-12-26	WOS:000581809800033
J	Saving, J; Heintz, E; Pettersson, H; Enocson, A; Navarro, CM				Saving, Jenny; Heintz, Emelie; Pettersson, Hans; Enocson, Anders; Mellstrand Navarro, Cecilia			Volar locking plate versus external fixation for unstable dorsally displaced distal radius fractures-A 3-year cost-utility analysis	PLOS ONE			English	Article							SURGICAL-TREATMENT; PERCUTANEOUS FIXATION; KIRSCHNER WIRES; ADULT PATIENTS; EUROQOL; HEALTH; DRAFFT; TRIAL	Aim To investigate the cost-effectiveness of Volar Locking Plate (VLP) compared to External Fixation (EF) for unstable dorsally displaced distal radius fractures in a 3-year perspective. Methods During 2009-2013, patients aged 50-74 years with an unstable dorsally displaced distal radius fracture were randomised to VLP or EF. Primary outcome was the incremental cost-effectiveness ratio (ICER) for VLP compared with EF. Data regarding health effects (Quality-adjusted life years, QALYs) was prospectively collected during the trial period until 3 years after surgery. Cost data was collected retrospectively for the same time period and included direct and indirect costs (production loss). Results One hundred and thirteen patients (VLP n = 58, EF n = 55) had complete data until 3 years and were used in the analysis. At one year, the VLP group had a mean incremental cost of 878 euros and a gain of 0.020 QALYs compared with the EF group, rendering an ICER of 43 900 euros per QALY. At three years, the VLP group had a mean incremental cost of 1 082 euros and a negative incremental effect of -0.005 QALYs compared to the EF group, which means that VLP was dominated by EF. The probability that VLP was cost-effective compared to EF at three years, was lower than 50% independent of the willingness to pay per QALY. Conclusion Three years after distal radius fracture surgery, VLP fixation resulted in higher costs and a smaller effect in QALYs compared to EF. Our results indicate that it is uncertain if VLP is a cost-effective treatment of unstable distal radius fractures compared to EF.	[Saving, Jenny; Pettersson, Hans; Enocson, Anders; Mellstrand Navarro, Cecilia] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Saving, Jenny] Capio Artro Clin, Stockholm, Sweden; [Heintz, Emelie] Karolinska Inst, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden; [Enocson, Anders] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden; [Mellstrand Navarro, Cecilia] Soder Sjukhuset, Dept Hand Surg, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Sodersjukhuset Hospital	Navarro, CM (corresponding author), Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden.; Navarro, CM (corresponding author), Soder Sjukhuset, Dept Hand Surg, Stockholm, Sweden.	cecilia.mellstrand-navarro@sll.se	Enocson, Anders/HGD-6351-2022; Heintz, Emelie/GYD-4031-2022	Heintz, Emelie/0000-0002-0715-7591; Mellstrand Navarro, Cecilia/0000-0002-3312-9375	ALF Region Stockholm, Sweden	ALF Region Stockholm, Sweden	The project was conducted with financial support from the government founded ALF Region Stockholm, Sweden grants for research. The funder provided support in the form of salaries for authors JS, AE, and CMN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Brazier J, 2008, J HEALTH SERV RES PO, V13, P70, DOI 10.1258/jhsrp.2008.008015; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Costa ML, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19170; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Karantana A, 2015, BONE JOINT J, V97B, P1264, DOI 10.1302/0301-620X.97B9.35560; Karantana A, 2013, J BONE JOINT SURG AM, V95A, P1737, DOI 10.2106/JBJS.L.00232; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; Mattila VM, 2011, J TRAUMA, V71, P939, DOI 10.1097/TA.0b013e3182231af9; Mellstrand-Navarro C, 2014, BONE JOINT J, V96B, P963, DOI 10.1302/0301-620X.96B7.33149; National Institute for H., 2013, GUID METH TECHN APPR; Navarro CM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214362; Navarro CM, 2016, J ORTHOP TRAUMA, V30, P217, DOI 10.1097/BOT.0000000000000519; Richardson G, 2004, HEALTH ECON, V13, P1203, DOI 10.1002/hec.901; Saving J, 2018, J HAND SURG; Tubeuf S, 2015, BONE JOINT J, V97B, P1082, DOI 10.1302/0301-620X.97B8.35234; Wilcke MKT, 2013, ACTA ORTHOP, V84, P292, DOI 10.3109/17453674.2013.792035; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	18	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240377	10.1371/journal.pone.0240377	http://dx.doi.org/10.1371/journal.pone.0240377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TB	33031472	gold, Green Published			2022-12-26	WOS:000581809800032
J	de Oliveira, LA; Borges, TK; Soares, RO; Buzzi, M; Kuckelhaus, SAS				de Oliveira, Leonel Alves; Borges, Tatiana Karla; Soares, Renata Oliveira; Buzzi, Marcelo; Kuckelhaus, Selma Aparecida Souza			Methodological variations affect the release of VEGF in vitro and fibrinolysis' time from platelet concentrates	PLOS ONE			English	Article							RICH FIBRIN; GROWTH-FACTORS; PLASMA; PRF; CELLS; AUGMENTATION; REGENERATION; MECHANISMS; DELIVERY; FUTURE	Blood Concentrates (BCs) are autologous non-transfusional therapeutical preparations with biological properties applied in tissue regeneration. These BCs differ in the preparation method, in fibrin network architecture, growth factors release as well as in platelet/cell content. Methodological changes result in distinct matrices that can compromise their clinical effectiveness. The present study evaluated the influence of different g-forces and types of tubes in the release of vascular endothelial growth factor (VEGF) from platelet-rich fibrin (PRF) as a function of time. The PRF-like samples were obtained with three g-forces (200, 400, and 800 x g) for 10 minutes in pure glass tubes or in polystyrene-clot activator tubes. Scanning and Transmission electron microscopy was used to morphometric analyzes of PRF's specimens and flow cytometry was used to quantify VEGF slow release until 7 days. Our results showed that platelets were intact and adhered to the fibrin network, emitting pseudopods and in degranulation. The fibrin network was rough and twisted with exosomic granulations impregnated on its surface. An increase in the concentration of VEGF in the PRF supernatant was observed until 7 days for all g forces (200, 400 or 800 xg), with the highest concentrations observed with 200 x g, in both tubes, glass or plastic. Morphological analyzes showed a reduction in the diameter of the PRF fibers after 7 days. Our results showed that g-force interferes with the shape of the fibrin network in the PRF, as well as affect the release of VEGF stored into platelets. This finding may be useful in applying PRF to skin lesions, in which the rapid release of growth factors can favor the tissue repair process. Our observations point to a greater clarification on the methodological variations related to obtaining PRF matrices, as they can generate products with different characteristics and degrees of effectiveness in specific applications.	[de Oliveira, Leonel Alves; Borges, Tatiana Karla; Soares, Renata Oliveira; Kuckelhaus, Selma Aparecida Souza] Univ Brasilia, Nucleus Res Appl Morphol & Immunol, Fac Med, Brasilia, DF, Brazil; [Buzzi, Marcelo] Innovacorium Inc, Gainesville, FL USA	Universidade de Brasilia	Kuckelhaus, SAS (corresponding author), Univ Brasilia, Nucleus Res Appl Morphol & Immunol, Fac Med, Brasilia, DF, Brazil.	selmask@gmail.com		Kuckelhaus, Selma/0000-0001-7677-772X				Ahmad E, 2015, INT J BIOL MACROMOL, V81, P121, DOI 10.1016/j.ijbiomac.2015.07.054; Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529; Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010; [Anonymous], 2015, IRAN OCCUPATIONAL HL, V12, P65; [Anonymous], 2018, IUVA NEWS, V20, P1, DOI DOI 10.1007/S42341-018-00089-0; [Anonymous], 2015, ANN REPORT, V7, P17; Arabaci T, 2018, J PERIODONTOL, V89, P255, DOI 10.1002/JPER.17-0294; Bannish BE, 2014, MATH MED BIOL, V31, P45, DOI 10.1093/imammb/dqs030; Bonazza V, 2016, MICROSC RES TECHNIQ, V79, P1173, DOI 10.1002/jemt.22772; Borsani E, 2015, BIOL MED PARIS, V7, P726, DOI DOI 10.4172/0974-8369.1000256; Bowen RAR, 2014, BIOCHEM MEDICA, V24, P31, DOI 10.11613/BM.2014.006; Chiaravalloti AJ, 2018, DERMATOL SURG, V44, P449, DOI 10.1097/DSS.0000000000001246; Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012; Choukroun J, 2018, EUR J TRAUMA EMERG S, V44, P87, DOI 10.1007/s00068-017-0767-9; Corbalan JJ, 2012, INT J NANOMED, V7, P631, DOI 10.2147/IJN.S28293; Dohan Ehrenfest David M, 2014, Muscles Ligaments Tendons J, V4, P3; Dohan S, 2004, IMPLANTODONTIE, V13, P87; Ehrenfest DMD, 2018, PLATELETS, V29, P171, DOI 10.1080/09537104.2017.1293812; Ehrenfest DMD, 2010, J PERIODONTOL, V81, P546, DOI 10.1902/jop.2009.090531; Ehrenfest DMD, 2009, ORAL SURG ORAL MED O, V108, P341, DOI 10.1016/j.tripleo.2009.04.020; Geaney LE, 2011, OPER TECHN SPORT MED, V19, P160, DOI 10.1053/j.otsm.2011.04.001; Gersh KC, 2009, THROMB HAEMOSTASIS, V102, P1169, DOI 10.1160/TH09-03-0199; Giannini S, 2015, EUR REV MED PHARMACO, V19, P927; Giannini S, 2010, INJURY, V41, P1196, DOI 10.1016/j.injury.2010.09.028; Henry P, 2015, ARTHROSCOPY, V31, P2472, DOI 10.1016/j.arthro.2015.06.038; Ilich A, 2017, INT J LAB HEMATOL, V39, P441, DOI 10.1111/ijlh.12688; Khorshidi H, 2016, INT J DENT, V2016, DOI 10.1155/2016/1849207; Kim TH, 2014, ARCH ORAL BIOL, V59, P550, DOI 10.1016/j.archoralbio.2014.02.004; Kobayashi M, 2012, BIOLOGICALS, V40, P323, DOI 10.1016/j.biologicals.2012.07.004; Kononova O, 2013, J BIOL CHEM, V288, P22681, DOI 10.1074/jbc.M113.472365; Kubesch A, 2019, PLATELETS, V30, P329, DOI 10.1080/09537104.2018.1445835; Lippi G, 2016, CLIN CHEM LAB MED, V54, P755, DOI 10.1515/cclm-2015-1274; Liu ZS, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4923767; Longstaff C, 2018, J THROMB HAEMOST, V16, P652, DOI 10.1111/jth.13957; Lourenco ES, 2018, J BIOMED MATER RES A, V106, P1373, DOI 10.1002/jbm.a.36346; Mariani E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041328; Masuki H, 2020, ODONTOLOGY, V108, P545, DOI 10.1007/s10266-020-00486-z; Miron RJ, 2019, J BIOMED MATER RES A, V107, P2257, DOI 10.1002/jbm.a.36734; Miron RJ, 2017, CLIN ORAL INVEST, V21, P2619, DOI 10.1007/s00784-017-2063-9; Miron RJ, 2018, INT J GROWTH FACT ST, V3, P80, DOI DOI 10.4103/GFSC.GFSC_23_18; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Mourão Carlos Fernando de Almeida Barros, 2015, Rev. Col. Bras. Cir., V42, P421, DOI 10.1590/0100-69912015006013; O'Connell SM, 2007, ORAL SURG ORAL MED O, V103, P587, DOI 10.1016/j.tripleo.2007.03.017; Oliveira LA, 2018, FIBRIN PROTOCOL REV, V18, P24; Pinto NR, 2018, PLATELETS, V29, P468, DOI 10.1080/09537104.2017.1327654; Polak D, 2019, J CLIN PERIODONTOL, V46, P241, DOI 10.1111/jcpe.13063; Pretorius E, 2009, INT J MORPHOL, V27, P69, DOI 10.4067/S0717-95022009000100013; Ratajczak J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32936-8; Rodella LF, 2011, MICROSC RES TECHNIQ, V74, P772, DOI 10.1002/jemt.20968; Rodeo SA, 2007, J SHOULDER ELB SURG, V16, p191S, DOI 10.1016/j.jse.2007.03.012; Soydan SS, 2014, J ORAL MAXIL SURG, V72, P322, DOI 10.1016/j.joms.2013.07.027; Su CY, 2009, ORAL SURG ORAL MED O, V108, P56, DOI 10.1016/j.tripleo.2009.02.004; Tohidnezhad M, 2014, BONE, V65, P9, DOI 10.1016/j.bone.2014.04.029; Tsujino T, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7020045; Wallace Stephen S, 2012, J Evid Based Dent Pract, V12, P161, DOI 10.1016/S1532-3382(12)70030-1; Wehner C, 2017, ARCH ORAL BIOL, V74, P136, DOI 10.1016/j.archoralbio.2016.09.014; Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639; Whyte CS, 2017, SEMIN THROMB HEMOST, V43, P115, DOI 10.1055/s-0036-1597283; Yavas S, 2012, TURK J HEMATOL, V29, P367, DOI 10.5505/tjh.2012.59254; Zhang Y, 2012, J CRANIO MAXILL SURG, V40, P321, DOI 10.1016/j.jcms.2011.04.020; Zubairova LD, 2015, SCI REP-UK, V5, DOI 10.1038/srep17611; Zumstein MA, 2011, OPER TECHN SPORT MED, V19, P190, DOI 10.1053/j.otsm.2011.01.001	62	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240134	10.1371/journal.pone.0240134	http://dx.doi.org/10.1371/journal.pone.0240134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027285	Green Published, gold			2022-12-26	WOS:000581808000030
J	Gao, Y; Zhu, CX; Li, KQ; Cheng, XY; Du, YJ; Yang, DY; Fan, XL; Gaur, U; Yang, MY				Gao, Yue; Zhu, Chenxing; Li, Keqin; Cheng, Xingyi; Du, Yanjiao; Yang, Deying; Fan, Xiaolan; Gaur, Uma; Yang, Mingyao			Comparative proteomics analysis of dietary restriction inDrosophila	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; LIFE-SPAN; CALORIE RESTRICTION; PROTEIN; AUTOPHAGY; DISEASE; SPLICEOSOME; RIBOFLAVIN; ACTIVATION; LONGEVITY	To explore the underlying mechanism of dietary restriction (DR) induced lifespan extension in fruit flies at protein level, we performed proteome sequencing inDrosophilaat day 7 (young) and day 42 (old) under DR andad libitum(AL) conditions. A total of 18629 unique peptides were identified in Uniprot, corresponding to 3,662 proteins. Among them, 383 and 409 differentially expressed proteins (DEPs) were identified from comparison between DR vs AL at day 7 and 42, respectively. Bioinformatics analysis revealed that membrane-related processes, post-transcriptional processes, spliceosome and reproduction related processes, were highlighted significantly. In addition, expression of proteins involved in pathways such as spliceosomes, oxidative phosphorylation, lysosomes, ubiquitination, and riboflavin metabolism was relatively higher during DR. A relatively large number of DEPs were found to participate in longevity and age-related disease pathways. We identified 20 proteins that were consistently regulated during DR and some of which are known to be involved in ageing, such as mTORC1, antioxidant, DNA damage repair and autophagy. In the integration analysis, we found 15 genes that were stably regulated by DR at both transcriptional as well as translational levels. Our results provided a useful dataset for further investigations on the mechanism of DR and aging.	[Gao, Yue; Zhu, Chenxing; Li, Keqin; Cheng, Xingyi; Du, Yanjiao; Yang, Deying; Fan, Xiaolan; Gaur, Uma; Yang, Mingyao] Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu, Peoples R China; [Yang, Deying; Fan, Xiaolan; Yang, Mingyao] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Yang, MY (corresponding author), Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu, Peoples R China.; Yang, MY (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China.	yangmingyao@sicau.edu.cn	Yang, Mingyao/AAX-9927-2020	Yang, Mingyao/0000-0001-6508-2738; Li, Keqin/0000-0003-0753-5887	National Natural Science Foundation of China [31471998]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China to MY (31471998).	[Anonymous], 2016, LANCET GLOB HEALTH, V4, pE427, DOI 10.1016/S2214-109X(16)30109-7; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; Arslan-Ergul A, 2016, NEUROSCIENCE, V334, P64, DOI 10.1016/j.neuroscience.2016.07.033; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Berdasco M, 2012, AGING CELL, V11, P181, DOI 10.1111/j.1474-9726.2012.00806.x; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; Brady M, 2019, HIV MED, V20, pS2, DOI 10.1111/hiv.12718; Brown CJ, 2018, INT J MASS SPECTROM, V425, P36, DOI 10.1016/j.ijms.2018.01.003; Canto C, 2016, P NUTR SOC, V75, P30, DOI 10.1017/S0029665115003225; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Cefalu WT, 2019, DIABETES CARE, V42, pS90, DOI 10.2337/dc19-S009; Chan J, 2010, AM J CLIN NUTR, V91, P1035, DOI 10.3945/ajcn.2009.28754; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chen YL, 2018, CELL DEATH DIFFER, V25, P2118, DOI 10.1038/s41418-018-0132-5; Cheng Z, 2017, J NEUROGENET, V31, P337, DOI 10.1080/01677063.2017.1395425; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Cobbaut M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2138502; Dushay MS, 2000, GENE, V246, P49, DOI 10.1016/S0378-1119(00)00041-X; El Marabti E, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00080; Emran S, 2014, AGING-US, V6, P390, DOI 10.18632/aging.100665; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Gebert N, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107565; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; Hammer S, 2008, J AM COLL CARDIOL, V52, P1006, DOI 10.1016/j.jacc.2008.04.068; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Heintz C, 2017, NATURE, V541, P102, DOI 10.1038/nature20789; Houthoofd K, 2005, J GERONTOL A-BIOL, V60, P1125, DOI 10.1093/gerona/60.9.1125; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Hursting SD, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-10; Jiang LH, 2020, CELL, V183, P269, DOI 10.1016/j.cell.2020.08.036; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Kanoh H, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005971; Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315; Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886; Kudryavtseva AV, 2016, ONCOTARGET, V7, P44879, DOI 10.18632/oncotarget.9821; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li HY, 2017, ADV EXP MED BIOL, V976, P1, DOI 10.1007/978-94-024-1088-4_1; Lin CY, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12981; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Lunin VV, 2004, J BIOL CHEM, V279, P23422, DOI 10.1074/jbc.M401648200; Maier D, 2019, G3-GENES GENOM GENET, V9, P2477, DOI 10.1534/g3.119.400307; Majercak J, 1997, MOL CELL BIOL, V17, P5915, DOI 10.1128/MCB.17.10.5915; Manthey KC, 2006, J NUTR BIOCHEM, V17, P250, DOI 10.1016/j.jnutbio.2005.05.004; Mattson MP, 2001, MECH AGEING DEV, V122, P757, DOI 10.1016/S0047-6374(01)00226-3; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Minjarez B, 2016, J PROTEOMICS, V139, P103, DOI 10.1016/j.jprot.2016.03.022; O'Flanagan CH, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0873-x; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Pallavi R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00318; Pasinetti GM, 2011, EXP NEUROL, V232, P1, DOI 10.1016/j.expneurol.2011.08.014; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rodriguez SA, 2016, AGING CELL, V15, P267, DOI 10.1111/acel.12433; Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sutton MN, 2018, AUTOPHAGY, V14, P637, DOI 10.1080/15548627.2018.1427022; Texada MJ, 2019, DEV CELL, V48, P659, DOI 10.1016/j.devcel.2019.01.007; Trinh Hung V, 2013, Int J Proteomics, V2013, P581862, DOI 10.1155/2013/581862; Ubaida-Mohien C, 2019, ELIFE, V8, DOI 10.7554/eLife.49874; Wadhwa R, 2018, CURR PHARM DESIGN, V24, P4711, DOI 10.2174/1381612825666190115121018; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wen H, 2013, MOL CELL PROTEOMICS, V12, P575, DOI 10.1074/mcp.M112.021352; Wiese S, 2007, PROTEOMICS, V7, P340, DOI 10.1002/pmic.200600422; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Yagil C, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036699; Yang DY, 2016, AGING-US, V8, P2182, DOI 10.18632/aging.101062; Yang L, 2019, MOL CELL PROTEOMICS, V18, P2078, DOI 10.1074/mcp.RA119.001621; Youm YH, 2010, AGING CELL, V9, P478, DOI 10.1111/j.1474-9726.2010.00574.x; Zhao HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011701; Zois CE, 2009, AUTOPHAGY, V5, P442, DOI 10.4161/auto.5.4.7667	71	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240596	10.1371/journal.pone.0240596	http://dx.doi.org/10.1371/journal.pone.0240596			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064752	Green Published, gold			2022-12-26	WOS:000585918300006
J	Mtshali, S; Mahomed, O				Mtshali, Sifiso; Mahomed, Ozayr			Patient-level predictors of diabetes-related lower extremity amputations at a quaternary hospital in South Africa	PLOS ONE			English	Article							RISK-FACTORS; CARE; MELLITUS	Introduction Diabetes-related lower extremity amputation has a major psycho-social and economic cost on the patient as well as a direct impact on financial expenditure within health facilities. Aim This study aimed to determine the incidence and patient-related factors related to diabetes-related amputations amongst patients that were referred to the quaternary hospital between 1 January 2014 and 31 December 2015. Methods A retrospective cohort study. Data were retrieved from the medical record for each diabetes patient that was managed at IALCH during the study period. The following variables were collected: sociodemographic parameters (age, gender, and ethnicity) and diabetes-related parameters (type of diabetes) and additional complications. Results Ninety-nine patients (0, 73%) of all diabetes patients managed were new diabetes-related lower-extremity amputations. There were statistically significant increased odds of female patients (OR: 1, 7) and patients with non-insulin dependent diabetes (OR: 1, 64) to have new diabetes-related amputations. Patients older than 60 years (OR: 1, 31); African patients (OR: 1, 35) patients with cardiovascular complications (OR: 1, 04) and patients with retinopathy (OR: 1, 48) were more likely to have diabetes-related amputations but not statistically significant. Conclusions A combination of primary preventive strategies, early detection and appropriate management of patients with diabetes and specific guidelines on the frequency, clinical and laboratory tests required for early diagnosis and referrals with early signs of diabetes-related complicationsat primary care level will assist in reducing the long term adverse outcomes including amputations.	[Mtshali, Sifiso; Mahomed, Ozayr] Univ KwaZulu Natal, Sch Nursing & Publ Hlth Med, Discipline Publ Hlth Med, Durban, South Africa	University of Kwazulu Natal	Mtshali, S (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth Med, Discipline Publ Hlth Med, Durban, South Africa.	smtshali@wol.co.za		Mtshali, Sifiso/0000-0001-6772-8424				Allender S, 2008, J URBAN HEALTH, V85, P938, DOI 10.1007/s11524-008-9325-4; Atosona A, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/7132861; Aziz Z, 2011, DIABET FOOT ANKLE, V2, DOI 10.3402/dfa.v2i0.7463; Bruun C, 2013, DIABETIC MED, V30, P964, DOI 10.1111/dme.12196; Coetzee A, 2019, JEMDSA, V24, P77, DOI 10.1080/16089677.2019.1620009; Feinglass J, 2012, DISABIL REHABIL, V34, P2158, DOI 10.3109/09638288.2012.677936; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Frykberg Robert G, 2006, J Foot Ankle Surg, V45, pS1; Geiss LS, 2019, DIABETES CARE, V42, P50, DOI 10.2337/dc18-1380; Hoffstad O, 2015, DIABETES CARE, V38, P1852, DOI 10.2337/dc15-0536; International Diabetes Federation, 2019, DF DIAB ATL, V9th; Jinadasa CVM, 2011, INT J COLLAB RES INT, V3, P115; Kogani M, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015044; Lacle A, 2012, REV PANAM SALUD PUBL, V32, P192, DOI 10.1590/S1020-49892012000900004; Pinchevsky Y, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/9536025; Rodrigues BT, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5941957; Sarfo-Kantanka O, 2019, BMC ENDOCR DISORD, V19, DOI 10.1186/s12902-019-0353-8; Shatnawi NJ, 2018, DIABET METAB SYND OB, V11, P313, DOI 10.2147/DMSO.S165967; Somasundram P, 2019, JEMDSA, V24, P32, DOI 10.1080/16089677.2018.1550956; Statistics South Africa, 2017, MORT CAUS DEATH S AF; Stokes A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184264; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; The British Diabetic Association, 2018, 26378 DIAB REL LOW L; Yesil S, 2009, HORM-INT J ENDOCRINO, V8, P286, DOI 10.14310/horm.2002.1245; Zubair Mohammad, 2012, Foot (Edinb), V22, P24, DOI 10.1016/j.foot.2011.09.003	26	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240588	10.1371/journal.pone.0240588	http://dx.doi.org/10.1371/journal.pone.0240588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064756	gold, Green Published			2022-12-26	WOS:000585918300043
J	Jong, CB; Lu, TS; Liu, PYT; Hsieh, MY; Meng, SW; Huang, CC; Kao, HL; Wu, CC				Jong, Chien-Boon; Lu, Tsui-Shan; Yan-Tyng Liu, Patrick; Hsieh, Mu-Yang; Meng, Shih-Wei; Huang, Ching-Chang; Kao, Hsien-Li; Wu, Chih-Cheng			High dose escalation of intracoronary adenosine in the assessment of fractional flow reserve: A retrospective cohort study	PLOS ONE			English	Article							INTRAVENOUS ADENOSINE; ANGIOPLASTY; ANGIOGRAPHY; HYPEREMIA; SEVERITY; PRESSURE; STENOSIS	Maximal hyperaemia for fractional flow reserve (FFR) may not be achieved with the current recommended doses of intracoronary adenosine. Higher doses (up to 720 mu g) have been reported to optimize hyperaemic stimuli in small dose-response studies. Real-world data from a large cohort of patients is needed to evaluate FFR results and the safety of high-dose escalation. This is a retrospective study aimed to evaluate the safety and frequency of FFR <= 0.8 after high-dose escalation of intracoronary adenosine. Data were extracted from the medical databases of two university hospitals. Increasing doses (100, 200, 400, 600, and 800 mu g) of adenosine were administered as intracoronary boluses until FFR <= 0.8 was achieved or heart block developed. The percentage of FFR <= 0.8 after higher-dose escalation was compared with those at conventional doses, and the predictors for FFR <= 0.8 after higher doses were analysed. In the 1163 vessels of 878 patients, 402 vessels (34.6%) achieved FFR <= 0.8 at conventional doses and 623 vessels (53.6%) received high-dose escalation. An additional 84 vessels (13.5%) achieved FFR <= 0.8 after high-dose escalation. No major complications developed during high-dose escalation. Borderline FFR (0.81-0.85) at the conventional dose, stenosis >60%, and triple-vessel disease increased the likelihood of FFR <= 0.8 after high-dose escalation, but chronic kidney disease decreased it. For vessels of borderline FFR at conventional doses, 46% achieved FFR <= 0.8 after high-dose escalation. In conclusion, High-dose escalation of intracoronary adenosine increases the frequency of FFR <= 0.8 without major complications. It could be especially feasible for borderline FFR values near the 0.8 diagnostic threshold.	[Jong, Chien-Boon; Meng, Shih-Wei] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Lu, Tsui-Shan] Natl Taiwan Normal Univ, Dept Math, Taipei, Taiwan; [Yan-Tyng Liu, Patrick; Huang, Ching-Chang; Kao, Hsien-Li] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Yan-Tyng Liu, Patrick; Huang, Ching-Chang; Kao, Hsien-Li] Natl Taiwan Univ Hosp, Cardiovasc Ctr, Taipei, Taiwan; [Hsieh, Mu-Yang; Huang, Ching-Chang; Kao, Hsien-Li; Wu, Chih-Cheng] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Wu, Chih-Cheng] Natl Taiwan Univ Hosp, Hsin Chu Branch, Cardiovasc Ctr, Hsinchu, Taiwan; [Wu, Chih-Cheng] Natl Tsing Hua Univ, Inst Biomed Engn, Hsinchu, Taiwan; [Wu, Chih-Cheng] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan Normal University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; National Health Research Institutes - Taiwan	Wu, CC (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Wu, CC (corresponding author), Natl Taiwan Univ Hosp, Hsin Chu Branch, Cardiovasc Ctr, Hsinchu, Taiwan.; Wu, CC (corresponding author), Natl Tsing Hua Univ, Inst Biomed Engn, Hsinchu, Taiwan.; Wu, CC (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	chihchengwumd@gmail.com		WU, CHIH-CHENG/0000-0002-9690-6573; KAO, HSIEN-LI/0000-0002-5278-3540; Liu, Patrick Yan-Tyng/0000-0003-0907-6207	Ministry of Science and Technology [MOST-106-2314-B-002-173-MY3]; National Taiwan University Hospital, Hsinchu branch [HCH-106036]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University Hospital, Hsinchu branch	Chih-Cheng Wu, grant no. MOST-106-2314-B-002-173-MY3,Ministry of Science and Technology. https://www.most.gov.tw/Chien-Boon Jong, grant no. HCH-106036 National Taiwan University Hospital, Hsinchu branch. https://www.hch.gov.tw/hch/hch_chinese.aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjedj J, 2015, JACC-CARDIOVASC INTE, V8, P1422, DOI 10.1016/j.jcin.2015.04.028; Bech GJW, 2001, CIRCULATION, V103, P2928, DOI 10.1161/01.CIR.103.24.2928; De Bruyne B, 2008, HEART, V94, P949, DOI 10.1136/hrt.2007.122838; De Luca G, 2011, JACC-CARDIOVASC INTE, V4, P1079, DOI 10.1016/j.jcin.2011.08.004; Hakeem A, 2016, J AM COLL CARDIOL, V68, P1181, DOI 10.1016/j.jacc.2016.06.035; Hirose K, 2018, J CARDIOL, V71, P52, DOI 10.1016/j.jjcc.2017.05.007; Jeremias A, 2000, AM HEART J, V140, P651, DOI 10.1067/mhj.2000.109920; Johnson NP, 2014, J AM COLL CARDIOL, V64, P1641, DOI 10.1016/j.jacc.2014.07.973; KERN MJ, 1991, J AM COLL CARDIOL, V18, P718, DOI 10.1016/0735-1097(91)90795-B; Leone AM, 2012, JACC-CARDIOVASC INTE, V5, P402, DOI 10.1016/j.jcin.2011.12.014; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lopez-Palop R, 2013, AM J CARDIOL, V111, P1277, DOI 10.1016/j.amjcard.2013.01.270; Marzilli M, 2000, CIRCULATION, V101, P2154, DOI 10.1161/01.CIR.101.18.2154; Murtagh B, 2003, AM HEART J, V146, P99, DOI 10.1016/S0002-8703(03)00120-0; NAHSER PJ, 1995, CIRCULATION, V91, P635, DOI 10.1161/01.CIR.91.3.635; Neumann FJ, 2019, EUR HEART J, V40, P87, DOI 10.1093/eurheartj/ehy394; Nijjer SS, 2016, EUR HEART J, V37, P2069, DOI 10.1093/eurheartj/ehv626; Petraco R, 2013, JACC-CARDIOVASC INTE, V6, P222, DOI 10.1016/j.jcin.2012.10.014; Sen S, 2019, J AM COLL CARDIOL, V73, P444, DOI 10.1016/j.jacc.2018.10.070; Tebaldi M, 2016, CATHETER CARDIO INTE, V88, P555, DOI 10.1002/ccd.26364; Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Toth GG, 2016, J AM COLL CARDIOL, V68, P742, DOI 10.1016/j.jacc.2016.05.067; UREN NG, 1994, NEW ENGL J MED, V331, P222, DOI 10.1056/NEJM199407283310402; van der Hoeven NW, 2019, JAMA CARDIOL, V4, P736, DOI 10.1001/jamacardio.2019.2138; Werner GS, 2001, CIRCULATION, V104, P1129, DOI 10.1161/hc3401.095098; Wijntjens GWM, 2020, CIRC-CARDIOVASC INTE, V13, DOI 10.1161/CIRCINTERVENTIONS.119.007893; WILSON RF, 1990, CIRCULATION, V82, P1595, DOI 10.1161/01.CIR.82.5.1595	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240699	10.1371/journal.pone.0240699	http://dx.doi.org/10.1371/journal.pone.0240699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057416	Green Published, gold			2022-12-26	WOS:000581814700076
J	Peralta-Rincon, JR; Aoulad, FZ; Prado, A; Edelaar, P				Peralta-Rincon, Juan Ramon; Aoulad, Fatima Zohra; Prado, Antonio; Edelaar, Pim			Phenotype-dependent habitat choice is too weak to cause assortative mating between Drosophila melanogaster strains differing in light sensitivity	PLOS ONE			English	Article							GENE FLOW; REPRODUCTIVE ISOLATION; FRUIT-FLIES; EVOLUTION; THERMOTAXIS; MECHANISMS; PHOTOTAXIS; PREFERENCE; SPECIATION; CONSEQUENCES	Matching habitat choice is gaining attention as a mechanism for maintaining biodiversity and driving speciation. It revolves around the idea that individuals select the habitat in which they perceive to obtain greater fitness based on a prior evaluation of their local performance across heterogeneous environments. This results in individuals with similar ecologically relevant traits converging to the same patches, and hence it could indirectly cause assortative mating when mating occurs in those patches. White-eyed mutants of Drosophila fruit flies have a series of disadvantages compared to wild type flies, including a poorer performance under bright light. It has been previously reported that, when given a choice, wild type Drosophila simulans preferred a brightly lit habitat while white-eyed mutants occupied a dimly lit one. This spatial segregation allowed the eye color polymorphism to be maintained for several generations, whereas normally it is quickly replaced by the wild type. Here we compare the habitat choice decisions of white-eyed and wild type flies in another species,D.melanogaster. We released groups of flies in a light gradient and recorded their departure and settlement behavior. Departure depended on sex and phenotype, but not on the light conditions of the release point. Settlement depended on sex, and on the interaction between phenotype and light conditions of the point of settlement. Nonetheless, simulations showed that this differential habitat use by the phenotypes would only cause a minimal degree of assortative mating in this species.	[Peralta-Rincon, Juan Ramon; Aoulad, Fatima Zohra; Edelaar, Pim] Univ Pablo de Olavide, Dept Mol Biol & Biochem Engn, Seville, Spain; [Prado, Antonio] Univ Pablo de Olavide, Dept Physiol Anat & Cell Biol, Seville, Spain	Universidad Pablo de Olavide; Universidad Pablo de Olavide	Peralta-Rincon, JR (corresponding author), Univ Pablo de Olavide, Dept Mol Biol & Biochem Engn, Seville, Spain.	juan.peralta@imagencientifica.es	Edelaar, Pim/P-5650-2014; Prado, Antonio/N-3401-2014	Edelaar, Pim/0000-0003-4649-6366; Prado, Antonio/0000-0001-9813-8566	Spanish Ministry of Economy and Competitiveness [CGL2016-79483-P, BES-2017-081415]; European Regional Development Fund	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund(European Commission)	This work was funded by grants from the Spanish Ministry of Economy and Competitiveness (grant refs. CGL2016-79483-P to P. E.; grant ref. BES-2017-081415 to J.R. P.-R.) with support from the European Regional Development Fund. https://www.mineco.gob.es/portal/site/mineco/https://ec.europa.eu/regional_policy/en/funding/erdf/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcali CK, 2017, EVOLUTION, V71, P2754, DOI 10.1111/evo.13375; [Anonymous], 2002, Jt Comm Perspect, V22, P1; Aranha MM, 2018, CURR OPIN NEUROBIOL, V52, P139, DOI 10.1016/j.conb.2018.06.005; Armsworth PR, 2005, AM NAT, V165, P449, DOI 10.1086/428595; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Berner D, 2015, J EVOLUTION BIOL, V28, P1641, DOI 10.1111/jeb.12683; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bolnick DI, 2013, ECOL EVOL, V3, P4722, DOI 10.1002/ece3.850; Bolnick DI, 2009, EVOLUTION, V63, P2004, DOI 10.1111/j.1558-5646.2009.00699.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Coyne J.A., 2004, SPECIATION; Danchin E, 2018, SCIENCE, V362, P1025, DOI 10.1126/science.aat1590; DELSOLAR E, 1966, P NATL ACAD SCI USA, V56, P484; Edelaar P., 2018, ECOLOGICAL SPECIATIO, P195, DOI [10.1007/978-3-319-91689-7_11, DOI 10.1007/978-3-319-91689-7_11]; Edelaar P, 2008, EVOLUTION, V62, P2462, DOI 10.1111/j.1558-5646.2008.00459.x; Edelaar P, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1343; Edelaar P, 2019, TRENDS ECOL EVOL, V34, P435, DOI 10.1016/j.tree.2019.02.001; Edelaar P, 2017, BEHAV ECOL, V28, P698, DOI 10.1093/beheco/arx016; Edelaar P, 2012, TRENDS ECOL EVOL, V27, P659, DOI 10.1016/j.tree.2012.07.009; Faria VG, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00061; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Garcia FD, 2009, P IEEE S SECUR PRIV, P3, DOI 10.1109/SP.2009.6; Hadler NM, 1964, HERITABILITY PHOTOTA; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HEISENBERG M, 1972, J COMP PHYSIOL, V80, P119, DOI 10.1007/BF00696485; HENGSTEN, 1967, KYBERNETIK, V3, P276; HOLT RD, 1990, TRENDS ECOL EVOL, V5, P311, DOI 10.1016/0169-5347(90)90088-U; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; Jiang YX, 2013, AM NAT, V181, pE125, DOI 10.1086/670160; JONES JS, 1980, NATURE, V287, P632, DOI 10.1038/287632a0; Ferreiro MJ, 2018, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00732; Kain JS, 2015, EVOLUTION, V69, P3171, DOI 10.1111/evo.12813; Kain JS, 2012, P NATL ACAD SCI USA, V109, P19834, DOI 10.1073/pnas.1211988109; Kalmus H, 1943, J GENET, V42, P206, DOI 10.1007/BF02982936; Kopp M, 2018, AM NAT, V191, P1, DOI 10.1086/694889; Krstic D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077904; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lowe WH, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2661; MARKOW TA, 1977, BEHAV GENET, V7, P139, DOI 10.1007/BF01066002; Nicolaus M, 2018, ECOL EVOL, V8, P3815, DOI 10.1002/ece3.3816; Pellerin F, 2019, OIKOS, V128, P221, DOI 10.1111/oik.05309; PLINE M, 1988, J NEMATOL, V20, P605; Puniamoorthy N, 2014, ANIM BEHAV, V98, P139, DOI 10.1016/j.anbehav.2014.10.005; R Core Team, 2021, R LANGUAGE ENV STAT; Ramot D, 2008, J NEUROSCI, V28, P12546, DOI 10.1523/JNEUROSCI.2857-08.2008; Ravigne V, 2009, AM NAT, V174, pE141, DOI 10.1086/605369; Rice WR, 1987, EVOL ECOL, V1, P301, DOI 10.1007/BF02071555; RICE WR, 1990, EVOLUTION, V44, P1140, DOI 10.1111/j.1558-5646.1990.tb05221.x; Richardson JL, 2014, TRENDS ECOL EVOL, V29, P165, DOI 10.1016/j.tree.2014.01.002; Rieger D, 2007, J BIOL RHYTHM, V22, P387, DOI 10.1177/0748730407306198; ROCKWELL RF, 1973, AM SCI, V61, P339; Seugnet L, 2009, GENES BRAIN BEHAV, V8, P377, DOI 10.1111/j.1601-183X.2009.00483.x; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; THORSON GUNNAR, 1964, OPHELIA, V1, P167; Vang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037495; Wang IJ, 2014, MOL ECOL, V23, P5649, DOI 10.1111/mec.12938; White NJ, 2020, TRENDS ECOL EVOL, V35, P10, DOI 10.1016/j.tree.2019.08.009; WU CF, 1977, J GEN PHYSIOL, V69, P705, DOI 10.1085/jgp.69.6.705; Xiao C., 2017, SCI REP, V7, P1; Zhang WQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00286-0; Zhu Y, 2009, CURR BIOL, V19, P613, DOI 10.1016/j.cub.2009.02.053	61	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0234223	10.1371/journal.pone.0234223	http://dx.doi.org/10.1371/journal.pone.0234223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057335	gold, Green Submitted, Green Published			2022-12-26	WOS:000581814700103
J	Zhang, SL; Xue, L; Liu, XH; Zhang, XJC; Zhou, R; Zhao, H; Shen, CS; Pin, JP; Rondard, P; Liu, JF				Zhang, Shenglan; Xue, Li; Liu, Xuehui; Zhang, Xuejun Cai; Zhou, Rui; Zhao, Han; Shen, Cangsong; Pin, Jean-Philippe; Rondard, Philippe; Liu, Jianfeng			Structural basis for distinct quality control mechanisms of GABA(B)receptor during evolution	FASEB JOURNAL			English	Article						cell surface trafficking; coiled-coil domain; endoplasmic reticulum retention; GPCR	ENDOPLASMIC-RETICULUM RETENTION; GABA(B) RECEPTOR; NMR-SPECTROSCOPY; SURFACE TRAFFICKING; GB2 SUBUNITS; EXPRESSION; DOMAIN; HETERODIMERIZATION; GABA(B)-RECEPTOR; CRYSTALLOGRAPHY	Cell surface trafficking of many G protein-coupled receptors is tightly regulated. Among them, the mandatory heterodimer GABA(B)receptor for the main inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), is a model. In mammals, its cell surface trafficking is highly controlled by an endoplasmic reticulum retention signal in the C-terminal intracellular region of the GB1 subunit that is masked through a coiled-coil interaction with the GB2 subunit. Here, we investigate the molecular basis for the export of its homolog inDrosophila melanogasterthat regulates the circadian rhythm and sleep. In contrast to mammals, the endoplasmic retention signal is carried by GB2, while GB1 reaches the cell surface alone. NMR analysis showed that the coiled-coil domain that controls GABA(B)heterodimer formation is structurally conserved between flies and mammals, despite specific features. These findings show the adaptation of a similar quality control system during evolution for maintaining the subunit composition of a functional heterodimeric receptor.	[Zhang, Shenglan; Xue, Li; Zhou, Rui; Zhao, Han; Shen, Cangsong; Liu, Jianfeng] Huazhong Univ Sci & Technol, Int Res Ctr Sensory Biol & Technol MOST, Key Lab Mol Biophys MOE, Cellular Signaling Lab,Sch Life Sci & Technol, Wuhan, Peoples R China; [Liu, Xuehui] Chinese Acad Sci, Inst Biophys, Core Facil Prot Res, Beijing, Peoples R China; [Zhang, Xuejun Cai] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing, Peoples R China; [Zhang, Xuejun Cai] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Pin, Jean-Philippe; Rondard, Philippe] Univ Montpellier, Inst Genom Fonct, CNRS, INSERM, Montpellier, France; [Liu, Jianfeng] Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China; [Xue, Li] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurosurg,Ctr Pituitary Tumor, Shanghai, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Shanghai Jiao Tong University	Rondard, P (corresponding author), Univ Montpellier, Inst Genom Fonct, CNRS, INSERM, Montpellier, France.; Liu, JF (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Key Lab Mol Biophys MOE, Wuhan 430074, Peoples R China.	philippe.rondard@igf.cnrs.fr; jfliu@mail.hust.edu.cn		XUE, Li/0000-0003-0650-2194	Ministry of Science and Technology of the People's Republic of China (MOST) [2018YFA0507003]; National Natural Science Foundation of China (NSFC) [81720108031, 81872945, 31721002, 31420102909]; Program for Introducing Talents of Discipline to the Universities of the Ministry of Education [B08029]; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Program Hubert Curien (PHC) Cai Yuanpei	Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for Introducing Talents of Discipline to the Universities of the Ministry of Education; Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Program Hubert Curien (PHC) Cai Yuanpei	Ministry of Science and Technology of the People's Republic of China (MOST), Grant/Award Number: 2018YFA0507003; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81720108031, 81872945, 31721002 and 31420102909; Program for Introducing Talents of Discipline to the Universities of the Ministry of Education, Grant/Award Number: B08029; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Program Hubert Curien (PHC) Cai Yuanpei	Agabio R, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00140; Bass J, 1998, J CELL BIOL, V141, P637, DOI 10.1083/jcb.141.3.637; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; BAX A, 1991, CIBA F SYMP, V161, P108; Blankenburg S, 2015, NEUROPHARMACOLOGY, V88, P134, DOI 10.1016/j.neuropharm.2014.08.022; Boyd GW, 2003, J BIOL CHEM, V278, P27681, DOI 10.1074/jbc.M304938200; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burmakina S, 2014, P NATL ACAD SCI USA, V111, P6958, DOI 10.1073/pnas.1400081111; Calver AR, 2001, J NEUROSCI, V21, P1203; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Comps-Agrar L, 2012, FASEB J, V26, P3430, DOI 10.1096/fj.12-203646; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Cryan JF, 2005, TRENDS PHARMACOL SCI, V26, P36, DOI 10.1016/j.tips.2004.11.004; Cunningham MR, 2012, J BIOL CHEM, V287, P16656, DOI 10.1074/jbc.M111.315911; Curtis DR, 1998, EXP BRAIN RES, V121, P319, DOI 10.1007/s002210050465; Dalmau J, 2018, NEW ENGL J MED, V378, P840, DOI 10.1056/NEJMra1708712; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doly S, 2016, MOL PSYCHIATR, V21, P480, DOI 10.1038/mp.2015.72; Doly S, 2015, TRENDS PHARMACOL SCI, V36, P636, DOI 10.1016/j.tips.2015.06.007; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Geng Y, 2013, NATURE, V504, P254, DOI 10.1038/nature12725; Gmeiner F, 2013, J EXP BIOL, V216, P3837, DOI 10.1242/jeb.085563; Grieder NC, 2005, GENE EXPR PATTERNS, V6, P11, DOI 10.1016/j.modgep.2005.06.001; Hamasaka Y, 2005, J NEUROBIOL, V65, P225, DOI 10.1002/neu.20184; Hasegawa H, 2016, BBA-MOL CELL RES, V1863, P1534, DOI 10.1016/j.bbamcr.2016.04.010; Havlickova M, 2002, MOL PHARMACOL, V62, P343, DOI 10.1124/mol.62.2.343; Howell RD, 2016, J PHYSIOL-LONDON, V594, P3651, DOI 10.1113/JP272124; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kammerer RA, 1999, BIOCHEMISTRY-US, V38, P13263, DOI 10.1021/bi991018t; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Li CP, 2008, ALCOHOL ALCOHOLISM, V43, P529, DOI 10.1093/alcalc/agn045; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Malitschek B, 1999, MOL PHARMACOL, V56, P448, DOI 10.1124/mol.56.2.448; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Pagano A, 2001, J NEUROSCI, V21, P1189; Pregitzer P, 2013, INT J BIOL SCI, V9, P707, DOI 10.7150/ijbs.6674; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rondard P, 2008, EMBO J, V27, P1321, DOI 10.1038/emboj.2008.64; Sammaraiee Y, 2019, MULT SCLER RELAT DIS, V27, P95, DOI 10.1016/j.msard.2018.10.009; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Shaye H, 2020, NATURE, V584, P298, DOI 10.1038/s41586-020-2408-4; Szabadi E, 2015, J PSYCHOPHARMACOL, V29, P744, DOI 10.1177/0269881115573807; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xue L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10834-5; Yoo Y, 2017, ANN NEUROL, V82, P466, DOI 10.1002/ana.25032	62	2	2	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16348	16363		10.1096/fj.202001355RR	http://dx.doi.org/10.1096/fj.202001355RR		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33058267	Green Submitted			2022-12-26	WOS:000581156300001
J	Ahn, WK; Bitran, A; Lebowitz, M				Ahn, Woo-kyoung; Bitran, Alma; Lebowitz, Matthew			Effects of genetic information on memory for severity of depressive symptoms	PLOS ONE			English	Article							SCHIZOPHRENIA; CONSEQUENCES; EXPLANATIONS; STIGMA; IMPACT	The general public is increasingly aware of the role of genes in causing depression. Recent studies have begun uncovering unintended negative consequences of learning about a person's genetic susceptibility to disorders. Because people tend to believe that genes determine one's identity, having genes related to a disorder can be misinterpreted as equivalent to having the disorder. Consequently, learning that a person is genetically predisposed to depression can make people misremember mild depression as more severe. Participants across three experiments read a target vignette about a character displaying mild depressive symptoms, while descriptions of the character's genetic susceptibility to depression were experimentally manipulated. Participants then read a foil vignette describing a character with more severe depressive symptoms. Afterwards, participants who had learned that the target character was genetically predisposed to depression were comparatively more likely to misremember the target symptoms as being severe, when in fact they were mild. This pattern of results was obtained among both laypeople (Experiments 1 and 2) and practicing master's-level, but not doctoral-level, mental health clinicians (Experiment 3). Given that depression is diagnosed primarily based on a person's memory of depressive symptoms, the current findings suggest that genetic information about depression may lead to over-diagnosis of depression.	[Ahn, Woo-kyoung; Bitran, Alma] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Lebowitz, Matthew] Columbia Univ, Dept Psychiat, New York, NY USA	Yale University; Columbia University	Ahn, WK (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	woo-kyoung.ahn@yale.edu		Ahn, Woo-kyoung/0000-0002-5203-2376; Bitran, Alma/0000-0002-3366-8731	National Institutes of Health [K99HG010084]; Yale University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University	This work was supported by research funding provided to W.A. by Yale University. M.L received support from the National Institutes of Health (grant K99HG010084).	Ahn WK, 2009, COGNITIVE SCI, V33, P147, DOI 10.1111/j.1551-6709.2009.01008.x; Angermeyer MC, 2004, SCHIZOPHRENIA BULL, V30, P1049, DOI 10.1093/oxfordjournals.schbul.a007120; Appelbaum PS, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0790-x; BODENHAUSEN GV, 1987, J PERS SOC PSYCHOL, V52, P871, DOI 10.1037/0022-3514.52.5.871; Dar-Nimrod I, 2011, PSYCHOL BULL, V137, P800, DOI 10.1037/a0021860; Haslam N., 2011, GENETIC ESSENTIALISM, P819; Hinshaw SP, 2008, ANNU REV CLIN PSYCHO, V4, P367, DOI 10.1146/annurev.clinpsy.4.022007.141245; Hogarth S, 2008, ANNU REV GENOM HUM G, V9, P161, DOI 10.1146/annurev.genom.9.081307.164319; Howard DM, 2019, NAT NEUROSCI, V22, P343, DOI 10.1038/s41593-018-0326-7; Institute NIHNationalHumanGenomeResearch., 2020, BIOL PATHW FACT SHEE; Kim K, 2020, EMOTION, V20, P192, DOI 10.1037/emo0000547; Kvaale EP, 2013, CLIN PSYCHOL REV, V33, P782, DOI 10.1016/j.cpr.2013.06.002; Lebowitz MS, 2018, J GENET COUNS, V27, P204, DOI 10.1007/s10897-017-0140-5; Lebowitz MS, 2014, P NATL ACAD SCI USA, V111, P17786, DOI 10.1073/pnas.1414058111; Lebowitz MS, 2017, J CONSULT CLIN PSYCH, V85, P1052, DOI 10.1037/ccp0000254; Lilienfeld SO, 2009, PERSPECT PSYCHOL SCI, V4, P390, DOI 10.1111/j.1745-6924.2009.01144.x; LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098; Malhotra AK, 2004, AM J PSYCHIAT, V161, P780, DOI 10.1176/appi.ajp.161.5.780; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Phelan J.C., 2011, PSYCHIAT REHABILITAT, V6, P159, DOI [DOI 10.1080/10973430208408431, 10.1080/10973430208408431]; Phelan JC, 2005, J HEALTH SOC BEHAV, V46, P307, DOI 10.1177/002214650504600401; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schomerus G, 2012, ACTA PSYCHIAT SCAND, V125, P440, DOI 10.1111/j.1600-0447.2012.01826.x	24	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0239714	10.1371/journal.pone.0239714	http://dx.doi.org/10.1371/journal.pone.0239714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052909	Green Published, gold			2022-12-26	WOS:000581820200066
J	Lee, JM; Heo, S; Kim, YS; Lee, JH; Jeong, D				Lee, Jung-Min; Heo, Sojeong; Kim, Yoon-Su; Lee, Jong-Hoon; Jeong, Do-Won			Culture-dependent and -independent investigations of bacterial migration intodoenjangfrom its componentsmejuand solar salt	PLOS ONE			English	Article							BACILLUS; MEJU; COMMUNITIES; DOENJANG	We determined bacterial migration intodoenjangfrom its components,mejuand solar salt using culture-based and 16S rRNA gene-based culture-independent techniques (pyrosequencing of total DNA). Pyrosequencing results suggested that the bacterial communities ofmeju, but not solar salt, significantly affected those ofdoenjangcommunities. Culture-based pyrosequencing analysis yielded similar results. These results indicate that most predominant bacterial species indoenjangmigrated frommeju, not solar salt. We therefore believe that the present study is one of the most comprehensive comparisons of bacterial communities of fermented soybeans using culture-dependent and -independent methods. Furthermore, pyrosequencing of the V3 and V4 regions of bacterial 16S rRNA did not distinguish amongBacillus amyloliquefaciens,B.siamensis, andB.velezensisas well as betweenEnterococcus faeciumandE.hirae.	[Lee, Jung-Min; Heo, Sojeong; Kim, Yoon-Su; Jeong, Do-Won] Dongduk Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Lee, Jong-Hoon] Kyonggi Univ, Dept Food Sci & Biotechnol, Suwon, South Korea	Dongduk Women's University; Kyonggi University	Jeong, D (corresponding author), Dongduk Womens Univ, Dept Food & Nutr, Seoul, South Korea.	dwjeong@dongduk.ac.kr		Lee, Jong-Hoon/0000-0001-8889-5504; Jeong, Do-Won/0000-0001-6586-748X	National Research Foundation of Korea (NRF) [NRF-2016R1D1A1B01011421, NRF-2019R1A2C1003639]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) [NRF-2016R1D1A1B01011421 for JHL and NRF-2019R1A2C1003639 for DWJ].	[Anonymous], 1998, EUR CONS STAT NEON H, V27, P259; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; 김용상, 2011, [Korean Journal of Microbiology, 미생물학회지], V47, P275; Cho D. H., 1970, Journal of the Korean Agricultural Chemical Society, V13, P35; Cho KM, 2007, FOOD SCI BIOTECHNOL, V16, P320; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dunlap CA, 2016, INT J SYST EVOL MICR, V66, P1212, DOI 10.1099/ijsem.0.000858; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Ha Gwangsu, 2020, [Korean Journal of Microbiology, 미생물학회지], V56, P74; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HORWITZ W., 2000, OFFICIAL METHODS ANA, V17th; Jang Mihyun, 2019, Microbiology and Biotechnology Letters, V47, P359, DOI 10.4014/mbl.1902.02007; Jeong DW, 2020, LWT-FOOD SCI TECHNOL, V122, DOI 10.1016/j.lwt.2019.108996; Jeong DW, 2019, J MICROBIOL BIOTECHN, V29, P191, DOI [10.4014/jmb.1807.11012, 10.4014/jmb.1811.11012]; Jeong DW, 2016, INT J FOOD MICROBIOL, V236, P9, DOI 10.1016/j.ijfoodmicro.2016.07.011; Jeong DW, 2014, J MICROBIOL BIOTECHN, V24, P648, DOI 10.4014/jmb.1401.01009; Jin Yong-Xie, 2011, 한국식품저장유통학회지, V18, P993; Jung JY, 2014, INT J FOOD MICROBIOL, V185, P112, DOI 10.1016/j.ijfoodmicro.2014.06.003; Jung WY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00827; Kim MJ, 2016, FOOD RES INT, V89, P724, DOI 10.1016/j.foodres.2016.09.032; Kim SY, 2017, J BIOTECHNOL, V259, P221, DOI 10.1016/j.jbiotec.2017.06.1206; Kim TW, 2009, INT J FOOD MICROBIOL, V131, P265, DOI 10.1016/j.ijfoodmicro.2009.03.001; Kim YS, 2011, J MICROBIOL, V49, P340, DOI 10.1007/s12275-011-0302-3; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lee Limgi, 2019, Microbiology and Biotechnology Letters, V47, P354, DOI 10.4014/mbl.1905.05004; Lee ME, 2015, J MICROBIOL BIOTECHN, V25, P559, DOI 10.4014/jmb.1501.01019; Lee Sang Sun, 1995, Korean Journal of Mycology, V23, P161; Lim SM, 2017, PLANT PATHOLOGY J, V33, P488, DOI 10.5423/PPJ.OA.04.2017.0073; Nam YD, 2012, INT J FOOD MICROBIOL, V155, P36, DOI 10.1016/j.ijfoodmicro.2012.01.013; Palazzini JM, 2016, MICROBIOL RES, V192, P30, DOI 10.1016/j.micres.2016.06.002; Park KunYoung, 2002, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V31, P343; Ruiz-Garcia C, 2005, INT J SYST EVOL MICR, V55, P191, DOI 10.1099/ijs.0.63310-0; Selling JA, 2010, HEYTHROP J, V51, P388; Vahidinasab M, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.00667-19; Yoo SK, 1999, KOREAN J APPL MICROB, V27, P113	35	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0239971	10.1371/journal.pone.0239971	http://dx.doi.org/10.1371/journal.pone.0239971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048960	gold, Green Published			2022-12-26	WOS:000581813300029
J	Carrol, DH; Chassagne, F; Dettweiler, M; Quave, CL				Carrol, Danielle H.; Chassagne, Francois; Dettweiler, Micah; Quave, Cassandra L.			Antibacterial activity of plant species used for oral health againstPorphyromonas gingivalis	PLOS ONE			English	Article							OLEA-EUROPAEA L.; PORPHYROMONAS-GINGIVALIS; JUGLANS-REGIA; CHEWING STICK; ETHNOBOTANICAL APPROACH; CHEMICAL-COMPOSITION; PERIODONTAL-DISEASE; INHIBITORY-ACTIVITY; MEDICINAL-PLANTS; ESSENTIAL OIL	Porphyromonas gingivalisis the keystone pathogen of periodontitis, a chronic inflammatory disease which causes tooth loss and deterioration of gingiva. Medicinal plants have been traditionally used for oral hygiene and health and might play a role as antibacterial agents against oral pathogens. In this work, we aimed to evaluate the antibacterial activity of plants used for oral hygiene or symptoms of periodontitis againstP.gingivalis. We first reviewed the literature to identify plant species used for oral hygiene or symptoms of periodontitis. Then, we cross-checked this species list with our in-house library of plant extracts to select extracts for testing. Antibacterial activity tests were then performed for each plant extract againstP.gingivalis, and their cytotoxicity was assessed on HaCaT cells. The selectivity index (SI) was then calculated. A total of 416 plant species belonging to 110 families and 305 genera were documented through our literature search, and 158 plant species were noted as being used by North American Native peoples Once cross-checked with the extracts contained in our library of natural products, 30 matches were identified and 21 were defined as high priority. Of the 109 extracts from 21 plant species selected and tested, 21 extracts from 11 plants had higher than 90% inhibition onP.gingivalisat 64 mu g/mL and were further selected for MIC (Minimum Inhibitory Concentration) assays. Out of 21 plant extracts, 13 extracts (7 plant species) had a SI > 10.Pistacia lentiscusfruits showed the best MIC with value of 8 mu g/mL, followed byZanthoxylum armatumfruits/seeds with a MIC of 16 mu g/mL.P.lentiscusfruits also showed the highest SI of 256. Most of the extracts tested present promising antibacterial activity and low cytotoxicity. Further testing for biofilm eradication and examination of activity against other dental pathogens and oral commensals should be performed to confirm the potential of these extracts as antibacterial agents. Future work will focus on application of a bioassay-guided fractionation approach to isolating and identifying the most active natural products in the top performing extracts. This study can serve as a basis for their future development as ingredients for oral hygiene products.	[Carrol, Danielle H.; Chassagne, Francois; Quave, Cassandra L.] Emory Univ, Ctr Study Human Hlth, Coll Arts & Sci, Atlanta, GA 30322 USA; [Dettweiler, Micah; Quave, Cassandra L.] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA	Emory University; Emory University	Quave, CL (corresponding author), Emory Univ, Ctr Study Human Hlth, Coll Arts & Sci, Atlanta, GA 30322 USA.; Quave, CL (corresponding author), Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA.	cquave@emory.edu	François, Chassagne/J-3082-2019	François, Chassagne/0000-0003-4179-7995	Emory University development funds	Emory University development funds	Funding for this study was provided by Emory University development funds to CLQ.	Achan J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-144; ADUTUTU M, 1979, ECON BOT, V33, P320, DOI 10.1007/BF02858262; Aksoy A, 2006, ARCH ORAL BIOL, V51, P476, DOI 10.1016/j.archoralbio.2005.11.003; Amabeoku GJ, 2010, J PHARM PHARMACOL, V62, P368, DOI 10.1211/jpp.62.03.0012; [Anonymous], 2010, JOVE J VISUALIZED EX, V15, pe1936; [Anonymous], 1896, STUDIO ILLUSTRATED M, V6, P58; Araghizadeh A, 2013, MED PRIN PRACT, V22, P368, DOI 10.1159/000348299; Ardila CM, 2010, J PERIODONTAL RES, V45, P557, DOI 10.1111/j.1600-0765.2010.01274.x; Aro AO, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2520-x; Attoub S, 2014, CELL PHYSIOL BIOCHEM, V33, P1400, DOI 10.1159/000358706; Aumeeruddy MZ, 2018, J ETHNOPHARMACOL, V213, P409, DOI 10.1016/j.jep.2017.11.030; Bairy Indira, 2002, Indian J Pathol Microbiol, V45, P307; Beikler T, 2004, J PERIODONTOL, V75, P169, DOI 10.1902/jop.2004.75.1.169; Belstrom D, 2011, INFECT IMMUN, V79, P1559, DOI 10.1128/IAI.01036-10; Boukeloua A, 2012, AFR J TRADIT COMPLEM, V9, P607, DOI 10.4314/ajtcam.v9i4.19; BOZORGI M, 2013, SCI WORLD J, DOI DOI 10.1155/2013/219815; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Cai LN, 1996, J NAT PROD, V59, P987, DOI 10.1021/np960451q; Cai LN, 2000, J AGR FOOD CHEM, V48, P909, DOI 10.1021/jf9909914; Chaieb K., 2013, Journal of Herbs, Spices & Medicinal Plants, V19, P168, DOI 10.1080/10496475.2012.762818; Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124; Chebbi Mahjoub R, 2011, ISRN Pharmacol, V2011, P564972, DOI 10.5402/2011/564972; Clinical and Laboratory Standards Institute, 2017, PERFORMANCE STANDARD; Colaric M, 2005, J AGR FOOD CHEM, V53, P6390, DOI 10.1021/jf050721n; Cornacchione LP, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01271-19; COX PA, 1994, SCI AM, V270, P82, DOI 10.1038/scientificamerican0694-82; Djerrou Z, 2013, AFR J TRADIT COMPLEM, V10, P480, DOI 10.4314/ajtcam.v10i3.15; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; Dzotam JK, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1583510; Erdemoglu N, 2003, J ETHNOPHARMACOL, V89, P123, DOI 10.1016/S0378-8741(03)00282-4; Farooqui A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118431; Favela-Hernandez JMJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21020247; Govoni M, 2008, NITRIC OXIDE-BIOL CH, V19, P333, DOI 10.1016/j.niox.2008.08.003; Gyllenhaal C, 2012, PHARM BIOL, V50, P30, DOI 10.3109/13880209.2011.634424; Halberstein RA, 2008, NAT PROD COMMUN, V3, P1813; Hashioka S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153723; Hebbar SS, 2004, J ETHNOPHARMACOL, V94, P261, DOI 10.1016/j.jep.2004.04.021; HOMER KA, 1990, ARCH ORAL BIOL, V35, P421, DOI 10.1016/0003-9969(90)90203-M; Hussain Khaja Amjad, 2015, Rocz Panstw Zakl Hig, V66, P173; Jayanti Ipsita, 2018, J Contemp Dent Pract, V19, P415; Jepsen K, 2016, PERIODONTOL 2000, V71, P82, DOI 10.1111/prd.12121; Kamer AR, 2015, NEUROBIOL AGING, V36, P627, DOI 10.1016/j.neurobiolaging.2014.10.038; Karygianni L, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2461-4; Khan MF, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00815; Kim J, 2006, ODONTOLOGY, V94, P10, DOI 10.1007/s10266-006-0060-6; Koychev S, 2017, J PERIODONTOL, V88, P511, DOI 10.1902/jop.2017.150691; Lakshmi T, 2015, Pharmacogn Rev, V9, P41, DOI 10.4103/0973-7847.156337; Lewis W., 2003, MED BOT, V2nd; Liao J, 2013, PHARM BIOL, V51, P1538, DOI 10.3109/13880209.2013.801995; Lundberg JO, 2004, NAT REV MICROBIOL, V2, P593, DOI 10.1038/nrmicro929; Mandal A, 2018, J NEPAL SOC PERIO OR, V2, P9, DOI [10.3126/jnspoi.v2i1.23602, DOI 10.3126/JNSPOI.V2I1.23602]; Masuda T, 2006, APPL ENVIRON MICROB, V72, P3458, DOI 10.1128/AEM.72.5.3458-3467.2006; Mehenni C, 2016, J FOOD DRUG ANAL, V24, P653, DOI 10.1016/j.jfda.2016.03.002; Minami M., 2019, Traditional & Kampo Medicine, V6, P79, DOI 10.1002/tkm2.1215; Mohieldin EAM, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1735-y; More G, 2008, J ETHNOPHARMACOL, V119, P473, DOI 10.1016/j.jep.2008.07.001; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; Mysak J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/476068; Nooreen Z, 2019, NAT PROD RES, V33, P665, DOI 10.1080/14786419.2017.1405404; Nooreen Z, 2017, BIOMED PHARMACOTHER, V89, P366, DOI 10.1016/j.biopha.2017.02.040; Omer SA, 2012, ASIAN J ANIM VET ADV, V7, P1175, DOI 10.3923/ajava.2012.1175.1182; Parkar SG, 2008, INT J FOOD MICROBIOL, V124, P295, DOI 10.1016/j.ijfoodmicro.2008.03.017; Persson GR, 2006, CLIN ORAL IMPLAN RES, V17, P386, DOI 10.1111/j.1600-0501.2006.01269.x; Phuyal N, 2019, J ETHNOPHARMACOL, V229, P326, DOI 10.1016/j.jep.2018.08.010; Pourhajibagher M, 2016, PHOTODIAGN PHOTODYN, V16, P50, DOI 10.1016/j.pdpdt.2016.08.013; Quave CL, 2008, J ETHNOPHARMACOL, V118, P418, DOI 10.1016/j.jep.2008.05.005; Ravanbakhsh A, 2016, ADV PHARM BULL, V6, P541, DOI [10.15171/apb.2016.067, 10.15171/apb.2016.068]; Reynolds EC, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.29125; Romero JB., 1954, BOT LORE CALIFORNIA; Rosas-Pinon Y, 2012, J ETHNOPHARMACOL, V141, P860, DOI 10.1016/j.jep.2012.03.020; ROTIMI VO, 1988, ANTIMICROB AGENTS CH, V32, P598, DOI 10.1128/AAC.32.4.598; Sakagami H, 2009, IN VIVO, V23, P215; Sakanaka A, 2016, MICROB PATHOGENESIS, V94, P42, DOI 10.1016/j.micpath.2015.10.003; Sarathy JP, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.02404-19; SHEMLUCK M, 1982, J ETHNOPHARMACOL, V5, P303, DOI 10.1016/0378-8741(82)90016-2; Shetty Sunaina, 2013, Ayu, V34, P445, DOI 10.4103/0974-8520.127732; Shetty Y Sunaina, 2018, J Contemp Dent Pract, V19, P690; Silva LN, 2016, CHEM REV, V116, P9162, DOI 10.1021/acs.chemrev.6b00184; Singhrao SK, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/137357; Sofrata AH, 2008, J PERIODONTOL, V79, P1474, DOI [10.1902/jop.2008.070506, 10.1902/jop.2008.070506 ]; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; Sukkarwalla Adnan, 2013, Dent Res J (Isfahan), V10, P314, DOI 10.4103/1735-3327.115138; Tao NG, 2009, INT J FOOD SCI TECH, V44, P1281, DOI 10.1111/j.1365-2621.2009.01947.x; Taylor LA., 1940, PLANTS USED CURATIVE; Vennila K, 2016, Indian J Dent Res, V27, P15, DOI 10.4103/0970-9290.179808; Watanabe S, 2019, MEDICINES, V6, P1; Widyarman AS, 2018, CONTEMP CLIN DENT, V9, P298, DOI 10.4103/ccd.ccd_53_18; Wu CD, 2001, J PERIODONTAL RES, V36, P275, DOI 10.1034/j.1600-0765.2001.360502.x; Yang R.T., 2001, ADV CHEM ENG, P79, DOI DOI 10.1016/50065-2377(01)27004-5; [No title captured]	90	15	15	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239316	10.1371/journal.pone.0239316	http://dx.doi.org/10.1371/journal.pone.0239316			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031410	gold, Green Published			2022-12-26	WOS:000581809800051
J	Bayu, H; Elias, B; Abdisa, S; Tune, A; Namo, H				Bayu, Hinsermu; Elias, Bedasa; Abdisa, Silashi; Tune, Abdurhaman; Namo, Husen			Post exposure prophylaxis coverage, vertical transmission and associated factors among hepatitis B exposed newborns delivered at Arsi zone health institutions, 2019	PLOS ONE			English	Article							VIRUS INFECTION; VACCINATION; PROGRAM; WOMEN	Introduction One third of the world population has been exposed to hepatitis B virus and an estimated 257 million people are chronically infected. The main route of hepatitis B virus (HBV) infection is vertical transmission. Post exposure prophylaxis is recommended by world health organization to have free Hepatitis B infection by 2030. Objective The main purpose of this research project was to assess Hepatitis B virus post exposure prophylaxis coverage, rate of vertical transmission and factors among exposed newborns delivered at Arsi zone health institution. Methods A cross-sectional study was conducted in Arsi zone health institutions among hepatitis B virus exposed newborns delivered at Arsi zone health institutions from January 2018 to September 2019. Systematic sampling technique was used to select 422 exposed newborns into the study. A pre-tested structured questionnaire and checklist were used to collect relevant data. Data was entered and cleaned using epidata7 & analyzed using SPSS version 25 software package. Both bivariate and multivariate analyses was carried out to identify associations. Odds ratio with 95% CI and P-value Results The study revealed that among 401 exposed newborns only 83(20.7%), have been administered post exposure prophylaxis. But vertical transmission of hepatitis B virus (HBV) was observed in 32.4% (27.9%-36.9%) exposed newborns. Antenatal (ANC) attendance (AOR = .40, 95%CI = .23-.69), Instrumental delivery (AOR = 4.18, 95%CI = 2.05-8.51) HIV coinfection (AOR = 9.7, 95%CI = 4.37-21.34), Post exposure Prophylaxis (AOR = .20, 95%CI = .08-.50) and Knowledge on HBV (AOR = .27, 95%CI = .14-.53) are significant predictors of HBV vertical transmission. Conclusion Magnitude of HBV post exposure prophylaxis coverage is very low while Rate of vertical transmission is high. Antenatal attendance, Instrumental delivery, Post exposure Prophylaxis and Knowledge on hepatitis B virus transmission are significant predictors of HBV vertical transmission.	[Bayu, Hinsermu; Namo, Husen] Arsi Univ, Dept Midwifery, Coll Hlth Sci, Mekelle, Ethiopia; [Elias, Bedasa] Arsi Univ, Coll Hlth Sci, Dept Obstet & Gynaecol, Mekelle, Ethiopia; [Abdisa, Silashi] Arsi Univ, Coll Hlth Sci, Dept Biomed, Mekelle, Ethiopia; [Tune, Abdurhaman] Arsi Univ, Coll Hlth Sci, Dept Anaesthesia, Mekelle, Ethiopia		Bayu, H (corresponding author), Arsi Univ, Dept Midwifery, Coll Hlth Sci, Mekelle, Ethiopia.	henybayu1@gmail.com			Arsi University [COHS/0022/2017/18]	Arsi University	HB, COHS/0022/2017/18, Arsi University, https://www.arsiun.edu.et.	[Anonymous], 2017, Wkly Epidemiol Rec, V92, P369; [Anonymous], 2015, PEDIATRICS, V135, pe1097; Borresen ML, 2012, AM J PUBLIC HEALTH, V102, P277, DOI 10.2105/AJPH.2011.300239; Candotti D, 2007, J GEN VIROL, V88, P2686, DOI 10.1099/vir.0.83102-0; Cheesbrough M, 2000, DISTRICT LAB PRACTIC, P250; Chen XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055303; Cong W, 2015, J MED VIROL, V87, P446, DOI 10.1002/jmv.24058; Devaraju P, 2015, MOL IMMUNOL, V64, P123, DOI 10.1016/j.molimm.2014.11.005; Jiang XY, 2010, CRIT CARE, V14, pR66; Kebede KM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3234-2; Keeble S, 2015, HUM VACC IMMUNOTHER, V11, P1153, DOI 10.1080/21645515.2015.1019977; Lee C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004790.pub2; Lincetto O, 2006, ANTENATAL CARE OPPOR, P55; Liu CP, 2015, INTERNAL MED, V54, P711, DOI 10.2169/internalmedicine.54.3514; Lu SQ, 2013, VACCINE, V31, P1864, DOI 10.1016/j.vaccine.2013.01.020; Pan CQ, 2013, CLIN GASTROENTEROL H, V11, P1349, DOI 10.1016/j.cgh.2013.04.026; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; Sangare L, 2009, Bull Soc Pathol Exot, V102, P226; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Wang JS, 2002, CHINESE MED J-PEKING, V115, P1510; WHO, HEP B VIR UPD FACT S; World Health Organization, 2015, WC536 WHO, pWC; Yang M, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1487-1; Yu MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054246; Zhang L, 2014, HUM VACC IMMUNOTHER, V10, P2755, DOI 10.4161/hv.29648	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0238987	10.1371/journal.pone.0238987	http://dx.doi.org/10.1371/journal.pone.0238987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052919	gold, Green Published			2022-12-26	WOS:000581820200072
J	Borba-Santos, LP; Vila, T; Rozental, S				Borba-Santos, Luana Pereira; Vila, Taissa; Rozental, Sonia			Identification of two potential inhibitors ofSporothrix brasiliensisandSporothrix schenckiiin the Pathogen Box collection	PLOS ONE			English	Article							AMPHOTERICIN-B	Sporotrichosis is a neglected endemic mycosis with a high incidence in Latin America, mainly in Brazil.Sporothrix schenckiiis the most frequent species in Latin America, whereasSporothrix brasiliensisis the predominant species observed in Brazil and is associated with both human and animal sporotrichosis. Sporotrichosis treatment remains restricted to a few options, itraconazole being the first choice for human and animal therapy. In this work, we screened the molecular library Pathogen Box (Medicines for Malaria Venture [MMV], Switzerland) in search of compounds with anti-Sporothrixactivity. Our initial screen of the 400 compounds identified five compounds that inhibited more than 80% ofS.brasiliensisandS.schenkiigrowth. Among those, three compounds (MMV675968, MMV102872, and MMV002817 (known as iodoquinol)) not previously described as antifungals or agrochemicals, were selected for further evaluation. MMV102872 and iodoquinol showed the most promising combination of antifungal activity (lower inhibitory concentration) and fungal selectivity (lower cytotoxicity in LLC-MK2 cells). Scanning electron microscopy and flow cytometry analyses revealed that MMV102872 and iodoquinol induced changes in cell morphology, membrane integrity, and the presence of neutral lipids, impairing fungal survival. Our results indicate that MMV102872 and iodoquinol are promising molecules for use as scaffolds for the development of new antifungal agents.	[Borba-Santos, Luana Pereira; Vila, Taissa; Rozental, Sonia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Borba-Santos, LP (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.	luanaborba@biof.ufrj.br	Pereira Borba-Santos, Luana/AAD-3064-2022; Vila, Taissa/AAY-3980-2020; P. Borba-Santos, Luana/GPS-4788-2022; Rozental, Sonia/A-8537-2013	Pereira Borba-Santos, Luana/0000-0001-6576-6646; Vila, Taissa/0000-0001-5600-4367; Rozental, Sonia/0000-0002-3659-5945	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by the Brazilian funding agencies Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Paes R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003094; Arrillaga-Moncrieff I, 2009, CLIN MICROBIOL INFEC, V15, P651, DOI 10.1111/j.1469-0691.2009.02824.x; Batista-Duharte A, 2018, FUNGAL BIOL-UK, V122, P1163, DOI 10.1016/j.funbio.2018.08.004; Bongomin F, 2017, J FUNGI, V3, DOI 10.3390/jof3040057; Borba-Santos LP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01759; Borba-Santos LP, 2015, MED MYCOL, V53, P178, DOI 10.1093/mmy/myu056; Burnett BP, 2008, CUTIS, V82, P273; CLSI-M27, 2017, M27 CLSI; Coelho RA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229630; Espinel-Ingroff A, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01057-17, 10.1128/aac.01057-17]; Gremiao IDF, 2020, EMERG INFECT DIS, V26, P621, DOI 10.3201/eid2603.190803; Gupta Y. K., 2004, Indian Journal of Pediatrics, V71, P55, DOI 10.1007/BF02725657; Hendrickson JA, 2019, CURR INFECT DIS REP, V21, DOI 10.1007/s11908-019-0702-9; Liu N, 2016, FUTURE MED CHEM, V8, P1435, DOI 10.4155/fmc-2016-0020; Lopes-Bezerra LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006169; Falcao EMM, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311X00109218, 10.1590/0102-311x00109218]; Mario DN, 2015, ANTIMICROB AGENTS CH, V59, P5018, DOI 10.1128/AAC.00052-15; Mayer FL, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00120-17, 10.1128/msphere.00120-17]; Queiroz-Telles F, 2017, LANCET INFECT DIS, V17, pE367, DOI 10.1016/S1473-3099(17)30306-7; Robbins N, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.FUNK-0002-2016; Rodrigues AM, 2020, MYCOPATHOLOGIA, V185, P813, DOI 10.1007/s11046-020-00425-0; Rodrigues AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005638; Nakasu CCT, 2021, BRAZ J MICROBIOL, V52, P163, DOI 10.1007/s42770-020-00290-5; Veale CGL, 2019, CHEMMEDCHEM, V14, P386, DOI 10.1002/cmdc.201800755; Vila T, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02006-16; Wall G, 2019, J FUNGI, V5, DOI 10.3390/jof5040092; Waller SB, 2021, BRAZ J MICROBIOL, V52, P73, DOI 10.1007/s42770-020-00307-z	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240658	10.1371/journal.pone.0240658	http://dx.doi.org/10.1371/journal.pone.0240658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052959	Green Published, gold			2022-12-26	WOS:000581820200067
J	Liu, AQ; Sanderson, WJ; Ingham, E; Fisher, J; Jennings, LM				Liu, Aiqin; Sanderson, William J.; Ingham, Eileen; Fisher, John; Jennings, Louise M.			Development of a specimen-specific in vitro pre-clinical simulation model of the human cadaveric knee with appropriate soft tissue constraints	PLOS ONE			English	Article							ANTERIOR CRUCIATE; JOINT LOAD; FORCE; PERFORMANCE; MECHANICS; INVITRO; LAXITY; MOTION	A human cadaveric specimen-specific knee model with appropriate soft tissue constraints was developed to appropriately simulate the biomechanical environment in the human knee, in order to pre-clinically evaluate the biomechanical and tribological performance of soft tissue interventions. Four human cadaveric knees were studied in a natural knee simulator under force control conditions in the anterior posterior (AP) and tibial rotation (TR) axes, using virtual springs to replicate the function of soft tissues. The most appropriate spring constraints for each knee were determined by comparing the kinematic outputs in terms of AP displacement and TR angle of the human knee with all the soft tissues intact, to the same knee with all the soft tissues resected and replaced with virtual spring constraints (spring rate and free length/degree). The virtual spring conditions that showed the least difference in the AP displacement and TR angle outputs compared to the intact knee were considered to be the most appropriate spring conditions for each knee. The resulting AP displacement and TR angle profiles under the appropriate virtual spring conditions all showed similar shapes to the individual intact knee for each donor. This indicated that the application of the combination of virtual AP and TR springs with appropriate free lengths/degrees was successful in simulating the natural human knee soft tissue function. Each human knee joint had different kinematics as a result of variations in anatomy and soft tissue laxity. The most appropriate AP spring rate for the four human knees varied from 20 to 55 N/mm and the TR spring rate varied from 0.3 to 1.0 Nm/degrees. Consequently, the most appropriate spring condition for each knee was unique and required specific combinations of spring rate and free length/degree in each of the two axes.	[Liu, Aiqin; Sanderson, William J.; Fisher, John; Jennings, Louise M.] Univ Leeds, Fac Engn & Phys Sci, Sch Mech Engn, Inst Med & Biol Engn, Leeds, W Yorkshire, England; [Ingham, Eileen] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Inst Med & Biol Engn, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Liu, AQ (corresponding author), Univ Leeds, Fac Engn & Phys Sci, Sch Mech Engn, Inst Med & Biol Engn, Leeds, W Yorkshire, England.	A.Liu@leeds.ac.uk		Ingham, Eileen/0000-0002-9757-3045; Sanderson, William/0000-0003-0170-9911	EPSRC Programme grant "Optimising knee therapies through improved population stratification and precision of the intervention" [EP/P001076/1]; EPSRC [WT088908/z/09/z, EP/G012172/1]; Medical Technologies Innovation and Knowledge Centre - EPSRC; BBSRC [EPI0191031]; Innovate UK; ERC [267114]; Leeds Centre of Excellence in Medical Engineering - Wellcome Trust; EPSRC centre for Innovative Manufacturing in Medical Devices; EPSRC [EP/N00941X/1, EP/P001076/1] Funding Source: UKRI	EPSRC Programme grant "Optimising knee therapies through improved population stratification and precision of the intervention"(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Technologies Innovation and Knowledge Centre - EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Innovate UK(UK Research & Innovation (UKRI)Innovate UK); ERC(European Research Council (ERC)European Commission); Leeds Centre of Excellence in Medical Engineering - Wellcome Trust; EPSRC centre for Innovative Manufacturing in Medical Devices(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC Programme grant "Optimising knee therapies through improved population stratification and precision of the intervention" (grant number EP/P001076/1). The work was also supported by EPSRC (Grant no. EP/G012172/1) Programme grant on Tribology of Cartilage Substitution, the Medical Technologies Innovation and Knowledge Centre supported by EPSRC, BBSRC (Grant no. EPI0191031) and Innovate UK and ERC (Grant no. 267114) Advanced Award REGENKNEE. The work was also supported by the Leeds Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC, WT088908/z/09/z. John Fisher is an NIHR Senior Investigator and is supported through The EPSRC centre for Innovative Manufacturing in Medical Devices. Simulation Solutions manufactured the natural knee joint simulator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AA, 2017, J BIOMECH, V57, P117, DOI 10.1016/j.jbiomech.2017.04.008; [Anonymous], 1424312009 BI; Bergmann G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086035; Bowland P, 2018, J BIOMECH, V77, P91, DOI 10.1016/j.jbiomech.2018.06.014; Chokhandre S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138226; D'Lima DD, 2012, P I MECH ENG H, V226, P95, DOI 10.1177/0954411911433372; DesJardins JD, 2000, J BIOMECH, V33, P1231, DOI 10.1016/S0021-9290(00)00094-4; Dornacher Daniel, 2018, J Exp Orthop, V5, P25, DOI 10.1186/s40634-018-0140-x; ElAttar M, 2011, KNEE SURG SPORT TR A, V19, P147, DOI 10.1007/s00167-010-1351-6; FUKUBAYASHI T, 1982, J BONE JOINT SURG AM, V64, P258, DOI 10.2106/00004623-198264020-00018; Giddings VL, 2001, J TRIBOL-T ASME, V123, P842, DOI 10.1115/1.1330735; Haider H, 2005, J BIOMECH, V38, P341, DOI 10.1016/j.jbiomech.2004.02.014; Haider H, 2002, 48 ANN M ORTH RES SO; Haider H, 2005, P 1 INT C MECH BIOM; Johnston H, 2019, J MECH BEHAV BIOMED, V100, DOI 10.1016/j.jmbbm.2019.103386; Johnston H, 2018, J MECH BEHAV BIOMED, V87, P87, DOI 10.1016/j.jmbbm.2018.07.011; Kurtz SM, 2016, PDL HANDB SER, P1; Kwon H, 2019, NAT REV RHEUMATOL, V15, P550, DOI 10.1038/s41584-019-0255-1; Liu AQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216872; Liu AQ, 2015, J BIOMECH, V48, P3004, DOI 10.1016/j.jbiomech.2015.07.043; Marchiori G, 2019, CLIN BIOMECH, V68, P58, DOI 10.1016/j.clinbiomech.2019.05.019; MARKOLF KL, 1981, J BONE JOINT SURG AM, V63, P570, DOI 10.2106/00004623-198163040-00007; Meireles S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187583; MORRISON JB, 1970, J BIOMECH, V3, P51, DOI 10.1016/0021-9290(70)90050-3; Reynolds RJ, 2017, J BIOMECH, V57, P39, DOI 10.1016/j.jbiomech.2017.03.016; SHOEMAKER SC, 1985, J BONE JOINT SURG AM, V67A, P136, DOI 10.2106/00004623-198567010-00017; Sikidar A, 2019, COMPUT BIOL MED, V110, P186, DOI 10.1016/j.compbiomed.2019.05.021; Sutton LG, 2010, J BIOMECH, V43, P2203, DOI 10.1016/j.jbiomech.2010.03.042; Tirico LEP, 2019, AM J SPORT MED, V47, P82, DOI 10.1177/0363546518812420; TORZILLI PA, 1994, AM J SPORT MED, V22, P105, DOI 10.1177/036354659402200117; UK AR, 2013, OST GEN PRACT; van Houtem M, 2006, P I MECH ENG H, V220, P449, DOI 10.1243/09544119JEIM57; Walker PS, 1997, J BIOMECH, V30, P83, DOI 10.1016/S0021-9290(96)00118-2; Willing R, 2018, J BIOMECH, V77, P62, DOI 10.1016/j.jbiomech.2018.06.019; Woo SLY, 1999, AM J SPORT MED, V27, P533, DOI 10.1177/03635465990270042301; 2012, CHIN NUCL IND, V6, P33	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0238785	10.1371/journal.pone.0238785	http://dx.doi.org/10.1371/journal.pone.0238785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052931	gold, Green Published			2022-12-26	WOS:000581820200075
J	Wang, YM; Tao, VL; Shin, CY; Salamanca, C; Chen, SY; Chow, C; Kobel, M; Ben-Neriah, S; Farnell, D; Steidl, C; Mcalpine, JN; Gilks, CB; Huntsman, DG				Wang, Yemin; Tao, Valerie Lan; Shin, Chae Young; Salamanca, Clara; Chen, Shary Yuting; Chow, Christine; Kobel, Martin; Ben-Neriah, Susana; Farnell, David; Steidl, Christian; Mcalpine, Jessica N.; Gilks, C. Blake; Huntsman, David G.			Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line	PLOS ONE			English	Article							DICER1 HOTSPOT MUTATIONS; PROTEIN EXPRESSION; SMARCA4 BRG1; UTERUS; ARID1A; OVARY; RISK; INI1	Dedifferentiated endometrial carcinoma (DDEC) is a rare but highly aggressive type of endometrial cancer, in which an undifferentiated carcinoma arises from a low-grade endometrioid endometrial carcinoma. The low-grade component is often eclipsed, likely due to an outgrowth of the undifferentiated component, and the tumor may appear as a pure undifferentiated endometrial carcinoma (UEC). We and others have recently identified inactivating mutations of SMARCA4, SMARCB1 or ARID1B, subunits of the SWI/SNF chromatin-remodeling complex, that are unique to the undifferentiated component and are present in a large portion of DDEC and UEC. However, the understanding of whether and how these mutations drive cancer progression and histologic dedifferentiation is hindered by lack of cell line models of DDEC or UEC. Here, we established the first UEC cell line, VOA1066, which is highly tumorigenicin vivo. This cell line has a stable genome with very few somatic mutations, which do include inactivating mutations ofARID1AandARID1B(2 mutations each), and a heterozygous hotspotDICER1mutation in its RNase IIIb domain. Immunohistochemistry staining confirmed the loss of ARID1B, but ARID1A staining was retained due to the presence of a truncating non-functional ARID1A protein. The heterozygousDICER1hotspot mutation has little effect on microRNA biogenesis. No additionalDICER1hotspot mutations have been identified in a cohort of 33 primary tumors. Therefore, we have established the first UEC cell line with dual inactivation of both ARID1A and ARID1B as the main genomic feature. This cell line will be useful for studying the roles of ARID1A and ARID1B mutations in the development of UEC.	[Wang, Yemin; Tao, Valerie Lan; Huntsman, David G.] British Columbia Canc Res Inst, Dept Mol Oncol, Vancouver, BC, Canada; [Wang, Yemin; Shin, Chae Young; Salamanca, Clara; Chen, Shary Yuting; Farnell, David; Steidl, Christian; Gilks, C. Blake; Huntsman, David G.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Chow, Christine] Vancouver Gen Hosp, Genet Pathol Evaluat Ctr, Vancouver, BC, Canada; [Chow, Christine] Univ British Columbia, Vancouver, BC, Canada; [Kobel, Martin] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Ben-Neriah, Susana; Steidl, Christian] British Columbia Canc Res Inst, Dept Lymphoid Canc, Vancouver, BC, Canada; [Mcalpine, Jessica N.; Huntsman, David G.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Calgary; University of British Columbia	Wang, YM; Huntsman, DG (corresponding author), British Columbia Canc Res Inst, Dept Mol Oncol, Vancouver, BC, Canada.; Wang, YM; Huntsman, DG (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.; Huntsman, DG (corresponding author), Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada.	yewang@bccrc.ca; dhuntsma@bccancer.bc.ca	Huntsman, David/ABE-6082-2020	Kobel, Martin/0000-0002-6615-2037; Wang, Yemin/0000-0002-2970-9510	National Cancer Institute of NIH (United States) [1R01CA195670-01]; Terry Fox Research Institute Initiative New Frontiers Program in Cancer [TFF1021]; Carraresi Foundation; VGH & UBC Hospital Foundation	National Cancer Institute of NIH (United States); Terry Fox Research Institute Initiative New Frontiers Program in Cancer; Carraresi Foundation; VGH & UBC Hospital Foundation	This work was supported by research funds from the National Cancer Institute of NIH (United States) (1R01CA195670-01, https://www.cancer.gov, to DGH), the Terry Fox Research Institute Initiative New Frontiers Program in Cancer (TFF1021, https://www.tfri.ca, to DGH), and the Carraresi Foundation and the Sumiko Kobayashi Marks Memorial OVCARE Research Grants supported by the VGH & UBC Hospital Foundation (2019 competition, http://www.ovcare.ca, to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Loh S, 2013, ARCH PATHOL LAB MED, V137, P438, DOI 10.5858/arpa.2011-0461-RS; Anglesio MS, 2013, J PATHOL, V229, P400, DOI 10.1002/path.4135; [Anonymous], 2013, SCHRIFTEN PSYCHOL ER, V3, P35; Chen JM, 2015, J PATHOL, V237, P215, DOI 10.1002/path.4569; Coatham M, 2016, MODERN PATHOL, V29, P1586, DOI 10.1038/modpathol.2016.156; DeLair DF, 2017, J PATHOL, V243, P230, DOI 10.1002/path.4947; Espinosa I, 2017, AM J SURG PATHOL, V41, P1121, DOI 10.1097/PAS.0000000000000873; Heravi-Moussavi A, 2012, NEW ENGL J MED, V366, P234, DOI 10.1056/NEJMoa1102903; Hoang LN, 2016, HISTOPATHOLOGY, V69, P560, DOI 10.1111/his.12989; Karnezis AN, 2016, MODERN PATHOL, V29, P302, DOI 10.1038/modpathol.2015.155; Kobel M, 2018, AM J SURG PATHOL, V42, P76, DOI 10.1097/PAS.0000000000000941; Kuhn E, 2014, AM J SURG PATHOL, V38, P660, DOI 10.1097/PAS.0000000000000166; McConechy MK, 2012, J PATHOL, V228, P20, DOI 10.1002/path.4056; Ramalingam P, 2017, HISTOPATHOLOGY, V70, P359, DOI 10.1111/his.13091; Rosa-Rosa JM, 2016, MODERN PATHOL, V29, P1390, DOI 10.1038/modpathol.2016.132; Setiawan VW, 2013, J CLIN ONCOL, V31, P2607, DOI 10.1200/JCO.2012.48.2596; Silva EG, 2006, INT J GYNECOL PATHOL, V25, P52, DOI 10.1097/01.pgp.0000183048.22588.18; Silva EG, 2007, PATHOLOGY, V39, P134, DOI 10.1080/00313020601159494; Stewart CJR, 2015, PATHOLOGY, V47, P439, DOI 10.1097/PAT.0000000000000270; Strehl JD, 2015, ANN DIAGN PATHOL, V19, P198, DOI 10.1016/j.anndiagpath.2015.04.001; Tafe LJ, 2010, MODERN PATHOL, V23, P781, DOI 10.1038/modpathol.2010.41; Travaglino A, 2020, PATHOL ONCOL RES, V26, P1411, DOI 10.1007/s12253-019-00784-0; Wang YM, 2020, ANNU REV PATHOL-MECH, V15, P467, DOI 10.1146/annurev-pathmechdis-012418-012917; Wang YM, 2017, J PATHOL, V242, P371, DOI 10.1002/path.4912; Wang YM, 2015, NEOPLASIA, V17, P650, DOI 10.1016/j.neo.2015.08.003; Yen TT, 2018, GYNECOL ONCOL, V150, P426, DOI 10.1016/j.ygyno.2018.06.025	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240412	10.1371/journal.pone.0240412	http://dx.doi.org/10.1371/journal.pone.0240412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052929	Green Published, gold			2022-12-26	WOS:000581820200039
J	Ganesan, R; Henkels, KM; Shah, K; De la Rosa, X; Libreros, S; Cheemarla, NR; Serhan, CN; Gomez-Cambronero, J				Ganesan, Ramya; Henkels, Karen M.; Shah, Krushangi; De La Rosa, Xavier; Libreros, Stephania; Cheemarla, Nagarjuna R.; Serhan, Charles N.; Gomez-Cambronero, Julian			D-series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution	FASEB JOURNAL			English	Article						macrophages; inflammation; resolution; phospholipase D; resolvins D-series; polarization	PHOSPHATIDIC-ACID; MACROPHAGE POLARIZATION; TUMOR-GROWTH; RECEPTOR; CANCER; EXPRESSION; PLD2; IDENTIFICATION; ADHESION; ROLES	A successful acute inflammatory response results in the elimination of infectious agents by neutrophils and monocytes, followed by resolution and repair through tissue-resident and recruited macrophages. Resolvins (D-series and E-series) are pro-resolving lipid mediators involved in resolution and tissue repair, whose intracellular signaling remains of interest. Here, we report that D-series resolvins (RvD1- RvD5) activate phospholipase D (PLD), a ubiquitously expressed membrane lipase enzyme activity in modulating phagocyte functions. The mechanism for PLD-mediated actions of Resolvin-D5 (RvD5) in polarizing macrophages (M1-like toward M2-like) was found to be two-pronged: (a) RvD5 inhibits post-transcriptional modifications, by miRs and 3'exonucleases that process PLD2 mRNA, thus increasing PLD2 expression and activity; and (b) RvD5 enhances PLD2-S6Kinase signaling required for membrane expansion and efferocytosis. In anin vivomodel of second organ reflow injury, we found that RvD5 did not reduce lung neutrophil myeloperoxidase levels in PLD2(-/-)mice compared to WT and PLD1(-/-)mice, confirming a novel role of PLD2 as the isoform in RvD5-mediated resolution processes. These results demonstrate that RvD5-PLD2 are attractive targets for therapeutic interventions in vascular inflammation such as ischemia-reperfusion injury and cardiovascular diseases.	[Ganesan, Ramya; Henkels, Karen M.; Shah, Krushangi; Gomez-Cambronero, Julian] Wright State Univ, Dept Biochem & Mol Biol, Sch Med, Dayton, OH USA; [Ganesan, Ramya; De La Rosa, Xavier; Libreros, Stephania; Serhan, Charles N.; Gomez-Cambronero, Julian] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Hale Bldg Transformat Med 3016,60 Fenwood Rd, Boston, MA 02115 USA; [Ganesan, Ramya; De La Rosa, Xavier; Libreros, Stephania; Serhan, Charles N.; Gomez-Cambronero, Julian] Harvard Med Sch, Hale Bldg Transformat Med 3016,60 Fenwood Rd, Boston, MA 02115 USA; [Cheemarla, Nagarjuna R.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA	University System of Ohio; Wright State University Dayton; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University	Serhan, CN (corresponding author), Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Hale Bldg Transformat Med 3016,60 Fenwood Rd, Boston, MA 02115 USA.; Serhan, CN (corresponding author), Harvard Med Sch, Hale Bldg Transformat Med 3016,60 Fenwood Rd, Boston, MA 02115 USA.; Ganesan, R (corresponding author), Emory Univ, Sch Med, Dept Med, 1760 Haygood Dr, Atlanta, GA 30322 USA.	ramya.ganesan@emory.edu; cnserhan@zeus.bwh.harvard.edu		Shah, Krushangi N/0000-0002-7908-6462	American Heart Association (AHA) [13GRNT17230097]; National Institutes of Health (NIH) [HL056653-14, P01GM095467]	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	American Heart Association (AHA), Grant/Award Number: 13GRNT17230097; National Institutes of Health (NIH), Grant/Award Number: HL056653-14 and P01GM095467	Abdulnour REE, 2018, J LEUKOCYTE BIOL, V103, P919, DOI 10.1002/JLB.3A0617-252RR; Bashir S, 2016, INFLAMM RES, V65, P1, DOI 10.1007/s00011-015-0874-1; Braga TT, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00602; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Chiang N, 1999, J CLIN INVEST, V104, P309, DOI 10.1172/JCI7016; Chiang N, 2017, J IMMUNOL, V198, P842, DOI 10.4049/jimmunol.1601650; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Dandekar Rishikesh C, 2011, Ann Maxillofac Surg, V1, P150, DOI 10.4103/2231-0746.92782; Fite K, 2016, MOL CELL BIOL, V36, P1078, DOI 10.1128/MCB.00711-15; Fite K, 2016, J BIOL CHEM, V291, P719, DOI 10.1074/jbc.M115.686006; Flak MB, 2020, J CLIN INVEST, V130, P359, DOI 10.1172/JCI131609; Foster DA, 2014, J BIOL CHEM, V289, P22583, DOI 10.1074/jbc.R114.566091; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Ganesan R, 2018, J LEUKOCYTE BIOL, V103, P867, DOI 10.1002/JLB.2A1017-407RR; Gobbetti T, 2017, P NATL ACAD SCI USA, V114, P3963, DOI 10.1073/pnas.1617290114; Gobel K, 2014, EUR J IMMUNOL, V44, P2295, DOI 10.1002/eji.201344107; Gomez-Cambronero J, 2017, METHOD ENZYMOL, V583, P327, DOI 10.1016/bs.mie.2016.09.042; Gomez-Cambronero J, 2007, J LEUKOCYTE BIOL, V82, P272, DOI 10.1189/jlb.0107033; Gomez-Cambronero J, 2014, J LEUKOCYTE BIOL, V96, P779, DOI 10.1189/jlb.2VMR0214-120RR; Gomez-Cambronero J, 2014, J BIOL CHEM, V289, P22557, DOI 10.1074/jbc.R114.574152; Gomez-Cambronero J, 2011, CELL SIGNAL, V23, P1885, DOI 10.1016/j.cellsig.2011.06.017; Gomez-Cambronero J, 2010, THESCIENTIFICWORLDJO, V10, P1356, DOI 10.1100/tsw.2010.116; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hatton N, 2015, MOL CELL BIOL, V35, P3131, DOI 10.1128/MCB.00286-15; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Henkels KM, 2016, ONCOTARGET, V7, P47002, DOI 10.18632/oncotarget.9685; Henkels KM, 2015, FASEB J, V29, P1299, DOI 10.1096/fj.14-260992; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Iyer SS, 2006, J IMMUNOL, V176, P3686, DOI 10.4049/jimmunol.176.6.3686; Iyer SS, 2004, J IMMUNOL, V173, P2615, DOI 10.4049/jimmunol.173.4.2615; Kang DW, 2014, J BIOL CHEM, V289, P22575, DOI 10.1074/jbc.R114.569822; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; Koch T, 2009, J NEUROCHEM, V110, P1288, DOI 10.1111/j.1471-4159.2009.06217.x; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Lee HY, 2004, EXP MOL MED, V36, P135, DOI 10.1038/emm.2004.20; Lee SK, 2015, J EXP MED, V212, P1381, DOI 10.1084/jem.20141813; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Lippestad M, 2018, EXP EYE RES, V173, P64, DOI 10.1016/j.exer.2018.04.015; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahankali M, 2013, J CELL SCI, V126, P1416, DOI 10.1242/jcs.117960; Mahankali M, 2012, J BIOL CHEM, V287, P41417, DOI 10.1074/jbc.M112.383596; Mahankali M, 2011, P NATL ACAD SCI USA, V108, P19617, DOI 10.1073/pnas.1114692108; Mancini F, 2015, NEW MICROBIOL, V38, P59; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Miller TE, 2017, BIOL OPEN, V6, P176, DOI 10.1242/bio.021261; Nelson RK, 2015, J LIPID RES, V56, P2229, DOI 10.1194/jlr.R059220; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Ohira T, 2010, J BIOL CHEM, V285, P3451, DOI 10.1074/jbc.M109.044131; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Park DW, 2013, BIOCHEM BIOPH RES CO, V430, P933, DOI 10.1016/j.bbrc.2012.11.135; Perkins GD, 2007, THORAX, V62, P36, DOI 10.1136/thx.2006.059410; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Schmid M, 2016, J IMMUNOL, V196, P3429, DOI 10.4049/jimmunol.1501701; Schonberger T, 2014, AM J PATHOL, V184, P2450, DOI 10.1016/j.ajpath.2014.06.005; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Speranza F, 2014, J BIOL CHEM, V289, P28885, DOI 10.1074/jbc.M114.597146; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Stegner D, 2013, ARTERIOSCL THROM VAS, V33, P2212, DOI 10.1161/ATVBAHA.113.302030; Sulciner ML, 2018, J EXP MED, V215, P115, DOI 10.1084/jem.20170681; Tan HY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2795090; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Usatyuk PV, 2013, PULM CIRC, V3, P108, DOI 10.4103/2045-8932.109925; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	81	7	7	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15888	15906		10.1096/fj.201903025RR	http://dx.doi.org/10.1096/fj.201903025RR		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047359	Green Accepted			2022-12-26	WOS:000581172200001
J	Ukai, S; Honma, R; Sakamoto, N; Yamamoto, Y; Pham, QT; Harada, K; Takashima, T; Taniyama, D; Asai, R; Fukada, K; Naka, K; Tanabe, K; Ohdan, H; Yasui, W				Ukai, Shoichi; Honma, Ririno; Sakamoto, Naoya; Yamamoto, Yusuke; Pham, Quoc Thang; Harada, Kenji; Takashima, Tsuyoshi; Taniyama, Daiki; Asai, Ryuichi; Fukada, Kaho; Naka, Kazuhito; Tanabe, Kazuaki; Ohdan, Hideki; Yasui, Wataru			Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell	ONCOGENE			English	Article							DRUG-RESISTANCE; EXPRESSION; LEUCOVORIN; INTERACTS; TISSUE	5-FU is one of the key drugs in the treatment of gastric cancer (GC). Much evidence has shown that cancer stem cells (CSCs) play a key role in the acquisition of drug resistance. The organoid is a novel 3D cell culture system technology that sustains stem-cell-driven formation of near-physiological, self-renewing tissues using specific niche factors in a dish. In this study, we established GC organoids (GCOs) and gradually treated them with higher concentrations of 5-FU. We successfully harvested four 5-FU-resistant GCOs, which were supported by significant changes in the expression of molecules related to 5-FU metabolism. We then performed microarray analysis using three normal gastric organoids and three pairs of 5-FU-resistant and parental GCOs. Through the comparison of expression profiles and further validation, we chose KHDRBS3 as a target gene. We found KHDRBS3 to be an independent prognostic factor in GC patients, especially in GC patients treated with 5-FU chemotherapy. We also determined that KHDRBS3 might play an important role in the acquisition of stem cell-like features, such as multi-drug resistance and organoid formation, by regulating CD44 variant expression. We found KHDRBS3, which is thought to play an important role in the acquisition of characteristics of CSCs in GC, to be a promising candidate marker for predicting therapeutic effect and prognosis in GC patients.	[Ukai, Shoichi; Honma, Ririno; Sakamoto, Naoya; Pham, Quoc Thang; Harada, Kenji; Takashima, Tsuyoshi; Taniyama, Daiki; Asai, Ryuichi; Fukada, Kaho; Yasui, Wataru] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima, Japan; [Yamamoto, Yusuke] Natl Canc Ctr, Div Mol & Cellular Med, Tokyo, Japan; [Naka, Kazuhito] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Stem Cell Biol, Hiroshima, Japan; [Tanabe, Kazuaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Hlth Care Adults, Hiroshima, Japan; [Ohdan, Hideki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan	Hiroshima University; National Cancer Center - Japan; Hiroshima University; Hiroshima University; Hiroshima University	Yasui, W (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima, Japan.	wyasui@hiroshima-u.ac.jp	tanabe, kazuaki/S-6282-2019; Ohdan, Hideki/G-4719-2019; Pham, Quoc Thang/AAP-5919-2021	Ohdan, Hideki/0000-0002-9066-1288; Pham, Quoc Thang/0000-0001-8787-367X; Ukai, Shoichi/0000-0001-8491-1183; Harada, Kenji/0000-0002-8995-2846; TSUYOSHI, TAKASHIMA/0000-0003-1362-3883	Japan Society for the Promotion of Science [JP15H04713, JP16K08691, JP16H06999, 26670175, JP16K15247]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The present study was supported by Grants in Aid for Scientific Research (JP15H04713, JP16K08691, JP16H06999) and for Challenging Exploratory Research (26670175, JP16K15247) from the Japan Society for the Promotion of Science.	Al-Batran SE, 2016, LANCET ONCOL, V17, P1697, DOI 10.1016/S1470-2045(16)30531-9; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Gao YY, 2019, INT J CLIN EXP PATHO, V12, P1095; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Honma R, 2017, GASTRIC CANCER, V20, P960, DOI 10.1007/s10120-017-0714-9; Ishikawa A, 2020, ONCOL REP, V43, P581, DOI 10.3892/or.2019.7422; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lei KF, 2011, ONCOL REP, V26, P1115, DOI 10.3892/or.2011.1369; Matsumoto Y, 2018, CANCER MED-US, V7, P454, DOI 10.1002/cam4.1296; Mazzoldi EL, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020368; Nakamura A, 2014, GASTRIC CANCER, V17, P188, DOI 10.1007/s10120-013-0249-7; Okuyama K, 2019, PATHOL ONCOL RES, V25, P603, DOI 10.1007/s12253-018-0529-y; Pacifico MD, 2006, INT J CANCER, V118, P1460, DOI 10.1002/ijc.21504; Sakamoto N, 2014, CANCER SCI, V105, P236, DOI 10.1111/cas.12330; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seidlitz T, 2019, GUT, V68, P207, DOI 10.1136/gutjnl-2017-314549; Shen XM, 2015, CELL BIOCHEM BIOPHYS, V71, P1653, DOI 10.1007/s12013-014-0387-5; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Steele NG, 2019, CELL MOL GASTROENTER, V7, P161, DOI 10.1016/j.jcmgh.2018.09.008; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Venables JP, 1999, HUM MOL GENET, V8, P959, DOI 10.1093/hmg/8.6.959; Wang WG, 2004, CANCER RES, V64, P8167, DOI 10.1158/0008-5472.CAN-04-0970; Yang HHN, 2018, CELL STEM CELL, V23, P882, DOI 10.1016/j.stem.2018.09.016	25	14	16	5	20	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2020	39	50					7265	7278		10.1038/s41388-020-01492-9	http://dx.doi.org/10.1038/s41388-020-01492-9		OCT 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PD4HE	33046798	Green Submitted			2022-12-26	WOS:000578784100002
J	Wood, GE; Iverson-Cabral, SL; Gillespie, CW; Lowens, MS; Manhart, LE; Totten, PA				Wood, Gwendolyn E.; Iverson-Cabral, Stefanie L.; Gillespie, Catherine W.; Lowens, M. Sylvan; Manhart, Lisa E.; Totten, Patricia A.			Sequence variation and immunogenicity of the Mycoplasma genitalium MgpB and MgpC adherence proteins during persistent infection of men with non-gonococcal urethritis	PLOS ONE			English	Article							FEMALE SEX WORKERS; GENETIC-VARIATION; RECOMBINATION; ADHESION; IDENTIFICATION; CHLAMYDIA; REVEALS; COHORT; ASSAY; CURE	Mycoplasma genitaliumis a sexually transmitted bacterial pathogen that infects men and women. Antigenic variation of MgpB and MgpC, the immunodominant adherence proteins ofM.genitalium, is thought to contribute to immune evasion and chronic infection. We investigated the evolution ofmgpBandmgpCsequences in men with non-gonococcal urethritis persistently infected withM.genitalium, including two men with anti-M.genitaliumantibodies at enrollment and two that developed antibodies during follow-up. Each of the four patients was persistently infected with a different strain type and each patient produced antibodies targeting MgpB and MgpC. Amino acid sequence evolution in the variable regions of MgpB and MgpC occurred in all four patients with changes observed in single and multiple variable regions over time. Using the available crystal structure of MgpC of the G37 type strain we found that predicted conformational B cell epitopes localize predominantly to the variable region of MgpC, amino acids that changed during patient infection lie in these epitopes, and variant amino acids are in close proximity to the conserved sialic acid binding pocket. These findings support the hypothesis that sequence variation functions to avoid specific antibodies thereby contributing to persistence in the genital tract.	[Wood, Gwendolyn E.; Iverson-Cabral, Stefanie L.; Totten, Patricia A.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Gillespie, Catherine W.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Lowens, M. Sylvan] Seattle King Cty Sexual Hlth Clin, Publ Hlth, Seattle, WA USA; [Manhart, Lisa E.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Manhart, Lisa E.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Totten, Patricia A.] Univ Washington, Dept Global Hlth, Pathobiol Interdisciplinary Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wood, GE (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA.	gwenwood@uw.edu		Wood, Gwendolyn/0000-0001-5109-3794	National Institute of Health, NIAID [R21 AI107402, U19 AI031448, R01 AI072728]	National Institute of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by the National Institute of Health, NIAID grants R21 AI107402 (GEW, SLIC, PAT), U19 AI031448 (SLIC, LEM, MSL, CWG), and R01 AI072728 (LEM, PAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06963-y; Baumann L, 2018, SEX TRANSM INFECT, V94, P254, DOI 10.1136/sextrans-2017-053384; Bradshaw CS, 2017, J INFECT DIS, V216, pS412, DOI 10.1093/infdis/jix132; Burgos R, 2006, J BACTERIOL, V188, P8627, DOI 10.1128/JB.00978-06; Burgos R, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00866-17; Burgos R, 2014, MOL MICROBIOL, V94, P290, DOI 10.1111/mmi.12760; Clausen HF, 2001, HUM REPROD, V16, P1866, DOI 10.1093/humrep/16.9.1866; Cohen CR, 2002, LANCET, V359, P765, DOI 10.1016/S0140-6736(02)07848-0; Cohen CR, 2007, SEX TRANSM DIS, V34, P274, DOI 10.1097/01.olq.0000237860.61298.54; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DALLO SF, 1991, MICROB PATHOGENESIS, V10, P475, DOI 10.1016/0882-4010(91)90113-O; Dutro SM, 2003, SEX TRANSM DIS, V30, P756, DOI 10.1097/01.OLQ.0000078821.27933.88; Fookes MC, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4399-6; Garcia-Morales L, 2016, MOL MICROBIOL, V100, P125, DOI 10.1111/mmi.13305; Grover RK, 2014, SCIENCE, V343, P656, DOI 10.1126/science.1246135; Haggerty CL, 2008, SEX TRANSM INFECT, V84, P338, DOI 10.1136/sti.2008.030486; HAGGERTY CL, 2006, INFECT DIS OBSTET GY, DOI DOI 10.1155/ID0G/2006/30184; Hamasuna R, 2007, J CLIN MICROBIOL, V45, P847, DOI 10.1128/JCM.02056-06; Hjorth SV, 2006, J CLIN MICROBIOL, V44, P2078, DOI 10.1128/JCM.00003-06; Horner PJ, 2017, J INFECT DIS, V216, pS396, DOI 10.1093/infdis/jix145; Iverson-Cabral SL, 2007, MOL MICROBIOL, V66, P55, DOI 10.1111/j.1365-2958.2007.05898.x; Iverson-Cabral SL, 2006, INFECT IMMUN, V74, P3715, DOI 10.1128/IAI.00239-06; Iverson-Cabral SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138244; Iverson-Cabral SL, 2011, CLIN VACCINE IMMUNOL, V18, P1783, DOI 10.1128/CVI.05174-11; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829; Lluch-Senar M, 2010, MOL MICROBIOL, V78, P278, DOI 10.1111/j.1365-2958.2010.07306.x; Ma L, 2007, MOL MICROBIOL, V66, P220, DOI 10.1111/j.1365-2958.2007.05911.x; Ma L, 2016, INFECT IMMUN, V84, P747, DOI 10.1128/IAI.01162-15; Ma L, 2014, INFECT IMMUN, V82, P1326, DOI 10.1128/IAI.01526-13; Ma LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014348; Manhart LE, 2008, J INFECT DIS, V197, P733, DOI 10.1086/526501; Manhart LE, 2007, AM J PUBLIC HEALTH, V97, P1118, DOI 10.2105/AJPH.2005.074062; Manhart LE, 2015, CLIN INFECT DIS, V61, pS802, DOI 10.1093/cid/civ785; Manhart LE, 2013, CLIN INFECT DIS, V56, P934, DOI 10.1093/cid/cis1022; Mavedzenge SN, 2012, AIDS, V26, P617, DOI 10.1097/QAD.0b013e32834ff690; Murray GL, 2017, EMERG INFECT DIS, V23, P809, DOI 10.3201/eid2305.161745; Romano SS, 2019, CLIN INFECT DIS, V69, P113, DOI 10.1093/cid/ciy843; Scheffer MP, 2017, MOL MICROBIOL, V105, P869, DOI 10.1111/mmi.13743; Sena AC, 2018, CLIN INFECT DIS, V67, P73, DOI 10.1093/cid/ciy025; Sonnenberg P, 2015, INT J EPIDEMIOL, V44, P1982, DOI 10.1093/ije/dyv194; Svenstrup HF, 2008, FERTIL STERIL, V90, P513, DOI 10.1016/j.fertnstert.2006.12.056; Svenstrup HF, 2006, CLIN VACCINE IMMUNOL, V13, P913, DOI 10.1128/CVI.00048-06; Svenstrup HF, 2002, J MED MICROBIOL, V51, P361, DOI 10.1099/0022-1317-51-5-361; Torres-Puig S, 2018, DNA RES, V25, P383, DOI 10.1093/dnares/dsy011; Torres-Puig S, 2015, NUCLEIC ACIDS RES, V43, P4923, DOI 10.1093/nar/gkv422; Vandepitte J, 2013, SEX TRANSM DIS, V40, P422, DOI 10.1097/OLQ.0b013e31828bfccf; Wiesenfeld HC, 2017, J INFECT DIS, V216, pS389, DOI 10.1093/infdis/jix198; Wood GE, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00738-16; Wood GE, 2013, INFECT IMMUN, V81, P2938, DOI 10.1128/IAI.01322-12; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	54	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240626	10.1371/journal.pone.0240626	http://dx.doi.org/10.1371/journal.pone.0240626			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045031	gold, Green Published			2022-12-26	WOS:000581811700016
J	Ball, KR; Power, SA; Brien, C; Woodin, S; Jewell, N; Berger, B; Pendall, E				Ball, Kirsten Rae; Power, Sally Anne; Brien, Chris; Woodin, Sarah; Jewell, Nathaniel; Berger, Bettina; Pendall, Elise			High-throughput, image-based phenotyping reveals nutrient-dependent growth facilitation in a grass-legume mixture	PLOS ONE			English	Article							N-P STOICHIOMETRY; NITROGEN-FIXATION; PLANT-GROWTH; ECONOMICS SPECTRUM; COMPETITION; COVER; COMPLEMENTARITY; NODULATION; ARROWLEAF; SYSTEMS	This study used high throughput, image-based phenotyping (HTP) to distinguish growth patterns, detect facilitation and interpret variations to nutrient uptake in a model mixed-pasture system in response to factorial low and high nitrogen (N) and phosphorus (P) application. HTP has not previously been used to examine pasture species in mixture. We used red-green-blue (RGB) imaging to obtain smoothed projected shoot area (sPSA) to predict absolute growth (AG) up to 70 days after planting (sPSA, DAP 70), to identify variation in relative growth rates (RGR, DAP 35-70) and detect overyielding (an increase in yield in mixture compared with monoculture, indicating facilitation) in a grass-legume model pasture. Finally, using principal components analysis we interpreted between species changes to HTP-derived temporal growth dynamics and nutrient uptake in mixtures and monocultures. Overyielding was detected in all treatments and was driven by both grass and legume. Our data supported expectations of more rapid grass growth and augmented nutrient uptake in the presence of a legume. Legumes grew more slowly in mixture and where growth became more reliant on soil P. Relative growth rate in grass was strongly associated with shoot N concentration, whereas legume RGR was not strongly associated with shoot nutrients. High throughput, image-based phenotyping was a useful tool to quantify growth trait variation between contrasting species and to this end is highly useful in understanding nutrient-yield relationships in mixed pasture cultivations.	[Ball, Kirsten Rae; Power, Sally Anne; Pendall, Elise] Western Sydney Univ, Hawkesbury Inst Environm, Penrith, NSW, Australia; [Ball, Kirsten Rae; Woodin, Sarah] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Brien, Chris; Jewell, Nathaniel; Berger, Bettina] Univ Adelaide, Australian Plant Phen Facil, Plant Accelerator, Sch Agr Food & Wine, Urrbrae, SA, Australia; [Ball, Kirsten Rae] Univ Arizona, Environm Sci, Tucson, AZ 85721 USA	Western Sydney University; University of Aberdeen; University of Adelaide; University of Arizona	Ball, KR (corresponding author), Western Sydney Univ, Hawkesbury Inst Environm, Penrith, NSW, Australia.; Ball, KR (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.; Ball, KR (corresponding author), Univ Arizona, Environm Sci, Tucson, AZ 85721 USA.	kirsten.ball@email.arizona.edu	Berger, Bettina/AAH-1190-2021; Brien, Chris/D-5630-2009; Power, Sally/I-2923-2012	Berger, Bettina/0000-0003-1195-4478; Brien, Chris/0000-0003-0581-1817; Power, Sally/0000-0002-2723-8671; Ball, Kirsten/0000-0001-9632-0874	Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS); Australian Plant Phenomics Facility towards the completion of this project	Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Plant Phenomics Facility towards the completion of this project	The Australian Plant Phenomics Facility received grant funding from the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS). KB received a Postgraduate Internship Award from the Australian Plant Phenomics Facility towards the completion of this project".	Agnusdei MG, 2010, NUTR CYCL AGROECOSYS, V88, P215, DOI 10.1007/s10705-010-9348-6; Agren GI, 2012, NEW PHYTOL, V194, P953, DOI 10.1111/j.1469-8137.2012.04116.x; Al-Tamimi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13342; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2009, HEINE JB, V48, P1; [Anonymous], 1954, ESTIMATION AVAILABLE; [Anonymous], 2010, WORLD PHOSPHATE ROCK; Bendig J, 2014, REMOTE SENS-BASEL, V6, P10395, DOI 10.3390/rs61110395; Berger Bettina, 2012, Methods Mol Biol, V918, P9, DOI 10.1007/978-1-61779-995-2_2; Bijelic Z., 2014, Biotechnology in Animal Husbandry, V30, P539, DOI 10.2298/BAH1403539B; Brien C., 2019, DAE FUNCTIONS USEFUL; Brien C., 2020, GROWTHPHENO PLOTTING; Brien C, 2020, PLANT METHODS, V16, DOI 10.1186/s13007-020-00577-6; Brien R, 2009, ISS ONLINE EDUC, P1; BRODERICK GA, 1995, J ANIM SCI, V73, P2760; Bryant F. B., 1995, PRINCIPAL COMPONENTS; Butler D, 2009, R PACKAGE VERSION 3; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Cavieres LA, 2014, ECOL LETT, V17, P193, DOI 10.1111/ele.12217; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Crops F, 1970, REV INFORM TEMPERATE; Crous KY, 2015, PLANT SOIL, V391, P293, DOI 10.1007/s11104-015-2426-4; De Vylder J, 2012, PLANT PHYSIOL, V160, P1149, DOI 10.1104/pp.112.202762; Del Pozo A, 2000, ACTA OECOL, V21, P79, DOI 10.1016/S1146-609X(00)00113-2; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Duchene O, 2017, AGR ECOSYST ENVIRON, V240, P148, DOI 10.1016/j.agee.2017.02.019; Evenson RE, 2001, HANDB ECON, V18, P573; EVERS GW, 1982, AGRON J, V74, P629, DOI 10.2134/agronj1982.00021962007400040010x; Facility APP, PLANT PHEN AUSTR PLA; Fahlgren N, 2015, CURR OPIN PLANT BIOL, V24, P93, DOI 10.1016/j.pbi.2015.02.006; FRANKLIN SB, 1995, J VEG SCI, V6, P99, DOI 10.2307/3236261; Ge YF, 2016, COMPUT ELECTRON AGR, V127, P625, DOI 10.1016/j.compag.2016.07.028; GRACE JB, 1992, OECOLOGIA, V90, P429, DOI 10.1007/BF00317702; Gravel D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2123; Grime J.P., 1988, PLANT EVOLUTIONARY B, P371, DOI DOI 10.1007/978-94-009-1207-6_14; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; Gruner E, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9020054; Hoffmann WA, 2002, ANN BOT-LONDON, V90, P37, DOI 10.1093/aob/mcf140; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Hooper DU, 1998, ECOLOGY, V79, P704, DOI 10.1890/0012-9658(1998)079[0704:TROCAC]2.0.CO;2; Hunt R, 2002, ANN BOT-LONDON, V90, P485, DOI 10.1093/aob/mcf214; LEDGARD SF, 1992, PLANT SOIL, V141, P137, DOI 10.1007/BF00011314; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Li L, 2014, SENSORS-BASEL, V14, P20078, DOI 10.3390/s141120078; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; MacLeod M, 2015, COST EFFECTIVENESS G; Main TM, 1997, LIMNOL OCEANOGR, V42, P1474, DOI 10.4319/lo.1997.42.6.1474; Marsden J.S., 1980, RETURNS AUSTR AGR RE; Mason NWH, 2016, ECOL EVOL, V6, P3079, DOI 10.1002/ece3.1964; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; McAllister CH, 2012, PLANT BIOTECHNOL J, V10, P1011, DOI 10.1111/j.1467-7652.2012.00700.x; Mendoza R, 2016, CROP PASTURE SCI, V67, P629, DOI 10.1071/CP15257; Nichols JD, 2001, FOREST ECOL MANAG, V152, P195, DOI 10.1016/S0378-1127(00)00603-4; Nyfeler D, 2006, P 21 GEN M EUR GRASS; Nyfeler D, 2009, J APPL ECOL, V46, P683, DOI 10.1111/j.1365-2664.2009.01653.x; Nyfeler D, 2011, AGR ECOSYST ENVIRON, V140, P155, DOI 10.1016/j.agee.2010.11.022; Peoples MB, 2015, SOIL BIOL BIOCHEM, V87, P97, DOI 10.1016/j.soilbio.2015.04.010; Ranells NN, 1997, AGRON J, V89, P659, DOI 10.2134/agronj1997.00021962008900040019x; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Robinson D, 1988, FUNCT ECOL, V2, P249, DOI 10.2307/2389701; Sapkota TB, 2014, FIELD CROP RES, V155, P233, DOI 10.1016/j.fcr.2013.09.001; Schlemmer MR, 2005, AGRON J, V97, P106, DOI 10.2134/agronj2005.0106; Schmid B, 2008, J PLANT ECOL, V1, P95, DOI 10.1093/jpe/rtn011; SCHOMBERG HH, 1992, AGRON J, V84, P1046, DOI 10.2134/agronj1992.00021962008400060026x; Schulze J, 2004, J PLANT NUTR SOIL SC, V167, P125, DOI 10.1002/jpln.200320358; Stevens RJ, 1998, NUTR CYCL AGROECOSYS, V52, P131, DOI 10.1023/A:1009715807023; Suter M, 2015, GLOBAL CHANGE BIOL, V21, P2424, DOI 10.1111/gcb.12880; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Vitousek PM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0119; Whitaker D, 2002, CYCDESIGN PACKAGE CO; White CM, 2017, AGR ECOSYST ENVIRON, V237, P121, DOI 10.1016/j.agee.2016.12.016; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	74	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239673	10.1371/journal.pone.0239673	http://dx.doi.org/10.1371/journal.pone.0239673			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027289	Green Published, gold			2022-12-26	WOS:000581808000055
J	Sofue, T; Nakagawa, N; Kanda, E; Nagasu, H; Matsushita, K; Nangaku, M; Maruyama, S; Wada, T; Terada, Y; Yamagata, K; Narita, I; Yanagita, M; Sugiyama, H; Shigematsu, T; Ito, T; Tamura, K; Isaka, Y; Okada, H; Tsuruya, K; Yokoyama, H; Nakashima, N; Kataoka, H; Ohe, K; Okada, M; Kashihara, N				Sofue, Tadashi; Nakagawa, Naoki; Kanda, Eiichiro; Nagasu, Hajime; Matsushita, Kunihiro; Nangaku, Masaomi; Maruyama, Shoichi; Wada, Takashi; Terada, Yoshio; Yamagata, Kunihiro; Narita, Ichiei; Yanagita, Motoko; Sugiyama, Hitoshi; Shigematsu, Takashi; Ito, Takafumi; Tamura, Kouichi; Isaka, Yoshitaka; Okada, Hirokazu; Tsuruya, Kazuhiko; Yokoyama, Hitoshi; Nakashima, Naoki; Kataoka, Hiromi; Ohe, Kazuhiko; Okada, Mihoko; Kashihara, Naoki			Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)	PLOS ONE			English	Article							SERUM POTASSIUM; RISK-FACTOR; MORTALITY; HYPERKALEMIA; ASSOCIATION; MANAGEMENT; OUTCOMES; CLASSIFICATION; BICARBONATE; PROGRESSION	Background The Japan Chronic Kidney Disease Database (J-CKD-DB) is a nationwide clinical database of patients with chronic kidney disease (CKD) based on electronic health records. The objective of this study was to assess the prevalences of hyperuricemia and electrolyte abnormalities in Japanese patients with CKD. Methods In total, 35,508 adult outpatients with estimated glomerular filtration rates of 5-60 ml/min/1.73 m(2)in seven university hospitals were included this analysis. The proportions of patients with CKD stages G3b, G4, and G5 were 23.5%, 7.6%, and 3.1%, respectively. Results Logistic regression analysis showed that prevalence of hyperuricemia was associated with CKD stages G3b (adjusted odds ratio [95% confidence interval]: 2.12 [1.90-2.37]), G4 (4.57 [3.92-5.32]), and G5 (2.25 [1.80-2.80]). The respective prevalences of hyponatremia, hypercalcemia, hyperphosphatemia, and narrower difference between serum sodium and chloride concentrations were elevated in patients with CKD stages G3b, G4, and G5, compared with those prevalences in patients with CKD stage G3a. The prevalences of hyperkalemia were 8.3% and 11.6% in patients with CKD stages G4 and G5, respectively. In patients with CKD stage G5, the proportions of patients with optimal ranges of serum uric acid, potassium, corrected calcium, and phosphate were 49.6%, 73.5%, 81.9%, and 56.1%, respectively. Conclusions We determined the prevalences of hyperuricemia and electrolyte abnormalities in Japanese patients with CKD using data from a nationwide cohort study.	[Sofue, Tadashi] Kagawa Univ, Div Nephrol & Dialysis, Dept Cardiorenal & Cerebrovasc Med, Takamatsu, Kagawa, Japan; [Nakagawa, Naoki] Asahikawa Med Univ, Div Cardiol Nephrol Resp & Neurol, Dept Internal Med, Asahikawa, Japan; [Kanda, Eiichiro] Kawasaki Med Sch, Med Sci, Kurashiki, Okayama, Japan; [Nagasu, Hajime; Kashihara, Naoki] Kawasaki Med Sch, Dept Hypertens & Nephrol, Kurashiki, Okayama, Japan; [Matsushita, Kunihiro] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidmiol, Baltimore, MD USA; [Nangaku, Masaomi] Univ Tokyo, Div Nephrol & Endocrinol, Grad Sch Med, Tokyo, Japan; [Maruyama, Shoichi] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Japan; [Wada, Takashi] Kanazawa Univ, Dept Nephrol & Lab Med, Kanazawa, Ishikawa, Japan; [Terada, Yoshio] Kochi Univ, Dept Endocrinol Metab & Nephrol, Kochi Med Sch, Kochi, Japan; [Yamagata, Kunihiro] Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Japan; [Narita, Ichiei] Niigata Univ, Div Clin Nephrol & Rheumatol, Grad Sch Med & Dent Sci, Niigata, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan; [Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med, Dept Human Resource Dev Dialysis Therapy Kidney D, Dev Dialysis Therapy Kidney Dis, Okayama, Japan; [Shigematsu, Takashi] Wakayama Med Univ, Dept Nephrol, Wakayama, Japan; [Ito, Takafumi] Shimane Univ, Fac Med, Div Nephrol, Yokohama, Japan; [Tamura, Kouichi] Yokohama City Univ, Dept Med Sci & Cardiorenal Med, Grad Sch Med, Yokohama, Japan; [Isaka, Yoshitaka] Osaka Univ, Dept Nephrol, Grad Sch Med, Suita, Osaka, Japan; [Okada, Hirokazu] Saitama Med Univ, Fac Med, Dept Nephrol, Saitama, Japan; [Tsuruya, Kazuhiko] Kyushu Univ, Dept Integrated Therapy Chron Kidney Dis, Fukuoka, Japan; [Tsuruya, Kazuhiko] Nara Med Univ, Dept Nephrol, Sch Med, Ishikawa, Japan; [Yokoyama, Hitoshi] Kanazawa Med Univ, Dept Nephrol, Sch Med, Ishikawa, Japan; [Nakashima, Naoki] Kyushu Univ Hosp, Med Informat Ctr, Fukuoka, Japan; [Kataoka, Hiromi] Kawasaki Univ Med Welf, Fac Hlth Sci & Technol, Kurashiki, Japan; [Ohe, Kazuhiko] Tokyo Univ Hosp, Dept Healthcare Informat Management, Tokyo, Japan; [Okada, Mihoko] Inst Hlth Data Infrastruct All, Tokyo, Japan	Kagawa University; Asahikawa Medical College; Kawasaki Medical School; Kawasaki Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Tokyo; Nagoya University; Kanazawa University; Kochi University; University of Tsukuba; Niigata University; Kyoto University; Okayama University; Wakayama Medical University; Shimane University; Yokohama City University; Osaka University; Saitama Medical University; Kyushu University; Kanazawa Medical University; Kyushu University; University of Tokyo	Sofue, T (corresponding author), Kagawa Univ, Div Nephrol & Dialysis, Dept Cardiorenal & Cerebrovasc Med, Takamatsu, Kagawa, Japan.	sofue@med.kagawa-u.ac.jp	Sugiyama, Hitoshi/B-2252-2011; Narita, Ichiei/G-5204-2017; Yanagita, Motoko/AAJ-7731-2021; Matsushita, Kunihiro/AAJ-5817-2020	Sugiyama, Hitoshi/0000-0002-4127-6471; Narita, Ichiei/0000-0001-7692-3096; Matsushita, Kunihiro/0000-0002-7179-718X; Yanagita, Motoko/0000-0002-0339-9008	Ministry of Health, Labour and Welfare of Japan [H28-ICT-ippan-002, 19AC1002]; Japan Agency for Medical Research and Development, Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus and Platform Program for Promotion of Genome Medicine [20ek0210135h0001, 19ek0210095h0003, 20km0405210h0003]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development, Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus and Platform Program for Promotion of Genome Medicine	This work was supported in part by grants for Development of Comprehensive Database of Chronic Kidney Disease, Research on Policy Planning and Evaluation from the Ministry of Health, Labour and Welfare of Japan awarded to NK (H28-ICT-ippan-002, 19AC1002), and Japan Agency for Medical Research and Development, Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus and Platform Program for Promotion of Genome Medicine in the form of grants awarded to NK (20ek0210135h0001, 19ek0210095h0003, 20km0405210h0003).	[Anonymous], 2013, Kidney Int Suppl (2011), V3, P19; Barbour SJ, 2008, KIDNEY INT, V74, P108, DOI 10.1038/ki.2008.151; BENNETT WM, 1973, J CLIN PHARMACOL, V13, P357, DOI 10.1002/j.1552-4604.1973.tb00224.x; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Dobre M, 2013, AM J KIDNEY DIS, V62, P670, DOI 10.1053/j.ajkd.2013.01.017; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Gilligan S, 2017, ADV CHRONIC KIDNEY D, V24, P315, DOI 10.1053/j.ackd.2017.06.004; Havlin J, 2017, AM J KIDNEY DIS, V69, P707, DOI 10.1053/j.ajkd.2016.12.019; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Inker LA, 2019, AM J KIDNEY DIS, V73, P206, DOI 10.1053/j.ajkd.2018.08.013; Iwagami M, 2017, NEPHROL DIAL TRANSPL, V32, P142, DOI 10.1093/ndt/gfw318; Japanese Soc Nephrology, 2014, CLIN EXP NEPHROL, V18, P346, DOI 10.1007/s10157-014-0949-2; Jolly SE, 2014, AM J NEPHROL, V39, P288, DOI 10.1159/000360306; Kamel S, FLUID ELECTROLYTE AC; Kashihara N, 2019, KIDNEY INT REP, V4, P1248, DOI 10.1016/j.ekir.2019.05.018; Kawazoe Y, 2016, JMIR MED INF, V4, P116, DOI 10.2196/medinform.5275; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kim LG, 2018, NEPHROL DIAL TRANSPL, V33, P1373, DOI 10.1093/ndt/gfx280; Kimura M, 2011, METHOD INFORM MED, V50, P131, DOI 10.3414/ME10-01-0015; Korgaonkar S, 2010, CLIN J AM SOC NEPHRO, V5, P762, DOI 10.2215/CJN.05850809; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Mandai S, 2017, CLIN EXP NEPHROL, V21, P104, DOI 10.1007/s10157-016-1261-0; Maruta Y, 2019, CLIN EXP NEPHROL, V23, P215, DOI 10.1007/s10157-018-1631-x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Momoki K, 2017, J ATHEROSCLER THROMB, V24, P630, DOI 10.5551/jat.37523; Nakagawa N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64123-z; Nakhoul GN, 2015, AM J NEPHROL, V41, P456, DOI 10.1159/000437151; Ohno I, 2011, NUCLEOS NUCLEOT NUCL, V30, P1039, DOI 10.1080/15257770.2011.611484; Ohta M, 2010, DIABETIC MED, V27, P1017, DOI 10.1111/j.1464-5491.2010.03049.x; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Petreski T, 2019, INT UROL NEPHROL, V51, P1013, DOI 10.1007/s11255-019-02154-w; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Seng JJB, 2018, INT UROL NEPHROL, V50, P1871, DOI 10.1007/s11255-018-1906-x; Sofue T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236132; Su GB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11861-2; Sugiyama T, 2017, DIABETOL INT, V8, P375, DOI 10.1007/s13340-017-0326-y; Travers K, 2013, INT J NEPHROL RENOV, V6, P1, DOI 10.2147/IJNRD.S30894; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Yamanaka H, 2011, NUCLEOS NUCLEOT NUCL, V30, P1018, DOI 10.1080/15257770.2011.596496; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	42	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240402	10.1371/journal.pone.0240402	http://dx.doi.org/10.1371/journal.pone.0240402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057377	gold, Green Published			2022-12-26	WOS:000581814700063
J	Tanaka, R; Yamashiro, K; Ogawa, T; Oyama, G; Nishioka, K; Umemura, A; Shimo, Y; Hattori, N				Tanaka, Ryota; Yamashiro, Kazuo; Ogawa, Takashi; Oyama, Genko; Nishioka, Kenya; Umemura, Atsushi; Shimo, Yasushi; Hattori, Nobutaka			The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson's disease	PLOS ONE			English	Article							CEREBRAL MICROBLEEDS; DEMENTIA; HYPOTENSION; PREVALENCE; DIAGNOSIS; SURVIVAL; FALLS; SYNUCLEINOPATHIES; ABNORMALITIES; DYSFUNCTION	Orthostatic hypotension (OH) frequently accompanies autonomic dysfunction and is an important risk factor for cognitive impairment in Parkinson's disease (PD). While OH is usually diagnosed based on an orthostatic blood pressure drop, the association between the heart rate response and cognitive impairment remains unclear. We retrospectively analyzed 143 cases of clinically diagnosed PD to determine the association between the absence of a heart rate response and cognitive impairment in PD with OH. Among the patients with OH, neurogenic OH was diagnosed in cases without a heart rate increase, while all other patients were diagnosed with non-neurogenic OH. Dementia was found in 23 of 143 PD cases (16.1%) in this cohort. The presence of OH was an independent risk factor for dementia in PD in addition to the disease severity, years of education and beta-blockers use. Neurogenic OH was significantly associated with dementia compared to the no OH group (hazard ratio [HR] 7.3, 95% confidence interval [CI] 2.2-24.6, P<0.01), an association that was preserved after adjusting for age, gender and other covariant factors. However, no such association was observed for non-neurogenic OH (HR 2.9, 95%CI 0.8-10.9, P = 0.12). While the cognitive impairment was significantly worse in the neurogenic OH group than the no-OH group, the groups were otherwise similar. The blood pressure decrease was significantly lower in both OH groups than in the no-OH group, despite no significant differences between the OH groups. Our finding showed that OH without a heart rate response was an important predictor of cognitive impairment in PD.	[Tanaka, Ryota] Jichi Med Univ, Div Neurol, Dept Med, Stroke Ctr,Jichi Med Univ Hosp, Shimotsuke, Tochigi, Japan; [Tanaka, Ryota; Ogawa, Takashi; Oyama, Genko; Nishioka, Kenya; Hattori, Nobutaka] Juntendo Univ, Dept Neurol, Tokyo, Japan; [Yamashiro, Kazuo] Juntendo Univ, Dept Neurol, Urayasu Hosp, Chiba, Japan; [Umemura, Atsushi] Juntendo Univ, Dept Neurosurg, Tokyo, Japan; [Shimo, Yasushi] Juntendo Univ, Dept Neurol, Nerima Hosp, Tokyo, Japan	Jichi Medical University; Juntendo University; Juntendo University; Juntendo University; Juntendo University	Tanaka, R (corresponding author), Jichi Med Univ, Div Neurol, Dept Med, Stroke Ctr,Jichi Med Univ Hosp, Shimotsuke, Tochigi, Japan.; Tanaka, R; Hattori, N (corresponding author), Juntendo Univ, Dept Neurol, Tokyo, Japan.	rtanaka@jichi.ac.jp; n_hattori@juntendo.ac.jp	Ogawa, Takashi/AAI-7004-2020; Nishioka, Kenya/T-8014-2019; Hattori, Nobutaka/ACR-0069-2022	Ogawa, Takashi/0000-0002-7335-0672; Tanaka, Ryota/0000-0003-3158-1955				Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; [Anonymous], 2020, BR J ANAESTH ADV, V125; Daida K, 2018, J NEUROL SCI, V393, P39, DOI 10.1016/j.jns.2018.08.009; De Pablo-Fernandez E, 2017, JAMA NEUROL, V74, P970, DOI 10.1001/jamaneurol.2017.1125; de Schipper LJ, 2017, NEUROIMAGE-CLIN, V15, P587, DOI 10.1016/j.nicl.2017.05.012; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Espay AJ, 2016, LANCET NEUROL, V15, P954, DOI 10.1016/S1474-4422(16)30079-5; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Gelber RP, 2013, NEUROLOGY, V81, P888, DOI 10.1212/WNL.0b013e3182a351d4; Goldstein DS, 2015, NEUROLOGY, V85, P1554, DOI 10.1212/WNL.0000000000002086; Hauser RA, 2016, CLIN NEUROPHARMACOL, V39, P220, DOI 10.1097/WNF.0000000000000168; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kim JS, 2012, NEUROLOGY, V79, P1323, DOI 10.1212/WNL.0b013e31826c1acd; Lawson RA, 2014, PARKINSONISM RELAT D, V20, P1071, DOI 10.1016/j.parkreldis.2014.07.004; Marras C, 2013, J NEUROL NEUROSUR PS, V84, P409, DOI 10.1136/jnnp-2012-303455; Martinez-Martin P, 2015, PARKINSONISM RELAT D, V21, P629, DOI 10.1016/j.parkreldis.2015.03.024; McDonald C, 2016, MOVEMENT DISORD, V31, P937, DOI 10.1002/mds.26632; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Min M, 2018, INT J GERIATR PSYCH, V33, P1541, DOI 10.1002/gps.4964; Raz L, 2016, J CEREBR BLOOD F MET, V36, P172, DOI 10.1038/jcbfm.2015.164; Rudzinka M, 2013, NEUROL NEUROCHIR POL, V47, P423, DOI 10.5114/ninp.2013.38222; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Sommerauer M, 2018, BRAIN, V141, P496, DOI 10.1093/brain/awx348; Svenningsson P, 2012, LANCET NEUROL, V11, P697, DOI 10.1016/S1474-4422(12)70152-7; Udow SJ, 2016, J NEUROL NEUROSUR PS, V87, P1311, DOI 10.1136/jnnp-2016-314123; Unal-Cevik I, 2011, J CEREBR BLOOD F MET, V31, P913, DOI 10.1038/jcbfm.2010.170; Ungar A, 2016, J AM GERIATR SOC, V64, P1567, DOI 10.1111/jgs.14225; Velseboer DC, 2011, PARKINSONISM RELAT D, V17, P724, DOI 10.1016/j.parkreldis.2011.04.016; Wolters FJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002143; Yamashiro K, 2017, ENEUROLOGICALSCI, V10, P5; Yamashiro K, 2015, PARKINSONISM RELAT D, V21, P1076, DOI 10.1016/j.parkreldis.2015.06.019	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240491	10.1371/journal.pone.0240491	http://dx.doi.org/10.1371/journal.pone.0240491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057432	Green Published, gold			2022-12-26	WOS:000581814700018
J	Caruso, G; Klaus, CJ; Hamm, HE; Gurevich, VV; Makino, CL; DiBenedetto, E				Caruso, Giovanni; Klaus, Colin J.; Hamm, Heidi E.; Gurevich, Vsevolod V.; Makino, Clint L.; DiBenedetto, Emmanuele			Position of rhodopsin photoisomerization on the disk surface confers variability to the rising phase of the single photon response in vertebrate rod photoreceptors	PLOS ONE			English	Article							BIPOLAR CELLS; LATERAL DIFFUSION; CYCLIC-GMP; MONOMERIC RHODOPSIN; RETINAL RODS; SIGNAL TRANSFER; OUTER SEGMENTS; MOUSE RODS; ACTIVATION; ARRESTIN	Retinal rods function as accurate photon counters to provide for vision under very dim light. To do so, rods must generate highly amplified, reproducible responses to single photons, yet outer segment architecture and randomness in the location of rhodopsin photoisomerization on the surface of an internal disk introduce variability to the rising phase of the photon response. Soon after a photoisomerization at a disk rim, depletion of cGMP near the plasma membrane closes ion channels and hyperpolarizes the rod. But with a photoisomerization in the center of a disk, local depletion of cGMP is distant from the channels in the plasma membrane. Thus, channel closure is delayed by the time required for the reduction of cGMP concentration to reach the plasma membrane. Moreover, the local fall in cGMP dissipates over a larger volume before affecting the channels, so response amplitude is reduced. This source of variability increases with disk radius. Using a fully space-resolved biophysical model of rod phototransduction, we quantified the variability attributable to randomness in the location of photoisomerization as a function of disk structure. In mouse rods that have small disks bearing a single incisure, this variability was negligible in the absence of the incisure. Variability was increased slightly by the incisure, but randomness in the shutoff of rhodopsin emerged as the main source of single photon response variability at all but the earliest times. Variability arising from randomness in the transverse location of photoisomerization increased in magnitude and persisted over a longer period in the photon response of large salamander rods. A symmetric arrangement of multiple incisures in the disks of salamander rods greatly reduced this variability during the rising phase, but the incisures had the opposite effect on variability arising from randomness in rhodopsin shutoff at later times.	[Caruso, Giovanni] Italian Natl Res Council, Ist Sci Patrimonio Culturale, Rome, Italy; [Klaus, Colin J.] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Hamm, Heidi E.; Gurevich, Vsevolod V.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Makino, Clint L.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [DiBenedetto, Emmanuele] Vanderbilt Univ, Dept Math, Nashville, TN USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze del Patrimonio Culturale (ISPC-CNR); University System of Ohio; Ohio State University; Vanderbilt University; Boston University; Vanderbilt University	Caruso, G (corresponding author), Italian Natl Res Council, Ist Sci Patrimonio Culturale, Rome, Italy.	giovanni.caruso@cnr.it		Makino, Clint/0000-0002-6005-9069	National Institute of General Medical Sciences [GM122491]; National Eye Institute [EY06062, EY 10291, EY011500, EY031702]; Cornelius Vanderbilt Chair; Mathematics Biosciences Institute - National Science Foundation [DMS 1440386];  [DMS 1812601]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cornelius Vanderbilt Chair; Mathematics Biosciences Institute - National Science Foundation; 	DMS 1812601 (GC, VVG, CJK, HEH, CLM, ED); the National Institute of General Medical Sciences: GM122491 (VVG); the National Eye Institute: EY06062 (HEH), EY 10291 (HEH), EY011500 (VVG), EY031702 (CLM); the Cornelius Vanderbilt Chair (VVG) and The Mathematics Biosciences Institute (CJK) which is funded by the National Science Foundation DMS 1440386. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript. The contents reported herein are those of the authors and do not necessarily express the official views of the National Science Foundation or the National Institutes of Health.	Andreucci D, 2003, BIOPHYS J, V85, P1358, DOI 10.1016/S0006-3495(03)74570-6; Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; ARSHAVSKY VY, 1985, FEBS LETT, V181, P264, DOI 10.1016/0014-5793(85)80272-6; BADER CR, 1979, J PHYSIOL-LONDON, V296, P1; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Berntson A, 2004, VISUAL NEUROSCI, V21, P693, DOI 10.1017/S0952523804215048; BIALEK W, 1990, BIOPHYS J, V58, P1227, DOI 10.1016/S0006-3495(90)82463-2; Bisegna P, 2008, BIOPHYS J, V94, P3363, DOI 10.1529/biophysj.107.114058; BORGES S, 1987, J NEUROPHYSIOL, V58, P1275, DOI 10.1152/jn.1987.58.6.1275; CAPOVILLA M, 1987, J PHYSIOL-LONDON, V391, P125, DOI 10.1113/jphysiol.1987.sp016730; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Caruso G, 2006, BIOPHYS J, V91, P1192, DOI 10.1529/biophysj.106.083618; Caruso G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225948; Caruso G, 2011, P NATL ACAD SCI USA, V108, P7804, DOI 10.1073/pnas.1018960108; Caruso G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001031; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Chen Y, 2008, PHOTOCHEM PHOTOBIOL, V84, P855, DOI 10.1111/j.1751-1097.2008.00310.x; COHEN AI, 1960, AM J ANAT, V107, P23, DOI 10.1002/aja.1001070103; COHEN AI, 1965, ANAT REC, V152, P63, DOI 10.1002/ar.1091520108; Doan T, 2009, J NEUROSCI, V29, P11867, DOI 10.1523/JNEUROSCI.0819-09.2009; FERNANDEZMORAN H, 1959, REV MOD PHYS, V31, P319, DOI 10.1103/RevModPhys.31.319; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Govardovskii VI, 2009, MOL VIS, V15, P1717; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; He YZ, 2017, CELL RES, V27, P728, DOI 10.1038/cr.2017.72; Holcman D, 2004, BIOPHYS J, V86, P2566, DOI 10.1016/S0006-3495(04)74312-X; Ingram NT, 2016, J PHYSIOL-LONDON, V594, P5415, DOI 10.1113/JP272556; Kang YY, 2018, NATURE, V558, P553, DOI 10.1038/s41586-018-0215-y; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; KOUTALOS Y, 1995, BIOPHYS J, V68, P373, DOI 10.1016/S0006-3495(95)80198-0; Koutalos Y, 1995, BIOPHYS J, V69, P2163, DOI 10.1016/S0006-3495(95)80090-1; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; LASANSKY A, 1978, J PHYSIOL-LONDON, V285, P531, DOI 10.1113/jphysiol.1978.sp012587; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; MARIANI AP, 1986, PROC R SOC SER B-BIO, V227, P483, DOI 10.1098/rspb.1986.0035; Mazzolini M, 2015, P NATL ACAD SCI USA, V112, pE2715, DOI 10.1073/pnas.1423162112; MILLER JL, 1986, BIOCHEMISTRY-US, V25, P4983, DOI 10.1021/bi00366a002; OLSON A, 1993, BIOPHYS J, V65, P1335, DOI 10.1016/S0006-3495(93)81177-9; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; Qureshi BM, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180075; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; Reingruber J, 2013, P NATL ACAD SCI USA, V110, P19378, DOI 10.1073/pnas.1314030110; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; Sampath AP, 2005, NEURON, V46, P413, DOI 10.1016/j.neuron.2005.04.006; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; SCHNAPF JL, 1983, J PHYSIOL-LONDON, V343, P147, DOI 10.1113/jphysiol.1983.sp014886; Shen L, 2010, IET SYST BIOL, V4, P12, DOI 10.1049/iet-syb.2008.0154; Sjostrand F. S., 1957, ELECTRON MICROS, P194; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Vinberg F, 2018, PROG RETIN EYE RES, V67, P87, DOI 10.1016/j.preteyeres.2018.06.001; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2013, CELL SIGNAL, V25, P2155, DOI 10.1016/j.cellsig.2013.07.009; Wang Q, 2008, J BIOL CHEM, V283, P30015, DOI 10.1074/jbc.M803953200; WEY CL, 1981, BIOPHYS J, V33, P225, DOI 10.1016/S0006-3495(81)84883-7; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; WU SM, 1985, P NATL ACAD SCI USA, V82, P3944, DOI 10.1073/pnas.82.11.3944; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Yamada E., 1957, KURUME MED J, V4, P127; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	71	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240527	10.1371/journal.pone.0240527	http://dx.doi.org/10.1371/journal.pone.0240527			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052986	Green Published, gold			2022-12-26	WOS:000581820200047
J	Li, XY; Plataniotis, KN				Li, Xingyu; Plataniotis, Konstantinos N.			How much off-the-shelf knowledge is transferable from natural images to pathology images?	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; DATASET	Deep learning has achieved a great success in natural image classification. To overcome data-scarcity in computational pathology, recent studies exploit transfer learning to reuse knowledge gained from natural images in pathology image analysis, aiming to build effective pathology image diagnosis models. Since transferability of knowledge heavily depends on the similarity of the original and target tasks, significant differences in image content and statistics between pathology images and natural images raise the questions: how much knowledge is transferable? Is the transferred information equally contributed by pre-trained layers? If not, is there a sweet spot in transfer learning that balances transferred model's complexity and performance? To answer these questions, this paper proposes a framework to quantify knowledge gain by a particular layer, conducts an empirical investigation in pathology image centered transfer learning, and reports some interesting observations. Particularly, compared to the performance baseline obtained by a random-weight model, though transferability of off-the-shelf representations from deep layers heavily depend on specific pathology image sets, the general representation generated by early layers does convey transferred knowledge in various image classification applications. The trade-off between transferable performance and transferred model's complexity observed in this study encourages further investigation of specific metric and tools to quantify effectiveness of transfer learning in future.	[Li, Xingyu] Univ Alberta, Elect & Comp Engn, Edmonton, AB, Canada; [Plataniotis, Konstantinos N.] Univ Toronto, Edward S Rogers Dept Elect & Comp Engn, Toronto, ON, Canada	University of Alberta; University of Toronto	Li, XY (corresponding author), Univ Alberta, Elect & Comp Engn, Edmonton, AB, Canada.	xingyu.li@ualberta.ca						Araujo T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177544; Bayramoglu N, 2016, LECT NOTES COMPUT SC, V9915, P532, DOI 10.1007/978-3-319-49409-8_46; Bhandari SH, 2015, P IEEE INT C IM PROC; Bidar R., 2018, P MED IM 2018 DIG PA; Cao HL, 2018, LECT NOTES COMPUT SC, V10882, P779, DOI 10.1007/978-3-319-93000-8_88; Cruz-Roa A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46450; Cruz-Roa A, 2014, PROC SPIE, V9041, DOI 10.1117/12.2043872; Donahue J., 2013, ARXIV13101531, P647; Filipczuk P, 2013, IEEE T MED IMAGING, V32, P2169, DOI 10.1109/TMI.2013.2275151; Fuchs TJ, 2011, COMPUT MED IMAG GRAP, V35, P515, DOI 10.1016/j.compmedimag.2011.02.006; George YM, 2014, IEEE SYST J, V8, P949, DOI 10.1109/JSYST.2013.2279415; Jarrett K, 2009, IEEE I CONF COMP VIS, P2146, DOI 10.1109/ICCV.2009.5459469; Kandemir M, 2014, LECT NOTES COMPUT SC, V8674, P228, DOI 10.1007/978-3-319-10470-6_29; Khosravi P, 2018, EBIOMEDICINE, V27, P317, DOI 10.1016/j.ebiom.2017.12.026; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Li X., 2016, P 14 ANN IM NETW ONT; Li X, 2018, NANO, V13, DOI 10.1142/S1793292018501199; Wludarski SCL, 2011, APPL IMMUNOHISTO M M, V19, P112, DOI 10.1097/PAI.0b013e3181f0b044; Mormont R, 2018, IEEE COMPUT SOC CONF, P2343, DOI 10.1109/CVPRW.2018.00303; Mou L., 2016, P C EMP METH NAT LAN; Oquab M, 2014, PROC CVPR IEEE, P1717, DOI 10.1109/CVPR.2014.222; Peikari M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24876-0; Razavian Ali Sharif, 2014, P IEEE C COMP VIS PA, P806, DOI DOI 10.1109/CVPRW.2014.131; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Sirinukunwattana K, 2016, IEEE T MED IMAGING, V35, P1196, DOI 10.1109/TMI.2016.2525803; Spanhol FA, 2017, 2017 IEEE INT C SYST; Spanhol FA, 2016, IEEE T BIO-MED ENG, V63, P1455, DOI 10.1109/TBME.2015.2496264; Spanhol FA, 2016, IEEE IJCNN, P2560, DOI 10.1109/IJCNN.2016.7727519; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; Veta M, 2014, IEEE T BIO-MED ENG, V61, P1400, DOI 10.1109/TBME.2014.2303852; Yosinski J, 2014, ADV NEUR IN, V27	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240530	10.1371/journal.pone.0240530	http://dx.doi.org/10.1371/journal.pone.0240530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052964	Green Published, Green Submitted, gold			2022-12-26	WOS:000581820200042
J	Merid, MW; Muluneh, AG; Yenit, MK; Kassa, GM				Merid, Mehari Woldemariam; Muluneh, Atalay Goshu; Yenit, Melaku Kindie; Kassa, Getahun Molla			Treatment interruption and associated factors among patients registered on drug-resistant tuberculosis treatment in Amhara regional state, Ethiopia: 2010-2017	PLOS ONE			English	Article							NONADHERENCE	Background Drug-Resistant Tuberculosis (DR-TB) is a rising threat of the TB control program caused mainly by treatment interruption in Ethiopia. The success of the current treatment regimen for DR-TB is poor partly due to a high treatment interruption rate. Thus, this study assessed treatment interruption and associated factors among DR-TB patients. Methods An institution-based cross-sectional study was conducted among 550 DR-TB patients who have initiated treatment from September 2010 to December 2017. Data were entered using Epi Data version 4.200 and exported to STATA version 14 for analysis. A bi-variable logistic regression model was first fitted, and variables having a p-value < 0.2 in the bi-variable analysis were entered into the multivariable logistic regression model. Crude and Adjusted Odds Ratios (COR and AOR) with 95% confidence interval (CI) were used to determine the strength of association between the treatment interruption and independent variables. Variables with p-value Results In this study, the prevalence of treatment interruption among patients registered on DR-TB treatment was14.55% (95% CI: 11.83, 17.76).Of the interrupters, the treatment interruption during the intensive and continuation phase of treatment was reported as 45% and 71.25%, respectively. Similarly, about 15% of patients had treatment interruption both during the intensive and continuation phase of treatment. The average duration of treatment interruption was 12 (+/- 2.03 SD) and 6 (+/- 1.2 SD) days during the intensive and continuation phase of treatment, respectively. Patients who had no treatment supporter [AOR = 1.45; 95% CI: 1.23-3.66] and developed adverse drug events [AOR = 1.60; 95% CI: 1.22-2.85] were statistically significant predictors of treatment interruption. Conclusions Treatment interruption was low in the study setting. The presence of treatment supporter and absence of drug side effects was significantly associated with decreased occurrence of treatment interruption. Thus, patient linkage to treatment supporter and excellent pharmacovigilance are highly recommended in the study setting.	[Merid, Mehari Woldemariam; Muluneh, Atalay Goshu; Yenit, Melaku Kindie; Kassa, Getahun Molla] Univ Gondar, Dept Epidemiol & Biostat, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar	Kassa, GM (corresponding author), Univ Gondar, Dept Epidemiol & Biostat, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	getahunm8@gmail.com		Kassa, Getahun Molla/0000-0002-9926-7797; Yenit, Melaku Kindie/0000-0002-8982-2814				Adejumo O.A., 2016, INT J CLIN MED, V7, P389, DOI [10.4236/ijcm.2016.76042, DOI 10.4236/IJCM.2016.76042]; Alene KA, 2017, TROP MED INT HEALTH, V22, P351, DOI 10.1111/tmi.12826; Bastard M, 2015, J INFECT DIS, V211, P1607, DOI 10.1093/infdis/jiu551; Breen RAM, 2006, THORAX, V61, P791, DOI 10.1136/thx.2006.058867; Challenge TB, 2015, INTRO ACTIVE TUBERCU; Chung-Delgado K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119332; DEMISSIE M, 1994, ETHIOPIAN MED J, V32, P97; Dodor EA, 2005, T ROY SOC TROP MED H, V99, P827, DOI 10.1016/j.trstmh.2005.06.011; Driver CR, 2005, J PUBLIC HEALTH MAN, V11, P361; Eshetie S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3401-5; Gorityala SB, 2015, J PHARM BIOALLIED SC, V7, P226, DOI 10.4103/0975-7406.160034; Gyamfi E, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0114-6; Ibrahim LM, 2014, PAN AFR MED J, V17, P1; Ingabire S., 2014, RWANDA MED J, V71, P5; Jaggarajamma K, 2007, Indian J Tuberc, V54, P130; Kalembo FW, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3354-9; Kulkarni PY, 2013, ANN MED HEALTH SCI R, V3, P67, DOI 10.4103/2141-9248.109507; Merid MW, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3919-1; Mesfin MM, 2009, HEALTH POLICY PLANN, V24, P457, DOI 10.1093/heapol/czp030; Ministry of Health-Ethiopia, 2014, GUID PROGR MAN DRUG; Ministry of Health-Ethiopia, 2018, NAT GUID TREATM TB D; Ministry of Health-Ethiopia, 2019, NAT PROGR MAN DRUG R; Mweemba M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2372-3; Namasopo-Oleja MS, 2015, AFR HEALTH SCI, V15, P344, DOI 10.4314/ahs.v15i2.6; Olantude O AE, 2019, INT J INFECT DIS, V18, P74; Podewils LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070064; Thim S, 2004, JAMA-J AM MED ASSOC, V292, P566, DOI 10.1001/jama.292.5.566-c; Tola HH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56553-1; Wang Y, 2019, PATIENT PREFER ADHER, V13, P1641, DOI 10.2147/PPA.S219920; Wares DF, 2003, INT J TUBERC LUNG D, V7, P327; Wei XL, 2015, INT J TUBERC LUNG D, V19, P413, DOI 10.5588/ijtld.14.0485; Woimo TT, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4188-9; World Health Organization, 2019, GLOB TUB REP; World Health Organization, 2015, ACT TUB DRUG SAF MON; World Health Organization, 2002, GUID TUB TREATM SUPP; Xu WG, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-169; Yin J, 2018, TROP MED INT HEALTH, V23, P668, DOI 10.1111/tmi.13066	37	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240564	10.1371/journal.pone.0240564	http://dx.doi.org/10.1371/journal.pone.0240564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052983	Green Published, gold			2022-12-26	WOS:000581820200022
J	Valencia, M; Becerra, JE; Reyes, JC; Castro, KG				Valencia, Miguel; Becerra, Jose E.; Reyes, Juan C.; Castro, Kenneth G.			Assessment of early mitigation measures against COVID-19 in Puerto Rico: March 15-May 15, 2020	PLOS ONE			English	Article								On March 15, 2020 Puerto Rico implemented non-pharmaceutical interventions (NPIs), including a mandatory curfew, as part of a state of emergency declaration to prevent the community transmission of the SARS-CoV-2 virus. The strict enforcement of this curfew was extended through May 25, with a gradual relaxation beginning on May 1. This report summarizes an assessment of these early mitigation measures on the progression of the COVID-19 pandemic in the island. From March 15 to May 15, 2020, 70,656 results of molecular (RT-PCR) tests were reported to the Puerto Rico Department of Health. Of these, 1,704 were positive, corresponding to 1,311 individuals with COVID-19 included in the study. We derived the epidemic growth rates (r) and the corresponding reproductive numbers (R) from the epidemic curve of these 1,311 individuals with laboratory-confirmed diagnosis of COVID-19 using their date of test collection as a proxy for symptoms onset. Through May 31, 2020, there were 143 COVID-19 associated deaths in Puerto Rico, for a case fatality risk of 10.9%. We compared the observed cases and deaths with Gompertz model projections had the mitigation measures not been implemented. The number of daily RT-PCR-confirmed cases peaked on March 30 (85 cases), showing a weekly cyclical trend, with lower counts on weekends and a decreasing secular trend since March 30. The initial exponential growth rate (r) was 15.87% (95% CI: 7.59%, 24.15%), corresponding to R of 1.82 (95% CI:1.37, 2.30). After March 30, the r value reverted to an exponential decay rate (negative) of -2.95% (95% CI: -4.99%, -0.92%), corresponding to R of 0.93 (95% CI: 0.86, 0.98). We estimate that, had the initial growth rate been maintained, a total of 6,155 additional COVID-19 cases would have occurred by May 15, with 211 additional COVID-19 deaths by May 31. These findings are consistent with very effective implementation of early NPIs as mitigation measures in Puerto Rico. These results also provide a baseline to assess the impact of the transition from mitigation to subsequent containment stages in Puerto Rico.	[Valencia, Miguel] Puerto Rico Dept Hlth, Data Management Operat COVID Legacy Syst 19, San Juan, PR USA; [Becerra, Jose E.] Univ Puerto Rico, Grad Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA; [Reyes, Juan C.] Univ Puerto Rico, Grad Sch Publ Hlth, Dept Biostat & Epidemiol, Med Sci Campus, San Juan, PR 00936 USA; [Castro, Kenneth G.] Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA USA; [Castro, Kenneth G.] Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; [Castro, Kenneth G.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University	Becerra, JE (corresponding author), Univ Puerto Rico, Grad Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA.	becerra.je@gmail.com	Castro, Kenneth G/P-1882-2018	Castro, Kenneth G/0000-0001-7964-6354; Becerra, Jose/0000-0002-7425-8501				Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; [Anonymous], 2020, AP NEWS 0313; Bi Q, 2020, LANCET INFECT DIS, DOI 10.1016/S1473-3099(20)30287-5; Gostin LO, 2020, JAMA-J AM MED ASSOC, V323, P2137, DOI 10.1001/jama.2020.5460; Hedges JR, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081768; Irvin-Barnwell EA, 2020, DISASTER MED PUBLIC, V14, P80, DOI 10.1017/dmp.2019.85; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Miranda M, 2020, CARIBBEAN BUSINESS; Omer SB, 2020, JAMA-J AM MED ASSOC, V323, P1767, DOI 10.1001/jama.2020.5788; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Santos-Burgoa C, 2018, LANCET PLANET HEALTH, V2, pE478, DOI 10.1016/s2542-5196(18)30209-2; Tjorve KMC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178691; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; WHO, 2020, 11 WHO; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	15	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240013	10.1371/journal.pone.0240013	http://dx.doi.org/10.1371/journal.pone.0240013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052958	Green Published, gold, Green Submitted			2022-12-26	WOS:000581820200041
J	Wang, H; Lee, JH; Wang, Y; Seo, HS; Wang, JB; Deshane, JS; Ponnazhagan, S				Wang, Hong; Hyoung Lee, Joo; Wang, Yong; Seo, Hwa-seon; Wang, Jianbo; Deshane, Jessy S.; Ponnazhagan, Selvarangan			A conserved aromatic moiety in the ectodomain is a key determinant for structural integrity and protein trafficking of TNFR superfamily	FASEB JOURNAL			English	Article						aromatic moiety; protein trafficking; structural integrity; tumor necrosis factor receptor superfamily	PERIODIC SYNDROME; FOLLICULAR LYMPHOMA; RECEPTOR; MUTATIONS; OSTEOPROTEGERIN; BINDING; GLYCOSYLATION; HETEROGENEITY; ENDOSTATIN; SECRETION	Extracellular trafficking of tumor necrosis factor receptor superfamily (TNFRSF) is tightly regulated, disruption of which triggers various autoinflammatory disorders, including TNF receptor-associated periodic syndrome (TRAPS). Here, we provide thus far unraveled molecular basis of noncysteine mutations in TNFR1 ectodomain where loss of an aromatic moiety in cysteine-rich domain (CRD) 2 results in TRAPS disease-associated phenotype. Our study characterized that a missense mutation on phenylalanine residue located in CRD2 (TNFR1(F60V)) causes a delay in TNFR1 transport to cell membrane, leading to sustained receptor responsiveness and downstream NF-kappa B activation, characteristic of clinical manifestation of a prolonged fever. By creating and characterizing identical mutations on structurally conserved ectodomains of osteoprotegerin (OPG) and decoy receptor 3, other two secreted forms of TNFRSF, we further identified that a conserved aromatic residue at the A1 submodule of CRD2 (A1CRD2) confers structural integrity of ectodomain where aromatic sidechain deletion increases thermal instability, interfering with efficient posttranslational modification and subsequent receptor secretion. Interestingly, our functional analyses indicated that this particular noncysteine mutation is not associated with either protein misfolding or loss of function. Finally, by using a synthetic agonist, we demonstrated gain-of-function of the trafficking defect, suggesting the possibility of rescuing affected pathology in related disorders. Given the structural and topological similarities present in the ectodomains of TNFRSF members, our findings provide mechanistic insights of defects in subcellular trafficking of TNF receptors, reported in various TNFRSF-associated diseases.	[Wang, Hong; Hyoung Lee, Joo; Ponnazhagan, Selvarangan] Univ Alabama Birmingham, Dept Pathol, 1825 Univ Blvd,SHEL 814, Birmingham, AL 35294 USA; [Wang, Yong; Deshane, Jessy S.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Seo, Hwa-seon; Wang, Jianbo] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ponnazhagan, S (corresponding author), Univ Alabama Birmingham, Dept Pathol, 1825 Univ Blvd,SHEL 814, Birmingham, AL 35294 USA.	pons@uab.edu	Lee, Joo Hyoung/A-7713-2017	Lee, Joo Hyoung/0000-0003-4450-3067	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR060948]; HHS \ NIH \ National Cancer Institute (NCI) [CA184770]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL128502]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS \ NIH \ National Cancer Institute (NCI); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI)	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR060948; HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: CA184770; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL128502	Aganna E, 2003, ARTHRITIS RHEUM-US, V48, P2632, DOI 10.1002/art.11215; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aksentijevich I, 2001, AM J HUM GENET, V69, P301, DOI 10.1086/321976; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Branschadel M, 2010, CELL SIGNAL, V22, P404, DOI 10.1016/j.cellsig.2009.10.011; Byun M, 2013, J EXP MED, V210, P1743, DOI 10.1084/jem.20130592; Cardinale CJ, 2013, GENES IMMUN, V14, P447, DOI 10.1038/gene.2013.43; Cheung KJJ, 2010, CANCER RES, V70, P9166, DOI 10.1158/0008-5472.CAN-10-2460; Haas SL, 2006, GASTROENTEROLOGY, V130, P172, DOI 10.1053/j.gastro.2005.09.014; Higgs JT, 2015, MOL CANCER RES, V13, P819, DOI 10.1158/1541-7786.MCR-14-0492; Kim YH, 2016, J CELL SCI, V129, P29, DOI 10.1242/jcs.176412; Kimberley FC, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2197; Lachmann HJ, 2014, ANN RHEUM DIS, V73, P2160, DOI 10.1136/annrheumdis-2013-204184; Lee JH, 2017, FASEB J, V31, P1608, DOI 10.1096/fj.201601178R; Lee JH, 2015, P NATL ACAD SCI USA, V112, P1392, DOI 10.1073/pnas.1417660112; Lin WW, 2011, BIOCHEM PHARMACOL, V81, P838, DOI 10.1016/j.bcp.2011.01.011; Lobito AA, 2006, BLOOD, V108, P1320, DOI 10.1182/blood-2005-11-006783; Lobito AA, 2011, TRENDS MOL MED, V17, P494, DOI 10.1016/j.molmed.2011.05.006; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Middleton-Hardie C, 2006, J BONE MINER RES, V21, P438, DOI 10.1359/JBMR.051104; Naismith JH, 1996, STRUCTURE, V4, P1251, DOI 10.1016/S0969-2126(96)00134-7; Nedjai B, 2008, ARTHRITIS RHEUM-US, V58, P273, DOI 10.1002/art.23123; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Schmidt J, 2016, BLOOD, V128, P1101, DOI 10.1182/blood-2016-03-703819; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Skrenkova K, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00188; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turner MD, 2012, BIOSCIENCE REP, V32, P105, DOI 10.1042/BSR20110089; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Ward-Kavanagh LK, 2016, IMMUNITY, V44, P1005, DOI 10.1016/j.immuni.2016.04.019; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004	34	0	0	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15687	15700		10.1096/fj.202000341R	http://dx.doi.org/10.1096/fj.202000341R		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047892				2022-12-26	WOS:000581171900001
J	Furnish, BJ; Keller, TA				Furnish, Brandon J.; Keller, Troy A.			Carbon limitation in hypereutrophic, periphytic algal wastewater treatment systems	PLOS ONE			English	Article							INORGANIC CARBON; NUTRIENT REMOVAL; FRESH-WATER; CHLORELLA-VULGARIS; CO2; PH; PHOSPHORUS; GROWTH; EUTROPHICATION; PRODUCTIVITY	Global eutrophication degrades water quality in freshwater ecosystems and limits the availability of freshwater for human consumption. While current wastewater treatment facilities (WWTF) remove pathogens and pollutants, many US WWTF continue to discharge nutrients that contribute to eutrophication. Traditional nutrient removal technologies can effectively reduce eutrophication risk, but can have unintended negative consequences on human and environmental health. Alternatives, such as algae-based treatment systems, improve the sustainability of the nutrient recovery process by producing biomass that can be converted to biofuel. However, research is needed to increase the productivity of algal treatment systems to improve their economic viability. Because algae in wastewater treatment systems are grown in wastewater rich in nutrients, the algae could become limited by dissolved inorganic carbon. This hypothesis was tested in 1.2 m long recirculating floways (n = 8 for each treatment/control) by quantifying algal dry mass and wastewater nutrient concentrations in 3 independent experiments: (1) carbon dioxide gas infused vs air infused control; (2) hydrochloric acid acidified vs neutralized solution control vs no chemical addition control; and (3) sodium bicarbonate addition vs no chemical control. Results showed increases in algal biomass after 18 days in wastewater augmented with dissolved inorganic carbon (carbon dioxide or sodium bicarbonate). In contrast, maintaining wastewater at near neutral pH with hydrochloric acid reduced algal productivity relative to controls. Nutrient reductions generally paralleled algal biomass increases except in the bicarbonate addition experiment. These findings provide evidence for the importance of carbon limitation in algal wastewater treatment floways. These results could help explain why carbon dioxide infusions stimulate algae in treatment systems. Furthermore, these results suggest that algae in nutrient enriched, sun-exposed streams (e.g., agricultural ditches or urbanized streams) may become carbon limited during peak periods of productivity. These findings could have important implications for ecosystems undergoing eutrophication as atmospheric carbon dioxide concentrations continue to rise.	[Furnish, Brandon J.; Keller, Troy A.] Columbus State Univ, Dept Earth & Space Sci, Columbus, GA 31907 USA; [Furnish, Brandon J.] Liberty Util, Dept Engn, Columbus, GA USA	University System of Georgia; Columbus State University	Keller, TA (corresponding author), Columbus State Univ, Dept Earth & Space Sci, Columbus, GA 31907 USA.	keller_troy@columbusstate.edu		Keller, Troy/0000-0003-0648-781X	Columbus State University; Liberty Utilities (BJF); Department of Earth and Space Sciences [TAK]	Columbus State University; Liberty Utilities (BJF); Department of Earth and Space Sciences [TAK]	This research was partially funded by Columbus State University's SRACE grant [BJF], Liberty Utilities (BJF), and the Department of Earth and Space Sciences [TAK]. The funding groups did not influence the research conclusions or its publication. Liberty Utilities provided support in the form of a salary for one author [BJF], but this entity did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the `author contributions' section.	Adey W., 1993, Restoration Ecology, V1, P29, DOI 10.1111/j.1526-100X.1993.tb00006.x; Adey WH, 2011, BIOSCIENCE, V61, P434, DOI 10.1525/bio.2011.61.6.5; Alexander RB, 2006, LIMNOL OCEANOGR, V51, P639, DOI 10.4319/lo.2006.51.1_part_2.0639; AZOV Y, 1982, APPL ENVIRON MICROB, V43, P1300, DOI 10.1128/AEM.43.6.1300-1306.1982; Barsanti L, 2014, ALGAE: ANATOMY, BIOCHEMISTRY, AND BIOTECHNOLOGY, 2ND EDITION, P1, DOI 10.1201/b16544; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Birkeland S, 2001, ECOL LAW QUART, V28, P297; BOLIN B, 1960, TELLUS, V12, P274, DOI 10.1111/j.2153-3490.1960.tb01311.x; Calahan D, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00538; CHEN CY, 1994, MAR ECOL PROG SER, V109, P83, DOI 10.3354/meps109083; Cole AJ, 2017, ALGAL RES, V27, P215, DOI 10.1016/j.algal.2017.09.014; Cole AJ, 2014, GCB BIOENERGY, V6, P637, DOI 10.1111/gcbb.12097; Copeland Claudia, 2016, CLEAN WATER ACT SUMM; Corp IBM, 2019, IBM SPSS STAT WIND V; Correll DL, 1998, J ENVIRON QUAL, V27, P261, DOI 10.2134/jeq1998.00472425002700020004x; Craggs RJ, 1996, ECOL ENG, V6, P149, DOI 10.1016/0925-8574(95)00056-9; Craggs RJ, 1996, WATER SCI TECHNOL, V33, P191, DOI 10.1016/0273-1223(96)00354-X; de-Bashan LE, 2002, WATER RES, V36, P2941, DOI 10.1016/S0043-1354(01)00522-X; DICKSON AG, 1981, DEEP-SEA RES, V28, P609, DOI 10.1016/0198-0149(81)90121-7; Environmental Sciences Section (ESS), 1991, ESS METHOD 1501 CHLO; Field A., 1998, BRIT PSYCHOL SOC MAT, V6, P13; Field A., 2009, DISCOVERING STAT IBM; Gardner RD, 2013, BIOTECHNOL BIOENG, V110, P87, DOI 10.1002/bit.24592; Ghirardi ML, 2000, TRENDS BIOTECHNOL, V18, P506, DOI 10.1016/S0167-7799(00)01511-0; Goldman JC, 1971, PAPER, V462, P637; HACH, 2017, 8190 HACH; Hach, 2014, NITROGEN TOTAL PERSU, P1; Hach, 2018, 8039 HACH; Hach, 2017, 8048 HACH; HENZE M, 1991, WATER SCI TECHNOL, V23, P669, DOI 10.2166/wst.1991.0517; Jetten MSM, 1997, WATER SCI TECHNOL, V35, P171, DOI 10.2166/wst.1997.0341; KING DL, 1970, J WATER POLLUT CON F, V42, P2035; Lancet Global Health, 2019, LANCET GLOBAL HLTH, V7, pe1; Lawton RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090223; Liang ZJ, 2013, CHEMOSPHERE, V92, P1383, DOI 10.1016/j.chemosphere.2013.05.014; Liu ZH, 2010, EARTH-SCI REV, V99, P162, DOI 10.1016/j.earscirev.2010.03.001; MILLER WE, 1974, WATER RES, V8, P667, DOI 10.1016/0043-1354(74)90126-2; Moheimani NR, 2013, J APPL PHYCOL, V25, P387, DOI 10.1007/s10811-012-9873-6; Moreira D, 2016, BIORESOURCE TECHNOL, V215, P371, DOI 10.1016/j.biortech.2016.03.060; Mulbry W, 2008, BIORESOURCE TECHNOL, V99, P8137, DOI 10.1016/j.biortech.2008.03.073; Neveux N, 2016, ALGAL RES, V13, P284, DOI 10.1016/j.algal.2015.12.010; Park JBK, 2011, WATER SCI TECHNOL, V63, P2403, DOI 10.2166/wst.2011.200; Park JBK, 2011, WATER SCI TECHNOL, V63, P1758, DOI 10.2166/wst.2011.114; Park JBK, 2011, BIORESOURCE TECHNOL, V102, P35, DOI 10.1016/j.biortech.2010.06.158; Pescod MB, 1992, WASTEWATER TREATMENT; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; Posadas E, 2015, CHEM ENG J, V265, P239, DOI 10.1016/j.cej.2014.12.059; Rahman SM, 2016, ENVIRON SCI TECHNOL, V50, P3020, DOI 10.1021/acs.est.5b05070; Schnurr PJ, 2016, BIORESOURCE TECHNOL, V219, P72, DOI 10.1016/j.biortech.2016.06.129; Selvaratnam T, 2015, RENEW ENERG, V82, P71, DOI 10.1016/j.renene.2014.07.061; Shen QH, 2015, BIORESOURCE TECHNOL, V190, P257, DOI 10.1016/j.biortech.2015.04.053; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Sokal R.R., 2012, BIOMETRY; Su YY, 2011, WATER RES, V45, P3351, DOI 10.1016/j.watres.2011.03.046; Sutherland DL, 2015, WATER RES, V70, P9, DOI 10.1016/j.watres.2014.10.064; Tang TY, 2018, WATER ENVIRON RES, V90, P650, DOI 10.2175/106143017X15131012153121; White DA, 2013, J APPL PHYCOL, V25, P153, DOI 10.1007/s10811-012-9849-6; Woertz I, 2009, J ENVIRON ENG-ASCE, V135, P1115, DOI 10.1061/(ASCE)EE.1943-7870.0000129; Zamalloa C, 2011, BIORESOURCE TECHNOL, V102, P1149, DOI 10.1016/j.biortech.2010.09.017	60	0	0	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240525	10.1371/journal.pone.0240525	http://dx.doi.org/10.1371/journal.pone.0240525			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045032	Green Published, gold			2022-12-26	WOS:000581811700046
J	Bertelsen, A; Elborn, SJ; Schock, BC; Omri, A; Omri, A				Bertelsen, Anne; Elborn, Stuart J.; Schock, Bettina C.; Omri, Abdelwahab; Omri, Abdelwahab			Toll like Receptor signalling by Prevotella histicola activates alternative NF-kappa B signalling in Cystic Fibrosis bronchial epithelial cells compared to P. aeruginosa	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; RELB; EXPRESSION; INFLAMMATION; FLAGELLIN; ALPHA; SUPPRESSION; MODULATION; IMMUNITY; MEMBER	Cystic Fibrosis (CF), caused by mutations affecting the CFTR gene, is characterised by viscid secretions in multiple organ systems. CF airways contain thick mucus, creating a gradient of hypoxia, which promotes the establishment of polymicrobial infection. Such inflammation predisposes to further infection, a self-perpetuating cycle in mediated by NF-kappa B. Anaerobic Gram-negative Prevotella spp. are found in sputum from healthy volunteers and CF patients and in CF lungs correlate with reduced levels of inflammation. Prevotella histicola (P. histicola) can suppress murine lung inflammation, however, no studies have examined the role of P. histicola in modulating infection and inflammation in the CF airways. We investigated innate immune signalling and NF-kB activation in CF epithelial cells CFBE41o- in response to clinical stains of P. histicola and Pseudomonas aeruginosa (P. aeruginosa). Toll-Like Receptor (TLR) expressing HEK-293 cells and siRNA assays for TLRs and IKK alpha were used to confirm signalling pathways. We show that P. histicola infection activated the alternative NF-kB signalling pathway in CF bronchial epithelial cells inducing HIF-1 alpha protein. TLR5 signalling was responsible for the induction of the alternative NF-kB pathway through phosphorylation of IKKa. The induction of transcription factor HIF-1a was inversely associated with the induction of the alternative NF-kB pathway and knockdown of IKK alpha partially restored canonical NF-kB activation in response to P. histicola. This study demonstrates that different bacterial species in the respiratory microbiome can contribute differently to inflammation, either by activating inflammatory cascades (P. aeruginosa) or by muting the inflammatory response by modulating similar or related pathways (P. histicola). Further work is required to assess the complex interactions of the lung microbiome in response to mixed bacterial infections and their effects in people with CF.	[Bertelsen, Anne; Elborn, Stuart J.; Schock, Bettina C.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland; [Bertelsen, Anne] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge, England; [Elborn, Stuart J.] Imperial Coll London, London, England	Queens University Belfast; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London	Schock, BC (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland.	b.schock@qub.ac.uk			Department for Employment and Learning (DEL), Northern Ireland, UK; Northern Ireland Chest Heart and Stroke (NICHS)	Department for Employment and Learning (DEL), Northern Ireland, UK; Northern Ireland Chest Heart and Stroke (NICHS)	AB received a PhD studentship from the Department for Employment and Learning (DEL), Northern Ireland, UK (https://www.nidirect.gov.uk/articles/department-economy-studentships).BCS was supported by a grant from Northern Ireland Chest Heart and Stroke (NICHS, 2014_15) (https://www.nicva.org/organisation/ni-chest-heart-stroke) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, NAT GENET, V51, P1, DOI 10.1038/s41588-018-0328-0; Bertelsen A, 2019, J CYSTIC FIBROSIS; Bevivino A, 2019, TRENDS MOL MED, V25, P1110, DOI 10.1016/j.molmed.2019.07.008; Blackwell TS, 2001, AM J PHYSIOL-LUNG C, V281, pL69, DOI 10.1152/ajplung.2001.281.1.L69; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Brennan S, 2008, PAEDIATR RESPIR REV, V9, P271, DOI 10.1016/j.prrv.2008.05.008; Buchanan PJ, 2009, BIOCHEM SOC T, V37, P863, DOI 10.1042/BST0370863; BUSCH DF, 1976, ANTIMICROB AGENTS CH, V10, P713, DOI 10.1128/AAC.10.4.713; Campodonico VL, 2010, INFECT IMMUN, V78, P746, DOI 10.1128/IAI.00806-09; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Chen XP, 2009, CLIN VACCINE IMMUNOL, V16, P104, DOI 10.1128/CVI.00320-08; Chillappagari S, 2014, AM J PHYSIOL-LUNG C, V307, pL791, DOI 10.1152/ajplung.00167.2014; Devi YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125627; Dillon SM, 2016, MUCOSAL IMMUNOL, V9, P24, DOI 10.1038/mi.2015.33; Eckle T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001665; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gilpin DF, 2017, J MED MICROBIOL, DOI [10.1099/jmm.0.000500:825-832, DOI 10.1099/JMM.0.000500:825-832]; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; John G, 2010, AM J RESP CELL MOL, V42, P424, DOI 10.1165/rcmb.2008-0408OC; Kelly C, 2013, EUR RESPIR J, V41, P1315, DOI 10.1183/09031936.00032412; Kelly C, 2013, AM J PHYSIOL-LUNG C, V304, pL371, DOI 10.1152/ajplung.00372.2011; Kosamo S, 2020, J CYST FIBROS, V19, P608, DOI 10.1016/j.jcf.2019.11.009; Larsen JM, 2015, IMMUNOLOGY, V144, P333, DOI 10.1111/imm.12376; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Marietta EV, 2016, ARTHRITIS RHEUMATOL, V68, P2878, DOI 10.1002/art.39785; McMillan DH, 2013, AM J PHYSIOL-LUNG C, V304, pL774, DOI 10.1152/ajplung.00352.2012; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Muhlebach MS, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00242-2018; O'Neill K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126980; Pachathundikandi SK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13506-6; Pattison SH, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01569-2016; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Rolli J, 2010, CRIT CARE, V14, DOI 10.1186/cc9235; Roussel L, 2011, J CYST FIBROS, V10, P107, DOI 10.1016/j.jcf.2010.11.005; Ruan YF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1272-3; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Schaible B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056491; Schaible B, 2010, RESP PHYSIOL NEUROBI, V174, P235, DOI 10.1016/j.resp.2010.08.006; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Steiner TS, 2007, INFECT IMMUN, V75, P545, DOI 10.1128/IAI.01506-06; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Tambo T, 2010, ARCH CLIN MICROBIOLO, V1; Tang AC, 2014, EUR RESPIR REV, V23, P320, DOI 10.1183/09059180.00006113; Tully JE, 2013, J IMMUNOL, V191, P5811, DOI 10.4049/jimmunol.1301329; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Veit G, 2012, MOL BIOL CELL, V23, P4188, DOI 10.1091/mbc.E12-06-0424; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wolfgang MC, 2004, P NATL ACAD SCI USA, V101, P6664, DOI 10.1073/pnas.0307553101; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Xia YY, 1997, AM J PATHOL, V151, P375; Xu ZZ, 2015, NAT MED, V21, P1326, DOI 10.1038/nm.3978; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zemanick ET, 2016, PEDIATR CLIN N AM, V63, P617, DOI 10.1016/j.pcl.2016.04.003; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005	64	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0235803	10.1371/journal.pone.0235803	http://dx.doi.org/10.1371/journal.pone.0235803			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031374	Green Published, gold			2022-12-26	WOS:000581809800007
J	Chen, H; Libring, S; Ruddraraju, KV; Miao, JM; Solorio, L; Zhang, ZY; Wendt, MK				Chen, Hao; Libring, Sarah; Ruddraraju, Kasi Viswanatharaju; Miao, Jinmin; Solorio, Luis; Zhang, Zhong-Yin; Wendt, Michael K.			SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE-PHOSPHATASE; ANTITUMOR IMMUNITY; KINASE INHIBITOR; ACTIVATION; CELLS; NERATINIB; PHOSPHORYLATION; MECHANISM; SUBSETS	Metastatic breast cancer (MBC) is an extremely recalcitrant disease capable of bypassing current targeted therapies via engagement of several growth promoting pathways. SH2 containing protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase known to facilitate growth and survival signaling downstream of numerous receptor inputs. Herein, we used inducible genetic depletion and two distinct pharmacological inhibitors to investigate the therapeutic potential of targeting SHP2 in MBC. Cells that acquired resistance to the ErbB kinase inhibitor, neratinib, displayed increased phosphorylation of SHP2 at the Y542 activation site. In addition, higher levels of SHP2 phosphorylation, but not expression, were associated with decreased survival of breast cancer patients. Pharmacological inhibition of SHP2 activity blocked ERK1/2 and AKT signaling generated from exogenous stimulation with FGF2, PDGF, and hGF and readily prevented MBC cell growth induced by these factors. SHP2 was also phosphorylated upon engagement of the extracellular matrix (ECM) via focal adhesion kinase. Consistent with the potential of SHP2-targeted compounds as therapeutic agents, the growth inhibitory property of SHP2 blockade was enhanced in ECM-rich 3D culture environments. In vivo blockade of SHP2 in the adjuvant setting decreased pulmonary metastasis and extended the survival of systemic tumor-bearing mice. Finally, inhibition of SHP2 in combination with FGFR-targeted kinase inhibitors synergistically blocked the growth of MBC cells. Overall, our findings support the conclusion that SHP2 constitutes a shared signaling node allowing MBC cells to simultaneously engage a diversity of growth and survival pathways, including those derived from the ECM.	[Chen, Hao; Ruddraraju, Kasi Viswanatharaju; Miao, Jinmin; Zhang, Zhong-Yin; Wendt, Michael K.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Libring, Sarah; Solorio, Luis] Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA; [Solorio, Luis; Zhang, Zhong-Yin; Wendt, Michael K.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wendt, MK (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.; Wendt, MK (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.	mwendt@purdue.edu	Ruddraraju, Kasi Viswanatharaju/D-2384-2016; Miao, Jinmin/AAU-8461-2021	Ruddraraju, Kasi Viswanatharaju/0000-0002-5614-720X; Libring, Sarah/0000-0001-8336-5862; Wendt, Mike/0000-0002-3665-7413; Chen, Hao/0000-0002-2070-5062	National Cancer Institute [R01CA207751, RO1CA207288]; Metavivor Foundation Translation Research Award; American Cancer Society Research Scholar Grant [RSG-CSM-130259]; SIRG Graduate Research Assistantships Award [P30CA023168]; Purdue University Center for Cancer Research	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Metavivor Foundation Translation Research Award; American Cancer Society Research Scholar Grant(American Cancer Society); SIRG Graduate Research Assistantships Award; Purdue University Center for Cancer Research	This work was supported by National Cancer Institute (R01CA207751), Metavivor Foundation Translation Research Award, and American Cancer Society Research Scholar Grant (RSG-CSM-130259) to MKW and National Cancer Institute (RO1CA207288) to ZYZ. We gratefully acknowledge the SIRG Graduate Research Assistantships Award (P30CA023168) and the support from the Purdue University Center for Cancer Research. We thank Dr. Jill E. Hutchcroft, Dr. Wen-Hung Wang, and Flow Cytometry and Cell Separation Core Facility at Bindley Bioscience Center, Purdue University for technical support. We also thank Saeed Salehin Akhand, Hang Lin, Juan Sebastian Paez and other members at Wendt Lab for technical support.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Ahmed TA, 2019, CELL REP, V26, P65, DOI 10.1016/j.celrep.2018.12.013; Alexander PB, 2017, J BIOL CHEM, V292, P748, DOI 10.1074/jbc.M116.754960; ALI R, 2018, CELL DEATH DIS, V9, P1, DOI DOI 10.1038/s41419-017-0012-9; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Brown WS, 2016, ONCOTARGET, V7, P83424, DOI 10.18632/oncotarget.13117; Brown WS, 2016, MOL CANCER THER, V15, P2096, DOI 10.1158/1535-7163.MCT-16-0136; Bunda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9859; Burstein HJ, 2010, J CLIN ONCOL, V28, P1301, DOI 10.1200/JCO.2009.25.8707; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Fedele C, 2018, CANCER DISCOV, V8, P1237, DOI 10.1158/2159-8290.CD-18-0444; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gotoh N, 2004, P NATL ACAD SCI USA, V101, P17144, DOI 10.1073/pnas.0407577101; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hanker AB, 2017, CANCER DISCOV, V7, P575, DOI 10.1158/2159-8290.CD-16-1431; Helsten T, 2016, CLIN CANCER RES, V22, P259, DOI 10.1158/1078-0432.CCR-14-3212; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Koyama T, 2008, J BIOL CHEM, V283, P24234, DOI 10.1074/jbc.M803907200; Lan LX, 2015, EMBO J, V34, P1493, DOI 10.15252/embj.201489004; Li DM, 2011, BREAST CANCER RES TR, V128, P7, DOI 10.1007/s10549-011-1499-x; Liu W, 2017, LEUKEMIA, V31, P1415, DOI 10.1038/leu.2016.326; Mariotto AB, 2017, CANCER EPIDEM BIOMAR, V26, P809, DOI [10.1158/1055-9965.EPI-16-0889, 10.1158/1055-9965.epi-16-0889]; Martin M, 2017, LANCET ONCOL, V18, P1688, DOI 10.1016/S1470-2045(17)30717-9; Minuti G, 2012, BRIT J CANCER, V107, P793, DOI 10.1038/bjc.2012.335; Montagner A, 2005, J BIOL CHEM, V280, P5350, DOI 10.1074/jbc.M410012200; Palakurthi S, 2019, CANCER IMMUNOL RES, V7, P1457, DOI 10.1158/2326-6066.CIR-18-0595; Pulaski BA, 2000, CURR PROTOC IMMUNOL, V39, P20; Ran H, 2016, CANCER CELL, V30, P194, DOI 10.1016/j.ccell.2016.07.010; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shinde A, 2018, MOL CANCER RES, V16, P1579, DOI 10.1158/1541-7786.MCR-18-0151; Stuhlmiller TJ, 2015, CELL REP, V11, P390, DOI 10.1016/j.celrep.2015.03.037; Sun J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3037; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wei T., 2017, STATISTICIAN, V56, pe24; Wendt MK, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3623; Wendt MK, 2011, MOL BIOL CELL, V22, P2423, DOI 10.1091/mbc.E11-04-0306; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Ye TH, 2014, BREAST CANCER RES TR, V143, P435, DOI 10.1007/s10549-013-2829-y; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zeng LF, 2014, J MED CHEM, V57, P6594, DOI 10.1021/jm5006176; Zhang RY, 2016, ONCOTARGET, V7, P73817, DOI 10.18632/oncotarget.12074; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002; Zhao H, 2019, ONCOGENE, V38, P2275, DOI 10.1038/s41388-018-0574-8; Zhao MX, 2019, ACTA PHARM SIN B, V9, P304, DOI 10.1016/j.apsb.2018.08.009; Zhou B, 2014, MOL CANCER RES, V12, P143, DOI 10.1158/1541-7786.MCR-13-0184	53	12	12	2	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2020	39	49					7166	7180		10.1038/s41388-020-01488-5	http://dx.doi.org/10.1038/s41388-020-01488-5		OCT 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PB0GA	33033382	hybrid, Green Published			2022-12-26	WOS:000576873200001
J	Droz, N; Hanaway, P; Hyman, M; Jin, YX; Beidelschies, M; Husni, ME				Droz, Nicole; Hanaway, Patrick; Hyman, Mark; Jin, Yuxuan; Beidelschies, Michelle; Husni, M. Elaine			The impact of functional medicine on patient-reported outcomes in inflammatory arthritis: A retrospective study	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; DEPRESSION; REMISSION; PAIN	Background Despite treatment advances for inflammatory arthritis, a significant amount of patients fail to achieve remission. Other modifiable factors such as diet, physical activity and environmental exposures may be an important area of focus to help patients achieve disease remission and greater overall health. Functional medicine focuses on these lifestyle factors and may be an important adjunctive therapy. In this study, we examined the impact of functional medicine on patient-reported outcomes in patients with inflammatory arthritis. Materials and methods In this 12-week, retrospective study, patients with confirmed diagnoses of rheumatoid arthritis (RA) or psoriatic arthritis (PsA) were treated according to guidelines from the American College of Rheumatology for RA or PSA respectively. Those in the functional medicine group underwent a functional medicine program adjunctive to the standard of care. Patient reported outcomes, such as PROMIS (Patient Reported Outcomes Measurement Information System) global physical health, mental health and pain scores were collected at baseline and 12 weeks. Multivariable statistical modeling was used to identify the impact of functional medicine on patient-reported outcomes. Results 318 patients were screened and 54 patients (mean age 52.9 +/- 11.3 years, females 74(67.9%)), were included. Baseline characteristics were similar in both patient groups with the exception of PROMIS global physical health and pain (PROMIS global physical health score 43 center dot 2 +/- 6 center dot 6 and 39 center dot 7 +/- 8 center dot 7 and pain scores of 3 center dot 5 +/- 1 center dot 9 and 5 center dot 2 +/- 2 center dot 7 in the functional medicine group vs. standard of care group respectively). Using multivariable model to account for these differences, patients in the functional medicine group had a statistically significant reduction in pain (0.92, p-value = 0.007) and change in PROMIS physical health score (2 center dot 84, p-value = 0.001) as compared to the standard of care. Changes in PROMIS global mental health scores were also significant and were dependent on age and were greatest in those older than 55. Limitations Retrospective design, baseline difference in patient reported outcomes. Conclusions Functional medicine may have an important role as adjunctive therapy to improve patients' pain, physical and mental health in those who do not see improvement with conventional therapy alone.	[Droz, Nicole; Husni, M. Elaine] Cleveland Clin, Orthopaed & Rheumatol Inst, Cleveland, OH 44106 USA; [Hanaway, Patrick; Hyman, Mark; Beidelschies, Michelle] Cleveland Clin, Ctr Funct Med, Cleveland, OH 44106 USA; [Jin, Yuxuan] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Husni, ME (corresponding author), Cleveland Clin, Orthopaed & Rheumatol Inst, Cleveland, OH 44106 USA.	HusniE@ccf.org	Beidelschies, Michelle/AAM-6446-2021	Beidelschies, Michelle/0000-0002-6344-0674; Hanaway, Patrick/0000-0002-7788-783X; Jin, Yuxuan/0000-0002-5240-6219	Center for Functional Medicine at Cleveland Clinic Foundation	Center for Functional Medicine at Cleveland Clinic Foundation	We would like to acknowledge the Center for Functional Medicine at Cleveland Clinic Foundation for their support with this project. We would specifically like to recognize Marilyn Alejandro-Rodriguez for her efforts.	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Bartlett SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138543; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0; Hanaway P, 2016, PERM J, V20, P125; Jacka FN, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0791-y; Lai JS, 2014, AM J CLIN NUTR, V99, P181, DOI 10.3945/ajcn.113.069880; Lee AC, 2017, J PAIN, V18, P1096, DOI 10.1016/j.jpain.2017.05.001; Nikiphorou E, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1151-6; Saag KG, 1997, ANN RHEUM DIS, V56, P463, DOI 10.1136/ard.56.8.463; Sanderson T, 2010, ARTHRIT CARE RES, V62, P647, DOI 10.1002/acr.20151; Sapranaviciute-Zabazlajeva L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014240; Shahouri SH, 2011, ARTHRITIS RHEUM-US, V63, P3204, DOI 10.1002/art.30524; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; Ward MM, 2016, ARTHRITIS RHEUMATOL, V68, P282, DOI 10.1002/art.39298; Wolfe F, 2007, J RHEUMATOL, V34, P1674; Wright GE, 1998, ARTHRITIS RHEUM, V41, P298, DOI 10.1002/1529-0131(199802)41:2<298::AID-ART14>3.3.CO;2-7	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240416	10.1371/journal.pone.0240416	http://dx.doi.org/10.1371/journal.pone.0240416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031458	gold, Green Published			2022-12-26	WOS:000581809800047
J	Mattoo, TK; Lu, H; Ayers, E; Thomas, R				Mattoo, Tej K.; Lu, Hong; Ayers, Eric; Thomas, Ronald			Total body water by BIA in children and young adults with normal and excessive weight	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; BIOIMPEDANCE SPECTROSCOPY; FLUID STATUS; HYDRATION; OBESE; DILUTION; VALIDATION; PREDICTION; ADOLESCENTS; MANAGEMENT	Background Estimation of total body water (TBW) is essential for clinical care. Objective Evaluation of changes in TBW by bioelectrical impedance analysis (BIA) in children and young adults with excessive weight. Design Data was collected in individuals aged 3-21 years with normal (n = 202) or excessive body weight (n = 133). The BIA results from individuals with normal weight were compared with two previously published studies in children by isotope dilution methods. Results Individuals with excessive weight had a higher mean TBW (27.87 L, SE 0.368) for height and age as compared to individuals with normal weight (23.95 L, SE 0.298), P<0.001. However, individuals with excessive weight had lower mean TBW (24.93 L, SE 0.37) for weight and body surface area (BSA) as compared to individuals with normal weight (26.94 L, SE 0.287), P<0.001. Comparison with two previously published studies showed no significant differences in mean TBW with one ((p = 1.00) but a significant difference with another study (p = 0.001). Conclusions Individuals with excessive weight had 16.5% higher mean TBW for height and age and 7.4% lower TBW for weight and BSA as compared to normal weight individuals. Our study validates the feasibility of data collection in pediatric outpatient setting by BIA.	[Mattoo, Tej K.; Lu, Hong; Thomas, Ronald] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Ayers, Eric] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Mattoo, TK (corresponding author), Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA.	tmattoo@med.wayne.edu	Mattoo, Tej K/CFB-5385-2022		Children's Foundation [R2-2017-28]	Children's Foundation	Tej Mattoo, MD Grant #R2-2017-28 Tej Mattoo, MD Children's Foundation https://yourchildrensfoundation.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglago KE, 2013, EUR J CLIN NUTR, V67, P1081, DOI 10.1038/ejcn.2013.125; Al-Ati T, 2015, PUBLIC HEALTH NUTR, V18, P259, DOI 10.1017/S1368980013003534; Androutsos O, 2015, J HUM NUTR DIET, V28, P165, DOI 10.1111/jhn.12259; [Anonymous], 1996, Nutrition, V12, P749; [Anonymous], **NON-TRADITIONAL**; Armstrong LE, 2005, NUTR REV, V63, pS40, DOI 10.1111/j.1753-4887.2005.tb00153.x; BATTISTINI N, 1992, INT J OBESITY, V16, P207; Beckmann L, 2009, IEEE ENG MED BIO, P4465, DOI 10.1109/IEMBS.2009.5333821; Bedogni G, 1997, EUR J CLIN NUTR, V51, P129, DOI 10.1038/sj.ejcn.1600351; CDC, 2013, NAT HLTH NUTR EX SUR; CHEEK DB, 1966, AM J DIS CHILD, V112, P312, DOI 10.1001/archpedi.1966.02090130086007; Dasgupta I, 2018, PEDIATR NEPHROL, V33, P1601, DOI 10.1007/s00467-018-3971-x; De Lorenzo A, 1999, CAN J PHYSIOL PHARM, V77, P17, DOI 10.1139/cjpp-77-1-17; DEHGHAN M, 2008, NUTR J, V7, DOI DOI 10.1186/1475-2891-7-26; El Harchaoui I, 2018, EUR J CLIN NUTR; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; FJELD CR, 1990, PEDIATR RES, V27, P98, DOI 10.1203/00006450-199001000-00024; FRIISHANSEN BJ, 1951, PEDIATRICS, V7, P321; Furstenberg A, 2011, AM J NEPHROL, V33, P150, DOI 10.1159/000324111; GUNDERSE.K, 1966, AM J CLIN NUTR, V19, P77, DOI 10.1093/ajcn/19.2.77; HANKIN ME, 1976, MED J AUSTRALIA, V2, P533, DOI 10.5694/j.1326-5377.1976.tb128209.x; Kyle UG, 2015, EUR J CLIN NUTR, V69, P1298, DOI 10.1038/ejcn.2015.86; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Leman CR, 2003, ANN TROP PAEDIATR, V23, P61, DOI 10.1179/000349803125002887; Lewy VD, 1999, J PEDIATR ENDOCR MET, V12, P443; Lukaski HC, 2007, NUTRITION, V23, P543, DOI 10.1016/j.nut.2007.05.001; Maffeis C, 2016, EUR J CLIN NUTR, V70, P560, DOI 10.1038/ejcn.2015.170; MCDONALD JJ, 1993, LANCET, V341, P1049, DOI 10.1016/0140-6736(93)92410-U; Meleleo D, 2017, EUR J SPORT SCI, V17, P710, DOI 10.1080/17461391.2017.1291750; MELLITS ED, 1970, MONOGR SOC RES CHILD, V35, P12, DOI 10.2307/1165809; Milani GP, 2017, AM J KIDNEY DIS, V69, P428, DOI 10.1053/j.ajkd.2016.10.023; Moissl U, 2013, CLIN J AM SOC NEPHRO, V8, P1575, DOI 10.2215/CJN.12411212; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; O'Lone EL, 2014, NEPHROL DIAL TRANSPL, V29, P1430, DOI 10.1093/ndt/gfu049; Oh G, 2014, PEDIATR NEPHROL, V29, P1417, DOI 10.1007/s00467-014-2778-7; Powers JS, 2009, J GERONTOL A-BIOL, V64, P664, DOI 10.1093/gerona/glp018; Raimann JG, 2014, KIDNEY INT, V85, P898, DOI 10.1038/ki.2013.358; Resende CMM, 2011, BRAZ J MED BIOL RES, V44, P1164, DOI [10.1590/S0100-879X2011001100013, 10.1590/S0100-879X2011007500122]; Ritz P, 2008, CLIN NUTR, V27, P740, DOI 10.1016/j.clnu.2008.07.010; Ritz P, 2000, ANN NY ACAD SCI, V904, P474; Rosinger AY, 2016, AM J CLIN NUTR, V104, P1554, DOI 10.3945/ajcn.116.137414; Sartorio A, 2005, EUR J CLIN NUTR, V59, P155, DOI 10.1038/sj.ejcn.1602049; Schaefer F, 2000, PEDIATR NEPHROL, V14, P673, DOI 10.1007/s004670000353; SEGAL KR, 1991, AM J CLIN NUTR, V54, P26, DOI 10.1093/ajcn/54.1.26; Stookey JD, 2007, EUR J CLIN NUTR, V61, P190, DOI 10.1038/sj.ejcn.1602521; Stupnicki Romuald, 2009, Pediatr Endocrinol Diabetes Metab, V15, P139; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Thurlow S, 2018, EUR J CLIN NUTR, V72, P148, DOI 10.1038/ejcn.2017.110; VIRGILI F, 1992, ANN HUM BIOL, V19, P57, DOI 10.1080/03014469200001922; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; Yang EM, 2017, J KOREAN MED SCI, V32, P1828, DOI 10.3346/jkms.2017.32.11.1828; Zaloszyc A, 2013, PEDIATR NEPHROL, V28, P2169, DOI 10.1007/s00467-013-2540-6	53	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239212	10.1371/journal.pone.0239212	http://dx.doi.org/10.1371/journal.pone.0239212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031479	gold, Green Published			2022-12-26	WOS:000581809800021
J	Hossain, MM; Staples, AE				Hossain, Md Monir; Staples, Anne E.			Effects of coral colony morphology on turbulent flow dynamics	PLOS ONE			English	Article							DIFFUSIVE BOUNDARY-LAYERS; WATER-FLOW; MADRACIS-MIRABILIS; MASS-TRANSFER; REEF CORAL; SURFACE-ROUGHNESS; AMMONIUM UPTAKE; OXYGEN; PHOTOSYNTHESIS; SIMULATION	Local flow dynamics play a central role in physiological processes like respiration and nutrient uptake in coral reefs. Despite the importance of corals as hosts to a quarter of all marine life, and the pervasive threats facing corals, characterizing the hydrodynamics between the branches of scleractinian corals has remained a significant challenge. Here, we investigate the effects of colony branch density and surface structure on the local flow field using three-dimensional immersed boundary, large-eddy simulations for four different colony geometries under unidirectional oncoming flow conditions. The first two colonies were from thePocilloporagenus, one with a densely branched geometry, and one with a comparatively loosely branched geometry. The second pair of geometries were derived from a scan of a singleMontipora capitatacolony, one with the roughness elements called verrucae covering the surface intact, and one with the verrucae removed. For thePocilloporacorals, we found that the mean velocity profiles changed substantially in the center of the dense colony, becoming significantly reduced at middle heights where flow penetration was poor, while the mean velocity profiles in the loosely branched colony remained similar in character from the front to the back of the colony. For theMontiporacorals, somewhat counterintuitively, the colony without verrucae produced almost double the maximum Reynolds stress magnitude above the colony compared to the colony without verrucae. This implies that the smooth colony will have enhanced mass transport and higher bed shear stress and friction velocity values relative to the colony with verrucae.	[Hossain, Md Monir; Staples, Anne E.] Virginia Tech, Dept Biomed Engn & Mech, Engn Mech Program, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hossain, MM (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Engn Mech Program, Blacksburg, VA 24061 USA.	mdmoh81@vt.edu	Staples, Anne/ABD-9704-2021	Staples, Anne/0000-0003-4823-8184; HOSSAIN, MD MONIR/0000-0002-3338-4173	United States Department of State's Bureau of Educational and Cultural Affairs through the Fulbright Program; Engineering Mechanics program at Virginia Tech; Virginia Tech Open Access Subvention Fund	United States Department of State's Bureau of Educational and Cultural Affairs through the Fulbright Program; Engineering Mechanics program at Virginia Tech; Virginia Tech Open Access Subvention Fund	This work was supported by the United States Department of State's Bureau of Educational and Cultural Affairs through the Fulbright Program and by the Engineering Mechanics program at Virginia Tech. Publication of this work was supported by the Virginia Tech Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 2007, Eur J Gastroenterol Hepatol, V19 Suppl 1, pS11; [Anonymous], 2020, PACIFIC ISLANDS OCEA; Asher S, 2016, J GEOPHYS RES-OCEANS, V121, P3549, DOI 10.1002/2015JC011428; Asman P, 2012, ANTLER CORAL POCILLO; ATKINSON MJ, 1992, LIMNOL OCEANOGR, V37, P273, DOI 10.4319/lo.1992.37.2.0273; Baird ME, 1997, LIMNOL OCEANOGR, V42, P1685, DOI 10.4319/lo.1997.42.8.1685; Balaras E, 2004, COMPUT FLUIDS, V33, P375, DOI 10.1016/S0045-7930(03)00058-6; Bruno JF, 1998, J EXP MAR BIOL ECOL, V229, P187, DOI 10.1016/S0022-0981(98)00050-1; CHAMBERLAIN JA, 1975, B MAR SCI, V25, P112; Chang S, 2009, LIMNOL OCEANOGR, V54, P1819, DOI DOI 10.4319/LO.2009.54.5.1819; Chang S, 2014, J GEOPHYS RES-OCEANS, V119, P2599, DOI 10.1002/2013JC009751; Chindapol N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002849; Delandmeter P, 2017, OCEAN DYNAM, V67, P897, DOI 10.1007/s10236-017-1066-z; DENNISON WC, 1988, J EXP MAR BIOL ECOL, V115, P67, DOI 10.1016/0022-0981(88)90190-6; Dipprey D.F., 1963, INT J HEAT MASS TRAN, V6, P329, DOI 10.1016/0017-9310(63)90097-8; Fabricius KE, 1995, LIMNOL OCEANOGR, V40, P1290, DOI 10.4319/lo.1995.40.7.1290; Falter JL, 2005, LIMNOL OCEANOGR, V50, P246, DOI 10.4319/lo.2005.50.1.0246; Finelli CM, 2006, CORAL REEFS, V25, P47, DOI 10.1007/s00338-005-0055-8; Finnigan J, 2000, ANNU REV FLUID MECH, V32, P519, DOI 10.1146/annurev.fluid.32.1.519; GRAUS RR, 1989, CORAL REEFS, V8, P9, DOI 10.1007/BF00304687; Hondzo M, 1998, WATER RESOUR RES, V34, P3525, DOI 10.1029/1998WR900009; Hossain MM, 2019, PHYS FLUIDS, V31, DOI 10.1063/1.5094076; Inaglory B., 2008, POCILLOPORA MEANDRIN; Jimenez IM, 2011, J R SOC INTERFACE, V8, P1785, DOI 10.1098/rsif.2011.0144; Kaandorp JA, 2005, P ROY SOC B-BIOL SCI, V272, P127, DOI 10.1098/rspb.2004.2934; Kaandorp JA, 2003, PHILOS T R SOC B, V358, P1551, DOI 10.1098/rstb.2003.1339; Kaandorp JA, 2001, VIRTUAL LAB, P1; Kastner-Klein P, 2004, BOUND-LAY METEOROL, V111, P55, DOI 10.1023/B:BOUN.0000010994.32240.b1; Larkum AWD, 2003, MAR BIOL, V142, P1073, DOI 10.1007/s00227-003-1022-y; LESSER MP, 1994, J EXP MAR BIOL ECOL, V178, P153, DOI 10.1016/0022-0981(94)90034-5; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002789; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI [10.1029/2004JC002711, 10.1029/2004JC002788]; Markl M, 2003, J MAGN RESON IMAGING, V17, P499, DOI 10.1002/jmri.10272; Mass T, 2008, MAR ECOL PROG SER, V369, P131, DOI 10.3354/meps07578; Meneveau C, 1996, J FLUID MECH, V319, P353, DOI 10.1017/S0022112096007379; Moltchanov S, 2013, WATER RESOUR RES, V49, P8222, DOI 10.1002/2013WR014488; Moltchanov S, 2011, BOUND-LAY METEOROL, V139, P333, DOI 10.1007/s10546-010-9582-0; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Osorio-Cano JD, 2019, J FLUID STRUCT, V88, P31, DOI 10.1016/j.jfluidstructs.2019.04.001; Reidenbach MA, 2006, LIMNOL OCEANOGR, V51, P1134, DOI 10.4319/lo.2006.51.2.1134; Reidenbach MA, 2006, LIMNOL OCEANOGR, V51, P1956, DOI 10.4319/lo.2006.51.5.1956; Sebens K., 1992, P 7 INT COR REEF S G, V1, P557; Sebens KP, 1997, J EXP MAR BIOL ECOL, V211, P1, DOI 10.1016/S0022-0981(96)02636-6; Sebens KP, 1996, MAR BIOL, V127, P303, DOI 10.1007/BF00942116; Shashar N, 1996, J EXP MAR BIOL ECOL, V199, P17, DOI 10.1016/0022-0981(95)00156-5; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; SHICK JM, 1990, BIOL BULL, V179, P148, DOI 10.2307/1541749; Stocking JB, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0448; Stocking JB, 2016, CORAL REEFS, V35, P1047, DOI 10.1007/s00338-016-1446-8; Storlazzi CD, 2011, CORAL REEFS, V30, P83, DOI 10.1007/s00338-011-0723-9; Thomas FIM, 2003, MAR ECOL PROG SER, V247, P51, DOI 10.3354/meps247051; Thomas FIM, 1997, LIMNOL OCEANOGR, V42, P81, DOI 10.4319/lo.1997.42.1.0081; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; Veron J.J., 1976, SCLERACTINIA E AUS 1	56	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0225676	10.1371/journal.pone.0225676	http://dx.doi.org/10.1371/journal.pone.0225676			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027270	Green Published, gold, Green Submitted			2022-12-26	WOS:000581808000004
J	Kenmotsu, H; Uchida, K; Hirose, Y; Eki, T				Kenmotsu, Harutaro; Uchida, Kiichi; Hirose, Yuu; Eki, Toshihiko			Taxonomic profiling of individual nematodes isolated from copse soils using deep amplicon sequencing of four distinct regions of the 18S ribosomal RNA gene	PLOS ONE			English	Article							COMMUNITY STRUCTURE; LIVING NEMATODES; DIVERSITY; FOREST; PLANT; ABUNDANCE	Nematodes are representative soil metazoans with diverged species that play crucial roles in nutrient recycling in the pedosphere. Qualitative and quantitative information on nematode communities is useful for assessing soil quality, and DNA barcode-mediated taxonomic analysis is a powerful tool to investigate taxonomic compositions and changes in nematode communities. Here, we investigated four regions (regions 1-4) of the 18S small subunit ribosomal RNA (SSU) gene as PCR targets of deep amplicon sequencing for the taxonomic profiling of individual soil nematodes. We determined the sequence variants (SVs) of 4 SSU regions for 96 nematodes (total 384 amplicons) isolated from copse soils and assigned their taxonomy using the QIIME2 software with dada2 or deblur algorithm and the SILVA database. Dada2 detected approximately 2-fold more nematode-derived SVs than deblur, and a larger number of SVs were obtained in regions 1 and 4 than those in other regions. These results and sufficient reference sequence coverage in region 4 indicated that DNA barcoding using a primer set for region 4 followed by dada2-based analysis would be most suitable for soil nematode taxonomic analysis. Eighteen SSU-derived operational taxonomic units (rOTUs) were obtained from 68 isolates, and their orders were determined based on the phylogenetic trees built by four regional sequences of rOTUs and 116 nematode reference species as well as the BLASTN search. The majority of the isolates were derived from three major orders Dorylaimida (6 rOTUs, 51.5% in 68 isolates), Rhabditida (4 rOTUs, 29.4%), and Triplonchida (7 rOTUs, 17.6%). The predicted feeding types of the isolates were fungivores (38.2% in total nematodes), plant feeders (32.4%), and 14.7% for both bacterivores and omnivores/predators. Additionally, we attempted to improve the branch structure of phylogenetic trees by using long nucleotide sequences artificially prepared by connecting regional sequences, but the effect was limited.	[Kenmotsu, Harutaro; Uchida, Kiichi; Hirose, Yuu; Eki, Toshihiko] Toyohashi Univ Technol, Dept Appl Chem & Life Sci, Mol Genet Lab, Toyohashi, Aichi, Japan	Toyohashi University of Technology	Eki, T (corresponding author), Toyohashi Univ Technol, Dept Appl Chem & Life Sci, Mol Genet Lab, Toyohashi, Aichi, Japan.	eki@chem.tut.ac.jp		Eki, Toshihiko/0000-0003-1553-8279	Takahashi Industrial and Economic Research Foundation	Takahashi Industrial and Economic Research Foundation	This work was financially supported in part by Takahashi Industrial and Economic Research Foundation (http://takahashi-f.or.jp) to T. E.	Ahmed Mohammed, 2019, Metabarcoding and Metagenomics, V3, P77, DOI 10.3897/mbmg.3.36408; Alphei J, 1998, APPL SOIL ECOL, V9, P9, DOI 10.1016/S0929-1393(98)00047-X; Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00199-16; [Anonymous], 2019, CANC DISCOV, V10, pOF5; Avramenko RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143559; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cristescu ME, 2014, TRENDS ECOL EVOL, V29, P566, DOI 10.1016/j.tree.2014.08.001; Dell'Anno A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144928; Derycke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013716; Dong K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03655-3; Du XF, 2020, APPL SOIL ECOL, V152, DOI 10.1016/j.apsoil.2020.103562; Forge TA, 2001, BIOL FERT SOILS, V34, P170, DOI 10.1007/s003740100390; Gutierrez C, 2016, ENVIRON POLLUT, V213, P184, DOI 10.1016/j.envpol.2016.02.012; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Herren GL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230153; Holovachov O, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170315; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hugerth LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095567; Ito T, 2015, APPL SOIL ECOL, V89, P50, DOI 10.1016/j.apsoil.2014.12.010; Kitagami Y, 2017, APPL SOIL ECOL, V119, P91, DOI 10.1016/j.apsoil.2017.05.030; Kitagami Yudai, 2016, Nematological Research, V46, P71; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YJ, 2015, NEMATOLOGY, V17, P79, DOI 10.1163/15685411-00002853; Liu T, 2016, AGR ECOSYST ENVIRON, V232, P199, DOI 10.1016/j.agee.2016.07.015; Macheriotou L, 2019, ECOL EVOL, V9, P1211, DOI 10.1002/ece3.4814; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matlack GR, 2001, FOREST ECOL MANAG, V146, P129, DOI 10.1016/S0378-1127(00)00454-0; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morise H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051785; Muller CA, 2019, FOREST ECOL MANAG, V453, DOI 10.1016/j.foreco.2019.117591; Mulder C, 2005, ECOTOX ENVIRON SAFE, V62, P278, DOI 10.1016/j.ecoenv.2005.03.028; Neher DA, 2005, APPL SOIL ECOL, V30, P47, DOI 10.1016/j.apsoil.2005.01.002; Neher DA, 2010, ANNU REV PHYTOPATHOL, V48, P371, DOI 10.1146/annurev-phyto-073009-114439; NYCZEPIR AP, 1983, PLANT DIS, V67, P507, DOI 10.1094/PD-67-507; Panesar TS, 2001, PEDOBIOLOGIA, V45, P193, DOI 10.1078/0031-4056-00080; Parvizi J, 2009, J ARTHROPLASTY, V24, P110, DOI 10.1016/j.arth.2009.05.021; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Porazinska DL, 1999, APPL SOIL ECOL, V13, P69, DOI 10.1016/S0929-1393(99)00018-9; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Pothula SK, 2019, J NEMATOL, V51, DOI 10.21307/jofnem-2019-011; PROCTER DLC, 1990, J NEMATOL, V22, P1; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Sapkota R, 2018, AGR ECOSYST ENVIRON, V257, P120, DOI 10.1016/j.agee.2018.01.032; Sapkota R, 2015, BMC ECOL, V15, DOI 10.1186/s12898-014-0034-4; Schenk J, 2020, ECOL EVOL, V10, P2885, DOI 10.1002/ece3.6104; Seesao Y, 2017, J MICROBIOL METH, V138, P37, DOI 10.1016/j.mimet.2016.05.030; Sohlenius B, 2002, APPL SOIL ECOL, V19, P261, DOI 10.1016/S0929-1393(02)00003-3; Sun XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082468; Treonis AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20366-5; van den Hoogen J, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0437-3; van den Hoogen J, 2019, NATURE, V572, P194, DOI 10.1038/s41586-019-1418-6; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Verschoor BC, 2002, J ECOL, V90, P753, DOI 10.1046/j.1365-2745.2002.00710.x; Waeyenberge L, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11040052; YEATES GW, 1993, J NEMATOL, V25, P315; Yeates GW, 1999, AGR ECOSYST ENVIRON, V74, P113, DOI 10.1016/S0167-8809(99)00033-X; Zeng YS, 2012, ZOOTAXA, P1; Zhang M, 2012, ZOOL STUD, V51, P619; Zhang XK, 2015, SOIL BIOL BIOCHEM, V80, P118, DOI 10.1016/j.soilbio.2014.10.003	64	5	5	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240336	10.1371/journal.pone.0240336	http://dx.doi.org/10.1371/journal.pone.0240336			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027282	Green Published, gold			2022-12-26	WOS:000581808000029
J	Berta, P; Paruolo, P; Verzillo, S; Lovaglio, PG				Berta, Paolo; Paruolo, Paolo; Verzillo, Stefano; Lovaglio, Pietro Giorgio			A bivariate prediction approach for adapting the health care system response to the spread of COVID-19	PLOS ONE			English	Article							COINTEGRATION	The spread of COVID-19 implied a large and fast increase of demand for intensive care services. To face this increase in demand, health care systems need to adapt their response by increasing hospital beds, intensive care unit (ICU) capacity and by (re-)deploying doctors and other personnel. This paper proposes a forecast approach based on the Vector Error Correction model for the daily counts of hospitalized patients with symptoms and of patients in ICU, using publicly available data on the current COVID-19 outbreak in Italy, Switzerland and Spain. The level of analysis is the local government managing the health care system response, which corresponds to regions for Italy. The one-week-ahead forecasts are validated with out-of-sample data over successive weeks; they are found to provide timely and robust prediction of ICU capacity needs in Lombardy, the most-affected Italian region, starting from the sample of the first 2 weeks of data. The same methodology is successfully validated on other Italian regions, Switzerland and Spain. This approach may be used in other countries/regions/provinces to help adapt the health care system response to COVID-19 (or other similar disease); for this purpose, the open-source software code to produce the forecasts is provided with the paper.	[Berta, Paolo; Lovaglio, Pietro Giorgio] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy; [Paruolo, Paolo; Verzillo, Stefano] European Commiss, Joint Res Ctr, Ispra, Italy	University of Milano-Bicocca; European Commission Joint Research Centre; EC JRC ISPRA Site	Verzillo, S (corresponding author), European Commiss, Joint Res Ctr, Ispra, Italy.	stefano.verzillo@ec.europa.eu		VERZILLO, STEFANO/0000-0002-1895-8554; Paruolo, Paolo/0000-0002-3982-4889	Regione Lombardia [2014IT16RFOP012]	Regione Lombardia(Regione Lombardia)	Paolo Berta, Pietro Giorgio Lovaglio acknowledge funding from Regione Lombardia (2014IT16RFOP012). Paolo Paruolo and Stefano Verzillo received no specific funding for this work. The funder had no roles in our study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bartoszek K., 2020, TECHNICAL REPORT; Benvenuto D, 2020, DATA BRIEF, V29, DOI 10.1016/j.dib.2020.105340; Berta P, 2020, WORKING PAPER; Branas CC., 2020, FLATTENING CURVE IT, DOI [10.1101/2020.04.01.20049759, DOI 10.1101/2020.04.01.20049759]; Chowell G, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1406-6; ECDC, 2020, TECHNICAL REPORT; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Ghysels E, 2016, J ECONOMETRICS, V193, P294, DOI 10.1016/j.jeconom.2016.04.008; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Hendry, 1995, DYNAMIC ECONOMETRICS; JOHANSEN S, 1991, ECONOMETRICA, V59, P1551, DOI 10.2307/2938278; Johansen S., 1996, LIKELIHOOD BASED INF; Kuzin V, 2011, INT J FORECASTING, V27, P529, DOI 10.1016/j.ijforecast.2010.02.006; Makridakis S, 2020, INT J FORECASTING, V36, P54, DOI 10.1016/j.ijforecast.2019.04.014; McAlinn K, 2020, J AM STAT ASSOC, V115, P1092, DOI 10.1080/01621459.2019.1660171; McAlinn K, 2019, J ECONOMETRICS, V210, P155, DOI 10.1016/j.jeconom.2018.11.010; Peracchi, 2020, COVID 19 PANDEMIC IT; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Richardson S., 2020, GUARDIAN; Rodriguez-Llanes J, 2020, TECHNICAL REPORT; Roosa K, 2020, INFECT DIS MODEL, V5, P256, DOI 10.1016/j.idm.2020.02.002; Stubinger J, 2020, ALGORITHMS, V13, DOI 10.3390/a13040095; Stubinger J, 2019, QUANT FINANC, V19, P921, DOI 10.1080/14697688.2018.1537503; Tofallis C, 2015, J OPER RES SOC, V66, P1352, DOI 10.1057/jors.2014.103	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240150	10.1371/journal.pone.0240150	http://dx.doi.org/10.1371/journal.pone.0240150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057389	Green Published, gold			2022-12-26	WOS:000581814700002
J	Cohen, ND; Cywes-Bentley, C; Kahn, SM; Bordin, AI; Bray, JM; Wehmeyer, SG; Pier, GB				Cohen, Noah D.; Cywes-Bentley, Colette; Kahn, Susanne M.; Bordin, Angela I.; Bray, Jocelyne M.; Wehmeyer, S. Garrett; Pier, Gerald B.			Vaccination of yearling horses against poly-N-acetyl glucosamine fails to protect against infection with Streptococcus equi subspecies equi	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; CONJUGATE VACCINES; STRANGLES; ANTIBODY	Strangles is a common disease of horses with worldwide distribution caused by the bacterium Streptococcus equi subspecies equi (SEE). Although vaccines against strangles are available commercially, these products have limitations in safety and efficacy. The microbial surface antigen beta 1 -> 6 poly-N-acetylglucosamine (PNAG) is expressed by SEE. Here we show that intramuscular (IM) injection alone or a combination of IM plus intranasal (IN) immunization generated antibodies to PNAG that functioned to deposit complement and mediate opsonophagocytic killing of SEE ex vivo. However, immunization strategies targeting PNAG either by either IM only injection or a combination of IM and IN immunizations failed to protect yearling horses against infection following contact with infected horses in an experimental setting. We speculate that a protective vaccine against strangles will require additional components, such as those targeting SEE enzymes that degrade or inactivate equine IgG.	[Cohen, Noah D.; Kahn, Susanne M.; Bordin, Angela I.; Bray, Jocelyne M.; Wehmeyer, S. Garrett] Texas A&M Univ, Coll Vet Med & Biomed Sci, Equine Infect Dis Lab, College Stn, TX 77843 USA; [Cywes-Bentley, Colette; Pier, Gerald B.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Texas A&M University System; Texas A&M University College Station; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cohen, ND (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Equine Infect Dis Lab, College Stn, TX 77843 USA.; Pier, GB (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.	ncohen@cvm.tamu.edu; gpier@bwh.harvard.edu	Pier, Gerald/AAO-2692-2021	Pier, Gerald/0000-0002-9112-2331; Cywes Bentley, Colette/0000-0002-6301-0930; Bordin, Angela/0000-0002-7678-3908; Cohen, Noah/0000-0002-0384-2903	Grayson-Jockey Club Research Foundation; Morris Animal Foundation [D19EQ-012]; Link Equine Research Endowment	Grayson-Jockey Club Research Foundation; Morris Animal Foundation; Link Equine Research Endowment	This work was supported by grants from the Grayson-Jockey Club Research Foundation (IM vaccination portion; no grant identifier) and the Morris Animal Foundation (IM+IN vaccination; grant number (D19EQ-012). Additional support was provided by the Link Equine Research Endowment (no grant identifier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, J CANC RES THER, V14, pS622; Borst LB, 2011, AM J VET RES, V72, P1130, DOI 10.2460/ajvr.72.8.1130; Boyle AG, 2018, J VET INTERN MED, V32, P633, DOI 10.1111/jvim.15043; Cursons R, 2015, VACCINE, V33, P3440, DOI 10.1016/j.vaccine.2015.05.009; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; D'Gama JD, 2019, MBIO, V10, DOI 10.1128/mBio.02500-19; Delph KM, 2019, J VET INTERN MED, V33, P275, DOI 10.1111/jvim.15388; Gening ML, 2010, INFECT IMMUN, V78, P764, DOI 10.1128/IAI.01093-09; Hulting G, 2009, FEMS MICROBIOL LETT, V298, P44, DOI 10.1111/j.1574-6968.2009.01698.x; Kaese Heather J, 2005, J Am Vet Med Assoc, V226, P1893, DOI 10.2460/javma.2005.226.1893; Kelly-Quintos C, 2006, INFECT IMMUN, V74, P2742, DOI 10.1128/IAI.74.5.2742-2750.2006; Kelly-Quintos C, 2005, J INFECT DIS, V192, P2012, DOI 10.1086/497604; Lannergard J, 2006, FEMS MICROBIOL LETT, V262, P230, DOI 10.1111/j.1574-6968.2006.00404.x; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; Morris ERA, 2020, VET MICROBIOL, V243, DOI 10.1016/j.vetmic.2020.108638; Naegeli A, 2019, J EXP MED, V216, P1615, DOI 10.1084/jem.20190293; Paillot R, 2017, EQUINE VET J, V49, P141, DOI 10.1111/evj.12659; Pozzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046648; Pusterla N, 2003, VET REC, V153, P118, DOI 10.1136/vr.153.4.118; Robinson C, 2020, VACCINE, V38, P4861, DOI 10.1016/j.vaccine.2020.05.046; Skurnik D, 2010, J CLIN INVEST, V120, P3220, DOI 10.1172/JCI42748; Slater JD, 2003, EQUINE VET J, V35, P118, DOI 10.2746/042516403776114252; Sponseller BT, 2005, JAVMA-J AM VET MED A, V227, P1800, DOI 10.2460/javma.2005.227.1800; SWEENEY CR, 1987, J AM VET MED ASSOC, V191, P1446; Sweeney CR, 2005, J VET INTERN MED, V19, P123, DOI 10.1892/0891-6640(2005)19&lt;123:SEIIHG&gt;2.0.CO;2; Waller AS, 2011, J MED MICROBIOL, V60, P1231, DOI 10.1099/jmm.0.028233-0	26	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240479	10.1371/journal.pone.0240479	http://dx.doi.org/10.1371/journal.pone.0240479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057397	Green Published, gold			2022-12-26	WOS:000581814700050
J	Willis, S; Moore, BCJ; Galvin, JJ; Fu, QJ				Willis, Shelby; Moore, Brian C. J.; Galvin, John J., III; Fu, Qian-Jie			Effects of noise on integration of acoustic and electric hearing within and across ears	PLOS ONE			English	Article							ENERGETIC MASKING RELEASE; COCHLEAR IMPLANT USERS; BINAURAL PITCH FUSION; SPEECH RECOGNITION; SPECTRAL CHANNELS; STIMULATION; PERCEPTION; ADAPTATION; LISTENERS; BENEFIT	In bimodal listening, cochlear implant (CI) users combine electric hearing (EH) in one ear and acoustic hearing (AH) in the other ear. In electric-acoustic stimulation (EAS), CI users combine EH and AH in the same ear. In quiet, integration of EH and AH has been shown to be better with EAS, but with greater sensitivity to tonotopic mismatch in EH. The goal of the present study was to evaluate how external noise might affect integration of AH and EH within or across ears. Recognition of monosyllabic words was measured for normal-hearing subjects listening to simulations of unimodal (AH or EH alone), EAS, and bimodal listening in quiet and in speech-shaped steady noise (10 dB, 0 dB signal-to-noise ratio). The input/output frequency range for AH was 0.1-0.6 kHz. EH was simulated using an 8-channel noise vocoder. The output frequency range was 1.2-8.0 kHz to simulate a shallow insertion depth. The input frequency range was either matched (1.2-8.0 kHz) or mismatched (0.6-8.0 kHz) to the output frequency range; the mismatched input range maximized the amount of speech information, while the matched input resulted in some speech information loss. In quiet, tonotopic mismatch differently affected EAS and bimodal performance. In noise, EAS and bimodal performance was similarly affected by tonotopic mismatch. The data suggest that tonotopic mismatch may differently affect integration of EH and AH in quiet and in noise.	[Willis, Shelby; Fu, Qian-Jie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA; [Moore, Brian C. J.] Univ Cambridge, Dept Expt Psychol, Cambridge, England; [Galvin, John J., III] House Inst Fdn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Cambridge	Fu, QJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.	qfu@mednet.ucla.edu		Fu, Qian-Jie/0000-0003-3494-7633; Moore, Brian/0000-0001-7071-0671	National Institute on Deafness and Other Communication Disorders (NIDCD) [R01-DC-016883]	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research was supported by The National Institute on Deafness and Other Communication Disorders (NIDCD) R01-DC-016883. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, RIV STORIA MINIATURA, V11, P301; Armstrong M, 1997, AM J OTOL, V18, pS140; Aronoff JM, 2016, EAR HEARING, V37, pe85, DOI 10.1097/AUD.0000000000000249; Aronoff JM, 2014, EAR HEARING, V35, P708, DOI 10.1097/AUD.0000000000000060; Bierer JA, 2016, TRENDS HEAR, V20, DOI 10.1177/2331216516653389; Boyd PJ, 2011, EAR HEARING, V32, P411, DOI 10.1097/AUD.0b013e3182064bda; Brown CA, 2009, EAR HEARING, V30, P489, DOI 10.1097/AUD.0b013e3181ab2b87; Chatterjee M, 2008, HEARING RES, V235, P143, DOI 10.1016/j.heares.2007.11.004; Crew JD, 2016, TRENDS HEAR, V20, DOI 10.1177/2331216516669329; Crew JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120279; Dalbert A, 2015, AUDIOL NEURO-OTOL, V20, P339, DOI 10.1159/000438742; Dorman MF, 2008, AUDIOL NEURO-OTOL, V13, P105, DOI 10.1159/000111782; Dorman MF, 2010, INT J AUDIOL, V49, P912, DOI 10.3109/14992027.2010.509113; Faulkner Andrew, 2006, Audiol Neurootol, V11 Suppl 1, P21, DOI 10.1159/000095610; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2017, J ACOUST SOC AM, V142, pEL561, DOI 10.1121/1.5017530; Fu QJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12298-3; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P180, DOI 10.1007/s10162-005-5061-6; Fu QJ, 1998, J ACOUST SOC AM, V104, P505, DOI 10.1121/1.423251; Fu QJ, 2002, J ACOUST SOC AM, V112, P1664, DOI 10.1121/1.1502901; Galvin JJ, 2007, EAR HEARING, V28, P302, DOI 10.1097/01.aud.0000261689.35445.20; Gantz BJ, 2016, LARYNGOSCOPE, V126, P962, DOI 10.1002/lary.25572; Gfeller Kate, 2002, Cochlear Implants Int, V3, P29, DOI 10.1179/cim.2002.3.1.29; Gifford RH, 2017, EAR HEARING, V38, P539, DOI 10.1097/AUD.0000000000000418; Gifford RH, 2015, OTOL NEUROTOL, V36, P1331, DOI 10.1097/MAO.0000000000000804; Gifford RH, 2014, AUDIOL NEURO-OTOL, V19, P57, DOI 10.1159/000355700; Gordon KA, 2011, BRAIN TOPOGR, V24, P204, DOI 10.1007/s10548-011-0181-2; Goupell MJ, 2013, J ACOUST SOC AM, V133, P2272, DOI 10.1121/1.4792936; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; Kan A, 2015, EAR HEARING, V36, pE62, DOI 10.1097/AUD.0000000000000135; Karsten SA, 2013, EAR HEARING, V34, P142, DOI 10.1097/AUD.0b013e318269ce87; Kong YY, 2011, J SPEECH LANG HEAR R, V54, P959, DOI 10.1044/1092-4388(2010/10-0197); Kong YY, 2005, J ACOUST SOC AM, V117, P1351, DOI 10.1121/1.1857526; Kral A, 2006, PROG BRAIN RES, V157, P283, DOI 10.1016/S0079-6123(06)57018-9; Kruger B, 2017, HEARING RES, V353, P185, DOI 10.1016/j.heares.2017.06.014; Kulkarni PN, 2012, INT J AUDIOL, V51, P334, DOI 10.3109/14992027.2011.642012; Laback B, 2015, HEARING RES, V322, P138, DOI 10.1016/j.heares.2014.10.004; Labadie RF, 2016, OTOL NEUROTOL, V37, P137, DOI 10.1097/MAO.0000000000000926; Li TH, 2009, EAR HEARING, V30, P238, DOI 10.1097/AUD.0b013e31819769ac; Looi V, 2008, INT J AUDIOL, V47, P257, DOI 10.1080/14992020801955237; Luo X, 2006, J ACOUST SOC AM, V120, P2260, DOI 10.1121/1.2336990; Micheyl C, 2012, J ACOUST SOC AM, V131, P3970, DOI 10.1121/1.3699231; Noble JH, 2016, OTOL NEUROTOL, V37, pE63, DOI 10.1097/MAO.0000000000000909; Oh Y, 2017, J ACOUST SOC AM, V142, P780, DOI 10.1121/1.4997190; Reiss LAJ, 2018, EAR HEARING, V39, P390, DOI 10.1097/AUD.0000000000000497; Reiss LAJ, 2014, JARO-J ASSOC RES OTO, V15, P235, DOI 10.1007/s10162-013-0434-8; Rosen S, 1999, J ACOUST SOC AM, V106, P3629, DOI 10.1121/1.428215; Sagi E, 2010, JARO-J ASSOC RES OTO, V11, P69, DOI 10.1007/s10162-009-0187-6; Shannon RV, 2011, AUDIOL NEURO-OTOL, V16, P113, DOI 10.1159/000315115; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shannon RV, 2004, ACTA OTO-LARYNGOL, V124, P50, DOI 10.1080/03655230410017562; Stone MA, 2016, J ACOUST SOC AM, V140, P832, DOI 10.1121/1.4960483; Stone MA, 2014, J ACOUST SOC AM, V135, P1967, DOI 10.1121/1.4868392; Svirsky MA, 2004, ACTA OTO-LARYNGOL, V124, P381, DOI 10.1080/00016480310000593; Svirsky MA, 2015, HEARING RES, V322, P163, DOI 10.1016/j.heares.2014.10.008; Tejani VD, 2019, HEARING RES, V373, P113, DOI 10.1016/j.heares.2019.01.002; Tyler RS, 2002, EAR HEARING, V23, P98, DOI 10.1097/00003446-200204000-00003; Yang HI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01419; Yoon Yang-Soo, 2015, Cochlear Implants Int, V16, P159, DOI 10.1179/1754762814Y.0000000101; Yoon YS, 2012, J SPEECH LANG HEAR R, V55, P105, DOI 10.1044/1092-4388(2011/10-0325); Zhang T, 2010, EAR HEARING, V31, P195, DOI 10.1097/AUD.0b013e3181c4758d; Zhang T, 2010, EAR HEARING, V31, P63, DOI 10.1097/AUD.0b013e3181b7190c; Zhou N, 2012, J ACOUST SOC AM, V132, P994, DOI 10.1121/1.4730907	63	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240752	10.1371/journal.pone.0240752	http://dx.doi.org/10.1371/journal.pone.0240752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057396	Green Published, gold			2022-12-26	WOS:000581814700052
J	Xu, LG; Huan, L; Guo, TA; Wu, YJ; Liu, YF; Wang, QF; Huang, SL; Xu, Y; Liang, LH; He, XH				Xu, Linguo; Huan, Lin; Guo, Tianan; Wu, Yangjun; Liu, Yanfang; Wang, Qifeng; Huang, Shenglin; Xu, Ye; Liang, Linhui; He, Xianghuo			LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1 alpha	ONCOGENE			English	Article							LONG NONCODING RNA; ALPHA; CANCER; LOCALIZATION; DEGRADATION; HIF-1	Epigenetic alteration is one of the hallmarks of colorectal cancer (CRC). Many driver genes are regulated by DNA methylation in CRC. However, the role of DNA methylation regulating lncRNAs remain elusive. Here, we identify that SNHG11 (small nucleolar RNA host gene 11) is upregulated by promotor hypomethylation in CRC and is associated with poor prognosis in CRC patients. SNHG11 can promote CRC cell migration and metastasis under hypoxia. Interestingly, the DNA-binding motif of SNHG11 is similar to that of HIF-1 alpha. In addition, SNHG11-associated genes are enriched with members of the HIF-1 signaling pathway in CRC. Mechanistically, SNHG11 binds to the pVHLrecognition sites on HIF-1 alpha, thus blocking the interaction of pVHL with HIF-1 alpha and preventing its ubiquitination and degradation. Moreover, SNHG11 upregulates the expression of HIF-1 alpha target genes, i.e., AK4, ENO1, HK2, and Twist1. Notably, SNHG11 can bind to the HRE sites in the promoter of these genes and increase their transcription. In summary, these results identify a SNHG11/ HIF-1 alpha axis that plays a pivotal role in tumor invasion and metastasis.	[Xu, Linguo; Huan, Lin; Wu, Yangjun; Liu, Yanfang; Huang, Shenglin; Liang, Linhui; He, Xianghuo] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Xu, Linguo; Huan, Lin; Wu, Yangjun; Liu, Yanfang; Huang, Shenglin; Liang, Linhui; He, Xianghuo] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Xu, Linguo; Huan, Lin; Guo, Tianan; Wu, Yangjun; Liu, Yanfang; Wang, Qifeng; Huang, Shenglin; Xu, Ye; Liang, Linhui; He, Xianghuo] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Guo, Tianan; Xu, Ye] Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Wang, Qifeng] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Liang, Linhui; He, Xianghuo] Fudan Univ, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Liang, LH; He, XH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Shanghai 200032, Peoples R China.; Liang, LH; He, XH (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China.; Xu, Y; Liang, LH; He, XH (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China.	xuye021@163.com; lianglinhui@fudan.edu.cn; xhhe@fudan.edu.cn	liang, linhui/AAW-4176-2021; xu, ye/GQO-8972-2022; liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022; He, Xianghuo/I-1497-2014; Huan, Lin/W-1334-2018; Huang, Shenglin/N-9472-2018	He, Xianghuo/0000-0001-8872-668X; Huan, Lin/0000-0002-5791-4482; xu, ye/0000-0003-0455-4556; Huang, Shenglin/0000-0003-1279-0794	National Natural Science Foundation of China [81672366, 81930123, 81790252]; China Postdoctoral Science Foundation [2020M671006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from National Natural Science Foundation of China (81672366, 81930123, 81790252) and China Postdoctoral Science Foundation (2020M671006).	Athauda A, 2019, CANCER TREAT REV, V73, P31, DOI 10.1016/j.ctrv.2018.12.004; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Chen LL, 2016, TRENDS BIOCHEM SCI, V41, P761, DOI 10.1016/j.tibs.2016.07.003; Chu Ci, 2012, J Vis Exp, DOI 10.3791/3912; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Gao S, 2014, FASEB J, V28, P1880, DOI 10.1096/fj.12-220152; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Gudenas BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34708-w; Han P, 2015, RNA BIOL, V12, P1094, DOI 10.1080/15476286.2015.1063770; Han P, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0583-1; Hou Y, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00936; Huan L, 2020, MOL CANCER, V19, DOI 10.1186/s12943-019-1122-z; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Jan YH, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0698-5; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Kondo Y, 2017, CANCER SCI, V108, P1927, DOI 10.1111/cas.13342; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lee ST, 2010, STROKE, V41, P1646, DOI 10.1161/STROKEAHA.110.579649; Li ZJ, 2020, J CELL BIOCHEM, V121, P2406, DOI 10.1002/jcb.29463; Lin AF, 2016, NAT CELL BIOL, V18, P213, DOI 10.1038/ncb3295; Mas-Ponte D, 2017, RNA, V23, P1080, DOI 10.1261/rna.060814.117; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Moinova HR, 2002, P NATL ACAD SCI USA, V99, P4562, DOI 10.1073/pnas.062459899; Neve B, 2018, CANCERS, V10, DOI 10.3390/cancers10110440; Pefanis E, 2015, CELL, V161, P774, DOI 10.1016/j.cell.2015.04.034; Saldana-Meyer R, 2019, MOL CELL, V76, P412, DOI 10.1016/j.molcel.2019.08.015; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shi LL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1332-8; Shih JW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15874; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Sun YT, 2019, CANCERS, V11, DOI 10.3390/cancers11020216; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yan SY, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0853-9; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Zhan PP, 2017, MOL CARCINOGEN, V56, P1427, DOI 10.1002/mc.22603; Zhao W, 2019, J CELL PHYSIOL, V234, P14519, DOI 10.1002/jcp.28143	39	29	31	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2020	39	46					7005	7018		10.1038/s41388-020-01512-8	http://dx.doi.org/10.1038/s41388-020-01512-8		OCT 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OQ9FF	33060856	hybrid, Green Published			2022-12-26	WOS:000577946300003
J	Huang, HL; Lu, WR; Liu, CL; Chang, HJ				Huang, Hsiu-Li; Lu, Wei-Ru; Liu, Chien-Liang; Chang, Hong-Jer			Advance care planning information intervention for persons with mild dementia and their family caregivers: Impact on end-of-life care decision conflicts	PLOS ONE			English	Article							OLDER-PEOPLE; PERCEPTIONS; RESIDENTS; MAKERS	Persons with dementia are at high risk for loss of decision-making ability due to increased cognitive decline as the disease progresses. Participation in advance care planning (ACP) discussions in the early stages of dementia is crucial for end-of-life (EoL) decision-making to ensure quality of EoL care. A lack of discussions about ACP and EoL care between persons with dementia and family caregivers (FCGs), can lead to decisional conflicts when persons with dementia are in the later stages of the disease. This study explored the effects of a family-centered ACP information intervention among persons with dementia and FCGs. The study was conducted in outpatient clinics in Taiwan. Participants were dyads (n = 40) consisting of persons diagnosed with mild cognitive impairment or mild dementia and their FCGs. A one-group, pretest-posttest, pre-experimental design was employed. The intervention was provided by an ACP-trained senior registered nurse and was guided by ACP manuals and family-centered strategies. Outcome data were collected with four structured questionnaires regarding knowledge of end-stage dementia treatment, knowledge of ACP, attitude towards ACP, and EoL decisional conflict about acceptance or refusal of cardiopulmonary resuscitation, ventilators, and tracheostomy. Paired t tests compared differences between pre-intervention data and 4-weeks' post-intervention data. The intervention resulted in significant improvements among persons with dementia and FCGs for knowledge of end-stage dementia treatment (p= .008 and p < .001, respectively), knowledge of ACP (bothp< .001), and significant reductions in decisional conflicts (both p < .001). Scores for positive and negative attitude toward ACP did not change for persons with dementia; however, there was a reduction in negative attitude for FCGs (p= .001). Clinical care for persons with dementia should incorporate ACP interventions that provide knowledge about EoL dementia care using family-centered care strategies that facilitate regular and continuous communication between FCGs, persons with dementia, and medical personnel to reduce decisional conflicts for EoL care.	[Huang, Hsiu-Li; Chang, Hong-Jer] Natl Taipei Univ Nursing & Hlth Sci, Coll Hlth Technol, Dept Long Term Care, Taipei, Taiwan; [Lu, Wei-Ru] Sijhih Cathay Gen Hosp, Dept Nursing, New Taipei, Taiwan; [Liu, Chien-Liang] Taipei City Hosp, Dementia Ctr, Taipei, Taiwan; [Liu, Chien-Liang] Univ Taipei, Taipei, Taiwan	National Taipei University of Nursing & Health Science (NTUNHS); Cathay General Hospital; Taipei City Hospital; University of Taipei	Huang, HL (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Coll Hlth Technol, Dept Long Term Care, Taipei, Taiwan.	hsiuli@ntunhs.edu.tw			Ministry of Science and Technology of Taiwan [MOST 106-2314-B-182 -006 -MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study received a fund from the Ministry of Science and Technology of Taiwan (MOST 106-2314-B-182 -006 -MY3). The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Disease International, 2018, GLOB VOIC DEM DEM ST; Bonner GJ, 2014, DEMENTIA-LONDON, V13, P79, DOI 10.1177/1471301212449408; Boopathiraj C., 2013, INT J SOC SCI INTERD, V2, P2; Brazil K, 2018, PALLIATIVE MED, V32, P603, DOI 10.1177/0269216317722413; Capacity Assessment Office, 2020, GUID COND ASS CAP; Caron CD., 2005, DEMENTIA, V4, P113, DOI [10.1177/1471301205049193, DOI 10.1177/1471301205049193]; Chan HYL, 2011, J CLIN NURS, V20, P1454, DOI 10.1111/j.1365-2702.2010.03670.x; Chang WZD, 2020, AM J SPEECH-LANG PAT, V29, P185, DOI 10.1044/2019_AJSLP-19-0028; Chung RY, 2017, J AM MED DIRECTORS A, V18, DOI 10.1016/j.jamda.2016.12.066; Clarfield AM, 2003, ARCH INTERN MED, V163, P2219, DOI 10.1001/archinte.163.18.2219; COHEN J, 1988, APPL PSYCH MEAS, V12, P425, DOI 10.1177/014662168801200410; Dementia Care Central, 2020, STAG ALZH DEM SCAL U; Dening KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159056; Department of Medical Affairs Ministry of Health and Welfare Taiwan ROC, 2015, PROT PAT AUT PAT AUT; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Dickinson C, 2013, INT PSYCHOGERIATR, V25, P2011, DOI 10.1017/S1041610213001531; Fox S, 2017, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-017-0221-0; Gao X, 2015, PALLIAT SUPPORT CARE, V13, P1677, DOI 10.1017/S147895151500067X; Giguere AMC, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2697-1; Gjerberg E, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0096-y; Goodman C, 2013, INT J NURS STUD, V50, P1639, DOI 10.1016/j.ijnurstu.2013.06.008; Hickman SE, 2016, J AM GERIATR SOC, V64, P2385, DOI 10.1111/jgs.14463; Hinderer KA, 2019, APPL NURS RES, V49, P91, DOI 10.1016/j.apnr.2019.04.003; Ho A, 2008, SCAND J CARING SCI, V22, P128, DOI 10.1111/j.1471-6712.2007.00561.x; Houben CH, 2014, J AM MED DIR ASSOC, V15, P454, DOI [10.1016/j.jamda.2014.04.016, DOI 10.1016/J.JAMDA.2014.04.016]; Huang, 2015, J LONG TERM CARE, V19, P295, DOI [10.6317/LTC.19.295, DOI 10.6317/LTC.19.295, 10.6317/LTC.2015.19(3).295-303, DOI 10.6317/LTC.2015.19(3).295-303]; Huang HL, 2018, J NURS RES, V26, P231, DOI 10.1097/jnr.0000000000000240; Huang HL, 2018, INT PSYCHOGERIATR, V30, P341, DOI 10.1017/S1041610217001661; Jones K, 2016, DEMENTIA-LONDON, DOI [10.1177/1471301216676121, DOI 10.1177/147130121667612127821714]; Kabasakalian A, 2009, INT REV NEUROBIOL, V84, P283, DOI 10.1016/S0074-7742(09)00415-2; Kaur J, 2016, ENDOCRINOL DIAB META, DOI 10.1530/EDM-16-0059; Lee H.-T.S., 2012, TAIWAN J HOSP PALLIA, V17, P187, DOI [10.6537/TJHPC.2012.17(2).5, DOI 10.6537/TJHPC.2012.17(2).5]; Lee MC, 2018, GERONTOL GERIATR MED, V4, DOI 10.1177/2333721418778195; Lord K, 2015, INT PSYCHOGERIATR, V27, P1301, DOI 10.1017/S1041610215000411; MAHONEY F I, 1965, Md State Med J, V14, P61; Mohamad MM, 2015, PROCD SOC BEHV, V204, P164, DOI 10.1016/j.sbspro.2015.08.129; National End of Life Care Programme, 2020, CAP CAR PLANN ADV CA; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Ouldred Emma, 2008, Br J Nurs, V17, P308; PAHO Pan American Health Organization, 2019, TOP 10 CAUS DEATH WO; Piers R, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0332-2; Poppe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060412; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Snyder EA, 2013, J AM MED DIR ASSOC, V14, P114, DOI 10.1016/j.jamda.2012.10.011; Sun A, 2017, J IMMIGR MINOR HEALT, V19, P381, DOI 10.1007/s10903-016-0365-7; Sun Y, 2014, REGION ANESTH PAIN M, V9, pe100303, DOI 10.1371/journal.pone.0100303; Sung HC, 2019, CLIN GERONTOLOGIST, V42, P238, DOI 10.1080/07317115.2017.1336142; Taiwan Alzheimer's Disease Association, 2019, AW DEM; Tay SY, 2015, J AM MED DIR ASSOC, V16, P957, DOI 10.1016/j.jamda.2015.05.014; van der Steen JT, 2016, ARCH GERONTOL GERIAT, V65, P225, DOI 10.1016/j.archger.2016.04.005; van der Steen JT, 2014, J ALZHEIMERS DIS, V40, P743, DOI 10.3233/JAD-131967; van der Steen JT, 2014, PALLIATIVE MED, V28, P197, DOI 10.1177/0269216313493685; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501; Yang CL, 2011, CANCER NURS, V34, P98, DOI 10.1097/NCC.0b013e3181f22cac	54	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240684	10.1371/journal.pone.0240684	http://dx.doi.org/10.1371/journal.pone.0240684			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052970	Green Published, gold			2022-12-26	WOS:000581820200025
J	Seiberth, JM; Moritz, K; Kucukay, N; Schiek, S; Bertsche, T				Seiberth, Jasmin Mina; Moritz, Katharina; Kuecuekay, Nagihan; Schiek, Susanne; Bertsche, Thilo			What is the attitude towards and the current practice of information exchange during self-medication counselling in German community pharmacies? An assessment through self-report and non-participant observation	PLOS ONE			English	Article							DRUG-RELATED PROBLEMS; THE-COUNTER DRUGS; NONPRESCRIPTION MEDICINES; PATIENTS WANT; PATIENT; COMMUNICATION; CARE; PHARMACOVIGILANCE; IMPLEMENTATION; CONSULTATIONS	Background Guidelines encourage relevant information exchange between pharmaceutical staff and patients during self-medication consultation. Thereby, assessing the patient's situation and providing information is crucial for patient safety. So far, limited studies have investigated this information exchange, particularly in Germany. We aimed to assess the attitude towards and the current practice of guideline-recommended information exchange in German community pharmacies. Methods In total, twelve guideline-recommended parameters were predefined for gathering patient-related information and for the provision of information. These information exchange parameters were evaluated in two parts: Firstly, in a self-report of pharmaceutical staff via an online questionnaire to assess the reported importance, difficulty and frequency of the parameters as well as barriers to their implementation; secondly, in a non-participant observation in five pharmacies to evaluate the actual consultation practice. Results In the self-report, all parameters were rated by more than 76% of 1068 participants as important. 'Concurrent medication' was determined to be the most difficult parameter to address (54%). All parameters of information gathering were rated to be addressed during routine counselling by at least 70% of the respondents. Parameters of information provision were all rated to be addressed by at least 45%. 'Lack of patient's interest' was identified as the most frequent barrier to appropriate counselling (84%). During the observation, the information gathering parameters were each addressed between 8 to 63% in the consultations, parameters of information provision between 3 to 34%. Conclusion Despite broad acceptance, the guideline parameters of information exchange were comparatively little addressed during the actual routine care. This might be due to a perceived 'lack of patient's interest' in counselling. Our results suggest to scrutinize whether patients are in fact not interested in counselling and to further explore how the positive intention of pharmaceutical staff towards information exchange can be further translated into everyday practice.	[Seiberth, Jasmin Mina; Moritz, Katharina; Kuecuekay, Nagihan; Schiek, Susanne; Bertsche, Thilo] Univ Leipzig, Fac Med, Inst Pharm, Dept Clin Pharm, Leipzig, Germany; [Seiberth, Jasmin Mina; Moritz, Katharina; Kuecuekay, Nagihan; Schiek, Susanne; Bertsche, Thilo] Univ Hosp Leipzig, Drug Safety Ctr, Leipzig, Germany; [Seiberth, Jasmin Mina; Moritz, Katharina; Kuecuekay, Nagihan; Schiek, Susanne; Bertsche, Thilo] Univ Leipzig, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Bertsche, T (corresponding author), Univ Leipzig, Fac Med, Inst Pharm, Dept Clin Pharm, Leipzig, Germany.; Bertsche, T (corresponding author), Univ Hosp Leipzig, Drug Safety Ctr, Leipzig, Germany.; Bertsche, T (corresponding author), Univ Leipzig, Leipzig, Germany.	thilo.bertsche@uni-leipzig.de		Bertsche, Thilo/0000-0002-4930-6655; Moritz, Katharina/0000-0001-5100-7761	ABDA Federal Union of German Associations of Pharmacists; AVOXA - Media Group German Pharmacist GmbH	ABDA Federal Union of German Associations of Pharmacists; AVOXA - Media Group German Pharmacist GmbH	Jasmin Mina Seiberth and Katharina Moritz were financially supported by the ABDA Federal Union of German Associations of Pharmacists (https://www.abda.de/) and the AVOXA - Media Group German Pharmacist GmbH (https://avoxa.de/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adepu R, 2009, INDIAN J PHARM SCI, V71, P285, DOI 10.4103/0250-474X.56029; Alaqeel S, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1220-6; Alte D, 2007, ANN PHARMACOTHER, V41, P1023, DOI 10.1345/aph.1H565; AMBADY N, 1993, J PERS SOC PSYCHOL, V64, P431, DOI 10.1037/0022-3514.64.3.431; American Society of Health-System Pharmacists, 1997, AM J HEALTH-SYST PH, V54, P431, DOI [DOI 10.1093/AJHP/54.4.431, 10.1093/ajhp/54.4.431]; [Anonymous], 2019, APPROBATIONSORDNUNG; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Atkinson J, 2014, PHARMACY, V2, P231, DOI 10.3390/pharmacy2030231; Barrenberg E, 2015, EUR J CLIN PHARMACOL, V71, P1389, DOI 10.1007/s00228-015-1929-5; Barrenberg E, 2018, PHARMACY, V6, DOI 10.3390/pharmacy6020052; Beitz R, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P1043, DOI 10.1007/s00103-004-0923-3; Benrimoj SI, 2007, QUAL SAF HEALTH CARE, V16, P354, DOI 10.1136/qshc.2006.019463; Berger K, 2005, J CLIN PHARM THER, V30, P45, DOI 10.1111/j.1365-2710.2004.00611.x; Berger Karin, 2012, Pharm Unserer Zeit, V41, P276, DOI 10.1002/pauz.201200475; Berreni A, 2015, FUND CLIN PHARMACOL, V29, P517, DOI 10.1111/fcp.12140; Berry DC, 1997, PSYCHOL HEALTH, V12, P467, DOI 10.1080/08870449708406723; Bertsche T, 2012, INT J CLIN PHARM-NET, V34, P17, DOI 10.1007/s11096-011-9584-0; Blenkinsopp A, 1996, BRIT MED J, V312, P629; Blom L, 1998, INT J PHARM PRACT, V6, P72, DOI [10.1111/j.2042-7174.1998.tb00919.x, DOI 10.1111/J.2042-7174.1998.TB00919.X]; Boeni F, 2015, PATIENT PREFER ADHER, V9, P597, DOI 10.2147/PPA.S76027; Bosch-Lenders D, 2016, AGE AGEING, V45, P402, DOI 10.1093/ageing/afw045; Brata C, 2019, PHARM PRACT-GRANADA, V17, DOI [10.18549/PharmPract.2019.2.1452, 10.18549/pharmpract.2019.2.1452]; Brata C, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0670-6; Brata C, 2013, RES SOC ADMIN PHARM, V9, P370, DOI 10.1016/j.sapharm.2012.08.001; Buring SM, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710108; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collins JC, 2017, INT J CLIN PHARM-NET, V39, P697, DOI 10.1007/s11096-017-0505-8; Deyoung M, 1996, AM J HEALTH-SYST PH, V53, P1277, DOI 10.1093/ajhp/53.11.1277; Dickinson D, 2003, BRIT MED J, V327, P861, DOI 10.1136/bmj.327.7419.861-a; Divine H, 2017, HDB NONPRESCRIPTION, P17; Eickhoff C, 2006, ANN PHARMACOTHER, V40, P729, DOI 10.1345/aph.1G458; Eickhoff C, 2012, PHARMACOEPIDEM DR S, V21, P254, DOI 10.1002/pds.2241; Federal Chamber of Pharmacists, 2017, KOMP LERNZ PHARM PER; Federal Chamber of Pharmacists, 2019, GUID FED CHAMB PHARM; Federal Union of German Associations of Pharmacists, 2020, LEITL; Federal Union of German Associations of Pharmacists, 2019, GERM PHARM FIG DAT F; Freyer J, 2016, DEUT MED WOCHENSCHR, V141, pE149, DOI 10.1055/s-0042-108618; Garner M, 2007, PATIENT EDUC COUNS, V65, P51, DOI 10.1016/j.pec.2006.05.004; Gokcekus L, 2012, INT J CLIN PHARM-NET, V34, P312, DOI 10.1007/s11096-011-9605-z; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Hassell K, 1998, J Health Serv Res Policy, V3, P219; Hibbert D, 2002, SOCIOL HEALTH ILL, V24, P46, DOI 10.1111/1467-9566.00003; International Pharmaceutical Federation, 1997, STAND QUAL PHRM SERV; Jin HK, 2018, ADV HEALTH SCI EDUC, V23, P633, DOI 10.1007/s10459-017-9791-0; Kaae S, 2013, RES SOC ADMIN PHARM, V9, P958, DOI 10.1016/j.sapharm.2012.10.003; Keller K., 1994, DRUG INF J, V28, P453, DOI [10.1177/009286159402800219, DOI 10.1177/009286159402800219]; Krishnan HS, 2000, PHARM WORLD SCI, V22, P102, DOI 10.1023/A:1008733207854; Krueger JL, 2011, J AM PHARM ASSOC, V51, P510, DOI 10.1331/JAPhA.2011.10069; Langer B, 2018, PHARM PHARM, V9, P257, DOI [10.4236/pp.2018.97020, DOI 10.4236/PP.2018.97020]; Langer Bernhard, 2019, F1000Res, V8, P1841, DOI 10.12688/f1000research.21045.1; Langer B, 2018, INT J PHARM PRACT, V26, P310, DOI 10.1111/ijpp.12405; Laven A, 2018, INT J CLIN PHARM-NET, V40, P1317, DOI 10.1007/s11096-018-0710-0; Leiner D, 2017, SOSCI SURVEY VERSION; Locquet M, 2017, DRUG AGING, V34, P359, DOI 10.1007/s40266-017-0445-y; Montastruc JL, 2016, THERAPIE, V71, P257, DOI 10.1016/j.therap.2016.02.012; Moritz K, 2019, J CLIN PHARM THER, V44, P895, DOI 10.1111/jcpt.13013; Nair K, 2002, CAN FAM PHYSICIAN, V48, P104; Narhi U, 2000, J CLIN PHARM THER, V25, P177; Netere AK, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0930-7; Pharmaceutical Society of Australia, 2017, PROF PRACT STAND V5; Pharmaceutical Society of Australia, 2000, CARER PROT PHARM MED; Rutter P, 2015, INTEGR PHARM RES PRA, V4, P57, DOI 10.2147/IPRP.S70403; Sclar DA, 1996, J CLIN PHARM THER, V21, P177; Seiberth JM, 2021, HEALTH SOC CARE COMM, V29, P194, DOI 10.1111/hsc.13082; Seubert LJ, 2019, PHARMACY-BASEL, V7, DOI 10.3390/pharmacy7020073; Seubert LJ, 2018, RES SOC ADMIN PHARM, V14, P979, DOI 10.1016/j.sapharm.2017.12.001; Seubert LJ, 2017, PHARMACY, V5, DOI 10.3390/pharmacy5040065; Shah BK, 2011, RES SOC ADMIN PHARM, V7, P272, DOI 10.1016/j.sapharm.2010.07.001; Smith H, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7168; Surur AS, 2017, PHARM PRACT-GRANADA, V15, DOI [10.18549/PharmPract.2017.01.890, 10.18549/pharmpract.2017.01.890]; Watson MC, 2006, QUAL SAF HEALTH CARE, V15, P244, DOI 10.1136/qshc.2005.014035; Watson MC, 2008, PHARM WORLD SCI, V30, P526, DOI 10.1007/s11096-008-9202-y; Westerlund LOT, 2001, ANN PHARMACOTHER, V35, P1343	73	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240672	10.1371/journal.pone.0240672	http://dx.doi.org/10.1371/journal.pone.0240672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3XB	33052955	gold, Green Published			2022-12-26	WOS:000581820200005
J	Arach, AAO; Nakasujja, N; Nankabirwa, V; Ndeezi, G; Kiguli, J; Mukunya, D; Odongkara, B; Achora, V; Tongun, JB; Musaba, MW; Napyo, A; Zalwango, V; Tylleskar, T; Tumwine, JK				Arach, Anna Agnes Ojok; Nakasujja, Noeline; Nankabirwa, Victoria; Ndeezi, Grace; Kiguli, Juliet; Mukunya, David; Odongkara, Beatrice; Achora, Vincentina; Tongun, Justin Bruno; Musaba, Milton Wamboko; Napyo, Agnes; Zalwango, Vivian; Tylleskar, Thorkild; Tumwine, James K.			Perinatal death triples the prevalence of postpartum depression among women in Northern Uganda: A community-based cross-sectional study	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTNATAL DEPRESSION; RISK-FACTORS; SYMPTOMS; MOTHERS; STILLBIRTHS; POPULATION; DISORDERS; PREGNANCY	Introduction Deaths during the perinatal period remain a big challenge in Africa, with 38 deaths per 1000 pregnancies in Uganda. The consequences of these deaths can be detrimental to the women; some ending up with postpartum depression. We examined the association between perinatal death and postpartum depression among women in Lira district, Northern Uganda. Methods We conducted a community-based cross-sectional study of 1,789 women. Trained research assistants screened women for postpartum depressive symptoms on day 50 postpartum using the Edinburgh postpartum depression scale (EPDS). Socio-demographic, economic, birth and survival status of the neonate were collected during pregnancy and within one week postpartum. We used generalized estimating equation for the Poisson family with a log link using Stata to estimate the prevalence ratio of the association between postpartum depressive symptoms (EPDS scores >= 14) and perinatal death. Mothers who lost their babies between 7-49 days postpartum were excluded. Results Of the 1,789 participants symptomatically screened for postpartum depression, 377 (21.1%) [95% confidence interval (95%CI): 17.2%, 23.0%] had probable depressive symptoms. The prevalence of postpartum depressive symptoms among the 77 women who had experienced perinatal death (37 stillbirths and 40 early neonatal deaths (<= 7 days of life)) was 62.3% [95% CI: 50.8%, 72.6%] compared to 19.2% [95% CI: 17.4%, 21.2%], among 1,712 with live infants at day 50 postpartum. Women who had experienced a perinatal death were three times as likely to have postpartum depressive symptoms as those who had a live birth [adjusted prevalence ratio 3.45 (95% CI: 2.67, 4.48)]. Conclusions The prevalence of postpartum depressive symptoms, assessed by EPDS, was high among women who had had a perinatal death in Northern Uganda. Women experiencing a perinatal death need to be screened for postpartum depressive symptoms in order to intervene and reduce associated morbidity.	[Arach, Anna Agnes Ojok] Lira Univ, Dept Nursing & Midwifery, Fac Hlth Sci, Lira, Uganda; [Nakasujja, Noeline] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Psychiat, Kampala, Uganda; [Nankabirwa, Victoria; Zalwango, Vivian] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Ndeezi, Grace; Tumwine, James K.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Paediat & Child Hlth, Kampala, Uganda; [Kiguli, Juliet] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Mukunya, David] Sanyu Africa Res Inst, Mbale, Uganda; [Odongkara, Beatrice] Gulu Univ, Dept Paediat & Child Hlth, Gulu, Uganda; [Achora, Vincentina] Gulu Univ, Dept Obstet & Gynaecol, Gulu, Uganda; [Tongun, Justin Bruno] Univ Juba, Dept Paediat & Child Hlth, Juba, South Sudan; [Musaba, Milton Wamboko] Busitema Univ, Dept Obstet & Gynaecol, Fac Hlth Sci, Mbale, Uganda; [Napyo, Agnes] Busitema Univ, Dept Publ Hlth, Fac Hlth Sci, Tororo, Uganda; [Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Bergen, Norway	Makerere University; Makerere University; Makerere University; Makerere University; University of Bergen	Arach, AAO (corresponding author), Lira Univ, Dept Nursing & Midwifery, Fac Hlth Sci, Lira, Uganda.	arachaa2000@gmail.com	Nakasujja, Noeline/GSI-4189-2022; Tylleskär, Thorkild/S-5529-2017	Tylleskär, Thorkild/0000-0003-4801-4324; Mukunya, David/0000-0002-3892-9777; Arach, Anna/0000-0002-8398-5153; Musaba, Milton/0000-0003-4145-4044	Norwegian Programme for Capacity Development in Higher Education and Research for Development (NORHED) through the Norwegian Agency for Development Cooperation (Norad), Norway via the Survival Pluss Project at Makerere University [UGA-13-0030]	Norwegian Programme for Capacity Development in Higher Education and Research for Development (NORHED) through the Norwegian Agency for Development Cooperation (Norad), Norway via the Survival Pluss Project at Makerere University	The study was funded by the Norwegian Programme for Capacity Development in Higher Education and Research for Development (NORHED) through the Norwegian Agency for Development Cooperation (Norad), Norway via the Survival Pluss Project at Makerere University (no. UGA-13-0030). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Agbaje OS, 2019, ARCH PUBLIC HEALTH, V77, DOI 10.1186/s13690-018-0329-6; Akena D, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-187; Alfayumi-Zeadna S, 2015, DEPRESS ANXIETY, V32, P120, DOI 10.1002/da.22290; American Psychiatric Association, 2000, DIAGN STAT MAN TEXT; [Anonymous], 2006, GLOBE MAIL, V06, pC1; [Anonymous], 2014, J MED INTERNET RES; [Anonymous], 2015, AM J PHARM BENEFITS, V7, pe141; Azale T, 2018, INT J MENT HEALTH SY, V12, DOI 10.1186/s13033-018-0219-x; Baron EC, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1291-z; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Cox JL, 1987, BR J PSYCHIAT, V150; Da Costa D, 2006, ARCH WOMEN MENT HLTH, V9, P95, DOI 10.1007/s00737-005-0108-6; de Tychey C, 2008, J CLIN NURS, V17, P312, DOI 10.1111/j.1365-2702.2006.01911.x; Eakes G G, 1998, Image J Nurs Sch, V30, P179; Ferrari AJ, 2013, PSYCHOL MED, V43, P471, DOI 10.1017/S0033291712001511; Fisher J, 2012, B WHO, P90; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Gausia K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-451; Gaynes B N, 2005, Evid Rep Technol Assess (Summ), P1; Giannandrea SAM, 2013, J WOMENS HEALTH, V22, P760, DOI 10.1089/jwh.2012.4011; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Heazell AEP, 2016, LANCET, V387, P604, DOI 10.1016/S0140-6736(15)00836-3; Huang Y, 2019, J AFFECTIVE DISORDER; Hughes PM, 1999, BMJ, V318; Josefsson A, 2001, ACTA OBSTET GYN SCAN, V80, P251; Kakyo TA, 2012, MIDWIFERY, V28, P374, DOI 10.1016/j.midw.2011.05.001; Kaminsky LM, 2008, J MATERN-FETAL NEO M, V21, P321, DOI 10.1080/14767050801995084; Kerie Sitotaw, 2018, BMC Res Notes, V11, P623, DOI 10.1186/s13104-018-3730-x; Kevin SM, 2007, SAMPLE SIZE CROSS SE; Kiguli J, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.24011; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S2; Mehta S, 2014, MENT ILLN, V6, P14, DOI 10.4081/mi.2014.5370; Mukunya D, 2021, J PUBLIC HEALTH-HEID, V29, P229, DOI 10.1007/s10389-019-01114-z; Norhayati MN, 2015, J AFFECT DISORDERS, V175, P34, DOI 10.1016/j.jad.2014.12.041; Ongeri L, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1904-7; Pearlstein T, 2009, AM J OBSTET GYNECOL, V200, P357, DOI 10.1016/j.ajog.2008.11.033; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Roberts B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-38; Rutstein SO, 2004, DHS WEALTH INDEX DHS, V6; Slomian J, 2019, WOMENS HEALTH, V15, DOI 10.1177/1745506519844044; Surkan PJ, 2016, ANN EPIDEMIOL, V26, P467, DOI 10.1016/j.annepidem.2016.06.001; Sutan R, 2010, J ZHEJIANG UNIV-SC B, V11, P209, DOI 10.1631/jzus.B0900245; Torres A, 2019, J AFFECT DISORDERS, V245, P965, DOI 10.1016/j.jad.2018.11.062; Tsai AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082521; UBOS, 2018, UG NAT HOUS SURV 201; UBOS, 2017, NAT POP HOUS CENS 20; Uganda Bureau of Statistcs (UBOS) and ICF, 2017, UG DEM HLTH SURV 201; WHO, 2017, MAT HLTH MAT CHILD A; Williams J, 2014, BEST PRACTICE GUIDEL; Woody CA, 2017, J AFFECT DISORDERS, V219, P86, DOI 10.1016/j.jad.2017.05.003; World Health Organization, 2014, EV NEWB ACT PLAN END	52	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240409	10.1371/journal.pone.0240409	http://dx.doi.org/10.1371/journal.pone.0240409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	33048971	gold, Green Published			2022-12-26	WOS:000581813300043
J	Chan, WWR; Li, W; Chang, RCC; Lau, KF				Chan, Wai Wa Ray; Li, Wen; Chang, Raymond Chuen Chung; Lau, Kwok-Fai			ARF6-Rac1 signaling-mediated neurite outgrowth is potentiated by the neuronal adaptor FE65 through orchestrating ARF6 and ELMO1	FASEB JOURNAL			English	Article						ADP ribosylation factor 6; amyloid-beta A4 precursor protein-binding family B member 1; engulfment and cell motility protein 1; neurite outgrowth; plasma membrane targeting; Ras-related C3 botulinum toxin substrate 1	AMYLOID PRECURSOR PROTEIN; NUCLEOTIDE EXCHANGE FACTOR; RHO GTPASES; DOWNSTREAM ACTIVATION; DEPENDENT REGULATION; PHOSPHORYLATION; INTERACTS; MEMBRANE; COMPLEX; BINDING	Ras-related C3 botulinum toxin substrate 1 (Rac1) is a member of the Rho family of GTPases that functions as a molecular switch to regulate many important cellular events including actin cytoskeleton remodeling during neurite outgrowth. Engulfment and cell motility 1 (ELMO1)-dedicator of cytokinesis 1 (DOCK180) is a bipartite guanine nucleotide exchange factor (GEF) complex that has been reported to activate Rac1 on the plasma membrane (PM). Emerging evidence suggests that the small GTPase ADP ribosylation factor 6 (ARF6) activates Rac1 via the ELMO1/DOCK180 complex. However, the exact mechanism by which ARF6 triggers ELMO1/DOCK180-mediated Rac1 signaling remains unclear. Here, we report that the neuronal scaffold protein FE65 serves as a functional link between ARF6 and ELMO1, allowing the formation of a multimeric signaling complex. Interfering with formation of this complex by transfecting either FE65-binding-defective mutants or FE65 siRNA attenuates both ARF6-ELMO1-mediated Rac1 activation and neurite elongation. Notably, the PM trafficking of ELMO1 is markedly decreased in cells with suppressed expression of either FE65 or ARF6. Likewise, this process is attenuated in the FE65-binding-defective mutants transfected cells. Moreover, overexpression of FE65 increases the amount of ELMO1 in the recycling endosome, an organelle responsible for returning proteins to the PM, whereas knockout of FE65 shows opposite effect. Together, our data indicates that FE65 potentiates ARF6-Rac1 signaling by orchestrating ARF6 and ELMO1 to promote the PM trafficking of ELMO1 via the endosomal recycling pathway, and thus, promotes Rac1-mediated neurite outgrowth.	[Chan, Wai Wa Ray; Li, Wen; Lau, Kwok-Fai] Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Hong Kong, Peoples R China; [Li, Wen] Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Lab Biomed Opt & Mol Imaging, Shenzhen, Peoples R China; [Chang, Raymond Chuen Chung] Univ Hong Kong, LKS Fac Med, Sch Biomed Sci, Lab Neurodegenerat Dis, Hong Kong, Peoples R China; [Chang, Raymond Chuen Chung] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Hong Kong; University of Hong Kong	Lau, KF (corresponding author), Fac Sci, Sch Life Sci, Shatin, H, Hong Kong, Peoples R China.	kflau@cuhk.edu.hk	LI, WEN/Y-6659-2018	Lau, Kwok-Fai/0000-0002-0193-1152	Research Grants Council, University Grants Committee (RGC, UGC); CUHK direct grant scheme; United College endowment fund; TUYF charitable Trust	Research Grants Council, University Grants Committee (RGC, UGC); CUHK direct grant scheme; United College endowment fund; TUYF charitable Trust	Research Grants Council, University Grants Committee (RGC, UGC); CUHK direct grant scheme; United College endowment fund; TUYF charitable Trust	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Ando K, 1999, J NEUROSCI, V19, P4421; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Auer M, 2011, ANN ANAT, V193, P259, DOI 10.1016/j.aanat.2011.02.015; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bustelo Xose R, 2012, Small GTPases, V3, P60, DOI 10.4161/sgtp.19111; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chang LC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15734-7; Chau DDL, 2019, FASEB J, V33, P12019, DOI 10.1096/fj.201802825RR; Cheung HNM, 2014, FASEB J, V28, P337, DOI 10.1096/fj.13-232694; Chow WNV, 2015, BIOCHEM J, V470, P303, DOI 10.1042/BJ20141485; Chow WNV, 2015, CELL MOL BIOL LETT, V20, P66, DOI 10.1515/cmble-2015-0002; Chow WNV, 2012, BIOCHEM J, V443, P681, DOI 10.1042/BJ20112175; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cool BH, 2010, J NEUROCHEM, V112, P410, DOI 10.1111/j.1471-4159.2009.06456.x; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Araujo Mariana E G, 2015, Cold Spring Harb Protoc, V2015, P1009, DOI 10.1101/pdb.prot083436; de Araujo Mariana E G, 2015, Cold Spring Harb Protoc, V2015, P1013, DOI 10.1101/pdb.prot083444; DeNardo BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082513; Denton K, 2018, HUM MOL GENET, V27, P2517, DOI 10.1093/hmg/ddy156; Deyts C, 2016, ELIFE, V5, DOI 10.7554/eLife.15645; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dumanis SB, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-9; Eades G, 2015, MOL CANCER RES, V13, P330, DOI 10.1158/1541-7786.MCR-14-0251; Fukaya M, 2014, J NEUROCHEM, V129, P21, DOI 10.1111/jnc.12524; Goldenring JR, 2015, CURR OPIN CELL BIOL, V35, P117, DOI 10.1016/j.ceb.2015.04.018; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Nguyen HTN, 2018, BIOCHEM BIOPHYS REP, V16, P24, DOI 10.1016/j.bbrep.2018.09.004; Jang DJ, 2017, NEUROBIOL LEARN MEM, V138, P31, DOI 10.1016/j.nlm.2016.06.017; Kesavapany S, 2002, NEUROSCIENCE, V115, P951, DOI 10.1016/S0306-4522(02)00422-0; Kim H, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-019-0543-3; Kim JY, 2011, J BIOL CHEM, V286, P37615, DOI 10.1074/jbc.M111.268029; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Lau KF, 2008, J BIOL CHEM, V283, P34728, DOI 10.1074/jbc.M801874200; Lee YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12334-2; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li W, 2018, J BIOL CHEM, V293, P7674, DOI 10.1074/jbc.RA117.000505; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Makino Y, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0113-y; Marei Hadir, 2017, Small GTPases, V8, P139, DOI 10.1080/21541248.2016.1211398; Margaron Y, 2013, J BIOL CHEM, V288, P1184, DOI 10.1074/jbc.M112.431825; Mauldin JP, 2013, CURR BIOL, V23, P162, DOI 10.1016/j.cub.2012.11.049; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mikdache A, 2020, CELL MOL LIFE SCI, V77, P161, DOI 10.1007/s00018-019-03167-5; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; Minopoli G, 2012, IUBMB LIFE, V64, P936, DOI 10.1002/iub.1094; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Patel M, 2011, J BIOL CHEM, V286, P38969, DOI 10.1074/jbc.M111.274191; Perez RG, 1997, J NEUROSCI, V17, P9407; Perkinton MS, 2004, J BIOL CHEM, V279, P22084, DOI 10.1074/jbc.M311479200; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Radhakrishna H, 1999, J CELL SCI, V112, P855; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rebelo S, 2013, J ALZHEIMERS DIS, V35, P761, DOI 10.3233/JAD-130095; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Sun YF, 2014, J BIOL CHEM, V289, P12217, DOI 10.1074/jbc.M113.526194; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; Torii T, 2014, J BIOL CHEM, V289, P33887, DOI 10.1074/jbc.M114.575787; Torii T, 2012, CELL SIGNAL, V24, P1872, DOI 10.1016/j.cellsig.2012.05.016; Wang YH, 2016, J CANCER, V7, P973, DOI 10.7150/jca.15118; Yamashita S, 2016, EPILEPSIA, V57, pE81, DOI 10.1111/epi.13338; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15	72	7	7	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16397	16413		10.1096/fj.202001703R	http://dx.doi.org/10.1096/fj.202001703R		OCT 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33047393				2022-12-26	WOS:000581170200001
J	Keith, DM; Sameoto, JA; Keyser, FM; Ward-Paige, CA				Keith, David M.; Sameoto, Jessica A.; Keyser, Freya M.; Ward-Paige, Christine A.			Evaluating socio-economic and conservation impacts of management: A case study of time-area closures on Georges Bank	PLOS ONE			English	Article							MARINE PROTECTED AREAS; PLACOPECTEN-MAGELLANICUS; FISHING EFFORT; DYNAMIC OCEAN; NORTH-SEA; FISHERIES; RESERVES; BYCATCH; CATCH; LINE	Globally, economies and marine ecosystems are increasingly dependent on sustainable fisheries management (SFM) to balance social, economic, and conservation needs. The overarching objectives of SFM are to maximize both conservation and socio-economic benefits, while minimizing short-term socio-economic costs. A number of tools have been developed to achieve SFM objectives, ranging from fishery specific to ecosystem-based strategies. Closures are a common SFM tool used to balance the trade-off between socio-economic and conservation considerations; they vary in scope from small-scale temporary closures to large-scale permanent networks. Unfortunately, closures are frequently implemented without a plan for monitoring or assessing whether SFM objectives are met. In situations in which a monitoring plan is not in place we propose that commonly available fishery data can often be used to evaluate whether management tools are effective in meeting SFM objectives. Here, we present a case study of closures on Georges Bank that shows how fishery data can be analyzed to perform such an assessment. Since 2006, on the Canadian side of Georges Bank, seasonal scallop fishery closures have been implemented with the aim of reducing by-catch of Atlantic cod (Gadus morhua) and yellowtail flounder (Pleuronectes ferruginea) during spawning. In lieu of data from a dedicated monitoring program, we analyzed data from Vessel Monitoring Systems (VMS), fishery logbooks, and a scallop survey to assess the impact of these closures on the scallop fishery, and use observer data (i.e. by-catch) to assess the effectiveness of these closures in meeting their conservation objective. While compliance for these time-area closures was high, the closures did not significantly displace fishing activity and overall there was limited evidence of an impact on the scallop fishery. Further, the discard rates for both cod and yellowtail were above average when their respective closures were active. These results suggest that improvements to the closures design and/or other measures may be required to achieve the desired SFM objectives.	[Keith, David M.; Sameoto, Jessica A.; Keyser, Freya M.] Fisheries & Oceans Canada, Populat Ecol Div, Bedford Inst Oceanog, Dartmouth, NS, Canada; [Keith, David M.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Ward-Paige, Christine A.] eOceans, Dartmouth, NS, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Dalhousie University	Keith, DM (corresponding author), Fisheries & Oceans Canada, Populat Ecol Div, Bedford Inst Oceanog, Dartmouth, NS, Canada.; Keith, DM (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	david.keith@dfo-mpo.gc.ca		Keith, David/0000-0003-3564-2030				Adlerstein SA, 1998, J SEA RES, V39, P153, DOI 10.1016/S1385-1101(97)00055-5; AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Ahmadia GN, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0275; Andrushchenko I, 2018, 201801 TRAC, V2018/01, P97; Andrushchenko I, 2016, 201602 TRAC, P89; [Anonymous], 2019, R LANG ENV STAT COMP; Arkema KK, 2006, FRONT ECOL ENVIRON, V4, P525, DOI 10.1890/1540-9295(2006)4[525:MEMFCT]2.0.CO;2; Armsworth PR, 2010, J APPL ECOL, V47, P36, DOI 10.1111/j.1365-2664.2009.01738.x; Benoit HP, 2011, MAR ECOL PROG SER, V442, P149, DOI 10.3354/meps09454; Bethoney ND, 2017, MAR POLICY, V83, P172, DOI 10.1016/j.marpol.2017.06.003; Brown CJ, 2012, J SEA RES, V72, P1, DOI 10.1016/j.seares.2012.04.009; CBD, 2018, AICH BIOD TARG; DFO, 2014, 2014034 DFO CAN SCI; DFO, 2007, 2007001 DFO CAN SCI; DFO, 2019, 2019019 DFO CAN SCI; Diamond SL, 2010, CAN J FISH AQUAT SCI, V67, P1335, DOI 10.1139/F10-044; Dinmore TA, 2003, ICES J MAR SCI, V60, P371, DOI 10.1016/S1054-3139(03)00010-9; Dunn DC, 2016, P NATL ACAD SCI USA, V113, P668, DOI 10.1073/pnas.1513626113; Dunn DC, 2011, FISH FISH, V12, P110, DOI 10.1111/j.1467-2979.2010.00388.x; Dureuil M, 2018, SCIENCE, V362, P1403, DOI 10.1126/science.aau0561; Frank KT, 2000, ICES J MAR SCI, V57, P1023, DOI 10.1006/jmsc.2000.0587; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gill DA, 2017, NATURE, V543, P665, DOI 10.1038/nature21708; Gilman EL, 2006, MAR POLICY, V30, P360, DOI 10.1016/j.marpol.2005.06.003; Gubbay S., 1995, MARINE PROTECTED ARE, P1, DOI DOI 10.1007/978-94-011-0527-9_1; HALLIDAY RG, 1988, NAFO SCI COUN STUDIE, V12, P27; Halpern BS, 2013, P NATL ACAD SCI USA, V110, P6229, DOI 10.1073/pnas.1217689110; Halpern BS, 2004, ECOL APPL, V14, P1248, DOI 10.1890/03-5136; Halpern BS, 2003, ECOL APPL, V13, pS117; Hastings A, 2017, P NATL ACAD SCI USA, V114, P8927, DOI 10.1073/pnas.1705169114; Hazen EL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar3001; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; HILBORN R, 1992; Hoos LA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211103; Kellner JB, 2007, ECOL APPL, V17, P1039, DOI 10.1890/05-1845; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Kristensen K, 2016, J STAT SOFTW, V70, P1; Legault CM, 2016, 201601 TRAC, P63; Little AS, 2015, FISH FISH, V16, P576, DOI 10.1111/faf.12080; Maxwell SM, 2015, MAR POLICY, V58, P42, DOI 10.1016/j.marpol.2015.03.014; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Murawski SA, 2000, B MAR SCI, V66, P775; MURRAY K, 2001, J CETACEAN RES MANAG, V2, P135; Neuenhoff RD, 2019, CAN J FISH AQUAT SCI, V76, P168, DOI 10.1139/cjfas-2017-0190; O'Brien L, 1993, NOAA TECHNICAL REPOR, P113; O'Keefe CE, 2014, ICES J MAR SCI, V71, P1286, DOI 10.1093/icesjms/fst063; O'Keefe CE, 2013, FISHERIES, V38, P434, DOI 10.1080/03632415.2013.838122; Pastoors MA, 2000, ICES J MAR SCI, V57, P1014, DOI 10.1006/jmsc.2000.0586; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Pebesma E, 2018, R J, V10, P439; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pomeroy RS, 2005, OCEAN COAST MANAGE, V48, P485, DOI 10.1016/j.ocecoaman.2005.05.004; Powers JE, 2009, FISH RES, V99, P216, DOI 10.1016/j.fishres.2009.06.011; Richardson EA, 2006, CONSERV BIOL, V20, P1191, DOI 10.1111/j.1523-1739.2006.00426.x; Rijnsdorp AD, 1998, ICES J MAR SCI, V55, P403, DOI 10.1006/jmsc.1997.0326; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Sarro CL, 2009, J SHELLFISH RES, V28, P497, DOI 10.2983/035.028.0311; Smith SJ, 2017, CAN J FISH AQUAT SCI, V74, P650, DOI 10.1139/cjfas-2015-0595; Smithson M, 2006, PSYCHOL METHODS, V11, P54, DOI 10.1037/1082-989X.11.1.54; Steneck RS, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao5493; Stone HH, 2004, J SEA RES, V51, P261, DOI 10.1016/j.seares.2003.08.004; Suuronen P, 2010, MAR POLICY, V34, P237, DOI 10.1016/j.marpol.2009.07.001; Thorson JT, 2015, ICES J MAR SCI, V72, P1245, DOI 10.1093/icesjms/fsu213; Tittensor DP, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay9969; Townsend DW, 1997, J PLANKTON RES, V19, P221, DOI 10.1093/plankt/19.2.221; Valentine P, 1991, SEA FLOOR ENV FISHER, P91; van der Lee A, 2013, CAN J FISH AQUAT SCI, V70, P973, DOI 10.1139/cjfas-2012-0341; Walters C, 2000, B MAR SCI, V66, P745; Welch H, 2019, J APPL ECOL, V56, P459, DOI 10.1111/1365-2664.13281; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood S.N., 2017, GEN ADDITIVE MODELS; Woodcock P, 2017, FISH FISH, V18, P668, DOI 10.1111/faf.12196	74	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240322	10.1371/journal.pone.0240322	http://dx.doi.org/10.1371/journal.pone.0240322			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	33048972	gold, Green Published			2022-12-26	WOS:000581813300021
J	Demmler-Harrison, GJ; Miller, JA				Demmler-Harrison, Gail J.; Miller, Jerry A.		Houston Congenital Cytomegalovirus	Maternal cytomegalovirus immune status and hearing loss outcomes in congenital cytomegalovirus-infected offspring	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; UNITED-STATES; INFANTS; MOTHERS; RISK; TRANSMISSION; VIRUS; BORN; HOSPITALIZATION; POPULATION	Objectives The purpose of this study is to determine the relationship between maternal primary and recurrent CMV infection during pregnancy, symptoms at birth in the newborn, and long term hearing loss through18 years of age. Patients and methods 237 mother-infant pairs in the Houston, Texas area identified through maternal CMV IgG and IgM antibody serologic screening and newborn screening using urine CMV culture to identify congenital CMV infection were enrolled in the Houston Congenital CMV Longitudinal Study. Mothers were categorized as having primary or recurrent or unknown maternal CMV infections, and newborns were categorized at birth as having symptomatic or asymptomatic congenital CMV infection, or as uninfected controls. All three newborn groups were followed longitudinally with serial hearing evaluations up to 18 years of age. The relationship between type of maternal CMV infection, newborn classification, and the occurrence of hearing loss over time was determined through Kaplan-Meier survival analysis, life table analysis, and a simulated ascertainment of maternal infection type for the unknown categories. Results Of 77 newborns with symptomatic congenital CMV infection, 12 (16%) of mothers had a primary CMV infection during pregnancy; 4 (5%) had a non-primary infection, and the type of infection in 48 (79%) could not be determined and were classified as unknown type of maternal infection. Fifty Seven (74%) of the 77 symptomatic children had hearing loss by 18 years of age, including 9 of the 12 (75%) who were born to mothers with primary infection and 48 (79%) of the 61 with unknown type of maternal infection. Of the 109 newborns with asymptomatic congenital CMV infection, 51 (47%) were born to mothers with a primary CMV infection during pregnancy, 18 (17%) to mothers with a recurrent infection; and 40 (37%) had unknown type of infection. Of these 109 asymptomatic cases, 22 (20%) developed hearing loss, including 14 out of 51 (28%) of those born to mothers with primary infection, two out of the 18 (11%) born to mothers with recurrent infection, and 6 out of the 40 (15%) to mothers of unknown infection type. Of the 51 uninfected newborn controls, 10 (20%) of mothers had a primary CMV infection during pregnancy, 5 (10%) had a non-primary infection, 10 (20%) were never infected, and 26 (51%) were assigned unknown type of infection. Three controls (6%) developed hearing loss, with 1 being born to a mother with primary infection and 1 to a mother never infected with CMV. Conclusions Both primary and non-primary maternal CMV infections during pregnancy resulted in symptomatic and asymptomatic congenital CMV infection. Symptomatic congenital CMV infection was more likely to occur after primary maternal CMV infection. Sensorineural hearing loss occurred in children born to mothers with both primary and non-primary CMV infections, and in both asymptomatic and symptomatic congenital CMV infection, but was more common after maternal primary infection. Most, but not all, hearing loss in children with cCMV associated hearing loss was first detected within the first year of life.	[Demmler-Harrison, Gail J.; Miller, Jerry A.] Baylor Coll Med, Houston, TX 77030 USA; [Demmler-Harrison, Gail J.; Miller, Jerry A.] Texas Childrens Hosp, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Demmler-Harrison, GJ (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.; Demmler-Harrison, GJ (corresponding author), Texas Childrens Hosp, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA.	gdemmler@bdm.edu		Miller, Jerry/0000-0001-9035-1434	Merck; Merck, Sharpe and Dohm, Inc., 2000 Galloping Hill Road, Kenilworth, N.J.; CMV Research Fund Donors at Baylor College of Medicine; Woman's Hospital of Texas Research Foundation; Office of Research Resources; General Clinical Research Center for Children at Texas Children's Hospital; Baylor College of Medicine (NIH) [5M0I RR00188-33]; Intellectual and Developmental Disabilities Research Center at Baylor College of Medicine (NIH-CHHD) [5 P30 HD24064P]; Research to Prevent Blindness, New York, NY; Deafness Foundation, Houston, TX; Vale Ashe Foundation, Houston, TX; Maddie's Mission Foundation, Katy, TX; Naymola Charitable Foundation, Beaumont, TX; American Pediatric Society-Society for Pediatric Research Summer Student Research Program (NIH-CHHD); Centers for Disease Control and Prevention [FOA IP 10-006]	Merck(Merck & Company); Merck, Sharpe and Dohm, Inc., 2000 Galloping Hill Road, Kenilworth, N.J.; CMV Research Fund Donors at Baylor College of Medicine; Woman's Hospital of Texas Research Foundation; Office of Research Resources; General Clinical Research Center for Children at Texas Children's Hospital; Baylor College of Medicine (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intellectual and Developmental Disabilities Research Center at Baylor College of Medicine (NIH-CHHD); Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Deafness Foundation, Houston, TX; Vale Ashe Foundation, Houston, TX; Maddie's Mission Foundation, Katy, TX; Naymola Charitable Foundation, Beaumont, TX; American Pediatric Society-Society for Pediatric Research Summer Student Research Program (NIH-CHHD); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Authors GDH and JAM received funding from Merck, Sharpe and Dohm, Inc., 2000 Galloping Hill Road, Kenilworth, N.J. 07033 (Merck.com/contact/), who provided editorial comments on the manuscript. The study was also supported, in part, by the CMV Research Fund Donors at Baylor College of Medicine; the Woman's Hospital of Texas Research Foundation; the Office of Research Resources and the General Clinical Research Center for Children at Texas Children's Hospital and Baylor College of Medicine (NIH 5M0I RR00188-33); the Intellectual and Developmental Disabilities Research Center at Baylor College of Medicine (NIH-CHHD 5 P30 HD24064P); the Research to Prevent Blindness, New York, NY; the Deafness Foundation, Houston, TX; the Vale Ashe Foundation, Houston, TX; the Maddie's Mission Foundation, Katy, TX; the Naymola Charitable Foundation, Beaumont, TX; the American Pediatric Society-Society for Pediatric Research Summer Student Research Program (NIH-CHHD); and the Centers for Disease Control and Prevention (Cooperative Agreement FOA IP 10-006). We would also like to thank Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA, for graciously providing salary support for data analysis.	Agarwal S, 2015, VASC MED, V20, P439, DOI 10.1177/1358863X15592486; AHLFORS K, 1981, NEW ENGL J MED, V305, P284; [Anonymous], 1995, 189 NAT BUR EC RES; Berkowitz SA, 2015, HEALTH SERV RES, V50, P398, DOI 10.1111/1475-6773.12229; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Britt W, 2015, MED MICROBIOL IMMUN, V204, P263, DOI 10.1007/s00430-015-0399-9; Britt WJ, 2017, J VIROL, V91, DOI 10.1128/JVI.02392-16; Cantwell MF, 1998, AM J RESP CRIT CARE, V157, P1016, DOI 10.1164/ajrccm.157.4.9704036; de Vries JJC, 2013, REV MED VIROL, V23, P241, DOI 10.1002/rmv.1744; de Vries JJC, 2011, J MED VIROL, V83, P1777, DOI 10.1002/jmv.22181; DEMMLER GJ, 1988, J INFECT DIS, V158, P1177, DOI 10.1093/infdis/158.6.1177; Demmler-Harrison GJ, 2009, J CLIN VIROL, V46, pS1, DOI 10.1016/j.jcv.2009.10.007; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Faure-Bardon V, 2019, CLIN INFECT DIS, V69, P1526, DOI 10.1093/cid/ciy1128; Fink Scott A, 2006, Gastroenterol Hepatol (N Y), V2, P380; Fomer G, 2016, J CLIN MICROBIOL, V54, P2149, DOI [10.1128/JCM.00561-16, DOI 10.1128/JCM.00561-16]; Foulon I, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2018-3095; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; Geronimus AT, 1993, RES REPORTS, V93-269; Giannattasio A, 2017, J CLIN VIROL, V91, P31, DOI 10.1016/j.jcv.2017.04.006; Gunkel J, 2017, FETAL DIAGN THER, V42, P144, DOI 10.1159/000456615; Hadar E, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2161-3; Hadar E, 2016, J PERINAT MED, V44, P339, DOI 10.1515/jpm-2014-0322; Hogea C, 2015, HUM VACC IMMUNOTHER, V11, P1788, DOI 10.1080/21645515.2015.1016665; Hughes BL, 2017, OBSTET GYNECOL, V130, P726, DOI 10.1097/AOG.0000000000002216; Hughes BL, 2016, AM J OBSTET GYNECOL, V214, pB5, DOI 10.1016/j.ajog.2016.02.042; IBM Corp, 2016, IBM SPSS STAT WIND; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Klein JP, 2001, BONE MARROW TRANSPL, V28, P909, DOI 10.1038/sj.bmt.1703260; Kleinbaum David G., 1997, SURVIVAL ANAL SELF L; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Kwok RK, 2001, ANN EPIDEMIOL, V11, P171, DOI 10.1016/S1047-2797(00)00205-2; Lanzieri TM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2610; Leruez-Ville M, 2017, CLIN INFECT DIS, V65, P398, DOI 10.1093/cid/cix337; Mack I, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00134; Nagamori T, 2010, J CLIN VIROL, V49, P134, DOI 10.1016/j.jcv.2010.06.021; Ornoy A, 2006, REPROD TOXICOL, V21, P399, DOI 10.1016/j.reprotox.2005.02.002; Picone O, 2017, J MATERN-FETAL NEO M, V30, P224, DOI 10.3109/14767058.2016.1169521; Puhakka L, 2017, INFECT DIS-NOR, V49, P445, DOI 10.1080/23744235.2017.1279344; Rawlinson WD, 2017, LANCET INFECT DIS, V17, pE177, DOI 10.1016/S1473-3099(17)30143-3; Ross SA, 2006, J PEDIATR-US, V148, P332, DOI 10.1016/j.jpeds.2005.09.003; Saldan A, 2017, J CLIN MICROBIOL, V55, P693, DOI 10.1128/JCM.01868-16; SCHAEFER L, 1988, J CLIN MICROBIOL, V26, P2041, DOI 10.1128/JCM.26.10.2041-2043.1988; Schleiss MR, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00268-17; SCHOPFER K, 1978, ARCH DIS CHILD, V53, P536, DOI 10.1136/adc.53.7.536; Silcocks PBS, 2001, J EPIDEMIOL COMMUN H, V55, P38, DOI 10.1136/jech.55.1.38; Simonazzi G, 2018, FETAL DIAGN THER, V43, P138, DOI 10.1159/000477168; STAGNO S, 1982, NEW ENGL J MED, V306, P945, DOI 10.1056/NEJM198204223061601; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; Tastad KJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221725; Trapp R.G., 2004, BASIC CLIN BIOSTATIS, V4th; Villanueva C, 2013, J COMMUN HEALTH, V38, P690, DOI 10.1007/s10900-013-9666-0; WALMUS BF, 1988, J INFECT DIS, V157, P172, DOI 10.1093/infdis/157.1.172; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; WILLIAMSON WD, 1990, AM J DIS CHILD, V144, P1365, DOI 10.1001/archpedi.1990.02150360091031; YOW MD, 1988, AM J OBSTET GYNECOL, V158, P1189, DOI 10.1016/0002-9378(88)90252-9; Zalel Y, 2008, ULTRASOUND OBST GYN, V31, P417, DOI 10.1002/uog.5255; 2014, REG ANESTH PAIN MED, V9	59	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240172	10.1371/journal.pone.0240172	http://dx.doi.org/10.1371/journal.pone.0240172			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3WA	33035237	Green Published, gold			2022-12-26	WOS:000581817500037
J	Singewar, K; Moschner, CR; Hartung, E; Fladung, M				Singewar, Kiran; Moschner, Christian R.; Hartung, Eberhard; Fladung, Matthias			Identification and analysis of key genes involved in methyl salicylate biosynthesis in different birch species	PLOS ONE			English	Article							ACID CARBOXYL METHYLTRANSFERASE; PHYLOGENETIC-RELATIONSHIPS; JASMONIC ACID; BIOCHEMICAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; REGULATORY ELEMENTS; BLACK COTTONWOOD; NATURAL ENEMIES; PLANT; GENOME	Species of the perennial woody plant genusBetuladominate subalpine forests and play a significant role in preserving biological diversity. In addition to their conventional benefits, birches synthesize a wide range of secondary metabolites having pharmacological significance. Methyl salicylate (MeSA) is one of these naturally occurring compounds constitutively produced by different birch species. MeSA is therapeutically important in human medicine for muscle injuries and joint pain. However, MeSA is now mainly produced synthetically due to a lack of information relating to MeSA biosynthesis and regulation. In this study, we performed a comprehensive bioinformatics analysis of two candidate genes mediating MeSA biosynthesis,SALICYLIC ACID METHYLTRANSFERASE(SAMT) andSALICYLIC ACID-BINDING PROTEIN2 (SABP2), of high (B.lenta,B.alleghaniensis,B.medwediewii, andB.grossa) and low (B.pendula,B.utilis,B.alnoides, andB.nana) MeSA-producing birch species. Phylogenetic analyses ofSAMTandSABP2genes and homologous genes from other plant species confirmed their evolutionary relationships. Multiple sequence alignments of the amino acid revealed the occurrence of important residues for substrate specificity in SAMT and SABP2. The analysis ofciselements in different birches indicated a functional multiplicity ofSAMTandSABP2and provided insights into the regulation of both genes. We successfully developed six prominent single nucleotide substitution markers that were validated with 38 additional birch individuals to differentiate high and low MeSA-producing birch species. Relative tissue-specific expression analysis ofSAMTin leaf and bark tissue of two high and two low MeSA-synthesizing birches revealed a high expression in the bark of both high MeSA-synthesizing birches. In contrast,SABP2expression in tissues revealed indifferent levels of expression between species belonging to the two groups. The comparative expression and bioinformatics analyses provided vital information that could be used to apply plant genetic engineering technology in the mass production of organic MeSA.	[Singewar, Kiran; Moschner, Christian R.; Hartung, Eberhard] Christian Albrechts Univ Kiel, Inst Agr Proc Engn, Kiel, Schleswig Holst, Germany; [Singewar, Kiran; Fladung, Matthias] Thunen Inst Forest Genet, Grosshansdorf, Schleswig Holst, Germany	University of Kiel; Johann Heinrich von Thunen Institute	Singewar, K (corresponding author), Christian Albrechts Univ Kiel, Inst Agr Proc Engn, Kiel, Schleswig Holst, Germany.; Singewar, K; Fladung, M (corresponding author), Thunen Inst Forest Genet, Grosshansdorf, Schleswig Holst, Germany.	kiran.singewar@thuenen.de; matthias.fladung@thuenen.de		Fladung, Matthias/0000-0001-9301-8581; Moschner, Christian Rainer/0000-0003-4835-963X	"Energiewende und Umweltinnovationen" state program for the economy; Ministry for Energy Transition, Agriculture, Environment, Nature and Digitalization of Schleswig-Holstein, Germany [LPW-L/1.2/24]; Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds	"Energiewende und Umweltinnovationen" state program for the economy; Ministry for Energy Transition, Agriculture, Environment, Nature and Digitalization of Schleswig-Holstein, Germany; Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds	Thank you very much to the funding agency; "Energiewende und Umweltinnovationen" state program for the economy; Ministry for Energy Transition, Agriculture, Environment, Nature and Digitalization of Schleswig-Holstein, Germany. (Project number: LPW-L/1.2/24). The Thunen -Institute provided basic office and lab equipment to perform this study, we thank for the cooperation. We acknowledge financial support by Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ament K, 2010, PLANT J, V62, P124, DOI 10.1111/j.1365-313X.2010.04132.x; Anderson A, 2017, MEDICINES BASEL, V4; Angier B, 1978, FIELD GUIDE MED PLAN; Applequist W.L., 2004, SYST BOT, V29, P1021; Ashburner K, 2013, GENUS BETULA TAXONOM; Barakat A, 2011, GENE, V479, P37, DOI 10.1016/j.gene.2011.02.008; Barkman TJ, 2007, MOL BIOL EVOL, V24, P1320, DOI 10.1093/molbev/msm053; Bina H, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1037-4; Chaiprasongsuk M, 2018, PHYTOCHEMISTRY, V149, P146, DOI 10.1016/j.phytochem.2018.02.010; Chen F, 2003, PLANT J, V36, P577, DOI 10.1046/j.1365-313X.2003.01902.x; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Clark GSIV, 1999, METHYL SALICYLATE OI, V24, P5; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Coppola M, 2018, ENTOMOL EXP APPL, V166, P386, DOI 10.1111/eea.12677; D'Auria JC, 2003, RECENT ADV PHYTOCHEM, V37, P253; de Jong P, 1993, P IDS BET S 2 4 OCT; Silva CCD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40552-3; Demirci F, 2000, CHEM NATURAL COMPOUN, V36; Du H, 1997, PLANT PHYSIOL, V113, P1319, DOI 10.1104/pp.113.4.1319; Dumolin S, 1995, THEOR APPL GENET, V91, P1253, DOI 10.1007/BF00220937; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Effmert U, 2005, PHYTOCHEMISTRY, V66, P1211, DOI 10.1016/j.phytochem.2005.03.031; FANG RX, 1989, PLANT CELL, V1, P141, DOI 10.1105/tpc.1.1.141; Fang T, 2015, J PLANT INTERACTIONS, V10, P1; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Forouhar F, 2005, J BIOL CHEM, V280, P40328, DOI 10.1074/jbc.M505332200; Fukami H, 2002, PLANT CELL PHYSIOL, V43, P1054, DOI 10.1093/pcp/pcf119; FURLOW JJ, 1990, J ARNOLD ARBORETUM, V71, P1; Gadino AN, 2012, BIOL CONTROL, V63, P48, DOI 10.1016/j.biocontrol.2012.06.006; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Gilbert W, 1987, EXON THEORY GENES, P0091; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Han XM, 2018, PLANT CELL PHYSIOL, V59, P392, DOI 10.1093/pcp/pcx198; Jarvinen P, 2004, AM J BOT, V91, P1834, DOI 10.3732/ajb.91.11.1834; Jianhua L, 2005, RHODORA, V107, P69; Joo E, 2011, ATMOS ENVIRON, V45, P3655, DOI 10.1016/j.atmosenv.2011.04.048; Joshi CP, 1998, PLANT MOL BIOL, V37, P663, DOI 10.1023/A:1006035210889; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; Kumar D, 2014, PLANT SCI, V228, P127, DOI 10.1016/j.plantsci.2014.04.014; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kuuluvainen T, 2015, RESTORATION BOREAL T, P251, DOI DOI 10.1201/B18809; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li JH, 2007, SYST BOT, V32, P357, DOI 10.1600/036364407781179699; Liu XG, 2016, GENE, V575, P458, DOI 10.1016/j.gene.2015.09.048; Lu FC, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0471-z; Mallinger RE, 2011, J ECON ENTOMOL, V104, P115, DOI 10.1603/EC10253; Manosalva PM, 2010, MOL PLANT MICROBE IN, V23, P1151, DOI 10.1094/MPMI-23-9-1151; MANTHE B, 1992, J CHEM ECOL, V18, P1525, DOI 10.1007/BF00993226; Mason L, 2004, BMJ-BRIT MED J, V328, P995, DOI 10.1136/bmj.38040.607141.EE; Mery G., 2010, IUFRO WORLD SERIES; Negre F, 2002, ARCH BIOCHEM BIOPHYS, V406, P261, DOI 10.1016/S0003-9861(02)00458-7; Nguyen Xuan Dung, 1995, Journal of Essential Oil Research, V7, P565; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; Pinosio S, 2016, MOL BIOL EVOL, V33, P2706, DOI 10.1093/molbev/msw161; Porth I, 2013, NEW PHYTOL, V200, P710, DOI 10.1111/nph.12422; Pott MB, 2002, J PLANT PHYSIOL, V159, P925, DOI 10.1078/0176-1617-00699; Qian P, 2015, CHEM J CHINESE U, V36, P2283, DOI 10.7503/cjcu20150674; Regel E, 1866, BEMERKUNGEN GATTUNGE; Ross J R., 1999, ARCH BIOCH BIOPHYSIC; Salojarvi J, 2017, NAT GENET, V49, P904, DOI 10.1038/ng.3862; Schenk MF, 2008, TREE GENET GENOMES, V4, P911, DOI 10.1007/s11295-008-0162-0; Schnaubelt K, 1998, N ATLANTIC BOOKS; Schroeder H, 2017, FORESTS, Vv. 8; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Singewar K, 2020, TREES; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van Den Boom CEM, 2004, J CHEM ECOL, V30, P69, DOI 10.1023/B:JOEC.0000013183.72915.99; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang N, 2016, ANN BOT-LONDON, V117, P1023, DOI 10.1093/aob/mcw048; Wang N, 2013, MOL ECOL, V22, P3098, DOI 10.1111/mec.12131; Wendy A, 2004, SYSTEMATIC BOT, V29, P1021; Williams JH, 2001, INT J PLANT SCI, V162, P1097, DOI 10.1086/321921; Winkler H, 1904, BETULACEAE; Wittek F, 2015, MOL PLANT PATHOL, V16, P616, DOI 10.1111/mpp.12216; Yan SP, 2014, CURR OPIN PLANT BIOL, V20, P64, DOI 10.1016/j.pbi.2014.04.006; Yang Yue, 2006, V40, P253; Yang Y, 2008, PLANT PHYSIOL, V147, P1034, DOI 10.1104/pp.108.118224; Zhang BY, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0474-7; Zhang MY, 2016, PROTOPLASMA, V253, P1347, DOI 10.1007/s00709-015-0893-3; Zhao N, 2008, PLANT PHYSIOL, V146, P455, DOI 10.1104/pp.107.110049; Zhao N, 2016, PLANT PHYSIOL BIOCH, V102, P125, DOI 10.1016/j.plaphy.2016.02.027; Zhao N, 2013, PHYTOCHEMISTRY, V94, P74, DOI 10.1016/j.phytochem.2013.06.014; Zhao N, 2009, PHYTOCHEMISTRY, V70, P32, DOI 10.1016/j.phytochem.2008.11.014; Zubieta C, 2003, PLANT CELL, V15, P1704, DOI 10.1105/tpc.014548	88	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240246	10.1371/journal.pone.0240246	http://dx.doi.org/10.1371/journal.pone.0240246			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031447	Green Published, gold			2022-12-26	WOS:000581809800060
J	Choi, MH; Yoon, SB; Song, MY; Lee, IS; Hong, TH; Lee, MA; Jung, ES				Choi, Moon Hyung; Yoon, Seung Bae; Song, Meiying; Lee, In Seok; Hong, Tae Ho; Lee, Myung Ah; Jung, Eun Sun			Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; TUMOR MEASUREMENT; SURGERY; GEMCITABINE; CT; CHEMORADIOTHERAPY; ADENOCARCINOMA; PATHOLOGY; RESECTION; THERAPY	Although pancreatic cancer tumors are irregularly shaped in terms of their three-dimensional (3D) structure, when T staging by imaging results, generally only the axial plane is used to measure the largest tumor diameter. We investigated the size of pancreatic cancer tumors using multi-plane and 3D reconstructed computed tomography (CT) images and investigated their clinical usefulness. Patients who underwent surgery for pancreatic adenocarcinoma were included. We measured the largest diameter of each pancreatic tumor in the axial, coronal, and sagittal planes of CT images. In addition, maximal diameter and cancer volume were measured from 3D images that were constructed using a semi-automated software system. Final data were compared with pathologic examination and the effect of each value on prognosis was analyzed. A total of 183 patients were analyzed. The maximal diameters measured on the axial, coronal, and sagittal planes were 2.9 +/- 1.1, 3.2 +/- 0.9, and 3.2 +/- 1.0 cm, respectively, which were significantly smaller than pathologic results (3.4 +/- 1.4 cm, allp<0.05 by paired t-test). The longest diameter among them (3.4 +/- 1.1 cm) was nearly similar to the pathologic diameter. Cancer volume measured on 3D images demonstrated a higher area under the receptor operating characteristic curve [0.714, (95% confidence interval: 0.640-0.788)] for predicting early death compared to any unidimensional CT diameters measured. The longest pancreatic tumor diameter measured on multiplanar CT images was most accurate when compared to its corresponding pathologic diameter. Tumor volume had a stronger correlation with overall survival than tumor diameter.	[Choi, Moon Hyung; Yoon, Seung Bae; Song, Meiying] Catholic Univ Korea, Coll Med, Canc Res Inst, Seoul, South Korea; [Choi, Moon Hyung] Catholic Univ Korea, Coll Med, Dept Radiol, Seoul, South Korea; [Yoon, Seung Bae; Song, Meiying; Lee, In Seok; Lee, Myung Ah] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Hong, Tae Ho] Catholic Univ Korea, Coll Med, Dept Surg, Seoul, South Korea; [Jung, Eun Sun] Catholic Univ Korea, Coll Med, Dept Hosp Pathol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Yoon, SB (corresponding author), Catholic Univ Korea, Coll Med, Canc Res Inst, Seoul, South Korea.; Yoon, SB (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea.	sbyoon@catholic.ac.kr		Yoon, Seung Bae/0000-0002-6119-7236	TAEJOON PHARM Co., Ltd. Korea; National Research Foundation of Korea - Korean Government [NRF-2018R1C1B6002375]	TAEJOON PHARM Co., Ltd. Korea; National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by a Research Fund from TAEJOON PHARM Co., Ltd. Korea and a grant from the National Research Foundation of Korea funded by the Korean Government (NRF-2018R1C1B6002375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 2017, ANN SURG, V265, P185, DOI 10.1097/SLA.0000000000001763; [Anonymous], 2012, NATL J COMMUNITY MED, V3, P326; Bankier AA, 2017, RADIOLOGY, V285, P584, DOI 10.1148/radiol.2017162894; Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea; Casadei R, 2015, J GASTROINTEST SURG, V19, P1802, DOI 10.1007/s11605-015-2890-4; Gillmore R, 2010, CLIN ONCOL-UK, V22, P564, DOI 10.1016/j.clon.2010.05.007; Jang JY, 2018, ANN SURG, V268, P215, DOI 10.1097/SLA.0000000000002705; Kakar S., 2016, AJCC CANC STAGING MA, V8th ed.; Kamarajah SK, 2017, ANN SURG ONCOL, V24, P2023, DOI 10.1245/s10434-017-5810-x; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Lampen-Sachar K, 2012, LUNG CANCER, V75, P332, DOI 10.1016/j.lungcan.2011.08.001; Lee KH, 2014, J THORAC ONCOL, V9, P74, DOI 10.1097/JTO.0000000000000019; Liu CJ, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0187-y; Marchegiani G, 2017, ANN SURG, V266, P142, DOI 10.1097/SLA.0000000000001837; Mokdad AA, 2017, J CLIN ONCOL, V35, P515, DOI 10.1200/JCO.2016.68.5081; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Park CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211141; Park S, 2019, KOREAN J RADIOL, V20, P1207, DOI 10.3348/kjr.2018.0824; Raufi AG, 2019, SEMIN ONCOL, V46, P19, DOI 10.1053/j.seminoncol.2018.12.002; Ridge CA, 2013, AM J ROENTGENOL, V201, P959, DOI 10.2214/AJR.12.10033; Rothe JH, 2013, EUR J RADIOL, V82, P1831, DOI 10.1016/j.ejrad.2012.05.018; Shubert CR, 2016, SURGERY, V160, P1080, DOI 10.1016/j.surg.2016.06.010; Stroom J, 2007, INT J RADIAT ONCOL, V69, P267, DOI 10.1016/j.ijrobp.2007.04.065; Ueno H, 2009, BRIT J CANCER, V101, P908, DOI 10.1038/sj.bjc.6605256	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240318	10.1371/journal.pone.0240318	http://dx.doi.org/10.1371/journal.pone.0240318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027288	Green Published, gold			2022-12-26	WOS:000581808000018
J	Vargas-Rodriguez, O; Bakhtina, M; McGowan, D; Abid, J; Goto, Y; Suga, H; Musier-Forsyth, K				Vargas-Rodriguez, Oscar; Bakhtina, Marina; McGowan, Daniel; Abid, Jawad; Goto, Yuki; Suga, Hiroaki; Musier-Forsyth, Karin			Human trans-editing enzyme displays tRNA acceptor-stem specificity and relaxed amino acid selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transfer RNA (tRNA); aminoacyl-tRNA synthetase; evolution; translation; protein synthesis; protein&#8211; nucleic acid interaction; deacylation; editing; translational quality control; identity elements	SPECIES-SPECIFIC DIFFERENCES; SYNTHETASE; PROTEIN; AMINOACYLATION; RECOGNITION; TRNA(PRO); MISTRANSLATION; CYS-TRNA(PRO); COMPLEX; DOMAIN	Accurate translation of genetic information into proteins is vital for cell sustainability. ProXp-ala prevents proteome-wide Pro-to-Ala mutations by hydrolyzing misacylated Ala-tRNA(Pro), which is synthesized by prolyl-tRNA synthetase. Bacterial ProXp-ala was previously shown to combine a size-based exclusion mechanism with conformational and chemical selection for the recognition of the alanyl moiety, whereas tRNA(Pro) is selected via recognition of tRNA acceptor-stem elements G72 and A73. The identity of these critical bases changed during evolution with eukaryotic cytosolic tRNA(Pro) possessing a cytosine at the corresponding positions. The mechanism by which eukaryotic ProXp-ala adapted to these changes remains unknown. In this work, recognition of the aminoacyl moiety and tRNA acceptor stem by human (Homo sapiens, or Hs) ProXp-ala was examined. Enzymatic assays revealed that Hs ProXp-ala requires C72 and C73 in the context of Hs cytosolic tRNA(Pro) for efficient deacylation of mischarged Ala-tRNA(Pro). The strong dependence on these bases prevents cross-species deacylation of bacterial Ala-tRNA(Pro) or of Hs mitochondrial Ala-tRNA(Pro) by the human enzyme. Similar to the bacterial enzyme, Hs ProXp-ala showed strong tRNA acceptor-stem recognition but differed in its amino acid specificity profile relative to bacterial ProXp-ala. Changes at conserved residues in both the Hs and bacterial ProXp-ala substrate-binding pockets modulated this specificity. These results illustrate how the mechanism of substrate selection diverged during the evolution of the ProXp-ala family, providing the first example of a trans-editing domain whose specificity evolved to adapt to changes in its tRNA substrate.	[Vargas-Rodriguez, Oscar; Bakhtina, Marina; McGowan, Daniel; Abid, Jawad; Musier-Forsyth, Karin] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Vargas-Rodriguez, Oscar; Bakhtina, Marina; McGowan, Daniel; Abid, Jawad; Musier-Forsyth, Karin] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Goto, Yuki; Suga, Hiroaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo, Japan	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Tokyo	Musier-Forsyth, K (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.; Musier-Forsyth, K (corresponding author), Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA.	musier-forsyth.1@osu.edu			National Institutes of Health [RO1 GM113656]; KAKENHI from the Japan Society for the Promotion of Science [JP20H05618, JP20H02866]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institutes of Health Grant RO1 GM113656 (to K. M.-F.) and by KAKENHI Grants JP20H05618 (to H. S.) and JP20H02866 (to Y. G.) from the Japan Society for the Promotion of Science. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Ahel I, 2002, J BIOL CHEM, V277, P34743, DOI 10.1074/jbc.M206928200; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; Bacher JM, 2007, P NATL ACAD SCI USA, V104, P1907, DOI 10.1073/pnas.0610835104; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Beuning PJ, 2001, J BIOL CHEM, V276, P30779, DOI 10.1074/jbc.M104761200; Burke B, 2001, J BIOL CHEM, V276, P20286, DOI 10.1074/jbc.M100456200; Burke B, 2000, BIOCHEMISTRY-US, V39, P15540, DOI 10.1021/bi001835p; Chen MR, 2020, NUCLEIC ACIDS RES, V48, P6445, DOI 10.1093/nar/gkaa469; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Crepin T, 2006, STRUCTURE, V14, P1511, DOI 10.1016/j.str.2006.08.007; Danhart EM, 2017, P NATL ACAD SCI USA, V114, pE6774, DOI 10.1073/pnas.1703925114; Das M, 2014, NUCLEIC ACIDS RES, V42, P3943, DOI 10.1093/nar/gkt1332; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Hilander T, 2018, NUCLEIC ACIDS RES, V46, P849, DOI 10.1093/nar/gkx1231; Imachi H, 2020, NATURE, V577, P519, DOI 10.1038/s41586-019-1916-6; Kamtekar S, 2003, P NATL ACAD SCI USA, V100, P1673, DOI 10.1073/pnas.0437911100; Kumar S, 2012, J BIOL CHEM, V287, P3175, DOI 10.1074/jbc.M111.313619; Kuncha SK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02204-w; Kuzmishin Nagy A. B., 2020, ENZYMES BIOL AMINOAC; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lemoine F, 2019, NUCLEIC ACIDS RES, V47, pW260, DOI 10.1093/nar/gkz303; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Lin BY, 2019, NUCLEIC ACIDS RES, V47, pW542, DOI 10.1093/nar/gkz438; Ling JQ, 2010, P NATL ACAD SCI USA, V107, P4028, DOI 10.1073/pnas.1000315107; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; LIU HJ, 1995, NUCLEIC ACIDS RES, V23, P165, DOI 10.1093/nar/23.1.165; Liu Y, 2014, P NATL ACAD SCI USA, V111, P17570, DOI 10.1073/pnas.1420196111; Mohler K, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.117; Mukherjee S, 2019, NUCLEIC ACIDS RES, V47, pD649, DOI 10.1093/nar/gky977; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Ruan LL, 2013, BIOCHEM J, V450, P243, DOI 10.1042/BJ20121493; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02201-z; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Stecher G, 2020, MOL BIOL EVOL, V37, P1237, DOI 10.1093/molbev/msz312; Stehlin C, 1998, BIOCHEMISTRY-US, V37, P8605, DOI 10.1021/bi980364s; Vargas-Rodriguez O, 2013, J BIOL CHEM, V288, P14391, DOI 10.1074/jbc.M113.467795; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wong FC, 2002, BIOCHEMISTRY-US, V41, P7108, DOI 10.1021/bi012178j; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3; Yaremchuk A, 2000, EMBO J, V19, P4745, DOI 10.1093/emboj/19.17.4745	50	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16180	16190		10.1074/jbc.RA120.015981	http://dx.doi.org/10.1074/jbc.RA120.015981			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	33051185	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000598519500001
J	Glass, TJ; Kelm-Nelson, CA; Szot, JC; Lake, JM; Connor, NP; Ciucci, MR				Glass, Tiffany J.; Kelm-Nelson, Cynthia A.; Szot, John C.; Lake, Jacob M.; Connor, Nadine P.; Ciucci, Michelle R.			Functional characterization of extrinsic tongue muscles in the Pink1-/- rat model of Parkinson disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN PATHOLOGY; DEFICITS; DEGENERATION; INVOLVEMENT; EXPRESSION; DYSPHAGIA; FEATURES; NERVES; FORCE	Parkinson disease (PD) is associated with speech and swallowing difficulties likely due to pathology in widespread brain and nervous system regions. In post-mortem studies of PD, pathology has been reported in pharyngeal and laryngeal nerves and muscles. However, it is unknown whether PD is associated with neuromuscular changes in the tongue. Prior work in a rat model of PD ( Pink1-/- ) showed oromotor and swallowing deficits in the premanifest stage which suggested sensorimotor impairments of these functions. The present study tested the hypothesis that Pink1-/- rats show altered tongue function coinciding with neuromuscular differences within tongue muscles compared to wildtype (WT). Male Pink1-/- and WT rats underwent behavioral tongue function assays at 4 and 6 months of age (n = 7-8 rats per group), which are time points early in the disease. At 6 months, genioglossus (GG) and styloglossus (SG) muscles were analyzed for myosin heavy chain isoforms (MyHC), alpha-synuclein levels, myofiber size, centrally nucleated myofibers, and neuromuscular junction (NMJ) innervation. Pink1-/- showed greater tongue press force variability, and greater tongue press forces and rates as compared to WT. Additionally, Pink1-/- showed relative increases of MyHC 2a in SG, but typical MyHC profiles in GG. Western blots revealed Pink1-/- had more alpha-synuclein protein than WT in GG, but not in SG. There were no differences between Pink1-/- and WT in myofiber size, centrally-nucleated myofibers, or NMJ innervation. alpha-synuclein protein was observed in nerves, NMJ, and vessels in both genotypes. Findings at these early disease stages suggest small changes or no changes in several peripheral biological measures, and intact motor innervation of tongue muscles. Future work should evaluate these measures at later disease stages to determine when robust pathological peripheral change contributes to functional change, and what CNS deficits cause behavioral changes. Understanding how PD affects central and peripheral mechanisms will help determine therapy targets for speech and swallowing disorders.	[Glass, Tiffany J.; Kelm-Nelson, Cynthia A.; Szot, John C.; Lake, Jacob M.; Connor, Nadine P.; Ciucci, Michelle R.] Univ Wisconsin, Dept Surg, 600 Highland Ave, Madison, WI 53706 USA; [Connor, Nadine P.; Ciucci, Michelle R.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Glass, TJ (corresponding author), Univ Wisconsin, Dept Surg, 600 Highland Ave, Madison, WI 53706 USA.	glass@surgery.wisc.edu	Ciucci, Michelle/O-9144-2016	Ciucci, Michelle/0000-0002-9913-8784	National Institute on Deafness and Other Communication Disorders (NIDCD) [R01 DC014358, R01 DC018071, R01DC008149, R21 DC016135]	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported through the National Institute on Deafness and Other Communication Disorders (NIDCD) R01 DC014358 (M.R.C.), R01 DC018071 (N.P.C.), R01DC008149 (N.P.C.), R21 DC016135 (C.A.K.) (URL: https://www.nidcd.nih.gov/).	Adreani CM, 2006, VET PATHOL, V43, P881, DOI 10.1354/vp.43-6-881; Alberts JL, 2000, EXP BRAIN RES, V134, P353, DOI 10.1007/s002210000468; Animals NRC (US) C for the U of the G for the C and U of L, 2011, GUIDE CARE USE LAB A, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; [Anonymous], 1999, AM J PHYSIOL-CELL PH, V277, pC1; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bougea A, 2019, J NEURAL TRANSM, V126, P1373, DOI 10.1007/s00702-019-02062-4; Cersosimo MG, 2012, J NEUROL SCI, V313, P57, DOI 10.1016/j.jns.2011.09.030; Ciucci MR, 2013, SEMIN SPEECH LANG, V34, P185, DOI 10.1055/s-0033-1358367; Ciucci MR, 2011, BEHAV BRAIN RES, V222, P315, DOI 10.1016/j.bbr.2011.03.057; Ciucci MR, 2009, EXP BRAIN RES, V194, P587, DOI 10.1007/s00221-009-1736-2; Clemente C.D., 1997, ANATOMY REGIONAL ATL; Cobourne MT, 2019, SEMIN CELL DEV BIOL, V91, P45, DOI 10.1016/j.semcdb.2018.04.016; Comi C, 2014, PARKINSONISM RELAT D, V20, P1329, DOI 10.1016/j.parkreldis.2014.10.010; Connor NP, 2009, J SPEECH LANG HEAR R, V52, P732, DOI 10.1044/1092-4388(2008/08-0105); Cullen KP, 2018, DYSPHAGIA, V33, P749, DOI 10.1007/s00455-018-9896-5; Dave KD, 2014, NEUROBIOL DIS, V70, P190, DOI 10.1016/j.nbd.2014.06.009; Dedkov EI, 2003, CELL TISSUE RES, V311, P401, DOI 10.1007/s00441-002-0686-9; Fuh JL, 1997, CLIN NEUROL NEUROSUR, V99, P106, DOI 10.1016/S0303-8467(97)00606-9; German RZ, 2017, DYSPHAGIA, V32, P73, DOI 10.1007/s00455-016-9778-7; Glass TJ, 2019, J APPL PHYSIOL, V126, P1326, DOI 10.1152/japplphysiol.00557.2018; Grant LM, 2015, J NEUROSCI RES, V93, P1713, DOI 10.1002/jnr.23625; Haaxma CA, 2010, MOVEMENT DISORD, V25, P1150, DOI 10.1002/mds.23100; Hegland KW, 2019, MOV DISORD CLIN PRAC, V6, P243, DOI 10.1002/mdc3.12732; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Jones CA, 2016, J PARKINSON DIS, V6, P197, DOI 10.3233/JPD-150687; Kelm-Nelson CA, 2018, NEUROSCIENCE, V379, P126, DOI 10.1016/j.neuroscience.2018.02.027; Kelm-Nelson CA, 2016, NEUROSCI LETT, V621, P75, DOI 10.1016/j.neulet.2016.04.003; Kim JY, 2019, J CLIN NEUROL, V15, P135, DOI 10.3988/jcn.2019.15.2.135; Kim KS, 2010, J BIOL CHEM, V285, P21416, DOI 10.1074/jbc.M110.103499; Leow LP, 2012, DYSPHAGIA, V27, P106, DOI 10.1007/s00455-011-9347-z; Mancini F, 2014, PARKINSONISM RELAT D, V20, P27, DOI 10.1016/j.parkreldis.2013.09.007; Meissner WG, 2011, NAT REV DRUG DISCOV, V10, P377, DOI 10.1038/nrd3430; Mu LC, 2015, DYSPHAGIA, V30, P404, DOI 10.1007/s00455-015-9612-7; Mu LC, 2013, J NEUROPATH EXP NEUR, V72, P614, DOI 10.1097/NEN.0b013e3182965886; Mu LC, 2013, J NEUROPATH EXP NEUR, V72, P119, DOI 10.1097/NEN.0b013e3182801cde; Naganuma K, 2001, BRAIN RES, V915, P185, DOI 10.1016/S0006-8993(01)02848-7; Narai H, 2009, NEUROL INT, V1, P57, DOI 10.4081/ni.2009.e16; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Pflug C, 2018, DYSPHAGIA, V33, P41, DOI 10.1007/s00455-017-9831-1; Pitts LL, 2018, J SPEECH LANG HEAR R, V61, P257, DOI 10.1044/2017_JSLHR-S-17-0259; Rogers RS, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00473; Schaser AJ, 2011, DYSPHAGIA, V26, P256, DOI 10.1007/s00455-010-9297-x; SCHNEIDER JS, 1986, ANN NEUROL, V19, P275, DOI 10.1002/ana.410190309; Shanmugalakshmi R., 2012, EUR J SCI RES, V71, P520; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Solomon NP, 2000, J SPEECH LANG HEAR R, V43, P256, DOI 10.1044/jslhr.4301.256; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Wang NS, 2013, NEUROLOGY, V81, P1604, DOI 10.1212/WNL.0b013e3182a9f449; Ziermann JM, 2018, GENESIS, V56, DOI 10.1002/dvg.23097	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240366	10.1371/journal.pone.0240366	http://dx.doi.org/10.1371/journal.pone.0240366			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064741	Green Published, gold			2022-12-26	WOS:000585918300029
J	Hermes, C; Nydahl, P; Blobner, M; Dubb, R; Filipovic, S; Kaltwasser, A; Ulm, B; Schaller, SJ				Hermes, Carsten; Nydahl, Peter; Blobner, Manfred; Dubb, Rolf; Filipovic, Silke; Kaltwasser, Arnold; Ulm, Bernhard; Schaller, Stefan J.			Assessment of mobilization capacity in 10 different ICU scenarios by different professions	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; ACUTE RESPIRATORY-FAILURE; BREATHING COORDINATION; IDENTIFYING BARRIERS; EARLY REHABILITATION; ACTIVE MOBILIZATION; POINT-PREVALENCE; CRITICAL ILLNESS; ADULT PATIENTS	Background Mobilization of intensive care patients is a multi-professional task. Aim of this study was to explore how different professions working at Intensive Care Units (ICU) estimate the mobility capacity using the ICU Mobility Score in 10 different scenarios. Methods Ten fictitious patient-scenarios and guideline-related knowledge were assessed using an online survey. Critical care team members in German-speaking countries were invited to participate. All datasets including professional data and at least one scenario were analyzed. Kruskal Wallis test was used for the individual scenarios, while a linear mixed-model was used over all responses. Results In total, 515 of 788 (65%) participants could be evaluated. Physicians (p = 0.001) and nurses (p = 0.002) selected a lower ICU Mobility Score (-0.7 95% CI -1.1 to -0.3 and -0.4 95% CI -0.7 to -0.2, respectively) than physical therapists, while other specialists did not (p = 0.81). Participants who classified themselves as experts or could define early mobilization in accordance to the "S2e guideline: positioning and early mobilisation in prophylaxis or therapy of pulmonary disorders" correctly selected higher mobilization levels (0.2 95% CI 0.0 to 0.4, p = 0.049 and 0.3 95% CI 0.1 to 0.5, p = 0.002, respectively). Conclusion Different professions scored the mobilization capacity of patients differently, with nurses and physicians estimating significantly lower capacity than physical therapists. The exact knowledge of guidelines and recommendations, such as the definition of early mobilization, independently lead to a higher score. Interprofessional education, interprofessional rounds and mobilization activities could further enhance knowledge and practice of mobilization in the critical care team.	[Hermes, Carsten; Schaller, Stefan J.] CCRN, Bonn, Germany; [Nydahl, Peter] Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Nursing Res, Kiel, Germany; [Blobner, Manfred; Ulm, Bernhard; Schaller, Stefan J.] Tech Univ Munich, Dept Anesthesiol & Intens Care, Sch Med, Klinikum Rechts Isar, Munich, Germany; [Dubb, Rolf; Kaltwasser, Arnold] Acad Dist Clin Reutlingen, Reutlingen, Germany; [Filipovic, Silke] Univ Hosp Giessen & Marburg, Dept Physiotherapy, Marburg, Germany; [Schaller, Stefan J.] Charite Univ Med Berlin, Freie Univ Berlin, Berlin, Germany; [Schaller, Stefan J.] Charite Univ Med Berlin, Humboldt Univ Berlin, Berlin, Germany; [Schaller, Stefan J.] Berlin Inst Hlth, Dept Anesthesiol & Operat Intens Care Med, Berlin, Germany	University of Kiel; Schleswig Holstein University Hospital; Technical University of Munich; University Hospital of Giessen & Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health	Hermes, C; Schaller, SJ (corresponding author), CCRN, Bonn, Germany.; Schaller, SJ (corresponding author), Tech Univ Munich, Dept Anesthesiol & Intens Care, Sch Med, Klinikum Rechts Isar, Munich, Germany.; Schaller, SJ (corresponding author), Charite Univ Med Berlin, Freie Univ Berlin, Berlin, Germany.; Schaller, SJ (corresponding author), Charite Univ Med Berlin, Humboldt Univ Berlin, Berlin, Germany.; Schaller, SJ (corresponding author), Berlin Inst Hlth, Dept Anesthesiol & Operat Intens Care Med, Berlin, Germany.	stefan.schaller@charite.de	Schaller, Stefan J/L-8054-2019; Nydahl, Peter/V-4516-2019; Blobner, Manfred/R-4411-2017	Schaller, Stefan J/0000-0002-6683-9584; Nydahl, Peter/0000-0002-5178-0364; Hermes, Carsten/0000-0003-0889-1381; Blobner, Manfred/0000-0002-0370-5247; Dubb, Rolf/0000-0002-1832-6338	German Research Foundation (DFG); Open Access Publication Fund of Charite - Universitats medizin Berlin	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Charite - Universitats medizin Berlin	We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite - Universitats medizin Berlin.	Bailey P, 2007, CRIT CARE MED, V35, P139, DOI 10.1097/01.CCM.0000251130.69568.87; Bakhru RN, 2016, ANN AM THORAC SOC, V13, P1527, DOI 10.1513/AnnalsATS.201601-078OC; Balas MC, 2014, CRIT CARE MED, V42, P1024, DOI 10.1097/CCM.0000000000000129; Berney SC, 2019, ARCH PHYS MED REHAB, V100, P261, DOI 10.1016/j.apmr.2018.07.438; Brock C, 2018, HEART LUNG, V47, P380, DOI 10.1016/j.hrtlng.2018.04.004; Costa DK, 2017, CHEST, V152, P304, DOI 10.1016/j.chest.2017.03.054; de Queiroz RS, 2018, HEART LUNG, V47, P253, DOI 10.1016/j.hrtlng.2018.03.003; Devlin JW, 2018, CRIT CARE MED, V46, P1532, DOI [10.1097/CCM.0000000000003259, 10.1097/CCM.0000000000003299]; Dubb R, 2016, ANN AM THORAC SOC, V13, P724, DOI 10.1513/AnnalsATS.201509-586CME; Fontela Paula Caitano, 2018, Rev. bras. ter. intensiva, V30, P187, DOI [10.5935/0103-507X.20180037, 10.5935/0103-507x.20180037]; Fuest K, 2018, CURR OPIN ANESTHESIO, V31, P144, DOI 10.1097/ACO.0000000000000568; Garzon-Serrano J, 2011, PM&R, V3, P307, DOI 10.1016/j.pmrj.2010.12.022; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; Hickmann CE, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0184-y; Hodgson C, 2014, HEART LUNG, V43, P19, DOI 10.1016/j.hrtlng.2013.11.003; Hodgson CL, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0658-y; Holdsworth C, 2015, J CRIT CARE, V30, P1243, DOI 10.1016/j.jcrc.2015.08.010; Jolley SE, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-84; Jolley SE, 2017, CRIT CARE MED, V45, P205, DOI 10.1097/CCM.0000000000002058; Krupp A, 2018, INTENS CRIT CARE NUR, V47, P30, DOI 10.1016/j.iccn.2018.04.003; Lee H, 2016, BLOOD PURIFICAT, V42, P83, DOI 10.1159/000446175; Lord RK, 2013, CRIT CARE MED, V41, P717, DOI 10.1097/CCM.0b013e3182711de2; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Needham DM, 2010, ARCH PHYS MED REHAB, V91, P536, DOI 10.1016/j.apmr.2010.01.002; Nessizius S, 2017, MED KLIN-INTENSIVMED, V112, P308, DOI 10.1007/s00063-017-0280-2; Nickels M, 2017, AUST CRIT CARE, V30, P79, DOI 10.1016/j.aucc.2016.03.003; Nydahl P, 2017, MED KLIN-INTENSIVMED, V112, P156, DOI 10.1007/s00063-016-0210-8; Nydahl P, 2016, MED KLIN-INTENSIVMED, V111, P153, DOI 10.1007/s00063-015-0073-4; Nydahl P, 2020, HEART LUNG, V49, P301, DOI 10.1016/j.hrtlng.2019.12.004; Nydahl P, 2017, ANN AM THORAC SOC, V14, P766, DOI 10.1513/AnnalsATS.201611-843SR; Nydahl P, 2014, CRIT CARE MED, V42, P1178, DOI 10.1097/CCM.0000000000000149; Parry SM, 2018, INTENS CARE MED, V44, P470, DOI 10.1007/s00134-017-4908-8; Parry SM, 2017, INTENS CARE MED, V43, P531, DOI 10.1007/s00134-017-4685-4; Parry SM, 2017, J CRIT CARE, V38, P137, DOI 10.1016/j.jcrc.2016.11.005; Schaller SJ, 2019, INTENS CARE MED, V45, P201, DOI 10.1007/s00134-019-05528-x; Schaller SJ, 2016, LANCET, V388, P1377, DOI 10.1016/S0140-6736(16)31637-3; Schaller SJ, 2016, J CRIT CARE, V32, P201, DOI 10.1016/j.jcrc.2015.12.020; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sibilla A, 2020, J INTENSIVE CARE MED, V35, P55, DOI 10.1177/0885066617728486; Taito S, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0179-7; Toonstra AL, 2017, DISABIL REHABIL, V39, P1143, DOI 10.1080/09638288.2016.1186751; Waldauf P, 2020, CRIT CARE MED, V48, P1055, DOI 10.1097/CCM.0000000000004382; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Young DL, 2018, AM J CRIT CARE, V27, P186, DOI 10.4037/ajcc2018368; [No title captured]; [No title captured]	46	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0239853	10.1371/journal.pone.0239853	http://dx.doi.org/10.1371/journal.pone.0239853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057435	gold, Green Published			2022-12-26	WOS:000581814700016
J	Mbuthia, GW; Nyamogoba, HDN; Chiang, SS; McGarvey, ST				Mbuthia, Grace Wambura; Nyamogoba, Henry D. N.; Chiang, Silvia S.; McGarvey, Stephen T.			Burden of stigma among tuberculosis patients in a pastoralist community in Kenya: A mixed methods study	PLOS ONE			English	Article							SOUTHERN THAILAND; HIV; DIAGNOSIS; BARRIERS; PERCEPTION; ADHERENCE; AWARENESS; HIV/AIDS; THERAPY; PEOPLE	Background Tuberculosis (TB) stigma remains a barrier to early diagnosis and treatment completion. Increased understanding of stigma is necessary for improved interventions to minimise TB stigma and its effects. The purpose of this study is to quantitatively measure TB stigma and to explore qualitatively its manifestation among TB patients in a rural Kenyan community. Methods This hospital based study using explanatory sequential mixed methods approach was conducted in 2016. In the quantitative part of the study, a questionnaire containing socio-demographic characteristics and scales measuring perceived TB stigma and experienced TB stigma, was administered to 208 adult pulmonary TB patients receiving treatment in West Pokot County. Respondents with high stigma were purposively selected to take part in in-depth interviews and focus group discussions. The qualitative data were collected through 15 in-depth interviews and 6 focus group discussions with TB patients. Descriptive and bivariate analysis was done for the quantitative data while the thematic analysis was done for qualitative data. Results The internal consistency reliability coefficients were satisfactory with Cronbach alphas of 0.87 and 0.86 for the 11-item and 12-item stigma measurement scale. The investigation revealed that TB stigma was high. The key drivers of TB stigma were the association of TB with HIV/AIDS and the fear of TB transmission. TB stigma was exemplified through patients being isolated by others, self-isolation, fear to disclose TB diagnosis, association of TB with human immunodeficiency virus (HIV) and lack of social support. Being a woman was significantly associated with high levels of both experienced stigma (p = 0.007) and perceived stigma (p = 0.005) while age, marital status, occupation and the patient's religion were not. Conclusion There is a need to implement stigma reduction interventions in order to improve TB program outcomes.	[Mbuthia, Grace Wambura] Jomo Kenyatta Univ Agr & Technol, Coll Hlth Sci, Nairobi, Kenya; [Nyamogoba, Henry D. N.] Moi Univ, Coll Hlth Sci, Eldoret, Kenya; [Chiang, Silvia S.] Brown Univ, Dept Pediat, Alpert Med Sch, Providence, RI 02912 USA; [Chiang, Silvia S.] Rhode Isl Hosp, Ctr Int Hlth Res, Providence, RI USA; [McGarvey, Stephen T.] Brown Univ, Sch Publ Hlth, Int Hlth Inst, Providence, RI 02912 USA; [McGarvey, Stephen T.] Brown Univ, Dept Epidemiol, Sch Publ Hlth, Providence, RI 02912 USA	Jomo Kenyatta University of Agriculture & Technology; Moi University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Mbuthia, GW (corresponding author), Jomo Kenyatta Univ Agr & Technol, Coll Hlth Sci, Nairobi, Kenya.	grace.mbuthia@jkuat.ac.ke		Chiang, Silvia/0000-0002-2318-3802; Mbuthia, Grace/0000-0003-0994-5249	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [B 8606 R02]; Sida [54100113]; DELTAS Africa Initiative [107768/Z/15/Z]; African Academy of sciences (AAS)'s Alliance for the Accelerating Excellence in Science in Africa(AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK); UK government	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; African Academy of sciences (AAS)'s Alliance for the Accelerating Excellence in Science in Africa(AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government	This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York(Grant No: B 8606 R02), Sida (Grant No: 54100113), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z), The DELA Africa Initiative is an independent funding scheme of the African Academy of sciences (AAS)'s Alliance for the Accelerating Excellence in Science in Africa(AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from Wellcome Trust (UK) and the UK government. The statements made and views expressed are solely the responsibility of the fellow.	Abney K, 2011, WHOEVER SAID LITTLED; [Anonymous], 1998, TRC S AFR REP, V3, P138; [Anonymous], 2018, FARSOTTAFRETTIR, V11, P1, DOI DOI 10.1186/s13071-017-2573-y; [Anonymous], 2011, INT J TUBERC LUNG DI, V15, pS50; Arcencio RA, 2014, PUBLIC HEALTH ACTION, V4, P195, DOI 10.5588/pha.13.0095; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Bobbio F, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027179; Bond V, 2006, J COMMUNITY APPL SOC, V16, P452, DOI 10.1002/casp.893; Buregyeya E, 2011, INT J TUBERC LUNG D, V15, P938, DOI 10.5588/ijtld.10.0211; Chakrabartty Arupkumar, 2019, Indian J Tuberc, V66, P259, DOI 10.1016/j.ijtb.2019.03.005; Chapple A, 2004, BMJ-BRIT MED J, V328, P1470, DOI 10.1136/bmj.38111.639734.7C; Chiang SS, 2017, INT J TUBERC LUNG D, V21, P154, DOI 10.5588/ijtld.16.0624; Chileshe M, 2010, AIDS CARE, V22, P51, DOI 10.1080/09540121003617372; Christodoulou M, 2011, LANCET INFECT DIS, V11, P663, DOI 10.1016/S1473-3099(11)70228-6; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Creswell J.W., 2007, DESIGNING CONDUCTING; Creswell J. W., 2014, RES DESIGN QUALITATI; Creswell JW., 2012, CONDUCT EVAL, V260, P375; Creswell JW, 2013, RES DESIGN QUALITATI; Di Gennaro F, 2017, TUBERCULOSIS, V103, P44, DOI 10.1016/j.tube.2017.01.002; Dodor EA, 2008, INT J TUBERC LUNG D, V12, P1048; Gelaw M, 2001, East Afr Med J, V78, P382; Gilbert L, 2010, HEALTH SOC CARE COMM, V18, P139, DOI 10.1111/j.1365-2524.2009.00881.x; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Greene J.C., 1989, EDUC EVAL POLICY AN, V11, P255, DOI [10.3102/01623737011003255, DOI 10.3102/01623737011003255]; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Huho J. M., 2012, Academic Research International, V3, P458; Ivankova NV, 2006, FIELD METHOD, V18, P3, DOI 10.1177/1525822X05282260; Jaramillo E, 1999, J Health Psychol, V4, P71, DOI 10.1177/135910539900400101; Kipp AM, 2011, INT J TUBERC LUNG D, V15, P1540, DOI 10.5588/ijtld.10.0273; Kurspahic-Mujcic Amira, 2013, Med Glas (Zenica), V10, P272; Lauer SA, 2017, IOWA HIST REV, V7, P55, DOI [10.17077/2373-1842-1039, DOI 10.17077/2373-1842-1039]; Liefooghe R, 1997, TROP MED INT HEALTH, V2, P809, DOI 10.1046/j.1365-3156.1997.d01-380.x; Macdonald H, 2015, QUALITATIVE HLTH RES, p1049732315606065; Marangu D, 2016, ADAPTING STIGMA SCAL; Mbuthia GW, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.287.14836; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Moya EM, 2014, PUBLIC HEALTH ACTION, V4, P226, DOI 10.5588/pha.14.0065; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Murray EJ, 2013, HEALTH POLICY PLANN, V28, P410, DOI 10.1093/heapol/czs072; National Tuberculosis Leprosy and Lung Disease Program (NTLD-P), 2015, ANN REPORT; Ngamvithayapong J, 2000, AIDS, V14, P1413, DOI 10.1097/00002030-200007070-00015; Nyamogoba HDN, 2012, AFR HEALTH SCI, V12, P305, DOI 10.4314/ahs.v12i3.9; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Raubenheimer J., 2004, SA J IND PSYCHOL, V30, P59, DOI [10.10520/EJC89023, DOI 10.4102/SAJIP.V30I4.168, 10.4102/sajip.v30i4.168]; Sengupta S, 2006, INT J TUBERC LUNG D, V10, P1008; Sharma N, 2007, ASIA-PAC J PUBLIC HE, V19, P10, DOI 10.1177/10105395070190020301; Strauss A., 1998, BASICS QUALITATIVE R; Teddlie C., 2003, HDB MIXED METHODS SO, P3, DOI DOI 10.4135/9781506335193; Van Rie A, 2008, TROP MED INT HEALTH, V13, P21, DOI 10.1111/j.1365-3156.2007.01971.x; Weiss MG, 2006, LANCET, V367, P536, DOI 10.1016/S0140-6736(06)68189-0; WHO, 2019, GLOB TUB REP; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Yang LH, 2007, SOC SCI MED, V64, P1524, DOI 10.1016/j.socscimed.2006.11.013	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240457	10.1371/journal.pone.0240457	http://dx.doi.org/10.1371/journal.pone.0240457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057420	gold, Green Published, Green Submitted			2022-12-26	WOS:000581814700075
J	Piekarowicz, A; Klyz, A; Adamczyk-Poplawska, M; Stein, DC				Piekarowicz, A.; Klyz, A.; Adamczyk-Poplawska, M.; Stein, D. C.			Association of host proteins with the broad host range filamentous phage Ngo phi 6 ofNeisseria gonorrhoeae	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIOPHAGE; GLYCOSYLATION; INTEGRATION; QUALITY; PHI	AllNeisseria gonorrhoeaestrains contain multiple copies of integrated filamentous phage genomes with undefined structures. In this study, we sought to characterize the capsid proteins of filamentousN.gonorrhoeaebacteriophage Ngo phi 6 and phagemids propagated in different bacteria. The data demonstrate that purified phage contain phage-encoded structural proteins and bacterial host proteins; host proteins consistently copurified with the phage particles. The bacterial host proteins associated with the phage filament (as identified by mass spectrometry) tended to be one of the predominant outer membrane components of the host strain, plus minor additional host proteins. We were able to copurify a functional ss-lactamase, a phagemid-encoded protein, with phage filaments. We used protein modeling and immunological analysis to identify the major phage encoded structural proteins. The antigenic properties of these proteins depended on the bacterium where the phages were propagated. Polyclonal antibodies againstN.gonorrhoeaephage Ngo phi 6 recognized phage-encoded proteins if the phage was propagated inN.gonorrhoeaeorH.influenzaecells but not if it was propagated inSalmonellaorE.coli. We show that the phage filaments isolated from gonococci andHaemophilusare glycosylated, and this may explain the antigenic diversity seen. Taken en toto, the data demonstrate that while the neisserial filamentous phage are similar to otherInoviruswith respect to overall genomic organization, their ability to closely associate with host proteins suggests that they have unique surface properties and are secreted by a here-to-fore unknown secretory pathway.	[Piekarowicz, A.; Klyz, A.; Adamczyk-Poplawska, M.] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Virol, Warsaw, Poland; [Stein, D. C.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University of Warsaw; University System of Maryland; University of Maryland College Park	Stein, DC (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dcstein@umd.edu	Adamczyk-Poplawska, Monika/AAX-9646-2021	Adamczyk-Poplawska, Monika/0000-0002-5885-9550	Polish Ministry of Science and Higher Education [UMO-2014/13/B/NZ6/00245]; National Institutes of Health [AI AI099819]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants to AP from the Polish Ministry of Science and Higher Education, UMO-2014/13/B/NZ6/00245 and a grant to DCS from the National Institutes of Health, AI AI099819. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants to AP from the Polish Ministry of Science and Higher Education, UMO-2014/13/B/NZ6/00245 and a grant to DCS from the National Institutes of Health, AI AI099819. AP wishes to thank Henry Ostapiej for his hospitality during the COVID-19 pandemic.	Ackermann Hans-W., 2009, V501, P127, DOI 10.1007/978-1-60327-164-6_13; Askora A, 2009, VIROLOGY, V384, P69, DOI 10.1016/j.virol.2008.11.007; BARCAK GJ, 1991, METHOD ENZYMOL, V204, P321; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; BHIVA/ BASHH, 2019, HIV MED S2, V20, ps2; Bhoopalan SV, 2016, SCI REP-UK, V6, DOI 10.1038/srep22372; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; BLAKE MS, 1995, INFECT IMMUN, V63, P1434, DOI 10.1128/IAI.63.4.1434-1439.1995; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CHANG CN, 1978, P NATL ACAD SCI USA, V75, P361, DOI 10.1073/pnas.75.1.361; Chouikha I, 2010, VIROLOGY, V407, P43, DOI 10.1016/j.virol.2010.07.048; Davis BM, 2003, CURR OPIN MICROBIOL, V6, P35, DOI 10.1016/S1369-5274(02)00005-X; Derbise A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00701; Eichler J, 2017, TRENDS MICROBIOL, V25, P662, DOI 10.1016/j.tim.2017.03.001; Gagic D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00429; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kawai M, 2005, DNA RES, V12, P389, DOI 10.1093/dnares/dsi021; Klyz A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202437; Loh B, 2019, MOL MICROBIOL, V111, P1132, DOI 10.1111/mmi.14187; Marvin DA, 2014, PROG BIOPHYS MOL BIO, V114, P80, DOI 10.1016/j.pbiomolbio.2014.02.003; Monjezi R, 2010, J CHROMATOGR B, V878, P1855, DOI 10.1016/j.jchromb.2010.05.028; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; Piekarowicz A, 2006, POL J MICROBIOL, V55, P251; Piekarowicz A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22549; Piekarowicz A, 2014, J VIROL, V88, P1002, DOI 10.1128/JVI.02707-13; Piekarowicz A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-66; PRICER WE, 1964, J BIOL CHEM, V239, P2607; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Russel M, 2006, FILAMENTOUS PHAGES; Sambrook J., 2001, MOL CLONING LAB MANU; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; WHITE LA, 1965, APPL MICROBIOL, V13, P171, DOI 10.1128/AEM.13.2.171-174.1965	38	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240579	10.1371/journal.pone.0240579	http://dx.doi.org/10.1371/journal.pone.0240579			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057372	gold, Green Published			2022-12-26	WOS:000581814700073
J	Tamai, Y; Ito, Y; Furuyama, T; Horinouchi, K; Murashima, N; Michimoto, I; Hishida, R; Shibuki, K; Hiryu, S; Kobayasi, KI				Tamai, Yuta; Ito, Yuki; Furuyama, Takafumi; Horinouchi, Kensuke; Murashima, Nagomi; Michimoto, Itsuki; Hishida, Ryuichi; Shibuki, Katsuei; Hiryu, Shizuko; Kobayasi, Kohta I.			Auditory cortical activity elicited by infrared laser irradiation from the outer ear in Mongolian gerbils	PLOS ONE			English	Article							NEURAL STIMULATION; OPTICAL STIMULATION; CORTEX; NEURONS; DISCRIMINATION; PLASTICITY; RESPONSES; SENSITIVITY; CHANNELS; HEARING	Infrared neural stimulation has been studied for its potential to replace an electrical stimulation of a cochlear implant. No studies, however, revealed how the technic reliably evoke auditory cortical activities. This research investigated the effects of cochlear laser stimulation from the outer ear on auditory cortex using brain imaging of activity-dependent changes in mitochondrial flavoprotein fluorescence signal. An optic fiber was inserted into the gerbil's ear canal to stimulate the lateral side of the cochlea with an infrared laser. Laser stimulation was found to activate the identified primary auditory cortex. In addition, the temporal profile of the laser-evoked responses was comparable to that of the auditory responses. Our results indicate that infrared laser irradiation from the outer ear has the capacity to evoke, and possibly manipulate, the neural activities of the auditory cortex and may substitute for the present cochlear implants in future.	[Tamai, Yuta; Ito, Yuki; Furuyama, Takafumi; Horinouchi, Kensuke; Murashima, Nagomi; Hiryu, Shizuko; Kobayasi, Kohta I.] Doshisha Univ, Fac Life & Med Sci, Kyoto, Japan; [Furuyama, Takafumi] Kanazawa Med Univ, Dept Physiol, Uchinada, Ishikawa, Japan; [Michimoto, Itsuki] Doshisha Univ, Fac Sci & Engn, Kyoto, Japan; [Hishida, Ryuichi; Shibuki, Katsuei] Niigata Univ, Brain Res Inst, Dept Neurophysiol, Niigata, Niigata, Japan	Doshisha University; Kanazawa Medical University; Doshisha University; Niigata University	Kobayasi, KI (corresponding author), Doshisha Univ, Fac Life & Med Sci, Kyoto, Japan.	kkobayas@mail.doshisha.ac.jp			Japan Society for the Promotion of Science, grants-in-aid for scientific research KAKENHI [17H01769, 19K16192, 18J21644]	Japan Society for the Promotion of Science, grants-in-aid for scientific research KAKENHI	This research was supported by Japan Society for the Promotion of Science, grants-in-aid for scientific research KAKENHI Grant number: 17H01769 to KIK; 19K16192 to TF; 18J21644 to YT Funders don't play any role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Albert ES, 2012, J NEUROPHYSIOL, V107, P3227, DOI 10.1152/jn.00424.2011; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; [Anonymous], 2005, NEPHROL CARLT, V10, pS157; BRUGGE JF, 1969, J NEUROPHYSIOL, V32, P1005, DOI 10.1152/jn.1969.32.6.1005; Capsius B, 1996, HEARING RES, V96, P59, DOI 10.1016/0378-5955(96)00038-X; Cayce JM, 2014, NEUROIMAGE, V84, P181, DOI 10.1016/j.neuroimage.2013.08.040; Cayce JM, 2011, NEUROIMAGE, V57, P155, DOI 10.1016/j.neuroimage.2011.03.084; Cotillon-Williams N, 2003, J NEUROPHYSIOL, V89, P1968, DOI 10.1152/jn.00728.2002; DEATHERAGE BH, 1959, J ACOUST SOC AM, V31, P479, DOI 10.1121/1.1907739; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; HEFFNER HE, 1986, J NEUROPHYSIOL, V56, P683, DOI 10.1152/jn.1986.56.3.683; Honma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068113; Horie M, 2013, NEUROSCI RES, V76, P207, DOI 10.1016/j.neures.2013.05.004; Izzo AD, 2008, BIOPHYS J, V94, P3159, DOI 10.1529/biophysj.107.117150; Izzo AD, 2006, LASER SURG MED, V38, P745, DOI 10.1002/lsm.20358; Kadakia S, 2013, PROC SPIE, V8565, DOI 10.1117/12.2013848; Kitaura H, 2010, BRAIN RES, V1319, P54, DOI 10.1016/j.brainres.2010.01.020; Kobayasi KI, 2013, NEUROSCI LETT, V534, P24, DOI 10.1016/j.neulet.2012.10.056; Komagata S, 2011, J NEUROSCI, V31, P4896, DOI 10.1523/JNEUROSCI.6753-10.2011; Kubota Y, 2008, NEUROSCI RES, V60, P422, DOI 10.1016/j.neures.2007.12.013; Matic AI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058189; Moreno LE, 2011, HEARING RES, V282, P289, DOI 10.1016/j.heares.2011.06.006; NIH Public Access Author Manuscript, 2011, J PHYS ACT HLTH, V8, pS257; Nishikawa J, 2018, J NEUROSCI METH, V293, P77, DOI 10.1016/j.jneumeth.2017.08.028; Ohl FW, 2001, NATURE, V412, P733, DOI 10.1038/35089076; Ohshima S, 2010, NEUROSCI RES, V67, P51, DOI 10.1016/j.neures.2010.01.005; Richter CP, 2008, HEARING RES, V242, P42, DOI 10.1016/j.heares.2008.01.011; Richter CP, 2013, PROC SPIE, V8565, DOI 10.1117/12.2013849; RIQUIMAROUX H, 1991, SCIENCE, V251, P565, DOI 10.1126/science.1990432; RYAN A, 1976, J ACOUST SOC AM, V59, P1222, DOI 10.1121/1.380961; Schultz M, 2012, BIOMED OPT EXPRESS, V3, P3332, DOI 10.1364/BOE.3.003332; Shapiro MG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1742; Shibuki K, 2006, NEUROIMAGE, V30, P735, DOI 10.1016/j.neuroimage.2005.10.004; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; Stuermer IW, 2000, HEARING RES, V146, P185, DOI 10.1016/S0378-5955(00)00113-1; Takahashi K, 2006, EUR J NEUROSCI, V23, P1365, DOI 10.1111/j.1460-9568.2006.04662.x; Tamai Yuta, 2019, 2019 IEEE 1st Global Conference on Life Sciences and Technologies (LifeTech), P54, DOI 10.1109/LifeTech.2019.8884023; Tan XD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18814-9; Tan XD, 2015, SCI REP-UK, V5, DOI 10.1038/srep13273; Terry B, 2015, JAMA OTOLARYNGOL, V141, P1012, DOI 10.1001/jamaoto.2015.2154; The Lancet HIV, 2015, LANCET HIV, V2, pe115; THOMAS H, 1993, EUR J NEUROSCI, V5, P882, DOI 10.1111/j.1460-9568.1993.tb00940.x; Thompson AC, 2015, HEARING RES, V324, P46, DOI 10.1016/j.heares.2015.03.005; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; Tohmi M, 2014, CURR BIOL, V24, P587, DOI 10.1016/j.cub.2014.01.061; Tohmi M, 2009, J NEUROCHEM, V109, P3, DOI 10.1111/j.1471-4159.2009.05926.x; Tsukano H, 2015, J NEUROPHYSIOL, V113, P2900, DOI 10.1152/jn.00932.2014; Verma RU, 2014, HEARING RES, V310, P69, DOI 10.1016/j.heares.2014.01.008; Wells J, 2005, OPT LETT, V30, P504, DOI 10.1364/OL.30.000504; Wells J, 2007, BIOPHYS J, V93, P2567, DOI 10.1529/biophysj.107.104786; Wells J, 2007, J NEUROSCI METH, V163, P326, DOI 10.1016/j.jneumeth.2007.03.016; Yanagawa Y, 2017, HEARING RES, V351, P98, DOI 10.1016/j.heares.2017.06.003; Yanagawa Y, 2016, NEUROSCI LETT, V633, P189, DOI 10.1016/j.neulet.2016.09.021; Yoshitake K, 2013, CELL REP, V5, P1365, DOI 10.1016/j.celrep.2013.11.006	56	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240227	10.1371/journal.pone.0240227	http://dx.doi.org/10.1371/journal.pone.0240227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057339	gold, Green Published			2022-12-26	WOS:000581814700091
J	de Almeida, SV; Costa, E; Lopes, FV; Santos, JV; Barros, PP				Valente de Almeida, Sara; Costa, Eduardo; Lopes, Francisca Vargas; Santos, Joao Vasco; Pita Barros, Pedro			Concerns and adjustments: How the Portuguese population met COVID-19	PLOS ONE			English	Article								Background The COVID-19 pandemic has led to disruptive changes worldwide, with different implications across countries. The evolution of citizens' concerns and behaviours over time is a central piece to support public policies. Objective To unveil perceptions and behaviours of the Portuguese population regarding social and economic impacts of the COVID-19 pandemic, allowing for more informed public policies. Methods Online panel survey distributed in three waves between March 13(th)and May 6(th)2020. Data collected from a non-representative sample of 7,448 respondents includes socio-demographic characteristics and self-reported measures on levels of concern and behaviours related to COVID-19. We performed descriptive analysis and probit regressions to understand relationships between the different variables. Results Most participants (85%) report being at least very concerned with the consequences of the COVID-19 pandemic and social isolation reached a high level of adherence during the state of emergency. Around 36% of the sample anticipated consumption decisions, stockpiling ahead of the state of emergency declaration. Medical appointments suffered severe consequences, being re-rescheduled or cancelled. We find important variation in concerns with the economic impact across activity sectors. Conclusion We show that high level of concern and behaviour adaptation in our sample preceded the implementation of lockdown measures in Portugal around mid-March. One month later, a large share of individuals had suffered disruption in their routine health care and negative impacts in their financial status.	[Valente de Almeida, Sara; Costa, Eduardo; Pita Barros, Pedro] Univ Nova Lisboa, Nova Sch Business & Econ, Campus Carcavelos, Carcavelos, Portugal; [Lopes, Francisca Vargas] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Santos, Joao Vasco] Univ Porto, MEDCIDS Dept Community Med Informat & Hlth Decis, Fac Med, Porto, Portugal; [Santos, Joao Vasco] CINTESIS Ctr Hlth Technol & Serv Res, Porto, Portugal; [Santos, Joao Vasco] ARS Norte, Publ Hlth Unit, ACES Grande Porto Espinho Gaia 8, Porto, Portugal	Universidade Nova de Lisboa; Erasmus University Rotterdam; Erasmus MC; Universidade do Porto	de Almeida, SV (corresponding author), Univ Nova Lisboa, Nova Sch Business & Econ, Campus Carcavelos, Carcavelos, Portugal.	sara.v.almeida.2015@novasbe.pt	Costa, Eduardo/AAA-4384-2022; Santos, João V/F-4602-2018; Costa, Eduardo/ACA-5016-2022; Santos, João/HHZ-5595-2022; Barros, Pedro/B-5958-2009	Costa, Eduardo/0000-0002-4347-6338; Santos, João V/0000-0003-4696-1002; Costa, Eduardo/0000-0002-4347-6338; Barros, Pedro/0000-0002-0881-4928	Fundacao para a Ciencia e a Tecnologia [UID/ECO/00124/2019, UIDB/00124/2020, BD128545/2017]; Fundacao para a Ciencia e a Tecnologia (Social Sciences DataLab) [PINFRA/22209/2016]; POR Lisboa and POR Norte (Social Sciences DataLab) [PINFRA/22209/2016]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia (Social Sciences DataLab); POR Lisboa and POR Norte (Social Sciences DataLab)	This work was supported by Fundacao para a Ciencia e a Tecnologia [PhD studentship: BD128545/2017], Fundacao para a Ciencia e a Tecnologia (UID/ECO/00124/2019, UIDB/00124/2020 and Social Sciences DataLab, PINFRA/22209/2016), POR Lisboa and POR Norte (Social Sciences DataLab, PINFRA/22209/2016).	Aksoy Cevat, 2020, 27401 NBER, P1, DOI [10.2139/ssrn.3625190, DOI 10.3386/W27401, DOI 10.2139/SSRN.3625190]; Atchison CJ, 2020, PERCEPTIONS BEHAV RE; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Baker S. R., 2020, NBER WORKING PAPER S, VNBER; Binder C, 2021, CLIN RES CARDIOL, V110, P532, DOI 10.1007/s00392-020-01698-7; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Choi H., 2020, J SOCIAL POLITICAL P; De Coninck D, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110220; DireccAo Geral de Saude (DGS), 2020, INF 005 2020; Fernandes N., 2020, WP1240E IESE BUS SCH, DOI [10.2139/ssrn.3557504, DOI 10.2139/SSRN.3557504]; Fetzer Thiemo, 2020, CORONAVIRUS PERCEPTI; Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912; Guille A, 2013, SIGMOD REC, V42, P17; Jay J., 2020, NEIGHBORHOOD INCOME; Karabag SF, 2020, J APPL ECON BUS RES, V10, P1; McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808; Meier K, 2020, PUBLIC PERSPECTIVES; Nazar W, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05602-6; Nelson LM, 2020, JAMA INTERN MED, V180, P1020, DOI 10.1001/jamainternmed.2020.1369; Peres D, 2020, J HOSP INFECT, V105, P434, DOI 10.1016/j.jhin.2020.05.038; Sabat I, 2020, HEALTH POLICY, V124, P909, DOI 10.1016/j.healthpol.2020.06.009; Sadorsky P, 2012, ENERG POLICY, V48, P130, DOI 10.1016/j.enpol.2012.04.064; Schmalzle R, 2015, SOC COGN AFFECT NEUR, V10, P1137, DOI 10.1093/scan/nsu168; Seale H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235112; Smith Louise E., 2020, FACTORS ASSOCIATED A; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Trueblood J., 2020, PSYARXIV; Bezerra ACV, 2020, CIENC SAUDE COLETIVA, V25, P2411, DOI 10.1590/1413-81232020256.1.10792020; Verbeke W., 2000, Agribusiness (New York), V16, P215, DOI 10.1002/(SICI)1520-6297(200021)16:2&lt;215::AID-AGR6&gt;3.0.CO;2-S; WHO, 2020, COVID 19 STRAT UPD; WHO, 2019, COVID 19 SITUATION R; WHO, 2020, DIS OUTBR NEWS EM PR; Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; World Health Organization, 2021, NOV COR 2019 NCOV SI; World Health Organization, 2020, NAT CAP REV TOOL NOV; World Health Organization, 2020, SURV TOOL GUID RAP S; World Health Organization, 2004, REP WHO EXP CONS OUT; Yurek LA, 2008, EVALUATION REV, V32, P435, DOI 10.1177/0193841X08316676	39	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240500	10.1371/journal.pone.0240500	http://dx.doi.org/10.1371/journal.pone.0240500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3XB	33052976	gold, Green Published			2022-12-26	WOS:000581820200059
J	Li, Y; Li, L; Qin, J; Wu, JY; Dai, XM; Xu, JM				Li, Yang; Li, Lei; Qin, Jun; Wu, Junyi; Dai, Xueming; Xu, Junming			OSR1 phosphorylates the Smad2/3 linker region and induces TGF-beta 1 autocrine to promote EMT and metastasis in breast cancer	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; STEM-CELLS; EXPRESSION; ACTIVATION; RESISTANCE; TURNOVER; GENE; WNK1	Oxidative stress-responsive kinase 1 (OSR1) plays a critical role in multiple carcinogenic signal pathways, and its overexpression has been found in various types of cancer; however, the pathophysiological role of OSR1 in breast cancer has not been evaluated. This study aims to elaborate on the role of OSR1 in breast cancer metastasis and the specific regulatory mechanism. Our results showed that OSR1 mRNA and protein were upregulated in both human breast cancer samples and cell lines. Moreover, phosphorylated OSR1 (p-OSR1) was an independent poor prognostic indicator in patients with breast cancer. OSR1 upregulation induced epithelial-to-mesenchymal transition (EMT) in normal and malignant mammary epithelial cells with the increasing metastatic capacity. In contrast, deleting OSR1 in aggressive breast cancer cells inhibited these phenotypes. OSR1 is the critical activator for transcription factors of EMT. Mechanistically, we found that OSR1 can directly interact and phosphorylate the linker region of Smad2 at Thr220 and Smad3 at Thr179. Phosphorylated Smad2/3 translocated into the nucleus to enhance transforming growth factor-beta 1 (TGF-beta 1) autocrine signalling and increase the transcription of EMT regulators. Importantly, interruption of the OSR1-Smad2/3-TGF-beta 1 signalling axis elicited a robust anti-EMT and anti-metastatic effect in vitro and in vivo. Taken together, we conclude that OSR1-mediated Smad2/3-TGF-beta 1 signalling promotes EMT and metastasis representing a promising therapeutic target in breast cancer treatment.	[Li, Yang; Li, Lei; Qin, Jun; Wu, Junyi; Dai, Xueming; Xu, Junming] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gen Surg, 100 Haining Rd, Shanghai 200080, Peoples R China	Shanghai Jiao Tong University	Xu, JM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Gen Surg, 100 Haining Rd, Shanghai 200080, Peoples R China.	junmingxusur@hotmail.com		Li, Yang/0000-0002-5882-2301	National Natural Science Foundation of China [81670595, 81970568]; Shanghai Natural Science Funds [16ZR1428200]; Excellent Youth Medical Talents Program of Shanghai General Hospital [06N1702011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Funds; Excellent Youth Medical Talents Program of Shanghai General Hospital	This work was supported by the National Natural Science Foundation of China (81670595, 81970568), Shanghai Natural Science Funds (16ZR1428200), and the Excellent Youth Medical Talents Program of Shanghai General Hospital (06N1702011).	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; AlAmri MA, 2017, CHEMMEDCHEM, V12, P639, DOI 10.1002/cmdc.201700077; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Burington B, 2008, CLIN CANCER RES, V14, P4821, DOI 10.1158/1078-0432.CCR-07-4568; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Chen ZH, 2011, RESP PHYSIOL NEUROBI, V176, P110, DOI 10.1016/j.resp.2011.02.001; Colak S, 2017, TRENDS CANCER, V3, P56, DOI 10.1016/j.trecan.2016.11.008; Conti A, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201800041; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Ernest NJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1451, DOI 10.1152/ajpcell.00503.2004; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Galliher Amy J, 2006, Future Oncol, V2, P743, DOI 10.2217/14796694.2.6.743; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Hung JY, 2017, ONCOTARGET, V8, P63691, DOI 10.18632/oncotarget.19475; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ju HR, 2003, CANCER LETT, V196, P197, DOI 10.1016/S0304-3835(03)00237-4; Kankanamalage SG, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0287-1; Krueger EM, 2011, ANN NEUROSCI, V18, P70, DOI 10.5214/ans.0972.7531.1118212; Lampropoulos P, 2012, CANCER LETT, V314, P1, DOI 10.1016/j.canlet.2011.09.041; Li Y, 2020, BREAST CANCER RES TR, V182, P35, DOI 10.1007/s10549-020-05671-w; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Niimi H, 2007, J CELL BIOL, V176, P695, DOI 10.1083/jcb.200612129; Nishida H, 2012, HYPERTENSION, V60, P981, DOI 10.1161/HYPERTENSIONAHA.112.201509; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Ruan HY, 2017, AM J CANCER RES, V7, P543; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shi XN, 2018, ONCOL REP, V40, P1592, DOI 10.3892/or.2018.6533; Shyamasundar S, 2016, INT J ONCOL, V49, P2629, DOI 10.3892/ijo.2016.3761; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Solomon A, 2004, GENETICS, V167, P161, DOI 10.1534/genetics.167.1.161; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Tamari M, 1999, J HUM GENET, V44, P116, DOI 10.1007/s100380050121; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tu SW, 2011, P NATL ACAD SCI USA, V108, P1385, DOI 10.1073/pnas.1018567108; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; Wtighton KH, 2008, CELL SIGNAL, V20, P1579, DOI 10.1016/j.cellsig.2008.02.003; Yeh HW, 2018, NAT CELL BIOL, V20, P479, DOI 10.1038/s41556-018-0062-y; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeng GC, 2000, INT J CANCER, V88, P53, DOI 10.1002/1097-0215(20001001)88:1<53::AID-IJC8>3.0.CO;2-7; Zhou YY, 2017, ONCOTARGET, V8, P66328, DOI 10.18632/oncotarget.20240; Zhu W, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-31	53	9	10	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					68	84		10.1038/s41388-020-01499-2	http://dx.doi.org/10.1038/s41388-020-01499-2		OCT 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33051597				2022-12-26	WOS:000577556100004
J	van Stralen, KJ; Ruijter, L; Frissen, J; den Boer, RH; Struben, VMD; van Oostveen, CJ				van Stralen, Karlijn J.; Ruijter, Lotte; Frissen, Judith; den Boer, Roeland H.; Struben, Veerle M. D.; van Oostveen, Catharina J.			Patients want to be seen: The top 3 information needs of patients with inguinal hernia	PLOS ONE			English	Article							TREATMENT DECISIONS	Background Good patient information has shown to improve surgical outcomes. In this study we explore what kind of pre-surgical information patients need and if the provision of a 360 degrees video of a surgical procedure can be of added value to the information provided by the hospital. Methods An explorative qualitative study using semi-structured interviews on information needs was conducted among 17 inguinal hernia patients to gain more insight in the patients' present surgical information needs. Patients either were planned to receive or already had received a surgical procedure. Questions were asked about the current information provision and, after being shown a 360 degrees video of the surgery, whether this would be of added value. Results Of the total group of 17 patients (mean age 56, interquartile range 45-64) 16 were male and one was female. Most had no previous experience with virtual reality (14/17), already had undergone a surgical procedure (11/17). Patient information needs were all about "seeing" which can be viewed from three different perspectives [1] being seen as a unique person in the treatment process, [2] being seen as a partner, and [3] seeing is understanding. Patients wanted the contact with the doctor to be more personal, with the possibility to see the anesthetist in person, the surgeon to see their wound in the recovery phase, and to receive personal answers to questions about their specific situation. Patients found the 360-video not fearsome, and believed that visual content could be beneficial as it appeals more to their imagination than written or oral information and increases their understanding. It also provided them with a better understanding of their treatment options, their pre-, peri-, and post-surgical procedures and identification of the cause of post-operative side effects. Conclusion To address patients' information needs, complementary tools or services are needed that increase personal contact as well as tailor it to individual patient's needs. Even though video-apps are a partial alternative, hospitals should still offer patients the possibility of having face-to-face meetings with physicians as this is highly valued by patients and leads to increased trust in physicians' performance.	[van Stralen, Karlijn J.; Ruijter, Lotte; Frissen, Judith; Struben, Veerle M. D.; van Oostveen, Catharina J.] Spaarne Gasthuis Acad, Spaarne Gasthuis Hosp, Hoofddorp, Netherlands; [den Boer, Roeland H.] Spaarne Gasthuis Hosp, Surg Dept, Hoofddorp, Netherlands; [van Oostveen, Catharina J.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands	Spaarne Hospital; Spaarne Hospital; Erasmus University Rotterdam	van Stralen, KJ (corresponding author), Spaarne Gasthuis Acad, Spaarne Gasthuis Hosp, Hoofddorp, Netherlands.	KvanStralen@spaarnegasthuis.nl			Spaarne Gasthuis innovation fund	Spaarne Gasthuis innovation fund	This study was funded by the Spaarne Gasthuis innovation fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpino L, 2004, NEUROL SCI, V25, P145, DOI 10.1007/s10072-004-0248-x; Asiri Abdulmajid, 2018, Acta Inform Med, V26, P201, DOI 10.5455/aim.2018.26.201-206; Bibault JE, 2019, J MED INTERNET RES, V21, DOI 10.2196/15787; Boss EF, 2016, OTOLARYNG HEAD NECK, V154, P405, DOI 10.1177/0194599815620558; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Broom A, 2005, QUAL HEALTH RES, V15, P325, DOI 10.1177/1049732304272916; Connor K, 2014, HERNIA, V18, P557, DOI 10.1007/s10029-013-1130-7; Coyne L, 2019, AM J PHARM EDUC, V83, DOI 10.5688/ajpe7456; Elkin EB, 2007, J CLIN ONCOL, V25, P5275, DOI 10.1200/JCO.2007.11.1922; Freeman D, 2017, PSYCHOL MED, V47, P2393, DOI 10.1017/S003329171700040X; Kyaw BM, 2019, J MED INTERNET RES, V21, DOI 10.2196/12959; Letterie GS, 2002, AM J OBSTET GYNECOL, V187, pS37, DOI 10.1067/mob.2002.127361; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; McNair AGK, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2292-3; Nguyen MH, 2019, J MED INTERNET RES, V21, DOI 10.2196/14407; Murphy MA, 2001, EUR J SURG, V167, P728; O'Connor G, 2014, EUR J ONCOL NURS, V18, P183, DOI 10.1016/j.ejon.2013.10.011; O'Sullivan B, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9596; Perin A, 2021, ACTA NEUROCHIR, V163, P301, DOI 10.1007/s00701-020-04303-y; Pomey MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122499; Powell HA, 2014, BRIT J CANCER, V110, P908, DOI 10.1038/bjc.2013.812; Powell R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008646.pub2; Rao R, 2012, PLAST RECONSTR SURG, V130, P44, DOI 10.1097/PRS.0b013e3182547d63; Semple JL, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3929; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Zieren J, 2007, QUAL LIFE RES, V16, P725, DOI 10.1007/s11136-007-9171-y	26	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240433	10.1371/journal.pone.0240433	http://dx.doi.org/10.1371/journal.pone.0240433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UK	33048961	gold, Green Published			2022-12-26	WOS:000581813300008
J	Hayashida, M; Miki, A; Nakai, S; Matsumiya, W; Imai, H; Kusuhara, S; Nakamura, M				Hayashida, Mayuka; Miki, Akiko; Nakai, Shunichiro; Matsumiya, Wataru; Imai, Hisanori; Kusuhara, Sentaro; Nakamura, Makoto			Predictive factors of metamorphopsia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy with good baseline visual acuity	PLOS ONE			English	Article							M-CHARTS	This retrospective study was conducted to investigate the predictive factors associated with metamorphopsia after reduced-fluence photodynamic therapy (RFPDT) in patients with central serous chorioretinopathy (CSC) with good baseline visual acuity. A total of 36 eyes of 36 consecutive patients with resolved CSC after RFPDT and best-corrected visual acuity (BCVA) better than 1.0 (logarithm of the minimal angle of resolution (logMAR) 0) at baseline were examined. Metamorphopsia was measured using M-CHARTS at 12 months after RFPDT. An average of the horizontal and vertical M-CHARTS scores was applied for defining the extent of metamorphopsia. The association between M-CHARTS score at 12 months after RFPDT and clinical parameters (age, sex, duration of symptoms, BCVA, and findings of optical coherence tomography (OCT)) was investigated at baseline or 12 months after RFPDT. The M-CHARTS score at 12 months correlated significantly with duration of symptoms (P= 0.005), baseline outer nuclear layer (ONL) thickness (P= 0.009), central foveal thickness (CFT) (P= 0.001) at 12 months, and ONL thickness (P= 0.001) at 12 months after RFPDT. In the multivariate analysis of baseline-related factors, thinner ONL thickness before RFPDT (P= 0.010) was significantly associated with large metamorphopsia at 12 months after RFPDT in CSC patients with good baseline BCVA. Baseline ONL thickness may be a useful predictive factor of metamorphopsia after RFPDT in CSC patients with good baseline BCVA.	[Hayashida, Mayuka; Miki, Akiko; Nakai, Shunichiro; Matsumiya, Wataru; Imai, Hisanori; Kusuhara, Sentaro; Nakamura, Makoto] Kobe Univ, Grad Sch Med, Dept Surg, Div Ophthalmol, Kobe, Hyogo, Japan	Kobe University	Miki, A (corresponding author), Kobe Univ, Grad Sch Med, Dept Surg, Div Ophthalmol, Kobe, Hyogo, Japan.	acacyey@med.kobe-u.ac.jp						AMSLER M, 1953, BRIT J OPHTHALMOL, V37, P521, DOI 10.1136/bjo.37.9.521; Arimura E, 2011, INVEST OPHTH VIS SCI, V52, P128, DOI 10.1167/iovs.09-3535; Bae S, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0170-4; Fujita K, 2014, RETINA-J RET VIT DIS, V34, P964, DOI 10.1097/IAE.0000000000000027; Gemenetzi M, 2010, EYE, V24, P1743, DOI 10.1038/eye.2010.130; Kinoshita T, 2015, CLIN OPHTHALMOL, V9, P225, DOI 10.2147/OPTH.S76847; Klais CM, 2006, RETINA, V4th, P1135; Matuskova V, 2018, SEMIN OPHTHALMOL, V33, P690, DOI 10.1080/08820538.2017.1416414; Ooto S, 2010, OPHTHALMOLOGY, V117, P1800, DOI 10.1016/j.ophtha.2010.01.042; Ozdemir I, 2019, INT OPHTHALMOL, V39, P1323, DOI 10.1007/s10792-018-0950-y; Stewart JM, 2006, BRIT J OPHTHALMOL, V90, P805, DOI 10.1136/bjo.2006.093328; Tsai MJ, 2014, OPTOMETRY VISION SCI, V91, P1140, DOI 10.1097/OPX.0000000000000360; van Rijssen TJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202549; Yu J, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1089-y	14	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240557	10.1371/journal.pone.0240557	http://dx.doi.org/10.1371/journal.pone.0240557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044997	Green Published, gold			2022-12-26	WOS:000581811700005
J	Damtie, D; Mekonnen, Y				Damtie, Destaw; Mekonnen, Yalemtsehay			Antibacterial activity of essential oils from Ethiopianthyme(Thymus serrulatusandThymus schimperi) against tooth decay bacteria	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; STREPTOCOCCUS-MUTANS; CHEMICAL-COMPOSITION; CONSTITUENTS; CARVACROL; THYMOL; PLANTS	In this study, we evaluated the antibacterial activities of the essential oils (EOs) of Thymus serrulatus and Thymus schimperi collected from Ofla (Ofl), Alamata (Ala), Yilmana Densa (Yil), Tarmaer (Tar), Butajira (Buta), and Bale (Bal) in Ethiopia against cariogenic bacteria (Streptococcus mutans and Lactobacillus) isolated from human teeth. Inhibition zones (IZs), minimum inhibitory concentrations (MICs), and minimum bactericidal concentrations (MBCs) were measures of the antibacterial activity. Significant bacterial inhibitions resulted in a dose-and EO-dependent manner. At 128 mu l/mL, IZs against S. mutans were 37.33 mm (Tar), 36.00 mm (Bal), 33.67 mm (Yil), 33.33 mm (Ofl), 30.00 (Ala), and 29.67 mm (Buta) and IZs against Lactobacillus were 31.00 mm (Tar), 30.67 mm (Yil), 27.67 (Bal), 27.00 (Buta), 26.67 (Ofl), and 21.33 (Ala). The respective inhibition zones due to 3% DMSO (negative control) and 3% H2O2 (positive control) were 0.00 mm/30.00 mm against S. mutans and 0.00 mm/29.00 mm against Lactobacillus. At 128 mu l/mL dose, all the EOs resulted in significantly higher inhibition zones than that of 3% H2O2 against S. mutans and Lactobacillus.	[Damtie, Destaw] Bahir Dar Univ, Dept Biol, Bahir Dar, Amhara Reg Stat, Ethiopia; [Mekonnen, Yalemtsehay] Addis Ababa Univ, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia	Bahir Dar University; Addis Ababa University	Damtie, D (corresponding author), Bahir Dar Univ, Dept Biol, Bahir Dar, Amhara Reg Stat, Ethiopia.	zegades96@gmail.com		Damtie, Destaw/0000-0002-7737-2932				Abdul-Hafeez E. Y., 2014, International Journal of Biosciences (IJB), V5, P219; Abreham Bekele, 2015, Journal of Medicinal Plants Research, V9, P379, DOI 10.5897/JMPR2015.5761; [Anonymous], 2013, CLIN TRANSL GASTROEN, V4, pe39; [Anonymous], 2013, CINEJ CINEMA J, V3, P107; [Anonymous], 2020, BMC PEDIATR, V20, P1, DOI DOI 10.1016/J.CLAE.2020.04.011; [Anonymous], 2015, HOGANAS HDB, V6, P58; Asfaw N, 2000, FLAVOUR FRAG J, V15, P123, DOI [10.1002/(SICI)1099-1026(200003/04)15:2&lt;123::AID-FFJ879&gt;3.0.CO;2-8, 10.1002/(SICI)1099-1026(200003/04)15:2<123::AID-FFJ879>3.3.CO;2-#]; Azuma K, 2003, B NATL I VEGETABLE T; Bagramian RA, 2009, AM J DENT, V22, P3; Barkat M., 2012, African Journal of Food Science, V6, P239; Bassole IHN, 2012, MOLECULES, V17, P3989, DOI 10.3390/molecules17043989; Bokhout B, 1996, CLEFT PALATE-CRAN J, V33, P424, DOI 10.1597/1545-1569(1996)033<0424:POSMAL>2.3.CO;2; Botelho MA, 2007, BRAZ J MED BIOL RES, V40, P349, DOI 10.1590/S0100-879X2007000300010; Cox SD, 2000, J APPL MICROBIOL, V88, P170, DOI 10.1046/j.1365-2672.2000.00943.x; Dagne E, 1998, B CHEM SOC ETHIOPIA, V12, P79; Damtie D., 2015, ETHIOPIAN J SCI TECH, V8, P81; Damtie D, 2019, J ESSENT OIL RES, V31, P120, DOI 10.1080/10412905.2018.1512907; Demissew S., 1994, LAMIALES NEWSLETTER, V3, P5; DIDRY N, 1993, PHARMAZIE, V48, P301; European Comm Antimicrobial Susc, 2000, CLIN MICROBIOL INFEC, V6, P509; Figueiredo AC, 2008, CURR PHARM DESIGN, V14, P3120, DOI 10.2174/138161208786404218; Freires IA, 2015, MOLECULES, V20, P7329, DOI 10.3390/molecules20047329; GIBBONS RJ, 1975, ANNU REV MED, V26, P121, DOI 10.1146/annurev.me.26.020175.001005; Hussien J, 2011, INT J PHARMACOL, V7, P635, DOI 10.3923/ijp.2011.635.640; Kaloustian J, 2005, J SCI FOOD AGR, V85, P2437, DOI 10.1002/jsfa.2274; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Mac Faddin J. F., 1976, BIOCH TESTS IDENTIFI; Martinez-Mier EA, 2012, J EVID-BASED INTEGR, V17, P28, DOI 10.1177/2156587211428076; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; MCGHIE D, 1977, BRIT HEART J, V39, P456; Mehrgan H, 2010, IRAN J PHARM RES, P291; Montanari RM, 2011, QUIM NOVA, V34, P1550, DOI 10.1590/S0100-40422011000900013; Nasir M, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0784-3; Navazesh M, 2008, J AM DENT ASSOC, V139, p35S, DOI 10.14219/jada.archive.2008.0353; Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451; Niculae M., 2009, Lucrari Stiintifice - Universitatea de Stiinte Agricole a Banatului Timisoara, Medicina Veterinara, V42, P170; Peking Medical College Fundamentals Department, 1878, ACUPUNCT RES, V1, P54, DOI DOI 10.1585/PFR.1.054; Penmetsa RKR, 2014, J CLIN DIAGN RES, V8, pZC1, DOI 10.7860/JCDR/2014/9010.4467; Phankhongsap A, 2014, J DENT ASS THAI, V64, P234; Pitts NB, 2017, NAT REV DIS PRIMERS, V3, P1, DOI 10.1038/nrdp.2017.30; Rehman H, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0158-5; Reichling J, 2009, FORSCH KOMPLEMENTMED, V16, P79, DOI 10.1159/000207196; Saokovic M, 2007, FOOD GLOBAL SCI BOOK; Sinkiewicz G, 2010, LACTOBACILLUS REUTER; Upadhyay RK, 2010, ASIAN J MED SCI, V2, P152; World Health Organization, 2020, DIS BURD MORT EST DI; Zengin H, 2014, MOLECULES, V19, P17773, DOI 10.3390/molecules191117773	47	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0239775	10.1371/journal.pone.0239775	http://dx.doi.org/10.1371/journal.pone.0239775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33036019	gold, Green Published			2022-12-26	WOS:000581817500033
J	Elenga, G; Bonenfant, C; Peron, G				Elenga, Gaius; Bonenfant, Christophe; Peron, Guillaume			Distance sampling of duikers in the rainforest: Dealing with transect avoidance	PLOS ONE			English	Article							N-MIXTURE MODELS; DEER DAMA-DAMA; UDZUNGWA MOUNTAINS; DENSITY; ABUNDANCE; COUNTS; DUNG; SUSTAINABILITY; BEHAVIOR; RELIABILITY	Bushmeat is a major source of protein and income in tropical regions but is often over-harvested. A better monitoring of bushmeat stocks could help achieve sustainability. We used a combination of simulations and transect survey data collected from blue duikers (Philantomba monticola) in the Lomako wildlife reserve, Democratic Republic of the Congo, to investigate the use of transect-based distance sampling to monitor bushmeat stocks. The comparison of dung piles and direct observations of duikers evidenced that animals avoided both the transects in the absence of observers, and the observers themselves. This type of behavioural response appeared common in a literature survey. It causes a negative bias in the estimates of population densities from the standard distance sampling methodology. This negative bias would lead to over-pessimistic predictions of population viability, especially if the behavioural response is more intense in the locations where the animals are hunted. In turn, this would lead to excessively conservative management recommendations. To correct for the effect of the behavioural response of the animals to either the transects or the observers, we recommend recording both the forward and perpendicular distances to the observers (2D distance sampling), not just the perpendicular distance. We also recommend multiple-observer protocols. As a cautionary note, we also demonstrate a scenario where the intensity of the behavioural response is too high to reliably estimate the abundance of the population. As a perspective, we outline the general principles of a local stakeholder-based program combining distance sampling with less intensive types of ecological indicators to monitor wildlife populations.	[Elenga, Gaius; Bonenfant, Christophe; Peron, Guillaume] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut UMR5558, Univ Lyon, Villeurbanne, France; [Elenga, Gaius] Univ Kinshasa, Dept Environm, Fac Sci, Kinshasa, DEM REP CONGO	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Kinshasa	Bonenfant, C (corresponding author), Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut UMR5558, Univ Lyon, Villeurbanne, France.	christophe.bonenfant@univ-lyon1.fr	Bonenfant, Christophe/I-8645-2019; PERON, Guillaume/C-5379-2013	Bonenfant, Christophe/0000-0002-9924-419X; PERON, Guillaume/0000-0002-6311-4377	Campus France program	Campus France program	G.E.'s stay in Lyon was funded by the Campus France program (https://www.rdc.campusfrance.org/).We received no other funding for this study	Alldredge MW, 2008, J APPL ECOL, V45, P1349, DOI 10.1111/j.1365-2664.2008.01517.x; [Anonymous], 2018, J JAES JSTS, V35, P1; Barker RJ, 2018, BIOMETRICS, V74, P369, DOI 10.1111/biom.12734; Barnes RFW, 2001, AFR J ECOL, V39, P1, DOI 10.1046/j.1365-2028.2001.00266.x; Bennett EL, 2007, CONSERV BIOL, V21, P884, DOI 10.1111/j.1523-1739.2006.00595.x; Bessone M, 2020, J APPL ECOL, V57, P963, DOI 10.1111/1365-2664.13602; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Borchers DL, 2017, BIOMETRICS, V73, P593, DOI 10.1111/biom.12581; Brodie JF, 2009, ECOL APPL, V19, P854, DOI 10.1890/08-0955.1; Brugiere D, 2000, PRIMATES, V41, P373, DOI 10.1007/BF02557648; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; BUCKLAND ST, 1992, BIOMETRICS, V48, P901, DOI 10.2307/2532356; Chassagneux A, 2019, WILDLIFE BIOL, DOI 10.2981/wlb.00545; Chiarello AG, 2017, MAMMALIA, V81, P489, DOI 10.1515/mammalia-2015-0134; Ciuti S, 2006, J ZOOL, V268, P97, DOI 10.1111/j.1469-7998.2005.00003.x; Croes BM, 2007, BIOTROPICA, V39, P257, DOI 10.1111/j.1744-7429.2006.00247.x; Davies G.J., 2008, BIOCHEM J, DOI [10.1042/BJ20080382, DOI 10.1042/BJ20080382]; Diarrassouba A, 2020, AFR J ECOL, V58, P58, DOI 10.1111/aje.12680; Duckworth JW, 1998, J ZOOL, V246, P466, DOI 10.1111/j.1469-7998.1998.tb00183.x; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; Elenga GBE, 2019, BIORXIV, DOI [10.1101/556332, DOI 10.1101/556332]; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fewster RM, 2008, WILDLIFE RES, V35, P275, DOI 10.1071/WR07077; Fowler C.W., 1987, Current Mammalogy, V1, P401; FULLER TK, 1991, J WILDLIFE MANAGE, V55, P393, DOI 10.2307/3808966; Garel M, 2010, J WILDLIFE MANAGE, V74, P1382, DOI 10.2193/2009-264; Glennie R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121333; HAYES RJ, 1983, BIOMETRICS, V39, P29, DOI 10.2307/2530804; Hilario RR, 2012, FOLIA PRIMATOL, V83, P47, DOI 10.1159/000339805; Howe EJ, 2017, METHODS ECOL EVOL, V8, P1558, DOI 10.1111/2041-210X.12790; Kamgaing TOW, 2018, AFR J ECOL, V56, P908, DOI 10.1111/aje.12518; Koganezawa Masaaki, 2002, Mammal Study, V27, P95, DOI 10.3106/mammalstudy.27.95; Kuehl HS, 2007, ECOL APPL, V17, P2403, DOI 10.1890/06-0934.1; Laing SE, 2003, J APPL ECOL, V40, P1102, DOI 10.1111/j.1365-2664.2003.00861.x; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; Ling S, 2006, CONSERV BIOL, V20, P1294, DOI 10.1111/j.1523-1739.2006.00414.x; Marini F, 2009, EUR J WILDLIFE RES, V55, P107, DOI 10.1007/s10344-008-0222-7; Marques TA, 2013, STAT METHOD APPL-GER, V22, P67, DOI 10.1007/s10260-012-0223-2; Mcshea WJ, 2011, WILDLIFE SOC B, V35, P177, DOI 10.1002/wsb.53; Miller DL, 2019, J STAT SOFTW, V89, P1, DOI 10.18637/jss.v089.i01; Miller DL, 2015, DISTANCE SAMPLING DE; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Mockrin MH, 2010, AFR J ECOL, V48, P239, DOI 10.1111/j.1365-2028.2009.01107.x; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Novaro AJ, 2000, CONSERV BIOL, V14, P713, DOI 10.1046/j.1523-1739.2000.98452.x; Papworth S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062000; Parry L, 2009, CONSERV BIOL, V23, P1270, DOI 10.1111/j.1523-1739.2009.01224.x; Peron G, 2019, ECOL INDIC, V106, DOI 10.1016/j.ecolind.2019.105546; Peron G, 2019, BIOL REV, V94, P1974, DOI 10.1111/brv.12545; Peron G, 2014, ECOLOGY, V95, P2548, DOI 10.1890/13-1779.1; Peron G, 2013, J ANIM ECOL, V82, P408, DOI 10.1111/1365-2656.12014; Pliosungnoen M, 2010, AM J PRIMATOL, V72, P1108, DOI 10.1002/ajp.20875; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Reinartz GE, 2006, INT J PRIMATOL, V27, P603, DOI 10.1007/s10764-006-9020-9; Rovero F, 2004, TROP ZOOL, V17, P267, DOI 10.1080/03946975.2004.10531208; Rovero F, 2006, INT J PRIMATOL, V27, P675, DOI 10.1007/s10764-006-9037-0; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Ruette S, 2003, J APPL ECOL, V40, P32, DOI 10.1046/j.1365-2664.2003.00776.x; Schmidt JH, 2017, ECOL EVOL, V7, P4812, DOI 10.1002/ece3.2912; Scholten J, 2018, EUR J WILDLIFE RES, V64, DOI 10.1007/s10344-018-1169-y; Schwarz CJ, 1999, STAT SCI, V14, P427; STAINBROOK D.P., 2013, ESTIMATING WHITE TAI; Stainbrook DP, 2011, METHODS ESTIMATING W; Tagg N, 2013, INT J PRIMATOL, V34, P554, DOI 10.1007/s10764-013-9681-0; Todd AF, 2008, INT J PRIMATOL, V29, P549, DOI 10.1007/s10764-008-9247-8; Tsujino Riyou, 2004, Mammal Study, V29, P105, DOI 10.3106/mammalstudy.29.105; TURNOCK BJ, 1991, BIOMETRICS, V47, P701, DOI 10.2307/2532156; Valente AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088459; van Velden J, 2018, BIOL CONSERV, V221, P345, DOI 10.1016/j.biocon.2018.03.022; van Vliet N, 2008, ORYX, V42, P392, DOI 10.1017/S0030605308000288; Van Vliet N, 2008, BIODIVERS CONSERV, V17, P1241, DOI 10.1007/s10531-007-9300-5; Viquerat SMA, 2012, S AFR J WILDL RES, V42, P1, DOI 10.3957/056.042.0110; Walsh PD, 1999, CONSERV BIOL, V13, P1194, DOI 10.1046/j.1523-1739.1999.98148.x; Waltert M, 2006, AFR J ECOL, V44, P290, DOI 10.1111/j.1365-2028.2006.00631.x; Waltert M, 2020, MAMMAL RES, V65, P151, DOI 10.1007/s13364-019-00450-5; Ward AI, 2004, MAMMAL REV, V34, P315, DOI 10.1111/j.1365-2907.2004.00046.x; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; Yasuoka H, 2015, ECOL SOC, V20, DOI 10.5751/ES-08041-200425	81	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240049	10.1371/journal.pone.0240049	http://dx.doi.org/10.1371/journal.pone.0240049			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031377	Green Published, gold			2022-12-26	WOS:000581809800014
J	Brown, PT; Saunders, H				Brown, Patrick T.; Saunders, Harry			Approximate calculations of the net economic impact of global warming mitigation targets under heightened damage estimates	PLOS ONE			English	Article							CLIMATE-CHANGE; INTEGRATED ASSESSMENT; SOCIAL COST; TEMPERATURE; CARBON; WEATHER; GROWTH; SHOCKS; RISK; UNCERTAINTY	Efforts to mitigate global warming are often justified through calculations of the economic damages that may occur absent mitigation. The earliest such damage estimates were speculative mathematical representations, but some more recent studies provide empirical estimates of damages on economic growth that accumulate over time and result in larger damages than those estimated previously. These heightened damage estimates have been used to suggest that limiting global warming this century to 1.5 degrees C avoids tens of trillions of 2010 US$ in damage to gross world product relative to limiting global warming to 2.0 degrees C. However, in order to estimate theneteffect on gross world product, mitigation costs associated with decarbonizing the world's energy systems must be subtracted from the benefits of avoided damages. Here, we follow previous work to parameterize the aforementioned heightened damage estimates into a schematic global climate-economy model (DICE) so that they can be weighed against mainstream estimates of mitigation costs in a unified framework. We investigate the net effect of mitigation on gross world product through finite time horizons under a spectrum of exogenously defined levels of mitigation stringency. We find that even under heightened damage estimates, the additional mitigation costs of limiting global warming to 1.5 degrees C (relative to 2.0 degrees C) are higher than the additional avoided damages this century under most parameter combinations considered. Specifically, using our central parameter values, limiting global warming to 1.5 degrees C results in a net loss of gross world product of roughly forty trillion US$ relative to 2 degrees C and achieving either 1.5 degrees C or 2.0 degrees C require a net sacrifice of gross world product, relative to a no-mitigation case, though 2100 with a 3%/year discount rate. However, the benefits of more stringent mitigation accumulate over time and our calculations indicate that stabilizing warming at 1.5 degrees C or 2.0 degrees C by 2100 would eventually confer net benefits of thousands of trillions of US$ in gross world product by 2300. The results emphasize the temporal asymmetry between the costs of mitigation and benefits of avoided damages from climate change and thus the long timeframe for which climate change mitigation investment pays off.	[Brown, Patrick T.] San Jose State Univ, Dept Meteorol & Climate Sci, San Jose, CA 95192 USA; [Saunders, Harry] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA	California State University System; San Jose State University; Carnegie Institution for Science	Brown, PT (corresponding author), San Jose State Univ, Dept Meteorol & Climate Sci, San Jose, CA 95192 USA.	patrick.brown@sjsu.edu		Brown, Patrick/0000-0002-5058-1718				Ackerman F, 2010, ECOL ECON, V69, P1657, DOI 10.1016/j.ecolecon.2010.03.013; Ackerman F, 2009, CLIMATIC CHANGE, V95, P297, DOI 10.1007/s10584-009-9570-x; [Anonymous], 2018, GDP TEMPERATURE RELA; [Anonymous], 2009, UNFCCC C PART COP AC; [Anonymous], 2014, CLIM CHANG 2014 MIT; [Anonymous], 2014, IEEE T SMART GRID, V5, P411; Anthoff D, 2009, ECOL ECON, V68, P836, DOI 10.1016/j.ecolecon.2008.06.017; Anthoff D, 2010, MITIG ADAPT STRAT GL, V15, P321, DOI 10.1007/s11027-010-9220-7; Arrow K, 2013, SCIENCE, V341, P349, DOI 10.1126/science.1235665; Auffhammer M, 2017, P NATL ACAD SCI USA, V114, P1886, DOI 10.1073/pnas.1613193114; Auffhammer M, 2014, ENERG ECON, V46, P522, DOI 10.1016/j.eneco.2014.04.017; BAUMOL WJ, 1972, AM ECON REV, V62, P307; Bell A, 2014, ENERG ECON, V46, P510, DOI 10.1016/j.eneco.2013.12.016; Bindoff N. L., 2013, CONTRIBUTION WORKING, P867; Blanford GJ, 2009, ENERG ECON, V31, pS82, DOI 10.1016/j.eneco.2009.06.003; Burke M, 2016, SCIENCE, V352, P292, DOI 10.1126/science.aad9634; Burke M, 2018, NATURE, V557, P549, DOI 10.1038/s41586-018-0071-9; Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Cai YY, 2015, P NATL ACAD SCI USA, V112, P4606, DOI 10.1073/pnas.1503890112; Carleton TA, 2016, SCIENCE, V353, DOI 10.1126/science.aad9837; Clarke L, 2009, ENERG ECON, V31, pS64, DOI 10.1016/j.eneco.2009.10.013; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Dennig F, 2015, P NATL ACAD SCI USA, V112, P15827, DOI 10.1073/pnas.1513967112; Deschenes O, 2014, ENERG ECON, V46, P606, DOI 10.1016/j.eneco.2013.10.013; Dietz S, 2015, ECON J, V125, P574, DOI 10.1111/ecoj.12188; Estrada F, 2015, ENVIRON MODELL SOFTW, V69, P155, DOI 10.1016/j.envsoft.2015.03.010; Fankhauser S, 2005, RESOUR ENERGY ECON, V27, P1, DOI 10.1016/j.reseneeco.2004.03.003; Fricko O, 2017, GLOBAL ENVIRON CHANG, V42, P251, DOI 10.1016/j.gloenvcha.2016.06.004; Gillingham K, 2018, J ASSOC ENVIRON RESO, V5, P791, DOI 10.1086/698910; Glanemann N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13961-1; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hoegh-Guldberg O., 2018, GLOBAL WARMING 15, P175, DOI [10.1017/9781009157940.005, DOI 10.1093/AJE/KWP410]; Hof AF, 2008, GLOBAL ENVIRON CHANG, V18, P412, DOI 10.1016/j.gloenvcha.2008.04.004; HOPE C, 1993, ENERG POLICY, V21, P327, DOI 10.1016/0301-4215(93)90253-C; Houghton JT, 1990, REPORT PREPARED INTE; Hsiang S, 2017, SCIENCE, V356, P1362, DOI 10.1126/science.aal4369; Hsiang S, 2016, ANNU REV RESOUR ECON, V8, P43, DOI 10.1146/annurev-resource-100815-095343; Hsiang SM, 2012, CLIM CHANG ECON, V3, DOI 10.1142/S201000781250011X; Huang JP, 2017, NAT CLIM CHANGE, V7, P417, DOI [10.1038/nclimate3275, 10.1038/NCLIMATE3275]; Huber V, 2014, EARTH SYST DYNAM, V5, P399, DOI 10.5194/esd-5-399-2014; Jacob B, 2007, J HUM RESOUR, V42, P489, DOI 10.3368/jhr.XLII.3.489; Kahn M.E., 2019, LONG TERM MACROECONO; Kopp RE, 2016, EARTHS FUTURE, V4, P346, DOI 10.1002/2016EF000362; Kriegler E., 2018, GLOBAL WARMING 15 C; Kriegler E, 2014, CLIMATIC CHANGE, V123, P353, DOI 10.1007/s10584-013-0953-7; Lemoine D, 2016, NAT CLIM CHANGE, V6, P514, DOI [10.1038/nclimate2902, 10.1038/NCLIMATE2902]; Letta M, 2019, ENVIRON RESOUR ECON, V73, P283, DOI 10.1007/s10640-018-0262-8; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lontzek TS, 2015, NAT CLIM CHANGE, V5, P441, DOI [10.1038/NCLIMATE2570, 10.1038/nclimate2570]; Moore FC, 2015, NAT CLIM CHANGE, V5, P127, DOI [10.1038/NCLIMATE2481, 10.1038/nclimate2481]; Moyer EJ, 2014, J LEGAL STUD, V43, P401, DOI 10.1086/678140; Nicholls RJ, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2016.0448; Nordhaus W., 2013, DICE 2013R INTRO USE; NORDHAUS WD, 1992, SCIENCE, V258, P1315, DOI 10.1126/science.258.5086.1315; Nordhaus WD, 1991, MANAGING GLOBAL COMM, V12, P37, DOI DOI 10.5547/ISSN0195-6574-EJ-Vol12-No1-4; Nordhaus WD, 1977, 443 COWL FDN; Nordhaus W, 2007, SCIENCE, V317, P201, DOI 10.1126/science.1137316; Nordhaus W, 2014, J ASSOC ENVIRON RESO, V1, P273, DOI 10.1086/676035; Nordhaus WD, 2017, P NATL ACAD SCI USA, V114, P1518, DOI 10.1073/pnas.1609244114; Palter JB, 2018, EARTH SYST DYNAM, V9, P817, DOI 10.5194/esd-9-817-2018; PEARCE D, 1991, ECON J, V101, P938, DOI 10.2307/2233865; Pretis F, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2016.0460; Ranson M, 2014, J ENVIRON ECON MANAG, V67, P274, DOI 10.1016/j.jeem.2013.11.008; Rogelj J, 2018, NAT CLIM CHANGE, V8, P325, DOI 10.1038/s41558-018-0091-3; Rogelj J, 2016, NATURE, V534, P631, DOI 10.1038/nature18307; Rogelj J, 2013, NATURE, V493, P79, DOI 10.1038/nature11787; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Scovronick N, 2017, P NATL ACAD SCI USA, V114, P12338, DOI [10.1073/pnas.1703167114, 10.1073/pnas.1618308114]; Sigmond M, 2018, NAT CLIM CHANGE, V8, P404, DOI 10.1038/s41558-018-0124-y; Somanathan E., 2015, WORKING PAPERS; Stern N, 2013, J ECON LIT, V51, P838, DOI 10.1257/jel.51.3.838; Sterner T, 2012, ANNU REV RESOUR ECON, V4, P286, DOI 10.1146/annurev-resource-110811-114507; Tol R. S. J., 1997, ENVIRON MODEL ASSESS, V2, P151, DOI [10.1023/A:1019017529030, DOI 10.1023/A:1019017529030]; Tol RSJ, 2019, ENERG ECON, V83, P555, DOI 10.1016/j.eneco.2019.07.006; Ueckerdt F, 2019, EARTH SYST DYNAM, V10, P741, DOI 10.5194/esd-10-741-2019; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; van Vuuren DP, 2020, NAT CLIM CHANGE, V10, P329, DOI 10.1038/s41558-020-0732-1; van Vuuren DP, 2017, GLOBAL ENVIRON CHANG, V42, P148, DOI 10.1016/j.gloenvcha.2016.10.009; Warren R, 2018, SCIENCE, V360, P791, DOI 10.1126/science.aar3646; Warren R, 2011, PHILOS T R SOC A, V369, P217, DOI 10.1098/rsta.2010.0271; WBG, 2021, GDP CAP CURR US AUST; Wehner MF, 2018, EARTH SYST DYNAM, V9, P187, DOI 10.5194/esd-9-187-2018; Weitzman M. L, 2010, GHG TARGETS IN UNPUB; Weitzman ML, 2010, CLIM CHANG ECON, V1, DOI 10.1142/S2010007810000042; Weitzman ML, 2009, REV ECON STAT, V91, P1, DOI 10.1162/rest.91.1.1; Weyant J, 2017, REV ENV ECON POLICY, V11, P115, DOI 10.1093/reep/rew018; Winkelmann R, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500589; Woodard DL, 2019, P NATL ACAD SCI USA, V116, P759, DOI 10.1073/pnas.1805187115; Zivin JG, 2014, J LABOR ECON, V32, P1, DOI 10.1086/671766	90	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239520	10.1371/journal.pone.0239520	http://dx.doi.org/10.1371/journal.pone.0239520			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3SJ	33027254	Green Published, gold			2022-12-26	WOS:000581808000011
J	Lee, S; Kim, I; Park, G; Lee, JK; Kim, JG				Lee, Sanghoon; Kim, Ikhyun; Park, Gisu; Lee, Jong Kook; Kim, Jae Gang			Thermochemical nonequilibrium flow analysis in low enthalpy shock-tunnel facility	PLOS ONE			English	Article							VIBRATIONAL NONEQUILIBRIUM; EQUATIONS; AIR; RECOMBINATION; CONDENSATION; RELAXATION; NITROGEN	A thermochemical nonequilibrium analysis was performed under the low enthalpy shock-tunnel flows. A quasi-one-dimensional flow calculation was employed by dividing the flow calculations into two parts, for the shock-tube and the Mach 6 nozzle. To describe the thermochemical nonequilibrium of the low enthalpy shock-tunnel flows, a three-temperature model is proposed. The three-temperature model treats the vibrational nonequilibrium of O-2 and NO separately from the single nonequilibrium energy mode of the previous two-temperature model. In the three-temperature model, electron-electronic energies and vibrational energy of N-2 are grouped as one energy mode, and vibrational energies of O-2, O-2(+), and NO are grouped as another energy mode. The results for the shock-tunnel flows calculated using the three-temperature model were then compared with existing experimental data and the results obtained from one- and two-temperature models, for various operating conditions of the K1 shock-tunnel facility. The results of the thermochemical nonequilibrium analysis of the low enthalpy shock-tunnel flows suggest that the nonequilibrium characteristics of N-2 and O-2 need to be treated separately. The vibrational relaxation of O-2 is much faster than that of N-2 in low enthalpy condition, and the dissociation rate of O-2 is manly influenced by the species vibrational temperature of O-2. The proposed three-temperature model is able to describe the thermochemical nonequilibrium characteristics of N(2)and O-2 behind the incident and reflected shock waves, and the rapid vibrational freezing of N-2 in nozzle expanding flows.	[Lee, Sanghoon; Kim, Ikhyun; Park, Gisu] Korea Adv Inst Sci & Technol, Dept Aerosp Engn, Daejeon, South Korea; [Lee, Jong Kook] Agcy Def Dev, Daejeon, South Korea; [Kim, Jae Gang] Sejong Univ, Dept Aerosp Syst Engn, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Agency of Defense Development (ADD), Republic of Korea; Sejong University	Kim, JG (corresponding author), Sejong Univ, Dept Aerosp Syst Engn, Seoul, South Korea.	jeagkim@sejong.ac.kr	Park, Gisu/F-6339-2014	Lee, Sanghoon/0000-0002-4851-097X	Defense Acquisition Program Administration (DAPA); Agency for Defense Development [UD140081CD]	Defense Acquisition Program Administration (DAPA); Agency for Defense Development(Agency of Defense Development (ADD), Republic of Korea)	This study was conducted at the HighSpeed Vehicle Research Center of KAIST with the support of the Defense Acquisition Program Administration (DAPA) and the Agency for Defense Development (No.UD140081CD). http://www.add.re.kr/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J., 2006, AIAA ED SERIES; APPLETON JP, 1964, J FLUID MECH, V20, P659, DOI 10.1017/S0022112064001458; Baek SC, 2004, J THERM SCI, V13, P235, DOI 10.1007/s11630-004-0037-0; Baulch D.L., 1973, EVALUATED KINETIC DA, V2, P211; Belouaggadia N, 2008, J FLUID MECH, V607, P167, DOI 10.1017/S0022112008001973; Bose D, 1996, 34 AER SCI M EXH; Candler GV, 1991, J THERMOPHYS HEAT TR, V5, P266, DOI 10.2514/3.260; CANUPP PW, 1993, AIAA J, V31, P1243, DOI 10.2514/3.49065; Gnoffo P.A., 1989, 2867 NASA; GROTH CPT, 1991, CAN J PHYS, V69, P897, DOI 10.1139/p91-144; Gupta RN, 1989, 101528 NASA; Gupta RN, 1990, NASA REFERENCE PUBLI, V1232; Herring GC, 2008, AIAA J, V46, P2107, DOI 10.2514/1.36107; Holman J., 1981, HEAT TRANSF; HURLE IR, 1964, J CHEM PHYS, V40, P2076, DOI 10.1063/1.1725476; Hurle IR., 1971, P 8 INT SHOCK TUB S; Hyun SY., 2010, THESIS; JACOBS PA, 1994, AIAA J, V32, P137, DOI 10.2514/3.11961; JAIN AK, 1976, J HYDR ENG DIV-ASCE, V102, P674; Jo SM, 2019, PHYS FLUIDS, V31, DOI 10.1063/1.5082240; Kim I, 2020, ACTA ASTRONAUT, V177, P386, DOI 10.1016/j.actaastro.2020.07.040; Kim I, 2019, INT J HEAT MASS TRAN, V138, P916, DOI 10.1016/j.ijheatmasstransfer.2019.04.049; Kim I, 2017, INT J AERONAUT SPACE, V18, P425, DOI 10.5139/IJASS.2017.18.3.425; Kim J., 2006, AIAA PAPER 2006 3803, DOI [10.2514/6.2006-3803, DOI 10.2514/6.2006-3803]; Kim JG, 2020, INT J HEAT MASS TRAN, V148, DOI 10.1016/j.ijheatmasstransfer.2019.119059; Kim JG, 2018, PHYS FLUIDS, V30, DOI 10.1063/1.4996799; Kim JG, 2016, INT J AERONAUT SPACE, V17, P455, DOI 10.5139/IJASS.2016.17.4.455; LEE JH, 1993, J THERMOPHYS HEAT TR, V7, P399, DOI 10.2514/3.432; Lee S, 2017, AIAA J, V55, P3995, DOI 10.2514/1.J055967; Liepmann H. W., 1957, ELEMENTS GASDYNAMICS; Lu FK, 2002, ADV HYPERSONIC TEST, V198; Luo K, 2020, AEROSP SCI TECHNOL, V104, DOI 10.1016/j.ast.2020.105958; MILLIKAN RC, 1963, J CHEM PHYS, V39, P3209, DOI 10.1063/1.1734182; NAGAMATSU HT, 1965, AIAA J, V3, P1386, DOI 10.2514/3.3157; Nompelis I., 2004, THESIS; Owen KG., 2014, THESIS; Paciorri R, 1998, MECCANICA, V33, P331, DOI 10.1023/A:1004389024709; PARK C, 1995, J THERMOPHYS HEAT TR, V9, P9, DOI 10.2514/3.622; Park C, 2001, J THERMOPHYS HEAT TR, V15, P76, DOI 10.2514/2.6582; PARK C, 1993, J THERMOPHYS HEAT TR, V7, P385, DOI 10.2514/3.431; Park C., 1990, NONEQUILIBRIUM HYPER; Park C., 1988, 26 AER SCI M; POURING AA, 1965, PHYS FLUIDS, V8, P1802, DOI 10.1063/1.1761112; Romeo E, 2002, CHEM ENG J, V86, P369, DOI 10.1016/S1385-8947(01)00254-6; Schlichting H., 1968, BOUNDARY LAYER THEOR; STEGER JL, 1981, J COMPUT PHYS, V40, P263, DOI 10.1016/0021-9991(81)90210-2; Streeter VL, 1981, FLUID MECH; Taylor R.L., 1967, S INT COMBUST, V11, P49, DOI [10.1016/S0082-0784(67)80133-4, DOI 10.1016/S0082-0784(67)80133-4, DOI 10.1016/S0082-0784(67)80133-4SYMCAQ]; Wright MJ, 2005, AIAA J, V43, P2558, DOI 10.2514/1.16713; Wright MJ, 2007, EXPT MODELLING SIMUL; Zhang GJ, 2020, APPL THERM ENG, V171, DOI 10.1016/j.applthermaleng.2020.115090; Zhang GJ, 2019, ENERGY, V187, DOI 10.1016/j.energy.2019.115982; Zhang GJ, 2019, APPL THERM ENG, V163, DOI 10.1016/j.applthermaleng.2019.114388; Zhang GJ, 2019, INT J MULTIPHAS FLOW, V120, DOI 10.1016/j.ijmultiphaseflow.2019.103083	54	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240300	10.1371/journal.pone.0240300	http://dx.doi.org/10.1371/journal.pone.0240300			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027277	Green Published, gold			2022-12-26	WOS:000581808000046
J	Carcelen, AC; Hayford, K; Moss, WJ; Book, C; Thuma, PE; Mwansa, FD; Patenaude, B				Carcelen, Andrea C.; Hayford, Kyla; Moss, William J.; Book, Christopher; Thuma, Philip E.; Mwansa, Francis D.; Patenaude, Bryan			How much does it cost to measure immunity? A costing analysis of a measles and rubella serosurvey in southern Zambia	PLOS ONE			English	Article							IMMUNIZATION	Background Serosurveys are a valuable surveillance tool because they provide a more direct measure of population immunity to infectious diseases, such as measles and rubella, than vaccination coverage estimates. However, there is concern that serological surveys are costly. We adapted a framework to capture the costs associated with conducting a serosurvey in Zambia. Methods We costed a nested serosurvey in Southern Province, Zambia that collected dried blood spots from household residents in a post-campaign vaccine coverage survey. The financial costs were estimated using an ingredients-based costing approach. Inputs included personnel, transportation, field consumable items, social mobilization, laboratory supplies, and capital items, and were classified by serosurvey function (survey preparation, data collection, biospecimen collection, laboratory testing, and coordination). Inputs were stratified by whether they were applicable to surveys in general or attributable specifically to serosurveys. Finally, we calculated the average cost per cluster and participant. Results We estimated the total nested serosurvey cost was US $68,558 to collect dried blood spots from 658 participants in one province in Zambia. A breakdown of the cost by serosurvey phase showed data collection accounted for almost one third of the total serosurvey cost (32%), followed by survey preparation (25%) and biospecimen collection (20%). Analysis by input categories indicated personnel costs were the largest contributing input to overall serosurvey costs (51%), transportation was second (23%), and field consumables were third (9%). By combining the serosurvey with a vaccination coverage survey, there was a savings of $43,957. We estimated it cost $4,285 per average cluster and $104 per average participant sampled. Conclusions Adding serological specimen collection to a planned vaccination coverage survey provided a more direct measurement of population immunity among a wide age group but increased the cost by approximately one-third. Future serosurveys could consider ways to leverage existing surveys conducted for other purposes to minimize costs.	[Carcelen, Andrea C.; Hayford, Kyla; Moss, William J.; Patenaude, Bryan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Moss, William J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Book, Christopher; Thuma, Philip E.] Macha Res Trust, Choma, Zambia; [Mwansa, Francis D.] Minist Hlth, Lusaka, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Carcelen, AC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	acarcel1@jh.edu		Patenaude, Bryan/0000-0002-5180-3626; Hayford, Kyla/0000-0002-9872-2313	Bill & Melinda Gates Foundation [OPP1094816]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The study was funded by the Bill & Melinda Gates Foundation (https://www.gatesfoundation.org/), grant number OPP1094816 awarded to KH and WJM as co-principal investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PEDIATRICS, V125, pe818; Borders AEB, 2007, J HEALTH CARE POOR U, V18, P100, DOI 10.1353/hpu.2007.0004; Cutts FT, 2016, TROP MED INT HEALTH, V21, P1086, DOI 10.1111/tmi.12737; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Hayford K, 2019, VACCINE, V37, P2387, DOI 10.1016/j.vaccine.2019.02.037; Herida M, 2016, EUR J PUBLIC HEALTH, V26, P674, DOI 10.1093/eurpub/ckv250; Itell HL, 2018, VACCINE, V36, P5600, DOI 10.1016/j.vaccine.2018.07.048; Keogh E, 2005, DEV FRAMEWORK BUDGET, P279; Kilic T., 2017, COSTING HOUSEHOLD SU; Lessler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067639; Levin H., 2001, COST EFFECTIVENESS A, V2nd ed; Luman ET, 2007, INT J EPIDEMIOL, V36, P633, DOI 10.1093/ije/dym025; MacNeil A, 2014, VACCINE, V32, P4893, DOI 10.1016/j.vaccine.2014.07.005; McEwan PJ, 2012, J DEV EFFECT, V4, P189, DOI 10.1080/19439342.2011.649044; Metcalf CJE, 2016, LANCET, V388, P728, DOI 10.1016/S0140-6736(16)30164-7; Parker SP, 1999, J CLIN PATHOL, V52, P633, DOI 10.1136/jcp.52.9.633; Patel M, 2016, MEASLES RUBELLA SERO; Schutte C, 2015, VACCINE, V33, pA47, DOI 10.1016/j.vaccine.2014.12.040; Thompson KM, 2016, RISK ANAL, V36, P1459, DOI 10.1111/risa.12430; Toscano CM, 2013, VACCINE, V31, pC88, DOI 10.1016/j.vaccine.2013.05.036; Travassos MA, 2015, AM J TROP MED HYG, V93, P416, DOI 10.4269/ajtmh.15-0198; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; Vojnov L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216277; Warrener L, 2011, B WORLD HEALTH ORGAN, V89, P675, DOI 10.2471/BLT.11.088427; World Bank, 2018, OFF EXCH RAT LCU PER; World Health Organization, 2015, GUID US SER SUPP MEA; World Health Organization, 2018, VACC COV CLUST SURV; World Health Organization, 2012, 9789241503396 WHO; Yansaneh I., 2005, HOUSEHOLD SAMPLE SUR, P253; Zambian Ministry of Health, 2019, CAS BAS SURV DAT; 2018, CURR OPIN TOXICOL, V10	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240734	10.1371/journal.pone.0240734	http://dx.doi.org/10.1371/journal.pone.0240734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057405	gold, Green Published			2022-12-26	WOS:000581814700102
J	Forson, AO; Adjei, DN; Olu-Taiwo, M; Quarchie, MN; Asmah, HR				Forson, Akua Obeng; Adjei, David Nana; Olu-Taiwo, Michael; Quarchie, Marjorie Ntiwaa; Asmah, Harry Richard			Characterization ofCampylobacterassociated gastric enteritis among patients with Human Immunodeficiency Virus (HIV) in a hospital in Accra, Ghana	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI INFECTIONS; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; COLI; DIARRHEA; PREVALENCE; POULTRY; SUSCEPTIBILITIES; IDENTIFICATION; BACTEREMIA	Background Campylobacterinfections in HIV positive patients often present with substantial mortality and morbidity when compared to HIV negative patients. Aim This study assessed the prevalence ofCampylobacter, antibiotic resistance phenotypes and genetic factors, and risk ofCampylobacterinfection associated with living in close proximity to domestic animals in HIV patients with gastric enteritis at Korle-Bu Teaching Hospital, Accra, Ghana. Methods Resistance to different antibiotics was assessed with Kirby-Bauer disk diffusion method. In addition, all theCampylobacterisolates were tested for ampicillin (bla(OXA-61)), erythromycin (aph-3-1), tetracyclinetet(O), streptomycin (aadE), and the energy-dependent multi-drug efflux pump (cmeB) resistance genes using multiplex polymerase chain reaction. Results Out of a total of 140 (97 females and 43 males) tested patients, 71 (50.7%) patients were positive forCampylobacter coli. Female patients aged within 31-40 years (31.6%) and 41-50 years (31.6%) had high frequency ofCampylobacterinfection. Most of the infected patients lived in close proximity to chickens (53.5%), however, some patients (14.1%) lived in close proximity to goats. Phenotypic resistance evaluation revealed widespread resistance to ampicillin (100%), tetracycline (100%), ciprofloxacin (71.8%), erythromycin (69%), and gentamicin (49.3%). However, limited no of isolates containedbla(OXA-61)(1.41%),cmeB (7.0%) andtet(O (7.0%) resistance genes. Conclusion HIV patients with gastric enteritis were infected with resistantCampylobacter coli. Further studies are required to examine correlation of infected patients withC.coliand risk of living in close proximity to poultry birds. There is the need for routine investigation ofCampylobacterin patients with gastroenteritis in order to assist in the development of strategies for combating diseases involving resistant zoonotic bacteria strains.	[Forson, Akua Obeng; Adjei, David Nana; Olu-Taiwo, Michael; Quarchie, Marjorie Ntiwaa] Univ Ghana, Sch Biomed & Allied Hlth Sci, Dept Med Lab Sci, Coll Hlth Sci, Legon, Ghana; [Asmah, Harry Richard] Univ Hlth & Allied Sci, Accra, Ghana	University of Ghana	Forson, AO (corresponding author), Univ Ghana, Sch Biomed & Allied Hlth Sci, Dept Med Lab Sci, Coll Hlth Sci, Legon, Ghana.	asobeng@ug.edu.gh		Forson, akua obeng/0000-0002-6398-3118	University of Ghana, Legon (Office of Research and Innovation) [UGRF/8/SF-016/2014-2015]	University of Ghana, Legon (Office of Research and Innovation)	The source of funding is from The University of Ghana, Legon (Office of Research and Innovation). It was a seed grant (Grant No: UGRF/8/SF-016/2014-2015) for purchasing regents for this study. All the authors are staff of the institution and received salaries from the institute. The University of Ghana did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our appreciation also goes to all the staff of Korle-Bu Teaching Hospital (Fevers Unit) and all patients for their cooperation and support during the various aspects of the study.	Aboderin A O, 2002, East Afr Med J, V79, P423; Akiba M, 2006, J ANTIMICROB CHEMOTH, V57, P52, DOI 10.1093/jac/dki419; Alfredson DA, 2007, FEMS MICROBIOL LETT, V277, P123, DOI 10.1111/j.1574-6968.2007.00935.x; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Allos BM, 2014, CAMPYLOBACTER SPECIE; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2010, EUR J CARDIOTHORA S1, V38, pS1; Avrain L, 2003, VET MICROBIOL, V96, P267, DOI 10.1016/j.vetmic.2003.07.001; Belanger AE, 2007, J ANTIMICROB CHEMOTH, V60, P715, DOI 10.1093/jac/dkm300; Brooks JT, 2006, CLIN INFECT DIS, V43, P393, DOI 10.1086/505866; Bullman S, 2011, FEMS IMMUNOL MED MIC, V63, P248, DOI 10.1111/j.1574-695X.2011.00847.x; Cagliero C, 2006, J ANTIMICROB CHEMOTH, V58, P168, DOI 10.1093/jac/dkl212; Center for Disease control (CDC), 2013, ZOON CAMP SOURC; CLSI, 2015, MO212 CLSI, VMO2-12; COKER AO, 1994, E AFR MED J, V71, P437; Connell SR, 2003, EMBO J, V22, P945, DOI 10.1093/emboj/cdg093; Deogratias AP, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-17; Derbise A, 1997, J BASIC MICROB, V37, P379, DOI 10.1002/jobm.3620370511; EFSA (European Food Safety Authority), 2010, EFSA J, V1496, P1, DOI [10.2903/j.efsa.2010.1496, DOI 10.2903/J.EFSA.2010.1496]; EUCAST, EUR COMM ANT SUSC TE; Fernandez-Cruz A, 2010, MEDICINE, V89, P319, DOI 10.1097/MD.0b013e3181f2638d; Ge BL, 2013, J MICROBIOL METH, V95, P57, DOI 10.1016/j.mimet.2013.06.021; Ghosh R, 2013, J CLIN DIAGN RES, V7, P247, DOI 10.7860/JCDR/2013/5267.2738; Guevremont E, 2006, CAN J VET RES, V70, P81; Gurtler M, 2005, EPIDEMIOL INFECT, V133, P1081, DOI 10.1017/S0950268805004164; Havelaar AH, 2009, CRIT REV MICROBIOL, V35, P1, DOI 10.1080/10408410802636017; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Huang HS, 2015, CAN J MICROBIOL, V61, P701, DOI 10.1139/cjm-2014-0770; Iovine NM, 2013, VIRULENCE, V4, P230, DOI 10.4161/viru.23753; Jeon B, 2011, J ANTIMICROB CHEMOTH, V66, P79, DOI 10.1093/jac/dkq418; Jeon B, 2009, J ANTIMICROB CHEMOTH, V63, P462, DOI 10.1093/jac/dkn529; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Karikari AB, 2017, OPEN J MED MICROBIOL, V7, P1; Keener KM, 2004, COMPR REV FOOD SCI F, V3, P105, DOI 10.1111/j.1541-4337.2004.tb00060.x; Kownhar H, 2007, SCAND J INFECT DIS, V39, P862, DOI 10.1080/00365540701393096; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Martinez R M, 1994, Enferm Infecc Microbiol Clin, V12, P90; Mason J, 2013, PLOS ONE, V8; MOLINA JM, 1995, AIDS, V9, P881, DOI 10.1097/00002030-199508000-00008; Obeng AS, 2012, J APPL MICROBIOL, V113, P294, DOI 10.1111/j.1365-2672.2012.05354.x; Oporto B, 2009, INT J MICROBIOLOGY, P1; Pacanowski J, 2008, CLIN INFECT DIS, V47, P790, DOI 10.1086/591530; PAGE WJ, 1989, ANTIMICROB AGENTS CH, V33, P297, DOI 10.1128/AAC.33.3.297; PERLMAN DM, 1988, ANN INTERN MED, V108, P540, DOI 10.7326/0003-4819-108-4-540; PINTOALPHANDARY H, 1990, ANTIMICROB AGENTS CH, V34, P1294, DOI 10.1128/AAC.34.6.1294; Potter RC, 2003, AM J PUBLIC HEALTH, V93, P2118, DOI 10.2105/AJPH.93.12.2118; Pratt A, 2005, J ANTIMICROB CHEMOTH, V55, P452, DOI 10.1093/jac/dki040; Pumbwe L, 2002, FEMS MICROBIOL LETT, V206, P185, DOI 10.1111/j.1574-6968.2002.tb11007.x; Rao MR, 2001, AM J EPIDEMIOL, V154, P166, DOI 10.1093/aje/154.2.166; Sahin O, 2017, ANNU REV ANIM BIOSCI, V5, P21, DOI 10.1146/annurev-animal-022516-022826; Said MM, 2010, J INFECT DEV COUNTR, V4, P546, DOI 10.3855/jidc.963; Shobo CO, 2016, J INFECT DEV COUNTR, V10, P1214, DOI 10.3855/jidc.8165; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; SORVILLO FJ, 1991, J ACQ IMMUN DEF SYND, V4, P598; Wang GH, 2002, J CLIN MICROBIOL, V40, P4744, DOI 10.1128/JCM.40.12.4744-4747.2002; Yongsi H B Nguendo, 2008, Int J Environ Res Public Health, V5, P213, DOI 10.3390/ijerph5040213; Zahin M, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/340605, 10.1155/2013/263509, 10.1155/2013/605831, 10.1155/2013/510736]; 2004, INFORM MANAGEMENT J, pS285; [No title captured]	59	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240242	10.1371/journal.pone.0240242	http://dx.doi.org/10.1371/journal.pone.0240242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057408	Green Published, gold			2022-12-26	WOS:000581814700066
J	Jordan, RK; Shah, SS; Desai, H; Tripi, J; Mitchell, A; Worth, RG				Jordan, Richard K.; Shah, Shivam S.; Desai, Harsh; Tripi, Jennifer; Mitchell, Anthony; Worth, Randall G.			Variation of stress levels, burnout, and resilience throughout the academic year in first-year medical students	PLOS ONE			English	Article							SUICIDAL IDEATION; MENTAL-HEALTH; DISTRESS; PREVALENCE; WELLNESS; QUALITY; GENDER; SCHOOL; LIFE; RACE	Medical student wellness is of great concern in the health care field. A growing number of studies point to increases in suicide, depression, anxiety, mood disorders, and burnout related to physician lifestyles. Mental health issues commencing in medical school have been suggested to have a significant impact on future physician lifestyle and burnout. Tracking the mental health of medical students at the University of Toledo College of Medicine and Life Sciences (UTCOMLS) with standardized indices will help elucidate triggers of poor mental health. Anonymous surveys were developed and distributed to preclinical medical students at five strategic time points throughout the 2018 2019 academic year. Surveys collected basic demographic information as well as inventories measuring perceived stress, burnout, resilience, and mindfulness. 172 M1s (83 males and 89 females) were included in the study and average response rate for the first 4 (out of 5) surveys averaged 74.8%. M1 males and females had on average increased personal burnout over time with females consistently scoring higher. Both males and females had an increase in stress from August to each subsequent month (p<0.05). Females reported a higher level of perceived stress than males in the beginning and middle of the academic year (p<0.05). Both males and females report a gradual decrease in resiliency throughout the academic year. These surveys demonstrated over half of males and females in medical school reported higher perceived stress scores than their gender-matched peers in the general United States population. Our study strengthens documented trends in resiliency, perceived stress, and burnout amongst medical students. More study in designing targeted approaches to ameliorate these findings in the medical student population is warranted.	[Jordan, Richard K.; Shah, Shivam S.; Desai, Harsh; Tripi, Jennifer; Mitchell, Anthony; Worth, Randall G.] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Worth, RG (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	randall.worth@utoledo.edu		Worth, Randall/0000-0002-2626-7964	NIH/NHLBI [HL122401]	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	RGW was supported in part by a grant from the NIH/NHLBI (HL122401).	Aherne D, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0728-8; [Anonymous], 2017, J ENDOCRINOL METAB D, V22, pS1; [Anonymous], 2014, J NURS REGUL, V5, pS3; Ayala EE, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1296-x; Bacchi S, 2017, ACAD PSYCHIATR, V41, P185, DOI 10.1007/s40596-016-0488-0; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brazeau CMLR, 2010, ACAD MED, V85, pS33, DOI 10.1097/ACM.0b013e3181ed4c47; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S., 1988, SOCIAL PSYCHOL HLTH; Drolet BC, 2010, ACAD MED, V85, P103, DOI 10.1097/ACM.0b013e3181c46963; Dyrbye L, 2012, MED EDUC, V46, P343, DOI 10.1111/j.1365-2923.2011.04206.x; Dyrbye LN, 2008, ANN INTERN MED, V149, P334, DOI 10.7326/0003-4819-149-5-200809020-00008; Dyrbye LN, 2019, ACAD MED, V94, P861, DOI 10.1097/ACM.0000000000002611; Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134; Dyrbye LN, 2011, ACAD MED, V86, P907, DOI 10.1097/ACM.0b013e31821da615; Dyrbye LN, 2010, ACAD MED, V85, P94, DOI 10.1097/ACM.0b013e3181c46aad; Dyrbye LN, 2009, MED EDUC, V43, P274, DOI 10.1111/j.1365-2923.2008.03282.x; Dyrbye LN, 2005, MAYO CLIN PROC, V80, P1613, DOI 10.4065/80.12.1613; FIRTH J, 1986, BRIT MED J, V292, P1177, DOI 10.1136/bmj.292.6529.1177; Hardeman RR, 2015, J RACIAL ETHN HEALTH, V2, P403, DOI 10.1007/s40615-015-0087-x; Ishak W, 2013, CLIN TEACH, V10, P242, DOI 10.1111/tct.12014; Jordan J, 2019, AEM EDUC TRAIN, V3, P218, DOI 10.1002/aet2.10354; Kristensen TS, 2005, WORK STRESS, V19, P192, DOI 10.1080/02678370500297720; Mazurkiewicz R, 2012, PSYCHOL HEALTH MED, V17, P188, DOI 10.1080/13548506.2011.597770; McConville J, 2017, EXPLORE-NY, V13, P26, DOI 10.1016/j.explore.2016.10.002; Niemi PM, 2006, MED TEACH, V28, P136, DOI 10.1080/01421590600607088; Osborne JW, 2001, CONTEMP EDUC PSYCHOL, V26, P291, DOI 10.1006/ceps.2000.1052; Peng L, 2012, PSYCHIAT RES, V196, P138, DOI 10.1016/j.psychres.2011.12.006; Rotenstein LS, 2016, JAMA-J AM MED ASSOC, V316, P2214, DOI 10.1001/jama.2016.17324; Sestili C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081708; Shah M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-2; Shaikh Babar T, 2004, Educ Health (Abingdon), V17, P346; Slavin SJ, 2014, ACAD MED, V89, P573, DOI 10.1097/ACM.0000000000000166; Smith B, 2013, FDN RESILIENCE WHAT; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Thompson G, 2016, TEACH LEARN MED, V28, P174, DOI 10.1080/10401334.2016.1146611; van der Riet P, 2018, NURS EDUC TODAY, V65, P201, DOI 10.1016/j.nedt.2018.03.018; West CP, 2011, JAMA-J AM MED ASSOC, V306, P952, DOI 10.1001/jama.2011.1247	38	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240667	10.1371/journal.pone.0240667	http://dx.doi.org/10.1371/journal.pone.0240667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057410	gold, Green Published			2022-12-26	WOS:000581814700032
J	Khairkhah, N; Aghasadeghi, MR; Namvar, A; Bolhassani, A				Khairkhah, Niloofar; Aghasadeghi, Mohammad Reza; Namvar, Ali; Bolhassani, Azam			Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis	PLOS ONE			English	Article							SARS-CORONAVIRUS; SPIKE PROTEIN; IMMUNE-RESPONSES; WEB SERVER; RECEPTOR; BINDING; DETERMINANTS	The causative agent of severe acute respiratory syndrome (SARS) reported by the Chinese Center for Disease Control (China CDC) has been identified as a novelBetacoronavirus(SARS-CoV-2). A computational approach was adopted to identify multiepitope vaccine candidates against SARS-CoV-2 based on S, N and M proteins being able to elicit both humoral and cellular immune responses. In this study, the sequence of the virus was obtained from NCBI database and analyzed within silicotools such as NetMHCpan, IEDB, BepiPred, NetCTL, Tap transport/proteasomal cleavage, (PaP)-P-3, GalexyPepDock, I-TASSER, Ellipro and ClusPro. To identify the most immunodominant regions, after analysis of population coverage and epitope conservancy, we proposed three different constructs based on linear B-cell, CTL and HTL epitopes. The 3D structure of constructs was assessed to find discontinuous B-cell epitopes. Among CTL predicted epitopes, S257-265, S(603-611)and S360-368, and among HTL predicted epitopes, N167-181, S(313-330)and S(1110-1126)had better MHC binding rank. We found one putative CTL epitope, S(360-368)related to receptor-binding domain (RBD) region for S protein. The predicted epitopes were non-allergen and showed a high quality of proteasomal cleavage and Tap transport efficiency and 100% conservancy within four different clades of SARS-CoV-2. For CTL and HTL epitopes, the highest population coverage of the world's population was calculated for S(27-37)with 86.27% and for S196-231, S303-323, S313-330, S(1009-1030)and N(328-349)with 90.33%, respectively. We identified overall 10 discontinuous B-cell epitopes for three multiepitope constructs. All three constructs showed strong interactions with TLRs 2, 3 and 4 supporting the hypothesis of SARS-CoV-2 susceptibility to TLRs 2, 3 and 4 like other Coronaviridae families. These data demonstrated that the novel designed multiepitope constructs can contribute to develop SARS-CoV-2 peptide vaccine candidates. Thein vivostudies are underway using several vaccination strategies.	[Khairkhah, Niloofar; Aghasadeghi, Mohammad Reza; Bolhassani, Azam] Pasteur Inst Iran, Dept Hepatitis AIDS & Blood Borne Dis, Tehran, Iran; [Khairkhah, Niloofar; Namvar, Ali] Iranian Comprehens Hemophilia Care Ctr, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Bolhassani, A (corresponding author), Pasteur Inst Iran, Dept Hepatitis AIDS & Blood Borne Dis, Tehran, Iran.; Namvar, A (corresponding author), Iranian Comprehens Hemophilia Care Ctr, Tehran, Iran.	azam.bolhassani@yahoo.com; A_bolhasani@pasteur.ac.ir	Bolhassani, Azam/HDN-7200-2022; Namvar, Ali/P-9808-2019; Namvar, Ali/ACF-9043-2022	Bolhassani, Azam/0000-0001-7363-7406; Namvar, Ali/0000-0002-2739-0518; Namvar, Ali/0000-0002-2739-0518				Abdelmageed MI, 2020, BIORXIV; [Anonymous], 2018, J CANC RES THER, V14, pS622; [Anonymous], 2019, CIRCULATION, V2019; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bhattacharya M, 2020, J MED VIROL, V92, P618, DOI 10.1002/jmv.25736; Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Chrysostomou C, 2014, IEEE ENG MED BIO, P808, DOI 10.1109/EMBC.2014.6943714; Derebail VK, 2020, NEW ENGL J MED, V382, P671, DOI 10.1056/NEJMe1917490; Dhanda SK, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-30; Durai P, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.76; Enayatkhani M, 2021, J BIOMOL STRUCT DYN, V39, P2857, DOI [10.1080/07391102.2020.1756411, 10.1080/07391102.2020.1857843]; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gupta S, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-27; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; He YQ, 2010, J BIOMED BIOTECHNOL, P1, DOI [10.1155/2010/218590, 10.1155/2010/297505]; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Keith P, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2836-4; Khairkhah N, 2018, PROTEINS, V86, P1284, DOI 10.1002/prot.25609; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Lapelosa M, 2009, J MOL BIOL, V385, P675, DOI 10.1016/j.jmb.2008.10.089; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Ma CQ, 2014, VACCINE, V32, P2100, DOI 10.1016/j.vaccine.2014.02.004; Malherbe L, 2009, ANN ALLERG ASTHMA IM, V103, P76, DOI 10.1016/S1081-1206(10)60147-0; Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021; Nagpal G, 2017, SCI REP-UK, V7, DOI 10.1038/srep42851; Namvar A, 2020, BIOTECHNOL LETT, V42, P403, DOI 10.1007/s10529-020-02792-6; Namvar A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51679-8; Oany AR, 2014, DRUG DES DEV THER, V8, P1139, DOI [10.2147/DDDT.567861, 10.2147/DDDT.S67861]; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Prompetchara E, 2020, ASIAN PAC J ALLERGY, V38, P1, DOI 10.12932/AP-200220-0772; Reynisson B, 2020, J PROTEOME RES, V19, P2304, DOI 10.1021/acs.jproteome.9b00874; Richardson P, 2020, LANCET, V395, pE30, DOI 10.1016/S0140-6736(20)30304-4; Sanjuan R, 2016, CELL MOL LIFE SCI, V73, P4433, DOI 10.1007/s00018-016-2299-6; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Skwarczynski M, 2016, CHEM SCI, V7, P842, DOI 10.1039/c5sc03892h; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Teimouri H, 2019, SILICO IMMUNOMODELLI; Thanh LT, 2020, NATURE REV DRUG DISC, P1; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Totura AL, 2015, MBIO, V6, DOI 10.1128/mBio.00638-15; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang CL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00594; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	50	22	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240577	10.1371/journal.pone.0240577	http://dx.doi.org/10.1371/journal.pone.0240577			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057358	Green Published, gold			2022-12-26	WOS:000581814700078
J	Alsafadi, S; Dayot, S; Tarin, M; Houy, A; Bellanger, D; Cornella, M; Wassef, M; Waterfall, JJ; Lehnert, E; Roman-Roman, S; Stern, MH; Popova, T				Alsafadi, Samar; Dayot, Stephane; Tarin, Malcy; Houy, Alexandre; Bellanger, Dorine; Cornella, Michele; Wassef, Michel; Waterfall, Joshua J.; Lehnert, Erik; Roman-Roman, Sergio; Stern, Marc-Henri; Popova, Tatiana			Genetic alterations ofSUGP1mimic mutant-SF3B1splice pattern in lung adenocarcinoma and other cancers	ONCOGENE			English	Article							SPLICING FACTOR SF3B1; MUTATIONS	Genes involved in 3 '-splice site recognition during mRNA splicing constitute an emerging class of oncogenes.SF3B1is the most frequently mutated splicing factor in cancer, and SF3B1 mutants corrupt branchpoint recognition leading to usage of cryptic 3 '-splice sites and subsequent aberrant junctions. For a comprehensive determination of alterations leading to this splicing pattern, we performed a pan-TCGA screening for SF3B1-specific aberrant acceptor usage. While the most of aberrant 3 '-splice patterns were explained bySF3B1mutations, we also detected nineSF3B1wild-type tumors (including five lung adenocarcinomas). Genomic profile analysis of these tumors identified somatic mutations combined with loss-of-heterozygosity in the splicing factorSUGP1in five of these cases. Modeling ofSUGP1loss and mutations in cell lines showed that both alterations induced mutant-SF3B1-like aberrant splicing. Our study provides definitive evidence that genetic alterations ofSUGP1genocopySF3B1mutations in lung adenocarcinoma and other cancers.	[Alsafadi, Samar; Tarin, Malcy; Waterfall, Joshua J.; Roman-Roman, Sergio] PSL Res Univ, Inst Curie, Translat Res Dept, Paris, France; [Alsafadi, Samar; Dayot, Stephane; Houy, Alexandre; Bellanger, Dorine; Cornella, Michele; Waterfall, Joshua J.; Stern, Marc-Henri; Popova, Tatiana] PSL Res Univ, Equipe Labellisee Ligue Natl Canc, DNA Repair & Uveal Melanoma DRUM, Inst Curie,INSERM U830, Paris, France; [Wassef, Michel] Sorbonne Univ, PSL Res Univ, Inst Curie, Paris, France; [Wassef, Michel] CNRS, UMR3215, INSERM, U934, Paris, France; [Lehnert, Erik] Seven Bridges Genom, Konigesberg, MA USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Stern, MH (corresponding author), PSL Res Univ, Equipe Labellisee Ligue Natl Canc, DNA Repair & Uveal Melanoma DRUM, Inst Curie,INSERM U830, Paris, France.	marc-henri.stern@curie.fr	Alsafadi, Samar/C-4659-2017; Stern, Marc-Henri/A-2728-2011; Bellanger, Dorine/AAC-2235-2022	Alsafadi, Samar/0000-0002-0060-1346; Stern, Marc-Henri/0000-0002-8100-2272; Waterfall, Joshua/0000-0002-3762-5050; Wassef, Michel/0000-0003-3748-5112; Tarin, Malcy/0000-0002-3865-9631	SIRIC Curie [INCa-DGOSInserm_12554]; European Union's Horizon 2020 project "UM Cure 2020" [667787]; Ligue Nationale Contre le Cancer (Labellisation); Canceropole Emergence from Canceropole Ile-de-France [EMERG-1 2017 ImmunSplice]; Federal funds from the National Cancer Institute, National Institutes of Health [HHSN261201400008C, HHSN261201500003I, 17x146]	SIRIC Curie; European Union's Horizon 2020 project "UM Cure 2020"; Ligue Nationale Contre le Cancer (Labellisation); Canceropole Emergence from Canceropole Ile-de-France; Federal funds from the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The translational group of UM at Institut Curie is supported by SIRIC Curie (Grant INCa-DGOSInserm_12554) and the European Union's Horizon 2020 project "UM Cure 2020" (grant no. 667787). This work benefits also from financial support of the Ligue Nationale Contre le Cancer (Labellisation) and a grant from Canceropole Emergence from Canceropole Ile-de-France (EMERG-1 2017 ImmunSplice). The Seven Bridges Cancer Genomics Cloud has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, contract no. HHSN261201400008C and ID/IQ agreement no. 17x146 under contract no. HHSN261201500003I.	Agafonov DE, 2011, MOL CELL BIOL, V31, P2667, DOI 10.1128/MCB.05266-11; Agudelo D, 2017, NAT METHODS, V14, P615, DOI [10.1038/NMETH.4265, 10.1038/nmeth.4265]; Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; Bryant DW, 2010, BIOINFORMATICS, V26, P1500, DOI 10.1093/bioinformatics/btq206; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; DeBoever C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004105; Dehghannasiri R, 2019, P NATL ACAD SCI USA, V116, P15524, DOI 10.1073/pnas.1900391116; Dvinge H, 2016, NAT REV CANCER, V16, P413, DOI 10.1038/nrc.2016.51; Furney SJ, 2013, CANCER DISCOV, V3, P1122, DOI 10.1158/2159-8290.CD-13-0330; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Ilagan JO, 2015, GENOME RES, V25, P14, DOI 10.1101/gr.181016.114; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Inoue D, 2019, NATURE, V574, P432, DOI 10.1038/s41586-019-1646-9; Kahles A, 2018, CANCER CELL, V34, P211, DOI 10.1016/j.ccell.2018.07.001; Kong Y, 2014, MELANOMA RES, V24, P332, DOI 10.1097/CMR.0000000000000071; Lau JW, 2017, CANCER RES, V77, pE3, DOI 10.1158/0008-5472.CAN-17-0387; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu ZQ, 2020, CANCER DISCOV, V10, P806, DOI 10.1158/2159-8290.CD-19-1330; Liu ZQ, 2020, P NATL ACAD SCI USA, V117, P10305, DOI 10.1073/pnas.1922622117; Maguire SL, 2015, J PATHOL, V235, P571, DOI 10.1002/path.4483; Martin M, 2013, NAT GENET, V45, P933, DOI 10.1038/ng.2674; Obeng EA, 2019, CANCER DISCOV, V9, P1493, DOI 10.1158/2159-8290.CD-19-0399; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Plaschka C, 2018, NATURE, V559, P420, DOI 10.1038/s41586-018-0323-8; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sampson ND, 2003, GENE, V305, P91, DOI 10.1016/S0378-1119(02)01230-1; Seiler M, 2018, CELL REP, V23, P282, DOI 10.1016/j.celrep.2018.01.088; Suzuki H, 2019, NATURE, V574, P707, DOI 10.1038/s41586-019-1650-0; van der Feltz C, 2019, CRIT REV BIOCHEM MOL, V54, P443, DOI 10.1080/10409238.2019.1691497; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Zhang J, 2019, MOL CELL, V76, P82, DOI 10.1016/j.molcel.2019.07.017	36	3	3	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					85	96		10.1038/s41388-020-01507-5	http://dx.doi.org/10.1038/s41388-020-01507-5		OCT 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33057152	Green Published, hybrid			2022-12-26	WOS:000577230500001
J	Neipel, J; Bauermann, J; Bo, SO; Harmon, T; Julicher, F				Neipel, Jonas; Bauermann, Jonathan; Bo, Stefano; Harmon, Tyler; Juelicher, Frank			Power-law population heterogeneity governs epidemic waves	PLOS ONE			English	Article							MODEL	We generalize the Susceptible-Infected-Removed (SIR) model for epidemics to take into account generic effects of heterogeneity in the degree of susceptibility to infection in the population. We introduce a single new parameter corresponding to a power-law exponent of the susceptibility distribution at small susceptibilities. We find that for this class of distributions the gamma distribution is the attractor of the dynamics. This allows us to identify generic effects of population heterogeneity in a model as simple as the original SIR model which is contained as a limiting case. Because of this simplicity, numerical solutions can be generated easily and key properties of the epidemic wave can still be obtained exactly. In particular, we present exact expressions for the herd immunity level, the final size of the epidemic, as well as for the shape of the wave and for observables that can be quantified during an epidemic. In strongly heterogeneous populations, the herd immunity level can be much lower than in models with homogeneous populations as commonly used for example to discuss effects of mitigation. Using our model to analyze data for the SARS-CoV-2 epidemic in Germany shows that the reported time course is consistent with several scenarios characterized by different levels of immunity. These scenarios differ in population heterogeneity and in the time course of the infection rate, for example due to mitigation efforts or seasonality. Our analysis reveals that quantifying the effects of mitigation requires knowledge on the degree of heterogeneity in the population. Our work shows that key effects of population heterogeneity can be captured without increasing the complexity of the model. We show that information about population heterogeneity will be key to understand how far an epidemic has progressed and what can be expected for its future course.	[Neipel, Jonas; Bauermann, Jonathan; Bo, Stefano; Harmon, Tyler; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, Dresden, Germany	Max Planck Society	Julicher, F (corresponding author), Max Planck Inst Phys Komplexer Syst, Dresden, Germany.	julicher@pks.mpg.de	Bo, Stefano/K-7845-2019; Julicher, Frank/B-1828-2009	Bo, Stefano/0000-0002-2738-867X; Julicher, Frank/0000-0003-4731-9185	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	Amaral LAN, 1998, PHYS REV LETT, V80, P1385, DOI 10.1103/PhysRevLett.80.1385; Anderson R.M., 2013, POPULATION DYNAMICS; [Anonymous], 1999, EPIDEMIC MODELLING I; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bar-On YM, 2020, ELIFE, V9, DOI 10.7554/eLife.57309; Becker N. G., 1989, AUSTR J STATIST, V31, P42, DOI DOI 10.1111/j.1467-842X.1989.tb00497.x; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Brito P.B., 2008, MATH SCI, V33, P127; Britton T, 2020, SCIENCE, V369, P846, DOI 10.1126/science.abc6810; Brownlee J, 1915, BRIT MED J, V1915, P250, DOI 10.1136/bmj.2.2850.250; Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Diekmann O., 2013, PRINCETON SERIES THE; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; FINE PEM, 1979, J ROY STAT SOC A STA, V142, P347, DOI 10.2307/2982487; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Gomes M Gabriela M, 2022, medRxiv, DOI 10.1101/2020.04.27.20081893; HETHCOTE H W, 1976, Mathematical Biosciences, V28, P335, DOI 10.1016/0025-5564(76)90132-2; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; HETHCOTE HW, 1978, THEOR POPUL BIOL, V14, P338, DOI 10.1016/0040-5809(78)90011-4; Huppert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045107; Ioannidis J., 2020, B WORLD HEALTH ORGAN, P2020, DOI [10.1101/2020.05.13.20101253, DOI 10.2471/BLT.20.265892]; John P.A.Ioannidis, 2020, POPULATION LEVEL COV; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Moran RJ, 2020, ESTIMATING REQUIRED; Murray J.D., 2002, INTERDISCIPLINARY AP, V17; Novozhilov AS, 2008, MATH BIOSCI, V215, P177, DOI 10.1016/j.mbs.2008.07.010; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; SHLESINGER MF, 1987, ANN NY ACAD SCI, V504, P214, DOI 10.1111/j.1749-6632.1987.tb48734.x; Sornette D., 2009, ENCY COMPLEXITY SYST, P7009, DOI DOI 10.1007/978-0-387-30440-3_418; Streeck H., 2020, INFECT FATALITY RATE, DOI [10.1101/2020.05.04.20090076, DOI 10.1101/2020.05.04.20090076]	36	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0239678	10.1371/journal.pone.0239678	http://dx.doi.org/10.1371/journal.pone.0239678			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052918	Green Submitted, Green Published, gold			2022-12-26	WOS:000581820200069
J	Valcin, J; Jean-Charles, S; Malfa, A; Tucker, R; Dorcelus, L; Gautier, J; Koster, MP; Lechner, BE				Valcin, Josie; Jean-Charles, Skenda; Malfa, Ana; Tucker, Richard; Dorcelus, Lindsay; Gautier, Jacqueline; Koster, Michael P.; Lechner, Beatrice E.			Mortality, morbidity and clinical care in a referral neonatal intensive care unit in Haiti	PLOS ONE			English	Article							SEPSIS	Background Neonatal mortality rates in Haiti are among the highest in the Western hemisphere. Few mothers deliver with a skilled birth attendant present, and there is a significant lack of pediatricians. The neonatal intensive care unit (NICU) at St. Damien Pediatric Hospital, a national referral center, is one of only five neonatology departments in Haiti. In order to target limited resources toward improving outcomes, this study seeks to describe clinical care in the St. Damien NICU. Methods A retrospective medical record review was performed on available medical records on all admissions to the NICU between April 2016 and April 2017. Results 220 neonates were admitted to the NICU within the study epoch. The mortality rate was 14.5%. Death was associated with a maternal diagnosis of hypertension (p = 0.03) and neonatal diagnoses of lower gestational age (p<0.0001), lower birth weight (p<0.0001), prematurity (p = 0.002), RDS p = 0.01), sepsis (p<0.0001) and kernicterus (p = 0.04). The most common diagnoses were sepsis, chorioamnionitis, respiratory distress syndrome, jaundice, prematurity and perinatal asphyxia. Conclusions This study demonstrates that preterm birth, sepsis, RDS and kernicterus are key contributors to neonatal mortality in a Haitian national pediatric referral center NICU and as such are promising interventional targets for reducing the neonatal mortality rate in Haiti.	[Valcin, Josie; Jean-Charles, Skenda; Koster, Michael P.; Lechner, Beatrice E.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Malfa, Ana] Brown Univ, Providence, RI 02912 USA; [Tucker, Richard; Lechner, Beatrice E.] Women & Infants Hosp Rhode Isl, Dept Neonatol, Providence, RI 02905 USA; [Dorcelus, Lindsay; Gautier, Jacqueline] Hop St Damien Nos Petits Freres & Soeurs, Tabarre, Haiti; [Koster, Michael P.] Hasbro Childrens Hosp, Dept Pediat, Providence, RI USA	Brown University; Brown University; Women & Infants Hospital Rhode Island; Hasbro Children's Hospital	Lechner, BE (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.; Lechner, BE (corresponding author), Women & Infants Hosp Rhode Isl, Dept Neonatol, Providence, RI 02905 USA.	blechner@wihri.org		Malfa, Ana/0000-0002-1555-5469	NIMHD NIH HHS [T37 MD008655] Funding Source: Medline	NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Abdallah Y, 2016, AFR HEALTH SCI, V16, P347, DOI 10.4314/ahs.v16i2.2; Al-Turkistani HK, 2013, J FAM COMMUNITY MED, V20, P113, DOI 10.4103/2230-8229.114774; Alken J, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0858; [Anonymous], 2018, HLTH NUTR POP DAT ST; Boerma T, 2018, LANCET, V392, P1341, DOI 10.1016/S0140-6736(18)31928-7; Boulos A, 2017, J TROP PEDIATRICS, V63, P70, DOI 10.1093/tropej/fmw077; Devpura B, 2016, INT J PEDIAT, V2016, DOI 10.1155/2016/1897039; Garces A, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0178-0; Ho T, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2017-4322; Institut Haitien de l'Enfance Petion-Ville H, 2018, HAIT ENQ MORT MORB U; Jacobs Lee D, 2016, Perm J, V20, P59, DOI 10.7812/TPP/15-116; Levels and Trends in Child Mortality Report, 2014, LEV TRENDS CHILD MOR; Moss TJM, 2006, CLIN EXP PHARMACOL P, V33, P280, DOI 10.1111/j.1440-1681.2006.04359.x; Ntigurirwa P, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0252-6; Olusanya BO, 2014, ARCH DIS CHILD, V99, P1117, DOI 10.1136/archdischild-2013-305506; Organization WH, 2018, PROP DEATHS HAIT; Parker M, 2013, J HUM LACT, V29, P354, DOI 10.1177/0890334413489374; Schultz MJ, 2017, INTENS CARE MED, V43, P612, DOI 10.1007/s00134-017-4750-z; World Health Organization, 2020, NEWB IMPR SURV WELL	19	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0240465	10.1371/journal.pone.0240465	http://dx.doi.org/10.1371/journal.pone.0240465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052937	gold, Green Published			2022-12-26	WOS:000581820200061
J	Horiguchi, H; Kadomatsu, T; Miyata, K; Terada, K; Sato, M; Torigoe, D; Morinaga, J; Moroishi, T; Oike, Y				Horiguchi, Haruki; Kadomatsu, Tsuyoshi; Miyata, Keishi; Terada, Kazutoyo; Sato, Michio; Torigoe, Daisuke; Morinaga, Jun; Moroishi, Toshiro; Oike, Yuichi			Stroma-derived ANGPTL2 establishes an anti-tumor microenvironment during intestinal tumorigenesis	ONCOGENE			English	Article							ANGIOPOIETIN-LIKE PROTEIN-2; CANCER; MACROPHAGES; CELLS; EXPRESSION; ANTIBODY; ROLES; MECHANISMS; INFECTION; SUBSETS	Previous studies show that tumor cell-derived angiopoietin-like protein 2 (ANGPTL2) functions as a tumor promoter in some cancer contexts. However, we recently reported that host ANGPTL2 also shows tumor suppressive activity by enhancing dendritic cell-mediated CD8(+)T cell anti-tumor immune responses in mouse kidney cancer and murine syngeneic models. However, mechanisms underlying ANGPTL2-mediated tumor suppression are complex and not well known. Here, we investigated ANGPTL2 tumor suppressive function in chemically-induced intestinal tumorigenesis. ANGPTL2 deficiency enhanced intestinal tumor growth in an experimental mouse colitis-associated colon cancer (CAC) model.Angptl2-deficient mice also showed a decrease not only in CD8(+)T cell responses but in CD4(+)T cell responses during intestinal tumorigenesis. Furthermore, we show that stroma-derived ANGPTL2 can activate the myeloid immune response. Notably, ANGPTL2 drove generation of immunostimulatory macrophages via the NF-kappa B pathway, accelerating CD4(+)T helper 1 (Th1) cell activation. These findings overall provide novel insight into the complex mechanisms underlying ANGPTL2 anti-tumor function in cancer pathology.	[Horiguchi, Haruki; Kadomatsu, Tsuyoshi; Miyata, Keishi; Terada, Kazutoyo; Sato, Michio; Morinaga, Jun; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8608556, Japan; [Horiguchi, Haruki; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Aging & Geriatr Med, Kumamoto 8608556, Japan; [Kadomatsu, Tsuyoshi; Miyata, Keishi; Terada, Kazutoyo; Moroishi, Toshiro; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Ctr Metab Regulat Hlth Aging CMHA, Kumamoto 8608556, Japan; [Sato, Michio; Torigoe, Daisuke] Kumamoto Univ, Inst Resource Dev & Anal IRDA, Kumamoto 8600811, Japan; [Moroishi, Toshiro] Kumamoto Univ, Dept Cell Signaling & Metab Med, Fac Life Sci, Kumamoto 8608556, Japan; [Moroishi, Toshiro] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi 3320012, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University; Japan Science & Technology Agency (JST)	Kadomatsu, T; Oike, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8608556, Japan.; Oike, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Aging & Geriatr Med, Kumamoto 8608556, Japan.; Kadomatsu, T; Oike, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Ctr Metab Regulat Hlth Aging CMHA, Kumamoto 8608556, Japan.	tkado@gpo.kumamoto-u.ac.jp; oike@gpo.kumamoto-u.ac.jp	Miyata, Keishi/HGF-1876-2022	Miyata, Keishi/0000-0003-0336-1859; Moroishi, Toshiro/0000-0001-6419-3882; SATO, MICHIO/0000-0001-9339-1642	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [18K07236, 18K15246]; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) [13417915]; CREST program of the Japan Agency for Medical Research and Development (AMED) [JP18gm0610007]; Takeda Science Foundation	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); CREST program of the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Kiyoka Tabu, Noriko Shirai, and Sayomi Iwaki for technical assistance. This work was supported by the Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (grant 18K07236 to TK, grant 18K15246 to HH), the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) (grant 13417915 to YO), the CREST program of the Japan Agency for Medical Research and Development (AMED) (grant JP18gm0610007 to YO), and the Takeda Science Foundation (HH, TK).	Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2014, IMMUNOL REV, V260, P102, DOI 10.1111/imr.12192; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Borst J, 2018, NAT REV IMMUNOL, V18, P635, DOI 10.1038/s41577-018-0044-0; Chung KY, 2010, J CLIN ONCOL, V28, P3485, DOI 10.1200/JCO.2010.28.3994; De Calisto J, 2012, EUR J IMMUNOL, V42, P3136, DOI 10.1002/eji.201243061; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Galdiero MR, 2016, INT J CANCER, V139, P446, DOI 10.1002/ijc.30076; Gnjatic S, 2003, P NATL ACAD SCI USA, V100, P8862, DOI 10.1073/pnas.1133324100; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Ho WL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0334-6; Horiguchi H, 2019, GENE DEV, V33, P1641, DOI 10.1101/gad.329417.119; Horiguchi H, 2017, EMBO J, V36, P409, DOI 10.15252/embj.201695690; Horiguchi H, 2014, CANCER SCI, V105, P1550, DOI 10.1111/cas.12554; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Kather JN, 2019, BRIT J CANCER, V120, P871, DOI 10.1038/s41416-019-0441-6; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Khalil H, 2013, JOVE-J VIS EXP, V12, P1; Kikuchi R, 2008, CANCER RES, V68, P5067, DOI 10.1158/0008-5472.CAN-08-0062; Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523; Kubota Y, 2005, GENE EXPR PATTERNS, V5, P679, DOI 10.1016/j.modgep.2005.02.006; Kuchiike D, 2013, ANTICANCER RES, V33, P2881; Kuraishy A, 2011, IMMUNITY, V35, P467, DOI 10.1016/j.immuni.2011.09.006; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Masuda T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09170; Moynihan KD, 2017, CANCER RES, V77, P5215, DOI 10.1158/0008-5472.CAN-17-1340; Na YR, 2019, NAT REV GASTRO HEPAT, V16, P531, DOI 10.1038/s41575-019-0172-4; Netsirisawan P, 2015, CANCER GENOM PROTEOM, V12, P201; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Oike Y, 2003, P NATL ACAD SCI USA, V100, P9494, DOI 10.1073/pnas.1531901100; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Osumi H, 2020, CANCER SCI, V111, P1241, DOI 10.1111/cas.14337; RUGTVEIT J, 1994, GUT, V35, P669, DOI 10.1136/gut.35.5.669; Rugtveit J, 1997, GASTROENTEROLOGY, V112, P1493, DOI 10.1016/S0016-5085(97)70030-1; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Soncin I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02834-8; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tay RE, 2021, CANCER GENE THER, V28, P5, DOI 10.1038/s41417-020-0183-x; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Yanagita T, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89140; Yugami M, 2016, J BIOL CHEM, V291, P18843, DOI 10.1074/jbc.M116.720870; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048	52	6	8	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					55	67		10.1038/s41388-020-01505-7	http://dx.doi.org/10.1038/s41388-020-01505-7		OCT 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33051596				2022-12-26	WOS:000577556100002
J	Jo, H; Park, Y; Kim, J; Kwon, H; Kim, T; Lee, J; Pyun, JC; Lee, M; Yun, M				Jo, HanHee; Park, Yusun; Kim, Jisu; Kwon, Hyeonjeong; Kim, Taehun; Lee, JongSook; Pyun, Jae-Chul; Lee, Misu; Yun, Mijin			Elevated miR-16-5p induces somatostatin receptor 2 expression in neuroendocrine tumor cells	PLOS ONE			English	Article								Somatostatin analogs, which are used to treat neuroendocrine tumors, inhibit hormone secretion or promote tumor shrinkage; however, their efficacy varies between patients, possibly because of differential expression of somatostatin receptors (SSTRs) in tumors. In this study, we evaluated the regulatory mechanism underlying the expression of SSTR2, the main octreotide target. Thirty miRNAs were found to be dysregulated in neuroendocrine cells (INS-1 cells) incubated with octreotide compared to that in placebo-treated cells. Among the upregulated miRNAs, miR-16-5p was elevated after short-term octreotide treatment. We conductedin vitroexperiments to determine whether the expression of miR-16-5p was associated with the regulation of SSTR2 expression and affected octreotide sensitivity in INS-1 cells. Overexpression of miR-16-5p by transfected mimics induced upregulation of SSTR2 expression. Additionally, the expression of miR-16-5p further enhanced octreotide-induced reduction in cell proliferation in both two- and three-dimensional culture of INS-1 cells. Thus, our results reveal the mechanism underlying SSTR2 expression regulation and may aid in developing therapeutic approaches for enhancing the response to octreotide, particularly in patients unresponsive to SSTR2-targeted somatostatin analog treatment.	[Jo, HanHee; Park, Yusun; Kim, Jisu; Kwon, Hyeonjeong; Lee, JongSook; Lee, Misu] Incheon Natl Univ, Coll Life Sci & Bioengn, Div Life Sci, Incheon, South Korea; [Jo, HanHee; Yun, Mijin] Yonsei Univ, Severance Hosp, Coll Med, Dept Nucl Med, Seoul, South Korea; [Kim, Taehun; Pyun, Jae-Chul] Yonsei Univ, Dept Mat Sci & Engn, Seoul, South Korea	Incheon National University; Yonsei University; Yonsei University Health System; Yonsei University	Lee, M (corresponding author), Incheon Natl Univ, Coll Life Sci & Bioengn, Div Life Sci, Incheon, South Korea.; Yun, M (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Dept Nucl Med, Seoul, South Korea.	misulee@inu.ac.kr; YUNMIJIN@yuhs.ac		Lee, Misu/0000-0001-9208-2127; Yun, Mijin/0000-0002-1712-163X	National Research Foundation of Korea [NRF-2015R1D1A1A01057737, NRF-2018R1C1B6003894]; Incheon National University Research Grant	National Research Foundation of Korea(National Research Foundation of Korea); Incheon National University Research Grant	This research was supported by the National Research Foundation of Korea (grant numbers NRF-2015R1D1A1A01057737 and NRF-2018R1C1B6003894) and Incheon National University Research Grant in 2018.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2003, MED ONCOL, V20, P255; Bodei L, 2017, J NUCL MED, V58, P1718, DOI 10.2967/jnumed.116.186361; BURGUS R, 1973, P NATL ACAD SCI USA, V70, P684, DOI 10.1073/pnas.70.3.684; Chronicle of Higher Education, 2010, CHRONICLE HIGHER ED, V17, pA3; Crona J, 2016, EUR J ENDOCRINOL, V174, pR275, DOI 10.1530/EJE-15-0972; do Nascimento MBR, 2010, BREASTFEED MED, V5, P79, DOI 10.1089/bfm.2009.0008; Dossing KBV, 2018, GENES-BASEL, V9, DOI 10.3390/genes9070337; Gatto F, 2013, ENDOCRINOLOGY, V154, P4715, DOI 10.1210/en.2013-1672; Grozinsky-Glasberg S, 2008, MOL CELL ENDOCRINOL, V286, P238, DOI 10.1016/j.mce.2007.10.006; Hofland LJ, 2003, ENDOCR REV, V24, P28, DOI 10.1210/er.2000-0001; Hubina E, 2006, EUR J ENDOCRINOL, V155, P371, DOI 10.1530/eje.1.02213; Jo H, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06822-4; Lahlou H, 2003, J BIOL CHEM, V278, P39356, DOI 10.1074/jbc.M304524200; Langhans SA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00006; Lee M, 2017, CLIN EXP METASTAS, V34, P251, DOI 10.1007/s10585-017-9847-9; Lee M, 2015, CLIN CANCER RES, V21, P3204, DOI 10.1158/1078-0432.CCR-15-0288; Lee M, 2011, MOL CANCER THER, V10, P1450, DOI 10.1158/1535-7163.MCT-11-0188; Lopez F, 1997, J BIOL CHEM, V272, P24448, DOI 10.1074/jbc.272.39.24448; Majem B, 2015, INT J MOL SCI, V16, P8676, DOI 10.3390/ijms16048676; PAN MG, 1992, SCIENCE, V256, P1215, DOI 10.1126/science.256.5060.1215; Shah MH, 2004, CLIN CANCER RES, V10, P6111, DOI 10.1158/1078-0432.CCR-04-0422; Taelman VF, 2016, J NUCL MED, V57, P1805, DOI 10.2967/jnumed.115.165092; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yu R, 2002, J ENDOCRINOL, V174, P379, DOI 10.1677/joe.0.1740379	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240107	10.1371/journal.pone.0240107	http://dx.doi.org/10.1371/journal.pone.0240107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045023	gold, Green Published			2022-12-26	WOS:000581811700019
J	Kirie, S; Iwasaki, H; Noshita, K; Iwata, H				Kirie, Shiryu; Iwasaki, Hideo; Noshita, Koji; Iwata, Hiroyoshi			A theoretical morphological model for quantitative description of the three-dimensional floral morphology in water lily (Nymphaea)	PLOS ONE			English	Article							PETAL SHAPE VARIATION; PRIMULA-SIEBOLDII; FOURIER DESCRIPTORS; COROLLA SHAPES; EVOLUTION; FLOWERS	Water lilies (Nymphaeaspp.) have diverse floral morphologies. Water lilies are not only commonly used as ornamental plants, but they are also important for understanding the diversification of basal angiosperms. Although the diversity in floral morphology of water lily provides useful information for evolutionary biology, horticulture, and horticultural science, it is difficult to describe and analyze the three-dimensional morphology of flowers. In this study, we propose a method to describe the floral morphology of water lily using a three-dimensional theoretical morphological model. The theoretical model was constructed based on three components, i.e., (1) the gradual change in size of floral organs, (2) spiral phyllotaxis, and (3) the interpolation of elevation angles, which were integrated into the model. We generated three-dimensional representation of water lily flowers and visualized theoretical morphospaces by varying each morphological parameter. The theoretical morphospace is a mathematical space of morphological spectrum generated by a theoretical morphological model. These morphospaces seems to display the large part of morphological variations of water lily. We measured morphological parameters of real flowers based on our theoretical model and display the occupation pattern of morphological parameters. We also surveyed the relation between morphological parameters and flower shape descriptions found in a catalog. In some parameters, we found breeders' description can link to our morphological model. In addition, the relationship between the global features of floral morphology and the parameters of the theoretical model was calculated with flower silhouettes simulated with a range of parameter values and the global features of the silhouette. We used two simple indices to assess the global morphological features, which were calculated with the convex hull. The results indicated that our method can effectively provide an objective and quantitative overview of the diversity in the floral morphology of water lily.	[Kirie, Shiryu; Iwata, Hiroyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo, Japan; [Iwasaki, Hideo] Waseda Univ, Dept Elect Engn & Biosci, MetaPhorest,TWIns, Shinjuku Ku, Tokyo, Japan; [Noshita, Koji] Kyushu Univ, Fac Sci Sci, Dept Biol, Fukuoka, Fukuoka, Japan; [Noshita, Koji] Kyushu Univ, Plant Frontier Res Ctr, Fukuoka, Fukuoka, Japan; [Noshita, Koji] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	University of Tokyo; Waseda University; Kyushu University; Kyushu University; Japan Science & Technology Agency (JST)	Iwata, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo, Japan.	hiroiwata@g.ecc.u-tokyo.ac.jp		Noshita, Koji/0000-0002-9510-5897	JST CREST [JPMJCR1602]	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was partially supported by JST CREST Grant Number JPMJCR1602. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradshaw HD, 1998, GENETICS, V149, P367; Bradski G, 2000, DR DOBBS J, V25, P120; Buzgo M, 2004, INT J PLANT SCI, V165, P925, DOI 10.1086/424024; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Campos EO, 2015, FUNCT ECOL, V29, P462, DOI 10.1111/1365-2435.12378; Chacon B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082165; Chanderbali AS, 2016, GENETICS, V202, P1255, DOI 10.1534/genetics.115.182964; Christenhusz MJM, 2016, PHYTOTAXA, V261, P201, DOI 10.11646/phytotaxa.261.3.1; Conard H. S., 1905, WATERLILIES MONOGRAP; Crepet WL, 2000, P NATL ACAD SCI USA, V97, P12939, DOI 10.1073/pnas.97.24.12939; Crepet WL, 1998, SCIENCE, V282, P1653, DOI 10.1126/science.282.5394.1653; FOWLER DR, 1992, COMP GRAPH, V26, P361, DOI 10.1145/142920.134093; Goethe J.W., 2009, METAMORPHOSIS PLANTS; Gomez JM, 2016, ANN BOT-LONDON, V117, P889, DOI 10.1093/aob/mcv194; Holmes C, 2015, WATER LILIES BORY LA; Hoshino A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13295; Hsu HC, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00558; Kawabata S, 2011, SCI HORTIC-AMSTERDAM, V132, P66, DOI 10.1016/j.scienta.2011.09.034; Kawabata S, 2009, SCI HORTIC-AMSTERDAM, V121, P206, DOI 10.1016/j.scienta.2009.01.024; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Les DH, 2004, HORTSCIENCE, V39, P219, DOI 10.21273/HORTSCI.39.2.219; Lintermann B, 1999, IEEE COMPUT GRAPH, V19, P56, DOI 10.1109/38.736469; Luo HL, 2011, PLANT CELL REP, V30, P1909, DOI 10.1007/s00299-011-1098-7; Nii K, 2011, J JPN SOC HORTIC SCI, V80, P200, DOI 10.2503/jjshs1.80.200; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Prusinkiewicz P, 2001, COMP GRAPH, P289, DOI 10.1145/383259.383291; RAUP DAVID M., 1966, J PALEONTOL, V40, P1178; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sheldon R, 2017, ENTREP HIST, V88, P147, DOI [10.3917/eh.088.0147, DOI 10.3917/EH.088.0147]; Slocum P. D., 2005, WATERLILIES LOTUSES; Volkova PA, 2007, BELG J BOT, V140, P60; Wang CN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00724; Yoshioka Y, 2005, HEREDITY, V94, P657, DOI 10.1038/sj.hdy.6800678; Yoshioka Y, 2004, ANN BOT-LONDON, V94, P657, DOI 10.1093/aob/mch190; Yoshioka Y, 2007, ANN BOT-LONDON, V99, P1175, DOI 10.1093/aob/mcm059; Yoshioka Y, 2007, PLANT SPEC BIOL, V22, P87, DOI 10.1111/j.1442-1984.2007.00180.x; Zhang LS, 2020, NATURE, V577, P79, DOI 10.1038/s41586-019-1852-5	38	1	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0239781	10.1371/journal.pone.0239781	http://dx.doi.org/10.1371/journal.pone.0239781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045021	Green Published, gold			2022-12-26	WOS:000581811700039
J	Moreno, A; dos Santos, DM; Neto, CLDM; Moreno, ALD; Bertoz, APD; Goiato, MC				Moreno, Amalia; dos Santos, Daniela Micheline; Lamartine de Moraes Melo Neto, Clovis; Luiz de Melo Moreno, Andre; de Magalhaes Bertoz, Andre Pinheiro; Goiato, Marcelo Coelho			In vitroevaluation of the effect of different disinfectants on the biofilm ofStaphylococcus epidermidisandStaphylococcus aureusformed on acrylic ocular prostheses	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS; ANOPHTHALMIC CAVITY; RECOMMENDATIONS; MICROHARDNESS; REMOVAL; RESINS; CARE	The aim of this study was to evaluate the effect of disinfectants on the biofilm ofStaphylococcus aureusandStaphylococcus epidermidisformed on the acrylic surface of ocular prostheses. In this study, 396 acrylic specimens were manufactured (50% forStaphylococcus epidermidis, and 50% forStaphylococcus aureus). For each bacterium, 66 specimens were subjected to biofilm formation on their surfaces for 24 hours, 66 specimens were subjected to biofilm formation on their surfaces for 48 hours, and 66 specimens were subjected to biofilm formation on their surfaces for 72 hours. Then, they were divided into groups according to disinfection method (n = 6): sterile distilled water for 10, 15, 30 min, and 6 hours (control); soap for 30 min (NES30); Opti-Free for 30 min (OPF30) and 6 h (OPF6); Efferdent for 15 min (EFF15); and 0.5%, 2%, and 4% chlorhexidine for 10 min (0.5% CHX10, 2% CHX10, and 4% CHX10). After the treatments, the specimens were vortexed to release the biofilm and the counting of bacterial colonies was performed (CFU/mL). Three-way ANOVA and the Tukey-Kramer HSD test were used (alpha = 0.05). ForStaphylococcus epidermidis, there was no significant difference between NES30, OPF30, and OPF6 with their respective control groups; nor between NES30, OPF30, and OPF6 themselves, regardless of the biofilm development period (P>0.05). ForStaphylococcus aureus, there was no significant difference between NES30 and OPF30 with their control group; nor between NES30 and OPF30 themselves, regardless of the biofilm development period (P>0.05). ForStaphylococcus aureus, OPF6 showed a significant reduction in the number of CFU/mL when compared with its control group, NES30, and OPF30, regardless of the biofilm development period (P<0.05). For both bacteria, 0.5% CHX10, 2% CHX10,4% CHX10, and EFF15 showed a significant reduction in the number of CFU/mL when compared with their control groups, NES30, OPF30, and OPF6, regardless of the biofilm development period (P<0.05). Therefore, EFF15 and CHX (0.5%, 2% and 4%) were effective in reducingStaphylococcus epidermidisandStaphylococcus aureuson acrylic surfaces. NES30 and OPF (30 and 6) are not recommended.	[Moreno, Amalia] Fed Univ Minas Gerais UFMG, Dept Oral Surg Pathol & Clin Dent, Sch Dent, Belo Horizonte, MG, Brazil; [dos Santos, Daniela Micheline; Lamartine de Moraes Melo Neto, Clovis; Goiato, Marcelo Coelho] Sao Paulo State Univ UNESP, Dept Dent Mat & Prosthodont, Sch Dent, Aracatuba, SP, Brazil; [dos Santos, Daniela Micheline; Goiato, Marcelo Coelho] Sao Paulo State Univ UNESP, Sch Dent, Oral Oncol Ctr, Aracatuba, SP, Brazil; [Luiz de Melo Moreno, Andre] Brazilian Inst Northern Educ IBEN, Manaus, Amazonas, Brazil; [de Magalhaes Bertoz, Andre Pinheiro] Sao Paulo State Univ UNESP, Sch Dent, Dept Pediat & Social Dent, Aracatuba, SP, Brazil	Universidade Federal de Minas Gerais; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Goiato, MC (corresponding author), Sao Paulo State Univ UNESP, Dept Dent Mat & Prosthodont, Sch Dent, Aracatuba, SP, Brazil.; Goiato, MC (corresponding author), Sao Paulo State Univ UNESP, Sch Dent, Oral Oncol Ctr, Aracatuba, SP, Brazil.	m.goiato@unesp.br	Santos, Daniela/GZK-5367-2022; Coelho goiato, marcelo/E-4092-2012	Moreno, Amalia/0000-0002-3474-2091; Coelho goiato, marcelo/0000-0002-3800-3050	Sao Paulo State Research Foundation (FAPESP) [12/13909-4]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was supported by the Sao Paulo State Research Foundation (FAPESP) (12/13909-4).	Alp G, 2019, J PROSTHET DENT, V121, P347, DOI 10.1016/j.prosdent.2018.03.001; Andreotti Agda Marobo, 2018, Eur J Dent, V12, P176, DOI 10.4103/ejd.ejd_50_18; BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2; da Silva PMB, 2011, MYCOSES, V54, pE712, DOI 10.1111/j.1439-0507.2010.02005.x; Bonaque-Gonzalez S, 2015, CONTACT LENS ANTERIO, V38, P397, DOI 10.1016/j.clae.2015.06.003; Cruz PC, 2011, J APPL ORAL SCI, V19, P668, DOI 10.1590/S1678-77572011000600021; dos Santos DM, 2016, MAT SCI ENG C-MATER, V69, P995, DOI 10.1016/j.msec.2016.07.081; Fernandes Aline Úrsula Rocha, 2009, Braz. oral res., V23, P263, DOI 10.1590/S1806-83242009000300007; Goiato MC, 2013, GERODONTOLOGY, V30, P276, DOI 10.1111/j.1741-2358.2012.00676.x; Goiato Marcelo Coelho, 2019, Med Arch, V73, P433, DOI 10.5455/medarh.2019.73.433-435; Goiato Marcelo Coelho, 2013, Journal of Medical Engineering & Technology, V37, P203, DOI 10.3109/03091902.2013.774444; Guiotti AM, 2018, LETT APPL MICROBIOL, V66, P104, DOI 10.1111/lam.12830; Henriques M, 2005, OPTOMETRY VISION SCI, V82, P446, DOI 10.1097/01.opx.0000168585.53845.64; Ingram DM, 2008, J MED TOXICOL, V4, P21, DOI 10.1007/BF03160946; James P, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008676.pub2; Moreno A, 2014, COLOR RES APPL, V39, P56, DOI 10.1002/col.21754; Moreno A, 2013, GERODONTOLOGY, V30, P32, DOI 10.1111/j.1741-2358.2012.00642.x; Mourits DL, 2017, CLIN OPHTHALMOL, V11, P165, DOI 10.2147/OPTH.S120653; Neppelenbroek KH, 2015, J APPL ORAL SCI, V23, P547, DOI 10.1590/1678-77572015ed006; Nobrega Adhara Smith, 2019, Eur J Dent, V13, P399, DOI 10.1055/s-0039-1700768; Osborn KL, 2010, OPTOMETRY, V81, P142, DOI 10.1016/j.optm.2009.11.003; Paranhos Helena de Freitas Oliveira, 2013, Braz. Dent. J., V24, P47, DOI 10.1590/0103-6440201301946; Pinheiro JB, 2018, BIOFOULING, V34, P15, DOI 10.1080/08927014.2017.1403591; Raizada Kuldeep, 2007, Cont Lens Anterior Eye, V30, P152, DOI 10.1016/j.clae.2007.01.002; Song JS, 2006, GRAEF ARCH CLIN EXP, V244, P330, DOI 10.1007/s00417-005-0037-0; Toribio A, 2019, INT J OPHTHALMOL-CHI, V12, P765, DOI 10.18240/ijo.2019.05.10; Toribio A, 2017, GRAEF ARCH CLIN EXP, V255, P1669, DOI 10.1007/s00417-017-3708-8; Vasquez R J, 1989, Ophthalmic Plast Reconstr Surg, V5, P277, DOI 10.1097/00002341-198912000-00010; VERHEYEN CCPM, 1993, BIOMATERIALS, V14, P383, DOI 10.1016/0142-9612(93)90059-B; Paranhos RMZF, 2007, J APPL ORAL SCI, V15, P33, DOI 10.1590/S1678-77572007000100008	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240116	10.1371/journal.pone.0240116	http://dx.doi.org/10.1371/journal.pone.0240116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044989	gold, Green Published			2022-12-26	WOS:000581811700006
J	Zhao, KW; Hohmann, A; Faber, I; Chang, Y; Gao, BH				Zhao, Kewei; Hohmann, Andreas; Faber, Irene; Chang, Yu; Gao, Binghong			A 2-year longitudinal follow-up of performance characteristics in Chinese male elite youth athletes from swimming and racket sports	PLOS ONE			English	Article							TOTAL HEMOGLOBIN MASS; TABLE-TENNIS; MUSCLE; STRENGTH; SWIMMERS; YOUNG; ERYTHROPOIESIS; TESTOSTERONE; SELECTION; CAPACITY	Training in elite sport aims at the optimization of the athletic performance, and to control the athletes`progress in physiological, anthropometrical and motor performance prerequisites. However, in most sports, the value of longitudinal testing is unclear. This study evaluates the longitudinal development and the influence of intense training over 2-years on specific physiological performance prerequisites, as well as certain body dimensions and motor abilities in elite youth athletes. Recruited between 11-13 years of age at Shanghai Elite Sport school, the sample of student-athletes (N = 21) was categorized as the swimming group (10 athletes), and the racket sports group (11 players: 7 table tennis and 4 badminton players). The performance monitoring took place over two years between September 2016 and September 2018 and included 5 test waves. In all the test waves, the athletes were assessed by means of three physiological measurements (vital capacity, hemoglobin concentration, heart rate at rest), three anthropometric parameters (body height, body weight, chest girth), and two motor tests (back strength, complex reaction speed). Seven out of eight diagnostic methods exhibit medium to high validity to discriminate between the different levels of performance development in the two sports groups. The investigated development of the performance characteristics is attributed partly to the inherited athletic disposition as well as to the different sport-specific training regimens of the two sports groups.	[Zhao, Kewei] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China; [Zhao, Kewei] Shandong Sport Univ, Jinan, Peoples R China; [Zhao, Kewei] China Inst Sport Sci, Beijing, Peoples R China; [Hohmann, Andreas] Univ Bayreuth, Inst Sports Sci, Bayreuth, Germany; [Faber, Irene] Carl von Ossietzky Univ Oldenburg, Inst Sports Sci, Oldenburg, Germany; [Chang, Yu] Shanghai Sports Sch, Shanghai, Peoples R China; [Gao, Binghong] Shanghai Univ Sport, Sch Phys Educ & Sport Training, Shanghai, Peoples R China	Shanghai University of Sport; Shandong Sport University; China Institute of Sport Science; University of Bayreuth; Carl von Ossietzky Universitat Oldenburg; Shanghai University of Sport	Hohmann, A (corresponding author), Univ Bayreuth, Inst Sports Sci, Bayreuth, Germany.; Gao, BH (corresponding author), Shanghai Univ Sport, Sch Phys Educ & Sport Training, Shanghai, Peoples R China.	Andreas.hohmann@uni-bayreuth.de; Binghong.gao@hotmail.com	Faber, Irene Renate/C-9699-2019	Faber, Irene Renate/0000-0002-4994-0453; Zhao, Kewei/0000-0001-5394-162X	Shanghai Key Lab of Human Performance (Shanghai University of Sport) [11DZ2261100]; Science and Technology Commission of Shanghai Municipality [18DZ1200600]; Graduate Abroad Visiting Program from Shanghai University of Sport, China [STFX20190104]	Shanghai Key Lab of Human Performance (Shanghai University of Sport); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Graduate Abroad Visiting Program from Shanghai University of Sport, China	We thank the Shanghai Key Lab of Human Performance (Shanghai University of Sport) (No. 11DZ2261100), and Directed Research Grants from Science and Technology Commission of Shanghai Municipality (No. 18DZ1200600), and the Graduate Abroad Visiting Program from Shanghai University of Sport, China (No. STFX20190104).	[Anonymous], 2017, MONITORING TRAINING; Astrand P-O., 1952, EXPT STUDIES PHYS WO; Badau D, 2018, SPORTS, V6, DOI 10.3390/sports6020045; Baker J., 2018, CURRENT ISSUES SPORT; Balyi I., 2004, LONG TERM ATHLETIC D; Berryman N, 2018, INT J SPORT PHYSIOL, V13, P57, DOI 10.1123/ijspp.2017-0032; Bloomfield J, 1984, Br J Sports Med, V18, P97; Brocherie F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144446; Buchheit M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00073; Bunn J. A., 2017, J STRENGTH COND RES, DOI [10.1519/0000000000002181, DOI 10.1519/0000000000002181]; Chaouachi A, 2009, J STRENGTH COND RES, V23, P1570, DOI 10.1519/JSC.0b013e3181a4e7f0; Comfort P, 2015, J STRENGTH COND RES, V29, P3089, DOI 10.1519/JSC.0000000000000815; Coviello AD, 2008, J CLIN ENDOCR METAB, V93, P914, DOI 10.1210/jc.2007-1692; Doherty M, 1997, BRIT J SPORT MED, V31, P337, DOI 10.1136/bjsm.31.4.337; Dorrell HF, 2019, J SPORT SCI, V37, P67, DOI 10.1080/02640414.2018.1482588; Eastwood A, 2009, EUR J APPL PHYSIOL, V105, P715, DOI 10.1007/s00421-008-0953-x; Elferink-Gemser MT, 2007, J SPORT SCI, V25, P481, DOI 10.1080/02640410600719945; Faber I.R., 2019, CURRENT ISSUES SPORT; Fransen J, 2012, J SPORT SCI, V30, P379, DOI 10.1080/02640414.2011.642808; Garvican LA, 2010, EUR J APPL PHYSIOL, V109, P221, DOI 10.1007/s00421-009-1349-2; Ghosh A K, 1985, Br J Sports Med, V19, P232; Handelsman DJ, 2018, ENDOCR REV, V39, P803, DOI 10.1210/er.2018-00020; Hawes M.R., 2001, HUMAN BODY COMPOSITI, VI; Hero M, 2005, J PEDIATR-US, V146, P245, DOI 10.1016/j.jpeds.2004.09.002; Hinrichs T, 2010, J STRENGTH COND RES, V24, P629, DOI 10.1519/JSC.0b013e3181a5bc59; Hoffman JR., 2006, NORMS FITNESS PERFOR; Hulsdunker T, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00165; HUTCHISON DC, 1973, THORAX, V28, P584, DOI 10.1136/thx.28.5.584; Jaggernath M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152184; Kahl Judith, 2014, PLI WARWICK J PHILOS, V26, P11; Kamandulis S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062097; Kondric M, 2013, J SPORT SCI MED, V12, P362; Lazovic B, 2015, EUR REV MED PHARMACO, V19, P2269; Leetun DT, 2004, MED SCI SPORT EXER, V36, P926, DOI 10.1249/01.MSS.0000128145.75199.C3; Lemaitre F, 2013, J SPORT SCI MED, V12, P630; Main LC, 2016, RES SPORTS MED, V24, P269, DOI 10.1080/15438627.2016.1202828; MERCIER J, 1987, INT J SPORTS MED, V8, P26, DOI 10.1055/s-2008-1025635; Miles J., 2001, APPL REGRESSION CORR; Montero D, 2017, J PHYSIOL-LONDON, V595, P3377, DOI 10.1113/JP273480; Morouco P, 2011, J HUM KINET, P105, DOI 10.2478/v10078-011-0065-2; Moura T, 2014, J HUM KINET, V42, P277, DOI 10.2478/hukin-2014-0081; Nakamoto H, 2008, PERCEPT MOTOR SKILL, V106, P163, DOI 10.2466/PMS.106.1.163-170; Nikolic Ivana, 2014, Coll Antropol, V38, P241; Noriega-Sanchez SA, 2015, J STRENGTH COND RES, V29, P188, DOI 10.1519/JSC.0000000000000634; Opstoel K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126282; Ozmen T, 2016, J BODYW MOV THER, V20, P565, DOI 10.1016/j.jbmt.2015.12.006; Phomsoupha M, 2015, SPORTS MED, V45, P473, DOI 10.1007/s40279-014-0287-2; Pollock S, 2019, J SPORT SCI MED, V18, P577; Prommer N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00251; Rampichini S, 2018, EUR J APPL PHYSIOL, V118, P2339, DOI 10.1007/s00421-018-3960-6; Reis JF, 2012, J SCI MED SPORT, V15, P58, DOI 10.1016/j.jsams.2011.05.012; Silva DAS, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3812197; Schmidt W, 2010, EXERC SPORT SCI REV, V38, P68, DOI 10.1097/JES.0b013e3181d4957a; Sieghartsleitner R, 2019, J SPORT SCI MED, V18, P32; Simpson ALE, 2012, UNDERSEA HYPERBAR M, V39, P829; Sitkowski D, 2018, RES SPORTS MED, V26, P381, DOI 10.1080/15438627.2018.1447936; Song Y, 2017, J PEDIATR-US, V183, P164, DOI 10.1016/j.jpeds.2017.01.012; Steiner T, 2011, MED SCI SPORT EXER, V43, P1735, DOI 10.1249/MSS.0b013e3182118760; Stewart A., 2011, INT STANDARDS ANTHRO; THOMSEN K, 1986, ACTA PAEDIATR SCAND, V75, P793, DOI 10.1111/j.1651-2227.1986.tb10292.x; Tsaklis P, 2015, OPEN ACCESS J SPORTS, V6, P209, DOI 10.2147/OAJSM.S79189; Ulrich G, 2011, EUR J APPL PHYSIOL, V111, P2855, DOI 10.1007/s00421-011-1920-5; Vaeyens R, 2008, SPORTS MED, V38, P703, DOI 10.2165/00007256-200838090-00001; Vasickova J, 2017, J SPORT SCI MED, V16, P521; Wang HJ, 2017, ENVIRON SCI POLLUT R, V24, P22442, DOI 10.1007/s11356-017-9812-9; Zagatto AM, 2010, J STRENGTH COND RES, V24, P942, DOI 10.1519/JSC.0b013e3181cb7003; Zagatto AM, 2018, J SPORT SCI, V36, P724, DOI 10.1080/02640414.2017.1335957; Zhao KW, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00405; Zong XN, 2014, B WORLD HEALTH ORGAN, V92, P555, DOI 10.2471/BLT.13.126243	69	5	5	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0239155	10.1371/journal.pone.0239155	http://dx.doi.org/10.1371/journal.pone.0239155			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044967	gold, Green Published			2022-12-26	WOS:000581811700053
J	Risko, N; Werner, K; Offorjebe, OA; Vecino-Ortiz, AI; Wallis, LA; Razzak, J				Risko, Nicholas; Werner, Kalin; Offorjebe, O. Agatha; Vecino-Ortiz, Andres I.; Wallis, Lee A.; Razzak, Junaid			Cost-effectiveness and return on investment of protecting health workers in low- and middle-income countries during the COVID-19 pandemic	PLOS ONE			English	Article								Background In this paper, we predict the health and economic consequences of immediate investment in personal protective equipment (PPE) for health care workers (HCWs) in low- and middle-income countries (LMICs). Methods To account for health consequences, we estimated mortality for HCWs and present a cost-effectiveness and return on investment (ROI) analysis using a decision-analytic model with Bayesian multivariate sensitivity analysis and Monte Carlo simulation. Data sources included inputs from the World Health Organization Essential Supplies Forecasting Tool and the Imperial College of London epidemiologic model. Results An investment of $9.6 billion USD would adequately protect HCWs in all LMICs. This intervention would save 2,299,543 lives across LMICs, costing $59 USD per HCW case averted and $4,309 USD per HCW life saved. The societal ROI would be $755.3 billion USD, the equivalent of a 7,932% return. Regional and national estimates are also presented. Discussion In scenarios where PPE remains scarce, 70-100% of HCWs will get infected, irrespective of nationwide social distancing policies. Maintaining HCW infection rates below 10% and mortality below 1% requires inclusion of a PPE scale-up strategy as part of the pandemic response. In conclusion, wide-scale procurement and distribution of PPE for LMICs is an essential strategy to prevent widespread HCW morbidity and mortality. It is cost-effective and yields a large downstream return on investment.	[Risko, Nicholas; Razzak, Junaid] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Werner, Kalin; Wallis, Lee A.] Univ Cape Town, Cape Town, South Africa; [Offorjebe, O. Agatha] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA; [Vecino-Ortiz, Andres I.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; University of Cape Town; University of Southern California; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Risko, N (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	nrisko1@jhmi.edu	Razzak, Junaid/ABE-3549-2020; Werner, Kalin/CAG-7411-2022	Wallis, Lee/0000-0003-2711-3139; Vecino-Ortiz, Andres I./0000-0002-8089-2488; Razzak, Junaid/0000-0003-0735-9094; Risko, Nicholas/0000-0002-7556-2804				[Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], GLOB STRAT HUM RES H; [Anonymous], COST EFF STRAT PLANN; [Anonymous], 2020, DAILY NEWS EGYPT; Association for Professionals in Infection Control and Prevention, 2020, PROT HEALTHC WORK CO; Centers for Disease Control and Prevention, 2020, CAS DEATHS HEALTHC P; Cheng VCC, 2020, INFECT CONT HOSP EP, V41, P493, DOI 10.1017/ice.2020.58; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Congressional Research Services (CRS), 2020, DEF PROD ACT DPA COV; Deb S, 2020, LANCET GLOB HEALTH, V8, pE545, DOI 10.1016/S2214-109X(20)30034-6; Degesys NF, 2020, JAMA-J AM MED ASSOC, V324, P94, DOI 10.1001/jama.2020.9843; European Commission, 2020, EXP REQ CERT PERS PR; Hopman J, 2020, JAMA-J AM MED ASSOC, V323, P1549, DOI 10.1001/jama.2020.4169; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; International Council of Nurses, 2020, MOR 600 NURS COVID 1; Istituto Superiore di Sanita, 2020, INT SURV COVID 19 IT; Keller JM, 2020, CAN DFIS CONTRIBUTE; Kluytmans-van Den Bergh MFQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9673; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Republic of South Africa Department of Health, 2020, NICD COVID 19 SURV S; Rey A, 2020, RAPPLER NEWS 0507; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; The World Bank, WORLD BANK COUNTR LE; Tih F, 2020, NIGERIA 800 HLTH WOR; United States Centers for Disease Control and Prevention (US CDC), US PERS PROT EQ CAR; United States Food and Drug Administration, INV DEC RES RESP PUB; Walker PG, 2020, GLOBAL IMPACT COVID; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; WHO, 2020, RAT US PERS PROT EQ; WHO, ROLL UPD COR DIS COV; World Health Organization, 2020, FAQ COVID 19 ESS SUP	32	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240503	10.1371/journal.pone.0240503	http://dx.doi.org/10.1371/journal.pone.0240503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035244	Green Submitted, Green Published, gold			2022-12-26	WOS:000581817500008
J	Sanchez, MIGL; Ziemann, M; Bachem, A; Makam, R; Crowston, JG; Pinkert, CA; McKenzie, M; Bedoui, S; Trounce, IA				Lopez Sanchez, M. Isabel G.; Ziemann, Mark; Bachem, Annabell; Makam, Rahul; Crowston, Jonathan G.; Pinkert, Carl A.; McKenzie, Matthew; Bedoui, Sammy; Trounce, Ian A.			Nuclear response to divergent mitochondrial DNA genotypes modulates the interferon immune response	PLOS ONE			English	Article							CELL-LINES; OXIDATIVE-PHOSPHORYLATION; VIRUS; EXPRESSION; MTDNA; DYSFUNCTION; INHIBITION; PARADIGM; SUBUNITS; DISEASES	Mitochondrial OXPHOS generates most of the energy required for cellular function. OXPHOS biogenesis requires the coordinated expression of the nuclear and mitochondrial genomes. This represents a unique challenge that highlights the importance of nuclear-mitochondrial genetic communication to cellular function. Here we investigated the transcriptomic and functional consequences of nuclear-mitochondrial genetic divergencein vitroandin vivo. We utilized xenomitochondrial cybrid cell lines containing nuclear DNA from the common laboratory mouseMus musculus domesticusand mitochondrial DNA (mtDNA) fromMus musculus domesticus, or exogenous mtDNA from progressively divergent mouse speciesMus spretus,Mus terricolor,Mus caroliandMus pahari. These cybrids model a wide range of nuclear-mitochondrial genetic divergence that cannot be achieved with other research models. Furthermore, we used a xenomitochondrial mouse model generated in our laboratory that harbors wild-type, C57BL/6JMus musculus domesticusnuclear DNA and homoplasmic mtDNA fromMus terricolor. RNA sequencing analysis of xenomitochondrial cybrids revealed an activation of interferon signaling pathways even in the absence of OXPHOS dysfunction or immune challenge. In contrast, xenomitochondrial mice displayed lower baseline interferon gene expression and an impairment in the interferon-dependent innate immune response upon immune challenge with herpes simplex virus, which resulted in decreased viral control. Our work demonstrates that nuclear-mitochondrial genetic divergence caused by the introduction of exogenous mtDNA can modulate the interferon immune response bothin vitroandin vivo, even when OXPHOS function is not compromised. This work may lead to future insights into the role of mitochondrial genetic variation and the immune function in humans, as patients affected by mitochondrial disease are known to be more susceptible to immune challenges.	[Lopez Sanchez, M. Isabel G.; Makam, Rahul; Crowston, Jonathan G.; Trounce, Ian A.] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Lopez Sanchez, M. Isabel G.; Crowston, Jonathan G.; Trounce, Ian A.] Univ Melbourne, Ophthalmol, Dept Surg, Melbourne, Vic, Australia; [Ziemann, Mark] Monash Univ, Dept Diabet, Cent Clin Sch, Alfred Med Res & Educ Precinct, Melbourne, Vic, Australia; [Ziemann, Mark; McKenzie, Matthew] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic, Australia; [Bachem, Annabell; Bedoui, Sammy] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Pinkert, Carl A.] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA; [McKenzie, Matthew] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Melbourne, Vic, Australia; [McKenzie, Matthew] Monash Univ, Dept Mol & Translat Sci, Melbourne, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Monash University; Deakin University; University of Melbourne; Auburn University System; Auburn University; Hudson Institute of Medical Research; Monash University	Sanchez, MIGL; Trounce, IA (corresponding author), Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.; Sanchez, MIGL; Trounce, IA (corresponding author), Univ Melbourne, Ophthalmol, Dept Surg, Melbourne, Vic, Australia.	isabel.lopez@unimelb.edu.au; i.trounce@unimelb.edu.au	Sanchez, Isabel G Lopez/A-5472-2019	Sanchez, Isabel G Lopez/0000-0002-1528-5964; Pinkert, Carl/0000-0001-7460-3881; Ziemann, Mark/0000-0002-7688-6974; Makam, Rahul/0000-0002-9077-8945; McKenzie, Matthew/0000-0001-7508-1800; Bachem, Annabell/0000-0002-0047-2097	National Health and Medical Research Council [APP115979]; Mito Foundation; State Government of Victoria, Operational Infrastructure Support (Centre for Eye Research Australia)	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Mito Foundation; State Government of Victoria, Operational Infrastructure Support (Centre for Eye Research Australia)	This research was funded by the National Health and Medical Research Council APP115979 (Dr Ian A. Trounce), the Mito Foundation (Dr M. Isabel G. Lopez Sanchez), and the State Government of Victoria, Operational Infrastructure Support (Centre for Eye Research Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Cannon MV, 2011, MITOCHONDRION, V11, P33, DOI 10.1016/j.mito.2010.07.003; CHEN TR, 1987, CANCER GENET CYTOGEN, V24, P95, DOI 10.1016/0165-4608(87)90086-0; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Davies SMK, 2012, FEBS LETT, V586, P3555, DOI 10.1016/j.febslet.2012.07.043; Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fetterman JL, 2013, BIOCHEM J, V455, P157, DOI 10.1042/BJ20130029; Greyer M, 2016, CELL REP, V14, P586, DOI 10.1016/j.celrep.2015.12.058; Hoogenraad NJ, 2002, BBA-MOL CELL RES, V1592, P97, DOI 10.1016/S0167-4889(02)00268-9; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kapniciz SM, 2018, METABOLISM, V81, P97, DOI 10.1016/j.metabol.2017.11.010; Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lee WT, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.62; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Li H, 2015, BIOINFORMATICS, V31, P2885, DOI 10.1093/bioinformatics/btv290; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim SC, 2016, FASEB J, V30, P2236, DOI 10.1096/fj.201500137R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKenzie M, 2000, J BIOL CHEM, V275, P31514, DOI 10.1074/jbc.M004070200; McKenzie M, 2004, P NATL ACAD SCI USA, V101, P1685, DOI 10.1073/pnas.0303184101; McKenzie M, 2003, MOL BIOL EVOL, V20, P1117, DOI 10.1093/molbev/msg132; McKenzie M, 2014, HUM MUTAT, V35, P1476, DOI 10.1002/humu.22694; MITTNACHT S, 1988, VIROLOGY, V164, P201, DOI 10.1016/0042-6822(88)90637-X; NAGANO Y, 1958, CR SOC BIOL, V152, P1627; Patananan AN, 2016, CELL METAB, V23, P785, DOI 10.1016/j.cmet.2016.04.004; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Rafehi H, 2014, GENOME RES, V24, P1271, DOI 10.1101/gr.168781.113; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanchez MIGL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10233-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Swiecki M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003728; Tourmente M, 2017, REPRODUCTION, V154, P341, DOI 10.1530/REP-17-0206; Trounce I, 1996, SOMAT CELL MOLEC GEN, V22, P81, DOI 10.1007/BF02374379; Trounce IA, 2004, J BIOENERG BIOMEMBR, V36, P421, DOI 10.1023/B:JOBB.0000041778.84464.16; Van Bergen NJ, 2014, MITOCHONDRION, V15, P24, DOI 10.1016/j.mito.2014.03.003; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Whitney PG, 2018, J VIROL, V92, DOI 10.1128/JVI.01508-17; Widdrington JD, 2017, J ALLERGY CLIN IMMUN, V140, P1461, DOI 10.1016/j.jaci.2017.04.048; Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108	46	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239804	10.1371/journal.pone.0239804	http://dx.doi.org/10.1371/journal.pone.0239804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031404	Green Published, gold			2022-12-26	WOS:000581809800058
J	Xiao, Y; Guo, MY; Li, XH; Luo, XX; Pan, RK; Ouyang, TP				Xiao, Yi; Guo, Mingyan; Li, Xiaohong; Luo, Xixiang; Pan, Ruikang; Ouyang, Tingping			Spatial distribution, pollution, and health risk assessment of heavy metal in agricultural surface soil for the Guangzhou-Foshan urban zone, South China	PLOS ONE			English	Article							PEARL RIVER DELTA; FOOD CROPS; JIANGSU PROVINCE; SOURCE IDENTIFICATION; WASTE-WATER; CONTAMINATION; VEGETABLES; ACCUMULATION; CONSUMPTION; INDUSTRIAL	During the past decades, heavy metal pollution in agricultural soil and its impact on human health have been becoming one of the most important global environmental problems. In this research, heavy metal (Cu, Pb, Zn, Cr, Cd, Ni, As, Hg) concentrations were measured for four hundred and two soil samples collected from agricultural area within the Guangzhou-Foshan urban zone. Soil heavy metal pollution was evaluated used geoaccumulation index and potential ecological risk index. The dose response model proposed by the USEPA was used to estimate the potential health risk caused by heavy metals in agricultural soil. The results showed that: 1) Cd and Hg were the main heavy metal pollutants in agricultural soil of the study area. 89.1% and 93.3% of total soil samples suffered medium to heavy potential ecological risk caused by Cd and Hg, respectively. 2) The THI and TCR were respectively greater than 1.0 and 1.0x10(-4), indicating that heavy metals in agricultural soil were likely to constitute non-carcinogenic and carcinogenic risks, both of which were mainly brought by product consumption, to the public in the study area. The non-carcinogenic risks were mainly caused by Cr and As, while the carcinogenic risks were mainly from Cr, Cd, and As.	[Xiao, Yi; Guo, Mingyan; Li, Xiaohong; Luo, Xixiang; Pan, Ruikang; Ouyang, Tingping] South China Normal Univ, Sch Geog, Guangzhou, Peoples R China; [Ouyang, Tingping] Chinese Acad Sci, Guangzhou Inst Geochem, Key Lab Ocean & Marginal Sea Geol, Guangzhou, Peoples R China	South China Normal University; Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS	Ouyang, TP (corresponding author), South China Normal Univ, Sch Geog, Guangzhou, Peoples R China.; Ouyang, TP (corresponding author), Chinese Acad Sci, Guangzhou Inst Geochem, Key Lab Ocean & Marginal Sea Geol, Guangzhou, Peoples R China.	oyangtp@m.scnu.edu.cn	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022	Guo, Ming-Yan/0000-0002-3646-155X; Ouyang, Tingping/0000-0003-2138-4157	Natural Science Foundation of China [41977261]; Guangzhou Science Technology and Innovation Commission [201707010402]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science Technology and Innovation Commission	This work was partially funded by the Natural Science Foundation of China (Grant No. 41977261) and the Guangzhou Science Technology and Innovation Commission (Grant No. 201707010402). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MAM, 2020, ACTA GEOCHIM, V39, P226, DOI 10.1007/s11631-019-00340-2; Arora M, 2008, FOOD CHEM, V111, P811, DOI 10.1016/j.foodchem.2008.04.049; Bai JM, 2014, ENVIRON MONIT ASSESS, V186, P8051, DOI 10.1007/s10661-014-4050-9; Baltas H, 2020, CHEMOSPHERE, V241, DOI 10.1016/j.chemosphere.2019.125015; Barbieri M, 2015, SENSES SCI, V2, P94, DOI DOI 10.14616/SANDS-2015-3-9497; Bermudez GMA, 2011, J HAZARD MATER, V193, P264, DOI 10.1016/j.jhazmat.2011.07.058; Bolan NS, 2013, ADV AGRON, V119, P183, DOI 10.1016/B978-0-12-407247-3.00004-4; Borgese L, 2013, ENVIRON SCI POLLUT R, V20, P5067, DOI 10.1007/s11356-013-1473-8; Brevik Eric C., 2018, Current Opinion in Environmental Science & Health, V5, P87, DOI 10.1016/j.coesh.2018.07.003; Chabukdhara M, 2013, ECOTOX ENVIRON SAFE, V87, P57, DOI 10.1016/j.ecoenv.2012.08.032; Chai ShiWei, 2003, China Environmental Science, V23, P592; Chang CY, 2014, ENVIRON MONIT ASSESS, V186, P1547, DOI 10.1007/s10661-013-3472-0; Chang Jing, 2009, China Environmental Science, V29, P548; Chen Feng, 2017, Huanjing Kexue, V38, P4360, DOI 10.13227/j.hjkx.201704140; Chen HY, 2015, SCI TOTAL ENVIRON, V512, P143, DOI 10.1016/j.scitotenv.2015.01.025; Cheng HX, 2014, J GEOCHEM EXPLOR, V139, P31, DOI 10.1016/j.gexplo.2013.08.012; China, 1995, ENV QUAL STAND SOILS; Dai LJ, 2018, SCI TOTAL ENVIRON, V621, P1433, DOI 10.1016/j.scitotenv.2017.10.085; Doabi SA, 2018, ECOTOX ENVIRON SAFE, V163, P153, DOI 10.1016/j.ecoenv.2018.07.057; DOFGP, 2015, B GUANGDONG MARINE E; Facchinelli A, 2001, ENVIRON POLLUT, V114, P313, DOI 10.1016/S0269-7491(00)00243-8; Fryer M, 2006, ENVIRON SCI POLICY, V9, P261, DOI 10.1016/j.envsci.2005.11.011; Gu YG, 2016, APPL GEOCHEM, V67, P52, DOI 10.1016/j.apgeochem.2016.02.004; Guangdong Environmental Monitoring Centre, 1990, HDB DAT ENV BACKGR V; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; [胡淼 Hu Miao], 2014, [环境科学学报, Acta Scientiae Circumstantiae], V34, P423; Hu X, 2011, ENVIRON POLLUT, V159, P1215, DOI 10.1016/j.envpol.2011.01.037; Huang SS, 2007, CHEMOSPHERE, V67, P2148, DOI 10.1016/j.chemosphere.2006.12.043; Huang Y, 2018, J ENVIRON MANAGE, V207, P159, DOI 10.1016/j.jenvman.2017.10.072; Jan FA, 2010, J HAZARD MATER, V179, P612, DOI 10.1016/j.jhazmat.2010.03.047; Ji K, 2013, ENVIRON POLLUT, V178, P322, DOI 10.1016/j.envpol.2013.03.031; Jia ZM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21569-6; Jiang YX, 2017, CHEMOSPHERE, V168, P1658, DOI 10.1016/j.chemosphere.2016.11.088; Jiang YX, 2015, ECOTOX ENVIRON SAFE, V122, P198, DOI 10.1016/j.ecoenv.2015.07.018; Khan S, 2008, ENVIRON POLLUT, V152, P686, DOI 10.1016/j.envpol.2007.06.056; Lei J.G., 2013, CHINA ENV SCI, V33, P49; Li C, 2015, ENVIRON POLLUT, V206, P264, DOI 10.1016/j.envpol.2015.07.007; Li Ru-zhong, 2013, Huanjing Kexue, V34, P1076; Li TT, 2016, LAND RESOUR HERALD, V13, P30, DOI [10.3969/j.issn.1672-5603.2016.02.006, DOI 10.3969/J.ISSN.1672-5603.2016.02.006]; Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090; Lin Y, 2018, SCI TOTAL ENVIRON, V610, P944, DOI 10.1016/j.scitotenv.2017.08.147; Liu XM, 2013, SCI TOTAL ENVIRON, V463, P530, DOI 10.1016/j.scitotenv.2013.06.064; Liu Y, 2007, J ENVIRON SCI HEAL B, V42, P219, DOI 10.1080/03601230601125404; MEPPRC, 2014, B NAT SURV SOIL CONT; Muller G.M.M.G.M.G.M.G.P., 1969, GEOJOURNAL, V2, P108, DOI DOI 10.1055/S-2007-1023171; Roy M, 2015, LAND DEGRAD DEV, V26, P785, DOI 10.1002/ldr.2237; Sawut R, 2018, SCI TOTAL ENVIRON, V642, P864, DOI 10.1016/j.scitotenv.2018.06.034; Scott D, 1996, NEW ZEAL J AGR RES, V39, P499, DOI 10.1080/00288233.1996.9513211; Sharma RK, 2007, ECOTOX ENVIRON SAFE, V66, P258, DOI 10.1016/j.ecoenv.2005.11.007; Solgi E, 2012, B ENVIRON CONTAM TOX, V88, P634, DOI 10.1007/s00128-012-0553-7; Tepanosyan G, 2017, CHEMOSPHERE, V184, P1230, DOI 10.1016/j.chemosphere.2017.06.108; US Environmental Protection Agency, 2005, FED REG; US Environmental Protection Agency, 2014, EPA100R14004 US EPA; US EPA, 2009, EPA540R070002; US EPA, 2001, GUID DEV SOIL SCRE S; US EPA, 2004, EPA540R99005 US EPA; US EPA, 2008, EPA600R06096F US EPA; US EPA Guiding Principles for Monte Carlo Analy, 1997, EPA630R97001 US EPA; USEPA, 1989, RISK ASSESSMENT GUID, VI; USEPA (United States Environmental Protection Agency), 2011, EXPOSURE FACTORS HDB; Vatanpour N, 2020, CHEMOSPHERE, V245, DOI 10.1016/j.chemosphere.2019.125639; Wei BG, 2009, MICROCHEM J, V93, P147, DOI 10.1016/j.microc.2009.06.001; Wong SC, 2002, ENVIRON POLLUT, V119, P33, DOI 10.1016/S0269-7491(01)00325-6; Wu ZH, 2011, ENVIRON EARTH SCI, V63, P163, DOI 10.1007/s12665-010-0680-6; Wuana RA, 2011, ISRN ECOL, V2011, P1, DOI [10.5402/2011/402647, DOI 10.5402/2011/402647]; [徐争启 Xu Zhengqi], 2008, [环境科学与技术, Enuivonmental Science and Technology], V31, P112; Yan Hui, 2013, Huanjing Kexue, V34, P4017; Yang QQ, 2018, SCI TOTAL ENVIRON, V642, P690, DOI 10.1016/j.scitotenv.2018.06.068; [张连科 Zhang Lianke], 2016, [水土保持研究, Research of Soil and Water Conservation], V23, P352; Zhang QJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36582-y; Zheng SN, 2020, FOOD CHEM, V316, DOI 10.1016/j.foodchem.2020.126213	71	15	15	10	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239563	10.1371/journal.pone.0239563	http://dx.doi.org/10.1371/journal.pone.0239563			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031419	gold, Green Published			2022-12-26	WOS:000581809800010
J	Sasaki, N; Iwaya, T; Chiba, T; Fujita, M; Ju, ZL; Endo, F; Yaegashi, M; Hachiya, T; Sugimoto, R; Sugai, T; Siwak, DR; Liotta, LA; Lu, YL; Mills, GB; Nakagawa, H; Nishizuka, SS				Sasaki, Noriyuki; Iwaya, Takeshi; Chiba, Takehiro; Fujita, Masashi; Ju, Zhenlin; Endo, Fumitaka; Yaegashi, Mizunori; Hachiya, Tsuyoshi; Sugimoto, Ryo; Sugai, Tamotsu; Siwak, Doris R.; Liotta, Lance A.; Lu, Yiling; Mills, Gordon B.; Nakagawa, Hidewaki; Nishizuka, Satoshi S.			Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA	PLOS ONE			English	Article							PROTEOGENOMIC CHARACTERIZATION; INTRATUMOR HETEROGENEITY; SOMATIC MUTATIONS; LIQUID BIOPSIES; EGFR MUTATION; OPEN-LABEL; EVOLUTION; BRAF; CHEMOTHERAPY; MULTICENTER	Circulating tumor DNA (ctDNA) is released from tumor cells into blood in advanced cancer patients. Although gene mutations in individual tumors can be diverse and heterogenous, ctDNA has the potential to provide comprehensive biomarker information. Here, we performed multi-region sampling (three sites) per resected specimen from 10 gastric cancer patients followed by targeted sequencing and proteomic profiling using reverse-phase protein arrays. A total of 126 non-synonymous mutations were identified from 30 samples from 10 tumors. Of these, 16 (12.7%) were present in all three regions and were designated as founder mutations. Variant allele frequencies (VAFs) of founder mutations were significantly higher than those of non-founder mutations. Phylogenetic analysis also demonstrated a good concordance between founder and truncal mutations, defined as mutations shared by all simulated clones at the trunk of the tumor phylogenetic tree. These findings led us to prioritize founder mutations for quantitative ctDNA monitoring by digital PCR with individually-designed primer/probe sets. In preoperative plasma, the average ctDNA VAF of founder mutations was significantly higher than that of non-founder mutations (p = 0.039). Proteomic heterogeneity was present across the tumor regions both within and between patients independent of mutational status. Our results suggest that, in practice, mutations having high VAF identified without multi-regional sequencing may be immediately useful for quantitative ctDNA monitoring but do not provide sufficient information to predict the proteomic composition of tumors.	[Sasaki, Noriyuki; Iwaya, Takeshi; Chiba, Takehiro; Endo, Fumitaka; Yaegashi, Mizunori] Iwate Med Univ, Sch Med, Dept Surg, Yahaba, Iwate, Japan; [Sasaki, Noriyuki; Iwaya, Takeshi] Iwate Med Univ, Sch Med, Dept Surg, Mol Therapeut Lab, Yahaba, Iwate, Japan; [Sasaki, Noriyuki; Nishizuka, Satoshi S.] Iwate Med Univ, Inst Biomed Sci, Div Biomed Res & Dev, Yahaba, Iwate, Japan; [Fujita, Masashi; Nakagawa, Hidewaki] RIKEN Ctr Integrat Med Sci, Lab Canc Genom, Yokohama, Kanagawa, Japan; [Ju, Zhenlin] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Hachiya, Tsuyoshi] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Div Biomed Informat Anal, Yahaba, Iwate, Japan; [Sugimoto, Ryo; Sugai, Tamotsu] Iwate Med Univ, Sch Med, Dept Mol Diagnost Pathol, Yahaba, Iwate, Japan; [Siwak, Doris R.; Lu, Yiling; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Liotta, Lance A.] George Mason Univ, Ctr Appl Prote & Mol Med, Fairfax, VA 22030 USA; [Mills, Gordon B.] Oregon Hlth & Sci Univ, Sch Med, Knight Canc Inst, Dept Cell Dev & Canc Biol, Portland, OR USA	Iwate Medical University; Iwate Medical University; Iwate Medical University; RIKEN; University of Texas System; UTMD Anderson Cancer Center; Iwate Medical University; Iwate Medical University; University of Texas System; UTMD Anderson Cancer Center; George Mason University; Oregon Health & Science University	Nishizuka, SS (corresponding author), Iwate Med Univ, Inst Biomed Sci, Div Biomed Res & Dev, Yahaba, Iwate, Japan.	snishizu@iwate-med.ac.jp	Hachiya, Tsuyoshi/AAM-8691-2021	Hachiya, Tsuyoshi/0000-0002-5274-3266; Sasaki, Noriyuki/0000-0001-8447-8535	SSN [JP16H01578, 15KK0317, 19K09224, 19K09130, 17K10605]	SSN	SSN JP16H01578, 15KK0317, 19K09224, 19K09130, and 17K10605 Grant-in-Aid for Scientific Research URL: https://www.jsps.go.jp/english/index.html Iwate Prefectural Regional Innovation Grant https://www.pref.iwate.jp/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Baumgartner JM, 2018, ANN SURG ONCOL, V25, P2400, DOI 10.1245/s10434-018-6561-z; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boeva V, 2014, BIOINFORMATICS, V30, P3443, DOI 10.1093/bioinformatics/btu436; Campbell BB, 2017, CELL, V171, P1042, DOI 10.1016/j.cell.2017.09.048; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Corcoran RB, 2015, J CLIN ONCOL, V33, P4023, DOI 10.1200/JCO.2015.63.2471; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Fang WL, 2016, INT J CANCER, V138, P2974, DOI 10.1002/ijc.30018; Gao J, 2017, CANCER SCI, V108, P1881, DOI 10.1111/cas.13314; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Jiang YC, 2016, P NATL ACAD SCI USA, V113, pE5528, DOI 10.1073/pnas.1522203113; Ju ZL, 2015, BIOINFORMATICS, V31, P912, DOI 10.1093/bioinformatics/btu736; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kopetz S, 2015, J CLIN ONCOL, V33, P4032, DOI 10.1200/JCO.2015.63.2497; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Leung ML, 2016, NAT PROTOC, V11, P214, DOI 10.1038/nprot.2016.005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lo YM, 2011, J PATHOL, V225, P318, DOI 10.1002/path.2960; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mun DG, 2019, CANCER CELL, V35, P111, DOI 10.1016/j.ccell.2018.12.003; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Nishizuka SS, 2019, METHODS MOL BIOL, V1908, P229, DOI 10.1007/978-1-4939-9004-7_16; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Parkinson CA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002198; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Price TJ, 2014, LANCET ONCOL, V15, P569, DOI 10.1016/S1470-2045(14)70118-4; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sato KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146275; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shen SY, 2018, NATURE, V563, P579, DOI 10.1038/s41586-018-0703-0; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Wang DS, 2019, GUT, V68, P1152, DOI 10.1136/gutjnl-2018-316522; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Whitcombe D, 1999, NAT BIOTECHNOL, V17, P804, DOI 10.1038/11751; Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	47	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239966	10.1371/journal.pone.0239966	http://dx.doi.org/10.1371/journal.pone.0239966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027286	Green Published, gold			2022-12-26	WOS:000581808000010
J	Patel, H; DiDomenico, RJ; Suda, KJ; Schumock, GT; Calip, GS; Lee, TA				Patel, Haridarshan; DiDomenico, Robert J.; Suda, Katie J.; Schumock, Glen T.; Calip, Gregory S.; Lee, Todd A.			Risk of cardiac events with azithromycin-A prediction model	PLOS ONE			English	Article							VENTRICULAR-ARRHYTHMIAS; DEATH; MECHANISMS	Previous studies have suggested an increased risk of cardiac events with azithromycin, but the predictors of such events are unknown. We sought to develop and validate two prediction models to identify such predictors. We used data from Truven Marketscan Database (01/2009 to 06/2015). Using a split-sample approach, we developed two prediction models, which included baseline demographics, clinical conditions (Model 1), concurrent use of any drug (Model 1) and therapeutic class (Model 2) with a risk of QT-prolongation (CQT-Rx). Patients enrolled in a health plan for 365 days before and five days after dispensing of azithromycin (episodes). Cardiac events included syncope, palpitations, ventricular arrhythmias, cardiac arrest as a primary diagnosis for hospitalization including death. For each model, a backward elimination of predictors using logistic regression was applied to identify predictors in 100 random samples of the training cohort. Predictors prevalent in >50% of the models were included in the final model. A score for the Assessment of Cardiac Risk with Azithromycin (ACRA) was generated using the training cohort then tested in the validation cohort. A cohort of 20,134,659 episodes with 0.03% cardiac events were included. Over 60% included females with mean age of 40.1 +/- 21.3 years. Age, sex, history of syncope, cardiac dysrhythmias, non-specific chest pain, and presence of a CQT-Rx were included as predictors for Model-1 (c-statistic = 0.68). For Model-2 (c-statistic = 0.64), predictors included age, sex, anti-arrhythmic agents, anti-emetics, antidepressants, loop diuretics, and ACE inhibitors. ACRA score is available online (bit.ly/ACRA_2020). The ACRA score may help identify patients who are at higher risk of cardiac events following treatment with azithromycin. Providers should assess the risk-benefit of using azithromycin and consider alternative antibiotics among high-risk patients.	[Patel, Haridarshan; DiDomenico, Robert J.; Schumock, Glen T.; Calip, Gregory S.; Lee, Todd A.] Univ Illinois, Coll Pharm, Dept Pharm Syst Outcomes & Policy PSOP, Chicago, IL 60607 USA; [DiDomenico, Robert J.] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA; [Suda, Katie J.] Univ Pittsburgh, Dept Med, VA Pittsburgh Healthcare Syst, Sch Med, Pittsburgh, PA USA; [Suda, Katie J.] Univ Pittsburgh, Ctr Hlth Equ Res & Promot, VA Pittsburgh Healthcare Syst, Sch Med, Pittsburgh, PA USA; [Calip, Gregory S.] Flatiron Hlth Inc, New York, NY USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Patel, H (corresponding author), Univ Illinois, Coll Pharm, Dept Pharm Syst Outcomes & Policy PSOP, Chicago, IL 60607 USA.	Haripatel86@gmail.com	DiDomenico, Robert J./AAU-2128-2021; DiDomenico, Robert J./AFV-5274-2022	DiDomenico, Robert J./0000-0002-9374-8012; DiDomenico, Robert J./0000-0002-9374-8012; Patel, Haridarshan/0000-0002-1827-5163				Abildskov JA, 1997, PACE, V20, P88, DOI 10.1111/j.1540-8159.1997.tb04816.x; [Anonymous], 2018, ADV CIV ENG, V2018, P1, DOI DOI 10.1017/S1473550418000022; ANTZELEVITCH C, 1994, J AM COLL CARDIOL, V23, P259, DOI 10.1016/0735-1097(94)90529-0; BENDAVID J, 1993, LANCET, V341, P1578, DOI 10.1016/0140-6736(93)90708-O; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; De Bruin ML, 2005, J CLIN EPIDEMIOL, V58, P1325, DOI 10.1016/j.jclinepi.2005.04.009; DELUNA AB, 1989, AM HEART J, V117, P151, DOI 10.1016/0002-8703(89)90670-4; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; Hansen L, 2018, TRUVEN HLTH MARKETSC; Hennessy S, 2010, PHARMACOEPIDEM DR S, V19, P555, DOI 10.1002/pds.1869; JACKMAN WM, 1988, PROG CARDIOVASC DIS, V31, P115, DOI 10.1016/0033-0620(88)90014-X; Kannel WB, 1998, AM HEART J, V136, P205, DOI 10.1053/hj.1998.v136.90226; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Marijon E, 2016, ANN INTERN MED, V164, P23, DOI 10.7326/M14-2342; Ohtani H, 2000, ANTIMICROB AGENTS CH, V44, P2630, DOI 10.1128/AAC.44.10.2630-2637.2000; Patel H, 2019, PHARMACOTHERAPY; Psaty BM, 1996, AM J HYPERTENS, V9, P178, DOI 10.1016/0895-7061(96)00015-5; Raebel MA, 2012, CARDIOVASC THER, V30, pe156, DOI 10.1111/j.1755-5922.2010.00258.x; Rea TD, 2004, AM J CARDIOL, V93, P1455, DOI 10.1016/j.amjcard.2004.03.002; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Tamariz L, 2012, PHARMACOEPIDEM DR S, V21, P148, DOI 10.1002/pds.2340; Wehrens XHT, 2002, ANN INTERN MED, V137, P981, DOI 10.7326/0003-4819-137-12-200212170-00012; Woosley R. L., QTDRUGS LIST; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240379	10.1371/journal.pone.0240379	http://dx.doi.org/10.1371/journal.pone.0240379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UY	33057356	gold, Green Published			2022-12-26	WOS:000581814700020
J	Bradley, A; Sami, S; Hwei, NG; Macleod, A; Prasanth, M; Zafar, M; Hemadasa, N; Neagle, G; Rosindell, I; Apollos, J				Bradley, Alison; Sami, Sharukh; Hwei, N. G.; Macleod, Anne; Prasanth, Manju; Zafar, Muneeb; Hemadasa, Niroshini; Neagle, Gregg; Rosindell, Isobelle; Apollos, Jeyakumar			A predictive Bayesian network that risk stratifies patients undergoing Barrett's surveillance for personalized risk of developing malignancy	PLOS ONE			English	Article							PRECISION MEDICINE; KNOWLEDGE; ESOPHAGUS; CANCER	Background Barrett's esophagus is strongly associated with esophageal adenocarcinoma. Considering costs and risks associated with invasive surveillance endoscopies better methods of risk stratification are required to assist decision-making and move toward more personalised tailoring of Barrett's surveillance. Methods A Bayesian network was created by synthesizing data from published studies analysing risk factors for developing adenocarcinoma in Barrett's oesophagus through a two-stage weighting process. Results Data was synthesized from 114 studies (n = 394,827) to create the Bayesian network, which was validated against a prospectively maintained institutional database (n = 571). Version 1 contained 10 variables (dysplasia, gender, age, Barrett's segment length, statin use, proton pump inhibitor use, BMI, smoking, aspirin and NSAID use) and achieved AUC of 0.61. Version 2 contained 4 variables with the strongest evidence of association with the development of adenocarcinoma in Barrett's (dysplasia, gender, age, Barrett's segment length) and achieved an AUC 0.90. Conclusion This Bayesian network is unique in the way it utilizes published data to translate the existing empirical evidence surrounding the risk of developing adenocarcinoma in Barrett's esophagus to make personalized risk predictions. Further work is required but this tool marks a vital step towards delivering a more personalized approach to Barrett's surveillance.	[Bradley, Alison; Sami, Sharukh; Hwei, N. G.; Macleod, Anne; Prasanth, Manju; Zafar, Muneeb; Hemadasa, Niroshini; Neagle, Gregg; Rosindell, Isobelle; Apollos, Jeyakumar] NHS Dumfries & Galloway, Dumfries & Galloway Royal Infirm, Dept Gen Surg, Dumfries, Scotland		Bradley, A (corresponding author), NHS Dumfries & Galloway, Dumfries & Galloway Royal Infirm, Dept Gen Surg, Dumfries, Scotland.	bradley_alison@live.co.uk		Ng, Hwei Jene/0000-0002-9077-2367; Macleod, Anne/0000-0002-2712-536X; Bradley, Alison/0000-0002-3899-8457; Zafar, Muneeb/0000-0001-8676-4981				Agenarisk, BAYES NETW SOFTW RIS; Ashley SW, 2012, CURR PROB SURG, V49, P731, DOI 10.1067/j.cpsurg.2012.08.002; Bradley A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222270; Cai BP, 2013, RISK ANAL, V33, P1293, DOI 10.1111/j.1539-6924.2012.01918.x; Cockburn G, 2012, GEORISK, V6, P128, DOI 10.1080/17499518.2011.650147; Dzau VJ, 2016, JAMA-J AM MED ASSOC, V316, P1659, DOI 10.1001/jama.2016.14117; Hager D, 2010, EUR J OPER RES, V207, P1635, DOI 10.1016/j.ejor.2010.06.020; Ismail MA, 2011, J FRANKLIN I, V348, P2539, DOI 10.1016/j.jfranklin.2011.07.015; Kabir G, 2015, EUR J OPER RES, V240, P220, DOI 10.1016/j.ejor.2014.06.033; MacConaill LE, 2015, JAMA ONCOL, V1, P879, DOI 10.1001/jamaoncol.2015.1540; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nadkarni S, 2001, EUR J OPER RES, V128, P479, DOI 10.1016/S0377-2217(99)00368-9; Neil M., 2019, RISK ASSESSMENT DECI, V2nd ed.; Obermeyer Z, 2017, NEW ENGL J MED, V377, P1209, DOI 10.1056/NEJMp1705348; Park WG, 2015, AM J GASTROENTEROL, V110, P60, DOI 10.1038/ajg.2014.384; Pearl J., 1988, PROBABILISTIC REASON; Poropudas J, 2011, EUR J OPER RES, V214, P644, DOI 10.1016/j.ejor.2011.05.007; Spechler SJ, 1996, GASTROENTEROLOGY, V110, P614, DOI 10.1053/gast.1996.v110.agast960614; Stein Hubert J., 1993, Dysphagia, V8, P276, DOI 10.1007/BF01354551; Sun LL, 2007, EUR J OPER RES, V180, P738, DOI 10.1016/j.ejor.2006.04.019; Tang Z, 2007, J COMPUT CIVIL ENG, V21, P265, DOI 10.1061/(ASCE)0887-3801(2007)21:4(265); Tonelli MR, 2017, JAMA-J AM MED ASSOC, V318, P1649, DOI 10.1001/jama.2017.11914; van de Schoot R, 2014, CHILD DEV, V85, P842, DOI 10.1111/cdev.12169; Vaughan TL, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-1022-0; Velikova M, 2014, INT J APPROX REASON, V55, P59, DOI 10.1016/j.ijar.2013.03.016; Verduijn M, 2007, J BIOMED INFORM, V40, P609, DOI 10.1016/j.jbi.2007.07.003; Yousef F, 2008, AM J EPIDEMIOL, V168, P237, DOI 10.1093/aje/kwn121; Zhao D, 2011, J BIOMED INFORM, V44, P859, DOI 10.1016/j.jbi.2011.05.004	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240620	10.1371/journal.pone.0240620	http://dx.doi.org/10.1371/journal.pone.0240620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045017	Green Published, gold			2022-12-26	WOS:000581811700055
J	Wang, C; Zhao, GH				Chen, Wang; Guohua, Zhao			Decomposition and adaptive weight adjustment method with biogeography/complex algorithm for many-objective optimization	PLOS ONE			English	Article							MULTIOBJECTIVE EVOLUTIONARY ALGORITHMS; MOEA/D	In the EMO (evolutionary multi-objective, EMO) algorithm, MaOPs (many objective optimization problems, MaOPs) are sometimes difficult to keep the balance of convergence and diversity. The decomposition based EMO developed for MaOPs has been proved to be effective, and BBO/Complex (the biogeography based optimization for complex system, BBO/Complex) algorithm is a low complexity algorithm. In this paper, a decomposition and adaptive weight adjustment based BBO/Complex algorithm (DAWA-BBO/Complex) for MaOPs is proposed. First, a new method based on crowding distance is designed to generate a set of weight vectors with good uniformly. Second, an adaptive weight adjustment method is used to solve MaOPs with complex Pareto optimal front. Subsystem space obtains a non-dominated solution by a new selection strategy. The experimental results show that the algorithm is superior to other new algorithms in terms of convergence and diversity in DTLZ benchmark problems. Finally, the algorithm is used to solve the problem of NC (numerical control machine, NC) cutting parameters, and the final optimization result is obtained by AHP (Analytic Hierarchy Process, AHP) method. The results show that the cutting speed is 10.8m/min, back cutting depth is 0.13mm, the cutting time is 504s and the cutting cost is 22.15yuan. The proposed algorithm can effectively solve the practical optimization problem.	[Chen, Wang; Guohua, Zhao] Hubei Univ Automot Technol, Dept Mech Engn, Shiyan, Peoples R China	Hubei University of Automotive Technology	Zhao, GH (corresponding author), Hubei Univ Automot Technol, Dept Mech Engn, Shiyan, Peoples R China.	893468804@qq.com			National Major Science and Technology Projects of China [2018ZX04027001]; Humanities and social sciences fund of the Ministry of Education of China [20YJCZH150]; key laboratory of automotive power train and electronics (Hubei University of Automotive Technology) [ZDK1201703]; Hubei Provincial Education Department Youth Fund [Q20181801]; Doctoral research initiation fund (Hubei University of Automotive Technology) [BK201905]	National Major Science and Technology Projects of China; Humanities and social sciences fund of the Ministry of Education of China(Ministry of Education, China); key laboratory of automotive power train and electronics (Hubei University of Automotive Technology); Hubei Provincial Education Department Youth Fund; Doctoral research initiation fund (Hubei University of Automotive Technology)	This work was supported by the National Major Science and Technology Projects of China (Grant No. 2018ZX04027001) to ZG, Humanities and social sciences fund of the Ministry of Education of China (Grant No. 20YJCZH150) to WC, key laboratory of automotive power train and electronics (Hubei University of Automotive Technology, No. ZDK1201703) to WC, Hubei Provincial Education Department Youth Fund (No. Q20181801) to WC, and Doctoral research initiation fund (Hubei University of Automotive Technology, No. BK201905) to WC.	Chen Wang, 2017, MODERN MANUFACTURING, V000, P77; Dai C, 2019, SOFT COMPUT, P1; Dai S., 2015, 2015 11 INT C COMP I; Deb K, 2014, IEEE T EVOLUT COMPUT, V18, P577, DOI 10.1109/TEVC.2013.2281535; Garg H, 2016, J INTELL FUZZY SYST, V30, P2417, DOI 10.3233/IFS-152010; Garg H, 2015, SWARM EVOL COMPUT, V24, P1, DOI 10.1016/j.swevo.2015.05.001; Guo W, 2016, NEURAL COMPUT APPL, P1; Li BD, 2015, ACM COMPUT SURV, V48, DOI 10.1145/2792984; Liao HL, 2014, ENERG CONVERS MANAGE, V87, P990, DOI 10.1016/j.enconman.2014.07.071; Ling T, 2018, MATHE MATICAL PROBLE; Liu Y., 2016, APPL SOFT COMPUTING; Peker M, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0477-6; Qi YT, 2014, EVOL COMPUT, V22, P231, DOI 10.1162/EVCO_a_00109; Rajasomashekar S, 2012, SWARM EVOL COMPUT, V7, P47, DOI 10.1016/j.swevo.2012.06.001; Trivedi A, 2017, IEEE T EVOLUT COMPUT, V21, P440, DOI 10.1109/TEVC.2016.2608507; von Lucken C, 2014, COMPUT OPTIM APPL, V58, P707, DOI 10.1007/s10589-014-9644-1; Wang C., 2017, MATH PROBLEMS ENG; Wang C, 2019, INT J MACH LEARN CYB, V10, P1961, DOI 10.1007/s13042-017-0728-y; Wang Chen, INT J MACHINE LEARNI; Zhang M., 2017, SOFT COMPUT, V23, P1, DOI DOI 10.1038/CDDIS.2017.467.PMID:28981116; Zhang QF, 2007, IEEE T EVOLUT COMPUT, V11, P712, DOI 10.1109/TEVC.2007.892759; Zhou AM, 2011, SWARM EVOL COMPUT, V1, P32, DOI 10.1016/j.swevo.2011.03.001; Zhu CW, 2016, IEEE T EVOLUT COMPUT, V20, P299, DOI 10.1109/TEVC.2015.2457245; Zhu HZ, 2016, INT J MACH LEARN CYB, V7, P581, DOI 10.1007/s13042-015-0443-5; Zitzler E, 1999, IEEE T EVOLUT COMPUT, V3, P257, DOI 10.1109/4235.797969	25	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240131	10.1371/journal.pone.0240131	http://dx.doi.org/10.1371/journal.pone.0240131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035263	gold, Green Published			2022-12-26	WOS:000581817500035
J	Blease, C; Kharko, A; Locher, C; DesRoches, CM; Mandl, KD				Blease, Charlotte; Kharko, Anna; Locher, Cosima; DesRoches, Catherine M.; Mandl, Kenneth D.			US primary care in 2029: A Delphi survey on the impact of machine learning	PLOS ONE			English	Article							MALPRACTICE CLAIMS; DIVERSITY; FUTURE	Objective To solicit leading health informaticians' predictions about the impact of AI/ML on primary care in the US in 2029. Design A three-round online modified Delphi poll. Participants Twenty-nine leading health informaticians. Methods In September 2019, health informatics experts were selected by the research team, and invited to participate the Delphi poll. Participation in each round was anonymous, and panelists were given between 4-8 weeks to respond to each round. In Round 1 open-ended questions solicited forecasts on the impact of AI/ML on: (1) patient care, (2) access to care, (3) the primary care workforce, (4) technological breakthroughs, and (5) the long-future for primary care physicians. Responses were coded to produce itemized statements. In Round 2, participants were invited to rate their agreement with each item along 7-point Likert scales. Responses were analyzed for consensus which was set at a predetermined interquartile range of <= 1. In Round 3 items that did not reach consensus were redistributed. Results A total of 16 experts participated in Round 1 (16/29, 55%). Of these experts 13/16 (response rate, 81%), and 13/13 (response rate, 100%), responded to Rounds 2 and 3, respectively. As a result of developments in AI/ML by 2029 experts anticipated workplace changes including incursions into the disintermediation of physician expertise, and increased AI/ML training requirements for medical students. Informaticians also forecast that by 2029 AI/ML will increase diagnostic accuracy especially among those with limited access to experts, minorities and those with rare diseases. Expert panelists also predicted that AI/ML-tools would improve access to expert doctor knowledge. Conclusions This study presents timely information on informaticians' consensus views about the impact of AI/ML on US primary care in 2029. Preparation for the near-future of primary care will require improved levels of digital health literacy among patients and physicians.	[Blease, Charlotte; DesRoches, Catherine M.] Beth Israel Deaconess Med Ctr, Div Gen Med, OpenNotes, Boston, MA 02215 USA; [Kharko, Anna] Univ Plymouth, Dept Psychol, Plymouth, Devon, England; [Locher, Cosima] Univ Basel, Div Clin Psychol & Psychotherapy, Basel, Switzerland; [Locher, Cosima] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA; [DesRoches, Catherine M.] Harvard Med Sch, Boston, MA 02115 USA; [Mandl, Kenneth D.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Mandl, Kenneth D.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Mandl, Kenneth D.] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; University of Plymouth; University of Basel; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Blease, C (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med, OpenNotes, Boston, MA 02215 USA.	cblease@bimdc.harvard.edu	Locher, Cosima/N-5671-2017; Kharko, Anna/AAN-1959-2021	Locher, Cosima/0000-0002-9660-0590; Kharko, Anna/0000-0003-0908-6173; DesRoches, Catherine/0000-0001-5373-855X; Blease, Charlotte/0000-0003-3657-2476	Irish Research Council-Marie Sklodowska-Curie Fellowship; Keane Scholar Award; School of Psychology, University of Plymouth; Swiss National Science Foundation grant [P400PS_180730]	Irish Research Council-Marie Sklodowska-Curie Fellowship; Keane Scholar Award; School of Psychology, University of Plymouth; Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF))	CB was supported by an Irish Research Council-Marie Sklodowska-Curie Fellowship, and a Keane Scholar Award. AK was funded by the School of Psychology, University of Plymouth. CL was funded by a Swiss National Science Foundation grant (P400PS_180730). The study funders played no role in the study design; writing of the report; or the decision to submit the manuscript for publication. Researchers were independent of influence from study funders.; It is standard practice in Delphi polls to acknowledge the panel of experts who shared their valuable insights. We are indebted to them for giving up their time. The following participants (12 out of 16) granted us permission to report their names: David Bates, MD; Andrew Beam, PhD; Gabriel Brat, MD; Wendy Chapman, PhD; Enrico Coiera, PhD FACMI; Peter Embi, MD, MS, FACP, FACMI, FAMIA; John Halamka, MD; Arjun Manrai, PhD; JP Onella, PhD; Neil Sebire, MBBS, BClinSCi, MD, FRCOG, FRCPath, FFCI; Jessie Tenenbaum, PhD; KunHsing Yu, MD PhD.	[Anonymous], 2013, AESTHETIC SURG J S, V22, p1S; Armour S., 2020, WALL STREET J; Blease C, 2019, ARXIV191009956; Blease C, 2019, J MED INTERNET RES, V21, DOI 10.2196/12802; Blease C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207418; Bodenheimer T, 2016, NEW ENGL J MED, V375, P1015, DOI 10.1056/NEJMp1606869; Boeldt DL, 2015, J MED INTERNET RES, V17; BUCK AJ, 1993, POLICY SCI, V26, P271, DOI 10.1007/BF00999473; Burgman MA., 2016, TRUSTING JUDGEMENTS; Coiera E, 2018, LANCET; Collins H., 2008, RETHINKING EXPERTISE; Custer R.L., 1999, J VOCAT TECH ED, V15, P1, DOI DOI 10.21061/JCTE.V15I2.702; D Damayanti D., 2018, BULLWHIP EFFECT SUPP, V1, P1, DOI DOI 10.1080/09593330.2018.1526217; DALKEY N, 1969, FUTURES, V1, P408, DOI 10.1016/S0016-3287(69)80025-X; Darcy AM, 2016, JAMA-J AM MED ASSOC, V315, P551, DOI 10.1001/jama.2015.18421; Delbecq AL, 1975, J HUMAN SCI; Donohoe H, 2012, AM J HEALTH EDUC, V43, P38, DOI 10.1080/19325037.2012.10599216; Doraiswamy PM, 2020, ARTIF INTELL MED, V102, DOI 10.1016/j.artmed.2019.101753; Dos Santos DP, 2018, EUROPEAN RADIOLOGY, P1; Frey CB, 2017, TECHNOL FORECAST SOC, V114, P254, DOI 10.1016/j.techfore.2016.08.019; Giunti G, 2019, J MED INTERNET RES, V21, DOI 10.2196/14086; Goldhahn J, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4563; Gordon NP, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5105; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hinton G, 2018, JAMA-J AM MED ASSOC, V320, P1101, DOI 10.1001/jama.2018.11100; Hsu CC, 2007, PARE, V12, P1; Jiang R, 2017, TECHNOL FORECAST SOC, V117, P84, DOI 10.1016/j.techfore.2017.01.006; Kohane IS, 2012, GLIMPSE NEXT 100 YEA; Lin SY, 2019, J GEN INTERN MED, V34, P1626, DOI 10.1007/s11606-019-05035-1; Lin SC, 2019, HEALTH AFFAIR, V38, P1850, DOI 10.1377/hlthaff.2018.05437; Linstone H. A., 1975, DELPHI METHOD TECHNI; Liyanage Harshana, 2019, Yearb Med Inform, V28, P41, DOI 10.1055/s-0039-1677901; Ludwig B., 1997, J EXT, V35, P1; Mandl K, 2017, JAMA-J AM MED ASSOC, V318, P1859, DOI 10.1001/jama.2017.15028; Mann DM, 2020, J AM MED INFORM ASS; Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092; Morse Susan, 2018, HLTHCARE IT NEWS; Newman-Toker DE, 2019, DIAGNOSIS, V6, P227, DOI 10.1515/dx-2019-0019; Norcross JC, 2013, PROF PSYCHOL-RES PR, V44, P363, DOI 10.1037/a0034633; ONC, 2020, 21 CENT CUR ACT INT; Paranjape K, 2019, JMIR MED ED, V5, DOI DOI 10.2196/1604831793895; Parente R, 2011, TECHNOL FORECAST SOC, V78, P1705, DOI 10.1016/j.techfore.2011.07.005; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Rodriguez Jorge A, 2020, J Gen Intern Med, V35, P3719, DOI 10.1007/s11606-020-05633-4; Rowe G, 2005, TECHNOL FORECAST SOC, V72, P377, DOI 10.1016/j.techfore.2004.03.004; Rubinson L, 1987, RES TECHNIQUES HLTH; Sheppard VB, 2014, PSYCHO-ONCOLOGY, V23, P143, DOI 10.1002/pon.3382; Sit C, 2020, INSIGHTS IMAGING, V11, DOI 10.1186/s13244-019-0830-7; Staff I of M, 2004, UNEQUAL TREATMENT CO; Steinhubl SR, 2018, LANCET, V391, P419, DOI 10.1016/S0140-6736(18)30109-0; Steinhubl SR, 2013, JAMA-J AM MED ASSOC, V310, P2395, DOI 10.1001/jama.2013.281078; Stirling A, 2007, J R SOC INTERFACE, V4, P707, DOI 10.1098/rsif.2007.0213; Susskind R, 2016, HARVARD BUSINESS REV, V11; Tehrani ASS, 2013, BMJ QUAL SAF, V22, P672, DOI 10.1136/bmjqs-2012-001550; Uckert F, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0074-5; Vayena E, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002689; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Yaniv I, 2011, INT J FORECASTING, V27, P41, DOI 10.1016/j.ijforecast.2010.05.009; Zuboff Shoshana, 2019, AGE SURVEILLANCE CAP	59	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0239947	10.1371/journal.pone.0239947	http://dx.doi.org/10.1371/journal.pone.0239947			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3TB	33031411	Green Submitted, Green Published, gold			2022-12-26	WOS:000581809800035
J	Ingasia, LAO; Kostaki, EG; Paraskevis, D; Kramvis, A				Ingasia, Luicer Anne Olubayo; Kostaki, Evangelia Georgia; Paraskevis, Dimitrios; Kramvis, Anna			Global and regional dispersal patterns of hepatitis B virus genotype E from and in Africa: A full-genome molecular analysis	PLOS ONE			English	Article							GENETIC DIVERSITY; HBV GENOTYPES; E-ANTIGEN; INFECTION; EPIDEMIOLOGY; RECOMBINATION; TRANSMISSION; INJECTIONS; MUTATIONS; ORIGINS	Description of the spatial characteristics of viral dispersal is important in understanding the history of infections. Nine hepatitis B virus (HBV) genotypes (A-I), and a putative 10(th)genotype (J), with distinct geographical distribution, are recognized. In sub-Saharan Africa (sub)-genotypes A1, D3 and E circulate, with E predominating in western Africa (WA), where HBV is hyperendemic. The low genetic diversity of genotype E (HBV/E) suggests its recent emergence. Our aim was to study the dispersal of HBV/E using full-length, non-redundant and non-recombinant sequences available in public databases. HBV/E was confirmed, and the phylogeny reconstruction performed using maximum likelihood (ML) with bootstrapping. Phylogeographic analysis was conducted by reconstruction of ancestral states using the criterion of parsimony on the estimated ML phylogeny. 46.5% of HBV/E sequences were found within monophyletic clusters. Country-wise analysis revealed the existence of 50 regional clusters. Sequences from WA were located close to the root of the tree, indicating this region as the most probable origin of the HBV/E epidemic and expanded to other geographical regions, within and outside of Africa. A localized dispersal was observed with sequences from Nigeria and Guinea as compared to other WA countries. Based on the sequences available in the databases, the phylogenetic results suggest that European strains originated primarily from WA whereas a majority of American strains originated in Western Central Africa. The differences in regional dispersal patterns of HBV/E suggest limited cross-border transmissions because of restricted population movements.	[Ingasia, Luicer Anne Olubayo; Kramvis, Anna] Univ Witwatersrand, Hepatitis Virus Div Res Unit, Dept Internal Med, Sch Clin Med,Fac Hlth Sci, Johannesburg, South Africa; [Kostaki, Evangelia Georgia; Paraskevis, Dimitrios] Natl & Kapodistrian Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece	University of Witwatersrand; Athens Medical School; National & Kapodistrian University of Athens	Kramvis, A (corresponding author), Univ Witwatersrand, Hepatitis Virus Div Res Unit, Dept Internal Med, Sch Clin Med,Fac Hlth Sci, Johannesburg, South Africa.	Anna.Kramvis@wits.ac.za	Kostaki, Evangelia Georgia/AAE-7014-2021	Kostaki, Evangelia Georgia/0000-0002-3346-0930; Olubayo, Luicer Anne Ingasia/0000-0002-7370-7272; Paraskevis, Dimitrios/0000-0001-6167-7152; Kramvis, Anna/0000-0001-6006-3765	National Research Foundation (NRF) of South Africa [65530, 93516]; Deutsche Forschungsgemeinschaft (DFG; English: German Research Foundation); Organization of Women in Science for the Developing World (OWSD) - Swedish International Development Cooperation (SIDA); L'Oreal-UNESCO For Women In Science (FWIS); Poliomyelitis Research Fund (PRF); Hellenic Association for the Study of Liver (HASL)	National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); Deutsche Forschungsgemeinschaft (DFG; English: German Research Foundation)(German Research Foundation (DFG)); Organization of Women in Science for the Developing World (OWSD) - Swedish International Development Cooperation (SIDA); L'Oreal-UNESCO For Women In Science (FWIS); Poliomyelitis Research Fund (PRF); Hellenic Association for the Study of Liver (HASL)	This work was supported by the National Research Foundation (NRF) of South Africa [https://www.nrf.ac.za/](grant numbers: UGN #65530 and GUN #93516) and Deutsche Forschungsgemeinschaft (DFG; English: German Research Foundation) [https://www.dfg.de/en/] awarded to A.K.. L.A.O.I. received a Doctoral Research fellowship grant from the Organization of Women in Science for the Developing World (OWSD) [https://owsd.net/] funded by the Swedish International Development Cooperation (SIDA) [https://www.sida.se/English/], and bursaries from the L'Oreal-UNESCO For Women In Science (FWIS)[https://www.forwomeninscience.com/en/home] and the Poliomyelitis Research Fund (PRF) [https://www.prf.ac.za/].E.G.K.received a travel grant provided by the Hellenic Association for the Study of Liver (HASL) to present part of this work at the International Liver Congress-EASL meeting held in Vienna, Austria in April 2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0; Andernach IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081690; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; [Anonymous], 2018, MODERN CASTING, V108, P13; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2012, VET ORIENTATION, V4, P74; [Anonymous], 2016, CANC DISCOV; Bell TG, 2016, STUDY HEPATITIS B VI; Bell TG, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3312-0; Caballero A, 2018, ANTIVIR RES, V158, P34, DOI 10.1016/j.antiviral.2018.07.019; Chen CH, 2005, J CLIN MICROBIOL, V43, P6000, DOI 10.1128/JCM.43.12.6000-6006.2005; Chu CJ, 2003, GASTROENTEROLOGY, V125, P444, DOI 10.1016/S0016-5085(03)00895-3; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Drucker E, 2001, LANCET, V358, P1989, DOI 10.1016/S0140-6736(01)06967-7; EDMUNDS WJ, 1993, P ROY SOC B-BIOL SCI, V253, P197, DOI 10.1098/rspb.1993.0102; ESRI, 2016, ARCGIS; Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; GALL D, 1954, ANN TROP MED PARASIT, V48, P242, DOI 10.1080/00034983.1954.11685622; Hayer J, 2013, HEPATITIS B VIRUS DA; Isiugo-Abanihe U C, 2006, Afr J Med Med Sci, V35 Suppl, P45; Jayaraman S, 2010, TRANSFUSION, V50, P433, DOI 10.1111/j.1537-2995.2009.002402.x; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kato H, 2004, J MED VIROL, V73, P516, DOI 10.1002/jmv.20120; KIDDLJUNGGREN K, 1994, J GEN VIROL, V75, P1485, DOI 10.1099/0022-1317-75-6-1485; Kramvis A, 2005, J MED VIROL, V77, P47, DOI 10.1002/jmv.20412; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2018, SAMJ, S. Afr. med. j., V108, P17, DOI [10.7196/samj.2018.v108i8.13495, 10.7196/SAMJ.2018.v108i8b.13495]; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kramvis A, 2016, REV MED VIROL, V26, P285, DOI 10.1002/rmv.1885; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105317; Liaw YF, 2010, ANTIVIR THER, V15, P25, DOI 10.3851/IMP1621; Liu HF, 2001, J PEDIATR GASTR NUTR, V32, P274, DOI 10.1097/00005176-200103000-00008; Locarnini S, 2013, SEMIN CANCER BIOL, V23, P561, DOI 10.1016/j.semcancer.2013.08.006; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MacLachlan JH, 2015, LANCET, V386, P1515, DOI 10.1016/S0140-6736(15)61116-3; Maddison W, 2019, MESQUITE 3 61 MODULA; Mahgoub S, 2011, J CLIN MICROBIOL, V49, P298, DOI 10.1128/JCM.00867-10; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; NORDER H, 1992, J GEN VIROL, V73, P1201, DOI 10.1099/0022-1317-73-5-1201; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079; Penny S. A., 2013, BMC CANC, V13, P1471; Rambaut A., 2016, FIGTREE V1 4 3 PROGR; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Schillie S MT, 2013, CDC GUIDANCE EVALUAT; SHAPIRO CN, 1989, PEDIATR INFECT DIS J, V8, P870, DOI 10.1097/00006454-198912000-00009; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; Singh J, 2009, INTERVIROLOGY, V52, P235, DOI 10.1159/000227279; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Uwaezuoke SN, 2007, J TROP PEDIATRICS, V53, P62, DOI 10.1093/tropej/fml081; van Steenbergen JE, 2002, J MED VIROL, V66, P159, DOI 10.1002/jmv.2125; Velkov S, 2018, GENES-BASEL, V9, DOI 10.3390/genes9100495; WHO, 2017, GLOBAL HEPATITS REPO; WHO, GLOBAL BURDEN DIS CL; WHO, 2020, HEPATITIS B FACT SHE; WHO, 2017, GUIDELINES HEPATITIS; Wiktor SZ, 2016, LANCET, V388, P1030, DOI 10.1016/S0140-6736(16)31018-2; Wilkinson E, 2015, SCI REP-UK, V5, DOI 10.1038/srep16897; World Health Organization (WHO), GLOB HLTH SECT STRAT; World Health Organization (WHO), 2013, GLOBAL POLICY REPORT; Yeung L T, 2001, Paediatr Child Health, V6, P655	73	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240375	10.1371/journal.pone.0240375	http://dx.doi.org/10.1371/journal.pone.0240375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031453	gold, Green Published			2022-12-26	WOS:000581809800034
J	Zhang, JQ; Bosbach, B; Loo, JK; Vitiello, GA; Zeng, S; Seifert, AM; Medina, BD; Param, NJ; Maltbaek, JH; Rossi, F; Antonescu, CR; Besmer, P; DeMatteo, RP				Zhang, Jennifer Q.; Bosbach, Benedikt; Loo, Jennifer K.; Vitiello, Gerardo A.; Zeng, Shan; Seifert, Adrian M.; Medina, Benjamin D.; Param, Nesteene J.; Maltbaek, Joanna H.; Rossi, Ferdinand; Antonescu, Cristina R.; Besmer, Peter; DeMatteo, Ronald P.			The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor	ONCOGENE			English	Article							C-KIT; IMATINIB MESYLATE; SIGNAL-TRANSDUCTION; INTERSTITIAL-CELLS; TARGETED MUTATION; DRUG-RESISTANCE; TYROSINE KINASE; INHIBITION; MECHANISMS; EFFICACY	Gastrointestinal stromal tumor (GIST) is the most common human sarcoma and arises in the gastrointestinal tract. Most GISTs are caused by activating mutations in the KIT receptor tyrosine kinase, such as the exon 11KITV559 Delta mutation. The small molecule imatinib inhibits KIT and has been a mainstay of therapy in GIST. Unfortunately, imatinib-treated patients typically relapse, most often due to clonal emergence of the resistance-associatedKITV654A mutation. To determine the biologic impact of this second-site mutation in vivo, we created a mouse model with the corresponding V558 Delta;V653AKitdouble mutation restricted (a) spatially to ETV1(+)cells, which include the interstitial cells of Cajal (ICCs) from which GISTs presumably originate, and (b) temporally through tamoxifen treatment after birth. This resulted in the first in vivo model of the most common second-site mutation associated with imatinib resistance in GIST and the first in vivo demonstration that cell-autonomous expression of mutant KIT in the ICC lineage leads to GIST. GISTs driven by the V558 Delta;V653AKitdouble mutation were resistant to imatinib, while cabozantinib was more effective in overcoming resistance than sunitinib. Compared to control mice with a single V558 Delta Kitmutation, mice with a double V558 Delta; V653AKitmutation had increased tumor oncogenesis and associated KIT-dependent STAT activation. Our findings demonstrate that the biologic consequences of a second-site mutation in an oncogenic driver may include not only a mechanism for drug resistance, but changes in tumor oncogenic potential and differential activation of signaling pathways.	[Zhang, Jennifer Q.; Loo, Jennifer K.; Vitiello, Gerardo A.; Zeng, Shan; Seifert, Adrian M.; Medina, Benjamin D.; Param, Nesteene J.; Maltbaek, Joanna H.; Rossi, Ferdinand; DeMatteo, Ronald P.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Bosbach, Benedikt; Besmer, Peter] Mem Sloan Kettering Canc Ctr, Dev Biol, New York, NY 10021 USA; [Bosbach, Benedikt] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Rossi, Ferdinand; DeMatteo, Ronald P.] Hosp Univ Penn, Dept Surg, 3400 Spruce St, Philadelphia, PA 19104 USA; [Antonescu, Cristina R.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center	DeMatteo, RP (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA.; DeMatteo, RP (corresponding author), Hosp Univ Penn, Dept Surg, 3400 Spruce St, Philadelphia, PA 19104 USA.	ronald.dematteo@pennmedicine.upenn.edu	Seifert, Adrian M./AAL-3453-2021	Seifert, Adrian M./0000-0002-5329-3164; Maltbaek, Joanna/0000-0003-3225-1843; Vitiello, Gerardo/0000-0002-7452-8903	NIH [R01 CA102613, T32 CA09501]; GIST Cancer Research Fund; Starr Cancer Consortium; Cancer Center Support Grant [P30 CA008748];  [F32 CA186534];  [P50 CA140146-01];  [R01 HL55748];  [CA102774]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GIST Cancer Research Fund; Starr Cancer Consortium; Cancer Center Support Grant; ; ; ; 	The investigators were supported by NIH grants R01 CA102613 and T32 CA09501, and Betsy Levine-Brown and Marc Brown (RPD); GIST Cancer Research Fund (RPD and CRA); F32 CA186534 (JQZ); P50 CA140146-01 and the Starr Cancer Consortium (CRA and PB); and R01 HL55748 and CA102774 (PB). The Flow Cytometry and Molecular Cytology Core Facilities were supported by Cancer Center Support Grant P30 CA008748.	Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Bahlawane C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0096-8; Balachandran VP, 2011, NAT MED, V17, P1094, DOI 10.1038/nm.2438; Beckett EAH, 2007, DEV DYNAM, V236, P60, DOI 10.1002/dvdy.20929; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Bosbach B, 2017, P NATL ACAD SCI USA, V114, pE8448, DOI 10.1073/pnas.1711449114; Bosbach B, 2012, P NATL ACAD SCI USA, V109, pE2276, DOI 10.1073/pnas.1115240109; Casteran N, 2003, ONCOGENE, V22, P4710, DOI 10.1038/sj.onc.1206587; Cavnar MJ, 2013, J EXP MED, V210, P2873, DOI 10.1084/jem.20130875; Chaix A, 2014, ONCOGENE, V33, P872, DOI 10.1038/onc.2013.12; Chaix A, 2011, J BIOL CHEM, V286, P5956, DOI 10.1074/jbc.M110.182642; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Cohen NA, 2015, CANCER RES, V75, P2061, DOI 10.1158/0008-5472.CAN-14-2564; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Gajiwala KS, 2009, P NATL ACAD SCI USA, V106, P1542, DOI 10.1073/pnas.0812413106; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Guo TH, 2009, CLIN CANCER RES, V15, P6862, DOI 10.1158/1078-0432.CCR-09-1315; Heinrich MC, 2008, J CLIN ONCOL, V26, P5360, DOI 10.1200/JCO.2008.17.4284; Heinrich MC, 2008, J CLIN ONCOL, V26, P5352, DOI 10.1200/JCO.2007.15.7461; Heydt C, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1311-0; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Joensuu H, 2012, ANNU REV MED, V63, P247, DOI 10.1146/annurev-med-043010-091813; Kim TS, 2014, CLIN CANCER RES, V20, P2350, DOI 10.1158/1078-0432.CCR-13-3033; Kluppel M, 1998, DEV DYNAM, V211, P60; Kwon JG, 2009, GASTROENTEROLOGY, V136, P630, DOI 10.1053/j.gastro.2008.10.031; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Miller CL, 1996, EXP HEMATOL, V24, P185; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Prenen H, 2006, CLIN CANCER RES, V12, P2622, DOI 10.1158/1078-0432.CCR-05-2275; Ran LL, 2015, CANCER DISCOV, V5, P304, DOI 10.1158/2159-8290.CD-14-0985; Regales L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000810; Roberts KG, 2007, MOL CANCER THER, V6, P1159, DOI 10.1158/1535-7163.MCT-06-0641; Schoffski P, 2020, EUR J CANCER, V134, P62, DOI 10.1016/j.ejca.2020.04.021; Seifert AM, 2017, CLIN CANCER RES, V23, P454, DOI 10.1158/1078-0432.CCR-16-1163; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Spector MS, 2012, LEUKEMIA, V26, P1422, DOI 10.1038/leu.2011.354; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Tamborini E, 2006, ONCOGENE, V25, P6140, DOI 10.1038/sj.onc.1209639; Torihashi S, 1997, GASTROENTEROLOGY, V112, P144, DOI 10.1016/S0016-5085(97)70229-4; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; YEE NS, 1994, J EXP MED, V179, P1777, DOI 10.1084/jem.179.6.1777; Zhang JQ, 2018, CANCER IMMUNOL RES, V6, P434, DOI 10.1158/2326-6066.CIR-17-0345; Zhao J, 2014, CANCER SCI, V105, P117, DOI 10.1111/cas.12320; Zhu MJ, 2007, ONCOGENE, V26, P6386, DOI 10.1038/sj.onc.1210464	49	4	4	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2020	39	49					7153	7165		10.1038/s41388-020-01489-4	http://dx.doi.org/10.1038/s41388-020-01489-4		OCT 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PB0GA	33024275	Green Accepted			2022-12-26	WOS:000575700700003
J	Castaldo, M; Cavani, A; Segneri, MC; Costanzo, G; Mirisola, C; Marrone, R				Castaldo, Miriam; Cavani, Andrea; Segneri, Maria Concetta; Costanzo, Gianfranco; Mirisola, Concetta; Marrone, Rosalia			Anthropological study on Chagas Disease: Sociocultural construction of illness and embodiment of health barriers in Bolivian migrants in Rome, Italy	PLOS ONE			English	Article							MIGRATION; MANAGEMENT; CHALLENGE; ACCESS; CARE	Introduction Chagas Disease (CD) is endemic in many Latin-American countries, Bolivia in particular. It is now spreading in Italy as a host country for transcontinental migrants and becoming an emerging health problem. This anthropological action-research, as part of a wider medical project on Neglected Tropical Diseases, has the purpose of analyzing the sociocultural construction of CD and its representation in Bolivian people living in Rome as well as barriers, such as the stigma about the illness, to access the National Health Service for those potentially affected. Methods The ethnographic study was carried out from 2016 to 2018 by a medical anthropologist at the National Institute for Health, Migration and Poverty (INMP) on 72 Bolivian migrants (47 women and 25 men) living in Rome. The study was carried out through: a territorial mapping of Bolivian networks and communities aimed at recruiting people, participant observation, and application of semi-structured and unstructured interviews. The interviews were hold in Spanish and proposed to all participants before or during medical examination, or during events organized by the Bolivian community in Rome. The interview consisted of 16 items and covered four macro areas: personal and migration history, health status, access to the Italian National Health Service and knowledge about CD; plus 5 items for those who received a diagnosis of Chagas Disease in Italy. Results The sociocultural construction and the deep stigma about the illness built by participants and their families could hinder both diagnosis and treatment. Institutional barriers also contributed to reduce adherence to screening tests: often, opening hours of the outpatient clinic were incompatible with participants' precarious employments. To guarantee participant's access to public health services and their adherence to the diagnostic protocol, we implemented a profound revision of our cultural and institutional approach to them. Conclusions The analysis evidenced the limitations of the conventional approach applied by the Italian National Health Service to this migrant community, such as the absence of socio-cultural and linguistics competences that can help understanding patients' perception and representation of the illness. The multidisciplinary approach instead-with clinicians using the ethnographic results to adjust their work to the participants' needs-was a successful attempt to ensure therapeutic alliance.	[Castaldo, Miriam; Segneri, Maria Concetta] Natl Inst Hlth Migrat & Poverty INMP, Med Anthropol Unit, Dept Mental Hlth, Rome, Italy; [Cavani, Andrea] Natl Inst Hlth Migrat & Poverty NIHMP, Sci Coordinat Unit, Rome, Italy; [Costanzo, Gianfranco] Natl Inst Hlth Migrat & Poverty INMP, Med Directorate, Rome, Italy; [Mirisola, Concetta] Natl Inst Hlth Migrat & Poverty INMP, INMP Directorate, Rome, Italy; [Marrone, Rosalia] Natl Inst Hlth Migrat & Poverty INMP, Multispecialty & Med Profess Dept, Rome, Italy		Castaldo, M (corresponding author), Natl Inst Hlth Migrat & Poverty INMP, Med Anthropol Unit, Dept Mental Hlth, Rome, Italy.	miriam.castaldo@inmp.it		Castaldo, Miriam/0000-0003-3267-0765	Italian Ministry of Health [CUP: J82I15000890005]	Italian Ministry of Health(Ministry of Health, Italy)	The current manuscript is part of the project "Strengthening the fight against neglected Tropical Diseases in the migrant population through the use of medical devices" which was carried out with the financial support of the Italian Ministry of Health (CUP: J82I15000890005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albajar-Vinas P, 2011, EUROSURVEILLANCE, V16, P19975, DOI DOI 10.2807/ESE.16.38.19975-EN; Angheben A, 2011, EUROSURVEILLANCE, V16, P2; [Anonymous], 2019, LANCET, V394, P1592, DOI 10.1016/S0140-6736(19)32670-4; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; [Anonymous], 2009, J GRAD MED ED, V1, P5; Antinori S, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.03.017; Antinori S, 2019, PANMINERVA MED, V61, P464, DOI 10.23736/S0031-0808.19.03723-6; Avaria A, 2008, ENFERM EMERG, V10, P40; Barona-Vilar C, 2012, EPIDEMIOL INFECT, V140, P1896, DOI 10.1017/S0950268811002482; Barrett R, 1998, ANNU REV ANTHROPOL, V27, P247, DOI 10.1146/annurev.anthro.27.1.247; Basile L, 2011, EUROSURVEILLANCE, V16, P14, DOI 10.2807/ese.16.37.19968-en; Beneduce R, 2008, SOC SCI INFORM, V47, P505, DOI 10.1177/0539018408096444; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Briceno-Leon R, 2007, MEM I OSWALDO CRUZ, V102, P109, DOI 10.1590/S0074-02762007005000095; Comelles J. M., 2010, MIGRACIONES Y SALUD; CSORDAS TJ, 1990, ETHOS, V18, P5, DOI 10.1525/eth.1990.18.1.02a00010; Devereux G, 1972, ETHNOPSYCHANALYSE CO; Di Girolamo C, 2016, J IMMIGR MINOR HEALT, V18, P616, DOI 10.1007/s10903-015-0214-0; Eisenberg L., 1981, RELEVANCE SOCIAL SCI, P1; Espinoza N, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002782; Farmer P., 1999, INFECT INEQUALITIES; Forsyth CJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005251; Golini A, 2010, MIGRAZIONI ITALIA PR; Kleinman A., 1981, PATIENTS HEALERS CON; Kleinman A, 1975, HLTH FAMILY; Linneberg MS, 2019, QUAL RES J, V19, P259, DOI 10.1108/QRJ-12-2018-0012; Malmusi D, 2010, SOC SCI MED, V71, P1610, DOI 10.1016/j.socscimed.2010.07.043; Manderson L, 1998, TROP MED INT HEALTH, V3, P1020, DOI 10.1046/j.1365-3156.1998.00334.x; Manne-Goehler J, 2015, AM J TROP MED HYG, V93, P108, DOI 10.4269/ajtmh.14-0826; Martelli G, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.02.024; Monge-Maillo B, 2017, CLIN MICROBIOL INFEC, V23, P290, DOI 10.1016/j.cmi.2017.04.013; Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4; Dias JCP, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/789758; Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540; Riniolo V., 2012, VISIONI LATINOAMERIC, V6, P91; Salm A, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3546-0; Sargent C, 2011, ANNU REV ANTHROPOL, V40, P345, DOI 10.1146/annurev-anthro-081309-145811; Strauss A., 1998, BASICS QUALITATIVE R; Torrico Montano RA, 1972, SALUD PUBLICA COCHAB, V1; Ventura-Garcia L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002410; Weiss MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000237; WHO, CHAG DIS ALS KNOWN A; Willen SS, 2012, SOC SCI MED, V74, P805, DOI 10.1016/j.socscimed.2011.10.041; World Medical Association, 2013, DECL HELS ETH PRINC	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240831	10.1371/journal.pone.0240831	http://dx.doi.org/10.1371/journal.pone.0240831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064748	Green Published, gold			2022-12-26	WOS:000585918300004
J	Conti, A; Dimonte, V; Rizzi, A; Clari, M; Mozzone, S; Garrino, L; Campagna, S; Borraccino, A				Conti, Alessio; Dimonte, Valerio; Rizzi, Antonella; Clari, Marco; Mozzone, Silvia; Garrino, Lorenza; Campagna, Sara; Borraccino, Alberto			Barriers and facilitators of education provided during rehabilitation of people with spinal cord injuries: A qualitative description	PLOS ONE			English	Article							PATIENT EDUCATION; INFORMATION NEEDS; HEALTH; PERCEPTIONS; IMPACT; INDIVIDUALS; INTERVIEWS; DEPRESSION; EXPERIENCE; KNOWLEDGE	Background After a spinal cord injury (SCI), individuals must acquire their maximum level of independence before returning to their previous social and working conditions. The education provided during rehabilitation is one of the basic but complex aspects that influence the health perspectives of people with SCI. Gaining the perspective of SCI survivors experienced barriers and resources to enhance the education process may assist healthcare professionals in understanding this complex aspect of their practice. Through a qualitative descriptive analysis, this study aimed to identify the perceived barriers and facilitators of education provided during the rehabilitation of individuals with SCI. Methods A purposive sample of 22 adults with SCI and at least six months of home experience was recruited. Participants were assigned into four mini focus groups according to their level of independence. The focus groups were audio-recorded, transcribed verbatim, and analysed using a thematic analysis. Results Three themes were identified: the readiness to education, the individual characteristics, and the environmental and social characteristics influencing education. Participants perceived education to be an ongoing process made up of consecutive phases, each of which had to be overcome before participants felt ready to reappraise their health and well-being. This process was affected by individual, environmental, and social factors. Conclusions Education is constantly provided by all members of the rehabilitation team. These must stress the relevance of the contents presented, increase SCI survivors' motivation to set achievable goals, and consider filling the gap that the patients perceive between rehabilitation centres and available community resources. The findings of this study promote the design of structured educational programmes, increasing knowledge, and improve the health perspective of SCI survivors, their families, and providers.	[Conti, Alessio; Dimonte, Valerio; Rizzi, Antonella; Clari, Marco; Garrino, Lorenza; Campagna, Sara; Borraccino, Alberto] Univ Torino, Dept Publ Hlth & Pediat, Turin, Italy; [Mozzone, Silvia] AOU Citta Salute & Sci Hosp Torino, Spinal Unit, Turin, Italy	University of Turin	Conti, A (corresponding author), Univ Torino, Dept Publ Hlth & Pediat, Turin, Italy.	alessio.conti@unito.it	Borraccino, Alberto/C-9013-2012; Campagna, Sara/J-9214-2019	Borraccino, Alberto/0000-0001-8235-8775; Campagna, Sara/0000-0003-2722-1818; Conti, Alessio/0000-0003-4301-8924				Alexander MS, 2009, SPINAL CORD, V47, P36, DOI 10.1038/sc.2008.121; Angel S, 2009, INT J QUAL STUD HEAL, V4, P39, DOI 10.1080/17482620802393492; Bernet M, 2019, REHABIL NURS, V44, P247, DOI 10.1097/rnj.0000000000000175; Bloor M, 2001, FOCUS GROUPS SOCIAL, DOI DOI 10.4135/9781849209175; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burkell JA, 2006, HEALTH INFO LIBR J, V23, P257, DOI 10.1111/j.1471-1842.2006.00686.x; Buscemi V, 2018, DISABIL REHABIL, V40, P577, DOI 10.1080/09638288.2016.1271023; Clifton S, 2014, DISABIL REHABIL, V36, P1823, DOI 10.3109/09638288.2013.872202; Conti A, 2022, DISABIL REHABIL, V44, P991, DOI 10.1080/09638288.2020.1783703; deRoon-Cassini TA, 2009, REHABIL PSYCHOL, V54, P306, DOI 10.1037/a0016545; Evardone M, 2018, J SPINAL CORD MED, V41, P17, DOI 10.1080/10790268.2016.1177269; Fann JR, 2011, ARCH PHYS MED REHAB, V92, P352, DOI 10.1016/j.apmr.2010.05.016; Gontkovsky ST, 2007, DISABIL REHABIL, V29, P1305, DOI 10.1080/09638280600964364; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hammell KW, 2007, SPINAL CORD, V45, P260, DOI 10.1038/sj.sc.3102034; Hoffman J, 2011, J SPINAL CORD MED, V34, P404, DOI 10.1179/2045772311Y.0000000015; Hoffman JM, 2011, ARCH PHYS MED REHAB, V92, P411, DOI 10.1016/j.apmr.2010.10.036; Irgens I, 2018, SPINAL CORD, V56, P643, DOI 10.1038/s41393-017-0033-3; Jeyathevan G, 2020, DISABIL REHABIL, V42, P1844, DOI 10.1080/09638288.2018.1541102; Kubler-Ross E., 2014, LIB C CATALOGIN PUBL; Maciejewski PK, 2007, JAMA-J AM MED ASSOC, V297, P716, DOI 10.1001/jama.297.7.716; Manns PJ, 2007, SPINAL CORD, V45, P411, DOI 10.1038/sj.sc.3101973; May L, 2006, DISABIL REHABIL, V28, P405, DOI 10.1080/09638280500192439; May L, 2006, DISABIL REHABIL, V28, P1041, DOI 10.1080/09638280500494744; Milne J, 2005, J WOUND OSTOMY CONT, V32, P413, DOI 10.1097/00152192-200511000-00014; Munce SEP, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-48; Neimeyer RA, 2001, MEANING RECONSTRUCTI; Polit DF, 2013, APPRAISING EVIDENCE, V8th; Pollard C, 2007, BRIT J HEALTH PSYCH, V12, P347, DOI 10.1348/135910707X197046; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Rivers CS, 2018, ARCH PHYS MED REHAB, V99, P443, DOI 10.1016/j.apmr.2017.06.012; Roepke AM, 2015, J CONSULT CLIN PSYCH, V83, P129, DOI 10.1037/a0036872; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Savic G, 2017, SPINAL CORD, V55, P891, DOI 10.1038/sc.2017.64; Shepherd JD, 2012, J SPINAL CORD MED, V35, P319, DOI 10.1179/2045772312Y.0000000044; Simpson LA, 2012, J NEUROTRAUM, V29, P1548, DOI 10.1089/neu.2011.2226; Skelton F, 2015, J SPINAL CORD MED, V38, P690, DOI 10.1179/2045772314Y.0000000269; Stewart DW, 2014, FOCUS GROUPS THEORY; Tederko P, 2017, INT J REHABIL RES, V40, P97, DOI 10.1097/MRR.0000000000000215; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van Wyk Kim, 2015, Top Spinal Cord Inj Rehabil, V21, P49, DOI 10.1310/sci2101-49; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	43	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240600	10.1371/journal.pone.0240600	http://dx.doi.org/10.1371/journal.pone.0240600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057362	Green Published, gold			2022-12-26	WOS:000581814700012
J	Elayeh, E; Aleidi, SM; Ya'acoub, R; Haddadin, RN				Elayeh, Eman; Aleidi, Shereen M.; Ya'acoub, Rawan; Haddadin, Randa N.			Before and after case reporting: A comparison of the knowledge, attitude and practices of the Jordanian population towards COVID-19	PLOS ONE			English	Article							SOCIAL MEDIA; INFLUENZA; RESIDENTS	Coronavirus disease- 2019 (COVID-19) is an emerging contagious infectious disease. It is pandemic and has affected more than 21 million people and resulted in more than 750,000 deaths worldwide (; 14/08/20). Our research group initiated a study to ascertain the knowledge, attitude and practices (KAP) of Jordanians toward COVID-19 prior to any initial case report in Jordan. This project was underway when the first Jordanian case was reported. We extended our study to identify how case reporting would alter public KAP towards COVID-19. This cross-sectional study randomly selected and recruited 2104 Jordanian adults. A four-section questionnaire was devised to address the sociodemographic characteristics of the subjects and their KAP toward COVID-19. The mean knowledge score for the study population was 15.9 +/- 2.2 (out of the 20 knowledge questions), with 60.9% of the participants having good knowledge about COVID-19. Participants' practices to prevent transmission of COVID-19 were adequate in more than 60% of participants. Most participants had positive attitudes regarding their role in preventing COVID-19 and many of the participants' attitudes and practices changed to more appropriate ones after reporting the first case of COVID-19 in Jordan. The percentage of participants who trust the government in confronting COVID-19 increased significantly (p value < 0.001). However, one alarming and unexpected finding was that the prevention practice score of participants working in the medical field was similar to those from the general population. This may necessitate stricter training and guidelines for this group who will be in the frontline in combating the disease. Impact of this study: The data generated from this study shows that when cases of disease were reported, the public's attitudes and practices improved in many aspects, and that confidence in the government to contain the disease was boosted. We believe that this study is important in allowing other, international governments to develop an understanding of public KAP during pandemic disease outbreaks.	[Elayeh, Eman; Aleidi, Shereen M.; Ya'acoub, Rawan] Univ Jordan, Sch Pharm, Dept Biopharmaceut & Clin Pharm, Amman, Jordan; [Haddadin, Randa N.] Univ Jordan, Dept Pharmaceut & Pharmaceut Technol, Sch Pharm, Amman, Jordan	University of Jordan; University of Jordan	Haddadin, RN (corresponding author), Univ Jordan, Dept Pharmaceut & Pharmaceut Technol, Sch Pharm, Amman, Jordan.	r_haddadin@ju.edu.jo	Haddadin, Randa Nayef/G-9401-2018; Elayeh, Eman/C-2946-2015	Haddadin, Randa Nayef/0000-0002-1214-0129; Elayeh, Eman/0000-0002-9406-1597				ABABNEH M, 2020, AM J KIDNEY DIS, V76, P2252; Abu-rish EY, 2016, FAM PRACT, V33, P690, DOI 10.1093/fampra/cmw086; Al Sharif O, 2020, AL MONITOR      0323; Al-Hazmi A, 2018, SAUDI J BIOL SCI, V25, P572, DOI 10.1016/j.sjbs.2016.01.032; Albarrak AI, 2019, J INFECT PUBLIC HEAL, DOI [10.1016/j.jiph.2019.06.029, DOI 10.1016/J.JIPH.2019.06.02931431424]; Alhaddad MS, 2018, SAUDI PHARM J, V26, P1106, DOI 10.1016/j.jsps.2018.05.021; [Anonymous], 2020, WHO SAYS PEOPL REC P; [Anonymous], 2020, ROYA NEWS       0314; Assaf AM, 2016, VIRAL IMMUNOL, V29, P516, DOI 10.1089/vim.2015.0135; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Brady JT, 2017, CLIN COLON RECT SURG, V30, P270, DOI 10.1055/s-0037-1604256; Brouard C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-576; Centers for Disease Control and Prevention, 2020, CENT DIS CONTROL PRE; Cheng ZKJ, 2020, INFECTION, V48, P155, DOI 10.1007/s15010-020-01401-y; Department of Statistics-Jordan Government, 2020, TABL 2 EST POP KINGD; Higher Health Council & World Health Organization, 2015, JORD NAT HLTH SECT S; Kreiger L, 2020, LOS ANGELES DAILY NE; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lee BY, 2020, FORBES; Lee K, 2009, GLOB INST, P1; Lenthang M, 2020, MAIL ONLINE; Li Q, 2020, N ENGL J MED MASSACH, DOI [10.1056/nejmoa2001316, DOI 10.1056/NEJM0A200131631995857]; Lino M, 2012, EUR J PUBLIC HEALTH, V22, P568, DOI 10.1093/eurpub/ckr115; Loeb S, 2020, EUR UROL FOCUS, V6, P437, DOI 10.1016/j.euf.2019.11.011; McCreary EK, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofz538; Mooney Chris, 2020, WASHINGTON POST; Nazer LH, 2017, CAN J HOSP PHARM, V70, P150; NIH/National Institute of Allergy and Infectious Diseases, 2020, SCI DAILY; Olaimat AN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00254; Parker C., 2020, SNOWBALL SAMPLING; Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1; Roya News, 2020, ROYA NEWS       0313; Roya News, 2020, ROYA NEWS       0310; Sharaydih R, 2020, INT J PHARM PRACT, V28, P84, DOI 10.1111/ijpp.12582; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; The Jordan Times, 2020, JORDAN TIMES    0316; Thurman N, 2009, JOURNALISM STUD, V10, P691, DOI 10.1080/14616700902812959; van Griethuijsen RALF, 2015, RES SCI EDUC, V45, P581, DOI 10.1007/s11165-014-9438-6; WHO, 2020, WHO COR COVID 19 DAS; WHO, 2020, Q A COVID 19 OLD PEO; WHO, 2020, EV THEY HAPP ROLL UP; WHO, 2020, 72 WHO; World Bank, 2018, REF POP COUNTR TERR; World Health Organization, 2020, 43 WHO; World Health Organization, 2020, DRAFT LANDSC COVID 1; Xiao S, 2018, INDOOR AIR, V28, P51, DOI 10.1111/ina.12430; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zucco R, 2018, INT J MED INFORM, V111, P131, DOI 10.1016/j.ijmedinf.2017.12.005	50	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2020	15	10							e0240780	10.1371/journal.pone.0240780	http://dx.doi.org/10.1371/journal.pone.0240780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3UY	33057382	Green Published, gold			2022-12-26	WOS:000581814700029
J	Jimenez, S; Rotger, L; Aguirre, C; Munoz, A; Granados, S; Tornero, J				Jimenez, Salvador; Rotger, Laura; Aguirre, Carlos; Munoz, Alberto; Granados, Sergio; Tornero, Jesus			Prefiltering based on experimental paradigm for analysis of fMRI complex brain networks	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; SMALL-WORLD	Brain networks offers a new insight about connections between function and anatomical regions of human brain. We present results from brain networks built from functional magnetic resonance images during finger tapping paradigm. Pearson voxel-voxel correlation in time and frequency domains were performed for all subjects. Besides this standard framework we have implemented a new approach consisting in filtering the data with respect to the fMRI paradigm (finger tapping) in order to obtain a better understanding of the network involved in the execution of the task. The main topological graph measures have been compared in both cases: voxel-voxel correlation and voxel-paradigm filtering plus voxel-voxel correlation. With the standard voxel-voxel correlation a clearly free-scale network was obtained. On the other hand, when we prefiltered the paradigm we obtained two different kind of networks: 1) free-scale; 2) random-like. To our best knowledge, this behaviour is reported here for first time for brain networks. We suggest that paradigm signal prefiltering can provide more infomation about the brain networks.	[Jimenez, Salvador] Univ Politecn Madrid, ETSI Telecomunicac, Dept Matemat Aplicada TIC, Madrid, Spain; [Aguirre, Carlos] Univ Autonoma Madrid, EPS, GNB, Madrid, Spain; [Rotger, Laura; Munoz, Alberto] Univ Complutense Madrid, Dept Radiol, Madrid, Spain; [Granados, Sergio; Tornero, Jesus] Hosp Los Madronos, Unidad Diagnost Imagen, Madrid, Spain	Universidad Politecnica de Madrid; Autonomous University of Madrid; Complutense University of Madrid	Jimenez, S (corresponding author), Univ Politecn Madrid, ETSI Telecomunicac, Dept Matemat Aplicada TIC, Madrid, Spain.; Tornero, J (corresponding author), Hosp Los Madronos, Unidad Diagnost Imagen, Madrid, Spain.	s.jimenez@upm.es; jesus.tornero@lmh.es	Jiménez, Salvador/ABH-2189-2020	Jiménez, Salvador/0000-0001-5265-7360; Tornero, Jesus/0000-0001-6116-6256	MINECO/FEDER [PGC2018-095895-B-I00]; Ministerio de Asuntos Economicos y Transformacion Digital; MINECO [MTM201567396-P]	MINECO/FEDER(Spanish Government); Ministerio de Asuntos Economicos y Transformacion Digital; MINECO(Spanish Government)	CA is supported by MINECO/FEDER, under grant PGC2018-095895-B-I00. Ministerio de Asuntos Economicos y Transformacion Digital. https:\\www.mineco.gob.es.SJ is partially supported by MINECO under grant MTM201567396-P. Ministerio de Asuntos Economicos y Transformacion Digital. https:\\www.mineco.gob.es.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asllani M, 2020, NEW J PHYS, V22, DOI 10.1088/1367-2630/ab8ef9; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Benesyt J., 2009, PEARSON CORRELATION; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fornito A., 2016, FUNDEMENTALS BRAIN N; GRAY RM, 1990, ENTROPY INFORM THEOR; Guan JJ, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.022318; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; James Jija S, 2014, Indian J Radiol Imaging, V24, P13, DOI 10.4103/0971-3026.130686; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li Weitao, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P477; Lindquist MA, 2014, NEUROIMAGE, V101, P531, DOI 10.1016/j.neuroimage.2014.06.052; Liu X, 2013, P NATL ACAD SCI USA, V110, P4392, DOI 10.1073/pnas.1216856110; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ou X, 2016, AM J NEURORADIOL, V37, P713, DOI 10.3174/ajnr.A4593; Panaggio MJ, 2019, CHAOS, V29, DOI 10.1063/1.5120784; Preti MG, 2017, NEUROIMAGE, V160, P41, DOI 10.1016/j.neuroimage.2016.12.061; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Swanson L.W, 2005, BRAIN ARCHITECTURE; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2020	15	10							e0238994	10.1371/journal.pone.0238994	http://dx.doi.org/10.1371/journal.pone.0238994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3XB	33052938	Green Published, gold			2022-12-26	WOS:000581820200013
J	Cui, R; Li, FD; Shao, J; Wang, YZ; Yue, C; Zheng, YH; Li, XM				Cui, Rui; Li, Fangda; Shao, Jiang; Wang, Yuzhu; Yue, Cai; Zheng, Yuehong; Li, Xuemei			Postoperative anemia is a risk factor for acute kidney injury after open aorta and vena cava surgeries	PLOS ONE			English	Article							ANEURYSM REPAIR; RENAL-FUNCTION; DISEASE; PREDICTORS; MORTALITY	Open aorta and vena cava surgeries are usually associated with substantial blood loss which may result in postoperative acute kidney injury (AKI). The present study is designed to investigate the prevalence, outcome and risk factors of postoperative AKI associated with open aorta and vena cava surgeries, with a focus on the role of anemia in these conditions. A retrospective review of medical records of Peking Union Medical College Hospital was conducted. Patients who underwent open aorta and vena cava surgeries during January 1, 2010 and June 30, 2014 were included in this study. The primary analysis was between patients underwent open aorta and vena cava surgeryies, with or without postoperative AKI. Multivariable logistic regression models were used to determine risk factors of postoperative AKI. The study included 79 patients (63.3% male) with a mean age of 52.5 +/- 17.3 years (range, 17-81 years). Postoperative AKI occurred in 23/79 (29.1%) of the patients. Anemia was present in 11/79 (16%) at baseline, and increased to 45/79 (52%) postoperatively. After adjustment for various risk factors, postoperative anemia (OR, 5.202; 95% CI 1.403-19.285) was independently associated with postoperative AKI. AKI is a common complication in patients who undergo open aorta and vena cava surgeries, and postoperative anemia was the most relevant predictive factor of AKI. Strategies to minimize bleeding and anemia for all patients may be advisable. Further studies are needed to assess the impact of AKI on long term outcome and to examine preventive strategies to address potentially modifiable risk factors.	[Cui, Rui; Yue, Cai; Li, Xuemei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nephrol, Beijing, Peoples R China; [Cui, Rui; Wang, Yuzhu] Beijing Haidian Hosp, Dept Nephrol, Beijing, Peoples R China; [Cui, Rui; Wang, Yuzhu] Peking Univ Third Hosp, Beijing Haidian Sect, Beijing, Peoples R China; [Li, Fangda; Shao, Jiang; Zheng, Yuehong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Vasc Surg, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Yue, C (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nephrol, Beijing, Peoples R China.; Zheng, YH (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Vasc Surg, Beijing, Peoples R China.	yuesi@pumch.cn; yuehongzheng@yahoo.com			Development of Medical Scientific Research Fund of the Capital [2011-4001-08]; National Key Technology Support Program [20llBAll0802, 2012BAJl8803]	Development of Medical Scientific Research Fund of the Capital; National Key Technology Support Program(National Key Technology R&D Program)	This study was supported by the Development of Medical Scientific Research Fund of the Capital (2011-4001-08) and the National Key Technology Support Program (20llBAll0802, 2012BAJl8803). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkandari O, 2011, CRIT CARE, V15, DOI 10.1186/cc10269; Bian A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181848; Bravi CA, 2019, EUR UROL, V76, P398, DOI 10.1016/j.eururo.2019.04.040; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Chae MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209164; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coupes Beatrice, 2015, BMC Res Notes, V8, P21, DOI 10.1186/s13104-014-0964-0; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Ghincea CV, 2019, J SURG RES, V242, P40, DOI 10.1016/j.jss.2019.03.055; Guo XZ, 2014, CLIN BIOCHEM, V47, P1220, DOI 10.1016/j.clinbiochem.2014.05.060; Handa Nobuhiro, 2012, Ann Vasc Dis, V5, P172, DOI 10.3400/avd.oa.12.00010; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Karkouti K, 2011, ANESTHESIOLOGY, V115, P523, DOI 10.1097/ALN.0b013e318229a7e8; Kumawat S, 2016, OPT FIBER TECHNOL, V30, P72, DOI 10.1016/j.yofte.2016.03.004; Liu D, 2018, EUR J VASC ENDOVASC, V55, P229, DOI 10.1016/j.ejvs.2017.11.031; McIlroy DR, 2010, CLIN J AM SOC NEPHRO, V5, P211, DOI 10.2215/CJN.04240609; Newland Richard F, 2017, J Extra Corpor Technol, V49, P224; O'Keeffe SD, 2010, J VASC SURG, V51, P616, DOI 10.1016/j.jvs.2009.10.045; Piffaretti G, 2014, ARCH MED SCI, V10, P273, DOI 10.5114/aoms.2014.42579; Piffaretti G, 2012, J VASC SURG, V56, P1527, DOI 10.1016/j.jvs.2012.05.106; Ren HL, 2015, J VASC SURG, V62, P229, DOI 10.1016/j.jvs.2014.04.010; Shema-Didi L, 2016, NEPHROLOGY, V21, P295, DOI 10.1111/nep.12609; Smilowitz NR, 2016, AM J MED, V129, P315, DOI 10.1016/j.amjmed.2015.10.012; Sueyoshi K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211429; van Lammeren GW, 2017, VASCULAR, V25, P234, DOI 10.1177/1708538116665268; Waskowski J, 2019, EUR J VASC ENDOVASC, V58, P130, DOI 10.1016/j.ejvs.2019.02.003; 2014, WEATHER FORECASTING, V0029, P00763	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2020	15	10							e0240243	10.1371/journal.pone.0240243	http://dx.doi.org/10.1371/journal.pone.0240243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3UK	33048948	Green Published, gold			2022-12-26	WOS:000581813300024
J	Keskinocak, P; Oruc, BE; Baxter, A; Asplund, J; Serban, N				Keskinocak, Pinar; Oruc, Buse Eylul; Baxter, Arden; Asplund, John; Serban, Nicoleta			The impact of social distancing on COVID19 spread: State of Georgia case study	PLOS ONE			English	Article							INFLUENZA; STRATEGIES	As the spread of COVID19 in the US continues to grow, local and state officials face difficult decisions about when and how to transition to a "new normal." The goal of this study is to project the number of COVID19 infections and resulting severe outcomes, and the need for hospital capacity under social distancing, particularly, shelter-in-place and voluntary quarantine for the State of Georgia. We developed an agent-based simulation model to project the infection spread. The model utilizes COVID19-specific parameters and data from Georgia on population interactions and demographics. The simulation study covered a seven and a half-month period, testing different social distancing scenarios, including baselines (no-intervention or school closure only) and combinations of shelter-in-place and voluntary quarantine with different timelines and compliance levels. The following outcomes are compared at the state and community levels: the number and percentage of cumulative and daily new symptomatic and asymptomatic infections, hospitalizations, and deaths; COVID19-related demand for hospital beds, ICU beds, and ventilators. The results suggest that shelter-in-place followed by voluntary quarantine reduced peak infections from approximately 180K under no intervention and 113K under school closure, respectively, to below 53K, and delayed the peak from April to July or later. Increasing shelter-in-place duration from four to five weeks yielded 2-9% and 3-11% decrease in cumulative infection and deaths, respectively. Regardless of the shelter-in-place duration, increasing voluntary quarantine compliance decreased daily new infections from almost 53K to 25K, and decreased cumulative infections by about 50%. The cumulative number of deaths ranged from 6,660 to 19,430 under different scenarios. Peak infection date varied across scenarios and counties; on average, increasing shelter-in-place duration delayed the peak day by 6 days. Overall, shelter-in-place followed by voluntary quarantine substantially reduced COVID19 infections, healthcare resource needs, and severe outcomes.	[Keskinocak, Pinar; Oruc, Buse Eylul; Baxter, Arden; Asplund, John; Serban, Nicoleta] Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA; [Keskinocak, Pinar] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Asplund, John] Metron Inc, Reston, VA USA	University System of Georgia; Georgia Institute of Technology; Emory University; Rollins School Public Health	Keskinocak, P (corresponding author), Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA.; Keskinocak, P (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	pinar@isye.gatech.edu		Baxter, Arden/0000-0002-6345-2229; Oruc Aglar, Buse Eylul/0000-0003-2431-3864	William W. George endowment; National Science Foundation Graduate Research Fellowship [DGE-1650044]; NSF [MRI 1828187]	William W. George endowment; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This research was supported in part by the William W. George endowment awarded to PK, the Virginia C. and Joseph C. Mello endowments awarded to NS, and the following benefactors at Georgia Tech: Andrea Laliberte, Joseph C. Mello, Richard "Rick" E. & Charlene Zalesky, and Claudia & Paul Raines. This research was also supported in part by the National Science Foundation Graduate Research Fellowship awarded to AB (DGE-1650044), a NSF grant to support the high performance computing facilities at Georgia Tech, which we used for the computational runs (MRI 1828187), and research cyberinfrastructure resources and services provided by the Partnership for an Advanced Computing Environment (PACE) at Georgia Tech. The funders played no role in the study design, data collection, analysis, interpretation, or in writing the manuscript.	Andrei M, 2020, ICELANDS TESTING SUG; [Anonymous], 2006, PLOS MED, V3, P563, DOI 10.1371/journal.pmed.0030252; [Anonymous], 2020, NY TIMES; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Boyle P, 2020, HERES WHY WE CANT RU; CBS Atlanta, 2020, BREAK COVID 19 GOV; CDC, PEOPL WHO ARE HIGH R; CDC, 2020, COVID 19 PAND PLANN; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Chavez N., 2020, CNN; Chen TM, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00640-3; Day M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1375; Ekici A, 2014, M&SOM-MANUF SERV OP, V16, P11, DOI 10.1287/msom.2013.0460; Ekici A, 2008, 2008 WINTER SIMULATION CONFERENCE, VOLS 1-5, P1592, DOI 10.1109/WSC.2008.4736242; Epicentro Epidemiology for Public Health, 2020, COVID 19 INT SURV KE; Esri, 2020, COVID 19 GIS HUB; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ganyani T, 2020, ESTIMATING GENERATIO, DOI DOI 10.1101/2020.03.05.20031815; Georgia Department of Public Health, 2020, REG HEALTHC COAL 201; Georgia Department of Public Health, 2020, GEORG DEP PUBL HLTH; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Greenblatt Library, 2020, REG MAPS AUG U; Hartley DM, 2020, JAMA-J AM MED ASSOC, V323, P1908, DOI 10.1001/jama.2020.5910; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Lever J, 2017, NAT METHODS, V14, P641, DOI 10.1038/nmeth.4346; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Li ZH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206293; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Maharaj S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-679; Mandavilli A., 2020, NEW YORK TIMES; Mervosh S., 2020, NEW YORK TIMES; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Prem K, 2020, EFFECT CONTROL STRAT, DOI [10.1101/2020.03.09.20033050, DOI 10.1101/2020.03.09.20033050]; Riou J, 2020, ADJUSTED AGE SPECIFI; Shi PY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-778; StreetLight Data Inc, UND IMP COVID 19 TRA; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDCWEEKLY 0214; Towers S, 2012, MATH BIOSCI, V240, P241, DOI 10.1016/j.mbs.2012.07.007; U.S. Census Bureau, CART BOUND FIL SHAP; U.S. Census Bureau, 2017, AM COMM SURV 2017 AM; U.S. Census Bureau, 2010, CENS SUMM FIL 1; U.S. Census Bureau, 2018, AM COMM SURV 2018 AM; U.S. Census Bureau, 2016, CENS TRANSP PLANN PR; Valdez LD, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036108; Walker M, 2020, KEMP ORDERS SCH CLOS; Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035; Weitz Joshua S, 2020, medRxiv, DOI 10.1101/2020.04.01.20049767; WHO, 2020, WHO TIM COVID 19 202; WHO, 2019, REP WHO CHIN JOINT M; WTVC / The Associated Press, 2020, KEMP GEORG BUS ALL R; Xie JF, 2020, INTENS CARE MED, V46, P837, DOI 10.1007/s00134-020-05979-7; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	58	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0239798	10.1371/journal.pone.0239798	http://dx.doi.org/10.1371/journal.pone.0239798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33045008	Green Published, Green Submitted, gold			2022-12-26	WOS:000581811700060
J	Seo, HY; Lee, SH; Lee, JH; Hwang, JS; Kim, MK; Jang, BK				Seo, Hye-Young; Lee, So-Hee; Lee, Ji-Ha; Hwang, Jae Seok; Kim, Mi Kyung; Jang, Byoung Kuk			Kahweol activates the Nrf2/HO-1 pathway by decreasing Keap1 expression independently of p62 and autophagy pathways	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; LIVER-DAMAGE; DEGRADATION; MECHANISMS	Kahweol is a diterpene found in coffee beans and unfiltered coffee drinks. Several studies have demonstrated that kahweol induces the nuclear factor erythroid-2 related factor 2/ hemeoxygenase-1 (Nrf2/HO-1) pathway; however, the mechanisms involved are currently unknown. Kelch-like ECH-associated protein 1 (Keap1) is a major regulator of Nrf2 expression and is degraded mostly by autophagy. The p62 protein enhances binding to Keap1 and contributes to the activation of Nrf2. Here, we examined the role of Keap1 regulation in the effect of kahweol on the Nrf2/HO-1 pathway in hepatocytes. In AML12 cells and primary mouse hepatocytes, kahweol increased the levels of Nrf2 and HO-1 protein without increasing expression of the Nrf2 mRNA. In addition, kahweol reduced Keap1 protein levels significantly without decreasing Keap1 mRNA levels. Although regulation of the Keap1-Nrf2-pathway by p62-dependent autophagy is well known, we confirmed here that the reduction of Keap1 protein levels by kahweol does not involve p62-dependent autophagy degradation or ubiquitination. In conclusion, kahweol increases the expression of Nrf2 in hepatocytes by inhibiting translation of the Keap1 mRNA.	[Seo, Hye-Young; Lee, So-Hee; Lee, Ji-Ha; Hwang, Jae Seok; Kim, Mi Kyung; Jang, Byoung Kuk] Keimyung Univ, Inst Med Sci, Sch Med, Dept Internal Med, Daegu, South Korea	Keimyung University	Kim, MK; Jang, BK (corresponding author), Keimyung Univ, Inst Med Sci, Sch Med, Dept Internal Med, Daegu, South Korea.	mdkmk@dsmc.or.kr; jangha106@dsmc.or.kr		Jang, Byoung Kuk/0000-0002-8950-0866	Keimyung University Dongsan Medical Center	Keimyung University Dongsan Medical Center	This work was supported by the research promoting grant from the Keimyung University Dongsan Medical Center in 2018.	[Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2011, BIOSOCIETIES, V6, P10; Apostolova N, 2011, CURR PHARM DESIGN, V17, P4047, DOI 10.2174/138161211798764924; Arauz J, 2016, ANN HEPATOL, V15, P160, DOI 10.5604/16652681.1193701; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Cardenas C, 2014, BIOCHEM BIOPH RES CO, V447, P452, DOI 10.1016/j.bbrc.2014.04.026; Casas-Grajales Sael, 2015, World J Gastrointest Pharmacol Ther, V6, P59, DOI 10.4292/wjgpt.v6.i3.59; Choi JH, 2019, FOOD CHEM TOXICOL, V125, P1, DOI 10.1016/j.fct.2018.12.038; Choi SY, 2006, B KOREAN CHEM SOC, V27, P1386; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082; Dodson M, 2015, BIOCHEM J, V469, P347, DOI 10.1042/BJ20150568; Furstenau CR, 2019, TOXICOL IN VITRO, V61, DOI 10.1016/j.tiv.2019.104601; Garcia-Ruiz C, 2018, HEPATOL COMMUN, V2, P1425, DOI 10.1002/hep4.1271; Hwang YP, 2008, FEBS LETT, V582, P2655, DOI 10.1016/j.febslet.2008.06.045; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Katsuragi Yoshinori, 2016, Current Opinion in Toxicology, V1, P54, DOI 10.1016/j.cotox.2016.09.005; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lee KJ, 2007, FOOD CHEM TOXICOL, V45, P2118, DOI 10.1016/j.fct.2007.05.010; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; Luangmonkong T, 2018, REV PHYSIOL BIOCH P, V175, P71, DOI 10.1007/112_2018_10; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Raghunath A, 2018, CANCERS, V10, DOI 10.3390/cancers10120481; Ren YQ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174238; Seo HY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070863; Seo HY, 2017, ONCOTARGET, V8, P87086, DOI 10.18632/oncotarget.19756; Shin SM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/763257; Spector A, 2000, J OCUL PHARMACOL TH, V16, P193, DOI 10.1089/jop.2000.16.193; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Tang W, 2014, WORLD J GASTROENTERO, V20, P13079, DOI 10.3748/wjg.v20.i36.13079; Wu KC, 2012, TOXICOL APPL PHARM, V263, P14, DOI 10.1016/j.taap.2012.05.017; Wu KC, 2012, TOXICOL APPL PHARM, V262, P321, DOI 10.1016/j.taap.2012.05.010; Xu DW, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01428	36	7	7	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2020	15	10							e0240478	10.1371/journal.pone.0240478	http://dx.doi.org/10.1371/journal.pone.0240478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TU	33044988	Green Published, gold			2022-12-26	WOS:000581811700008
J	Kim, TH; Park, DE; Chon, HK				Kim, Tae Hyeon; Park, Dong Eun; Chon, Hyung Ku			Endoscopic transpapillary gallbladder drainage for the management of acute calculus cholecystitis patients unfit for urgent cholecystectomy	PLOS ONE			English	Article							2018 DIAGNOSTIC-CRITERIA; PERCUTANEOUS CHOLECYSTOSTOMY; METAL STENT; OUTCOMES; PLACEMENT	Objectives Endoscopic transpapillary gallbladder drainage (ETGBD) has been proposed as an alternative to surgery or percutaneous cholecystostomy in patients with acute calculus cholecystitis (ACC). We aimed to evaluate the safety and efficacy of ETGBD via endoscopic transpapillary gallbladder stenting (ETGBS) or endoscopic naso-gallbladder drainage (ENGBD) as either a bridging or a definitive treatment option for patients with ACC when a cholecystectomy is delayed or cannot be performed. Methods From July 2014 to December 2018, 171 patients with ACC in whom ETGBD were attempted were retrospectively reviewed. The technical and clinical success rates and adverse events were evaluated. Moreover, the predictive factors for technical success and the stent patency in the ETGBS group with high surgical risk were examined. Results The technical and clinical success rates by intention-to-treat analysis for ETGBD were 90.6% (155/171) and 90.1% (154/171), respectively. Visible cystic duct on cholangiography were significant technical success predictor (adjusted odds ratio: 7.099, 95% confidence interval: 1.983-25.407,P= 0.003) as per logistic regression analysis. Adverse events occurred in 12.2% of patients (21/171: mild pancreatitis, n = 9; acute cholangitis, n = 6; post-endoscopic sphincterotomy bleeding, n = 4; and stent migration, n = 1; ACC recurrence, n = 1), but all patients were treated with conservative management and endoscopic treatment. Among the ETGBS group, the median stent patency in 70 patients with high surgical risk was 503 days (interquartile range: 404.25-775 days). Conclusions ETGBD, using either ETGBS or ENGBD, may be a suitable bridging option for ACC patients unfit for urgent cholecystectomy. In high surgical risk patients, ETGBS may be a promising and useful treatment modality with low ACC recurrence.	[Kim, Tae Hyeon; Chon, Hyung Ku] Wonkwang Univ, Coll Med & Hosp, Dept Internal Med, Iksan, South Korea; [Park, Dong Eun] Wonkwang Univ, Coll Med & Hosp, Dept Surg, Iksan, South Korea	Wonkwang University; Wonkwang University	Chon, HK (corresponding author), Wonkwang Univ, Coll Med & Hosp, Dept Internal Med, Iksan, South Korea.	gipb2592@wku.ac.kr	Chon, Hyung ku/AGO-1334-2022		Wonkwang University	Wonkwang University	This report was supported by the Wonkwang University 2020.	[Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Banz V, 2011, ANN SURG, V254, P964, DOI 10.1097/SLA.0b013e318228d31c; Baron TH, 2007, GASTROINTEST ENDOSC, V65, P735, DOI 10.1016/j.gie.2006.07.041; Brunt LM, 2001, SURG ENDOSC-ULTRAS, V15, P700, DOI 10.1007/s004640000388; Chen YI, 2018, GASTROINTEST ENDOSC, V88, P267, DOI 10.1016/j.gie.2018.03.021; Choi JH, 2014, ENDOSCOPY, V46, P656, DOI 10.1055/s-0034-1365720; Corral JE, 2019, SURG ENDOSC, V33, P3567, DOI 10.1007/s00464-019-07026-z; de la Serna-Higuera C, 2013, GASTROINTEST ENDOSC, V77, P303, DOI 10.1016/j.gie.2012.09.021; FERETIS CB, 1990, GASTROINTEST ENDOSC, V36, P523, DOI 10.1016/S0016-5107(90)71134-0; Fugazza A, 2020, CLIN EXP GASTROENTER, V13, P193, DOI 10.2147/CEG.S203626; Gurusamy KS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005440.pub3; Higa JT, 2019, GASTROINTEST ENDOSC, V90, P483, DOI 10.1016/j.gie.2019.04.238; Itoi T, 2011, J HEPATO-BIL-PAN SCI, V18, P282, DOI 10.1007/s00534-010-0310-4; Itoi T, 2010, GASTROINTEST ENDOSC, V71, P1038, DOI 10.1016/j.gie.2010.01.026; Jain D, 2018, CLIN ENDOSC, V51, P450, DOI 10.5946/ce.2018.024; Jang JW, 2011, GASTROINTEST ENDOSC, V74, P176, DOI 10.1016/j.gie.2011.03.1120; Katabathina VS, 2015, TECH VASC INTERV RAD, V18, P256, DOI 10.1053/j.tvir.2015.07.009; Kaura K, 2020, HPB, V22, P996, DOI 10.1016/j.hpb.2019.10.1530; Kiriyama S, 2018, J HEPATO-BIL-PAN SCI, V25, P17, DOI 10.1002/jhbp.512; Kjaer DW, 2007, ENDOSCOPY, V39, P304, DOI 10.1055/s-2007-966335; Kwon CI, 2016, CLIN ENDOSC, V49, P139, DOI 10.5946/ce.2016.024; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Lee TH, 2011, ENDOSCOPY, V43, P702, DOI 10.1055/s-0030-1256226; Maekawa Satoshi, 2014, Journal of UOEH, V36, P265; Maekawa S, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-65; McGillicuddy EA, 2012, BRIT J SURG, V99, P1254, DOI 10.1002/bjs.8836; Miura F, 2018, J HEPATO-BIL-PAN SCI, V25, P31, DOI 10.1002/jhbp.509; Mori Y, 2018, J HEPATO-BIL-PAN SCI, V25, P87, DOI 10.1002/jhbp.504; Oh D, 2019, GASTROINTEST ENDOSC, V89, P289, DOI 10.1016/j.gie.2018.08.052; Pessaux P, 2001, SURG LAPARO ENDO PER, V11, P252, DOI 10.1097/00129689-200108000-00005; Sanjay P, 2013, HPB, V15, P511, DOI 10.1111/j.1477-2574.2012.00610.x; Schlenker C, 2006, AM J GASTROENTEROL, V101, P278, DOI 10.1111/j.1572-0241.2006.00403.x; Shrestha R, 1999, LIVER TRANSPLANT SUR, V5, P275, DOI 10.1002/lt.500050402; The Lancet Global Health, 2018, LANCET GLOB HEALTH, V6, pE593; Walter D, 2016, GUT, V65, P6, DOI 10.1136/gutjnl-2015-309925; Yang MJ, 2016, SCAND J GASTROENTERO, V51, P472, DOI 10.3109/00365521.2015.1115116; Yeo CSW, 2016, J HEPATO-BIL-PAN SCI, V23, P65, DOI 10.1002/jhbp.304; Yokoe M, 2018, J HEPATO-BIL-PAN SCI, V25, P41, DOI 10.1002/jhbp.515	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240219	10.1371/journal.pone.0240219	http://dx.doi.org/10.1371/journal.pone.0240219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035230	gold, Green Published			2022-12-26	WOS:000581817500054
J	Kurek, K; Gewartowska, O; Tolkacz, K; Jedrzejewska, B; Myslajek, RW				Kurek, Korneliusz; Gewartowska, Olga; Tolkacz, Katarzyna; Jedrzejewska, Bogumila; Myslajek, Robert W.			Home range size, habitat selection and roost use by the whiskered bat (Myotis mystacinus) in human-dominated montane landscapes	PLOS ONE			English	Article							BEHAVIOR; ECOLOGY; MOUNTAINS; FIDELITY; FORESTS; FEMALE; POLAND; APART; FOOD; KUHL	Our understanding of animal adaptations to human pressure is limited by the focus on rare taxa, despite that common species are more significant in shaping structure, function and service provision of ecosystems. Thus better understanding of their ecology and behavioural adjustments is central for drafting conservation actions. In this study, we used radio-telemetry on 21 individuals (10 females, 11 males) to provide data on spatial ecology, habitat selection and use of roosts of one of the commonest species, the whiskered bat (Myotis mystacinus), inhabiting the Carpathian Mountains (southern Poland). We tested, whether this species prefers natural over human-modified landscapes to seek prey and roosts. Mean home range size of the whiskered bat in the Carpathian Mountains was 26.3 ha (SE +/- 3.2, Local Convex Hull) and 110 ha (SE +/- 22.1, Minimum Convex Polygon with all locations), and included between one and three patches, among which bats moved along linear environmental features, such as scrubby banks of streams or lines of trees. During foraging whiskered bats selected small woodlands within agricultural landscapes, avoided large mountain forests and open areas, and used built-up areas proportionally to their availability. Whiskered bats occupied roosts located mainly in buildings (>97%), at an average altitude of 547.9 m above sea level (SE +/- 8.3). Roosts were used for 5.4 days, on average. Our study shows that whiskered bats adapted well to the mosaic of semi-natural and anthropogenic habitats. It highlights the importance of buildings serving as roosts and small woodlands used as foraging areas in human-dominated montane landscapes.	[Kurek, Korneliusz; Gewartowska, Olga; Myslajek, Robert W.] Univ Warsaw, Fac Biol, Biol & Chem Res Ctr, Inst Funct Biol & Ecol,Dept Ecol, Warsaw, Poland; [Tolkacz, Katarzyna] Polish Acad Sci, Inst Biochem & Biophys, Dept Antarctic Biol, Warsaw, Poland; [Jedrzejewska, Bogumila] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland	University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences	Myslajek, RW (corresponding author), Univ Warsaw, Fac Biol, Biol & Chem Res Ctr, Inst Funct Biol & Ecol,Dept Ecol, Warsaw, Poland.	robert.myslajek@biol.uw.edu.pl	Mysłajek, Robert W./AAD-9569-2022; Tołkacz, Katarzyna/AAJ-5452-2021; Myslajek, Robert/K-8248-2015	Tołkacz, Katarzyna/0000-0002-8578-3870; Myslajek, Robert/0000-0001-9619-2868; Jedrzejewska, Bogumila/0000-0002-9652-0953; Gewartowska, Olga/0000-0003-2623-0309				Bashta AT, 2011, FOLIA ZOOL, V60, P1; Berthinussen A, 2014, BAT CONSERVATION GLO; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Buckley DJ, 2013, MAMM BIOL, V78, P198, DOI 10.1016/j.mambio.2012.06.007; Calenge C., 2011, HOME RANGE ESTIMATIO; Dietz C, 2009, HDB BATS EUROPE NW A; Fenton MB, 2002, CAN J ZOOL, V80, P1004, DOI 10.1139/Z02-083; Gaston KJ, 2007, PROG PHYS GEOG, V31, P213, DOI 10.1177/0309133307076488; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Grodzinska K, 1997, ENVIRON POLLUT, V98, P369, DOI 10.1016/S0269-7491(97)00145-0; Hillen J, 2009, BIOL CONSERV, V142, P817, DOI 10.1016/j.biocon.2008.12.017; Hubner G., 2004, NYCTALUS NF, V9, P396; Hutterer Rainer, 2005, P1; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Jones KE, 1996, J ZOOL, V240, P788, DOI 10.1111/j.1469-7998.1996.tb05325.x; Jung K, 2011, DIVERS DISTRIB, V17, P262, DOI 10.1111/j.1472-4642.2010.00738.x; Kanuch P, 2008, MAMM BIOL, V73, P147, DOI 10.1016/j.mambio.2006.12.001; Kapfer G, 2008, MAMM BIOL, V73, P267, DOI 10.1016/j.mambio.2007.01.001; Kerth G, 2001, BEHAV ECOL SOCIOBIOL, V50, P283, DOI 10.1007/s002650100352; Kurek K, 2017, APPL ECOL ENV RES, V15, P241, DOI 10.15666/aeer/1504_241248; Kurek Korneliusz, 2008, Vespertilio, V12, P33; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Mackie LJ, 2007, BIOL CONSERV, V140, P70, DOI 10.1016/j.biocon.2007.07.031; Main-Knorn M, 2009, FOREST ECOL MANAG, V258, P60, DOI 10.1016/j.foreco.2009.03.034; Margielewski W, 2006, GEOMORPHOLOGY, V77, P47, DOI 10.1016/j.geomorph.2006.01.003; Mech L.D., 1983, HDB ANIMAL RADIO TRA; Myslajek R.W., 2016, Wildlife Biology in Practice, V12, P36; Myslajek Robert W., 2007, Fragmenta Faunistica (Warsaw), V50, P77; Nicholls B, 2006, BEHAV ECOL SOCIOBIOL, V61, P131, DOI 10.1007/s00265-006-0244-7; Piksa K, 2008, ACTA CHIROPTEROL, V10, P69, DOI 10.3161/150811008X331108; Piksa K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068066; Poland Statistics, 2018, DEMOGRAPHIC YB POLAN; R Core Team, 2020, R LANG ENV STAT COMP; Rindle U, 1997, NYCTALUS, V6, P304; Robinson MF, 1997, J ZOOL, V243, P117, DOI 10.1111/j.1469-7998.1997.tb05759.x; Roen A, 2013, POL J ECOL, V61, P145; Roswag A, 2019, POPUL ECOL, V61, P14, DOI 10.1002/1438-390X.1003; Russo D, 2015, MAMM BIOL, V80, P205, DOI 10.1016/j.mambio.2014.10.003; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Taake Karl-Hans, 1992, Myotis, V30, P7; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Voigt C.C., 2016, BATS ANTHROPOCENE CO; Voigt CC, 2020, LANDSCAPE ECOL, V35, P189, DOI 10.1007/s10980-019-00942-4; Wermundsen T, 2008, ACTA THERIOL, V53, P229, DOI 10.1007/BF03193119; Zahn A, 1997, J ZOOL, V243, P659, DOI 10.1111/j.1469-7998.1997.tb01968.x	46	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0237243	10.1371/journal.pone.0237243	http://dx.doi.org/10.1371/journal.pone.0237243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035231	Green Accepted, gold, Green Published			2022-12-26	WOS:000581817500047
J	Long, S; Berkemeier, B				Long, Samuel; Berkemeier, Brian			Development and optimization of a simian immunodeficiency virus (SIV) droplet digital PCR (ddPCR) assay	PLOS ONE			English	Article							VIRAL RESERVOIR; MACAQUE MODEL	Accurate and sensitive quantification of rebound competent HIV that persists despite combination antiretroviral treatment (cART), including in latently infected cells (i.e., viral reservoir), is critical for evaluating cure strategies for decreasing or eliminating this reservoir. Simian immunodeficiency virus (SIV)-infected Rhesus macaques are an important non-human primate (NHP) system for studying potential cure strategies as they model many key aspects of human HIV-infection including the persistence of a latent viral reservoir in resting memory CD4+ T cells in animals receiving prolonged cART. In this report, we describe the design and testing of a sensitive SIV droplet digital PCR (ddPCR) assay through exploring the combination and optimization of different probe systems (including single, double quencher probes and minor groove binder (MGB) probes) and reaction conditions to eliminate background signal(s), ensure distinct target signal cluster separation from non-target signals, and enable detection and quantification of low level authentic target signals. Similar reaction conditions and assay validation procedures can be explored for potential development of additional assays for other applications that require sensitive detection of low-level targets in a large background of nucleic acid input derived from cell or tissue sources.	[Long, Samuel; Berkemeier, Brian] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Long, S (corresponding author), Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD 21701 USA.	Samuel.Long@nih.gov	Long, Samuel/AAR-8118-2021	Long, Samuel/0000-0001-7559-3232	National Cancer Institute, National Institutes of Health [HHSN261200800001E]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SL and BB were funded with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CANCER DISCOV, V1, pOF1; Berger AW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174308; Biernacka K, 2016, RES VET SCI, V109, P74, DOI 10.1016/j.rvsc.2016.09.014; Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583; Brait M, 2017, BRIT J CANCER, V116, P515, DOI 10.1038/bjc.2016.450; Calascibetta F, 2016, J VIROL, V90, P7541, DOI 10.1128/JVI.00598-16; Cline AN, 2005, J MED PRIMATOL, V34, P303; Comte A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173495; de Bruin EC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175779; Dickinson KK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215139; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hellwig S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197333; Henderson LJ, 2020, J VIROL, V94, DOI 10.1128/JVI.00375-19; Hirsch VM, 1996, J VIROL, V70, P3741, DOI 10.1128/JVI.70.6.3741-3752.1996; Hsin-Ta Li, 2016, 2016 International Conference on Biomedical Engineering (BME-HUST). Proceedings, P113, DOI 10.1109/BME-HUST.2016.7782096; Kosir AB, 2019, FOOD CHEM, V294, P73, DOI 10.1016/j.foodchem.2019.05.029; Krakoff E, 2019, J VIROL, V93, DOI 10.1128/JVI.00538-19; Leibovitch EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092328; LIN PKT, 1992, NUCLEIC ACIDS RES, V20, P5149; Long S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233085; Long S, 2020, J VIROL, V94, DOI 10.1128/JVI.01308-19; McManus M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154391; Mehle N, 2018, ANAL BIOANAL CHEM, V410, P3815, DOI 10.1007/s00216-018-1053-3; Monico J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186185; Moreno-Fernandez ME, 2012, J VIROL, V86, P10262, DOI 10.1128/JVI.00993-12; Rosa SF, 2016, FOOD CHEM, V201, P110, DOI 10.1016/j.foodchem.2016.01.007; Shen AD, 2003, J VIROL, V77, P4938, DOI 10.1128/JVI.77.8.4938-4949.2003; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; Weaver S, 2010, METHODS, V50, P271, DOI 10.1016/j.ymeth.2010.01.003; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594	31	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240447	10.1371/journal.pone.0240447	http://dx.doi.org/10.1371/journal.pone.0240447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3WA	33035247	Green Published, gold			2022-12-26	WOS:000581817500016
J	Rosenwohl-Mack, A; Tamar-Mattis, S; Baratz, AB; Dalke, KB; Ittelson, A; Zieselman, K; Flatt, JD				Rosenwohl-Mack, Amy; Tamar-Mattis, Suegee; Baratz, Arlene B.; Dalke, Katharine B.; Ittelson, Alesdair; Zieselman, Kimberly; Flatt, Jason D.			A national study on the physical and mental health of intersex adults in the US	PLOS ONE			English	Article							QUALITY-OF-LIFE; DISORDERS; DEPRESSION	Objectives To describe the health of intersex adults (people with differences of sex development) in the U.S. using community-based research methods. Methods In July-September 2018, we conducted a national health study of intersex adults aged 18 and older in the U.S., using a survey hosted on Qualtrics. The study describes the physical and mental health experiences of intersex adults, including differences by age (18 to 39 vs. 40 and older). Questions were derived from national (Behavioral Risk Factor Surveillance System) and intersex-related health studies. Results A non-probability sample of 198 intersex adults completed the survey over three months. Over 43% of participants rated their physical health as fair/poor and 53% reported fair/poor mental health. Prevalent health diagnoses included depression, anxiety, arthritis, and hypertension, with significant differences by age. Nearly a third reported difficulty with everyday tasks and over half reported serious difficulties with cognitive tasks. Conclusions To our knowledge, this is the first national study of intersex adults in the U.S. Greater understanding of intersex health over the life course is essential. Findings highlight the need for longitudinal studies and further examination of potential health disparities experienced by intersex populations.	[Rosenwohl-Mack, Amy; Tamar-Mattis, Suegee; Flatt, Jason D.] Univ Calif San Francisco, Sch Nursing, Inst Hlth & Aging, San Francisco, CA 94143 USA; [Tamar-Mattis, Suegee; Baratz, Arlene B.; Ittelson, Alesdair; Zieselman, Kimberly] InterACT Advocates Intersex Youth, Sudbury, MA USA; [Baratz, Arlene B.] Androgen Insensit Syndrome Differences Sex Dev Su, Duncan, OK USA; [Dalke, Katharine B.] Penn State Coll Med, Penn State Milton S Hershey Med Ctr, Dept Psychiat, Hershey, PA USA; [Flatt, Jason D.] Univ Nevada, Sch Publ Hlth, Social & Behav Program, Las Vegas, NV 89154 USA	University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Rosenwohl-Mack, A (corresponding author), Univ Calif San Francisco, Sch Nursing, Inst Hlth & Aging, San Francisco, CA 94143 USA.	amy.rosenwohl-mack@ucsf.edu		Flatt, Jason/0000-0003-1244-738X; Rosenwohl-Mack, Amy/0000-0002-1961-4622	University of California, San Francisco School of Nursing [IMR-201803]	University of California, San Francisco School of Nursing	This research was supported by a grant from the University of California, San Francisco School of Nursing (JF). Grant number: IMR-201803. https://nursing.ucsf.edu/research/officeresearch The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral RC, 2015, CLIN ENDOCRINOL, V82, P159, DOI 10.1111/cen.12561; Amnesty International, 2017, 1 DO NOT HARM ENS RI; [Anonymous], 2017, HUMAN RIGHTS WATCH; [Anonymous], 2016, SELF REP HLTH STAT; Badgett M. V. L., 2009, BEST PRACTICES ASKIN; Baratz AB, 2014, ENDOCR DEV, V27, P99, DOI 10.1159/000363634; Beale JM, 2016, MATURITAS, V94, P143, DOI 10.1016/j.maturitas.2016.10.003; Bennecke E, 2017, CLIN ENDOCRINOL, V86, P634, DOI 10.1111/cen.13296; Bureau USC, 2018, AM COMM SURV 1 YEAR; Centers for Disease Control and Prevention, 2018, LLCP 2017 COD REP BE; Commonwealth of Australia, 2013, INV COER STER INT PE; Control CfD Prevention, 2010, CTR DIS CONTROL PREV; de Vries ALC, 2019, PSYCHOSOM MED, V81, P629, DOI 10.1097/PSY.0000000000000718; Dreger AD, 2009, GLQ-J LESBIAN GAY ST, V15, P199, DOI 10.1215/10642684-2008-134; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Falhammar H, 2018, ENDOCR CONNECT, V7, P466, DOI 10.1530/EC-18-0031; German Ethics Council, 2012, GERM ETH COUNC INT P; Haas A. P., 2014, SUICIDE ATTEMPTS TRA; Jones T, 2018, SAGE OPEN, V8, DOI 10.1177/2158244017745577; Jones T, 2016, SEX EDUC-SEX SOC LEA, V16, P602, DOI 10.1080/14681811.2016.1149808; Kogan BA, 2012, HORM RES PAEDIAT, V78, P40, DOI 10.1159/000339863; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Landers S, 2019, AM J PUBLIC HEALTH, V109, P849, DOI 10.2105/AJPH.2019.305087; Liang WC, 1999, AM J PREV MED, V17, P8, DOI 10.1016/S0749-3797(99)00040-9; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024; National Institutes of Health Sexual and Gender Minority Research Coordinating Committee, 2015, NIH FY 2016 2010 STR; Nock MK, 2006, J ABNORM PSYCHOL, V115, P616, DOI 10.1037/0021-843X.115.3.616; OECD, 2017, HLTH GLANC, DOI 10.1787/health_glance-2017-en; Rapp M, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0881-3; Rohle R, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0198-y; Tamar-Mattis S, 2018, LGBT HEALTH, V5, P320, DOI 10.1089/lgbt.2017.0180; Thompson WW, 2012, AM J PUBLIC HEALTH, V102, P496, DOI 10.2105/AJPH.2011.300500; Thyen U, 2014, J GEN INTERN MED, V29, pS752, DOI 10.1007/s11606-014-2917-7; Twenge JM, 2010, CLIN PSYCHOL REV, V30, P145, DOI 10.1016/j.cpr.2009.10.005; Wallace RB, 1995, J HUM RESOUR, V30, pS84, DOI 10.2307/146279; WHO, 2014, EL FORC COERC OTH IN; Zeeman L, 2019, EUR J PUBLIC HEALTH, V29, P974, DOI 10.1093/eurpub/cky226	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2020	15	10							e0240088	10.1371/journal.pone.0240088	http://dx.doi.org/10.1371/journal.pone.0240088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3WA	33035248	Green Published, gold			2022-12-26	WOS:000581817500026
J	Parkinson, E; Lawson, J; Tiegs, SD				Parkinson, Elizabeth; Lawson, Justine; Tiegs, Scott D.			Artificial light at night at the terrestrial-aquatic interface: Effects on predators and fluxes of insect prey	PLOS ONE			English	Article							ORB-WEB SPIDERS; STABLE-ISOTOPE; POLLUTION; STREAM; ATTRACTIVENESS; BIODIVERSITY; ABUNDANCE; DYNAMICS; VISION; FISH	The outcomes of species interactions-such as those between predators and prey-increasingly depend on environmental conditions that are modified by human activities. Light is among the most fundamental environmental parameters, and humans have dramatically altered natural light regimes across much of the globe through the addition of artificial light at night (ALAN). The consequences for species interactions, communities and ecosystems are just beginning to be understood. Here we present findings from a replicated field experiment that simulated over-the-water lighting in the littoral zone of a small lake. We evaluated responses by emergent aquatic insects and terrestrial invertebrate communities, and riparian predators (tetragnathid spiders). On average ALAN plots had 51% more spiders than control plots that were not illuminated. Mean individual spider body mass was greater in ALAN plots relative to controls, an effect that was strongly sex-dependent; mean male body mass was 34% greater in ALAN plots while female body mass was 176% greater. The average number of prey items captured in spider webs was 139% greater on ALAN mesocosms, an effect attributed to emergent aquatic insects. Non-metric multidimensional scaling and a multiple response permutation procedure revealed significantly different invertebrate communities captured in pan traps positioned in ALAN plots and controls. Control plots had taxonomic-diversity values (as H') that were 58% greater than ALAN plots, and communities that were 83% more-even. We attribute these differences to the aquatic family Caenidae which was the dominant family across both light treatments, but was 818% more abundant in ALAN plots. Our findings show that when ALAN is located in close proximity to freshwater it can concentrate fluxes of emergent aquatic insects, and that terrestrial predators in the littoral zone can compound this effect and intercept resource flows, preventing them from entering the terrestrial realm.	[Parkinson, Elizabeth; Lawson, Justine; Tiegs, Scott D.] Oakland Univ, Dept Biol Sci, Rochester, MI 48063 USA	Oakland University	Tiegs, SD (corresponding author), Oakland Univ, Dept Biol Sci, Rochester, MI 48063 USA.	tiegs@oakland.edu		Tiegs, Scott/0000-0003-1660-5816				Akamatsu F, 2004, ECOL RES, V19, P655, DOI 10.1111/j.1440-1703.2004.00680.x; [Anonymous], 2004, FOOD WEBS LANDSCAPE; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Becker A, 2013, J APPL ECOL, V50, P43, DOI 10.1111/1365-2664.12024; Bennie J, 2018, J APPL ECOL, V55, P2698, DOI 10.1111/1365-2664.13240; Boswell ME, 2019, CJEM, V21, pe00122; Bouchard Jr R.W., 2004, GUIDE AQUATIC INVERT; Bruning A, 2011, AQUAT SCI, V73, P143, DOI 10.1007/s00027-010-0167-2; Collier KJ, 2002, FRESHWATER BIOL, V47, P1651, DOI 10.1046/j.1365-2427.2002.00903.x; Davies TW, 2014, FRONT ECOL ENVIRON, V12, P347, DOI 10.1890/130281; Davies TW, 2012, BIOL LETTERS, V8, P764, DOI 10.1098/rsbl.2012.0216; Desouhant E, 2019, ENTOMOL EXP APPL, V167, P37, DOI 10.1111/eea.12754; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Eisenbeis Gerhard, 2006, P281; Epanchin PN, 2010, ECOLOGY, V91, P2406, DOI 10.1890/09-1974.1; Falchi F, 2019, J ENVIRON MANAGE, V248, DOI 10.1016/j.jenvman.2019.06.128; Firebaugh A, 2019, BASIC APPL ECOL, V34, P118, DOI 10.1016/j.baae.2018.07.005; Fox J., 2019, R COMPANION APPL REG, V.; Fukui D, 2006, J ANIM ECOL, V75, P1252, DOI 10.1111/j.1365-2656.2006.01146.x; Gillespie RG, 1987, J ARACHNOL, V86, P383; Heiling AM, 1999, BEHAV ECOL SOCIOBIOL, V46, P43, DOI 10.1007/s002650050590; Henschel JR, 2001, OIKOS, V93, P429, DOI 10.1034/j.1600-0706.2001.930308.x; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; Holzhauer SIJ, 2015, SUSTAINABILITY-BASEL, V7, P15593, DOI 10.3390/su71115593; Horvath G, 2008, NATURWISSENSCHAFTEN, V95, P1093, DOI 10.1007/s00114-008-0425-5; Horvath G, 2011, PHYSIOL BEHAV, V104, P1010, DOI 10.1016/j.physbeh.2011.06.022; Horvath G, 2009, FRONT ECOL ENVIRON, V7, P317, DOI 10.1890/080129; Iwata T, 2007, ECOL RES, V22, P619, DOI 10.1007/s11284-006-0060-6; Jackson MC, 2016, ECOL EVOL, V6, P1745, DOI 10.1002/ece3.1893; Janetski DJ, 2009, OECOLOGIA, V159, P583, DOI 10.1007/s00442-008-1249-x; Kato C, 2003, OIKOS, V103, P113, DOI 10.1034/j.1600-0706.2003.12477.x; Knop E, 2017, NATURE, V548, P206, DOI 10.1038/nature23288; Kriska G, 1998, J EXP BIOL, V201, P2273; Larsson M, 2020, INSECT CONSERV DIVER, V13, P296, DOI 10.1111/icad.12379; Manfrin A, 2018, OIKOS, V127, P960, DOI 10.1111/oik.04696; Manfrin A, 2017, FRONT ENV SCI-SWITZ, V5, DOI 10.3389/fenvs.2017.00061; Marczak LB, 2008, OECOLOGIA, V156, P249, DOI 10.1007/s00442-008-0989-y; Marczak LB, 2007, OIKOS, V116, P1651, DOI 10.1111/j.2007.0030-1299.15982.x; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; MCCAFFERTY WP, 1998, AQUATIC ENTOMOLOGY; Meyer LA, 2013, ECOL APPL, V23, P1322, DOI 10.1890/12-2007.1; Minnaar C, 2015, J APPL ECOL, V52, P522, DOI 10.1111/1365-2664.12381; Monson Paul G., 2016, AM BENEDICTINE REV, V67, P309; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Paetzold A, 2005, J N AM BENTHOL SOC, V24, P395, DOI 10.1899/04-049.1; Parkinson E., 2017, THESIS; Perkin EK, 2014, FRESHWATER BIOL, V59, P368, DOI 10.1111/fwb.12270; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Russo D, 2019, ENVIRON POLLUT, V252, P1671, DOI 10.1016/j.envpol.2019.06.105; Sanchez-Bayo F, 2019, BIOL CONSERV, V232, P8, DOI 10.1016/j.biocon.2019.01.020; Sanders D, 2018, J EXP ZOOL PART A, V329, P394, DOI 10.1002/jez.2157; Sanders D, 2018, CURR BIOL, V28, P2474, DOI 10.1016/j.cub.2018.05.078; Stephens JP, 2013, FRESHWATER BIOL, V58, P1631, DOI 10.1111/fwb.12155; Sullivan SMP, 2019, ECOL APPL, V29, DOI 10.1002/eap.1821; van Grunsven RHA, 2014, J INSECT CONSERV, V18, P225, DOI 10.1007/s10841-014-9633-9; Wakefield A, 2018, J APPL ECOL, V55, P714, DOI 10.1111/1365-2664.13004; Wakefield A, 2016, ECOL EVOL, V6, P8028, DOI 10.1002/ece3.2527; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852; Wensink SM, 2016, FRESHW SCI, V35, P764, DOI 10.1086/687279; Willmott NJ, 2019, ETHOLOGY, V125, P289, DOI 10.1111/eth.12852; Willmott NJ, 2018, PEERJ, V6, DOI 10.7717/peerj.5599; **DATA OBJECT**; **DATA OBJECT**	63	10	10	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2020	15	10							e0240138	10.1371/journal.pone.0240138	http://dx.doi.org/10.1371/journal.pone.0240138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3TB	33031444	Green Published, gold			2022-12-26	WOS:000581809800029
J	Armstrong, MJ; Gamez, N; Alliance, S; Majid, T; Taylor, A; Kurasz, AM; Patel, B; Smith, G				Armstrong, Melissa J.; Gamez, Noheli; Alliance, Slande; Majid, Tabassum; Taylor, Angela; Kurasz, Andrea M.; Patel, Bhavana; Smith, Glenn			Research priorities of caregivers and individuals with dementia with Lewy bodies: An interview study	PLOS ONE			English	Article							PARKINSONS-DISEASE; BODY; DIAGNOSIS; MORTALITY; PATIENT; PEOPLE	Background Funding bodies are placing increased emphasis on patient and public involvement in research, but the research priorities of individuals and caregivers living with dementia with Lewy bodies (DLB) are unknown. Method Investigators conducted telephone interviews with individuals living with DLB and caregivers. Participants were recruited from a Lewy Body Dementia Association Research Center of Excellence. Interviews employed a semi-structured questionnaire querying research needs in different categories and then asking participants to select their top priorities. Investigators used a qualitative descriptive approach to analyze transcripts and identify themes. Results Twenty individuals with DLB and 25 caregivers participated. Seventeen from each group participated as part of a patient-caregiver dyad. Twenty-three of the caregivers were spouses, two were daughters. Individuals with DLB and caregivers identified research needs relating to focusing on awareness, determining the cause of DLB, improving diagnosis, and investigating what to expect/disease stages. Participants also highlighted DLB symptoms needing additional research, therapies to prevent, cure, or slow the progression of DLB, and research targeting daily function and quality of life, caregiving, and improving education. Conclusions These findings support the research priorities defined in the National Institutes of Health dementia care summits in addition to ADRD priority-setting summits. Research is needed across all domains of DLB. Funding should be informed by the priorities of all relevant stakeholders and support research investigating causes, natural history, biomarkers, and treatment in addition to research targeting themes regarding living with disease (e.g. independence, quality of life, caregiving, and education).	[Armstrong, Melissa J.; Gamez, Noheli; Alliance, Slande; Patel, Bhavana] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Majid, Tabassum] Univ Maryland Baltimore Cty, Erickson Sch Aging Studies, Baltimore, MD 21228 USA; [Taylor, Angela] Lewy Body Dementia Assoc, Lilburn, GA USA; [Kurasz, Andrea M.; Smith, Glenn] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA	State University System of Florida; University of Florida; University System of Maryland; University of Maryland Baltimore County; State University System of Florida; University of Florida	Armstrong, MJ (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.	melissa.armstrong@neurology.ufl.edu		Armstrong, Melissa/0000-0002-2163-1907; Patel, Bhavana/0000-0001-6419-0139; Alliance, Slande/0000-0003-1290-8422; Mejia Kurasz, Andrea/0000-0002-6523-4081; Bedenfield, Noheli/0000-0003-3371-8433	Agency for Healthcare Research and Quality [AHRQ K08HS24159]; National Institute on Aging [NIA AG047266]; University of Florida Dorothy Mangurian Headquarters for Lewy Body Dementia; Raymond E. Kassar Research Fund for Lewy Body Dementia	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Florida Dorothy Mangurian Headquarters for Lewy Body Dementia; Raymond E. Kassar Research Fund for Lewy Body Dementia	This work was supported in part by the Agency for Healthcare Research and Quality (AHRQ K08HS24159, PI: MJA) and the National Institute on Aging (NIA AG047266, PI: T. Golde). Lewy body dementia research at the University of Florida is supported by the University of Florida Dorothy Mangurian Headquarters for Lewy Body Dementia and the Raymond E. Kassar Research Fund for Lewy Body Dementia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, IEEE T POWER ELECTR, V28, P135, DOI DOI 10.1093/ARCLIN/ACS109; Armstrong MJ, 2020, AM J HOSP PALLIAT ME, V37, P728, DOI 10.1177/1049909119897241; Armstrong MJ, 2020, HEALTH EXPECT, V23, P423, DOI 10.1111/hex.13018; Armstrong MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217039; Armstrong MJ, 2019, J AM GERIATR SOC, V67, P67, DOI 10.1111/jgs.15608; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Bethell J, 2018, J AM GERIATR SOC, V66, P1608, DOI 10.1111/jgs.15453; Bostrom F, 2007, ALZ DIS ASSOC DIS, V21, P150, DOI 10.1097/WAD.0b013e318065c4a9; Chudin E, 2002, GENOME BIOL, V3; Colorafi KJ, 2016, HERD-HEALTH ENV RES, V9, P16, DOI 10.1177/1937586715614171; Corriveau RA, 2017, NEUROLOGY, V89, P2381, DOI 10.1212/WNL.0000000000004717; Crowe Sally, 2015, Res Involv Engagem, V1, P2, DOI 10.1186/s40900-015-0003-x; de Lau LML, 2005, ARCH NEUROL-CHICAGO, V62, P1265, DOI 10.1001/archneur.62.8.1265; Deane KHO, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006434; Espay AJ, 2019, NEUROLOGY, V92, P329, DOI 10.1212/WNL.0000000000006926; Frank L, 2020, AM J GERIAT PSYCHIAT, V28, P421, DOI 10.1016/j.jagp.2019.10.014; Galvin JE, 2010, PARKINSONISM RELAT D, V16, P388, DOI 10.1016/j.parkreldis.2010.03.007; Gitlin LN., 2018, NATL RES SUMMIT CARE; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Kelly S, 2015, AGE AGEING, V44, P985, DOI 10.1093/ageing/afv143; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; Mullins CD, 2012, JAMA-J AM MED ASSOC, V307, P1587, DOI 10.1001/jama.2012.442; Porock D, 2015, J GERONTOL NURS, V41, P9, DOI 10.3928/00989134-20150710-02; Price A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017504; [Public Members of the Advisory Council on Alzheimer's Research Care and Services U.S. Department of Health & Human Services], 2018, PUBL MEMB ADV COUNC; Ricci Monica, 2009, Arch Gerontol Geriatr, V49, pe101, DOI 10.1016/j.archger.2008.10.001; Roger KS, 2008, CLIN INTERV AGING, V3, P573; Sacristan Jose A, 2016, Patient Prefer Adherence, V10, P631, DOI 10.2147/PPA.S104259; Schipper K, 2014, PARKINSONISM RELAT D, V20, P862, DOI 10.1016/j.parkreldis.2014.04.025; Svendsboe E, 2016, INT J GERIATR PSYCH, V31, P1075, DOI 10.1002/gps.4433; Thomas AJ, 2017, INT J GERIATR PSYCH, V32, P1280, DOI 10.1002/gps.4609; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van de Beek M, 2019, J ALZHEIMERS DIS, V70, P387, DOI 10.3233/JAD-190041; Vatter S, 2020, J GERIATR PSYCH NEUR, V33, P3, DOI 10.1177/0891988719853043; Walker Z, 2015, LANCET, V386, P1683, DOI 10.1016/S0140-6736(15)00462-6; Williams MM, 2006, NEUROLOGY, V67, P1935, DOI 10.1212/01.wnl.0000247041.63081.98	36	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0239279	10.1371/journal.pone.0239279	http://dx.doi.org/10.1371/journal.pone.0239279			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OG3SJ	33027276	Green Published, gold			2022-12-26	WOS:000581808000057
J	Noto, FK; Sangodkar, J; Adedeji, BT; Moody, S; McClain, CB; Tong, M; Ostertag, E; Crawford, J; Gao, XH; Hurst, L; O'Connor, CM; Hanson, EN; Izadmehr, S; Tohme, R; Narla, J; LeSueur, K; Bhattacharya, K; Rupani, A; Tayeh, MK; Innis, JW; Galsky, MD; Evers, BM; DiFeo, A; Narla, G; Jamling, TY				Noto, Fallon K.; Sangodkar, Jaya; Adedeji, Bisoye Towobola; Moody, Sam; McClain, Christopher B.; Tong, Ming; Ostertag, Eric; Crawford, Jack; Gao, Xiaohua; Hurst, Lauren; O'Connor, Caitlin M.; Hanson, Erika N.; Izadmehr, Sudeh; Tohme, Rita; Narla, Jyothsna; LeSueur, Kristin; Bhattacharya, Kajari; Rupani, Amit; Tayeh, Marwan K.; Innis, Jeffrey W.; Galsky, Matthew D.; Evers, B. Mark; DiFeo, Analisa; Narla, Goutham; Jamling, Tseten Y.			The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies	PLOS ONE			English	Article							HEALTH-STATUS; XENOGRAFTS; GENERATION; SIRPA	We have created the immunodeficient SRG rat, aSprague-DawleyRag2/Il2rgdouble knockout that lacks mature B cells, T cells, and circulating NK cells. This model has been tested and validated for use in oncology (SRGOncoRat (R)). The SRG rat demonstrates efficient tumor take rates and growth kinetics with different human cancer cell lines and PDXs. Although multiple immunodeficient rodent strains are available, some important human cancer cell lines exhibit poor tumor growth and high variability in those models. The VCaP prostate cancer model is one such cell line that engrafts unreliably and grows irregularly in existing models but displays over 90% engraftment rate in the SRG rat with uniform growth kinetics. Since rats can support much larger tumors than mice, the SRG rat is an attractive host for PDX establishment. Surgically resected NSCLC tissue from nine patients were implanted in SRG rats, seven of which engrafted and grew for an overall success rate of 78%. These developed into a large tumor volume, over 20,000 mm(3)in the first passage, which would provide an ample source of tissue for characterization and/or subsequent passage into NSG mice for drug efficacy studies. Molecular characterization and histological analyses were performed for three PDX lines and showed high concordance between passages 1, 2 and 3 (P1, P2, P3), and the original patient sample. Our data suggest the SRGOncoRatis a valuable tool for establishing PDX banks and thus serves as an alternative to current PDX mouse models hindered by low engraftment rates, slow tumor growth kinetics, and multiple passages to develop adequate tissue banks.	[Noto, Fallon K.; Adedeji, Bisoye Towobola; Moody, Sam; McClain, Christopher B.; Crawford, Jack; Narla, Goutham; Jamling, Tseten Y.] Hera BioLabs Inc, Lexington, KY USA; [Sangodkar, Jaya; Gao, Xiaohua; Hurst, Lauren; O'Connor, Caitlin M.; Hanson, Erika N.; Narla, Goutham] Univ Michigan, Dept Med, Div Med Genet, Ann Arbor, MI 48109 USA; [Tong, Ming; Ostertag, Eric] Poseida Therapeut Inc, San Diego, CA USA; [Izadmehr, Sudeh; Galsky, Matthew D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Div Hematol & Med Oncol, New York, NY 10029 USA; [Tohme, Rita] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Tohme, Rita] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Narla, Jyothsna] Reg Med Ctr, San Jose, CA USA; [LeSueur, Kristin; Bhattacharya, Kajari; Rupani, Amit; Tayeh, Marwan K.; Innis, Jeffrey W.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Innis, Jeffrey W.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Innis, Jeffrey W.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Evers, B. Mark] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [DiFeo, Analisa] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai; Case Western Reserve University; Case Western Reserve University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Kentucky; University of Michigan System; University of Michigan	Noto, FK (corresponding author), Hera BioLabs Inc, Lexington, KY USA.	fnoto@herabiolabs.com	O'Connor, Caitlin M./AAC-5203-2020	O'Connor, Caitlin M./0000-0002-7840-6399; DiFeo, Analisa/0000-0001-8319-6763; McClain, Christopher/0000-0002-8246-4639; Hurst, Lauren/0000-0002-3016-9419	NCI [HHSN261201700017C]; Hera Biolabs, Inc.; Poseida Therapeutics, Inc.; Michigan Medical Genetics Laboratories in the Department of Pediatrics; Biospecimen Procurement & Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer Center [P30CA177558]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hera Biolabs, Inc.; Poseida Therapeutics, Inc.; Michigan Medical Genetics Laboratories in the Department of Pediatrics; Biospecimen Procurement & Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer Center	NCI contract HHSN261201700017C supported PDX establishment and their molecular and histological characterizations, along with their drug response studies. Hera Biolabs, Inc. provided support in the form of salaries for authors (FKN, BTA, SM, CM, JC, TYJ) and Poseida Therapeutics, Inc. provided support in the form of salaries for authors (EO, MT), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section."Support: Sequencing studies were carried out with the support of the Michigan Medical Genetics Laboratories in the Department of Pediatrics and the support of C.S. Mott Children's Hospital.PDX research was supported by the Biospecimen Procurement & Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer Center (P30CA177558).	Ben-David U, 2017, NAT GENET, V49, P1567, DOI 10.1038/ng.3967; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Eskra J., 2015, PROTOCOL EXCHANGE NA; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; He D, 2019, FASEB J, V33, P140, DOI 10.1096/fj.201800102RR; Hickman DL, 2010, J AM ASSOC LAB ANIM, V49, P155; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jung CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31455; Maletzki C, 2020, LAB INVEST, V100, P27, DOI 10.1038/s41374-019-0298-6; Marchetti C, 2018, J MED CHEM, V61, P2500, DOI 10.1021/acs.jmedchem.7b01781; Mashimo T, 2012, CELL REP, V2, P685, DOI 10.1016/j.celrep.2012.08.009; Menoret S, 2018, TRANSPLANTATION, V102, P1271, DOI 10.1097/TP.0000000000002251; Morgan KM, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00002; Noto FK, 2018, MOL CANCER THER, V17, P2481, DOI 10.1158/1535-7163.MCT-18-0156; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Wang X, 2013, BRIT J CANCER, V108, P319, DOI 10.1038/bjc.2012.591; Yamauchi T, 2013, BLOOD, V121, P1316, DOI 10.1182/blood-2012-06-440354; Zhang XC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-168	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2020	15	10							e0240169	10.1371/journal.pone.0240169	http://dx.doi.org/10.1371/journal.pone.0240169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OG3SJ	33027304	Green Published, gold			2022-12-26	WOS:000581808000014
